PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Atomi, T; Noriuchi, M; Oba, K; Atomi, Y; Kikuchi, Y				Atomi, Tomoaki; Noriuchi, Madoka; Oba, Kentaro; Atomi, Yoriko; Kikuchi, Yoshiaki			Self-Recognition of One's Own Fall Recruits the Genuine Bodily Crisis- Related Brain Activity	PLOS ONE			English	Article							PARIETOINSULAR VESTIBULAR CORTEX; PARABRACHIAL NUCLEUS; NEURAL MECHANISMS; BODY SCHEMA; REPRESENTATIONS; RESPONSES; MOTION; STIMULATION; ANXIETY; MICROSTIMULATION	While bipedalism is a fundamental evolutionary adaptation thought to be essential for the development of the human brain, the erect body is always an inch or two away from falling. Although the neural mechanism for automatically detecting one's own body instability is an important consideration, there have thus far been few functional neuroimaging studies because of the restrictions placed on participants' movements. Here, we used functional magnetic resonance imaging to investigate the neural substrate underlying whole body instability, based on the self-recognition paradigm that uses video stimuli consisting of one's own and others' whole bodies depicted in stable and unstable states. Analyses revealed significant activity in the regions which would be activated during genuine unstable bodily states: The right parieto- insular vestibular cortex, inferior frontal junction, posterior insula and parabrachial nucleus. We argue that these right-lateralized cortical and brainstem regions mediate vestibular information processing for detection of vestibular anomalies, defensive motor responding in which the necessary motor responses are automatically prepared/simulated to protect one's own body, and sympathetic activity as a form of alarm response during whole body instability.	[Atomi, Tomoaki; Noriuchi, Madoka; Oba, Kentaro; Kikuchi, Yoshiaki] Tokyo Metropolitan Univ, Dept Frontier Hlth Sci, Div Human Hlth Sci, Grad Sch, Tokyo 158, Japan; [Atomi, Tomoaki] Teikyo Univ Sci, Fac Med Sci, Dept Phys Therapy, Uenohara, Japan; [Oba, Kentaro] Tohoku Univ, Tohoku Med Megabank Org, Dept Community Med Supports, Div Med Neuroimage Anal, Sendai, Miyagi 980, Japan; [Atomi, Yoriko] Tokyo Univ Agr & Technol, Fac & Grad Sch Engn, Dept Mat Hlth Sci, Tokyo, Japan	Tokyo Metropolitan University; Tohoku University; Tokyo University of Agriculture & Technology	Kikuchi, Y (corresponding author), Tokyo Metropolitan Univ, Dept Frontier Hlth Sci, Div Human Hlth Sci, Grad Sch, Tokyo 158, Japan.	ykikuchi@tmu.ac.jp	Atomi, Yoriko/AAF-4783-2019	Atomi, Yoriko/0000-0003-3808-6543; Kikuichi, Yoshiaki/0000-0002-8770-139X; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Science, Sports and Culture [25291109, 2013-2015]; Grants-in-Aid for Scientific Research [26840160, 26560323] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (B) (No. 25291109, 2013-2015 to YK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1992, J COMP NEUROL, V326, P423, DOI 10.1002/cne.903260308; Aspell JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006488; Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Bottini G, 2001, BRAIN, V124, P1182, DOI 10.1093/brain/124.6.1182; Buxbaum LJ, 2003, NEUROPSYCHOLOGIA, V41, P1091, DOI 10.1016/S0028-3932(02)00314-7; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; CHAMBERLIN NL, 1992, J COMP NEUROL, V326, P245, DOI 10.1002/cne.903260207; Chan AWY, 2004, NEUROREPORT, V15, P2407, DOI 10.1097/00001756-200410250-00021; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Costantini M, 2005, CEREB CORTEX, V15, P1761, DOI 10.1093/cercor/bhi053; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT NEUROSCI, V3; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Damasio AR, 1999, SCI AM, V281, P112, DOI 10.1038/scientificamerican1299-112; Daprati E, 2007, EXP BRAIN RES, V177, P31, DOI 10.1007/s00221-006-0646-9; DARWIN C, 1965, EXPRESSION EMOTION M; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Downing PE, 2006, SOC NEUROSCI, V1, P52, DOI 10.1080/17470910600668854; Felician O, 2004, ANN NEUROL, V55, P749, DOI 10.1002/ana.20109; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; Fujii N, 1998, P NATL ACAD SCI USA, V95, P12034, DOI 10.1073/pnas.95.20.12034; Gallagher S, 1995, J MIND BEHAV, V16, P369; GALLAGHER S, 1986, J MIND BEHAV, V7, P541; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; GULDIN WO, 1992, J COMP NEUROL, V326, P375, DOI 10.1002/cne.903260306; HEILMAN KM, 1982, NEUROLOGY, V32, P342, DOI 10.1212/WNL.32.4.342; Hodzic A, 2009, NEUROIMAGE, V45, P1264, DOI 10.1016/j.neuroimage.2009.01.027; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Jokisch D, 2006, PERCEPTION, V35, P911, DOI 10.1068/p5540; Kammers MPM, 2006, NEUROPSYCHOLOGIA, V44, P2430, DOI 10.1016/j.neuropsychologia.2006.04.009; Knoblich G, 2003, CONSCIOUS COGN, V12, P620, DOI 10.1016/S1053-8100(03)00070-9; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lobel E, 1998, J NEUROPHYSIOL, V80, P2699, DOI 10.1152/jn.1998.80.5.2699; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Loula F, 2005, J EXP PSYCHOL HUMAN, V31, P210, DOI 10.1037/0096-1523.31.1.210; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; McCandless CH, 2010, EXP BRAIN RES, V202, P271, DOI 10.1007/s00221-009-2130-9; Myers A, 2008, NEUROIMAGE, V42, P1669, DOI 10.1016/j.neuroimage.2008.05.045; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; Paillard J., 1991, BRAIN SPACE, P163; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pfeiffer C, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00031; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Raposo A, 2011, SOC COGN AFFECT NEUR, V6, P260, DOI 10.1093/scan/nsq033; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Saxe R, 2006, CEREB CORTEX, V16, P178, DOI 10.1093/cercor/bhi095; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2; Zhang ZH, 2000, BRAIN RES, V863, P25, DOI 10.1016/S0006-8993(00)02068-0	73	2	3	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115303	10.1371/journal.pone.0115303	http://dx.doi.org/10.1371/journal.pone.0115303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25525808	Green Published, gold			2022-12-27	WOS:000347186200021
J	Maraula, G; Lana, D; Coppi, E; Gentile, F; Mello, T; Melani, A; Galli, A; Giovannini, MG; Pedata, F; Pugliese, AM				Maraula, Giovanna; Lana, Daniele; Coppi, Elisabetta; Gentile, Francesca; Mello, Tommaso; Melani, Alessia; Galli, Andrea; Giovannini, Maria Grazia; Pedata, Felicita; Pugliese, Anna Maria			The Selective Antagonism of P2X(7) and P2Y(1) Receptors Prevents Synaptic Failure and Affects Cell Proliferation Induced by Oxygen and Glucose Deprivation in Rat Dentate Gyrus	PLOS ONE			English	Article							NEURAL STEM-CELLS; LONG-TERM POTENTIATION; NEURONS IN-VITRO; GLUTAMATE RELEASE; ADULT NEUROGENESIS; BRAIN ISCHEMIA; P2X7 RECEPTORS; EXTRACELLULAR CONCENTRATIONS; HIPPOCAMPAL NEUROGENESIS; PURINERGIC RECEPTORS	Purinergic P2X and P2Y receptors are broadly expressed on both neurons and glial cells in the central nervous system (CNS), including dentate gyrus (DG). The aim of this research was to determine the synaptic and proliferative response of the DG to severe oxygen and glucose deprivation (OGD) in acute rat hippocampal slices and to investigate the contribution of P2X(7) and P2Y(1) receptor antagonism to recovery of synaptic activity after OGD. Extracellular field excitatory post-synaptic potentials (fEPSPs) in granule cells of the DG were recorded from rat hippocampal slices. Nine-min OGD elicited an irreversible loss of fEPSP and was invariably followed by the appearance of anoxic depolarization (AD). Application of MRS2179 (selective antagonist of P2Y(1) receptor) and BBG (selective antagonist of P2X(7) receptor), before and during OGD, prevented AD appearance and allowed a significant recovery of neurotransmission after 9-min OGD. The effects of 9-min OGD on proliferation and maturation of cells localized in the subgranular zone (SGZ) of slices prepared from rats treated with 5-Bromo-2'-deoxyuridine (BrdU) were investigated. Slices were further incubated with an immature neuron marker, doublecortin (DCX). The number of BrdU(+) cells in the SGZ was significantly decreased 6 hours after OGD. This effect was antagonized by BBG, but not by MRS2179. Twenty-four hours after 9-min OGD, the number of BrdU(+) cells returned to control values and a significant increase of DCX immunofluorescence was	[Maraula, Giovanna; Gentile, Francesca; Melani, Alessia; Pedata, Felicita; Pugliese, Anna Maria] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, NEUROFARBA, Div Pharmacol & Toxicol, Florence, Italy; [Lana, Daniele; Coppi, Elisabetta; Giovannini, Maria Grazia] Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Unit, Florence, Italy; [Mello, Tommaso; Galli, Andrea] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy	University of Florence; University of Florence; University of Florence	Pugliese, AM (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, NEUROFARBA, Div Pharmacol & Toxicol, Florence, Italy.	annamaria.pugliese@unifi.it	Coppi, Elisabetta/K-6705-2016; Mello, Tommaso/AAO-7831-2021; Galli, Andrea/AAC-1623-2019; Mello, Tommaso/I-4715-2012	Coppi, Elisabetta/0000-0003-4434-5919; Mello, Tommaso/0000-0002-6192-6902; Mello, Tommaso/0000-0002-6192-6902; Lana, Daniele/0000-0002-5193-0019; Galli, Andrea/0000-0001-5416-6290; PUGLIESE, ANNA MARIA/0000-0001-7554-5740; Pedata, Felicita/0000-0002-6841-3712	Italian Ministry of Health; Fondazione Ente Cassa di Risparmio di Firenze, Italy	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Ente Cassa di Risparmio di Firenze, Italy(Fondazione Cassa Risparmio Firenze)	This investigation was supported by grants from Italian Ministry of Health; Fondazione Ente Cassa di Risparmio di Firenze (FP, AMP), Italy.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; AUER RN, 1989, J NEUROSCI, V9, P1641; Ballerini P, 2005, INT J IMMUNOPATH PH, V18, P255, DOI 10.1177/039463200501800208; Bartley J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-15; Boyer JL, 1998, BRIT J PHARMACOL, V124, P1, DOI 10.1038/sj.bjp.0701837; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burnstock G, 2008, PURINERG SIGNAL, V4, P79, DOI 10.1007/s11302-007-9094-7; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Carmo MRS, 2014, EUR J NEUROSCI, V39, P614, DOI 10.1111/ejn.12435; Chechneva O, 2006, NEUROBIOL DIS, V23, P247, DOI 10.1016/j.nbd.2006.02.015; Cho JH, 2010, NEUROREPORT, V21, P865, DOI 10.1097/WNR.0b013e32833d9142; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Coppi E, 2007, PURINERG SIGNAL, V3, P203, DOI 10.1007/s11302-006-9049-4; Csolle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066547; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; del Puerto A, 2012, J CELL SCI, V125, P176, DOI 10.1242/jcs.091736; Deuchars SA, 2001, J NEUROSCI, V21, P7143, DOI 10.1523/JNEUROSCI.21-18-07143.2001; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Domercq M, 2010, GLIA, V58, P730, DOI 10.1002/glia.20958; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Fellin Tommaso, 2006, Novartis Found Symp, V276, P208; Frenguelli BG, 2007, J NEUROCHEM, V101, P1400, DOI 10.1111/j.1471-4159.2006.04425.x; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Giovannini MG, 2003, J NEUROSCI, V23, P9016; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Klempin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025760; Kuboyama K, 2011, J CEREBR BLOOD F MET, V31, P1930, DOI 10.1038/jcbfm.2011.49; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Liu JL, 1998, J NEUROSCI, V18, P7768; Malarkey EB, 2008, NEUROCHEM INT, V52, P142, DOI 10.1016/j.neuint.2007.06.005; Maraula G, 2013, NEUROPHARMACOLOGY, V67, P511, DOI 10.1016/j.neuropharm.2012.12.002; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2012, EXP NEUROL, V233, P193, DOI 10.1016/j.expneurol.2011.09.036; Miras-Portugal MT, 2003, NEUROCHEM RES, V28, P1597, DOI 10.1023/A:1025690913206; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Moore D, 2000, J COMP NEUROL, V421, P374, DOI 10.1002/(SICI)1096-9861(20000605)421:3<374::AID-CNE6>3.0.CO;2-Z; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Okano H, 2008, PHILOS T R SOC B, V363, P2111, DOI 10.1098/rstb.2008.2264; Pedata F, 2007, PURINERG SIGNAL, V3, P299, DOI 10.1007/s11302-007-9085-8; Pugliese AM, 2009, BRIT J PHARMACOL, V157, P818, DOI 10.1111/j.1476-5381.2009.00218.x; Pugliese AM, 2003, BRIT J PHARMACOL, V140, P305, DOI 10.1038/sj.bjp.0705442; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SICK TJ, 1987, BRAIN RES, V418, P227, DOI 10.1016/0006-8993(87)90090-4; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sperlagh B, 2007, NEUROSCIENCE, V149, P99, DOI 10.1016/j.neuroscience.2007.07.035; Sperlagh B, 2002, J NEUROCHEM, V81, P1196, DOI 10.1046/j.1471-4159.2002.00920.x; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Sun Jing-Jun, 2008, Neurosci Bull, V24, P231, DOI 10.1007/s12264-008-0430-x; Sun SH, 1999, J NEUROCHEM, V73, P334, DOI 10.1046/j.1471-4159.1999.0730334.x; Suyama S, 2012, J NEUROSCI, V32, P9238, DOI 10.1523/JNEUROSCI.4001-11.2012; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tonazzini I, 2007, EUR J NEUROSCI, V26, P890, DOI 10.1111/j.1460-9568.2007.05697.x; Traini C, 2011, EUR J NEUROSCI, V33, P2203, DOI 10.1111/j.1460-9568.2011.07667.x; Tsao HK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.274; Wang S, 2005, EXP BRAIN RES, V165, P250, DOI 10.1007/s00221-005-2296-8; Yamamoto S, 1997, J NEUROPHYSIOL, V78, P903, DOI 10.1152/jn.1997.78.2.903; Zeng JW, 2008, J NEUROCHEM, V106, P2106, DOI 10.1111/j.1471-4159.2008.05560.x; Zheng W, 2013, J CEREBR BLOOD F MET, V33, P600, DOI 10.1038/jcbfm.2012.214	75	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115273	10.1371/journal.pone.0115273	http://dx.doi.org/10.1371/journal.pone.0115273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526634	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200020
J	Rafiq, S; Khan, S; Tapper, W; Collins, A; Upstill-Goddard, R; Gerty, S; Blomqvist, C; Aittomaki, K; Couch, FJ; Liu, JJ; Nevanlinna, H; Eccles, D				Rafiq, Sajjad; Khan, Sofia; Tapper, William; Collins, Andrew; Upstill-Goddard, Rosanna; Gerty, Susan; Blomqvist, Carl; Aittomaki, Kristiina; Couch, Fergus J.; Liu, Jianjun; Nevanlinna, Heli; Eccles, Diana			A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis	PLOS ONE			English	Editorial Material							ESTROGEN-RECEPTOR; TRANSCRIPTION FACTOR; CONFER SUSCEPTIBILITY; EARLY-ONSET; VARIANTS; SURVIVAL; ETS-1	Objective: Genome wide association studies (GWAs) of breast cancer mortality have identified few potential associations. The concordance between these studies is unclear. In this study, we used a meta-analysis of two prognostic GWAs and a replication cohort to identify the strongest associations and to evaluate the loci suggested in previous studies. We attempt to identify those SNPs which could impact overall survival irrespective of the age of onset. Methods: To facilitate the meta-analysis and to refine the association signals, SNPs were imputed using data from the 1000 genomes project. Cox-proportional hazard models were used to estimate hazard ratios (HR) in 536 patients from the POSH cohort (Prospective study of Outcomes in Sporadic versus Hereditary breast cancer) and 805 patients from the HEBCS cohort (Helsinki Breast Cancer Study). These hazard ratios were combined using a Mantel-Haenszel fixed effects meta-analysis and a p-value threshold of 5 x 10(-8) was used to determine significance. Replication was performed in 1523 additional patients from the POSH study. Results: Although no SNPs achieved genome wide significance, three SNPs have significant association in the replication cohort and combined p-values less than 5.6 x 10(-6). These SNPs are; rs421379 which is 556 kb upstream of ARRDC3 (HR = 1.49, 95% confidence interval (CI) = 1.27-1.75, P = 1.1x10(-6)), rs12358475 which is between ECHDC3 and PROSER2 (HR = 0.75, CI = 0.67-0.85, P = 1.8x10(-6)), and rs1728400 which is between LINC00917 and FOXF1. Conclusions: In a genome wide meta-analysis of two independent cohorts from UK and Finland, we identified potential associations at three distinct loci. Phenotypic heterogeneity and relatively small sample sizes may explain the lack of genome wide significant findings. However, the replication at three SNPs in the validation cohort shows promise for future studies in larger cohorts. We did not find strong evidence for concordance between the few associations highlighted by previous GWAs of breast cancer survival and this study.	[Rafiq, Sajjad; Tapper, William; Collins, Andrew; Upstill-Goddard, Rosanna] Univ Southampton, Fac Med, Genet Epidemiol & Bioinformat Res Grp, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Gerty, Susan] Univ Southampton, Fac Med, Clin Trials Unit, Southampton SO9 5NH, Hants, England; [Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Khan, Sofia; Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynaecol, Helsinki, Finland; [Khan, Sofia; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Blomqvist, Carl] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Liu, Jianjun] Genome Inst Singapore, Singapore, Singapore; [Eccles, Diana] Univ Southampton, Canc Sci Div, Sch Med, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton; Mayo Clinic; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Southampton	Eccles, D (corresponding author), Univ Southampton, Canc Sci Div, Sch Med, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England.	d.m.eccles@soton.ac.uk	Collins, Andrew/S-2196-2019; Liu, Jianjun/AAK-4989-2020; Eccles, Diana/K-6327-2019; Collins, Andrew/A-6595-2010	Collins, Andrew/0000-0001-7108-0771; Liu, Jianjun/0000-0002-3255-3019; Eccles, Diana/0000-0002-9935-3169; Collins, Andrew/0000-0001-7108-0771; Khan, Sofia/0000-0003-4185-8882; Tapper, William/0000-0002-5896-1889; Upstill-Goddard, Rosie/0000-0002-2666-0934; Rafiq, Sajjad/0000-0003-4873-4540; Blomqvist, Carl/0000-0003-3041-1938	NATIONAL CANCER INSTITUTE [R01CA128978] Funding Source: NIH RePORTER; Cancer Research UK [A11699, A7572, C22524] Funding Source: Medline; NCI NIH HHS [CA128978, R01 CA128978] Funding Source: Medline; Breast Cancer Now [2010NOVPR62] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Now		Azzato EM, 2010, J NATL CANCER I, V102, P650, DOI 10.1093/jnci/djq057; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Buggy Y, 2004, BRIT J CANCER, V91, P1308, DOI 10.1038/sj.bjc.6602128; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen W, 2012, BREAST CANCER RES TR, V136, P847, DOI 10.1007/s10549-012-2309-9; Downey L, 2010, CLIN CANCER RES, V16, P1281, DOI 10.1158/1078-0432.CCR-09-1643; Eccles D, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-160; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Fasching PA, 2012, HUM MOL GENET, V21, P3926, DOI 10.1093/hmg/dds159; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haiman CA, 2011, NAT GENET, V43, P1210, DOI 10.1038/ng.985; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hartman M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1737; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Levine DM, 2013, NAT GENET, V45, P1487, DOI 10.1038/ng.2796; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Lincoln DW, 2005, FRONT BIOSCI-LANDMRK, V10, P506, DOI 10.2741/1546; Lindstrom LS, 2007, LANCET ONCOL, V8, P1001, DOI 10.1016/S1470-2045(07)70282-6; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rafiq S, 2013, CANC RES; Rafiq S, 2013, CANCER RES, V73, P1883, DOI 10.1158/0008-5472.CAN-12-3377; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Silbiger VN, 2013, CLIN CHIM ACTA, V421, P184, DOI 10.1016/j.cca.2013.03.011; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Verschoor ML, 2010, CAN J PHYSIOL PHARM, V88, P204, DOI 10.1139/Y09-135; Wilson JRF, 2010, J MED GENET, V47, P771, DOI 10.1136/jmg.2010.078113	37	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e101488	10.1371/journal.pone.0101488	http://dx.doi.org/10.1371/journal.pone.0101488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526632	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200063
J	Chiu, CY; Tsai, MH; Yao, TC; Tu, YL; Hua, MC; Yeh, KW; Huang, JL				Chiu, Chih-Yung; Tsai, Ming-Han; Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long			Urinary LTE4 Levels as a Diagnostic Marker for IgE-Mediated Asthma in Preschool Children: A Birth Cohort Study	PLOS ONE			English	Article							TOTAL SERUM IGE; CYSTEINYL LEUKOTRIENES; ANTILEUKOTRIENES; INFLAMMATION; MONTELUKAST; ASSOCIATION; EXCRETION; MODIFIERS; ALLERGIES; SKIN	Objectives: Leukotrienes play a central pathophysiological role in allergic asthma. The aim of this study was to investigate the utility of measuring urinary leukotriene E-4 (LTE4) levels in the diagnosis of atopic diseases in early childhood. Methods: Children aged 0 through 4 years from a birth cohort in the Prediction of Allergies in Taiwanese Children (PATCH) study were enrolled. Urinary LTE4 levels were measured and its association between total serum IgE levels, allergen-specific IgE sensitization and atopic diseases were assessed. Results: A total of 182 children were regular followed up at clinics for a four-year follow-up period. Urinary LTE4 levels appeared to be elevated in children with total serum IgE levels exceeding 100 kU/L, allergen-specific IgE sensitization after 2 years of age. Elevation of urinary LTE4 levels (>= 500 pg/mg of creatinine) significantly discriminated high serum total IgE levels (>= 100 kU/L) at age 2 (P=0.027). A higher level of total serum IgE or urinary LTE4 was significantly associated with the risk of developing allergic rhinitis and asthma at age 3. A significantly higher urinary LTE4 level was found in children with a combination of IgE sensitization and asthma at age 4. Conclusions: Urinary LTE4 levels appear to be highly associated with IgE sensitization and its related allergic airway diseases after age 2. The measurement of urinary LTE4 (>= 500 pg/mg of creatinine) could not only be a non-invasive method for atopic predisposition but also potentially provide a strategy for the diagnosis and management of asthma in preschool children.	[Chiu, Chih-Yung; Tsai, Ming-Han; Hua, Man-Chin] Chang Gung Mem Hosp Keelung, Dept Pediat, Taoyuan, Taiwan; [Chiu, Chih-Yung; Tsai, Ming-Han; Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Taoyuan, Taiwan; [Chiu, Chih-Yung; Tsai, Ming-Han; Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chiu, Chih-Yung] Chang Gung Mem Hosp, Div Pediat Pulmonol, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Tu, Yu-Ling; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp Linkou, Div Allergy Asthma & Rheumatol, Dept Pediat, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yeh, KW (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.	kwyeh@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Chiu, CY/Q-4238-2019; Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG2B0050-52]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG2B0050-52 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, CLIN EXP ALLERGY, V40, P85, DOI 10.1111/j.1365-2222.2009.03386.x; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; Borish L, 2005, ANN ALLERG ASTHMA IM, V95, P247, DOI 10.1016/S1081-1206(10)61221-5; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Busse W, 2005, CHEST, V127, P1312, DOI 10.1378/chest.127.4.1312; Busse W, 2001, J ALLERGY CLIN IMMUN, V107, P461, DOI 10.1067/mai.2001.114657; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; GERGEN PJ, 1992, ANN ALLERGY, V68, P507; Green SA, 2004, THORAX, V59, P100, DOI 10.1136/thorax.2003.006825; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Halvorsen R, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/460737; KUMLIN M, 1992, AM REV RESPIR DIS, V146, P96, DOI 10.1164/ajrccm/146.1.96; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Martinez FD, 2002, PEDIATRICS, V109, P362; Montuschi P, 2010, CLIN EXP ALLERGY, V40, P1732, DOI 10.1111/j.1365-2222.2010.03630.x; Montuschi P, 2008, MINI-REV MED CHEM, V8, P647, DOI 10.2174/138955708784567395; Montuschi P, 2007, DRUG DISCOV TODAY, V12, P404, DOI 10.1016/j.drudis.2007.03.004; Montuschi P, 2006, J ALLERGY CLIN IMMUN, V118, P347, DOI 10.1016/j.jaci.2006.04.010; Montuschi P, 2014, J CHROMATOGR B, V964, P12, DOI 10.1016/j.jchromb.2014.02.059; Peters-Golden M, 2006, CLIN EXP ALLERGY, V36, P689, DOI 10.1111/j.1365-2222.2006.02498.x; Price DB, 2003, THORAX, V58, P211, DOI 10.1136/thorax.58.3.211; Rosenthal LA, 2010, J ALLERGY CLIN IMMUN, V125, P1212, DOI 10.1016/j.jaci.2010.04.002; Satwani Hema, 2009, JPMA Journal of the Pakistan Medical Association, V59, P698; Severien C, 2000, EUR RESPIR J, V16, P588, DOI 10.1034/j.1399-3003.2000.16d03.x; SEYMOUR JL, 1987, J AM ACAD DERMATOL, V17, P988, DOI 10.1016/S0190-9622(87)70288-6; SMITH CM, 1992, EUR RESPIR J, V5, P693; Sunyer J, 1996, EUR RESPIR J, V9, P1880, DOI 10.1183/09031936.96.09091880; Togias Alkis G., 2000, Journal of Allergy and Clinical Immunology, V106, pS247; WENZEL SE, 1995, AM J RESP CRIT CARE, V152, P897, DOI 10.1164/ajrccm.152.3.7663802; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; Wong GWK, 2013, ALLERGY ASTHMA IMMUN, V5, P251, DOI 10.4168/aair.2013.5.5.251; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115216	10.1371/journal.pone.0115216	http://dx.doi.org/10.1371/journal.pone.0115216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521113	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600026
J	Knorr, RL; Nakatogawa, H; Ohsumi, Y; Lipowsky, R; Baumgart, T; Dimova, R				Knorr, Roland L.; Nakatogawa, Hitoshi; Ohsumi, Yoshinori; Lipowsky, Reinhard; Baumgart, Tobias; Dimova, Rumiana			Membrane Morphology Is Actively Transformed by Covalent Binding of the Protein Atg8 to PE-Lipids	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; AMPHIPATHIC HELICES; EARLY STEPS; VESICLES; MECHANISM; DOMAIN	Autophagy is a cellular degradation pathway involving the shape transformation of lipid bilayers. During the onset of autophagy, the water-soluble protein Atg8 binds covalently to phosphatdylethanolamines (PEs) in the membrane in an ubiquitin-like reaction coupled to ATP hydrolysis. We reconstituted the Atg8 conjugation system in giant and nm-sized vesicles with a minimal set of enzymes and observed that formation of Atg8-PE on giant vesicles can cause substantial tubulation of membranes even in the absence of Atg12-Atg5-Atg16. Our findings show that ubiquitin-like processes can actively change properties of lipid membranes and that membrane crowding by proteins can be dynamically regulated in cells. Furthermore we provide evidence for curvature sorting of Atg8-PE. Curvature generation and sorting are directly linked to organelle shapes and, thus, to biological function. Our results suggest that a positive feedback exists between the ubiquitin-like reaction and the membrane curvature, which is important for dynamic shape changes of cell membranes, such as those involved in the formation of autophagosomes.	[Knorr, Roland L.; Lipowsky, Reinhard; Dimova, Rumiana] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany; [Nakatogawa, Hitoshi; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan; [Baumgart, Tobias] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Max Planck Society; Tokyo Institute of Technology; University of Pennsylvania	Knorr, RL (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Potsdam, Germany.	knorr@mpikg.mpg.de; dimova@mpikg.mpg.de	Dimova, Rumiana/C-4330-2008; Nakatogawa, Hitoshi/D-5155-2015; Ohsumi, Yoshinori/C-6449-2009	Dimova, Rumiana/0000-0002-3872-8502; Nakatogawa, Hitoshi/0000-0002-5828-0741; Ohsumi, Yoshinori/0000-0003-2384-2166; Lipowsky, Reinhard/0000-0001-8417-8567	German Science Foundation [1524]; NIH [GM 097552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097552] Funding Source: NIH RePORTER	German Science Foundation(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the German Science Foundation within the framework of IGRTG 1524 and by NIH grant GM 097552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Dimova R, 2007, SOFT MATTER, V3, P817, DOI 10.1039/b703580b; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Jensen MB, 2011, J BIOL CHEM, V286, P42603, DOI 10.1074/jbc.M111.271130; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Knorr RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032753; Knorr RL, 2010, SOFT MATTER, V6, P1990, DOI 10.1039/b925929e; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; LAI MZ, 1985, BIOCHEMISTRY-US, V24, P1654, DOI 10.1021/bi00328a013; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipowsky R, 1996, PHYS REV LETT, V77, P1652, DOI 10.1103/PhysRevLett.77.1652; Lipowsky R, 2013, FARADAY DISCUSS, V161, P305, DOI 10.1039/c2fd20105d; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Mizushima N, 2009, CURR TOP MICROBIOL, V335, P71, DOI 10.1007/978-3-642-00302-8_3; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Nakatogawa H, 2012, METHODS MOL BIOL, V832, P519, DOI 10.1007/978-1-61779-474-2_37; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Nikolaus J, 2010, BIOPHYS J, V98, P1192, DOI 10.1016/j.bpj.2009.11.042; Rauch J, 2003, J BIOL CHEM, V278, P47508, DOI 10.1074/jbc.M308089200; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; S Nath JD, 2013, BIOPHYSICAL J, V104; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Stachowiak JC, 2012, NAT CELL BIOL, V14, P944, DOI 10.1038/ncb2561; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; WAUGH R, 1979, BIOPHYS J, V26, P115, DOI 10.1016/S0006-3495(79)85239-X; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xie ZP, 2009, AUTOPHAGY, V5, P217, DOI 10.4161/auto.5.2.7201; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814	37	45	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115357	10.1371/journal.pone.0115357	http://dx.doi.org/10.1371/journal.pone.0115357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522362	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600037
J	Anchan, RM; Lachke, SA; Gerami-Naini, B; Lindsey, J; Ng, N; Naber, C; Nickerson, M; Cavallesco, R; Rowan, S; Eaton, JL; Xi, QC; Maas, RL				Anchan, Raymond M.; Lachke, Salil A.; Gerami-Naini, Behzad; Lindsey, Jennifer; Ng, Nicholas; Naber, Catherine; Nickerson, Michael; Cavallesco, Resy; Rowan, Sheldon; Eaton, Jennifer L.; Xi, Qiongchao; Maas, Richard L.			Pax6- and Six3-Mediated Induction of Lens Cell Fate in Mouse and Human ES Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LENTOID BODIES; ECTOPIC EYES; GENE; EXPRESSION; MUTATIONS; ANIRIDIA; DIFFERENTIATION; MORPHOGENESIS; REQUIREMENT	Embryonic stem (ES) cells provide a potentially useful in vitro model for the study of in vivo tissue differentiation. We used mouse and human ES cells to investigate whether the lens regulatory genes Pax6 and Six3 could induce lens cell fate in vitro. To help assess the onset of lens differentiation, we derived a new mES cell line (Pax6-GFP mES) that expresses a GFP reporter under the control of the Pax6 P0 promoter and lens ectoderm enhancer. Pax6 or Six3 expression vectors were introduced into mES or hES cells by transfection or lentiviral infection and the differentiating ES cells analyzed for lens marker expression. Transfection of mES cells with Pax6 or Six3 but not with other genes induced the expression of lens cell markers and up-regulated GFP reporter expression in Pax6-GFP mES cells by 3 days post-transfection. By 7 days post-transfection, mES cell cultures exhibited a. 10-fold increase over controls in the number of colonies expressing gamma A-crystallin, a lens fiber cell differentiation marker. RT-PCR and immunostaining revealed induction of additional lens epithelial or fiber cell differentiation markers including Foxe3, Prox1, alpha- and beta-crystallins, and Tdrd7. Moreover, gamma A-crystallin-or Prox1-expressing lentoid bodies formed by 30 days in culture. In hES cells, Pax6 or Six3 lentiviral vectors also induced lens marker expression. mES cells that express lens markers reside close to but are distinct from the Pax6 or Six3 transduced cells, suggesting that the latter induce nearby undifferentiated ES cells to adopt a lens fate by non-cell autonomous mechanisms. In sum, we describe a novel mES cell GFP reporter line that is useful for monitoring induction of lens fate, and demonstrate that Pax6 or Six3 is sufficient to induce ES cells to adopt a lens fate, potentially via non-cell autonomous mechanisms. These findings should facilitate investigations of lens development.	[Anchan, Raymond M.; Lachke, Salil A.; Gerami-Naini, Behzad; Naber, Catherine; Cavallesco, Resy; Rowan, Sheldon; Eaton, Jennifer L.; Xi, Qiongchao; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Anchan, Raymond M.; Lachke, Salil A.; Gerami-Naini, Behzad; Lindsey, Jennifer; Ng, Nicholas; Naber, Catherine; Nickerson, Michael; Cavallesco, Resy; Rowan, Sheldon; Eaton, Jennifer L.; Xi, Qiongchao; Maas, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Anchan, Raymond M.; Gerami-Naini, Behzad; Lindsey, Jennifer; Ng, Nicholas; Nickerson, Michael] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Med, Div Reprod Endocrinol & Infertil, Boston, MA 02115 USA; [Lachke, Salil A.] Univ Delaware, Dept Biol Sci, Ctr Bioinformat & Computat Biol, Newark, DE 19716 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Delaware	Anchan, RM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	ranchan@partners.org; maas@genetics.med.harvard	Rowan, Sheldon/AAA-3271-2019	Rowan, Sheldon/0000-0002-1123-6743; Lachke, Salil/0000-0001-8845-010X	National Institutes of Health [T32 HD040135, K12 HD001255, NEI R01 EY10123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040135] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants T32 HD040135 and K12 HD001255 to RMA and NEI R01 EY10123 to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CR, 1997, DEV BIOL, V185, P119, DOI 10.1006/dbio.1997.8573; Anchan RM, 2011, HUM MOL GENET, V20, P962, DOI 10.1093/hmg/ddq542; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Brown A, 1998, NUCLEIC ACIDS RES, V26, P259, DOI 10.1093/nar/26.1.259; Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324; Chow RL, 1999, DEVELOPMENT, V126, P4213; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Cvekl A, 2007, PROG RETIN EYE RES, V26, P555, DOI 10.1016/j.preteyeres.2007.07.002; Donner AL, 2006, SEMIN CELL DEV BIOL, V17, P676, DOI 10.1016/j.semcdb.2006.10.005; Duncan MK, 2002, MECH DEVELOP, V112, P195, DOI 10.1016/S0925-4773(01)00645-1; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Goudreau G, 2002, P NATL ACAD SCI USA, V99, P8719, DOI 10.1073/pnas.132195699; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Lachke SA, 2012, INVEST OPHTH VIS SCI, V53, P1617, DOI 10.1167/iovs.11-8839; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lachke SA, 2010, WIRES SYST BIOL MED, V2, P305, DOI 10.1002/wsbm.59; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lengner CJ, 2010, ANN NY ACAD SCI, V1192, P38, DOI 10.1111/j.1749-6632.2009.05213.x; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; MARTHA A, 1994, AM J HUM GENET, V54, P801; Negre O, 2011, BLOOD, V117, P5321, DOI 10.1182/blood-2010-01-263582; Oliver G, 1996, MECH DEVELOP, V60, P233, DOI 10.1016/S0925-4773(96)00632-6; Ooto S, 2003, INVEST OPHTH VIS SCI, V44, P2689, DOI 10.1167/iovs.02-1168; Qiu XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032612; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Takahashi Masayo, 2006, V330, P417; van Raamsdonk CD, 2000, DEVELOPMENT, V127, P5439; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; Yang CB, 2010, FASEB J, V24, P3274, DOI 10.1096/fj.10-157255; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	41	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115106	10.1371/journal.pone.0115106	http://dx.doi.org/10.1371/journal.pone.0115106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517354	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600041
J	Chen, YY; Chen, JC; Lin, YC; Kitikiew, S; Li, HF; Bai, JC; Tseng, KC; Lin, BW; Liu, PC; Shi, YZ; Kuo, YH; Chang, YH				Chen, Yu-Yuan; Chen, Jiann-Chu; Lin, Yong-Chin; Kitikiew, Suwaree; Li, Hui-Fang; Bai, Jia-Chin; Tseng, Kuei-Chi; Lin, Bo-Wei; Liu, Po-Chun; Shi, Yin-Ze; Kuo, Yi-Hsuan; Chang, Yu-Hsuan			Endogenous Molecules Induced by a Pathogen-Associated Molecular Pattern (PAMP) Elicit Innate Immunity in Shrimp	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; PROPHENOLOXIDASE SYSTEM; HEMOCYTES; ACTIVATION; RESPONSES; PROTEINS; INVITRO; ASTACUS; GENES; DAMPS	Invertebrates rely on an innate immune system to combat invading pathogens. The system is initiated in the presence of cell wall components from microbes like lipopolysaccharide (LPS), beta-1,3-glucan (beta G) and peptidoglycan (PG), altogether known as pathogen-associated molecular patterns (PAMPs), via a recognition of pattern recognition protein (PRP) or receptor (PRR) through complicated reactions. We show herein that shrimp hemocytes incubated with LPS, beta G, and PG caused necrosis and released endogenous molecules (EMs), namely EM-L, EM-beta, and EM-P, and found that shrimp hemocytes incubated with EM-L, EM-beta, and EM-P caused changes in cell viability, degranulation and necrosis of hemocytes, and increased phenoloxidase (PO) activity and respiratory burst (RB) indicating activation of immunity in vitro. We found that shrimp receiving EM-L, EM-beta, and EM-P had increases in hemocyte count and other immune parameters as well as higher phagocytic activity toward a Vibrio pathogen, and found that shrimp receiving EM-L had increases in proliferation cell ratio and mitotic index of hematopoietic tissues (HPTs). We identified proteins of EMs deduced from SDS-PAGE and LC-ESI-MS/MS analyses. EM-L and EM-P contained damage-associated molecular patterns (DAMPs) including HMGBa, HMGBb, histone 2A (H2A), H2B, and H4, and other proteins including proPO, Rab 7 GPTase, and Rab 11 GPTase, which were not observed in controls (EM-C, hemocytes incubated in shrimp salt solution). We concluded that EMs induced by PAMPs contain DAMPs and other immune molecules, and they could elicit innate immunity in shrimp. Further research is needed to identify which individual molecule or combined molecules of EMs cause the results, and determine the mechanism of action in innate immunity.	[Chen, Yu-Yuan; Chen, Jiann-Chu; Lin, Yong-Chin; Kitikiew, Suwaree; Li, Hui-Fang; Bai, Jia-Chin; Tseng, Kuei-Chi; Lin, Bo-Wei; Liu, Po-Chun; Shi, Yin-Ze; Kuo, Yi-Hsuan; Chang, Yu-Hsuan] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan	National Taiwan Ocean University	Chen, JC (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan.	jcchen@mail.ntou.edu.tw		Shi, Yin-Ze/0000-0001-5142-985X	National Science Council, Taiwan [NSC 100-2313-B-019-010-My 3, NSC101-2313-B-019-002]; Center of Excellence for the Oceans, National Taiwan Ocean University	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Center of Excellence for the Oceans, National Taiwan Ocean University	This research was supported by grants from the National Science Council (NSC 100-2313-B-019-010-My 3 and NSC101-2313-B-019-002), Taiwan, and partially supported by the Center of Excellence for the Oceans, National Taiwan Ocean University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2013, FISH SHELLFISH IMMUN, V34, P990, DOI 10.1016/j.fsi.2012.08.019; Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; BELL KL, 1993, DEV COMP IMMUNOL, V17, P211, DOI 10.1016/0145-305X(93)90040-W; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cardenas W, 2004, FISH SHELLFISH IMMUN, V17, P223, DOI 10.1016/j.fsi.2003.03.001; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chen YY, 2014, FISH SHELLFISH IMMUN, V36, P352, DOI 10.1016/j.fsi.2013.12.004; Dubaniewicz A, 2013, HUM IMMUNOL, V74, P1550, DOI 10.1016/j.humimm.2013.08.275; Gazzola D, 2014, FOOD CHEM, V155, P132, DOI 10.1016/j.foodchem.2014.01.032; Giulianini PG, 2007, MICRON, V38, P49, DOI 10.1016/j.micron.2006.03.019; HernandezLopez J, 1996, COMP BIOCHEM PHYS C, V113, P61, DOI 10.1016/0742-8413(95)02033-0; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jearaphunt M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004059; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; JOHANSSON MW, 1995, BIOCHEM BIOPH RES CO, V216, P1079, DOI 10.1006/bbrc.1995.2731; Kitikiew S, 2013, FISH SHELLFISH IMMUN, V34, P280, DOI 10.1016/j.fsi.2012.11.016; Li GQ, 2013, SEMIN CANCER BIOL, V23, P380, DOI 10.1016/j.semcancer.2013.08.002; Lin YongChin, 2013, PLoS ONE, V8, pe69722, DOI 10.1371/journal.pone.0069722; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Moleri S, 2011, GENE EXPR PATTERNS, V11, P3, DOI 10.1016/j.gep.2010.08.006; Pisetsky DS, 2012, CLIN IMMUNOL, V144, P32, DOI 10.1016/j.clim.2012.04.006; Pisetsky DS, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13256; Rao YL, 2013, DEV COMP IMMUNOL, V41, P164, DOI 10.1016/j.dci.2013.06.002; Rieger AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2597; SMITH VJ, 1983, CELL TISSUE RES, V233, P295; SMITH VJ, 1983, BIOL BULL, V164, P299, DOI 10.2307/1541146; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Vera-Jimenez NJ, 2013, MOL IMMUNOL, V55, P231, DOI 10.1016/j.molimm.2013.01.016; Wang L, 2008, DEV COMP IMMUNOL, V32, P706, DOI 10.1016/j.dci.2007.10.010; Xian JA, 2009, AQUACULTURE, V298, P139, DOI 10.1016/j.aquaculture.2009.10.008; Yang CR, 2013, DEV COMP IMMUNOL, V39, P133, DOI 10.1016/j.dci.2012.11.008; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	38	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115232	10.1371/journal.pone.0115232	http://dx.doi.org/10.1371/journal.pone.0115232			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517999	Green Submitted, Green Published, gold			2022-12-27	WOS:000347215600055
J	da Costa, RS; Bicca-Marques, JC				da Costa, Renata Souza; Bicca-Marques, Julio Cesar			Owl Monkeys (Aotus nigriceps and A. infulatus) Follow Routes Instead of Food-Related Cues during Foraging in Captivity	PLOS ONE			English	Article							TAMARINS SAGUINUS-IMPERATOR; WILD; INFORMATION; FUSCICOLLIS; CALLICEBUS; DECISIONS; PRIMATES	Foraging at night imposes different challenges from those faced during daylight, including the reliability of sensory cues. Owl monkeys (Aotus spp.) are ideal models among anthropoids to study the information used during foraging at low light levels because they are unique by having a nocturnal lifestyle. Six Aotus nigriceps and four A. infulatus individuals distributed into five enclosures were studied for testing their ability to rely on olfactory, visual, auditory, or spatial and quantitative information for locating food rewards and for evaluating the use of routes to navigate among five visually similar artificial feeding boxes mounted in each enclosure. During most experiments only a single box was baited with a food reward in each session. The baited box changed randomly throughout the experiment. In the spatial and quantitative information experiment there were two baited boxes varying in the amount of food provided. These baited boxes remained the same throughout the experiment. A total of 45 sessions (three sessions per night during 15 consecutive nights) per enclosure was conducted in each experiment. Only one female showed a performance suggestive of learning of the usefulness of sight to locate the food reward in the visual information experiment. Subjects showed a chance performance in the remaining experiments. All owl monkeys showed a preference for one box or a subset of boxes to inspect upon the beginning of each experimental session and consistently followed individual routes among feeding boxes.	[da Costa, Renata Souza; Bicca-Marques, Julio Cesar] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul	Bicca-Marques, JC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	jcbicca@pucrs.br	Bicca-Marques, Júlio César/F-7487-2012	Bicca-Marques, Júlio César/0000-0002-5400-845X	Brazilian National Research Council [303154/2009-8, 303306/2013-0]	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding from Brazilian National Research Council (RSC: Master's studentship; JCBM: PQ # 303154/2009-8 and 303306/2013-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES M., 2007, BIOESTAT; BEECHER MD, 1974, J COMP PHYSIOL PSYCH, V86, P898, DOI 10.1037/h0036416; Bicca-Marques JC, 2005, INT J PRIMATOL, V26, P1321, DOI 10.1007/s10764-005-8855-9; Bicca-Marques JC, 2005, J COMP PSYCHOL, V119, P343, DOI 10.1037/0735-7036.119.3.343; Bicca-Marques JC, 2004, AM J PRIMATOL, V62, P171, DOI 10.1002/ajp.20014; Bicca-Marques JC, 2003, AM J PRIMATOL, V60, P139, DOI 10.1002/ajp.10101; Bicca-Marques JC, 2007, PRIMATOLOGIA BRASIL, P401; Bolen RH, 1997, J COMP PSYCHOL, V111, P152; Cant J.G.H., 1984, P304; Carlstead Kathy, 1996, P317; Castauo JH., 2010, PRIMATOLOGIA COLOMBI, P69; Donati Giuseppe, 2006, Journal of Anthropological Sciences, V84, P7; Fernandez-Duque E., 2012, International Zoo Yearbook, V46, P80, DOI 10.1111/j.1748-1090.2011.00156.x; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Ford Susan M., 1994, P1; Garber PA, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P201; Garber PA, 1997, FOLIA PRIMATOL, V68, P236, DOI 10.1159/000157250; GARBER PA, 1987, ANNU REV ANTHROPOL, V16, P339; Garber PA, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P261; Garber PA, 2010, SPATIAL COGNITION SP, P180; Gomes DF, 2012, AM J PRIMATOL, V74, P58, DOI 10.1002/ajp.21009; Hayek LAC, 1996, MEASURING MONITORING, P343; JACOBS GH, 1993, VISION RES, V33, P1773, DOI 10.1016/0042-6989(93)90168-V; Kamil Alan C., 1994, P11; King J.E., 1982, P327; Leigh S., 1999, READINGS BIOL BASES, P71; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Martin R.D., 1990, PRIMATE ORIGINS EVOL; McGuigan FG, 1994, BIOL PSYCHOL CYBEMET; Stevens M, 2013, SENSORY ECOLOGY, BEHAVIOUR, AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199601776.001.0001; Wright Patricia C., 1994, P97; WRIGHT PC, 1989, J HUM EVOL, V18, P635, DOI 10.1016/0047-2484(89)90098-5	33	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115188	10.1371/journal.pone.0115188	http://dx.doi.org/10.1371/journal.pone.0115188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517894	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600052
J	Timmis, MA; Turner, K; van Paridon, KN				Timmis, Matthew A.; Turner, Kieran; van Paridon, Kjell N.			Visual Search Strategies of Soccer Players Executing a Power vs. Placement Penalty Kick	PLOS ONE			English	Article							EYE-MOVEMENTS; DECISION-MAKING; GAZE BEHAVIOR; EXPERTISE; SKILL; ANTICIPATION; GOALKEEPERS; DIRECTION; ACCURACY; INSTEP	Introduction: When taking a soccer penalty kick, there are two distinct kicking techniques that can be adopted; a 'power' penalty or a 'placement' penalty. The current study investigated how the type of penalty kick being taken affected the kicker's visual search strategy and where the ball hit the goal (end ball location). Method: Wearing a portable eye tracker, 12 university footballers executed 2 power and placement penalty kicks, indoors, both with and without the presence of a goalkeeper. Video cameras were used to determine initial ball velocity and end ball location. Results: When taking the power penalty, the football was kicked significantly harder and more centrally in the goal compared to the placement penalty. During the power penalty, players fixated on the football for longer and more often at the goalkeeper (and by implication the middle of the goal), whereas in the placement penalty, fixated longer at the goal, specifically the edges. Findings remained consistent irrespective of goalkeeper presence. Discussion/conclusion: Findings indicate differences in visual search strategy and end ball location as a function of type of penalty kick. When taking the placement penalty, players fixated and kicked the football to the edges of the goal in an attempt to direct the ball to an area that the goalkeeper would have difficulty reaching and saving. Fixating significantly longer on the football when taking the power compared to placement penalty indicates a greater importance of obtaining visual information from the football. This can be attributed to ensuring accurate foot-to-ball contact and subsequent generation of ball velocity. Aligning gaze and kicking the football centrally in the goal when executing the power compared to placement penalty may have been a strategy to reduce the risk of kicking wide of the goal altogether.	[Timmis, Matthew A.; Turner, Kieran; van Paridon, Kjell N.] Anglia Ruskin Univ, Dept Life Sci, Sport & Exercise Sci Res Grp, Cambridge, England	Anglia Ruskin University	Timmis, MA (corresponding author), Anglia Ruskin Univ, Dept Life Sci, Sport & Exercise Sci Res Grp, Cambridge, England.	Matthew.Timmis@anglia.ac.uk			STFC [ST/I001212/1, ST/J500008/1] Funding Source: UKRI	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Asai T., 2002, SPORTS ENG, V5, P183, DOI DOI 10.1046/J.1460-2687.2002.00108.X; Asami T., 1983, BIOMECHANICS 8 B, P695; Bakker FC, 2006, INT J SPORT PSYCHOL, V37, P265; Bar-Eli M., 2009, SOCCER SOC, V10, P183; Bar-Eli M, 2007, J ECON PSYCHOL, V28, P606, DOI 10.1016/j.joep.2006.12.001; BARELI M, 1988, SOCCER J, V33, P49; Bull-Andersen T., 1999, SPORTS ENG, V2, P121, DOI [10.1046/j.1460-2687.1999.00015.x, DOI 10.1046/J.1460-2687.1999.00015.X]; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Jordet G, 2007, J SPORT SCI, V25, P121, DOI 10.1080/02640410600624020; Kellis E, 2007, J SPORT SCI MED, V6, P154; Kim S., 2006, INT J APPL SPORTS SC, V18, P96; Kuhn W., 1988, SCI FOOTBALL, P489; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Lees A, 1998, J SPORT SCI, V16, P211, DOI 10.1080/026404198366740; Lees A., 2002, SCI FOOTBALL 4, P16; Levanon J, 1998, MED SCI SPORT EXER, V30, P917, DOI 10.1097/00005768-199806000-00022; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Masters RSW, 2007, PSYCHOL SCI, V18, P222, DOI 10.1111/j.1467-9280.2007.01878.x; Morya E., 2003, SCI FOOTBALL, P237; Nagano T, 2006, PERCEPT MOTOR SKILL, V102, P147, DOI 10.2466/PMS.102.1.147-156; Navarro M, 2013, J SPORT SCI, V31, P921, DOI 10.1080/02640414.2012.762602; Neilson P, 2005, SCI FOOTBALL; Noel B, 2012, INT J SPORT PSYCHOL, V43, P326; Palacios-Huerta I, 2003, REV ECON STUD, V70, P395, DOI 10.1111/1467-937X.00249; Savelsbergh GJP, 2005, ERGONOMICS, V48, P1686, DOI 10.1080/00140130500101346; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; The Football Association, 2005, GUID IND OUTD AR SMA; Vaeyens R, 2007, J MOTOR BEHAV, V39, P395, DOI 10.3200/JMBR.39.5.395-408; Vaeyens R, 2007, J SPORT EXERCISE PSY, V29, P147, DOI 10.1123/jsep.29.2.147; van den Tillaar R, 2014, J MOTOR BEHAV, V46, P287, DOI 10.1080/00222895.2014.898609; Van der Kamp J, 2006, J SPORT SCI, V24, P467, DOI 10.1080/02640410500190841; Welsh TN, 2004, Q J EXP PSYCHOL-A, V57, P1031, DOI 10.1080/02724980343000666; WILLIAMS AM, 1994, RES Q EXERCISE SPORT, V65, P127, DOI 10.1080/02701367.1994.10607607; Williams AM, 2000, J SPORT SCI, V18, P737, DOI 10.1080/02640410050120113; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677; Williams AM, 1993, AUSTR J SCI MED SPOR, V25, P147; Wilson MR, 2009, J SPORT EXERCISE PSY, V31, P761, DOI 10.1123/jsep.31.6.761; Wood G, 2010, J SPORT SCI, V28, P937, DOI 10.1080/02640414.2010.495995	40	26	27	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115179	10.1371/journal.pone.0115179	http://dx.doi.org/10.1371/journal.pone.0115179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517405	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347215600049
J	Hromadnikova, I; Kotlabova, K; Hympanova, L; Doucha, J; Krofta, L				Hromadnikova, Ilona; Kotlabova, Katerina; Hympanova, Lucie; Doucha, Jindrich; Krofta, Ladislav			First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension	PLOS ONE			English	Article							PLACENTA-SPECIFIC MICRORNAS; HUMAN CHORIONIC-GONADOTROPIN; FREE FETAL DNA; MATERNAL PLASMA; HYPERMETHYLATED RASSF1A; PRENATAL-DIAGNOSIS; GROWTH RESTRICTION; ANGIOGENIC FACTORS; PREGNANT-WOMEN; PREECLAMPSIA	Objective: The objective of the study was to evaluate risk assessment for gestational hypertension based on the profile of circulating placental specific C19MC microRNAs in early pregnancy. Study design: The prospective longitudinal cohort study of women enrolled at first trimester screening at 10 to 13 weeks was carried out (n=267). Relative quantification of placental specific C19MC microRNAs (miR-516-5p, miR-517*, miR-518b, miR-520a*, miR-520h, miR-525 and miR-526a) was determined in 28 normal pregnancies and 18 pregnancies which developed gestational hypertension using real-time PCR and a comparative Ct method relative to synthetic C. elegans microRNA (cel-miR-39). Results: Increased extracellular C19MC microRNA plasmatic levels (miR-516-5p, p<0.001; miR-517*, p-0.007; miR-520h, p<0.001; miR-518b, p=0.002) were detected in patients destined to develop gestational hypertension. MiR-520h had the best predictive performance with a PPV of 84.6% at a 7.1% false positive rate. The combination of miR-520h and miR-518b was able to predict 82.6% of women at the same false positive rate. The overall predictive capacity of single miR-518b (73.3% at 14.3% FPR), miR-516-5p (70.6% at 17.9% FPR) and miR-517* (57.9% at 28.6% FPR) biomarkers was lower. Conclusion: The study brought interesting finding that the up-regulation of miR516-5p, miR-517*, miR-520h and miR-518b is associated with a risk of later development of gestational hypertension. First trimester screening of extracellular miR-520h alone or in combination with miR-518b identified a significant proportion of women with subsequent gestational hypertension.	[Hromadnikova, Ilona; Kotlabova, Katerina; Hympanova, Lucie] Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Prague 10000, Czech Republic; [Hympanova, Lucie; Krofta, Ladislav] Charles Univ Prague, Fac Med 3, Inst Care Mother & Child, Prague 14700, Czech Republic; [Doucha, Jindrich] Charles Univ Prague, Fac Med 2, Clin Obstet & Gynecol, Prague 15006, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague	Hromadnikova, I (corresponding author), Charles Univ Prague, Fac Med 3, Dept Mol Biol & Cell Pathol, Ruska 87, Prague 10000, Czech Republic.	Ilona.Hromadnikova@lf3.cuni.cz	Hympanova, Lucie/AAS-7474-2020; Hromadnikova, Ilona/E-1957-2017; Hympanova, Lucie/GRJ-1255-2022	Hympanova, Lucie/0000-0002-9002-9231; Hromadnikova, Ilona/0000-0002-4396-3304; Hympanova, Lucie/0000-0002-9002-9231; Kotlabova, Katerina/0000-0002-8824-4653	Grant Agency of Czech Republic [304/12/1352]; Charles University research program [PRVOUK P32]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Charles University research program	The work was exclusively supported by the Grant Agency of Czech Republic (no. 304/12/1352) and partially supported by the Charles University research program PRVOUK P32 (www.gacr.cz) (IH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asvold BO, 2014, ACTA OBSTET GYN SCAN, V93, P454, DOI 10.1111/aogs.12363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Byrne BM, 2003, HYPERTENS PREGNANCY, V22, P157, DOI 10.1081/PRG-120021062; Caramelli E, 2003, PRENATAL DIAG, V23, P367, DOI 10.1002/pd.596; Chambers AE, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-113; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Ciarmela P, 2010, EUR J OBSTET GYN R B, V148, P144, DOI 10.1016/j.ejogrb.2009.10.026; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Faas BHW, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60534-X; Gunel T, 2011, GENET MOL RES, V10, P4034, DOI 10.4238/2011.November.8.5; Higashijima A, 2013, PRENATAL DIAG, V33, P214, DOI 10.1002/pd.4045; Hromadnikova I, 2005, J HISTOCHEM CYTOCHEM, V53, P301, DOI 10.1369/jhc.4A6372.2005; Hromadnikova I, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/186041; Hromadnikova I, 2012, DNA CELL BIOL, V31, P1221, DOI 10.1089/dna.2011.1530; Hromadnikova I, 2012, J MOL DIAGN, V14, P160, DOI 10.1016/j.jmoldx.2011.11.003; Hromadnikova I, 2010, DNA CELL BIOL, V29, P295, DOI 10.1089/dna.2009.0971; Hromadnikova I, 2009, DNA CELL BIOL, V28, P351, DOI 10.1089/dna.2009.0855; Hu YL, 2009, CLIN CHEM LAB MED, V47, P923, DOI 10.1515/CCLM.2009.228; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Karahasanovic A, 2014, CLIN CHEM LAB MED, V52, P521, DOI 10.1515/cclm-2013-0338; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau TW, 2002, CLIN CHEM, V48, P2141; Li HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970265; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1999, CLIN CHEM, V45, P184; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Luque A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04882; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morales-Prieto DM, 2013, J REPROD IMMUNOL, V97, P51, DOI 10.1016/j.jri.2012.11.001; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; National Collaborating Centre for Women's and Children's Health (UK), 2010, HYPERTENSION PREGNAN; Neale DM, 2005, J PERINAT MED, V33, P471, DOI 10.1515/JPM.2005.085; Nelson DM, 1996, PLACENTA, V17, P387, DOI 10.1016/S0143-4004(96)90019-3; Nishikawa S, 2000, LIFE SCI, V67, P1447, DOI 10.1016/S0024-3205(00)00736-0; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Oudejans CBM, 2003, PRENATAL DIAG, V23, P111, DOI 10.1002/pd.539; Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Poon LC, 2014, PRENATAL DIAG, V34, P618, DOI 10.1002/pd.4397; Rijnders RJP, 2001, OBSTET GYNECOL, V98, P374, DOI 10.1016/S0029-7844(01)01480-6; Robinson R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.011; Schmitz U., 2013, MICRORNA CANC REGULA; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sekizawa A, 2003, AM J OBSTET GYNECOL, V188, P480, DOI 10.1067/mob.2003.27; Sezer SD, 2013, GYNECOL ENDOCRINOL, V29, P797, DOI 10.3109/09513590.2013.801437; Smid M, 2001, ANN NY ACAD SCI, V945, P132; Spencer K, 2007, ULTRASOUND OBST GYN, V29, P128, DOI 10.1002/uog.3876; Sziller I, 2005, MOL HUM REPROD, V11, P207, DOI 10.1093/molehr/gah151; Tal R, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102723; TAYLOR RN, 1990, J CLIN ENDOCR METAB, V71, P1675, DOI 10.1210/jcem-71-6-1675; Tsui DWY, 2007, PRENATAL DIAG, V27, P1212, DOI 10.1002/pd.1897; Ura B, 2014, TAIWAN J OBSTET GYNE, V53, P232, DOI 10.1016/j.tjog.2014.03.001; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Whitehead CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078487; Whitley GSJ, 2007, AM J PATHOL, V170, P1903, DOI 10.2353/ajpath.2007.070006; Winger EE, 2014, AM J REPROD IMMUNOL, V72, P515, DOI 10.1111/aji.12287; World Health Organization, 2011, WHO REC PREV TREATM; Wu L, 2012, REPRODUCTION, V143, P389, DOI 10.1530/REP-11-0304; Xu P, 2014, HYPERTENSION, V63, P1276, DOI 10.1161/HYPERTENSIONAHA.113.02647; Yang Q, 2011, CLIN CHIM ACTA, V412, P2167, DOI 10.1016/j.cca.2011.07.029; Yi KW, 2014, PLACENTA, V35, P64, DOI 10.1016/j.placenta.2013.09.008; Zhao LL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-61; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	73	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e113735	10.1371/journal.pone.0113735	http://dx.doi.org/10.1371/journal.pone.0113735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502889	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100007
J	Lin, L; Pan, S; Zhao, JQ; Liu, C; Wang, PG; Fu, L; Xu, XL; Jin, ML; Zhang, AD				Lin, Lan; Pan, Shan; Zhao, Jianqing; Liu, Cheng; Wang, Pingan; Fu, Lei; Xu, Xinlin; Jin, Meilin; Zhang, Anding			HSPD1 Interacts with IRF3 to Facilitate Interferon-Beta Induction	PLOS ONE			English	Article							REGULATORY FACTOR-3 ACTIVATION; ANTIVIRAL RESPONSE; PROTEIN; PHOSPHORYLATION; ADAPTER; MAVS; UBIQUITINATION; ASSOCIATION; SYNTHASE; SENSOR	The production of IFN-I (IFN-alpha/beta) is one of the earliest and most important host-protective responses. Interferon regulatory factor 3 (IRF3) is a critical transcriptional factor in the IFN-beta signaling pathway. Although significant progress has been achieved in the regulation of IRF3, the process may be more complicated than previously considered. In the present study, heat shock protein 60 (HSP60, HSPD1) was identified as a novel IRF3-interacting protein. Overexpression of HSPD1 facilitated the phosphorylation and dimerization of IRF3 and enhanced IFN-beta induction induced by SeV infection. In contrast, knockdown of endogenous HSPD1 significantly inhibited the signaling pathway. Furthermore, HSPD1 enhanced activation of the IFN-beta promoter mediated by RIG-I, MDA-5, MAVS, TBK1 and IKK epsilon but not IRF3/5D, a mock phosphorylated form of IRF3. The present study indicated that HSPD1 interacted with IRF3 and it contributed to the induction of IFN-beta.	[Lin, Lan; Pan, Shan; Jin, Meilin; Zhang, Anding] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Lin, Lan; Pan, Shan; Zhao, Jianqing; Wang, Pingan; Fu, Lei; Xu, Xinlin; Jin, Meilin; Zhang, Anding] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Liu, Cheng] Liaocheng Univ, Coll Agr, Liaocheng, Shandong, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Liaocheng University	Zhang, AD (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	andye8019@mail.hzau.edu.cn			National Natural Science Foundation of China [31172328, 31272544]; 973 program [2012CB518805]; Program for New Century Excellent Talents in University; fundamental research funds for the central university [2011PY006, 2014PY016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); fundamental research funds for the central university	This work was supported by the National Natural Science Foundation of China (31172328, 31272544), the 973 program (2012CB518805), Program for New Century Excellent Talents in University, and the fundamental research funds for the central university (2011PY006; 2014PY016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Bergstroem B, 2010, J BIOL CHEM, V285, P24904, DOI 10.1074/jbc.M109.084822; Chen KR, 2012, J BIOL CHEM, V287, P32216, DOI 10.1074/jbc.C112.394346; Chun JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009422; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Gu LL, 2013, MOL CELL BIOL, V33, P2004, DOI 10.1128/MCB.01603-12; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Lee YR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056284, 10.1371/journal.pone.0063255]; Levy DE, 2004, NAT IMMUNOL, V5, P699, DOI 10.1038/ni0704-699; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang JT, 2014, INNATE IMMUN-LONDON, V20, P78, DOI 10.1177/1753425913485307; Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027; Wang YT, 2012, J BIOL CHEM, V287, P34626, DOI 10.1074/jbc.M112.390401; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhang AP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009936; Zhou Z, 2014, P NATL ACAD SCI USA, V111, pE245, DOI 10.1073/pnas.1316941111	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114874	10.1371/journal.pone.0114874	http://dx.doi.org/10.1371/journal.pone.0114874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506707	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100028
J	Ben-David, BM; Eidels, A; Donkin, C				Ben-David, Boaz M.; Eidels, Ami; Donkin, Chris			Effects of Aging and Distractors on Detection of Redundant Visual Targets and Capacity: Do Older Adults Integrate Visual Targets Differently than Younger Adults?	PLOS ONE			English	Article							DIFFUSION-MODEL ANALYSIS; INFORMATION-PROCESSING RATES; SAME-DIFFERENT JUDGMENTS; AGE-RELATED-CHANGES; COLOR-WORD STROOP; WORKLOAD CAPACITY; SELECTIVE ATTENTION; DIVIDED ATTENTION; SENSORY ORIGIN; RECOGNITION	In the redundant target effect, participants respond faster with two (redundant) targets. We compared the magnitude of this effect in younger and older adults, with and without distractors, in a simple visual-detection task. We employed additional measures that allow non-parametric assessment of performance (Townsend's capacity coefficient) and parametric estimates (Linear Ballistic Accumulator model). Older participants' latencies were slower, especially in the presence of distractors, and their calculated capacity indicators increased with distractors. Parametric estimates indicated that these increases were generated by the older adults' increased difficulty in inhibiting the distractors, and not the results of either improved detection of redundant-targets, or of a generalized slowing of processing.	[Ben-David, Boaz M.] Interdisciplinary Ctr IDC Herzliya, Sch Psychol, Herzliyya, Israel; [Ben-David, Boaz M.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Ben-David, Boaz M.] Toronto Rehabil Inst, Toronto, ON, Canada; [Ben-David, Boaz M.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Eidels, Ami] Univ Newcastle, Sch Psychol, Callaghan, NSW 2308, Australia; [Donkin, Chris] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Reichman University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Newcastle; University of New South Wales Sydney	Ben-David, BM (corresponding author), Interdisciplinary Ctr IDC Herzliya, Sch Psychol, Herzliyya, Israel.	boaz.ben.david@idc.ac.il		Ben-David, Boaz/0000-0002-0392-962X; Donkin, Chris/0000-0002-4285-8537; Eidels, Ami/0000-0003-4301-6072	Natural Sciences and Engineering Research Council of Canada [RGBPIN 9952]; Keats Endowment Research Fund; Marie Curie Career Integration Grant from the European Commission (FP7-PEOPLE-CIG); Australian Research Council's Discovery Projects funding scheme [DP130100124]; Australian Research Council Discovery Early Career Award [DE130100129]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Keats Endowment Research Fund; Marie Curie Career Integration Grant from the European Commission (FP7-PEOPLE-CIG); Australian Research Council's Discovery Projects funding scheme(Australian Research Council); Australian Research Council Discovery Early Career Award(Australian Research Council)	This work was supported by: 1) The Natural Sciences and Engineering Research Council of Canada (RGBPIN 9952) awarded to B. A. Schneider, who was the post-doctoral advisor for BBD at the time of data collection (www.nserccrsng.gc.ca/index_eng.asp). 2) The Keats Endowment Research Fund awarded to AE (http://www.newcastle.edu.au/Resources/News/2008/01/Keats%20endow%20research%20fund.pdf). 3) BBD was partially supported by the Marie Curie Career Integration Grant from the European Commission (FP7-PEOPLE-2012-CIG) (ec.europa.eu/research/mariecurieactions/about-mca/.../cig/index_en.htm). 4) CD's contribution to this research was supported under Australian Research Council's Discovery Projects funding scheme (DP130100124), (www.arc.gov.au/ncgp/dp/dp_default.htm). 5) CD's work was also supported by an Australian Research Council Discovery Early Career Award (DE130100129) (www.arc.gov.au/ncgp/decra.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALGOM D, 2014, OXFORD HANDBOOK OF C; ALLEN PA, 1993, J GERONTOL, V48, pP189, DOI 10.1093/geronj/48.4.P189; ALLEN PA, 1994, J GERONTOL, V49, pP213, DOI 10.1093/geronj/49.5.P213; ALLEN PA, 1992, J GERONTOL, V47, pP69, DOI 10.1093/geronj/47.2.P69; Ben-David BM, 2014, J ALZHEIMERS DIS, V38, P923, DOI 10.3233/JAD-131244; Ben-David BM, 2012, HEARING RES, V290, P55, DOI 10.1016/j.heares.2012.04.022; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Ben-David BM, 2011, J SPEECH LANG HEAR R, V54, P243, DOI 10.1044/1092-4388(2010/09-0233); Ben-David BM, 2010, AGING NEUROPSYCHOL C, V17, P730, DOI 10.1080/13825585.2010.510553; Ben-David BM, 2009, AGING NEUROPSYCHOL C, V16, P505, DOI 10.1080/13825580902855862; Ben-David BM, 2009, J EXP PSYCHOL HUMAN, V35, P958, DOI 10.1037/a0014511; Bertone A, 2007, J CLIN EXP NEUROPSYC, V29, P467, DOI 10.1080/13803390600770793; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Bucur B, 2005, PSYCHOL AGING, V20, P435, DOI 10.1037/0882-7974.20.3.435; Bucur B, 2005, J GERONTOL B-PSYCHOL, V60, pP279, DOI 10.1093/geronb/60.5.P279; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Eidels A, 2011, J MATH PSYCHOL, V55, P176, DOI 10.1016/j.jmp.2010.11.003; Eidels A, 2010, PSYCHON B REV, V17, P763, DOI 10.3758/PBR.17.6.763; Eidels A, 2010, COGNITION, V114, P129, DOI 10.1016/j.cognition.2009.08.008; Eidels A, 2008, J EXP PSYCHOL HUMAN, V34, P1441, DOI 10.1037/a0012320; Guerreiro MJS, 2010, PSYCHOL BULL, V136, P975, DOI 10.1037/a0020731; HARTLEY AA, 1993, PSYCHOL AGING, V8, P371, DOI 10.1037/0882-7974.8.3.371; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; Houpt JW, 2012, J MATH PSYCHOL, V56, P341, DOI 10.1016/j.jmp.2012.05.004; Hugenschmidt CE, 2010, INFORM FUSION, V11, P12, DOI 10.1016/j.inffus.2009.04.004; KRUEGER LE, 1978, PSYCHOL REV, V85, P278, DOI 10.1037/0033-295X.85.4.278; KRUEGER LE, 1987, PERCEPT PSYCHOPHYS, V41, P329, DOI 10.3758/BF03208234; KRUEGER LE, 1985, PERCEPT PSYCHOPHYS, V37, P266, DOI 10.3758/BF03207574; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Madden DJ, 2004, ADV CELL AGING GERON, V15, P41; McDowd J., 2000, HDB AGING COGNITION, P221; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; MILLER J, 1991, J EXP PSYCHOL HUMAN, V17, P160, DOI 10.1037/0096-1523.17.1.160; MYERSON J, 1992, PSYCHOL AGING, V7, P257, DOI 10.1037/0882-7974.7.2.257; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Plude DJ, 1986, PSYCHOL AGING, V1, P4, DOI 10.1037/0882-7974.1.1.4; Raab D., 1962, T NEW YORK ACADEMY S, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Ratcliff R, 2004, PSYCHOL AGING, V19, P278, DOI 10.1037/0882-7974.19.2.278; Ratcliff R, 2004, J MEM LANG, V50, P408, DOI 10.1016/j.jml.2003.11.002; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2006, PSYCHON B REV, V13, P626, DOI 10.3758/BF03193973; Ratcliff R, 2006, PSYCHOL AGING, V21, P353, DOI 10.1037/0882-7974.21.2.353; Ratcliff R, 2010, COGNITIVE PSYCHOL, V60, P127, DOI 10.1016/j.cogpsych.2009.09.001; RAVEN JC, 1958, GUIDE TO USING THE M; SALTHOUSE TA, 1988, DEV REV, V8, P238, DOI 10.1016/0273-2297(88)90006-8; Schneider B.A., 2000, HDB AGING COGNITION, P155; Townsend JT, 2011, PSYCHON B REV, V18, P659, DOI 10.3758/s13423-011-0106-9; Townsend JT, 1995, J MATH PSYCHOL, V39, P321, DOI 10.1006/jmps.1995.1033; van Lieshout P, 2014, J FLUENCY DISORD, V40, P93, DOI 10.1016/j.jfludis.2014.02.003; Verhaeghen P, 2011, CURR DIR PSYCHOL SCI, V20, P174, DOI 10.1177/0963721411408772; Vetter Sebastian, 2010, Occupational Ergonomics, V9, P99, DOI 10.3233/OER-2010-0175; Wagenmakers EJ, 2009, EUR J COGN PSYCHOL, V21, P641, DOI 10.1080/09541440802205067	53	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113551	10.1371/journal.pone.0113551	http://dx.doi.org/10.1371/journal.pone.0113551			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25501850	Green Submitted, Green Published			2022-12-27	WOS:000346375400010
J	Gao, JH; Sun, YZ; Lu, YG; Li, LP				Gao, Jinghong; Sun, Yunzong; Lu, Yaogui; Li, Liping			Impact of Ambient Humidity on Child Health: A Systematic Review	PLOS ONE			English	Review							RESPIRATORY SYNCYTIAL VIRUS; PEDIATRIC ASTHMA ADMISSIONS; MIDDLE-SCHOOL CHILDREN; GLOBAL CLIMATE-CHANGE; METEOROLOGICAL FACTORS; ENVIRONMENTAL-FACTORS; WEATHER VARIABILITY; ROTAVIRUS DIARRHEA; ALLERGIC RHINITIS; MALARIA INCIDENCE	Background and Objectives: Changes in relative humidity, along with other meteorological factors, accompany ongoing climate change and play a significant role in weather-related health outcomes, particularly among children. The purpose of this review is to improve our understanding of the relationship between ambient humidity and child health, and to propose directions for future research. Methods: A comprehensive search of electronic databases (PubMed, Medline, Web of Science, ScienceDirect, OvidSP and EBSCO host) and review of reference lists, to supplement relevant studies, were conducted in March 2013. All identified records were selected based on explicit inclusion criteria. We extracted data from the included studies using a pre-designed data extraction form, and then performed a quality assessment. Various heterogeneities precluded a formal quantitative meta-analysis, therefore, evidence was compiled using descriptive summaries. Results: Out of a total of 3797 identified records, 37 papers were selected for inclusion in this review. Among the 37 studies, 35% were focused on allergic diseases and 32% on respiratory system diseases. Quality assessment revealed 78% of the studies had reporting quality scores above 70%, and all findings demonstrated that ambient humidity generally plays an important role in the incidence and prevalence of climate-sensitive diseases among children. Conclusions: With climate change, there is a significant impact of ambient humidity on child health, especially for climate-sensitive infectious diseases, diarrhoeal diseases, respiratory system diseases, and pediatric allergic diseases. However, some inconsistencies in the direction and magnitude of the effects are observed.	[Gao, Jinghong; Lu, Yaogui; Li, Liping] Shantou Univ, Coll Med, Injury Prevent Res Ctr, Shantou 515041, Guangdong, Peoples R China; [Sun, Yunzong] Shantou Univ, Coll Med, Dept Publ Hlth, Shantou 515041, Guangdong, Peoples R China	Shantou University; Shantou University	Li, LP (corresponding author), Shantou Univ, Coll Med, Injury Prevent Res Ctr, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	lpli@stu.edu.cn						Aimone AM, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-1; Al-Toum R, 2006, J TROP PEDIATRICS, V52, P282, DOI 10.1093/tropej/fml002; Amarillo AC, 2012, ENVIRON POLLUT, V170, P217, DOI 10.1016/j.envpol.2012.07.005; Arnedo-Pena A, 2011, INT J BIOMETEOROL, V55, P423, DOI 10.1007/s00484-010-0353-x; Assembly UG, 1989, TREATY SERIES, V1577; Balbus JM, 2009, J OCCUP ENVIRON MED, V51, P33, DOI 10.1097/JOM.0b013e318193e12e; Bennet L, 2006, EUR J CLIN MICROBIOL, V25, P426, DOI 10.1007/s10096-006-0167-2; Bernstein AS, 2011, CURR OPIN PEDIATR, V23, P221, DOI 10.1097/MOP.0b013e3283444c89; Bielory L, 2012, CURR ALLERGY ASTHM R, V12, P485, DOI 10.1007/s11882-012-0314-z; Chang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046845; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Chou WC, 2010, SCI TOTAL ENVIRON, V409, P43, DOI 10.1016/j.scitotenv.2010.09.001; Connelly M, 2010, HEADACHE, V50, P779, DOI 10.1111/j.1526-4610.2009.01586.x; D'Amato G, 2008, CLIN EXP ALLERGY, V38, P1264, DOI 10.1111/j.1365-2222.2008.03033.x; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Dapul-Hidalgo G, 2012, ANN ALLERG ASTHMA IM, V109, P166, DOI 10.1016/j.anai.2012.02.008; Devi N. Pemola, 2006, Journal of Vector Borne Diseases, V43, P21; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; Ebi KL, 2010, CURR PROB PEDIATR AD, V40, P2, DOI 10.1016/j.cppeds.2009.12.001; El-Fadel M, 2012, SCI TOTAL ENVIRON, V437, P15, DOI 10.1016/j.scitotenv.2012.07.041; Gao HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043686; Garcia-Marcos L, 2009, INT J BIOMETEOROL, V53, P53, DOI 10.1007/s00484-008-0190-3; Guo YLL, 1999, ENVIRON HEALTH PERSP, V107, P1001, DOI 10.1289/ehp.991071001; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hashimoto M, 2004, PEDIATR INT, V46, P48, DOI 10.1111/j.1442-200X.2004.01835.x; Hashizume M, 2008, EPIDEMIOL INFECT, V136, P1281, DOI 10.1017/S0950268807009776; Jensen PM, 2000, EXP APPL ACAROL, V24, P695, DOI 10.1023/A:1010640219816; Jusot JF, 2012, INFLUENZA OTHER RESP, V6, P87, DOI 10.1111/j.1750-2659.2011.00286.x; Kan HD, 2012, ENVIRON INT, V42, P10, DOI 10.1016/j.envint.2011.03.003; Kashiwabara K, 2003, J ASTHMA, V40, P405, DOI 10.1081/JAS-120018710; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Knulle W., 1982, Current Themes in Tropical Science, V1, P43; Konstantinou GN, 2011, PEDIAT ALLERG IMM-UK, V22, P36, DOI 10.1111/j.1399-3038.2010.01093.x; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Kurt E, 2007, PEDIAT ALLERG IMM-UK, V18, P566, DOI 10.1111/j.1399-3038.2007.00551.x; Lapena S, 2005, EUR J EPIDEMIOL, V20, P271, DOI 10.1007/s10654-004-4539-6; Lee YL, 2003, EUR RESPIR J, V21, P964, DOI 10.1183/09031936.03.00094602; Lee YL, 2008, J INVEST DERMATOL, V128, P2412, DOI 10.1038/jid.2008.110; Loh TP, 2011, EPIDEMIOL INFECT, V139, P1884, DOI 10.1017/S0950268810002955; Mallen C, 2006, J CLIN EPIDEMIOL, V59, P765, DOI 10.1016/j.jclinepi.2005.12.010; Meerhoff TJ, 2009, PEDIATR INFECT DIS J, V28, P860, DOI 10.1097/INF.0b013e3181a3e949; Mireku N, 2009, ANN ALLERG ASTHMA IM, V103, P220, DOI 10.1016/S1081-1206(10)60185-8; Mirski T, 2012, POL J ENVIRON STUD, V21, P525; Suarez-Varela MM, 2008, INT J BIOMETEOROL, V52, P833, DOI 10.1007/s00484-008-0177-0; Murdoch DR, 2009, J INFECTION, V58, P37, DOI 10.1016/j.jinf.2008.10.011; Nakai S, 1999, INT J BIOMETEOROL, V43, P124, DOI 10.1007/s004840050127; Nascimento-Carvalho CM, 2010, SCAND J INFECT DIS, V42, P839, DOI 10.3109/00365548.2010.498020; Nastos PT, 2008, J ASTHMA, V45, P59, DOI 10.1080/02770900701815818; Nichols A, 2009, ENVIRON HEALTH INSIG, V3, P63; Nicolai T, 1998, THORAX, V53, P1035, DOI 10.1136/thx.53.12.1035; Noyola DE, 2008, EPIDEMIOL INFECT, V136, P1328, DOI 10.1017/S0950268807000143; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1369, DOI 10.1017/S0950268810002451; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1692, DOI 10.1017/S0950268810002967; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Pachauri R.K, 2007, CONTRIBUTION WORKING, P104, DOI DOI 10.1017/CBO9780511546013; Paynter S, 2010, LANCET, V376, P1804, DOI 10.1016/S0140-6736(10)62141-1; Priftis KN, 2006, RESPIRATION, V73, P783, DOI 10.1159/000093817; Rajtar B, 2008, ANN AGR ENV MED, V15, P199; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Rietmeijer-Mentink M, 2013, MATERN CHILD NUTR, V9, P3, DOI 10.1111/j.1740-8709.2012.00462.x; Rohayem J, 2009, CLIN MICROBIOL INFEC, V15, P524, DOI 10.1111/j.1469-0691.2009.02846.x; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; SATTAR SA, 1986, J HYG-CAMBRIDGE, V96, P277, DOI 10.1017/S0022172400066055; Shannon MW, 2007, PEDIATRICS, V120, P1149, DOI 10.1542/peds.2007-2645; Shea KM, 2007, PEDIATRICS, V120, pE1359, DOI 10.1542/peds.2007-2646; Sheffield PE, 2011, ENVIRON HEALTH PERSP, V119, P291, DOI 10.1289/ehp.1002233; Sheffield PE, 2011, MT SINAI J MED, V78, P78, DOI 10.1002/msj.20232; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tchidjou HK, 2010, J TROP PEDIATRICS, V56, P317, DOI 10.1093/tropej/fmp127; Tillett T, 2011, ENVIRON HEALTH PERSP, V119, P132; Turkish Neonatal Soc, 2012, TURKISH J PEDIATR, V54, P216; Viegas M, 2004, J INFECTION, V49, P222, DOI 10.1016/j.jinf.2003.10.006; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang VJ, 2012, J ENVIRON HEALTH, V75, P8; Weiland SK, 2004, OCCUP ENVIRON MED, V61, P609, DOI 10.1136/oem.2002.006809; Williams LJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036161, 10.1371/journal.pone.0048695]; Xirasagar S, 2006, EUR J PEDIATR, V165, P747, DOI 10.1007/s00431-006-0164-6; Xu ZW, 2012, INT J ENV RES PUB HE, V9, P3298, DOI 10.3390/ijerph9093298; Xu ZW, 2012, ENVIRON RES, V117, P120, DOI 10.1016/j.envres.2012.07.002; Ye Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-101; YoussefAgha AH, 2012, J ASTHMA, V49, P464, DOI 10.3109/02770903.2012.677896; Yuksel H, 1996, ACTA PAEDIATR JAPON, V38, P606; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X; Zacarias OP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-93; Zou XN, 2012, BRAZ J INFECT DIS, V16, P457, DOI 10.1016/j.bjid.2012.08.001	88	30	32	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e112508	10.1371/journal.pone.0112508	http://dx.doi.org/10.1371/journal.pone.0112508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503413	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400004
J	Hou, XS; McMillan, M; Coumans, JVF; Poljak, A; Raftery, MJ; Pereg, L				Hou, Xingsheng; McMillan, Mary; Coumans, Joelle V. F.; Poljak, Anne; Raftery, Mark J.; Pereg, Lily			Cellular Responses during Morphological Transformation in Azospirillum brasilense and Its flcA Knockout Mutant	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; FUNGUS THIELAVIOPSIS-BASICOLA; ESCHERICHIA-COLI K-12; N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; AUREUS STRESS TOLERANCE; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; MEMBRANE-PROTEINS; OXIDATIVE STRESS; OUTER-MEMBRANE	FlcA is a response regulator controlling flocculation and the morphological transformation of Azospirillum cells from vegetative to cyst-like forms. To understand the cellular responses of Azospirillum to conditions that cause morphological transformation, proteins differentially expressed under flocculation conditions in A. brasilense Sp7 and its flcA knockout mutant were investigated. Comparison of 2-DE protein profiles of wild-type (Sp7) and a flcA deletion mutant (Sp7-flcA Delta) revealed a total of 33 differentially expressed 2-DE gel spots, with 22 of these spots confidently separated to allow protein identification. Analysis of these spots by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and MASCOT database searching identified 48 proteins (>= 10% emPAI in each spot). The functional characteristics of these proteins included carbon metabolism (beta-ketothiolase and citrate synthase), nitrogen metabolism (Glutamine synthetase and nitric oxide synthase), stress tolerance (superoxide dismutase, Alkyl hydroperoxidase and ATP-dependent Clp protease proteolytic subunit) and morphological transformation (transducer coupling protein). The observed differences between Sp7 wild-type and flcA(-) strains enhance our understanding of the morphological transformation process and help to explain previous phenotypical observations. This work is a step forward in connecting the Azospirillum phenome and genome.	[Hou, Xingsheng; McMillan, Mary; Coumans, Joelle V. F.; Pereg, Lily] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Hou, Xingsheng] Shanxi Med Univ, Dept Microbiol & Immunol, Taiyuan, Shanxi, Peoples R China; [Coumans, Joelle V. F.] Univ New England, Sch Rural Med, Armidale, NSW, Australia; [Poljak, Anne; Raftery, Mark J.] Univ New S Wales, Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW, Australia; [Poljak, Anne] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New England; Shanxi Medical University; University of New England; University of New South Wales Sydney; University of New South Wales Sydney	Pereg, L (corresponding author), Univ New England, Sch Sci & Technol, Armidale, NSW, Australia.	lily.pereg@une.edu.au	Coumans, Joelle/D-9793-2011	Coumans, Joelle/0000-0001-6642-5202; Poljak, Anne/0000-0001-9953-1984; McMillan, Mary/0000-0002-2336-3985	University of New England; Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province [2014-95]	University of New England; Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province	L.P. received a Faculty of the Sciences Internal Research Grant, from the University of New England. X.H. was supported by a UNERA International Fee & Stipend Scholarship from the University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Xingsheng Hou received funding under the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province (No. 2014-95) for the period 01/2014 to 12/2015.	ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ARMSTRONGBUISSERET L, 1995, MICROBIOL-SGM, V141, P1655, DOI 10.1099/13500872-141-7-1655; ASSMUS B, 1995, APPL ENVIRON MICROB, V61, P1013, DOI 10.1128/AEM.61.3.1013-1019.1995; Bellenger K, 2002, J BACTERIOL, V184, P5654, DOI 10.1128/JB.184.20.5654-5660.2002; Berleman JE, 2005, MOL MICROBIOL, V56, P1457, DOI 10.1111/j.1365-2958.2005.04646.x; Bible A, 2012, J BACTERIOL, V194, P3343, DOI 10.1128/JB.00310-12; Bible AN, 2008, J BACTERIOL, V190, P6365, DOI 10.1128/JB.00734-08; BONNEFOY V, 1992, MOL MICROBIOL, V6, P3595; BOZOUKLIAN H, 1986, ANN INST PASTEUR MIC, V137B, P3, DOI 10.1016/S0769-2609(86)80089-8; Burdman S, 1998, MICROBIOL-SGM, V144, P1989, DOI 10.1099/00221287-144-7-1989; Burdman S, 2000, FEMS MICROBIOL LETT, V189, P259, DOI 10.1111/j.1574-6968.2000.tb09240.x; Burdman S, 2000, CRIT REV MICROBIOL, V26, P91, DOI 10.1080/10408410091154200; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Castellen P, 2009, EUR J SOIL BIOL, V45, P100, DOI 10.1016/j.ejsobi.2008.09.010; Chang HY, 1996, MICROB PATHOGENESIS, V20, P255, DOI 10.1006/mpat.1996.0024; Clegg S, 2002, MOL MICROBIOL, V44, P143, DOI 10.1046/j.1365-2958.2002.02858.x; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Coumans JVF, 2011, ENVIRON MICROBIOL, V13, P576, DOI 10.1111/j.1462-2920.2010.02358.x; Coumans JVF, 2010, PROTEOMICS, V10, P1573, DOI 10.1002/pmic.200900301; Coumans JVF, 2009, PROTEOMICS, V9, P335, DOI 10.1002/pmic.200800251; DAMERAU K, 1993, J BACTERIOL, V175, P53, DOI 10.1128/JB.175.1.53-63.1993; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; DEZAMAROCZY M, 1993, J BACTERIOL, V175, P2507, DOI 10.1128/JB.175.9.2507-2515.1993; DEZAMAROCZY M, 1990, MOL GEN GENET, V224, P421, DOI 10.1007/BF00262437; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; Frees D, 1999, MOL MICROBIOL, V31, P79, DOI 10.1046/j.1365-2958.1999.01149.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Frees D, 2012, J PROTEOME RES, V11, P95, DOI 10.1021/pr200956s; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Genevaux P, 1999, ARCH MICROBIOL, V172, P1, DOI 10.1007/s002030050732; Gerk LP, 2000, APPL ENVIRON MICROB, V66, P2175, DOI 10.1128/AEM.66.5.2175-2184.2000; Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; GREENBERG JT, 1988, EMBO J, V7, P2611, DOI 10.1002/j.1460-2075.1988.tb03111.x; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Hashimoto W, 2005, BIOCHEMISTRY-US, V44, P13783, DOI 10.1021/bi050873b; Herschkovitz Y, 2005, MICROB ECOL, V50, P277, DOI 10.1007/s00248-004-0148-x; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Kadouri D, 2005, CRIT REV MICROBIOL, V31, P55, DOI 10.1080/10408410590899228; Kadouri D, 2003, APPL ENVIRON MICROB, V69, P3244, DOI 10.1128/AEM.69.6.3244-3250.2003; Kadouri D, 2002, APPL ENVIRON MICROB, V68, P2943, DOI 10.1128/AEM.68.6.2943-2949.2002; KATUPITIYA S, 1995, APPL ENVIRON MICROB, V61, P1987, DOI 10.1128/AEM.61.5.1987-1995.1995; Kock H, 2004, J BACTERIOL, V186, P5856, DOI 10.1128/JB.186.17.5856-5864.2004; KRAMER GF, 1987, J BACTERIOL, V169, P2259, DOI 10.1128/jb.169.5.2259-2266.1987; Kruger E, 2000, J BACTERIOL, V182, P3259, DOI 10.1128/JB.182.11.3259-3265.2000; Lee AI, 1999, J BACTERIOL, V181, P5309, DOI 10.1128/JB.181.17.5309-5316.1999; Lerner A, 2009, MICROBIOL-SGM, V155, P4058, DOI 10.1099/mic.0.031807-0; Lim H, 2003, J AM SOC MASS SPECTR, V14, P957, DOI 10.1016/S1044-0305(03)00144-2; MAGASANIK B, 1982, ANNU REV GENET, V16, P135, DOI 10.1146/annurev.ge.16.120182.001031; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Malhotra M, 2008, NITRIC OXIDE S UNPUB; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; McMillan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098162; Mollerach M, 1998, J EXP MED, V188, P2047, DOI 10.1084/jem.188.11.2047; Mothes G, 1996, ARCH MICROBIOL, V166, P405, DOI 10.1007/BF01682987; Mothes G, 1998, ARCH MICROBIOL, V169, P360, DOI 10.1007/s002030050583; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Otani M, 2001, J BACTERIOL, V183, P6282, DOI 10.1128/JB.183.21.6282-6287.2001; Pereg Gerk L, 1998, MOL PLANT MICROBE IN, V11, P177; Priebe GP, 2004, INFECT IMMUN, V72, P4224, DOI 10.1128/IAI.72.7.4224-4232.2004; QADRI F, 1988, J CLIN MICROBIOL, V26, P1343, DOI 10.1128/JCM.26.7.1343-1348.1988; RABIN RS, 1993, J BACTERIOL, V175, P3259, DOI 10.1128/jb.175.11.3259-3268.1993; RABIN RS, 1992, P NATL ACAD SCI USA, V89, P8419, DOI 10.1073/pnas.89.18.8419; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; SADASIVAN L, 1987, J BACTERIOL, V169, P1670, DOI 10.1128/jb.169.4.1670-1677.1987; SADASIVAN L, 1985, J BACTERIOL, V163, P716, DOI 10.1128/JB.163.2.716-723.1985; Salonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077894; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SANDLIN RC, 1995, INFECT IMMUN, V63, P229, DOI 10.1128/IAI.63.1.229-237.1995; SCHULMAN H, 1977, J BIOL CHEM, V252, P6299; Steenhoudt O, 2000, FEMS MICROBIOL REV, V24, P487, DOI 10.1111/j.1574-6976.2000.tb00552.x; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; SUTCLIFFE JG, 1978, NUCLEIC ACIDS RES, V5, P2721, DOI 10.1093/nar/5.8.2721; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Thomsen LE, 2002, MICROBIOL-SGM, V148, P2727, DOI 10.1099/00221287-148-9-2727; Trainer MA, 2006, APPL MICROBIOL BIOT, V71, P377, DOI 10.1007/s00253-006-0354-1; Valverde A, 2006, FEMS MICROBIOL LETT, V265, P186, DOI 10.1111/j.1574-6968.2006.00482.x; Van Dommelen A, 2003, APPL ENVIRON MICROB, V69, P5699, DOI 10.1128/AEM.69.9.5699-5701.2003; von Lohneysen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034237; Wang G, 1998, LETT APPL MICROBIOL, V26, P31, DOI 10.1046/j.1472-765X.1998.00264.x; Wasim M, 2009, MICROBIOL-SGM, V155, P1192, DOI 10.1099/mic.0.022541-0; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Young K, 1995, J BIOL CHEM, V270, P30384, DOI 10.1074/jbc.270.51.30384; Zhao ZX, 2008, PLANT CELL, V20, P3210, DOI 10.1105/tpc.108.063263	91	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114435	10.1371/journal.pone.0114435	http://dx.doi.org/10.1371/journal.pone.0114435			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502569	Green Published, gold			2022-12-27	WOS:000346375400031
J	Wu, JX; Zhao, YY; Wu, X; An, HX				Wu, Jing-Xun; Zhao, Yuan-Yuan; Wu, Xuan; An, Han-Xiang			Clinicopathological and Prognostic Significance of CD24 Overexpression in Patients with Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							HEAT-STABLE ANTIGEN; P-SELECTIN; SIGNAL-TRANSDUCTION; CELLS; EXPRESSION; CARCINOMA; ADENOCARCINOMA; PROGRESSION; METASTASIS; SURVIVAL	Objective: The prognostic significance of CD24 expression for survival in patients with gastric cancer remains controversial. We conducted a meta-analysis to investigate the impact of CD24 expression on clinicopathological features and survival outcomes in gastric cancer. Methods: A comprehensive literature search of the electronic databases PubMed, Embase, Web of Science and China National Knowledge Infrastructure (CNKI; up to April 8, 2014) was performed for relevant studies using multiple search strategies. Correlations between CD24 expression and clinicopathological features and overall survival (OS) were analyzed. Results: A total of 1,041 patients with gastric cancer from 9 studies were included. The pooled odds ratios (ORs) indicated CD24 expression was associated with tumor depth (OR=0.45, 95% confidence interval [CI] 50.32-0.63; P<0.00001), status of lymph nodes (OR=0.40, 95% CI=0.25-0.64; P=0.0001) and tumor node metastasis (TNM) stage (OR=0.56, 95% CI=0.41-0.77; P=0.0003). The pooled hazard ratio (HR) for OS showed overexpression of CD24 reduced OS in gastric cancer (HR=1.99, 95% CI=1.29-3.07, P=0.002). Whereas, combined ORs showed that CD24 expression had no correlation with tumor differentiation or Lauren classifications. Conclusion: CD24 overexpression in patients with gastric cancer indicated worse survival outcomes and was associated with common clinicopathological poor prognostic factors.	[Wu, Jing-Xun; An, Han-Xiang] Xiamen Univ, Affiliated Hosp 1, Dept Med Oncol, Xiamen, Fujian, Peoples R China; [Zhao, Yuan-Yuan] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Xuan] Peking Univ, Shenzhen Hosp, Dept Med Oncol, Shenzhen, Guangdong, Peoples R China	Xiamen University; State Key Lab Oncology South China; Sun Yat Sen University; Peking University	An, HX (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Med Oncol, Xiamen, Fujian, Peoples R China.	anhanxiang@yahoo.com	Wu, Xuan/AAE-4778-2020; ZHAO, YUAN/HCI-5831-2022	An, Han-Xiang/0000-0002-3453-9149				Adachi Y, 2000, CANCER-AM CANCER SOC, V89, P1418; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bektas S, 2010, PATHOL ONCOL RES, V16, P569, DOI 10.1007/s12253-010-9248-8; Chen M, 2006, ARCH IMMUNOL THER EX, V54, P75, DOI 10.1007/s00005-006-0010-6; Chou YY, 2007, ANN SURG ONCOL, V14, P2748, DOI 10.1245/s10434-007-9501-x; Darwish Nevine S, 2004, Cancer Res Treat, V36, P298, DOI 10.4143/crt.2004.36.5.298; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FISCHER GF, 1990, J IMMUNOL, V144, P638; Friederichs J, 2000, CANCER RES, V60, P6714; Hundahl SA, 1997, CANCER, V80, P2333, DOI 10.1002/(SICI)1097-0142(19971215)80:12<2333::AID-CNCR15>3.0.CO;2-V; Japanese Gastric Cancer Association Registration Committee, 2006, Gastric Cancer, V9, P51; Jian, 2009, J CHONGQING MED U, V34, P1348; KADMON G, 1994, BIOCHEM BIOPH RES CO, V198, P1209, DOI 10.1006/bbrc.1994.1171; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kristiansen G, 2004, J MOL HISTOL, V35, P255; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2009, ONCOL REP, V22, P1149, DOI 10.3892/or_00000548; Li O, 2004, J EXP MED, V200, P1083, DOI 10.1084/jem.20040779; Liu XW, 2014, J SURG ONCOL, V109, P859, DOI 10.1002/jso.23599; Lynch HT, 2005, J SURG ONCOL, V90, P114, DOI 10.1002/jso.20214; MANTEL N, 1959, J NATL CANCER I, V22, P719; Ming Si-Chun, 1998, Gastric Cancer, V1, P31, DOI 10.1007/s101200050053; Nielsen PJ, 1997, BLOOD, V89, P1058, DOI 10.1182/blood.V89.3.1058; Niu, 2009, J NONGKEN MED, V31, P129; PIRRUCCELLO SJ, 1986, J IMMUNOL, V136, P3779; SAMMAR M, 1994, INT IMMUNOL, V6, P1027, DOI 10.1093/intimm/6.7.1027; SERLIN O, 1977, CANCER, V40, P1318, DOI 10.1002/1097-0142(197709)40:3<1318::AID-CNCR2820400349>3.0.CO;2-9; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Su MC, 2006, CANCER LETT, V235, P34, DOI 10.1016/j.canlet.2005.03.059; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Takahashi M, 2013, HEPATO-GASTROENTEROL, V60, P653, DOI 10.5754/hge12763; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wells GA, 2011, NEWCATSLE OTTAWA SCA; [杨世斌 Yang Shibin], 2012, [中国病理生理杂志, Chinese Journal of Pathophysiology], V28, P1224; 姚宏亮, 2008, [中国病理生理杂志, Chinese Journal of Pathophysiology], V24, P1629	39	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114746	10.1371/journal.pone.0114746	http://dx.doi.org/10.1371/journal.pone.0114746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503963	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400048
J	Lacroix, L; Manzano, S; Vandertuin, L; Hugon, F; Galetto-Lacour, A; Gervaix, A				Lacroix, Laurence; Manzano, Sergio; Vandertuin, Lynda; Hugon, Florence; Galetto-Lacour, Annick; Gervaix, Alain			Impact of the Lab-Score on Antibiotic Prescription Rate in Children with Fever without Source: A Randomized Controlled Trial	PLOS ONE			English	Article							SERIOUS BACTERIAL-INFECTIONS; PNEUMOCOCCAL CONJUGATE VACCINE; YOUNG FEBRILE INFANTS; C-REACTIVE PROTEIN; EMERGENCY-DEPARTMENT; PRACTICE GUIDELINE; PROCALCITONIN; MANAGEMENT; ERA; MENINGITIS	Background: The Lab-score, based on the combined determination of procalcitonin, C-reactive protein and urinary dipstick results, has been shown accurate in detecting serious bacterial infections (SBI) in children with fever without source (FWS) on retrospective cohorts. We aimed to prospectively assess the utility of the Lab-score in safely decreasing antibiotic prescriptions in children with FWS and to determine its diagnostic characteristics compared to common SBI biomarkers. Methods: Randomized controlled trial in children 7 days to 36 months old with FWS, allocated either to the Lab-score group (Lab-score reported, blinded WBC count) or to the control group (WBC, bands and C-reactive protein determined, blinded procalcitonin and Lab-score), followed up until recovery. Demographic data, antibiotic prescription rate, admission rate and diagnostic properties of the Labscore were analyzed. Results: 271 children were analyzed. No statistically significant difference concerning antibiotic prescription rate was observed: 41.2% (54 of 131) in the Labscore group and 42.1% (59 of 140) in the control group (p = 1.000). If recommendations based on the Lab-score had been strictly applied, a hypothetical 30.6% treatment rate would have been encountered, compared to the overall 41.7% observed rate (p = 0.0095). A Lab-score >= 3 showed the following characteristics: sensitivity 85.1% (95% CI: 76.5-93.6%), specificity 87.3% (95% CI: 82.7-91.8%), positive predictive value 68.7% (95% CI: 58.7-78.7%), negative predictive value 94.1% (95% CI: 91.5-97.9%), positive and negative likelihood ratios: 6.68 and 0.17 respectively. Area under the receiver operating characteristic curve was best for the Lab-score (0.911, 95% CI: 0.871-0.950). Discussion: No difference regarding antibiotic treatment rate was observed when using the Lab-score, due to lack of adherence to the related recommendations. However, if strictly followed, a significant 26.5% reduction of antibiotic prescriptions would have been encountered. Medical education needs to be reinforced in order to observe rather than treat low-risk well-appearing children with FWS.	[Lacroix, Laurence; Manzano, Sergio; Vandertuin, Lynda; Hugon, Florence; Galetto-Lacour, Annick; Gervaix, Alain] Univ Hosp Geneva, Pediat Emergency Med Dept, Geneva, Switzerland	University of Geneva	Lacroix, L (corresponding author), Univ Hosp Geneva, Pediat Emergency Med Dept, Geneva, Switzerland.	laurence.lacroix@hcuge.ch	Lacroix, Laurence/ABF-5052-2021; Lacroix-Ducardonnoy, Laurence/HDN-9583-2022; Manzano, Sergio/ABG-6281-2020	Lacroix, Laurence/0000-0002-6636-3344; Lacroix-Ducardonnoy, Laurence/0000-0002-6636-3344; Manzano, Sergio/0000-0001-9603-5520	bioMerieux	bioMerieux	This work was financially supported by bioMerieux (http://www.biomerieux.fr) for data management and statistical analysis. The funder also provided technical support through the loan of the procalcitonin assay. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Arora R, 2013, PEDIATR CLIN N AM, V60, P1049, DOI 10.1016/j.pcl.2013.06.009; Baraff LJ, 2008, PEDIATR ANN, V37, P673, DOI 10.3928/00904481-20081001-01; BARAFF LJ, 1993, ANN EMERG MED, V22, P1198, DOI 10.1016/S0196-0644(05)80991-6; Baraff LJ, 2000, ANN EMERG MED, V36, P602, DOI 10.1067/mem.2000.110820; Basmaci R, 2011, J CLIN MICROBIOL, V49, P3442, DOI 10.1128/JCM.01015-11; Belfer RA, 2001, PEDIATR EMERG CARE, V17, P83, DOI 10.1097/00006565-200104000-00001; Benador N, 1998, PEDIATRICS, V102, P1422, DOI 10.1542/peds.102.6.1422; Bressan S, 2012, PEDIATR INFECT DIS J, V31, P1239, DOI 10.1097/INF.0b013e318266a9aa; Bressan S, 2012, ACTA PAEDIATR, V101, P271, DOI 10.1111/j.1651-2227.2011.02478.x; Chiappini E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-300; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Galetto-Lacour A, 2010, ARCH DIS CHILD, V95, P968, DOI 10.1136/adc.2009.176800; Galetto-Lacour A, 2010, EXPERT REV ANTI-INFE, V8, P1231, DOI 10.1586/ERI.10.118; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Herz AM, 2006, PEDIATR INFECT DIS J, V25, P293, DOI 10.1097/01.inf.0000207485.39112.bf; Holstiege J, 2013, EUR J PEDIATR, V172, P787, DOI 10.1007/s00431-013-1958-y; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Irwin AD, 2011, ARCH DIS CHILDHOOD-E, V96, P228, DOI 10.1136/archdischild-2011-300178; Lacour AG, 2001, EUR J PEDIATR, V160, P95, DOI 10.1007/s004310000681; Lacour AG, 2008, PEDIATR INFECT DIS J, V27, P654, DOI 10.1097/INF.0b013e318168d2b4; Lacroix L, 2012, CLIN BIOCHEM, V45, P593, DOI 10.1016/j.clinbiochem.2012.02.011; Luthander J, 2013, ACTA PAEDIATR, V102, P182, DOI 10.1111/apa.12077; Mahajan P, 2014, ACAD EMERG MED, V21, P171, DOI 10.1111/acem.12316; Maniaci V, 2008, PEDIATRICS, V122, P701, DOI 10.1542/peds.2007-3503; Manzano S, 2011, ARCH DIS CHILD, V96, P440, DOI 10.1136/adc.2010.203760; Manzano S, 2010, AM J EMERG MED, V28, P647, DOI 10.1016/j.ajem.2009.02.022; Massin MM, 2006, ACTA PAEDIATR, V95, P1446, DOI 10.1080/08035250600669751; MCCARTHY PL, 1985, PEDIATRICS, V76, P167; MCCARTHY PL, 1982, PEDIATRICS, V70, P802; Mintegi S, 2013, EMERG MED J; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Sard B, 2006, PEDIATR EMERG CARE, V22, P295, DOI 10.1097/01.pec.0000215137.51909.16; Simon AE, 2013, PEDIATR EMERG CARE, V29, P560, DOI 10.1097/PEC.0b013e31828e56e1	34	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115061	10.1371/journal.pone.0115061	http://dx.doi.org/10.1371/journal.pone.0115061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503770	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700089
J	Liang, JW; Shi, ZZ; Shen, TY; Che, X; Wang, Z; Shi, SS; Xu, X; Cai, Y; Zhao, P; Wang, CF; Zhou, ZX; Wang, MR				Liang, Jian-Wei; Shi, Zhi-Zhou; Shen, Tian-Yun; Che, Xu; Wang, Zheng; Shi, Su-Sheng; Xu, Xin; Cai, Yan; Zhao, Ping; Wang, Cheng-Feng; Zhou, Zhi-Xiang; Wang, Ming-Rong			Identification of Genomic Alterations in Pancreatic Cancer Using Array-Based Comparative Genomic Hybridization	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; SIGNALING PATHWAY; TUMOR GRADE; EXPRESSION; GROWTH; HMGA2; DELETION; APOBEC3B; AKT2; GENE	Background: Genomic aberration is a common feature of human cancers and also is one of the basic mechanisms that lead to overexpression of oncogenes and underexpression of tumor suppressor genes. Our study aims to identify frequent genomic changes in pancreatic cancer. Materials and Methods: We used array comparative genomic hybridization (array CGH) to identify recurrent genomic alterations and validated the protein expression of selected genes by immunohistochemistry. Results: Sixteen gains and thirty-two losses occurred in more than 30% and 60% of the tumors, respectively. High-level amplifications at 7q21.3-q22.1 and 19q13.2 and homozygous deletions at 1p33-p32.3, 1p22.1, 1q22, 3q27.2, 6p22.3, 6p21.31, 12q13.2, 17p13.2, 17q21.31 and 22q13.1 were identified. Especially, amplification of AKT2 was detected in two carcinomas and homozygous deletion of CDKN2C in other two cases. In 15 independent validation samples, we found that AKT2 (19q13.2) and MCM7 (7q22.1) were amplified in 6 and 9 cases, and CAMTA2 (17p13.2) and PFN1 (17p13.2) were homozygously deleted in 3 and 1 cases. AKT2 and MCM7 were overexpressed, and CAMTA2 and PFN1 were underexpressed in pancreatic cancer tissues than in morphologically normal operative margin tissues. Both GISTIC and Genomic Workbench software identified 22q13.1 containing APOBEC3A and APOBEC3B as the only homozygous deletion region. And the expression levels of APOBEC3A and APOBEC3B were significantly lower in tumor tissues than in morphologically normal operative margin tissues. Further validation showed that overexpression of PSCA was significantly associated with lymph node metastasis, and overexpression of HMGA2 was significantly associated with invasive depth of pancreatic cancer. Conclusion: These recurrent genomic changes may be useful for revealing the mechanism of pancreatic carcinogenesis and providing candidate biomarkers.	[Liang, Jian-Wei; Che, Xu; Wang, Zheng; Zhao, Ping; Wang, Cheng-Feng; Zhou, Zhi-Xiang] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp & Inst, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China; [Shi, Zhi-Zhou; Shen, Tian-Yun] Kunming Univ Sci & Technol, Fac Med, Kunming, Peoples R China; [Shi, Su-Sheng] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp & Inst, Dept Pathol, Beijing 100730, Peoples R China; [Xu, Xin; Cai, Yan; Wang, Ming-Rong] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp & Inst, State Key Lab Mol Oncol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kunming University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, ZZ (corresponding author), Kunming Univ Sci & Technol, Fac Med, Kunming, Peoples R China.	zhizhoushi@126.com; wangmr2015@126.com		Shen, Tianyun/0000-0003-4300-5349	National Science and Technology Major Project of China [2012ZX09506001, 2011YQ17006710]; National Natural Science Foundation of China [81241086]; Yunnan Provincial Research Foundation for Basic Research, China [2013FD012]	National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Research Foundation for Basic Research, China	This work was supported by National Science and Technology Major Project of China (2012ZX09506001, 2011YQ17006710), and National Natural Science Foundation of China (81241086), and the Yunnan Provincial Research Foundation for Basic Research, China (Grant No. 2013FD012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2009, J INFECT DIS, V200, P1054, DOI 10.1086/605644; Aumayr K, 2013, APPL IMMUNOHISTOCHEM; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Boyd KD, 2011, CLIN CANCER RES, V17, P7776, DOI 10.1158/1078-0432.CCR-11-1791; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chen D, 2012, INT J MOL SCI, V13, P1186, DOI 10.3390/ijms13011186; Ding X, 2014, CELL PROLIFERAT, V47, P146, DOI 10.1111/cpr.12096; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Harada T, 2002, CANCER RES, V62, P835; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kitoh H, 2005, J GASTROENTEROL, V40, P511, DOI 10.1007/s00535-005-1577-0; Kulkarni MS, 2002, LEUKEMIA, V16, P127, DOI 10.1038/sj.leu.2402328; Lehnen NC, 2013, HISTOPATHOLOGY, V63, P157, DOI 10.1111/his.12115; Leonard B, 2013, CANC RES; Leone PE, 2008, CLIN CANCER RES, V14, P6033, DOI 10.1158/1078-0432.CCR-08-0347; Miwa W, 1996, BIOCHEM BIOPH RES CO, V225, P968, DOI 10.1006/bbrc.1996.1280; Morishita A, 2013, CANCER RES, V73, P4289, DOI 10.1158/0008-5472.CAN-12-3848; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nitsche C, 2012, GASTROENTEROLOGY, V142, P377, DOI 10.1053/j.gastro.2011.10.026; Pham P, 2013, J BIOL CHEM, V288, P29294, DOI 10.1074/jbc.M113.504175; Piscuoglio S, 2012, HISTOPATHOLOGY, V60, P397, DOI 10.1111/j.1365-2559.2011.04121.x; Shi XH, 2009, CANCER GENE THER, V16, P227, DOI 10.1038/cgt.2008.82; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Tanno S, 2001, CANCER RES, V61, P589; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Xi YN, 2014, ASIAN PAC J TROP MED, V7, P289, DOI 10.1016/S1995-7645(14)60040-7; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zhou J, 2012, ASIAN PAC J CANCER P, V13, P719, DOI 10.7314/APJCP.2012.13.2.719	34	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114616	10.1371/journal.pone.0114616	http://dx.doi.org/10.1371/journal.pone.0114616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502777	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700033
J	Lu, Q; Yu, MX; Shen, CY; Chen, XP; Feng, T; Yao, YC; Li, JR; Li, H; Tu, WW				Lu, Qiao; Yu, Meixing; Shen, Chongyang; Chen, Xiaoping; Feng, Ting; Yao, Yongchao; Li, Jinrong; Li, Hong; Tu, Wenwei			Negligible Immunogenicity of Induced Pluripotent Stem Cells Derived from Human Skin Fibroblasts	PLOS ONE			English	Article							REGULATORY T-CELLS; NAIVE PRECURSORS; GENERATION; INDUCTION; ENGRAFT; GAMMA	Human induced pluripotent stem cells (hiPSCs) have potential applications in cell replacement therapy and regenerative medicine. However, limited information is available regarding the immunologic features of iPSCs. In this study, expression of MHC and T cell co-stimulatory molecules in hiPSCs, and the effects on activation, proliferation and cytokine production in allogeneic human peripheral blood mononuclear cells were examined. We found that no-integrate hiPSCs had no MHC-II and T cell co-stimulatory molecules expressions but had moderate level of MHC-I and HLA-G expressions. In contrast to human skin fibroblasts (HSFs) which significantly induced allogeneic T cell activation and proliferation, hiPSCs failed to induce allogeneic CD45(+) lymphocyte and CD8(+) T cell activation and proliferation but could induce a low level of allogeneic CD4(+) T cell proliferation. Unlike HSFs which induced allogeneic lymphocytes to produce high levels of IFN-gamma, TNF-alpha and IL-17, hiPSCs only induced allogeneic lymphocytes to produce IL-2 and IL-10, and promote IL-10-secreting regulatory Tcell (Treg) generation. Our study suggests that the integration-free hiPSCs had low or negligible immunogenicity, which may result from their induction of IL-10-secreting Treg.	[Lu, Qiao; Yu, Meixing; Shen, Chongyang; Feng, Ting; Li, Jinrong; Li, Hong; Tu, Wenwei] Sichuan Univ, Joint Res Ctr, West China Univ Hosp 2, Chengdu 610041, Sichuan, Peoples R China; [Lu, Qiao; Yu, Meixing; Shen, Chongyang; Feng, Ting; Li, Jinrong; Li, Hong; Tu, Wenwei] Sichuan Univ, Univ Hong Kong, Fac Med, Chengdu 610041, Sichuan, Peoples R China; [Lu, Qiao] Hubei Univ Nationalities, Dept Pediat, Univ Hosp, Enshi 445000, Hubei, Peoples R China; [Chen, Xiaoping; Yao, Yongchao] Chinese Acad Sci, Lab Pathogen Biol, State Key Lab Resp Dis, Ctr Infect & Immun,Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Li, Hong] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth De, West China Univ Hosp 2, Minist Educ, Chengdu 610041, Sichuan, Peoples R China; [Tu, Wenwei] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China	Sichuan University; Sichuan University; University of Hong Kong; Hubei Minzu University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Sichuan University; University of Hong Kong	Li, H (corresponding author), Sichuan Univ, Joint Res Ctr, West China Univ Hosp 2, Chengdu 610041, Sichuan, Peoples R China.	lh3985@gmail.com; wwtu@hkucc.hku.hk	Shen, Chongyang/W-8463-2019		National Natural Science Foundation of China (NSFC); Research Grants Council (RGC) of Hong Kong [N_HKU 747/11]; National Natural Science Foundation of China [81170606]; Doctoral Fund of Ministry of Education of China [20120181110087]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported in part by the grants from National Natural Science Foundation of China (NSFC) and the Research Grants Council (RGC) of Hong Kong Joint Research Scheme (N_HKU 747/11), National Natural Science Foundation of China (No. 81170606), and Doctoral Fund of Ministry of Education of China (No. 20120181110087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Audus KL, 2002, J PHARMACOL EXP THER, V301, P402, DOI 10.1124/jpet.301.2.402; Bradley JA, 2002, NAT REV IMMUNOL, V2, P859, DOI 10.1038/nri934; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Chadha R, 2011, TRANSPLANTATION, V91, P939, DOI 10.1097/TP.0b013e3182126eeb; Chan PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067969; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Falsini B, 2012, LANCET, V379, P2050, DOI 10.1016/S0140-6736(12)60890-3; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Itoh S, 2010, J CLIN IMMUNOL, V30, P235, DOI 10.1007/s10875-009-9366-9; Janeway CA, 1999, IMMUNOL RES, V19, P107, DOI 10.1007/BF02786480; Kim EM, 2013, BLOOD, V121, P5167, DOI 10.1182/blood-2012-11-467753; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; Liu PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069617; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Mauritz C, 2011, EUR HEART J, V32, P2634, DOI 10.1093/eurheartj/ehr166; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Pick M, 2012, STEM CELLS, V30, P2700, DOI 10.1002/stem.1242; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Schuerwegh AJ, 1999, CYTOKINE, V11, P783, DOI 10.1006/cyto.1998.0483; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Song M, 2012, ARCH PHARM RES, V35, P245, DOI 10.1007/s12272-012-0205-9; Suarez-Alvarez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tu WW, 2008, BLOOD, V112, P2554, DOI 10.1182/blood-2008-04-152041; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081; Wunderlich S, 2012, CELL REPROGRAM, V14, P471, DOI 10.1089/cell.2012.0041; Xi JY, 2011, STEM CELLS DEV, V20, P821, DOI 10.1089/scd.2010.0398; Yao YC, 2012, HUM GENE THER, V23, P238, DOI 10.1089/hum.2011.126; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zheng J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004943; Zheng JA, 2011, EUR J IMMUNOL, V41, P128, DOI 10.1002/eji.201040724; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329	48	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114949	10.1371/journal.pone.0114949	http://dx.doi.org/10.1371/journal.pone.0114949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503995	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700075
J	Tinne, N; Kaune, B; Kruger, A; Ripken, T				Tinne, Nadine; Kaune, Brigitte; Krueger, Alexander; Ripken, Tammo			Interaction Mechanisms of Cavitation Bubbles Induced by Spatially and Temporally Separated fs-Laser Pulses	PLOS ONE			English	Article							INDUCED BREAKDOWN THRESHOLDS; FEMTOSECOND LASER; OPTICAL-BREAKDOWN; AQUEOUS-MEDIA; 1ST-ORDER MODEL; WATER; DYNAMICS; NANOSECOND; TISSUE; COMPUTATION	The emerging use of femtosecond lasers with high repetition rates in the MHz regime together with limited scan speed implies possible mutual optical and dynamical interaction effects of the individual cutting spots. In order to get more insight into the dynamics a time-resolved photographic analysis of the interaction of cavitation bubbles is presented. Particularly, we investigated the influence of fs-laser pulses and their resulting bubble dynamics with various spatial as well as temporal separations. Different time courses of characteristic interaction effects between the cavitation bubbles were observed depending on pulse energy and spatio-temporal pulse separation. These ranged from merely no interaction to the phenomena of strong water jet formation. Afterwards, the mechanisms are discussed regarding their impact on the medical application of effective tissue cutting lateral to the laser beam direction with best possible axial precision: the mechanical forces of photodisruption as well as the occurring water jet should have low axial extend and a preferably lateral priority. Furthermore, the overall efficiency of energy conversion into controlled mechanical impact should be maximized compared to the transmitted pulse energy and unwanted long range mechanical side effects, e. g. shock waves, axial jet components. In conclusion, these experimental results are of great importance for the prospective optimization of the ophthalmic surgical process with high-repetition rate fs-lasers.	[Tinne, Nadine; Kaune, Brigitte; Krueger, Alexander; Ripken, Tammo] Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany		Tinne, N (corresponding author), Laser Zentrum Hannover eV, Biomed Opt Dept, Hannover, Germany.	n.tinne@lzh.de			fellowship "Foundation of German Business," Berlin, Germany - Germany's Federal Ministry for Education and Research; German Research Foundation (DFG) [Ri 2066/2-1]	fellowship "Foundation of German Business," Berlin, Germany - Germany's Federal Ministry for Education and Research; German Research Foundation (DFG)(German Research Foundation (DFG))	N. Tinne acknowledged support from the fellowship "Foundation of German Business," Berlin, Germany (funded by Germany's Federal Ministry for Education and Research). This work was funded by the German Research Foundation (DFG); DFG-Grant: Ri 2066/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CL, 2007, OPT EXPRESS, V15, P10303, DOI 10.1364/OE.15.010303; Arnold CL, 2005, APPL PHYS B-LASERS O, V80, P247, DOI 10.1007/s00340-004-1701-5; Blake JR, 1999, PHILOS T R SOC A, V357, P251, DOI 10.1098/rsta.1999.0326; BLAKE JR, 1987, ANNU REV FLUID MECH, V19, P99, DOI 10.1146/annurev.fl.19.010187.000531; Brujan EA, 2002, PHYS FLUIDS, V14, P85, DOI 10.1063/1.1421102; Brujan EA, 2006, J FLUID MECH, V558, P281, DOI 10.1017/S0022112006000115; Evans R, 2008, OPT EXPRESS, V16, P7481, DOI 10.1364/OE.16.007481; Glezer EN, 1997, OPT LETT, V22, P1817, DOI 10.1364/OL.22.001817; Hammer DX, 1996, IEEE J QUANTUM ELECT, V32, P670, DOI 10.1109/3.488842; Hammer DX, 1997, APPL OPTICS, V36, P5630, DOI 10.1364/AO.36.005630; Hansen A, 2013, BIOMED OPT EXPRESS, V4, P852, DOI 10.1364/BOE.4.000852; Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.3.CO;2-2; Jungnickel K., 1992, LASERS LIGHT OPHTHAL, V5, P95; Jungnickel K., 1994, BUBBLE DYNAMICS INTE; KENNEDY PK, 1995, IEEE J QUANTUM ELECT, V31, P2241, DOI 10.1109/3.477753; KENNEDY PK, 1995, IEEE J QUANTUM ELECT, V31, P2250, DOI 10.1109/3.477754; Kennedy PK, 1997, PROG QUANT ELECTRON, V21, P155, DOI 10.1016/S0079-6727(97)00002-5; Kiselev SB, 1999, PHYSICA A, V269, P252, DOI 10.1016/S0378-4371(99)00169-7; Klaseboer E, 2005, J FLUID MECH, V537, P387, DOI 10.1017/S0022112005005306; Knorz MC, 2008, J REFRACT SURG, V24, P875, DOI 10.3928/1081597X-20081101-04; LAUTERBORN W, 1985, ULTRASONICS, V23, P260, DOI 10.1016/0041-624X(85)90048-4; Lauterborn W, 1998, APPL SCI RES, V58, P63; LAUTERBORN W, 1974, ACUSTICA, V31, P51; LeClair ML, 2005, United States Patent, Patent No. [US 6,932,914 B2, 6932914]; Lubatschowski H, 2008, J REFRACT SURG, V24, P102, DOI 10.3928/1081597X-20080101-18; Nagy Z, 2009, J REFRACT SURG, V25, P1053, DOI 10.3928/1081597X-20091117-04; Noack J, 1998, J APPL PHYS, V83, P7488, DOI 10.1063/1.367512; Perez-Gutierrez F, 2007, PROC SPIE, V6435, DOI 10.1117/12.701566; Quinto-Su PA, 2009, J FLUID MECH, V633, P425, DOI 10.1017/S0022112009008064; Rungsiyaphornrat S, 2003, COMPUT FLUIDS, V32, P1049, DOI 10.1016/S0045-7930(02)00078-6; SACCHI CA, 1991, J OPT SOC AM B, V8, P337, DOI 10.1364/JOSAB.8.000337; Schaffer C. B., 2001, THESIS HARVARD U; Shima A, 1997, SHOCK WAVES, V7, P33, DOI 10.1007/s001930050060; TESTUDGIOVANNESCHI P, 1990, J APPL PHYS, V67, P3560, DOI 10.1063/1.345305; Tinne N, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.048001; Tinne N, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526366; TOMITA Y, 1990, APPL PHYS LETT, V57, P234, DOI 10.1063/1.103726; Tomita Y, 2003, J APPL PHYS, V94, P2809, DOI 10.1063/1.1594277; TOMITA Y, 1986, J FLUID MECH, V169, P535, DOI 10.1017/S0022112086000745; TOMITA Y, 1990, ACUSTICA, V71, P161; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 1999, APPL PHYS B-LASERS O, V68, P271, DOI 10.1007/s003400050617; Vogel A, 2001, PROC SPIE, V4257, P167, DOI 10.1117/12.434701; Vogel A., 1998, THESIS; Vogel A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038102	45	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114437	10.1371/journal.pone.0114437	http://dx.doi.org/10.1371/journal.pone.0114437			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502697	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700024
J	Roine, A; Saviauk, T; Kumpulainen, P; Karjalainen, M; Tuokko, A; Aittoniemi, J; Vuento, R; Lekkala, J; Lehtimaki, T; Tammela, TL; Oksala, NKJ				Roine, Antti; Saviauk, Taavi; Kumpulainen, Pekka; Karjalainen, Markus; Tuokko, Antti; Aittoniemi, Janne; Vuento, Risto; Lekkala, Jukka; Lehtimaki, Terho; Tammela, Teuvo L.; Oksala, Niku K. J.			Rapid and Accurate Detection of Urinary Pathogens by Mobile IMS-Based Electronic Nose: A Proof-of-Principle Study	PLOS ONE			English	Article							ISOLATES IN-VITRO; TRACT-INFECTIONS; GAS SENSORS; IDENTIFICATION; SPECTROMETRY; DIAGNOSIS	Urinary tract infection (UTI) is a common disease with significant morbidity and economic burden, accounting for a significant part of the workload in clinical microbiology laboratories. Current clinical chemisty point-of-care diagnostics rely on imperfect dipstick analysis which only provides indirect and insensitive evidence of urinary bacterial pathogens. An electronic nose (eNose) is a handheld device mimicking mammalian olfaction that potentially offers affordable and rapid analysis of samples without preparation at athmospheric pressure. In this study we demonstrate the applicability of ion mobility spectrometry (IMS) -based eNose to discriminate the most common UTI pathogens from gaseous headspace of culture plates rapidly and without sample preparation. We gathered a total of 101 culture samples containing four most common UTI bacteries: E. coli, S. saprophyticus, E. faecalis, Klebsiella spp and sterile culture plates. The samples were analyzed using ChemPro 100i device, consisting of IMS cell and six semiconductor sensors. Data analysis was conducted by linear discriminant analysis (LDA) and logistic regression (LR). The results were validated by leave-one-out and 5-fold cross validation analysis. In discrimination of sterile and bacterial samples sensitivity of 95% and specificity of 97% were achieved. The bacterial species were identified with sensitivity of 95% and specificity of 96% using eNose as compared to urine bacterial cultures. In conclusion: These findings strongly demonstrate the ability of our eNose to discriminate bacterial cultures and provides a proof of principle to use this method in urinanalysis of UTI.	[Roine, Antti; Saviauk, Taavi; Tuokko, Antti; Lehtimaki, Terho] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kumpulainen, Pekka; Karjalainen, Markus; Lekkala, Jukka] Tampere Univ Technol, Dept Automat Sci & Engn, FIN-33101 Tampere, Finland; [Aittoniemi, Janne; Vuento, Risto] Fimlab Labs, Dept Clin Microbiol, Tampere, Finland; [Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Tammela, Teuvo L.; Oksala, Niku K. J.] Univ Tampere, Sch Med, Dept Surg, FIN-33101 Tampere, Finland; [Tammela, Teuvo L.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Oksala, Niku K. J.] Tampere Univ Hosp, Dept Vasc Surg, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital	Roine, A (corresponding author), Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.	antti.roine@uta.fi	Lekkala, Jukka/G-4263-2014; Lehtimäki, Terho/AAD-1094-2022; Roine, Antti/AAU-5071-2020	Lekkala, Jukka/0000-0001-9293-2240; Lehtimäki, Terho/0000-0002-2555-4427; Roine, Antti/0000-0002-1811-2671; Kumpulainen, Pekka/0000-0003-4121-2707	Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital [9N035, X51001]; Tekes - the Finnish Funding Agency for Innovation for project "DiagNOSE - from extrasensory olfactory cues to status of wellbeing" for Tampere University of Technology [1010/31/2013]; University of Tampere [564/31/2013]	Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital; Tekes - the Finnish Funding Agency for Innovation for project "DiagNOSE - from extrasensory olfactory cues to status of wellbeing" for Tampere University of Technology; University of Tampere	This study was funded by the Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (grants 9N035 and X51001 for TL) and Tekes - the Finnish Funding Agency for Innovation for project "DiagNOSE - from extrasensory olfactory cues to status of wellbeing" project number 1010/31/2013 for Tampere University of Technology and 564/31/2013 for University of Tampere. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2001, J CLIN MICROBIOL, V39, P2590, DOI 10.1128/JCM.39.7.2590-2593.2001; Arasaradnam R. P., 2012, Journal of Medical Engineering & Technology, V36, P333, DOI 10.3109/03091902.2012.690015; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Bishop C. M, 2006, PATTERN RECOGNITION; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Bruins M, 2009, EUR J CLIN MICROBIOL, V28, P775, DOI 10.1007/s10096-009-0700-1; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Dutta R, 2002, BIOMED ENG ONLINE, V1, DOI 10.1186/1475-925X-1-4; Foxman B, 2002, AM J MED, V113, p5S; Geerlings SE, 1999, J MED MICROBIOL, V48, P535, DOI 10.1099/00222615-48-6-535; Gibson TD, 1997, SENSOR ACTUAT B-CHEM, V44, P413, DOI 10.1016/S0925-4005(97)00235-9; Grabe M, 2008, GUIDELINES MANAGEMEN; Hajek V, 1996, INT J SYST BACTERIOL, V46, P792, DOI 10.1099/00207713-46-3-792; Jackson J.E., 1991, WILEY SERIES PROBABI; Kodogiannis V, 2005, INT J NEURAL SYST, V15, P363, DOI 10.1142/S0129065705000347; Kodogiannis VS, 2005, J INTELL FUZZY SYST, V16, P1; Lykos P, 2001, J MICROBIOL, V39, P213; Mach KE, 2011, TRENDS PHARMACOL SCI, V32, P330, DOI 10.1016/j.tips.2011.03.001; Murray PR, 2012, J MOL DIAGN, V14, P419, DOI 10.1016/j.jmoldx.2012.03.007; Pavlou A, 2002, LETT APPL MICROBIOL, V35, P366, DOI 10.1046/j.1472-765X.2002.01197.x; Pavlou AK, 2002, BIOSENS BIOELECTRON, V17, P893, DOI 10.1016/S0956-5663(02)00078-7; Roine A, 2014, J UROLOGY, V192, P230, DOI 10.1016/j.juro.2014.01.113; Roine A, 2012, FUTURE ONCOL, V8, P1157, DOI [10.2217/FON.12.93, 10.2217/fon.12.93]; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; Schiffman S. S., 2000, EFFECTIVENESS ELECT, P1; Turner APF, 2004, NAT REV MICROBIOL, V2, P161, DOI 10.1038/nrmicro823; Utriainen M, 2003, SENSOR ACTUAT B-CHEM, V93, P17, DOI 10.1016/S0925-4005(03)00337-X; VernatRossi V, 1996, SENSOR ACTUAT B-CHEM, V37, P43, DOI 10.1016/S0925-4005(97)80070-6; Wilson AD, 2011, SENSORS-BASEL, V11, P1105, DOI 10.3390/s110101105	29	30	30	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114279	10.1371/journal.pone.0114279	http://dx.doi.org/10.1371/journal.pone.0114279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526592	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200003
J	Dalenberg, JR; Gutjar, S; ter Horst, GJ; de Graaf, K; Renken, RJ; Jager, G				Dalenberg, Jelle R.; Gutjar, Swetlana; ter Horst, Gert J.; de Graaf, Kees; Renken, Remco J.; Jager, Gerry			Evoked Emotions Predict Food Choice	PLOS ONE			English	Article							CONSUMPTION; WORDS; FACES; MODEL	In the current study we show that non-verbal food-evoked emotion scores significantly improve food choice prediction over merely liking scores. Previous research has shown that liking measures correlate with choice. However, liking is no strong predictor for food choice in real life environments. Therefore, the focus within recent studies shifted towards using emotion-profiling methods that successfully can discriminate between products that are equally liked. However, it is unclear how well scores from emotion-profiling methods predict actual food choice and/or consumption. To test this, we proposed to decompose emotion scores into valence and arousal scores using Principal Component Analysis (PCA) and apply Multinomial Logit Models (MLM) to estimate food choice using liking, valence, and arousal as possible predictors. For this analysis, we used an existing data set comprised of liking and food-evoked emotions scores from 123 participants, who rated 7 unlabeled breakfast drinks. Liking scores were measured using a 100-mm visual analogue scale, while food-evoked emotions were measured using 2 existing emotion-profiling methods: a verbal and a non-verbal method (EsSense Profile and PrEmo, respectively). After 7 days, participants were asked to choose 1 breakfast drink from the experiment to consume during breakfast in a simulated restaurant environment. Cross validation showed that we were able to correctly predict individualized food choice (1 out of 7 products) for over 50% of the participants. This number increased to nearly 80% when looking at the top 2 candidates. Model comparisons showed that evoked emotions better predict food choice than perceived liking alone. However, the strongest predictive strength was achieved by the combination of evoked emotions and liking. Furthermore we showed that non-verbal food-evoked emotion scores more accurately predict food choice than verbal food-evoked emotions scores.	[Dalenberg, Jelle R.; Gutjar, Swetlana; ter Horst, Gert J.; de Graaf, Kees; Renken, Remco J.; Jager, Gerry] Top Inst Food & Nutr, Wageningen, Netherlands; [Dalenberg, Jelle R.; ter Horst, Gert J.; Renken, Remco J.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Gutjar, Swetlana; de Graaf, Kees; Jager, Gerry] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; Wageningen University & Research	Dalenberg, JR (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	j.r.dalenberg@umcg.nl		Renken, Remco Jan/0000-0002-7777-9484; Dalenberg, Jelle R./0000-0001-8580-5358	TI Food and Nutrition; Danone and FrieslandCampina	TI Food and Nutrition; Danone and FrieslandCampina(Danone Nutricia)	Funding was realized by TI Food and Nutrition: http://www.tifn.nl/. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The sponsors Danone and FrieslandCampina did have a role in the study design. More specifically: the choice of stimuli, which were produced by these sponsors. Danone and FrieslandCampina had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DISCRETE CHOICE METH; Bhumiratana N, 2014, FOOD RES INT, V61, P83, DOI 10.1016/j.foodres.2014.03.008; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cardello AV, 2012, FOOD QUAL PREFER, V24, P243, DOI 10.1016/j.foodqual.2011.12.002; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; Desmet P., 2003, FUNOLOGY ENJOYMENT, P111, DOI [DOI 10.1007/1-4020-2967-5_12, 10.1007/1-4020-2967-5_12]; Desmet PMA, 2008, APPETITE, V50, P290, DOI 10.1016/j.appet.2007.08.003; Desmet Pieter M. A., 2007, KNOWLEDGE TECHNOLOGY, V20, P141, DOI DOI 10.1007/S12130-007-9018-4; Desmet PMA, 2000, ADV CONSUM RES, V27, P111; Fruhholz S, 2011, BIOL PSYCHOL, V87, P265, DOI 10.1016/j.biopsycho.2011.03.008; Gutjar S, 2014, APPETITE, V80, P109, DOI 10.1016/j.appet.2014.05.006; HAUSMAN J, 1984, ECONOMETRICA, V52, P1219, DOI 10.2307/1910997; Jiang Y, 2014, TRENDS FOOD SCI TECH, V36, P15, DOI 10.1016/j.tifs.2013.12.005; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; King SC, 2010, FOOD QUAL PREFER, V21, P168, DOI 10.1016/j.foodqual.2009.02.005; Koster EP, 2009, FOOD QUAL PREFER, V20, P70, DOI 10.1016/j.foodqual.2007.11.002; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Larsen R.J., 1992, EMOTION, P25; Levy CM, 2006, ACTA PSYCHOL, V123, P394, DOI 10.1016/j.actpsy.2006.06.006; Manzocco L, 2013, FOOD QUAL PREFER, V28, P17, DOI 10.1016/j.foodqual.2012.08.014; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; McFadden D, 1978, BEHAV TRAVEL MODELLI, P279, DOI DOI 10.4324/9781003156055-18; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Ng M, 2013, FOOD QUAL PREFER, V28, P193, DOI 10.1016/j.foodqual.2012.08.012; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schifferstein HNJ, 2010, FOOD QUAL PREFER, V21, P1100, DOI 10.1016/j.foodqual.2010.07.004; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Thomson DMH, 2010, FOOD QUAL PREFER, V21, P1117, DOI 10.1016/j.foodqual.2010.04.011; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zandstra EH, 1999, FOOD QUAL PREFER, V10, P411, DOI 10.1016/S0950-3293(98)00050-0	34	95	96	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115388	10.1371/journal.pone.0115388	http://dx.doi.org/10.1371/journal.pone.0115388			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25521352	Green Published, gold			2022-12-27	WOS:000348845600040
J	Oleson, EM; Slrovic, A; Bayless, AR; Hildebrand, JA				Oleson, Erin M.; Slrovic, Ana; Bayless, Alexandra R.; Hildebrand, John A.			Synchronous Seasonal Change in Fin Whale Song in the North Pacific	PLOS ONE			English	Article							BALAENOPTERA-PHYSALUS; HUMPBACK WHALES; GEOGRAPHIC-VARIATION; BLUE; CALLS; FREQUENCY; HAWAIIAN	Fin whale (Balaenoptera physalus) song consists of down-swept pulses arranged into stereotypic sequences that can be characterized according to the interval between successive pulses. As in blue (B. musculus) and humpback whales (Megaptera novaeangliae), these song sequences may be geographically distinct and may correlate with population boundaries in some regions. We measured inter-pulse intervals of fin whale songs within year-round acoustic datasets collected between 2000 and 2006 in three regions of the eastern North Pacific: Southern California, the Bering Sea, and Hawaii. A distinctive song type that was recorded in all three regions is characterized by singlet and doublet inter-pulse intervals that increase seasonally, then annually reset to the same shorter intervals at the beginning of each season. This song type was recorded in the Bering Sea and off Southern California from September through May and off Hawaii from December through April, with the song interval generally synchronized across all monitoring locations. The broad geographic and seasonal occurrence of this particular fin whale song type may represent a single population broadly distributed throughout the eastern Pacific with no clear seasonal migratory pattern. Previous studies attempting to infer population structure of fin whales in the North Pacific using synchronous individual song samples have been unsuccessful, likely because they did not account for the seasonal lengthening in song intervals observed here.	[Oleson, Erin M.] NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA; [Slrovic, Ana; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Bayless, Alexandra R.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa	Oleson, EM (corresponding author), NOAA Fisheries, Pacific Islands Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA.	erin.oleson@noaa.gov	Oleson, Erin/AAA-9681-2019	Oleson, Erin/0000-0002-4889-6059; Hildebrand, John/0000-0002-5418-9799	NOAA Fisheries Pacific Islands Fisheries Science Center; Alaska Department of Fish and Wildlife; United States Navy Chief of Naval Operations Environmental Compliance [CNO-N45]; Strategic Environmental Research and Development Program (SERDP)	NOAA Fisheries Pacific Islands Fisheries Science Center; Alaska Department of Fish and Wildlife; United States Navy Chief of Naval Operations Environmental Compliance; Strategic Environmental Research and Development Program (SERDP)	The Ecosystem and Oceanography and Protected Species Divisions at NOAA Fisheries Pacific Islands Fisheries Science Center supported deployment of HARPs at Cross Seamount and provided salary support for E. Oleson and A. Bayless during a portion of this work. The Alaska Department of Fish and Wildlife provided funds for the deployment and maintenance of HARPs in the Bering Sea. United States Navy Chief of Naval Operations Environmental Compliance (CNO-N45) and the Strategic Environmental Research and Development Program (SERDP) provided funds for deployment and maintenance of ARPs and HARPs off Hawaii Island and in the Southern California Bight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J., 2001, ANIMAL BEHAV EVOLUTI, V7th ed.; Aroyan JL, 2000, ACOUSTIC MODELS SOUN, P485; Beecher MD, 1996, ANIMAL BEHAV, V52; Castellote M, 2012, MAR MAMMAL SCI, V28, P325, DOI 10.1111/j.1748-7692.2011.00491.x; Cerchio S, 2001, ANIM BEHAV, V62, P313, DOI 10.1006/anbe.2001.1747; Cholewiak DM, 1998, THESIS CORNELL U ITH; Connor RC, 2000, CETACEAN SOCIETIES, P247; Croll DA, 2002, NATURE, V417, P809, DOI 10.1038/417809a; Darling J.D., 1983, THESIS U CALIFORNIA; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Delarue J, 2009, J ACOUST SOC AM, V125, P1774, DOI 10.1121/1.3068454; EDDS P L, 1988, Bioacoustics, V1, P131; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gedamke J, 2001, J ACOUST SOC AM, V109, P3038, DOI 10.1121/1.1371763; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Hatch L. T., 2004, SC56SD8 INT WHAL COM; Helweg DA, 1998, BEHAVIOUR, V135, P1; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Hut RA, 2011, PHILOS T R SOC B, V366, P2141, DOI 10.1098/rstb.2010.0409; KARSCH FJ, 1989, BIOL REPROD, V41, P1034, DOI 10.1095/biolreprod41.6.1034; Kellogg R, 1929, SMITHSONIAN I ANN RE, V1928, P457; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; Laws R. M., 1961, Discovery Reports, V31, P327; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; Mizroch SA, 2009, MAMMAL REV, V39, P193, DOI 10.1111/j.1365-2907.2009.00147.x; Moore SE, 1998, MAR MAMMAL SCI, V14, P617, DOI 10.1111/j.1748-7692.1998.tb00749.x; Morano JL, 2012, J ACOUST SOC AM, V132, P1207, DOI 10.1121/1.4730890; Nieukirk SL, 2012, J ACOUST SOC AM, V131, P1102, DOI 10.1121/1.3672648; Ohsumi S., 1958, Scientific Reports of the Whales Research Institute Tokyo, VNo. 13, P97; Oleson EM, 2003, MAR MAMMAL SCI, V19, P407; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; PAYNE K, 1985, Z TIERPSYCHOL, V68, P89; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rankin S, 2005, J ACOUST SOC AM, V118, P3346, DOI 10.1121/1.2046747; Sears R., 2002, ENCY MARINE MAMMALS, P112; Simon M, 2010, J ACOUST SOC AM, V128, P3200, DOI 10.1121/1.3495946; Sirovic A, 2004, DEEP-SEA RES PT II, V51, P2327, DOI 10.1016/j.dsr2.2004.08.005; Sirovic A, 2009, MAR MAMMAL SCI, V25, P125, DOI 10.1111/j.1748-7692.2008.00239.x; SMALS AGH, 1976, J CLIN ENDOCR METAB, V42, P979, DOI 10.1210/jcem-42-5-979; Smith JN, 2008, ANIMAL BEHAV, V76; THOMPSON PO, 1992, J ACOUST SOC AM, V92, P3051, DOI 10.1121/1.404201; Tomilin AJ, 1957, ZVERI SSSR PRILEZHAS; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; WATKINS WA, 1987, J ACOUST SOC AM, V82, P1901, DOI 10.1121/1.395685; WATKINS WA, 1981, SCI REP WHALES RES, V33, P83; Watkins William A., 2000, Oceanography, V13, P62; Wiggins S, 2003, MAR TECHNOL SOC J, V37, P13, DOI 10.4031/002533203787537375; Wiggins SM, 2007, HIGH FREQUENCY ACOUS, P551; Winn H.E., 1976, Cetology, VNo. 19, P1	50	37	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115678	10.1371/journal.pone.0115678	http://dx.doi.org/10.1371/journal.pone.0115678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521493	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600053
J	Jeannot, K; Diancourt, L; Vaux, S; Thouverez, M; Ribeiro, A; Coignard, B; Courvalin, P; Brisse, S				Jeannot, Katy; Diancourt, Laure; Vaux, Sophie; Thouverez, Michelle; Ribeiro, Amandina; Coignard, Bruno; Courvalin, Patrice; Brisse, Sylvain			Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France	PLOS ONE			English	Article							PREVALENT OXA CARBAPENEMASES; ANTIBIOTIC-RESISTANCE; STRAINS; OUTBREAK; CLONE; IDENTIFICATION; HOSPITALS; EMERGENCE; EVOLUTION; PCR	Carbapenem-resistant Acinetobacter baumannii have emerged globally. The objective of this study was to investigate the epidemiology, clonal diversity and resistance mechanisms of imipenem non-susceptible A. baumannii isolates in France. Between December 2010 and August 2011, 132 notifications were collected, including 37 outbreaks corresponding to 242 cases (2 to 55 per cluster). Multilocus sequence typing, pulsed-field gel electrophoresis (PFGE) and characterisation of carbapenemase-encoding genes were performed on 110 non-repetitive isolates. Gene bla(OXA-23) was the most frequently detected (82%), followed by bla(OXA-24) (11%) and bla(OXA-58) (7%). Eleven sequence types (ST) were distinguished, among which sequence types ST1, ST2 (64%), ST20, ST25, ST85 and ST107. Isolates from epidemiological clusters had the same ST and resistance genes, indicating probable transmission within centres. In contrast, PFGE types of isolates differed among centres, arguing against transmission among centers. This study provides the first epidemiological snapshot of the population of A. baumannii with reduced susceptibility to carbapenems from France, and further underlines the predominance of international clones.	[Jeannot, Katy; Ribeiro, Amandina; Courvalin, Patrice] Inst Pasteur, Ctr Natl Reference Resistance Antibiot, Unite Agents Antibacteriens, Paris, France; [Diancourt, Laure; Brisse, Sylvain] Inst Pasteur, Paris, France; [Vaux, Sophie] French Inst Publ Hlth Surveillance InVS, St Maurice, France; [Thouverez, Michelle] CHRU Jean Minjoz, Lab Epidemiol & Hyg Hosp, Besancon, France; [Brisse, Sylvain] CNRS, UMR3525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institute of Public Health Surveillance; Universite de Franche-Comte; CHU Besancon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Brisse, S (corresponding author), Inst Pasteur, Paris, France.	Sylvain.Brisse@pasteur.fr	Brisse, Sylvain/M-8723-2013	Brisse, Sylvain/0000-0002-2516-2108; Jeannot, katy/0000-0002-4634-8550; Vaux, Sophie/0000-0001-6648-6320; DIANCOURT, Laure/0000-0002-9670-3274	Institut Pasteur; French Ministry of Health through the French Institute for Public Health Surveillance	Institut Pasteur(European Commission); French Ministry of Health through the French Institute for Public Health Surveillance	This work was supported by the Institut Pasteur and the French Ministry of Health through the French Institute for Public Health Surveillance (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Alsultan AA, 2013, J MED MICROBIOL, V62, P885, DOI 10.1099/jmm.0.057216-0; [Anonymous], 2013, RESEAU ALERTE INVEST; Bonnin RA, 2013, EXPERT REV ANTI-INFE, V11, P571, DOI [10.1586/ERI.13.38, 10.1586/eri.13.38]; Bonnin RA, 2013, EMERG INFECT DIS, V19, P822, DOI 10.3201/eid1905.121618; Bourdon N, 2011, J ANTIMICROB CHEMOTH, V66, P713, DOI 10.1093/jac/dkq524; Coignard B, 2006, EUROSURVEILLANCE, V11; D'Arezzo S, 2011, J ANTIMICROB CHEMOTH, V66, P54, DOI 10.1093/jac/dkq407; Decousser JW, 2013, EURO SURVEILL, V18; Desenclos JC, 2009, EUROSURVEILLANCE, V14, P1; Di Popolo A, 2011, CLIN MICROBIOL INFEC, V17, P197, DOI 10.1111/j.1469-0691.2010.03254.x; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Endo S, 2012, J ANTIMICROB CHEMOTH, V67, P1623, DOI 10.1093/jac/dks094; European Centre for Disease Prevention and Control, EUR ANT RES SURV NET; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; Heritier C, 2005, J ANTIMICROB CHEMOTH, V55, P115, DOI 10.1093/jac/dkh500; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Higgins PG, 2010, INT J ANTIMICROB AG, V35, P305, DOI 10.1016/j.ijantimicag.2009.10.014; Higgins PG, 2009, J ANTIMICROB CHEMOTH; Karah N, 2012, DRUG RESIST UPDATE, V15, P237, DOI 10.1016/j.drup.2012.06.001; Kempf M, 2013, APMIS, V121, P64, DOI 10.1111/j.1600-0463.2012.02935.x; Koh TH, 2012, EPIDEMIOL INFECT, V140, P535, DOI 10.1017/S0950268811001129; Liakopoulos A., 2012, EURO SURVEILL, V17; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Naas T, 2006, EMERG INFECT DIS, V12, P1214, DOI 10.3201/eid1708.051547; National_ Committee_ for_ Clinical_ Laboratory_ Standards, 2010, PERF STAND ANT SUS S; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; TANKOVIC J, 1994, J CLIN MICROBIOL, V32, P2677, DOI 10.1128/JCM.32.11.2677-2681.1994; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Vaux S, 2011, B EPIDEMIOLOGIQUE HE, V31-32, P355; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zarrilli R, 2013, INT J ANTIMICROB AG, V41, P11, DOI 10.1016/j.ijantimicag.2012.09.008	39	32	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115452	10.1371/journal.pone.0115452	http://dx.doi.org/10.1371/journal.pone.0115452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517732	gold, Green Published			2022-12-27	WOS:000347215600067
J	Sorii, LJJ; Leggett, LE; Lorenzetti, DL; Silvius, J; Robertson, D; Mansell, L; Holroyd-Leduc, J; Noseworthy, TW; Clement, FM				Sorii, Lesley J. J.; Leggett, Laura E.; Lorenzetti, Diane L.; Silvius, James; Robertson, Duncan; Mansell, Lynne; Holroyd-Leduc, Jayna; Noseworthy, Tom W.; Clement, Fiona M.			Effective Use of the Built Environment to Manage Behavioural and Psychological Symptoms of Dementia: A Systematic Review	PLOS ONE			English	Review							LONG-TERM-CARE; INTERVENTIONS; QUALITY; DESIGN; PEOPLE	Objective: To determine the effectiveness of built environment interventions in managing behavioural and psychological symptoms of dementia (BPSD) among residents in long-term care settings. Methods: Systematic review of literature published from 1995-2013. Studies were included if they: were randomized controlled trials, quasi-experimental trials, or comparative cohort studies; were in long-term or specialized dementia care; included residents with dementia and BPSD; and examined effectiveness of a built environment intervention on frequency and/or severity of BPSD. Quality of included studies was assessed using the Downs and Black Checklist. Study design, patient population, intervention, and outcomes were extracted and narratively synthesized. Results: Five low to moderate quality studies were included. Three categories of interventions were identified: change/redesign of existing physical space, addition of physical objects to environment, and type of living environment. One of the two studies that examined change/redesign of physical spaces reported improvements in BPSD. The addition of physical objects to an existing environment (n=1) resulted in no difference in BPSD between treatment and control groups. The two studies that examined relocation to a novel living environment reported decreased or no difference in the severity and/or frequency of BPSD post-intervention. No studies reported worsening of BPSD following a built environment intervention. Conclusions: The range of built environment interventions is broad, as is the complex and multi-dimensional nature of BPSD. There is inconclusive evidence to suggest a built environment intervention which is clinically superior in long-term care settings. Further high-quality methodological and experimental studies are required to demonstrate the feasibility and effectiveness of such interventions.	[Sorii, Lesley J. J.; Leggett, Laura E.; Lorenzetti, Diane L.; Holroyd-Leduc, Jayna; Noseworthy, Tom W.; Clement, Fiona M.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Sorii, Lesley J. J.; Leggett, Laura E.; Lorenzetti, Diane L.; Noseworthy, Tom W.; Clement, Fiona M.] Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada; [Lorenzetti, Diane L.] Inst Hlth Econ, Edmonton, AB, Canada; [Holroyd-Leduc, Jayna] Univ Calgary, Dept Med, Calgary, AB, Canada; [Silvius, James; Robertson, Duncan; Mansell, Lynne; Holroyd-Leduc, Jayna; Noseworthy, Tom W.] Alberta Hlth Serv, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	Clement, FM (corresponding author), Univ Calgary, Dept Community Hlth Sci, Teaching Res & Wellness Bldg, Calgary, AB, Canada.	fclement@ucalgary.ca		Lorenzetti, Diane L./0000-0001-8423-3458				Alzheimer Society of Canada, 2010, RIS TID IMP DEM CAN; Azermai M, 2012, AGEING RES REV, V11, P78, DOI 10.1016/j.arr.2011.07.002; Ballard CG, 2006, COCHRANE DATABASE SY, V1; Buffington ALH, 2013, J AM OSTEOPATH ASSOC, V113, P768, DOI 10.7556/jaoa.2013.046; Cadieux MA, 2013, AM J ALZHEIMERS DIS, V28, P723, DOI 10.1177/1533317513500840; Calkins M.P., 1988, DESIGN DEMENTIA; Calkins MP, 2009, NEUROREHABILITATION, V25, P145, DOI 10.3233/NRE-2009-0512; Caspi E, 2013, AGGRESSIVE BEHAV RES; Cohen U, 1993, CONT ENV PEOPLE DEME; Cohen U, 1991, HOLDING HOME DESIGNI; Cohen-Mansfield J, 2005, ALZ DIS ASSOC DIS, V19, P37, DOI 10.1097/01.wad.0000155066.39184.61; Conn DK, 2006, CAN J GERIATR, V9, pS59; Corcoran M, 1991, PHYSICAL OCCUPATIONA, V9, P5, DOI DOI 10.1080/J148V09N03_; Cox Helen, 2004, J Gerontol Nurs, V30, P37; Day K, 2000, GERONTOLOGIST, V40, P397, DOI 10.1093/geront/40.4.397; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Edgerton Edward, 2010, Issues Ment Health Nurs, V31, P306, DOI 10.3109/01612840903383976; Fauth EB, 2013, INT J GERIATRIC PSYC; Gitlin LN, 2003, ALZHEIMERS CARE Q, V4, P85; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Namazi KH, 1992, AM J ALZHEIMERS DIS, V7, P16, DOI DOI 10.1177/153331759200700105; National Collaborating Centre for mental health, 2007, DEMENTIA NICE SCIE G; Ouslander JG, 2003, J AM GERIATR SOC, V51, P1287; Radhakrishnan R, 2012, ADV PSYCHIAT TREATME, V18, P144, DOI DOI 10.1192/APT.BP.110.008268; Reimer MA, 2004, J AM GERIATR SOC, V52, P1085, DOI 10.1111/j.1532-5415.2004.52304.x; Scottish Intercollegiate Guideline Network (SIGN), 2006, MAN PAT DEM NAT CLIN; Seitz DP, 2012, J AM MED DIR ASSOC, V13, P503, DOI 10.1016/j.jamda.2011.12.059; van der Linde RM, 2013, INT J GERIATR PSYCH, V28, P700, DOI 10.1002/gps.3873; van Hoof J, 2010, AM J ALZHEIMERS DIS, V25, P202, DOI 10.1177/1533317509358885; Wilkes L, 2005, AUSTRALAS J AGEING, V24, P141, DOI 10.1111/j.1741-6612.2005.00105.x	30	22	26	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115425	10.1371/journal.pone.0115425	http://dx.doi.org/10.1371/journal.pone.0115425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517508	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600066
J	Kawamoto, R; Ninomiya, D; Hasegawa, Y; Kasai, Y; Kusunoki, T; Ohtsuka, N; Kumagi, T				Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Kumagi, Teru			Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Elderly Persons	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; RISK; LIPOPROTEIN; ANTIOXIDANT; MEN	Chronic kidney disease (CKD) is a major public health problem. However, few studies have examined the significance of serum bilirubin as a risk factor for the development of CKD in the general Japanese population. The subjects comprised 413 men (mean age: 79 +/- 9 years; (range, 60-100 years) and 637 women (mean age: 81 +/- 8 years; range, 60-106 years) who visited the medical department of Seiyo Municipal Nomura Hospital. We examined the relationship between increased serum bilirubin and renal function that was evaluated by estimated glomerular filtration rate (eGFR) using CKD-EPI equations modified by a Japanese coefficient. Stepwise multiple regression analysis with eGFR as the objective variable, and adjusted risk factors as the explanatory variables, showed that serum bilirubin (beta=0.11, P<0.001) was significantly and independently associated with eGFR, in addition to gender, age, prevalence of antihypertensive medication, triglycerides, prevalence of antidiabetic medication, and serum uric acid. Compared with stages 1+2 (eGFR >= 60.0 ml/min/1.73 m(2)), mean multivariate-adjusted odds ratio {95% (confidence interval (CI)} for hypobilirubinemia (first quartile, <0.52 mg/dL) was 3.52 (range: 1.88-6.59). Next, to control potential confounding factors, data were further stratified by gender, age, medication (antihypertensive, antidyslipidemic, and antidiabetic agents), and prevalence of cardiovascular disease. The standardized coefficient for eGFR was significant in both groups, and there was no interaction between the groups. Our data demonstrated an independent positive association between serum bilirubin and eGFR in both genders. Low serum bilirubin level would be useful as a potential risk factor for renal function.	[Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kumagi, Teru] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan; [Kawamoto, Ryuichi; Ninomiya, Daisuke; Hasegawa, Yoichi; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Seiyo, Ehime, Japan	Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 790, Japan.	rykawamo@m.ehime.ca.jp	Kumagi, Teru/AAS-7427-2021	Kumagi, Teru/0000-0002-2292-7750	Foundation for the Development of the Community	Foundation for the Development of the Community	This study was supported, in part, by a grant-in-aid from the Foundation for the Development of the Community (2014). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Fukui M, 2008, KIDNEY INT, V74, P1197, DOI 10.1038/ki.2008.398; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Ishizaka N, 2007, HYPERTENS RES, V30, P1035, DOI 10.1291/hypres.30.1035; Kalkan GY, 2014, ANGIOLOGY, V65, P308, DOI 10.1177/0003319713507627; Kawamoto R, 2014, PLOS ONE IN PRESS; Kumar A, 2007, J TROP PEDIATRICS, V53, P69, DOI 10.1093/tropej/fml060; Levey AS, 2007, AM J KIDNEY DIS, V49, P175, DOI 10.1053/j.ajkd.2006.12.013; Mazzone GL, 2009, BIOCHEM BIOPH RES CO, V386, P338, DOI 10.1016/j.bbrc.2009.06.029; Meisinger C, 2006, EUR HEART J, V27, P1245, DOI 10.1093/eurheartj/ehi880; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Ollinger R, 2007, CELL CYCLE, V6, P39, DOI 10.4161/cc.6.1.3700; Ohnaka K, 2010, EXPERT REV ENDOCRINO, V5, P891, DOI [10.1586/eem.10.65, 10.1586/EEM.10.65]; Ryu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0075178; Schwertner HA, 1998, ATHEROSCLEROSIS, V136, P383, DOI 10.1016/S0021-9150(97)00232-3; Schwertner HA, 2000, ATHEROSCLEROSIS, V150, P381, DOI 10.1016/S0021-9150(99)00387-1; Shin HS, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-29; Stec DE, 2013, AM J HYPERTENS, V26, P918, DOI 10.1093/ajh/hpt038; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Targher G, 2009, KIDNEY INT, V75, P863, DOI 10.1038/ki.2008.677; Tiribelli C, 2005, J HEPATOL, V42, P170, DOI 10.1016/j.jhep.2004.12.002; Vera T, 2010, AM J PHYSIOL-REG I, V299, pR1044, DOI 10.1152/ajpregu.00316.2010; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024	26	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115294	10.1371/journal.pone.0115294	http://dx.doi.org/10.1371/journal.pone.0115294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514359	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300050
J	Kelly, NI; Alzaid, A; Nash, GW; Gamperl, AK				Kelly, Nick I.; Alzaid, Abdullah; Nash, Gordon W.; Gamperl, A. Kurt			Metabolic Depression in Cunner (Tautogolabrus adspersus) Is Influenced by Ontogeny, and Enhances Thermal Tolerance	PLOS ONE			English	Article							COD GADUS-MORHUA; JUVENILE ATLANTIC COD; ANOXIA TOLERANCE; AEROBIC SCOPE; BODY-MASS; TEMPERATURE; FISH; RESPONSES; ANIMALS; WINTER	To examine the effect of ontogeny on metabolic depression in the cunner (Tautogolabrus adspersus), and to understand how ontogeny and the ability to metabolically depress influence this species' upper thermal tolerance: 1) the metabolic rate of 9 degrees C-acclimated cunner of three size classes [0.2-0.5 g, young of the year (YOY); 3-6 g, small; and 80-120 g, large (adult)] was measured during a 2 degrees C per day decrease in temperature; and 2) the metabolic response of the same three size classes of cunner to an acute thermal challenge [2 degrees C h(-1) from 10 degrees C until Critical Thermal Maximum, CTMax] was examined, and compared to that of the Atlantic cod (Gadus morhua). The onset-temperature for metabolic depression in cunner increased with body size, i.e. from 5 degrees C in YOY cunner to 7 degrees C in adults. In contrast, the extent of metabolic depression was similar to 80% (Q(10)=similar to 15) for YOY fish similar to 65% (Q(10)=similar to 8) for small fish and similar to 55% (Q(10)=similar to 5) for adults, and this resulted in the metabolic scaling exponent (b) gradually increasing from 0.84 to 0.92 between 9 degrees C to 1 degrees C. All size classes of cunner had significantly (approximately 60%) lower routine metabolic rates at 10 degrees C than Atlantic cod. However, there was no species' difference in the temperature-induced maximum metabolic rate, and this resulted in factorial metabolic scope values that were more than two-fold greater for cunner, and CTMax values that were 6-9 degrees C higher (similar to 21 vs. 28 degrees C). These results: 1) show that ontogeny influences the temperature of initiation and the extent of metabolic depression in cunner, but not O-2 consumption when in a hypometabolic state; and 2) suggest that the evolution of cold-induced metabolic depression in this northern wrasse species has not resulted in a trade-off with upper thermal tolerance, but instead, an enhancement of this species' metabolic plasticity.	[Kelly, Nick I.; Alzaid, Abdullah; Nash, Gordon W.; Gamperl, A. Kurt] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	Memorial University Newfoundland	Gamperl, AK (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada.	kgamperl@mun.ca			Natural Sciences and Research Council of Canada	Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The Natural Sciences and Research Council of Canada (http://www.nserc-crsng.gc.ca) provided funding for this research to AKG through their Discovery Grants program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auster PJ, 1989, BIOL REP, V82; BEAMISH FWH, 1970, J FISH RES BOARD CAN, V27, P1209, DOI 10.1139/f70-143; Benfey TJ, 1997, ENVIRON BIOL FISH, V49, P259, DOI 10.1023/A:1007361231325; Bigelow HB, 1953, FISHES GULF MAINE; Brett J., 1979, FISH PHYSIOL, V8, P279, DOI DOI 10.1016/S1546-5098(08)60029-1; Cargnelli LM, 1997, T AM FISH SOC, V126, P153, DOI 10.1577/1548-8659(1997)126<0153:NFELIE>2.3.CO;2; Carline RF, 2001, T AM FISH SOC, V130, P1211, DOI 10.1577/1548-8659(2001)130&lt;1211:CTMOWA&gt;2.0.CO;2; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Corkum CP, 2009, J EXP ZOOL PART A, V311A, P231, DOI 10.1002/jez.520; COSTA IAS, 2007, THESIS MEMORIAL U NE; Costa IASF, 2013, PHYSIOL BIOCHEM ZOOL, V86, P233, DOI 10.1086/669538; Curran MC, 1992, THESIS MIT; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; DEW C B, 1976, Chesapeake Science, V17, P101, DOI 10.2307/1351052; Gollock MJ, 2006, J EXP BIOL, V209, P2961, DOI 10.1242/jeb.02319; GREEN JM, 1971, CAN J ZOOLOG, V49, P1497, DOI 10.1139/z71-218; GUPPY M, 1994, COMP BIOCHEM PHYS B, V109, P175, DOI 10.1016/0305-0491(94)90001-9; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hansen SL, 2009, J FISH BIOL, V74, P1355, DOI 10.1111/j.1095-8649.2008.02169.x; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Huang QD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082837; Kemp JOG, 2009, AFR ZOOL, V44, P151, DOI 10.3377/004.044.0203; Kerfoot JR, 2012, J EXP ZOOL PART A, V317A, P266, DOI 10.1002/jez.1720; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Killen SS, 2010, ECOL LETT, V13, P184, DOI 10.1111/j.1461-0248.2009.01415.x; Lewis JM, 2007, AM J PHYSIOL-REG I, V293, pR474, DOI 10.1152/ajpregu.00594.2006; Nilsson GE, 2004, J EXP BIOL, V207, P3131, DOI 10.1242/jeb.00979; Ospina AF, 2004, ENVIRON BIOL FISH, V70, P339, DOI 10.1023/B:EBFI.0000035429.39129.34; Peck MA, 2003, CAN J FISH AQUAT SCI, V60, P929, DOI 10.1139/F03-079; Perez-Casanova JC, 2008, J FISH BIOL, V72, P899, DOI 10.1111/j.1095-8649.2007.01763.x; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Post JR, 1996, CAN J FISH AQUAT SCI, V53, P910, DOI 10.1139/cjfas-53-4-910; Recsetar MS, 2012, T AM FISH SOC, V141, P1433, DOI 10.1080/00028487.2012.694830; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Rome Lawrence C., 1992, P183; SAUNDERS RL, 1963, J FISH RES BOARD CAN, V20, P373, DOI 10.1139/f63-031; Sayer MDJ, 1996, J FISH BIOL, V49, P64, DOI 10.1111/j.1095-8649.1996.tb00005.x; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Scott WB, 1988, ATLANTIC FISHES CANA; Spaas JT, 1960, HYDROBIOLOGIA, V15, P75; Steinhausen MF, 2008, J EXP BIOL, V211, P3915, DOI 10.1242/jeb.019281; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; STOREY KB, 1990, Q REV BIOL, V65, P145, DOI 10.1086/416717; VANWAVERSVELD J, 1989, J EXP BIOL, V142, P325; WALSH PJ, 1983, PHYSIOL ZOOL, V56, P532, DOI 10.1086/physzool.56.4.30155876; Wang T, 2007, SCIENCE, V315, P49, DOI 10.1126/science.1137359	48	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114765	10.1371/journal.pone.0114765	http://dx.doi.org/10.1371/journal.pone.0114765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514755	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000349146300021
J	Zhao, F; Malm, SW; Hinchman, AN; Li, H; Beeks, CG; Klimecki, WT				Zhao, Fei; Malm, Scott W.; Hinchman, Alyssa N.; Li, Hui; Beeks, Connor G.; Klimecki, Walter T.			Arsenite-Induced Pseudo-Hypoxia Results in Loss of Anchorage-Dependent Growth in BEAS-2B Pulmonary Epithelial Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; DRINKING-WATER; NEOPLASTIC TRANSFORMATION; HYDROXYLASE; HIF-1-ALPHA; EXPOSURE; GENES; ADIPOGENESIS; GLYCOLYSIS; METABOLISM	Epidemiology studies have established a strong link between lung cancer and arsenic exposure. Currently, the role of disturbed cellular energy metabolism in carcinogenesis is a focus of scientific interest. Hypoxia inducible factor-1 alpha (HIF-1A) is a key regulator of energy metabolism, and it has been found to accumulate during arsenite exposure under oxygen-replete conditions. We modeled arsenic-exposed human pulmonary epithelial cells in vitro with BEAS-2B, a non-malignant lung epithelial cell line. Constant exposure to 1 mu M arsenite (As) resulted in the early loss of anchorage-dependent growth, measured by soft agar colony formation, beginning at 6 weeks of exposure. This arsenite exposure resulted in HIF-1A accumulation and increased glycolysis, similar to the physiologic response to hypoxia, but in this case under oxygen-replete conditions. This "pseudo-hypoxia" response was necessary for the maximal acquisition of anchorage-independent growth in arsenite-exposed BEAS-2B. The HIF-1A accumulation and induction in glycolysis was sustained throughout a 52 week course of arsenite exposure in BEAS-2B. There was a time-dependent increase in anchorage-independent growth during the exposure to arsenite. When HIF-1A expression was stably suppressed, arsenite-induced glycolysis was abrogated, and the anchorage-independent growth was reduced. These findings establish that arsenite exerts a hypoxia-mimetic effect, which plays an important role in the subsequent gain of malignancy-associated phenotypes.	[Zhao, Fei; Malm, Scott W.; Hinchman, Alyssa N.; Li, Hui; Beeks, Connor G.; Klimecki, Walter T.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of Arizona	Klimecki, WT (corresponding author), Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA.	klimecki@pharmacy.arizona.edu	; Zhao, Fei/D-1857-2014	Li, Hui/0000-0001-5578-7259; Malm, Scott/0000-0002-3376-3421; Zhao, Fei/0000-0002-2149-1457	National Institutes of Health and National Institute of Environmental Health Sciences [ES 04940, ES00694]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940, R03ES023921, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health and National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health and National Institute of Environmental Health Sciences, grants ES 04940 and ES00694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; AMSTAD P, 1988, MOL CARCINOGEN, V1, P151, DOI 10.1002/mc.2940010303; Aposhian H, 1989, REV BIOCHEM TOXICOL, V10, P265; Bolt AM, 2010, TOXICOL LETT, V199, P153, DOI 10.1016/j.toxlet.2010.08.017; Carpenter RL, 2011, BIOCHEM BIOPH RES CO, V414, P533, DOI 10.1016/j.bbrc.2011.09.102; Ganapathy S, 2014, J BIOL CHEM, V289, P5340, DOI 10.1074/jbc.M113.531020; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Guo HR, 2004, CANCER EPIDEM BIOMAR, V13, P638; He Q, 2011, AM J PHYSIOL-ENDOC M, V300, pE877, DOI 10.1152/ajpendo.00626.2010; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hou YY, 2013, ENVIRON HEALTH PERSP, V121, P237, DOI 10.1289/ehp.1205731; Hu YM, 2012, CELL RES, V22, P399, DOI 10.1038/cr.2011.145; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Johnen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064139; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Li GW, 2011, J CELL PHYSIOL, V226, P3225, DOI 10.1002/jcp.22683; Li Q, 2006, TOXICOL APPL PHARM, V213, P245, DOI 10.1016/j.taap.2005.11.006; Li YN, 2014, TOXICOL LETT, V224, P165, DOI 10.1016/j.toxlet.2013.10.029; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazurek S, 1999, J CELL PHYSIOL, V181, P136; McNeill LA, 2002, BIOORG MED CHEM LETT, V12, P1547, DOI 10.1016/S0960-894X(02)00219-6; Moran LA., 2012, PRINCIPLES BIOCH; Ribeiro CAD, 2008, ENVIRON TOXICOL PHAR, V25, P304, DOI 10.1016/j.etap.2007.10.033; PIZER LI, 1963, J BIOL CHEM, V238, P3934; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Smith AH, 1998, AM J EPIDEMIOL, V147, P660, DOI 10.1093/oxfordjournals.aje.a009507; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Stueckle TA, 2012, TOXICOL APPL PHARM, V261, P204, DOI 10.1016/j.taap.2012.04.003; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wong BW, 2013, TRENDS BIOCHEM SCI, V38, P3, DOI 10.1016/j.tibs.2012.10.004; Xu Y, 2013, TOXICOL APPL PHARM, V272, P542, DOI 10.1016/j.taap.2013.06.017; Zhang T, 2012, TOXICOL SCI, V130, P298, DOI 10.1093/toxsci/kfs240; Zhao F, 2013, TOXICOL APPL PHARM, V271, P72, DOI 10.1016/j.taap.2013.04.020; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	41	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114549	10.1371/journal.pone.0114549	http://dx.doi.org/10.1371/journal.pone.0114549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513814	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300015
J	Zubillaga, M; Skewes, O; Soto, N; Rabinovich, JE; Colchero, F				Zubillaga, Maria; Skewes, Oscar; Soto, Nicolas; Rabinovich, Jorge E.; Colchero, Fernando			Bayesian Inference on the Effect of Density Dependence and Weather on a Guanaco Population from Chile	PLOS ONE			English	Article							VICUGNA-VICUGNA; TIME-SERIES; MODEL; CLIMATE; DYNAMICS; MANAGEMENT; SURVIVAL; DROUGHT; HARVEST; ELK	Understanding the mechanisms that drive population dynamics is fundamental for management of wild populations. The guanaco (Lama guanicoe) is one of two wild camelid species in South America. We evaluated the effects of density dependence and weather variables on population regulation based on a time series of 36 years of population sampling of guanacos in Tierra del Fuego, Chile. The population density varied between 2.7 and 30.7 guanaco/km(2), with an apparent monotonic growth during the first 25 years; however, in the last 10 years the population has shown large fluctuations, suggesting that it might have reached its carrying capacity. We used a Bayesian state-space framework and model selection to determine the effect of density and environmental variables on guanaco population dynamics. Our results show that the population is under density dependent regulation and that it is currently fluctuating around an average carrying capacity of 45,000 guanacos. We also found a significant positive effect of previous winter temperature while sheep density has a strong negative effect on the guanaco population growth. We conclude that there are significant density dependent processes and that climate as well as competition with domestic species have important effects determining the population size of guanacos, with important implications for management and conservation.	[Zubillaga, Maria; Rabinovich, Jorge E.] Univ Nacl La Plata, Ctr Estudios Parasitol & Vectores CEPAV, CONICET CCT La Plata, La Plata, Argentina; [Colchero, Fernando] Univ Southern Denmark, Dept Math & Comp Sci IMADA, DK-5230 Odense, Denmark; [Colchero, Fernando] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging MaxO, DK-5230 Odense, Denmark; [Skewes, Oscar] Univ Concepcion, Dept Ciencias Pecuarias, Chillan, Chile; [Soto, Nicolas] Serv Agr Ganadero, Dept Prot Recursos Nat, Santiago, Chile	University of Southern Denmark; University of Southern Denmark; Universidad de Concepcion	Zubillaga, M (corresponding author), Univ Nacl La Plata, Ctr Estudios Parasitol & Vectores CEPAV, CONICET CCT La Plata, La Plata, Argentina.	mariazubillaga22@gmail.com; colchero@imada.sdu.dk	Rabinovich, Jorge E./AAI-2536-2019; Colchero, Fernando/A-9368-2015	Rabinovich, Jorge E./0000-0002-3792-742X; Colchero, Fernando/0000-0001-8613-4568				Abrams PA, 2009, AM NAT, V174, P321, DOI 10.1086/603627; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Bank MS, 2002, J ZOOL, V258, P215, DOI 10.1017/S0952836902001334; Bardsen BJ, 2012, J ANIM ECOL, V81, P364, DOI 10.1111/j.1365-2656.2011.01913.x; Bateman AW, 2012, J ANIM ECOL, V81, P628, DOI 10.1111/j.1365-2656.2011.01934.x; Bonacic C, 2002, ORYX, V36, P118, DOI 10.1017/S0030605302000182; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Case T. J, 2000, ILLUSTRATED GUIDE TH; Caughley G, 1980, ANAL VERTEBRATE POPU; Clark J. S, 2007, MODELS ECOLOGICAL DA; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; Davis D.E., 1987, MANUAL TECNICAS GEST, P233; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; FRANKLIN WL, 1994, WILDLIFE SOC B, V22, P253; Franklin WL, 1997, WILDLIFE SOC B, V25, P65; Fujita H, 1982, IDIA, V397/400, P1; Gelfand AE, 1998, BIOMETRIKA, V85, P1, DOI 10.1093/biomet/85.1.1; Gelman A., 2004, BAYESIAN DATA ANAL; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; HORN HS, 1968, ECOLOGY, V49, P776, DOI 10.2307/1935548; Jacobson AR, 2004, ECOLOGY, V85, P1598, DOI 10.1890/02-0753; Koons DN, 2012, J MAMMAL, V93, P475, DOI 10.1644/11-MAMM-A-281.1; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; McCullough DR, 1999, J MAMMAL, V80, P1130, DOI 10.2307/1383164; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MOUSSALLI E, 1986, CAN J FISH AQUAT SCI, V43, P135, DOI 10.1139/f86-014; Novaro AJ, 2009, MAMMALIA, V73, P148, DOI 10.1515/MAMM.2009.016; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; Pascual MA, 1997, CONSERV BIOL, V11, P966, DOI 10.1046/j.1523-1739.1997.95437.x; Patterson BR, 2002, OECOLOGIA, V130, P62, DOI 10.1007/s004420100783; RABINOVICH JE, 1985, ECOL MODEL, V30, P275, DOI 10.1016/0304-3800(85)90071-7; Rabinvich J.E., 1991, P337; Raedeke KJ, 1978, GUANACO MAGALLANES; Rey A, 2012, SMALL RUMINANT RES, V107, P92, DOI 10.1016/j.smallrumres.2012.05.009; Sarno RJ, 1999, J APPL ECOL, V36, P937, DOI 10.1046/j.1365-2664.1999.00449.x; Sarno RJ, 1999, J MAMMAL, V80, P1158, DOI 10.2307/1383166; Sarno RJ, 1999, BEHAV ECOL, V10, P41, DOI 10.1093/beheco/10.1.41; Serrano E, 2008, BIOL LETTERS, V4, P512, DOI 10.1098/rsbl.2008.0221; Shaw AK, 2012, J MAMMAL, V93, P658, DOI 10.1644/11-MAMM-A-257.1; SKOGLAND T, 1986, J WILDLIFE MANAGE, V50, P314, DOI 10.2307/3801919; Soto N, 2010, DISTRIBUCION ABUNDAN; Stewart KM, 2006, WILDLIFE MONOGR, P1, DOI 10.2193/0084-0173(2006)167[1:HOBNAE]2.0.CO;2; Taper ML, 2002, J WILDLIFE MANAGE, V66, P106, DOI 10.2307/3802877; Team. RDC, 2007, R LANG ENV STAT COMP; Telleria JL, 1986, MANUAL CENSO VERTEBR; Zubillaga M, 2014, F1000RESEARCH	51	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115307	10.1371/journal.pone.0115307	http://dx.doi.org/10.1371/journal.pone.0115307			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514510	Green Published, gold			2022-12-27	WOS:000349146300051
J	Falk, MK; Singh, A; Faber, C; Nissen, MH; Hviid, T; Sorensen, TL				Falk, Mads Kruger; Singh, Amardeep; Faber, Carsten; Nissen, Mogens Holst; Hviid, Thomas; Sorensen, Torben Lykke			CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine/Chemokine Receptor Complex in Patients with AMD	PLOS ONE			English	Article							MACULAR DEGENERATION; SUBRETINAL MICROGLIA; RETINAL MICROGLIA; ANIMAL-MODEL; T-CELLS; EXPRESSION; PATHOGENESIS; CHEMOKINE; ACCUMULATION; MONOCYTES	Purpose: The chemokine receptors CX3CR1 and CCR2 have been implicated in the development of age-related macular degeneration (AMD). The evidence is mainly derived from experimental cell studies and murine models of AMD. The purpose of this study was to investigate the association between expression of CX3CR1 and CCR2 on different leukocyte subsets and AMD. Furthermore we measured the plasma levels of ligands CX3CL1 and CCL2. Methods: Patients attending our department were asked to participate in the study. The diagnosis of AMD was based on clinical examination and multimodal imaging techniques. Chemokine plasma level and chemokine receptor expression were measured by flow-cytometry. Results: A total of 150 participants were included. We found a significantly lower expression of CX3CR1 on CD8(+) T cells in the neovascular AMD group compared to the control group (p=0.04). We found a significant positive correlation between CCR2 and CX3CR1 expression on CD8(+) cells (r=0.727, p=0.0001). We found no difference in plasma levels of CX3CL1 and CCL2 among the groups. Conclusions: Our results show a down regulation of CX3CR1 on CD8(+) cells; this correlated to a low expression of CCR2 on CD8(+) cells. Further studies are needed to elucidate the possible role of this cell type in AMD development.	[Falk, Mads Kruger; Singh, Amardeep; Sorensen, Torben Lykke] Univ Copenhagen, Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark; [Falk, Mads Kruger; Singh, Amardeep; Hviid, Thomas; Sorensen, Torben Lykke] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Faber, Carsten; Nissen, Mogens Holst] Univ Copenhagen, Fac Hlth Sci, Dept Microbiol Immunol & Int Hlth, Copenhagen, Denmark; [Hviid, Thomas] Univ Copenhagen, Hosp Roskilde, Dept Clin Biochem, Ctr Immune Regulat & Reprod Immunol, Roskilde, Denmark; [Faber, Carsten] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Falk, MK (corresponding author), Univ Copenhagen, Hosp Roskilde, Dept Ophthalmol, Clin Eye Res Unit, Roskilde, Denmark.	madskrugerfalk@gmail.com	Nissen, Mogens/B-4825-2008; Faber, Carsten/I-4150-2013; Faber, Carsten/N-3210-2019; Singh, Amardeep/ABI-4544-2020	Nissen, Mogens/0000-0001-7729-8667; Faber, Carsten/0000-0002-2517-7270; Faber, Carsten/0000-0002-2517-7270; 	Danish Eye Health Society (Vaern om Synet); Danish Eye Research foundation; Synoptik Foundation; Region Zealand's Research Fund	Danish Eye Health Society (Vaern om Synet); Danish Eye Research foundation; Synoptik Foundation; Region Zealand's Research Fund	This study was supported by the Danish Eye Health Society (Vaern om Synet) - www.vos.dk, the Danish Eye Research foundation - www.dkblind.dk, Region Zealand's Research Fund -http://www.regionsjaelland.dk/sundhed/forskning/praktisk%20om%20forskning/sider/den-regionale-forskningsfond.aspx, and the Synoptik Foundation http://synoptik-fonden.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bloch SB, 2013, ACTA OPHTHALMOL, V91, P42, DOI 10.1111/j.1755-3768.2011.02268.x; Burgisser P, 2007, CYTOM PART A, V71A, P632, DOI 10.1002/cyto.a.20414; Buschini E, 2011, PROG NEUROBIOL, V95, P14, DOI 10.1016/j.pneurobio.2011.05.011; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Faber C, 2013, OPHTHALMOLOGY, V120, P2310, DOI 10.1016/j.ophtha.2013.04.014; Falk MK, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-22; Falk MK, 2014, INVEST OPHTHALMOL VI; Fujimura S, 2012, INVEST OPHTH VIS SCI, V53, P1999, DOI 10.1167/iovs.11-8232; Grunin M, 2012, INVEST OPHTH VIS SCI, V53, P5292, DOI 10.1167/iovs.11-9165; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Issa PC, 2011, GRAEF ARCH CLIN EXP, V249, P163, DOI 10.1007/s00417-010-1568-6; Jonas JB, 2010, ARCH OPHTHALMOL-CHIC, V128, P1281, DOI 10.1001/archophthalmol.2010.227; Kaiser Peter K, 2009, Trans Am Ophthalmol Soc, V107, P311; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mizutani T, 2013, INVEST OPHTH VIS SCI, V54, P1564, DOI 10.1167/iovs.11-9095; Nanki T, 2002, ARTHRITIS RHEUM, V46, P2878, DOI 10.1002/art.10622; Ng TF, 2001, INVEST OPHTH VIS SCI, V42, P3301; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Raoul W, 2010, J NEUROINFLAMM, V7, P87; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Singh A, 2013, OPHTHALMOLOGY, V120, P1029, DOI 10.1016/j.ophtha.2012.11.002; Singh A, 2012, AM J OPHTHALMOL, V154, P193, DOI 10.1016/j.ajo.2012.01.036; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1	42	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e112473	10.1371/journal.pone.0112473	http://dx.doi.org/10.1371/journal.pone.0112473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503251	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100004
J	Schirutschke, H; Gladrow, L; Norkus, C; Parmentier, SP; Hohenstein, B; Hugo, CPM				Schirutschke, Holger; Gladrow, Lars; Norkus, Christian; Parmentier, Simon Paul; Hohenstein, Bernd; Hugo, Christian P. M.			A New Apparatus for Standardized Rat Kidney Biopsy	PLOS ONE			English	Article							MODEL	Survival biopsies are frequently applied in rat kidney disease models, but several drawbacks such as surgical kidney trauma, bleeding risk and variable loss of kidney tissue are still unsolved. Therefore, we developed an easy-to-use core biopsy instrument and evaluated whether two consecutive kidney biopsies within the same kidney can be carried out in a standardized manner. On day 0, 18 Lewis rats underwent a right nephrectomy and 9 of these rats a subsequent first biopsy of the left kidney (Bx group). 9 control rats had a sham biopsy of the left kidney (Ctrl group). On day 7, a second kidney biopsy/sham biopsy was performed. On day 42, all animals were sacrificed and their kidneys were removed for histology. Biopsy cylinders contained 57 +/- 28 glomeruli per transversal section, representing an adequate sample size. PAS staining showed that the biopsy depth was limited to the renal cortex whereas surgical tissue damage was limited to the area immediately adjacent to the taken biopsy cylinder. On day 42, the reduction of functional renal mass after two biopsies was only 5.2% and no differences of body weight, blood pressure, proteinuria, serum creatinine, glomerulosclerosis, interstitial fibrosis or number of ED-1 positive macrophages were found between both groups. In summary, our apparatus offers a safe method to perform repetitive kidney biopsies with minimal trauma and sufficient sample size and quality even in experimental disease models restricted to one single kidney.	[Schirutschke, Holger; Parmentier, Simon Paul; Hohenstein, Bernd; Hugo, Christian P. M.] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Div Nephrol, D-01062 Dresden, Germany; [Gladrow, Lars; Norkus, Christian] Tech Univ Dresden, Inst Engn Mech, D-01062 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Schirutschke, H (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 3, Div Nephrol, D-01062 Dresden, Germany.	Holger.Schirutschke@uniklinikum-dresden.de			Deutsche Forschungsgemeinschaft [HU 600/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (grant no. HU 600/6-1, http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	IRUELAARISPE L, 1995, AM J PATHOL, V147, P1715; Kang DH, 2001, J AM SOC NEPHROL, V12, P1434, DOI 10.1681/ASN.V1271434; Keller K, 2006, NEPHROL DIAL TRANSPL, V21, P2724, DOI 10.1093/ndt/gfl340; Metcalfe W, 2007, NEPHROL DIAL TRANSPL, V22, P26, DOI 10.1093/ndt/gfm446; MORRISON AB, 1962, LAB INVEST, V11, P321; Nangaku M, 1997, KIDNEY INT, V52, P182, DOI 10.1038/ki.1997.318; Wittmann S, 2008, NEPHRON EXP NEPHROL, V108, P45, DOI 10.1159/000116112; Yu HT, 2003, ARCH INTERN MED, V163, P1417, DOI 10.1001/archinte.163.12.1417	8	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115368	10.1371/journal.pone.0115368	http://dx.doi.org/10.1371/journal.pone.0115368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506931	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100071
J	Feuillie, C; Merheb, MM; Gillet, B; Montagnac, G; Daniel, I; Hanni, C				Feuillie, Cecile; Merheb, Maxime M.; Gillet, Benjamin; Montagnac, Gilles; Daniel, Isabelle; Haenni, Catherine			Detection of DNA Sequences Refractory to PCR Amplification Using a Biophysical SERRS Assay (Surface Enhanced Resonant Raman Spectroscopy)	PLOS ONE			English	Article							ANCIENT DNA; ENZYMATIC AMPLIFICATION; SPECIES IDENTIFICATION; NONENZYMATIC DETECTION; DEOXYRIBONUCLEIC-ACID; ABASIC SITE; SCATTERING; POLYMERASE; DAMAGE; NANOPARTICLES	The analysis of ancient or processed DNA samples is often a great challenge, because traditional Polymerase Chain Reaction - based amplification is impeded by DNA damage. Blocking lesions such as abasic sites are known to block the bypass of DNA polymerases, thus stopping primer elongation. In the present work, we applied the SERRS-hybridization assay, a fully non-enzymatic method, to the detection of DNA refractory to PCR amplification. This method combines specific hybridization with detection by Surface Enhanced Resonant Raman Scattering (SERRS). It allows the detection of a series of double-stranded DNA molecules containing a varying number of abasic sites on both strands, when PCR failed to detect the most degraded sequences. Our SERRS approach can quickly detect DNA molecules without any need for DNA repair. This assay could be applied as a pre-requisite analysis prior to enzymatic reparation or amplification. A whole new set of samples, both forensic and archaeological, could then deliver information that was not yet available due to a high degree of DNA damage.	[Feuillie, Cecile; Montagnac, Gilles; Daniel, Isabelle] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Lab Geol Lyon,UMR 5276, F-69364 Lyon 07, France; [Merheb, Maxime M.; Gillet, Benjamin; Haenni, Catherine] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,UMR 5242, F-69364 Lyon 07, France; [Gillet, Benjamin; Haenni, Catherine] Ecole Normale Super Lyon, CNRS, Plateforme Natl Paleogenet PALGENE, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Feuillie, C (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	cecile.feuillie@gmail.com	Montagnac, Gilles/S-6440-2019; Daniel, Isabelle/D-2677-2012; Gillet, Benjamin/ABD-6704-2020	Montagnac, Gilles/0000-0001-9938-0282; Daniel, Isabelle/0000-0002-1448-7919; 	Interdisciplinary Program of CNRS "Interface physique, biologie et chimie: soutien a la prise de risque"; Interdisciplinary program of Ecole Normale Superieure de Lyon; Region Rhone-Alpes CIBLE	Interdisciplinary Program of CNRS "Interface physique, biologie et chimie: soutien a la prise de risque"; Interdisciplinary program of Ecole Normale Superieure de Lyon; Region Rhone-Alpes CIBLE(Region Auvergne-Rhone-Alpes)	The project was supported by the Interdisciplinary Program of CNRS "Interface physique, biologie et chimie: soutien a la prise de risque", the Interdisciplinary program of Ecole Normale Superieure de Lyon and by the Region Rhone-Alpes CIBLE 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeddini R, 2010, FORENSIC SCI INT-GEN, V4, P148, DOI 10.1016/j.fsigen.2009.09.007; Barnes I, 2000, J ARCHAEOL SCI, V27, P91, DOI 10.1006/jasc.1999.0440; Beaulieu M, 2001, NUCLEIC ACIDS RES, V29, P1114, DOI 10.1093/nar/29.5.1114; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brotherton P, 2008, FORENS SCI INT-GEN S, V1, P19, DOI 10.1016/j.fsigss.2007.10.111; d'Abbadie M, 2007, NAT BIOTECHNOL, V25, P939, DOI 10.1038/nbt1321; Fajardo V, 2006, J AGR FOOD CHEM, V54, P1144, DOI 10.1021/jf051766r; Faulds K, 2004, ANAL CHEM, V76, P412, DOI 10.1021/ac035060c; Faulds K, 2007, ANGEW CHEM INT EDIT, V46, P1829, DOI 10.1002/anie.200604265; Feuillie C, 2012, ANAL BIOANAL CHEM; Feuillie C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017847; Gloeckner C, 2007, ANGEW CHEM INT EDIT, V46, P3115, DOI 10.1002/anie.200603987; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graham D, 1997, ANAL CHEM, V69, P4703, DOI 10.1021/ac970657b; Graham D, 2008, CHEM SOC REV, V37, P1042, DOI 10.1039/b707941a; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Heyn P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq572; Hill HD, 2007, ANAL CHEM, V79, P9218, DOI 10.1021/ac701626y; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Jensen L, 2006, J PHYS CHEM A, V110, P5973, DOI 10.1021/jp0610867; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3618, DOI 10.1021/bi00769a019; Maher RC, 2002, CHEM PHYS LETT, V352, P378, DOI 10.1016/S0009-2614(01)01474-9; McDonald JP, 2006, NUCL ACIDS RES, V34; Monaghan PB, 2007, ANAL CHEM, V79, P2844, DOI 10.1021/ac061769i; Moretti T, 1998, BIOTECHNIQUES, V25, P716; Newman ME, 2002, J ARCHAEOL SCI, V29, P77, DOI 10.1006/jasc.2001.0688; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; Rizzi E, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-21; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; Sikorsky JA, 2007, BIOCHEM BIOPH RES CO, V355, P431, DOI 10.1016/j.bbrc.2007.01.169; Song CX, 2014, ANAL CHIM ACTA, V827, P74, DOI 10.1016/j.aca.2014.04.006; Storhoff JJ, 2004, BIOSENS BIOELECTRON, V19, P875, DOI 10.1016/j.bios.2003.08.014; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wolf C, 1999, J AGR FOOD CHEM, V47, P1350, DOI 10.1021/jf9808426; Wozney KM, 2012, FORENSIC SCI INT, V219, P106, DOI 10.1016/j.forsciint.2011.12.006; Zhao XJ, 2003, J AM CHEM SOC, V125, P11474, DOI 10.1021/ja0358854	47	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114148	10.1371/journal.pone.0114148	http://dx.doi.org/10.1371/journal.pone.0114148			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502338	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400022
J	Giles, GE; Mahoney, CR; Brunye, TT; Taylor, HA; Kanarek, RB				Giles, Grace E.; Mahoney, Caroline R.; Brunye, Tad T.; Taylor, Holly A.; Kanarek, Robin B.			Stress Effects on Mood, HPA Axis, and Autonomic Response: Comparison of Three Psychosocial Stress Paradigms	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; HEALTHY-YOUNG MEN; WORKING-MEMORY; CORTISOL RESPONSES; MATH-ANXIETY; COGNITIVE PERFORMANCE; PSYCHOLOGICAL STRESS; PREFRONTAL CORTEX; MENSTRUAL-CYCLE; HEART-RATE	Extensive experimental psychology research has attempted to parse the complex relationship between psychosocial stress, mood, cognitive performance, and physiological changes. To do so, it is necessary to have effective, validated methods to experimentally induce psychosocial stress. The Trier Social Stress Test (TSST) is the most commonly used method of experimentally inducing psychosocial stress, but it is resource intensive. Less resource intense psychosocial stress tasks include the Socially Evaluative Cold Pressor Task (SECPT) and a computerized mental arithmetic task (MAT). These tasks effectively produce a physiological and psychological stress response and have the benefits of requiring fewer experimenters and affording data collection from multiple participants simultaneously. The objective of this study was to compare the magnitude and duration of these three experimental psychosocial stress induction paradigms. On each of four separate days, participants completed either a control non-stressful task or one of the three experimental stressors: the TSST, SECPT, or MAT. We measured mood, working memory performance, salivary cortisol and alpha-amylase (AA), and heart rate. The TSST and SECPT exerted the most robust effects on mood and physiological measures. TSST effects were generally evident immediately post-stress as well as 10- and 20-minutes after stress cessation, whereas SECPT effects were generally limited to the duration of the stressor. The stress duration is a key determinant when planning a study that utilizes an experimental stressor, as researchers may be interested in collecting dependent measures prior to stress cessation. In this way, the TSST would allow the investigator a longer window to administer tasks of interest.	[Giles, Grace E.; Mahoney, Caroline R.; Brunye, Tad T.; Taylor, Holly A.; Kanarek, Robin B.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Giles, GE (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	grace.giles@tufts.edu						Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Ashcraft MH, 2001, J EXP PSYCHOL GEN, V130, P224, DOI 10.1037/0096-3445.130.2.224; Backhaus J, 2004, PSYCHONEUROENDOCRINO, V29, P1184, DOI 10.1016/j.psyneuen.2004.01.010; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; Banderet LE, 1989, BRAIN RES B, V22, P851; Bosch JA, 2011, PSYCHONEUROENDOCRINO, V36, P449, DOI 10.1016/j.psyneuen.2010.12.019; Brunye TT, 2013, LEARN INDIVID DIFFER, V27, P1, DOI 10.1016/j.lindif.2013.06.008; Childs E, 2006, PSYCHOPHYSIOLOGY, V43, P366, DOI 10.1111/j.1469-8986.2006.00414.x; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Duncko R, 2009, NEUROBIOL LEARN MEM, V91, P377, DOI 10.1016/j.nlm.2009.01.006; Foley P, 2010, NEUROSCI BIOBEHAV R, V35, P91, DOI 10.1016/j.neubiorev.2010.01.010; Gerra G, 2001, PSYCHONEUROENDOCRINO, V26, P91, DOI 10.1016/S0306-4530(00)00046-9; Hamada Toshihiko, 2006, Rinsho Byori, V54, P329; Hellhammer J, 2012, PSYCHONEUROENDOCRINO, V37, P119, DOI 10.1016/j.psyneuen.2011.05.012; Het S, 2009, PSYCHONEUROENDOCRINO, V34, P1075, DOI 10.1016/j.psyneuen.2009.02.008; Kanarek RB, 2004, PSYCHOPHARMACOLOGY, V173, P57, DOI 10.1007/s00213-003-1699-0; Kimura K, 2007, BIOL PSYCHOL, V74, P39, DOI 10.1016/j.biopsycho.2006.06.006; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Kudielka BM, 2004, INT J BEHAV MED, V11, P116, DOI 10.1207/s15327558ijbm1102_8; Kudielka BM, 2004, PSYCHONEUROENDOCRINO, V29, P983, DOI 10.1016/j.psyneuen.2003.08.009; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Kuhlmann S, 2005, PSYCHOPHARMACOLOGY, V183, P65, DOI 10.1007/s00213-005-0143-z; Kuhlmann S, 2005, J NEUROSCI, V25, P2977, DOI 10.1523/JNEUROSCI.5139-04.2005; Lieberman HR, 1996, AVIAT SPACE ENVIR MD, V67, P841; Lieberman HR, 2002, PSYCHOPHARMACOLOGY, V164, P250, DOI 10.1007/s00213-002-1217-9; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Maheu FS, 2005, PROG NEURO-PSYCHOPH, V29, P1281, DOI 10.1016/j.pnpbp.2005.08.012; Mattarella-Micke A, 2011, EMOTION, V11, P1000, DOI 10.1037/a0023224; McNair D., 1971, MANUAL PROFILE MOOD; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2006, PSYCHONEUROENDOCRINO, V31, P49, DOI 10.1016/j.psyneuen.2005.05.010; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Porcelli AJ, 2008, PHYSIOL BEHAV, V95, P282, DOI 10.1016/j.physbeh.2008.04.027; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Quesada AA, 2012, PSYCHONEUROENDOCRINO, V37, P125, DOI 10.1016/j.psyneuen.2011.05.013; Robinson SJ, 2008, STRESS, V11, P115, DOI 10.1080/10253890701559970; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schoofs D, 2009, BEHAV NEUROSCI, V123, P1066, DOI 10.1037/a0016980; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2007, LEARN MEMORY, V14, P109, DOI 10.1101/lm.435807; Schwabe L, 2010, PSYCHONEUROENDOCRINO, V35, P977, DOI 10.1016/j.psyneuen.2009.12.010; Smeets T, 2006, BEHAV NEUROSCI, V120, P1204, DOI 10.1037/0735-7044.120.6.1204; Starcke K, 2011, PSYCHONEUROENDOCRINO, V36, P210, DOI 10.1016/j.psyneuen.2010.07.010; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Uhart M, 2006, PSYCHONEUROENDOCRINO, V31, P642, DOI 10.1016/j.psyneuen.2006.02.003; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; vanEck M, 1996, PSYCHOSOM MED, V58, P447, DOI 10.1097/00006842-199609000-00007; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; Weerda R, 2010, HUM BRAIN MAPP, V31, P1418, DOI 10.1002/hbm.20945; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013; Wolf OT, 2001, PSYCHONEUROENDOCRINO, V26, P711, DOI 10.1016/S0306-4530(01)00025-7	60	51	53	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113618	10.1371/journal.pone.0113618	http://dx.doi.org/10.1371/journal.pone.0113618			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25502466	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400012
J	Zhou, X; Han, DW; Xu, RL; Li, SH; Wu, HW; Qu, CX; Wang, F; Wang, XY; Zhao, YC				Zhou, Xin; Han, Dewu; Xu, Ruiling; Li, Suhong; Wu, Huiwen; Qu, Chongxiao; Wang, Feng; Wang, Xiangyu; Zhao, Yuanchang			A Model of Metabolic Syndrome and Related Diseases with Intestinal Endotoxemia in Rats Fed a High Fat and High Sucrose Diet	PLOS ONE			English	Article							INSULIN-RESISTANCE; INDUCED OBESITY; ADIPOSE-TISSUE; BLOOD-PRESSURE; NONALCOHOLIC STEATOHEPATITIS; LIVER-DISEASE; MICE; INFLAMMATION; DYSFUNCTION; FRUCTOSE	Aim: We sought develop and characterize a diet-induced model of metabolic syndrome and its related diseases. Methods: The experimental animals (Spague-Dawley rats) were randomly divided into two groups, and each group was fed a different feed for 48 weeks as follows: 1) standard control diet (SC), and 2) a high sucrose and high fat diet (HSHF). The blood, small intestine, liver, pancreas, and adipose tissues were sampled for analysis and characterization. Results: Typical metabolic syndrome (MS), non-alcoholic fatty liver disease (NAFLD), and type II diabetes (T2DM) were common in the HSHF group after a 48 week feeding period. The rats fed HSHF exhibited signs of obesity, dyslipidemia, hyperglycaemia, glucose intolerance, and insulin resistance (IR). At the same time, these animals had significantly increased levels of circulating LPS, TNF alpha, and IL-6 and increased ALP in their intestinal tissue homogenates. These animals also showed a significant reduction in the expression of occluding protein. The HSHF rats showed fatty degeneration, inflammation, fibrosis, cirrhosis, and lipid accumulation when their liver pathologies were examined. The HSHF rats also displayed increased islet diameters from 12 to 24 weeks, while reduced islet diameters occurred from 36 to 48 weeks with inflammatory cell infiltration and islet fat deposition. The morphometry of adipocytes in HSHF rats showed hypertrophy and inflammatory cell infiltration. HSHF CD68 analysis showed macrophage infiltration and significant increases in fat and pancreas size. HSHF Tunel analysis showed significant increases in liver and pancreas cell apoptosis. Conclusions: This work demonstrated the following: 1) a characteristic rat model of metabolic syndrome (MS) can be induced by a high sucrose and high fat diet, 2) this model can be used to research metabolic syndrome and its related diseases, such as NAFLD and T2DM, and 3) intestinal endotoxemia (IETM) may play an important role in the pathogenesis of MS and related diseases, such as NAFLD and T2DM.	[Zhou, Xin; Han, Dewu; Xu, Ruiling; Wu, Huiwen; Wang, Feng; Zhao, Yuanchang] Shanxi Med Univ, Dept Pathophysiol, Taiyuan 030001, Shanxi, Peoples R China; [Li, Suhong] Shanxi Tumor Hosp, Dept Pathol, Taiyuan 030013, Shanxi, Peoples R China; [Wu, Huiwen] Shanxi Med Univ, Fenyang Coll, Ctr Sci & Technol, Fenyang 032200, Shanxi, Peoples R China; [Qu, Chongxiao] Shanxi Prov Peoples Hosp, Dept Pathol, Taiyuan 030012, Shanxi, Peoples R China; [Wang, Xiangyu] Shanxi Med Univ, Dept Oral Med, Taiyuan 030001, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University	Han, DW (corresponding author), Shanxi Med Univ, Dept Pathophysiol, Taiyuan 030001, Shanxi, Peoples R China.	DewuHan@126.com			Dr. Start Fund of Shanxi Medical University; 331 Technology cultivate Fund of Basic Medical College of Shanxi Medical University; Youth Science and Technology Research Fund; Basic research projects in Shanxi [2014021040-3]	Dr. Start Fund of Shanxi Medical University; 331 Technology cultivate Fund of Basic Medical College of Shanxi Medical University; Youth Science and Technology Research Fund; Basic research projects in Shanxi	The authors gratefully acknowledge the financial support by the Dr. Start Fund of Shanxi Medical University in 2012, the 331 Technology cultivate Fund of Basic Medical College of Shanxi Medical University, the Youth Science and Technology Research Fund, Basic research projects in Shanxi (Grant No. 2014021040-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila MB, 2003, NUTRITION, V19, P347, DOI 10.1016/S0899-9007(02)00934-6; Al-Attas OS, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-20; Aschner P, 2010, EXPERT REV CARDIOVAS, V8, P407, DOI [10.1586/erc.10.13, 10.1586/ERC.10.13]; Bauduceau B, 2007, DIABETES METAB, V33, P333, DOI 10.1016/j.diabet.2007.04.001; Bocarsly ME, 2010, PHARMACOL BIOCHEM BE, V97, P101, DOI 10.1016/j.pbb.2010.02.012; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Church T, 2011, PROG CARDIOVASC DIS, V53, P412, DOI 10.1016/j.pcad.2011.03.013; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Frazier Thomas H, 2011, JPEN J Parenter Enteral Nutr, V35, p14S, DOI 10.1177/0148607111413772; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; [郭江红 GUO Jiang-hong], 2010, [中国病理生理杂志, Chinese Journal of Pathophysiology], V26, P1009; Han DW, 2002, WORLD J GASTROENTERO, V8, P961, DOI 10.3748/wjg.v8.i6.961; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hsieh PS, 2008, EUR J CLIN INVEST, V38, P640, DOI 10.1111/j.1365-2362.2008.01991.x; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; KANAREK RB, 1987, AM J PHYSIOL, V253, pR158, DOI 10.1152/ajpregu.1987.253.1.R158; Kawasaki T, 2009, J NUTR, V139, P2067, DOI 10.3945/jn.109.105858; Kim SM, 2010, J CLIN BIOCHEM NUTR, V47, P12, DOI 10.3164/jcbn.09-124; Kobayasi R, 2010, J HYPERTENS, V28, P2111, DOI 10.1097/HJH.0b013e32833ca68c; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Le KA, 2006, CURR OPIN CLIN NUTR, V9, P469, DOI 10.1097/01.mco.0000232910.61612.4d; Li H, 2001, CHINESE J PATHOPHYSI, V17, P353; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Palanisamy N, 2010, CAN J PHYSIOL PHARM, V88, P28, DOI 10.1139/Y09-110; Panchal SK, 2011, J CARDIOVASC PHARM, V57, P611, DOI [10.1097/FJC.0b013e3181feb90a, 10.1097/FJC.0b013e31821b1379]; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Santure M, 2002, BRIT J PHARMACOL, V137, P185, DOI 10.1038/sj.bjp.0704864; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Sweazea KL, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-48; Tarantino G, 2007, J GASTROEN HEPATOL, V22, P293, DOI 10.1111/j.1440-1746.2007.04824.x; Tran LT, 2009, MOL CELL BIOCHEM, V332, P145, DOI 10.1007/s11010-009-0184-4; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Zhang HY, 2007, WORLD J GASTROENTERO, V13, P3500, DOI 10.3748/wjg.v13.i25.3500; Zhao LF, 2000, WORLD CHIN J DIGESTO, V8, P1145; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	49	54	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115148	10.1371/journal.pone.0115148	http://dx.doi.org/10.1371/journal.pone.0115148			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502558	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700094
J	Halupka, L; Halupka, K; Klimczuk, E; Sztwiertnia, H				Halupka, Lucyna; Halupka, Konrad; Klimczuk, Ewelina; Sztwiertnia, Hanna			Coping with Shifting Nest Predation Refuges by European Reed Warblers Acrocephalus scirpaceus	PLOS ONE			English	Article							SITE SELECTION; BREEDING DISPERSAL; SYLVIA-ATRICAPILLA; CLUTCH SIZE; SUCCESS; RISK; PARASITISM; SONGBIRDS; SURVIVAL; BIRDS	Predation, the most important source of nest mortality in altricial birds, has been a subject of numerous studies during past decades. However, the temporal dynamics between changing predation pressures and parental responses remain poorly understood. We analysed characteristics of 524 nests of European reed warblers monitored during six consecutive breeding seasons in the same area, and found some support for the shifting nest predation refuge hypothesis. Nest site characteristics were correlated with nest fate, but a nest with the same nest-site attributes could be relatively safe in one season and vulnerable to predation in another. Thus nest predation refuges were ephemeral and there was no between-season consistency in nest predation patterns. Reed warblers that lost their first nests in a given season did not disperse farther for the subsequent reproductive attempt, compared to successful individuals, but they introduced more changes to their second nest sites. In subsequent nests, predation risk remained constant for birds that changed nest-site characteristics, but increased for those that did not. At the between-season temporal scale, individual birds did not perform better with age in terms of reducing nest predation risk. We conclude that the experience acquired in previous years may not be useful, given that nest predation refuges are not stable.	[Halupka, Lucyna] Univ Wroclaw, Ornithol Stn, PL-50138 Wroclaw, Poland; [Halupka, Konrad; Sztwiertnia, Hanna] Univ Wroclaw, Dept Behav Ecol, PL-50138 Wroclaw, Poland; [Klimczuk, Ewelina] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Halupka, L (corresponding author), Univ Wroclaw, Ornithol Stn, PL-50138 Wroclaw, Poland.	lucyna.halupka@uni.wroc.pl	Halupka, Konrad/E-2534-2018	Halupka, Lucyna/0000-0002-8043-8111; Halupka, Konrad/0000-0001-5139-1134	University of Wroclaw [1018/S/IZ/2006-12]	University of Wroclaw	The study was funded by the University of Wroclaw (project 1018/S/IZ/2006-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Barrientos R, 2009, ACTA OECOL, V35, P499, DOI 10.1016/j.actao.2009.03.005; Benson TJ, 2010, J ANIM ECOL, V79, P225, DOI 10.1111/j.1365-2656.2009.01604.x; Berry D A, 1985, BANDIT PROBLEMS SEQU; BERRY DA, 1972, ANN MATH STAT, V43, P871, DOI 10.1214/aoms/1177692553; Buler JJ, 2000, AUK, V117, P739, DOI 10.1642/0004-8038(2000)117[0739:PONAAN]2.0.CO;2; Chalfoun AD, 2010, OECOLOGIA, V163, P885, DOI 10.1007/s00442-010-1679-0; Chase MK, 2002, CONDOR, V104, P103, DOI 10.1650/0010-5422(2002)104[0103:NSSANS]2.0.CO;2; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cornelius C, 2008, CONDOR, V110, P615, DOI 10.1525/cond.2008.8608; Cox WA, 2012, AUK, V129, P147, DOI 10.1525/auk.2012.11169; Cresswell W, 1997, ANIM BEHAV, V53, P93, DOI 10.1006/anbe.1996.0281; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Fisher RJ, 2006, OECOLOGIA, V147, P744, DOI 10.1007/s00442-005-0310-2; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Gill F. B., 1995, ORNITHOLOGY; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Gregoire A, 2007, OSTRICH, V78, P633, DOI 10.2989/OSTRICH.2007.78.3.10.321; GREIGSMITH PW, 1982, ORNIS SCAND, V13, P232, DOI 10.2307/3676304; Haas CA, 1998, AUK, V115, P929, DOI 10.2307/4089511; Halupka K, 1998, FOLIA ZOOL, V47, P29; Halupka K, 2009, J AVIAN BIOL, V40, P658, DOI 10.1111/j.1600-048X.2009.04772.x; Halupka L, 2014, ORNIS FENNICA, V91, P187; Honza M, 1998, BIRD STUDY, V45, P104, DOI 10.1080/00063659809461083; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Horie S, 2012, IBIS, V154, P285, DOI 10.1111/j.1474-919X.2011.01204.x; Kearns LJ, 2013, J ORNITHOL, V154, P163, DOI 10.1007/s10336-012-0882-7; KELLY JP, 1993, CONDOR, V95, P83, DOI 10.2307/1369389; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; MARZLUFF JM, 1988, ANIM BEHAV, V36, P1, DOI 10.1016/S0003-3472(88)80244-6; Naiwanga D, 2004, OSTRICH, V75, P269, DOI 10.2989/00306520409485454; NILSSON SG, 1984, ORNIS SCAND, V15, P167, DOI 10.2307/3675958; Nur N, 2004, CONDOR, V106, P457, DOI 10.1650/7336; Oien IJ, 1996, J ANIM ECOL, V65, P147, DOI 10.2307/5717; Pelech SA, 2010, OIKOS, V119, P841, DOI 10.1111/j.1600-0706.2009.17786.x; Peterson BL, 2004, J FIELD ORNITHOL, V75, P89, DOI 10.1648/0273-8570-75.1.89; Pope TL, 2013, CONDOR, V115, P155, DOI 10.1525/cond.2012.110141; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REDONDO T, 1988, ANIM BEHAV, V36, P653, DOI 10.1016/S0003-3472(88)80147-7; Remes V, 2005, IBIS, V147, P213, DOI 10.1111/j.1474-919x.2004.00339; Remes V, 2012, J AVIAN BIOL, V43, P435, DOI 10.1111/j.1600-048X.2012.05599.x; Richardson TW, 2007, WEST N AM NATURALIST, V67, P251, DOI 10.3398/1527-0904(2007)67[251:YPCCCQ]2.0.CO;2; Rodewald AD, 2011, CONDOR, V113, P899, DOI 10.1525/cond.2011.100132; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Roper James J., 2003, Ornitologia Neotropical, V14, P1; Schaefer T, 2004, BIRD STUDY, V51, P170, DOI 10.1080/00063650409461349; Schmidt KA, 2006, OECOLOGIA, V148, P22, DOI 10.1007/s00442-005-0340-9; SCHULZEHAGEN K, 1992, J ORNITHOL, V133, P237, DOI 10.1007/BF01645635; SchulzeHagen K, 1996, J ORNITHOL, V137, P181, DOI 10.1007/BF01653633; Sperry JH, 2008, J AVIAN BIOL, V39, P379, DOI 10.1111/j.0908-8857.2008.04451.x; Stokke BG, 2007, OIKOS, V116, P913, DOI 10.1111/j.0030-1299.2007.15832.x; Styrsky JN, 2005, CONDOR, V107, P133, DOI 10.1650/7609; Therneau T. M., 2014, PACKAGE SURVIVAL R P; Thompson FR, 2004, CONSERV BIOL, V18, P373, DOI 10.1111/j.1523-1739.2004.00167.x; Wegrzyn E, 2011, ARDEOLA, V58, P113; Weidinger K, 2010, OIKOS, V119, P138, DOI 10.1111/j.1600-0706.2009.17649.x; Weidinger K, 2009, IBIS, V151, P352, DOI 10.1111/j.1474-919X.2009.00907.x; Wesolowski T, 2009, BIRD STUDY, V56, P26, DOI 10.1080/00063650802681540; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilson RR, 1998, CONDOR, V100, P673, DOI 10.2307/1369748; Wyllie L., 1975, British Birds, V68, P369	61	16	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115456	10.1371/journal.pone.0115456	http://dx.doi.org/10.1371/journal.pone.0115456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522327	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600048
J	Durez, P; Vandepapeliere, P; Miranda, P; Toncheva, A; Berman, A; Kehler, T; Mociran, E; Fautrel, B; Mariette, X; Dhellin, O; Fanget, B; Ouary, S; Grouard-Vogel, G; Boissier, MC				Durez, Patrick; Vandepapeliere, Pierre; Miranda, Pedro; Toncheva, Antoaneta; Berman, Alberto; Kehler, Tatjana; Mociran, Eugenia; Fautrel, Bruno; Mariette, Xavier; Dhellin, Olivier; Fanget, Bernard; Ouary, Stephane; Grouard-Vogel, Geraldine; Boissier, Marie-Christophe			Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVE IMMUNIZATION; DISEASE-ACTIVITY; IMMUNOGENICITY; ANTIBODIES; MICE; VALIDATION; PROTECTION; CRITERIA	Objectives: Active immunization, or vaccination, with tumor necrosis factor (TNF)-Kinoid (TNF-K) is a novel approach to induce polyclonal anti-TNF antibodies in immune-mediated inflammatory diseases. This study was performed to transfer the proof of concept obtained in mice model of rheumatoid arthritis (RA) into human. We designed a pilot study to demonstrate the feasibility of therapeutic vaccination in RA. Methods: This was a phase IIa, placebo-controlled, multicenter study in adults with RA who previously experienced secondary failure of TNF antagonists. Patients were immunized intramuscularly with 2 or 3 doses of placebo (n = 10) or 90 (n = 6), 180 (n = 12), or 360 mu g TNF-K (n = 12). The primary objective was to identify the best dose and schedule based on anti-TNF antibody titers. Clinical symptoms and safety were assessed during 12 months and solicited reactions for 7 days after each injection. Results: The highest anti-TNF antibody response was detected in patients immunized with 360 mu g TNF-K and with 3 injections, although this difference was not significant with all other groups. Similar proportions of patients receiving TNF-K and placebo reported adverse events up to month 12. Serious adverse events were reported by 4 patients treated with TNF-K (13.3%) and 3 treated with placebo (30.0%), all unrelated to treatment. At month 12, DAS28-CRP, tender and swollen joint counts, and HAQ scores decreased significantly more in patients who exhibited anti-TNF antibody response than in patients who did not. Conclusions: TNF-K therapeutic vaccination induced dose- and schedule-dependent anti-TNF antibodies in RA patients and was well tolerated. Patients who developed anti-TNF antibodies showed a trend toward clinical improvement. Although the most aggressive dose and schedule, i.e. 360 mg dose administered 3 times, did show a strong trend of higher antibody response, further studies are warranted to examine even higher and more frequent doses in order to establish the best conditions for clinical improvement.	[Durez, Patrick] Clin Univ St Luc, Serv & Pole Rhumatol, B-1200 Brussels, Belgium; [Durez, Patrick] Catholic Univ Louvain, Inst Rech Expt & Clin, B-1200 Brussels, Belgium; [Vandepapeliere, Pierre; Dhellin, Olivier; Fanget, Bernard; Ouary, Stephane; Grouard-Vogel, Geraldine] Neovacs SA, Paris, France; [Miranda, Pedro] Ctr Estudios Reumatol, Santiago, Chile; [Toncheva, Antoaneta] Natl Multiprofile Transport Hosp Tzar Boris III, Sofia, Bulgaria; [Berman, Alberto] Ctr Med Privado Reumatol, San Miguel De Tucuman, Tucuman, Argentina; [Kehler, Tatjana] Thalassotherapia Opatija, Opatija, Croatia; [Mociran, Eugenia] Emergency Cty Hosp Dr Constantin Opris, Baia Mare, Romania; [Fautrel, Bruno] UPMC, Inst Pierre Louis Epidemiol & Sante Publ, GRC EEMOIS 08, Paris, France; [Fautrel, Bruno] Pitie Salpetriere Univ Hosp, AP HP, Dept Rheumatol, Paris, France; [Mariette, Xavier] Univ Paris Sud, Hop Univ Paris Sud, AP HP, INSERM,U1012, F-94275 Le Kremlin Bicetre, France; [Boissier, Marie-Christophe] INSERM, U1125, Bobigny, France; [Boissier, Marie-Christophe] Univ Paris 13, Sorbonne Paris Cite, Bobigny, France; [Boissier, Marie-Christophe] Avicenne Univ Hosp, AP HP, Dept Rheumatol, Bobigny, France	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; University of Rijeka; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Vandepapeliere, P (corresponding author), Neovacs SA, Paris, France.	pvandepapeliere@neovacs.com	Kehler, Tatjana/R-5098-2018	Kehler, Tatjana/0000-0003-4228-1632; durez, patrick/0000-0002-7156-2356	Neovacs	Neovacs	The funder Neovacs, as the sponsor of the clinical trial, had a role in the study design, data analysis, decision to publish, and preparation of the manuscript. People from Neovacs involved in the study design, data analysis, decision to publish, and preparation of the manuscript were: PV OD BF SO GGV.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Biton J, 2011, J IMMUNOL, V186, P3899, DOI 10.4049/jimmunol.1003372; Breedveld FC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3093; CHATZIDIONYSIOU K, 2013, ANN RHEUM DIS, DOI DOI 10.1136/ANNRHEUMDIS-2013-204714.; Delavallee L, 2008, ANN RHEUM DIS, V67, P1332, DOI 10.1136/ard.2007.079137; Delavallee L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2897; FLICK DA, 1984, J IMMUNOL METHODS, V68, P167, DOI 10.1016/0022-1759(84)90147-9; Gaujoux-Viala C, 2012, JOINT BONE SPINE, V79, P149, DOI 10.1016/j.jbspin.2011.04.008; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; Hayward Michael D., 2007, BMC Physiology, V7, P13, DOI 10.1186/1472-6793-7-13; Hetland ML, 2010, ARTHRITIS RHEUM-US, V62, P22, DOI 10.1002/art.27227; Lauwerys BR, 2013, ARTHRITIS RHEUM-US, V65, P447, DOI 10.1002/art.37785; Le Buanec H, 2006, P NATL ACAD SCI USA, V103, P19442, DOI 10.1073/pnas.0604827103; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mulleman D, 2012, JOINT BONE SPINE, V79, P109, DOI 10.1016/j.jbspin.2011.11.004; Rubbert-Roth A, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2666; Russell AS, 2008, PHARMACOECONOMICS, V26, P831, DOI 10.2165/00019053-200826100-00004; Saidenberg-Kermanac'h N, 2012, INT J TUBERC LUNG D, V16, P1307, DOI 10.5588/ijtld.12.0111; SCHNEERSON R, 1980, J EXP MED, V152, P361, DOI 10.1084/jem.152.2.361; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Semerano L, 2013, CLIN EXP IMMUNOL, V172, P54, DOI 10.1111/cei.12040; Semerano L, 2011, EXPERT OPIN BIOL TH, V11, P545, DOI 10.1517/14712598.2011.566856; Sfikakis PP, 2010, CURR DIR AUTOIMMUN, V11, P180, DOI 10.1159/000289205; Spinelli FR, 2013, CLIN EXP RHEUMATOL, V31, P954; Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; van Schouwenburg PA, 2013, NAT REV RHEUMATOL, V9, P164, DOI 10.1038/nrrheum.2013.4; Vandepapeliere P, 2011, GASTROENTEROLOGY, V140, pS123; Waterston AM, 2004, BRIT J CANCER, V90, P1279, DOI 10.1038/sj.bjc.6601670; Zuany-Amorim C, 2004, INT ARCH ALLERGY IMM, V133, P154, DOI 10.1159/000076441	31	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113465	10.1371/journal.pone.0113465	http://dx.doi.org/10.1371/journal.pone.0113465			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517733	Green Submitted, Green Published, gold			2022-12-27	WOS:000347215600004
J	Kim, TN; Park, MS; Ryu, JY; Choi, HY; Hong, HC; Yoo, HJ; Kang, HJ; Song, W; Park, SW; Baik, SH; Newman, AB; Choi, KM				Kim, Tae Nyun; Park, Man Sik; Ryu, Ja Young; Choi, Hae Yoon; Hong, Ho Cheol; Yoo, Hye Jin; Kang, Hyun Joo; Song, Wook; Park, Seok Won; Baik, Sei Hyun; Newman, Anne B.; Choi, Kyung Mook			Impact of Visceral Fat on Skeletal Muscle Mass and Vice Versa in a Prospective Cohort Study: The Korean Sarcopenic Obesity Study (KSOS)	PLOS ONE			English	Article							INSULIN-RESISTANCE; VITAMIN-D; METABOLIC SYNDROME; BODY-COMPOSITION; OLDER PERSONS; LEAN MASS; PREVALENCE; STRENGTH; HEALTH; MEN	Objectives: Sarcopenia and visceral obesity have been suggested to aggravate each other, resulting in a vicious cycle. However, evidence based on prospective study is very limited. Our purpose was to investigate whether visceral fat promotes a decrease in skeletal muscle mass and vice versa. Methods: We observed changes in anthropometric and body composition data during a follow-up period of 27.6 +/- 2.8 months in 379 Korean men and women (mean age 51.9 +/- 14.6 years) from the Korean Sarcopenic Obesity Study (KSOS). Appendicular lean soft tissue (ALST) mass was calculated using dual-energy X-ray absorptiometry, and visceral fat area (VFA) was measured using computed tomography at baseline and follow-up examination. Results: ALST mass significantly decreased, whereas trunk and total fat mass increased in both men and women despite no significant change in weight and body mass index. In particular, women with visceral obesity at baseline had a greater decrease in ALST mass than those without visceral obesity (P=0.001). In multiple linear regression analysis, baseline VFA was an independent negative predictor of the changes in ALST after adjusting for confounding factors including age, gender, life style and body composition parameters, insulin resistance, high sensitivity C-reactive protein and vitamin D levels (P=0.001), whereas the association between baseline ALST mass and changes in VFA was not statistically significant (P=0.555). Conclusions: This longitudinal study showed that visceral obesity was associated with future loss of skeletal muscle mass in Korean adults. These results may provide novel insight into sarcopenic obesity in an aging society.	[Kim, Tae Nyun; Ryu, Ja Young; Choi, Hae Yoon; Hong, Ho Cheol; Yoo, Hye Jin; Baik, Sei Hyun; Choi, Kyung Mook] Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea; [Kim, Tae Nyun] Inje Univ, Coll Med, Dept Internal Med, Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Park, Man Sik] Sungshin Womens Univ, Dept Stat, Coll Nat Sci, Seoul, South Korea; [Kang, Hyun Joo] Soonchunhyang Univ, Div Phys Educ, Asan, South Korea; [Song, Wook] Seoul Natl Univ, Dept Phys Educ, Inst Sports Sci, Hlth & Exercise Sci Lab, Seoul, South Korea; [Park, Seok Won] Pochon CHA Univ, Dept Internal Med, Ponchon, South Korea; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Korea University; Korea University Medicine (KU Medicine); Inje University; Sungshin Women's University; Soonchunhyang University; Seoul National University (SNU); Pochon Cha University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Choi, KM (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 136705, South Korea.	medica7@gmail.com	Kim, Tae Nyun/AAV-5521-2020; Newman, Anne B./C-6408-2013; Choi, Kyung Mook/C-4195-2018; Song, Wook/AAV-4940-2020	Newman, Anne B./0000-0002-0106-1150; Choi, Kyung Mook/0000-0001-6175-0225; Song, Wook/0000-0002-8825-6259; Yoo, Hye Jin/0000-0003-0600-0266	National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [2012006363]; Priority Research Centers Program through the NRF - Ministry of Education, Science, and Technology [2010-0020224]	National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology; Priority Research Centers Program through the NRF - Ministry of Education, Science, and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology (2012006363) (K. M. C.) and by Priority Research Centers Program through the NRF funded by the Ministry of Education, Science, and Technology (2010-0020224) (T. N. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2011, J NUTR HEALTH AGING, V15, P890, DOI 10.1007/s12603-011-0366-0; Baumgartner RN, 2004, OBES RES, V12, P1995, DOI 10.1038/oby.2004.250; Baz-Hecht M, 2010, CURR OPIN ENDOCRINOL, V17, P113, DOI 10.1097/MED.0b013e3283372859; Biolo G, 2014, CLIN NUTR IN PRESS; Bluher M, 2012, DIABETES METAB J, V36, P317, DOI 10.4093/dmj.2012.36.5.317; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Carbo N, 2000, J NUTR BIOCHEM, V11, P431, DOI 10.1016/S0955-2863(00)00101-7; Di Francesco V, 2004, OBES SURG, V14, P1095, DOI 10.1381/0960892041975622; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Evans WJ, 2010, BIOGERONTOLOGY, V11, P527, DOI 10.1007/s10522-010-9297-0; Galban CJ, 2007, J GERONTOL A-BIOL, V62, P453, DOI 10.1093/gerona/62.4.453; Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004; HEYMSFIELD SB, 1990, AM J CLIN NUTR, V52, P52, DOI 10.1093/ajcn/52.1.52; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kent-Braun JA, 2000, J APPL PHYSIOL, V88, P662, DOI 10.1152/jappl.2000.88.2.662; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim TN, 2013, CLIN ENDOCRINOL, V78, P525, DOI 10.1111/j.1365-2265.2012.04433.x; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Koster A, 2011, J GERONTOL A-BIOL, V66, P888, DOI 10.1093/gerona/glr070; Kouda K, 2012, CIRC J, V76, P2848, DOI 10.1253/circj.CJ-12-0417; Lim KI, 2010, CLIN ENDOCRINOL, V73, P588, DOI 10.1111/j.1365-2265.2010.03841.x; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Masgrau A, 2012, J PHYSIOL-LONDON, V590, P5199, DOI 10.1113/jphysiol.2012.238576; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Parr EB, 2013, MATURITAS, V74, P109, DOI 10.1016/j.maturitas.2012.10.014; Pasco JA, 2014, OBESITY, V22, P863, DOI 10.1002/oby.20496; Roubenoff R, 2004, OBES RES, V12, P887, DOI 10.1038/oby.2004.107; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Salamone LM, 2000, J APPL PHYSIOL, V89, P345, DOI 10.1152/jappl.2000.89.1.345; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Sitnick M, 2009, J PHYSIOL-LONDON, V587, P5753, DOI 10.1113/jphysiol.2009.180174; Stewart LK, 2007, MED SCI SPORT EXER, V39, P1714, DOI 10.1249/mss.0b013e31811ece1c; Vincent HK, 2012, AGEING RES REV, V11, P361, DOI 10.1016/j.arr.2012.03.002; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Yamada Y, 2010, J GERONTOL A-BIOL, V65, P510, DOI 10.1093/gerona/glq001; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002; Zoico E, 2004, J GERONTOL A-BIOL, V59, P935, DOI 10.1093/gerona/59.9.M935; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	44	62	66	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115407	10.1371/journal.pone.0115407	http://dx.doi.org/10.1371/journal.pone.0115407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517117	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000347215600064
J	Rodriguez-Campello, A; Jimenez-Conde, J; Ois, A; Cuadrado-Godia, E; Giralt-Steinhauer, E; Schroeder, H; Romeral, G; Llop, M; Soriano-Tarraga, C; Garralda-Anaya, M; Roquer, J				Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Schroeder, Helmut; Romeral, Gemma; Llop, Mireia; Soriano-Tarraga, Carolina; Garralda-Anaya, Montserrat; Roquer, Jaume			Dietary Habits in Patients with Ischemic Stroke: A Case-Control Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; WHOLE-GRAIN; PHYSICAL-ACTIVITY; RISK; CONSUMPTION; PREVENTION; PATTERNS; FRUIT	Background and Aims: Diet appears to have some role in stroke development. The objective of our study was to describe the dietary habits in patients admitted with acute ischemic stroke and compare selected dietary components with healthy controls. Adherence to healthy diet behaviors was also assessed. Methods: A case-control study of consecutive patients with acute ischemic stroke admitted to the Neurology Department of Hospital del Mar from 2007 to 2010. Patients were matched by age and sex with control subjects. A previously validated nutritional survey was administered to patients and controls. Demographic data, vascular risk factors, caloric intake and dietary nutrients were evaluated. Intention to follow a healthy diet was also assessed in both groups. Results: A total of 300 acute ischemic stroke patients and 300 controls with evaluation of dietary habits. No differences were observed in vascular risk factors, except smoking habit, diabetes and ischemic heart disease. Stroke patients reported a higher caloric intake: 2444.8(1736.8-3244.5) vs 2208.7(1753.1-2860.7) Kcal, p=0.001. After adjusting for energy intake, patients had higher intake of proteins (p<0.001; OR 1.02), total cholesterol (p=0.001; OR 1.04), and breaded foods (p=0.001; OR 1.94) and lower consumption of probiotic yogurt (p=0.002; OR 0.88). Compared to patients, control participants indicated greater intention to eat vegetables (p=0.002; OR 1.5) and whole foods (p=0.000; OR 2.4) and reduce their intake of salt (p=0.002; OR 1.7), fat (p=0.000; OR 3.7) and sweets (p=0.004; OR 1.7) than patients. Conclusion: We observed different dietary patterns between stroke patients and controls. Stroke patients have a higher caloric intake and are less concerned about maintaining healthy nutritional	[Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Schroeder, Helmut; Romeral, Gemma; Llop, Mireia; Soriano-Tarraga, Carolina; Garralda-Anaya, Montserrat; Roquer, Jaume] IMIM Hosp del Mar, Inst Hosp del Mar Invest Med, Neurovasc Res Grp, Stroke Unit,Dept Neurol, Barcelona, Spain; [Rodriguez-Campello, Ana; Jimenez-Conde, Jordi; Ois, Angel; Cuadrado-Godia, Elisa; Giralt-Steinhauer, Eva; Romeral, Gemma; Llop, Mireia; Soriano-Tarraga, Carolina; Garralda-Anaya, Montserrat] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Cuadrado-Godia, Elisa; Roquer, Jaume] Univ Pompeu Fabra, DCEXS, Barcelona, Spain; [Schroeder, Helmut] IMIM Hosp del Mar, Inst Hosp del Mar Invest Med, Program Res Inflammatory & Cardiovasc Disorders R, Cardiovasc Risk & Nutr Res Grp CARIN ULEC, Barcelona, Spain; [Schroeder, Helmut] Inst Salud Carlos III, CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III	Rodriguez-Campello, A (corresponding author), IMIM Hosp del Mar, Inst Hosp del Mar Invest Med, Neurovasc Res Grp, Stroke Unit,Dept Neurol, Barcelona, Spain.	92269@hospitaldelmar.cat	Campello, Ana Rodriguez/AAP-7757-2021; Ois, A/AAE-7583-2022; Schroder, Helmut/G-2586-2015; Roquer, Jaume/G-8919-2017; TARRAGA, CAROLINA SORIANO/AAG-8777-2019; Ois, A/X-2922-2019; JIMENEZ-CONDE, JORDI/C-1941-2012; Stefanadis, Christodoulos/ABH-2232-2020	Campello, Ana Rodriguez/0000-0001-8621-1420; Ois, A/0000-0002-1375-5950; Schroder, Helmut/0000-0003-2231-5081; Roquer, Jaume/0000-0001-5992-2606; Ois, A/0000-0002-1375-5950; Stefanadis, Christodoulos/0000-0001-5974-6454; Giralt Steinhauer, Eva/0000-0002-7463-0983; Cuadrado-Godia, Elisa/0000-0002-9147-875X; Soriano Tarraga, Carolina/0000-0002-5635-273X	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FEDER) [RD12/0042/0020]; Recercaixa'13 [JJ086116]	Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FEDER); Recercaixa'13	This study was partly funded in part by Spain's Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, FEDER, RD12/0042/0020). Additional support provided by Recercaixa'13 (JJ086116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Benitez-Arciniega AA, 2011, PUBLIC HEALTH NUTR, V14, P2015, DOI 10.1017/S1368980011001212; Bernstein AM, 2012, STROKE, V43, P637, DOI 10.1161/STROKEAHA.111.633404; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Ding EL, 2006, SEMIN NEUROL, V26, P11, DOI 10.1055/s-2006-933305; Drewnowski A, 2001, J Nutr Health Aging, V5, P75; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hankey GJ, 2012, LANCET NEUROL, V11, P66, DOI 10.1016/S1474-4422(11)70265-4; Hoevenaar-Blom MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045458; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Kaluza J, 2012, STROKE, V43, P2556, DOI 10.1161/STROKEAHA.112.663286; Kastorini CM, 2012, ATHEROSCLEROSIS, V225, P187, DOI 10.1016/j.atherosclerosis.2012.08.004; Kokubo Y, 2012, CURR OPIN NEUROL, V25, P11, DOI 10.1097/WCO.0b013e32834eb58e; Lin JS, 2010, ANN INTERN MED, V153, P736, DOI 10.7326/0003-4819-153-11-201012070-00007; Liu SM, 2000, JAMA-J AM MED ASSOC, V284, P1534, DOI 10.1001/jama.284.12.1534; Mahe G, 2010, J VASC SURG, V52, P62, DOI 10.1016/j.jvs.2010.02.258; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; Masia R, 1998, J EPIDEMIOL COMMUN H, V52, P707, DOI 10.1136/jech.52.11.707; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Oude Griep LM, 2011, STROKE, V42, P3190, DOI 10.1161/STROKEAHA.110.611152; Panagiotakos D, 2009, NUTR METAB CARDIOVAS, V19, P253, DOI 10.1016/j.numecd.2008.06.005; Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006; Preis SR, 2010, AM J CLIN NUTR, V91, P39, DOI 10.3945/ajcn.2009.28060; Riccioni G, 2012, INT J MOL SCI, V13, P1524, DOI 10.3390/ijms13021524; Schroder H, 2001, CLIN NUTR, V20, P429, DOI 10.1054/clnu.2001.0460; Schulze MB, 2006, BRIT J NUTR, V95, P860, DOI 10.1079/BJN20061731; Shay CM, 2012, EUR J NUTR, V51, P917, DOI 10.1007/s00394-011-0268-2; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383	32	12	12	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114716	10.1371/journal.pone.0114716	http://dx.doi.org/10.1371/journal.pone.0114716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506934	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100023
J	Chitale, VS; Behera, MD; Roy, PS				Chitale, Vishwas Sudhir; Behera, Mukund Dev; Roy, Partha Sarthi			Future of Endemic Flora of Biodiversity Hotspots in India	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; RANGE SHIFTS; CONSERVATION; RICHNESS; AREAS	India is one of the 12 mega biodiversity countries of the world, which represents 11% of world's flora in about 2.4% of global land mass. Approximately 28% of the total Indian flora and 33% of angiosperms occurring in India are endemic. Higher human population density in biodiversity hotspots in India puts undue pressure on these sensitive eco-regions. In the present study, we predict the future distribution of 637 endemic plant species from three biodiversity hotspots in India; Himalaya, Western Ghats, Indo-Burma, based on A1B scenario for year 2050 and 2080. We develop individual variable based models as well as mixed models in MaxEnt by combining ten least co-related bioclimatic variables, two disturbance variables and one physiography variable as predictor variables. The projected changes suggest that the endemic flora will be adversely impacted, even under such a moderate climate scenario. The future distribution is predicted to shift in northern and northeastern direction in Himalaya and Indo-Burma, while in southern and south-western direction in Western Ghats, due to cooler climatic conditions in these regions. In the future distribution of endemic plants, we observe a significant shift and reduction in the distribution range compared to the present distribution. The model predicts a 23.99% range reduction and a 7.70% range expansion in future distribution by 2050, while a 41.34% range reduction and a 24.10% range expansion by 2080. Integration of disturbance and physiography variables along with bioclimatic variables in the models improved the prediction accuracy. Mixed models provide most accurate results for most of the combinations of climatic and non-climatic variables as compared to individual variable based models. We conclude that a) regions with cooler climates and higher moisture availability could serve as refugia for endemic plants in future climatic conditions; b) mixed models provide more accurate results, compared to single variable based models.	[Chitale, Vishwas Sudhir; Behera, Mukund Dev] Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci, Kharagpur, W Bengal, India; [Chitale, Vishwas Sudhir] Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal; [Roy, Partha Sarthi] Univ Hyderabad, Univ Ctr Earth & Space Sci, Hyderabad 500134, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; University of Hyderabad	Chitale, VS (corresponding author), Indian Inst Technol Kharagpur, Ctr Oceans Rivers Atmosphere & Land Sci, Kharagpur, W Bengal, India.	vschitale@iitkgp.ac.in		Behera, Mukunda/0000-0002-9976-6270				Anderson RP, 2002, OIKOS, V98, P3, DOI 10.1034/j.1600-0706.2002.t01-1-980116.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bawa KS, 2010, SCIENCE, V327, P1457, DOI 10.1126/science.1185164; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Brodie J, 2012, TRENDS ECOL EVOL, V27, P145, DOI 10.1016/j.tree.2011.09.008; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chitale VS, 2012, CURR SCI INDIA, V102, P1126; Chitale V.S., 2014, NAT INDIA, DOI [10.1038/nindia.2014.21, DOI 10.1038/NINDIA.2014.21]; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Corlett RT, 2012, BIOL CONSERV, V151, P22, DOI 10.1016/j.biocon.2011.11.027; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; Forest Survey of India (FSI) Website, 2011, PND STAT FOR REP; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hof AR, 2012, ECOL MODEL, V246, P86, DOI 10.1016/j.ecolmodel.2012.07.028; Irwin Sheeba J., 2011, Rheedea, V21, P87; Iverson LR, 2013, LANDSCAPE ECOL, V28, P879, DOI 10.1007/s10980-013-9885-x; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Krishnaswamy J, 2014, GLOBAL CHANGE BIOL, V20, P203, DOI 10.1111/gcb.12362; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Kuussaari M, 2007, AGR ECOSYST ENVIRON, V122, P366, DOI 10.1016/j.agee.2007.02.008; Lele N, 2009, ENVIRON MONIT ASSESS, V156, P159, DOI 10.1007/s10661-008-0472-6; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newbold T, 2009, J BIOGEOGR, V36, P2085, DOI 10.1111/j.1365-2699.2009.02140.x; Ni J, 2011, REG ENVIRON CHANGE, V11, pS49, DOI 10.1007/s10113-010-0170-0; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parry ML, 2007, IPCC CLIM CHANG IMP; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pineda E, 2012, GLOBAL ECOL BIOGEOGR, V21, P935, DOI 10.1111/j.1466-8238.2011.00741.x; Reich PB, 2013, NAT CLIM CHANGE, V3, P278, DOI [10.1038/nclimate1694, 10.1038/NCLIMATE1694]; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; Roy PS, 2013, CURR SCI INDIA, V105, P774; Roy P.S., 2012, BIODIVERSITY CHARACT, P140; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Tingley MW, 2013, NATURE, V500, P271, DOI 10.1038/500271a; Trivino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029373; US Geological Survey, SHUTTL RAD TOP MISS; Velho N, 2012, BIOL CONSERV, V148, P210, DOI 10.1016/j.biocon.2012.01.022; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1	51	43	53	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115264	10.1371/journal.pone.0115264	http://dx.doi.org/10.1371/journal.pone.0115264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501852	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400089
J	Mao, K; Jiang, LB; Bo, WH; Xu, F; Wu, RL				Mao, Ke; Jiang, Libo; Bo, Wenhao; Xu, Fang; Wu, Rongling			Cloning of the Cryptochrome-Encoding PeCRY1 Gene from Populus euphratica and Functional Analysis in Arabidopsis	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTORS; UNSTRUCTURED PROTEINS; SIGNALING MECHANISM; MOLECULAR-CLONING; HYPOCOTYL GROWTH; THALIANA; EXPRESSION; RECEPTOR; ELONGATION; AUXIN	Cryptochromes are photolyase-like blue/UV-A light receptors that evolved from photolyases. In plants, cryptochromes regulate various aspects of plant growth and development. Despite of their involvement in the control of important plant traits, however, most studies on cryptochromes have focused on lower plants and herbaceous crops, and no data on cryptochrome function are available for forest trees. In this study, we isolated a cryptochrome gene, PeCRY1, from Euphrates poplar (Populus euphratica), and analyzed its structure and function in detail. The deduced PeCRY1 amino acid sequence contained a conserved N-terminal photolyase-homologous region (PHR) domain as well as a C-terminal DQXVP-acidic-STAES (DAS) domain. Secondary and tertiary structure analysis showed that PeCRY1 shares high similarity with AtCRY1 from Arabidopsis thaliana. PeCRY1 expression was upregulated at the mRNA level by light. Using heterologous expression in Arabidopsis, we showed that PeCRY1 overexpression rescued the cry1 mutant phenotype. In addition, PeCRY1 overexpression inhibited hypocotyl elongation, promoted root growth, and enhanced anthocyanin accumulation in wild-type background seedlings grown under blue light. Furthermore, we examined the interaction between PeCRY1 and AtCOP1 using a bimolecular fluorescence complementation (BiFc) assay. Our data provide evidence for the involvement of PeCRY1 in the control of photomorphogenesis in poplar.	[Mao, Ke; Jiang, Libo; Bo, Wenhao; Xu, Fang; Wu, Rongling] Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China	Beijing Forestry University	Wu, RL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Ctr Computat Biol, Beijing 100083, Peoples R China.	rwu@bjfu.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare [201404102]; Changjiang Scholars Award; "Thousand-person Plan" Award;  [NSF/IOS-0923975]	Special Fund for Forest Scientific Research in the Public Welfare; Changjiang Scholars Award; "Thousand-person Plan" Award(Chinese Academy of Sciences); 	This work is supported by the Special Fund for Forest Scientific Research in the Public Welfare (201404102), NSF/IOS-0923975, Changjiang Scholars Award, and "Thousand-person Plan" Award (http://www.1000plan.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 1998, NATURE, V392, P720, DOI 10.1038/33701; AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2005, PLANTA, V220, P498, DOI 10.1007/s00425-004-1418-z; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Canamero RC, 2006, PLANTA, V224, P995, DOI 10.1007/s00425-006-0280-6; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chatterjee M, 2006, PLANT PHYSIOL, V141, P61, DOI 10.1104/pp.105.076323; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Correll MJ, 2005, PLANT CELL PHYSIOL, V46, P317, DOI 10.1093/pcp/pci038; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Folta KM, 2003, PLANT J, V36, P203, DOI 10.1046/j.1365-313X.2003.01870.x; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; GEOURJON C, 1994, PROTEIN ENG, V7, P157, DOI 10.1093/protein/7.2.157; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hoffman PD, 1996, MOL GEN GENET, V253, P259, DOI 10.1007/s004380050321; Imaizumi T, 2002, PLANT CELL, V14, P373, DOI 10.1105/tpc.010388; Imaizumi T, 2000, PLANT CELL, V12, P81, DOI 10.1105/tpc.12.1.81; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kleine T, 2003, PLANT J, V35, P93, DOI 10.1046/j.1365-313X.2003.01787.x; KOORNNEEF M, 1980, Z PFLANZENPHYSIOL, V100, P147, DOI 10.1016/S0044-328X(80)80208-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li YY, 2013, PLANT PHYSIOL BIOCH, V67, P169, DOI 10.1016/j.plaphy.2013.02.031; Li YY, 2013, PLANT CELL REP, V32, P555, DOI 10.1007/s00299-013-1387-4; Lin C., 1996, PLANT PHYSIOL, V110, P1047; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lin CT, 2002, PLANT CELL, V14, pS207, DOI 10.1105/tpc.000646; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MALHOTRA K, 1995, BIOCHEMISTRY-US, V34, P6892, DOI 10.1021/bi00020a037; MANDOLI DF, 1990, PLANT CELL ENVIRON, V13, P287, DOI 10.1111/j.1365-3040.1990.tb01313.x; Matsumoto N, 2003, PLANT PHYSIOL, V133, P1494, DOI 10.1104/pp.103.025759; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Ninu L, 1999, PLANT J, V18, P551, DOI 10.1046/j.1365-313X.1999.00466.x; Ohgishi M, 2004, P NATL ACAD SCI USA, V101, P2223, DOI 10.1073/pnas.0305984101; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Partch CL, 2005, METHOD ENZYMOL, V393, P726, DOI 10.1016/S0076-6879(05)93038-3; Platten JD, 2005, PLANT PHYSIOL, V139, P1472, DOI 10.1104/pp.105.067462; Platten JD, 2005, PLANT MOL BIOL, V59, P683, DOI 10.1007/s11103-005-0828-z; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Sakamoto K, 2002, PLANT CELL, V14, P1723, DOI 10.1105/tpc.003293; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Sharma P, 2014, PLANT CELL ENVIRON, V37, P961, DOI 10.1111/pce.12212; SOMERS DE, 1995, PLANT PHYSIOL, V107, P523, DOI 10.1104/pp.107.2.523; Song SH, 2006, J PHOTOCH PHOTOBIO B, V85, P1, DOI 10.1016/j.jphotobiol.2006.03.007; Sorce C, 2008, J PLANT PHYSIOL, V165, P482, DOI 10.1016/j.jplph.2007.03.012; Sullivan JA, 2003, DEV BIOL, V260, P289, DOI 10.1016/S0012-1606(03)00212-4; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Wang HY, 2001, SCIENCE, V294, P154, DOI 10.1126/science.1063630; Wu G, 2007, P NATL ACAD SCI USA, V104, P18813, DOI 10.1073/pnas.0705082104; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang JP, 2005, PLANT CELL, V17, P804, DOI 10.1105/tpc.104.030205; Yu X, 2007, PLANT CELL, V19, P3146, DOI 10.1105/tpc.107.053017; Yu Xuhong, 2010, Arabidopsis Book, V8, pe0135, DOI 10.1199/tab.0135; Zhang YC, 2006, PLANT J, V46, P971, DOI 10.1111/j.1365-313X.2006.02753.x	68	8	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115201	10.1371/journal.pone.0115201	http://dx.doi.org/10.1371/journal.pone.0115201			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503486	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400081
J	Ismail, F; Couvin, D; Farakhin, I; Rahman, ZA; Rastogi, N; Suraiya, S				Ismail, Fazli; Couvin, David; Farakhin, Izzah; Rahman, Zaidah Abdul; Rastogi, Nalin; Suraiya, Siti			Study of Mycobacterium tuberculosis Complex Genotypic Diversity in Malaysia Reveals a Predominance of Ancestral East-African-Indian Lineage with a Malaysia-Specific Signature	PLOS ONE			English	Article							BEIJING GENOTYPE; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; DRUG-RESISTANT; STRAINS; SPOLIGOTYPES; RUSSIA; FAMILY	Background: Tuberculosis (TB) still constitutes a major public health problem in Malaysia. The identification and genotyping based characterization of Mycobacterium tuberculosis complex (MTBC) isolates causing the disease is important to determine the effectiveness of the control and surveillance programs. Objectives: This study intended a first assessment of spoligotyping-based MTBC genotypic diversity in Malaysia followed by a comparison of strains with those prevailing in neighboring countries by comparison with an international MTBC genotyping database. Methods: Spoligotyping was performed on a total of 220 M. tuberculosis clinical isolates collected in Kelantan and Kuala Lumpur. The results were compared with the SITVIT2 international database of the Pasteur Institute of Guadeloupe. Results: Spoligotyping revealed 77 different patterns: 22 corresponded to orphan patterns while 55 patterns containing 198 isolates were assigned a Spoligo International Type (SIT) designation in the database (the latter included 6 newly created SITs). The eight most common SITs grouped 141 isolates (5 to 56 strains per cluster) as follows: SIT1/Beijing, n = 56, 25.5%; SIT745/EAI1-SOM, n = 33, 15.0%; SIT591/EAI6-BGD1, n = 13, 5.9%; SIT256/EAI5, n = 12, 5.5%; SIT236/EAI5, n = 10, 4.6%; SIT19/EAI2-Manila, n = 9, 4.1%; SIT89/EAI2-Nonthaburi, n = 5, 2.3%; and SIT50/H3, n = 3, 1.4%. The association between city of isolation and lineages was statistically significant; Haarlem and T lineages being higher in Kuala Lumpur (p < 0.01). However, no statistically significant differences were noted when comparing drug resistance vs. major lineages, nor between gender and clades. Conclusions: The ancestral East-African-Indian (EAI) lineage was most predominant followed by the Beijing lineage. A comparison of strains with those prevailing in neighboring countries in South Asia, East Asia and South East Asia underlined the phylogeographical specificity of SIT745 for Malaysia, and its probable ongoing evolution with locally evolved strains sharing a specific signature characterized by absence of spacers 37, 38, and 40. Pending complementary genotyping confirmation, we propose that SIT745/EAI-SOM is tentatively reclassified as SIT745/EAI-MYS.	[Ismail, Fazli; Farakhin, Izzah; Rahman, Zaidah Abdul; Suraiya, Siti] Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Kota Baharu, Kelantan, Malaysia; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, WHO, Supranat TB Reference Lab, Abymes, Guadeloupe, France	Universiti Sains Malaysia; World Health Organization	Suraiya, S (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Kota Baharu, Kelantan, Malaysia.	ssuraiya@usm.my	Rahman, Zaidah Abdul/AAD-1505-2020; Suraiya, Siti/D-7701-2016; RASTOGI, NALIN/AAP-1958-2020	Rahman, Zaidah Abdul/0000-0002-6612-8360; RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023	USM Research University Grant [1001/PPSP/853001]; Universiti Sains Malaysia; European Social Funds through the Regional Council of Guadeloupe, France	USM Research University Grant; Universiti Sains Malaysia(Universiti Sains Malaysia); European Social Funds through the Regional Council of Guadeloupe, France	This study was supported by USM Research University Grant (1001/PPSP/853001). Fazli Ismail was awarded a USM Fellowship by Universiti Sains Malaysia. David Couvin was awarded a Ph.D. fellowship by the European Social Funds through the Regional Council of Guadeloupe, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanna AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025075; Aristimuno L, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-90; Brown T, 2010, EMERG INFECT DIS, V16, P272, DOI 10.3201/eid1602.091032; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Chan MY, 2001, EPIDEMIOL INFECT, V127, P169, DOI 10.1017/S0950268801005659; Dale JW, 1999, J CLIN MICROBIOL, V37, P1265, DOI 10.1128/JCM.37.5.1265-1268.1999; David H, 1989, METHODES LAB MYCOBAC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Fallico L, 2014, INFECT GENET EVOL, V26, P58, DOI 10.1016/j.meegid.2014.05.004; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Iyawoo K, 2004, TUBERCULOSIS, V84, P4, DOI 10.1016/j.tube.2003.08.014; JAGIELSKI T, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/645802; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Liu Q, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-288; Mokrousov I, 2012, INFECT GENET EVOL, V12, P619, DOI 10.1016/j.meegid.2011.09.026; Molina-Torres CA, 2010, J CLIN MICROBIOL, V48, P448, DOI 10.1128/JCM.01894-09; Nissapatorn V, 2007, SE ASIAN J TROP MED, V38, P231; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rosales S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-208; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Tang C, 2008, BIOINFORMATICS, V24, P2414, DOI 10.1093/bioinformatics/btn434; Toungoussova OS, 2002, J CLIN MICROBIOL, V40, P1930, DOI 10.1128/JCM.40.6.1930-1937.2002; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yorsangsukkamol J, 2009, TUBERCULOSIS, V89, P304, DOI 10.1016/j.tube.2009.05.001	32	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114832	10.1371/journal.pone.0114832	http://dx.doi.org/10.1371/journal.pone.0114832			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502956	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700057
J	Liu, XD; Yang, JJ; Fang, D; Cai, J; Wan, Y; Xing, GG				Liu, Xiao-Dan; Yang, Jing-Jing; Fang, Dong; Cai, Jie; Wan, You; Xing, Guo-Gang			Functional Upregulation of Nav1.8 Sodium Channels on the Membrane of Dorsal Root Ganglia Neurons Contributes to the Development of Cancer-Induced Bone Pain	PLOS ONE			English	Article							ACTION-POTENTIAL ELECTROGENESIS; NR2B-CONTAINING NMDA RECEPTORS; PRIMARY AFFERENT NEURONS; RESISTANT NA+ CURRENT; NEUROPATHIC PAIN; INFLAMMATORY PAIN; SENSORY NEURONS; DRG NEURONS; RAT MODEL; EXPRESSION	We have previously reported that enhanced excitability of dorsal root ganglia (DRG) neurons contributes to the development of bone cancer pain, which severely decreases the quality of life of cancer patients. Nav1.8, a tetrodotoxin-resistant (TTX-R) sodium channel, contributes most of the sodium current underlying the action potential upstroke and accounts for most of the current in later spikes in a train. We speculate that the Nav1.8 sodium channel is a potential candidate responsible for the enhanced excitability of DRG neurons in rats with bone cancer pain. Here, using electrophysiology, Western blot and behavior assays, we documented that the current density of TTX-R sodium channels, especially the Nav1.8 channel, increased significantly in DRG neurons of rats with cancer-induced bone pain. This increase may be due to an increased expression of Nav1.8 on the membrane of DRG neurons. Accordantly, blockade of Nav1.8 sodium channels by its selective blocker A-803467 significantly alleviated the cancer-induced mechanical allodynia and thermal hyperalgesia in rats. Taken together, these results suggest that functional upregulation of Nav1.8 channels on the membrane of DRG neurons contributes to the development of cancer-induced bone pain.	[Liu, Xiao-Dan; Yang, Jing-Jing; Fang, Dong; Cai, Jie; Xing, Guo-Gang] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Liu, Xiao-Dan; Cai, Jie; Wan, You; Xing, Guo-Gang] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Beijing 100871, Peoples R China; [Xing, Guo-Gang] Minist Educ, Key Lab Neurosci, Beijing, Peoples R China; [Xing, Guo-Gang] Minist Hlth, Beijing, Peoples R China	Peking University; Peking University	Xing, GG (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Neurobiol, Beijing 100871, Peoples R China.	ywan@hsc.pku.edu.cn; ggxing@bjmu.edu.cn	cai, jie/HHS-0606-2022; Wan, You/M-5279-2019	Wan, You/0000-0001-6110-7192	National Natural Science Foundation of China [81371237, 31171063, 81072951]; Beijing Natural Science Foundation [7112079]; special foundation for public welfare profession scientific research program from Ministry of Health of the People's Republic of China [201302013-01]; "973" Program of the Ministry of Science and Technology of China [2013CB531905]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); special foundation for public welfare profession scientific research program from Ministry of Health of the People's Republic of China; "973" Program of the Ministry of Science and Technology of China(National Basic Research Program of China)	The present work was supported by grants from the National Natural Science Foundation of China (81371237, 31171063,81072951), the Beijing Natural Science Foundation (7112079), the special foundation for public welfare profession scientific research program from Ministry of Health of the People's Republic of China (201302013-01) and the "973" Program of the Ministry of Science and Technology of China (2013CB531905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1999, NAT NEUROSCI, V2, P541, DOI 10.1038/9195; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Berta T, 2008, MOL CELL NEUROSCI, V37, P196, DOI 10.1016/j.mcn.2007.09.007; Black JA, 2004, PAIN, V108, P237, DOI 10.1016/j.pain.2003.12.035; Blair NT, 2002, J NEUROSCI, V22, P10277; Brouwer BA, 2014, J PERIPHER NERV SYST, V19, P53, DOI 10.1111/jns5.12071; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen X, 2011, EXP NEUROL, V227, P279, DOI 10.1016/j.expneurol.2010.11.017; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Djouhri L, 2003, J PHYSIOL-LONDON, V550, P739, DOI 10.1113/jphysiol.2003.042127; Dong XW, 2007, NEUROSCIENCE, V146, P812, DOI 10.1016/j.neuroscience.2007.01.054; Fang X, 2002, J NEUROSCI, V22, P7425; Geng SJ, 2010, EXP NEUROL, V222, P256, DOI 10.1016/j.expneurol.2010.01.003; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Jimenez-Andrade JM, 2010, ANN NY ACAD SCI, V1198, P173, DOI 10.1111/j.1749-6632.2009.05429.x; Joshi SK, 2009, J PAIN, V10, P306, DOI 10.1016/j.jpain.2008.09.007; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Liu M, 2013, PAIN, V154, P1551, DOI 10.1016/j.pain.2013.04.022; Matsutomi T, 2006, PFLUG ARCH EUR J PHY, V453, P83, DOI 10.1007/s00424-006-0104-3; McGaraughty S, 2008, J PHARMACOL EXP THER, V324, P1204, DOI 10.1124/jpet.107.134148; Medhurst SJ, 2002, PAIN, V96, P129, DOI 10.1016/S0304-3959(01)00437-7; Miao XR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-216; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Moldovan M, 2013, EUR J PHARMACOL, V708, P105, DOI 10.1016/j.ejphar.2013.03.001; Momin A, 2008, CURR OPIN NEUROBIOL, V18, P383, DOI 10.1016/j.conb.2008.08.017; Qiu F, 2012, NEUROSCI LETT, V512, P61, DOI 10.1016/j.neulet.2012.01.069; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rugiero F, 2003, J NEUROSCI, V23, P2715; Rush AM, 2004, BRAIN RES, V1023, P264, DOI 10.1016/j.brainres.2004.07.042; Zhao J, 2010, LIFE SCI, V87, P120, DOI 10.1016/j.lfs.2010.05.015; Zheng Q, 2013, PAIN, V154, P434, DOI 10.1016/j.pain.2012.12.005; Zheng Q, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-24; Zimmermann K, 2007, NATURE, V447, P855, DOI 10.1038/nature05880; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	40	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114623	10.1371/journal.pone.0114623	http://dx.doi.org/10.1371/journal.pone.0114623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503076	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700034
J	Wang, X; Qian, YJ; Zhou, Q; Ye, P; Duan, N; Huang, XF; Zhu, YN; Li, JJ; Hu, LP; Zhang, WY; Han, XD; Wang, WM				Wang, Xiang; Qian, Ya-jie; Zhou, Qian; Ye, Pei; Duan, Ning; Huang, Xiao-feng; Zhu, Ya-nan; Li, Jing-jing; Hu, Li-ping; Zhang, Wei-yun; Han, Xiao-dong; Wang, Wen-mei			Caspase-12 Silencing Attenuates Inhibitory Effects of Cigarette Smoke Extract on NOD1 Signaling and hBDs Expression in Human Oral Mucosal Epithelial Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; OXIDATIVE STRESS; GENE-EXPRESSION; MACROPHAGES; INFECTIONS; INDUCTION; RESPONSES; CANCER; HEALTH; TISSUE	Cigarette smoke exposure is associated with increased risk of various diseases. Epithelial cells-mediated innate immune responses to infectious pathogens are compromised by cigarette smoke. Although many studies have established that cigarette smoke exposure affects the expression of Toll-liked receptor (TLR), it remains unknown whether the nucleotide-binding oligomerization domaincontaining protein 1 (NOD1) expression is affected by cigarette smoke exposure. In the study, we investigated effects of cigarette smoke extract (CSE) on NOD1 signaling in an immortalized human oral mucosal epithelial (Leuk-1) cell line. We first found that CSE inhibited NOD1 expression in a dose-dependent manner. Moreover, CSE modulated the expression of other crucial molecules in NOD1 signaling and human b defensin (hBD) 1, 2 and 3. We found that RNA interferenceinduced Caspase-12 silencing increased NOD1 and phospho-NF-kappa B (p-NF-kappa B) expression and down-regulated RIP2 expression. The inhibitory effects of CSE on NOD1 signaling can be attenuated partially through Caspase-12 silencing. Intriguingly, Caspase-12 silencing abrogated inhibitory effects of CSE on hBD1, 3 expression and augmented induced effect of CSE on hBD2 expression. Caspase-12 could play a vital role in the inhibitory effects of cigarette smoke on NOD1 signaling and hBDs expression in oral mucosal epithelial cells.	[Wang, Xiang; Qian, Ya-jie; Ye, Pei; Duan, Ning; Li, Jing-jing; Wang, Wen-mei] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Qian; Zhu, Ya-nan] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Endodont, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Xiao-feng] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Hu, Li-ping] Nanjing Univ, Sch Med, Inst & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xiang; Han, Xiao-dong] Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xiang; Zhang, Wei-yun; Han, Xiao-dong] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Xiang; Zhang, Wei-yun; Han, Xiao-dong] Nanjing Univ, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Nanjing University	Han, XD (corresponding author), Nanjing Univ, Sch Med, Immunol & Reprod Biol Lab, Nanjing 210008, Jiangsu, Peoples R China.	hanxd@nju.edu.cn; wenmei-wang@hotmail.com	Wang, Xiang/F-8467-2014; han, xiao/HDN-9782-2022	Wang, Xiang/0000-0002-2135-8576; 	National Natural Scientific Foundation of China [81070839, 81273121]; Jiangsu Province's Outstanding Medical Academic Leader program [LJ201110]; Medical Science and technology development Foundation, Nanjing Department of Health [ZKX10030]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Outstanding Medical Academic Leader program; Medical Science and technology development Foundation, Nanjing Department of Health	This work was supported by the National Natural Scientific Foundation of China (No. 81070839 & No. 81273121), Jiangsu Province's Outstanding Medical Academic Leader program (No. LJ201110), and Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (No. ZKX10030).	Alberg AJ, 2008, DRUG TODAY, V44, P895, DOI 10.1358/dot.2008.44.12.1308898; Aldhous MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024715; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Baboni FB, 2009, MYCOPATHOLOGIA, V168, P227, DOI 10.1007/s11046-009-9217-5; Bogefors J, 2012, FEMS IMMUNOL MED MIC, V65, P431, DOI 10.1111/j.1574-695X.2012.00959.x; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chung WO, 2007, CURR PHARM DESIGN, V13, P3073, DOI 10.2174/138161207782110435; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Di Cello F, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-90; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Gan GX, 2011, CELL PHYSIOL BIOCHEM, V28, P725, DOI 10.1159/000335766; He P, 2009, NEUROTOXICOLOGY, V30, P10, DOI 10.1016/j.neuro.2008.10.004; Homer CR, 2012, J BIOL CHEM, V287, P25565, DOI 10.1074/jbc.M111.326835; Jiao YZ, 2013, CELL HOST MICROBE, V13, P595, DOI 10.1016/j.chom.2013.04.005; Kavathas PB, 2013, MUCOSAL IMMUNOL, V6, P235, DOI 10.1038/mi.2012.63; Kim SR, 2009, BIOMED CHROMATOGR, V23, P273, DOI 10.1002/bmc.1110; Kimball JR, 2006, ARCH ORAL BIOL, V51, P775, DOI 10.1016/j.archoralbio.2006.05.007; Kitaguchi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038038; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Li YF, 2013, DIS MARKERS, V34, P247, DOI [10.1155/2013/983568, 10.3233/DMA-130967]; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Mahanonda R, 2009, J PERIODONTAL RES, V44, P557, DOI 10.1111/j.1600-0765.2008.01153.x; Moraitis D, 2005, CANCER RES, V65, P664; Pace E, 2014, TOXICOL IN VITRO, V28, P292, DOI 10.1016/j.tiv.2013.11.004; Pace E, 2013, TOXICOL LETT, V223, P198, DOI 10.1016/j.toxlet.2013.09.013; Park JW, 2008, J IMMUNOL, V180, P4668, DOI 10.4049/jimmunol.180.7.4668; Patil AJ, 2009, CURR EYE RES, V34, P672, DOI 10.1080/02713680903015892; Rao SVK, 2013, ASIAN PAC J CANCER P, V14, P5567, DOI 10.7314/APJCP.2013.14.10.5567; Sacks PG, 1996, CANCER METAST REV, V15, P27, DOI 10.1007/BF00049486; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Sarioglu S, 2011, APPL IMMUNOHISTO M M, V19, P470, DOI 10.1097/PAI.0b013e318214e543; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Semlali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052614; Sharma A, 2008, INVEST OPHTH VIS SCI, V49, P5111, DOI 10.1167/iovs.08-2060; Shi JX, 2012, RESP PHYSIOL NEUROBI, V181, P154, DOI 10.1016/j.resp.2012.02.011; Shibata Y, 2008, RESPIROLOGY, V13, P1061, DOI 10.1111/j.1440-1843.2008.01362.x; Soysa NS, 2005, ORAL DIS, V11, P268, DOI 10.1111/j.1601-0825.2005.01115.x; Sugawara Y, 2006, J DENT RES, V85, P524, DOI 10.1177/154405910608500609; Suzuki Y, 2011, BURNS, V37, P109, DOI 10.1016/j.burns.2010.08.004; Todt JC, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-33; Uchiyama R, 2014, ARCH IMMUNOL THER EX; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Wang Q, 2013, CARCINOGENESIS, V34, P2119, DOI 10.1093/carcin/bgt143; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895; Wang X, 2014, INT J CLIN EXP PATHO, V7, P1677; Wolgin M, 2012, J DENT, V40, P949, DOI 10.1016/j.jdent.2012.07.017; Yuan FJ, 2013, EXP TOXICOL PATHOL, V65, P1011, DOI 10.1016/j.etp.2013.02.004; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zhao XP, 2007, BIOCHEM BIOPH RES CO, V359, P896, DOI 10.1016/j.bbrc.2007.05.175	53	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115053	10.1371/journal.pone.0115053	http://dx.doi.org/10.1371/journal.pone.0115053			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503380	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700087
J	Baumer, N; Baumer, S; Berkenfeld, F; Stehling, M; Kohler, G; Berdel, WE; Muller-Tidow, C; Tschanter, P				Baeumer, Nicole; Baeumer, Sebastian; Berkenfeld, Frank; Stehling, Martin; Koehler, Gabriele; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Tschanter, Petra			Maintenance of Leukemia-Initiating Cells Is Regulated by the CDK Inhibitor Inca1	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; CYCLIN-DEPENDENT KINASES; MURINE MODEL; SELF-RENEWAL; IN-VIVO; FLT3; GENE; DIFFERENTIATION; P21(CIP1/WAF1)	Functional differences between healthy progenitor and cancer initiating cells may provide unique opportunities for targeted therapy approaches. Hematopoietic stem cells are tightly controlled by a network of CDK inhibitors that govern proliferation and prevent stem cell exhaustion. Loss of Inca1 led to an increased number of short-term hematopoietic stem cells in older mice, but Inca1 seems largely dispensable for normal hematopoiesis. On the other hand, Inca1-deficiency enhanced cell cycling upon cytotoxic stress and accelerated bone marrow exhaustion. Moreover, AML1-ETO9a-induced proliferation was not sustained in Inca1-deficient cells in vivo. As a consequence, leukemia induction and leukemia maintenance were severely impaired in Inca1(-/-) bone marrow cells. The re-initiation of leukemia was also significantly inhibited in absence of Inca1(-/-) in MLL-AF9- and c-myc/BCL2-positive leukemia mouse models. These findings indicate distinct functional properties of Inca1 in normal hematopoietic cells compared to leukemia initiating cells. Such functional differences might be used to design specific therapy approaches in leukemia.	[Baeumer, Nicole; Baeumer, Sebastian; Berkenfeld, Frank; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Tschanter, Petra] Univ Munster, Dept Med A, D-48129 Munster, Germany; [Baeumer, Nicole; Mueller-Tidow, Carsten; Tschanter, Petra] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48129 Munster, Germany; [Berkenfeld, Frank; Stehling, Martin] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48129 Munster, Germany; [Berkenfeld, Frank] Univ Munster, Fac Med, D-48129 Munster, Germany; [Mueller-Tidow, Carsten; Tschanter, Petra] Univ Halle Wittenberg, Dept Med 4, D-06120 Halle, Germany; [Koehler, Gabriele] Clin Ctr Fulda, Inst Pathol, D-36043 Fulda, Germany	University of Munster; University of Munster; Max Planck Society; University of Munster; Martin Luther University Halle Wittenberg	Baumer, N (corresponding author), Univ Munster, Dept Med A, D-48129 Munster, Germany.	nbaeumer@uni-muenster.de; Carsten.Mueller-Tidow@UK-Halle.de	Baeumer, Sebastian/GYU-0544-2022; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	IZKF at the University of Munster; Deutsche Forschungsgemeinschaft [Mu1328/6-1]; Deutsche Forschungsgemeinschaft, DFG EXC Cells in Motion - Cluster of Excellence, Munster, Germany [1003]	IZKF at the University of Munster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, DFG EXC Cells in Motion - Cluster of Excellence, Munster, Germany	This work is supported by grants from the IZKF at the University of Munster (http://campus.uni-muenster.de/izkf.html), and the Deutsche Forschungsgemeinschaft (Mu1328/6-1; www.dfg.de). Work of W.E.B. is supported by the Deutsche Forschungsgemeinschaft, DFG EXC 1003 Cells in Motion - Cluster of Excellence, Munster, Germany (www.dfg.de). The authors disclose all commercial affiliation and competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Baumer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094993; Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bruyere C, 2013, CURR OPIN CELL BIOL, V25, P772, DOI 10.1016/j.ceb.2013.08.004; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; LERNER C, 1990, EXP HEMATOL, V18, P114; Leung AYH, 2013, LEUKEMIA, V27, P260, DOI 10.1038/leu.2012.195; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Metzelder SK, 2012, LEUKEMIA, V26, P2353, DOI 10.1038/leu.2012.105; Nakamura M, 2001, LEUKEMIA, V15, P1136, DOI 10.1038/sj.leu.2402160; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Schemionek M, 2010, BLOOD, V115, P3185, DOI 10.1182/blood-2009-04-215376; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Steffen B, 2011, BLOOD, V117, P4328, DOI 10.1182/blood-2009-09-242545; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Tallen G, 2014, FEBS LETT, V588, P2728, DOI 10.1016/j.febslet.2014.03.011; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021505; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115578	10.1371/journal.pone.0115578	http://dx.doi.org/10.1371/journal.pone.0115578			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525809	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200036
J	Yan, MX; Zheng, DD; Li, Y; Zheng, QL; Chen, J; Yang, BB				Yan, Maoxiao; Zheng, Dandan; Li, Ying; Zheng, Qiaoli; Chen, Jia; Yang, Beibei			Biodegradable Nasal Packings for Endoscopic Sinonasal Surgery: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SYNTHETIC POLYURETHANE FOAM; MICROPOROUS POLYSACCHARIDE HEMOSPHERES; SINUS SURGERY; ENDONASAL OPERATIONS; RANDOMIZED-TRIAL; DOUBLE-BLIND; FIBRIN GLUE; NO PACKING; RHINOSINUSITIS; SEPTOPLASTY	Objectives: To assess biodegradable nasal packing effectiveness for improving postoperative symptoms and mucosal healing after endoscopic sinonasal surgery as compared with conventional/non-packing groups. Methods: Relevant articles were searched on PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. We included randomized controlled trials (RCTs) that compared biodegradable packings with conventional packings or no packing, reporting postoperative symptoms and/or mucosal healing outcomes. Results: This review included 19 studies, of which 11 compared biodegradable packings with conventional packings. Meta-analysis found that biodegradable packings significantly improved postoperative symptoms: bleeding at removal, pain at removal, pain in situ, and nasal blockage. Mucosal healing outcomes were inconsistent within studies, with no data could be pooled. Eight studies compared biodegradable packings with non-packing group. Postoperative symptom data in this comparison could not be pooled: A protective or equal effect on postoperative bleeding was reported in different studies; no difference was reported in pain status and nasal blockage. As for mucosal healing, meta-analysis showed that two arms of comparison had similar effect on synechiae, edema, infection and granulation at each time point. Conclusion: The limiting evidence suggests that biodegradable nasal packings are statistically better than conventional packings in postoperative symptoms, and probably comparable to non-packing group, as in this comparison we could not carry out meta-analysis. No beneficial or detrimental effect on postoperative mucosal healing could be determined based on existing evidence.	[Yan, Maoxiao; Zheng, Dandan; Li, Ying; Chen, Jia; Yang, Beibei] Zhejiang Univ, Affiliated Hosp 2, Dept Otorhinolaryngol, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Qiaoli] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Clin Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yang, BB (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Otorhinolaryngol, Hangzhou 310003, Zhejiang, Peoples R China.	yangbb1959@sina.com		Yang, Beibei/0000-0002-2738-7896				Akbari E, 2012, RHINOLOGY, V50, P306, DOI [10.4193/Rhin11.215, 10.4193/Rhino11.215]; [Anonymous], 2012, REV MAN REVMAN COMP; Antisdel JL, 2011, AM J RHINOL ALLERGY, V25, P268, DOI 10.2500/ajra.2011.25.3619; Antisdel JL, 2009, OTOLARYNG HEAD NECK, V141, P353, DOI 10.1016/j.otohns.2009.06.078; Ardehali MM, 2009, INT J ORAL MAX SURG, V38, P1022, DOI 10.1016/j.ijom.2009.05.012; Berlucchi M, 2009, EUR ARCH OTO-RHINO-L, V266, P839, DOI 10.1007/s00405-008-0841-3; Celik O, 2013, J CRANIOFAC SURG, V24, P1931, DOI 10.1097/01.SCS.0000435809.68641.6c; Cenni E, 2000, J BIOMAT SCI-POLYM E, V11, P685, DOI 10.1163/156856200743959; Chandra Rakesh K, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P21, DOI 10.1097/00020840-200402000-00007; Chandra RK, 2005, AM J RHINOL, V19, P240, DOI 10.1177/194589240501900304; Chandra RK, 2003, AM J RHINOL, V17, P51, DOI 10.1177/194589240301700109; Cho KS, 2013, LARYNGOSCOPE, V123, P564, DOI 10.1002/lary.23643; Cruise AS, 2006, CLIN OTOLARYNGOL, V31, P25, DOI 10.1111/j.1749-4486.2006.01122.x; Dorion RP, 1998, ARCH PATHOL LAB MED, V122, P887; Eliashar R, 2006, OTOLARYNG HEAD NECK, V134, P276, DOI 10.1016/j.otohns.2005.10.012; Franklin JH, 2007, AM J RHINOL, V21, P214, DOI 10.2500/ajr.2007.21.3011; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu KH, 2008, INT J PEDIATR OTORHI, V72, P1535, DOI 10.1016/j.ijporl.2008.07.006; Jacob A, 2002, LARYNGOSCOPE, V112, P37, DOI 10.1097/00005537-200201000-00007; Kastl KG, 2009, AMJ RHINOL ALLERGY, V23, P80, DOI 10.2500/ajra.2009.23.3267; Kastl KG, 2009, EUR ARCH OTO-RHINO-L, V266, P1239, DOI 10.1007/s00405-008-0881-8; Kim ST, 2013, INT J PEDIATR OTORHI, V77, P113, DOI 10.1016/j.ijporl.2012.10.007; Kim YS, 2011, AM J RHINOL ALLERGY, V25, pE77, DOI 10.2500/ajra.2011.25.3600; KLOKKEVOLD PR, 1991, J ORAL MAXIL SURG, V49, P858, DOI 10.1016/0278-2391(91)90017-G; Leunig A, 2009, RHINOLOGY, V47, P36; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Maccabee MS, 2003, AM J RHINOL, V17, P203, DOI 10.1177/194589240301700405; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mehta U, 2006, OTOLARYNG HEAD NECK, V134, P483, DOI 10.1016/j.otohns.2005.10.053; Miller RS, 2003, OTOLARYNG HEAD NECK, V128, P862, DOI 10.1016/S0194-5998(03)00460-1; Mo JH, 2008, AM J RHINOL, V22, P525, DOI 10.2500/ajr.2008.22.3218; Rudmik L, 2011, INT FORUM ALLERGY RH, V1, P417, DOI 10.1002/alr.20072; Seol JH, 2013, RHINOLOGY, V51, P137, DOI [10.4193/Rhin12.176, 10.4193/Rhino12.176]; Shoman N, 2009, J OTOLARYNGOL-HEAD N, V38, P112, DOI 10.2310/7070.2008.OA0217; Shrime MG, 2007, AM J RHINOL, V21, P174, DOI 10.2500/ajr.2007.21.2986; STAMMBERGER H, 1990, EUR ARCH OTO-RHINO-L, V247, P63; Szczygielski K, 2010, EUR ARCH OTO-RHINO-L, V267, P537, DOI 10.1007/s00405-009-1117-2; Tom LWC, 1997, AM J RHINOL, V11, P229, DOI 10.2500/105065897781751884; Vaiman M, 2005, ISR MED ASSOC J, V7, P571; Vaiman M, 2005, ANN OTO RHINOL LARYN, V114, P237, DOI 10.1177/000348940511400313; Vaiman M, 2002, RHINOLOGY, V40, P185; Valentine Rowan, 2009, Otolaryngol Clin North Am, V42, P813, DOI 10.1016/j.otc.2009.07.009; Valentine R, 2010, AM J RHINOL ALLERGY, V24, P70, DOI 10.2500/ajra.2010.24.3422; Verim A, 2014, LARYNGOSCOPE, V124, P1529, DOI 10.1002/lary.24543; Weber R, 2000, RHINOLOGY, V38, P49; Weber R, 2001, AM J OTOLARYNG, V22, P306, DOI 10.1053/ajot.2001.26499; Wee JH, 2012, EUR ARCH OTO-RHINO-L, V269, P897, DOI 10.1007/s00405-011-1768-7; Wormald PJ, 2006, AM J RHINOL, V20, P7, DOI 10.1177/194589240602000102; Yilmaz MS, 2013, OTOLARYNG HEAD NECK, V148, P140, DOI 10.1177/0194599812465587	49	24	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115458	10.1371/journal.pone.0115458	http://dx.doi.org/10.1371/journal.pone.0115458			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526585	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200029
J	Lindberg, MH; Wettergren, L; Wiklander, M; Svedhem-Johansson, V; Eriksson, LE				Lindberg, Maria H.; Wettergren, Lena; Wiklander, Maria; Svedhem-Johansson, Veronica; Eriksson, Lars E.			Psychometric Evaluation of the HIV Stigma Scale in a Swedish Context	PLOS ONE			English	Article							QUALITY-OF-LIFE; YOUNG MEN; HEALTH; HIV/AIDS; SAMPLE; EXPERIENCES; FRAMEWORK; IMPACT; WOMEN	Background: HIV-related stigma has negative consequences for infected people's lives and is a barrier to HIV prevention. Therefore valid and reliable instruments to measure stigma are needed to enable mapping of HIV stigma. This study aimed to evaluate the psychometric properties of the HIV stigma scale in a Swedish context with regard to construct validity, data quality, and reliability. Methods: The HIV stigma scale, developed by Berger, Ferrans, and Lashley (2001), was distributed to a cross-sectional sample of people living with HIV in Sweden (n=194). The psychometric evaluation included exploratory factor analysis together with an analysis of the distribution of scores, convergent validity by correlations between the HIV stigma scale and measures of emotional well-being, and an analysis of missing items and floor and ceiling effects. Reliability was assessed using Cronbach's alpha. Results: The exploratory factor analysis suggested a four-factor solution, similar to the original scale, with the dimensions personalised stigma, disclosure concerns, negative self-image, and concerns with public attitudes. One item had unacceptably low loadings and was excluded. Correlations between stigma dimensions and emotional well-being were all in the expected direction and ranged between -0.494 and -0.210. The instrument generated data of acceptable quality except for participants who had not disclosed their HIV status to anybody. In line with the original scale, all subscales demonstrated acceptable internal consistency with Cronbach's alpha 0.87-0.96. Conclusion: A 39-item version of the HIV stigma scale used in a Swedish context showed satisfactory construct validity and reliability. Response alternatives are suggested to be slightly revised for items assuming the disclosure of diagnosis to another person. We recommend that people that have not disclosed should skip all questions belonging to the dimension personalised stigma. Our analysis confirmed construct validity of the instrument even without this dimension.	[Lindberg, Maria H.; Wettergren, Lena; Wiklander, Maria; Eriksson, Lars E.] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Wiklander, Maria] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Svedhem-Johansson, Veronica; Eriksson, Lars E.] Karolinska Univ Hosp, Dept Infect Dis, Huddinge, Sweden; [Svedhem-Johansson, Veronica] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London EC1V 0HB, England	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; City University London	Eriksson, LE (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden.	lars.eriksson@ki.se	Wiklander, Maria/N-1634-2014; Reinius, Maria/AAA-2277-2022	Wiklander, Maria/0000-0002-8250-3773; Reinius, Maria/0000-0003-0864-8701	National Research School in Health Care Sciences, Karolinska Institutet, Stockholm, Sweden	National Research School in Health Care Sciences, Karolinska Institutet, Stockholm, Sweden	The study was financially supported by the National Research School in Health Care Sciences, Karolinska Institutet, Stockholm, Sweden (partial PhD studentship grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; BRORSSON B, 1993, QUAL LIFE RES, V2, P33, DOI 10.1007/BF00642887; Buseh AG, 2008, PUBLIC HEALTH NURS, V25, P409, DOI 10.1111/j.1525-1446.2008.00725.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dowshen N, 2009, AIDS PATIENT CARE ST, V23, P371, DOI 10.1089/apc.2008.0256; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Emlet CA, 2007, AIDS PATIENT CARE ST, V21, P740, DOI 10.1089/apc.2007.0010; Eriksson Lars E, 2005, Health Qual Life Outcomes, V3, P32, DOI 10.1186/1477-7525-3-32; Eriksson LE, 2000, J ADV NURS, V32, P1213, DOI 10.1046/j.1365-2648.2000.01592.x; Eriksson LE, 2012, POSITIVE LIFE STATE; Fife BL, 2000, J HEALTH SOC BEHAV, V41, P50, DOI 10.2307/2676360; Fonteyn Marsha E, 1993, QUAL HEALTH RES, V3, P430, DOI 10.1177/104973239300300403; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Holzemer WL, 2009, J ASSOC NURSE AIDS C, V20, P161, DOI 10.1016/j.jana.2009.02.002; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maughan-Brown B, 2014, AIDS BEHAV, V18, P958, DOI 10.1007/s10461-013-0636-4; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; R Core Team, 2021, R LANGUAGE ENV STAT; Raiche G, 2011, R PACKAGE PARALLEL A; Saris-Baglama RN., 2004, SF HLTH OUTCOMES SCO, DOI Lincoln; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Sowell RL, 1997, PUBLIC HEALTH NURS, V14, P302, DOI 10.1111/j.1525-1446.1997.tb00379.x; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Wiklander M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-195; Willis BG, 2005, COGNITIVE INTERVIEWI; Wright K, 2007, J ADOLESCENT HEALTH, V40, P96, DOI 10.1016/j.jadohealth.2006.08.001	35	26	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114867	10.1371/journal.pone.0114867	http://dx.doi.org/10.1371/journal.pone.0114867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522127	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000348845600009
J	Woo, HG; Kim, SS; Cho, H; Kwon, SM; Cho, HJ; Ahn, SJ; Park, ES; Lee, JS; Cho, SW; Cheong, JY				Woo, Hyun Goo; Kim, Soon Sun; Cho, Hyunwoo; Kwon, So Mee; Cho, Hyo Jung; Ahn, Seun Joo; Park, Eun Sung; Lee, Ju-Seog; Cho, Sung Won; Cheong, Jae Youn			Profiling of Exome Mutations Associated with Progression of HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; DNA-SEQUENCING DATA; HEPATITIS-B-VIRUS; RECURRENT MUTATIONS; SOMATIC MUTATIONS; TUMOR PROGRESSION; GENOME; CANCER; LIVER; GENES	Recent advances in sequencing technology have allowed us to profile genome-wide mutations of various cancer types, revealing huge heterogeneity of cancer genome variations. However, its heterogeneous landscape of somatic mutations according to liver cancer progression is not fully understood. Here, we profiled the mutations and gene expressions of early and advanced hepatocellular carcinoma (HCC) related with Hepatitis B-viral infection. Integrative analysis was performed with whole-exome sequencing and gene expression profiles of the 12 cases of early and advanced HCCs and paired non-tumoral adjacent liver tissues. A total of 293 tumor-specific somatic variants and 202 non-tumoral variants were identified. The tumor-specific variants were found to be enriched at chromosome 1q particularly in the advanced HCC, compared to the non-tumoral variants. Functional enrichment analysis revealed frequent mutations at the genes encoding cytoskeleton organization, cell adhesion, and cell cycle-related genes. In addition, to elucidate actionable somatic mutations, we performed an integrative analysis of gene mutations and gene expression profiles together. This revealed the 48 mutated genes which were differentially mutated with concomitant gene expression enrichment. Of these, CTNNB1 was found to have a pivotal role in the differential progression of the HCC subgroup. In conclusion, our integrative analysis of whole-exome sequencing and transcriptome profiles could provide actionable mutations which might play pivotal roles in the heterogeneous progression of HCC.	[Woo, Hyun Goo; Cho, Hyunwoo; Kwon, So Mee] Ajou Univ, Dept Physiol, Sch Med, Suwon 441749, South Korea; [Kim, Soon Sun; Ahn, Seun Joo; Cho, Sung Won; Cheong, Jae Youn] Ajou Univ, Dept Gastroenterol, Sch Med, Suwon 441749, South Korea; [Woo, Hyun Goo; Cho, Hyunwoo; Kwon, So Mee; Cho, Hyo Jung] Ajou Univ, Grad Sch Biomed Sci, Sch Med, Suwon 441749, South Korea; [Park, Eun Sung] Yonsei Univ, Coll Med, Inst Med Convergence, Seoul, South Korea; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA	Ajou University; Ajou University; Ajou University; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center	Cheong, JY (corresponding author), Ajou Univ, Dept Gastroenterol, Sch Med, Suwon 441749, South Korea.	jaeyoun620@gmail.com	Woo, Hyun Goo/AEJ-7372-2022; Woo, Hyun Goo | 우현구/I-8954-2019; Lee, Ju-Seog/X-1786-2018	Woo, Hyun Goo/0000-0002-0916-893X; Woo, Hyun Goo | 우현구/0000-0002-0916-893X; Lee, Ju-Seog/0000-0002-5666-9753	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111574]	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant (A111574) of the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Calvisi DF, 2001, CANCER RES, V61, P2085; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gartner JJ, 2013, P NATL ACAD SCI USA, V110, P13481, DOI 10.1073/pnas.1304227110; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Ikeda A, 2014, GASTROENTEROLOGY, V146, P222, DOI 10.1053/j.gastro.2013.09.025; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kwon So Mee, 2012, Genomics & Informatics, V10, P69, DOI 10.5808/GI.2012.10.2.69; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nakagawa H, 2013, CANCER LETT, V340, P234, DOI 10.1016/j.canlet.2012.10.035; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Poon TCW, 2006, GASTROENTEROLOGY, V131, P1262, DOI 10.1053/j.gastro.2006.08.014; Sung WK, 2012, NAT GENET; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034; Woo HG, 2010, CANCER RES, V70, P3034, DOI 10.1158/0008-5472.CAN-09-2823; Woo HG, 2009, CANCER RES, V69, P4059, DOI 10.1158/0008-5472.CAN-09-0164; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622	40	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115152	10.1371/journal.pone.0115152	http://dx.doi.org/10.1371/journal.pone.0115152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521761	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600019
J	Yin, T; Shi, PF; Gou, SM; Shen, Q; Wang, CY				Yin, Tao; Shi, Pengfei; Gou, Shanmiao; Shen, Qiang; Wang, Chunyou			Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro	PLOS ONE			English	Article							INITIATING CELLS; RESISTANCE; GLIOBLASTOMA; POPULATIONS; VACCINATION; MELANOMA; CD133	According to the cancer stem cells (CSCs) theory, malignant tumors may be heterogeneous in which a small population of CSCs drive the progression of cancer. Because of their intrinsic abilities, CSCs may survive a variety of treatments and then lead to therapeutic resistance and cancer recurrence. Pancreatic CSCs have been reported to be responsible for the malignant behaviors of pancreatic cancer, including suppression of immune protection. Thus, development of immune strategies to eradicate pancreatic CSCs may be of great value for the treatment of pancreatic cancer. In this study, we enriched pancreatic CSCs by culturing Panc-1 cells under sphere-forming conditions. Panc-1 CSCs expressed low levels of HLA-ABC and CD86, as measured by flow cytometry analysis. We further found that the Panc-1 CSCs modulate immunity by inhibiting lymphocyte proliferation which is promoted by phytohemagglutinin (PHA) and anti-CD3 monoclonal antibodies. The monocyte derived dendritic cells (DCs) were charged with total lysates generated from Panc-1 CSCs obtained from tumor sphere culturing. After co-culturing with lymphocytes at different ratios, the Panc-1 CSCs lysates modified DC effectively promoted lymphocyte proliferation. The activating efficiency reached 72.4% and 74.7% at the ratios of 1: 10 and 1: 20 with lymphocytes. The activated lymphocytes secreted high levels of INF-gamma and IL-2, which are strong antitumor cytokines. Moreover, Panc-1 CSCs lysates modified DC induced significant cytotoxic effects of lymphocytes on Panc-1 CSCs and parental Panc-1 cells, respectively, as shown by lactate dehydrogenase (LDH) assay. Our study demonstrates that the development of CSCs-based vaccine is a promising strategy for treating pancreatic cancer.	[Yin, Tao; Shi, Pengfei; Gou, Shanmiao; Wang, Chunyou] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Pancreat Dis Inst,Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China; [Shen, Qiang] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center	Yin, T (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Pancreat Dis Inst,Dept Gen Surg, 1277 Jiefang Ave, Wuhan 430074, Hubei, Peoples R China.	ytwhun@126.com; chunyouwang52@126.com		Shen, Qiang/0000-0002-1491-5434	National Natural Science Foundation of China [30801100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (No. 30801100).	Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Goldszmid RS, 2003, J IMMUNOL, V171, P5940, DOI 10.4049/jimmunol.171.11.5940; Gou SM, 2007, PANCREAS, V34, P429, DOI 10.1097/MPA.0b013e318033f9f4; Hayashi T, 2002, CLIN IMMUNOL, V104, P14, DOI 10.1006/clim.2002.5224; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Lee HJ, 2011, J KOREAN SURG SOC, V81, P263, DOI 10.4174/jkss.2011.81.4.263; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mimeault M, 2007, J CELL MOL MED, V11, P981, DOI 10.1111/j.1582-4934.2007.00088.x; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Schatton T, 2010, CANCER RES, V70, P697, DOI 10.1158/0008-5472.CAN-09-1592; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Vik-Mo EO, 2013, CANCER IMMUNOL IMMUN, V62, P1499, DOI 10.1007/s00262-013-1453-3; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Wei J, 2010, MOL CANCER THER, V9, P67, DOI 10.1158/1535-7163.MCT-09-0734; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Xu QJ, 2009, STEM CELLS, V27, P1734, DOI 10.1002/stem.102; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595	21	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114581	10.1371/journal.pone.0114581	http://dx.doi.org/10.1371/journal.pone.0114581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521461	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600004
J	Cassim, N; Coetzee, LM; Schnippel, K; Glencross, DK				Cassim, Naseem; Coetzee, Lindi M.; Schnippel, Kathryn; Glencross, Deborah K.			Estimating Implementation and Operational Costs of an Integrated Tiered CD4 Service including Laboratory and Point of Care Testing in a Remote Health District in South Africa	PLOS ONE			English	Article							EXTERNAL QUALITY ASSESSMENT; ANTIRETROVIRAL THERAPY; ART INITIATION; HIV; PERFORMANCE; ENUMERATION	Background: An integrated tiered service delivery model (ITSDM) has been proposed to provide 'full-coverage' of CD4 services throughout South Africa. Five tiers are described, defined by testing volumes and number of referring health-facilities. These include: (1) Tier-1/decentralized point-of-care service (POC) in a single site; Tier-2/POC-hub servicing processing <30-40 samples from 8-10 health-clinics; Tier-3/Community laboratories servicing similar to 50 health-clinics, processing <150 samples/day; high-volume centralized laboratories (Tier-4 and Tier-5) processing <300 or >600 samples/day and serving >100 or >200 health-clinics, respectively. The objective of this study was to establish costs of existing and ITSDM-tiers 1, 2 and 3 in a remote, under-serviced district in South Africa. Methods: Historical health-facility workload volumes from the Pixley-ka-Seme district, and the total volumes of CD4 tests performed by the adjacent district referral CD4 laboratories, linked to locations of all referring clinics and related laboratory-to-result turn-around time (LTR-TAT) data, were extracted from the NHLS Corporate-Data-Warehouse for the period April-2012 to March-2013. Tiers were costed separately (as a cost-per-result) including equipment, staffing, reagents and test consumable costs. A one-way sensitivity analyses provided for changes in reagent price, test volumes and personnel time. Results: The lowest cost-per-result was noted for the existing laboratory-based Tiers-4 and 5 ($6.24 and $5.37 respectively), but with related increased LTR-TAT of >24-48 hours. Full service coverage with TAT <6-hours could be achieved with placement of twenty-seven Tier-1/POC or eight Tier-2/POC-hubs, at a cost-per-result of $32.32 and $15.88 respectively. A single district Tier-3 laboratory also ensured 'full service coverage' and <24 hour LTR-TAT for the district at $7.42 per-test. Conclusion: Implementing a single Tier-3/community laboratory to extend and improve delivery of services in Pixley-ka-Seme, with an estimated local similar to 12-24-hour LTR-TAT, is similar to$2 more than existing referred services per-test, but 2-4 fold cheaper than implementing eight Tier-2/POC-hubs or providing twenty-seven Tier1/POCT CD4 services.	[Cassim, Naseem; Coetzee, Lindi M.; Glencross, Deborah K.] Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa; [Glencross, Deborah K.] Univ Witwatersrand, Fac Hlth Sci, Dept Mol Med & Haematol, Johannesburg, South Africa; [Schnippel, Kathryn] Univ Witwatersrand, Fac Hlth Sci, Dept Clin Med, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa	National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand	Glencross, DK (corresponding author), Natl Hlth Lab Serv, Natl Prior Programmes, Johannesburg, South Africa.	debbie.glencross@nhls.ac.za	Cassim, Naseem/AFU-5522-2022; Cassim, Naseem/GLR-4911-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Glencross, Deborah/0000-0001-7106-769X; Schnippel, Kathryn/0000-0003-0757-4325	National Health Laboratory Service; National Priority Programmes division	National Health Laboratory Service; National Priority Programmes division	The authors thank Glynis Davis (Alere) and Ank Gowans (Beckman Coulter) for relevant equipment information and pricing. The authors acknowledge the assistance and support of the National Health Laboratory Service, the National Priority Programmes division including Prof. W. Stevens and Drs S. Carmona and L. Berrie, as well as the CD4 training staff, Mrs. S. Mojalefa and Mrs. S. Drury. The authors also acknowledge assistance from team of the NHLS CDW and all staff across all the NHLS CD4 laboratories, as well as the NHLS COO, Dr. N. Sangweni, for her support for this work.	Black Samantha, 2013, S Afr Med J, V103, P557, DOI 10.7196/samj.6565; Boyle DS, 2012, TRENDS BIOTECHNOL, V30, P45, DOI 10.1016/j.tibtech.2011.06.015; Cassim N, 2012, 1 AFR SOC LAB MED AS; Cassim N, 2012, AFR SOC LAB MED 1 IN; Cassim N, 2014, AFR SOC LAB MED 2 IN; Coetzee LM, 2014, 8 HIV INT M LUS ZAMB; Coetzee LM, 2013, UNPUB; Department of Public Service and Administration, 2013, APP C DPSA CIRC 2 20; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Fajardo E, 2014, HIGH FREQUENCY INVAL; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS40, DOI 10.1002/cyto.b.20384; Glencross DK, 2008, CYTOM PART B-CLIN CY, V74B, pS69, DOI 10.1002/cyto.b.20397; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Glencross DK, 2012, AFR SOC LAB MED 1 IN; Glencross DK, 2014, PLOS ONE IN PRESS; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Husereau Don, 2013, J Med Econ, V16, P713, DOI 10.3111/13696998.2013.784591; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Larson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035444; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Lawrie D, 2010, CYTOM PART B-CLIN CY, V78B, P201, DOI 10.1002/cyto.b.20520; Magoro MT, 2013, COMMUNICATION; Medecins Sans Frontiers, 2013, NEW ROOTS S AFR CHAL; Mnyani CN, 2012, JAIDS-J ACQ IMM DEF, V60, P260, DOI 10.1097/QAI.0b013e318256b651; Mwau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107410; National Department of Health, 2013, REV ANT TREATM GUID; National Department of Health, 2013, NO CAP PIXL KA SEM D; National Department of Health, 2012, BUS PLAN NAT HLTH IN; National Health Laboratory Service, 2013, ANN REPORT; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Smith H, 2012, GEOGRAPHIC LOCATION; St John Andrew, 2013, Clin Biochem Rev, V34, P61; Standard Bank of South Africa (SBSA), 2013, FOR CLOS IND RAT 28; Statistics South Africa (STASSA), 2013, STAT PLAC NO CAP	37	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115420	10.1371/journal.pone.0115420	http://dx.doi.org/10.1371/journal.pone.0115420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517412	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600065
J	Watson, MK; Stern, AW; Labelle, AL; Joslyn, S; Fan, TM; Leister, K; Kohles, M; Marshall, K; Mitchell, MA				Watson, Megan K.; Stern, Adam W.; Labelle, Amber L.; Joslyn, Stephen; Fan, Timothy M.; Leister, Katie; Kohles, Micah; Marshall, Kemba; Mitchell, Mark A.			Evaluating the Clinical and Physiological Effects of Long Term Ultraviolet B Radiation on Guinea Pigs (Cavia porcellus)	PLOS ONE			English	Article							VITAMIN-D; DENTAL DISEASE; SKIN; ENHANCEMENT; METABOLISM; EXPOSURE; SUNLIGHT	Vitamin D is an important hormone in vertebrates. Most animals acquire this hormone through their diet, secondary to exposure to ultraviolet B (UVB) radiation, or a combination thereof. The objectives for this research were to evaluate the clinical and physiologic effects of artificial UVB light supplementation on guinea pigs (Cavia porcellus) and to evaluate the long-term safety of artificial UVB light supplementation over the course of six months. Twelve juvenile acromelanic Hartley guinea pigs were randomly assigned to one of two treatment groups: Group A was exposed to 12 hours of artificial UVB radiation daily and Group B received only ambient fluorescent light for 12 hours daily. Animals in both groups were offered the same diet and housed under the same conditions. Blood samples were collected every three weeks to measure blood chemistry values, parathyroid hormone, ionized calcium, and serum 25-hydroxyvitamin D-3 (25-OHD3) levels. Serial ophthalmologic examinations, computed tomography scans, and dual energy x-ray absorptiometry scans were performed during the course of the study. At the end of the study the animals were euthanized and necropsied. Mean +/- SD serum 25-OHD3 concentrations differed significantly in the guinea pigs (p<0.0001) between the UVB supplementation group (101.49 +/- 21.81 nmol/L) and the control group (36.33 +/- 24.42 nmol/L). An increased corneal thickness in both eyes was also found in the UVB supplementation compared to the control group (right eye [OD]: p<0.0001; left eye [OS]: p<0.0001). There were no apparent negative clinical or pathologic side effects noted between the groups. This study found that exposing guinea pigs to UVB radiation long term significantly increased their circulating serum 25-OHD3 levels, and that this increase was sustainable over time. Providing guinea pigs exposure to UVB may be an important husbandry consideration that is not currently recommended.	[Watson, Megan K.; Labelle, Amber L.; Joslyn, Stephen; Fan, Timothy M.; Leister, Katie; Mitchell, Mark A.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Stern, Adam W.] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Kohles, Micah] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA; [Kohles, Micah] Oxbow Anim Hlth, Murdock, NE USA; [Marshall, Kemba] PetSmart, Phoenix, AZ USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln	Mitchell, MA (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.	mmitch@illinois.edu	, Adam/AAY-4010-2021	, Adam/0000-0002-6794-6592; Fan, Timothy/0000-0003-2510-7050	PetSmart Charities; Oxbow Animal Health; Fluker Farms (Port Allen, LA)	PetSmart Charities; Oxbow Animal Health; Fluker Farms (Port Allen, LA)	PetSmart Charities provided funding for this project. Dr. Kemba Marshall was included as a co-author as a member of the team that designed the study, provided additional resources, and helped with the preparation of the manuscript. Oxbow Animal Health provided funding for this project. Dr. Micah Kohles was included as a coauthor as a member of the team that designed the study, provided additional resources, and helped with the preparation of the manuscript. Fluker Farms (Port Allen, LA) was a sponsor that contributed funding but played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; [Anonymous], 1995, NUTR REQUIREMENTS LA; Balasubramanian D, 2000, J OCUL PHARMACOL TH, V16, P285, DOI 10.1089/jop.2000.16.285; Bergauer K. L., 1991, INT CONTACT LENS CLI, V18, P182; BROMMAGE R, 1988, BONE, V9, P131, DOI 10.1016/8756-3282(88)90002-6; Cafaro TA, 2009, VET OPHTHALMOL, V12, P234, DOI 10.1111/j.1463-5224.2009.00708.x; DORN CR, 1971, J NATL CANCER I, V46, P1073; Emerson JA, 2014, AM J VET RES, V75, P380, DOI 10.2460/ajvr.75.4.380; Gallagher RP, 2006, PROG BIOPHYS MOL BIO, V92, P119, DOI 10.1016/j.pbiomolbio.2006.02.011; Harcourt-Brown FM, 2007, J EXOT PET MED, V16, P146, DOI 10.1053/j.jepm.2007.06.003; Hazewinkel HAW, 2002, MOL CELL ENDOCRINOL, V197, P23, DOI 10.1016/S0303-7207(02)00275-7; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; HOLICK MF, 1990, J NUTR, V120, P1464, DOI 10.1093/jn/120.suppl_11.1464; HOLICK MF, 1995, P NATL ACAD SCI USA, V92, P3124, DOI 10.1073/pnas.92.8.3124; HOLICK MF, 1981, SCIENCE, V211, P590, DOI 10.1126/science.6256855; Holick MF, 2006, PRIMER METABOLIC BON, P129; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2014, Adv Exp Med Biol, V810, P1; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Jekl V, 2013, J SMALL ANIM PRACT, V54, P481, DOI 10.1111/jsap.12124; Jensen JA, 2013, COMPARATIVE MED, V63, P156; Kadoya K, 2005, BRIT J DERMATOL, V153, P607, DOI 10.1111/j.1365-2133.2005.06716.x; KLIGMAN AM, 1986, J AM ACAD DERMATOL, V15, P836, DOI 10.1016/S0190-9622(86)70242-9; Kraus C, 2004, OIKOS, V105, P489, DOI 10.1111/j.0030-1299.2004.12941.x; Lebas F, 2010, WORLD RABBIT SCI, V8, P185; Lin YP, 2012, CURR EYE RES, V37, P871, DOI 10.3109/02713683.2012.688235; Mitchell MA., 2009, MANUAL EXOTIC PET PR, P456, DOI 10.1016/B978-1-4160-0119-5.X5001-X; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Pigiere F, 2012, J ARCHAEOL SCI, V39, P1020, DOI 10.1016/j.jas.2011.11.021; *Quesenberry KE., 2012, FERRETS RABBITS RODE, P279, DOI DOI 10.1016/B978-1-4160-6621-7-00022-1; Rivas AE, 2014, J EXOT PET MED, V23, P270, DOI 10.1053/j.jepm.2014.05.012; SchmidtGayk H, 1997, SCAND J CLIN LAB INV, V57, P35; Shepherd AJ, 2008, JAVMA-J AM VET MED A, V232, P695, DOI 10.2460/javma.232.5.695; Stockham S. L., 2008, FUNDAMENTALS VET CLI, P593; STUMPF WE, 1979, SCIENCE, V206, P1188, DOI 10.1126/science.505004; Van Saun RJ, 2009, VET CLIN N AM-FOOD A, V25, P797, DOI 10.1016/j.cvfa.2009.07.013; Wang C, 2011, LEVEL SET BASED SEGM; WEBB AR, 1988, ANNU REV NUTR, V8, P375, DOI 10.1146/annurev.nu.08.070188.002111; Yin ZH, 2011, INVEST OPHTH VIS SCI, V52, P7359, DOI 10.1167/iovs.11-7605; Zigman S, 1995, OPTOMETRY VISION SCI, V72, P899, DOI 10.1097/00006324-199512000-00008	40	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114413	10.1371/journal.pone.0114413	http://dx.doi.org/10.1371/journal.pone.0114413			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517408	Green Published, gold			2022-12-27	WOS:000347215600017
J	Yip, S; McCall, K; Aristophanous, M; Chen, AB; Aerts, HJWL; Berbeco, R				Yip, Stephen; McCall, Keisha; Aristophanous, Michalis; Chen, Aileen B.; Aerts, Hugo J. W. L.; Berbeco, Ross			Comparison of Texture Features Derived from Static and Respiratory-Gated PET Images in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DUAL TIME-POINT; STANDARDIZED UPTAKE VALUES; F-18-FDG PET; UPTAKE HETEROGENEITY; PROGNOSTIC VALUE; FDG UPTAKE; CT; SURVIVAL; THERAPY	Background: PET-based texture features have been used to quantify tumor heterogeneity due to their predictive power in treatment outcome. We investigated the sensitivity of texture features to tumor motion by comparing static (3D) and respiratory-gated (4D) PET imaging. Methods: Twenty-six patients (34 lesions) received 3D and 4D [F-18] FDG-PET scans before the chemo-radiotherapy. The acquired 4D data were retrospectively binned into five breathing phases to create the 4D image sequence. Texture features, including Maximal correlation coefficient (MCC), Long run low gray (LRLG), Coarseness, Contrast, and Busyness, were computed within the physician-defined tumor volume. The relative difference (delta(3D-4D)) in each texture between the 3D-and 4D-PET imaging was calculated. Coefficient of variation (CV) was used to determine the variability in the textures between all 4D-PET phases. Correlations between tumor volume, motion amplitude, and delta(3D-4D) were also assessed. Results: 4D-PET increased LRLG (=1%-2%, p<0.02), Busyness (=7%-19%, p<0.01), and decreased MCC (=1%-2%, p<7.5x10(-3)), Coarseness (=5%-10%, p<0.05) and Contrast (=4%-6%, p>0.08) compared to 3D-PET. Nearly negligible variability was found between the 4D phase bins with CV<5% for MCC, LRLG, and Coarseness. For Contrast and Busyness, moderate variability was found with CV=9% and 10%, respectively. No strong correlation was found between the tumor volume and delta(3D-4D) for the texture features. Motion amplitude had moderate impact on delta for MCC and Busyness and no impact for LRLG, Coarseness, and Contrast. Conclusions: Significant differences were found in MCC, LRLG, Coarseness, and Busyness between 3D and 4D PET imaging. The variability between phase bins for MCC, LRLG, and Coarseness was negligible, suggesting that similar quantification can be obtained from all phases. Texture features, blurred out by respiratory motion during 3D-PET acquisition, can be better resolved by 4D-PET imaging. 4D-PET textures may have better prognostic value as they are less susceptible to tumor motion.	[Yip, Stephen; Chen, Aileen B.; Aerts, Hugo J. W. L.; Berbeco, Ross] Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Yip, Stephen; McCall, Keisha; Chen, Aileen B.; Aerts, Hugo J. W. L.; Berbeco, Ross] Harvard Univ, Sch Med, Boston, MA USA; [McCall, Keisha] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA; [Aristophanous, Michalis] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Div Radiat Oncol, Houston, TX 77030 USA; [Aerts, Hugo J. W. L.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital	Yip, S (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA.	syip@lroc.harvard.edu	Aerts, Hugo/ABF-2821-2020; Aerts, Hugo/P-6350-2015	Aerts, Hugo/0000-0002-2122-2003; Aerts, Hugo/0000-0002-2122-2003; Aristophanous, Michalis/0000-0001-9117-1515				AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Aristophanous M, 2012, RADIOTHER ONCOL, V102, P377, DOI 10.1016/j.radonc.2011.12.015; Castellano G, 2004, CLIN RADIOL, V59, P1061, DOI 10.1016/j.crad.2004.07.008; Cheng G, 2013, EUR J NUCL MED MOL I, V40, P779, DOI 10.1007/s00259-013-2343-9; Cheng NM, 2013, ANN NUCL MED, V27, P867, DOI 10.1007/s12149-013-0759-8; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Didierlaurent D, 2012, PHYS MED BIOL, V57, P7829, DOI 10.1088/0031-9155/57/23/7829; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; Eary JF, 2008, J NUCL MED, V49, P1973, DOI 10.2967/jnumed.108.053397; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Erasmus Jeremy J, 2009, Proc Am Thorac Soc, V6, P171, DOI 10.1513/pats.200806-059LC; Fang YHD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/248505; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Vicente AMG, 2010, ANN NUCL MED, V24, P207, DOI 10.1007/s12149-010-0345-2; Vicente AMG, 2011, J NUCL MED TECHNOL, V39, P91, DOI 10.2967/jnmt.110.082719; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Guerra L, 2012, EUR J NUCL MED MOL I, V39, P1381, DOI 10.1007/s00259-012-2148-2; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Higgins KA, 2012, INT J RADIAT ONCOL, V82, P548, DOI 10.1016/j.ijrobp.2010.11.050; Huang TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058886; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Li XA, 2006, MED PHYS, V33, P145, DOI 10.1118/1.2147743; Lin P, 2011, RADIOTHER ONCOL, V101, P284, DOI 10.1016/j.radonc.2011.06.030; Lupi A, 2009, ANN NUCL MED, V23, P191, DOI 10.1007/s12149-008-0225-1; MacManus M, 2009, RADIOTHER ONCOL, V91, P85, DOI 10.1016/j.radonc.2008.11.008; Matthies A, 2002, J NUCL MED, V43, P871; Nehmeh SA, 2002, J NUCL MED, V43, P876; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Pan TS, 2005, J NUCL MED, V46, P1481; Pandit N, 2003, EUR J NUCL MED MOL I, V30, P78, DOI 10.1007/s00259-002-0937-8; Park SJ, 2008, PHYS MED BIOL, V53, P3661, DOI 10.1088/0031-9155/53/13/018; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Rizk N, 2006, ANN THORAC SURG, V81, P1076, DOI 10.1016/j.athoracsur.2005.09.063; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Usmanij EA, 2013, J NUCL MED, V54, P1528, DOI 10.2967/jnumed.112.116921; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201, DOI 10.1200/JCO.1999.17.10.3201; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Weber WA, 2003, J CLIN ONCOL, V21, P2651, DOI 10.1200/JCO.2003.12.004; Werner MK, 2009, AM J ROENTGENOL, V193, P1640, DOI 10.2214/AJR.09.2516; Yang F, 2013, EUR J NUCL MED MOL I, V40, P716, DOI 10.1007/s00259-012-2332-4; Yen RF, 2008, EUR J NUCL MED MOL I, V35, P1305, DOI 10.1007/s00259-008-0733-1; Yu H, 2009, INT J RADIAT ONCOL, V75, P618, DOI 10.1016/j.ijrobp.2009.04.043; Yu H, 2009, IEEE T MED IMAGING, V28, P374, DOI 10.1109/TMI.2008.2004425; Zhang HQ, 2011, EUR J RADIOL, V77, P92, DOI 10.1016/j.ejrad.2009.07.023	51	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115510	10.1371/journal.pone.0115510	http://dx.doi.org/10.1371/journal.pone.0115510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517987	Green Submitted, Green Published, gold			2022-12-27	WOS:000347215600070
J	Pichler, G; Cheung, PY; Binder, C; O'Reilly, M; Schwaberger, B; Aziz, K; Urlesberger, B; Schmolzer, GM				Pichler, Gerhard; Cheung, Po-Yin; Binder, Corinna; O'Reilly, Megan; Schwaberger, Bernhard; Aziz, Khalid; Urlesberger, Berndt; Schmoelzer, Georg M.			Time Course Study of Blood Pressure in Term and Preterm Infants Immediately after Birth	PLOS ONE			English	Article							REGIONAL OXYGEN-SATURATION; LEFT-VENTRICULAR OUTPUT; CORD; TRANSITION; FETAL; FLOW	Objective: To describe temporal changes in systolic, diastolic, and mean blood pressure (SBP, DBP, and MBP, respectively) in term and preterm infants immediately after birth. Methods: Prospective observational two-center study. In term infants SBP, DBP, and MBP were assessed non-invasively every minute for the first 15 minutes, and in preterm infants every minute for the first 15 minutes, as well as at 20, 25, 30, 45, and 60 minutes after birth. Regression analyses were performed by gender and respiratory support in all neonates; and by mode of delivery, cord clamping time, and development of ultrasound-detected brain injury in preterm neonates. Results: Term infants (n=54) had a mean (SD) birth weight of 3298 (442) g and gestational age of 38 (1) weeks, and preterm infants (n=94) weighed 1340 (672) g and were 30 (3) weeks gestation. Term infants' SBP, DBP and MBP within the first 15 minutes after birth were independent of gender or respiratory support. Linear mixed regression analysis showed that preterm infants, who were female, born vaginally, had delayed cord clamping and did not require positive pressure ventilation nor develop periventricular injury or ventriculomegaly, had significantly higher SBP, DBP, and MBP at some measurement points within the first hour after birth. Conclusions: We present novel reference ranges of BP immediately after birth in a cohort of term and preterm neonates. They may aid in optimization of cardiovascular support during early transition at all gestations.	[Pichler, Gerhard; Cheung, Po-Yin; O'Reilly, Megan; Aziz, Khalid; Schmoelzer, Georg M.] Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada; [Pichler, Gerhard; Cheung, Po-Yin; O'Reilly, Megan; Aziz, Khalid; Schmoelzer, Georg M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Pichler, Gerhard; Binder, Corinna; Schwaberger, Bernhard; Urlesberger, Berndt; Schmoelzer, Georg M.] Med Univ, Dept Pediat, Div Neonatol, Graz, Austria	Royal Alexandra Hospital; University of Alberta; Medical University of Graz	Schmolzer, GM (corresponding author), Royal Alexandra Hosp, Neonatal Res Unit, Ctr Studies Asphyxia & Resuscitat, Edmonton, AB, Canada.	georg.schmoelzer@me.com	Schwaberger, Bernhard/M-7929-2019; Aziz, Khalid/ABG-3331-2020; Schmölzer, Georg M/E-7883-2010; Cheung, Po-Yin/C-2804-2013	Schwaberger, Bernhard/0000-0001-5499-3712; Aziz, Khalid/0000-0001-8054-9113; Schmölzer, Georg M/0000-0001-9798-2415; Cheung, Po-Yin/0000-0002-7141-1523; Pichler, Gerhard/0000-0003-2405-7143; Urlesberger, Berndt/0000-0003-0648-5785	Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Foundation Canada Scholarship; Banting Postdoctoral Fellowship; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions Clinical Fellowship; Molly Towell Fellowship	Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation; Heart and Stroke Foundation Canada Scholarship; Banting Postdoctoral Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions Clinical Fellowship; Molly Towell Fellowship	GMS is a recipient of the Heart and Stroke Foundation/University of Alberta Professorship of Neonatal Resuscitation, the Heart and Stroke Foundation Canada Scholarship, the Banting Postdoctoral Fellowship, Canadian Institutes of Health Research, and the Alberta Innovates - Health Solutions Clinical Fellowship. MOR is supported by a Molly Towell Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATA Y, 1991, J PEDIATR-US, V119, P441, DOI 10.1016/S0022-3476(05)82060-8; Agata Y, 1995, BIOL NEONATE, V68, P404; AGATA Y, 1994, PEDIATR RES, V36, P805, DOI 10.1203/00006450-199412000-00022; Bhatt S, 2013, J PHYSL, V591, P211; Binder C, 2013, J PEDIATR-US, V163, P394, DOI 10.1016/j.jpeds.2013.01.026; Dawson JA, 2010, ARCH DIS CHILD-FETAL, V95, pF177, DOI 10.1136/adc.2009.169102; Kamlin COF, 2006, J PEDIATR-US, V148, P585, DOI 10.1016/j.jpeds.2005.12.050; Lima A, 2005, INTENS CARE MED, V31, P1316, DOI 10.1007/s00134-005-2790-2; McCoy L, 1999, ARCH DIS CHILD-FETAL, V80, pF38; Mercer JS, 2006, PEDIATRICS, V117, P1235, DOI 10.1542/peds.2005-1706; Noori S, 2012, ARCH DIS CHILD-FETAL, V97, pF340, DOI 10.1136/fetalneonatal-2011-301090; Noori S, 2012, J PEDIATR-US, V160, P943, DOI 10.1016/j.jpeds.2011.12.008; Polglase GR, 2006, CURR PEDIATR REV, V2, P287, DOI 10.2174/157339606778699653; Polglase GR, 2009, J APPL PHYSIOL, V106, P1347, DOI 10.1152/japplphysiol.91445.2008; Rabi Y, 2006, J PEDIATR-US, V148, P590, DOI 10.1016/j.jpeds.2005.12.047; Raju TNK, 2012, CLIN PERINATOL, V39, P889, DOI 10.1016/j.clp.2012.09.006; RUDOLPH AM, 1977, AM REV RESPIR DIS, V115, P11; Sehgal A, 2010, ARCH DIS CHILD-FETAL, V95, pF345, DOI 10.1136/adc.2009.173724; Sommers R, 2012, PEDIATRICS, V129, pE667, DOI 10.1542/peds.2011-2550; Takci S, 2012, ACTA PAEDIATR, V101, P132, DOI 10.1111/j.1651-2227.2011.02458.x; Urlesberger B, 2013, NEONATOLOGY, V103, P259, DOI 10.1159/000346384; Urlesberger B, 2011, J PEDIATR-US, V159, P404, DOI 10.1016/j.jpeds.2011.02.030; WALTHER FJ, 1993, J PEDIATR-US, V123, P625, DOI 10.1016/S0022-3476(05)80966-7; YAO AC, 1968, LANCET, V1, P380; YAO AC, 1969, LANCET, V2, P871; Zararnella P, 2008, EARLY HUM DEV, V84, P195, DOI 10.1016/j.earlhumdev.2007.04.003	26	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114504	10.1371/journal.pone.0114504	http://dx.doi.org/10.1371/journal.pone.0114504			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514747	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300013
J	Baron, DM; Kaindl, U; Haudek-Prinz, VJ; Bayer, E; Rohrl, C; Gerner, C; Marian, B				Baron, David M.; Kaindl, Ulrike; Haudek-Prinz, Verena J.; Bayer, Editha; Roehrl, Clemens; Gerner, Christopher; Marian, Brigitte			Autonomous Inhibition of Apoptosis Correlates with Responsiveness of Colon Carcinoma Cell Lines to Ciglitazone	PLOS ONE			English	Article							COLORECTAL-CANCER; PPAR-GAMMA; NUCLEAR RECEPTORS; GENE-EXPRESSION; DNA-DAMAGE; PROTEIN; ACTIVATION; MICE; IDENTIFICATION; INFLAMMATION	Colorectal cancer is a leading cause of mortality worldwide. Resistance to therapy is common and often results in patients succumbing to the disease. The mechanisms of resistance are poorly understood. Cells basically have two possibilities to survive a treatment with potentially apoptosis-inducing substances. They can make use of their existing proteins to counteract the induced reactions or quickly upregulate protective factors to evade the apoptotic signal. To identify protein patterns involved in resistance to apoptosis, we studied two colorectal adenocarcinoma cell lines with different growth responses to low-molar concentrations of the thiazolidinedione Ciglitazone: HT29 cells underwent apoptosis, whereas SW480 cells increased cell number. Fluorescence detection and autoradiography scans of 2D-PAGE gels were performed in both cell lines to assess protein synthesis and turnover, respectively. To verify the data we performed shotgun analysis using the same treatment procedure as in 2D-experiments. Biological functions of the identified proteins were mainly associated with apoptosis regulation, chaperoning, intrinsic inflammation, and DNA repair. The present study suggests that different growth response of two colorectal carcinoma cell lines after treatment with Ciglitazone results from cell- specific protein synthesis and differences in protein regulation.	[Baron, David M.; Kaindl, Ulrike; Bayer, Editha; Roehrl, Clemens; Marian, Brigitte] Med Univ Vienna, Inst Canc Res, Clin Internal Med 1, Dept Med 1, Vienna, Austria; [Baron, David M.] Med Univ Vienna, Dept Anesthesia Gen Intens Care & Pain Management, Vienna, Austria; [Haudek-Prinz, Verena J.; Gerner, Christopher] Univ Vienna, Fac Chem, Inst Analyt Chem, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna	Gerner, C (corresponding author), Univ Vienna, Fac Chem, Inst Analyt Chem, Vienna, Austria.	christopher.gerner@univie.ac.at		Rohrl, Clemens/0000-0002-1192-0748; Gerner, Christopher/0000-0003-4964-0642	Austrian National Bank [10630]	Austrian National Bank	This study was funded by the Austrian National Bank project 10630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Boyle P, 2008, WORLD CANC REPORT; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; FUJITA T, 1983, DIABETES, V32, P804, DOI 10.2337/diabetes.32.9.804; Gelman L, 1999, CELL MOL LIFE SCI, V55, P932, DOI 10.1007/s000180050345; Gerner C, 2002, MOL CELL PROTEOMICS, V1, P528, DOI 10.1074/mcp.M200026-MCP200; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; GRISS J, 2009, J PROTEOM BIOINFORM, V2, P167, DOI DOI 10.4172/JPB.1000074; Gundacker N, 2006, ELECTROPHORESIS, V27, P2712, DOI 10.1002/elps.200500964; Gundacker NC, 2009, J PROTEOME RES, V8, P2799, DOI 10.1021/pr8011039; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Koch S, 2013, MUCOSAL IMMUNOL, V6, P136, DOI 10.1038/mi.2012.57; Krasikova YS, 2013, J BIOL CHEM, V288, P10936, DOI 10.1074/jbc.M112.444026; KYRIAZIS AP, 1978, CANCER RES, V38, P3186; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Maxia C, 2008, J CELL MOL MED, V12, P2372, DOI 10.1111/j.1582-4934.2008.00256.x; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Miyazaki M, 2005, CANCER SCI, V96, P695, DOI 10.1111/j.1349-7006.2005.00093.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Musch MW, 2001, CELL GROWTH DIFFER, V12, P419; Osawa E, 2003, GASTROENTEROLOGY, V124, P361, DOI 10.1053/gast.2003.50067; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Petricoin EF, 2005, J CLIN ONCOL, V23, P3614, DOI 10.1200/JCO.2005.02.509; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Resch U, 2008, BIOCHEM BIOPH RES CO, V375, P156, DOI 10.1016/j.bbrc.2008.07.142; Rohrl C, 2011, J CANCER RES CLIN, V137, P29, DOI 10.1007/s00432-010-0856-1; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Sagynaliev E, 2005, PROTEOMICS, V5, P3066, DOI 10.1002/pmic.200402107; Sanjuan X, 1997, GASTROENTEROLOGY, V113, P1906, DOI 10.1016/S0016-5085(97)70010-6; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schellerer VS, 2014, ONCOL REP, V31, P255, DOI 10.3892/or.2013.2860; Segal NH, 2009, ANNU REV MED, V60, P207, DOI 10.1146/annurev.med.60.041807.132435; Seike M, 2004, PROTEOMICS, V4, P2776, DOI 10.1002/pmic.200300795; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tormanen-Napankangas U, 2001, INT J CANCER, V93, P192, DOI 10.1002/ijc.1315; Traxler E, 2004, PROTEOMICS, V4, P1314, DOI 10.1002/pmic.200300774; URBAN T, 1993, J NATL CANCER I, V85, P2008, DOI 10.1093/jnci/85.24.2008; Wenzel U, 2004, PROTEOMICS, V4, P2160, DOI 10.1002/pmic.200300726; Yadav N, 2014, MITOCHONDRION, V16, P18, DOI 10.1016/j.mito.2013.11.005; Yang LL, 2003, CANCER RES, V63, P831; Yang WL, 2001, CARCINOGENESIS, V22, P1379, DOI 10.1093/carcin/22.9.1379; Yang YX, 2006, PROTEOMICS, V6, P2009, DOI 10.1002/pmic.200402031; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Young LC, 2007, CARCINOGENESIS, V28, P2131, DOI 10.1093/carcin/bgm153; Zhang Y-T, 2005, EUROPEAN J GASTROENT, V7, P725; Zhang YT, 2005, WORLD J GASTROENTERO, V11, P4679, DOI 10.3748/wjg.v11.i30.4679; Zou TT, 2004, AM J PHYSIOL-CELL PH, V286, pC1009, DOI 10.1152/ajpcell.00480.2003	58	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114158	10.1371/journal.pone.0114158	http://dx.doi.org/10.1371/journal.pone.0114158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502518	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700016
J	Carpi, S; Fogli, S; Giannetti, A; Adinolfi, B; Tombelli, S; Da Pozzo, E; Vanni, A; Martinotti, E; Martini, C; Breschi, MC; Pellegrino, M; Nieri, P; Baldini, F				Carpi, Sara; Fogli, Stefano; Giannetti, Ambra; Adinolfi, Barbara; Tombelli, Sara; Da Pozzo, Eleonora; Vanni, Alessia; Martinotti, Enrica; Martini, Claudia; Breschi, Maria Cristina; Pellegrino, Mario; Nieri, Paola; Baldini, Francesco			Theranostic Properties of a Survivin-Directed Molecular Beacon in Human Melanoma Cells	PLOS ONE			English	Article							TARGETING SURVIVIN; APOPTOSIS PROTEINS; MESSENGER-RNA; CANCER; EXPRESSION; GENE; COMBINATION; SUPPRESSANT; CHALLENGES; INHIBITORS	Survivin is an inhibitor of apoptosis overexpressed in different types of tumors and undetectable in most terminally differentiated normal tissues. In the current study, we sought to evaluate the in vitro theranostic properties of a molecular beaconoligodeoxynucleotide (MB) that targets survivin mRNA. We used laser scanning confocal microscopy to study MB delivery in living cells and real-time PCR and western blot to assess selective survivin-targeting in human malignant melanoma cells. We further assess the pro-apoptotic effect of MB by measuring internucleosomal DNA fragmentation, dissipation of mitochondrial membrane potential (MMP) and changes in nuclear morphology. Transfection of MB into A375 and 501 Mel cells generated high signal intensity from the cytoplasm, while no signal was detected in the extracellular environment and in survivin-negative cells (i. e., human melanocytes and monocytes). MB time dependently decreased survivin mRNA and protein expression in melanoma cells with the maximum effect reached at 72 h. Treatment of melanoma cells with MB induced apoptosis by significant changes in MMP, accumulation of histone-complexed DNA fragments in the cytoplasm and nuclear condensation. MB also enhanced the pro-apoptotic effect of standard chemotherapeutic drugs tested at clinically relevant concentrations. The MB tested in the current study conjugates the ability of imaging with the pharmacological silencing activity against survivin mRNA in human melanoma cells and may represent an innovative approach for cancer diagnosis and treatment.	[Carpi, Sara; Fogli, Stefano; Adinolfi, Barbara; Da Pozzo, Eleonora; Vanni, Alessia; Martinotti, Enrica; Martini, Claudia; Breschi, Maria Cristina; Nieri, Paola] Univ Pisa, Dept Pharm, Pisa, Italy; [Giannetti, Ambra; Tombelli, Sara; Baldini, Francesco] IFAC CNR, Inst Appl Phys Nello Carrara, Florence, Italy; [Pellegrino, Mario] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisica Applicata "Nello Carrara" (IFAC-CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa	Carpi, S (corresponding author), Univ Pisa, Dept Pharm, Pisa, Italy.	sara.carpi@for.unipi.it	Giannetti, Ambra/Q-2681-2015; Fogli, Stefano/AAB-5874-2022; Nieri, Paola/K-5814-2016; carpi, sara/AAG-7683-2021; Da Pozzo, Eleonora/M-2215-2015; Tombelli, Sara/H-6430-2013; Baldini, Francesco/C-2210-2015; Fogli, Stefano/AAC-1939-2019; Martini, Claudia/AAC-4089-2019; Da Pozzo, Eleonora/AAW-8186-2020	Giannetti, Ambra/0000-0002-0002-2977; Fogli, Stefano/0000-0002-7845-2598; Da Pozzo, Eleonora/0000-0003-4762-8949; Tombelli, Sara/0000-0003-1660-9833; Baldini, Francesco/0000-0002-2689-5952; Martini, Claudia/0000-0001-9379-3027; Da Pozzo, Eleonora/0000-0003-4762-8949; Carpi, Sara/0000-0002-3291-9009; Adinolfi, barbara/0000-0002-0603-6333	regional project NANOCELL - Optical Nanosensors inside cells (PAR FAS REGIONE TOSCANA Linea 1.1.a.3); national flagship project NANOMAX; Association against Melanoma Onlus (Italy)	regional project NANOCELL - Optical Nanosensors inside cells (PAR FAS REGIONE TOSCANA Linea 1.1.a.3); national flagship project NANOMAX; Association against Melanoma Onlus (Italy)	This work was supported by the regional project NANOCELL - Optical Nanosensors inside cells (PAR FAS REGIONE TOSCANA Linea 1.1.a.3), by the national flagship project NANOMAX, and by Association against Melanoma Onlus (Italy). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2001, TRENDS MOL MED, V7, P542, DOI 10.1016/S1471-4914(01)02243-2; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Carrasco RA, 2011, MOL CANCER THER, V10, P221, DOI 10.1158/1535-7163.MCT-10-0756; Chen N, 2009, HUM PATHOL, V40, P950, DOI 10.1016/j.humpath.2008.12.001; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Giannetti A, 2013, ANAL BIOANAL CHEM, V405, P6181, DOI 10.1007/s00216-013-7086-8; Groner B, 2014, BIODRUGS, V28, P27, DOI 10.1007/s40259-013-0058-x; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Grossman D, 1999, J INVEST DERMATOL, V113, P1076, DOI 10.1046/j.1523-1747.1999.00776.x; Han SX, 2013, ARCH IMMUNOL THER EX, V61, P139, DOI 10.1007/s00005-012-0209-7; Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010; Ikeguchi M, 2002, APOPTOSIS, V7, P23, DOI 10.1023/A:1013556727182; Kaneko N, 2013, BIOL PHARM BULL, V36, P1921, DOI 10.1248/bpb.b13-00515; Kolpashchikov DM, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/928783; Li G, 2013, ASIAN PAC J CANCER P, V14, P4943, DOI 10.7314/APJCP.2013.14.9.4943; Li HC, 2006, EXP EYE RES, V83, P176, DOI 10.1016/j.exer.2005.11.024; McKenzie JA, 2013, CARCINOGENESIS, V34, P2137, DOI 10.1093/carcin/bgt155; Mckenzie JA, 2012, ANTICANCER RES, V32, P397; McKenzie JA, 2010, CANCER RES, V70, P7927, DOI 10.1158/0008-5472.CAN-10-0194; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Neri T, 2012, CARDIOVASC RES, V94, P537, DOI 10.1093/cvr/cvs125; Nitin N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh063; Peng XH, 2005, CANCER RES, V65, P1909, DOI 10.1158/0008-5472.CAN-04-3196; Pennati M, 2008, EXPERT OPIN THER TAR, V12, P463, DOI 10.1517/14728222.12.4.463 ; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Santangelo P, 2006, ANN BIOMED ENG, V34, P39, DOI 10.1007/s10439-005-9003-6; Santangelo PJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh062; Shi WL, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0893-8; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; Sullivan RJ, 2014, BRIT J DERMATOL, V170, P36, DOI 10.1111/bjd.12698; Szafer-Glusman E, 2011, MOL BIOL CELL, V22, P3779, DOI 10.1091/mbc.E11-06-0569; Takeuchi H, 2005, INT J CANCER, V117, P1032, DOI 10.1002/ijc.21267; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang Q, 2013, THERANOSTICS, V3, P395, DOI 10.7150/thno.5935; World Health Organization, SKIN CANC; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yang H, 2008, J INT MED RES, V36, P734, DOI 10.1177/147323000803600416; Zheng WE, 2012, J BUON, V17, P284; Zhou L, 2013, ACTA BIOMATER, V9, P6019, DOI 10.1016/j.actbio.2012.12.030	41	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114588	10.1371/journal.pone.0114588	http://dx.doi.org/10.1371/journal.pone.0114588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501971	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700032
J	Wu, MM; Xiao, H; Ren, WK; Yin, J; Hu, JY; Duan, JL; Liu, G; Tan, B; Xiong, X; Oso, AO; Adeola, O; Yao, K; Yin, YL; Li, TJ				Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Hu, Jiayu; Duan, Jielin; Liu, Gang; Tan, Bie; Xiong, Xia; Oso, Abimbola Oladele; Adeola, Olayiwola; Yao, Kang; Yin, Yulong; Li, Tiejun			An NMR-Based Metabolomic Approach to Investigate the Effects of Supplementation with Glutamic Acid in Piglets Challenged with Deoxynivalenol	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; COMPOSITE ANTIMICROBIAL PEPTIDES; MYCOTOXIN DEOXYNIVALENOL; ENTEROCYTE MASS; METABONOMIC APPROACH; INTESTINAL FAILURE; PLASMA CITRULLINE; FEED INGREDIENTS; SYSTEMS BIOLOGY; AMINO-ACID	Deoxynivalenol (DON) has various toxicological effects in humans and pigs that result from the ingestion of contaminated cereal products. This study was conducted to investigate the protective effects of dietary supplementation with glutamic acid on piglets challenged with DON. A total of 20 piglets weaned at 28 d of age were randomly assigned to receive 1 of 4 treatments (5 piglets/treatment): 1) basal diet, negative control (NC); 2) basal diet +4 mg/kg DON (DON); 3) basal diet +2% (g/g) glutamic acid (GLU); 4) basal diet +4 mg/kg DON +2% glutamic acid (DG). A 7-d adaptation period was followed by 30 days of treatment. A metabolite analysis using nuclear magnetic resonance spectroscopy (H-1-NMR)-based metabolomic technology and the determination of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities for plasma, as well as the activity of Caspase-3 and the proliferation of epithelial cells were conducted. The results showed that contents of low-density lipoprotein, alanine, arginine, acetate, glycoprotein, trimethylamine-N-oxide (TMAO), glycine, lactate, and urea, as well as the glutamate/creatinine ratio were higher but high-density lipoprotein, proline, citrate, choline, unsaturated lipids and fumarate were lower in piglets of DON treatment than that of NC treatment (P<0.05). Compared with DON treatment, dietary supplementation with glutamic acid increased the plasma concentrations of proline, citrate, creatinine, unsaturated lipids, and fumarate, and decreased the concentrations of alanine, glycoprotein, TMAO, glycine, and lactate, as well as the glutamate/creatinine ratio (P<0.05). Addition glutamic acid to DON treatment increased the plasma activities of SOD and GSH-Px and the proliferating cell nuclear antigen (PCNA) labeling indexes for the jejunum and ileum (P<0.05). These novel findings indicate that glutamic acid has the potential to repair the injuries associated with oxidative stress as well as the disturbances of energy and amino acid metabolism induced by DON.	[Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Hu, Jiayu; Duan, Jielin; Liu, Gang; Tan, Bie; Xiong, Xia; Yao, Kang; Yin, Yulong; Li, Tiejun] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg,Sci Observing &, Hunan Prov Engn Res Ctr Hlthy Livestock,Minist Ag, Changsha, Hunan, Peoples R China; [Wu, Miaomiao; Xiao, Hao; Ren, Wenkai; Yin, Jie; Hu, Jiayu; Duan, Jielin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Oso, Abimbola Oladele] Coll Anim Sci & Livestock Prod, Dept Anim Nutr, Abeokuta, Ogun State, Nigeria; [Adeola, Olayiwola] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Xiong, X (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg,Sci Observing &, Hunan Prov Engn Res Ctr Hlthy Livestock,Minist Ag, Changsha, Hunan, Peoples R China.	xx@isa.ac.cn; yaokang@isa.ac.cn	YIN, Jie/H-3578-2019; Liu, Gang/G-5283-2017	YIN, Jie/0000-0003-1852-1042; Liu, Gang/0000-0002-9475-5134; OSO, ABIMBOLA/0000-0001-9107-0933	Research Subject of State Science and Technology Support Program [2013BAD21B04]; National Natural Science Foundation of China [31272463, 31072042]; Hunan Provincial Natural Science Foundation of China [12JJ2020, 13JJ2034]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2011T2S15]	Research Subject of State Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists	This research was jointly supported by grants from the Research Subject of State Science and Technology Support Program (No. 2013BAD21B04), the National Natural Science Foundation of China (No. 31272463 and 31072042), Hunan Provincial Natural Science Foundation of China (No. 12JJ2020 and 13JJ2034) and Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (Grant No. 2011T2S15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad WA, 2010, FOOD ADDIT CONTAM A, V27, P510, DOI 10.1080/19440040903571747; Bensassi F, 2009, TOXICOLOGY, V264, P104, DOI 10.1016/j.tox.2009.07.020; Binder EM, 2007, ANIM FEED SCI TECH, V137, P265, DOI 10.1016/j.anifeedsci.2007.06.005; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Boutry C, 2012, AMINO ACIDS, V43, P1485, DOI 10.1007/s00726-012-1221-2; Bracarense APFL, 2012, BRIT J NUTR, V107, P1776, DOI 10.1017/S0007114511004946; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; COLE E, 1995, CLIN TRANSPLANT, V9, P282; Constantinou MA, 2004, ANAL CHIM ACTA, V511, P303, DOI 10.1016/j.aca.2004.02.012; Cornell HJ, 2007, AMINO ACIDS, V33, P43, DOI 10.1007/s00726-006-0420-0; Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; Diesing AK, 2011, TOXICOL LETT, V200, P8, DOI 10.1016/j.toxlet.2010.10.006; Dinu D, 2011, TOXICON, V57, P1023, DOI 10.1016/j.toxicon.2011.04.006; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Foxall PJD, 1996, THER DRUG MONIT, V18, P498, DOI 10.1097/00007691-199608000-00032; Gabriel AS, 2013, AMINO ACIDS, V45, P451, DOI 10.1007/s00726-012-1371-2; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; Griffin JL, 2003, CURR OPIN CHEM BIOL, V7, P648, DOI 10.1016/j.cbpa.2003.08.008; Guan S, 2011, J FOOD AGRIC ENVIRON, V9, P163; Guo DD, 2013, TOXICOL IN VITRO, V27, P731, DOI 10.1016/j.tiv.2012.12.001; Halawa A, 2013, ARCH ANIM NUTR, V67, P134, DOI 10.1080/1745039X.2013.776327; Hauet T, 2000, J SURG RES, V93, P1, DOI 10.1006/jsre.2000.5885; HE P, 1993, J ANIM SCI, V71, P963, DOI 10.2527/1993.714963x; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; He QH, 2009, AMINO ACIDS, V37, P199, DOI 10.1007/s00726-008-0192-9; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kouadio JH, 2005, TOXICOLOGY, V213, P56, DOI 10.1016/j.tox.2005.05.010; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Prelusky Dan B., 1994, Natural Toxins, V2, P97, DOI 10.1002/nt.2620020302; Reeds PJ, 2000, J NUTR, V130, p978S, DOI 10.1093/jn/130.4.978S; Rezzi S, 2007, J PROTEOME RES, V6, P513, DOI 10.1021/pr060522z; Rhoads JM, 2005, J PEDIATR-US, V146, P542, DOI 10.1016/j.jpeds.2004.12.027; Sahu SC, 2010, J APPL TOXICOL, V30, P566, DOI 10.1002/jat.1527; Saxena V, 2006, NMR BIOMED, V19, P521, DOI 10.1002/nbm.1034; Schollenberger M, 2002, INT J FOOD MICROBIOL, V72, P85, DOI 10.1016/S0168-1605(01)00627-4; Serkova N, 2005, KIDNEY INT, V67, P1142, DOI 10.1111/j.1523-1755.2005.00181.x; Strzalka W, 2011, ANN BOT-LONDON, V107, P1127, DOI 10.1093/aob/mcq243; Sugita Y, 2007, AMINO ACIDS, V33, P253, DOI 10.1007/s00726-007-0532-1; Volkl A, 2004, J BASIC MICROB, V44, P147, DOI 10.1002/jobm.200310353; Williams R, 2006, MOL BIOSYST, V2, P174, DOI 10.1039/b516356k; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100591; Xiao H, 2013, J ANIM SCI, V91, P4750, DOI 10.2527/jas.2013-6427; Xiao H, 2013, J ANIM SCI, V91, P4772, DOI 10.2527/jas.2013-6426; Xu MH, 2003, WORLD J GASTROENTERO, V9, P1246, DOI 10.3748/wjg.v9.i6.1246; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Young VR, 2000, J NUTR, V130, p892S, DOI 10.1093/jn/130.4.892S; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	58	21	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113687	10.1371/journal.pone.0113687	http://dx.doi.org/10.1371/journal.pone.0113687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502722	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700009
J	Chon, SJ; Choi, YR; Roh, YH; Yun, BH; Cho, S; Choi, YS; Lee, BS; Seo, SK				Chon, Seung Joo; Choi, Yun Rak; Roh, Yun Ho; Yun, Bo Hyon; Cho, SiHyun; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo			Association between Levels of Serum Ferritin and Bone Mineral Density in Korean Premenopausal and Postmenopausal Women: KNHANES 2008-2010	PLOS ONE			English	Article							IRON; PERIMENOPAUSAL; DISEASE; MEN; MENOPAUSE; RATES	Background: As women go through menopause, serum estrogen decreases and ferritin increases. Decreased serum estrogen is well known to cause detrimental effects on bone health; however, data on the associations of serum ferritin with BMD before and after menopause are still lacking. Therefore, this study aimed to investigate the association between serum ferritin levels and BMD in premenopausal and postmenopausal Korean women. Methods: This study was performed using data from the 2008-2010 Korean National Health and Nutrition Examination Survey, including 7300 women (4229 premenopausal and 3071 postmenopausal). BMD was measured using dual X-ray absorptiometry at the femur and the lumbar spine, and serum ferritin levels were measured by chemiluminescent immunoassay. Results: Median serum ferritin levels in postmenopausal women were higher than those in premenopausal women despite the same age ranges. Serum ferritin levels were only significantly correlated with BMD on the lumbar spine (beta=20.189, pvalue=0.005) in premenopausal women after adjusting confounding factors. Additionally, BMD on the lumbar spine had tended to decrease as serum ferritin quartiles increase (P for trend=0.035) in premenopausal women after adjusting confounding factors. On the other hand, there were no significant associations between serum ferritin levels and BMD on the total femur and, femur neck in premenopausal women, and BMD on the total femur, femur neck, and lumbar spine in postmenopausal women. Conclusion: Increased serum ferritin levels were significantly associated with BMD in premenopausal women, particularly on the lumbar spine, but not in postmenopausal women.	[Chon, Seung Joo; Yun, Bo Hyon; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Severance Hosp, Seoul, South Korea; [Choi, Yun Rak] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Severance Hosp, Seoul, South Korea; [Roh, Yun Ho] Yonsei Univ, Coll Med, Dept Biostat Collaborat, Seoul, South Korea; [Cho, SiHyun] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Gangnam Severance Hosp, Seoul, South Korea; [Chon, Seung Joo; Yun, Bo Hyon; Cho, SiHyun; Choi, Young Sik; Lee, Byung Seok; Seo, Seok Kyo] Yonsei Univ, Coll Med, Inst Womens Life Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Seo, SK (corresponding author), Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Severance Hosp, Seoul, South Korea.	TUDEOLSEO@yuhs.ac	Choi, Yun-Rak/AAG-9914-2019	Seo, Seok Kyo/0000-0003-3404-0484; Choi, Young Sik/0000-0002-1157-4822; Yun, Bo Hyon/0000-0001-5703-797X; LEE, Byung Seok/0000-0001-6001-2079; Cho, SiHyun/0000-0003-2718-6645				Barton J. C., 2010, HDB IRON OVERLOAD DI, P28; Bjornerem A, 2011, BONE, V49, P1125, DOI 10.1016/j.bone.2011.08.009; CUMMINGS SR, 1989, ARCH INTERN MED, V149, P2445, DOI 10.1001/archinte.149.11.2445; D'Amelio P, 2008, BONE, V43, P1010, DOI 10.1016/j.bone.2008.08.107; Goral V, 2010, WORLD J GASTROENTERO, V16, P1639, DOI 10.3748/wjg.v16.i13.1639; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Guggenbuhl P, 2011, OSTEOPOROSIS INT, V22, P2313, DOI 10.1007/s00198-010-1456-2; Guthrie JR, 2004, OSTEOPOROSIS INT, V15, P881, DOI 10.1007/s00198-004-1624-3; Halle M, 1997, ATHEROSCLEROSIS, V128, P235, DOI 10.1016/S0021-9150(96)05994-1; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; IPAQ Core Group, 2005, GUIDL DAT PROC AN IN; Jian JL, 2009, ANTIOXID REDOX SIGN, V11, P2939, DOI [10.1089/ars.2009.2576, 10.1089/ARS.2009.2576]; Karabulut A, 2010, GYNECOL ENDOCRINOL, V26, P307, DOI 10.3109/09513590903511471; Katsumata S, 2006, BIOSCI BIOTECH BIOCH, V70, P2547, DOI 10.1271/bbb.60221; Kim BJ, 2013, OSTEOPOROSIS INT, V24, P2627, DOI 10.1007/s00198-013-2363-0; Kim BJ, 2012, J BONE MINER RES, V27, P2279, DOI 10.1002/jbmr.1692; Li GF, 2012, OSTEOPOROSIS INT, V23, P2403, DOI 10.1007/s00198-012-1982-1; Loria I, 2010, TRANSPL P, V42, P1191, DOI 10.1016/j.transproceed.2010.03.096; Low LCK, 1997, J PEDIATR ENDOCR MET, V10, P175; Mahachoklertwattana P, 2003, J CLIN ENDOCR METAB, V88, P3966, DOI 10.1210/jc.2002-021548; Mazzuoli G, 2000, BONE, V26, P381, DOI 10.1016/S8756-3282(00)00242-8; McCance RA, 1938, J PHYSIOL-LONDON, V94, P148, DOI 10.1113/jphysiol.1938.sp003669; MILMAN N, 1992, ANN HEMATOL, V64, P22, DOI 10.1007/BF01811467; Milman N, 1992, ANN HEMATOL, V63, P103; MOSEKILDE L, 1990, BONE, V11, P67, DOI 10.1016/8756-3282(90)90052-Z; Nelson HD, 2008, LANCET, V371, P760, DOI 10.1016/S0140-6736(08)60346-3; PECK WA, 1993, AM J MED, V94, P646; Recker R, 2000, J BONE MINER RES, V15, P1965, DOI 10.1359/jbmr.2000.15.10.1965; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; RIGGS BL, 1986, J CLIN INVEST, V77, P1487, DOI 10.1172/JCI112462; Rizzoli R, 1997, LANCET, V349, pS20, DOI 10.1016/S0140-6736(97)90007-6; Sadat-Ali M, 2011, BIOMETALS, V24, P19, DOI 10.1007/s10534-010-9391-4; Sarrai M, 2007, BRIT J HAEMATOL, V136, P666, DOI 10.1111/j.1365-2141.2006.06487.x; SCHNITZLER CM, 1994, J BONE MINER RES, V9, P1865; SEIDMAN H, 1985, CA-CANCER J CLIN, V35, P36, DOI 10.3322/canjclin.35.1.36; Seifert-Klauss V, 2012, CLIMACTERIC, V15, P433, DOI 10.3109/13697137.2012.658110; Sirola J, 2003, MATURITAS, V45, P159, DOI 10.1016/S0378-5122(03)00150-6; Soules Michael R., 2001, Fertility and Sterility, V76, P874, DOI 10.1016/S0015-0282(01)02909-0; Sowers M, 1998, J BONE MINER RES, V13, P1134, DOI 10.1359/jbmr.1998.13.7.1134; Tiosano D, 2001, J ENDOCRINOL INVEST, V24, P716, DOI 10.1007/BF03343916; Weinberg Eugene D, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P81; World Health Organization, 1994, WHO TECHN REP SER, V843	42	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114972	10.1371/journal.pone.0114972	http://dx.doi.org/10.1371/journal.pone.0114972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522357	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600012
J	Ahonen, SJ; Arumilli, M; Seppala, E; Hakosalo, O; Kaukonen, MK; Komaromy, AM; Lohi, H				Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Komaromy, Andras M.; Lohi, Hannes			Increased Expression of MERTK Associated with a Unique Form of Canine Retinopathy	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; INHERITED RETINAL DYSTROPHY; CONE-ROD DYSTROPHY; LEBER CONGENITAL AMAUROSIS; RETINITIS-PIGMENTOSA; APOPTOTIC CELLS; NONSENSE MUTATION; SITE MUTATION; GENE; GENOME	Progressive retinal degenerations are among the most common causes of blindness both in human and in dogs. Canine progressive retinal atrophy (PRA) resembles human retinitis pigmentosa (RP) and is typically characterized by a progressive loss of rod photoreceptors followed by a loss of cone function. The disease gradually progress from the loss of night and day vision to a complete blindness. We have recently described a unique form of retinopathy characterized by the multifocal gray/brown discoloration and thinning of the retina in the Swedish Vallhund (SV) breed. We aimed to identify the genetic cause by performing a genome wide association analysis in a cohort of 18 affected and 10 healthy control dogs using Illumina's canine 22k SNP array. We mapped the disease to canine chromosome 17 (p=7.7 x 10(-5)) and found a 6.1 Mb shared homozygous region in the affected dogs. A combined analysis of the GWAS and replication data with additional 60 dogs confirmed the association (p=4.3 x 10(-8), OR=11.2 for homozygosity). A targeted resequencing of the entire associated region in four cases and four controls with opposite risk haplotypes identified several variants in the coding region of functional candidate genes, such as a known retinopathy gene, MERTK. However, none of the identified coding variants followed a compelling case- or breed- specific segregation pattern. The expression analyses of four candidate genes in the region, MERTK, NPHP1, ANAPC1 and KRCC1, revealed specific upregulation of MERTK in the retina of the affected dogs. Collectively, these results indicate that the retinopathy is associated with overexpression of MERTK, however further investigation is needed to discover the regulatory mutation for the better understanding of the disease pathogenesis. Our study establishes a novel gain-of-function model for the MERTK biology and provides a therapy model for retinopathy MERTK inhibitors. Meanwhile, a marker-based genetic counseling can be developed to revise breeding programs.	[Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Seppala, Eija; Hakosalo, Osmo; Kaukonen, Maria K.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Komaromy, Andras M.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Komaromy, Andras M.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	University of Helsinki; University of Helsinki; Michigan State University; University of Pennsylvania	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Arumilli, Meharji/0000-0003-4072-0996; Kaukonen, Maria/0000-0002-2146-4694; Ahonen, Saija/0000-0003-3313-784X	Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation [ERCStG-260997]; Academy of Finland; Biocentrum Helsinki; University of Helsinki Research Funds; NIH [K12-EY15398, R01-EY019304]; NATIONAL EYE INSTITUTE [R01EY019304, K12EY015398] Funding Source: NIH RePORTER	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Biocentrum Helsinki; University of Helsinki Research Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study has been supported partly by the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation, ERCStG-260997, the Academy of Finland, Biocentrum Helsinki, University of Helsinki Research Funds, private donations, and NIH grants K12-EY15398 and R01-EY019304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguirre G D, 1998, Mol Vis, V4, P23; Ahonen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072122; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; Brea-Fernandez AJ, 2008, BRIT J OPHTHALMOL, V92, P1419, DOI 10.1136/bjo.2008.139204; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cooper AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106610; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Downs LL, 2012, TRAV GENRE SOC, P169; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Ebermann I, 2007, HUM MUTAT, V28, P571, DOI 10.1002/humu.20478; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Goldstein O, 2010, GENOMICS, V96, P362, DOI 10.1016/j.ygeno.2010.09.003; Goldstein O, 2010, MOL VIS, V16, P1549; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Henderson RH, 2007, INVEST OPHTH VIS SCI, V48, P5684, DOI 10.1167/iovs.07-0207; HERRON WL, 1969, INVEST OPHTH VISUAL, V8, P595; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F, 2007, J AM SOC NEPHROL, V18, P1855, DOI 10.1681/ASN.2006121344; Issa PC, 2009, BRIT J OPHTHALMOL, V93, P920, DOI 10.1136/bjo.2008.147397; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jorgensen PM, 2001, GENE, V262, P51, DOI 10.1016/S0378-1119(00)00511-4; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Knubel KH, 2014, ONCOTARGET, V5, P1338, DOI 10.18632/oncotarget.1793; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Ksantini M, 2012, EUR J OPHTHALMOL, V22, P647, DOI 10.5301/ejo.5000096; Kukekova AV, 2009, CANINE RD3 MUTATION; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mackay DS, 2010, MOL VIS, V16, P369; McHenry CL, 2004, INVEST OPHTH VIS SCI, V45, P1456, DOI 10.1167/iovs.03-0909; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Migdall-Wilson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031635; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nguyen KQN, 2014, J BIOL CHEM, V289, P25737, DOI 10.1074/jbc.M114.570838; Ostergaard E, 2011, MOL VIS, V17, P1485; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shahzadi A, 2010, BRIT J OPHTHALMOL, V94, P1094, DOI 10.1136/bjo.2009.171892; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Siemiatkowska AM, 2011, MOL VIS, V17, P3013; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; Tanaka-Matakatsu M, 2007, DEV BIOL, V309, P222, DOI 10.1016/j.ydbio.2007.07.007; Thompson DA, 2002, AM J HUM GENET, V70, P224, DOI 10.1086/338455; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; Tschernutter M, 2006, BRIT J OPHTHALMOL, V90, P718, DOI 10.1136/bjo.2005.084897; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Vilboux T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-10; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zangerl B, 2010, MOL VIS, V16, P2791; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	75	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114552	10.1371/journal.pone.0114552	http://dx.doi.org/10.1371/journal.pone.0114552			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517981	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600022
J	Chang, MC; Chang, HH; Chan, CP; Yeung, SY; Hsien, HC; Lin, BR; Yeh, CY; Tseng, WY; Tseng, SK; Jeng, JH				Chang, Mei-Chi; Chang, Hsiao-Hua; Chan, Chiu-Po; Yeung, Sin-Yuet; Hsien, Hsiang-Chi; Lin, Bor-Ru; Yeh, Chien-Yang; Tseng, Wan-Yu; Tseng, Shui-Kuan; Jeng, Jiiang-Huei			p-Cresol Affects Reactive Oxygen Species Generation, Cell Cycle Arrest, Cytotoxicity and Inflammation/Atherosclerosis-Related Modulators Production in Endothelial Cells and Mononuclear Cells	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PLASMINOGEN-ACTIVATOR RECEPTOR; DENTAL-PULP CELLS; FUNCTION IN-VITRO; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASES; UREMIC TOXICITY; ORGAN DAMAGE; INFLAMMATION; DYSFUNCTION	Aims: Cresols are present in antiseptics, coal tar, some resins, pesticides, and industrial solvents. Cresol intoxication leads to hepatic injury due to coagulopathy as well as disturbance of hepatic circulation in fatal cases. Patients with uremia suffer from cardiovascular complications, such as atherosclerosis, thrombosis, hemolysis, and bleeding, which may be partly due to p-cresol toxicity and its effects on vascular endothelial and mononuclear cells. Given the role of reactive oxygen species (ROS) and inflammation in vascular thrombosis, the objective of this study was to evaluate the effect of p-cresol on endothelial and mononuclear cells. Methods: EA. hy926 (EAHY) endothelial cells and U937 cells were exposed to different concentrations of p-cresol. Cytotoxicity was evaluated by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and trypan blue dye exclusion technique, respectively. Cell cycle distribution was analyzed by propidium iodide flow cytometry. Endothelial cell migration was studied by wound closure assay. ROS level was measured by 2',7'-dichlorofluorescein diacetate (DCF) fluorescence flow cytometry. Prostaglandin F-2 alpha (PGF(2 alpha)), plasminogen activator inhibitor-1 (PAI-1), soluble urokinase plasminogen activator receptor (suPAR), and uPA production were determined by Enzyme-linked immunosorbant assay (ELISA). Results: Exposure to 100-500 mu M p-cresol decreased EAHY cell number by 30-61%. P-cresol also decreased the viability of U937 mononuclear cells. The inhibition of EAHY and U937 cell growth by p-cresol was related to induction of S-phase cell cycle arrest. Closure of endothelial wounds was inhibited by p-cresol (> 100 mu M). P-cresol (> 50 mu M) also stimulated ROS production in U937 cells and EAHY cells but to a lesser extent. Moreover, p-cresol markedly stimulated PAI-1 and suPAR, but not PGF(2 alpha), and uPA production in EAHY cells. Conclusions: p-Cresol may contribute to atherosclerosis and thrombosis in patients with uremia and cresol intoxication possibly due to induction of ROS, endothelial/mononuclear cell damage and production of inflammation/atherosclerosis-related molecules.	[Chang, Mei-Chi] Chang Gung Univ Sci & Technol, Biomed Sci Team, Taoyuan, Taiwan; [Chang, Hsiao-Hua; Yeh, Chien-Yang; Tseng, Wan-Yu; Tseng, Shui-Kuan; Jeng, Jiiang-Huei] Natl Taiwan Univ, Coll Med, Dept Dent, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Chang, Hsiao-Hua; Yeh, Chien-Yang; Tseng, Wan-Yu; Tseng, Shui-Kuan; Jeng, Jiiang-Huei] Natl Taiwan Univ, Sch Dent, Coll Med, Taipei 10764, Taiwan; [Chan, Chiu-Po; Yeung, Sin-Yuet; Hsien, Hsiang-Chi] Chang Gung Mem Hosp, Dept Dent, Taipei 10591, Taiwan; [Lin, Bor-Ru] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	Chang Gung University of Science & Technology; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chan, CP (corresponding author), Chang Gung Mem Hosp, Dept Dent, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	smallpig86778231@yahoo.com.tw; jhjeng@ntu.edu.tw	Tseng, Wan-Yu/V-4444-2019	TSENG, WAN-YU/0000-0002-9012-3703; LIN, BOR-RU/0000-0001-9545-7393	National Science Council, Taiwan, R.O.C. [NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, NSC-101-2320-B-255-002]; Chang Gung Memorial Hospital [CMRPF-3B0191, CMRPG-3B0192, NMRPF3C0061, NMRPF3C0091, NMRPF3B0071]	National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by grants from National Science Council, Taiwan, R.O.C. (NSC102-2314-B-255-003-MY2, NSC102-2628-B-255-001-MY3, NSC101-2320-B-255-002, NSC-100-2314-B-002-094, and NSC-101-2320-B-255-002) and Chang Gung Memorial Hospital (CMRPF-3B0191, CMRPG-3B0192, NMRPF3C0061, NMRPF3C0091, and NMRPF3B0071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bifulco K, 2013, MOL CANCER THER, V12, P1981, DOI 10.1158/1535-7163.MCT-13-0077; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Buckley JR, 1904, J AM DENT ASSOC, V3, P764; Cerini C, 2004, THROMB HAEMOSTASIS, V92, P140, DOI 10.1160/th03-07-0491; Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021; Chang MC, 2004, J BIOL CHEM, V279, P50676, DOI 10.1074/jbc.M404465200; Chang MC, 2002, BRIT J PHARMACOL, V135, P619, DOI 10.1038/sj.bjp.0704492; Chang MC, 2011, ATHEROSCLEROSIS, V219, P559, DOI 10.1016/j.atherosclerosis.2011.09.031; Chang MC, 2010, BIOMATERIALS, V31, P8164, DOI 10.1016/j.biomaterials.2010.07.049; Chillon J. -M., 2009, Annales Pharmaceutiques Francaises, V67, P234, DOI 10.1016/j.pharma.2009.04.001; CURTIUS HC, 1976, J CHROMATOGR, V126, P569, DOI 10.1016/S0021-9673(01)84102-9; de Carvalho JTG, 2011, ARTIF ORGANS, V35, pE27, DOI 10.1111/j.1525-1594.2010.01116.x; Dietz Dennis, 1991, Toxic Rep Ser, V9, P1; Dou L, 2002, KIDNEY INT, V62, P1999, DOI 10.1046/j.1523-1755.2002.t01-1-00651.x; Dou L, 2004, KIDNEY INT, V65, P442, DOI 10.1111/j.1523-1755.2004.00399.x; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Edsfeldt A, 2012, STROKE, V43, P3305, DOI 10.1161/STROKEAHA.112.664094; Enocsson H, 2013, TRANSL RES, V162, P287, DOI 10.1016/j.trsl.2013.07.003; Faure V, 2006, INT IMMUNOL, V18, P1453, DOI 10.1093/intimm/dxl077; Filiopoulos Vasilis, 2009, Inflammation & Allergy Drug Targets, V8, P369; Galle J, 2003, KIDNEY BLOOD PRESS R, V26, P65, DOI 10.1159/000070986; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; Ghiadoni L, 2004, J NEPHROL, V17, P512; Glorieux G, 2009, SEMIN DIALYSIS, V22, P423, DOI 10.1111/j.1525-139X.2009.00593.x; Gunthner T, 2009, SEMIN DIALYSIS, V22, P428, DOI 10.1111/j.1525-139X.2009.00594.x; Himmelfarb J, 2009, SEMIN DIALYSIS, V22, P636, DOI 10.1111/j.1525-139X.2009.00659.x; Hirsh J., 1974, PHYSL PHARM, P99; Hosler GA, 2003, ARCH PATHOL LAB MED, V127, P834; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kamijo Y, 2003, ARCH PATHOL LAB MED, V127, P364; Kawakami K, 2009, IMMUNOPHARM IMMUNOT, V31, P304, DOI 10.1080/08923970802680299; Ketteler M, 2006, KIDNEY INT, V70, pS5, DOI 10.1038/sj.ki.5001996; Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174; MADYASTHA KM, 1992, DRUG METAB DISPOS, V20, P295; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Merino A, 2008, CONTRIB NEPHROL, V161, P83, DOI 10.1159/000130412; MYERS DR, 1978, J AM DENT ASSOC, V96, P805, DOI 10.14219/jada.archive.1978.0187; Noh H, 2014, STEM CELLS, V32, P2443, DOI 10.1002/stem.1738; Ochodnicky P, 2006, J NEPHROL, V19, P246; OHARA P, 1993, J ENDODONT, V19, P498, DOI 10.1016/S0099-2399(06)81490-1; RAGHUNATH PN, 1995, ARTERIOSCL THROM VAS, V15, P1432, DOI 10.1161/01.ATV.15.9.1432; RANLY DM, 1988, ENDOD DENT TRAUMATOL, V4, P70; Recht PA, 2004, ATHEROSCLEROSIS, V173, P321, DOI 10.1016/j.atherosclerosis.2003.11.023; Sahin G, 2007, BLOOD PURIFICAT, V25, P309, DOI 10.1159/000106103; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; SEQUEIRA DJ, 1992, BIOCHEM PHARMACOL, V44, P1171, DOI 10.1016/0006-2952(92)90382-S; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Sloand EA, 2008, EXP HEMATOL, V36, P1616, DOI 10.1016/j.exphem.2008.06.016; Tseng SK, 2012, CLIN ORAL INVEST, V16, P1267, DOI 10.1007/s00784-011-0604-1; Tseng SK, 2014, J DENT SCI IN PRESS; VANHOLDER R, 1995, KIDNEY INT, V47, P510, DOI 10.1038/ki.1995.64; Vanholder R, 1999, NEPHROL DIAL TRANSPL, V14, P2813, DOI 10.1093/ndt/14.12.2813; Westrick RJ, 2007, CURR DRUG TARGETS, V8, P996, DOI 10.2174/138945007781662328; Wratten ML, 1999, BLOOD PURIFICAT, V17, P134, DOI 10.1159/000014385; Xu YC, 1996, KIDNEY INT, V50, P2011, DOI 10.1038/ki.1996.523; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; Yuhki K, 2010, INT ANGIOL, V29, P19; Zhang GQ, 2008, FRONT BIOSCI-LANDMRK, V13, P5462, DOI 10.2741/3093; Zhu JZ, 2012, NEPHROL DIAL TRANSPL, V27, P4323, DOI 10.1093/ndt/gfs382	62	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114446	10.1371/journal.pone.0114446	http://dx.doi.org/10.1371/journal.pone.0114446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517907	Green Submitted, gold, Green Published			2022-12-27	WOS:000347215600020
J	Ma, N; Yuan, JZ; Li, M; Li, J; Zhang, LY; Liu, LX; Naeem, MS; Zhang, CL				Ma, Ni; Yuan, Jinzhan; Li, Ming; Li, Jun; Zhang, Liyan; Liu, Lixin; Naeem, Muhammad Shahbaz; Zhang, Chunlei			Ideotype Population Exploration: Growth, Photosynthesis, and Yield Components at Different Planting Densities in Winter Oilseed Rape (Brassica napus L.)	PLOS ONE			English	Article							SEED YIELD; GRAIN-YIELD; OIL CONTENT; EFFICIENCY; QUALITY; TRAITS; CANOPY; MAIZE	Rapeseed is one of the most important edible oil crops in the world and the seed yield has lagged behind the increasing demand driven by population growth. Winter oilseed rape (Brassica napus L.) is widely cultivated with relatively low yield in China, so it is necessary to find the strategies to improve the expression of yield potential. Planting density has great effects on seed yield of crops. Hence, field experiments were conducted in Wuhan in the Yangtze River basin with one conventional variety (Zhongshuang 11, ZS11) and one hybrid variety (Huayouza 9, HYZ9) at five planting densities (27.0x10(4), 37.5x10(4), 48.0x10(4), 58.5x10(4), 69.0x10(4) plants ha(-1)) during 2010-2012 to investigate the yield components. The physiological traits for high-yield and normal-yield populations were measured during 2011-2013. Our results indicated that planting densities of 58.5x10(4) plants ha-1 in ZS11 and 48.0x10(4) plants ha(-1) in HYZ9 have significantly higher yield compared with the density of 27.0x10(4) plants ha(-1)for both varieties. The ideal silique numbers for ZS11 and HYZ9 were similar to 0.9x10(4) (n m(-2)) and,16104 (n m(-2)), respectively, and ideal primary branches for ZS11 and HYZ9 were similar to 250 (n m(-2)) and,300 (n m(-2)), respectively. The highest leaf area index (LAI) and silique wall area index (SAI) was similar to 5.0 and 7.0, respectively. Moreover, higher leaf net photosynthetic rate (Pn) and water use efficiency (WUE) were observed in the high-yield populations. A significantly higher level of silique wall photosynthesis and rapid dry matter accumulation were supposed to result in the maximum seed yield. Our results suggest that increasing the planting density within certain range is a feasible approach for higher seed yield in winter rapeseed in China.	[Ma, Ni; Yuan, Jinzhan; Li, Ming; Li, Jun; Zhang, Liyan; Liu, Lixin; Naeem, Muhammad Shahbaz; Zhang, Chunlei] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Crop Cultivat & Physiol, Key Lab Oil Crop Biol,Minist Agr, Wuhan, Peoples R China; [Li, Ming] Huazhong Agr Univ, Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Middle Rea, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, CL (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Crop Cultivat & Physiol, Key Lab Oil Crop Biol,Minist Agr, Wuhan, Peoples R China.	zhangchunlei@caas.cn	Zhang, Li/GWM-7501-2022; Naeem, Muhammad Shahbaz/B-4892-2013	Naeem, Muhammad Shahbaz/0000-0002-2996-1927; Li, Ming/0000-0001-9962-6545	National Natural Science Foundation of China [31071372, 31271671]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (Nos. 31071372, 31271671). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuelgasim EH, 1991, ADV PLANT BREEDING, V2, P254; Adamsen FJ, 2005, IND CROP PROD, V21, P293, DOI 10.1016/j.indcrop.2004.04.012; Brahim K, 1998, IND CROP PROD, V9, P63, DOI 10.1016/S0926-6690(98)00015-6; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; CLARKE JM, 1978, CAN J PLANT SCI, V58, P1103, DOI 10.4141/cjps78-167; Diepenbrock W, 2000, FIELD CROP RES, V67, P35, DOI 10.1016/S0378-4290(00)00082-4; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hiltbrunner J, 2007, FIELD CROP RES, V102, P163, DOI 10.1016/j.fcr.2007.03.009; Hua W, 2012, PLANT J, V69, P432, DOI 10.1111/j.1365-313X.2011.04802.x; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; Leach JE, 1999, J AGR SCI, V132, P173, DOI 10.1017/S0021859698006091; Lopez-Bellido FJ, 2005, EUR J AGRON, V23, P359, DOI 10.1016/j.eja.2005.02.002; Ma N, 2012, J INTEGR AGR, V11, P1297; MARSHALL DR, 1991, FIELD CROP RES, V26, P171, DOI 10.1016/0378-4290(91)90034-S; Masoni A, 2007, EUR J AGRON, V26, P179, DOI 10.1016/j.eja.2006.09.006; MOCK JJ, 1975, EUPHYTICA, V24, P613, DOI 10.1007/BF00132898; Momoh EJJ, 2001, J AGRON CROP SCI, V186, P253, DOI 10.1046/j.1439-037x.2001.00476.x; Murchie EH, 2002, J EXP BOT, V53, P2217, DOI 10.1093/jxb/erf064; Peltonen-Sainio P, 2008, FIELD CROP RES, V108, P101, DOI 10.1016/j.fcr.2008.04.006; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; RAO MSS, 1991, J AGR SCI-CAMBRIDGE, V117, P189, DOI 10.1017/S0021859600065278; Rathke GW, 2006, AGR ECOSYST ENVIRON, V117, P80, DOI 10.1016/j.agee.2006.04.006; Sieling K, 1997, EUR J AGRON, V6, P215, DOI 10.1016/S1161-0301(96)02049-7; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tandon JP, 2004, PLANT BREEDING: MENDELIAN TO MOLECULAR APPROACHES, P585; THURLING N, 1991, FIELD CROP RES, V26, P201, DOI 10.1016/0378-4290(91)90036-U; Tollenaar M, 2006, MAYDICA, V51, P399; Virk P. S., 2004, International Rice Research Notes, V29, P5; [王汉中 WANG Hanzhong], 2007, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V29, P101; [王汉中 Wang Hanzhong], 2002, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V24, P82; Weiner J, 2010, EVOL APPL, V3, P473, DOI 10.1111/j.1752-4571.2010.00144.x; Zhang YB, 2009, FIELD CROP RES, V114, P91, DOI 10.1016/j.fcr.2009.07.008	34	20	28	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114232	10.1371/journal.pone.0114232	http://dx.doi.org/10.1371/journal.pone.0114232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517990	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600015
J	Tenggardjaja, KA; Bowen, BW; Bernardi, G				Tenggardjaja, Kimberly A.; Bowen, Brian W.; Bernardi, Giacomo			Vertical and Horizontal Genetic Connectivity in Chromis verater, an Endemic Damselfish Found on Shallow and Mesophotic Reefs in the Hawaiian Archipelago and Adjacent Johnston Atoll	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATION-GENETICS; CORAL ECOSYSTEMS; CONTROL-REGION; DNA; PHYLOGEOGRAPHY; ECOLOGY; EVOLUTION; TRANSPORT; PATTERNS	Understanding vertical and horizontal connectivity is a major priority in research on mesophotic coral ecosystems (30-150 m). However, horizontal connectivity has been the focus of few studies, and data on vertical connectivity are limited to sessile benthic mesophotic organisms. Here we present patterns of vertical and horizontal connectivity in the Hawaiian Islands-Johnston Atoll endemic threespot damselfish, Chromis verater, based on 319 shallow specimens and 153 deep specimens. The mtDNA markers cytochrome b and control region were sequenced to analyze genetic structure: 1) between shallow (<30 m) and mesophotic (30-150 m) populations and 2) across the species' geographic range. Additionally, the nuclear markers rhodopsin and internal transcribed spacer 2 of ribosomal DNA were sequenced to assess connectivity between shallow and mesophotic populations. There was no significant genetic differentiation by depth, indicating high levels of vertical connectivity between shallow and deep aggregates of C. verater. Consequently, shallow and deep samples were combined by location for analyses of horizontal connectivity. We detected low but significant population structure across the Hawaiian Archipelago (overall cytochrome b: Phi(ST)=0.009, P=0.020; control region: Phi(ST)=0.012, P=0.009) and a larger break between the archipelago and Johnston Atoll (cytochrome b: Phi(ST)=0.068, P<0.001; control region: Phi(ST)=0.116, P<0.001). The population structure within the archipelago was driven by samples from the island of Hawaii at the southeast end of the chain and Lisianski in the middle of the archipelago. The lack of vertical genetic structure supports the refugia hypothesis that deep reefs may constitute a population reservoir for species depleted in shallow reef habitats. These findings represent the first connectivity study on a mobile organism that spans shallow and mesophotic depths and provide a reference point for future connectivity studies on mesophotic fishes.	[Tenggardjaja, Kimberly A.; Bernardi, Giacomo] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA	University of California System; University of California Santa Cruz; University of Hawaii System	Tenggardjaja, KA (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	ktenggar@ucsc.edu	Bernardi, Giacomo/F-6346-2011	Bernardi, Giacomo/0000-0002-8249-4678	National Oceanic and Atmospheric Administration Dr. Nancy Foster Scholarship; Raney Fund for Ichthyology; Sigma Xi; American Academy of Underwater Sciences Kathy Johnston Scholarship; Lerner Gray Memorial Fund; Myers Trust; Friends of the Long Marine Lab; National Science Foundation [OCE-0453167, OCE-0929031]; NOAA National Marine Sanctuaries Program MOA grant [2005-008/66882]; Hawai'i Sea Grant [NA05OAR4171048]	National Oceanic and Atmospheric Administration Dr. Nancy Foster Scholarship; Raney Fund for Ichthyology; Sigma Xi; American Academy of Underwater Sciences Kathy Johnston Scholarship; Lerner Gray Memorial Fund; Myers Trust; Friends of the Long Marine Lab; National Science Foundation(National Science Foundation (NSF)); NOAA National Marine Sanctuaries Program MOA grant; Hawai'i Sea Grant	This study arose from fieldwork and lab work supported by the National Oceanic and Atmospheric Administration Dr. Nancy Foster Scholarship (http://fosterscholars.noaa.gov/), the Raney Fund for Ichthyology (http://www.amphilsoc.org/grants/lewisandclark), Sigma Xi Grants-in-Aid of Research (http ://www.sigmaxi.org/programs/grants-in-aid), the American Academy of Underwater Sciences Kathy Johnston Scholarship (http://www.aausfoundation.org/#!scholarships), the Lerner Gray Memorial Fund (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships),the Myers Trust, and the Friends of the Long Marine Lab (all to KAT). Additionally, this study was supported by National Science Foundation grants (http://www.nsf.gov; grants OCE-0453167 and OCE-0929031 to BWB), NOAA National Marine Sanctuaries Program (http://sanctuaries.noaa.gov) MOA grant 2005-008/66882 (R. J. Toonen) and Hawai'i Sea Grant (http://seagrant.soest.hawaii.edu/) NA05OAR4171048 (BWB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Andrews KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091665; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Benjamini Y, 2001, ANN STAT, V29, P1165; Blyth-Skyrme VJ, 2013, MESOPHOTIC CORAL ECO; Boland R, 2011, AM SOC LIMN OC AQ SC; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Costantini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061546; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; DeMartini EE, 2004, MAR ECOL PROG SER, V271, P281, DOI 10.3354/meps271281; DiBattista JD, 2011, J MAR BIOL, DOI DOI 10.1155/2011/839134; Dickey TD, 2008, DEEP-SEA RES PT II, V55, P1195, DOI 10.1016/j.dsr2.2008.01.006; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Ersts PJ, 2014, GEOGRAPHIC DISTANCE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gomes G, 2012, AN ACAD BRAS CIENC, V84, P979, DOI 10.1590/S0001-37652012000400013; GOSLINE WILLIAM A., 1955, PACIFIC SCI, V9, P442; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hoover JP, 2007, HAWAIIS FISHES GUIDE; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jordan DS, 1912, DESCRIPTINS 2 NEW SP; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; KENYON JC, 1992, CORAL REEFS, V11, P37, DOI 10.1007/BF00291933; Kobayashi DR, 2006, CORAL REEFS, V25, P407, DOI 10.1007/s00338-006-0118-5; LEE WJ, 1995, J MOL EVOL, V41, P54; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LOBEL PS, 1986, DEEP-SEA RES, V33, P483, DOI 10.1016/0198-0149(86)90127-5; Luck DG, 2013, PEERJ, V1, DOI 10.7717/peerj.132; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; McMillan WO, 1997, J MOL EVOL, V45, P473, DOI 10.1007/PL00006252; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mundy Bruce C., 2005, Bishop Museum Bulletins in Zoology, V6, P1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palumbi Stephen R., 1996, P205; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Presa P, 2002, MOL BIOL EVOL, V19, P2161, DOI 10.1093/oxfordjournals.molbev.a004041; Puglise KA, 2009, MESOPHOTIC CORAL ECO; Pyle RL, 1996, NAT HIST, V105, P59; Ramon ML, 2008, MAR BIOL, V153, P1207, DOI 10.1007/s00227-007-0894-7; Randall JE, 1998, SHORE FISHES HAWAII; Rivera M.A.J., 2011, J MAR BIOL; Roberts CM, 2003, ECOL APPL, V13, pS199; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Skillings Derek J., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/783030; Swerdloff SN, 1970, THESIS U HAWAII; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Toonen Robert J, 2011, J Mar Biol, V2011, DOI 10.1155/2011/460173; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x	68	43	43	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115493	10.1371/journal.pone.0115493	http://dx.doi.org/10.1371/journal.pone.0115493			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517964	gold, Green Published			2022-12-27	WOS:000347215600069
J	Budini, F; McManus, LM; Berchicci, M; Menotti, F; Macaluso, A; Di Russo, F; Lowery, MM; De Vito, G				Budini, Francesco; McManus, Lara M.; Berchicci, Marika; Menotti, Federica; Macaluso, Andrea; Di Russo, Francesco; Lowery, Madeleine M.; De Vito, Giuseppe			Alpha Band Cortico-Muscular Coherence Occurs in Healthy Individuals during Mechanically-Induced Tremor	PLOS ONE			English	Article							CEREBRAL OSCILLATORY NETWORK; TASK-DEPENDENT MODULATION; MONKEY MOTOR CORTEX; CORTICOMUSCULAR COHERENCE; PHYSIOLOGICAL TREMOR; ISOMETRIC CONTRACTION; RECURRENT INHIBITION; REFLEX RESPONSES; EXTENSOR MUSCLES; HUMAN HAND	The present work aimed at investigating the effects of mechanically amplified tremor on cortico-muscular coherence (CMC) in the alpha band. The study of CMC in this specific band is of particular interest because this coherence is usually absent in healthy individuals and it is an aberrant feature in patients affected by pathological tremors; understanding its mechanisms is therefore important. Thirteen healthy volunteers (23 +/- 4 years) performed elbow flexor sustained contractions both against a spring load and in isometric conditions at 20% of maximal voluntary isometric contraction (MVC). Spring stiffness was selected to induce instability in the stretch reflex servo loop. 64 EEG channels, surface EMG from the biceps brachii muscle and force were simultaneously recorded. Contractions against the spring resulted in greater fluctuations of the force signal and EMG amplitude compared to isometric conditions (p<.05). During isometric contractions CMC was systematically found in the beta band and sporadically observed in the alpha band. However, during the contractions against the spring load, CMC in the alpha band was observed in 12 out of 13 volunteers. Partial directed coherence (PDC) revealed an increased information flow in the EMG to EEG direction in the alpha band (p<.05). Therefore, coherence in the alpha band between the sensory-motor cortex and the biceps brachii muscle can be systematically induced in healthy individuals by mechanically amplifying tremor. The increased information flow in the EMG to EEG direction may reflect enhanced afferent activity from the muscle spindles. These results may contribute to the understanding of the presence of alpha band CMC in tremor related pathologies by suggesting that the origin of this phenomenon may not only be at cortical level but may also be affected by spinal circuit loops.	[Budini, Francesco; Berchicci, Marika; Menotti, Federica; Macaluso, Andrea; Di Russo, Francesco] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Budini, Francesco; De Vito, Giuseppe] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [McManus, Lara M.; Lowery, Madeleine M.] Univ Coll Dublin, Sch Elect Elect & Commun Engn, Dublin 2, Ireland; [Di Russo, Francesco] IRCCS Santa Lucia Fdn, Neuropsychol Unit, Rome, Italy	Foro Italico University of Rome; University College Dublin; University College Dublin; IRCCS Santa Lucia	Macaluso, A (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	andrea.macaluso@uniroma4.it	Macaluso, Andrea/K-1101-2014; Di Russo, Francesco/N-6686-2015; De Vito, Giuseppe/J-4499-2012; Lowery, Madeleine/K-6153-2012; McManus, Lara/AAV-1552-2020	Macaluso, Andrea/0000-0001-9029-6156; Di Russo, Francesco/0000-0002-3127-9433; De Vito, Giuseppe/0000-0002-6855-9180; Lowery, Madeleine/0000-0001-6743-360X; McManus, Lara/0000-0002-2255-7382; Budini, Francesco/0000-0002-1729-3853; , Marika/0000-0001-8470-191X	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	FB was financially supported for his PhD by a grant from the "Irish Research Council for Science, Engineering and Technology". LMM was financially supported for her PhD by a grant from the "Irish Research Council for Science, Engineering and Technology". http://research.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SN, 2003, J NEUROPHYSIOL, V89, P1941, DOI 10.1152/jn.00832.2002; Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; BROWN TIH, 1982, J PHYSIOL-LONDON, V332, P113, DOI 10.1113/jphysiol.1982.sp014404; Budini F, 2014, J ELECTROMYOGR KINES, V24, P412, DOI 10.1016/j.jelekin.2014.02.003; BULLER NP, 1980, J PHYSIOL-LONDON, V303, P337, DOI 10.1113/jphysiol.1980.sp013289; Campfens SF, 2013, EXP BRAIN RES, V228, P141, DOI 10.1007/s00221-013-3545-x; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Durbaba R, 2005, EXP BRAIN RES, V163, P295, DOI 10.1007/s00221-004-2165-x; Durbaba R, 2013, J APPL PHYSIOL, V114, P1647, DOI 10.1152/japplphysiol.00917.2011; Freriks B, 1999, EUROPEAN RECOMMENDAT, P1; FROMM C, 1977, BRAIN RES, V120, P459, DOI 10.1016/0006-8993(77)90399-7; Graham P, 1993, NEURAL NETWORKS, V6, P947; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hari R, 1999, NEUROREPORT, V10, pR1; Hellwig B, 2000, CLIN NEUROPHYSIOL, V111, P806, DOI 10.1016/S1388-2457(00)00248-0; JOYCE GC, 1974, J PHYSIOL-LONDON, V240, P375, DOI 10.1113/jphysiol.1974.sp010615; Kilner JM, 1999, J PHYSIOL-LONDON, V516, P559, DOI 10.1111/j.1469-7793.1999.0559v.x; Kilner JM, 2000, J NEUROSCI, V20, P8838; LEMON RN, 1976, PROC R SOC SER B-BIO, V194, P313, DOI 10.1098/rspb.1976.0082; LIPPOLD OCJ, 1957, J PHYSIOL-LONDON, V137, P473, DOI 10.1113/jphysiol.1957.sp005828; Macaluso A, 2003, J APPL PHYSIOL, V95, P2544, DOI 10.1152/japplphysiol.00416.2003; MATTHEWS PBC, 1980, J PHYSIOL-LONDON, V302, P427; Mayston MJ, 2001, J PHYSIOL-LONDON, V530, P551, DOI 10.1111/j.1469-7793.2001.0551k.x; McClelland VM, 2012, EXP BRAIN RES, V219, P275, DOI 10.1007/s00221-012-3087-7; Menotti F, 2014, NEUROMUSCULAR DISORD, V24, P516, DOI 10.1016/j.nmd.2014.03.010; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Nakazawa K, 1997, EXP BRAIN RES, V116, P20, DOI 10.1007/PL00005740; Pollok B, 2004, J PHYSIOL-LONDON, V554, P871, DOI 10.1113/jphysiol.2003.051235; POMPEIANO O, 1975, ARCH ITAL BIOL, V113, P238; Raethjen J, 2007, J NEUROPHYSIOL, V97, P3219, DOI 10.1152/jn.00477.2006; Riddle CN, 2005, J PHYSIOL-LONDON, V566, P625, DOI 10.1113/jphysiol.2005.089607; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; Schelter B, 2006, J PHYSIOLOGY-PARIS, V99, P37, DOI 10.1016/j.jphysparis.2005.06.006; Takahashi DY, 2010, BIOL CYBERN, V103, P463, DOI 10.1007/s00422-010-0410-x; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Ushiyama J, 2011, J APPL PHYSIOL, V110, P1233, DOI 10.1152/japplphysiol.01194.2010; Ushiyama J, 2010, J APPL PHYSIOL, V109, P1086, DOI 10.1152/japplphysiol.00869.2009; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; Williams ER, 2010, P NATL ACAD SCI USA, V107, P11098, DOI 10.1073/pnas.0913373107; Williams ER, 2009, J NEUROSCI, V29, P6616, DOI 10.1523/JNEUROSCI.0272-09.2009	40	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115012	10.1371/journal.pone.0115012	http://dx.doi.org/10.1371/journal.pone.0115012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514444	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300027
J	Li, CW; Chen, DH; Zhong, JT; Bin Lin, Z; Peng, H; Lu, HG; Yang, Y; Yin, J; Li, TY				Li, Chun Wei; Chen, De Hua; Zhong, Jia Tao; Bin Lin, Zhi; Peng, Hua; Lu, Han Gui; Yang, Yan; Yin, Jia; Li, Tian Ying			Epidemiological Characterization and Risk Factors of Allergic Rhinitis in the General Population in Guangzhou City in China	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ASTHMA AND/OR RHINITIS; CHANGING PREVALENCE; SENSITIZATIONS; CHALLENGE; EXPOSURE; CHILDREN	The prevalence of allergic rhinitis (AR) in China has increased with an apparent geographic variation. The current study aims to investigate the AR prevalence/classification, diagnosis/treatment conditions, trigger factors, and risk factors in the general population of Guangzhou, the third biggest city in China. A cross-sectional survey was performed in the citizens in Guangzhou from December 2009 to March 2010 by using a stratified multistage cluster sampling method. All subjects were asked to complete a comprehensive questionnaire via a face to face interview. A total of 9,899 questionnaires were valid. The prevalence rate of AR in the general population of Guangzhou was 6.24%, with a significant higher prevalence in urban area (8.32%) versus rural area (3.43%). Among the AR subjects, most (87%) were diagnosed with intermittent AR and 87% suffered from moderate-severe symptoms. High percentages of the AR patients did not have previously physician-based diagnosis (34%) or specific medical treatment (55%). Morning time, winter season, and cold air were the most common trigger factors of AR. Family history of AR, current living place, living place during babyhood, smoking, home renovation, and pet ownership were the significant risk factors associated with AR prevalence in the population. The study demonstrated comprehensive epidemiological and clinical information about the AR in Guangzhou population. Change of living environment and lifestyles had strong impacts on the prevalence of AR. Public health policies should help the patients benefit from a proper diagnosis/treatment and specifically target the local risk factors, in order to control the AR incidence.	[Li, Chun Wei] Natl Univ Singapore, Dept Otolaryngol, Natl Univ Hlth Syst, Singapore 117548, Singapore; [Chen, De Hua; Bin Lin, Zhi; Li, Tian Ying] Sun Yat Sen Univ, Dept Allergy, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Chen, De Hua; Zhong, Jia Tao; Bin Lin, Zhi; Peng, Hua; Lu, Han Gui; Li, Tian Ying] Sun Yat Sen Univ, Dept Otorhinolaryngol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yan] Sun Yat Sen Univ, Dept Nutr, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Yin, Jia] Chinese Acad Med Sci, Dept Allergy, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Yin, Jia] Peking Union Med Coll, Beijing 100021, Peoples R China	National University of Singapore; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yin, J (corresponding author), Chinese Acad Med Sci, Dept Allergy, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	doctorying@126.com; litianying@yeah.net	yang, yang/GWB-9426-2022; Lang, Ming/HIK-0758-2022; Peng, Gloria/GWI-6523-2022		Industry Funds of the Ministry of Health of the People's Republic of China [200802001]	Industry Funds of the Ministry of Health of the People's Republic of China	This study was supported by a grant from Industry Funds of the Ministry of Health of the People's Republic of China (No. 200802001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Davila I, 2009, J INVEST ALLERG CLIN, V19, P25; Diaz-Sanchez D, 2006, J ALLERGY CLIN IMMUN, V118, P441, DOI 10.1016/j.jaci.2006.04.047; Kusunoki Takashi, 2009, Allergology International, V58, P543, DOI 10.2332/allergolint.09-OA-0085; Lannero E, 2008, THORAX, V63, P172, DOI 10.1136/thx.2007.079053; Lee SY, 2013, ASIA PAC ALLERGY, V3, P145, DOI [10.5415/apallergy.2013.3.3.145, 10.5415/apallergy.2013.3.1.15]; Leynaert B, 2001, AM J RESP CRIT CARE, V164, P1829, DOI 10.1164/ajrccm.164.10.2103137; Li J, 2009, ALLERGY, V64, P1083, DOI 10.1111/j.1398-9995.2009.01967.x; Li J, 2012, AM J RHINOL ALLERGY, V26, P85, DOI 10.2500/ajra.2012.26.3751; Liu MM, 2013, J EPIDEMIOL, V23, P280, DOI 10.2188/jea.JE20120175; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Sheikh Aziz, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P232, DOI 10.1097/01.moo.0000122311.13359.30; Sly RM, 1999, ANN ALLERG ASTHMA IM, V82, P233, DOI 10.1016/S1081-1206(10)62603-8; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Tang XF, 2012, J INVEST ALLERG CLIN, V22, P55; WANG JH, 1995, J ALLERGY CLIN IMMUN, V96, P669, DOI 10.1016/S0091-6749(95)70266-0; Zhang L, 2009, INT ARCH ALLERGY IMM, V149, P47, DOI 10.1159/000176306	19	27	27	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114950	10.1371/journal.pone.0114950	http://dx.doi.org/10.1371/journal.pone.0114950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514026	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300024
J	Denil, SLIJ; Rietzschel, ER; De Buyzere, ML; Van daele, CM; Segers, P; De Bacquer, D; Van Criekinge, W; Bekaert, S; Gillebert, TC; De Meyer, T				Denil, Simon L. I. J.; Rietzschel, Ernst R.; De Buyzere, Marc L.; Van daele, Caroline M.; Segers, Patrick; De Bacquer, Dirk; Van Criekinge, Wim; Bekaert, Sofie; Gillebert, Thierry C.; De Meyer, Tim		Asklepios Investigators	On Cross-Sectional Associations of Leukocyte Telomere Length with Cardiac Systolic, Diastolic and Vascular Function: The Asklepios Study	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; HEART-FAILURE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; PROGNOSTIC VALUE; PULSE PRESSURE; RISK; STIFFNESS	Background: Systemic telomere length has been associated with measures of diastolic function, vascular stiffness and left ventricular mass mainly in smaller, patient-specific settings and not in a general population. In this study we describe the applicability of these findings in a large, representative population. Methods and Results: Peripheral blood leukocyte telomere length (PBL TL) was measured using telomere restriction fragment analysis in the young to middle-aged (>2500 volunteers, similar to 35 to 55 years old) Asklepios study population, free from overt cardiovascular disease. Subjects underwent extensive echocardiographic, hemodynamic and biochemical phenotyping. After adjusting for relevant confounders (age, sex, systolic blood pressure, heart rate, body mass index and use of antihypertensive drugs) we found no associations between PBL TL and left ventricular mass index (P = 0.943), ejection fraction (P = 0.933), peak systolic septal annular motion (P = 0.238), pulse wave velocity (P = 0.971) or pulse pressure (P = 0.999). In contrast, our data showed positive associations between PBL TL and parameters of LV filling: the transmitral flow early (E) to late (A) velocity ratio (E/Aratio; P < 0.001), the ratio of early (e') to late (a') mitral annular velocities (e'/a'-ratio; P = 0.012) and isovolumic relaxation time (P = 0.015). Interestingly, these associations were stronger in women than in men and were driven by associations between PBL TL and the late diastolic components (A and a'). Conclusions: In a generally healthy, young to middle-aged population, PBL TL is not related to LV mass or systolic function, but might be associated with an altered LV filling pattern, especially in women.	[Denil, Simon L. I. J.; Van Criekinge, Wim; De Meyer, Tim] Univ Ghent, Dept Math Modelling Stat & Bioinformat, Fac Biosci Engn, B-9000 Ghent, Belgium; [Rietzschel, Ernst R.; De Buyzere, Marc L.; Van daele, Caroline M.; Gillebert, Thierry C.] Univ Ghent, Dept Cardiovasc Dis, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Segers, Patrick] Univ Ghent, IbiTech BioMMeda, B-9000 Ghent, Belgium; [De Bacquer, Dirk] Univ Ghent, Dept Publ Hlth, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Bekaert, Sofie] Ghent Univ Hosp, Clin Res Ctr Ghent, Bimetra, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University; Ghent University Hospital	De Meyer, T (corresponding author), Univ Ghent, Dept Math Modelling Stat & Bioinformat, Fac Biosci Engn, B-9000 Ghent, Belgium.	Tim.DeMeyer@UGent.be	De Bacquer, Dirk/HGU-3191-2022; Stefanadis, Christodoulos/ABH-2232-2020; Gillebert, Thierry C/F-5551-2014; Segers, Patrick/AAA-7844-2020; De Meyer, Tim/D-3892-2011	Stefanadis, Christodoulos/0000-0001-5974-6454; Gillebert, Thierry C/0000-0002-3832-919X; Segers, Patrick/0000-0003-3870-3409; De Meyer, Tim/0000-0003-2994-9693; De Bacquer, Dirk/0000-0002-3202-7238	Research Foundation Flanders (FWO) [G.0427.03, G.0838.10N]; agency for Innovation by Science and Technology (IWT) [SB101371]	Research Foundation Flanders (FWO)(FWO); agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	The Asklepios Study is supported by Research Foundation Flanders (FWO, http://www. fwo.be/en/) research grants G.0427.03 and G.0838.10N. SD is supported by the agency for Innovation by Science and Technology (IWT, http://www.iwt.be/english/welcome) grant SB101371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2005, CIRCULATION, V112, P1428, DOI 10.1161/CIRCULATIONAHA.104.508465; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bhella PS, 2011, CIRC-CARDIOVASC IMAG, V4, P482, DOI 10.1161/CIRCIMAGING.110.960575; BRECKER SJD, 1992, BRIT HEART J, V68, P567; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Chirinos JA, 2009, HYPERTENSION, V54, P558, DOI 10.1161/HYPERTENSIONAHA.109.131870; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; De Meyer T, 2007, HUM MOL GENET, V16, P3097, DOI 10.1093/hmg/ddm271; De Meyer T, 2011, AGEING RES REV, V10, P297, DOI 10.1016/j.arr.2010.11.001; De Meyer T, 2009, EUR HEART J, V30, P3074, DOI 10.1093/eurheartj/ehp324; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fyhrquist F, 2011, J Hum Hypertens, V25, P711, DOI 10.1038/jhh.2011.57; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Ha JW, 2004, J AM SOC ECHOCARDIOG, V17, P428, DOI 10.1016/j.echo.2004.02.007; Huber M, 2012, J MOL MED, V90, P1059, DOI 10.1007/s00109-012-0874-3; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Masi S, 2014, EUR HEART J; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nawrot Tim S, 2010, Front Biosci (Elite Ed), V2, P1164; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Qian YJ, 2010, HISTOL HISTOPATHOL, V25, P515, DOI 10.14670/HH-25.515; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Rietzschel ER, 2007, EUR J CARDIOV PREV R, V14, P179, DOI 10.1097/HJR.0b013e328012c380; STODDARD MF, 1989, J AM COLL CARDIOL, V13, P327, DOI 10.1016/0735-1097(89)90507-X; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; van der Harst P, 2010, ANN MED, V42, P36, DOI 10.3109/07853890903321567; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang YY, 2011, AGING MALE, V14, P27, DOI 10.3109/13685538.2010.529196; Willeit P, 2010, ARTERIOSCL THROM VAS, V30, P1649, DOI 10.1161/ATVBAHA.110.205492; Wong LSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023118	48	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115071	10.1371/journal.pone.0115071	http://dx.doi.org/10.1371/journal.pone.0115071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506937	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100047
J	Lawlor, DA; Benn, M; Zuccolo, L; De Silva, NMG; Tybjaerg-Hansen, A; Smith, GD; Nordestgaard, BG				Lawlor, Debbie A.; Benn, Marianne; Zuccolo, Luisa; De Silva, N. Maneka G.; Tybjaerg-Hansen, Anne; Smith, George Davey; Nordestgaard, Borge G.			ADH1B and ADH1C Genotype, Alcohol Consumption and Biomarkers of Liver Function: Findings from a Mendelian Randomization Study in 58,313 European Origin Danes	PLOS ONE			English	Article							K(M) ALDEHYDE DEHYDROGENASE; GENE; DISEASE; POPULATION; RISK; ASSOCIATIONS; DEPENDENCE; ADIPOSITY; LINKAGE	Background: The effect of alcohol consumption on liver function is difficult to determine because of reporting bias and potential residual confounding. Our aim was to determine this effect using genetic variants to proxy for the unbiased effect of alcohol. Methods: We used variants in ADH1B and ADH1C genes as instrumental variables (IV) to estimate the causal effect of long-term alcohol consumption on alanine aminotransferase (ALT), gamma-glutamyl-transferase (gamma-GT),alkaline phosphatase (ALP), bilirubin and prothrombin action. Analyses were undertaken on 58,313 Danes (mean age 56). Results: In both confounder adjusted multivariable and genetic-IV analyses greater alcohol consumption, amongst those who drank any alcohol, was associated with higher ALT [mean difference per doubling of alcohol consumption: 3.4% (95% CI: 3.1, 3.7) from multivariable analyses and 3.7% (24.5, 11.9) from genetic-IV analyses] and c-GT [8.2% (7.8, 8.5) and 6.8% (22.8, 16.5)]. The point estimates from the two methods were very similar and statistically the results from the two methods were consistent with each other for effects with ALT and c- GT (both pdiff. 0.3). Results from the multivariable analyses suggested a weak inverse association of alcohol with ALP [21.5% (21.7, 21.3)], which differed from the strong positive effect found in genetic-IV analyses [11.6% (6.8, 16.4)] (p(diff)<0.0001). In both multivariable and genetic- IV analyses associations with bilirubin and protrombin action were weak and close to the null. Conclusions: Our results suggest that greater consumption of alcohol is related to poorer liver function as indicated by higher ALT, gamma-GT and ALP, but not to clotting or bilirubin.	[Lawlor, Debbie A.; Zuccolo, Luisa; De Silva, N. Maneka G.; Smith, George Davey] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Lawlor, Debbie A.; Zuccolo, Luisa; De Silva, N. Maneka G.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Benn, Marianne; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Herlev Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Benn, Marianne; Tybjaerg-Hansen, Anne; Nordestgaard, Borge G.] Univ Copenhagen, Copenhagen Univ Hosp, Fac Hlth & Med Sci, Copenhagen, Denmark; [Benn, Marianne; Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	University of Bristol; University of Bristol; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Lawlor, DA (corresponding author), Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Benn, Marianne/O-4164-2019; Nordestgaard, Borge Gronne/ABF-1310-2020; Davey Smith, George/A-7407-2013	Benn, Marianne/0000-0002-1701-595X; Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Nordestgaard, Borge/0000-0002-1954-7220; Zuccolo, Luisa/0000-0002-7049-3037	Herlev Hospital; Copenhagen County Research Fund; Danish Medical Research Council; UK Medical Research Council (MRC) [MC_UU_12013/5, MC_UU_12013/1]; UK MRC [G0601625]; MRC Population Health Scientist postdoctoral fellowship [G0902144]; Copenhagen University Hospital; Medical Research Council [MC_UU_12013/1, G0902144, MC_UU_12013/5, G0601625, G0501864] Funding Source: researchfish; MRC [MC_UU_12013/1, MC_UU_12013/5, G0501864, G0601625, G0902144] Funding Source: UKRI	Herlev Hospital; Copenhagen County Research Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Population Health Scientist postdoctoral fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Copenhagen University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by Herlev Hospital, Copenhagen University Hospital, The Copenhagen County Research Fund, and The Danish Medical Research Council. DAL, LZ and GDS work in a Unit that receives funding from the UK Medical Research Council (MRC) (MC_UU_12013/5 and MC_UU_12013/1). The contributions of DAL to this paper were also supported by an additional grant from the UK MRC (G0601625). LZ is funded by an MRC Population Health Scientist postdoctoral fellowship (G0902144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2013, EUR HEART J, V34, P2519, DOI 10.1093/eurheartj/eht081; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; LEWONTIN RC, 1964, GENETICS, V49, P49; Li DW, 2012, HUM GENET, V131, P1361, DOI 10.1007/s00439-012-1163-5; Li DW, 2011, BIOL PSYCHIAT, V70, P504, DOI 10.1016/j.biopsych.2011.02.024; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Maddrey W C, 2000, Clin Liver Dis, V4, P115, DOI 10.1016/S1089-3261(05)70099-4; McCullough AJ, 1998, AM J GASTROENTEROL, V93, P2022; Morimoto K, 1996, ENVIRON HEALTH PERSP, V104, P563, DOI 10.2307/3432824; Murata CT, 2003, METABOLISM, V52, P1096, DOI 10.1016/S0026-0495(03)00183-5; Pierce BL, 2012, INT J EPIDEMIOL, V41, P1383, DOI 10.1093/ije/dys141; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Sethi AA, 2004, CLIN CHEM, V50, P443, DOI 10.1373/clinchem.2003.026047; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2011, GENES NUTR, V6, P27, DOI 10.1007/s12263-010-0181-y; SORENSEN TIA, 1989, LIVER, V9, P189; Takeshita T, 2000, HUM GENET, V106, P589, DOI 10.1007/s004390050029; TAKESHITA T, 1993, LANCET, V341, P837, DOI 10.1016/0140-6736(93)90620-V; Thomasson H R, 1995, Recent Dev Alcohol, V12, P163; Timpson NJ, 2009, HYPERTENSION, V54, P84, DOI 10.1161/HYPERTENSIONAHA.109.130005; Tolstrup JS, 2009, AM J GASTROENTEROL, V104, P2182, DOI 10.1038/ajg.2009.370; Wilsnack RW, 2000, ADDICTION, V95, P251, DOI 10.1046/j.1360-0443.2000.95225112.x; Yang X, 1999, ALCOHOL CLIN EXP RES, V23, P751; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zuccolo L, 2009, HUM MOL GENET, V18, P4457, DOI 10.1093/hmg/ddp388	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114294	10.1371/journal.pone.0114294	http://dx.doi.org/10.1371/journal.pone.0114294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503943	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100010
J	Scribner, E; Saut, O; Province, P; Bag, A; Colin, T; Fathallah-Shaykh, HM				Scribner, Elizabeth; Saut, Olivier; Province, Paula; Bag, Asim; Colin, Thierry; Fathallah-Shaykh, Hassan M.			Effects of Anti-Angiogenesis on Glioblastoma Growth and Migration: Model to Clinical Predictions	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; NEWLY-DIAGNOSED GLIOBLASTOMA; TUMOR-CELL INVASION; ANTIANGIOGENIC THERAPY; RECURRENT GLIOBLASTOMA; PROGRESSION; BEVACIZUMAB; VEGF; MRI; PATTERNS	Glioblastoma multiforme (GBM) causes significant neurological morbidity and short survival times. Brain invasion by GBM is associated with poor prognosis. Recent clinical trials of bevacizumab in newly-diagnosed GBM found no beneficial effects on overall survival times; however, the baseline health-related quality of life and performance status were maintained longer in the bevacizumab group and the glucocorticoid requirement was lower. Here, we construct a clinical-scale model of GBM whose predictions uncover a new pattern of recurrence in 11/70 bevacizumab-treated patients. The findings support an exception to the Folkman hypothesis: GBM grows in the absence of angiogenesis by a cycle of proliferation and brain invasion that expands necrosis. Furthermore, necrosis is positively correlated with brain invasion in 26 newly-diagnosed GBM. The unintuitive results explain the unusual clinical effects of bevacizumab and suggest new hypotheses on the dynamic clinical effects of migration by active transport, a mechanism of hypoxia-driven brain invasion.	[Scribner, Elizabeth; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA; [Saut, Olivier; Colin, Thierry] Univ Bordeaux, Dept Math, Talence, France; [Province, Paula; Fathallah-Shaykh, Hassan M.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA; [Bag, Asim] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; UDICE-French Research Universities; Universite de Bordeaux; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama Birmingham, Dept Math, Birmingham, AL 35294 USA.	hfathall@uab.edu	Bag, Asim/G-8308-2019	Bag, Asim/0000-0001-6164-5863; Fathallah-Shaykh, Hassan/0000-0002-2690-7685	National Institutes of Health [R01GM096191]; French State; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French State; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HF-S is supported by R01GM096191 from the National Institutes of Health. TC and OS are supported by the French State, managed by the French National Research Agency (ANR) in the frame of the "Investments for the future'' Programme IdEx Bordeaux - CPU (ANR-10-IDEX-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Baker GJ, 2014, NEOPLASIA, V16, P543, DOI 10.1016/j.neo.2014.06.003; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Ellingson BM, 2014, NEURO-ONCOLOGY, V16, P2, DOI 10.1093/neuonc/nou224; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Hatzikirou H, 2012, MATH MED BIOL, V29, P49, DOI 10.1093/imammb/dqq011; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; KELLY PJ, 1987, J NEUROSURG, V66, P865, DOI 10.3171/jns.1987.66.6.0865; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim EY, 2014, J NEURO-ONCOL, V116, P291, DOI 10.1007/s11060-013-1290-4; Konukoglu E, 2010, MED IMAGE ANAL, V14, P111, DOI 10.1016/j.media.2009.11.005; Konukoglu E, 2010, IEEE T MED IMAGING, V29, P77, DOI 10.1109/TMI.2009.2026413; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lin MI, 2004, CANCER CELL, V6, P529, DOI 10.1016/S1535-6108(04)00340-X; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Nowosielski M, 2014, NEUROLOGY, V82, P1684, DOI 10.1212/WNL.0000000000000402; Plasswilm L, 2000, PATHOBIOLOGY, V68, P99, DOI 10.1159/000055909; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Ribatti D., 2009, HIST RES TUMOR ANGIO; Saut O, 2014, B MATH BIOL, V76, P2306, DOI 10.1007/s11538-014-0007-y; Schoenegger K, 2009, EUR J NEUROL, V16, P874, DOI 10.1111/j.1468-1331.2009.02613.x; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swanson KR, 2008, MATH COMPUT MODEL, V47, P638, DOI 10.1016/j.mcm.2007.02.024; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tan X, 2012, PLOS ONE, V7; Tang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075436; Weller M, 2013, NEURO-ONCOLOGY, V15, P971, DOI 10.1093/neuonc/not106; Wen PY, 2014, NEUROLOGY, V82, P1670, DOI 10.1212/WNL.0000000000000421; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WHITE CW, 1989, NEW ENGL J MED, V320, P1197, DOI 10.1056/NEJM198905043201807; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Zhang Z, 2014, J NEURO-ONCOL, V119, P207, DOI 10.1007/s11060-014-1478-2; Zinn PO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025451; Zuniga RM, 2009, J NEURO-ONCOL, V91, P329, DOI 10.1007/s11060-008-9718-y	44	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115018	10.1371/journal.pone.0115018	http://dx.doi.org/10.1371/journal.pone.0115018			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506702	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100044
J	Abdelnabi, Z; Saleh, N; Baraghithi, S; Glebe, D; Azzeh, M				Abdelnabi, Zakeih; Saleh, Niveen; Baraghithi, Sabri; Glebe, Dieter; Azzeh, Maysa			Subgenotypes and Mutations in the S and Polymerase Genes of Hepatitis B Virus Carriers in the West Bank, Palestine	PLOS ONE			English	Article							SURFACE-ANTIGEN HBSAG; LIVER-TRANSPLANT RECIPIENTS; BLOOD-DONORS; HBV INFECTION; IMMUNE GLOBULIN; PERINATAL TRANSMISSION; REVERSE-TRANSCRIPTASE; VERTICAL TRANSMISSION; LAMIVUDINE THERAPY; DIAGNOSTIC IMPACT	The mutation rate and genetic variability of hepatitis B virus (HBV) are crucial factors for efficient treatment and successful vaccination against HBV. Until today, genetic properties of this virus among the Palestinian population remain unknown. Therefore, we performed genetic analysis of the overlapping S and polymerase genes of HBV, isolated from 40 Palestinian patients' sera. All patients were HBsAg positive and presented with a viral load above 105 HBV genome copies/ml. The genotyping results of the S gene demonstrated that HBV D1 was detected in 90% of the samples representing the most prominent subgenotype among Palestinians carrying HBV. Various mutations existed within the S gene; in five patients four known escape mutations including the common G145R and D144E were found. Furthermore, a ratio of 4.25 of non-synonymous to synonymous mutations in the S gene indicated a strong selection pressure on the HBs antigen loops of HBV strains circulating in those Palestinian patients. Although all patients were treatment-naive, with the exception of one, several mutations were found in the HBV polymerase gene, but none pointed to drug resistance. The study presented here is the first report to address subgenotypes and mutation analyses of HBV S and polymerase genes in Palestine.	[Abdelnabi, Zakeih; Saleh, Niveen; Azzeh, Maysa] Al Quds Univ, Med Res Ctr, Virol Res Lab, Abu Dies East Jerusalem, Israel; [Baraghithi, Sabri] Al Makassed Islamic Charitable Hosp MICH Cent Lab, East Jerusalem, Israel; [Glebe, Dieter] Univ Giessen, German Ctr Infect Res DZIF, Natl Reference Ctr Hepatitis B&D Viruses, Biomed Res Ctr,Inst Med Virol, D-35390 Giessen, Germany	German Center for Infection Research; Justus Liebig University Giessen	Azzeh, M (corresponding author), Al Quds Univ, Med Res Ctr, Virol Res Lab, Abu Dies East Jerusalem, Israel.	mazzeh@med.alquds.edu			German Research Foundation (DFG) [GL595/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by German Research Foundation (DFG) grant No. GL595/2-1.	Allain JP, 2013, TRANSFUSION, V53, P1405, DOI 10.1111/trf.12096; Antaki N, 2010, EPIDEMIOL INFECT, V138, P40, DOI 10.1017/S0950268809990288; Araujo NM, 2009, BRAZ J INFECT DIS, V13, P266, DOI 10.1590/S1413-86702009000400005; Asimina F, 2011, J MED VIROL, V83, P245, DOI 10.1002/jmv.21969; Baig Saeeda, 2009, BMC Res Notes, V2, P1, DOI 10.1186/1756-0500-2-1; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; BEASLEY RP, 1983, LANCET, V2, P1099; Ben-Ari Z, 2003, TRANSPLANT P, V35, P609, DOI 10.1016/S0041-1345(03)00008-3; BROWN SE, 1984, LANCET, V2, P184; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; CARMAN WF, 1990, LANCET, V336, P325, DOI 10.1016/0140-6736(90)91874-A; Chang MH, 2007, SEMIN FETAL NEONAT M, V12, P160, DOI 10.1016/j.siny.2007.01.013; Chang MH, 2010, ANTIVIR THER, V15, P463, DOI 10.3851/IMP1555; Colonno RJ, 2006, HEPATOLOGY, V44, P1656, DOI 10.1002/hep.21422; Costantini A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-310; COUROUCEPAUTY AM, 1974, VOX SANG, V27, P533, DOI 10.1111/j.1423-0410.1974.tb02451.x; Cox LE, 2011, J MED VIROL, V83, P1321, DOI 10.1002/jmv.22118; Cuestas ML, 2006, J CLIN MICROBIOL, V44, P2191, DOI 10.1128/JCM.00057-06; El Chaar M, 2012, J CLIN MICROBIOL, V50, P3159, DOI 10.1128/JCM.01251-12; Garmiri P, 2011, J MED VIROL, V83, P948, DOI 10.1002/jmv.21772; Geipel A, 2011, PHANOTYPISCHE CHARAK; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Gerlich WH, 2010, DIGEST DIS, V28, P116, DOI 10.1159/000282074; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; Ghany MG, 1998, HEPATOLOGY, V27, P213, DOI 10.1002/hep.510270133; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P10015, DOI 10.1073/pnas.87.24.10015; GUERRERO E, 1990, MOL IMMUNOL, V27, P435, DOI 10.1016/0161-5890(90)90168-Y; Gunther S, 1999, ADV VIRUS RES, V52, P25, DOI 10.1016/S0065-3527(08)60298-5; Hanada K, 2007, MOL BIOL EVOL, V24, P2235, DOI 10.1093/molbev/msm152; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Harder KM, 2011, VACCINE, V29, P9303, DOI 10.1016/j.vaccine.2011.10.028; HINO K, 1995, DIGEST DIS SCI, V40, P566, DOI 10.1007/BF02064370; HOWARD CR, 1988, VIRAL HEPATITIS LIVE, P1094; Hu YL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-221; Jursch CA, 2002, MED MICROBIOL IMMUN, V190, P189, DOI 10.1007/s00430-001-0103-0; KARTHIGESU VD, 1994, J GEN VIROL, V75, P443, DOI 10.1099/0022-1317-75-2-443; Katsoulidou A, 2009, J MED VIROL, V81, P815, DOI 10.1002/jmv.21499; Khaled IAE, 2011, MOL BIOL REP, V38, P4353, DOI 10.1007/s11033-010-0562-8; Kim JH, 2010, J KOREAN MED SCI, V25, P257, DOI 10.3346/jkms.2010.25.2.257; Komatsu Haruki, 2012, BMC Res Notes, V5, P22, DOI 10.1186/1756-0500-5-22; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Lee JM, 2011, WORLD J GASTROENTERO, V17, P283, DOI 10.3748/wjg.v17.i3.283; Locarinin S, 2004, MOL VIROLOGY, V24; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Ma Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-315; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Masaadeh HA, 2008, WORLD J GASTROENTERO, V14, P7231, DOI 10.3748/wjg.14.7231; Mathet VL, 2006, J CLIN MICROBIOL, V44, P3435, DOI 10.1128/JCM.00866-06; McMahon BJ, 2011, HEPATOLOGY, V54, P801, DOI 10.1002/hep.24442; Mele A, 2001, J INFECT DIS, V184, P905, DOI 10.1086/323396; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Norouzi M, 2012, IRAN J PUBLIC HEALTH, V41, P104; OKADA K, 1976, NEW ENGL J MED, V294, P746, DOI 10.1056/NEJM197604012941402; Olinger CM, 2007, MED MICROBIOL IMMUN, V196, P247, DOI 10.1007/s00430-007-0050-5; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Plitt SS, 2007, CAN J PUBLIC HEALTH, V98, P194, DOI 10.1007/BF03403711; Pollicino T, 2009, ANTIVIR THER, V14, P649; Ragheb M, 2012, J MED VIROL, V84, P587, DOI 10.1002/jmv.23234; Sayan M, 2012, ANN HEPATOL, V11, P849, DOI 10.1016/S1665-2681(19)31409-7; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Spada E, 2011, J INFECTION, V62, P165, DOI 10.1016/j.jinf.2010.11.014; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Weber B, 2005, J CLIN VIROL, V32, P102, DOI 10.1016/j.jcv.2004.10.008; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Willis BC, 2010, PEDIATRICS, V125, P704, DOI 10.1542/peds.2009-1831; Wu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094864; Yu JW, 2011, LIVER INT, V31, P499, DOI 10.1111/j.1478-3231.2011.02450.x; Zekri ARN, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-74; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	74	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113821	10.1371/journal.pone.0113821	http://dx.doi.org/10.1371/journal.pone.0113821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503289	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400016
J	Ulanet, DB; Couto, K; Jha, A; Choe, S; Wang, A; Woo, HK; Steadman, M; DeLaBarre, B; Gross, S; Driggers, E; Dorsch, M; Hurov, JB				Ulanet, Danielle B.; Couto, Kiley; Jha, Abhishek; Choe, Sung; Wang, Amanda; Woo, Hin-Koon; Steadman, Mya; DeLaBarre, Byron; Gross, Stefan; Driggers, Edward; Dorsch, Marion; Hurov, Jonathan B.			Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition	PLOS ONE			English	Article							BREAST-CANCER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; TUMOR-CELLS; STEM-CELLS; GROWTH; METABOLISM; TRANSITION; EXPRESSION; EMT; DIFFERENTIATION	Recent work has highlighted glutaminase (GLS) as a key player in cancer cell metabolism, providing glutamine-derived carbon and nitrogen to pathways that support proliferation. There is significant interest in targeting GLS for cancer therapy, although the gene is not known to be mutated or amplified in tumors. As a result, identification of tractable markers that predict GLS dependence is needed for translation of GLS inhibitors to the clinic. Herein we validate a small molecule inhibitor of GLS and show that non-small cell lung cancer cells marked by low E-cadherin and high vimentin expression, hallmarks of a mesenchymal phenotype, are particularly sensitive to inhibition of the enzyme. Furthermore, lung cancer cells induced to undergo epithelial to mesenchymal transition (EMT) acquire sensitivity to the GLS inhibitor. Metabolic studies suggest that the mesenchymal cells have a reduced capacity for oxidative phosphorylation and increased susceptibility to oxidative stress, rendering them unable to cope with the perturbations induced by GLS inhibition. These findings elucidate selective metabolic dependencies of mesenchymal lung cancer cells and suggest novel pathways as potential targets in this aggressive cancer type.	[Ulanet, Danielle B.; Couto, Kiley; Jha, Abhishek; Choe, Sung; Wang, Amanda; Woo, Hin-Koon; Steadman, Mya; DeLaBarre, Byron; Gross, Stefan; Driggers, Edward; Dorsch, Marion; Hurov, Jonathan B.] Agios Pharmaceut, Cambridge, MA 02139 USA	Agios Pharmaceuticals	Hurov, JB (corresponding author), Agios Pharmaceut, Cambridge, MA 02139 USA.	jonathan.hurov@agios.com		Choe, Sung/0000-0001-9140-4198; Jha, Abhishek/0000-0001-9161-0450	Agios Pharmaceuticals	Agios Pharmaceuticals	All work was funded by Agios Pharmaceuticals. The funders, through its employees, who are the authors of this manuscript, had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aledo JC, 2000, MAMM GENOME, V11, P1107, DOI 10.1007/s003350010190; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRODIE AE, 1990, ARCH BIOCHEM BIOPHYS, V276, P212, DOI 10.1016/0003-9861(90)90028-W; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294; EAGLE H, 1956, J BIOL CHEM, V218, P607; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gorowiec MR, 2012, FREE RADICAL BIO MED, V52, P1024, DOI 10.1016/j.freeradbiomed.2011.12.020; Grant CM., 2008, J BIOL-LONDON, V7, P1, DOI DOI 10.1186/jbiol63; Grassian AR, 2012, J BIOL CHEM, V287, P42180, DOI 10.1074/jbc.M112.417832; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mates JM, 2013, CURR MOL MED, V13, P514; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Qie S, 2013, J CELL BIOCH; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shen CH, 2011, J BUON, V16, P733; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Simpson NE, 2012, BREAST CANCER RES TR, V133, P959, DOI 10.1007/s10549-011-1871-x; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sobhakumari A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048175; Soeters PB, 2012, ANN NUTR METAB, V60, P17, DOI 10.1159/000334880; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; VAIDYANATHAN VV, 1993, MOL CELL BIOCHEM, V129, P57, DOI 10.1007/BF00926576; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; WILLIAMS WJ, 1958, J BIOL CHEM, V232, P229; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107	49	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115144	10.1371/journal.pone.0115144	http://dx.doi.org/10.1371/journal.pone.0115144			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502225	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400076
J	Hirsch, PE; Cayon, D; Svanback, R				Hirsch, Philipp Emanuel; Cayon, David; Svanback, Richard			Plastic Responses of a Sessile Prey to Multiple Predators: A Field and Experimental Study	PLOS ONE			English	Article							MUSSEL DREISSENA-POLYMORPHA; ROACH RUTILUS-RUTILUS; ZEBRA MUSSELS; PHENOTYPIC PLASTICITY; INDUCIBLE DEFENSES; BLUE MUSSEL; NICHE WIDTH; TRADE-OFF; SHELL; CRAYFISH	Background: Theory predicts that prey facing a combination of predators with different feeding modes have two options: to express a response against the feeding mode of the most dangerous predator, or to express an intermediate response. Intermediate phenotypes protect equally well against several feeding modes, rather than providing specific protection against a single predator. Anti-predator traits that protect against a common feeding mode displayed by all predators should be expressed regardless of predator combination, as there is no need for trade-offs. Principal Findings: We studied phenotypic anti-predator responses of zebra mussels to predation threat from a handling-time-limited (crayfish) and a gape-size-limited (roach) predator. Both predators dislodge mussels from the substrate but diverge in their further feeding modes. Mussels increased expression of a nonspecific defense trait (attachment strength) against all combinations of predators relative to a control. In response to roach alone, mussels showed a tendency to develop a weaker and more elongated shell. In response to crayfish, mussels developed a harder and rounder shell. When exposed to either a combination of predators or no predator, mussels developed an intermediate phenotype. Mussel growth rate was positively correlated with an elongated weaker shell and negatively correlated with a round strong shell, indicating a trade-off between anti-predator responses. Field observations of prey phenotypes revealed the presence of both anti-predator phenotypes and the trade-off with growth, but intra-specific population density and bottom substrate had a greater influence than predator density. Conclusions: Our results show that two different predators can exert both functionally equivalent and inverse selection pressures on a single prey. Our field	[Hirsch, Philipp Emanuel; Cayon, David; Svanback, Richard] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Evolut, Uppsala, Sweden	Uppsala University	Hirsch, PE (corresponding author), Univ Basel, Program Man Soc Environm MGU, Basel, Switzerland.	philipp.hirsch@unibas.ch		Hirsch, Philipp Emanuel/0000-0002-6927-2368	Malmens stiftelse; VR	Malmens stiftelse; VR(Swedish Research Council)	This study was funded by grants form the Malmens stiftelse to PEH and from VR to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; [Anonymous], 1992, WATER QUALITY MEASUR; Bagenal T.B., 1978, IBP HDB, P101; Beadman HA, 2003, MAR BIOL, V142, P487, DOI 10.1007/s00227-002-0977-4; BOULDING EG, 1984, J EXP MAR BIOL ECOL, V76, P201, DOI 10.1016/0022-0981(84)90189-8; Bourdeau PE, 2012, OIKOS, V121, P1175, DOI 10.1111/j.1600-0706.2012.20235.x; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Bourdeau PE, 2009, ECOLOGY, V90, P1659, DOI 10.1890/08-1653.1; Bouwma P, 2001, ANIM BEHAV, V61, P771, DOI 10.1006/anbe.2000.1649; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; Brown GE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2712; Cheung SG, 2004, MAR BIOL, V144, P675, DOI 10.1007/s00227-003-1233-2; Czarnoleski M, 2005, EVOL ECOL RES, V7, P821; Czarnoleski M, 2003, EVOL ECOL RES, V5, P571; Czarnoleski M, 2011, ANIM BEHAV, V82, P543, DOI 10.1016/j.anbehav.2011.06.008; Czarnoleski M, 2010, FUND APPL LIMNOL, V176, P269, DOI 10.1127/1863-9135/2010/0176-0269; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Douhan B, 2007, HACKANDE SJOFAGLER E, P16; Doyle S, 2010, J EXP MAR BIOL ECOL, V394, P98, DOI 10.1016/j.jembe.2010.07.023; Egea-Serrano A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3266; Eklov P, 2000, OIKOS, V88, P250, DOI 10.1034/j.1600-0706.2000.880203.x; Eriksson L., 2006, MULTI MEGAVARIATE 1; Forsberg C, 1998, ADV LIMNOLOGY; Freeman AS, 2009, OIKOS, V118, P758, DOI 10.1111/j.1600-0706.2008.17176.x; Gons H. J., 1986, HYDROBIOL B, V20, P109, DOI [10.1007/BF02291156, DOI 10.1007/BF02291156]; Hagen NT, 2002, MAR BIOL, V140, P365, DOI 10.1007/s002270100694; HELLER J, 1976, J ZOOL, V179, P201; Herzog Q, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-113; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Hirsch PE, 2013, OECOLOGIA, V172, P245, DOI 10.1007/s00442-013-2611-1; Hoverman JT, 2007, OECOLOGIA, V154, P551, DOI 10.1007/s00442-007-0847-3; Howes D., 1999, BRIT COLUMBIA ESTUAR; Hughes RN, 1995, J EXP MAR BIOL ECOL, V193, P225, DOI 10.1016/0022-0981(95)00119-0; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Kobak J, 2011, AQUAT ECOL, V45, P357, DOI 10.1007/s10452-011-9359-7; Kobak J, 2010, HYDROBIOLOGIA, V644, P195, DOI 10.1007/s10750-010-0113-2; Kobak J, 2009, FUND APPL LIMNOL, V174, P193, DOI 10.1127/1863-9135/2009/0174-0193; Laurila A, 2006, OECOLOGIA, V147, P585, DOI 10.1007/s00442-005-0301-3; Lei J, 1996, CAN J FISH AQUAT SCI, V53, P29, DOI 10.1139/cjfas-53-1-29; Leonard GH, 1999, ECOLOGY, V80, P1; Lesku JA, 2008, BEHAV BRAIN RES, V189, P298, DOI 10.1016/j.bbr.2008.01.006; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; LOOSE CJ, 1994, ECOLOGY, V75, P2255, DOI 10.2307/1940881; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; MICHELI F, 1995, J ANIM ECOL, V64, P63, DOI 10.2307/5827; Mikolajewski DJ, 2006, EVOLUTION, V60, P1306; Molloy Daniel P., 1997, Reviews in Fisheries Science, V5, P27; Morrison TW, 1997, J GREAT LAKES RES, V23, P177, DOI 10.1016/S0380-1330(97)70895-5; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2007, FRESHWATER BIOL, V52, P823, DOI 10.1111/j.1365-2427.2007.01732.x; Naddafi R, 2010, J N AM BENTHOL SOC, V29, P444, DOI 10.1899/09-071.1; Nagelkerke LAJ, 1996, CAN J FISH AQUAT SCI, V53, P2847, DOI 10.1139/cjfas-53-12-2847; Newell RIE, 2007, MAR BIOL, V152, P449, DOI 10.1007/s00227-007-0706-0; Olsson K, 2009, FRESHWATER BIOL, V54, P1731, DOI 10.1111/j.1365-2427.2009.02221.x; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; Perry WL, 1997, CAN J FISH AQUAT SCI, V54, P120, DOI 10.1139/cjfas-54-1-120; PREJS A, 1990, OECOLOGIA, V83, P378, DOI 10.1007/BF00317563; Ray WJ, 1997, ENVIRON BIOL FISH, V50, P267, DOI 10.1023/A:1007379220052; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; RHOADS DC, 1970, LETHAIA, V3, P143, DOI 10.1111/j.1502-3931.1970.tb01854.x; Schreiber S, 1998, ERGEB LIMNOL, V51, P169; SEED R, 1968, J MAR BIOL ASSOC UK, V48, P561, DOI 10.1017/S0025315400019159; Selin NI, 2003, RUSS J MAR BIOL, V29, P230; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Smith LD, 2000, MAR BIOL, V136, P461, DOI 10.1007/s002270050705; Spencer M, 2008, ECOLOGY, V89, P1134, DOI 10.1890/07-0941.1; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Teplitsky C, 2004, ECOLOGY, V85, P2888, DOI 10.1890/03-3043; Toomey MB, 2002, J N AM BENTHOL SOC, V21, P468, DOI 10.2307/1468483; Touchon JC, 2011, BEHAV ECOL, V22, P169, DOI 10.1093/beheco/arq192; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Urban MC, 2007, P NATL ACAD SCI USA, V104, P14377, DOI 10.1073/pnas.0704645104; Van Buskirk J, 1998, BIOL J LINN SOC, V65, P301, DOI 10.1006/bijl.1998.0249; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; West-Eberhard Mary Jane, 2003, pi; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x	79	3	3	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115192	10.1371/journal.pone.0115192	http://dx.doi.org/10.1371/journal.pone.0115192			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517986	Green Submitted, Green Published, gold			2022-12-27	WOS:000347215600054
J	Krebs, SJ; McBurney, SP; Kovarik, DN; Waddell, CD; Jaworski, JP; Sutton, WF; Gomes, MM; Trovato, M; Waagmeester, G; Barnett, SJ; DeBerardinis, P; Haigwood, NL				Krebs, Shelly J.; McBurney, Sean P.; Kovarik, Dina N.; Waddell, Chelsea D.; Jaworski, J. Pablo; Sutton, William F.; Gomes, Michelle M.; Trovato, Maria; Waagmeester, Garret; Barnett, Susan J.; DeBerardinis, Piergiuseppe; Haigwood, Nancy L.			Multimeric Scaffolds Displaying the HIV-1 Envelope MPER Induce MPER-Specific Antibodies and Cross-Neutralizing Antibodies when Co-Immunized with gp160 DNA	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; DEHYDROGENASE MULTIENZYME COMPLEX; INTERMOLECULAR DISULFIDE BOND; MONOCLONAL-ANTIBODIES; IMMUNOLOGICAL CHARACTERIZATION; BACILLUS-STEAROTHERMOPHILUS; VARIABLE REGIONS; VACCINE EFFICACY; PASSIVE TRANSFER	Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that directs antibody (Ab) responses toward conserved regions of the viral Envelope (Env). However, the generation of neutralizing Abs (NAbs) targeting these regions through vaccination has proven to be difficult. One conserved region of particular interest is the membrane proximal external region (MPER) of Env located within the gp41 ectodomain. In order to direct the immune response to this region, the MPER and gp41 ectodomain were expressed separately as N-terminal fusions to the E2 protein of Geobacillus stearothermophilus. The E2 protein acts as a scaffold by self-assembling into 60-mer particles, displaying up to 60 copies of the fused target on the surface. Rabbits were immunized with E2 particles displaying MPER and/or the gp41 ectodomain in conjunction with DNA encoding full-length gp160. Only vaccines including E2 particles displaying MPER elicited MPER-specific Ab responses. NAbs were elicited after two immunizations that largely targeted the V3 loop. To overcome V3 immunodominance in the DNA component, E2 particles displaying MPER were used in conjunction with gp160 DNA lacking hypervariable regions V2, V3, or combined V1V2V3. All rabbits had HIV binding Ab responses and NAbs following the second vaccination. Using HIV-2/HIV-1 MPER chimeric viruses as targets, NAbs were detected in 12/16 rabbits after three immunizations. Low levels of NAbs specific for Tier 1 and 2 viruses were observed in all groups. This study provides evidence that co-immunizing E2 particles displaying MPER and gp160 DNA can focus Ab responses toward conserved regions of Env.	[Krebs, Shelly J.; McBurney, Sean P.; Waddell, Chelsea D.; Jaworski, J. Pablo; Sutton, William F.; Gomes, Michelle M.; Waagmeester, Garret; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Trovato, Maria; DeBerardinis, Piergiuseppe] CNR, Inst Prot Biochem, I-80125 Naples, Italy; [Kovarik, Dina N.; Haigwood, Nancy L.] Seattle Biomed Res Inst, Viral Vaccines Program, Seattle, WA 98109 USA; [Barnett, Susan J.] Novartis Vaccines & Diagnost, Emeryville, CA USA	Oregon Health & Science University; Oregon National Primate Research Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Center for Infectious Disease Research; Novartis	Haigwood, NL (corresponding author), Oregon Hlth & Sci Univ, Div Pathobiol & Immunol, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.	haigwoon@ohsu.edu	Jaworski, Juan/ABA-4503-2020; De Berardinis, Piergiuseppe/HCI-0893-2022; Haigwood, Nancy Logan/AAV-7484-2020; De Berardinis, Piergiuseppe/AAX-1049-2020; Krebs, Shelly/D-8015-2016	Jaworski, Juan/0000-0002-1311-060X; De Berardinis, Piergiuseppe/0000-0001-6579-1729; Haigwood, Nancy/0000-0002-1477-9575; Gomes, Michelle/0000-0003-4809-2664; Krebs, Shelly/0000-0003-1136-1760; Trovato, Maria/0000-0002-3831-6073	National Institutes of Health [R01AI AI074379]; Ruth L. Kirschstein National Research Service [T32A1074494, F32AI104689];  [P51 OD-011092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI106489, R01AI074379] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health R01AI AI074379 to NLH, P51 OD-011092 for ONPRC support, and the Ruth L. Kirschstein National Research Service Awards T32A1074494 to SJK and F32AI104689 to SPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2010, AIDS RES HUM RETROV, V26, P717, DOI 10.1089/aid.2009.0254; Arnold GF, 2009, J VIROL, V83, P5087, DOI 10.1128/JVI.00184-09; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Caivano A, 2010, VIROLOGY, V407, P296, DOI 10.1016/j.virol.2010.08.026; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Domingo GJ, 1999, EUR J BIOCHEM, V266, P1136, DOI 10.1046/j.1432-1327.1999.00966.x; Domingo GJ, 2001, J MOL BIOL, V305, P259, DOI 10.1006/jmbi.2000.4311; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; Frey G, 2010, NAT STRUCT MOL BIOL, V17, P1486, DOI 10.1038/nsmb.1950; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Jaworski JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031464; Kim M, 2007, VACCINE, V25, P5102, DOI 10.1016/j.vaccine.2006.09.071; Law M, 2007, J VIROL, V81, P4272, DOI 10.1128/JVI.02536-06; LESSARD IAD, 1995, BIOCHEM J, V306, P727, DOI 10.1042/bj3060727; Li JY, 2013, VACCINE, V31, P3747, DOI 10.1016/j.vaccine.2013.04.037; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Lu S, 1998, AIDS RES HUM RETROV, V14, P151, DOI 10.1089/aid.1998.14.151; Lu S, 1998, CURR TOP MICROBIOL, V226, P161; Luo M, 2006, VACCINE, V24, P435, DOI 10.1016/j.vaccine.2005.08.006; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; Mehandru S, 2004, J VIROL, V78, P14039, DOI 10.1128/JVI.78.24.14039-14042.2004; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; PERHAM RN, 1995, METHOD ENZYMOL, V251, P436, DOI 10.1016/0076-6879(95)51147-4; Phogat S, 2008, VIROLOGY, V373, P72, DOI 10.1016/j.virol.2007.11.005; PLANELLES V, 1991, AIDS RES HUM RETROV, V7, P889, DOI 10.1089/aid.1991.7.889; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Toukam DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038068; UNAIDS, 2008, REP GLOB AIDS EP; Wahome N, 2012, CHEM BIOL DRUG DES, V80, P349, DOI 10.1111/j.1747-0285.2012.01423.x; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang J, 2011, VACCINE, V29, P8542, DOI 10.1016/j.vaccine.2011.09.032; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018233; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Yi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072205; Zhou MK, 2013, EUR J IMMUNOL, V43, P499, DOI 10.1002/eji.201242974; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	67	32	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113463	10.1371/journal.pone.0113463	http://dx.doi.org/10.1371/journal.pone.0113463			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514675	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300005
J	Becker, L; Kling, E; Schiller, E; Zeh, R; Schrewe, A; Holter, SM; Mossbrugger, I; Calzada-Wack, J; Strecker, V; Wittig, I; Dumitru, I; Wenz, T; Bender, A; Aichler, M; Janik, D; Neff, F; Walch, A; Quintanilla-Fend, L; Floss, T; Bekeredjian, R; Gailus-Durner, V; Fuchs, H; Wurst, W; Meitinger, T; Prokisch, H; de Angelis, MH; Klopstock, T				Becker, Lore; Kling, Eva; Schiller, Evelyn; Zeh, Ramona; Schrewe, Anja; Hoelter, Sabine M.; Mossbrugger, Ilona; Calzada-Wack, Julia; Strecker, Valentina; Wittig, Ilka; Dumitru, Iulia; Wenz, Tina; Bender, Andreas; Aichler, Michaela; Janik, Dirk; Neff, Frauke; Walch, Axel; Quintanilla-Fend, Leticia; Floss, Thomas; Bekeredjian, Raffi; Gailus-Durner, Valerie; Fuchs, Helmut; Wurst, Wolfgang; Meitinger, Thomas; Prokisch, Holger; de Angelis, Martin Hrabe; Klopstock, Thomas			MTO1-Deficient Mouse Model Mirrors the Human Phenotype Showing Complex I Defect and Cardiomyopathy	PLOS ONE			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; RESPIRATORY-CHAIN DEFICIENCY; OXIDATIVE-PHOSPHORYLATION; DISEASE; RNA; TRANSLATION; MUTATIONS; CELLS; GENE; QUANTIFICATION	Recently, mutations in the mitochondrial translation optimization factor 1 gene (MTO1) were identified as causative in children with hypertrophic cardiomyopathy, lactic acidosis and respiratory chain defect. Here, we describe an MTO1-deficient mouse model generated by gene trap mutagenesis that mirrors the human phenotype remarkably well. As in patients, the most prominent signs and symptoms were cardiovascular and included bradycardia and cardiomyopathy. In addition, the mutant mice showed a marked worsening of arrhythmias during induction and reversal of anaesthesia. The detailed morphological and biochemical workup of murine hearts indicated that the myocardial damage was due to complex I deficiency and mitochondrial dysfunction. In contrast, neurological examination was largely normal in Mto1-deficient mice. A translational consequence of this mouse model may be to caution against anaesthesia-related cardiac arrhythmias which may be fatal in patients.	[Becker, Lore; Schiller, Evelyn; Zeh, Ramona; Bender, Andreas; Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany; [Becker, Lore; Kling, Eva; Schiller, Evelyn; Zeh, Ramona; Schrewe, Anja; Hoelter, Sabine M.; Mossbrugger, Ilona; Calzada-Wack, Julia; Janik, Dirk; Neff, Frauke; Bekeredjian, Raffi; Gailus-Durner, Valerie; Fuchs, Helmut; Wurst, Wolfgang; de Angelis, Martin Hrabe; Klopstock, Thomas] Helmholtz Zentrum Munchen, German Res Ctr Environm & Hlth, German Mouse Clin, Neuherberg, Germany; [Becker, Lore; Schiller, Evelyn; Zeh, Ramona; Gailus-Durner, Valerie; Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Schrewe, Anja; Bekeredjian, Raffi] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Hoelter, Sabine M.; Floss, Thomas; Wurst, Wolfgang] Helmholtz Zentrum Munchen, Inst Dev Genet, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Mossbrugger, Ilona; Calzada-Wack, Julia; Janik, Dirk; Neff, Frauke; Quintanilla-Fend, Leticia] Helmholtz Zentrum Munchen, Inst Pathol, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Strecker, Valentina; Wittig, Ilka] Goethe Univ Frankfurt, D-60054 Frankfurt, Germany; [Dumitru, Iulia; Wenz, Tina] Univ Cologne, Inst Genet, Cologne, Germany; [Aichler, Michaela; Walch, Axel] Helmholtz Zentrum Munchen, Res Unit Analyt Pathol, Inst Pathol, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Chair Dev Genet, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Wurst, Wolfgang; Klopstock, Thomas] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang; de Angelis, Martin Hrabe; Klopstock, Thomas] German Ctr Vertigo & Balance Disorders, Munich, Germany; [Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm & Hlth, Neuherberg, Germany; [Meitinger, Thomas] Deutsch Forschungszentrum Herz Kreislauferkrankun, Munich, Germany; [Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany; [Wittig, Ilka; Wenz, Tina; Prokisch, Holger; Klopstock, Thomas] German Network Mitochondrial Disorders mitoNET, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ruprecht Karls University Heidelberg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; University of Cologne; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Klopstock, T (corresponding author), Univ Munich, Friedrich Baur Inst, Dept Neurol, Munich, Germany.	Thomas.Klopstock@med.uni-muenchen.de	Aichler, Michaela/B-5356-2014; Hölter, Sabine M./N-5868-2014; Gailus-Durner, Valerie/M-7337-2014; Walch, Axel/B-4554-2012; de Angelis, Martin Hrabe/F-5531-2012; Becker, Lore/AAJ-1203-2020; Meitinger, Thomas/O-1318-2015	Hölter, Sabine M./0000-0003-4878-5241; Walch, Axel/0000-0001-5578-4023; de Angelis, Martin Hrabe/0000-0002-7898-2353; Becker, Lore/0000-0002-6890-4984; Meitinger, Thomas/0000-0002-8838-8403; Bender, Andreas/0000-0002-6328-7104; Wurst, Wolfgang/0000-0003-4422-7410; Calzada, Julia/0000-0003-0816-9305; Prokisch, Holger/0000-0003-2379-6286	German Federal Ministry of Education and Research (BMBF, Bonn, Germany) grants (mitoNET) [01GM1113A-C]; National Genome Research Net (NGFN-Plus) [01GS0850, 01GS0851, 01GS0854]; German Center for Vertigo and Balance Disorders [01EO0901]; EU grants (EUMODIC) [LSHG-2006-037188, 211404, 01KX1012]; Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 815]; Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project [EXC 115]; Helmholtz Alliance for Mental Health in an Ageing Society (HelMA) through the Initiative and Network Fund of the Helmholtz Association	German Federal Ministry of Education and Research (BMBF, Bonn, Germany) grants (mitoNET); National Genome Research Net (NGFN-Plus); German Center for Vertigo and Balance Disorders; EU grants (EUMODIC); Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project; Helmholtz Alliance for Mental Health in an Ageing Society (HelMA) through the Initiative and Network Fund of the Helmholtz Association	This work was supported by German Federal Ministry of Education and Research (BMBF, Bonn, Germany) grants to the German Network for Mitochondrial Disorders (mitoNET, 01GM1113A-C), the National Genome Research Net (NGFN-Plus, No. 01GS0850, 01GS0851, 01GS0854) the German Center for Vertigo and Balance Disorders (no. 01EO0901) and by EU grants (EUMODIC, LSHG-2006-037188 and Infrafrontier Contracts No. 211404 and 01KX1012 to the GMC). In addition, T. W. is supported by the Emmy-Noether-Programm of the Deutsche Forschungsgemeinschaft, and I. W. by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815, Project Z1 (Redox-Proteomics) and by the Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project EXC 115. W. W. was also funded by the Helmholtz Alliance for Mental Health in an Ageing Society (HelMA) through the Initiative and Network Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruffini E, 2013, HUMAN MUTATION; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chouchani ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094157; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gaignard P, 2013, JIMD REP, V11, P117, DOI 10.1007/8904_2013_230; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Ghezzi D, 2012, AM J HUMAN GENETICS; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Haack TB, 2013, AM J HUMAN GENETICS; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; Kemp JP, 2011, BRAIN, V134, P183, DOI 10.1093/brain/awq320; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Li RH, 2003, BBA-GENE STRUCT EXPR, V1629, P53, DOI 10.1016/S0167-4781(03)00160-X; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Pearce S, 2012, MOL CELLULAR NEUROSC; Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z; Sgobbo P, 2007, BBA-BIOENERGETICS, V1767, P222, DOI 10.1016/j.bbabio.2007.01.023; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995; Vauti F, 2007, GENE, V389, P174, DOI 10.1016/j.gene.2006.11.004; Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909; Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang KC, 2014, FREE RADICAL BIO MED, V71, P351, DOI 10.1016/j.freeradbiomed.2014.03.033; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	41	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114918	10.1371/journal.pone.0114918	http://dx.doi.org/10.1371/journal.pone.0114918			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506927	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100034
J	Tozbikian, G; Brogi, E; Kadota, K; Catalano, J; Akram, M; Patil, S; Ho, AY; Reis, JS; Weigelt, B; Norton, L; Adusumilli, PS; Wen, HY				Tozbikian, Gary; Brogi, Edi; Kadota, Kyuichi; Catalano, Jeffrey; Akram, Muzaffar; Patil, Sujata; Ho, Alice Y.; Reis-Filho, Jorge S.; Weigelt, Britta; Norton, Larry; Adusumilli, Prasad S.; Wen, Hannah Yong			Mesothelin Expression in Triple Negative Breast Carcinomas Correlates Significantly with Basal-Like Phenotype, Distant Metastases and Decreased Survival	PLOS ONE			English	Article							PROLONGED PATIENT SURVIVAL; HUMAN T-CELLS; PHASE-I; MONOCLONAL-ANTIBODY; HIGH-AFFINITY; CANCER; MARKERS; RECEPTOR; TISSUE; OVEREXPRESSION	Mesothelin is a cell surface associated antigen expressed on mesothelial cells and in some malignant neoplasms. Mesothelin-targeted therapies are in phase I/II clinical trials. The clinicopathologic and prognostic significance of mesothelin expression in triple negative breast carcinomas (TNBC) has not been fully assessed. We evaluated the expression of mesothelin and of basal markers in tissue microarrays of 226 TNBC and 88 non-TNBC and assessed the clinicopathologic features of mesothelin-expressing breast carcinomas. Furthermore, we investigated the impact of mesothelin expression on the disease-free and overall survival of patients with TNBC. We found that mesothelin expression is significantly more frequent in TNBC than in non-TNBC (36% vs 16%, respectively; p=0.0006), and is significantly correlated with immunoreactivity for basal keratins, but not for EGFR. Mesothelin-positive and mesothelin-negative TNBC were not significantly different by patients' race, tumor size, histologic grade, tumor subtype, lymphovascular invasion and lymph node metastases. Patients with mesothelin-positive TNBC were older than patients with mesothelin-negative TNBC, developed more distant metastases with a shorter interval, and had significantly lower overall and disease-free survival. Based on our results, patients with mesothelin-positive TNBC could benefit from mesothelin-targeted therapies.	[Tozbikian, Gary; Brogi, Edi; Catalano, Jeffrey; Akram, Muzaffar; Reis-Filho, Jorge S.; Weigelt, Britta; Wen, Hannah Yong] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Kadota, Kyuichi; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Patil, Sujata] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Ho, Alice Y.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Wen, HY (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	weny@mskcc.org	Kadota, Kyuichi/AAY-2676-2021	Kadota, Kyuichi/0000-0002-6835-453X; Norton, Larry/0000-0003-3701-9250; Tozbikian, Gary/0000-0002-5941-5652	Department of Defense (DOC) Breast Cancer Research Program [BC132124]	Department of Defense (DOC) Breast Cancer Research Program(United States Department of Defense)	This work was supported by the Department of Defense (DOC) Breast Cancer Research Program (BC132124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Baba K, 2012, J SURG ONCOL, V105, P195, DOI 10.1002/jso.22024; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Bharadwaj U, 2008, MOL CANCER RES, V6, P1755, DOI 10.1158/1541-7786.MCR-08-0095; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Einama T, 2012, BRIT J CANCER, V107, P137, DOI 10.1038/bjc.2012.235; Einama T, 2011, PANCREAS, V40, P1276, DOI 10.1097/MPA.0b013e318221bed8; Fan D, 2002, MOL CANCER THER, V1, P595; Frierson HF, 2003, HUM PATHOL, V34, P605, DOI 10.1016/S0046-8177(03)00177-1; Glass JP, 2011, INT J SURG PATHOL, V19, P588, DOI 10.1177/1066896911409575; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Haffty BG, 2006, J CLIN ONCOL, V24, P5652, DOI 10.1200/JCO.2006.06.5664; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Harris LN, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1622; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Hellstrom I, 2006, CANCER EPIDEM BIOMAR, V15, P1014, DOI 10.1158/1055-9965.EPI-05-0334; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Kachala SS, 2014, CLIN CANCER RES, V20, P1020, DOI 10.1158/1078-0432.CCR-13-1862; Kawamata F, 2012, INT J ONCOL, V41, P2109, DOI 10.3892/ijo.2012.1662; Kelly RJ, 2012, MOL CANCER THER, V11, P517, DOI 10.1158/1535-7163.MCT-11-0454; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Le DT, 2012, CLIN CANCER RES, V18, P858, DOI 10.1158/1078-0432.CCR-11-2121; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Morris GJ, 2007, CANCER-AM CANCER SOC, V110, P876, DOI 10.1002/cncr.22836; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Parinyanitikul N, 2013, CLIN BREAST CANCER, V13, P378, DOI 10.1016/j.clbc.2013.05.001; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rakha EA, 2009, PATHOLOGY, V41, P40, DOI 10.1080/00313020802563510; Rizk NP, 2012, CANCER EPIDEM BIOMAR, V21, P482, DOI 10.1158/1055-9965.EPI-11-0993; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Servais EL, 2012, CLIN CANCER RES, V18, P2478, DOI 10.1158/1078-0432.CCR-11-2614; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swierczynski SL, 2004, HUM PATHOL, V35, P357, DOI 10.1016/j.humpath.2003.10.012; Tchou J, 2012, BREAST CANCER RES TR, V133, P799, DOI 10.1007/s10549-012-2018-4; Thike AA, 2010, AM J SURG PATHOL, V34, P956, DOI 10.1097/PAS.0b013e3181e02f45; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yen MJ, 2006, CLIN CANCER RES, V12, P827, DOI 10.1158/1078-0432.CCR-05-1397	55	60	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114900	10.1371/journal.pone.0114900	http://dx.doi.org/10.1371/journal.pone.0114900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506917	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100030
J	MacIsaac, KD; Baumgartner, R; Kang, J; Loboda, A; Peterfy, C; DiCarlo, J; Riek, J; Beals, C				MacIsaac, Kenzie D.; Baumgartner, Richard; Kang, Jia; Loboda, Andrey; Peterfy, Charles; DiCarlo, Julie; Riek, Jonathan; Beals, Chan			Pre-Treatment Whole Blood Gene Expression Is Associated with 14-Week Response Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging in Infliximab-Treated Rheumatoid Arthritis Patients	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING FACTOR; DISEASE-ACTIVITY; FACTOR-ALPHA; TNF; MRI; INTERLEUKIN-1; PATHOGENESIS; PREDICTORS; ACTIVATION	Approximately 30% of rheumatoid arthritis patients achieve inadequate response to anti-TNF biologics. Attempts to identify molecular biomarkers predicting response have met with mixed success. This may be attributable, in part, to the variable and subjective disease assessment endpoints with large placebo effects typically used to classify patient response. Sixty-one patients with active RA despite methotrexate treatment, and with MRI-documented synovitis, were randomized to receive infliximab or placebo. Blood was collected at baseline and genome-wide transcription in whole blood was measured using microarrays. The primary endpoint in this study was determined by measuring the transfer rate constant (K-trans) of a gadolinium-based contrast agent from plasma to synovium using MRI. Secondary endpoints included repeated clinical assessments with DAS28(CRP), and assessments of osteitis and synovitis by the RAMRIS method. Infliximab showed greater decrease from baseline in DCE-MRI K-trans of wrist and MCP at all visits compared with placebo (P<0.001). Statistical analysis was performed to identify genes associated with treatment-specific 14-week change in K-trans. The 256 genes identified were used to derive a gene signature score by averaging their log expression within each patient. The resulting score correlated with improvement of K-trans in infliximab-treated patients and with deterioration of K-trans in placebo-treated subjects. Poor responders showed high expression of activated B-cell genes whereas good responders exhibited a gene expression pattern consistent with mobilization of neutrophils and monocytes and high levels of reticulated platelets. This gene signature was significantly associated with clinical response in two previously published whole blood gene expression studies using anti-TNF therapies. These data provide support for the hypothesis that anti-TNF inadequate responders comprise a distinct molecular subtype of RA characterized by differences in pre-treatment blood mRNA expression. They also highlight the importance of placebo controls and robust, objective endpoints in biomarker discovery.	[MacIsaac, Kenzie D.; Loboda, Andrey] Merck & Co Inc, Dept Genet & Pharmacogen, Boston, MA 02115 USA; [Baumgartner, Richard; Kang, Jia] Merck & Co Inc, Dept Biometr Res, Whitehouse Stn, NJ USA; [Peterfy, Charles; DiCarlo, Julie] Spire Sci Inc, Boca Raton, FL USA; [Riek, Jonathan] Virtual Scop, Rochester, NY USA; [Beals, Chan] Merck & Co Inc, Clin Res, Whitehouse Stn, NJ USA	Merck & Company; Merck & Company; Merck & Company	MacIsaac, KD (corresponding author), Merck & Co Inc, Dept Genet & Pharmacogen, Boston, MA 02115 USA.	kenzie_macisaac@merck.com			Merck Company	Merck Company(Merck & Company)	This study was funded from a commercial source: Merck & Company. The funder provided support in the form of salaries for authors KM, RB, JK, AL, and CB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American College of Rheumatology Rheumatoid Arthritis Clinical Trials Task Force Imaging Group and Outcome Measures in Rheumatology Magnetic Resonance Imaging Inflammatory Arthritis Working Group, 2013, Arthritis Rheum, V65, P2513, DOI 10.1002/art.38083; Axelsen MB, 2013, SCAND J RHEUMATOL, V42, P115, DOI 10.3109/03009742.2012.723745; Bienkowska JR, 2009, GENOMICS, V94, P423, DOI 10.1016/j.ygeno.2009.08.008; Boilard E, 2012, NAT REV RHEUMATOL, V8, P534, DOI 10.1038/nrrheum.2012.118; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Coulthard LR, 2012, CLIN EXP IMMUNOL, V170, P36, DOI 10.1111/j.1365-2249.2012.04626.x; DAN K, 1995, ACTA HAEMATOL-BASEL, V93, P67; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Greenwood MC, 2007, RHEUMATOLOGY, V46, P1165, DOI 10.1093/rheumatology/kem109; Hodgson R, 2008, ANN RHEUM DIS, V67, P270, DOI 10.1136/ard.2007.077271; Hodgson RJ, 2008, RHEUMATOLOGY, V47, P13, DOI 10.1093/rheumatology/kem250; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Julia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007556; KAUSHANSKY K, 1988, J IMMUNOL, V141, P3410; Kekow J, 2012, BIOL-TARGETS THER, V6, P191, DOI 10.2147/BTT.S32244; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; LEIZER T, 1990, BLOOD, V76, P1989, DOI 10.1182/blood.V76.10.1989.1989; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Liang K-Y, 2000, SANKHYA INDIAN J S B, P134, DOI [DOI 10.2307/25053123, DOI 10.2337/DB12-0868]; McQueen F, 2003, J RHEUMATOL, V30, P1387; Meany HJ, 2008, J IMMUNOTHER, V31, P679, DOI 10.1097/CJI.0b013e3181826d72; O'Dell JR, 2011, ARTHRITIS RHEUM-US, V63, P2151, DOI 10.1002/art.30402; Oduro KA, 2012, BLOOD, V120, P2203, DOI 10.1182/blood-2011-11-391342; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Orguc S, 2013, RHEUMATOL INT, V33, P1837, DOI 10.1007/s00296-012-2658-z; Ostergaard M, 1998, MAGN RESON IMAGING, V16, P743, DOI 10.1016/S0730-725X(98)00008-3; Parker A, 2007, J RHEUMATOL, V34, P1817; Peterfy C, 2013, ANN RHEUM DIS, V72, P794, DOI 10.1136/annrheumdis-2012-202696; Pignatelli P, 2005, BLOOD, V106, P1992, DOI 10.1182/blood-2005-03-1247; Piguet PF, 2002, CYTOKINE, V18, P222, DOI 10.1006/cyto.2002.0889; Prajapati R, 2011, PHARMACOGENOMICS, V12, P1571, DOI [10.2217/PGS.11.114, 10.2217/pgs.11.114]; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Strand V, 2004, RHEUMATOLOGY, V43, P640, DOI 10.1093/rheumatology/keh140; Stuhlmuller B, 2010, CLIN PHARMACOL THER, V87, P311, DOI 10.1038/clpt.2009.244; Tacchini-Cottier F, 1998, J IMMUNOL, V160, P6182; Tanino M, 2009, BIOCHEM BIOPH RES CO, V387, P261, DOI 10.1016/j.bbrc.2009.06.149; Toonen EJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033199; Trocme C, 2009, ANN RHEUM DIS, V68, P1328, DOI 10.1136/ard.2008.093153; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; Van Steendam K, 2011, RHEUMATOLOGY, V50, P830, DOI 10.1093/rheumatology/keq419; Villalvilla A, 2014, EXPERT OPIN THER TAR, V18, P1077, DOI 10.1517/14728222.2014.930440; Workie DW, 2005, MAGN RESON MED, V54, P560, DOI 10.1002/mrm.20597	44	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113937	10.1371/journal.pone.0113937	http://dx.doi.org/10.1371/journal.pone.0113937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504080	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400018
J	Radwan, ZH; Wang, XB; Waqar, F; Pirim, D; Niemsiri, V; Hokanson, JE; Hamman, RF; Bunker, CH; Barmada, MM; Demirci, FY; Kamboh, MI				Radwan, Zaheda H.; Wang, Xingbin; Waqar, Fahad; Pirim, Dilek; Niemsiri, Vipavee; Hokanson, John E.; Hamman, Richard F.; Bunker, Clareann H.; Barmada, M. Michael; Demirci, F. Yesim; Kamboh, M. Ilyas			Comprehensive Evaluation of the Association of APOE Genetic Variation with Plasma Lipoprotein Traits in US Whites and African Blacks	PLOS ONE			English	Article							HUMAN APOLIPOPROTEIN-E; SAN-LUIS-VALLEY; CHOLESTEROL TRANSPORT; E POLYMORPHISM; A-I; POPULATION; DISEASE; RISK; PROFILES; VARIANTS	Although common APOE genetic variation has a major influence on plasma LDL-cholesterol, its role in affecting HDL-cholesterol and triglycerides is not well established. Recent genome-wide association studies suggest that APOE also affects plasma variation in HDL-cholesterol and triglycerides. It is thus important to resequence the APOE gene to identify both common and uncommon variants that affect plasma lipid profile. Here, we have sequenced the APOE gene in 190 subjects with extreme HDL-cholesterol levels selected from two well-defined epidemiological samples of U.S. non-Hispanic Whites (NHWs) and African Blacks followed by genotyping of identified variants in the entire datasets (623 NHWs, 788 African Blacks) and association analyses with major lipid traits. We identified a total of 40 sequence variants, of which 10 are novel. A total of 32 variants, including common tagSNPs (>= 5% frequency) and all uncommon variants (<5% frequency) were successfully genotyped and considered for genotype-phenotype associations. Other than the established associations of APOE*2 and APOE*4 with LDL-cholesterol, we have identified additional independent associations with LDL-cholesterol. We have also identified multiple associations of uncommon and common APOE variants with HDL-cholesterol and triglycerides. Our comprehensive sequencing and genotype-phenotype analyses indicate that APOE genetic variation impacts HDL-cholesterol and triglycerides in addition to affecting LDL-cholesterol.	[Radwan, Zaheda H.; Wang, Xingbin; Waqar, Fahad; Pirim, Dilek; Niemsiri, Vipavee; Barmada, M. Michael; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Hokanson, John E.; Hamman, Richard F.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Bunker, Clareann H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	kamboh@pitt.edu	PIRIM, DILEK/ABA-4957-2020	PIRIM, DILEK/0000-0002-0522-9432; Demirci, F. Yesim/0000-0001-6907-9843; Kamboh, M. Ilyas/0000-0002-3453-1438; Barmada, M Michael/0000-0002-3604-6460	National Heart, Lung and Blood Institute (NHLBI) [HL084613]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084613] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung and Blood Institute (NHLBI) grant, HL084613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanji AO, 2007, METABOLISM, V56, P484, DOI 10.1016/j.metabol.2006.11.006; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; Bryant EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063469; BUNKER CH, 1995, HYPERTENSION, V26, P616, DOI 10.1161/01.HYP.26.4.616; Bunker CH, 1996, ATHEROSCLEROSIS, V123, P215, DOI 10.1016/0021-9150(96)05810-8; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; DAS HK, 1985, J BIOL CHEM, V260, P6240; De Blasi S, 2009, EXP GERONTOL, V44, P224, DOI 10.1016/j.exger.2008.11.005; Demirci FY, 2010, ANN NUTR METAB, V56, P59, DOI 10.1159/000268019; Dumanis SB, 2013, J NEUROCHEM, V124, P4, DOI 10.1111/j.1471-4159.2012.07908.x; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; Harris MR, 1998, ATHEROSCLEROSIS, V137, P187, DOI 10.1016/S0021-9150(97)00230-X; HAVEL RJ, 1983, J CLIN INVEST, V72, P379, DOI 10.1172/JCI110978; Johansen CT, 2012, CURR ATHEROSCLER REP, V14, P227, DOI 10.1007/s11883-012-0243-2; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kamboh MI, 1997, AM J EPIDEMIOL, V146, P1011, DOI 10.1093/oxfordjournals.aje.a009229; Ken-Dror G, 2010, MOL MED, V16, P389, DOI 10.2119/molmed.2010.00044; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lucatelli JF, 2011, NEUROCHEM RES, V36, P1533, DOI 10.1007/s11064-011-0481-7; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Medina-Urrutia AX, 2004, HUM BIOL, V76, P605, DOI 10.1353/hub.2004.0059; MIETTINEN TA, 1992, ARTERIOSCLER THROMB, V12, P1044, DOI 10.1161/01.ATV.12.9.1044; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; Nikodemova M, 2013, SLEEP, V36, P873, DOI 10.5665/sleep.2714; Ordovas JM, 2008, J PERIODONTOL, V79, P1508, DOI 10.1902/jop.2008.080232; Ozturk Z, 2010, METAB SYNDR RELAT D, V8, P531, DOI 10.1089/met.2010.0034; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; RALL SC, 1989, J CLIN INVEST, V83, P1095, DOI 10.1172/JCI113988; Rewers Marian, 1993, Ethnicity and Disease, V3, P44; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Savitz J, 2006, BRAIN RES REV, V51, P125, DOI 10.1016/j.brainresrev.2005.10.006; Silander K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003615; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VANDENMAAGDENBERG AMJM, 1993, AM J HUM GENET, V52, P937; Viitanen L, 2001, J MOL MED-JMM, V79, P732, DOI 10.1007/s001090100265; Westlye LT, 2012, NEUROLOGY, V79, P1961, DOI 10.1212/WNL.0b013e3182735c9c; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	51	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114618	10.1371/journal.pone.0114618	http://dx.doi.org/10.1371/journal.pone.0114618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502880	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000346375400041
J	Tarafdar, PK; Vedantam, LV; Sankhala, RS; Purushotham, P; Podile, AR; Swamy, MJ				Tarafdar, Pradip K.; Vedantam, Lakshmi Vasudev; Sankhala, Rajeshwer S.; Purushotham, Pallinti; Podile, Appa Rao; Swamy, Musti J.			Oligomerization, Conformational Stability and Thermal Unfolding of Harpin, HrpZ(Pss) and Its Hypersensitive Response-Inducing C-Terminal Fragment, C-214-HrpZ(Pss)	PLOS ONE			English	Article							KEY FUNCTIONAL REGION; HEAT-CAPACITY CHANGE; ERWINIA-AMYLOVORA; PROTEIN; XANTHOMONAS; ELICITOR; IDENTIFICATION; AGGREGATION; EXPRESSION; MEMBRANES	HrpZ-a harpin from Pseudomonas syringae-is a highly thermostable protein that exhibits multifunctional abilities e.g., it elicits hypersensitive response (HR), enhances plant growth, acts as a virulence factor, and forms pores in plant plasma membranes as well as artificial membranes. However, the molecular mechanism of its biological activity and high thermal stability remained poorly understood. HR inducing abilities of non-overlapping short deletion mutants of harpins put further constraints on the ability to establish structure-activity relationships. We characterized HrpZ(Pss) from Pseudomonas syringae pv. syringae and its HR inducing C-terminal fragment with 214 amino acids (C-214-HrpZ(Pss)) using calorimetric, spectroscopic and microscopic approaches. Both C-214-HrpZ(Pss) and HrpZPss were found to form oligomers. We propose that leucine-zipper-like motifs may take part in the formation of oligomeric aggregates, and oligomerization could be related to HR elicitation. CD, DSC and fluorescence studies showed that the thermal unfolding of these proteins is complex and involves multiple steps. The comparable conformational stability at 25 degrees C (similar to 10.0 kcal/mol) of HrpZ(Pss) and C-214-HrpZ(Pss) further suggest that their structures are flexible, and the flexibility allows them to adopt proper conformation for multifunctional abilities.	[Tarafdar, Pradip K.; Sankhala, Rajeshwer S.; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India; [Vedantam, Lakshmi Vasudev; Purushotham, Pallinti; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; University of Hyderabad	Swamy, MJ (corresponding author), Univ Hyderabad, Sch Chem, Hyderabad 500134, Andhra Pradesh, India.	mjswamy1@gmail.com	Swamy, Musti/B-9418-2009; Podile, Appa Rao/W-5077-2018	Swamy, Musti/0000-0002-3108-3633; Pallinti, Purushotham Naidu/0000-0002-5565-1762; Podile, Appa Rao/0000-0003-3208-765X	Department of Science & Technology (India); Council of Scientific and Industrial Research (India); Indian Council of Medical Research (ICMR); University Grants Commission (India); CAS; DST (India)	Department of Science & Technology (India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); University Grants Commission (India)(University Grants Commission, India); CAS(Chinese Academy of Sciences); DST (India)(Department of Science & Technology (India))	This work was supported by a research project from Department of Science & Technology (India) to MJS. PKT and RSS thank Council of Scientific and Industrial Research (India) for Senior Research Fellowships. LVV was supported by a Senior Research Fellowship from Indian Council of Medical Research (ICMR). The authors thank the University Grants Commission (India) for their support through the UPE (to University of Hyderabad), and CAS (to School of Chemistry and School of Life Sciences) programs, and DST (India) for the support through the FIST II program to the School of Chemistry and the Department of Plant Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 1996, MOL MICROBIOL, V19, P715, DOI 10.1046/j.1365-2958.1996.415946.x; Anil K, 2014, J PLANT PATHOL, V96, P57; [Anonymous], 2008, BMC BIOINFORMATICS; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Chen CH, 1998, PHYSIOL MOL PLANT P, V52, P139, DOI 10.1006/pmpp.1997.0120; Choi MS, 2013, MOL PLANT MICROBE IN, V26, P1115, DOI 10.1094/MPMI-02-13-0050-CR; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Forouhar F, 2003, J BIOL CHEM, V278, P21980, DOI 10.1074/jbc.M208650200; GRIKO YV, 1992, BIOCHEMISTRY-US, V31, P8810, DOI 10.1021/bi00152a017; Haapalainen M, 2011, MOL PLANT PATHOL, V12, P151, DOI 10.1111/j.1364-3703.2010.00655.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2004, J BACTERIOL, V186, P6239, DOI 10.1128/JB.186.18.6239-6247.2004; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Koklic T, 2009, BIOPHYS J, V97, P2232, DOI 10.1016/j.bpj.2009.07.043; Kumar S, 2001, BIOCHEMISTRY-US, V40, P14152, DOI 10.1021/bi0106383; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P530; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lidon-Moya MC, 2005, PROTEIN SCI, V14, P2387, DOI 10.1110/ps.041324305; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Melo AM, 2013, J PHYS CHEM B, V117, P2906, DOI 10.1021/jp310396v; Mukherjee A, 1997, MOL PLANT MICROBE IN, V10, P462, DOI 10.1094/MPMI.1997.10.4.462; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; Pace CN, 1999, PROTEIN SCI, V8, P1500, DOI 10.1110/ps.8.7.1500; Pike SM, 1998, PHYSIOL MOL PLANT P, V53, P39, DOI 10.1006/pmpp.1998.0167; Riechmann L, 2005, J MOL BIOL, V348, P1261, DOI 10.1016/j.jmb.2005.03.029; Sankhala RS, 2010, BIOCHEMISTRY-US, V49, P3908, DOI 10.1021/bi100051d; Shrestha R, 2008, MOL CELLS, V25, P30; Tarafdar PK, 2013, BIOCHIMIE, V95, P2437, DOI 10.1016/j.biochi.2013.09.006; Tarafdar PK, 2009, BBA-PROTEINS PROTEOM, V1794, P1684, DOI 10.1016/j.bbapap.2009.07.023; Wang XY, 2007, MOL BIOL REP, V34, P189, DOI 10.1007/s11033-006-9034-6; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e109871	10.1371/journal.pone.0109871	http://dx.doi.org/10.1371/journal.pone.0109871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502017	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400002
J	Bruno, G; Barutta, F; Landi, A; Perin, PC; Gruden, G				Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella			NT-proBNP Linking Low-Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PROBRAIN NATRIURETIC PEPTIDE; C-REACTIVE PROTEIN; KIDNEY-DISEASE; TYPE-2; ASSOCIATION; PREDICTION; COMPLICATIONS; ALBUMINURIA; HEART	Background: Few data are available to assess whether a low-moderate reduction in estimated glomerular filtration rates (eGFR) has a role per se on cardiovascular (CV) mortality or other biomarkers such as NT-proBNP allow to explain such association. Methods and Findings: In a prospective study including 1,645 type 2 diabetic subjects of the population-based Casale Monferrato Study, who had no clinical evidence of heart failure and eGFR >45 ml/min/1.73 m(2), we examined 6 years CV mortality. Multivariate Cox proportional hazards modeling were used to estimate the effect of NT-proBNP on the association between eGFR and mortality, independently of baseline CV risk factors, albumin excretion rate (AER) and C-reactive protein (CRP). During follow-up, 327 people died (149 of CV diseases) out of 8334.5 person-years. Compared to eGFR >= 90 ml/min/1.73 m(2), values of 60-89 and 45-59 ml/min/1.73 m(2) conferred a fully adjusted hazard ratios (HRs) of CV mortality of 1.74 (1.08-2.82) and 1.95 (1.03-3.68), respectively. After further adjustment for NT-proBNP, however, HRs were no longer significant (HRs 1.42, 0.83-2.42 and 1.22, 0.59-2.51). In this model, HR for logNT-proBNP was 1.84 (1.52-2.22). Adding NT-proBNP to the model improved the C-statistic of CV mortality from 0.79 (0.76-0.83) to 0.84 (0.81-0.87), yielded an IDI of 0.03 (p = 0.02), and a NRI of 0.44 (p = 0.016). Conclusions: In diabetic people a modest reduction in renal function increased 6-year CV mortality independently of albuminuria. This association, however, was mainly explained by the effect of NT-proBNP, that remained the strongest prognostic marker for a worse CV outcome, even after adjustment for other CV risk factors and pre-existing CVD.	[Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella] Univ Turin, Dept Med Sci, Turin, Italy	University of Turin	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it		BRUNO, Graziella/0000-0002-3011-8304				Amin AP, 2013, AM J KIDNEY DIS, V61, pS12, DOI 10.1053/j.ajkd.2013.01.005; Bruno G, 2007, DIABETOLOGIA, V50, P941, DOI 10.1007/s00125-007-0616-1; Bruno G, 2008, NUTR METAB CARDIOVAS, V18, P39, DOI 10.1016/j.numecd.2006.08.007; Bruno G, 2013, DIABETES CARE, V36, P2677, DOI 10.2337/dc13-0353; Bruno G, 2009, DIABETES, V58, P926, DOI 10.2337/db08-0900; Das SR, 2008, AM J CARDIOL, V102, P1394, DOI 10.1016/j.amjcard.2008.07.018; DeFilippi C, 2008, AM J CARDIOL, V101, p82A, DOI 10.1016/j.amjcard.2007.11.029; Delles C, 2011, DIABETOLOGIA, V54, P4, DOI 10.1007/s00125-010-1942-2; Desai AS, 2011, AM J KIDNEY DIS, V58, P717, DOI 10.1053/j.ajkd.2011.05.020; Echouffo-Tcheugui JB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001344; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gruden G, 2014, DIABETES CARE, V37, P2899, DOI 10.2337/dc14-0669; Gruden G, 2012, DIABETES CARE, V35, P1931, DOI 10.2337/dc12-0089; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Pagano E, 2013, DIABETOLOGIA, V56, P1726, DOI 10.1007/s00125-013-2933-x; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Reutens AT, 2013, MED CLIN N AM, V97, P1, DOI 10.1016/j.mcna.2012.10.001; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163	19	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114855	10.1371/journal.pone.0114855	http://dx.doi.org/10.1371/journal.pone.0114855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503636	Green Published, gold			2022-12-27	WOS:000347146700060
J	Cumming, O; Elliott, M; Overbo, A; Bartram, J				Cumming, Oliver; Elliott, Mark; Overbo, Alycia; Bartram, Jamie			Does Global Progress on Sanitation Really Lag behind Water? An Analysis of Global Progress on Community- and Household-Level Access to Safe Water and Sanitation	PLOS ONE			English	Article							REPORTED DIARRHEAL DISEASE; DRINKING-WATER; DISTANCE; HEALTH; METAANALYSIS; ASSOCIATION; POOR; HOME	Safe drinking water and sanitation are important determinants of human health and wellbeing and have recently been declared human rights by the international community. Increased access to both were included in the Millennium Development Goals under a single dedicated target for 2015. This target was reached in 2010 for water but sanitation will fall short; however, there is an important difference in the benchmarks used for assessing global access. For drinking water the benchmark is community-level access whilst for sanitation it is household-level access, so a pit latrine shared between households does not count toward the Millennium Development Goal (MDG) target. We estimated global progress for water and sanitation under two scenarios: with equivalent household-and community-level benchmarks. Our results demonstrate that the "sanitation deficit" is apparent only when household-level sanitation access is contrasted with community-level water access. When equivalent benchmarks are used for water and sanitation, the global deficit is as great for water as it is for sanitation, and sanitation progress in the MDG-period (1990-2015) outstrips that in water. As both drinking water and sanitation access yield greater benefits at the household-level than at the community-level, we conclude that any post-2015 goals should consider a household-level benchmark for both.	[Cumming, Oliver] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect Trop Dis, London WC1, England; [Elliott, Mark] Univ Alabama, Dept Civil Construct & Environm Engn, Tuscaloosa, AL USA; [Elliott, Mark; Overbo, Alycia; Bartram, Jamie] Univ N Carolina, Water Inst, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of London; London School of Hygiene & Tropical Medicine; University of Alabama System; University of Alabama Tuscaloosa; University of North Carolina; University of North Carolina Chapel Hill	Cumming, O (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect Trop Dis, London WC1, England.	oliver.cumming@lshtm.ac.uk; jbartram@email.unc.edu	Elliott, Mark/N-1574-2019	Elliott, Mark/0000-0002-7835-0612; Cumming, Oliver/0000-0002-5074-8709; Bartram, Jamie/0000-0002-6542-6315; Overbo, Alycia/0000-0002-1274-1258	UK Aid from the Department of International Development (DFID), Sanitation and Hygiene Applied Research for Equity (SHARE) Research Consortium	UK Aid from the Department of International Development (DFID), Sanitation and Hygiene Applied Research for Equity (SHARE) Research Consortium	This research was partially funded by UK Aid from the Department of International Development (DFID) as part of the Sanitation and Hygiene Applied Research for Equity (SHARE) Research Consortium (www.SHAREresearch.org). However, the views expressed do not necessarily reflect the Department's official policies. There are no additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram J, INT J ENV R IN PRESS; Bartram J, 2014, INT J ENV RES PUB HE, V11, P8137, DOI 10.3390/ijerph110808137; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Biran A, 2011, TROP MED INT HEALTH, V16, P854, DOI 10.1111/j.1365-3156.2011.02764.x; Cairncross S., 1993, ENV HLTH ENG TROPICS, V2nd; Campbell O, GETTING BASICS RIGHT; Chant S, 2013, ENVIRON URBAN, V25, P9, DOI 10.1177/0956247813477809; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; DESA U, 2011, ESPWP220 UN DEP EC S; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Heijnen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093300; Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009; ICFInternational, 2004, DEM HLTH SURV; Jasper C, 2012, INT J ENV RES PUB HE, V9, P2772, DOI 10.3390/ijerph9082772; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luh J, 2013, INT J HYG ENVIR HEAL, V216, P662, DOI 10.1016/j.ijheh.2012.12.007; Onda K, 2014, INT J HYG ENVIR HEAL, V217, P379, DOI 10.1016/j.ijheh.2013.07.017; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Rheingans R, 2014, TROP MED INT HEALTH, V19, P2, DOI 10.1111/tmi.12220; Subaiya S, 2011, AM J TROP MED HYG, V84, P504, DOI 10.4269/ajtmh.2011.10-0591a; UN, 2013, REP HIGH LEV PAN EM; UNGA, 2010, RIGHT WAT; Unicef, 2012, MULT IND CLUST SURV; UNNC, 2013, DEP UN CHIEF CALLS U; Wang X, 2010, AM J TROP MED HYG, V83, P582, DOI 10.4269/ajtmh.2010.10-0215; White G., 1972, DRAWERS WATER; WHO/UNICEF, 2012, PROGR SAN DRINK WAT; WHO/UNICEF, 2013, PROGR SAN DRINK WAT; Wolf J, 2013, J WATER HEALTH, V11, P64, DOI 10.2166/wh.2012.107; Yang H, 2013, ENVIRON SCI TECHNOL, V47, P1222, DOI 10.1021/es303345p	32	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114699	10.1371/journal.pone.0114699	http://dx.doi.org/10.1371/journal.pone.0114699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502659	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700046
J	Garcia, NS; Hutchins, DA				Garcia, Nathan S.; Hutchins, David A.			Light-Limited Growth Rate Modulates Nitrate Inhibition of Dinitrogen Fixation in the Marine Unicellular Cyanobacterium Crocosphaera watsonii	PLOS ONE			English	Article							NITROGEN-FIXATION; N-2 FIXATION; TRICHODESMIUM ERYTHRAEUM; CULTURES; SENSITIVITY; PHOSPHORUS; AMMONIUM; RATIOS; CO2; REQUIREMENTS	Biological N-2 fixation is the dominant supply of new nitrogen (N) to the oceans, but is often inhibited in the presence of fixed N sources such as nitrate (NO3-). Anthropogenic fixed N inputs to the ocean are increasing, but their effect on marine N-2 fixation is uncertain. Thus, global estimates of new oceanic N depend on a fundamental understanding of factors that modulate N source preferences by N-2-fixing cyanobacteria. We examined the unicellular diazotroph Crocosphaera watsonii (strain WH0003) to determine how the light-limited growth rate influences the inhibitory effects of fixed N on N-2 fixation. When growth (mu) was limited by low light (mu=0.23 d(-1)), short-term experiments indicated that 0.4 mu M NH4+ reduced N-2-fixation by similar to 90% relative to controls without added NH4+. In fast-growing, high-light-acclimated cultures (mu=0.68 d(-1)), 2.0 mu M NH4+ was needed to achieve the same effect. In long-term exposures to NO3-, inhibition of N-2 fixation also varied with growth rate. In high-light-acclimated, fast-growing cultures, NO3- did not inhibit N-2-fixation rates in comparison with cultures growing on N-2 alone. Instead NO3- supported even faster growth, indicating that the cellular assimilation rate of N-2 alone (i.e. dinitrogen reduction) could not support the light-specific maximum growth rate of Crocosphaera. When growth was severely light-limited, NO3- did not support faster growth rates but instead inhibited N-2-fixation rates by 55% relative to controls. These data rest on the basic tenet that light energy is the driver of photoautotrophic growth while various nutrient substrates serve as supports. Our findings provide a novel conceptual framework to examine interactions between N source preferences and predict degrees of inhibition of N-2 fixation by fixed N sources based on the growth rate as controlled by light.	[Garcia, Nathan S.; Hutchins, David A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Garcia, NS (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	n8garcia@gmail.com	Hutchins, David A/D-3301-2013	Hutchins, David A/0000-0002-6637-756X	National Science Foundation (NSF) Division of Ocean Sciences (OCE) [0962309, 1260490]; Directorate For Geosciences [1260490] Funding Source: National Science Foundation	National Science Foundation (NSF) Division of Ocean Sciences (OCE)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Grant support was provided by the National Science Foundation (NSF) Division of Ocean Sciences (OCE) 0962309 and 1260490 to D. Hutchins (DAH) and F. Fu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Brauer VS, 2013, ISME J, V7, P2105, DOI 10.1038/ismej.2013.103; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CAPONE DG, 1994, APPL ENVIRON MICROB, V60, P3989, DOI 10.1128/AEM.60.11.3989-3995.1994; Capone DG, 2007, NATURE, V445, P159, DOI 10.1038/445159a; Capone DG, 2013, NAT GEOSCI, V6, P711, DOI 10.1038/NGEO1916; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; Dekaezemacker J, 2011, MAR ECOL PROG SER, V438, P33, DOI 10.3354/meps09297; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Falkowski P. G., 1983, NITROGEN MARINE ENV, P839; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; FLYNN KJ, 1990, ARCH MICROBIOL, V153, P574, DOI 10.1007/BF00245267; Fu FX, 2014, AQUAT MICROB ECOL, V72, P33, DOI 10.3354/ame01683; Fu FX, 2008, LIMNOL OCEANOGR, V53, P2472, DOI 10.4319/lo.2008.53.6.2472; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia NS, 2013, LIMNOL OCEANOGR, V58, P1501, DOI 10.4319/lo.2013.58.4.1501; Garcia NS, 2013, EUR J PHYCOL, V48, P128, DOI 10.1080/09670262.2013.773383; Garcia NS, 2011, J PHYCOL, V47, P1292, DOI 10.1111/j.1529-8817.2011.01078.x; GARCIA NS, 2014, ISME, DOI DOI 10.1038/ISMEJ.2014.104; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Hutchins DA, 2013, NAT GEOSCI, V6, P790, DOI [10.1038/NGEO1858, 10.1038/ngeo1858]; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; Knapp AN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00374; Knapp AN, 2012, AQUAT MICROB ECOL, V66, P223, DOI 10.3354/ame01577; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Masuda T, 2013, LIMNOL OCEANOGR, V58, P2029, DOI 10.4319/lo.2013.58.6.2029; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Mulholland MR, 2004, AQUAT MICROB ECOL, V37, P85, DOI 10.3354/ame037085; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; OHKI K, 1991, ARCH MICROBIOL, V156, P335, DOI 10.1007/BF00248706; RAVEN JA, 1992, NEW PHYTOL, V121, P19, DOI 10.1111/j.1469-8137.1992.tb01088.x; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Sohm JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048315; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Ward BA, 2013, LIMNOL OCEANOGR, V58, P2059, DOI 10.4319/lo.2013.58.6.2059; Westberry TK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002673; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	45	7	7	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114465	10.1371/journal.pone.0114465	http://dx.doi.org/10.1371/journal.pone.0114465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503244	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700027
J	Morgan, MM; Reid, RA; Saville, KA				Morgan, Michael M.; Reid, Rachel A.; Saville, Kimber A.			Functionally Selective Signaling for Morphine and Fentanyl Antinociception and Tolerance Mediated by the Rat Periaqueductal Gray	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; N-TERMINAL KINASE; DESENSITIZATION; AGONIST; PROTEIN; PHOSPHORYLATION; MICROINJECTION; ACTIVATION; DEPENDENCE; EFFICACY	Functionally selective signaling appears to contribute to the variability in mechanisms that underlie tolerance to the antinociceptive effects of opioids. The present study tested this hypothesis by examining the contribution of G protein-coupled receptor kinase (GRK)/Protein kinase C (PKC) and C-Jun N-terminal kinase (JNK) activation on both the expression and development of tolerance to morphine and fentanyl microinjected into the ventrolateral periaqueductal gray of the rat. Microinjection of morphine or fentanyl into the periaqueductal gray produced a dose-dependent increase in hot plate latency. Microinjection of the nonspecific GRK/PKC inhibitor Ro 32-0432 into the periaqueductal gray to block muopioid receptor phosphorylation enhanced the antinociceptive effect of morphine but had no effect on fentanyl antinociception. Microinjection of the JNK inhibitor SP600125 had no effect on morphine or fentanyl antinociception, but blocked the expression of tolerance to repeated morphine microinjections. In contrast, a microinjection of Ro 32-0432 blocked the expression of fentanyl, but not morphine tolerance. Repeated microinjections of Ro 32-0432 blocked the development of morphine tolerance and inhibited fentanyl antinociception whether rats were tolerant or not. Repeated microinjections of SP600125 into the periaqueductal gray blocked the development of tolerance to both morphine and fentanyl microinjections. These data demonstrate that the signaling molecules that contribute to tolerance vary depending on the opioid and methodology used to assess tolerance (expression vs. development of tolerance). This signaling difference is especially clear for the expression of tolerance in which JNK contributes to morphine tolerance and GRK/PKC contributes to fentanyl tolerance.	[Morgan, Michael M.; Reid, Rachel A.; Saville, Kimber A.] Washington State Univ, Dept Psychol, Vancouver, WA 98686 USA	Washington State University	Morgan, MM (corresponding author), Washington State Univ, Dept Psychol, Vancouver, WA 98686 USA.	mmmorgan@vancouver.wsu.edu			National Institute on Drug Abuse [DA015498]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015498] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by the National Institute on Drug Abuse (http://www.drugabuse.gov/) grant # DA015498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2000, EUR J PHARMACOL, V403, P1, DOI 10.1016/S0014-2999(00)00419-2; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bobeck EN, 2012, J PAIN, V13, P799, DOI 10.1016/j.jpain.2012.05.005; Bobeck EN, 2009, PAIN, V147, P210, DOI 10.1016/j.pain.2009.09.008; BODNAR RJ, 1990, BRAIN RES, V529, P324, DOI 10.1016/0006-8993(90)90845-3; Buntin-Mushock C, 2005, ANESTH ANALG, V100, P1740, DOI 10.1213/01.ANE.0000152191.29311.9B; Chia YT, 1999, CAN J ANAESTH, V46, P872, DOI 10.1007/BF03012978; do K Kim, 2011, J NEUROCHEM, V116, P1077; Doll C, 2012, BRIT J PHARMACOL, V167, P1259, DOI 10.1111/j.1476-5381.2012.02080.x; Eidson LN, 2013, J NEUROSCI, V33, P15952, DOI 10.1523/JNEUROSCI.1609-13.2013; Eidson LN, 2013, J PAIN, V14, P393, DOI 10.1016/j.jpain.2012.12.010; Fan XL, 2003, NEUROSCIENCE, V122, P997, DOI 10.1016/j.neuroscience.2003.08.062; Fossum EN, 2008, BRAIN RES, V1204, P53, DOI 10.1016/j.brainres.2008.02.022; Gunn A, 2011, J PAIN, V12, P222, DOI 10.1016/j.jpain.2010.06.011; Hull LC, 2010, J PHARMACOL EXP THER, V332, P1127, DOI 10.1124/jpet.109.161455; JACQUET YF, 1974, SCIENCE, V185, P1055, DOI 10.1126/science.185.4156.1055; Johnson EA, 2006, MOL PHARMACOL, V70, P676, DOI 10.1124/mol.106.022376; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kim JA, 2008, CURR BIOL, V18, P129, DOI 10.1016/j.cub.2007.12.057; Lamberts JT, 2013, J NEUROSCI, V33, P4369, DOI 10.1523/JNEUROSCI.5470-12.2013; Lane DA, 2005, BRAIN RES, V1047, P65, DOI 10.1016/j.brainres.2005.04.001; Ma WY, 2001, EUR J NEUROSCI, V14, P1091, DOI 10.1046/j.0953-816x.2001.01731.x; McPherson J, 2010, MOL PHARMACOL, V78, P756, DOI 10.1124/mol.110.066613; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Morgan MM, 2006, PHARMACOL BIOCHEM BE, V85, P214, DOI 10.1016/j.pbb.2006.08.003; Morgan MM, 2009, BRAIN RES, V1295, P59, DOI 10.1016/j.brainres.2009.07.100; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Rivero G, 2012, MOL PHARMACOL, V82, P178, DOI 10.1124/mol.112.078659; Smith FL, 2002, BRAIN RES, V958, P28, DOI 10.1016/S0006-8993(02)03394-2; Smith FL, 2006, PHARMACOL RES, V54, P474, DOI 10.1016/j.phrs.2006.09.007; Tallarida RJ., 2000, DRUG SYNERGISM DOSE; Tortorici V, 1999, BEHAV NEUROSCI, V113, P833, DOI 10.1037/0735-7044.113.4.833; TRUJILLO KA, 1995, NEUROPSYCHOPHARMACOL, V13, P301, DOI 10.1038/sj.npp.1380296; Wagley Y, 2013, BBA-MOL CELL RES, V1833, P1476, DOI 10.1016/j.bbamcr.2013.02.017; Zhang L, 1996, J BIOL CHEM, V271, P11449, DOI 10.1074/jbc.271.19.11449	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114269	10.1371/journal.pone.0114269	http://dx.doi.org/10.1371/journal.pone.0114269			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503060	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700019
J	Patton, DF; Katsuyama, AM; Pavlovski, I; Michalik, M; Patterson, Z; Parfyonov, M; Smit, AN; Marchant, EG; Chung, J; Abizaid, A; Storch, KF; de la Iglesia, H; Mistlberger, RE				Patton, Danica F.; Katsuyama, Angela M.; Pavlovski, Ilya; Michalik, Mateusz; Patterson, Zachary; Parfyonov, Maksim; Smit, Andrea N.; Marchant, Elliott G.; Chung, John; Abizaid, Alfonso; Storch, Kai-Florian; de la Iglesia, Horacio; Mistlberger, Ralph E.			Circadian Mechanisms of Food Anticipatory Rhythms in Rats Fed Once or Twice Daily: Clock Gene and Endocrine Correlates	PLOS ONE			English	Article							DORSOMEDIAL HYPOTHALAMIC NUCLEUS; SUPRACHIASMATIC NUCLEUS; BRAIN-AREAS; PHASE-SHIFT; 2 MEALS; EXPRESSION; OSCILLATORS; ENTRAINMENT; TEMPERATURE; GHRELIN	Circadian clocks in many brain regions and peripheral tissues are entrained by the daily rhythm of food intake. Clocks in one or more of these locations generate a daily rhythm of locomotor activity that anticipates a regular mealtime. Rats and mice can also anticipate two daily meals. Whether this involves 1 or 2 circadian clocks is unknown. To gain insight into how the circadian system adjusts to 2 daily mealtimes, male rats in a 12:12 light-dark cycle were fed a 2 h meal either 4 h after lights-on or 4 h after lights-off, or a 1 h meal at both times. After 30 days, brain, blood, adrenal and stomach tissue were collected at 6 time points. Multiple clock genes from adrenals and stomachs were assayed by RT-PCR. Blood was assayed for corticosterone and ghrelin. Bmal1 expression was quantified in 14 brain regions by in situ hybridization. Clock gene rhythms in adrenal and stomach from day-fed rats oscillated in antiphase with the rhythms in night-fed rats, and at an intermediate phase in rats fed twice daily. Corticosterone and ghrelin in 1-meal rats peaked at or prior to the expected mealtime. In 2-meal rats, corticosterone peaked only prior the nighttime meal, while ghrelin peaked prior to the daytime meal and then remained elevated. The olfactory bulb, nucleus accumbens, dorsal striatum, cerebellum and arcuate nucleus exhibited significant daily rhythms of Bmal1 in the night-fed groups that were approximately in antiphase in the day-fed groups, and at intermediate levels (arrhythmic) in rats anticipating 2 daily meals. The dissociations between anticipatory activity and the peripheral clocks and hormones in rats anticipating 2 daily meals argue against a role for these signals in the timing of behavioral rhythms. The absence of rhythmicity at the tissue level in brain regions from rats anticipating 2 daily meals support behavioral evidence that circadian clock cells in these tissues may reorganize into two populations coupled to different meals.	[Patton, Danica F.; Pavlovski, Ilya; Michalik, Mateusz; Parfyonov, Maksim; Smit, Andrea N.; Marchant, Elliott G.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Katsuyama, Angela M.; Chung, John; de la Iglesia, Horacio] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Patterson, Zachary; Abizaid, Alfonso] Carleton Univ, Dept Neurosci, Ottawa, ON K1S 5B6, Canada; [Storch, Kai-Florian] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Simon Fraser University; University of Washington; University of Washington Seattle; Carleton University; McGill University	Mistlberger, RE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	mistlber@sfu.ca	Parfyonov, Maksim/AAP-7478-2020	Parfyonov, Maksim/0000-0003-0582-0852	NSERC Postgraduate Scholarship; NSERC Undergraduate Summer Research Awards; NSERC Canada [RGPIN341538, RGPIN155172]; NSF [IOS1145796]	NSERC Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Undergraduate Summer Research Awards; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF))	DFP was supported by an NSERC Postgraduate Scholarship (http://www.nserc.gc.ca). MM and MP were supported by NSERC Undergraduate Summer Research Awards (http://www.nserc.gc.ca). AA was supported by NSERC Canada operating grant RGPIN341538 (http://www.nserc.gc.ca). HI was supported by NSF IOS1145796 (www.nsf.gov). REM was supported by NSERC Canada operating grant RGPIN155172 (http://www.nserc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Antle MC, 2000, J NEUROSCI, V20, P9326; Barclay JL, 2012, PROG BRAIN RES, V199, P163, DOI 10.1016/B978-0-444-59427-3.00030-7; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; BOLLES RC, 1973, J COMP PHYSIOL PSYCH, V83, P510, DOI 10.1037/h0034666; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Dailey MJ, 2012, ENDOCRINOLOGY, V153, P132, DOI 10.1210/en.2011-1464; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dattolo T, 2014, SOC RES BIOL RHYTHMS, V14, P219; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; de la Iglesia Horacio O, 2007, Methods Mol Biol, V362, P513; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Gallardo CM, 2014, ELIFE, V3, DOI 10.7554/eLife.03781; Gallardo CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095990; Girotti M, 2009, AM J PHYSIOL-ENDOC M, V296, pE888, DOI 10.1152/ajpendo.90946.2008; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Gunapala KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018377; Hirao A, 2010, AM J PHYSIOL-GASTR L, V299, pG1045, DOI 10.1152/ajpgi.00330.2010; HONMA KI, 1984, AM J PHYSIOL, V246, pR721, DOI 10.1152/ajpregu.1984.246.5.R721; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; KRIEGER DT, 1974, ENDOCRINOLOGY, V95, P1195, DOI 10.1210/endo-95-5-1195; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Landry GJ, 2006, AM J PHYSIOL-REG I, V290, pR1527, DOI 10.1152/ajpregu.00874.2005; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Mendoza J, 2008, J NEUROENDOCRINOL, V20, P251, DOI 10.1111/j.1365-2826.2007.01636.x; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Minana-Solis MC, 2009, CHRONOBIOL INT, V26, P808, DOI 10.1080/07420520903044240; Mistlberger RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031772; Mistlberger RE, 2011, ESSAYS BIOCHEM, V49, P119, DOI [10.1042/BSE0490119, 10.1042/bse0490119]; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mordel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058457; Moriya T, 2009, EUR J NEUROSCI, V29, P1447, DOI 10.1111/j.1460-9568.2009.06697.x; Natsubori A, 2013, EUR J NEUROSCI, V37, P251, DOI 10.1111/ejn.12034; Nolasco N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047779; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Patton DF, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00185; Pendergast JS, 2012, P NATL ACAD SCI USA, V109, P14218, DOI 10.1073/pnas.1206213109; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Reddy AB, 2014, ANNU REV BIOCHEM, V83, P165, DOI 10.1146/annurev-biochem-060713-035623; STEPHAN FK, 1989, J BIOL RHYTHM, V4, P467, DOI 10.1177/074873048900400406; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1983, BEHAV BRAIN RES, V7, P81, DOI 10.1016/0166-4328(83)90006-2; STEPHAN FK, 1989, PHYSIOL BEHAV, V46, P489, DOI 10.1016/0031-9384(89)90026-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Szentirmai E, 2010, AM J PHYSIOL-REG I, V298, pR467, DOI 10.1152/ajpregu.00557.2009; Takasu NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048892; Verwey M, 2011, NEUROSCIENCE, V192, P304, DOI 10.1016/j.neuroscience.2011.07.016; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Webb IC, 2014, BEHAV NEUROSCI, V128, P304, DOI 10.1037/a0035885; Zizzari P, 2011, J NEUROENDOCRINOL, V23, P804, DOI 10.1111/j.1365-2826.2011.02183.x	79	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e112451	10.1371/journal.pone.0112451	http://dx.doi.org/10.1371/journal.pone.0112451			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502949	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700005
J	Velada, I; Ragonezi, C; Arnholdt-Schmitt, B; Cardoso, H				Velada, Isabel; Ragonezi, Carla; Arnholdt-Schmitt, Birgit; Cardoso, Helia			Reference Genes Selection and Normalization of Oxidative Stress Responsive Genes upon Different Temperature Stress Conditions in Hypericum perforatum L.	PLOS ONE			English	Article							REAL-TIME PCR; ALTERNATIVE OXIDASE GENE; ST-JOHNS-WORT; RT-PCR; EXPRESSION ANALYSIS; HOUSEKEEPING GENES; HEAT-STRESS; ARABIDOPSIS-THALIANA; ANTIOXIDANT ENZYMES; SALICYLIC-ACID	Reverse transcription-quantitative real-time PCR (RT-qPCR) is a widely used technique for gene expression analysis. The reliability of this method depends largely on the suitable selection of stable reference genes for accurate data normalization. Hypericum perforatum L. (St. John's wort) is a field growing plant that is frequently exposed to a variety of adverse environmental stresses that can negatively affect its productivity. This widely known medicinal plant with broad pharmacological properties (anti-depressant, anti-tumor, anti-inflammatory, antiviral, antioxidant, anti-cancer, and antibacterial) has been overlooked with respect to the identification of reference genes suitable for RT-qPCR data normalization. In this study, 11 candidate reference genes were analyzed in H. perforatum plants subjected to cold and heat stresses. The expression stability of these genes was assessed using GeNorm, NormFinder and BestKeeper algorithms. The results revealed that the ranking of stability among the three algorithms showed only minor differences within each treatment. The best-ranked reference genes differed between cold- and heat-treated samples; nevertheless, TUB was the most stable gene in both experimental conditions. GSA and GAPDH were found to be reliable reference genes in cold-treated samples, while GAPDH showed low expression stability in heat-treated samples. 26SrRNA and H2A had the highest stabilities in the heat assay, whereas H2A was less stable in the cold assay. Finally, AOX1, AOX2, CAT1 and CHS genes, associated with plant stress responses and oxidative stress, were used as target genes to validate the reliability of identified reference genes. These target genes showed differential expression profiles over time in treated samples. This study not only is the first systematic analysis for the selection of suitable reference genes for RT-qPCR studies in H. perforatum subjected to temperature stress conditions, but may also provide valuable information about the roles of genes associated with temperature stress responses.	[Velada, Isabel; Ragonezi, Carla; Arnholdt-Schmitt, Birgit; Cardoso, Helia] Univ Evora, IIFA, ICAAM, EU Marie Curie Chair, P-7006554 Evora, Portugal	University of Evora	Cardoso, H (corresponding author), Univ Evora, IIFA, ICAAM, EU Marie Curie Chair, Ap 94, P-7006554 Evora, Portugal.	hcardoso@uevora.pt	Cardoso, Hélia/O-7562-2018; Ragonezi, Carla/AAF-4418-2020; Velada, Isabel/M-2742-2016	Cardoso, Hélia/0000-0003-3688-607X; Ragonezi, Carla/0000-0002-1822-5473; Velada, Isabel/0000-0002-1590-3769	Portuguese Foundation for Science and Technology [PTDC/AGR-GPL/099263/2008]; program POPH Operational Program for Human Potential [C2008-UE/ICAM/06]; FEDER Funds through the Operational Program for Competitiveness Factors - COMPETE; National Funds through FCT under the Strategic Projects [PEst-C/AGR/UI0115/2011, PEst-OE/AGR/UI0115/2014]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); program POPH Operational Program for Human Potential; FEDER Funds through the Operational Program for Competitiveness Factors - COMPETE; National Funds through FCT under the Strategic Projects	This work was supported by the Portuguese Foundation for Science and Technology within the frame of the project PTDC/AGR-GPL/099263/2008 and the program POPH Operational Program for Human Potential (Ciencia 2007 to BA and Ciencia 2008 to HC: C2008-UE/ICAM/06). This work is funded by FEDER Funds through the Operational Program for Competitiveness Factors - COMPETE, and National Funds through FCT under the Strategic Projects PEst-C/AGR/UI0115/2011 and PEst-OE/AGR/UI0115/2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Amirsadeghi S, 2007, PHYSIOL PLANTARUM, V129, P253, DOI 10.1111/j.1399-3054.2006.00775.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arnholdt-Schmitt B, 2006, TRENDS PLANT SCI, V11, P281, DOI 10.1016/j.tplants.2006.05.001; Ayers Duncan, 2007, BMC Vet Res, V3, P7; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Birt DF, 2009, PHARM BIOL, V47, P774, DOI 10.1080/13880200902988645; Borowski JM, 2014, PLANTA, P1; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butterweck V, 2003, CNS DRUGS, V17, P539, DOI 10.2165/00023210-200317080-00001; Cansev A, 2011, HORTIC ENVIRON BIOTE, V52, P113, DOI 10.1007/s13580-011-0126-4; Caraci F, 2011, CURR DRUG METAB, V12, P570; Cardoso H. G., 2013, DIAGNOSTICS PLANT BR, V21, P467, DOI DOI 10.1007/978-94-007-5687-8_21; Castro-Quezada P, 2013, PLANT MOL BIOL REP, V31, P936, DOI 10.1007/s11105-013-0566-3; Chaitanya KV, 2002, PLANT GROWTH REGUL, V36, P175, DOI 10.1023/A:1015092628374; Chen Y, 2006, S AFR J BOT, V72, P272, DOI 10.1016/j.sajb.2005.09.004; Costa JH, 2014, MITOCHONDRION, V19, P172, DOI 10.1016/j.mito.2014.04.007; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; Dechorgnat J, 2012, PLOS ONE, V7; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Demidenko N V., 2011, PLOS ONE, V6; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Everaert BR, 2011, PLOS ONE, V6; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feng HQ, 2013, ACTA BIOCH BIOPH SIN, V45, P985, DOI 10.1093/abbs/gmt094; Ferreira AO, 2009, PHYSIOL PLANTARUM, V137, P520, DOI 10.1111/j.1399-3054.2009.01291.x; Figueiredo Andreia, 2013, BMC Res Notes, V6, P388, DOI 10.1186/1756-0500-6-388; Fiorani F, 2005, PLANT PHYSIOL, V139, P1795, DOI 10.1104/pp.105.070789; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Gadzovska S, 2013, PLANT CELL TISS ORG, V113, P25, DOI 10.1007/s11240-012-0248-0; Gong XW, 2014, 2014 48TH ANNUAL CONFERENCE ON INFORMATION SCIENCES AND SYSTEMS (CISS); Goulao LF, 2012, PLANT MOL BIOL REP, V30, P741, DOI 10.1007/s11105-011-0382-6; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; He M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042081; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; He YL, 2005, CROP SCI, V45, P988, DOI 10.2135/cropsci2003.0678; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoenemann C, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue1-fulltext-8; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jiang YW, 2001, J EXP BOT, V52, P341, DOI 10.1093/jexbot/52.355.341; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Kuk YI, 2003, CROP SCI, V43, P2109, DOI 10.2135/cropsci2003.2109; Kumar R. R., 2012, International Journal of Plant Physiology and Biochemistry, V4, P83; Li CR, 2013, GENET MOL RES, V12, P5424, DOI 10.4238/2013.November.11.4; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lin YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095445; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Liu MX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084408, 10.1371/journal.pone.0108012, 10.1371/journal.pone.0102344]; Locato V, 2008, PLANT CELL ENVIRON, V31, P1606, DOI 10.1111/j.1365-3040.2008.01867.x; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo XY, 2014, SCI HORTIC-AMSTERDAM, V165, P281, DOI 10.1016/j.scienta.2013.10.030; Ma NL, 2013, INT J MOL SCI, V14, P7515, DOI 10.3390/ijms14047515; Ma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064666; Maksup S, 2013, CHINESE SCI BULL, V58, P1919, DOI 10.1007/s11434-013-5726-1; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; Matsumura T, 2002, PHYSIOL PLANTARUM, V116, P317, DOI 10.1034/j.1399-3054.2002.1160306.x; McClung CR, 1997, FREE RADICAL BIO MED, V23, P489, DOI 10.1016/S0891-5849(97)00109-3; Mhamdi A, 2012, ARCH BIOCHEM BIOPHYS, V525, P181, DOI 10.1016/j.abb.2012.04.015; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moller IM, 2001, PLANT MITOCHONDRIA O; Monteiro F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072998; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Orendi G, 2001, PLANT SCI, V161, P301, DOI 10.1016/S0168-9452(01)00409-5; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Popov VN, 1997, FEBS LETT, V415, P87, DOI 10.1016/S0014-5793(97)01099-5; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Rivera-Vega L, 2012, PLANT MOL BIOL REP, V30, P242, DOI 10.1007/s11105-011-0340-3; Sairam RK, 2000, BIOL PLANTARUM, V43, P245, DOI 10.1023/A:1002756311146; Sato Y, 2001, J EXP BOT, V52, P145, DOI 10.1093/jexbot/52.354.145; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sirvent TM, 2003, J CHEM ECOL, V29, P2667, DOI 10.1023/B:JOEC.0000008011.77213.64; Skyba M, 2012, J PLANT PHYSIOL, V169, P955, DOI 10.1016/j.jplph.2012.02.017; Sugie A, 2006, GENES GENET SYST, V81, P349, DOI 10.1266/ggs.81.349; Umbach AL, 2002, BBA-BIOENERGETICS, V1554, P118, DOI 10.1016/S0005-2728(02)00219-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Watanabe CK, 2008, PLANT CELL ENVIRON, V31, P1190, DOI 10.1111/j.1365-3040.2008.01834.x; Xia W, 2014, BOTANY, V92, P179, DOI 10.1139/cjb-2013-0212; Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Yeap WC, 2014, PLANT CELL TISS ORG, V116, P55, DOI 10.1007/s11240-013-0382-3; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Zeng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097039; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	105	30	31	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115206	10.1371/journal.pone.0115206	http://dx.doi.org/10.1371/journal.pone.0115206			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503716	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700097
J	Xu, HL; Zhang, WP; Zhang, T; Li, J; Wu, X; Dong, LY				Xu, Hongle; Zhang, Wenpan; Zhang, Teng; Li, Jun; Wu, Xian; Dong, Liyao			Determination of Ploidy Level and Isolation of Genes Encoding Acetyl-CoA Carboxylase in Japanese Foxtail (Alopecurus japonicus)	PLOS ONE			English	Article							ACCASE-INHIBITING HERBICIDES; COENZYME-A CARBOXYLASE; NUCLEAR-DNA CONTENT; ACETOLACTATE SYNTHASE; MOLECULAR-BASIS; CARBOXYLTRANSFERASE DOMAIN; CONFER RESISTANCE; TRIBENURON-METHYL; SITE MUTATIONS; POPULATIONS	Ploidy level is important in biodiversity studies and in developing strategies for isolating important plant genes. Many herbicide-resistant weed species are polyploids, but our understanding of these polyploid weeds is limited. Japanese foxtail, a noxious agricultural grass weed, has evolved herbicide resistance. However, most studies on this weed have ignored the fact that there are multiple copies of target genes. This may complicate the study of resistance mechanisms. Japanese foxtail was found to be a tetraploid by flow cytometer and chromosome counting, two commonly used methods in the determination of ploidy levels. We found that there are two copies of the gene encoding plastidic acetyl-CoA carboxylase (ACCase) in Japanese foxtail and all the homologous genes are expressed. Additionally, no difference in ploidy levels or ACCase gene copy numbers was observed between an ACCase-inhibiting herbicide-resistant and a herbicide-sensitive population in this study.	[Xu, Hongle; Zhang, Wenpan; Zhang, Teng; Li, Jun; Wu, Xian; Dong, Liyao] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Xu, Hongle; Zhang, Teng; Li, Jun; Wu, Xian; Dong, Liyao] Nanjing Agr Univ, Minist Agr, Key Lab Integrated Pest Management Crops East Chi, Beijing, Peoples R China; [Zhang, Wenpan] Nanjing Agr Univ, Natl Key Lab Crop Genet & Germplasm Enhancement, Cotton Res Inst, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Nanjing Agricultural University	Dong, LY (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	dly@njau.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [201303031]; Ph. D. Programs Foundation of Ministry of Education of China [20120097110038]; Natural Science Foundation for Young Scientists of Jiangsu Province [BK2012360]	Special Fund for Agro-scientific Research in the Public Interest; Ph. D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation for Young Scientists of Jiangsu Province	This research was supported by Special Fund for Agro-scientific Research in the Public Interest (201303031), Ph. D. Programs Foundation of Ministry of Education of China (20120097110038) and the Natural Science Foundation for Young Scientists of Jiangsu Province (BK2012360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Amsellem L, 2001, PLANT SYST EVOL, V228, P171, DOI 10.1007/s006060170027; Beckie HJ, 2012, CROP PROT, V35, P15, DOI 10.1016/j.cropro.2011.12.018; Bennett MD, 1998, ANN BOT-LONDON, V82, P121, DOI 10.1006/anbo.1998.0785; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Bi YL, 2013, J PESTIC SCI, V38, P74, DOI 10.1584/jpestics.D12-075; Christoffers MJ, 2002, GENOME, V45, P1049, DOI 10.1139/G02-080; Clayton WD, GRASSBASE ONLINE WOR; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui HL, 2012, PESTIC BIOCHEM PHYS, V102, P229, DOI 10.1016/j.pestbp.2012.01.007; Cui HL, 2011, WEED SCI, V59, P376, DOI 10.1614/WS-D-10-00099.1; Cui HL, 2008, WEED SCI, V56, P775, DOI 10.1614/WS-08-058.1; Delye C, 2005, WEED SCI, V53, P728, DOI 10.1614/WS-04-203R.1; Delye C, 2005, PLANT PHYSIOL, V137, P794, DOI 10.1104/pp.104.046144; Delye C, 2011, WEED RES, V51, P353, DOI 10.1111/j.1365-3180.2011.00852.x; Delye C, 2013, TRENDS GENET, V29, P649, DOI 10.1016/j.tig.2013.06.001; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Gherekhloo J, 2012, WEED RES, V52, P367, DOI 10.1111/j.1365-3180.2012.00919.x; Green AF, 2013, BIOL INVASIONS, V15, P2219, DOI 10.1007/s10530-013-0446-7; Hanson L, 2001, ANN BOT-LONDON, V87, P251, DOI 10.1006/anbo.2000.1325; HARWOOD JL, 1988, ANNU REV PLANT PHYS, V39, P101, DOI 10.1146/annurev.arplant.39.1.101; Heap I., 2021, INT SURVEY HERBICIDE, DOI DOI 10.1002/ps.3790; Iwakami S, 2012, PEST MANAG SCI, V68, P1098, DOI 10.1002/ps.3287; Jang SR, 2013, NEW PHYTOL, V197, P1110, DOI 10.1111/nph.12117; Jin T, 2011, PESTIC BIOCHEM PHYS, V100, P160, DOI 10.1016/j.pestbp.2011.03.005; Kaundun SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058012; Kaundun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039759; Kaundun SS, 2010, PEST MANAG SCI, V66, P1249, DOI 10.1002/ps.2003; Kaundun SS, 2006, WEED RES, V46, P34, DOI 10.1111/j.1365-3180.2006.00487.x; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Lafuma L, 2003, PLANT SYST EVOL, V243, P59, DOI 10.1007/s00606-003-0075-0; Lamego FP, 2009, WEED SCI, V57, P474, DOI 10.1614/WS-09-056.1; Liu WT, 2013, PESTIC BIOCHEM PHYS, V107, P50, DOI 10.1016/j.pestbp.2013.05.003; Liu WT, 2013, WEED SCI, V61, P390, DOI 10.1614/WS-D-12-00200.1; Liu WJ, 2007, P NATL ACAD SCI USA, V104, P3627, DOI 10.1073/pnas.0611572104; Mohamed IA, 2012, WEED SCI, V60, P167, DOI 10.1614/WS-D-11-00111.1; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Puri A, 2007, WEED SCI, V55, P578, DOI 10.1614/WS-07-034.1; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; Scarabel L, 2010, PEST MANAG SCI, V66, P337, DOI 10.1002/ps.1883; SIEBER VK, 1979, BOT J LINN SOC, V79, P343, DOI 10.1111/j.1095-8339.1979.tb01822.x; Sun JA, 2011, AGR SCI CHINA, V10, P86, DOI 10.1016/S1671-2927(11)60310-6; Tang HW, 2012, PEST MANAG SCI, V68, P1241, DOI 10.1002/ps.3285; Tang W, 2014, PESTIC BIOCHEM PHYS, V108, P16, DOI 10.1016/j.pestbp.2013.11.001; Uchino A, 2007, WEED BIOL MANAG, V7, P89, DOI 10.1111/j.1445-6664.2007.00240.x; Wang Y, 2009, HORTSCIENCE, V44, P2049, DOI 10.21273/HORTSCI.44.7.2049; Warwick SI, 2010, WEED SCI, V58, P244, DOI 10.1614/WS-D-09-00083.1; Xu HL, 2014, PEST MANAG SCI, V70, P1894, DOI 10.1002/ps.3753; Xu HL, 2013, PESTIC BIOCHEM PHYS, V107, P25, DOI 10.1016/j.pestbp.2013.04.008; Yang CH, 2007, WEED SCI, V55, P537, DOI 10.1614/WS-07-016.1; Yu Q, 2013, HEREDITY, V110, P220, DOI 10.1038/hdy.2012.69; Yu Q, 2007, PLANT PHYSIOL, V145, P547, DOI 10.1104/pp.107.105262; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	56	16	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114712	10.1371/journal.pone.0114712	http://dx.doi.org/10.1371/journal.pone.0114712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503308	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700048
J	Gumbo, H; Chasekwa, B; Church, JA; Ntozini, R; Mutasa, K; Humphrey, JH; Prendergast, AJ				Gumbo, Hlanai; Chasekwa, Bernard; Church, James A.; Ntozini, Robert; Mutasa, Kuda; Humphrey, Jean H.; Prendergast, Andrew J.			Congenital and Postnatal CMV and EBV Acquisition in HIV-Infected Zimbabwean Infants	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CYTOMEGALOVIRUS-INFECTION; DISEASE PROGRESSION; VIRAL LOAD; CHILDREN; BORN; PREVALENCE; TYPE-1; REPLICATION; COINFECTION	Background: HIV-infected infants in sub-Saharan Africa have rapid disease progression. We hypothesized that co-infection with cytomegalovirus (CMV) or Epstein Barr virus (EBV) increases mortality in HIV-infected infants. Methods: 257 antiretroviral therapy-naive HIV-infected Zimbabwean infants were tested for CMV and EBV at 6 weeks of age by real-time PCR; if positive, birth samples were retrieved where available to distinguish congenital and postnatal infection. The impact of co-infection on mortality through 6 months was estimated using Kaplan-Meier and Cox proportional hazards methods. Results: At 6 weeks, 203/257 (79%) HIV-infected infants were CMV-positive; 27 (11%) had congenital CMV, 108 (42%) postnatal CMV and 68 (26%) indeterminate timing of infection. By 6 months, 37/108 (34%) infants with postnatal CMV versus 16/54 (30%) CMV-negative infants died (adjusted hazard ratio (aHR) 1.1 [95%CI 0.6, 2.2]). At 6 weeks, 33/257 (13%) HIV-infected infants had EBV co-infection; 6 (2%) had congenital EBV, 18 (7%) postnatal EBV and 9 (4%) indeterminate timing of infection. By 6 months, 5/18 (28%) infants with postnatal EBV versus 72/224 (32%) EBV-negative infants died (aHR 0.8 [95%CI 0.3, 2.3]). Conclusions: The vast majority of HIV-infants had acquired CMV by 6 weeks, and EBV co-infection occurred earlier than expected, with one in eight HIV-infected infants positive for EBV by 6 weeks. There was a high prevalence of congenital CMV infection and we identified 6 infants with congenital EBV infection, which has not previously been reported in Africa or in the context of HIV infection. Neither CMV nor EBV co-infection was associated with increased mortality.	[Gumbo, Hlanai; Chasekwa, Bernard; Church, James A.; Ntozini, Robert; Mutasa, Kuda; Humphrey, Jean H.; Prendergast, Andrew J.] Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe; [Church, James A.; Prendergast, Andrew J.] Queen Mary Univ London, Blizard Inst, Ctr Paediat, London, England; [Humphrey, Jean H.; Prendergast, Andrew J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of London; Queen Mary University London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Prendergast, AJ (corresponding author), Zvitambo Inst Maternal & Child Hlth Res, Harare, Zimbabwe.	a.prendergast@qmul.ac.uk	Ntozini, Robert/AAD-8403-2020; Ntozini, Robert/AFU-4878-2022	Ntozini, Robert/0000-0002-8543-2835; Prendergast, Andrew/0000-0001-7904-7992; Chasekwa, Bernard/0000-0001-8080-7573	Wellcome Trust [093768/Z/10/Z]; National Institute for Health Research [ACF-2012-19-003] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust (www.wellcome.ac.uk); grant 093768/Z/10/Z. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lafuente R, 2008, FORENSIC SCI INT, V178, P106, DOI 10.1016/j.forsciint.2008.02.007; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Bates M, 2008, VIROLOGY, V382, P28, DOI 10.1016/j.virol.2008.09.001; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Bowser CS, 2006, FETAL PEDIATR PATHOL, V25, P321, DOI 10.1080/15513810701209553; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chan KH, 2001, J CLIN VIROL, V21, P57, DOI 10.1016/S1386-6532(01)00149-4; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Dickover RE, 1998, J INFECT DIS, V178, P375, DOI 10.1086/515637; Doyle M, 1996, PEDIATR INFECT DIS J, V15, P1102, DOI 10.1097/00006454-199612000-00010; Gibson RS, 1990, Q REV BIOL; GOLDBERG GN, 1981, JAMA-J AM MED ASSOC, V246, P1579, DOI 10.1001/jama.246.14.1579; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Guibert G, 2009, CLIN INFECT DIS, V48, P1516, DOI 10.1086/598934; Holder B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014013; Humphrey JH, 2006, J INFECT DIS, V193, P960; Ito Y, 2009, J MED VIROL, V81, P1399, DOI 10.1002/jmv.21527; JONCAS J, 1974, CAN MED ASSOC J, V110, P33; JONCAS JH, 1977, CAN MED ASSOC J, V117, P1417; KAFUKO GW, 1972, LANCET, V1, P706; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; KOVAL V, 1991, J VIROL, V65, P6969, DOI 10.1128/JVI.65.12.6969-6978.1991; Kraft CS, 2012, CLIN INFECT DIS, V54, P1793, DOI 10.1093/cid/cis212; Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010; Long SS, 2009, DNA VIRUSES HERPESVI, P1029; Gabriel MAM, 2007, MED SCI MONITOR, V13, pCR177; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McMichael G, 2012, J MATERN-FETAL NEO M, V25, P2078, DOI 10.3109/14767058.2012.666587; Miller CS, 2006, J CLIN MICROBIOL, V44, P2409, DOI 10.1128/JCM.00256-06; Mutasa K, 2012, PEDIATR INFECT DIS J, V31, P948, DOI 10.1097/INF.0b013e318266aac2; Mwaanza N, 2014, CLIN INFECT DIS, V58, P728, DOI 10.1093/cid/cit766; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Nilsson C, 2005, J ALLERGY CLIN IMMUN, V116, P438, DOI 10.1016/j.jaci.2005.04.027; Pedneault L, 1998, J INFECT DIS, V177, P1087, DOI 10.1086/517401; PETERSON PK, 1992, J CLIN INVEST, V89, P574, DOI 10.1172/JCI115623; Petrara MR, 2014, J INFECT DIS, V210, P392, DOI 10.1093/infdis/jiu099; Piriou E, 2012, J INFECT DIS, V205, P906, DOI 10.1093/infdis/jir872; RODIER MH, 1995, ACTA TROP, V59, P271, DOI 10.1016/0001-706X(95)00087-U; Rouet F, 2003, PEDIATRICS, V112, pE289, DOI 10.1542/peds.112.4.e289; Saghafian-Hedengren S, 2009, J IMMUNOL, V182, P2511, DOI 10.4049/jimmunol.0801699; Schaftenaar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099243; SCHOUB BD, 1993, S AFR MED J, V83, P108; SCHUSTER V, 1993, MONATSSCHR KINDERH, V141, P401; SEVER JL, 1995, PEDIATR AIDS HIV INF, V6, P75; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Slyker J, 2014, CLIN INFECT DIS, V58, P564, DOI 10.1093/cid/cit727; Slyker JA, 2014, CLIN INFECT DIS, V58, P1333, DOI 10.1093/cid/ciu088; Slyker JA, 2013, J INFECT DIS, V207, P1798, DOI 10.1093/infdis/jit093; Slyker JA, 2009, AIDS, V23, P2173, DOI 10.1097/QAD.0b013e32833016e8; Spector SA, 1999, J VIROL, V73, P7027, DOI 10.1128/JVI.73.8.7027-7030.1999; TOTH FD, 1995, J VIROL, V69, P2223; UNAIDS, GLOB REP UNAIDS REP; Wang X, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-247	53	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114870	10.1371/journal.pone.0114870	http://dx.doi.org/10.1371/journal.pone.0114870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522217	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600010
J	Rosa, G; Huaylinos, ML; Gil, A; Lanata, C; Clasen, T				Rosa, Ghislaine; Huaylinos, Maria L.; Gil, Ana; Lanata, Claudio; Clasen, Thomas			Assessing the Consistency and Microbiological Effectiveness of Household Water Treatment Practices by Urban and Rural Populations Claiming to Treat Their Water at Home: A Case Study in Peru	PLOS ONE			English	Article							DRINKING-WATER; DEVELOPING-COUNTRIES; DISINFECTING WATER; HYGIENE PRACTICES; DIARRHEA; COST; QUESTIONNAIRES; INTERVENTIONS; METAANALYSIS; GUATEMALA	Background: Household water treatment (HWT) can improve drinking water quality and prevent disease if used correctly and consistently by vulnerable populations. Over 1.1 billion people report treating their water prior to drinking it. These estimates, however, are based on responses to household surveys that may exaggerate the consistency and microbiological performance of the practice-key factors for reducing pathogen exposure and achieving health benefits. The objective of this study was to examine how HWT practices are actually performed by households identified as HWT users, according to international monitoring standards. Methods and Findings: We conducted a 6-month case study in urban (n=117 households) and rural (n=115 households) Peru, a country in which 82.8% of households report treating their water at home. We used direct observation, in-depth interviews, surveys, spot-checks, and water sampling to assess water treatment practices among households that claimed to treat their drinking water at home. While consistency of reported practices was high in both urban (94.8%) and rural (85.3%) settings, availability of treated water (based on self-report) at time of collection was low, with 67.1% and 23.0% of urban and rural households having treated water at all three sampling visits. Self-reported consumption of untreated water in the home among adults and children <5 was common and this was corroborated during home observations. Drinking water of self-reported users was significantly better than source water in the urban setting and negligible but significantly better in the rural setting. However, only 46.3% and 31.6% of households had drinking water,1 CFU/100 mL at all follow-up visits. Conclusions: Our results raise questions about the usefulness of current international monitoring of HWT practices and their usefulness as a proxy indicator for drinking water quality. The lack of consistency and sub-optimal microbiological effectiveness also raises questions about the potential of HWT to prevent waterborne diseases.	[Rosa, Ghislaine; Clasen, Thomas] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Huaylinos, Maria L.; Gil, Ana; Lanata, Claudio] Inst Invest Nutr, Lima, Peru; [Clasen, Thomas] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of London; London School of Hygiene & Tropical Medicine; Emory University; Rollins School Public Health	Rosa, G (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	ghislaine.rosa@lshtm.ac.uk			Unicef and Hindustan Unilever Ltd.	Unicef and Hindustan Unilever Ltd.	This study was funded by Unicef and Hindustan Unilever Ltd. Unilever manufactures and sells point-of-use water treatment products. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2012, TROP MED INT HEALTH, V17, P684, DOI 10.1111/j.1365-3156.2012.02987.x; [Anonymous], 2009, DIARRH WHY CHILDR AR; APHA, 2001, STANDARD METHODS EXA; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Boerma J T, 1993, World Health Stat Q, V46, P222; Boisson S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012613; Brown J, 2012, AM J TROP MED HYG; Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030955, 10.1371/journal.pone.0036735]; Clasen T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004794.pub2; Clasen T, 2008, AM J TROP MED HYG, V79, P407, DOI 10.4269/ajtmh.2008.79.407; Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Colindres RE, 2007, J WATER HEALTH, V5, P367, DOI 10.2166/wh.2007.032; CURTIS V, 1993, B WORLD HEALTH ORGAN, V71, P23; Curtis V, 1997, HEALTH POLICY PLANN, V12, P122, DOI 10.1093/heapol/12.2.122; ENDES, 2004, END CONT 2004 2006; ENDES, 2009, PER DHS 2009 FIN REP; Enger KS, 2013, WATER RES, V47, P1181, DOI 10.1016/j.watres.2012.11.034; Enger KS, 2012, ENVIRON SCI TECHNOL, V46, P5160, DOI 10.1021/es204381e; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; GILMAN RH, 1993, AM J PUBLIC HEALTH, V83, P1554, DOI 10.2105/AJPH.83.11.1554; Kayser GL, 2013, INT J ENV RES PUB HE, V10, P4812, DOI 10.3390/ijerph10104812; Mausezahl D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000125; ManunEbo M, 1997, TROP MED INT HEALTH, V2, P1015, DOI 10.1046/j.1365-3156.1997.d01-180.x; Moser S., 2005, DETERMINANTS DIFFUSI; Pruss-Ustun A, 2014, TROP MED INT HLTH; Psutka R, 2011, ENVIRON SCI TECHNOL, V45, P6095, DOI 10.1021/es2004045; Rosa G, 2010, AM J TROP MED HYG, V82, P473, DOI 10.4269/ajtmh.2010.09-0320; Rosa G, 2010, AM J TROP MED HYG, V82, P289, DOI 10.4269/ajtmh.2010.09-0382; Ruel MT, 2002, J HEALTH POPUL NUTR, V20, P65; Sodha SV, 2011, J WATER HEALTH, V9, P577, DOI 10.2166/wh.2011.255; STANTON BF, 1987, B WORLD HEALTH ORGAN, V65, P217; STONE L, 1984, HUM ORGAN, V43, P27, DOI 10.17730/humo.43.1.6wl5k01724878166; WHO, 2011, GUID DRINK WAT QUAL; *WHO UNICEF, 2005, WAT LIF MAK IT HAPP; WHO/UNICEF, 2006, COR QUEST DRINK WAT; WHO & UNICEF, 2014, PROGR SAN DRINK WAT; Yang H, 2012, AM J TROP MED HYG, V86, P554, DOI 10.4269/ajtmh.2012.11-0730a; Zwane AP, 2011, P NATL ACAD SCI US	39	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114997	10.1371/journal.pone.0114997	http://dx.doi.org/10.1371/journal.pone.0114997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522371	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000348845600013
J	Runavot, JL; Guo, XY; Willats, WGT; Knox, JP; Goubet, F; Meulewaeter, F				Runavot, Jean-Luc; Guo, Xiaoyuan; Willats, William G. T.; Knox, J. Paul; Goubet, Florence; Meulewaeter, Frank			Non-Cellulosic Polysaccharides from Cotton Fibre Are Differently Impacted by Textile Processing	PLOS ONE			English	Article							CELL-WALL; ARABINOGALACTAN-PROTEIN; MONOCLONAL-ANTIBODIES; CRYSTALLINITY CHANGES; FABRICS; FUNCTIONALIZATION; ELONGATION; EXTRACTION; GENERATION; LOCATION	Cotton fibre is mainly composed of cellulose, although non-cellulosic polysaccharides play key roles during fibre development and are still present in the harvested fibre. This study aimed at determining the fate of non-cellulosic polysaccharides during cotton textile processing. We analyzed non-cellulosic cotton fibre polysaccharides during different steps of cotton textile processing using GC-MS, HPLC and comprehensive microarray polymer profiling to obtain monosaccharide and polysaccharide amounts and linkage compositions. Additionally, in situ detection was used to obtain information on polysaccharide localization and accessibility. We show that pectic and hemicellulosic polysaccharide levels decrease during cotton textile processing and that some processing steps have more impact than others. Pectins and arabinose-containing polysaccharides are strongly impacted by the chemical treatments, with most being removed during bleaching and scouring. However, some forms of pectin are more resistant than others. Xylan and xyloglucan are affected in later processing steps and to a lesser extent, whereas callose showed a strong resistance to the chemical processing steps. This study shows that non-cellulosic polysaccharides are differently impacted by the treatments used in cotton textile processing with some hemicelluloses and callose being resistant to these harsh treatments.	[Runavot, Jean-Luc; Goubet, Florence; Meulewaeter, Frank] Bayer CropSci NV, Innovat Ctr, Ghent, Belgium; [Guo, Xiaoyuan; Willats, William G. T.] Univ Copenhagen, Dept Plant & Environm Sci, DK-1871 Frederiksberg, Denmark; [Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England	Bayer AG; Bayer CropScience; University of Copenhagen; University of Leeds	Meulewaeter, F (corresponding author), Bayer CropSci NV, Innovat Ctr, Technol Pk 38, Ghent, Belgium.	Frank.meulewaeter@bayer.com	Knox, Paul/H-4577-2012; Runavot, Jean-Luc/F-6930-2012	Knox, Paul/0000-0002-9231-6891; Meulewaeter, Frank/0000-0002-3589-6471; Runavot, Jean-Luc/0000-0001-5451-2616	European Union [263916]	European Union(European Commission)	This work was supported by the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (grant agreement No. 263916). This paper reflects the authors' views only. The European Community is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Halim ES, 2013, CARBOHYD POLYM, V92, P1844, DOI 10.1016/j.carbpol.2012.11.045; Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074; Agrawal Pramod B., 2007, Biotechnology Journal, V2, P306, DOI 10.1002/biot.200600169; ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; Allen S, 2013, J BIOL CHEM, V288, P11093, DOI 10.1074/jbc.M113.452763; [Anonymous], 2005, BIODEGRADABLE SUSTAI; Avci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056315; Battan B, 2012, INDIAN J MICROBIOL, V52, P222, DOI 10.1007/s12088-011-0118-1; BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Colom X, 2002, EUR POLYM J, V38, P2225, DOI 10.1016/S0014-3057(02)00132-5; Denizli A, 2001, J BIOCHEM BIOPH METH, V49, P391, DOI 10.1016/S0165-022X(01)00209-3; Dinand E, 2002, CELLULOSE, V9, P7, DOI 10.1023/A:1015877021688; Fang L, 2013, CARBOHYD POLYM, V91, P363, DOI 10.1016/j.carbpol.2012.08.049; Filpponen I, 2012, BIOMACROMOLECULES, V13, P736, DOI 10.1021/bm201661k; Gabrielii I, 2000, CARBOHYD POLYM, V43, P367, DOI 10.1016/S0144-8617(00)00181-8; Guillon F, 2004, J CEREAL SCI, V40, P167, DOI 10.1016/j.jcs.2004.06.004; HAIGLER CH, 2012, FRONT PLANT SCI; Huang GQ, 2013, PLANT PHYSIOL, V161, P1278, DOI 10.1104/pp.112.203760; Ibrahim NA, 2012, CARBOHYD POLYM, V90, P908, DOI 10.1016/j.carbpol.2012.06.019; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kljun A, 2011, BIOMACROMOLECULES, V12, P4121, DOI 10.1021/bm201176m; Kohler A, 2000, BIOTECHNIQUES, V28, P1084, DOI 10.2144/00286bm06; Kumar V, 1999, INT J PHARM, V177, P173, DOI 10.1016/S0378-5173(98)00340-8; Lee KJD, 2005, PLANT CELL, V17, P3051, DOI 10.1105/tpc.105.034413; Li A, 2013, PLANTA, V237, P1585, DOI 10.1007/s00425-013-1868-2; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088; Montazer M, 2012, COLLOID SURFACE B, V89, P196, DOI 10.1016/j.colsurfb.2011.09.015; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Peng F, 2012, BIOTECHNOL ADV, V30, P879, DOI 10.1016/j.biotechadv.2012.01.018; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Rajendran R, 2011, Pak J Biol Sci, V14, P519, DOI 10.3923/pjbs.2011.519.525; Schindler W. D., 2004, CHEM FINISH TEXT; Seagull R. W., 2000, Journal of Cotton Science, V4, P97; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Sun XF, 2005, J AGR FOOD CHEM, V53, P860, DOI 10.1021/jf040456q; TANG F, 2014, FIELD CROPS RES; Tokumoto H, 2003, J PLANT PHYSIOL, V160, P1411, DOI 10.1078/0176-1617-01066; Tokumoto H, 2002, PLANT CELL PHYSIOL, V43, P411, DOI 10.1093/pcp/pcf048; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Vismara E, 2009, J HAZARD MATER, V170, P798, DOI 10.1016/j.jhazmat.2009.05.042; Wakelyn PJ, 2007, INT FIBER SCI TECHNO, V17; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131	51	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115150	10.1371/journal.pone.0115150	http://dx.doi.org/10.1371/journal.pone.0115150			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517975	Green Published, gold			2022-12-27	WOS:000347215600046
J	Putcha, N; Puhan, MA; Drummond, MB; Han, MK; Regan, EA; Hanania, NA; Martinez, CH; Foreman, M; Bhatt, SP; Make, B; Ramsdell, J; Demeo, DL; Barr, RG; Rennard, SI; Martinez, F; Silverman, EK; Crapo, J; Wise, RA; Hansel, NN				Putcha, Nirupama; Puhan, Milo A.; Drummond, M. Bradley; Han, MeiLan K.; Regan, Elizabeth A.; Hanania, Nicola A.; Martinez, Carlos H.; Foreman, Marilyn; Bhatt, Surya P.; Make, Barry; Ramsdell, Joe; DeMeo, Dawn L.; Barr, R. Graham; Rennard, Stephen I.; Martinez, Fernando; Silverman, Edwin K.; Crapo, James; Wise, Robert A.; Hansel, Nadia N.			A Simplified Score to Quantify Comorbidity in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; GEORGES RESPIRATORY QUESTIONNAIRE; HEALTH; RISK; MORBIDITY; VALIDATION; INDEX; INFORMATION; PREVALENCE	Importance: Comorbidities are common in COPD, but quantifying their burden is difficult. Currently there is a COPD-specific comorbidity index to predict mortality and another to predict general quality of life. We sought to develop and validate a COPD-specific comorbidity score that reflects comorbidity burden on patient-centered outcomes. Materials and Methods: Using the COPDGene study (GOLD II-IV COPD), we developed comorbidity scores to describe patient-centered outcomes employing three techniques: 1) simple count, 2) weighted score, and 3) weighted score based upon statistical selection procedure. We tested associations, area under the Curve (AUC) and calibration statistics to validate scores internally with outcomes of respiratory disease-specific quality of life (St. George's Respiratory Questionnaire, SGRQ), six minute walk distance (6MWD), modified Medical Research Council (mMRC) dyspnea score and exacerbation risk, ultimately choosing one score for external validation in SPIROMICS. Results: Associations between comorbidities and all outcomes were comparable across the three scores. All scores added predictive ability to models including age, gender, race, current smoking status, pack-years smoked and FEV1 (p<0.001 for all comparisons). Area under the curve (AUC) was similar between all three scores across outcomes: SGRQ (range 0.7624-0.7676), MMRC (0.7590-0.7644), 6MWD (0.7531-0.7560) and exacerbation risk (0.6831-0.6919). Because of similar performance, the comorbidity count was used for external validation. In the SPIROMICS cohort, the comorbidity count performed well to predict SGRQ (AUC 0.7891), MMRC (AUC 0.7611), 6MWD (AUC 0.7086), and exacerbation risk (AUC 0.7341). Conclusions: Quantifying comorbidity provides a more thorough understanding of the risk for patient-centered outcomes in COPD. A comorbidity count performs well to quantify comorbidity in a diverse population with COPD.	[Putcha, Nirupama; Drummond, M. Bradley; Wise, Robert A.; Hansel, Nadia N.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Puhan, Milo A.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Han, MeiLan K.; Martinez, Carlos H.] Univ Michigan, Ann Arbor, MI 48109 USA; [Regan, Elizabeth A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Hanania, Nicola A.] Baylor Coll Med, Houston, TX 77030 USA; [Foreman, Marilyn] Morehouse Sch Med, Atlanta, GA 30310 USA; [Bhatt, Surya P.] Univ Alabama Birmingham, Birmingham, AL USA; [Make, Barry; Crapo, James] Natl Jewish Hlth, Pulm & Crit Care, Denver, CO USA; [Ramsdell, Joe] Univ Calif San Diego, San Diego, CA 92103 USA; [DeMeo, Dawn L.; Silverman, Edwin K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med, Boston, MA 02115 USA; [Barr, R. Graham] Columbia Univ, Dept Med, Dept Epidemiol, Med Ctr, New York, NY USA; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Omaha, NE USA; [Martinez, Fernando] New York Presbyterian Weill Cornell Med Coll, New York, NY USA	Johns Hopkins University; University of Zurich; University of Michigan System; University of Michigan; National Jewish Health; Baylor College of Medicine; Morehouse School of Medicine; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; University of Nebraska System; University of Nebraska Medical Center; Cornell University	Putcha, N (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	Nputcha1@jhmi.edu	Puhan, Milo/ABE-6298-2020; Hanania, Nicola A/C-5875-2016	Puhan, Milo/0000-0003-4721-1879; Hanania, Nicola A/0000-0003-3087-9530; Foreman, Marilyn/0000-0002-9405-7475; Wise, Robert/0000-0002-8353-2349; Drummond, Michael/0000-0002-6968-4610	institutional training grant at Johns Hopkins University - National Heart, Lung, and Blood Institute (NHLBI) [T32HL007534]; Chest Foundation (Respiratory Health Association of Metropolitan Chicago Women's Lung Health Award); COPD Foundation; AstraZeneca Pharmaceuticals LP through COPDGene(R) Industry Advisory Board; Novartis Pharmaceuticals Corporation through COPDGene(R) Industry Advisory Board; Pfizer through COPDGene(R) Industry Advisory Board; Siemens through COPDGene(R) Industry Advisory Board; Sunovion Inc through COPDGene(R) Industry Advisory Board; NHLBI of the National Institutes of Health [HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN2682009000019C, HHSN268200900020C];  [2R01HL089897];  [2R01HL089856]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089856, T32HL007534, R01HL089897, K23HL103192] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	institutional training grant at Johns Hopkins University - National Heart, Lung, and Blood Institute (NHLBI); Chest Foundation (Respiratory Health Association of Metropolitan Chicago Women's Lung Health Award); COPD Foundation; AstraZeneca Pharmaceuticals LP through COPDGene(R) Industry Advisory Board; Novartis Pharmaceuticals Corporation through COPDGene(R) Industry Advisory Board; Pfizer through COPDGene(R) Industry Advisory Board; Siemens through COPDGene(R) Industry Advisory Board; Sunovion Inc through COPDGene(R) Industry Advisory Board; NHLBI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NP is a postdoctoral research fellow supported by the institutional training grant at Johns Hopkins University, funded the National Heart, Lung, and Blood Institute (NHLBI) [T32HL007534]. She obtained further support for this specific project through the Chest Foundation (Respiratory Health Association of Metropolitan Chicago Women's Lung Health Award). The COPDGene (R) Study is funded by 2R01HL089897 (PI: James Crapo) and 2R01HL089856 (PI: Edwin Silverman). This work is also supported by the COPD Foundation. AstraZeneca Pharmaceuticals LP, Novartis Pharmaceuticals Corporation, Pfizer, Siemens and Sunovion Inc are ongoing supporters of the project through the COPDGene (R) Industry Advisory Board. The SPIROMICS study is funded by the NHLBI of the National Institutes of Health, contract and grant numbers: HHSN268200900013C, HHSN268200900014C, HHSN268200900015C, HHSN268200900016C, HHSN268200900017C, HHSN268200900018C, HHSN2682009000019C, and HHSN268200900020C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SG, 2014, STAT MED, V33, P3946, DOI 10.1002/sim.6195; Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Beckett M, 2000, AM J EPIDEMIOL, V151, P315, DOI 10.1093/oxfordjournals.aje.a010208; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Della Porta MG, 2011, HAEMATOL-HEMATOL J, V96, P441, DOI 10.3324/haematol.2010.033506; Desai MM, 2001, AM J EPIDEMIOL, V153, P299, DOI 10.1093/aje/153.3.299; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Frei A, 2014, J CLIN EPIDEMIOL, V67, P904, DOI 10.1016/j.jclinepi.2014.03.005; GRANT I, 1982, ARCH INTERN MED, V142, P1470, DOI 10.1001/archinte.142.8.1470; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V59, P1; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; Oksanen T, 2010, ANN EPIDEMIOL, V20, P547, DOI 10.1016/j.annepidem.2010.03.017; PAGANINIHILL A, 1993, AM J EPIDEMIOL, V138, P101, DOI 10.1093/oxfordjournals.aje.a116832; Putcha N, 2013, COPD, V10, P324, DOI 10.3109/15412555.2012.744963; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Schnell K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-26; Schunemann HJ, 2003, J CLIN EPIDEMIOL, V56, P1170, DOI 10.1016/S0895-4356(03)00115-X; Sorror ML, 2007, BLOOD, V110, P4606, DOI 10.1182/blood-2007-06-096966; St Germaine-Smith C, 2011, EPILEPSIA, V52, P2161, DOI 10.1111/j.1528-1167.2011.03292.x; StataCorp, 2011, STAT STAT SOFTW REL, P173; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; van Manen JG, 2001, RESP MED, V95, P496, DOI 10.1053/rmed.2001.1077; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Wijnhoven HAH, 2003, RESP MED, V97, P468, DOI 10.1053/rmed.2002.1463; Yeo J, 2006, AGE AGEING, V35, P33, DOI 10.1093/ageing/afj002	31	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114438	10.1371/journal.pone.0114438	http://dx.doi.org/10.1371/journal.pone.0114438			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514500	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300011
J	Zhang, RL; Zhang, JP; Wang, QQ				Zhang, Rui-Li; Zhang, Jing-Ping; Wang, Qian-Qiu			Recombinant Treponema pallidum Protein Tp0965 Activates Endothelial Cells and Increases the Permeability of Endothelial Cell Monolayer	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TIGHT JUNCTION; LEUKOCYTE TRANSMIGRATION; NEISSERIA-MENINGITIDIS; MOLECULAR-MECHANISMS; FIBRONECTIN-BINDING; ADHESION MOLECULES; MEMBRANE-PROTEIN; RHO-KINASE; F-ACTIN	The recombinant Treponema pallidum protein Tp0965 (rTp0965), one of the many proteins derived from the genome of T. pallidum subsp. pallidum, shows strong immunogenicity and immunoreactivity. In this study, we investigated the effects of rTp0965 on the endothelial barrier. Treatment of human umbilical vein endothelial cells (HUVECs) with rTp0965 resulted in increased levels of ICAM-1, E-selectin, and MCP-1 mRNA and protein expression. These increases contributed to the adhesion and chemataxis of monocytes (THP-1 cells) to HUVECs preincubated with rTp0965. In addition, rTp0965 induced reorganization of F-actin and decreased expression of claudin-1 in HUVECs. Interestingly, inhibition of the RhoA/ROCK signal pathway protected against rTp0965-induced higher endothelial permeability as well as transendothelial migration of monocytes. These data indicate that Tp0965 protein may play an important role in the immunopathogenesis of syphilis.	[Zhang, Rui-Li] Nanjing Med Univ, Wuxi Affiliated Hosp 2, Dept Dermatol, Wuxi, Jiangsu, Peoples R China; [Zhang, Jing-Ping; Wang, Qian-Qiu] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Zhang, Jing-Ping; Wang, Qian-Qiu] Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhang, Jing-Ping; Wang, Qian-Qiu] China Ctr Dis Control & Prevent, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention	Wang, QQ (corresponding author), Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China.	doctorwqq@163.com	Zhang, Jingping/ABA-4179-2020	Zhang, Jingping/0000-0002-7800-9617	Natural Science Foundation of Jiangsu Province, China [BK2010136]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	Funding for this work was provided by the Natural Science Foundation of Jiangsu Province, China No BK2010136. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Amerongen GPV, 2000, ARTERIOSCL THROM VAS, V20, pE127, DOI 10.1161/01.ATV.20.12.e127; Backert S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-72; Beekhuizen H, 1997, J IMMUNOL, V158, P774; Bogatcheva NV, 2008, MICROVASC RES, V76, P202, DOI 10.1016/j.mvr.2008.06.003; Brautigam CA, 2012, J BACTERIOL, V194, P6771, DOI 10.1128/JB.01494-12; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Cameron CE, 2004, J BACTERIOL, V186, P7019, DOI 10.1128/JB.186.20.7019-7022.2004; Campos SB, 2009, AM J PHYSIOL-RENAL, V296, pF487, DOI 10.1152/ajprenal.00112.2008; Chavez A, 2011, INT REV CEL MOL BIO, V290, P205, DOI 10.1016/B978-0-12-386037-8.00001-6; Daniel AE, 2013, J INNATE IMMUN, V5, P324, DOI 10.1159/000348828; David M, 2012, CELL CYCLE, V11, P3003, DOI 10.4161/cc.21088; Deka RK, 2004, J BACTERIOL, V186, P2303, DOI 10.1128/JB.186.8.2303-2308.2004; Dickerson MT, 2012, BIOCONJUGATE CHEM, V23, P184, DOI 10.1021/bc200436x; Dixon GLJ, 1999, INFECT IMMUN, V67, P5626, DOI 10.1128/IAI.67.11.5626-5633.1999; Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Elsheikha HM, 2010, FEMS MICROBIOL REV, V34, P532, DOI 10.1111/j.1574-6976.2010.00215.x; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gavrilin MA, 2005, BIOCHEM BIOPH RES CO, V327, P533, DOI 10.1016/j.bbrc.2004.12.037; Gjestland T, 1955, Acta Derm Venereol Suppl (Stockh), V35, P3; Gopalakrishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC102, DOI 10.1152/ajpcell.00583.2002; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Grin EI, 1953, WHO MONOGRAPHY SERIE; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; Hirano S, 2004, CELL BIOL TOXICOL, V20, P1, DOI 10.1023/B:CBTO.0000021019.50889.aa; Houston S, 2011, INFECT IMMUN, V79, P1386, DOI 10.1128/IAI.01083-10; Hudson LC, 2010, HIV AIDS-RES PALLIAT, V2, P7; Imhof BA, 1997, HORM METAB RES, V29, P614, DOI 10.1055/s-2007-979112; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; Kim SJ, 2013, KOREAN J INTERN MED, V28, P231, DOI 10.3904/kjim.2013.28.2.231; Kluger Martin S, 2004, Adv Dermatol, V20, P163; Kniesel U, 2000, CELL MOL NEUROBIOL, V20, P57, DOI 10.1023/A:1006995910836; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee KH, 2000, YONSEI MED J, V41, P623, DOI 10.3349/ymj.2000.41.5.623; Lee WL, 2011, CURR OPIN HEMATOL, V18, P191, DOI 10.1097/MOH.0b013e328345a3d1; Lippoldt A, 2000, NEUROREPORT, V11, P1427, DOI 10.1097/00001756-200005150-00015; Long FQ, 2012, CHINESE MED J-PEKING, V125, P1920, DOI 10.3760/cma.j.issn.0366-6999.2012.11.015; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; Puavilai Siripen, 1993, Journal of the Medical Association of Thailand, V76, P85; RIVIERE GR, 1989, INFECT IMMUN, V57, P2267, DOI 10.1128/IAI.57.8.2267-2271.1989; Rocha N, 2004, J EUR ACAD DERMATOL, V18, P517, DOI 10.1111/j.1468-3083.2004.00960.x; SAMSO M, 1995, EUR J BIOCHEM, V232, P818, DOI 10.1111/j.1432-1033.1995.818zz.x; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Sellati TJ, 1996, INFECT IMMUN, V64, P3180, DOI 10.1128/IAI.64.8.3180-3187.1996; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Simoneau B, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-18; Smurova K M, 2011, Tsitologiia, V53, P359; Sumitomo T, 2011, J BIOL CHEM, V286, P2750, DOI 10.1074/jbc.M110.171504; Tacke F, 2009, DEUT MED WOCHENSCHR, V134, P1645, DOI 10.1055/s-0029-1233994; Tani Kenji, 2001, Journal of Medical Investigation, V48, P133; THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608; Tu CL, 2011, J INVEST DERMATOL, V131, P1119, DOI 10.1038/jid.2010.414; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vieira ML, 2013, INFECT IMMUN, V81, P1764, DOI 10.1128/IAI.00020-13; Walsh SV, 2001, GASTROENTEROLOGY, V121, P566, DOI 10.1053/gast.2001.27060; Wang ZJ, 2011, IUBMB LIFE, V63, P659, DOI 10.1002/iub.485; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wong D, 2007, J NEUROIMMUNOL, V184, P136, DOI 10.1016/j.jneuroim.2006.12.003; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006	70	13	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115134	10.1371/journal.pone.0115134	http://dx.doi.org/10.1371/journal.pone.0115134			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514584	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300036
J	Kim, DK; Lillehoj, HS; Jang, SI; Lee, SH; Hong, YH; Cheng, HH				Kim, Duk Kyung; Lillehoj, Hyun S.; Jang, Seung I.; Lee, Sung Hyen; Hong, Yeong Ho; Cheng, Hans H.			Transcriptional Profiles of Host-Pathogen Responses to Necrotic Enteritis and Differential Regulation of Immune Genes in Two Inbreed Chicken Lines Showing Disparate Disease Susceptibility	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS; BROILER-CHICKENS; EIMERIA-MAXIMA; RISK-FACTORS; EXPRESSION; RESISTANCE; INFECTION; PROTEINS; TENELLA; CELLS	Necrotic enteritis (NE) is an important intestinal infectious disease of commercial poultry flocks caused by Clostridium perfringens. Using an experimental model of NE involving co-infection with C. perfringens and Eimeria maxima, transcriptome profiling and functional genomics approaches were applied to identify the genetic mechanisms that might regulate the host response to this disease. Microarray hybridization identified 1,049 transcripts whose levels were altered (601 increased, 448 decreased) in intestinal lymphocytes from C. perfringens/E. maxima co-infected Ross chickens compared with uninfected controls. Five biological functions, all related to host immunity and inflammation, and 11 pathways were identified from this dataset. To further elucidate the role of host genetics in NE susceptibility, two inbred chicken lines, ADOL line 6 and line 7 which share an identical B-2 major histocompatibility complex haplotype but differ in their susceptibility to virus infection, were compared for clinical symptoms and the expression levels of a panel of immune-related genes during experimental NE. Line 6 chickens were more susceptible to development of experimental NE compared with line 7, as revealed by decreased body weight gain and increased E. maxima oocyst shedding. Of 21 immune-related genes examined, 15 were increased in C. perfringens/E. maxima co-infected line 6 vs. line 7 chickens. These results suggest that immune pathways are activated in response to experimental NE infection and that genetic determinants outside of the chicken B complex influence resistance to this disease.	[Kim, Duk Kyung; Lillehoj, Hyun S.; Jang, Seung I.; Lee, Sung Hyen] Agr Res Serv, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD 20705 USA; [Kim, Duk Kyung] Hankyong Natl Univ, Anim Genom & Breeding Ctr, Ansong 456749, Gyeonggi, South Korea; [Lee, Sung Hyen] Natl Acad Agr Sci, Rural Dev Adm, Wanju Gun 565851, Jeollabuk Do, South Korea; [Hong, Yeong Ho] Chung Ang Univ, Dept Anim Sci & Technol, Ansong 456756, South Korea; [Cheng, Hans H.] Agr Res Serv, Avian Dis & Oncol Lab, USDA, E Lansing, MI 48823 USA	United States Department of Agriculture (USDA); Hankyong National University; Rural Development Administration (RDA); Chung Ang University; United States Department of Agriculture (USDA)	Lillehoj, HS (corresponding author), Agr Res Serv, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD 20705 USA.	Hyun.Lillehoj@ars.usda.gov		Hong, Yeong Ho/0000-0002-4510-7851; Cheng, Hans/0000-0003-2071-4644	ARS CRIS; Next-Generation BioGreen 21 Program [PJ008084, PJ008196]; project 'Investigation of the functional activity and the development of functional foods of Allium hookeri' [PJ010490]; Rural Development Administration, Republic of Korea	ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); project 'Investigation of the functional activity and the development of functional foods of Allium hookeri'; Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by ARS CRIS, partially by grants from the Next-Generation BioGreen 21 Program (No. PJ008084 and No. PJ008196) and the project 'Investigation of the functional activity and the development of functional foods of Allium hookeri (PJ010490)', Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; BUMSTEAD JM, 1995, PARASITOLOGY, V111, P143, DOI 10.1017/S003118200006488X; BUMSTEAD N, 1987, BRIT POULTRY SCI, V28, P705, DOI 10.1080/00071668708417006; Collier CT, 2008, VET IMMUNOL IMMUNOP, V122, P104, DOI 10.1016/j.vetimm.2007.10.014; Dagvadorj J, 2010, IMMUNOLOGY, V129, P97, DOI 10.1111/j.1365-2567.2009.03154.x; Feng Zhi-ying, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1338; Gobel TWF, 2001, INT IMMUNOL, V13, P757, DOI 10.1093/intimm/13.6.757; Hermans PG, 2007, AVIAN PATHOL, V36, P43, DOI 10.1080/03079450601109991; Jang SI, 2012, VACCINE, V30, P5401, DOI 10.1016/j.vaccine.2012.06.007; Ji ZZ, 2011, CHINESE MED J-PEKING, V124, P177, DOI 10.3760/cma.j.issn.0366-6999.2011.02.004; Jia Y, 2013, J CELL PHYSIOL, V228, P476, DOI 10.1002/jcp.24156; JOHNSON J, 1970, EXP PARASITOL, V28, P30, DOI 10.1016/0014-4894(70)90063-9; Kang H, 2012, BIOCHEM BIOPH RES CO, V423, P188, DOI 10.1016/j.bbrc.2012.05.114; Kim DK, 2012, AVIAN DIS, V56, P670, DOI 10.1637/10069-013112-Reg.1; Kim DK, 2013, BRIT J NUTR, V109, P76, DOI 10.1017/S0007114512000530; Langers AMJ, 2008, BRIT J CANCER, V98, P1820, DOI 10.1038/sj.bjc.6604380; Lee KW, 2011, POULTRY SCI, V90, P1381, DOI 10.3382/ps.2010-01319; Lee K, 2011, RES VET SCI, V91, pE80, DOI 10.1016/j.rvsc.2011.01.017; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lee SH, 2009, VET PARASITOL, V163, P123, DOI 10.1016/j.vetpar.2009.04.020; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Liu HC, 2001, ANIM GENET, V32, P351, DOI 10.1046/j.1365-2052.2001.00798.x; McShane LM, 2003, J MAMMARY GLAND BIOL, V8, P359, DOI 10.1023/B:JOMG.0000010035.57912.5a; Min WG, 2005, MOL BIOTECHNOL, V30, P143, DOI 10.1385/MB:30:2:143; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Olkowski AA, 2008, RES VET SCI, V85, P543, DOI 10.1016/j.rvsc.2008.02.007; Park SS, 2008, AVIAN DIS, V52, P14, DOI 10.1637/7997-041707-Reg; Sarson AJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-260; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Timbermont L, 2009, COMP IMMUNOL MICROB, V32, P503, DOI 10.1016/j.cimid.2008.07.001; Van Immerseel F, 2004, AVIAN PATHOL, V33, P537, DOI 10.1080/03079450400013162; Wilson CL, 2009, J BIOL CHEM, V284, P8301, DOI 10.1074/jbc.M809744200; Yoo J, 2009, VET IMMUNOL IMMUNOP, V132, P318, DOI 10.1016/j.vetimm.2009.06.003; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001731; Zhou H, 2009, POULTRY SCI, V88, P1023, DOI 10.3382/ps.2008-00343; Zhou J, 2011, ONCOGENE, V30, P1892, DOI 10.1038/onc.2010.575	37	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114960	10.1371/journal.pone.0114960	http://dx.doi.org/10.1371/journal.pone.0114960			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25504150	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700076
J	deAlmeida, CE; Ochoa, R; de Lima, MC; David, MG; Pires, EJ; Peixoto, JG; Salata, C; Bernal, MA				deAlmeida, Carlos Eduardo; Ochoa, Ricardo; de Lima, Marilene Coelho; David, Mariano Gazineu; Pires, Evandro Jesus; Peixoto, Jose Guilherme; Salata, Camila; Bernal, Mario Antonio			A Feasibility Study of Fricke Dosimetry as an Absorbed Dose to Water Standard for Ir-192 HDR Sources	PLOS ONE			English	Article							MONTE-CARLO CALCULATIONS; FERROUS SULFATE DOSIMETER; WALL CORRECTION FACTORS; CO-60 GAMMA-RAYS; BRACHYTHERAPY SOURCES; CALORIMETRIC METHODS; IONIZATION-CHAMBER; X-RAYS; CALIBRATION; ENERGY	High dose rate brachytherapy (HDR) using Ir-192 sources is well accepted as an important treatment option and thus requires an accurate dosimetry standard. However, a dosimetry standard for the direct measurement of the absolute dose to water for this particular source type is currently not available. An improved standard for the absorbed dose to water based on Fricke dosimetry of HDR Ir-192 brachytherapy sources is presented in this study. The main goal of this paper is to demonstrate the potential usefulness of the Fricke dosimetry technique for the standardization of the quantity absorbed dose to water for Ir-192 sources. A molded, double-walled, spherical vessel for water containing the Fricke solution was constructed based on the Fricke system. The authors measured the absorbed dose to water and compared it with the doses calculated using the AAPM TG-43 report. The overall combined uncertainty associated with the measurements using Fricke dosimetry was 1.4% for k=1, which is better than the uncertainties reported in previous studies. These results are promising; hence, the use of Fricke dosimetry to measure the absorbed dose to water as a standard for HDR Ir-192 may be possible in the future.	[deAlmeida, Carlos Eduardo; Ochoa, Ricardo; de Lima, Marilene Coelho; David, Mariano Gazineu; Pires, Evandro Jesus; Salata, Camila] Univ Estado Rio De Janeiro, IBRAG, LCR, Rio De Janeiro, RJ, Brazil; [Peixoto, Jose Guilherme] Inst Radioprotecao & Dosimetria, LNMRI, Rio de Janeiro, RJ, Brazil; [Bernal, Mario Antonio] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Universidade do Estado do Rio de Janeiro; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Radioprotecao e Dosimetria; Universidade Estadual de Campinas	Salata, C (corresponding author), Univ Estado Rio De Janeiro, IBRAG, LCR, Rio De Janeiro, RJ, Brazil.	mila.salata@gmail.com	Bernal, Mario A/F-2251-2010	Bernal, Mario A/0000-0002-8305-5298; David, Mariano/0000-0002-0254-519X; Salata, Camila/0000-0001-7328-1200	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) - (CS, CEA), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/) - (MGD, CEA), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) - (MAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz C, 2008, MED PHYS, V35, P5360, DOI 10.1118/1.2996178; Borg J, 1999, MED PHYS, V26, P2441, DOI 10.1118/1.598763; Daskalov GM, 1998, MED PHYS, V25, P2200, DOI 10.1118/1.598418; Ferreira IH, 1999, PHYS MED BIOL, V44, P1897, DOI 10.1088/0031-9155/44/8/304; Franco L, 2011, INIS, V50, P111; FREGENE AO, 1967, RADIAT RES, V31, P256, DOI 10.2307/3572325; FREGENE AO, 1966, NATURE, V212, P818, DOI 10.1038/212818a0; IAEA, 1999, TECDOC1079 IAEA; ICRU, 1970, 16 ICRU, DOI [10.1093/jicru/os9.1.Report16, DOI 10.1093/JICRU/OS9.1.REPORT16]; Klassen NV, 1999, PHYS MED BIOL, V44, P1609, DOI 10.1088/0031-9155/44/7/303; MA CM, 1993, PHYS MED BIOL, V38, P93, DOI 10.1088/0031-9155/38/1/007; MA CM, 1993, MED PHYS, V20, P283, DOI 10.1118/1.597128; Marechal MH, 2003, PHYS MEDICA, V19, P131; Meesungnoen J, 2001, RADIAT RES, V155, P269, DOI 10.1667/0033-7587(2001)155[0269:MCCOTP]2.0.CO;2; Melhus CS, 2006, MED PHYS, V33, P1729, DOI 10.1118/1.2199987; Morrison R T., 1992, ORGANIC CHEM; NATH R, 1995, MED PHYS, V22, P209, DOI 10.1118/1.597458; Ochoa R, 2007, RADIOTHER ONCOL, V82, P222, DOI 10.1016/j.radonc.2007.01.005; Olszanski A, 2002, PIRS0815 I NAT MEAS; Rivard MJ, 2004, MED PHYS, V31, P633, DOI 10.1118/1.1646040; Salvat F., 2019, WORK P; Sarfehnia A, 2007, MED PHYS, V34, P4957, DOI 10.1118/1.2815941; Sarfehnia A, 2010, MED PHYS, V37, P1924, DOI 10.1118/1.3352685; Sarfehnia A, 2010, MED PHYS, V37, P1914, DOI 10.1118/1.3366254; Shalek R J, 1969, Ann N Y Acad Sci, V161, P44; Stump KE, 2002, MED PHYS, V29, P1483, DOI 10.1118/1.1487860; Wulff J, 2010, PHYS MED BIOL, V55, P4481, DOI 10.1088/0031-9155/55/16/S04	27	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115155	10.1371/journal.pone.0115155	http://dx.doi.org/10.1371/journal.pone.0115155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521914	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600020
J	Santhakumar, R; Vidyasekar, P; Verma, RS				Santhakumar, Rajalakshmi; Vidyasekar, Prasanna; Verma, Rama Shanker			Cardiogel: A Nano-Matrix Scaffold with Potential Application in Cardiac Regeneration Using Mesenchymal Stem Cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; TISSUE-REPAIR; DIFFERENTIATION; GENE; FIBRONECTIN; INTEGRIN; PROTEIN; VEGF; MECHANISMS; PROSAPOSIN	3-Dimensional conditions for the culture of Bone Marrow-derived Stromal/Stem Cells (BMSCs) can be generated with scaffolds of biological origin. Cardiogel, a cardiac fibroblast-derived Extracellular Matrix (ECM) has been previously shown to promote cardiomyogenic differentiation of BMSCs and provide protection against oxidative stress. To determine the matrix composition and identify significant proteins in cardiogel, we investigated the differences in the composition of this nanomatrix and a BMSC-derived ECM scaffold, termed as 'mesogel'. An optimized protocol was developed that resulted in efficient decellularization while providing the maximum yield of ECM. The proteins were sequentially solubilized using acetic acid, Sodium Dodecyl Sulfate (SDS) and Dithiothreitol (DTT). These proteins were then analyzed using surfactant-assisted in-solution digestion followed by nano-liquid chromatography and tandem mass spectrometry (nLC-MS/MS). The results of these analyses revealed significant differences in their respective compositions and 17 significant ECM/matricellular proteins were differentially identified between cardiogel and mesogel. We observed that cardiogel also promoted cell proliferation, adhesion and migration while enhancing cardiomyogenic differentiation and angiogenesis. In conclusion, we developed a reproducible method for efficient extraction and solubilization of in vitro cultured cell-derived extracellular matrix. We report several important proteins differentially identified between cardiogel and mesogel, which can explain the biological properties of cardiogel. We also demonstrated the cardiomyogenic differentiation and angiogenic potential of cardiogel even in the absence of any external growth factors. The transplantation of Bone Marrow derived Stromal/Stem Cells (BMSCs) cultured on such a nanomatrix has potential applications in regenerative therapy for Myocardial Infarction (MI).	[Santhakumar, Rajalakshmi; Vidyasekar, Prasanna; Verma, Rama Shanker] Indian Inst Technol, Stem Cell & Mol Biol Lab, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Verma, RS (corresponding author), Indian Inst Technol, Stem Cell & Mol Biol Lab, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	vermars@iitm.ac.in		Verma, Rama/0000-0001-7287-7803	MHRD, India; CSIR, India	MHRD, India; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank Dr. Madhulika Dixit, Vascular Biology Lab, Department of Biotechnology, Indian Institute of Technology Madras (IITM), India for providing EA. hy926 cells and Dr. Abdul Jaleel, Rajiv Gandhi Centre for Biotechnology, Trivandrum, India for his assistance in nLC-MS/MS analysis. The authors also would like to thank MHRD, India (RS) and CSIR, India (PV) for their fellowships.	Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011; Banerjee I, 2012, CIRC RES, V110, P456, DOI 10.1161/CIRCRESAHA.111.258616; Bick RJ, 1998, CELL ADHES COMMUN, V6, P301, DOI 10.3109/15419069809010789; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boudoulas KD, 2009, DIS MODEL MECH, V2, P344, DOI 10.1242/dmm.000240; Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Chang W, 2007, TISSUE ENG REGEN MED, V4, P370; Cohen T, 2005, MOL CELL BIOL, V25, P2431, DOI 10.1128/MCB.25.6.2431-2440.2005; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Feng Yong-qiang, 2013, Zhonghua Yi Xue Za Zhi, V93, P939; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gillette JM, 2004, J CELL SCI, V117, P441, DOI 10.1242/jcs.00909; Gronthos S, 2009, STEM CELLS DEV, V18, P1253, DOI 10.1089/scd.2008.0400; Heng BC, 2009, BIOL PROCED ONLINE, V11, P161, DOI 10.1007/s12575-009-9001-4; HILENSKI LL, 1991, CELL TISSUE RES, V264, P577, DOI 10.1007/BF00319047; HILENSKI LL, 1992, CELL MOTIL CYTOSKEL, V21, P87, DOI 10.1002/cm.970210202; Ho JH, 2010, J ORTHOP RES, V28, P131, DOI 10.1002/jor.20956; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jo JO, 2010, BBA-MOL CELL RES, V1803, P1244, DOI 10.1016/j.bbamcr.2010.07.005; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Konttinen YT, 2011, REGENERATIVE MEDICINE: FROM PROTOCOL TO PATIENT, P21, DOI 10.1007/978-90-481-9075-1_2; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/ERC.12.99, 10.1586/erc.12.99]; Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003; Li JP, 2007, AM J PHYSIOL-HEART C, V293, pH3415, DOI 10.1152/ajpheart.00532.2007; Li N, 2010, J NEUROCHEM, V112, P1527, DOI 10.1111/j.1471-4159.2009.06565.x; Liu LY, 2007, LANGMUIR, V23, P11168, DOI 10.1021/la701435x; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; Pino AM, 2012, BIOL RES, V45, P279, DOI 10.4067/S0716-97602012000300009; Masago Y, 2012, J CELL SCI, V125, P1118, DOI 10.1242/jcs.089748; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; Palumbo S, 2013, TISSUE ENG PT A, V19, P2176, DOI [10.1089/ten.tea.2012.0550, 10.1089/ten.TEA.2012.0550]; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; Sauer H, 2013, STEM CELLS DEV, V22, P1443, DOI 10.1089/scd.2012.0640; Schmuck EG, 2014, CARDIOVASC ENG TECHN, V5, P119, DOI 10.1007/s13239-013-0167-1; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052; Segers VFM, 2010, J CARDIOVASC TRANSL, V3, P469, DOI 10.1007/s12265-010-9207-5; Shyamsunder P, 2013, GENE, V531, P444, DOI 10.1016/j.gene.2013.08.082; Shyamsunder P, 2013, GENE, V527, P521, DOI 10.1016/j.gene.2013.06.051; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467; Sreejit P, 2013, CELL TISSUE RES, V353, P443, DOI 10.1007/s00441-013-1661-3; Sreejit P, 2011, EUR CELLS MATER, V21, P107, DOI 10.22203/eCM.v021a09; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Tekkatte C, 2012, CELL TISSUE RES, V347, P383, DOI 10.1007/s00441-012-1328-5; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Turturici G, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/618127; VanWinkle WB, 1996, IN VITRO CELL DEV-AN, V32, P478; Villegas SN, 2013, ELIFE, V2, DOI 10.7554/eLife.00806; VITADELLO M, 1990, J CELL SCI, V97, P11; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; Yan BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075580; Ye L, 2013, CIRCULATION, V128, pS32, DOI 10.1161/CIRCULATIONAHA.112.000025; Zhang FB, 2005, BIOCHEM BIOPH RES CO, V336, P784, DOI 10.1016/j.bbrc.2005.08.177; Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0	68	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114697	10.1371/journal.pone.0114697	http://dx.doi.org/10.1371/journal.pone.0114697			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521816	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600007
J	Wang, CK; Da, Y				Wang, Chunkao; Da, Yang			Quantitative Genetics Model as the Unifying Model for Defining Genomic Relationship and Inbreeding Coefficient	PLOS ONE			English	Article							WIDE ASSOCIATION; SELECTION; DEPRESSION; VARIANCE	The traditional quantitative genetics model was used as the unifying approach to derive six existing and new definitions of genomic additive and dominance relationships. The theoretical differences of these definitions were in the assumptions of equal SNP effects (equivalent to across-SNP standardization), equal SNP variances (equivalent to within-SNP standardization), and expected or sample SNP additive and dominance variances. The six definitions of genomic additive and dominance relationships on average were consistent with the pedigree relationships, but had individual genomic specificity and large variations not observed from pedigree relationships. These large variations may allow finding least related genomes even within the same family for minimizing genomic relatedness among breeding individuals. The six definitions of genomic relationships generally had similar numerical results in genomic best linear unbiased predictions of additive effects (GBLUP) and similar genomic REML (GREML) estimates of additive heritability. Predicted SNP dominance effects and GREML estimates of dominance heritability were similar within definitions assuming equal SNP effects or within definitions assuming equal SNP variance, but had differences between these two groups of definitions. We proposed a new measure of genomic inbreeding coefficient based on parental genomic co-ancestry coefficient and genomic additive correlation as a genomic approach for predicting offspring inbreeding level. This genomic inbreeding coefficient had the highest correlation with pedigree inbreeding coefficient among the four methods evaluated for calculating genomic inbreeding coefficient in a Holstein sample and a swine sample.	[Wang, Chunkao; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Da, Y (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	yda@umn.edu			United States Department of Agriculture (USDA) National Institute of Food and Agriculture [2011-67015-30333]; Agricultural Experiment Station at the University of Minnesota [MN-16-043]; National Research Initiative Competitive [2008-35205-18846]; USDA National Institute of Food and Agriculture; Holstein Association USA	United States Department of Agriculture (USDA) National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Agricultural Experiment Station at the University of Minnesota(University of Minnesota System); National Research Initiative Competitive(United States Department of Agriculture (USDA)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Holstein Association USA	This research was supported by United States Department of Agriculture (USDA) National Institute of Food and Agriculture Grant no. 2011-67015-30333 and by project MN-16-043 of the Agricultural Experiment Station at the University of Minnesota. The Holstein SNP data were supported by National Research Initiative Competitive Grant no. 2008-35205-18846 from the USDA National Institute of Food and Agriculture and by a financial contribution from Holstein Association USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GENETICS ANAL QUANTI; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Da Y, 2013, PLANT ANIMAL GENOME; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; Falconer D. S., 1996, INTRO QUANTITATIVE G; Garbe J., 2008, PEDIGRAPH SOFTWARE T; Garbe JR, 2008, MINIINBRED COMPUTER; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Ma L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-536; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Wang CK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-270; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	21	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114484	10.1371/journal.pone.0114484	http://dx.doi.org/10.1371/journal.pone.0114484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517971	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600021
J	Huang, K; Kiefer, C; Kamal, A				Huang, Keven; Kiefer, Christine; Kamal, Adeela			Novel Role for NFAT3 in ERK-Mediated Regulation of CXCR4	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; PROTEIN-COUPLED RECEPTOR; HUMAN T-LYMPHOCYTES; CELL LUNG-CANCER; ENDOTHELIAL-CELLS; UP-REGULATION; HIV-1 ENTRY; TRANSCRIPTIONAL REGULATION; TYROSINE PHOSPHORYLATION; FUNCTIONAL EXPRESSION	The G-protein coupled chemokine (C-X-C motif) receptor CXCR4 is linked to cancer, HIV, and WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) syndrome. While CXCR4 is reported to be overexpressed in multiple human cancer types and many hematological cancer cell lines, we have observed poor in vitro cell surface expression of CXCR4 in many solid tumor cell lines. We explore further the possible factors and pathways involved in regulating CXCR4 expression. Here, we showed that MEK-ERK signaling pathway and NFAT3 transcriptional factor plays a novel role in regulating CXCR4 expression. When cultured as 3D spheroids, HeyA8 ovarian tumor cells showed a dramatic increase in surface CXCR4 protein levels as well as mRNA transcripts. Furthermore, HeyA8 3D spheroids showed a decrease in phospho-ERK levels when compared to adherent cells. The treatment of adherent HeyA8 cells with an inhibitor of the MEK-ERK pathway, U0126, resulted in a significant increase in surface CXCR4 expression. Additional investigation using the PCR array assay comparing adherent to 3D spheroid showed a wide range of transcription factors being up-regulated, most notably a> 20 fold increase in NFAT3 transcription factor mRNA. Finally, chromatin immunoprecipitation (ChIP) analysis showed that direct binding of NFAT3 on the CXCR4 promoter corresponds to increased CXCR4 expression in HeyA8 ovarian cell line. Taken together, our results suggest that high phospho-ERK levels and NFAT3 expression plays a novel role in regulating CXCR4 expression.	[Huang, Keven; Kamal, Adeela] MedImmune, Dept Oncol Res, Gaithersburg, MD 20878 USA; [Kiefer, Christine] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Huang, K (corresponding author), MedImmune, Dept Oncol Res, Gaithersburg, MD 20878 USA.	huangke@medimmune.com		Kiefer, Christine/0000-0003-0823-9502	MedImmune	MedImmune(AstraZenecaMedimmune)	MedImmune funded the work mentioned. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Baal N, 2009, LAB INVEST, V89, P152, DOI 10.1038/labinvest.2008.126; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; BATES RC, 1994, J CELL BIOL, V125, P403, DOI 10.1083/jcb.125.2.403; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Cristillo AD, 2003, MOL IMMUNOL, V40, P539, DOI 10.1016/S0161-5890(03)00169-X; Cristillo AD, 2002, FASEB J, V16, DOI 10.1096/fj.01-0744com; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Feil C, 1998, BIOCHEM BIOPH RES CO, V247, P38, DOI 10.1006/bbrc.1998.8499; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Feng YK, 2011, EUR J CANCER, V47, P2353, DOI 10.1016/j.ejca.2011.05.006; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; GOLD MR, 1994, ADV IMMUNOL, V55, P221; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Han YL, 2001, BRAIN RES, V888, P1, DOI 10.1016/S0006-8993(00)02924-3; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Huang YC, 2007, BIOCHEM PHARMACOL, V74, P1702, DOI 10.1016/j.bcp.2007.08.025; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Ishikawa T, 2009, ONCOL REP, V21, P707, DOI 10.3892/or_00000275; Jourdan P, 2000, J IMMUNOL, V165, P716, DOI 10.4049/jimmunol.165.2.716; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kress TR, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-1; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Kuroda Y, 2012, MOL CELL BIOL, V32, P2954, DOI 10.1128/MCB.05611-11; Lincz LF, 1997, DIFFERENTIATION, V61, P261, DOI 10.1046/j.1432-0436.1997.6140261.x; Luo C, 1996, MOL CELL BIOL, V16, P3955; MILLER FR, 1989, CANCER RES, V49, P6091; Moriuchi M, 1999, J IMMUNOL, V162, P5986; Moriuchi M, 1997, J IMMUNOL, V159, P4322; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Pfeiffer M, 2009, BRIT J CANCER, V100, P1949, DOI 10.1038/sj.bjc.6605068; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang JH, 2001, J BIOL CHEM, V276, P49236, DOI 10.1074/jbc.M108523200; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754; WEISS A, 1984, J IMMUNOL, V133, P123; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	57	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115249	10.1371/journal.pone.0115249	http://dx.doi.org/10.1371/journal.pone.0115249			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514788	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300046
J	Brehm, MA; Kempen, JCE; van der Kooi, AJ; de Groot, IJM; van den Bergen, JC; Verschuuren, JJGM; Niks, EH; Harlaar, J				Brehm, Merel-Anne; Kempen, Jiska C. E.; van der Kooi, Anneke J.; de Groot, Imelda J. M.; van den Bergen, Janneke C.; Verschuuren, Jan J. G. M.; Niks, Erik H.; Harlaar, Jaap			Age-Related Longitudinal Changes in Metabolic Energy Expenditure during Walking in Boys with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							COST; GAIT; CHILDREN; OXYGEN; DISEASE; SPEED	Objective: The aim of this study was to evaluate age-related changes in metabolic walking energy expenditure in ambulant boys affected by Duchenne muscular dystrophy over a follow-up period of 12 months. Methods: At baseline (T1) and 12 months later (T2), metabolic walking energy expenditure was assessed during a 6-minute walk test at comfortable speed in 14 ambulant boys with Duchenne (age range: 6.0-12.5 years, mean 8.2). Outcome measures derived from the assessment included the 6-minute comfortable walking distance (m) and net-nondimensional energy cost relative to speed-matched control cost (SMC-EC, %). Statistical comparisons were made using a two-way repeated measures ANOVA (factors: time (T1 versus T2) and age (<8 years of age (yoa) versus >= 8 yoa)). Results: Over the course of the study, a significant decrease of -28m (-8.2%, p=0.043) was noted in the walked distance at comfortable speed. Besides, SMC-EC increased with 4.4%, although this change was not significant (p=0.452). Regarding age groups, boys below 8 yoa showed a smaller annual decrease in the walked distance (-15 m) compared to boys above 8 yoa (-37 m). SMC-EC increased with 10% in the older boys, while in the younger boys it decreased (-2.1%). The main effect of age group on walking distance and SMC-EC however was not significant (p>0.158), and also there were no interaction effects (p>0.248). Conclusions: The results of our small study suggest that the natural course of walking performance in ambulant boys with Duchenne is characterized by a decrease in comfortable walking distance and an increase in walking energy cost. The rate of energy cost seems to increase with age, while walking distance decreases, which is opposite from the trend in typically developing children.	[Brehm, Merel-Anne; Kempen, Jiska C. E.; Harlaar, Jaap] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Brehm, Merel-Anne; Kempen, Jiska C. E.; Harlaar, Jaap] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst, Amsterdam, Netherlands; [Brehm, Merel-Anne] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1105 AZ Amsterdam, Netherlands; [van der Kooi, Anneke J.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [de Groot, Imelda J. M.] Radboud Univ Nijmegen Med Ctr, Dept Rehabil, Nijmegen, Netherlands; [van den Bergen, Janneke C.; Verschuuren, Jan J. G. M.; Niks, Erik H.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brehm, MA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands.	m.a.brehm@amc.uva.nl	Brehm, Merel-Anne/AAK-7419-2020; Niks, Erik H/M-3520-2016; Brehm, Merel-Anne/K-8638-2017; de Groot, I.J.M./L-4339-2015	Brehm, Merel-Anne/0000-0002-3425-4661; Niks, Erik H/0000-0001-5892-5143; Brehm, Merel-Anne/0000-0002-3425-4661; Verschuuren, Jan/0000-0002-4572-1501; van der Kooi, Anneke/0000-0002-5261-5512; Harlaar, Jaap/0000-0003-2889-271X	Prosensa Therapeutics BV	Prosensa Therapeutics BV	This study was funded by Prosensa Therapeutics BV. The funder contributed to discussions regarding the study protocol and study execution. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funder had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	BarOr O, 1996, MED SCI SPORT EXER, V28, P421, DOI 10.1097/00005768-199604000-00005; Bendixen RM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-43; Brehm MA, 2006, ARCH PHYS MED REHAB, V87, P136, DOI 10.1016/j.apmr.2005.08.123; Brehm MA, 2004, GAIT POSTURE, V20, P67, DOI 10.1016/S0966-6362(03)00097-3; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'Angelo MG, 2009, GAIT POSTURE, V29, P36, DOI 10.1016/j.gaitpost.2008.06.002; European Medical Agency, 2013, GUID CLIN INV MED PR; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Henricson E, 2013, PLOS CURR, V5, DOI [10.1371/currents.md.9e17658b007eb79fcd6f723089f79e06, DOI 10.1371/CURRENTS.MD.9E17658B007EB79FCD6F723089F79E06]; HSU JD, 1993, CLIN ORTHOP RELAT R, P122; Kempen JCE, 2014, NEUROMUSCULAR DISORD, V24, P216, DOI 10.1016/j.nmd.2013.11.015; Marconi V, 2012, EUR J PHYS REHAB MED, V48, P403; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Morgan DW, 2004, EUR J APPL PHYSIOL, V91, P30, DOI 10.1007/s00421-003-0945-9; PRIEDE IG, 1977, NATURE, V267, P610, DOI 10.1038/267610a0; Schwartz MH, 2006, GAIT POSTURE, V24, P14, DOI 10.1016/j.gaitpost.2005.06.014; SUTHERLAND DH, 1981, DEV MED CHILD NEUROL, V23, P3; Thomas SS, 2011, J PEDIATR REHAB MED, V4, P225, DOI 10.3233/PRM-2011-0178; Thomas SS, 2010, J CHILD NEUROL, V25, P1103, DOI 10.1177/0883073810371002; Van de Walle P, 2010, GAIT POSTURE, V31, P495, DOI 10.1016/j.gaitpost.2010.02.008; WATERS RL, 1983, DEV MED CHILD NEUROL, V25, P184; WATERS RL, 1988, J ORTHOPAED RES, V6, P215, DOI 10.1002/jor.1100060208; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0	30	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115200	10.1371/journal.pone.0115200	http://dx.doi.org/10.1371/journal.pone.0115200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506914	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100058
J	Olotu, A; Clement, F; Jongert, E; Vekemans, J; Njuguna, P; Ndungu, FM; Marsh, K; Leroux-Roels, G; Bejon, P				Olotu, Ally; Clement, Frederic; Jongert, Erik; Vekemans, Johan; Njuguna, Patricia; Ndungu, Francis M.; Marsh, Kevin; Leroux-Roels, Geert; Bejon, Philip			Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01(E) in Young Children	PLOS ONE			English	Article							CANDIDATE MALARIA VACCINE; PHASE 2A TRIAL; PLASMODIUM-FALCIPARUM INFECTION; LINKED-IMMUNOSORBENT-ASSAY; HUMORAL IMMUNE-RESPONSES; NAIVE ADULTS; DOUBLE-BLIND; EFFICACY; PROTEIN; SAFETY	Background: The nature of protective immune responses elicited by immunization with the candidate malaria vaccine RTS, S is still incompletely understood. Antibody levels correlate with protection against malaria infection, but considerable variation in outcome is unexplained (e.g., children may experience malaria despite high anticircumsporozoite [CS] titers). Methods and Findings: We measured the avidity index (AI) of the anti-CS antibodies raised in subgroup of 5-17 month old children in Kenya who were vaccinated with three doses of RTS, S/AS01(E) between March and August 2007. We evaluated the association between the AI and the subsequent risk of clinical malaria. We selected 19 cases (i.e., with clinical malaria) and 42 controls (i.e., without clinical malaria), matching for anti-CS antibody levels and malaria exposure. We assessed their sera collected 1 month after the third dose of the vaccine, in March 2008 (range 4-10 months after the third vaccine), and at 12 months after the third vaccine dose. The mean AI was 45.2 (95% CI: 42.4 to 48.1), 45.3 (95% CI: 41.4 to 49.1) and 46.2 (95% CI; 43.2 to 49.3) at 1 month, in March 2008 (4-10 months), and at 12 months after the third vaccination, respectively (p=0.9 by ANOVA test for variation over time). The AI was not associated with protection from clinical malaria (OR=0.90; 95% CI: 0.49 to 1.66; p=0.74). The AI was higher in children with high malaria exposure, as measured using the weighted local prevalence of malaria, compared to those with low malaria exposure at 1 month post dose 3 (p=0.035). Conclusion: Our data suggest that in RTS, S/AS01(E)-vaccinated children residing in malaria endemic countries, the avidity of anti-circumsporozoite antibodies, as measured using an elution ELISA method, was not associated with protection from clinical malaria. Prior natural malaria exposure might have primed the response to RTS, S/AS01(E) vaccination.	[Olotu, Ally; Njuguna, Patricia; Ndungu, Francis M.; Marsh, Kevin; Bejon, Philip] KEMRI Wellcome Trust Res Programme, Ctr Geog Med Res, Coast, Kilifi, Kenya; [Clement, Frederic; Leroux-Roels, Geert] Univ Ghent, Ctr Vaccinol, B-9000 Ghent, Belgium; [Jongert, Erik; Vekemans, Johan] GlaxoSmithKline Vaccines, Wavre, Belgium; [Olotu, Ally] Ifakara Hlth Inst, Bagamoyo, Tanzania	Ghent University; GlaxoSmithKline; Ifakara Health Institute	Olotu, A (corresponding author), KEMRI Wellcome Trust Res Programme, Ctr Geog Med Res, Coast, Kilifi, Kenya.	Aolotu@ihi.or.tz	Ndungu, Francis Maina/C-2199-2019; Clement, Frederic P/B-2204-2009	Ndungu, Francis Maina/0000-0002-8977-0030; Clement, Frederic P/0000-0002-2720-3655	PATH Malaria Vaccine Initiative (MVI); Wellcome Trust; MRC [G1002624]; Wellcome Trust [084538]; Medical Research Council [G1002624] Funding Source: researchfish	PATH Malaria Vaccine Initiative (MVI); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project has been funded by PATH Malaria Vaccine Initiative (MVI) and Wellcome Trust. KM is supported by the Wellcome Trust. PB is funded by an MRC Fellowship (G1002624). AO is funded by a Wellcome Trust Strategic Award (084538). The Wellcome Trust had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MVI had no other role in data collection or analysis, and the decision to publish was covered by a pre-study agreement.	Almanzar G, 2013, J IMMUNOL METHODS, V387, P36, DOI 10.1016/j.jim.2012.09.008; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Anttila M, 1998, J INFECT DIS, V177, P1614, DOI 10.1086/515298; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bachmann MF, 1997, SCIENCE, V276, P2024, DOI 10.1126/science.276.5321.2024; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; CHAROENVIT Y, 1991, J IMMUNOL, V146, P1020; Chroboczek J, 2014, ACTA BIOCHIM POL, V61, P531; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Daher LJ, 2010, INFECT IMMUN, V78, P477, DOI 10.1128/IAI.00941-08; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Hearty S, 2010, EXPERT REV VACCINES, V9, P645, DOI [10.1586/erv.10.52, 10.1586/ERV.10.52]; Ibison F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052939; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lalvani A, 1999, J INFECT DIS, V180, P1656, DOI 10.1086/315074; Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Longworth E, 2002, VACCINE, V20, P2592, DOI 10.1016/S0264-410X(02)00151-2; Ndungu FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052870; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Olotu AI, 2010, J INFECT DIS, V201, P970, DOI 10.1086/651025; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Reddy SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032242; Reed RC, 1996, VACCINE, V14, P828, DOI 10.1016/0264-410X(95)00175-Z; Reed RC, VACCINE J IMMUNOL, V14146; Romero-Steiner S, 2005, CLIN DIAGN LAB IMMUN, V12, P1029, DOI 10.1128/CDLI.12.9.1029-1035.2005; Rzepczyk CM, 1997, INFECT IMMUN, V65, P1098, DOI 10.1128/IAI.65.3.1098-1100.1997; SCHLESINGER Y, 1992, JAMA-J AM MED ASSOC, V267, P1489, DOI 10.1001/jama.267.11.1489; Schwenk R, 2003, PARASITE IMMUNOL, V25, P17, DOI 10.1046/j.1365-3024.2003.00495.x; SHI YP, 1993, INFECT IMMUN, V61, P2425, DOI 10.1128/IAI.61.6.2425-2433.1993; Siegrist CA, 2004, VACCINE, V23, P615, DOI 10.1016/j.vaccine.2004.07.014; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; ZAVALA F, 1986, J IMMUNOL METHODS, V93, P55, DOI 10.1016/0022-1759(86)90432-1; ZAVALA F, 1983, J EXP MED, V157, P1947, DOI 10.1084/jem.157.6.1947; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	50	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115126	10.1371/journal.pone.0115126	http://dx.doi.org/10.1371/journal.pone.0115126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506706	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100052
J	Wiech, K; Edwards, R; Moseley, GL; Berna, C; Ploner, M; Tracey, I				Wiech, Katja; Edwards, Robert; Moseley, Graham Lorimer; Berna, Chantal; Ploner, Markus; Tracey, Irene			Dissociable Neural Mechanisms Underlying the Modulation of Pain and Anxiety? An fMRI Pilot Study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; PERCEIVED CONTROLLABILITY; PLACEBO ANALGESIA; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; VOLUNTARY SUPPRESSION; BRAIN RESPONSES; VISCERAL PAIN; EMOTION; CONNECTIVITY	The down-regulation of pain through beliefs is commonly discussed as a form of emotion regulation. In line with this interpretation, the analgesic effect has been shown to co-occur with reduced anxiety and increased activity in the ventrolateral prefrontal cortex (VLPFC), which is a key region of emotion regulation. This link between pain and anxiety modulation raises the question whether the two effects are rooted in the same neural mechanism. In this pilot fMRI study, we compared the neural basis of the analgesic and anxiolytic effect of two types of threat modulation: a "behavioral control'' paradigm, which involves the ability to terminate a noxious stimulus, and a "safety signaling'' paradigm, which involves visual cues that signal the threat (or absence of threat) that a subsequent noxious stimulus might be of unusually high intensity. Analgesia was paralleled by VLPFC activity during behavioral control. Safety signaling engaged elements of the descending pain control system, including the rostral anterior cingulate cortex that showed increased functional connectivity with the periaqueductal gray and VLPFC. Anxiety reduction, in contrast, scaled with dorsolateral prefrontal cortex activation during behavioral control but had no distinct neural signature during safety signaling. Our pilot data therefore suggest that analgesic and anxiolytic effects are instantiated in distinguishable neural mechanisms and differ between distinct stress-and pain-modulatory approaches, supporting the recent notion of multiple pathways subserving top-down modulation of the pain experience. Additional studies in larger cohorts are needed to follow up on these preliminary findings.	[Wiech, Katja; Tracey, Irene] Univ Oxford, John Radcliffe Hosp, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Wiech, Katja; Moseley, Graham Lorimer; Berna, Chantal; Tracey, Irene] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Edwards, Robert] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Chestnut Hill, MA USA; [Moseley, Graham Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia; [Moseley, Graham Lorimer] Neurosci Res Australia, Sydney, NSW, Australia; [Berna, Chantal] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Ploner, Markus] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany	University of Oxford; University of Oxford; Harvard University; Brigham & Women's Hospital; University of South Australia; Neuroscience Research Australia; University of Oxford; Technical University of Munich	Wiech, K (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Div Anaesthet, Nuffield Dept Clin Neurosci, Headley Way, Oxford OX3 9DU, England.	katja.wiech@ndcn.ox.ac.uk	Ploner, Markus/C-3281-2013; Moseley, Lorimer/A-7095-2009	Ploner, Markus/0000-0002-7767-7170; Moseley, Lorimer/0000-0002-3750-4945; Tracey, Irene/0000-0003-4134-6115; Berna, Chantal/0000-0001-8258-7412	Odysseus Grant by the 'Fund for Scientific Research' - Flanders, Belgium (FWO); National Health & Medical Research Council of Australia [571090]; MRC [G0700399] Funding Source: UKRI; Medical Research Council [G0700399] Funding Source: researchfish; National Center for Complementary & Integrative Health [P01AT006663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR051315, R01AR064367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034982] Funding Source: NIH RePORTER	Odysseus Grant by the 'Fund for Scientific Research' - Flanders, Belgium (FWO); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The contribution of KW was supported by an Odysseus Grant by the 'Fund for Scientific Research' - Flanders, Belgium (FWO). GLM was supported by the National Health & Medical Research Council of Australia (571090). The authors wish to acknowledge the Medical Research Council Great Britain and Northern Ireland and Wellcome Trust (FMRIB Centre and IT), and the International Association for the Study of Pain (RE, IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Berman SM, 2008, J NEUROSCI, V28, P349, DOI 10.1523/JNEUROSCI.2500-07.2008; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Borckardt JJ, 2011, PAIN, V152, P182, DOI 10.1016/j.pain.2010.10.018; Campbell CM, 2009, TRANSL RES, V153, P97, DOI 10.1016/j.trsl.2008.12.002; Christianson JP, 2008, J NEUROSCI, V28, P13703, DOI 10.1523/JNEUROSCI.4270-08.2008; Edwards RR, 2011, NAT REV RHEUMATOL, V7, P216, DOI 10.1038/nrrheum.2011.2; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Fairhurst M, 2007, PAIN, V128, P101, DOI 10.1016/j.pain.2006.09.001; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Flaten MA, 2011, PHILOS T R SOC B, V366, P1818, DOI 10.1098/rstb.2010.0407; Friston K, 1995, HUM BRAIN MAPP, V2, P1; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Hubbard CS, 2011, PAIN, V152, P1632, DOI 10.1016/j.pain.2011.03.001; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Lee HF, 2012, PAIN, V153, P1301, DOI 10.1016/j.pain.2012.03.018; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Mayer EA, 2005, PAIN, V115, P398, DOI 10.1016/j.pain.2005.03.023; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; Mohr C, 2012, EUR J PAIN, V16, P496, DOI 10.1016/j.ejpain.2011.07.010; Moseley GL, 2007, PAIN, V133, P64, DOI 10.1016/j.pain.2007.03.002; Moseley GL, 2004, EUR J PAIN, V8, P39, DOI 10.1016/S1090-3801(03)00063-6; Moseley GL, 2003, AUST J PHYSIOTHER, V49, P263, DOI 10.1016/S0004-9514(14)60142-2; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Pellino TA, 1998, J PAIN SYMPTOM MANAG, V15, P110, DOI 10.1016/S0885-3924(97)00255-8; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Petrovic P, 2010, PAIN, V150, P59, DOI 10.1016/j.pain.2010.03.011; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Porto PR, 2009, J NEUROPSYCH CLIN N, V21, P114, DOI 10.1176/appi.neuropsych.21.2.114; Rokke PD, 2004, J BEHAV MED, V27, P343, DOI 10.1023/B:JOBM.0000042409.81856.5c; Salomons TV, 2007, J COGNITIVE NEUROSCI, V19, P993, DOI 10.1162/jocn.2007.19.6.993; Salomons TV, 2004, J NEUROSCI, V24, P7199, DOI 10.1523/JNEUROSCI.1315-04.2004; SCHARFF L, 1995, HEADACHE, V35, P527, DOI 10.1111/j.1526-4610.1995.hed3509527.x; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Skinner EA, 2011, OXFORD HDB STRESS HL; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Van Oudenhove L, 2010, AM J GASTROENTEROL, V105, P913, DOI 10.1038/ajg.2010.39; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; WEISENBERG M, 1985, PAIN, V23, P187, DOI 10.1016/0304-3959(85)90059-4; Wiech K, 2008, PAIN, V139, P467, DOI 10.1016/j.pain.2008.07.030; Wiech K, 2006, J NEUROSCI, V26, P11501, DOI 10.1523/JNEUROSCI.2568-06.2006	54	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e110654	10.1371/journal.pone.0110654	http://dx.doi.org/10.1371/journal.pone.0110654			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502237	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000346607100001
J	Olivieri, L; Gardebien, F				Olivieri, Lilian; Gardebien, Fabrice			Structure-Affinity Properties of a High-Affinity Ligand of FKBP12 Studied by Molecular Simulations of a Binding Intermediate	PLOS ONE			English	Article							X-RAY STRUCTURES; DYNAMICS SIMULATIONS; COMPUTATIONAL ANALYSIS; PROTEIN; COMPLEXES; FK506; RAPAMYCIN; IMMUNOPHILIN; INHIBITORS; DESIGN	With a view to explaining the structure-affinity properties of the ligands of the protein FKBP12, we characterized a binding intermediate state between this protein and a high-affinity ligand. Indeed, the nature and extent of the intermolecular contacts developed in such a species may play a role on its stability and, hence, on the overall association rate. To find the binding intermediate, a molecular simulation protocol was used to unbind the ligand by gradually decreasing the biasing forces introduced. The intermediate was subsequently refined with 17 independent stochastic boundary molecular dynamics simulations that provide a consistent picture of the intermediate state. In this state, the core region of the ligand remains stable, notably because of the two anchoring oxygen atoms that correspond to recurrent motifs found in all FKBP12 ligand core structures. Besides, the non-core regions participate in numerous transient intermolecular and intramolecular contacts. The dynamic aspect of most of the contacts seems important both for the ligand to retain at least a part of its configurational entropy and for avoiding a trapped state along the binding pathway. Since the transient and anchoring contacts contribute to increasing the stability of the intermediate, as a corollary, the dissociation rate constant k(-1) of this intermediate should be decreased, resulting in an increase of the affinity constant K-a. The present results support our previous conclusions and provide a coherent rationale for explaining the prevalence in high-affinity ligands of (i) the two oxygen atoms found in carbonyl or sulfonyl groups of dissimilar core structures and of (ii) symmetric or pseudo-symmetric mobile groups of atoms found as non-core moieties. Another interesting aspect of the intermediate is the distortion of the flexible 80 s loop of the protein, mainly in its tip region, that promotes the accessibility to the bound state.	[Gardebien, Fabrice] INSERM, DSIMB, U1134, F-75015 Paris, France; Univ Reunion, Fac Sci & Technol, UMR S 1134, F-97715 St Denis 05, Reunion, France; Inst Natl Transfus Sanguine, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; University of La Reunion	Gardebien, F (corresponding author), INSERM, DSIMB, U1134, F-75015 Paris, France.	Fabrice.Gardebien@univ-reunion.fr		Gardebien, Fabrice/0000-0002-2019-010X	French Ministry of Research; Laboratory of Excellence GR-Ex [ANR-11-LABX-0051]; French National Research Agency [ANR-11-IDEX-0005-02]	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Laboratory of Excellence GR-Ex; French National Research Agency(French National Research Agency (ANR))	L. Olivieri was the recipient of a doctoral fellowship from the French Ministry of Research. This study was supported by grants from Laboratory of Excellence GR-Ex, reference ANR-11-LABX-0051. The labex GR-Ex is funded by the program 'Investissements d'avenir' of the French National Research Agency, reference ANR-11-IDEX-0005-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babine RE, 1997, CHEM REV, V97, P1359, DOI 10.1021/cr960370z; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Burkhard P, 2000, J MOL BIOL, V295, P953, DOI 10.1006/jmbi.1999.3411; Chang CEA, 2008, P NATL ACAD SCI USA, V105, P7456, DOI 10.1073/pnas.0800452105; Curcio R, 2005, PROTEIN SCI, V14, P2499, DOI 10.1110/ps.041280705; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; DeCenzo MT, 1996, PROTEIN ENG, V9, P173, DOI 10.1093/protein/9.2.173; Frisch M. J., 2004, GAUSSIAN03; Hamilton GS, 1997, BIOORG MED CHEM LETT, V7, P1785, DOI 10.1016/S0960-894X(97)00304-1; Herdegen Thomas, 2000, Trends in Pharmacological Sciences, V21, P3, DOI 10.1016/S0165-6147(99)01407-8; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Huang H, 2009, J CHEM THEORY COMPUT, V5, P1304, DOI 10.1021/ct9000153; Ivery MTG, 1997, BIOORGAN MED CHEM, V5, P217, DOI 10.1016/S0968-0896(96)00229-5; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Lamb ML, 1998, J MED CHEM, V41, P3928, DOI 10.1021/jm980062o; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lemons DS, 1997, AM J PHYS, V65, P1079, DOI 10.1119/1.18725; Li AJ, 1998, J MOL BIOL, V275, P677, DOI 10.1006/jmbi.1997.1484; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MICHNICK SW, 1991, SCIENCE, V252, P836, DOI 10.1126/science.1709301; Mittag T, 2004, J AM CHEM SOC, V126, P9017, DOI 10.1021/ja0392519; Olivieri L, 2014, J MOL GRAPH MODEL, V49, P118, DOI 10.1016/j.jmgm.2014.02.003; Olivieri L, 2011, J CHEM THEORY COMPUT, V7, P725, DOI 10.1021/ct100394d; Paci E, 2001, J MOL BIOL, V314, P589, DOI 10.1006/jmbi.2001.5103; Peters GH, 1999, PROTEIN ENG, V12, P747, DOI 10.1093/protein/12.9.747; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROSEN MK, 1992, ANGEW CHEM INT EDIT, V31, P384, DOI 10.1002/anie.199203841; ROSEN MK, 1993, J AM CHEM SOC, V115, P821, DOI 10.1021/ja00055a082; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sun F, 2003, BIOPHYS J, V85, P3194, DOI 10.1016/S0006-3495(03)74737-7; Swegat W, 2003, BIOPHYS J, V84, P1493, DOI 10.1016/S0006-3495(03)74962-5; Szep S, 2009, PROTEINS, V74, P603, DOI 10.1002/prot.22176; Teplyakov A, 1996, EMBO J, V15, P3487, DOI 10.1002/j.1460-2075.1996.tb00717.x; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; WILSON KP, 1995, ACTA CRYSTALLOGR D, V51, P511, DOI 10.1107/S0907444994014514; Xu Y, 2006, PROTEINS, V64, P1058, DOI 10.1002/prot.21044; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Zacharias M, 2004, PROTEINS, V54, P759, DOI 10.1002/prot.10637; Zhao LQ, 2006, BIOORG MED CHEM LETT, V16, P4385, DOI 10.1016/j.bmcl.2006.05.044	46	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114610	10.1371/journal.pone.0114610	http://dx.doi.org/10.1371/journal.pone.0114610			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502559	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400039
J	Peng, L; Paulson, A; Li, H; Piekos, S; He, X; Li, LH; Zhong, XB				Peng, Lai; Paulson, Ariel; Li, Hua; Piekos, Stephanie; He, Xi; Li, Linheng; Zhong, Xiao-bo			Developmental Programming of Long Non-Coding RNAs during Postnatal Liver Maturation in Mice	PLOS ONE			English	Article							INTEGRATIVE ANNOTATION; REVEALS; MOUSE; DIFFERENTIATION; TRANSCRIPTION; QUANTIFICATION; ORGANOGENESIS; FRONTIER; GENOME; SEQ	The liver is a vital organ with critical functions in metabolism, protein synthesis, and immune defense. Most of the liver functions are not mature at birth and many changes happen during postnatal liver development. However, it is unclear what changes occur in liver after birth, at what developmental stages they occur, and how the developmental processes are regulated. Long non-coding RNAs (lncRNAs) are involved in organ development and cell differentiation. Here, we analyzed the transcriptome of lncRNAs in mouse liver from perinatal (day -2) to adult (day 60) by RNA-Sequencing, with an attempt to understand the role of lncRNAs in liver maturation. We found around 15,000 genes expressed, including about 2,000 lncRNAs. Most lncRNAs were expressed at a lower level than coding RNAs. Both coding RNAs and lncRNAs displayed three major ontogenic patterns: enriched at neonatal, adolescent, or adult stages. Neighboring coding and noncoding RNAs showed the trend to exhibit highly correlated ontogenic expression patterns. Gene ontology (GO) analysis revealed that some lncRNAs enriched at neonatal ages have their neighbor protein coding genes also enriched at neonatal ages and associated with cell proliferation, immune activation related processes, tissue organization pathways, and hematopoiesis; other lncRNAs enriched at adolescent ages have their neighbor protein coding genes associated with different metabolic processes. These data reveal significant functional transition during postnatal liver development and imply the potential importance of lncRNAs in liver maturation.	[Peng, Lai; Piekos, Stephanie; Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Paulson, Ariel; Li, Hua; He, Xi; Li, Linheng] Stowers Inst Med Res, Kansas City, MO USA	University of Connecticut; Stowers Institute for Medical Research	Zhong, XB (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	xiaobo.zhong@uconn.edu		Li, Linheng/0000-0001-9963-430X	National Institutes of Health National Institute for Environmental Health Sciences [R01ES-019487]; National Institutes of Health National Institute of General Medical Sciences [R01GM-087376]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087376] Funding Source: NIH RePORTER	National Institutes of Health National Institute for Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health National Institute for Environmental Health Sciences [R01ES-019487 to X.B.Z.] and the National Institutes of Health National Institute of General Medical Sciences [R01GM-087376 to X.B.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen WD, 2011, BBA-MOL BASIS DIS, V1812, P888, DOI 10.1016/j.bbadis.2010.12.006; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jaeschke H., 2008, CASARETT DOULLS TOXI, P557, DOI [10.1036/0071470514, DOI 10.1036/0071470514]; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kin TS, 2007, BIOINFORMATICS, V23, P2945, DOI 10.1093/bioinformatics/btm455; Li GB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780521; Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peng L, 2013, DRUG METAB DISPOS, V41, P2175, DOI 10.1124/dmd.113.054635; Pineiro-Carrero VM, 2004, PEDIATRICS, V113, P1097; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Takeuchi M, 2006, HEMATOPOIESIS FETAF, P1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	31	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114917	10.1371/journal.pone.0114917	http://dx.doi.org/10.1371/journal.pone.0114917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503252	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700071
J	Jacobsen, AV; Yemaneab, BT; Jass, J; Scherbak, N				Jacobsen, Annette V.; Yemaneab, Bisrat T.; Jass, Jana; Scherbak, Nikolai			Reference Gene Selection for qPCR Is Dependent on Cell Type Rather than Treatment in Colonic and Vaginal Human Epithelial Cell Lines	PLOS ONE			English	Article							RNA EXPRESSION; NORMALIZATION; TOOL; IDENTIFICATION; MODULATION; PROBIOTICS; MICROBIOTA; BLADDER; DESIGN	The ability of commensal bacteria to influence gene expression in host cells under the influence of pathogenic bacteria has previously been demonstrated, however the extent of this interaction is important for understanding how bacteria can be used as probiotics. Real-time quantitative polymerase chain reaction is the most sensitive tool for evaluating relative changes to gene expression levels. However as a result of its sensitivity an appropriate method of normalisation should be used to account for any variation incurred in preparatory experimental procedures. These variations may result from differences in the amount of starting material, quality of extracted RNA, or in the efficiency of the reverse transcriptase or polymerase enzymes. Selection of an endogenous control gene is the preferred method of normalisation, and ideally a proper validation of the gene's appropriateness for the study in question should be performed. In this study we used quantitative polymerase chain reaction data and applied four different algorithms (geNorm, BestKeeper, NormFinder, and comparative Delta C-q) to evaluate eleven different genes as to their suitability as endogenous controls for use in studies involving colonic (HT-29) and vaginal (VK2/E6E7) human mucosal epithelial cells treated with probiotic and pathogenic bacteria. We found phosphoglycerate kinase 1 to be most appropriate for HT-29 cells, and ribosomal protein large P0 to be the best choice for VK2/E6E7 cells. We also showed that use of less stable reference genes can lead to less accurate quantification of expression levels of gene of interest (GOI) and also can result in decreased statistical significance for GOI expression levels when compared to control. Additionally, we found the cell type being analysed had greater influence on reference gene selection than the treatment performed. This study provides recommendations for stable endogenous control genes for use in further studies involving colonic and vaginal cell lines after bacterial challenge.	[Jacobsen, Annette V.; Yemaneab, Bisrat T.; Jass, Jana; Scherbak, Nikolai] Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden; [Jacobsen, Annette V.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	Orebro University; Charles Sturt University	Scherbak, N (corresponding author), Univ Orebro, Sch Sci & Technol, SE-70182 Orebro, Sweden.	nikolai.scherbak@oru.se	Jass, Jana/D-1617-2013; Jacobsen, Annette/G-5594-2016	Jass, Jana/0000-0001-7957-0310; Jacobsen, Annette/0000-0003-0252-7685; Scherbak, Nikolai/0000-0001-9713-2365	Knowledge Foundation; Carl Tryggers Foundation, Sweden	Knowledge Foundation; Carl Tryggers Foundation, Sweden	The work was supported by the Knowledge Foundation, www.kks.se (JJ), and Carl Tryggers Foundation, www.carltryggersstiftelse.se/ (NS), Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bahrami B, 2011, J APPL MICROBIOL, V110, P353, DOI 10.1111/j.1365-2672.2010.04889.x; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bourgine J, 2012, DRUG METAB DISPOS, V40, P694, DOI 10.1124/dmd.111.042465; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Coudeyras Sophie, 2008, Infect Dis Obstet Gynecol, V2008, P549640, DOI 10.1155/2008/549640; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Howarth GS, 2013, NUTRIENTS, V5, P58, DOI 10.3390/nu5010058; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Karlsson M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-15; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinto MGV, 2009, INT J FOOD MICROBIOL, V133, P86, DOI 10.1016/j.ijfoodmicro.2009.05.013; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schmitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039632; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Wagner RD, 2012, OPEN J MED MICROBIOL, V02, P54, DOI [10.4236/ojmm.2012.23008, DOI 10.4236/OJMM.2012.23008]; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	36	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115592	10.1371/journal.pone.0115592	http://dx.doi.org/10.1371/journal.pone.0115592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526394	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200038
J	Liu, XL; Zhang, J; Li, J; Volk, A; Breslin, P; Zhang, JW; Zhang, Z				Liu, Xinli; Zhang, Jun; Li, Jing; Volk, Andrew; Breslin, Peter; Zhang, Jiwang; Zhang, Zhou			The Synergistic Repressive Effect of NF-kappa B and JNK Inhibitor on the Clonogenic Capacity of Jurkat Leukemia Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TNF-ALPHA; INFLAMMATION; ACTIVATION; APOPTOSIS; LYMPHOMA; KINASE; TUMORIGENESIS; RESISTANCE; DEFICIENT	Deregulation of Nuclear Transcription Factor-kappa B (NF-kappa B) and Jun N-terminal kinase (JNK) signaling is commonly detected in leukemia, suggesting an important role for these two signaling pathways in the pathogenesis of leukemia. In this study, using Jurkat cells, an acute T-lymphoblastic leukemia (T-ALL) cell line, we evaluated the effects of an NF-kB inhibitor and a JNK inhibitor individually and in combination on the proliferation, survival and clonogenic capacity of leukemic cells. We found that leukemic stem/progenitor cells (LSPCs) were more sensitive to NF-kappa B inhibitor treatment than were healthy hematopoietic stem/progenitor cells (HSPCs), as shown by a reduction in the clonogenic capacity of the former. Inactivation of NF-kappa B leads to the activation of JNK signaling in both leukemic cells and healthy HSPCs. Interestingly, JNK inhibitor treatment enhanced the repressive effects of NF-kappa B inhibitor on LSPCs but prevented such repression in HSPCs. Our data suggest that JNK signaling stimulates proliferation/survival in LSPCs but is a death signal in HSPCs. The combination of NF-kappa B inhibitor and JNK inhibitor might provide a better treatment for T-ALL leukemia by synergistically killing LSPCs while simultaneously preventing the death of normal HPCs.	[Liu, Xinli; Zhang, Jun; Li, Jing] Shanghai Normal Univ, Coll Life & Environm Sci, Dept Biol, Shanghai, Peoples R China; [Zhang, Zhou] Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang, Peoples R China; [Volk, Andrew; Breslin, Peter; Zhang, Jiwang] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Inst Oncol, Maywood, IL 60153 USA; [Volk, Andrew; Breslin, Peter; Zhang, Jiwang] Loyola Univ Chicago, Dept Pathol, Maywood, IL 60153 USA; [Volk, Andrew; Breslin, Peter; Zhang, Jiwang] Loyola Univ Chicago, Dept Mol Cellular Physiol, Maywood, IL 60153 USA	Shanghai Normal University; Shenyang Pharmaceutical University; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Zhang, Z (corresponding author), Shenyang Pharmaceut Univ, Coll Life Sci & Biopharm, Shenyang, Peoples R China.	zhouzhang@hotmail.com	Zhang, Jiwang/AAG-2706-2021		State Key Development Program for Basic Research of China [2013CB966800]; Major Key Projects for the Fundamental Research of the Science and Technology Commission of Shanghai [13JC1406403]; Innovation Program of Shanghai Municipal Education Commission [13ZZ103]; National Natural Science Foundation of China [31270883]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Major Key Projects for the Fundamental Research of the Science and Technology Commission of Shanghai; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the State Key Development Program for Basic Research of China (Grant No. 2013CB966800) and Major Key Projects for the Fundamental Research of the Science and Technology Commission of Shanghai (Grant No. 13JC1406403) to JWZ; the Innovation Program of Shanghai Municipal Education Commission (Grant No. 13ZZ103) and the National Natural Science Foundation of China (Grant No. 31270883) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fuchs O, 2004, CURR PHARM, V3, P98; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hernandez-Ilizaliturri FJ, 2011, CANCER-AM CANCER SOC, V117, P5058, DOI 10.1002/cncr.26135; Hess P, 2002, NAT GENET, V32, P201, DOI 10.1038/ng946; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Jiang XJ, 2012, CANCER LETT, V326, P135, DOI 10.1016/j.canlet.2012.07.030; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Katsman A, 2009, CURR PHARM DESIGN, V15, P792, DOI 10.2174/138161209787582156; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McConkey DJ, 2008, DRUG RESIST UPDATE, V11, P164, DOI 10.1016/j.drup.2008.08.002; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Munzert G, 2004, LEUKEMIA LYMPHOMA, V45, P1181, DOI 10.1080/10428190310001657326; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oguma K, 2010, FUTURE ONCOL, V6, P515, DOI [10.2217/fon.10.13, 10.2217/FON.10.13]; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Salem K, 2013, EXP HEMATOL, V41, P209, DOI 10.1016/j.exphem.2012.10.002; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Walsby E, 2012, ONCOTARGET, V3, P525; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	39	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115490	10.1371/journal.pone.0115490	http://dx.doi.org/10.1371/journal.pone.0115490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526629	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200030
J	Osonoi, T; Saito, M; Tamasawa, A; Ishida, H; Tsujino, D; Nishimura, R; Utsunomiya, K				Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Ishida, Hidenori; Tsujino, Daisuke; Nishimura, Rimei; Utsunomiya, Kazunori			Effect of Hemodialysis on Plasma Glucose Profile and Plasma Level of Liraglutide in Patients with Type 2 Diabetes Mellitus and End-Stage Renal Disease: A Pilot Study	PLOS ONE			English	Editorial Material							ANALOG LIRAGLUTIDE; PHARMACOKINETICS; IMPAIRMENT; METABOLISM	The effect of hemodialysis on the plasma glucose profile and liraglutide level after liraglutide injection was investigated in patients with diabetes and end-stage renal disease (ESRD). Either 0.6 mg or 0.9 mg liraglutide was subcutaneously administered daily to 10 Japanese type 2 diabetic patients with ESRD. Hemodialysis was conducted on days 1 and 3. Plasma liraglutide and glucose concentrations were measured by enzyme-linked immunosorbent assay and a continuous glucose monitoring system, respectively. The safety profile of liraglutide was also assessed. Hemodialysis had no effect on the pharmacokinetic parameters of liraglutide in patients with diabetes and ESRD; the maximum plasma concentration (C-max), t(max), area under the concentration-time curve (AUC), and CL/f were unaltered. Similarly, hemodialysis did not affect the mean or minimum glucose levels, AUC, or duration of hyperglycemia (>180 mg/dL) and hypoglycemia (, 70 mg/dL) following liraglutide administration. However, significant increases in mean amplitude of glycemic excursions (MAGE) and standard deviation (SD) as markers of glucose fluctuation, and the maximum glucose level were observed during hemodialysis. No adverse events, including hypoglycemia, were observed after liraglutide injection, either off-hemodialysis (day 2) or on-hemodialysis (day 3). Liraglutide was well tolerated in patients with type 2 diabetes and ESRD undergoing hemodialysis. The present results suggested that hemodialysis did not affect the pharmacokinetic profile of liraglutide or most glycemic indices, with the exception of MAGE, SD, and the maximum glucose level. These results suggested that it may be possible to use liraglutide during hemodialysis for diabetes with ESRD, without dose adjustment.	[Osonoi, Takeshi; Saito, Miyoko; Tamasawa, Atsuko; Ishida, Hidenori] Nakakinen Clin, Dept Internal Med, Naka, Ibaraki, Japan; [Tsujino, Daisuke; Nishimura, Rimei; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, Tokyo, Japan; [Nishimura, Rimei] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Jikei University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Osonoi, T (corresponding author), Nakakinen Clin, Dept Internal Med, Naka, Ibaraki, Japan.	t-osonoi@kensei-kai.com						Abe M, 2011, CURR DRUG METAB, V12, P57, DOI 10.2174/138920011794520053; Bode B, 2011, AM J MANAG CARE, V17, pS59; Brock CM, 2010, US PHARM, V35, P8; Jacobsen LV, 2009, BRIT J CLIN PHARMACO, V68, P898, DOI 10.1111/j.1365-2125.2009.03536.x; Krepinsky J, 2000, AM J KIDNEY DIS, V35, P500, DOI 10.1016/S0272-6386(00)70204-6; Kuriyama S, 2001, NURSING, V21, P82; Linnebjerg H, 2007, BRIT J CLIN PHARMACO, V64, P317, DOI 10.1111/j.1365-2125.2007.02890.x; Malm-Erjefalt M, 2010, DRUG METAB DISPOS, V38, P1944, DOI 10.1124/dmd.110.034066; Ministry of Health, 2008, ETH GUID CLIN STUD A; Mirani M, 2010, DIABETES TECHNOL THE, V12, P749, DOI 10.1089/dia.2010.0052; Mori Y, 2011, DIABETES TECHNOL THE, V13, P1139, DOI 10.1089/dia.2011.0137; National Institute for Health and Care Excellence, 2010, DIAB TYP 2 LIR TREAT; Nauck M, 2013, DIABETES OBES METAB, V15, P204, DOI 10.1111/dom.12012; Neumiller JJ, 2010, DIABET METAB SYND OB, V3, P215; Schmidt WE, 2010, INT J CLIN PRACT, V64, P12, DOI 10.1111/j.1742-1241.2010.02500.x; Terawaki Y, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-10	16	17	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e113468	10.1371/journal.pone.0113468	http://dx.doi.org/10.1371/journal.pone.0113468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526642	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000347186200068
J	Sint, D; Niederklapfer, B; Kaufmann, R; Traugott, M				Sint, Daniela; Niederklapfer, Bettina; Kaufmann, Ruediger; Traugott, Michael			Group-Specific Multiplex PCR Detection Systems for the Identification of Flying Insect Prey	PLOS ONE			English	Article							GUT-CONTENT-ANALYSIS; MOLECULAR-IDENTIFICATION; INVERTEBRATE PREDATORS; GENERALIST PREDATORS; DIET ANALYSIS; DNA; PRIMERS; GENE; AMPLIFICATION; COLLEMBOLA	The applicability of species-specific primers to study feeding interactions is restricted to those ecosystems where the targeted prey species occur. Therefore, group-specific primer pairs, targeting higher taxonomic levels, are often desired to investigate interactions in a range of habitats that do not share the same species but the same groups of prey. Such primers are also valuable to study the diet of generalist predators when next generation sequencing approaches cannot be applied beneficially. Moreover, due to the large range of prey consumed by generalists, it is impossible to investigate the breadth of their diet with species-specific primers, even if multiplexing them. However, only few group-specific primers are available to date and important groups of prey such as flying insects have rarely been targeted. Our aim was to fill this gap and develop group-specific primers suitable to detect and identify the DNA of common taxa of flying insects. The primers were combined in two multiplex PCR systems, which allow a time- and cost-effective screening of samples for DNA of the dipteran subsection Calyptratae (including Anthomyiidae, Calliphoridae, Muscidae), other common dipteran families (Phoridae, Syrphidae, Bibionidae, Chironomidae, Sciaridae, Tipulidae), three orders of flying insects (Hymenoptera, Lepidoptera, Plecoptera) and coniferous aphids within the genus Cinara. The two PCR assays were highly specific and sensitive and their suitability to detect prey was confirmed by testing field-collected dietary samples from arthropods and vertebrates. The PCR assays presented here allow targeting prey at higher taxonomic levels such as family or order and therefore improve our ability to assess (trophic) interactions with flying insects in terrestrial and aquatic habitats.	[Sint, Daniela; Niederklapfer, Bettina; Kaufmann, Ruediger; Traugott, Michael] Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria	University of Innsbruck	Sint, D (corresponding author), Univ Innsbruck, Inst Ecol, A-6020 Innsbruck, Austria.	Daniela.Sint@uibk.ac.at	Sint, Daniela/HCI-8508-2022	Sint, Daniela/0000-0003-3387-4284; Traugott, Michael/0000-0001-9719-5059	Austrian Science Fund FWF [P20859-B17]; Alpine Research Centre Obergurgl of the University of Innsbruck; University of Innsbruck; Austrian Science Fund (FWF) [P 20859] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Alpine Research Centre Obergurgl of the University of Innsbruck; University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was financed and supported by the Austrian Science Fund FWF ("Invertebrate food webs in recently deglaciated alpine areas", project number P20859-B17), the Alpine Research Centre Obergurgl of the University of Innsbruck and an 'Excellentia fellowship' of the University of Innsbruck awarded to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admassu B, 2006, SOIL BIOL BIOCHEM, V38, P1308, DOI 10.1016/j.soilbio.2005.08.019; Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bohmann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021441; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P1160, DOI 10.1111/1755-0998.12265; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P117, DOI 10.1111/1755-0998.12162; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Deagle BE, 2010, CONSERV GENET, V11, P2039, DOI 10.1007/s10592-010-0096-6; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; DIEFFENBACH CW, 2003, PCR PRIMER LAB MANUA, P13102; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Juen A, 2007, MOL ECOL, V16, P1545, DOI 10.1111/j.1365-294X.2007.03238.x; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; Juen A, 2006, SOIL BIOL BIOCHEM, V38, P1872, DOI 10.1016/j.soilbio.2005.11.034; Juen A, 2012, J PEST SCI, V85, P89, DOI 10.1007/s10340-011-0406-x; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2011, MOL ECOL RESOUR, V11, P370, DOI 10.1111/j.1755-0998.2010.02913.x; Koester M, 2013, CONSERV GENET RESOUR, V5, P1091, DOI 10.1007/s12686-013-9998-1; Kuusk AK, 2008, MOL ECOL RESOUR, V8, P678, DOI 10.1111/j.1471-8286.2007.02046.x; Kuusk AK, 2012, J PEST SCI, V85, P253, DOI 10.1007/s10340-012-0431-4; Luan YX, 2003, SCI CHINA SER C, V46, P67, DOI 10.1007/BF03182686; Ma J, 2005, J APPL ENTOMOL, V129, P330, DOI 10.1111/j.1439-0418.2005.00977.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Morales SE, 2009, APPL ENVIRON MICROB, V75, P2677, DOI 10.1128/AEM.02166-08; O'Rorke R, 2012, MOL ECOL RESOUR, V12, P5, DOI 10.1111/j.1755-0998.2011.03091.x; Pinol J, 2014, MOL ECOL RESOUR, V14, P18, DOI 10.1111/1755-0998.12156; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quemere E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058971; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Romeu-Dalmau C, 2012, B ENTOMOL RES, V102, P566, DOI 10.1017/S0007485312000132; SCHOENLY K, 1990, ECOL ENTOMOL, V15, P333, DOI 10.1111/j.1365-2311.1990.tb00815.x; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Sint D, 2011, MOL ECOL RESOUR, V11, P795, DOI 10.1111/j.1755-0998.2011.03018.x; Symondson William O.C., 2012, P166; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Traugott M, 2012, B ENTOMOL RES, V102, P239, DOI 10.1017/S0007485311000551; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Wallinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029473; Westheide W, 1996, SPEZIELLE ZOOLOGIE 1; Zarzoso-Lacoste D, 2013, MOL ECOL RESOUR, V13, P117, DOI 10.1111/1755-0998.12029	49	15	15	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115501	10.1371/journal.pone.0115501	http://dx.doi.org/10.1371/journal.pone.0115501			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525799	Green Submitted, gold, Green Published			2022-12-27	WOS:000347186200031
J	Stojowska, K; Krawczyk, B				Stojowska, Karolina; Krawczyk, Beata			A New Double Digestion Ligation Mediated Suppression PCR Method for Simultaneous Bacteria DNA-Typing and Confirmation of Species: An Acinetobacter sp Model	PLOS ONE			English	Article							MELTING PROFILE METHOD; RESISTANT ENTEROCOCCUS-FAECIUM; GENOTYPING ANALYSIS; BAUMANNII; IDENTIFICATION; AMPLIFICATION; FRAGMENTS; AFLP; DIFFERENTIATION; STRAINS	We have designed a new ddLMS PCR (double digestion Ligation Mediated Suppression PCR) method based on restriction site polymorphism upstream from the specific target sequence for the simultaneous identification and differentiation of bacterial strains. The ddLMS PCR combines a simple PCR used for species or genus identification and the LM PCR strategy for strain differentiation. The bacterial identification is confirmed in the form of the PCR product(s), while the length of the PCR product makes it possible to differentiate between bacterial strains. If there is a single copy of the target sequence within genomic DNA, one specific PCR product is created (simplex ddLMS PCR), whereas for multiple copies of the gene the fingerprinting patterns can be obtained (multiplex ddLMS PCR). The described ddLMS PCR method is designed for rapid and specific strain differentiation in medical and microbiological studies. In comparison to other LM PCR it has substantial advantages: enables specific species' DNA-typing without the need for pure bacterial culture selection, is not sensitive to contamination with other cells or genomic DNA, and gives univocal "band-based" results, which are easy to interpret. The utility of ddLMS PCR was shown for Acinetobacter calcoaceticus-baumannii (Acb) complex, the genetically closely related and phenotypically similar species and also important nosocomial pathogens, for which currently, there are no recommended methods for screening, typing and identification. In this article two models are proposed: 39 recA-ddLMS PCR-MaeII/RsaI for Acb complex interspecific typing and 59 rrn-ddLMS PCR-HindIII/ApaI for Acinetobacter baumannii intraspecific typing. ddLMS PCR allows not only for DNA-typing but also for confirmation of species in one reaction. Also, practical guidelines for designing a diagnostic test based on ddLMS PCR for genotyping different species of bacteria are provided.	[Stojowska, Karolina; Krawczyk, Beata] Gdansk Univ Technol, Dept Microbiol, Fac Chem, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology	Krawczyk, B (corresponding author), Gdansk Univ Technol, Dept Microbiol, Fac Chem, Gdansk, Poland.	beakrawc@pg.gda.pl	Krawczyk, Beata/ABG-4358-2020	Krawczyk, Beata/0000-0001-5528-8898	State Committee for Scientific Research, Poland [N N401 101138]; Department of Microbiology, Gdansk University of Technology	State Committee for Scientific Research, Poland(Polish State Committee for Scientific Research); Department of Microbiology, Gdansk University of Technology	This work was supported by the State Committee for Scientific Research, Poland (grant no N N401 101138 to KS BK) and the Department of Microbiology, Gdansk University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Grosso F, 2011, CLIN MICROBIOL INFEC, V17, P1275, DOI 10.1111/j.1469-0691.2011.03469.x; Grosso F, 2010, J HOSP INFECT, V75, P82, DOI 10.1016/j.jhin.2010.01.007; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Jeung JU, 2005, J BIOCHEM BIOPH METH, V64, P110, DOI 10.1016/j.jbbm.2005.06.001; Krawczyk B, 2003, J MICROBIOL METH, V52, P341, DOI 10.1016/S0167-7012(02)00187-2; Krawczyk B, 2002, MOL CELL PROBE, V16, P1, DOI 10.1006/mcpr.2001.0388; Krawczyk B, 2007, J MICROBIOL METH, V71, P114, DOI 10.1016/j.mimet.2007.08.010; Krawczyk B, 2006, J CLIN MICROBIOL, V44, P2327, DOI 10.1128/JCM.00052-06; Krawczyk B, 2011, J MICROBIOL BIOTECHN, V21, P1336, DOI 10.4014/jmb.1104.04019; Krawczyk Beata, 2007, Polish Journal of Microbiology, V56, P65; Kulah C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-30; Lai CC, 2012, J CLIN MICROBIOL, V50, P2982, DOI 10.1128/JCM.01194-12; Leibner-Ciszak J, 2010, J MED MICROBIOL, V59, P185, DOI 10.1099/jmm.0.013458-0; Li WJ, 2009, FEMS MICROBIOL REV, V33, P892, DOI 10.1111/j.1574-6976.2009.00182.x; Lim YM, 2007, J CLIN MICROBIOL, V45, P902, DOI 10.1128/JCM.01573-06; Masny A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng116; Masny A, 2001, BIOTECHNIQUES, V31, P930, DOI 10.2144/01314rr04; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Nowak-Zaleska A, 2008, POL J MICROBIOL, V57, P11; Park KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065026; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Smith D R, 1992, PCR Methods Appl, V2, P21; Stojowska K, 2009, EUR J CLIN MICROBIOL, V28, P1263, DOI 10.1007/s10096-009-0768-7; Stojowska K, 2009, POL J MICROBIOL, V58, P247; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; van der Wurff AWG, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.24.e105; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WISE KA, 1990, J HOSP INFECT, V16, P319, DOI 10.1016/0195-6701(90)90004-8	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115181	10.1371/journal.pone.0115181	http://dx.doi.org/10.1371/journal.pone.0115181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522278	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600023
J	Gorham, JC; Clark, DR; Bresette, MJ; Bagley, DA; Keske, CL; Traxler, SL; Witherington, BE; Shamblin, BM; Nairn, CJ				Gorham, Jonathan C.; Clark, David R.; Bresette, Michael J.; Bagley, Dean A.; Keske, Carrie L.; Traxler, Steve L.; Witherington, Blair E.; Shamblin, Brian M.; Nairn, Campbell J.			Characterization of a Subtropical Hawksbill Sea Turtle (Eretmocheyles imbricata) Assemblage Utilizing Shallow Water Natural and Artificial Habitats in the Florida Keys	PLOS ONE			English	Article							FEEDING GROUNDS; CHELONIA-MYDAS; GREEN TURTLES; GROWTH-RATES; HOME-RANGE; AGGREGATION; MIGRATIONS; ECOLOGY; ISLAND; RATIO	In order to provide information to better inform management decisions and direct further research, vessel-based visual transects, snorkel transects, and in-water capture techniques were used to characterize hawksbill sea turtles in the shallow marine habitats of a Marine Protected Area (MPA), the Key West National Wildlife Refuge in the Florida Keys. Hawksbills were found in hardbottom and seagrass dominated habitats throughout the Refuge, and on man-made rubble structures in the Northwest Channel near Cottrell Key. Hawksbills captured (N=82) were exclusively juveniles and subadults with a straight standard carapace length (SSCL) ranging from 21.4 to 69.0cm with a mean of 44.1 cm (SD=10.8). Somatic growth rates were calculated from 15 recaptured turtles with periods at large ranging from 51 to 1188 days. Mean SSCL growth rate was 7.7 cm/year (SD=4.6). Juvenile hawksbills (, 50 cm SSCL) showed a significantly higher growth rate (9.2 cm/year, SD=4.5, N=11) than subadult hawksbills (50-70 cm SSCL, 3.6 cm/year, SD=0.9, N=4). Analysis of 740 base pair mitochondrial control region sequences from 50 sampled turtles yielded 12 haplotypes. Haplotype frequencies were significantly different compared to four other Caribbean juvenile foraging aggregations, including one off the Atlantic coast of Florida. Many-to-one mixed stock analysis indicated Mexico as the primary source of juveniles in the region and also suggested that the Refuge may serve as important developmental habitat for the Cuban nesting aggregation. Serum testosterone radioimmunoassay results from 33 individuals indicated a female biased sex ratio of 3.3 females: 1 male for hawksbills in the Refuge. This assemblage of hawksbills is near the northern limit of the species range, and is one of only two such assemblages described in the waters of the continental United States. Since this assemblage resides in an MPA with intensive human use, basic information on the assemblage is vital to resource managers charged with conservation and species protection in the MPA.	[Gorham, Jonathan C.; Clark, David R.; Bresette, Michael J.; Bagley, Dean A.; Keske, Carrie L.; Traxler, Steve L.; Witherington, Blair E.] Inwater Res Grp Inc, Jensen Beach, FL 34957 USA; [Shamblin, Brian M.; Nairn, Campbell J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Gorham, JC (corresponding author), Inwater Res Grp Inc, Jensen Beach, FL 34957 USA.	jgorham@inwater.org	Nairn, Campbell J/B-6547-2018	Nairn, Campbell J/0000-0002-1690-1730	Florida Sea Turtle Grants Program [09-021R, 10-031R]	Florida Sea Turtle Grants Program	This work was supported by grant numbers 09-021R and 10-031R from the Florida Sea Turtle Grants Program (http://www.helpingseaturtles.org/) to JCG. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois F. A., 2006, 26 ANN S SEA TURTL B; Amos AF, 1989, P 9 ANN WORKSH SEA T, P9; BJORNDAL KA, 1988, COPEIA, P555, DOI 10.2307/1445373; BJORNDAL KA, 1985, BIOL CONSERV, V34, P353, DOI 10.1016/0006-3207(85)90040-0; Bjorndal KA, 2010, MAR BIOL, V157, P135, DOI 10.1007/s00227-009-1304-0; Blanvillian G, 2007, HERPETOLOGICAL CONSE, V3, P21; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Boulon Jr R, 1983, SOME NOTES POPULATIO; Bowen BW, 1999, ECOLOGICAL APPL, V6, P566; Bresette Michael J., 2010, Endangered Species Research, V9, P105, DOI 10.3354/esr00245; Browne DC, 2010, CONSERV GENET, V11, P1541, DOI 10.1007/s10592-009-9883-3; CARR ARCHIE FAIRLY, 1940, UNIV FLORIDA PUBL BIOL SCI SER, V3, P1; De Sola C. R., 1935, Copeia Ann Arbor, V1935, P44, DOI 10.2307/1436641; Diaz-Fernandez Rogelio, 1999, Chelonian Conservation and Biology, V3, P296; DIEZ C.E., 1997, P 8 INT COR REEF S, V2, P1421, DOI DOI 10.1007/S00227-011-1681-Z; Diez CE, 2003, J HERPETOL, V37, P533, DOI 10.1670/56-02N; Diez CE, 2002, MAR ECOL PROG SER, V234, P301, DOI 10.3354/meps234301; Ehrhart Llewellyn M., 1999, P61; Geis A, 2003, J HERPETOL, V37, P400, DOI 10.1670/0022-1511(2003)037[0400:PSROJH]2.0.CO;2; Hart KM, 2013, MAR BIOL, V160, P2567, DOI 10.1007/s00227-013-2249-x; Hart KM, 2012, MAR ECOL PROG SER, V457, P193, DOI 10.3354/meps09744; Leon YM, 2002, MAR ECOL PROG SER, V245, P249, DOI 10.3354/meps245249; Leon Yolanda M., 1999, Chelonian Conservation and Biology, V3, P230; Leroux RA, 2012, J HERED, V103, P806, DOI 10.1093/jhered/ess055; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Meylan Anne, 2006, Chelonian Research Monographs, V3, P105; Meylan PA, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/357.1; National Marine Fisheries Service and U. S. Fish and Wildlife Service, 2013, HAWKSB SEA TURTL ER; National Marine Fisheries Service US Fish and Wildlife Service., 1993, REC PLAN HAWKSB TURT; Nuttal SM, 2012, P 31 ANN S SEA TURTL; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Pella J, 2001, FISH B-NOAA, V99, P151; Pritchard CH, 1983, W ATL TURTL S; Shamblin BM, 2012, MOL ECOL, V21, P2330, DOI 10.1111/j.1365-294X.2012.05530.x; Tikochinski Y, 2012, MAR GENOM, V6, P17, DOI 10.1016/j.margen.2012.01.002; van Dam RP, 1998, J EXP MAR BIOL ECOL, V220, P15, DOI 10.1016/S0022-0981(97)00080-4; Vilaca ST, 2013, J EXP MAR BIOL ECOL, V446, P334, DOI 10.1016/j.jembe.2013.06.004; Wood LD, 2013, HERPETOL CONSERV BIO, V8, P258	38	19	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114171	10.1371/journal.pone.0114171	http://dx.doi.org/10.1371/journal.pone.0114171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517946	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600013
J	Pavlova, MA; Weber, S; Simoes, E; Sokolov, AN				Pavlova, Marina A.; Weber, Susanna; Simoes, Elisabeth; Sokolov, Alexander N.			Gender Stereotype Susceptibility	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEX-DIFFERENCES; DIAGNOSIS THREAT; TEST-PERFORMANCE; MENTAL ROTATION; COGNITIVE PERFORMANCE; MATH; WOMEN; IMPACT; AGE	Gender affects performance on a variety of cognitive tasks, and this impact may stem from socio-cultural factors such as gender stereotyping. Here we systematically manipulated gender stereotype messages on a social cognition task on which no initial gender gap has been documented. The outcome reveals: (i) Stereotyping affects both females and males, with a more pronounced impact on females. Yet an explicit negative message for males elicits a striking paradoxical deterioration in performance of females. (ii) Irrespective of gender and directness of message, valence of stereotype message affects performance: negative messages have stronger influence than positive ones. (iii) Directness of stereotype message differentially impacts performance of females and males: females tend to be stronger affected by implicit than explicit negative messages, whereas in males this relationship is opposite. The data are discussed in the light of neural networks underlying gender stereotyping. The findings provide novel insights into the sources of gender related fluctuations in cognition and behavior.	[Pavlova, Marina A.] Univ Tubingen, Dept Biomed Magnet Resonance, Sch Med, Tubingen, Germany; [Weber, Susanna] Univ Zurich, Dept Econ, Zurich, Switzerland; [Simoes, Elisabeth; Sokolov, Alexander N.] Univ Tubingen, Univ Hosp, Ctr Womens Hlth, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Zurich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pavlova, MA (corresponding author), Univ Tubingen, Dept Biomed Magnet Resonance, Sch Med, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Pavlova, Marina/0000-0001-8239-3589	Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Eberhard Karls University of Tubingen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Eberhard Karls University of Tubingen	We are grateful to the students of the University of Tubingen for participation and assistance with testing, Dr. Christel Bidet-Ildei, Dr. Arseny A. Sokolov, and Samuel Kruger for assistance and valuable comments, Franziska Hosl for administrative assistance, and Bernd Kardatzki for technical support. The authors acknowledge support toward open access publishing by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Abrams D, 2006, PSYCHOL AGING, V21, P691, DOI 10.1037/0882-7974.21.4.691; Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Aronson J, 1999, J EXP SOC PSYCHOL, V35, P29, DOI 10.1006/jesp.1998.1371; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; Blaine H, 2013, J NEUROTRAUM, V30, P1405, DOI 10.1089/neu.2013.2865; Brownlow S, 2008, PERCEPT MOTOR SKILL, V107, P307, DOI 10.2466/PMS.107.1.307-316; Cadinu M, 2005, PSYCHOL SCI, V16, P572, DOI 10.1111/j.0956-7976.2005.01577.x; Cadinu M, 2003, EUR J SOC PSYCHOL, V33, P267, DOI 10.1002/ejsp.145; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cattaneo Z, 2011, NEUROIMAGE, V56, P1839, DOI 10.1016/j.neuroimage.2011.02.037; Chalabaev A, 2008, J SPORT EXERCISE PSY, V30, P143, DOI 10.1123/jsep.30.2.143; Cvencek D, 2014, J EXP CHILD PSYCHOL, V117, P73, DOI 10.1016/j.jecp.2013.07.018; Dunst B, 2013, PERS INDIV DIFFER, V55, P744, DOI 10.1016/j.paid.2013.06.007; Ford TE, 2004, PERS SOC PSYCHOL B, V30, P643, DOI 10.1177/0146167203262851; Good C, 2012, J PERS SOC PSYCHOL, V102, P700, DOI 10.1037/a0026659; Gustafsson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2713; Halim ML, 2013, BRIT J DEV PSYCHOL, V31, P128, DOI 10.1111/j.2044-835X.2012.02084.x; Hamilton C., 2008, COGNITION SEX DIFFER; Hartley BL, 2013, CHILD DEV, V84, P1716, DOI 10.1111/cdev.12079; Hausmann M, 2009, PSYCHONEUROENDOCRINO, V34, P389, DOI 10.1016/j.psyneuen.2008.09.019; Hess TM, 2004, PSYCHOL AGING, V19, P495, DOI 10.1037/0882-7974.19.3.495; Hess TM, 2003, J GERONTOL B-PSYCHOL, V58, pP3, DOI 10.1093/geronb/58.1.P3; Johns M, 2005, PSYCHOL SCI, V16, P175, DOI 10.1111/j.0956-7976.2005.00799.x; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Kit KA, 2008, NEUROPSYCHOL REV, V18, P132, DOI 10.1007/s11065-008-9059-9; Kit KA, 2014, J INT NEUROPSYCH SOC, V20, P157, DOI 10.1017/S1355617713001264; Kray LJ, 2001, J PERS SOC PSYCHOL, V80, P942, DOI 10.1037/0022-3514.80.6.942; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Kruger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081716; Leyens JP, 2000, PERS SOC PSYCHOL B, V26, P1189, DOI 10.1177/0146167200262002; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Milne E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-12-j0001.2001; Nguyen HHD, 2008, J APPL PSYCHOL, V93, P1314, DOI 10.1037/a0012702; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pavlova M, 2008, J COGNITIVE NEUROSCI, V20, P494, DOI 10.1162/jocn.2008.20034; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Quadflieg S, 2009, J COGNITIVE NEUROSCI, V21, P1560, DOI 10.1162/jocn.2009.21091; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Rydell RJ, 2014, PERS SOC PSYCHOL B, V40, P377, DOI 10.1177/0146167213513475; Schmader T, 2002, J EXP SOC PSYCHOL, V38, P194, DOI 10.1006/jesp.2001.1500; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Seibt B, 2004, J PERS SOC PSYCHOL, V87, P38, DOI 10.1037/0022-3514.87.1.38; Shih M, 2002, J PERS SOC PSYCHOL, V83, P638, DOI 10.1037//0022-3514.83.3.638; Simoes E, 2013, GEBURTSH FRAUENHEILK, V73, P239, DOI 10.1055/s-0032-1328303; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stone J, 1999, J PERS SOC PSYCHOL, V77, P1213, DOI 10.1037/0022-3514.77.6.1213; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wechsler D, 1997, WECHSLER INTELLIGENZ; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Wolf C, 2009, PSYCHOL RES, V74, P429; Wraga M, 2007, SOC COGN AFFECT NEUR, V2, P12, DOI 10.1093/scan/nsl041; Wraga M, 2006, PSYCHON B REV, V13, P813, DOI 10.3758/BF03194002; Yeung NCJ, 2008, ACCIDENT ANAL PREV, V40, P667, DOI 10.1016/j.aap.2007.09.003	63	19	19	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114802	10.1371/journal.pone.0114802	http://dx.doi.org/10.1371/journal.pone.0114802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517903	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600028
J	Badve, SV; Paul, SK; Klein, K; Clayton, PA; Hawley, CM; Brown, FG; Boudville, N; Polkinghorne, KR; McDonald, SP; Johnson, DW				Badve, Sunil V.; Paul, Sanjoy K.; Klein, Kerenaftali; Clayton, Philip A.; Hawley, Carmel M.; Brown, Fiona G.; Boudville, Neil; Polkinghorne, Kevan R.; McDonald, Stephen P.; Johnson, David W.			The Association between Body Mass Index and Mortality in Incident Dialysis Patients	PLOS ONE			English	Article							PERITONEAL-DIALYSIS; OBESITY PARADOX; HEMODIALYSIS-PATIENTS; SURVIVAL ADVANTAGE; SIZE; OUTCOMES; WEIGHT; FAT; INFLAMMATION; SURROGATES	Objectives: To study the body mass index (BMI) trajectory in patients with incident end-stage kidney disease and its association with all-cause mortality. Methods: This longitudinal cohort study included 17022 adult patients commencing hemodialysis [HD] (n=10860) or peritoneal dialysis [PD] (n=6162) between 2001 and 2008 and had >= 6-month follow-up and >= 2 weight measurements, using the Australia and New Zealand Dialysis and Transplant Registry data. The association of time-varying BMI with all-cause mortality was explored using multivariate Cox regression models. Results: The median follow-up was 2.3 years. There was a non-linear change in the mean BMI (kg/m2) over time, with an initial decrease from 27.6 (95% confidence interval [CI]: 27.5, 27.7) to 26.7 (95% CI: 26.6, 26.9) at 3-month, followed by increments to 27.1 (95% CI: 27, 27.2) at 1-year and 27.2 (95% CI: 26.8, 27.1) at 3-year, and a gradual decrease subsequently. The BMI trajectory was significantly lower in HD patients who died than those who survived, although this pattern was not observed in PD patients. Compared to the reference time-varying BMI category of 25.1-28 kg/m(2), the mortality risks of both HD and PD patients were greater in all categories of time-varying BMI <25 kg/m(2). The mortality risks were significantly lower in all categories of time-varying BMI >28.1 kg/m(2) among HD patients, but only in the category 28.1-31 kg/m(2) among PD patients. Conclusions: BMI changed over time in a non-linear fashion in incident dialysis patients. Time-varying measures of BMI were significantly associated with mortality risk in both HD and PD patients.	[Badve, Sunil V.; Hawley, Carmel M.; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld 4102, Australia; [Paul, Sanjoy K.; Klein, Kerenaftali] QIMR Berghofer Med Res Inst, Clin Trials Biostat Unit, Brisbane, Qld, Australia; [Clayton, Philip A.] Royal Prince Alfred Hosp, Dept Renal Med, Sydney, NSW, Australia; [Brown, Fiona G.; Polkinghorne, Kevan R.] Monash Med Ctr, Dept Nephrol & Med, Melbourne, Vic, Australia; [Brown, Fiona G.; Polkinghorne, Kevan R.] Monash Univ, Melbourne, Vic 3004, Australia; [Boudville, Neil] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [McDonald, Stephen P.] Univ Adelaide, Australia & New Zealand Dialysis & Transplant Reg, Cent Northern Adelaide Renal & Transplant Serv, Adelaide, SA, Australia	QIMR Berghofer Medical Research Institute; University of Sydney; Monash University; Monash University; University of Western Australia; University of Adelaide	Paul, SK (corresponding author), QIMR Berghofer Med Res Inst, Clin Trials Biostat Unit, Brisbane, Qld, Australia.	Sanjoy.paul@qimrberghofer.edu.au	Hawley, Carmel Mary/C-4905-2011; Boudville, Neil/H-8864-2014; Badve, Sunil/F-9049-2010; Clayton, Philip A/D-5613-2011; Paul, Sanjoy K/F-8199-2010; Johnson, David/F-2897-2011	Hawley, Carmel Mary/0000-0002-1392-5649; Badve, Sunil/0000-0003-2269-312X; Clayton, Philip A/0000-0001-9190-6753; Paul, Sanjoy K/0000-0003-0848-7194; Polkinghorne, Kevan/0000-0002-9851-002X; Boudville, Neil/0000-0002-5884-640X; Johnson, David/0000-0001-5491-3460	Merck; Novo Nordisk; Pfizer; Amylin Pharmaceuticals; Hospira; Amgen; Shire; Genzyme; Fresenius; Baxter; Baxter ANZ PD Academy; Roche; Janssen Cilag; Amgen Australia; Janssen-Cilag Pty Ltd; Boehringer-Ingelheim	Merck(Merck & Company); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Amylin Pharmaceuticals(Bristol-Myers Squibb); Hospira; Amgen(Amgen); Shire; Genzyme(Sanofi-AventisGenzyme Corporation); Fresenius; Baxter; Baxter ANZ PD Academy; Roche(Roche Holding); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen Australia(Amgen); Janssen-Cilag Pty Ltd(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer-Ingelheim(Boehringer Ingelheim)	Drs. Badve, Klein and Clayton have reported that they have no potential conflicts of interest relevant to the contents of this paper to disclose. Dr. Paul has acted as a consultant and speaker for Novartis and Amylin Pharmaceuticals, LLC. He has received grants in support of investigator and investigator initiated clinical studies from Merck, Novo Nordisk and Pfizer, Amylin Pharmaceuticals and Hospira. Dr. Hawley has received consultancy fees from Amgen, Shire, Genzyme and Fresenius; research grant from Baxter and payment for lectures from Amgen and Shire. Dr. Brown has served as a member of the Fresenius ANZ Clinical Advisory Board and has received payment for lectures from Baxter ANZ PD Academy. Dr. Boudville has received research grant and payment for lectures from Roche; and travel grants from Roche, Amgen and Janssen Cilag. Dr. Polkinghorne has received payment for lectures from Amgen Australia and Janssen-Cilag Pty Ltd; and travel grants from Amgen Australia. Dr. McDonald has received consultancy fees from Amgen and Shire; research grants from Amgen; and travel grants from Amgen. Dr. Johnson has received consultancy fees from Baxter, Shire and Amgen; research grants from Baxter, Fresenius, Amgen, Janssen Cilag and Roche; payment for lectures from Baxter, Fresenius, Amgen, Shire and Boehringer-Ingelheim; payment for development of educational presentations from Baxter, Shire, Boehringer-Ingelheim and Lilley; and travel grants from Baxter, Fresenius, Shire, Amgen and Roche. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abbott KC, 2004, KIDNEY INT, V65, P597, DOI 10.1111/j.1523-1755.2004.00385.x; Ayala ER, 2004, NEPHROL DIAL TRANSPL, V19, P421, DOI 10.1093/ndt/gfg559; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2366, DOI 10.1097/01.ASN.0000083905.72794.E6; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; Bradbury BD, 2007, CLIN J AM SOC NEPHRO, V2, P89, DOI 10.2215/CJN.01170905; Campbell KL, 2010, J RENAL NUTR, V20, P414, DOI 10.1053/j.jrn.2010.04.003; Chazot C, 2009, NEPHROL DIAL TRANSPL, V24, P2871, DOI 10.1093/ndt/gfp168; Cho KH, 2010, NEPHROL DIAL TRANSPL, V25, P593, DOI 10.1093/ndt/gfp473; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; de Mutsert R, 2009, CONTRIB NEPHROL, V163, P124, DOI 10.1159/000223790; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Deurenberg-Yap M, 2000, INT J OBESITY, V24, P1011, DOI 10.1038/sj.ijo.0801353; Fernstrom A, 1998, PERITON DIALYSIS INT, V18, P166; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Johansen KL, 2004, AM J CLIN NUTR, V80, P324, DOI 10.1093/ajcn/80.2.324; Johnson DW, 2000, PERITON DIALYSIS INT, V20, P715; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kalantar-Zadeh K, 2012, AM J EPIDEMIOL, V175, P793, DOI 10.1093/aje/kwr384; Kalantar-Zadeh K, 2010, MAYO CLIN PROC, V85, P991, DOI 10.4065/mcp.2010.0336; Kotanko P, 2009, BLOOD PURIFICAT, V27, P38, DOI 10.1159/000167007; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Lievense H, 2012, NEPHROL DIAL TRANSPL, V27, P3631, DOI 10.1093/ndt/gfs131; Mcdonald SP, 2003, J AM SOC NEPHROL, V14, P2894, DOI 10.1097/01.ASN.0000091587.55159.5F; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Molnar MZ, 2011, AM J TRANSPLANT, V11, P725, DOI 10.1111/j.1600-6143.2011.03468.x; National Health Medical Research Council (Australia), 2003, CLIN PRACT GUID MAN; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pellicano R, 2011, CLIN J AM SOC NEPHRO, V6, P1668, DOI 10.2215/CJN.06790810; Pliakogiannis T, 2007, INT UROL NEPHROL, V39, P281, DOI 10.1007/s11255-006-9142-1; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Snyder JJ, 2003, KIDNEY INT, V64, P1838, DOI 10.1046/j.1523-1755.2003.00287.x; Stack AG, 2004, KIDNEY INT, V65, P2398, DOI 10.1111/j.1523-1755.2004.00654.x; Stenvinkel P, 2000, J AM SOC NEPHROL, V11, P1303, DOI 10.1681/ASN.V1171303; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vashistha T, 2014, AM J KIDNEY DIS, V63, P612, DOI 10.1053/j.ajkd.2013.07.021; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	41	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114897	10.1371/journal.pone.0114897	http://dx.doi.org/10.1371/journal.pone.0114897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513810	Green Published, gold			2022-12-27	WOS:000349146300023
J	Braesch-Andersen, S; Beckman, L; Paulie, S; Kumagai-Braesch, M				Braesch-Andersen, Sten; Beckman, Lena; Paulie, Staffan; Kumagai-Braesch, Makiko			ApoD Mediates Binding of HDL to LDL and to Growing T24 Carcinoma	PLOS ONE			English	Article							APOLIPOPROTEIN-D; ALZHEIMERS-DISEASE; GENETIC-VARIATION; PERIPHERAL-NERVE; CANCER CELLS; HUMAN-PLASMA; HIGH-DENSITY; CHOLESTEROL ACYLTRANSFERASE; OXIDATIVE STRESS; MESSENGER-RNA	Apolipoprotein (Apo) D is an important protein produced in many parts of the body. It is necessary for the development and repair of the brain and protection from oxidative stress. The purpose of this study was to investigate the extent to which apoD interacts with lipoproteins in human plasma. By using detergent-free ELISA, we show that immobilized monoclonal antibodies against apoD very efficiently bind to low density lipoprotein (LDL) from plasma; this binding is as equally efficient as binding to an anti-apoB monoclonal antibody. Adding detergent to the plasma inhibited the binding, suggesting that the binding is dependent on the presence of intact lipoprotein particles. Reversing the system by using immobilized anti-apoB revealed that the affinity of apoD for LDL is rather low, suggesting that multiple bindings are needed for a durable connection. Biosensor experiments using purified lipoproteins also showed that purified apoD and high density lipoprotein 3 (HDL3), a lipoprotein fraction rich in apoD, were both able to bind LDL very efficiently, indicating that the HDL3-LDL interaction may be a physiological consequence of the affinity of apoD for LDL. Furthermore, we found that apoD increases the binding of HDL to actively growing T24 bladder carcinoma cells but not to quiescent, contact-inhibited, confluent T24 cells. This result is especially intriguing given that the T24 supernatant only contained detectable levels of apoD after growth inhibition, raising the possibility that alternating the expression of apoD and a putative apoD-receptor could give direction to the flow of lipids. In the current paper, we conclude that apoD mediates binding of HDL to LDL and to growing T24 carcinomas, thereby highlighting the importance of apoD in lipid metabolism.	[Braesch-Andersen, Sten; Beckman, Lena; Paulie, Staffan] Mabtech, Nacka Strand, Sweden; [Beckman, Lena] Karolinska Univ, Huddinge Hosp, Dept Endocrinol Metab & Diabet, Huddinge Hosp,Metab Unit, Stockholm, Sweden; [Kumagai-Braesch, Makiko] Karolinska Inst, Div Transplantat Surg, CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Braesch-Andersen, S (corresponding author), Mabtech, Nacka Strand, Sweden.	sten@mabtech.com		Kumagai-Braesch, Makiko/0000-0001-6011-0744				Bajo-Graneras R, 2013, INT J COLORECTAL DIS, V28, P751, DOI 10.1007/s00384-012-1616-2; BALBIN M, 1990, BIOCHEM J, V271, P803, DOI 10.1042/bj2710803; Bancells C, 2010, J LIPID RES, V51, P3508, DOI 10.1194/jlr.M009258; Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; BON GB, 1981, J LIPID RES, V22, P998; BOYLES JK, 1990, J BIOL CHEM, V265, P17805; Chen Y, 2008, BRAIN RES, V1233, P196, DOI 10.1016/j.brainres.2008.07.018; Dassati S, 2014, NEUROBIOL AGING, V35, P1632, DOI 10.1016/j.neurobiolaging.2014.01.148; Desai PP, 2003, AM J MED GENET B, V116B, P98, DOI 10.1002/ajmg.b.10798; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; Do Carmo S, 2002, J BIOL CHEM, V277, P5514, DOI 10.1074/jbc.M105057200; Do Carmo S, 2008, J NEUROSCI, V28, P10330, DOI 10.1523/JNEUROSCI.2644-08.2008; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Elliott DA, 2010, CLIN LIPIDOL, V5, P555, DOI 10.2217/CLP.10.37; FIELDING PE, 1980, P NATL ACAD SCI-BIOL, V77, P3327, DOI 10.1073/pnas.77.6.3327; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Ganfornina MD, 2010, GLIA, V58, P1320, DOI 10.1002/glia.21010; Helisalmi S, 2004, J NEUROL, V251, P951, DOI 10.1007/s00415-004-0470-8; HOLMQUIST L, 1989, J BIOCHEM BIOPH METH, V19, P93, DOI 10.1016/0165-022X(89)90054-7; Jimenez-Palomares M, 2011, METABOLISM, V60, P1767, DOI 10.1016/j.metabol.2011.04.013; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; LopezBoado YS, 1997, CANCER RES, V57, P4091; Mehdi H, 1999, HUM GENET, V105, P63, DOI 10.1007/s004390051065; MILLER NE, 1977, J CLIN INVEST, V60, P78, DOI 10.1172/JCI108772; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Muffat J, 2010, CELL CYCLE, V9, P269, DOI 10.4161/cc.9.2.10433; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Perdomo G, 2009, AGING-US, V1, P17; PROVOST PR, 1991, FEBS LETT, V290, P139, DOI 10.1016/0014-5793(91)81244-3; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; Sarjeant JM, 2003, ARTERIOSCL THROM VAS, V23, P2172, DOI 10.1161/01.ATV.0000100404.05459.39; Shao B, 2009, J LIPID RES, V50, P599, DOI 10.1194/jlr.E900001-JLR200; SPREYER P, 1990, EMBO J, V9, P2479, DOI 10.1002/j.1460-2075.1990.tb07426.x; STEYRER E, 1988, BIOCHIM BIOPHYS ACTA, V958, P484, DOI 10.1016/0005-2760(88)90235-4; SUGIMOTO K, 1994, J STEROID BIOCHEM, V51, P167, DOI 10.1016/0960-0760(94)90090-6; Tsukamoto K, 2013, P NATL ACAD SCI USA, V110, P17023, DOI 10.1073/pnas.1315986110; Yoshikawa M, 1997, CLIN BIOCHEM, V30, P221, DOI 10.1016/S0009-9120(97)00031-3	37	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115180	10.1371/journal.pone.0115180	http://dx.doi.org/10.1371/journal.pone.0115180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513803	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300039
J	Engel, D; Woolley, AW; Jing, LX; Chabris, CF; Malone, TW				Engel, David; Woolley, Anita Williams; Jing, Lisa X.; Chabris, Christopher F.; Malone, Thomas W.			Reading the Mind in the Eyes or Reading between the Lines? Theory of Mind Predicts Collective Intelligence Equally Well Online and Face-To-Face	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; EMOTIONAL INTELLIGENCE; INDIVIDUAL-DIFFERENCES; COGNITIVE-ABILITY; ASPERGER-SYNDROME; TEAM PERFORMANCE; NORMAL ADULTS; PERSONALITY; CHILDREN; COMMUNICATION	Recent research with face-to-face groups found that a measure of general group effectiveness (called "collective intelligence") predicted a group's performance on a wide range of different tasks. The same research also found that collective intelligence was correlated with the individual group members' ability to reason about the mental states of others (an ability called "Theory of Mind" or "ToM"). Since ToM was measured in this work by a test that requires participants to "read" the mental states of others from looking at their eyes (the "Reading the Mind in the Eyes" test), it is uncertain whether the same results would emerge in online groups where these visual cues are not available. Here we find that: (1) a collective intelligence factor characterizes group performance approximately as well for online groups as for face-to-face groups; and (2) surprisingly, the ToM measure is equally predictive of collective intelligence in both face-to-face and online groups, even though the online groups communicate only via text and never see each other at all. This provides strong evidence that ToM abilities are just as important to group performance in online environments with limited nonverbal cues as they are face-to-face. It also suggests that the Reading the Mind in the Eyes test measures a deeper, domain-independent aspect of social reasoning, not merely the ability to recognize facial expressions of mental states.	[Engel, David; Jing, Lisa X.; Malone, Thomas W.] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Woolley, Anita Williams] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; [Chabris, Christopher F.] Union Coll, Dept Psychol, Schenectady, NY 12308 USA; [Engel, David; Woolley, Anita Williams; Jing, Lisa X.; Chabris, Christopher F.; Malone, Thomas W.] MIT, Ctr Collect Intelligence, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Carnegie Mellon University; Union College; Massachusetts Institute of Technology (MIT)	Engel, D (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dengel@mit.edu; awoolley@cmu.edu; malone@mit.edu		Williams Woolley, Anita/0000-0003-0620-4744	National Science Foundation [IIS-0963285, ACI-1322254, IIS-0963451]; U.S. Army Research Office [56692-MA, 64079-NS]; Cisco Systems, Inc. through MIT Center for Collective Intelligence; Direct For Computer & Info Scie & Enginr [0963285] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Army Research Office; Cisco Systems, Inc. through MIT Center for Collective Intelligence; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was made possible by financial support from the National Science Foundation (grant numbers IIS-0963285, ACI-1322254, and IIS-0963451), the U.S. Army Research Office (grant numbers 56692-MA and 64079-NS) and Cisco Systems, Inc. through their sponsorship of the MIT Center for Collective Intelligence. The funding was awarded to TM, AW and CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly IA, 2012, Q J EXP PSYCHOL, V65, P825, DOI 10.1080/17470218.2012.676055; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barsade SG, 2007, ACAD MANAGE PERSPECT, V21, P36, DOI 10.5465/AMP.2007.24286163; Begeer S, 2010, EUR J DEV PSYCHOL, V7, P104, DOI 10.1080/17405620903024263; Bender L, 2012, COMPUTER SCI ED, P403; Brenner J., 2013, SOCIAL NETWORKING; Byron K, 2008, ACAD MANAGE REV, V33, P309, DOI 10.5465/AMR.2008.31193163; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Cummings JN, 2007, RES POLICY, V36, P1620, DOI 10.1016/j.respol.2007.09.001; Deary I. J., 2000, LOOKING HUMAN INTELL; Devine DJ, 2001, SMALL GR RES, V32, P507, DOI 10.1177/104649640103200501; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Elfenbein HA, 2005, LINK EMOTIONAL INTEL; Elfenbein HA, 2010, J RES PERS, V44, P199, DOI 10.1016/j.jrp.2010.01.001; Elfenbein HA, 2007, RES EMOTION ORGAN, V3, P87, DOI 10.1016/S1746-9791(07)03004-0; Ellis APJ, 2003, J APPL PSYCHOL, V88, P821, DOI 10.1037/0021-9010.88.5.821; Feyerherm A.E., 2002, INT J ORG ANAL, V10, P343, DOI DOI 10.1108/EB028957; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; GOODHUE DL, 1995, MIS QUART, V19, P213, DOI 10.2307/249689; Hallerback Maria Unenge, 2009, Cogn Neuropsychiatry, V14, P127, DOI 10.1080/13546800902901518; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Heyes CM, 2014, SCIENCE, V344, P1356, DOI 10.1126/science.1243091; Ickes W., 1996, WHATS SOCIAL SOCIAL, P285; Jordan P.J., 2002, HUM RESOUR MANAGE R, V12, P195, DOI [DOI 10.1016/S1053-4822(02)00046-3, 10.1016/s1053-4822(02)00046-3]; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kruger J, 2005, J PERS SOC PSYCHOL, V89, P925, DOI 10.1037/0022-3514.89.6.925; Krych-Appelbaum M, 2007, J INTERACT STUD; Larson Jr James R., 2009, SEARCH SYNERGY SMALL; LePine JA, 2005, J APPL PSYCHOL, V90, P1153, DOI 10.1037/0021-9010.90.6.1153; LePine JA, 1997, J APPL PSYCHOL, V82, P803, DOI 10.1037/0021-9010.82.5.803; MacCann C, 2014, EMOTION, V14, P358, DOI 10.1037/a0034755; Majchrzak A, 2000, MIS QUART, V24, P569, DOI 10.2307/3250948; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; Mayer Salovey P, 1993, INTELLIGENCE, V17, P433; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; McGrath J. E., 1984, GROUPS INTERACTION P; Neuman GA, 1999, GROUP ORGAN MANAGE, V24, P28, DOI 10.1177/1059601199241003; O'Leary MB, 2007, MIS Q, V31; OBRIEN GE, 1969, J APPL PSYCHOL, V53, P525, DOI 10.1037/h0028659; Peterson CC, 2007, J CHILD PSYCHOL PSYC, V48, P1243, DOI 10.1111/j.1469-7610.2007.01810.x; Pinkham AE, 2013, SCHIZOPHR B; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ren YQ, 2011, ACAD MANAG ANN, V5, P189, DOI 10.1080/19416520.2011.590300; Rousseau D.M., 1985, RES ORGAN BEHAV, V7, P1, DOI DOI 10.1177/0149206310371692; Russell SP, 2010, ARTIFICIAL INTELLIGE; Rutherford MD, 2002, J AUTISM DEV DISORD, V32, P189, DOI 10.1023/A:1015497629971; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; SHARDA R, 1988, MANAGE SCI, V34, P139, DOI 10.1287/mnsc.34.2.139; Smith EE., 2007, COGNITIVE PSYCHOL MI; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; SPROULL L, 1986, MANAGE SCI, V32, P1492, DOI 10.1287/mnsc.32.11.1492; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Stone VE, 2002, P NATL ACAD SCI USA, V99, P11531, DOI 10.1073/pnas.122352699; TZINER A, 1985, J APPL PSYCHOL, V70, P85, DOI 10.1037/0021-9010.70.1.85; Volmer J, 2006, THESIS TU CAROLO WIL; Watson AC, 1999, DEV PSYCHOL, V35, P386, DOI 10.1037/0012-1649.35.2.386; Wegner D.M., 1987, THEORIES GROUP BEHAV, P185, DOI DOI 10.1007/978-1-4612-4634-3_9; Woodley MA, 2011, INTELLIGENCE, V39, P79, DOI 10.1016/j.intell.2011.01.004; Woolley AW, 2008, SMALL GR RES, V39, P352, DOI 10.1177/1046496408317792; Woolley AW, 2007, SOC NEUROSCI, V2, P96, DOI 10.1080/17470910701363041; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Yip JA, 2013, PSYCHOL SCI, V24, P48, DOI 10.1177/0956797612450031	63	112	113	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115212	10.1371/journal.pone.0115212	http://dx.doi.org/10.1371/journal.pone.0115212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514387	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300043
J	Shiraki, T; Aoyama, T; Yokoyama, C; Hayakawa, Y; Tanaka, T; Nishigaki, K; Sawamura, T; Minatoguchi, S				Shiraki, Takeru; Aoyama, Takuma; Yokoyama, Chiharu; Hayakawa, Yuka; Tanaka, Toshiki; Nishigaki, Kazuhiko; Sawamura, Tatsuya; Minatoguchi, Shinya			LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OX-LDL RECEPTOR-1; VASCULAR ENDOTHELIAL-CELLS; HIGH-CHOLESTEROL DIET; SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; OXIDIZED LDL; ATHEROSCLEROTIC LESIONS; MEDIATED ARTERIOGENESIS; NAD(P)H OXIDASE	LOX-1, lectin-like oxidized low-density lipoprotein (LDL) receptor-1, is a single transmembrane receptor mainly expressed on endothelial cells. LOX-1 mediates the uptake of oxidized LDL, an early step in atherosclerosis; however, little is known about whether LOX-1 is involved in angiogenesis during tissue ischemia. Therefore, we examined the role of LOX-1 in ischemia-induced angiogenesis in the hindlimbs of LOX-1 knockout (KO) mice. Angiogenesis was evaluated in a surgically induced hindlimb ischemia model using laser Doppler blood flowmetry (LDBF) and histological capillary density (CD) and arteriole density (AD). After right hindlimb ischemia, the ischemic/nonischemic hindlimb blood flow ratio was persistently lower in LOX-1 KO mice than in wild-type (WT) mice. CD and AD were significantly smaller in LOX-1 KO mice than in WT mice on postoperative day 14. Immunohistochemical analysis revealed that the number of macrophages infiltrating ischemic tissues was significantly smaller in LOX-1 KO mice than in WT mice. The number of infiltrated macrophages expressing VEGF was also significantly smaller in LOX-1 KO mice than in WT mice. Western blot analysis and ROS production assay revealed that LOX-KO mice show significant decrease in Nox2 expression, ROS production and HIF-1 alpha expression, the phosphorylation of p38 MAPK and NF-kappa B p65 subunit as well as expression of redox-sensitive vascular cell adhesion molecule-1 (VCAM-1) and LOX-1 itself in ischemic muscles, which is supposed to be required for macrophage infiltration expressing angiogenic factor VEGF. Reduction of VEGF expression successively suppressed the phosphorylation of Akt and eNOS, which accelerated angiogenesis, in the ischemic leg of LOX-1 KO mice. Our findings indicate that LOX-1 plays an important role in ischemia-induced angiogenesis by 1) Nox2-ROS-NF-kappa B activation, 2) upregulated expression of adhesion molecules: VCAM-1 and LOX-1 and 3) promoting macrophage infiltration, which expresses angiogenic factor VEGF.	[Shiraki, Takeru; Aoyama, Takuma; Yokoyama, Chiharu; Hayakawa, Yuka; Tanaka, Toshiki; Nishigaki, Kazuhiko; Minatoguchi, Shinya] Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan; [Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Vasc Physiol, Suita, Osaka, Japan; [Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Matsumoto, Nagano 390, Japan	Gifu University; National Cerebral & Cardiovascular Center - Japan; Shinshu University	Aoyama, T (corresponding author), Gifu Univ, Grad Sch Med, Dept Cardiol, Gifu, Japan.	TKMAOYAMA@aol.com	Sawamura, Tatsuya/E-7103-2010					Aoyama T, 2000, FEBS LETT, V467, P217, DOI 10.1016/S0014-5793(00)01154-6; Aoyama T, 1999, BIOCHEM J, V339, P177, DOI 10.1042/0264-6021:3390177; Aoyama T, 1999, J MOL CELL CARDIOL, V31, P2101, DOI 10.1006/jmcc.1999.1041; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen MY, 2000, ARTERIOSCL THROM VAS, V20, P1107, DOI 10.1161/01.ATV.20.4.1107; Chen XP, 2007, VASC PHARMACOL, V47, P1, DOI 10.1016/j.vph.2007.01.004; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; Diebold I, 2012, J CELL SCI, V125, P956, DOI 10.1242/jcs.094060; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Feron O, 2006, CARDIOVASC RES, V69, P788, DOI 10.1016/j.cardiores.2005.12.014; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; He Y, 2006, J CLIN INVEST, V116, P2344, DOI 10.1172/JCI28123; Honjo M, 2003, P NATL ACAD SCI USA, V100, P1274, DOI 10.1073/pnas.0337528100; Hu CP, 2008, CARDIOVASC RES, V79, P287, DOI 10.1093/cvr/cvn110; Hu CP, 2008, J BIOL CHEM, V283, P10226, DOI 10.1074/jbc.M708820200; Hu C, 2008, J MOL CELL CARDIOL, V44, P76, DOI 10.1016/j.yjmcc.2007.10.009; Hu CP, 2007, CARDIOVASC RES, V76, P292, DOI 10.1016/j.cardiores.2007.07.003; Inomata Y, 2009, INVEST OPHTH VIS SCI, V50, P3970, DOI 10.1167/iovs.07-1177; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kanata S, 2006, BIOCHEM BIOPH RES CO, V348, P1003, DOI 10.1016/j.bbrc.2006.07.133; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Kataoka H, 2001, ARTERIOSCL THROM VAS, V21, P955, DOI 10.1161/01.ATV.21.6.955; Kawamura I, 2010, AM J PHYSIOL-HEART C, V299, pH372, DOI 10.1152/ajpheart.00035.2010; Kume N, 1998, CIRC RES, V83, P322, DOI 10.1161/01.RES.83.3.322; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Luo DH, 2006, AM J PATHOL, V169, P1886, DOI 10.2353/ajpath.2006.060603; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moriwaki H, 1998, ARTERIOSCL THROM VAS, V18, P1541, DOI 10.1161/01.ATV.18.10.1541; Nishimura S, 2004, OSTEOARTHR CARTILAGE, V12, P568, DOI 10.1016/j.joca.2004.04.005; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Sangle GV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1243, DOI 10.1152/ajpendo.90415.2008; Sasaki K, 2002, J CLIN INVEST, V109, P603, DOI 10.1172/JCI200213055; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Urao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057618; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; White SJ, 2010, CARDIOVASC PATHOL; Yoshida H, 1998, BIOCHEM J, V334, P9, DOI 10.1042/bj3340009; Zhang FX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/691023	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114542	10.1371/journal.pone.0114542	http://dx.doi.org/10.1371/journal.pone.0114542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514797	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300014
J	Siebert, E; Bohner, G; Endres, M; Liman, TG				Siebert, Eberhard; Bohner, Georg; Endres, Matthias; Liman, Thomas G.			Clinical and Radiological Spectrum of Posterior Reversible Encephalopathy Syndrome: Does Age Make a Difference? - A Retrospective Comparison between Adult and Pediatric Patients	PLOS ONE			English	Article							CHILDREN; PATHOPHYSIOLOGY; CHILDHOOD	Background: Posterior reversible encephalopathy syndrome (PRES) is a serious and increasingly recognized disorder, but data from observational studies on clinicoradiological differences between etiologies and age groups are limited. In this study, we aimed to investigate the clinical and imaging characteristics of PRES in children compared to adults in a large cohort. Methods: We retrospectively reviewed the radiological report data bases between January 1999 and August 2012 for patients with PRES (total of 110 patients). Patients fulfilling the criteria for PRES after detailed investigation of clinical charts and imaging studies were separated into children (<18years) and adults (>= 18years). Various imaging features at onset of symptoms and on follow-up as well as clinical and paraclinical data were analyzed. Results: A total of 19 pediatric and 91 adult patients with PRES were included into the study. In pediatric PRES patients, seizures were significantly more frequent as initial PRES-related symptom (p=0.01). In addition, in children the superior frontal sulcus topographic lesion pattern occurred as frequent as the parieto-occipital one and was significantly more prevalent than in adults (p=0.02). In contrast, in adults visual disturbances tended to occur more frequently than in children (p=0.05). Also, severity of edema tended to be greater in adults than in children (p=0.07). Conclusion: In our PRES cohort, we found relevant clinicoradiological differences between pediatric and adult PRES patients. However, prospective studies are warranted to establish factors that are specifically associated with pediatric PRES.	[Siebert, Eberhard; Bohner, Georg] Charite, Dept Neuroradiol, D-13353 Berlin, Germany; [Endres, Matthias; Liman, Thomas G.] Charite, Dept Neurol, D-13353 Berlin, Germany; [Endres, Matthias; Liman, Thomas G.] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Endres, Matthias] Charite, German Ctr Cardiovasc Res DZHK Partner Site, D-13353 Berlin, Germany; [Endres, Matthias] Charite, German Ctr Neurodegenerat Dis DZNE Partner Sit, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Siebert, E (corresponding author), Charite, Dept Neuroradiol, D-13353 Berlin, Germany.	eberhard.siebert@charite.de		Siebert, Eberhard/0000-0001-7395-6546; Bohner, Georg/0000-0002-1919-092X; Liman, Thomas/0000-0002-8471-8049; Endres, Matthias/0000-0001-6520-3720				Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1043, DOI 10.3174/ajnr.A0929; Bartynski WS, 2008, AM J NEURORADIOL, V29, P447, DOI 10.3174/ajnr.A0839; Bartynski WS, 2007, AM J NEURORADIOL, V28, P1320, DOI 10.3174/ajnr.A0549; Chen TH, 2013, J CHILD NEUROL, V28, P1378, DOI 10.1177/0883073813500714; Covarrubias DJ, 2002, AM J NEURORADIOL, V23, P1038; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Dunn KM, 2014, AM J PHYSIOL-HEART C, V306, pH1, DOI 10.1152/ajpheart.00364.2013; Endo A, 2012, PEDIATR EMERG CARE, V28, P153, DOI 10.1097/PEC.0b013e3182442fe8; Hefzy HM, 2009, AM J NEURORADIOL, V30, P1371, DOI 10.3174/ajnr.A1588; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Ishikura K, 2006, AM J KIDNEY DIS, V48, P231, DOI 10.1053/j.ajkd.2006.04.076; Ishikura K, 2012, PEDIATR NEPHROL, V27, P375, DOI 10.1007/s00467-011-1873-2; Jones BV, 1997, AM J NEURORADIOL, V18, P101; Lee VH, 2008, ARCH NEUROL-CHICAGO, V65, P205, DOI 10.1001/archneurol.2007.46; Legriel S, 2014, PLOS ONE, V7; Liman TG, 2014, ACTA NEUROL SCAND, V130, P34, DOI 10.1111/ane.12213; Liman TG, 2012, EUR J NEUROL, V19, P935, DOI 10.1111/j.1468-1331.2011.03629.x; Liman TG, 2012, J NEUROL, V259, P155, DOI 10.1007/s00415-011-6152-4; McCoy B, 2011, EUR J PAEDIATR NEURO, V15, P91, DOI 10.1016/j.ejpn.2010.10.002; McKinney AM, 2007, AM J ROENTGENOL, V189, P904, DOI 10.2214/AJR.07.2024; Morris EB, 2007, PEDIATR BLOOD CANCER, V48, P152, DOI 10.1002/pbc.20703; Mueller-Mang C, 2009, NEURORADIOLOGY, V51, P373, DOI 10.1007/s00234-009-0504-0; National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, 2011, PEDIATRICS, V114, P555; Onder AM, 2007, PEDIATR NEPHROL, V22, P1921, DOI 10.1007/s00467-007-0578-z; Raj S, 2013, PEDIATR NEUROL, V49, P335, DOI 10.1016/j.pediatrneurol.2013.06.007; Sharma A, 2010, NEURORADIOLOGY, V52, P855, DOI 10.1007/s00234-009-0632-6; Siebert E, 2013, EUR J PAEDIATR NEURO, V17, P169, DOI 10.1016/j.ejpn.2012.08.003; Thachil J, 2010, ARCH NEUROL-CHICAGO, V67, P1536, DOI 10.1001/archneurol.2010.315; TUOR UI, 1994, J COMP NEUROL, V342, P439, DOI 10.1002/cne.903420310; TUOR UI, 1994, AM J PHYSIOL-HEART C, V267, pH2220, DOI 10.1152/ajpheart.1994.267.6.H2220; Won SC, 2009, J PEDIAT HEMATOL ONC, V31, P505, DOI 10.1097/MPH.0b013e3181a71868; Yamada A, 2012, PEDIATR NEPHROL, V27, P277, DOI 10.1007/s00467-011-1974-y; Zheng W, 2001, J TOXICOL-CLIN TOXIC, V39, P711, DOI 10.1081/CLT-100108512	34	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115073	10.1371/journal.pone.0115073	http://dx.doi.org/10.1371/journal.pone.0115073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514795	Green Submitted, gold, Green Published			2022-12-27	WOS:000349146300030
J	Khuu, SK; Chung, CYL; Lord, S; Pearson, J				Khuu, Sieu K.; Chung, Charles Y. L.; Lord, Stephanie; Pearson, Joel			Unconscious Local Motion Alters Global Image Speed	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; APPARENT-MOTION; VISUAL-SYSTEM; PERCEPTION; ADAPTATION; VISION	Accurate motion perception of self and object speed is crucial for successful interaction in the world. The context in which we make such speed judgments has a profound effect on their accuracy. Misperceptions of motion speed caused by the context can have drastic consequences in real world situations, but they also reveal much about the underlying mechanisms of motion perception. Here we show that motion signals suppressed from awareness can warp simultaneous conscious speed perception. In Experiment 1, we measured global speed discrimination thresholds using an annulus of 8 local Gabor elements. We show that physically removing local elements from the array attenuated global speed discrimination. However, removing awareness of the local elements only had a small effect on speed discrimination. That is, unconscious local motion elements contributed to global conscious speed perception. In Experiment 2 we measured the global speed of the moving Gabor patterns, when half the elements moved at different speeds. We show that global speed averaging occurred regardless of whether local elements were removed from awareness, such that the speed of invisible elements continued to be averaged together with the visible elements to determine the global speed. These data suggest that contextual motion signals outside of awareness can both boost and affect our experience of motion speed, and suggest that such pooling of motion signals occurs before the conscious extraction of the surround motion speed.	[Khuu, Sieu K.; Chung, Charles Y. L.; Lord, Stephanie] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2052, Australia; [Pearson, Joel] Univ New S Wales, Sch Psychol, Kensington, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Chung, CYL (corresponding author), Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2052, Australia.	charles.chung@unsw.edu.au	Khuu, Sieu/N-7957-2019	Khuu, Sieu/0000-0003-1850-0225; Pearson, Joel/0000-0003-3704-5037				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; BLAKE R, 1993, VISION RES, V33, P1589, DOI 10.1016/0042-6989(93)90152-M; BLAKE R, 1977, J EXP PSYCHOL HUMAN, V3, P251, DOI 10.1037/0096-1523.3.2.251; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Brogaard B, 2014, BEHAV BRAIN SCI, V37, P22, DOI 10.1017/S0140525X13000654; Chung CYL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00195; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Grunewald A, 2002, J NEUROSCI, V22, P6195; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; HIRIS E, 1992, P NATL ACAD SCI USA, V89, P9025, DOI 10.1073/pnas.89.19.9025; Ho C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028814; Kaunitz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060787; Kaunitz L, 2011, J VISION, V11, DOI 10.1167/11.13.10; Khuu SK, 2014, J VISION, V14, DOI 10.1167/14.3.25; Khuu SK, 2006, VISION RES, V46, P407, DOI 10.1016/j.visres.2005.05.002; Khuu SK, 2002, VISION RES, V42, P3031, DOI 10.1016/S0042-6989(02)00384-X; Khuu SK, 2011, J VISION, V11; Khuu SK, 2012, J VISION, V12; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; LEHMKUHLE SW, 1975, VISION RES, V15, P855, DOI 10.1016/0042-6989(75)90266-7; Lewis DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064960; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Mareschal I, 2012, P NATL ACAD SCI USA, V109, P7553, DOI 10.1073/pnas.1200952109; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; Muckli L, 2005, PLOS BIOL, V3, P1501, DOI 10.1371/journal.pbio.0030265; Newell BR, 2014, BEHAV BRAIN SCI, V37, P1, DOI 10.1017/S0140525X12003214; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nishida S, 2011, J VISION, V11, DOI 10.1167/11.5.11; ORBAN GA, 1995, PERCEPTION, V24, P269, DOI 10.1068/p240269; OSHEA RP, 1981, VISION RES, V21, P801, DOI 10.1016/0042-6989(81)90177-2; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; Ro T, 2008, NEUROPSYCHOLOGIA, V46, P379, DOI 10.1016/j.neuropsychologia.2007.09.005; SNOWDEN RJ, 1994, J OPT SOC AM A, V11, P25, DOI 10.1364/JOSAA.11.000025; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Verghese P, 1996, NATURE, V381, P161, DOI 10.1038/381161a0; WATAMANIUK SNJ, 1992, VISION RES, V32, P931, DOI 10.1016/0042-6989(92)90036-I; WEISKRANTZ L, 1986, ACTA NEUROL SCAND, V74, P69, DOI 10.1111/j.1600-0404.1986.tb04865.x; WIESENFELDER H, 1991, VISION RES, V31, P1589, DOI 10.1016/0042-6989(91)90135-R; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Yamada Y, 2011, J VIS, V11; Yang E, 2010, J VISION, V10, DOI 10.1167/10.12.24	47	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e112804	10.1371/journal.pone.0112804	http://dx.doi.org/10.1371/journal.pone.0112804			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503603	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100005
J	Sante, T; Vergult, S; Volders, PJ; Kloosterman, WP; Trooskens, G; De Preter, K; Dheedene, A; Speleman, F; De Meyer, T; Menten, B				Sante, Tom; Vergult, Sarah; Volders, Pieter-Jan; Kloosterman, Wigard P.; Trooskens, Geert; De Preter, Katleen; Dheedene, Annelies; Speleman, Frank; De Meyer, Tim; Menten, Bjorn			ViVar: A Comprehensive Platform for the Analysis and Visualization of Structural Genomic Variation	PLOS ONE			English	Article							READ ALIGNMENT; DATABASE; REARRANGEMENTS; SEQUENCES; TOOL	Structural genomic variations play an important role in human disease and phenotypic diversity. With the rise of high-throughput sequencing tools, mate-pair/paired-end/single-read sequencing has become an important technique for the detection and exploration of structural variation. Several analysis tools exist to handle different parts and aspects of such sequencing based structural variation analyses pipelines. A comprehensive analysis platform to handle all steps, from processing the sequencing data, to the discovery and visualization of structural variants, is missing. The ViVar platform is built to handle the discovery of structural variants, from Depth Of Coverage analysis, aberrant read pair clustering to split read analysis. ViVar provides you with powerful visualization options, enables easy reporting of results and better usability and data management. The platform facilitates the processing, analysis and visualization, of structural variation based on massive parallel sequencing data, enabling the rapid identification of disease loci or genes. ViVar allows you to scale your analysis with your work load over multiple (cloud) servers, has user access control to keep your data safe and is easy expandable as analysis techniques advance.	[Sante, Tom; Vergult, Sarah; Volders, Pieter-Jan; De Preter, Katleen; Dheedene, Annelies; Speleman, Frank; Menten, Bjorn] Univ Ghent, Fac Med & Hlth Sci, Ctr Med Genet, B-9000 Ghent, Belgium; [Kloosterman, Wigard P.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Trooskens, Geert; De Meyer, Tim] Univ Ghent, Fac Biosci Engn, BioBix, B-9000 Ghent, Belgium	Ghent University; Utrecht University; Utrecht University Medical Center; Ghent University	Menten, B (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Ctr Med Genet, B-9000 Ghent, Belgium.	bjorn.menten@UGent.be	Volders, Pieter-Jan/I-1567-2019; De Preter, Katleen/I-7135-2013; speleman, frank/AAR-5184-2020; Menten, Björn/B-3072-2013; De Meyer, Tim/D-3892-2011	Volders, Pieter-Jan/0000-0002-2685-2637; De Preter, Katleen/0000-0002-7726-5096; speleman, frank/0000-0002-6628-8559; De Meyer, Tim/0000-0003-2994-9693; Vergult, Sarah/0000-0002-0816-6262	Special Research Fund (BOF) from Ghent University; Research Foundation - Flanders (FWO); Special Research Fund of Ghent University	Special Research Fund (BOF) from Ghent University; Research Foundation - Flanders (FWO)(FWO); Special Research Fund of Ghent University(Ghent University)	Sarah Vergult is supported by a postdoctoral grant from the Special Research Fund (BOF) from Ghent University. Katleen De Preter is supported by a postdoctoral grant from the Research Foundation - Flanders (FWO). This article presents research results of the Belgian program of Interuniversity Poles of attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming (IUAP). The authors would like to acknowledge the N2N (Nucleotide 2 Networks) Multidisciplinary Research Partnership funded by the Special Research Fund of Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bressler R, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-15; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Duan JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059128, 10.1371/journal.pone.0062087]; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; McKenna A., 2010, GENOME RES; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; O'Brien TM, 2010, IEEE T VIS COMPUT GR, V16, P918, DOI 10.1109/TVCG.2010.163; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pavlopoulos GA, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt254; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Vergult S, 2013, EUR J HUM GENET; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	29	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113800	10.1371/journal.pone.0113800	http://dx.doi.org/10.1371/journal.pone.0113800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503062	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400015
J	Bate, S; Karp, NA				Bate, Simon; Karp, Natasha A.			A Common Control Group - Optimising the Experiment Design to Maximise Sensitivity	PLOS ONE			English	Article							STATISTICAL POWER ANALYSIS; HISTORICAL CONTROL DATA	Methods for choosing an appropriate sample size in animal experiments have received much attention in the statistical and biological literature. Due to ethical constraints the number of animals used is always reduced where possible. However, as the number of animals decreases so the risk of obtaining inconclusive results increases. By using a more efficient experimental design we can, for a given number of animals, reduce this risk. In this paper two popular cases are considered, where planned comparisons are made to compare treatments back to control and when researchers plan to make all pairwise comparisons. By using theoretical and empirical techniques we show that for studies where all pairwise comparisons are made the traditional balanced design, as suggested in the literature, maximises sensitivity. For studies that involve planned comparisons of the treatment groups back to the control group, which are inherently more sensitive due to the reduced multiple testing burden, the sensitivity is maximised by increasing the number of animals in the control group while decreasing the number in the treated groups.	[Bate, Simon] GlaxoSmithKline, Stat Sci Europe, Stevenage, Herts, England; [Karp, Natasha A.] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England	GlaxoSmithKline; Wellcome Trust Sanger Institute	Bate, S (corresponding author), GlaxoSmithKline, Stat Sci Europe, Stevenage, Herts, England.	simon.t.bate@gsk.com		Karp, Natasha/0000-0002-8404-2907	National Institutes of Health [1 U54 HG006370-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health (www.nih.gov), grant number 1 U54 HG006370-01 (Natasha Karp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bate S.T., 2014, DESIGN STAT ANAL ANI; Clark RA, 2012, J PSYCHOPHARMACOL, V26, P1136, DOI 10.1177/0269881111420313; Cohen J.E., 1988, STAT POWER ANAL BEHA; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garcia-Perez MA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00325; Greim H, 2003, HUM EXP TOXICOL, V22, P541, DOI 10.1191/0960327103ht394oa; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Lee SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095733; Lenth RV, 2001, AM STAT, V55, P187, DOI 10.1198/000313001317098149; Nekohashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097901; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Rozza AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086686; RUSSELL W. M. S., 1959; Ruxton G. D., 2006, EXPT DESIGN LIFE SCI; SNEDECOR G W, 1980; Sun TT, 2004, NAT REV MOL CELL BIO, V5, P577, DOI 10.1038/nrm1429; Thomas L, 1996, ANIM BEHAV, V52, P856, DOI 10.1006/anbe.1996.0232; Viele K, 2014, PHARM STAT, V13, P41, DOI 10.1002/pst.1589; Zar, 2011, BIOSTAT ANAL; Zhou KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098905	22	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114872	10.1371/journal.pone.0114872	http://dx.doi.org/10.1371/journal.pone.0114872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25504147	gold, Green Published			2022-12-27	WOS:000347146700062
J	Guillemin, ML; Valero, M; Faugeron, S; Nelson, W; Destombe, C				Guillemin, Marie-Laure; Valero, Myriam; Faugeron, Sylvain; Nelson, Wendy; Destombe, Christophe			Tracing the Trans-Pacific Evolutionary History of a Domesticated Seaweed (Gracilaria chilensis) with Archaeological and Genetic Data	PLOS ONE			English	Article							POPULATION-GROWTH; RHODOPHYTA; DNA; ECOLOGY; VERMICULOPHYLLA; CULTIVATION; NEUTRALITY; SIGNATURE; PROGRAM; TESTS	The history of a domesticated marine macroalga is studied using archaeological, phylogeographic and population genetic tools. Phylogeographic and population genetic analyses demonstrated that the cultivated red alga Gracilaria chilensis colonised the Chilean coast from New Zealand. Combining archaeological observations with phylogeographic data provided evidence that exchanges between New Zealand and Chile have occurred at least before the Holocene, likely at the end of the Last Glacial Maximum (LGM) and we suggest that migration probably occurred via rafting. Furthermore, the remarkably low microsatellite diversity found in the Chilean populations compared to those in New Zealand is consistent with a recent genetic bottleneck as a result of over-exploitation of natural populations and/or the process of domestication. Therefore, the aquaculture of this seaweed, based essentially on clonal propagation, is occurring from genetically depressed populations and may be driving the species to an extinction vortex in Chile.	[Guillemin, Marie-Laure] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Guillemin, Marie-Laure; Valero, Myriam; Faugeron, Sylvain; Destombe, Christophe] Univ Paris 06, Sorbonne Univ, CNRS, UMI 3614,Stn Biol Roscoff, F-296888 Roscoff, France; [Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Conservac Marina, Santiago, Chile; [Faugeron, Sylvain] Pontificia Univ Catolica Chile, Fac Ciencias Biol, CeBiB, Santiago, Chile; [Nelson, Wendy] Univ Auckland, Sch Biol Sci, Natl Inst Water & Atmospher Res, Wellington 6241, New Zealand	Universidad Austral de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland	Guillemin, ML (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Casilla 567, Valdivia, Chile.	marielaure.guillemin@gmail.com	Valero, Myriam/M-6052-2019; Valero, Myriam/C-7550-2011	Valero, Myriam/0000-0002-9000-1423; Valero, Myriam/0000-0002-9000-1423; nelson, wendy/0000-0003-0014-5560; Guillemin, Marie-Laure/0000-0001-5703-7662; Destombe, Christophe/0000-0001-5656-9659; Faugeron, Sylvain/0000-0001-7258-5229	European Research Cooperation for Development INCO-DEV Programme (INCO-EPIFIGHT) [ICA4-CT- 2001-10021]; French National Research Agency [ANR-10-BTBR-04-02]; CONICYT; Comision Nacional de Investigacion Cientifica y Tecnologica; Gobierno de Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT) [1090360, 1130868]; Iniciativa Cientifica Milenio (ICM) [P10-033F]; European Network of Excellence 'Marine Genomics' (Algal Node); 'ARCUS' programme of the French Ministry of Foreign Affairs; International Research Network "Diversity, Evolution and Biotechnology of Marine Algae'' (GDRI) [0803]; National Institute of Water and Atmospheric Research (NIWA) Coasts & Oceans CORE funding [COBR1401]	European Research Cooperation for Development INCO-DEV Programme (INCO-EPIFIGHT); French National Research Agency(French National Research Agency (ANR)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Comision Nacional de Investigacion Cientifica y Tecnologica; Gobierno de Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio (ICM); European Network of Excellence 'Marine Genomics' (Algal Node); 'ARCUS' programme of the French Ministry of Foreign Affairs; International Research Network "Diversity, Evolution and Biotechnology of Marine Algae'' (GDRI); National Institute of Water and Atmospheric Research (NIWA) Coasts & Oceans CORE funding	This research was supported by the European Research Cooperation for Development INCO-DEV Programme (INCO-EPIFIGHT ICA4-CT- 2001-10021), research grants IDEAL G "Seaweed biotechnology and bioresources: a french challenge'' ANR-10-BTBR-04-02 from the French National Research Agency, CONICYT, Comision Nacional de Investigacion Cientifica y Tecnologica, Gobierno de Chile (Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT No 1090360 and No 1130868) and Iniciativa Cientifica Milenio (ICM P10-033F). Additional support came from the European Network of Excellence 'Marine Genomics' (Algal Node), from the 'ARCUS' programme of the French Ministry of Foreign Affairs, International Research Network "Diversity, Evolution and Biotechnology of Marine Algae'' (GDRI No 0803), National Institute of Water and Atmospheric Research (NIWA) Coasts & Oceans CORE funding (COBR1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adovasio J., 1997, MONTE VERDE LATE PLE, P221; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BIRD CJ, 1986, CAN J BOT, V64, P2928, DOI 10.1139/b86-387; BIRD CJ, 1990, J APPL PHYCOL, V2, P375, DOI 10.1007/BF02180928; Boo GH, 2014, AQUAT BOT, V119, P73, DOI 10.1016/j.aquabot.2014.08.004; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; BUSCHMANN AH, 1995, J APPL PHYCOL, V7, P291, DOI 10.1007/BF00004003; Buschmann AH, 2001, AQUACULTURE, V194, P203, DOI 10.1016/S0044-8486(00)00518-4; Buschmann AH, 2008, INT J ENVIRON POLLUT, V33, P432, DOI 10.1504/IJEP.2008.020571; Byrne Kellie, 2002, Phycological Research, V50, P295, DOI 10.1111/j.1440-1835.2002.tb00162.x; Cohen S, 2004, J PHYCOL, V40, P742, DOI 10.1111/j.1529-8817.2004.03203.x; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2012, QUATERNARY RES, V77, P418, DOI 10.1016/j.yqres.2012.02.003; Duarte CM, 2007, SCIENCE, V316, P382, DOI 10.1126/science.1138042; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Erlandson JM, 2011, QUATERN INT, V239, P28, DOI 10.1016/j.quaint.2011.02.030; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fraser CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069138; Fraser CI, 2009, P NATL ACAD SCI USA, V106, P3249, DOI 10.1073/pnas.0810635106; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemin ML, 2008, EVOLUTION, V62, P1500, DOI 10.1111/j.1558-5646.2008.00373.x; Guillemin ML, 2005, MOL ECOL NOTES, V5, P155, DOI 10.1111/j.1471-8286.2005.00867.x; Gurgel CFD, 2004, J PHYCOL, V40, P748, DOI 10.1111/j.1529-8817.2004.03070.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jones TC, 2008, AQUAT BOT, V88, P39, DOI 10.1016/j.aquabot.2007.08.017; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Leakey R.E., 1995, 6 EXTINCTION PATTERN; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lyons DA, 2009, DIVERS DISTRIB, V15, P762, DOI 10.1111/j.1472-4642.2009.00580.x; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; May V, 1948, CSIRO B, V235, P7; MCCARTHY C, 1997, CHROMAS; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nelson WA, 2012, NZ INVENTORY BIODIVE, V3, P327; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; POBLETE A, 1991, REV CHIL HIST NAT, V64, P335; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Redman CL, 1999, HUMAN IMPACT ANCIENT, P239; Rioux Paquette S., 2011, POPGENKIT USEFUL FUN; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHIEL DR, 1990, HYDROBIOLOGIA, V204, P25, DOI 10.1007/BF00040211; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Thiers B., 2022, INDEX HERBARIORUM GL; Toggweiler JR, 2008, NATURE, V451, P286, DOI 10.1038/nature06590; Weinberger F, 2008, AQUAT BIOL, V3, P251, DOI 10.3354/ab00083; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Womersley H.B.S., 1996, MARINE BENTHIC FL 3B; Yang EC, 2008, J APPL PHYCOL, V20, P161, DOI 10.1007/s10811-007-9201-8; Zhou B, 2007, MOL PLANT MICROBE IN, V20, P63, DOI 10.1094/MPMI-20-0063	62	27	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114039	10.1371/journal.pone.0114039	http://dx.doi.org/10.1371/journal.pone.0114039			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501717	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700014
J	Hurley, B; Lee, D; Mott, A; Wilton, M; Liu, J; Liu, YC; Angers, S; Coaker, G; Guttman, DS; Desveaux, D				Hurley, Brenden; Lee, Donghyuk; Mott, Adam; Wilton, Michael; Liu, Jun; Liu, Yulu C.; Angers, Stephane; Coaker, Gitta; Guttman, David S.; Desveaux, Darrell			The Pseudomonas syringae Type III Effector HopF2 Suppresses Arabidopsis Stomatal Immunity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PHYTOTOXIN CORONATINE; TRIGGERED IMMUNITY; PV. PHASEOLICOLA; TOMATO DC3000; VIRULENCE; RESISTANCE; PATTERN; AVIRULENCE; SYSTEM	Pseudomonas syringae subverts plant immune signalling through injection of type III secreted effectors (T3SE) into host cells. The T3SE HopF2 can disable Arabidopsis immunity through Its ADP-ribosyltransferase activity. Proteomic analysis of HopF2 interacting proteins identified a protein complex containing ATPases required for regulating stomatal aperture, suggesting HopF2 may manipulate stomatal immunity. Here we report HopF2 can inhibit stomatal immunity independent of its ADP-ribosyltransferase activity. Transgenic expression of HopF2 in Arabidopsis inhibits stomatal closing in response to P. syringae and increases the virulence of surface inoculated P. syringae. Further, transgenic expression of HopF2 inhibits flg22 induced reactive oxygen species production. Intriguingly, ADP-ribosyltransferase activity is dispensable for inhibiting stomatal immunity and flg22 induced reactive oxygen species. Together, this implies HopF2 may be a bifunctional T3SE with ADP-ribosyltransferase activity required for inhibiting apoplastic immunity and an independent function required to inhibit stomatal immunity.	[Hurley, Brenden; Mott, Adam; Wilton, Michael; Guttman, David S.; Desveaux, Darrell] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Lee, Donghyuk; Liu, Jun; Coaker, Gitta] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Liu, Yulu C.; Angers, Stephane] Univ Toronto, Dept Biochem, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Guttman, David S.; Desveaux, Darrell] Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON, Canada	University of Toronto; University of California System; University of California Davis; University of Toronto; University of Toronto	Guttman, DS (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON, Canada.	david.guttman@utoronto.ca; darrell.desveaux@utoronto.ca	Angers, Stephane/E-1432-2014; Guttman, David S/A-7839-2011; Liu, Yulu Cherry/AAC-6960-2019	Angers, Stephane/0000-0001-7241-9044; Guttman, David S/0000-0001-8479-3869; Liu, Yulu Cherry/0000-0003-4861-6915; Mott, Adam/0000-0001-9803-103X	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Plant-Microbe Systems Biology; Queen Elizabeth II Graduate Scholarship in Science and Technology; Centre for the Analysis of Genome Evolution and Function; CFI; CIHR; Canada Research Chair program; NSF [MCB-1054298]; NIH [RO1GM092772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092772] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Plant-Microbe Systems Biology; Queen Elizabeth II Graduate Scholarship in Science and Technology; Centre for the Analysis of Genome Evolution and Function; CFI(Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair program(Canada Research Chairs); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Natural Sciences and Engineering Research Council of Canada awards (to B.H., D.S.G., and D.D.); a Canada Research Chair in Plant-Microbe Systems Biology (to D.D.) or Comparative Genomics (to D.S.G.); Queen Elizabeth II Graduate Scholarship in Science and Technology (B.H.); the Centre for the Analysis of Genome Evolution and Function (D.D., and D.S.G.). S.A. is supported by CFI, CIHR and the Canada Research Chair program. G.C., J.L., and D.L. were supported through NSF grant number MCB-1054298 and NIH grant number RO1GM092772 awarded to G.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Deng WL, 1998, J BACTERIOL, V180, P4523, DOI 10.1128/JB.180.17.4523-4531.1998; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Freeman BC, 2009, MOL PLANT MICROBE IN, V22, P857, DOI 10.1094/MPMI-22-7-0857; Geng XQ, 2014, PLANTA, V240, P1149, DOI 10.1007/s00425-014-2151-x; Gimenez-Ibanez S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001792; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Hou SG, 2011, FEMS MICROBIOL LETT, V323, P35, DOI 10.1111/j.1574-6968.2011.02356.x; Keinath NF, 2010, J BIOL CHEM, V285, P39140, DOI 10.1074/jbc.M110.160531; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Krall R, 2000, INFECT IMMUN, V68, P6066, DOI 10.1128/IAI.68.10.6066-6068.2000; Lee J, 2012, PLANT PHYSIOL, V158, P1803, DOI 10.1104/pp.111.190686; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lewis JD, 2009, SEMIN CELL DEV BIOL, V20, P1055, DOI 10.1016/j.semcdb.2009.06.003; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Lozano-Duran R, 2014, NEW PHYTOL, V202, P259, DOI 10.1111/nph.12651; MA SW, 1991, MOL PLANT MICROBE IN, V4, P69, DOI 10.1094/MPMI-4-069; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Macho AP, 2012, PLANT PHYSIOL, V159, P1845, DOI 10.1104/pp.112.199810; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Merlot S, 2007, EMBO J, V26, P3216, DOI 10.1038/sj.emboj.7601750; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; MOORE RA, 1989, CAN J MICROBIOL, V35, P910, DOI 10.1139/m89-151; Morris CE, 2013, ANNU REV PHYTOPATHOL, V51, P85, DOI 10.1146/annurev-phyto-082712-102402; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicaise V, 2009, PLANT PHYSIOL, V150, P1638, DOI 10.1104/pp.109.139709; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Qi YP, 2011, J BIOL CHEM, V286, P31297, DOI 10.1074/jbc.M110.211615; Qi YP, 2009, PLANT J, V57, P932, DOI 10.1111/j.1365-313X.2008.03736.x; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Robert-Seilaniantz A, 2006, MOL PLANT MICROBE IN, V19, P130, DOI 10.1094/MPMI-19-0130; Sawinski K, 2013, MOL PLANT MICROBE IN, V26, P626, DOI 10.1094/MPMI-12-12-0288-CR; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; Tsuda K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004015; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang YJ, 2010, PLANT CELL, V22, P2033, DOI 10.1105/tpc.110.075697; Wilton M, 2010, P NATL ACAD SCI USA, V107, P2349, DOI 10.1073/pnas.0904739107; Zeng WQ, 2010, PLANT PHYSIOL, V153, P1188, DOI 10.1104/pp.110.157016; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zhou JG, 2014, PLANT J, V77, P235, DOI 10.1111/tpj.12381	56	43	43	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114921	10.1371/journal.pone.0114921	http://dx.doi.org/10.1371/journal.pone.0114921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503437	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700072
J	Liu, X; Cui, T; Li, YY; Wang, YT; Wang, QH; Li, X; Bi, Y; Wei, XP; Liu, L; Li, TY; Chen, J				Liu, Xia; Cui, Ting; Li, Yingying; Wang, Yuting; Wang, Qinghong; Li, Xin; Bi, Yang; Wei, Xiaoping; Liu, Lan; Li, Tingyu; Chen, Jie			Vitamin A Supplementation in Early Life Enhances the Intestinal Immune Response of Rats with Gestational Vitamin A Deficiency by Increasing the Number of Immune Cells	PLOS ONE			English	Article							RETINOIC ACID; DENDRITIC CELLS; MOUSE MODEL; T-CELLS; GUT; CHILDREN; LYMPHOCYTES; EXPRESSION; TOLERANCE; INFECTION	Vitamin A is a critical micronutrient for regulating immunity in many organisms. Our previous study demonstrated that gestational or early-life vitamin A deficiency decreases the number of immune cells in offspring. The present study aims to test whether vitamin A supplementation can restore lymphocyte pools in vitamin A-deficient rats and thereby improve the function of their intestinal mucosa; furthermore, the study aimed to identify the best time frame for vitamin A supplementation. Vitamin A-deficient pregnant rats or their offspring were administered a low-dose of vitamin A daily for 7 days starting on gestational day 14 or postnatal day 1, day 14 or day 28. Serum retinol concentrations increased significantly in all four groups that received vitamin A supplementation, as determined by high-performance liquid chromatography. The intestinal levels of secretory immunoglobulin A and polymeric immunoglobulin receptor increased significantly with lipopolysaccharide challenge in the rats that received vitamin A supplementation starting on postnatal day 1. The rats in this group had higher numbers of CD8(+) intestinal intraepithelial lymphocytes, CD11(C)(+) dendritic cells in the Peyer's patches and CD4(+) CD25(+) T cells in the spleen compared with the vitamin A-deficient rats; flow cytometric analysis also demonstrated that vitamin A supplementation decreased the number of B cells in the mesenteric lymph nodes. Additionally, vitamin A supplementation during late gestation increased the numbers of CD8(+) intestinal intraepithelial lymphocytes and decreased the numbers of B lymphocytes in the mesenteric lymph nodes. However, no significant differences in lymphocyte levels were found between the rats in the other two vitamin A supplement groups and the vitamin A-deficient group. In conclusion, the best recovery of a subset of lymphocytes in the offspring of gestational vitamin A-deficient rats and the greatest improvement in the intestinal mucosal immune response are achieved when vitamin A supplementation occurs during the early postnatal period.	[Liu, Xia; Cui, Ting; Li, Yingying; Wang, Yuting; Bi, Yang; Wei, Xiaoping; Li, Tingyu; Chen, Jie] Chongqing Med Univ, Childrens Nutr Res Ctr,Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Minist Educ,Key Lab Child Dev & Disorders,Key Lab, Chongqing 400014, Peoples R China; [Wang, Qinghong; Li, Xin] Chongqing Med Univ, Childrens Hosp, Inst Pediat, Chongqing 400014, Peoples R China; [Liu, Lan] Univ Maryland, Sch Med, Dept Surg, Lab Intestinal Physiol & Pathol, Baltimore, MD 21201 USA	Chongqing Medical University; Chongqing Medical University; University System of Maryland; University of Maryland Baltimore	Chen, J (corresponding author), Chongqing Med Univ, Childrens Nutr Res Ctr,Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Minist Educ,Key Lab Child Dev & Disorders,Key Lab, CSTC2009 CA5002, Chongqing 400014, Peoples R China.	jchen010@cqmu.edu.cn	wang, qinghong/M-7969-2017	Li, Tingyu/0000-0002-1940-7076	National Nature Science of Foundation of China [81070286, 81470799]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2009-1001]; Science & Technology Project of Yuzhong District of Chongqing	National Nature Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Science & Technology Project of Yuzhong District of Chongqing	This work was supported by grants from National Nature Science of Foundation of China (81070286, 81470799) and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2009-1001), as well as Science & Technology Project of Yuzhong District of Chongqing (2012) to Professor JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2012, SEMIN IMMUNOPATHOL, V34, P551, DOI 10.1007/s00281-012-0316-x; Agace WW, 2012, TRENDS IMMUNOL, V33, P42, DOI 10.1016/j.it.2011.10.001; Alberg T, 2011, INHAL TOXICOL, V23, P268, DOI 10.3109/08958378.2011.566898; Blacquiere MJ, 2010, INT ARCH ALLERGY IMM, V153, P173, DOI 10.1159/000312635; Cao JY, 2013, ASIA PAC J CLIN NUTR, V22, P214, DOI 10.6133/apjcn.2013.22.2.10; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chen K, 2008, J NUTR SCI VITAMINOL, V54, P440, DOI 10.3177/jnsv.54.440; Donnen P, 1998, AM J CLIN NUTR, V68, P1254, DOI 10.1093/ajcn/68.6.1254; Frossard CP, 2004, J ALLERGY CLIN IMMUN, V114, P377, DOI 10.1016/j.jaci.2004.03.040; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Imdad A., 2010, COCHRANE DATABASE SY, P12; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Jiang W, 2012, J NEUROCHEM, V121, P932, DOI 10.1111/j.1471-4159.2012.07697.x; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Liu X, 2014, NUTRITION, V30, P350, DOI 10.1016/j.nut.2013.09.008; Long KZ, 2006, J NUTR, V136, P1365, DOI 10.1093/jn/136.5.1365; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mayo-Wilson E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5094; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Organization WH, 2009, GLOB PREV VIT DEF PO, P283; Ross AC, 2011, VITAM HORM, V86, P103, DOI 10.1016/B978-0-12-386960-9.00005-8; Sauvant P, 2012, CURR OPIN CLIN NUTR, V15, P310, DOI 10.1097/MCO.0b013e3283526968; Seguin-Devaux C, 2005, MOL CELL ENDOCRINOL, V245, P67, DOI 10.1016/j.mce.2005.10.006; Seo GY, 2013, J LEUKOCYTE BIOL, V94, P325, DOI 10.1189/jlb.0313128; Sheridan Brian S, 2010, Curr Gastroenterol Rep, V12, P513, DOI 10.1007/s11894-010-0148-6; Stock A, 2013, IMMUNOL CELL BIOL, V91, P240, DOI 10.1038/icb.2012.73; Takano M, 1998, INFECT IMMUN, V66, P3270, DOI 10.1128/IAI.66.7.3270-3278.1998; Takenouchi-Ohkubo N, 2004, CLIN EXP IMMUNOL, V135, P448, DOI 10.1111/j.1365-2249.2004.02398.x; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; Wei H, 2009, J NUTR SCI VITAMINOL, V55, P208, DOI 10.3177/jnsv.55.208; World Health Organization, 1996, NUTR IND ASS VIT A D; Zhang X, 2011, J NUTR BIOCHEM, V22, P1112, DOI 10.1016/j.jnutbio.2010.09.010	37	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114934	10.1371/journal.pone.0114934	http://dx.doi.org/10.1371/journal.pone.0114934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503794	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700074
J	Cheval, B; Sarrazin, P; Pelletier, L				Cheval, Boris; Sarrazin, Philippe; Pelletier, Luc			Impulsive Approach Tendencies towards Physical Activity and Sedentary Behaviors, but Not Reflective Intentions, Prospectively Predict Non-Exercise Activity Thermogenesis	PLOS ONE			English	Article							NONEXERCISE ACTIVITY THERMOGENESIS; IMPLICIT; ADULTS; HEALTH; EMG	Understanding the determinants of non-exercise activity thermogenesis (NEAT) is crucial, given its extensive health benefits. Some scholars have assumed that a proneness to react differently to environmental cues promoting sedentary versus active behaviors could be responsible for inter-individual differences in NEAT. In line with this reflection and grounded on the Reflective-Impulsive Model, we test the assumption that impulsive processes related to sedentary and physical activity behaviors can prospectively predict NEAT, operationalized as spontaneous effort exerted to maintain low intensity muscle contractions within the release phases of an intermittent maximal isometric contraction task. Participants (n=91) completed a questionnaire assessing their intentions to adopt physical activity behaviors and a manikin task to assess impulsive approach tendencies towards physical activity behaviors (IAPA) and sedentary behaviors (IASB). Participants were then instructed to perform a maximal handgrip strength task and an intermittent maximal isometric contraction task. As hypothesized, multilevel regression analyses revealed that spontaneous effort was (a) positively predicted by IAPA, (b) negatively predicted by IASB, and (c) was not predicted by physical activity intentions, after controlling for some confounding variables such as age, sex, usual PA level and average force provided during the maximal-contraction phases of the task. These effects remained constant throughout all the phases of the task. This study demonstrated that impulsive processes may play a unique role in predicting spontaneous physical activity behaviors. Theoretically, this finding reinforces the utility of a motivational approach based on dual-process models to explain inter-individual differences in NEAT. Implications for health behavior theories and behavior change interventions are outlined.	[Cheval, Boris; Sarrazin, Philippe] Univ Grenoble Alpes, Lab Sport & Environm Social SENS, F-38000 Grenoble, France; [Cheval, Boris; Pelletier, Luc] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Cheval, Boris] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Ottawa; University of Geneva	Sarrazin, P (corresponding author), Univ Grenoble Alpes, Lab Sport & Environm Social SENS, F-38000 Grenoble, France.	philippe.sarrazin@ujf-grenoble.fr	Cheval, Boris/H-4574-2019	Cheval, Boris/0000-0002-6236-4673; Sarrazin, Philippe/0000-0003-0598-7564				Aiken L. S., 1991, MULTIPLE REGRESSION; Cheval B, 2014, HLTH PSYCHO IN PRESS; Conroy DE, 2010, ANN BEHAV MED, V39, P112, DOI 10.1007/s12160-010-9161-0; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; De Houwer J, 2001, COGNITION EMOTION, V15, P189, DOI 10.1080/0269993004200051; DUQUE J, 1995, APPL ERGON, V26, P61, DOI 10.1016/0003-6870(94)00003-H; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Friese M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044130; Friese M, 2011, SELF IDENTITY, V10, P336, DOI 10.1080/15298868.2010.536417; Friese M, 2008, EUR REV SOC PSYCHOL, V19, P285, DOI 10.1080/10463280802556958; Gast A, 2012, LEARN MOTIV, V43, P79, DOI 10.1016/j.lmot.2012.06.004; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Hofmann W., 2008, HEALTH PSYCHOL REV, V2, P111, DOI [10.1080/17437190802617668, DOI 10.1080/17437190802617668]; Hoozemans MJM, 2005, J ELECTROMYOGR KINES, V15, P358, DOI 10.1016/j.jelekin.2004.09.001; Krieglmeyer R, 2010, COGNITION EMOTION, V24, P810, DOI 10.1080/02699930903047298; Levine J, 2001, AM J PHYSIOL-ENDOC M, V281, pE670, DOI 10.1152/ajpendo.2001.281.4.E670; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Mogg K, 2003, ADDICTION, V98, P825, DOI 10.1046/j.1360-0443.2003.00392.x; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wiers RW, 2011, PSYCHOL SCI, V22, P490, DOI 10.1177/0956797611400615; Xu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087881	29	27	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115238	10.1371/journal.pone.0115238	http://dx.doi.org/10.1371/journal.pone.0115238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526596	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200019
J	Li, ZL; Liang, XL; Liu, SX; Ye, ZM; Chen, YH; Wang, WJ; Li, RZ; Xu, LX; Feng, ZL; Shi, W				Li, Zhilian; Liang, Xinling; Liu, Shuangxin; Ye, Zhiming; Chen, Yuanhan; Wang, Wenjian; Li, Ruizhao; Xu, Lixia; Feng, Zhonglin; Shi, Wei			Pulmonary Hypertension: Epidemiology in Different CKD Stages and Its Association with Cardiovascular Morbidity	PLOS ONE			English	Article							ECHOCARDIOGRAPHY RECOMMENDATIONS; INDEPENDENT PREDICTOR; EUROPEAN ASSOCIATION; KIDNEY-DISEASE; HEART-FAILURE; PREVALENCE; MORTALITY; EVENTS; PROGNOSIS; PRESSURE	Background: Pulmonary hypertension (PH) was recently recognized as a common complication of end-stage renal disease (ESRD) that causes an increased risk of mortality. Epidemiological data for this disorder in earlier stages of chronic kidney disease (CKD) and its association with cardiovascular (CV) morbidity are scarce. Methods: We retrospectively analyzed 2,351 Chinese CKD patients with complete clinical records and echocardiography data between Jan 2008 and May 2012. The patients were divided into the following 6 groups: CKD Stages 1-4; Stage 5 for those not on or initiated on hemodialysis for <3 months; and Stage 5D for the patients undergoing hemodialysis for >= 3 months. The prevalence of PH and CV morbidity was investigated, and their association was evaluated with a logistic regression model. Results: PH was detected in 426 patients (18.1%). Mild, moderate and severe PH was diagnosed in 12.1%, 4.9% and 1.1% of the patients, respectively. Severe PH was detected in CKD Stages 5 and 5D. CV morbidity was found in 645 patients (27.4%). Compared with the non-PH group, the PH group had a higher risk for cardiac disease but not for cerebrovascular disease risk. PH severity was associated with cardiac morbidity risk [odds ratio (95% CI) for mild PH: 1.79 (1.30-2.47); moderate PH: 2.75 (1.73-4.37); severe PH: 3.90 (1.46-10.42)]. Conclusions: Our study showed for the first time the epidemiology profile of PH across the spectrum of CKD. Mild-to-moderate PH occurs with more frequency in advanced CKD, and severe PH is scarce in non-ESRD CKD. PH in CKD is associated with cardiac but not cerebrovascular disease, with increasing cardiac morbidity seen with increasing PH severity. Evidence from prospective studies addressing PH in this population is needed to predict cardiac events.	[Li, Zhilian; Liang, Xinling] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Li, Zhilian; Liang, Xinling; Liu, Shuangxin; Ye, Zhiming; Chen, Yuanhan; Wang, Wenjian; Li, Ruizhao; Xu, Lixia; Feng, Zhonglin; Shi, Wei] Southern Med Univ, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Southern Medical University - China	Shi, W (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.	shiw_ggh@163.com	liu, shuangxin/AAS-7429-2020		National Natural Science Foundation [81200544, 81170683]; National Key Technology RD Program [2011BAI10B08]; National Clinical Key Specialty Construction Preparatory Projects, China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Clinical Key Specialty Construction Preparatory Projects, China	This study was supported by grants from the National Natural Science Foundation (81200544 and 81170683), National Key Technology R&D Program (2011BAI10B08), and the National Clinical Key Specialty Construction Preparatory Projects, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab S, 2008, AM J NEPHROL, V28, P990, DOI 10.1159/000146076; Acarturk G, 2008, INT UROL NEPHROL, V40, P509, DOI 10.1007/s11255-007-9269-8; Agarwal R, 2012, NEPHROL DIAL TRANSPL, V27, P3908, DOI 10.1093/ndt/gfr661; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; Bolignano D, 2013, AM J KIDNEY DIS, V61, P612, DOI 10.1053/j.ajkd.2012.07.029; Covic A, 2009, NEPHROL DIAL TRANSPL, V24, P1506, DOI 10.1093/ndt/gfn613; Dagli CE, 2009, RESPIRATION, V78, P411, DOI 10.1159/000247334; Di Lullo L, 2013, CARDIORENAL MED, V3, P96, DOI 10.1159/000350952; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fabbian F, 2010, INT J NEPHROL, V11, P463; Fenstad ER, 2013, CHEST, V144, P1530, DOI 10.1378/chest.12-3033; Havlucu Y, 2007, RESPIRATION, V74, P503, DOI 10.1159/000102953; Hinderliter AL, 1999, AM J CARDIOL, V84, P481, DOI 10.1016/S0002-9149(99)00342-2; Humbert M, 2012, EUR RESPIR REV, V21, P306, DOI 10.1183/09059180.00005112; Issa N, 2008, TRANSPLANTATION, V86, P1384, DOI 10.1097/TP.0b013e318188d640; Kawar B, 2013, AM J NEPHROL, V37, P281, DOI 10.1159/000348804; Kumbar Lalathaksha, 2007, Adv Perit Dial, V23, P127; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P307, DOI 10.1093/ejechocard/jeq031; Lancellotti P, 2010, EUR J ECHOCARDIOGR, V11, P223, DOI 10.1093/ejechocard/jeq030; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li ZL, 2014, INT UROL NEPHROL, V46, P141, DOI 10.1007/s11255-013-0486-z; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; McQuillan BM, 2001, CIRCULATION, V104, P2797, DOI 10.1161/hc4801.100076; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Navaneethan SD, 2014, CLIN J AM SOC NEPHRO, V9, P855, DOI 10.2215/CJN.10191013; Pabst S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035310; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sise ME, 2013, KIDNEY INT, V84, P682, DOI 10.1038/ki.2013.186; Unal A, 2009, PERITON DIALYSIS INT, V29, P191; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; Yigla M, 2003, CHEST, V123, P1577, DOI 10.1378/chest.123.5.1577; Yigla M, 2006, SEMIN DIALYSIS, V19, P353, DOI 10.1111/j.1525-139X.2006.00186.x; Yigla M, 2009, KIDNEY INT, V75, P969, DOI 10.1038/ki.2009.10; Zoccali C, 2013, J AM SOC NEPHROL, V24, P639, DOI 10.1681/ASN.2012100990	35	24	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114392	10.1371/journal.pone.0114392	http://dx.doi.org/10.1371/journal.pone.0114392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525807	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200005
J	Tachibana, Y; Sakurai, T; Bai, H; Shiota, K; Nambo, Y; Nagaoka, K; Imakawa, K				Tachibana, Yurika; Sakurai, Toshihiro; Bai, Hanako; Shiota, Kunio; Nambo, Yasuo; Nagaoka, Kentaro; Imakawa, Kazuhiko			RNA-Seq Analysis of Equine Conceptus Transcripts during Embryo Fixation and Capsule Disappearance	PLOS ONE			English	Article							EXPRESSION; GENES; TIME; GLYCOPROTEINS; ENDOMETRIUM; PROTEINS; GIRDLE; CELLS; VEGF; TAU	Extensive studies have been conducted to characterize the unique phenomena of equine pregnancy. Most studies have focused on embryo transmigration when the embryo is covered with a mucin-like glycoprotein capsule and on the characterization of the chorionic girdle and chorionic gonadotropin (CG) secretion. However, the events preceding and following capsule disappearance have not been well studied. In this study, the mRNA expression in conceptus membranes at days 19, 21, and 25 (day 0=day of ovulation) was analyzed by RNA-seq (SOLiD3), and transcript levels on these three days and day 13 were confirmed by real-time PCR. Of the 26,416 equine genes registered, 20,436 transcripts were aligned to sequences in the Ensembl database, from which 4,625 transcripts were registered in both Ensembl and the KEGG pathway. Each of the 4,625 transcripts was examined through KEGG pathway analysis, and 12 transcripts of integrins (ITGs) and collagens (COLs) were confirmed through real-time PCR. Our data indicated that extracellular matrix (ECM)-related mRNAs were highly expressed in day 19, 21, and 25 conceptus membranes. In combination with previous results, which confirmed a lack of laminin and fibronectin transcript expression in the endometrium, these observations suggest that in contrast to attachment through focal adhesion, conceptus chorionic membrane ECMs function as a scaffold-like structure to possibly maintain the shape of the conceptus and a separation between chorionic membranes and the uterine luminal epithelium.	[Tachibana, Yurika; Sakurai, Toshihiro; Bai, Hanako; Imakawa, Kazuhiko] Univ Tokyo, Lab Theriogenol & Anim Breeding, Tokyo 1138657, Japan; [Tachibana, Yurika; Shiota, Kunio] Univ Tokyo, Lab Cellular Biochem, Tokyo 1138657, Japan; [Tachibana, Yurika; Shiota, Kunio] Univ Tokyo, Anim Resource Ctr, Tokyo 1138657, Japan; [Nambo, Yasuo] Japan Racing Assoc, Hidaka Training & Res Ctr, Urakawa 0570171, Japan; [Nagaoka, Kentaro] Tokyo Univ Agr & Technol, Vet Physiol Lab, Dept Vet Med, Fuchu, Tokyo 1838509, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo University of Agriculture & Technology	Imakawa, K (corresponding author), Univ Tokyo, Lab Theriogenol & Anim Breeding, Tokyo 1138657, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Bai, Hanako/K-4769-2019; Imakawa, Kazuhiko/AAD-3211-2022; Nagaoka, Kentaro/C-2019-2013	Bai, Hanako/0000-0001-9940-1880; Nagaoka, Kentaro/0000-0003-1038-1380	Japan Racing Association (JRA) [2009-2010]	Japan Racing Association (JRA)	The grant (2009-2010) from Japan Racing Association (JRA) to KI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WR, 2009, PLACENTA, V30, P1005, DOI 10.1016/j.placenta.2009.09.007; Allen WR, 2001, REPROD FERT DEVELOP, V13, P623, DOI 10.1071/RD01063; Allen WR, 2001, REPRODUCTION, V121, P513, DOI 10.1530/rep.0.1210513; ALLEN WR, 1972, J REPROD FERTIL, V29, P313, DOI 10.1530/jrf.0.0290313; ALLEN WR, 1973, ANAT REC, V177, P485, DOI 10.1002/ar.1091770403; [Anonymous], 1969, CIB FDN S FOET AUT L, DOI DOI 10.1002/9780470719688.CH2; Ashton-Beaucage D, 2010, CELL, V143, P251, DOI 10.1016/j.cell.2010.09.014; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Mestre AM, 2009, BIOL REPROD, V80, P227, DOI 10.1095/biolreprod.108.070920; de Ruijter-Villani M, 2013, THERIOGENOLOGY, V80, P979, DOI 10.1016/j.theriogenology.2013.07.024; ENDERS AC, 1991, J REPROD FERTIL, P427; Furmento VA, 2014, PLACENTA, V35, P937, DOI 10.1016/j.placenta.2014.09.003; Gastal MO, 1996, THERIOGENOLOGY, V46, P1171, DOI 10.1016/S0093-691X(96)00288-9; Ginther O.J., 1992, REPROD BIOL MARE BAS; Ginther O.J., 1998, CATTLE BOOK 3, VVolume 46, P100; GINTHER OJ, 1993, THERIOGENOLOGY, V40, P1, DOI 10.1016/0093-691X(93)90336-4; GINTHER OJ, 1983, THERIOGENOLOGY, V19, P603, DOI 10.1016/0093-691X(83)90180-2; GINTHER OJ, 1983, THERIOGENOLOGY, V19, P613, DOI 10.1016/0093-691X(83)90181-4; Haneda S, 2009, DOMEST ANIM ENDOCRIN, V36, P209, DOI 10.1016/j.domaniend.2008.11.006; Hartt LS, 2005, REPRODUCTION, V130, P241, DOI 10.1530/rep.1.00596; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kikuchi M, 2011, J REPROD DEVELOP, V57, P203, DOI 10.1262/jrd.10-079K; Klein C, 2011, BIOL REPROD, V84, P872, DOI 10.1095/biolreprod.110.088732; Kostourou V, 2014, BBA-GEN SUBJECTS, V1840, P2403, DOI 10.1016/j.bbagen.2014.02.018; Lyu JY, 2013, J CELL BIOCHEM, V114, P1744, DOI 10.1002/jcb.24517; MCDOWELL KJ, 1990, J REPROD FERTIL, V89, P107, DOI 10.1530/jrf.0.0890107; Mohanty S, 2010, PLACENTA, V31, P144, DOI 10.1016/j.placenta.2009.11.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagaoka K, 2003, BIOL REPROD, V68, P1413, DOI 10.1095/biolreprod.102.008912; Nakagawa S, 2013, GENOME BIOL EVOL, V5, P296, DOI 10.1093/gbe/evt007; Nambo Y, 2002, THERIOGENOLOGY, V57, P1707, DOI 10.1016/S0093-691X(02)00683-0; Neely D P, 1979, J Reprod Fertil Suppl, P181; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; ORIOL JG, 1993, J REPROD FERTIL, V99, P653, DOI 10.1530/jrf.0.0990653; ORIOL JG, 1993, MOL REPROD DEV, V34, P255, DOI 10.1002/mrd.1080340305; ORIOL JG, 1991, J REPROD FERTIL, P455; Sakurai T, 2009, BIOL REPROD, V80, P1223, DOI 10.1095/biolreprod.108.073916; Stout TAE, 2002, REPRODUCTION, V123, P261, DOI 10.1530/rep.0.1230261; Stout TAE, 2001, REPRODUCTION, V121, P771, DOI 10.1530/rep.0.1210771; Tachibana Y, 2013, J REPROD DEVELOP, V59, P85; Walter I, 2010, REPROD FERT DEVELOP, V22, P405, DOI 10.1071/RD08280; Wooding FBP, 2001, PLACENTA, V22, P749, DOI 10.1053/plac.2001.0707	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114414	10.1371/journal.pone.0114414	http://dx.doi.org/10.1371/journal.pone.0114414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514169	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300009
J	Yu, AL; Li, Y; Ni, YL; Yang, WB; Yang, DQ; Cui, ZY; Wang, ZL; Yin, YP				Yu, Anling; Li, Yong; Ni, Yingli; Yang, Weibing; Yang, Dongqing; Cui, Zhengyong; Wang, Zhenlin; Yin, Yanping			Differences of Starch Granule Distribution in Grains from Different Spikelet Positions in Winter Wheat	PLOS ONE			English	Article							SIZE-DISTRIBUTION; INFERIOR GRAINS; RICE CULTIVAR; A-GRANULE; GROWTH; POSTANTHESIS; ENDOSPERM; SUPERIOR; ENZYMES; STRENGTH	Wheat starch development is a complex process and is markedly difference by changes in spikelet spatial position. The present study deals with endosperm starch granule distribution and spatial position during filling development. The study was conducted with pure starch isolated from wheat (Triticum aestivum L.), Jimai20 and Shannong1391, at 7-35 days after anthesis (DAA). The results showed that grain number, spikelet weight and grain weight per spikelet in different spatial position showed parabolic changes. Upper spikelets had highest starch and amylose content followed by basal spikelets, then middle spikelets. The paper also suggested the volume percents of B-type and A-type granule in grain of middle spikelets were remarkably higher and lower than those of basal and upper spikelets, respectively. However, no significant difference occurred in the number percents of the two type granule. The ratio of amylase to amylopectin was positively correlated with the volume proportion of 22.8-42.8 mu m, but was negatively related to the volume proportion of <9.9 mu m. The results indicated that the formation and distribution of starch granules were affected significantly by spikelet position, and grains at upper and basal spikelet had the potential of increasing grain weight through increasing the volume of B-type granules.	[Yu, Anling; Li, Yong; Yang, Weibing; Yang, Dongqing; Cui, Zhengyong; Wang, Zhenlin; Yin, Yanping] Shandong Agr Univ, Natl Key Lab Crop Biol, Minist Sci & Technol, Agron Coll, Tai An, Shandong, Peoples R China; [Yu, Anling] Agr Prod Qual Inspect Ctr Jining, Jining, Shandong, Peoples R China; [Ni, Yingli] Agr Bur Rencheng Dist, Jining, Shandong, Peoples R China		Wang, ZL (corresponding author), Shandong Agr Univ, Natl Key Lab Crop Biol, Minist Sci & Technol, Agron Coll, Tai An, Shandong, Peoples R China.	zlwang@sdau.edu.cn; ypyin@sdau.edu.cn			National Natural Science Foundation of China [31271661, 31271667]; Public Service Sector (Agriculture) Research Program of China [201203100]; Postdoctoral Science Foundation of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Sector (Agriculture) Research Program of China; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	The research was supported by the National Natural Science Foundation of China (31271661, 31271667), the Public Service Sector (Agriculture) Research Program of China (201203100) and Postdoctoral Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2002, CEREAL CHEM, V79, P458, DOI 10.1094/CCHEM.2002.79.3.458; Ahuja G, 2014, CARBOHYD POLYM, V114, P87, DOI 10.1016/j.carbpol.2014.08.004; Ames NP, 1999, VARIATION STARCH GRA; BECHTEL DB, 1990, CEREAL CHEM, V67, P59; Calderini DF, 2000, AUST J PLANT PHYSIOL, V27, P183; Chiotelli E, 2002, CEREAL CHEM, V79, P286, DOI 10.1094/CCHEM.2002.79.2.286; Dai ZM, 2010, RUSS J PLANT PHYSL+, V57, P74, DOI 10.1134/S1021443710010103; Dai ZhongMin, 2008, Acta Agronomica Sinica, V34, P795, DOI 10.3724/SP.J.1006.2008.00795; Dengate H. N., 1984, Advances in Cereal Science and Technology, V6, P49; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Jeng TL, 2003, J AGR SCI-CAMBRIDGE, V141, P303, DOI 10.1017/S0021859603003599; Jiang D, 2003, PLANT GROWTH REGUL, V41, P247, DOI 10.1023/B:GROW.0000007500.90240.7d; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kim HS, 2008, J CEREAL SCI, V48, P159, DOI 10.1016/j.jcs.2007.09.002; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Li W, 2010, J AGR SCI-CAMBRIDGE, V148, P183, DOI 10.1017/S0021859609990554; [李文阳 LI WenYang], 2009, [生态学报, Acta Ecologica Sinica], V29, P298; Liang TaiBo, 2008, Acta Agronomica Sinica, V34, P150, DOI 10.3724/SP.J.1006.2008.00150; MACLEOD LC, 1988, J CEREAL SCI, V8, P29, DOI 10.1016/S0733-5210(88)80046-8; MALOUF RB, 1992, CEREAL CHEM, V69, P164; MURTY PSS, 1982, INDIAN J PLANT PHYSI, V25, P40; Ni Y, 2012, J AGR SCI, V150, P45, DOI 10.1017/S0021859611000475; Pan Jie, 2005, Acta Agronomica Sinica, V31, P431; Park SH, 2009, J CEREAL SCI, V49, P98, DOI 10.1016/j.jcs.2008.07.011; Park SH, 2004, CEREAL CHEM, V81, P699, DOI 10.1094/CCHEM.2004.81.6.699; PARKER ML, 1985, J CEREAL SCI, V3, P271, DOI 10.1016/S0733-5210(85)80001-1; Peng M, 1999, CEREAL CHEM, V76, P375, DOI 10.1094/CCHEM.1999.76.3.375; Peng MS, 2001, PLANT SCI, V161, P1055, DOI 10.1016/S0168-9452(01)00481-2; Raeker MO, 1998, CEREAL CHEM, V75, P721, DOI 10.1094/CCHEM.1998.75.5.721; Sahlstrom S, 2003, J CEREAL SCI, V37, P285, DOI 10.1006/jcrs.2002.0504; Sahlstrom S, 1998, J CEREAL SCI, V28, P157, DOI 10.1006/jcrs.1998.0192; Seib P.A., 1994, OYO TOSHITSU KAGAKU, V41, P49; Shinde SV, 2003, CEREAL CHEM, V80, P91, DOI 10.1094/CCHEM.2003.80.1.91; Sikder H. P., 1976, Indian Agriculturalist, V20, P133; Soh HN, 2006, CEREAL CHEM, V83, P513, DOI 10.1094/CC-83-0513; SOULAKA AB, 1985, J SCI FOOD AGR, V36, P709, DOI 10.1002/jsfa.2740360811; STAMP P H, 1976, Zeitschrift fuer Acker- und Pflanzenbau, V142, P264; Stoddard FL, 1999, CEREAL CHEM, V76, P139, DOI 10.1094/CCHEM.1999.76.1.139; Tan XS, 2012, ACTA AGRON SIN, V11, P1809; Vermeylen R, 2005, CARBOHYD POLYM, V62, P170, DOI 10.1016/j.carbpol.2005.07.021; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang F, 2006, PLANT GROWTH REGUL, V49, P1, DOI 10.1007/s10725-006-0017-3; Wang Y.-R., 1981, International Rice Research Newsletter, V6, P23; Wang Z, 2003, J AGRON CROP SCI, V189, P280, DOI 10.1046/j.1439-037X.2003.00041.x; Yan S, 2010, J AGR SCI-CAMBRIDGE, V148, P567, DOI 10.1017/S0021859610000407; Yan SuHui, 2008, Acta Agronomica Sinica, V34, P1092, DOI 10.3724/SP.J.1006.2008.01092; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JianChang, 2002, Agricultural Sciences in China, V1, P155; Yang JC, 2010, J EXP BOT, V61, P3177, DOI 10.1093/jxb/erq112; Yang JianChang, 1998, Scientia Agricultura Sinica, V31, P7; Yu S L, 1990, WHEAT SHANDONG PROVI; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang H, 2009, PLANT PHYSIOL BIOCH, V47, P195, DOI 10.1016/j.plaphy.2008.11.012; Zhang QY, 2000, J TRITICEAE CROPS, V20, P55	54	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114342	10.1371/journal.pone.0114342	http://dx.doi.org/10.1371/journal.pone.0114342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514032	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300008
J	Fang, CS; Zhang, JQ; Qi, D; Fan, XQ; Luo, JC; Liu, L; Tan, QY				Fang, Chunshu; Zhang, Jingqing; Qi, Di; Fan, Xiaoqing; Luo, Jianchun; Liu, Ling; Tan, Qunyou			Evodiamine Induces G2/M Arrest and Apoptosis via Mitochondrial and Endoplasmic Reticulum Pathways in H446 and H1688 Human Small-Cell Lung Cancer Cells	PLOS ONE			English	Article							MEDIATED APOPTOSIS; A549 CELLS; ER STRESS; IN-VITRO; GROWTH; COMPLEX; CYCLE; DERIVATIVES; ACTIVATION; INDUCTION	The goal of this study was to evaluate the ability of EVO to decrease cell viability and promote cell cycle arrest and apoptosis in small cell lung cancer (SCLC) cells. Lung cancer has the highest incidence and mortality rates among all cancers. Chemotherapy is the primary treatment for SCLC; however, the drugs that are currently used for SCLC are less effective than those used for non-small cell lung cancer (NSCLC). Therefore, it is necessary to develop new drugs to treat SCLC. In this study, the effects of evodiamine (EVO) on cell growth, cell cycle arrest and apoptosis were investigated in the human SCLC cell lines NCI-H446 and NCI-H1688. The results represent the first report that EVO can significantly inhibit the viability of both H446 and H1688 cells in dose-and time-dependent manners. EVO induced cell cycle arrest at G2/M phase, induced apoptosis by up-regulating the expression of caspase-12 and cytochrome C protein, and induced the expression of Bax mRNA and by down-regulating of the expression of Bcl-2 mRNA in both H446 and H1688 cells. However, there was no effect on the protein expression of caspase-8. Taken together, the inhibitory effects of EVO on the growth of H446 and H1688 cells might be attributable to G2/M arrest and subsequent apoptosis, through mitochondria-dependent and endoplasmic reticulum stress-induced pathways (intrinsic caspase-dependent pathways) but not through the death receptor-induced pathway (extrinsic caspase-dependent pathway). Our findings suggest that EVO is a promising novel and potent antitumor drug candidate for SCLC. Furthermore, the cell cycle, the mitochondria and the ER stress pathways are rational targets for the future development of an EVO delivery system to treat SCLC.	[Fang, Chunshu; Qi, Di; Fan, Xiaoqing; Liu, Ling; Tan, Qunyou] Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Inst Surg Res, Chongqing, Peoples R China; [Zhang, Jingqing; Luo, Jianchun] Chongqing Med Univ, Med Engn Res Ctr, Chongqing, Peoples R China	Army Medical University; Chongqing Medical University	Tan, QY (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Thorac Surg, Inst Surg Res, Chongqing, Peoples R China.	tanqy001@163.com			Chongqing Science and Technology Committee, Chongqing, People's Republic of China [CSTC2012JJB10027]	Chongqing Science and Technology Committee, Chongqing, People's Republic of China	This study was supported by the grant CSTC2012JJB10027 from Chongqing Science and Technology Committee, Chongqing, People's Republic of China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091388; Cao R, 2013, J MED CHEM, V56, P3636, DOI 10.1021/jm4001665; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0069704, 10.1371/journal.pone.0066841]; Cheng CY, 2010, MOL MED REP, V3, P645, DOI 10.3892/mmr_00000310; Choi AY, 2014, APOPTOSIS, V19, P682, DOI 10.1007/s10495-013-0955-y; Christodoulou MS, 2013, BIOORGAN MED CHEM, V21, P6920, DOI 10.1016/j.bmc.2013.09.030; Cui WY, 2014, TUMOR BIOL, V35, P5213, DOI 10.1007/s13277-014-1677-7; Dong GQ, 2012, J MED CHEM, V55, P7593, DOI 10.1021/jm300605m; Du J, 2013, ONCOL REP, V30, P685, DOI 10.3892/or.2013.2498; Fei ZH, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/497456; Jiang JL, 2009, MOLECULES, V14, P1852, DOI 10.3390/molecules14051852; Ju YH, 2013, MOL MED REP, V8, P794, DOI 10.3892/mmr.2013.1584; Khanna N, 2004, LIFE SCI, V75, P179, DOI 10.1016/j.lfs.2003.11.026; Li L, 2012, CHINESE J CANCER RES, V24, P109, DOI 10.1007/s11670-012-0109-8; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Lin Y, 2014, TUMOR BIOL, V35, P3305, DOI 10.1007/s13277-013-1433-4; Ling YH, 2008, MOL PHARMACOL, V74, P793, DOI 10.1124/mol.107.044396; Liu AJ, 2013, CHEM-BIOL INTERACT, V205, P20, DOI 10.1016/j.cbi.2013.06.004; Liu ZG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-494; Lu B, 2003, DRUG DELIV, V10, P87, DOI 10.1080/713840364; Lv C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.484; Meng J, 2012, ONCOL REP, V28, P384, DOI 10.3892/or.2012.1793; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Seong YA, 2014, CELL BIOCHEM BIOPHYS, V68, P369, DOI 10.1007/s12013-013-9717-2; Shyu KG, 2006, LIFE SCI, V78, P2234, DOI 10.1016/j.lfs.2005.09.027; Song SC, 2013, MOLECULES, V18, P15750, DOI 10.3390/molecules181215750; Takada Y, 2005, J BIOL CHEM, V280, P17203, DOI 10.1074/jbc.M500077200; Tan QY, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035102; Tan QY, 2012, INT J NANOMED, V7, P5385, DOI 10.2147/IJN.S36404; Tan QY, 2012, AAPS PHARMSCITECH, V13, P534, DOI 10.1208/s12249-012-9772-9; Tan YH, 2008, CLIN CANCER RES, V14, P1823, DOI 10.1158/1078-0432.CCR-07-1806; Tao L, 2014, TOXICOL LETT; Wang Y, 2013, J MED CHEM, V56, P9601, DOI 10.1021/jm4016312; Wei WT, 2012, INT J BIOL SCI, V8, P1, DOI 10.7150/ijbs.8.1; Wei YL, 2013, FOOD CHEM TOXICOL, V59, P118, DOI 10.1016/j.fct.2013.05.054; Wu SH, 2010, ANTICANCER RES, V30, P2125; Xiao F, 2012, MOL CELL BIOCHEM, V371, P65, DOI 10.1007/s11010-012-1423-7; Xu WS, 2014, PHYTOTHER RES, V28, P296, DOI 10.1002/ptr.4984; Xu WS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/426521; Xu Y, 2014, MOL CLIN ONCOL, V2, P3, DOI 10.3892/mco.2013.202; Yang CL, 2012, DNA CELL BIOL, V31, P139, DOI 10.1089/dna.2011.1300; Yang L, 2014, MOL MED REP, V9, P1147, DOI 10.3892/mmr.2014.1924; Yang LN, 2013, IUBMB LIFE, V65, P533, DOI 10.1002/iub.1161; Yoon JW, 2014, ONCOL REP, V31, P314, DOI 10.3892/or.2013.2840; Yu HX, 2014, CELL BIOCHEM BIOPHYS, V70, P63, DOI 10.1007/s12013-014-9910-y; Zhang T, 2014, INT J MOL SCI, V15, P3154, DOI 10.3390/ijms15023154; Zhang YL, 2013, AM J CHINESE MED, V41, P1137, DOI 10.1142/S0192415X13500778; Zhu GY, 2012, CHEM PHARM BULL, V60, P1029, DOI 10.1248/cpb.c12-00302	48	43	54	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115204	10.1371/journal.pone.0115204	http://dx.doi.org/10.1371/journal.pone.0115204			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506932	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100059
J	Jo, H; Patterson, V; Stoessel, S; Kuan, CY; Hoh, J				Jo, Hakryul; Patterson, Victoria; Stoessel, Sean; Kuan, Chia-Yi; Hoh, Josephine			Protoporphyrins Enhance Oligomerization and Enzymatic Activity of HtrA1 Serine Protease	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; MACULAR DEGENERATION; FAMILY PROTEINS; QUALITY CONTROL; SERUM-ALBUMIN; CANCER; OXYGEN; GENE; THERAPY; TARGETS	High temperature requirement protein A1 (HtrA1), a secreted serine protease of the HtrA family, is associated with a multitude of human diseases. However, the exact functions of HtrA1 in these diseases remain poorly understood. We seek to unravel the mechanisms of HtrA1 by elucidating its interactions with chemical or biological modulators. To this end, we screened a small molecule library of 500 bioactive compounds to identify those that alter the formation of extracellular HtrA1 complexes in the cell culture medium. An initial characterization of two novel hits from this screen showed that protoporphyrin IX (PPP-IX), a precursor in the heme biosynthetic pathway, and its metalloporphyrin (MPP) derivatives fostered the oligomerization of HtrA1 by binding to the protease domain. As a result of the interaction with MPPs, the proteolytic activity of HtrA1 against Fibulin-5, a specific HtrA1 substrate in age-related macular degeneration (AMD), was increased. This physical interaction could be abolished by the missense mutations of HtrA1 found in patients with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Furthermore, knockdown of HtrA1 attenuated apoptosis induced by PPP-IX. These results suggest that PPP-IX, or its derivatives, and HtrA1 may function as co-factors whereby porphyrins enhance oligomerization and the protease activity of HtrA1, while active HtrA1 elevates the pro-apoptotic actions of porphyrin derivatives. Further analysis of this interplay may shed insights into the pathogenesis of diseases such as AMD, CARASIL and protoporphyria, as well as effective therapeutic development.	[Jo, Hakryul; Patterson, Victoria; Stoessel, Sean; Hoh, Josephine] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA; [Jo, Hakryul; Patterson, Victoria; Stoessel, Sean; Hoh, Josephine] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Kuan, Chia-Yi] Emory Univ, Sch Med & Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	Yale University; Yale University; Children's Healthcare of Atlanta (CHOA); Emory University	Hoh, J (corresponding author), Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06520 USA.	Josephine.hoh@yale.edu			Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	Rosebay Medical Foundation; Yale Medical School Dean's Research Fund	This work was funded by Rosebay Medical Foundation and Yale Medical School Dean's Research Fund. No URL is available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SM, 2002, BIOPHYS J, V82, P1607, DOI 10.1016/S0006-3495(02)75512-4; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Beacham DW, 2010, J BIOMOL SCREEN, V15, P441, DOI 10.1177/1087057109359807; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Chow JM, 2008, TOXICOL LETT, V177, P97, DOI 10.1016/j.toxlet.2008.01.004; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Ethirajan M, 2011, CHEM SOC REV, V40, P340, DOI 10.1039/b915149b; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Jo H, 2008, MOL CELL BIOL, V28, P4285, DOI 10.1128/MCB.01240-07; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kobuchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050082; Korinek M, 2006, J FLUORESC, V16, P355, DOI 10.1007/s10895-005-0057-5; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Marchetti P, 1996, J IMMUNOL, V157, P4830; Nishimoto Y, 2011, NEUROLOGY, V76, P1353, DOI 10.1212/WNL.0b013e318215281d; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Polireddy K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040005; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Tominaga TT, 1997, J INORG BIOCHEM, V65, P235, DOI 10.1016/S0162-0134(96)00137-7; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; TSUTSUI K, 1982, J BIOL CHEM, V257, P3925; Vierkotten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022959; Wang GF, 2014, EXP EYE RES, V119, P1, DOI 10.1016/j.exer.2013.11.009; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yushmanov VE, 1996, MAGN RESON IMAGING, V14, P255, DOI 10.1016/0730-725X(95)02103-Z; Zurawa-Janicka D, 2010, EXPERT OPIN THER TAR, V14, P665, DOI 10.1517/14728222.2010.487867	42	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115362	10.1371/journal.pone.0115362	http://dx.doi.org/10.1371/journal.pone.0115362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506911	gold, Green Submitted, Green Published			2022-12-27	WOS:000346607100070
J	Laufer, S; Mazuz, A; Nachmansson, N; Fellig, Y; Corn, BW; Bokstein, F; Ben Bashat, D; Abramovitch, R				Laufer, Shlomi; Mazuz, Ahinoam; Nachmansson, Nathalie; Fellig, Yakov; Corn, Benjamin William; Bokstein, Felix; Ben Bashat, Dafna; Abramovitch, Rinat			Monitoring Brain Tumor Vascular Heamodynamic following Anti-Angiogenic Therapy with Advanced Magnetic Resonance Imaging in Mice	PLOS ONE			English	Article							RECURRENT MALIGNANT GLIOMAS; MRI; HYPEROXIA; GROWTH; BEVACIZUMAB; HYPERCAPNIA; SUSCEPTIBILITY; RESPONSES; EFFICACY; MODEL	Advanced MR imaging methods have an essential role in classification, grading, follow-up and therapeutic management in patients with brain tumors. With the introduction of new therapeutic options, the challenge for better tissue characterization and diagnosis increase, calling for new reliable non-invasive imaging methods. In the current study we evaluated the added value of a combined protocol of blood oxygen level dependent (BOLD) imaging during hyperoxic challenge (termed hemodynamic response imaging (HRI)) in an orthotopic mouse model for glioblastoma under anti-angiogenic treatment with B20-4.1.1, an anti-VEGF antibody. In glioblastoma tumors, the elevated HRI indicated progressive angiogenesis as further confirmed by histology. In the current glioblastoma model, B20-treatment caused delayed tumor progression with no significant changes in HRI yet with slightly reduced tumor vascularity as indicated by histology. Furthermore, fewer apoptotic cells and higher proliferation index were detected in the B20-treated tumors compared to control-treated tumors. In conclusion, HRI provides an easy, safe and contrast agent free method for the assessment of the brain hemodynamic function, an additionally important clinical information.	[Laufer, Shlomi; Mazuz, Ahinoam; Nachmansson, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Laufer, Shlomi; Mazuz, Ahinoam; Nachmansson, Nathalie; Abramovitch, Rinat] Hadassah Hebrew Univ Med Ctr, MRI MRS Lab HBRC, Jerusalem, Israel; [Fellig, Yakov] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel; [Corn, Benjamin William] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Radiotherapy, IL-69978 Tel Aviv, Israel; [Bokstein, Felix] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Neurooncol Serv, IL-69978 Tel Aviv, Israel; [Ben Bashat, Dafna] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel; [Ben Bashat, Dafna] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben Bashat, Dafna] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Abramovitch, R (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rinat@hadassah.org.il			James S. McDonnell Foundation [220020176]; Translational Research Program (RTOG) [U10 CA21661]; CCOP grant from the National Cancer Institute (NCI) [U10 CA37422]; NATIONAL CANCER INSTITUTE [U10CA037422, U10CA180822, UG1CA189867, U10CA021661, U10CA180868] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Translational Research Program (RTOG); CCOP grant from the National Cancer Institute (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the James S. McDonnell Foundation (grant number 220020176), http://www.jsmf.org/; and was also supported by the Translational Research Program (RTOG) grant U10 CA21661 and CCOP grant U10 CA37422 from the National Cancer Institute (NCI). This manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 1999, CANCER RES, V59, P5012; Abramovitch R, 2004, NEOPLASIA, V6, P480, DOI 10.1593/neo.03520; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Cabrera AR, 2013, INT J RADIAT ONCOL, V86, P873, DOI 10.1016/j.ijrobp.2013.04.029; Edrei Y, 2012, BRIT J CANCER, V107, P658, DOI 10.1038/bjc.2012.322; Gerstner ER, 2008, CURR OPIN NEUROL, V21, P728, DOI 10.1097/WCO.0b013e328318402a; Guinovart C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032362; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hsu YY, 2004, J MAGN RESON IMAGING, V19, P160, DOI 10.1002/jmri.10447; Huettel SA, 2004, NEUROIMAGE, V23, P402, DOI 10.1016/j.neuroimage.2004.04.031; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jalali S, 2014, NEURO-ONCOLOGY, V16, P868, DOI 10.1093/neuonc/nou040; Kiessling F, 2007, EUR RADIOL, V17, P2136, DOI 10.1007/s00330-006-0566-x; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Levin VA, 2011, INT J RADIAT ONCOL, V79, P1487, DOI 10.1016/j.ijrobp.2009.12.061; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lu J, 2009, NEUROIMAGE, V45, P1126, DOI 10.1016/j.neuroimage.2008.11.037; Mandell DM, 2011, AM J NEURORADIOL, V32, P721, DOI 10.3174/ajnr.A2365; Milman Z, 2013, NEPHROL DIAL TRANSPL, V28, P1150, DOI 10.1093/ndt/gfs541; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2009, J NEURO-ONCOL, V92, P149, DOI 10.1007/s11060-008-9745-8; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pope WB, 2006, NEUROLOGY, V66, P1258, DOI 10.1212/01.wnl.0000208958.29600.87; Reijneveld JC, 2000, J NEUROL, V247, P597, DOI 10.1007/s004150070128; Robinson SP, 2003, J MAGN RESON IMAGING, V17, P445, DOI 10.1002/jmri.10274; Sela Y, 2011, IEEE T BIO-MED ENG, V58, P2574, DOI 10.1109/TBME.2011.2159501; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x	31	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115093	10.1371/journal.pone.0115093	http://dx.doi.org/10.1371/journal.pone.0115093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506833	gold, Green Submitted, Green Published			2022-12-27	WOS:000346607100049
J	Tesson, SVM; Montresor, M; Procaccini, G; Kooistra, WHCF				Tesson, Sylvie V. M.; Montresor, Marina; Procaccini, Gabriele; Kooistra, Wiebe H. C. F.			Temporal Changes in Population Structure of a Marine Planktonic Diatom	PLOS ONE			English	Article							GENETIC-STRUCTURE; COMPUTER-PROGRAM; COASTAL WATERS; TYRRHENIAN SEA; SPRING BLOOM; TIME; BACILLARIOPHYCEAE; SOFTWARE; NAPLES; GULF	A prevailing question in phytoplankton research addresses changes of genetic diversity in the face of huge population sizes and apparently unlimited dispersal capabilities. We investigated population genetic structure of the pennate planktonic marine diatom Pseudo-nitzschia multistriata at the LTER station MareChiara in the Gulf of Naples (Italy) over four consecutive years and explored possible changes over seasons and from year to year. A total of 525 strains were genotyped using seven microsatellite markers, for a genotypic diversity of 75.05%, comparable to that found in other Pseudo-nitzschia species. Evidence from Bayesian clustering analysis (BA) identified two genetically distinct clusters, here interpreted as populations, and several strains that could not be assigned with >= 90% probability to either population, here interpreted as putative hybrids. Principal Component Analysis (PCA) recovered these two clusters in distinct clouds with most of the putative hybrids located in-between. Relative proportions of the two populations and the putative hybrids remained similar within years, but changed radically between 2008 and 2009 and between 2010 and 2011, when the 2008-population apparently became the dominant one again. Strains from the two populations are inter-fertile, and so is their offspring. Inclusion of genotypes of parental strains and their offspring shows that the majority of the latter could not be assigned to any of the two parental populations. Therefore, field strains classified by BA as the putative hybrids could be biological hybrids. We hypothesize that P. multistriata population dynamics in the Gulf of Naples follows a meta-population-like model, including establishment of populations by cell inocula at the beginning of each growth season and remixing and dispersal governed by moving and mildly turbulent water masses.	[Tesson, Sylvie V. M.; Montresor, Marina; Procaccini, Gabriele; Kooistra, Wiebe H. C. F.] Staz Zool Anton Dohrn, I-80121 Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Tesson, SVM (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, POB 462, SE-40530 Gothenburg, Sweden.	sylvie.tesson@gu.se	Procaccini, Gabriele/AAA-7040-2019; Tesson, Sylvie VM/D-9018-2015; Procaccini, Gabriele/A-6618-2010	Procaccini, Gabriele/0000-0002-6179-468X; Tesson, Sylvie VM/0000-0002-0751-6953; Procaccini, Gabriele/0000-0002-6179-468X; Kooistra, Wiebe/0000-0002-8641-9739; Montresor, Marina/0000-0002-2475-1787	Stazione Zoologica Anton Dohrn (SZN); MIUR Italian Flagship project RITMARE (La Ricerca Italiana per il Mare); SZN PhD fellowship	Stazione Zoologica Anton Dohrn (SZN); MIUR Italian Flagship project RITMARE (La Ricerca Italiana per il Mare); SZN PhD fellowship	This research was funded by the Stazione Zoologica Anton Dohrn (SZN) and the MIUR Italian Flagship project RITMARE (La Ricerca Italiana per il Mare). ST has been supported by a SZN PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NG, 2009, J PHYCOL, V45, P1037, DOI 10.1111/j.1529-8817.2009.00746.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Bagley MJ, 2000, MARINE BIOINVASIONS, P241; Belkhir K., 1996, 5171 CNRS UMR; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Casabianca S, 2011, P BIOL SCI, V279, P129; Casteleyn G, 2010, P NATL ACAD SCI USA, V107, P12952, DOI 10.1073/pnas.1001380107; Casteleyn G, 2009, MAR BIOL, V156, P1149, DOI 10.1007/s00227-009-1157-6; Congestri R, 2008, NATO SCI PEACE SEC A, P197, DOI 10.1007/978-1-4020-8480-5_7; Cornuet JM, 1996, GENETICS, V144, P2001; D'Alcala MR, 2004, SCI MAR, V68, P65; D'Alelio D, 2010, LIMNOL OCEANOGR, V55, P106, DOI 10.4319/lo.2010.55.1.0106; D'Alelio D, 2009, HARMFUL ALGAE, V8, P225, DOI 10.1016/j.hal.2008.05.004; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edler L., 2010, MICROSCOPIC MOL METH, P13, DOI DOI 10.1016/J.RESP.2011.02.009; Erdner DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022965; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Godhe A, 2010, MOL ECOL, V19, P4478, DOI 10.1111/j.1365-294X.2010.04841.x; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Harnstrom K, 2011, P NATL ACAD SCI USA, V108, P4252, DOI 10.1073/pnas.1013528108; Hanski I., 1999, METAPOPULATION ECOLO; Hartl D., 1989, PRINCIPLES POPULATIO; Hendry AP, 2007, FUNCT ECOL, V21, P455, DOI 10.1111/j.1365-2435.2007.01240.x; Koester JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-1; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Menna M, 2007, NUOVO CIMENTO C, V30, P605, DOI 10.1393/ncc/i2008-10270-0; Montresor M, 2013, MAR ECOL PROG SER, V484, P79, DOI 10.3354/meps10236; Nagai S, 2009, MOL ECOL, V18, P2337, DOI 10.1111/j.1365-294X.2009.04193.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2018, R LANG ENV STAT COMP; Richlen ML, 2012, ECOL EVOL, V2, P2583, DOI 10.1002/ece3.373; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Rynearson TA, 2004, J PHYCOL, V40, P34, DOI 10.1046/j.1529-8817.2004.03089.x; Rynearson TA, 2009, PROTIST, V160, P111, DOI 10.1016/j.protis.2008.10.003; Tesson SVM, 2013, PROTIST, V164, P89, DOI 10.1016/j.protis.2012.07.001; Tesson SVM, 2011, AM J BOT, V98, pE33, DOI 10.3732/ajb.1000430; Uttieri M, 2011, OCEAN DYNAM, V61, P779, DOI 10.1007/s10236-011-0401-z; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Zingone A, 2006, HARMFUL ALGAE, V5, P321, DOI 10.1016/j.hal.2005.09.002	45	38	38	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114984	10.1371/journal.pone.0114984	http://dx.doi.org/10.1371/journal.pone.0114984			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506926	Green Submitted, gold, Green Published			2022-12-27	WOS:000346607100038
J	Chen, JB; Long, S				Chen, Jiangbo; Long, Shuo			Tea and Coffee Consumption and Risk of Laryngeal Cancer: A Systematic Review Meta-Analysis	PLOS ONE			English	Review							PROSPECTIVE COHORT; ESOPHAGEAL CANCER; PREVALENCE; ALCOHOL; TRACT	Background: Tea and coffee are the most commonly consumed beverages in the worldwide. The relationship between tea and coffee consumption on the risk of laryngeal cancer was still unclear. Methods: Relevant studies were identified by searching electronic database (Medline and EMBASE) and reviewing the reference lists of relevant articles until Oct. 2013. Observational studies that reported RRs and 95% CIs for the link of tea and coffee consumption on the risk of laryngeal cancer were eligible. A meta-analysis was obtained to combine study- specific RRs with a random-effects model. Results: A total of 2,803 cases and 503,234 controls in 10 independent studies were identified. The overall analysis of all 10 studies, including the case-control and cohort studies, found that tea drinking was not associated with laryngeal carcinoma (RR=1.03; 95% CI: 0.66-1.61). However, coffee consumption was significantly associated with the laryngeal carcinoma (RR=1.47; 95% CI: 1.03-2.11). A dose-response relationship between coffee intake and laryngeal carcinoma was detected; however, no evidence of dose-response link between tea consumption and laryngeal carcinoma risk was detected. Conclusions: The results from this meta-analysis of observational studies demonstrate that coffee consumption would increase the laryngeal cancer risk, while tea intake was not associated with risk of laryngeal carcinoma.	[Chen, Jiangbo; Long, Shuo] Cent South Univ, Xiangya Hosp 3, Dept Otolaryngol, Changsha, Hunan, Peoples R China	Central South University	Long, S (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Otolaryngol, Changsha, Hunan, Peoples R China.	longshuo201@163.com						Abel EL, 2007, EUR J CANCER PREV, V16, P446, DOI 10.1097/01.cej.0000243850.59362.73; Babaev VR, 2013, CIRCULATION, V128; Bandyopadhyay P, 2012, FOOD FUNCT, V3, P592, DOI 10.1039/c2fo00006g; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Braem MGM, 2012, AM J CLIN NUTR, V95, P1172, DOI 10.3945/ajcn.111.026393; Bray I, 2000, INT J CANCER, V87, P122, DOI 10.1002/1097-0215(20000701)87:1<122::AID-IJC18>3.0.CO;2-W; Brockmoller J, 2000, PHARMACOLOGY, V61, P212, DOI 10.1159/000028403; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cavin C, 2002, FOOD CHEM TOXICOL, V40, P1155, DOI 10.1016/S0278-6915(02)00029-7; Chen MH, 2012, AM J IND MED, V55, P669, DOI 10.1002/ajim.22037; Edefonti V, 2010, CANCER EPIDEM BIOMAR, V19, P18, DOI 10.1158/1055-9965.EPI-09-0900; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Franceschi S, 1999, BRIT J CANCER, V80, P614, DOI 10.1038/sj.bjc.6690400; Galeone C, 2010, CANCER EPIDEM BIOMAR, V19, P1723, DOI 10.1158/1055-9965.EPI-10-0191; Garavello W, 2009, ORAL ONCOL, V45, P85, DOI 10.1016/j.oraloncology.2008.02.011; Geybels MS, 2013, CANC CAUSES CONTROL; Il'yasova D, 2003, EUR J CANCER PREV, V12, P439, DOI 10.1097/00008469-200310000-00016; Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445; Je YJ, 2011, CANCER EPIDEM BIOMAR, V20, P2487, DOI 10.1158/1055-9965.EPI-11-0766; Kapil Umesh, 2005, Asian Pac J Cancer Prev, V6, P202; La Vecchia C, 2008, EUR J CANCER PREV, V17, P116, DOI 10.1097/CEJ.0b013e3282b6fd40; LAVECCHIA C, 1990, CANCER RES, V50, P4497; LAVECCHIA C, 1992, NUTR CANCER, V17, P27, DOI 10.1080/01635589209514170; Li XW, 2013, J INFECT DIS, V207, P479, DOI 10.1093/infdis/jis698; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; NOTANI P N, 1987, Nutrition and Cancer, V10, P103; PINTOS J, 1994, EPIDEMIOLOGY, V5, P583, DOI 10.1097/00001648-199411000-00005; Poljak M, 2013, VACCINE, V31, pH59, DOI 10.1016/j.vaccine.2013.03.029; Ren JS, 2010, EUR J CANCER, V46, P1873, DOI 10.1016/j.ejca.2010.03.025; Sang LX, 2013, NUTR CANCER, V65, P802, DOI 10.1080/01635581.2013.805423; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang NP, 2010, LUNG CANCER, V67, P17, DOI 10.1016/j.lungcan.2009.03.012; Turati F, 2011, ANN ONCOL, V22, P536, DOI 10.1093/annonc/mdq603; Ui A, 2009, CANCER CAUSE CONTROL, V20, P1939, DOI 10.1007/s10552-009-9388-x; Vassileiou A, 2012, B-ENT, V8, P273; Villanueva-Reyes A, 2008, P R HEALTH SCI J, V27, P196; Zvrko E, 2008, ARH HIG RADA TOKSIKO, V59, P11, DOI 10.2478/10004-1254-59-2008-1863	37	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e112006	10.1371/journal.pone.0112006	http://dx.doi.org/10.1371/journal.pone.0112006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502726	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400003
J	Cooper, DL; Harirforoosh, S				Cooper, Dustin L.; Harirforoosh, Sam			Effect of Formulation Variables on Preparation of Celecoxib Loaded Polylactide-Co-Glycolide Nanoparticles	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SOLID LIPID NANOPARTICLES; PLGA-BASED NANOPARTICLES; ORAL DELIVERY-SYSTEM; WATER-SOLUBLE DRUG; RHEUMATOID-ARTHRITIS; IN-VITRO; BIODEGRADABLE NANOPARTICLES; PARTICLE-SIZE; ACUTE PAIN	Polymer based nanoparticle formulations have been shown to increase drug bioavailability and/or reduce drug adverse effects. Nonsteroidal anti-inflammatory drugs (e. g. celecoxib) reduce prostaglandin synthesis and cause side effects such as gastrointestinal and renal complications. The aim of this study was to formulate celecoxib entrapped poly lactide-co-glycolide based nanoparticles through a solvent evaporation process using didodecyldimethylammonium bromide or poly vinyl alcohol as stabilizer. Nanoparticles were characterized for zeta potential, particle size, entrapment efficiency, and morphology. Effects of stabilizer concentration (0.1, 0.25, 0.5, and 1% w/v), drug amount (5, 10, 15, and 20 mg), and emulsifier (lecithin) on nanoparticle characterization were examined for formula optimization. The use of 0.1, 0.25, and 0.5% w/v didodecyldimethylammonium bromide resulted in a more than 5-fold increase in zeta potential and a more than 1.5-fold increase in entrapment efficiency with a reduction in particle size over 35%, when compared to stabilizer free formulation. Nanoparticle formulations were also highly influenced by emulsifier and drug amount. Using 0.25% w/v didodecyldimethylammonium bromide NP formulations, peak zeta potential was achieved using 15 mg celecoxib with emulsifier (17.15 +/- 0.36 mV) and 20 mg celecoxib without emulsifier (25.00 +/- 0.18 mV). Peak NP size reduction and entrapment efficiency was achieved using 5 mg celecoxib formulations with (70.87 +/- 1.24 nm and 95.55 +/- 0.66%, respectively) and without (92.97 +/- 0.51 nm and 95.93 +/- 0.27%, respectively) emulsifier. In conclusion, formulations using 5 mg celecoxib with 0.25% w/v didodecyldimethylammonium bromide concentrations produced nanoparticles exhibiting enhanced size reduction and entrapment efficiency. Furthermore, emulsifier free formulations demonstrated improved zeta potential when compared to formulations containing emulsifier (p<0.01). Therefore, our results suggest the use of emulsifier free 5 mg celecoxib drug formulations containing 0.25% w/v didodecyldimethylammonium bromide for production of polymeric NPs that demonstrate enhanced zeta potential, small particle size, and high entrapment efficiency.	[Cooper, Dustin L.; Harirforoosh, Sam] E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA	East Tennessee State University	Harirforoosh, S (corresponding author), E Tennessee State Univ, Gatton Coll Pharm, Dept Pharmaceut Sci, Johnson City, TN 37614 USA.	harirfor@etsu.edu	Harirforoosh, Sam/J-9493-2013	Harirforoosh, Sam/0000-0002-2631-3756	Research and Development Committee Major Grant, East Tennessee State University	Research and Development Committee Major Grant, East Tennessee State University	This study was funded by a Research and Development Committee Major Grant, East Tennessee State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SR, 2002, DRUG SAFETY, V25, P537, DOI 10.2165/00002018-200225070-00007; Amrite AC, 2006, INVEST OPHTH VIS SCI, V47, P1149, DOI 10.1167/iovs.05-0531; Amrite A, 2010, EXPERT OPIN DRUG DEL, V7, P631, DOI 10.1517/17425241003663236; Ayalasomayajula SP, 2005, EUR J PHARMACOL, V511, P191, DOI 10.1016/j.ejphar.2005.02.019; Bachar M, 2012, J CONTROL RELEASE, V160, P164, DOI 10.1016/j.jconrel.2012.01.004; Bala I, 2006, J DRUG TARGET, V14, P27, DOI 10.1080/10611860600565987; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Bhardwaj V, 2009, PHARM RES-DORDR, V26, P2495, DOI 10.1007/s11095-009-9965-4; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chen JB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04841; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Clemett D, 2000, DRUGS, V59, P957, DOI 10.2165/00003495-200059040-00017; Cooper DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087326; Crofford LJ, 1997, J RHEUMATOL, V24, P15; Crosasso P, 2000, J CONTROL RELEASE, V63, P19, DOI 10.1016/S0168-3659(99)00166-2; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; De SJ, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050453; Dhanda DS, 2013, J CONTROL RELEASE, V168, P239, DOI 10.1016/j.jconrel.2013.03.027; Fisk ID, 2013, FOOD RES INT, V54, P861, DOI 10.1016/j.foodres.2013.08.024; Fitzpatrick FA, 2004, CURR PHARM DESIGN, V10, P577, DOI 10.2174/1381612043453144; Frampton JE, 2007, DRUGS, V67, P2433, DOI 10.2165/00003495-200767160-00008; Goldenberg MM, 1999, CLIN THER, V21, P1497, DOI 10.1016/S0149-2918(00)80005-3; Gomaa YA, 2014, EUR J PHARM BIOPHARM, V86, P145, DOI 10.1016/j.ejpb.2013.01.026; Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3; Han CY, 2011, MOL DIVERS, V15, P857, DOI 10.1007/s11030-011-9317-2; Hariharan S, 2006, PHARM RES-DORDR, V23, P184, DOI 10.1007/s11095-005-8418-y; Harirforoosh S, 2013, J PHARM PHARM SCI, V16, P821, DOI 10.18433/J3VW2F; HILLS BA, 1983, J APPL PHYSIOL, V54, P420, DOI 10.1152/jappl.1983.54.2.420; Hoffmann U, 2006, TRANSPL INT, V19, P203, DOI 10.1111/j.1432-2277.2005.00261.x; Hu KL, 2012, INT J NANOMED, V7, P3537, DOI 10.2147/IJN.S32880; Immordino ML, 2006, INT J NANOMED, V1, P297; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Joshi M, 2008, INT J PHARMACEUT, V346, P124, DOI 10.1016/j.ijpharm.2007.05.060; Kenawi IM, 2008, J MOL STRUC-THEOCHEM, V851, P46, DOI 10.1016/j.theochem.2007.10.034; Labhasetwar V, 1998, J PHARM SCI, V87, P1229, DOI 10.1021/js980021f; Lakshmi K, 2013, Curr Drug Discov Technol, V10, P305; McCormack PL, 2011, DRUGS, V71, P2457, DOI 10.2165/11208240-000000000-00000; Mohammadi Z, 2012, ACTA PHARMACEUT, V62, P83, DOI 10.2478/v10007-012-0008-z; Morgen M, 2012, PHARM RES-DORDR, V29, P427, DOI 10.1007/s11095-011-0558-7; Mosqueira VCF, 2000, J PHARM SCI-US, V89, P614, DOI 10.1002/(SICI)1520-6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7; Palamoor M, 2013, COLLOID SURFACE B, V112, P474, DOI 10.1016/j.colsurfb.2013.07.039; Parhi P, 2012, DRUG DISCOV TODAY, V17, P1044, DOI 10.1016/j.drudis.2012.05.010; Qiao JL, 2013, J POWER SOURCES, V237, P1, DOI 10.1016/j.jpowsour.2013.02.059; Rao DA, 2010, J PHARM SCI-US, V99, P2018, DOI 10.1002/jps.21970; Rodriguez M, 2006, FOOD RES INT, V39, P840, DOI 10.1016/j.foodres.2006.04.002; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Savjani KT, 2012, ISRN PHARM, V2012, DOI DOI 10.5402/2012/195727; Schubert MA, 2005, EUR J PHARM BIOPHARM, V61, P77, DOI 10.1016/j.ejpb.2005.03.006; SEIBERT K, 1995, AGENT ACTION SUPPL, V46, P41; Seibert K, 1997, ADV EXP MED BIOL, V400, P167; SEIBERT K, 1994, RECEPTOR, V4, P17; Shakeel F, 2009, PHARMAZIE, V64, P258, DOI 10.1691/ph.2009.8282; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Song XR, 2008, EUR J PHARM BIOPHARM, V69, P445, DOI 10.1016/j.ejpb.2008.01.013; Tan A, 2011, PHARM RES-DORDR, V28, P2273, DOI 10.1007/s11095-011-0458-x; Tan A, 2009, J CONTROL RELEASE, V134, P62, DOI 10.1016/j.jconrel.2008.10.014; Thakkar H, 2005, AAPS PHARMSCITECH, V6; Thakkar Hetal, 2007, Drugs R D, V8, P275, DOI 10.2165/00126839-200708050-00002; Nguyen TH, 2013, J CONTROL RELEASE, V167, P85, DOI 10.1016/j.jconrel.2013.01.012; Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003; Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027; Xu AR, 2012, INT J NANOMED, V7, P3547, DOI 10.2147/IJN.S32188; Xu YL, 2013, PAK J PHARM SCI, V26, P495; Yamamoto Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1791, DOI 10.1271/bbb.61.1791; Zainol S, 2012, INT J MOL SCI, V13, P13049, DOI 10.3390/ijms131013049; Zidar N, 2009, J CELL MOL MED, V13, P3753, DOI 10.1111/j.1582-4934.2008.00430.x	67	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113558	10.1371/journal.pone.0113558	http://dx.doi.org/10.1371/journal.pone.0113558			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502102	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400011
J	Leferink, AM; Fratila, RM; Koenrades, MA; van Blitterswijk, CA; Velders, A; Moroni, L				Leferink, Anne M.; Fratila, Raluca M.; Koenrades, Maaike A.; van Blitterswijk, Clemens A.; Velders, Aldrik; Moroni, Lorenzo			An Open Source Image Processing Method to Quantitatively Assess Tissue Growth after Non-Invasive Magnetic Resonance Imaging in Human Bone Marrow Stromal Cell Seeded 3D Polymeric Scaffolds	PLOS ONE			English	Article							INTENSITY NONUNIFORMITY CORRECTION; IRON-OXIDE NANOPARTICLES; MESENCHYMAL STEM-CELLS; X-RAY MICROTOMOGRAPHY; ENGINEERED CONSTRUCTS; ARTICULAR-CARTILAGE; MRI; MICROSCOPY; SPECTROSCOPY; PERFUSION	Monitoring extracellular matrix (ECM) components is one of the key methods used to determine tissue quality in three-dimensional (3D) scaffolds for regenerative medicine and clinical purposes. This is even more important when multipotent human bone marrow stromal cells (hMSCs) are used, as it could offer a method to understand in real time the dynamics of stromal cell differentiation and eventually steer it into the desired lineage. Magnetic Resonance Imaging (MRI) is a promising tool to overcome the challenge of a limited transparency in opaque 3D scaffolds. Technical limitations of MRI involve non-uniform background intensity leading to fluctuating background signals and therewith complicating quantifications on the retrieved images. We present a post-imaging processing sequence that is able to correct for this non-uniform background intensity. To test the processing sequence we investigated the use of MRI for in vitro monitoring of tissue growth in three-dimensional poly(ethylene oxide terephthalate)-poly(butylene terephthalate) (PEOT/PBT) scaffolds. Results showed that MRI, without the need to use contrast agents, is a promising non-invasive tool to quantitatively monitor ECM production and cell distribution during in vitro culture in 3D porous tissue engineered constructs.	[Leferink, Anne M.; Koenrades, Maaike A.; van Blitterswijk, Clemens A.; Moroni, Lorenzo] Univ Twente, MIRA, Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands; [Fratila, Raluca M.] Univ Twente, MIRA, Inst Biomed Technol & Tech Med, NeuroImaging Grp, NL-7500 AE Enschede, Netherlands; [van Blitterswijk, Clemens A.; Moroni, Lorenzo] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Complex Tissue Regenerat, Maastricht, Netherlands; [Velders, Aldrik] Univ Twente, MIRA, Inst Nanotechnol, Lab SupraMol Chem & Technol, NL-7500 AE Enschede, Netherlands; [Velders, Aldrik] Wageningen Univ, Dept BioNanotechnol Agrotechnol & Food Sci, NL-6700 AP Wageningen, Netherlands	University of Twente; University of Twente; Maastricht University; University of Twente; Wageningen University & Research	Moroni, L (corresponding author), Univ Twente, MIRA, Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.	l.moroni@utwente.nl	Leferink, Ir. A. M./G-5024-2012; Moroni, Lorenzo/D-2826-2014; v, a/ABA-6163-2021; Fratila, Raluca Maria/C-9014-2012	Leferink, Ir. A. M./0000-0002-3765-8450; Moroni, Lorenzo/0000-0003-1298-6025; Fratila, Raluca Maria/0000-0001-5559-8757; Velders, Aldrik/0000-0002-6925-854X	Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]	Netherlands Institute for Regenerative Medicine (NIRM)	This work was supported by the Netherlands Institute for Regenerative Medicine (NIRM) through the grant number FES0908 [http://www.regeneratieve-geneeskunde.nl/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2012, J R SOC INTERFACE, V9, P2321, DOI 10.1098/rsif.2012.0068; Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033; Baradez MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026104; Barbetta A, 2012, ANN I SUPER SANITA, V48, P10, DOI 10.4415/ANN_12_01_03; BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504; Bhirde A, 2011, NANOSCALE, V3, P142, DOI 10.1039/c0nr00493f; Burg KJL, 2002, J BIOMED MATER RES, V61, P380, DOI 10.1002/jbm.10146; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chen WL, 2010, TISSUE ENG PART C-ME, V16, P913, DOI [10.1089/ten.tec.2009.0596, 10.1089/ten.TEC.2009.0596]; Chesnick IE, 2008, BIOPHYS J, V95, P2017, DOI 10.1529/biophysj.107.120923; Constantinidis I, 1998, TISSUE ENG, V4, P9, DOI 10.1089/ten.1998.4.9; Crowe JJ, 2011, CHEM ENG SCI, V66, P4138, DOI 10.1016/j.ces.2011.05.046; de Bruijn J D, 1999, Adv Dent Res, V13, P74; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fishbein KW, 2007, MAGN RESON MED, V57, P866, DOI 10.1002/mrm.21189; Gordillo N, 2013, MAGN RESON IMAGING, V31, P1426, DOI 10.1016/j.mri.2013.05.002; Grootendorst DJ, 2013, CONTRAST MEDIA MOL I, V8, P83, DOI 10.1002/cmmi.1498; Hachani R, 2013, NANOSCALE, V5, P11362, DOI 10.1039/c3nr03861k; Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105; Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0; Kotecha M, 2013, TISSUE ENG PART B-RE, V19, P470, DOI [10.1089/ten.teb.2012.0755, 10.1089/ten.TEB.2012.0755]; Leferink AM, 2013, J TISSUE ENG REGENER; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Milles J, 2007, COMPUT MED IMAG GRAP, V31, P81, DOI 10.1016/j.compmedimag.2006.11.001; Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127; Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499; Mountain KM, 2011, MAGN RESON MED, V66, P520, DOI 10.1002/mrm.23036; Neves AA, 2006, TISSUE ENG, V12, P53, DOI 10.1089/ten.2006.12.53; Nissi MJ, 2006, OSTEOARTHR CARTILAGE, V14, P1265, DOI 10.1016/j.joca.2006.06.002; Peptan IA, 2006, TISSUE ENG, V12, P843, DOI 10.1089/ten.2006.12.843; Ramaswamy S, 2009, TISSUE ENG PT A, V15, P3899, DOI 10.1089/ten.tea.2008.0677; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; TAUBIN G, 1995, SIGGRAPH 95 C P, P351, DOI 10.1145/218380.218473; Washburn NR, 2004, J BIOMED MATER RES A, V69A, P738, DOI 10.1002/jbm.a.30054; Xia Y, 2001, OSTEOARTHR CARTILAGE, V9, P393, DOI 10.1053/joca.2000.0405; Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515; Yang C.-Y., 2009, J APPL PHYS, V105; Zheng SK, 2010, CARTILAGE, V1, P55, DOI 10.1177/1947603509359784	40	7	8	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115000	10.1371/journal.pone.0115000	http://dx.doi.org/10.1371/journal.pone.0115000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502022	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400068
J	Mrzilkova, J; Koutela, A; Kutova, M; Patzelt, M; Ibrahim, I; Al-Kayssi, D; Bartos, A; Ripova, D; Cermakova, P; Zach, P				Mrzilkova, Jana; Koutela, Antonella; Kutova, Martina; Patzelt, Matej; Ibrahim, Ibrahim; Al-Kayssi, Dina; Bartos, Ales; Ripova, Daniela; Cermakova, Pavla; Zach, Petr			Hippocampal Spatial Position Evaluation on MRI for Research and Clinical Practice	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; VARIABILITY; FMRI; VOLUMETRICS; DIAGNOSIS; CRITERIA; TASK	In clinical practice as well as in many volumetric studies we use different reorientations of the brain position towards x and y axis on the magnetic resonance imaging (MRI) scans. In order to find out whether it has an overall effect on the resulting 2D data, manual hippocampal area measurements and rotation variability of the brain (in two reoriented axes) and the skull were performed in 23 Alzheimer's disease patients and 31 healthy controls. After the MRI scanning, native brain scans (nat) were reoriented into the two different artificial planes (anterior commissure - posterior commissure axis (AC-PC) and hippocampal horizontal long axis (hipp)). Hippocampal area and temporal horn of the lateral ventricle was measured manually using freeware Image J program. We found that 1) hippocampal area of nat images is larger compared to hipp images, area of the nat images is equal to the AC-PC images and area of the hipp images is smaller compared to AC-PC images, 2) hippocampal area together with the area of the temporal horn for nat images is larger compared to hipp images, area of the hipp images is smaller compared to the AC-PC images and area of the nat images is smaller compared to the AC-PC images. The conclusion is that the measured area of the hippocampus in the native MRI is almost the same as the area of MRI reoriented only into the AC-PC axis. Therefore, when performing 2D area studies of the hippocampus or in the clinical practice we recommend usage of not-reoriented MRI images or to reorient them into the AC-PC axis. Surprising finding was that rotation of both AC-PC and hipp line towards x-axis among patients varies up to 35 degrees and the same is true for the skull rotation so that it is not only a matter of the brain position.	[Mrzilkova, Jana; Koutela, Antonella; Kutova, Martina; Patzelt, Matej; Al-Kayssi, Dina; Zach, Petr] Charles Univ Prague, Fac Med 3, Inst Anat, Prague 10000 10, Czech Republic; [Bartos, Ales; Ripova, Daniela] Prague Psychiat Ctr, AD Ctr, Prague 18103 8, Czech Republic; [Bartos, Ales] Charles Univ Prague, Fac Med 3, Teaching Hosp Kralovske Vinohrady, Prague 10034 10, Czech Republic; [Cermakova, Pavla] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimer Dis Res Ctr, S-14186 Stockholm, Sweden; [Cermakova, Pavla] Int Clin Res Ctr, Brno 65691, Czech Republic; [Cermakova, Pavla] St Annes Univ Hosp, Brno 65691, Czech Republic; [Ibrahim, Ibrahim] Inst Clin & Expt Med, Dept Radiodiagnost & Intervent Radiol, Prague 14021 4, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Vinohrady; Karolinska Institutet; St Anne's University Hospital Brno (FNUSA-ICRC); St Anne's University Hospital Brno (FNUSA-ICRC); Institute for Clinical & Experimental Medicine (IKEM)	Zach, P (corresponding author), Charles Univ Prague, Fac Med 3, Inst Anat, Ruska 87, Prague 10000 10, Czech Republic.	zach.petr@post.cz	Zach, Petr/D-8955-2016; Cermakova, Pavla/C-5890-2019; Bartos, Ales/C-4353-2019; Šanderová, Martina/D-1588-2018; Mrzilkova, Jana/C-3588-2018; Patzelt, Matej/S-1341-2017	Zach, Petr/0000-0003-1941-2972; Cermakova, Pavla/0000-0002-9282-9363; Bartos, Ales/0000-0002-8020-8252; Šanderová, Martina/0000-0001-6481-049X; Mrzilkova, Jana/0000-0002-9474-5040; Patzelt, Matej/0000-0001-8269-5499; Ibrahim, Ibrahim/0000-0003-3530-5165; Mrzilkova, Jana/0000-0003-0913-8041	Grant Agency of the Czech Republic [P 304/12/G069]; Research Project Charles University in Prague [PRVOUK 34]; Czech Republic [260045/SVV/2014, GAUK 1894214]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Research Project Charles University in Prague; Czech Republic(Czech Republic Government)	The study was supported by grant P 304/12/G069 from the Grant Agency of the Czech Republic and the Research Project Charles University in Prague, PRVOUK 34, project 260045/SVV/2014 of the Czech Republic and GAUK 1894214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; FINLAY LM, 1980, ANGLE ORTHOD, V50, P312; Fleisher AS, 2008, NEUROLOGY, V70, P191, DOI 10.1212/01.wnl.0000287091.57376.65; Geuze E, 2005, MOL PSYCHIATR, V10, P147, DOI 10.1038/sj.mp.4001580; Hayashi T, 2009, MAGN RESON MED SCI, V8, P33, DOI 10.2463/mrms.8.33; Maller JJ, 2006, HIPPOCAMPUS, V16, P80, DOI 10.1002/hipo.20133; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mrzilkova J, 2012, DEMENT GERIATR COGN, V34, P224, DOI 10.1159/000343445; Oksengard AR, 2010, DEMENT GERIATR COGN, V30, P374, DOI 10.1159/000321121; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scher AI, 2007, NEUROIMAGE, V36, P8, DOI 10.1016/j.neuroimage.2006.12.036; Soltysik DA, 2011, NEUROIMAGE, V56, P1329, DOI 10.1016/j.neuroimage.2011.03.023; Teipel SJ, 2010, PSYCHIAT RES-NEUROIM, V182, P244, DOI 10.1016/j.pscychresns.2010.03.003; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506	18	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115174	10.1371/journal.pone.0115174	http://dx.doi.org/10.1371/journal.pone.0115174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502906	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400078
J	Rohringer, S; Holnthoner, W; Hackl, M; Weihs, AM; Runzler, D; Skalicky, S; Karbiener, M; Scheideler, M; Proll, J; Gabriel, C; Schweighofer, B; Groger, M; Spittler, A; Grillari, J; Redl, H				Rohringer, Sabrina; Holnthoner, Wolfgang; Hackl, Matthias; Weihs, Anna M.; Ruenzler, Dominik; Skalicky, Susanna; Karbiener, Michael; Scheideler, Marcel; Proell, Johannes; Gabriel, Christian; Schweighofer, Bernhard; Groeger, Marion; Spittler, Andreas; Grillari, Johannes; Redl, Heinz			Molecular and Cellular Effects of In Vitro Shockwave Treatment on Lymphatic Endothelial Cells	PLOS ONE			English	Article							WAVE THERAPY; SECONDARY LYMPHEDEMA; RAT MODEL; LIFE-SPAN; TISSUE; PODOPLANIN; EXPRESSION; LYMPHANGIOGENESIS; INFLAMMATION; MECHANISMS	Extracorporeal shockwave treatment was shown to improve orthopaedic diseases and wound healing and to stimulate lymphangiogenesis in vivo. The aim of this study was to investigate in vitro shockwave treatment (IVSWT) effects on lymphatic endothelial cell (LEC) behavior and lymphangiogenesis. We analyzed migration, proliferation, vascular tube forming capability and marker expression changes of LECs after IVSWT compared with HUVECs. Finally, transcriptome- and miRNA analyses were conducted to gain deeper insight into the IVSWT-induced molecular mechanisms in LECs. The results indicate that IVSWT-mediated proliferation changes of LECs are highly energy flux density-dependent and LEC 2D as well as 3D migration was enhanced through IVSWT. IVSWT suppressed HUVEC 3D migration but enhanced vasculogenesis. Furthermore, we identified podoplanin(high) and podoplanin(low) cell subpopulations, whose ratios changed upon IVSWT treatment. Transcriptome- and miRNA analyses on these populations showed differences in genes specific for signaling and vascular tissue. Our findings help to understand the cellular and molecular mechanisms underlying shockwave-induced lymphangiogenesis in vivo.	[Rohringer, Sabrina; Holnthoner, Wolfgang; Redl, Heinz] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Rohringer, Sabrina; Holnthoner, Wolfgang; Hackl, Matthias; Weihs, Anna M.; Ruenzler, Dominik; Skalicky, Susanna; Proell, Johannes; Gabriel, Christian; Spittler, Andreas; Grillari, Johannes; Redl, Heinz] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Weihs, Anna M.; Ruenzler, Dominik] Univ Appl Sci Tech Wien, Dept Biochem Engn, Vienna, Austria; [Hackl, Matthias; Skalicky, Susanna] TAmiRNA GmbH, Vienna, Austria; [Karbiener, Michael; Scheideler, Marcel] Graz Univ Technol, Inst Mol Biotechnol, A-8010 Graz, Austria; [Proell, Johannes; Gabriel, Christian] Red Cross Blood Transfus Serv, Linz, Austria; [Schweighofer, Bernhard; Groeger, Marion] Med Univ Vienna, Dept Dermatol, Skin & Endothelium Res Div, Vienna, Austria; [Groeger, Marion] Med Univ Vienna, Core Facil Imaging, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Core Facil, Flow Cytometry & Surg Res Labs, Vienna, Austria; [Grillari, Johannes] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria	Ludwig Boltzmann Institute; Technische Universitat Wien; Graz University of Technology; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Natural Resources & Life Sciences, Vienna	Holnthoner, W (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, Vienna, Austria.	Wolfgang.Holnthoner@trauma.lbg.ac.at	Rünzler, Dominik/G-9393-2014; Gabriel, Christian/A-1689-2014; Scheideler, Marcel/B-3087-2015; Grillari, Johannes/B-2967-2011; Redl, Heinz/AAD-8157-2019	Rünzler, Dominik/0000-0002-6020-3411; Gabriel, Christian/0000-0003-2043-9320; Scheideler, Marcel/0000-0003-4650-7387; Grillari, Johannes/0000-0001-5474-6332; Rohringer, Sabrina/0000-0002-9019-283X; Weihs, Anna/0000-0003-4802-328X; Holnthoner, Wolfgang/0000-0001-6425-9028; Spittler, Andreas/0000-0003-2657-6836; Hackl, Matthias/0000-0002-4136-7293	EU Biodesign Program [262948]; Austrian research promotion agency FFG; Austrian research promotion agency [CFFG 818412]; City of Vienna (MA27) [06-06]; City of Vienna Competence team reacTissue Project (MA27) [12-06]; TAmiRNA GmbH	EU Biodesign Program; Austrian research promotion agency FFG; Austrian research promotion agency; City of Vienna (MA27); City of Vienna Competence team reacTissue Project (MA27); TAmiRNA GmbH	This study was funded by: EU Biodesign Program (262948) (www.biodesign.eu) to HR and WH, a Femtech student fellowship from the Austrian research promotion agency FFG (www.ffg.at) to SR, the NewTissue Project (CFFG 818412) from the Austrian research promotion agency and City of Vienna (MA27 #06-06) and the City of Vienna Competence team reacTissue Project (MA27 #12-06) to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MH and SS are employed by TAmiRNA GmbH. TAmiRNA GmbH provided support in the form of salaries for authors MH and SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang MWF, 2005, EXP CELL RES, V309, P121, DOI 10.1016/j.yexcr.2005.05.002; Chen YJ, 2004, BONE, V34, P466, DOI 10.1016/j.bone.2003.11.013; Cheng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067675; Cortez MA, 2010, GENE CHROMOSOME CANC, V49, P981, DOI 10.1002/gcc.20808; Davis TA, 2009, INT WOUND J, V6, P11, DOI 10.1111/j.1742-481X.2008.00540.x; Dellago H, 2013, AGING CELL, V12, P446, DOI 10.1111/acel.12069; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Gerdesmeyer L, 2003, JAMA-J AM MED ASSOC, V290, P2573, DOI 10.1001/jama.290.19.2573; Groger M, 2007, J INVEST DERMATOL, V127, P2893, DOI 10.1038/sj.jid.5701031; Groger M, 2004, J IMMUNOL, V173, P7161, DOI 10.4049/jimmunol.173.12.7161; Haupt G, 1997, J UROLOGY, V158, P4, DOI 10.1097/00005392-199707000-00003; Hofbauer P, 2014, CYTOTHERAPY, V16, P1238, DOI 10.1016/j.jcyt.2014.04.009; Holfeld J, 2014, J VISUALIZED EXPT, V86; Holfeld J, 2014, INFLAMMATION, V37, P65, DOI 10.1007/s10753-013-9712-1; Holnthoner W, 2015, J TISSUE ENG REGEN M, V9, P127, DOI 10.1002/term.1620; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kubo M, 2010, J VASC SURG, V52, P429, DOI 10.1016/j.jvs.2010.03.017; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P522, DOI 10.1111/j.1524-475X.2009.00504.x; Kuo YR, 2009, WOUND REPAIR REGEN, V17, P80, DOI 10.1111/j.1524-475X.2008.00444.x; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Marin T, 2013, FREE RADICAL BIO MED, V64, P61, DOI 10.1016/j.freeradbiomed.2013.05.034; MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8; Mittermayr R, 2012, WOUND REPAIR REGEN, V20, P456, DOI 10.1111/j.1524-475X.2012.00796.x; Mittermayr R, 2011, ANN SURG, V253, P1024, DOI 10.1097/SLA.0b013e3182121d6e; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Nisato RE, 2004, AM J PATHOL, V165, P11, DOI 10.1016/S0002-9440(10)63271-3; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; Primo L, 2007, J CELL BIOL, V176, P1035, DOI 10.1083/jcb.200607053; Rohringer S, 2014, ANGIOGENESIS, V17, P921, DOI 10.1007/s10456-014-9439-0; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Schaden W, 2007, J SURG RES, V143, P1, DOI 10.1016/j.jss.2007.01.009; Schoppmann SF, 2004, MICROCIRCULATION, V11, P261, DOI 10.1080/10739680490425967; Serizawa F, 2011, EUR J VASC ENDOVASC, V42, P254, DOI 10.1016/j.ejvs.2011.02.029; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070; Teruyama K, 2001, FEBS LETT, V504, P1, DOI 10.1016/S0014-5793(01)02724-7; Verma K, 2013, ANGIOLOGY, V1, P2; Wang CJ, 2009, J SURG RES, V152, P96, DOI 10.1016/j.jss.2008.01.026; Wang CJ, 2006, AM J SPORT MED, V34, P592, DOI 10.1177/0363546505281811; Weihs AM, 2014, J BIOL CHEM, V289, P27090, DOI 10.1074/jbc.M114.580936; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Yip HK, 2008, CIRC J, V72, P150, DOI 10.1253/circj.72.150; Zins SR, 2010, ANGIOGENESIS, V13, P293, DOI 10.1007/s10456-010-9186-9	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114806	10.1371/journal.pone.0114806	http://dx.doi.org/10.1371/journal.pone.0114806			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502694	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700055
J	Wali, S; Gupta, R; Veselenak, RL; Li, YS; Yu, JJ; Murthy, AK; Cap, AP; Guentzel, MN; Chambers, JP; Zhong, GM; Rank, RG; Pyles, RB; Arulanandam, BP				Wali, Shradha; Gupta, Rishein; Veselenak, Ronald L.; Li, Yansong; Yu, Jieh-Juen; Murthy, Ashlesh K.; Cap, Andrew P.; Guentzel, M. Neal; Chambers, James P.; Zhong, Guangming; Rank, Roger G.; Pyles, Richard B.; Arulanandam, Bernard P.			Use of a Guinea Pig-Specific Transcriptome Array for Evaluation of Protective Immunity against Genital Chlamydial Infection following Intranasal Vaccination in Guinea Pigs	PLOS ONE			English	Article							TRACHOMATIS INFECTIONS; TRACT INFECTION; ANIMAL-MODELS; HOST RESPONSE; REPRODUCTIVE-TRACT; IFN-GAMMA; T-CELLS; IMMUNIZATION; AGENT; HEALTH	Guinea pigs have been used as a second animal model to validate putative anti-chlamydial vaccine candidates tested in mice. However, the lack of guinea pig-specific reagents has limited the utility of this animal model in Chlamydia sp. vaccine studies. Using a novel guinea pig-specific transcriptome array, we determined correlates of protection in guinea pigs vaccinated with Chlamydia caviae (C. caviae) via the intranasal route, previously reported by us and others to provide robust antigen specific immunity against subsequent intravaginal challenge. C. caviae vaccinated guinea pigs resolved genital infection by day 3 post challenge. In contrast, mock vaccinated animals continued to shed viable Chlamydia up to day 18 post challenge. Importantly, at day 80 post challenge, vaccinated guinea pigs experienced significantly reduced genital pathology - a sequelae of genital chlamydial infections, in comparison to mock vaccinated guinea pigs. Sera from vaccinated guinea pigs displayed antigen specific IgG responses and increased IgG1 and IgG2 titers capable of neutralizing GPIC in vitro.	[Wali, Shradha; Gupta, Rishein; Yu, Jieh-Juen; Guentzel, M. Neal; Chambers, James P.; Arulanandam, Bernard P.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Wali, Shradha; Gupta, Rishein; Yu, Jieh-Juen; Guentzel, M. Neal; Chambers, James P.; Arulanandam, Bernard P.] Univ Texas San Antonio, Ctr Excellence Infect Genom, San Antonio, TX 78249 USA; [Veselenak, Ronald L.; Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Veselenak, Ronald L.; Pyles, Richard B.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Li, Yansong; Cap, Andrew P.] US Army Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Murthy, Ashlesh K.] Midwestern Univ, Dept Pathol, Downers Grove, IL 60148 USA; [Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Rank, Roger G.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72202 USA; [Rank, Roger G.] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72202 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Defense; United States Army; Midwestern University; University of Texas System; University of Texas Health San Antonio; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Arulanandam, BP (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, One UTSA Circle, San Antonio, TX 78249 USA.	Bernard.Arulanandam@utsa.edu		Wali, Shradha/0000-0002-6077-7618	National Institutes of Health [1RO1AI074860, 1R03AI092621-01]; Army Research Office of the Department of Defense [W911NF-11-1-0136]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI092621, R01AI074860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office of the Department of Defense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1RO1AI074860, 1R03AI092621-01 and the Army Research Office of the Department of Defense under Contract No. W911NF-11-1-0136. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DW, 2011, J REPROD IMMUNOL, V91, P9, DOI 10.1016/j.jri.2011.06.100; Bannantine JP, 1999, MICROBIOL-UK, V145, P2077, DOI 10.1099/13500872-145-8-2077; BARRON AL, 1984, INFECT IMMUN, V44, P82, DOI 10.1128/IAI.44.1.82-85.1984; BARRON AL, 1988, SEX TRANSM DIS, V15, P169, DOI 10.1097/00007435-198807000-00013; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; BATTEIGER BE, 1993, J GEN MICROBIOL, V139, P2965, DOI 10.1099/00221287-139-12-2965; Beagley KW, 2000, J REPROD IMMUNOL, V48, P47, DOI 10.1016/S0165-0378(00)00069-3; Bell Jason D, 2011, Infect Dis Obstet Gynecol, V2011, P675360, DOI 10.1155/2011/675360; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown THT, 2012, VACCINE, V30, P350, DOI 10.1016/j.vaccine.2011.10.086; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2013, VACCINE, V31, P1892, DOI 10.1016/j.vaccine.2013.01.024; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Cong Y, 2007, VACCINE, V25, P3773, DOI 10.1016/j.vaccine.2007.02.010; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; Deng J, 2002, INT IMMUNOL, V14, P513, DOI 10.1093/intimm/14.5.513; Duncan B, 1999, BRIT MED J, V318, P931, DOI 10.1136/bmj.318.7188.931; Edelstein Paul H, 2013, Methods Mol Biol, V954, P521, DOI 10.1007/978-1-62703-161-5_32; Eko FO, 2004, J IMMUNOL, V173, P3375, DOI 10.4049/jimmunol.173.5.3375; Enderle JL, 2014, CURR MICROBIOL, V68, P220, DOI 10.1007/s00284-013-0465-8; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Folger AT, 2013, MATERNAL CHILD HLTH; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Gaydos CA, 2013, INT J STD AIDS, V24, P736, DOI 10.1177/0956462413483252; Jain R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-520; JOHNSON AP, 1982, AM J PATHOL, V106, P132; Kashino SS, 2008, MICROBES INFECT, V10, P1469, DOI 10.1016/j.micinf.2008.08.010; Khan E R, 2011, Mymensingh Med J, V20, P362; LAFERRIERE C, 1993, J IMMUNOL METHODS, V163, P123, DOI 10.1016/0022-1759(93)90246-4; LAMONT HC, 1978, INFECT IMMUN, V19, P807, DOI 10.1128/IAI.19.3.807-813.1978; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPEZ H, 1977, LAB ANIM SCI, V27, P522; Mardh PA, 2001, EUR J CONTRACEP REPR, V6, P115, DOI 10.1080/713604211; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; McGowin CL, 2010, INFECT IMMUN, V78, P726, DOI 10.1128/IAI.00840-09; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Morre SA, 2000, INFECT IMMUN, V68, P7209, DOI 10.1128/IAI.68.12.7209-7211.2000; Murphey C, 2006, CELL IMMUNOL, V242, P110, DOI 10.1016/j.cellimm.2006.10.002; Murthy AK, 2004, CELL IMMUNOL, V230, P56, DOI 10.1016/j.cellimm.2004.09.002; Murthy AK, 2007, INFECT IMMUN, V75, P666, DOI 10.1128/IAI.01280-06; Murthy AK, 2011, VACCINE, V29, P2519, DOI 10.1016/j.vaccine.2011.01.074; Murthy AK, 2009, FEMS IMMUNOL MED MIC, V55, P271, DOI 10.1111/j.1574-695X.2008.00517.x; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; Paterson TL, 1996, SEX TRANSM DIS, V23, P145, DOI 10.1097/00007435-199603000-00010; PENN CW, 1977, J GEN MICROBIOL, V100, P159, DOI 10.1099/00221287-100-1-159; Pitsouni E, 2007, INT J ANTIMICROB AG, V30, P213, DOI 10.1016/j.ijantimicag.2007.04.015; Popescu C, 1981, Arch Roum Pathol Exp Microbiol, V40, P241; Ralli-Jain P, 2010, VACCINE, V28, P7659, DOI 10.1016/j.vaccine.2010.09.040; RANK RG, 1994, METHOD ENZYMOL, V235, P83; Rank RG, 2003, INFECT IMMUN, V71, P6148, DOI 10.1128/IAI.71.11.6148-6154.2003; RANK RG, 1992, AM J PATHOL, V140, P927; RANK RG, 1990, INFECT IMMUN, V58, P2599, DOI 10.1128/IAI.58.8.2599-2605.1990; RANK RG, 1979, INFECT IMMUN, V26, P573, DOI 10.1128/IAI.26.2.573-579.1979; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Sakthivel SK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-136; Skelding KA, 2006, VACCINE, V24, P355, DOI 10.1016/j.vaccine.2005.07.104; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; Tifrea DF, 2013, INFECT IMMUN, V81, P1741, DOI 10.1128/IAI.00734-12; Tree JA, 2006, INFECT IMMUN, V74, P1436, DOI 10.1128/IAI.74.2.1436-1441.2006; Tseng CTK, 1998, INFECT IMMUN, V66, P5867, DOI 10.1128/IAI.66.12.5867-5875.1998; Vanrompay D, 2006, DRUGS TODAY, V42, P55; Veselenak RL, 2014, MOL BIOTECH IN PRESS; Volp K, 2001, IMMUNOL CELL BIOL, V79, P245, DOI 10.1046/j.1440-1711.2001.01005.x; Waight Maria T, 2013, J La State Med Soc, V165, P219; Wang Y, 2010, INFECT IMMUN, V78, P1670, DOI 10.1128/IAI.01339-09; WHITE HJ, 1979, INFECT IMMUN, V26, P728, DOI 10.1128/IAI.26.2.728-735.1979; Witherden DA, 2000, J IMMUNOL, V165, P1902, DOI 10.4049/jimmunol.165.4.1902; Yu H, 2012, INFECT IMMUN, V80, P1510, DOI 10.1128/IAI.06338-11; Zhou HY, 2013, J INTERF CYTOK RES, V33, P115, DOI 10.1089/jir.2012.0099	73	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114261	10.1371/journal.pone.0114261	http://dx.doi.org/10.1371/journal.pone.0114261			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502875	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700018
J	Kuo, HC; Guo, MMH; Liu, SF; Chen, CC; Sheen, JM; Yu, HR; Tiao, MM; Tain, YL; Huang, LT				Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Liu, Shih-Feng; Chen, Chih-Cheng; Sheen, Jiunn-Ming; Yu, Hong-Ren; Tiao, Mao-Meng; Tain, You-Lin; Huang, Li-Tung			Cross-Fostering Increases Th1/Th2 Expression in a Prenatal Dexamethasone Exposure Rat Model	PLOS ONE			English	Article							T-CELLS; GLUCOCORTICOIDS; ATOPY; ASSOCIATION; ASTHMA; FETAL	Background: Prenatal dexamethasone exposure has been reported to increase allergy potential in childhood possibly by interference with normal immunological development in utero. This study investigated the effects of prenatal dexamethasone on T helper cell immune responses in a rat model. Methods: Pregnant rats received either dexamethasone 0.1 mg/kg/day or normal saline from gestational day 14-21. Off-springs were cared for by their biological mother, or cross-fostered by the opposing group. Spleen and blood samples were collected at post-natal day 7 and 120 and tested for mRNA expression and plasma cytokine levels of Th1/Th2/Th17 immune response. Results: Both Th1 (T-bet) and Th2 (GATA-3) mRNA expression were shown to have a significant increase in the prenatal dexamethasone exposure group at day 120 (p<0.05). The plasma levels for Th1 (IFN gamma and IL-2) and Th2 (IL-4, IL-5, IL-13) were found to have no significant differences between the two group (p>0.05). The mRNA expression of Th17 (ROR gamma t) showed a significant decrease at post-natal day 120 as well as the plasma level of IL-17A at day 7 (11.21 +/- 1.67 vs. 6.23 +/- 1.06 pg/ml, p=0.02). Cross-fostering by a dexamethasone exposed mother resulted in a significant increase in Th1/Th2 mRNA expression (p<0.05) and decrease of Th17. Conclusions: Prenatal dexamethasone exposure increased Th1, Th2 and decreased Th17 expression. Cross-fostering by a dexamethasone exposed mother results in more prominent increase of Th1 and Th2 expression.	[Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Chen, Chih-Cheng; Sheen, Jiunn-Ming; Yu, Hong-Ren; Tiao, Mao-Meng; Tain, You-Lin; Huang, Li-Tung] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Guo, Mindy Ming-Huey; Liu, Shih-Feng; Chen, Chih-Cheng; Sheen, Jiunn-Ming; Yu, Hong-Ren; Tiao, Mao-Meng; Tain, You-Lin] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Liu, Shih-Feng] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy & Internal Med, Kaohsiung, Taiwan; [Huang, Li-Tung] Chang Gung Univ, Dept Tradit Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Huang, LT (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.	litung.huang@gmail.com	Tain, You-Lin/H-2827-2019; Kuo, Ho-Chang/AAQ-6644-2020; 于, 鴻仁/AAW-6827-2021	Tain, You-Lin/0000-0002-7059-6407; Kuo, Ho-Chang/0000-0002-3295-2984; 于, 鴻仁/0000-0003-1242-8760; Liu, Shih-Feng/0000-0003-1394-5401; Tiao, Mao-Meng/0000-0002-0338-3495	Chang Gung Memorial Hospital, Kaohsiung, Taiwan [CMRPG8B0151]; National Science Council, Taiwan [NSC 102-2314-B-182-053-MY3]	Chang Gung Memorial Hospital, Kaohsiung, Taiwan(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant CMRPG8B0151 from the Chang Gung Memorial Hospital, Kaohsiung, Taiwan and Grant NSC 102-2314-B-182-053-MY3 from the National Science Council, Taiwan. The authors' funding source had no involvement in the study design, collection, analysis or interpretation of data, in the writing of the manuscript or decisions regarding submission.	Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Bunn TL, 2001, TOXICOL SCI, V64, P57, DOI 10.1093/toxsci/64.1.57; Dalziel SR, 2006, THORAX, V61, P678, DOI 10.1136/thx.2005.051763; Dietert RR, 2003, TOXICOLOGY, V194, P163, DOI 10.1016/j.tox.2003.07.001; Dietert RR, 2002, HUM EXP TOXICOL, V21, P479, DOI 10.1191/0960327102ht285oa; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fahey AJ, 2006, J LEUKOCYTE BIOL, V80, P133, DOI 10.1189/jlb.0605296; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Hauser J, 2006, BEHAV BRAIN RES, V175, P51, DOI 10.1016/j.bbr.2006.07.026; Hauser J, 2009, HORM BEHAV, V56, P364, DOI 10.1016/j.yhbeh.2009.07.003; Henderson JJ, 2008, PEDIATRICS, V121, pE92, DOI 10.1542/peds.2007-1107; Huang YC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-40; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Lemanske RF, 2001, NEW ENGL J MED, V344, P1643; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liberman AC, 2009, FASEB J, V23, P1558, DOI 10.1096/fj.08-121236; Liu CA, 2003, J ALLERGY CLIN IMMUN, V112, P899, DOI 10.1016/j.jaci.2003.08.030; Martino DJ, 2010, ALLERGY, V65, P7, DOI 10.1111/j.1398-9995.2009.02186.x; Peden DB, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454539; Plyusnina IZ, 2009, BEHAV GENET, V39, P202, DOI 10.1007/s10519-008-9248-6; Pole JD, 2010, J PREGNANCY, V2010, DOI 10.1155/2010/789748; Pole J, 2009, J ASTHMA, V46, P47, DOI 10.1080/02770900802262795; Prescott SL, 1998, J IMMUNOL, V160, P4730; Ramirez F, 1996, J IMMUNOL, V156, P2406; Ronmark E, 2009, J ALLERGY CLIN IMMUN, V124, P357, DOI 10.1016/j.jaci.2009.05.011; Tain YL, 2014, J AM SOC HYPERTENS, V8, P216, DOI 10.1016/j.jash.2014.01.009; Tang JI, 2011, J HYPERTENS, V29, P282, DOI 10.1097/HJH.0b013e328340aa18; Tiao MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/942172; Wu CY, 1998, J IMMUNOL, V161, P2723; Yang KD, 2007, CLIN EXP ALLERGY, V37, P680, DOI 10.1111/j.1365-2222.2007.02698.x; Yu HR, 2014, IMMUNOLOGY	33	4	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115554	10.1371/journal.pone.0115554	http://dx.doi.org/10.1371/journal.pone.0115554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526616	gold, Green Submitted, Green Published			2022-12-27	WOS:000347186200034
J	Moore, AL; McCarthy, MA; Parris, KM; Moore, JL				Moore, Alana L.; McCarthy, Michael A.; Parris, Kirsten M.; Moore, Joslin L.			The Optimal Number of Surveys when Detectability Varies	PLOS ONE			English	Article							IMPERFECT DETECTION; DESIGNING OCCUPANCY; NONDETECTION; CONSERVATION; BIAS	The survey of plant and animal populations is central to undertaking field ecology. However, detection is imperfect, so the absence of a species cannot be determined with certainty. Methods developed to account for imperfect detectability during surveys do not yet account for stochastic variation in detectability over time or space. When each survey entails a fixed cost that is not spent searching (e.g., time required to travel to the site), stochastic detection rates result in a trade-off between the number of surveys and the length of each survey when surveying a single site. We present a model that addresses this trade-off and use it to determine the number of surveys that: 1) maximizes the expected probability of detection over the entire survey period; and 2) is most likely to achieve a minimally-acceptable probability of detection. We illustrate the applicability of our approach using three practical examples (minimum survey effort protocols, number of frog surveys per season, and number of quadrats per site to detect a plant species) and test our model's predictions using data from experimental plant surveys. We find that when maximizing the expected probability of detection, the optimal survey design is most sensitive to the coefficient of variation in the rate of detection and the ratio of the search budget to the travel cost. When maximizing the likelihood of achieving a particular probability of detection, the optimal survey design is most sensitive to the required probability of detection, the expected number of detections if the budget were spent only on searching, and the expected number of detections that are missed due to travel costs. We find that accounting for stochasticity in detection rates is likely to be particularly important for designing surveys when detection rates are low. Our model provides a framework to do this.	[Moore, Alana L.] CNRS UMR Ecol Forets Guyane, Lab Modelisat, Kourou, French Guiana; [Moore, Alana L.; McCarthy, Michael A.; Parris, Kirsten M.] Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; [Moore, Joslin L.] Royal Bot Gardens Melbourne, Australian Res Ctr Urban Ecol, Parkville, Vic, Australia; [Moore, Joslin L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	University of Melbourne; Monash University	Moore, AL (corresponding author), CNRS UMR Ecol Forets Guyane, Lab Modelisat, Kourou, French Guiana.	moa@unimelb.edu.au	Moore, Joslin L/C-5270-2009; Moore, Joslin/AAE-3819-2020; Parris, Kirsten/K-7684-2012; McCarthy, Michael/O-5655-2014	Moore, Joslin L/0000-0001-9809-5092; Moore, Joslin/0000-0001-9809-5092; Parris, Kirsten/0000-0003-2550-585X; McCarthy, Michael/0000-0003-1039-7980	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions; ARC Future Fellowship [FT100100923]; GUYASIM project [31032, FEDER 2007-2013]; Agence Nationale de la Recherche (CEBA) [ANR-10-LABX-0025]	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions(Australian Research Council); ARC Future Fellowship(Australian Research Council); GUYASIM project; Agence Nationale de la Recherche (CEBA)(French National Research Agency (ANR))	The authors gratefully acknowledge funding support from the Australian Research Council (ARC) Centre of Excellence for Environmental Decisions and an ARC Future Fellowship to MAM (FT100100923). This study was also supported by the GUYASIM project (31032, programme operationnel FEDER 2007-2013), with financial support provided by European structural funds and has benefited from an "Investissement d9Avenir" grant managed by Agence Nationale de la Recherche (CEBA, ref. ANR-10-LABX-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Beaulieu NC, 2004, IEEE COMMUN LETT, V8, P709, DOI 10.1109/LCOMM.2004.837657; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Chades I, 2011, P NATL ACAD SCI USA, V108, P8323, DOI 10.1073/pnas.1016846108; Chen G, 2012, J ECOLOGY; Clarke KD, 2012, ENVIRON MONIT ASSESS, V184, P625, DOI 10.1007/s10661-011-1991-0; de Solla SR, 2005, BIOL CONSERV, V121, P585, DOI 10.1016/j.biocon.2004.06.018; Driscoll DA, 2010, AUSTRAL ECOL, V35, P13, DOI 10.1111/j.1442-9993.2009.02007.x; Elphick CS, 2008, J APPL ECOL, V45, P1313, DOI 10.1111/j.1365-2664.2008.01545.x; Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Guillera-Arroita G, 2010, METHODS ECOL EVOL, V1, P131, DOI 10.1111/j.2041-210X.2010.00017.x; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Kery M, 2003, J ECOL, V91, P265, DOI 10.1046/j.1365-2745.2003.00759.x; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2006, J ECOL, V94, P980, DOI 10.1111/j.1365-2745.2006.01151.x; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Loyn R, 2011, SURVEY STANDARDS POW; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; Mattfeldt SD, 2009, BIOL CONSERV, V142, P720, DOI 10.1016/j.biocon.2008.12.002; McCarthy MA, 2013, OIKOS, V122, P717, DOI 10.1111/j.1600-0706.2012.20781.x; McCarthy MA, 2011, ECOL LETT, V14, P470, DOI 10.1111/j.1461-0248.2011.01608.x; Moilanen A, 2002, OIKOS, V96, P516, DOI 10.1034/j.1600-0706.2002.960313.x; Moore JL, 2011, ECOL APPL, V21, P601, DOI 10.1890/10-0590.1; Parris KM, 2001, BIOL CONSERV, V99, P285, DOI 10.1016/S0006-3207(00)00194-4; Pollock KH, 1990, WILDLIFE MONOGRAPHS, V1-97; Regan TJ, 2011, J APPL ECOL, V48, P76, DOI 10.1111/j.1365-2664.2010.01915.x; Rout TM, 2009, J APPL ECOL, V46, P110, DOI 10.1111/j.1365-2664.2008.01586.x; Southwell C, 2009, J APPL ECOL, V46, P136, DOI 10.1111/j.1365-2664.2008.01584.x; Spiegelhalter D., 2007, OPEN BUGS USER MANUA; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Watson CA, 2008, ANIM CONSERV, V11, P484, DOI 10.1111/j.1469-1795.2008.00204.x; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x	38	24	24	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115345	10.1371/journal.pone.0115345	http://dx.doi.org/10.1371/journal.pone.0115345			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526514	Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200023
J	Chen, YC; Chiou, C; Lin, MN; Lin, CL				Chen, Yen-Chun; Chiou, Chia; Lin, Ming-Nan; Lin, Chin-Lon			The Prevalence and Risk Factors for Gallstone Disease in Taiwanese Vegetarians	PLOS ONE			English	Article							GALLBLADDER-DISEASE; GENERAL-POPULATION; PHYSICAL-ACTIVITY; UNITED-STATES; CHOLELITHIASIS; PREGNANCY; WOMEN; DIET; CHOLECYSTECTOMY; CHOLESTEROL	Introduction: Gallstone disease (GSD) and its complications are major public health issues globally. Although many community-based studies had addressed the risk factors for GSD, little is known about GSD prevalence and risk factors among Taiwanese vegetarians. Methods: This study included 1721 vegetarians who completed a questionnaire detailing their demographics, medical history, and life-styles. GSD was ascertained by ultrasonography or surgical history of cholecystectomy for GSD. The predictive probability of GSD for male and female vegetarians was estimated from the fitted model. Results: The prevalence of GSD was 8.2% for both male and female vegetarians. The risk of GSD is similar in men and women across all age groups, and increases steadily with increasing age. For male vegetarians, age (OR: 1.04; 95% CI: 1.00-1.08) and serum total bilirubin level (OR: 2.35; 95% CI: 1.31-4.22) predict risk for GSD. For female vegetarians, age (OR: 1.03; 95% CI: 1.01-1.05), BMI (OR: 1.07; 95% CI: 1.01-1.13), and alcohol consumption (OR: 7.85; 95% CI: 1.83-33.73) are associated with GSD. GSD is not associated with type of vegetarian diet, duration of vegetarianism, low education level, physical inactivity, diabetes, coronary artery disease, cerebral vascular accident, chronic renal failure, hepatitis C virus infection, and lipid abnormalities. GSD is also not associated with age at menarche, postmenopausal status, and multiparity in female vegetarians. Conclusions: Risk factors useful for predicting GSD in vegetarians are (1) age and total bilirubin level in men, and (2) age, BMI, and alcohol consumption in women. Many previously identified risk factors for general population does not seem to apply to Taiwanese vegetarians.	[Chen, Yen-Chun] Dalin Tzu Chi Hosp, Dept Internal Med, Buddhist Tzu Chi Med Fdn, Dalin Township, Chiayi County, Taiwan; [Chiou, Chia; Lin, Ming-Nan] Dalin Tzu Chi Hosp, Dept Family Med, Buddhist Tzu Chi Med Fdn, Dalin Township, Chiayi County, Taiwan; [Lin, Ming-Nan] Tzu Chi Univ, Dept Family Med, Coll Med, Hualien, Taiwan; [Lin, Chin-Lon] Tzu Chi Fdn, Hualien, Taiwan; [Lin, Chin-Lon] Buddhist Hualien Tzu Chi Hosp, Dept Internal Med, Hualien, Taiwan; [Lin, Chin-Lon] Tzu Chi Univ, Dept Internal Med, Coll Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Tzu Chi University; Tzu Chi University	Lin, MN (corresponding author), Dalin Tzu Chi Hosp, Dept Family Med, Buddhist Tzu Chi Med Fdn, Dalin Township, Chiayi County, Taiwan.	mingnan.lin@gmail.com						Abu-Eshy S. A., 2007, Eastern Mediterranean Health Journal, V13, P794; ATTILI AF, 1995, HEPATOLOGY, V21, P656, DOI 10.1002/hep.1840210309; BARBARA L, 1995, AM J EPIDEMIOL, V141, P158, DOI 10.1093/oxfordjournals.aje.a117403; BASSO L, 1992, SURG GYNECOL OBSTET, V175, P41; Bini EJ, 2005, HEPATOLOGY, V41, P1029, DOI 10.1002/hep.20647; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; Chen CY, 1998, AGE AGEING, V27, P437, DOI 10.1093/ageing/27.4.437; Chen CY, 1999, HEPATO-GASTROENTEROL, V46, P1607; Chiu TH, PUBLIC HLTH NUTR, V17, P1459; Chiu THT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088547; de Pancorbo CM, 1997, J CLIN EPIDEMIOL, V50, P1347, DOI 10.1016/S0895-4356(97)00198-4; DeSantis A, 1997, HEPATOLOGY, V25, P787, DOI 10.1002/hep.510250401; DWYER JT, 1988, AM J CLIN NUTR, V48, P712, DOI 10.1093/ajcn/48.3.712; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Festi D, 2008, WORLD J GASTROENTERO, V14, P5282, DOI 10.3748/wjg.14.5282; Gaby AR, 2009, ALTERN MED REV, V14, P258; Halldestam I, 2009, BRIT J SURG, V96, P1315, DOI 10.1002/bjs.6687; HEATON KW, 1991, GUT, V32, P316, DOI 10.1136/gut.32.3.316; Hung SC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-111; HWANG WS, 1970, GUT, V11, P141, DOI 10.1136/gut.11.2.141; Kothari SN, 2013, J AM COLL SURGEONS, V216, P1057, DOI 10.1016/j.jamcollsurg.2013.02.009; Lee YC, 2014, SCAND J GASTROENTERO, V49, P1001, DOI 10.3109/00365521.2014.920912; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Liu B, 2009, INT J EPIDEMIOL, V38, P312, DOI 10.1093/ije/dyn174; MARINGHINI A, 1993, ANN INTERN MED, V119, P116, DOI 10.7326/0003-4819-119-2-199307150-00004; MARKS JW, 1984, DIGEST DIS SCI, V29, P1118, DOI 10.1007/BF01317086; Moerman Clara J., 1994, Annals of Epidemiology, V4, P248, DOI 10.1016/1047-2797(94)90104-X; NOMURA H, 1988, AM J EPIDEMIOL, V128, P598, DOI 10.1093/oxfordjournals.aje.a115007; Phillips F, 2005, NUTR BULL, V30, P132, DOI 10.1111/j.1467-3010.2005.00467.x; PIXLEY F, 1985, BRIT MED J, V291, P11, DOI 10.1136/bmj.291.6487.11; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; SMITH DA, 1979, AM J CLIN NUTR, V32, P1519, DOI 10.1093/ajcn/32.7.1519; Stender S, 2013, HEPATOLOGY, V58, P2133, DOI 10.1002/hep.26563; Stender S, 2013, JAMA INTERN MED, V173, P1222, DOI 10.1001/jamainternmed.2013.6465; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; THORNTON J, 1983, LANCET, V2, P819; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; Tsai CJ, 2006, AM J MED, V119, P760, DOI 10.1016/j.amjmed.2006.02.040; VALDIVIESO V, 1993, HEPATOLOGY, V17, P1; Walcher T, 2010, EUR J GASTROEN HEPAT, V22, P1345, DOI 10.1097/MEG.0b013e32833efdb2	41	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115145	10.1371/journal.pone.0115145	http://dx.doi.org/10.1371/journal.pone.0115145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521621	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600018
J	Ray, AM; Arnold, RA; Swift, I; Schapker, PA; McCann, S; Marshall, CJ; McElfresh, JS; Millar, JG				Ray, Ann M.; Arnold, Richard A.; Swift, Ian; Schapker, Philip A.; McCann, Sean; Marshall, Christopher J.; McElfresh, J. Steven; Millar, Jocelyn G.			(R)-Desmolactone Is a Sex Pheromone or Sex Attractant for the Endangered Valley Elderberry Longhorn Beetle Desmocerus californicus dimorphus and Several Congeners (Cerambycidae: Lepturinae)	PLOS ONE			English	Article							PLANT VOLATILES; HOST-PLANT; COLEOPTERA; IDENTIFICATION; COMPONENTS; GENUS	We report here that (4R, 9Z)-hexadec-9-en-4-olide [(R)-desmolactone] is a sex attractant or sex pheromone for multiple species and subspecies in the cerambycid genus Desmocerus. This compound was previously identified as a female-produced sex attractant pheromone of Desmocerus californicus californicus. Headspace volatiles from female Desmocerus aureipennis aureipennis contained (R)-desmolactone, and the antennae of adult males of two species responded strongly to synthetic (R)-desmolactone in coupled gas chromatography-electroantennogram analyses. In field bioassays in California, Oregon, and British Columbia, traps baited with synthetic (R)-desmolactone captured males of several Desmocerus species and subspecies. Only male beetles were captured, indicating that this compound acts as a sex-specific attractant, rather than as a signal for aggregation. In targeted field bioassays, males of the US federally threatened subspecies Desmocerus californicus dimorphus responded to the synthetic attractant in a dose dependent manner. Our results represent the first example of a "generic'' sex pheromone used by multiple species in the subfamily Lepturinae, and demonstrate that pheromone-baited traps may be a sensitive and efficient method of monitoring the threatened species Desmocerus californicus dimorphus, commonly known as the valley elderberry longhorn beetle.	[Ray, Ann M.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA; [Arnold, Richard A.] Entomol Consulting Serv Ltd, Pleasant Hill, CA USA; [Swift, Ian] Calif State Collect Arthropods, Sacramento, CA USA; [Schapker, Philip A.; Marshall, Christopher J.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [McCann, Sean] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [McElfresh, J. Steven; Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Xavier University; Oregon State University; Simon Fraser University; University of California System; University of California Riverside	Ray, AM (corresponding author), Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA.	raya6@xavier.edu	Ray, Ann/GWC-1693-2022	Ray, Ann/0000-0002-5411-8974; Millar, Jocelyn/0000-0001-7639-9001; McCann, Sean/0000-0001-6030-6456	Robert Borcer Endowment; National Science Foundation Division of Biological Infrastructure [0847965]; National Research Initiative of the United States Department of Agriculture Cooperative State Research; Education and Extension Service [2009-3530205047]	Robert Borcer Endowment; National Science Foundation Division of Biological Infrastructure(National Science Foundation (NSF)); National Research Initiative of the United States Department of Agriculture Cooperative State Research(United States Department of Agriculture (USDA)); Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funding for this project was provided by the Robert Borcer Endowment (Xavier University, www.xavier.edu, to AMR), National Science Foundation Division of Biological Infrastructure (www.nsf.gov) grant number #0847965 (to CJM), and the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service (www.csrees.usda.gov), grant number #2009-3530205047 (to JGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Atkins North America, 2013, PEER REV SCI FIND PR; Barbour JD, 2011, ANN ENTOMOL SOC AM, V104, P588, DOI 10.1603/AN10182; Barr CB, 1991, DISTRIBUTION HABITAT; Bolli R., 1994, DISSERTATIONES BOT; Burke HE, 1921, J ECON ENTOMOL, V14, P450, DOI 10.1093/jee/14.5.450; CHEMSAK JA, 2005, ILLUSTRATED REVISION, V2; Collinge SK, 2001, BIOL CONSERV, V100, P103, DOI 10.1016/S0006-3207(00)00211-1; Davis A., 1924, Bulletin of the Southern California Academy of Sciences, V23, P179; Eliyahu D, 2012, P NATL ACAD SCI USA, V109, pE490, DOI 10.1073/pnas.1111748109; Fonseca MG, 2010, J CHEM ECOL, V36, P1132, DOI 10.1007/s10886-010-9850-y; Graham EE, 2010, J ECON ENTOMOL, V103, P641, DOI 10.1603/EC10013; Halstead JA, 2000, PAN-PAC ENTOMOL, V76, P74; Hanks LM, 2014, ANN ENTOMOL SOC AM, V107, P211, DOI 10.1603/AN13067; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Hardie J, 1999, PHEROMONES NONLEPIDO; Hart CJ, 2013, COLEOPTS BULL, V67, P133, DOI 10.1649/0010-065X-67.2.133; Holyoak M, 2008, ENVIRON MANAGE, V42, P444, DOI 10.1007/s00267-008-9113-7; Huxel Gary R., 2000, Biological Invasions, V2, P81, DOI 10.1023/A:1010015722996; LADD TL, 1981, J ECON ENTOMOL, V74, P665, DOI 10.1093/jee/74.6.665; LINSLEY EG, 1972, CERAMBYCIDAE N AM 6; Maurel N, 2013, OREINA           SEP, V23, P13; MICHELSEN AXEL, 1963, BEHAVIOUR, V22, P152, DOI 10.1163/156853963X00338; Millar JG, 2010, J CHEM ECOL, V36, P923, DOI 10.1007/s10886-010-9831-1; Mitchell RF, 2013, CHEMOECOLOGY, V23, P121, DOI 10.1007/s00049-012-0122-x; Morrison M. L., 2003, Ecological Restoration, V21, P95, DOI 10.3368/er.21.2.95; Nehme ME, 2010, ENVIRON ENTOMOL, V39, P169, DOI 10.1603/EN09177; Pajares JA, 2010, J CHEM ECOL, V36, P570, DOI 10.1007/s10886-010-9791-5; Partners River, 2007, VELB HAB COL REMN PL; Paschen MA, 2012, J INSECT BEHAV, V25, P569, DOI 10.1007/s10905-012-9321-0; Ray AM, 2012, J CHEM ECOL, V38, P1151, DOI 10.1007/s10886-012-0181-z; Ray AM, 2012, J CHEM ECOL, V38, P157, DOI 10.1007/s10886-012-0070-5; Ray AM, 2011, J CHEM ECOL, V37, P173, DOI 10.1007/s10886-011-9908-5; Rodstein J, 2011, J CHEM ECOL, V37, P114, DOI 10.1007/s10886-010-9890-3; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Silk PJ, 2007, NATURWISSENSCHAFTEN, V94, P697, DOI 10.1007/s00114-007-0244-0; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Suckling DM, 2012, J ECON ENTOMOL, V105, P1, DOI 10.1603/EC11293; SVACHA P, 1988, Acta Universitatis Carolinae-Biologica, V32, P1; Svensson GP, 2012, J INSECT CONSERV, V16, P549, DOI 10.1007/s10841-011-9440-5; Swaine JM, 1928, NATL MUSEUM CANADA B, V52, P1; Talley TS, 2007, BIOL CONSERV, V135, P21, DOI 10.1016/j.biocon.2006.09.022; Talley TS, 2006, ENVIRON MANAGE, V37, P647, DOI 10.1007/s00267-004-0320-6; Tavakilian G, 2013, BAS DONN TIT CER LON; USDA, 2012, GYPS MOTH PROGR MAN; USFWS, 2012, FED REGISTER, V77, P60237; USFWS, 1984, VALL ELD LONGH BEETL; USFWS, 2006, VALL ELD LONGH BEETL; *USFWS, 1999, CONS GUID VALL ELD L; USFWS, 2014, FED REGISTER, V79, P55874; Wickham JD, 2014, J ECON ENTOMOL, V107, P259, DOI 10.1603/EC13333; 1980, FED REG, V45, P52803	52	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115498	10.1371/journal.pone.0115498	http://dx.doi.org/10.1371/journal.pone.0115498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521293	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845600051
J	Wang, Q; Li, XF; Ji, XL; Wang, JF; Shen, N; Gao, YL; Qi, XL; Wang, YQ; Gao, HL; Zhang, SD; Wang, XM				Wang, Qi; Li, Xiaofei; Ji, Xiaolin; Wang, Jingfei; Shen, Nan; Gao, Yulong; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Zhang, Shide; Wang, Xiaomei			A Recombinant Avian Leukosis Virus Subgroup J for Directly Monitoring Viral Infection and the Selection of Neutralizing Antibodies	PLOS ONE			English	Article							CONTRIBUTES; PARTICLES; CHICKENS; ELEMENT; CHINA; CELLS	Avian leukosis virus subgroup J (ALV-J) has induced serious clinical outbreaks and has become a serious infectious disease of chickens in China. We describe here the creation of a recombinant ALV-J tagged with the enhanced green fluorescent protein (named rHPRS-103EGFP). We successfully utilize the rHPRS-103EGFP to visualize viral infection and for development of a simplified serum-neutralization test.	[Wang, Qi; Li, Xiaofei; Ji, Xiaolin; Gao, Yulong; Qi, Xiaole; Wang, Yongqiang; Gao, Honglei; Wang, Xiaomei] Chinese Acad Agr Sci, Div Avian Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China; [Wang, Jingfei; Shen, Nan] Chinese Acad Agr Sci, Ctr Anim Infect Dis Diag & Tech Serv, Harbin 150001, Peoples R China; [Wang, Jingfei; Shen, Nan] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China; [Zhang, Shide] Harbin Med Univ, Dept Radiol, Affiliated Hosp 2, Harbin 150086, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Harbin Medical University	Zhang, SD (corresponding author), Harbin Med Univ, Dept Radiol, Affiliated Hosp 2, Harbin 150086, Peoples R China.	zhangshide65@126.com; xmw@hvri.ac.cn	Li, xiaofei/GXF-7187-2022		National Natural Science Foundation of China [31072146, 31201923]; earmarked fund for the Modern Agro-industry Technology Research System [nycytx-42-G3-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agro-industry Technology Research System	This study was funded by the National Natural Science Foundation of China (31072146), the National Natural Science Foundation of China (31201923) and the earmarked fund for the Modern Agro-industry Technology Research System (no. nycytx-42-G3-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA TW, 1984, J VIROL, V51, P123, DOI 10.1128/JVI.51.1.123-130.1984; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Chesters PM, 2006, J GEN VIROL, V87, P2685, DOI 10.1099/vir.0.81884-0; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Hussain AI, 2003, J VIROL, V77, P1105, DOI 10.1128/JVI.77.2.1105-1111.2003; Ji XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084797; Jin J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000163; Kucerova D, 2013, J VIROL, V87, P8399, DOI 10.1128/JVI.03180-12; Li Y, 2013, J CLIN MICROBIOL; Martin N, 2009, CURR OPIN HIV AIDS, V4, P143, DOI 10.1097/COH.0b013e328322f94a; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Meng QW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-556; NASIOULAS G, 1995, P NATL ACAD SCI USA, V92, P11940, DOI 10.1073/pnas.92.25.11940; ROBINSON HL, 1982, P NATL ACAD SCI-BIOL, V79, P1225, DOI 10.1073/pnas.79.4.1225; RUDDELL A, 1995, VIROLOGY, V206, P1, DOI 10.1016/S0042-6822(95)80013-1; STIERHOF YD, 1991, J ELECTRON MICR TECH, V17, P336, DOI 10.1002/jemt.1060170307; Venugopal K, 1998, J GEN VIROL, V79, P757, DOI 10.1099/0022-1317-79-4-757; Wang Q, 2012, J VIROL, V86, P12849, DOI 10.1128/JVI.01113-12; WELT S, 1979, IMMUNOLOGY, V37, P587	20	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115422	10.1371/journal.pone.0115422	http://dx.doi.org/10.1371/journal.pone.0115422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522008	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600045
J	Fushing, H; Chen, C; Hsieh, YC; Farrell, P				Fushing, Hsieh; Chen, Chen; Hsieh, Yin-Chen; Farrell, Patrick			Lewis Carroll's Doublets Net of English Words: Network Heterogeneity in a Complex System	PLOS ONE			English	Article							COMMUNITY STRUCTURE	Lewis Carroll's English word game Doublets is represented as a system of networks with each node being an English word and each connectivity edge confirming that its two ending words are equal in letter length, but different by exactly one letter. We show that this system, which we call the Doublets net, constitutes a complex body of linguistic knowledge concerning English word structure that has computable multiscale features. Distributed morphological, phonological and orthographic constraints and the language's local redundancy are seen at the node level. Phonological communities are seen at the network level. And a balancing act between the language's global efficiency and redundancy is seen at the system level. We develop a new measure of intrinsic node-to-node distance and a computational algorithm, called community geometry, which reveal the implicit multiscale structure within binary networks. Because the Doublets net is a modular complex cognitive system, the community geometry and computable multi-scale structural information may provide a foundation for understanding computational learning in many systems whose network structure has yet to be fully analyzed.	[Fushing, Hsieh; Chen, Chen] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Hsieh, Yin-Chen] Amsterdam Univ Coll, Amsterdam, Netherlands; [Farrell, Patrick] Univ Calif Davis, Dept Linguist, Davis, CA 95616 USA	University of California System; University of California Davis; University of Amsterdam; University of California System; University of California Davis	Farrell, P (corresponding author), Univ Calif Davis, Dept Linguist, Davis, CA 95616 USA.	pmfarrell@ucdavis.edu			National Science Foundation [1007219]	National Science Foundation(National Science Foundation (NSF))	Funding provided to HF: National Science Foundation (http://www.nsf.gov) Cyber-enabled Discovery and Innovation Initiative and Division of Mathematical Sciences, grant #1007219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Anand K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.045102; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Arbesman S, 2010, INT J BIFURCAT CHAOS, V20, P679, DOI 10.1142/S021812741002596X; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Borge-Holthoefer J, 2010, ENTROPY-SWITZ, V12, P1264, DOI 10.3390/e12051264; BROWN AS, 1991, PSYCHOL BULL, V109, P204, DOI 10.1037/0033-2909.109.2.204; Cheng Ye, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P424, DOI 10.1007/978-3-642-40246-3_53; Clements GeorgeN., 1983, CV PHONOLOGY GENERAT, DOI 10.2307/414790; Dehmer M, 2012, MATCH-COMMUN MATH CO, V67, P147; Dehmer M, 2011, INFORM SCIENCES, V181, P57, DOI 10.1016/j.ins.2010.08.041; Estrada E, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066102; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Kello CT, 2009, PHONOL PHONET, V16, P171, DOI 10.1515/9783110223958.171; Kenett YN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023912; Kessler B, 1997, J MEM LANG, V37, P295, DOI 10.1006/jmla.1997.2522; Kucera H, 1968, COMP QUANTITATIVE PH; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; SCHANE S, 1970, TESOL QUART, V4, P137, DOI 10.2307/3586184; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Vitevitch MS, 2008, J SPEECH LANG HEAR R, V51, P408, DOI 10.1044/1092-4388(2008/030); WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107	37	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114177	10.1371/journal.pone.0114177	http://dx.doi.org/10.1371/journal.pone.0114177			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517974	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600014
J	Saugy, JJ; Schmitt, L; Cejuela, R; Faiss, R; Hauser, A; Wehrlin, JP; Rudaz, B; Delessert, A; Robinson, N; Millet, GP				Saugy, Jonas J.; Schmitt, Laurent; Cejuela, Roberto; Faiss, Raphael; Hauser, Anna; Wehrlin, Jon P.; Rudaz, Benjamin; Delessert, Audric; Robinson, Neil; Millet, Gregoire P.			Comparison of "Live High-Train Low'' in Normobaric versus Hypobaric Hypoxia	PLOS ONE			English	Article							SEA-LEVEL PERFORMANCE; TOTAL HEMOGLOBIN MASS; MAXIMAL OXYGEN-UPTAKE; MODERATE-ALTITUDE; EXERCISE PERFORMANCE; PHYSIOLOGICAL-RESPONSES; AEROBIC PERFORMANCE; REBREATHING METHOD; FLUID BALANCE; BLOOD-VOLUME	We investigated the changes in both performance and selected physiological parameters following a Live High-Train Low (LHTL) altitude camp in either normobaric hypoxia (NH) or hypobaric hypoxia (HH) replicating current "real'' practices of endurance athletes. Well-trained triathletes were split into two groups (NH, n=14 and HH, n=13) and completed an 18-d LHTL camp during which they trained at 1100-1200 m and resided at an altitude of 2250 m (PiO2 = 121.7 +/- 1.2 vs. 121.4 +/- 0.9 mmHg) under either NH (hypoxic chamber; FiO2 15.8 +/- 0.8%) or HH (real altitude; barometric pressure 580 +/- 23 mmHg) conditions. Oxygen saturations (SpO2) were recorded continuously daily overnight. PiO(2) and training loads were matched daily. Before (Pre-) and 1 day after (Post-) LHTL, blood samples, VO2max, and total haemoglobin mass (Hb(mass)) were measured. A 3-km running test was performed near sea level twice before, and 1, 7, and 21 days following LHTL. During LHTL, hypoxic exposure was lower for the NH group than for the HH group (220 vs. 300 h; P<0.001). Night SpO(2) was higher (92.1 +/- 0.3 vs. 90.9 +/- 0.3%, P<0.001), and breathing frequency was lower in the NH group compared with the HH group (13.9 +/- 2.1 vs. 15.5 +/- 1.5 breath. min(-1), P<0.05). Immediately following LHTL, similar increases in VO2max (6.1 +/- 6.8 vs. 5.2 +/- 4.8%) and Hbmass (2.6 +/- 1.9 vs. 3.4 +/- 2.1%) were observed in NH and HH groups, respectively, while 3-km performance was not improved. However, 21 days following the LHTL intervention, 3-km run time was significantly faster in the HH (3.3 +/- 3.6%; P<0.05) versus the NH (1.2 +/- 2.9%; ns) group. In conclusion, the greater degree of race performance enhancement by day 21 after an 18-d LHTL camp in the HH group was likely induced by a larger hypoxic dose. However, one cannot rule out other factors including differences in sleeping desaturations and breathing patterns, thus suggesting higher hypoxic stimuli in the HH group.	[Saugy, Jonas J.; Faiss, Raphael; Hauser, Anna; Rudaz, Benjamin; Delessert, Audric; Millet, Gregoire P.] Univ Lausanne, Inst Sport Sci, ISSUL, Fac Biol & Med, Lausanne, Switzerland; [Saugy, Jonas J.; Faiss, Raphael; Millet, Gregoire P.] Univ Lausanne, Dept Physiol, Fac Biol & Med, Lausanne, Switzerland; [Schmitt, Laurent] Natl Ski Nord Ctr, Natl Sch Mt Sports, Premanon, France; [Cejuela, Roberto] Univ Alicante, Dept Sect Phys Educ & Sports, E-03080 Alicante, Spain; [Hauser, Anna; Wehrlin, Jon P.] Swiss Fed Inst Sport, Magglingen, Switzerland; [Robinson, Neil] Univ Lausanne, Swiss Lab Doping Analyses, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Universitat d'Alacant; University of Lausanne	Millet, GP (corresponding author), Univ Lausanne, Inst Sport Sci, ISSUL, Fac Biol & Med, Lausanne, Switzerland.	gregoire.millet@unil.ch	Wehrlin, Jon Peter/P-1984-2019; Millet, Grégoire/M-3220-2019; Wehrlin, Jon Peter/G-5101-2011; Millet, Gregoire P/F-4104-2012; Cejuela, Roberto/AAE-7727-2022; Faiss, Raphaël/AAX-3714-2021	Wehrlin, Jon Peter/0000-0002-8854-7937; Millet, Grégoire/0000-0001-8081-4423; Wehrlin, Jon Peter/0000-0002-8854-7937; Millet, Gregoire P/0000-0001-8081-4423; Cejuela, Roberto/0000-0003-4315-6307; Faiss, Raphaël/0000-0001-6029-9516	Ministere des Sports, de la Jeunesse, de l'Education Populaire et de la Vie Associative (MSJEPVA)/Institut National du Sport, de l'Expertise et de la Performance (INSEP); Bundes Amt fur Sport (BASPO; Switzerland)	Ministere des Sports, de la Jeunesse, de l'Education Populaire et de la Vie Associative (MSJEPVA)/Institut National du Sport, de l'Expertise et de la Performance (INSEP); Bundes Amt fur Sport (BASPO; Switzerland)	This study was funded by grants from the Ministere des Sports, de la Jeunesse, de l'Education Populaire et de la Vie Associative (MSJEPVA)/Institut National du Sport, de l'Expertise et de la Performance (INSEP) and from Bundes Amt fur Sport (BASPO; Switzerland).	Ashenden MJ, 2003, HAEMATOLOGICA, V88, P1053; Bonetti DL, 2009, SPORTS MED, V39, P107, DOI 10.2165/00007256-200939020-00002; Burtscher M, 1996, EUR J APPL PHYSIOL, V74, P558; Anta RC, 2011, J HUM SPORT EXERC, V6, P218, DOI 10.4100/jhse.2011.62.03; Chapman RF, 2014, J APPL PHYSIOL, V116, P837, DOI 10.1152/japplphysiol.00663.2013; Chapman RF, 2014, J APPL PHYSIOL, V116, P595, DOI 10.1152/japplphysiol.00634.2013; Chapman RF, 2013, BRIT J SPORT MED, V47, P40; Clark SA, 2009, EUR J APPL PHYSIOL, V106, P399, DOI 10.1007/s00421-009-1027-4; Conkin J, 2008, AVIAT SPACE ENVIR MD, V79, P975, DOI 10.3357/ASEM.2331.2008; COYLE EF, 1990, INT J SPORTS MED, V11, P116, DOI 10.1055/s-2007-1024774; Dehnert C, 2002, INT J SPORTS MED, V23, P561, DOI 10.1055/s-2002-35533; Faiss R, 2013, MED SCI SPORT EXER, V45, P253, DOI 10.1249/MSS.0b013e31826d5aa2; Fulco CS, 2011, AM J PHYSIOL-REG I, V300, pR428, DOI 10.1152/ajpregu.00633.2010; Garvican L, 2012, SCAND J MED SCI SPOR, V22, P95, DOI 10.1111/j.1600-0838.2010.01145.x; Garvican-Lewis LA, 2013, BRIT J SPORT MED, V47, P70; Gore CJ, 2013, BRIT J SPORT MED, V47, P31, DOI 10.1136/bjsports-2013-092840; Gore CJ, 2007, MED SCI SPORT EXER, V39, P1600, DOI 10.1249/mss.0b013e3180de49d3; Gore CJ, 2001, ACTA PHYSIOL SCAND, V173, P275, DOI 10.1046/j.1365-201X.2001.00906.x; Gough CE, 2012, EUR J APPL PHYSIOL, V112, P3275, DOI 10.1007/s00421-011-2291-7; Hahn AG, 2001, COMP BIOCHEM PHYS A, V128, P777, DOI 10.1016/S1095-6433(01)00283-5; Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613; Lamon S, 2010, ENDOCRIN METAB CLIN, V39, P141, DOI 10.1016/j.ecl.2009.10.004; Laymon ASL, 2009, MED SCI SPORTS EXERC, V41, P320; Levine BD, 1997, J APPL PHYSIOL, V83, P102, DOI 10.1152/jappl.1997.83.1.102; LEVINE BD, 1988, J APPL PHYSIOL, V64, P419, DOI 10.1152/jappl.1988.64.1.419; Levine BD, 2006, ADV EXP MED BIOL, V588, P233; Loeppky JA, 2005, HIGH ALT MED BIOL, V6, P60, DOI 10.1089/ham.2005.6.60; Lundby C, 2012, BRIT J SPORT MED, V46, P792, DOI 10.1136/bjsports-2012-091231; Millet GP, 2012, J APPL PHYSIOL, V112, P1783, DOI 10.1152/japplphysiol.00067.2012; Millet GP, 2010, SPORTS MED, V40, P1, DOI 10.2165/11317920-000000000-00000; Mounier R, 2012, J APPL PHYSIOL, V112, P1784, DOI 10.1152/japplphysiol.00067.2012a; Navarrete-Opazo AA, 2014, AM J PHYSL REGUL INT; Prommer N, 2010, MED SCI SPORT EXER, V42, P791, DOI 10.1249/MSS.0b013e3181badd67; Richalet JP, 2008, SCAND J MED SCI SPOR, V18, P29, DOI 10.1111/j.1600-0838.2008.00830.x; Richard NA, 2012, AVIAT SPACE ENVIR MD, V83, P677, DOI 10.3357/ASEM.3182.2012; Robach P, 2006, EUR J APPL PHYSIOL, V96, P423, DOI 10.1007/s00421-005-0089-1; Roberts AD, 2003, EUR J APPL PHYSIOL, V88, P390, DOI 10.1007/s00421-002-0720-3; Robertson EY, 2010, EUR J APPL PHYSIOL, V110, P379, DOI 10.1007/s00421-010-1516-5; Rusko HK, 2004, J SPORT SCI, V22, P928, DOI 10.1080/02640410400005933; Saunders PU, 2004, J APPL PHYSIOL, V96, P931, DOI 10.1152/japplphysiol.00725.2003; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; Schmidt W, 2005, EUR J APPL PHYSIOL, V95, P486, DOI 10.1007/s00421-005-0050-3; Schmitt L, 2006, EUR J APPL PHYSIOL, V97, P627, DOI 10.1007/s00421-006-0228-3; Siebenmann C, 2012, J APPL PHYSIOL, V112, P106, DOI 10.1152/japplphysiol.00388.2011; Singh B, 2010, AVIAT SPACE ENVIR MD, V81, P857, DOI 10.3357/ASEM.2640.2010; Steiner T, 2011, MED SCI SPORT EXER, V43, P1735, DOI 10.1249/MSS.0b013e3182118760; Stray-Gundersen J, 2008, SCAND J MED SCI SPOR, V18, P21, DOI 10.1111/j.1600-0838.2008.00829.x; Stray-Gundersen J, 2001, J APPL PHYSIOL, V91, P1113, DOI 10.1152/jappl.2001.91.3.1113; Wehrlin JP, 2006, J APPL PHYSIOL, V100, P1938, DOI 10.1152/japplphysiol.01284.2005; Wehrlin JP, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019729; Wilber RL, 2007, MED SCI SPORT EXER, V39, P1590, DOI 10.1249/mss.0b013e3180de49bd	51	44	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114418	10.1371/journal.pone.0114418	http://dx.doi.org/10.1371/journal.pone.0114418			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517507	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600018
J	Wang, RL; Yu, GR; He, NP; Wang, QF; Xia, FC; Zhao, N; Xu, ZW; Ge, JP				Wang, Ruili; Yu, Guirui; He, Nianpeng; Wang, Qiufeng; Xia, Fucai; Zhao, Ning; Xu, Zhiwei; Ge, Jianping			Elevation-Related Variation in Leaf Stomatal Traits as a Function of Plant Functional Type: Evidence from Changbai Mountain, China	PLOS ONE			English	Article							VACCINIUM-MYRTILLUS; DIFFERENT ALTITUDES; ATMOSPHERIC CO2; DENSITY; CONDUCTANCE; PHOTOSYNTHESIS; CLIMATE; DRIVEN; GROWTH; ADAPTATION	Understanding the variation in stomatal characteristics in relation to climatic gradients can reveal the adaptation strategies of plants, and help us to predict their responses to future climate changes. In this study, we investigated stomatal density (SD) and stomatal length (SL) in 150 plant species along an elevation gradient (540-2357 m) in Changbai Mountain, China, and explored the patterns and drivers of stomatal characteristics across species and plant functional types (PFTs: trees, shrubs, and herbs). The average values of SD and SL for all species combined were 156 mm(-2) and 35 mu m, respectively. SD was higher in trees (224 mm(-2)) than in shrubs (156 mm(-2)) or herbs (124 mm(-2)), and SL was largest in herbs (37 mu m). SD was negatively correlated with SL in all species and PFTs (P<0.01). The relationship between stomatal characteristics and elevation differed among PFTs. In trees, SD decreased and SL increased with elevation; in shrubs and herbs, SD initially increased and then decreased. Elevation-related differences in SL were not significant. PFT explained 7.20-17.6% of the total variation in SD and SL; the contributions of CO2 partial pressure (P-CO2), precipitation, and soil water content (SWC) were weak (0.02-2.28%). Our findings suggest that elevation-related patterns of stomatal characteristics in leaves are primarily a function of PFT, and highlight the importance of differences among PFTs in modeling gas exchange in terrestrial ecosystems under global climate change.	[Wang, Ruili; Yu, Guirui; He, Nianpeng; Wang, Qiufeng; Zhao, Ning; Xu, Zhiwei] Chinese Acad Sci, Synth Res Ctr Chinese Ecosystem Res Network, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Wang, Ruili; Zhao, Ning; Xu, Zhiwei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xia, Fucai] Beihua Univ, Coll Forestry, Jilin, Peoples R China; [Ge, Jianping] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beihua University; Beijing Normal University	Yu, GR (corresponding author), Chinese Acad Sci, Synth Res Ctr Chinese Ecosystem Res Network, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	yugr@igsnrr.ac.cn; henp@igsnrr.ac.cn	wang, qiufeng/C-1654-2013; 于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	Major Program of the National Natural Science Foundation of China [31290221]; Environmental Public Welfare Scientific Research Project [201209028]; Chinese Academy of Sciences Strategic Priority Research Program [XDA05050702]; Program for "Kezhen'' Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Public Welfare Scientific Research Project; Chinese Academy of Sciences Strategic Priority Research Program; Program for "Kezhen'' Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS	This work was partially supported by the Major Program of the National Natural Science Foundation of China (No. 31290221), the Environmental Public Welfare Scientific Research Project (201209028), the Chinese Academy of Sciences Strategic Priority Research Program (XDA05050702), and the Program for "Kezhen'' Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Beaulieu JM, 2008, NEW PHYTOL, V179, P975, DOI 10.1111/j.1469-8137.2008.02528.x; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Haworth M, 2011, OECOLOGIA, V167, P11, DOI 10.1007/s00442-011-1969-1; Haworth M, 2010, ANN BOT-LONDON, V105, P411, DOI 10.1093/aob/mcp309; He HS, 2005, J BIOGEOGR, V32, P2043, DOI 10.1111/j.1365-2699.2005.01353.x; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Holland N., 2009, Journal of Sustainable Forestry, V28, P63, DOI 10.1080/10549810802626142; Hovenden MJ, 2000, AUST J PLANT PHYSIOL, V27, P451, DOI 10.1071/PP99164; JAMES JC, 1994, J ECOL, V82, P297, DOI 10.2307/2261297; KELLY CK, 1995, FUNCT ECOL, V9, P422, DOI 10.2307/2390005; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; KORNER C, 1986, OECOLOGIA, V69, P577, DOI 10.1007/BF00410366; Korner C, 1999, ALPINE PLANT LIFE; Korner C, 2003, FUNCTIONAL PLANT ECO; Kouwenberg LLR, 2007, REV MINERAL GEOCHEM, V66, P215, DOI 10.2138/rmg.2007.66.9; Lammertsma EI, 2011, P NATL ACAD SCI USA, V108, P4035, DOI 10.1073/pnas.1100371108; Li CY, 2004, TREES-STRUCT FUNCT, V18, P277, DOI 10.1007/s00468-003-0304-9; Luo JX, 2006, FOREST ECOL MANAG, V221, P285, DOI 10.1016/j.foreco.2005.10.004; Miller-Rushing AJ, 2009, AM J BOT, V96, P1779, DOI 10.3732/ajb.0800410; Mott KA, 2009, PLANT CELL ENVIRON, V32, P1479, DOI 10.1111/j.1365-3040.2009.02022.x; Pato J, 2012, ECOSCIENCE, V19, P59, DOI 10.2980/19-1-3407; Premoli AC, 2007, AUST J BOT, V55, P585, DOI 10.1071/BT06026; Qiang WY, 2003, TREES-STRUCT FUNCT, V17, P258, DOI 10.1007/s00468-002-0235-x; R Development Core Team, 2012, R LANG ENV STAT COMP; Read QD, 2014, FUNCT ECOL, V28, P37, DOI 10.1111/1365-2435.12162; Reich PB, 2007, ECOL APPL, V17, P1982, DOI 10.1890/06-1803.1; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Santrucek J, 2014, ANN BOT-LONDON, V114, P191, DOI 10.1093/aob/mcu095; Schoettle AW, 2000, AM J BOT, V87, P1797, DOI 10.2307/2656832; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Taylor SH, 2012, NEW PHYTOL, V193, P387, DOI 10.1111/j.1469-8137.2011.03935.x; TERASHIMA I, 1995, ECOLOGY, V76, P2663, DOI 10.2307/2265838; Wang RZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026209; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WOODWARD FI, 1986, OECOLOGIA, V70, P580, DOI 10.1007/BF00379908; WOODWARD FI, 1988, J EXP BOT, V39, P1771, DOI 10.1093/jxb/39.12.1771; [徐文铎 Xu Wenduo], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P162; Yang XX, 2014, BASIC APPL ECOL, V15, P122, DOI 10.1016/j.baae.2014.01.003; Zhang SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040080; Zhao N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095196; Zhou YM, 2012, TREES-STRUCT FUNCT, V26, P1389, DOI 10.1007/s00468-012-0713-8	49	33	38	5	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115395	10.1371/journal.pone.0115395	http://dx.doi.org/10.1371/journal.pone.0115395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517967	Green Submitted, gold, Green Published			2022-12-27	WOS:000347215600061
J	Bhutra, S; Lenkala, D; LaCroix, B; Ye, M; Huang, RS				Bhutra, Steven; Lenkala, Divya; LaCroix, Bonnie; Ye, Meng; Huang, R. Stephanie			Identifying and Validating a Combined mRNA and MicroRNA Signature in Response to Imatinib Treatment in a Chronic Myeloid Leukemia Cell Line	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE; CHROMATIN IMMUNOPRECIPITATION; CANCER CELLS; EXPRESSION; GENE; INHIBITOR; METHYLATION; SUPPRESSION; RESISTANCE	Imatinib, a targeted tyrosine kinase inhibitor, is the gold standard for managing chronic myeloid leukemia (CML). Despite its wide application, imatinib resistance occurs in 20-30% of individuals with CML. Multiple potential biomarkers have been identified to predict imatinib response; however, the majority of them remain externally uncorroborated. In this study, we set out to systematically identify gene/microRNA (miRNA) whose expression changes are related to imatinib response. Through a Gene Expression Omnibus search, we identified two genome-wide expression datasets that contain expression changes in response to imatinib treatment in a CML cell line (K562): one for mRNA and the other for miRNA. Significantly differentially expressed transcripts/miRNAs post imatinib treatment were identified from both datasets. Three additional filtering criteria were applied 1) miRbase/miRanda predictive algorithm; 2) opposite direction of imatinib effect for genes and miRNAs; and 3) literature support. These criteria narrowed our candidate gene-miRNA to a single pair: IL8 and miR-493-5p. Using PCR we confirmed the significant up-regulation and down-regulation of miR-493-5p and IL8 by imatinib treatment, respectively in K562 cells. In addition, IL8 expression was significantly down-regulated in K562 cells 24 hours after miR-493-5p mimic transfection (p=0.002). Furthermore, we demonstrated significant cellular growth inhibition after IL8 inhibition through either gene silencing or by over-expression of miR-493-5p (p=0.0005 and p=0.001 respectively). The IL8 inhibition also further sensitized K562 cells to imatinib cytotoxicity (p<0.0001). Our study combined expression changes in transcriptome and miRNA after imatinib exposure to identify a potential gene-miRNA pair that is a critical target in imatinib response. Experimental validation supports the relationships between IL8 and miR-493-5p and between this gene-miRNA pair and imatinib sensitivity in a CML cell line. Our data suggests integrative analysis of multiple omic level data may provide new insight into biomarker discovery as well as mechanisms of imatinib resistance.	[Bhutra, Steven] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Lenkala, Divya; LaCroix, Bonnie; Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ye, Meng; Huang, R. Stephanie] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China	University of Chicago; University of Chicago; Ningbo University	Huang, RS (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu		Huang, R. Stephanie/0000-0002-9862-0368; LaCroix, Bonnie/0000-0002-6833-5267	NHLBI [5R25HL096383-05]; NIH/NIGMS grant [UO1GM61393, K08GM089941]; Natural Science Foundation of Ningbo City, China [2014A610235]; NIH/NCI grant [R21 CA139278]; University of Chicago Cancer Center Support Grant [P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; National Center for Advancing Translational Sciences of the NIH [UL1RR024999]; NATIONAL CANCER INSTITUTE [R21CA139278, P30CA014599, P50CA125183] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL096383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM089941, U01GM061393] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIGMS grant; Natural Science Foundation of Ningbo City, China; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Center Support Grant; Breast Cancer SPORE Career Development Award; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the NHLBI 5R25HL096383-05, NIH/NIGMS grant UO1GM61393 and by Natural Science Foundation of Ningbo City (2014A610235), China. RSH also received support from NIH/NIGMS grant K08GM089941, NIH/NCI grant R21 CA139278, University of Chicago Cancer Center Support Grant (#P30 CA14599), Breast Cancer SPORE Career Development Award [CA125183] and the National Center for Advancing Translational Sciences of the NIH [UL1RR024999]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN NC, 1995, LANCET, V345, P1392, DOI 10.1016/S0140-6736(95)92596-1; AUER H, 2004, GEODATASETS BIOPROJE; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bournia VK, 2013, SEMIN ARTHRITIS RHEU, V42, P377, DOI 10.1016/j.semarthrit.2012.06.001; Chen Wei-wei, 2012, Zhonghua Yi Xue Za Zhi, V92, P1405; Ciarcia R, 2012, J CELL PHYSIOL, V227, P2798, DOI 10.1002/jcp.23029; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dickens D, 2013, PHARMACOGENET GENOM, V23, P314, DOI 10.1097/FPC.0b013e328360d10c; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Esposito N, 2011, BLOOD, V118, P3634, DOI 10.1182/blood-2011-03-341073; Frame D, 2007, AM J HEALTH-SYST PH, V64, pS16, DOI 10.2146/ajhp070483; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gromicho M, 2013, ONCOL REP, V29, P741, DOI 10.3892/or.2012.2153; Hayashi Y, 2013, LEUKEMIA, V27, P619, DOI 10.1038/leu.2012.258; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Jalkanen SE, 2012, EXP HEMATOL, V40, P705, DOI 10.1016/j.exphem.2012.05.010; John B, 2004, PLOS BIOL, V2, pe363, DOI [10.1371/journal.pbio.0020363, DOI 10.1371/J0URNAL.PBI0.0020363]; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Koon HB, 2014, J CLIN ONCOL, V32, P402, DOI 10.1200/JCO.2012.48.6365; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Li ZY, 2013, CHINESE J CANCER RES, V25, P600, DOI 10.3978/j.issn.1000-9604.2013.10.14; Liu YC, 2014, MOL CARCINOGEN, V53, P951, DOI 10.1002/mc.22061; Liu YH, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-14; Liuzzi JP, 2013, BIOL TRACE ELEM RES, V156, P350, DOI 10.1007/s12011-013-9816-3; Lucas CM, 2011, BLOOD, V117, P6660, DOI 10.1182/blood-2010-08-304477; Mauro M J, 2001, Curr Oncol Rep, V3, P223, DOI 10.1007/s11912-001-0054-z; Nardinelli L, 2012, ACTA HAEMATOL-BASEL, V127, P228, DOI 10.1159/000336610; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Ouerhani S, 2012, CANCER GENET-NY, V205, P436, DOI 10.1016/j.cancergen.2012.05.008; Pollack A., 2013, THE NEW YORK TIMES; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rokah OH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035501; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sakai H, 2014, CANCER SCI, V105, P425, DOI 10.1111/cas.12380; Shibata M, 2011, LEUKEMIA RES, V35, P1205, DOI 10.1016/j.leukres.2011.01.012; Stella S, 2013, MOL CANCER THER, V12, P1085, DOI 10.1158/1535-7163.MCT-12-0550; Sunil Y, 2010, INT J COLORECTAL DIS, V25, P323, DOI 10.1007/s00384-009-0847-3; Tobin LA, 2013, ONCOGENE, V32, P1784, DOI 10.1038/onc.2012.203; Turrini E, 2012, PHARMACOGENET GENOM, V22, P198, DOI 10.1097/FPC.0b013e328350012b; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; von Bubnoff N, 2010, DTSCH ARZTEBL INT, V107, P114, DOI 10.3238/arztebl.2010.0114; Wang LH, 2012, EXP HEMATOL, V40, P811, DOI 10.1016/j.exphem.2012.05.013; Wilkinson K, 2003, BLOOD, V102, P4187, DOI 10.1182/blood-2003-04-1150; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Yang H, 2012, INT J HEMATOL, V96, P65, DOI 10.1007/s12185-012-1106-x; Zhang J, 2012, INT J LAB HEMATOL, V34, P267, DOI 10.1111/j.1751-553X.2011.01389.x; Zhang WW, 2010, MICROBIOL-SGM, V156, P287, DOI 10.1099/mic.0.034793-0	50	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115003	10.1371/journal.pone.0115003	http://dx.doi.org/10.1371/journal.pone.0115003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506832	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100041
J	De Coninck, Z; Feyissa, IA; Ekstrom, AM; Marrone, G				De Coninck, Zaake; Feyissa, Ibrahim A.; Ekstrom, Anna Mia; Marrone, Gaetano			Improved HIV Awareness and Perceived Empowerment to Negotiate Safe Sex among Married Women in Ethiopia between 2005 and 2011	PLOS ONE			English	Article							COHABITING COUPLES; CONDOM USE; RISK	Introduction: The HIV prevalence rate in Ethiopia for married (or cohabiting) women is 3 times that found amongst women who have never been married. While marriage used to be seen as a protective factor against HIV, evidence suggests that this is no longer necessarily the case. This study analyses the trend and socio-demographic determinants of HIV awareness and safe sex negotiation among married women in Ethiopia between 2005 and 2011. Methods: Data from Ethiopian Demographic and Health Surveys conducted in 2005 and in 2011 were analysed. Socio-demographic variables as well as 'survey year' were selected to assess their interaction with selected HIV awareness and safe sex negotiation indicators. Multivariable regression analyses were performed. Odds ratios and confidence intervals were computed. Results: A significant increase in knowledge of HIV and ability to negotiate safer sex occurred between 2005 and 2011 reflecting a positive trend in gender empowerment amongst married Ethiopian women. Some of these advancements were striking, for instance respondents were 3.6 times more likely to have "Heard of AIDS'' in 2011 than in 2005. HIV awareness and safer sex negotiation were significantly associated with higher education, higher socioeconomic status, those who had heard of HIV, those of the Orthodox Christian faith, and (to some extent) those living in rural areas. Conclusion: HIV awareness has increased significantly in Ethiopia over the last decade but married women are still disproportionately susceptible to HIV. Community programmes, already effective in Ethiopia, also need to target this vulnerable sub-group of women.	[De Coninck, Zaake; Ekstrom, Anna Mia; Marrone, Gaetano] Karolinska Inst, Dept Publ Hlth Sci Global Hlth IHCAR, Stockholm, Sweden; [Feyissa, Ibrahim A.] WHO, Immunizat Unit, Expanded Program, Nairobi, Kenya; [Ekstrom, Anna Mia; Marrone, Gaetano] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; World Health Organization; Karolinska Institutet; Karolinska University Hospital	De Coninck, Z (corresponding author), Karolinska Inst, Dept Publ Hlth Sci Global Hlth IHCAR, Stockholm, Sweden.	zaake.deconinck@gmail.com		Marrone, Gaetano/0000-0002-2991-1663	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2012, UG DEM HLTH SURV 201; [Anonymous], 2013, 2012 TANZ POP HOUS C; Callegari L, 2008, SEX TRANSM DIS, V35, P624, DOI 10.1097/OLQ.0b013e31816b3208; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Erulkar AS, 2008, IMPROVING REPROD HLT; Federal Democratic Republic of Ethiopia, 1998, POL ON HIV AIDS; Federal HIV/AIDS Prevention and Control Office, 2010, ANN PERF REP MULT HI; Federal HIV/AIDS Prevention and Control Office, 2014, STRAT PLAN INT MULT; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; (ISTEEBU) IdSedEEdB (MSPLS) MdlSPedlLclSB International I, 2012, ENQ DEM SANT 2010; Jacubowski N, 2008, CULT HEALTH SEX, V10, P87, DOI 10.1080/13691050601058573; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Ministry of Health, 2004, ETH STRAT PLAN INT M; Mumtaz Z, 2004, CONDOM USE UGANDA ZI; Mundi Index, 2011, TOT FERT RAT CHILDR; National Institute of Statistics of Rwanda (NISR) MoHMR ICF International, 2012, RWAND DEM HLTH SURV; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Oljira L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17349; Rombo DO, 2009, THESIS U MINNESOTA; Shannon K, 2008, SOC SCI MED, V66, P911, DOI 10.1016/j.socscimed.2007.11.008; Teferra D., 2003, AFRICAN HIGHER ED IN; Tenkorang EY, 2012, ARCH SEX BEHAV, V41, P1353, DOI 10.1007/s10508-012-9960-4; UNAIDS, 2012, COUNTR PROGR REP HIV; Ung M, 2013, J BIOSOC SCI, V21, P1; Varam DS, 2010, J WOMENS HEALTH, V19, P815; World Bank, 2012, ETH COUNTR METADATA	30	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115453	10.1371/journal.pone.0115453	http://dx.doi.org/10.1371/journal.pone.0115453			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506823	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100077
J	Lopez-Emparan, A; Quezada-Martinez, D; Zuniga-Bustos, M; Cifuentes, V; Iniguez-Luy, F; Federico, ML				Lopez-Emparan, Ada; Quezada-Martinez, Daniela; Zuniga-Bustos, Matias; Cifuentes, Victor; Iniguez-Luy, Federico; Laura Federico, Maria			Functional Analysis of the Brassica napus L. Phytoene Synthase (PSY) Gene Family	PLOS ONE			English	Article							CAROTENOID BIOSYNTHESIS; MACULAR PIGMENT; BETA-CAROTENE; ABSCISIC-ACID; KEY ENZYME; ARABIDOPSIS; GENOME; EXPRESSION; PATHWAY; EVOLUTION	Phytoene synthase (PSY) has been shown to catalyze the first committed and rate-limiting step of carotenogenesis in several crop species, including Brassica napus L. Due to its pivotal role, PSY has been a prime target for breeding and metabolic engineering the carotenoid content of seeds, tubers, fruits and flowers. In Arabidopsis thaliana, PSY is encoded by a single copy gene but small PSY gene families have been described in monocot and dicotyledonous species. We have recently shown that PSY genes have been retained in a triplicated state in the A- and C-Brassica genomes, with each paralogue mapping to syntenic locations in each of the three "Arabidopsis-like'' subgenomes. Most importantly, we have shown that in B. napus all six members are expressed, exhibiting overlapping redundancy and signs of subfunctionalization among photosynthetic and non photosynthetic tissues. The question of whether this large PSY family actually encodes six functional enzymes remained to be answered. Therefore, the objectives of this study were to: (i) isolate, characterize and compare the complete protein coding sequences (CDS) of the six B. napus PSY genes; (ii) model their predicted tridimensional enzyme structures; (iii) test their phytoene synthase activity in a heterologous complementation system and (iv) evaluate their individual expression patterns during seed development. This study further confirmed that the six B. napus PSY genes encode proteins with high sequence identity, which have evolved under functional constraint. Structural modeling demonstrated that they share similar tridimensional protein structures with a putative PSY active site. Significantly, all six B. napus PSY enzymes were found to be functional. Taking into account the specific patterns of expression exhibited by these PSY genes during seed development and recent knowledge of PSY suborganellar localization, the selection of transgene candidates for metabolic engineering the carotenoid content of oilseeds is discussed.	[Lopez-Emparan, Ada; Quezada-Martinez, Daniela; Iniguez-Luy, Federico; Laura Federico, Maria] CGNA, Agriaquaculture Nutr Genom Ctr, Genom & Bioinformat Unit, Temuco, La Araucania, Chile; [Lopez-Emparan, Ada; Zuniga-Bustos, Matias] Univ Talca, Inst Biol Vegetal & Biotecnol, Talca, Maule, Chile; [Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ecol, Santiago, Region Metropol, Chile	Universidad de Talca; Universidad de Chile	Federico, ML (corresponding author), CGNA, Agriaquaculture Nutr Genom Ctr, Genom & Bioinformat Unit, Temuco, La Araucania, Chile.	maria.federico@cgna.cl		Quezada-Martinez, Daniela/0000-0003-0470-9925; Zuniga-Bustos, Matias/0000-0003-2448-9376	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1090726]; Proyecto Fortalecimiento [R13F1001]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Araucania Regional Government [/CGNA/R10C1001]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Fortalecimiento; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Araucania Regional Government	This research was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1090726), Proyecto Fortalecimiento R13F1001, Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Regional Program and the Araucania Regional Government /CGNA/R10C1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2010, PLANTA, V232, P1251, DOI 10.1007/s00425-010-1250-6; BARTLEY GE, 1992, J BIOL CHEM, V267, P5036; BARTLEY GE, 1993, J BIOL CHEM, V268, P25718; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bollag W, 1996, FASEB J, V10, P938, DOI 10.1096/fasebj.10.9.8801175; Busch M, 2002, PLANT PHYSIOL, V128, P439, DOI [10.1104/pp.128.2.439, 10.1104/pp.010573]; Cardenas PD, 2012, THEOR APPL GENET, V124, P1215, DOI 10.1007/s00122-011-1781-7; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Dong JZ, 2004, PLANTA, V218, P483, DOI 10.1007/s00425-003-1124-2; Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Farre G, 2011, TRENDS PLANT SCI, V16, P532, DOI 10.1016/j.tplants.2011.08.001; Federico ML, 2005, PLANT MOL BIOL, V57, P35, DOI 10.1007/s11103-004-6769-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gady ALF, 2012, MOL BREEDING, V29, P801, DOI 10.1007/s11032-011-9591-9; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; Gallagher CE, 2003, APPL MICROBIOL BIOT, V60, P713, DOI 10.1007/s00253-002-1182-6; Hammond BR, 1997, OPTOMETRY VISION SCI, V74, P499, DOI 10.1097/00006324-199707000-00017; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Huh JH, 2001, THEOR APPL GENET, V102, P524, DOI 10.1007/s001220051677; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kidwell Kimberlee K., 1992, P1; Landrum JT, 1997, EXP EYE RES, V65, P57, DOI 10.1006/exer.1997.0309; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu S, 2014, NAT PROD COMMUN, V9, P7, DOI 10.1038/ncomms4930; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Maass D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006373; Maluf MP, 1997, J EXP BOT, V48, P1259, DOI 10.1093/jxb/48.6.1259; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Niu Y, 2009, MOL PLANT, V2, P1107, DOI 10.1093/mp/ssp042; O'Hara P, 2002, PLANT PHYSIOL, V129, P310, DOI 10.1104/pp.010956; O'Neill CM, 2000, PLANT J, V23, P233, DOI 10.1046/j.1365-313x.2000.00781.x; Ortiz-Monasterio JI, 2007, J CEREAL SCI, V46, P293, DOI 10.1016/j.jcs.2007.06.005; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Park JY, 2005, MOL GENET GENOMICS, V274, P579, DOI 10.1007/s00438-005-0041-4; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rana D, 2004, PLANT J, V40, P725, DOI 10.1111/j.1365-313X.2004.02244.x; Rodriguez-Villalon A, 2009, PLANT J, V60, P424, DOI 10.1111/j.1365-313X.2009.03966.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saez PL, 2013, PLANT SCI, V201, P12, DOI 10.1016/j.plantsci.2012.11.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Shumskaya M, 2013, PLANT SCI, V208, P58, DOI 10.1016/j.plantsci.2013.03.012; Shumskaya M, 2012, PLANT CELL, V24, P3725, DOI 10.1105/tpc.112.104174; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; U. N., 1935, Japanese Journal of Botany, V7, P389; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2003, PLANTA, V216, P523, DOI 10.1007/s00425-002-0885-3; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Welsch R, 2010, PLANT CELL, V22, P3348, DOI 10.1105/tpc.110.077560; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wurtzel ET, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00029; Yan JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095088; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	74	23	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114878	10.1371/journal.pone.0114878	http://dx.doi.org/10.1371/journal.pone.0114878			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506829	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100029
J	Pereira, RV; Siler, JD; Bicalho, RC; Warnick, LD				Pereira, Richard Van Vleck; Siler, Julie D.; Bicalho, Rodrigo Carvalho; Warnick, Lorin D.			In Vivo Selection of Resistant E. coli after Ingestion of Milk with Added Drug Residues	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; LONG-TERM IMPACTS; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; MOLECULAR CHARACTERIZATION; TETRACYCLINE ANTIBIOTICS; SALMONELLA-ENTERICA; CLASS-1 INTEGRONS; STABILITY; GENES	Antimicrobial resistance represents a major global threat to modern medicine. In vitro studies have shown that very low concentrations of drugs, as frequently identified in the environment, and in foods and water for human and animal consumption, can select for resistant bacteria. However, limited information is currently available on the in vivo impact of ingested drug residues. The objective of our study was to evaluate the effect of feeding preweaned calves milk containing antimicrobial drug residues (below the minimum inhibitory concentration), similar to concentrations detected in milk commonly fed to dairy calves, on selection of resistant fecal E. coli in calves from birth to weaning. At birth, thirty calves were randomly assigned to a controlled feeding trial where: 15 calves were fed raw milk with no drug residues (NR), and 15 calves were fed raw milk with drug residues (DR) by adding ceftiofur, penicillin, ampicillin, and oxytetracycline at final concentrations in the milk of 0.1, 0.005, 0.01, and 0.3 mu g/ml, respectively. Fecal samples were rectally collected from each calf once a week starting at birth prior to the first feeding in the trial (pre-treatment) until 6 weeks of age. A significantly greater proportion of E. coli resistant to ampicillin, cefoxitin, ceftiofur, streptomycin and tetracycline was observed in DR calves when compared to NR calves. Additionally, isolates from DR calves had a significant decrease in susceptibility to ceftriaxone and ceftiofur when compared to isolates from NR calves. A greater proportion of E. coli isolates from calves in the DR group were resistant to 3 or more antimicrobial drugs when compared to calves in the ND group. These findings highlight the role that low concentrations of antimicrobial drugs have on the evolution and selection of resistance to multiple antimicrobial drugs in vivo.	[Pereira, Richard Van Vleck; Siler, Julie D.; Bicalho, Rodrigo Carvalho; Warnick, Lorin D.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Pereira, RV (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rvp25@cornell.edu	Pereira, Richard/L-2684-2019	Pereira, Richard/0000-0003-2028-8761	Office of the Director, National Institutes of Health of the National Institutions of Health [T32ODO011000]; United States Department of Agriculture (USDA) [NYC-478400]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011000] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health of the National Institutions of Health; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the Office of the Director, National Institutes of Health of the National Institutions of Health under Award Number T32ODO011000. Research reported here was also supported the United States Department of Agriculture (USDA), under Hatch award number NYC-478400. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health, the National Institute of Food and Agriculture (NIFA), or the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseev VG, 2006, RUSS J GEN CHEM+, V76, P317, DOI 10.1134/S1070363206020265; AMABILECUEVAS CF, 1991, NUCLEIC ACIDS RES, V19, P4479, DOI 10.1093/nar/19.16.4479; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; ARIZA RR, 1995, J BACTERIOL, V177, P1655, DOI 10.1128/jb.177.7.1655-1661.1995; Arkin RL, 2005, FDA NEWSLETTER CVM R; BARR V, 1986, J ANTIMICROB CHEMOTH, V17, P409, DOI 10.1093/jac/17.4.409; Batchelor Miranda, 2005, Expert Rev Anti Infect Ther, V3, P403, DOI 10.1586/14787210.3.3.403; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Berendsen BJA, 2011, FOOD ADDIT CONTAM A, V28, P1657, DOI 10.1080/19440049.2011.604045; Berge AC, 2010, JAVMA-J AM VET MED A, V236, P1338, DOI 10.2460/javma.236.12.1338; Braoudaki M, 2004, J CLIN MICROBIOL, V42, P73, DOI 10.1128/JCM.42.1.73-78.2004; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Cha E, 2011, J DAIRY SCI, V94, P4476, DOI 10.3168/jds.2010-4123; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; CLSI, 2012, M100D22 CLIN LAB STA; CLSI, 2008, PERFORMANCE STANDARD; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Couce A, 2009, FEMS MICROBIOL REV, V33, P531, DOI 10.1111/j.1574-6976.2009.00165.x; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Daniels JB, 2009, APPL ENVIRON MICROB, V75, P3648, DOI 10.1128/AEM.02435-08; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Du XD, 2005, FEMS MICROBIOL LETT, V245, P295, DOI 10.1016/j.femsle.2005.03.021; Elizondo-Salazar JA, 2010, J DAIRY SCI, V93, P5509, DOI 10.3168/jds.2010-3460; Flanders SA, 2014, JAMA INTERN MED, V174, P661, DOI 10.1001/jamainternmed.2014.897; Galimand A, 2005, ANTIMICROB AGENTS CH, V49, P2949, DOI 10.1128/AAC.49.7.2949-2953.2005; GEORGE AM, 1983, J BACTERIOL, V155, P531, DOI 10.1128/JB.155.2.531-540.1983; Gillings M, 2008, J BACTERIOL, V190, P5095, DOI 10.1128/JB.00152-08; Godden SM, 2005, JAVMA-J AM VET MED A, V226, P1547, DOI 10.2460/javma.2005.226.1547; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Hernando MD, 2006, TALANTA, V69, P334, DOI 10.1016/j.talanta.2005.09.037; Hoelzer K, 2011, FOODBORNE PATHOG DIS, V8, P1281, DOI 10.1089/fpd.2011.0933; Huttner A, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-31; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Karageorgou EG, 2010, J SEP SCI, V33, P2862, DOI 10.1002/jssc.201000385; Karageorgou EG, 2010, J SEP SCI, V33, P17; Khachatryan AR, 2004, APPL ENVIRON MICROB, V70, P752, DOI 10.1128/AEM.70.2.752-757.2004; Kim S, 2014, SCI TOTAL ENVIRON, V468, P813, DOI 10.1016/j.scitotenv.2013.08.100; Kitazono Y, 2012, J HAZARD MATER, V243, P112, DOI 10.1016/j.jhazmat.2012.10.009; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Li XL, 2011, J AGR FOOD CHEM, V59, P10176, DOI 10.1021/jf202325c; Lindgren M, 2009, SCAND J INFECT DIS, V41, P215, DOI 10.1080/00365540802651897; Lopez E, 2007, MOL MICROBIOL, V64, P83, DOI 10.1111/j.1365-2958.2007.05642.x; Lopez E, 2009, ANTIMICROB AGENTS CH, V53, P3411, DOI 10.1128/AAC.00358-09; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MA D, 1993, J BACTERIOL, V175, P6299, DOI 10.1128/JB.175.19.6299-6313.1993; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Maneewannakul K, 1996, ANTIMICROB AGENTS CH, V40, P1695, DOI 10.1128/AAC.40.7.1695; Maron DF, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-48; Michnik A, 2004, INT J PHARM, V273, P149, DOI 10.1016/j.ijpharm.2004.01.002; Navarro PG, 2003, INT J BIOL MACROMOL, V33, P159, DOI 10.1016/S0141-8130(03)00081-3; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Pereira R. V., 2014, J DAIRY SCI; Pereira RVV, 2011, J DAIRY SCI, V94, P4556, DOI 10.3168/jds.2011-4337; Perlin MH, 2009, P ROY SOC B-BIOL SCI, V276, P3759, DOI 10.1098/rspb.2009.0997; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Riediker S, 2004, J CHROMATOGR A, V1054, P359, DOI [10.1016/j.chroma.2004.07.085, 10.1016/S0021-9673(04)01289-0]; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Roca M, 2011, J DAIRY SCI, V94, P1155, DOI 10.3168/jds.2010-3599; Sandegren L, 2014, UPSALA J MED SCI, V119, P103, DOI 10.3109/03009734.2014.904457; Schenck FJ, 2000, FOOD ADDIT CONTAM, V17, P675, DOI 10.1080/02652030050083196; Schriks M, 2010, WATER RES, V44, P461, DOI 10.1016/j.watres.2009.08.023; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; Silley P, 2012, REV SCI TECH OIE, V31, P33; Thuy DT, 2011, J ANTIMICROB CHEMOTH, V66, P531, DOI 10.1093/jac/dkq496; USDA, 2008, REF DAIR CATTL HLT 1; Wardwell Leslie H, 2011, Curr Infect Dis Rep, V13, P28, DOI 10.1007/s11908-010-0147-7; World Health Organization, 2014, ANT RES GLOB REP SUR; Wu KH, 2012, INT J ANTIMICROB AG, V40, P264, DOI 10.1016/j.ijantimicag.2012.05.017; Zwald AG, 2004, J DAIRY SCI, V87, P191, DOI 10.3168/jds.S0022-0302(04)73158-6	76	32	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115223	10.1371/journal.pone.0115223	http://dx.doi.org/10.1371/journal.pone.0115223			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506918	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100062
J	Tisato, V; Garrovo, C; Biffi, S; Petrera, F; Voltan, R; Casciano, F; Meroni, G; Agnoletto, C; Zauli, G; Secchiero, P				Tisato, Veronica; Garrovo, Chiara; Biffi, Stefania; Petrera, Francesca; Voltan, Rebecca; Casciano, Fabio; Meroni, Germana; Agnoletto, Chiara; Zauli, Giorgio; Secchiero, Paola			Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model	PLOS ONE			English	Article							SEGMENTAL ANTIGEN CHALLENGE; LATE ASTHMATIC RESPONSE; BONE-MARROW; T-CELLS; APOPTOSIS; LIGAND; EXPRESSION; NEUTROPHILS; MICE; ACTIVATION	Ovalbumin (OVA)-sensitized BALB/c mice were i.n. instilled with recombinant TNF-related apoptosis inducing ligand (TRAIL) 24 hours before OVA challenge. The total number of leukocytes and the levels of the chemokine CXCL-1/KC significantly increased in the bronchoalveolar lavage (BAL) fluids of allergic animals with respect to control littermates, but not in the BAL of mice i.n. pretreated with recombinant TRAIL before OVA challenge. In particular, TRAIL pretreatment significantly reduced the BAL percentage of both eosinophils and neutrophils. On the other hand, when TRAIL was administrated simultaneously to OVA challenge its effect on BAL infiltration was attenuated. Overall, the results show that the i.n. pretreatment with TRAIL down-modulated allergic airway inflammation.	[Tisato, Veronica; Voltan, Rebecca; Casciano, Fabio; Agnoletto, Chiara; Secchiero, Paola] Univ Ferrara, Dept Morphol Surg Expt Med, I-44100 Ferrara, Italy; [Tisato, Veronica; Voltan, Rebecca; Casciano, Fabio; Agnoletto, Chiara; Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Garrovo, Chiara; Biffi, Stefania; Zauli, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Petrera, Francesca; Meroni, Germana] CBM Scrl, Area Sci Pk, Trieste, Italy	University of Ferrara; University of Ferrara; IRCCS Burlo Garofolo	Secchiero, P (corresponding author), Univ Ferrara, Dept Morphol Surg Expt Med, I-44100 Ferrara, Italy.	paola.secchiero@unife.it	Biffi, Stefania/C-6652-2015; Tisato, Veronica/K-4525-2016; Casciano, Fabio FC/H-3219-2015; Zauli, Giorgio/ABE-8001-2020; Agnoletto, Chiara/J-8575-2017; secchiero, paola/G-9689-2015	Biffi, Stefania/0000-0003-2257-2053; Casciano, Fabio FC/0000-0002-6431-3335; Agnoletto, Chiara/0000-0002-1363-5852; secchiero, paola/0000-0003-4101-7987; Zauli, Giorgio/0000-0002-3750-8698; Garrovo, Chiara/0000-0003-1432-0147; Petrera, Francesca/0000-0003-2075-5219; Tisato, Veronica/0000-0001-8448-066X	Italian Ministry of Health [GR-2010-2310832]	Italian Ministry of Health(Ministry of Health, Italy)	This study was supported by a grant from Italian Ministry of Health (GR-2010-2310832) to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2011, BLOOD, V118, P4231, DOI 10.1182/blood-2011-01-333617; Biffi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057150; Cao J, 2011, CYTOKINE, V56, P823, DOI 10.1016/j.cyto.2011.09.016; Collison A, 2014, AM J RESP CELL MOL, V51, P86, DOI 10.1165/rcmb.2013-0490OC; Collison A, 2013, NAT MED, V19, P232, DOI 10.1038/nm.3049; Collison A, 2009, CLIN EXP PHARMACOL P, V36, P1049, DOI 10.1111/j.1440-1681.2009.05258.x; Condotta SA, 2013, CRIT REV IMMUNOL, V33, P23, DOI 10.1615/CritRevImmunol.2013006721; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Faustino L, 2014, MUCOSAL IMMUNOL; Liu LY, 2003, J ALLERGY CLIN IMMUN, V112, P556, DOI 10.1067/mai.2003.1700; Martinez FD, 2013, LANCET, V382, P1360, DOI 10.1016/S0140-6736(13)61536-6; Milani D, 2003, J NEUROCHEM, V86, P126, DOI 10.1046/j.1471-4159.2003.01805.x; Nabe T, 2005, EUR J PHARMACOL, V521, P144, DOI 10.1016/j.ejphar.2005.08.015; Nabe T, 2011, LIFE SCI, V88, P1127, DOI 10.1016/j.lfs.2011.04.003; Nagarkar DR, 2009, J IMMUNOL, V183, P6698, DOI 10.4049/jimmunol.0900298; Nair P, 2012, CLIN EXP ALLERGY, V42, P1097, DOI 10.1111/j.1365-2222.2012.04014.x; Qiu YS, 2007, THORAX, V62, P475, DOI 10.1136/thx.2006.066670; RE MC, 1993, AIDS, V7, P1049, DOI 10.1097/00002030-199308000-00004; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; Robertson NM, 2004, VITAM HORM, V67, P149; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Secchiero P, 2001, BLOOD, V98, P2220, DOI 10.1182/blood.V98.7.2220; Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2013, CLIN CANCER RES, V19, P1949, DOI 10.1158/1078-0432.CCR-12-3027; Secchiero P, 2009, BLOOD, V113, P4300, DOI 10.1182/blood-2008-11-187708; Secchiero P, 2008, STEM CELLS, V26, P2955, DOI 10.1634/stemcells.2008-0512; Stein LH, 2009, J INNATE IMMUN, V1, P618, DOI 10.1159/000233235; VARNER AE, 2000, ASTHMA RHINITIS, P1172; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Weckmann M, 2011, PEDIAT ALLERG IMM-UK, V22, P25, DOI 10.1111/j.1399-3038.2010.01027.x; Xu NJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/290565; Yalcin AD, 2012, MED SCI MONITOR, V18, pPI11, DOI 10.12659/MSM.882504; Zauli G, 2005, J CELL PHYSIOL, V202, P900, DOI 10.1002/jcp.20202; Zauli G, 2008, J CELL PHYSIOL, V214, P117, DOI 10.1002/jcp.21165; Zauli G, 2011, CLIN CANCER RES, V17, P762, DOI 10.1158/1078-0432.CCR-10-2572; Zauli G, 2010, DIABETES, V59, P1261, DOI 10.2337/db09-1771	40	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115387	10.1371/journal.pone.0115387	http://dx.doi.org/10.1371/journal.pone.0115387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506835	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100073
J	Wang, ZF; Chen, YP; Pan, JR				Wang, Zhifang; Chen, Yaping; Pan, Jinren			Trends of Acute Hepatitis B Notification Rates in Eastern China from 2005 to 2013	PLOS ONE			English	Article							VIRUS-INFECTIONS; VACCINATION; POPULATION; PREVALENCE	Zhejiang Province was a high endemicity for hepatitis B disease in the 1990' s. A number of measures implemented since then have begun to control and prevent hepatitis B. In 1992, hepatitis B vaccine came on the market. In 2002, hepatitis B vaccine was included in the national Expanded Programme on Immunization (EPI). Between 2007 and 2010, catch-up vaccination was implemented for children under 15. Since 2010, vaccination guidelines for high-risk groups have also been adopted. This study evaluated the impact of these control and prevention strategies on acute hepatitis B notification rates from 2005 through 2013. Data from the National Notifiable Disease Reporting System (NNDRS) revealed a steady downward trend in notification rates of acute hepatitis B. The most dramatic decline occurred among pre-adults, highlighting the benefits of EPI's policy of universal vaccination for children. However, the highest notification rates occurred among young adults of lower socio-economic status. These findings indicate the strong need to vaccinate young adults at risk for HBV infection as well as to collect risk-factor information in the NNDRS for monitoring and following up persons with acute hepatitis B.	[Wang, Zhifang; Chen, Yaping; Pan, Jinren] Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Wang, ZF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China.	zfwang@cdc.zj.cn		Pan, jinren/0000-0001-7062-0887	Medical Research Foundation of Zhejiang Province, China [2014KYB060]	Medical Research Foundation of Zhejiang Province, China	This study was supported by Medical Research Foundation of Zhejiang Province, China (Grant No. 2014KYB060). The funders had no role in study design, data collection and analysis, decision to publish, or prepare of the manuscript.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P441; [Anonymous], 2007, THESIS; Ay P, 2013, EURO SURVEILL, V18; Chan CY, 2004, J GASTROEN HEPATOL, V19, P121, DOI 10.1111/j.1440-1746.2004.03153.x; CHEN PW, 2013, PLOS COMPUT BIOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0056444; *CHIN CTR DIS CONT, 2011, NAT HEP B EP SURV RE; Cui FQ, 2013, VACCINE, V31, pJ29, DOI 10.1016/j.vaccine.2012.07.048; Hwang EW, 2011, N AM J MED SCI BOSTO, V4; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Luo ZB, 2011, EUR J GASTROEN HEPAT, V23, P695, DOI 10.1097/MEG.0b013e328347322b; McMahon BJ, 1998, HEPATOLOGY, V28, P265, DOI 10.1002/hep.510280135; *NAT CTR HIV AIDA, 2011, NAT CTR HIV AIDS VIR; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Yang SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047808; YAO J, 1997, DIS SURVEILLANCE, V12, P258; ZHANG GM, 2013, CHIN J VAC IMMUN, V19, P266	19	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114645	10.1371/journal.pone.0114645	http://dx.doi.org/10.1371/journal.pone.0114645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504088	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400042
J	Li, JW; Mo, M; Yu, KD; Chen, CM; Hu, Z; Hou, YF; Di, GH; Wu, J; Shen, ZZ; Shao, ZM; Liu, GY				Li, Jian-wei; Mo, Miao; Yu, Ke-da; Chen, Can-ming; Hu, Zhen; Hou, Yi-feng; Di, Gen-hong; Wu, Jiong; Shen, Zhen-zhou; Shao, Zhi-ming; Liu, Guang-yu			ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE REMISSION; OPEN-LABEL; PREOPERATIVE CHEMOTHERAPY; GUIDELINE RECOMMENDATIONS; ADJUVANT BREAST; SENTINEL; BIOPSY; TRIAL; MULTICENTER; PACLITAXEL	Purpose: The study was to estimate the likelihood of axillary downstaging and to identify the factors predicting a pathologically node negative status after neoadjuvant chemotherapy (NAC) with or without trastuzumab in HER2-positive breast cancer. Methods: Patients with HER2-positive, stage IIa-IIIc breast cancer were enrolled. Axillary status was evaluated by palpation and fine needle aspiration (FNA) before NAC. All patients received 4-6 cycles of PCrb (paclitaxel 80 mg/m(2) and carboplatin AUC=2 d1, 8, and 15 of a 28-day cycle, or paclitaxel 175 mg/m(2) and carboplatin AUC=6 every-3-week) and were non-randomly administered trastuzumab (2 mg/kg weekly or 6 mg/kg every-3-week) or not. After NAC, each patient underwent standard axillary lymph node dissection and breast-conserving surgery or mastectomy. And some patients received sentinel lymph node biopsy (SLNB) before axillary dissection. Results: Between November-2007 and June-2013, 255 patients were enrolled. Of them, 157 were confirmed as axillary node positive by FNA (group-A) and 98 as axillary node negative either by FNA or impalpable (group-B). After axillary dissection, the overall pathologically node negative rates (pNNR) were 52.9% in group-A and 69.4% in group-B. The ER-poor/HER2-positive subtype acquired the highest pNNR (79.6% in group-A and 87.9% in group-B, respectively) and the lowest rate of residual with >= 4 nodes involvement (1.9% and 3%, respectively) after PCrb plus trastuzumab. In multivariate analysis, trastuzumab added and ERpoor status were independent factors in predicting a higher pNNR in HER2-positive breast cancer. Forty-six tested patients showed that the ER-poor/HER2-positive subtype acquired a considerable high pNNR and axillary status with SLNB was well macthed with the axillary dissection. Conclusions: ER-poor/HER2-positive subtype of breast cancer is a potential candidate for undergoing sentinel lymph node biopsy instead of regional node dissection for accurate axillary evaluation after effective downstaging by neoadjuvant chemo-trastuzumab therapy.	[Li, Jian-wei; Yu, Ke-da; Chen, Can-ming; Hu, Zhen; Hou, Yi-feng; Di, Gen-hong; Wu, Jiong; Shen, Zhen-zhou; Shao, Zhi-ming; Liu, Guang-yu] Fudan Univ, Inst Canc, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China; [Li, Jian-wei; Mo, Miao; Yu, Ke-da; Chen, Can-ming; Hu, Zhen; Hou, Yi-feng; Di, Gen-hong; Wu, Jiong; Shen, Zhen-zhou; Shao, Zhi-ming; Liu, Guang-yu] Fudan Univ, Coll Med, Dept Oncol, Shanghai 200433, Peoples R China; [Mo, Miao] Fudan Univ, Ctr Canc, Clin Stat Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Liu, GY (corresponding author), Fudan Univ, Inst Canc, Shanghai Canc Ctr, Dept Breast Surg, Shanghai 200433, Peoples R China.	Liugy123@yahoo.com		Di, Genhong/0000-0003-1171-7907	Shanghai Committee of Science and Technology, China [12DZ2260100]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Key Clinical Program of the Ministry of Health	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); Shanghai United Developing Technology Project of Municipal Hospitals; Key Clinical Program of the Ministry of Health	This research is supported by the Shanghai Committee of Science and Technology, China (grant 12DZ2260100), and the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Key Clinical Program of the Ministry of Health (2010-2012). The research funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other potential confict of interest relevant to this article was reported.	Alvarado R, 2012, ANN SURG ONCOL, V19, P3177, DOI 10.1245/s10434-012-2484-2; Ashikaga T, 2010, J SURG ONCOL, V102, P111, DOI 10.1002/jso.21535; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Boughey JC, 2013, JAMA-J AM MED ASSOC, V310, P1455, DOI 10.1001/jama.2013.278932; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122, DOI 10.6004/jnccn.2009.0012; Chen XS, 2010, ANN ONCOL, V21, P961, DOI 10.1093/annonc/mdq041; Classe JM, 2009, J CLIN ONCOL, V27, P726, DOI 10.1200/JCO.2008.18.3228; Fitzal F, 2011, BREAST CANCER RES TR, V127, P121, DOI 10.1007/s10549-010-1164-9; Galimberti V, 2013, LANCET ONCOL, V14, P297, DOI 10.1016/S1470-2045(13)70035-4; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Kuehn T, 2000, BREAST CANCER RES TR, V64, P275, DOI 10.1023/A:1026564723698; Kuehn T, 2013, LANCET ONCOL, V14, P609, DOI 10.1016/S1470-2045(13)70166-9; Lee S, 2007, BREAST CANCER RES TR, V102, P283, DOI 10.1007/s10549-006-9330-9; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mieog JSD, 2007, BRIT J SURG, V94, P1189, DOI 10.1002/bjs.5894; Newman EA, 2007, ANN SURG ONCOL, V14, P2946, DOI 10.1245/s10434-007-9403-y; Phillips T, 2007, APPL IMMUNOHISTO M M, V15, P325, DOI 10.1097/01.pai.0000213135.16783.bc; Reese DM, 1997, STEM CELLS, V15, P1, DOI 10.1002/stem.150001; Regan MM, 2006, JNCI-J NATL CANCER I, V98, P1571, DOI 10.1093/jnci/djj415; Robidoux A, 2013, LANCET ONCOL, V14, P1183, DOI 10.1016/S1470-2045(13)70411-X; Rouzier R, 2002, J CLIN ONCOL, V20, P1304, DOI 10.1200/JCO.20.5.1304; Shen J, 2007, CANCER-AM CANCER SOC, V109, P1255, DOI 10.1002/cncr.22540; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Straver ME, 2010, J CLIN ONCOL, V28, P731, DOI 10.1200/JCO.2008.21.7554; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yu KD, 2013, ONCOLOGIST, V18, P511, DOI 10.1634/theoncologist.2012-0057	33	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114646	10.1371/journal.pone.0114646	http://dx.doi.org/10.1371/journal.pone.0114646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25504233	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700039
J	Sekizuka, T; Kai, M; Nakanaga, K; Nakata, N; Kazumi, Y; Maeda, S; Makino, M; Hoshino, Y; Kuroda, M				Sekizuka, Tsuyoshi; Kai, Masanori; Nakanaga, Kazue; Nakata, Noboru; Kazumi, Yuko; Maeda, Shinji; Makino, Masahiko; Hoshino, Yoshihiko; Kuroda, Makoto			Complete Genome Sequence and Comparative Genomic Analysis of Mycobacterium massiliense JCM 15300 in the Mycobacterium abscessus Group Reveal a Conserved Genomic Island MmGI-1 Related to Putative Lipid Metabolism	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; CYSTIC-FIBROSIS; LUNG-DISEASE; MCE OPERONS; ALIGNMENT; VISUALIZATION; INFECTIONS; OUTBREAK; THERAPY; TOOL	Mycobacterium abscessus group subsp., such as M. massiliense, M. abscessus sensu stricto and M. bolletii, are an environmental organism found in soil, water and other ecological niches, and have been isolated from respiratory tract infection, skin and soft tissue infection, postoperative infection of cosmetic surgery. To determine the unique genetic feature of M. massiliense, we sequenced the complete genome of M. massiliense type strain JCM 15300 (corresponding to CCUG 48898). Comparative genomic analysis was performed among Mycobacterium spp. and among M. abscessus group subspp., showing that additional ss-oxidation-related genes and, notably, the mammalian cell entry (mce) operon were located on a genomic island, M. massiliense Genomic Island 1 (MmGI-1), in M. massiliense. In addition, putative anaerobic respiration system-related genes and additional mycolic acid cyclopropane synthetase-related genes were found uniquely in M. massiliense. Japanese isolates of M. massiliense also frequently possess the MmGI-1 (14/44, approximately 32%) and three unique conserved regions (26/44; approximately 60%, 34/44; approximately 77% and 40/44; approximately 91%), as well as isolates of other countries (Malaysia, France, United Kingdom and United States). The well-conserved genomic island MmGI-1 may play an important role in high growth potential with additional lipid metabolism, extra factors for survival in the environment or synthesis of complex membrane-associated lipids. ORFs on MmGI-1 showed similarities to ORFs of phylogenetically distant M. avium complex (MAC), suggesting that horizontal gene transfer or genetic recombination events might have occurred within MmGI-1 among M. massiliense and MAC.	[Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Kai, Masanori; Nakanaga, Kazue; Nakata, Noboru; Makino, Masahiko; Hoshino, Yoshihiko] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Maeda, Shinji] Japan AntiTB Assoc, Res Inst TB, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID)	Sekizuka, T (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	sekizuka@niid.go.jp; yhoshino@niid.go.jp	Hoshino, Yoshihiko/B-5159-2019	Hoshino, Yoshihiko/0000-0002-3132-0715; Sekizuka, Tsuyoshi/0000-0002-1302-5472	Japan Society for the Promotion of Science [25461178]; Ohyama Health Foundation; Ministry of Health, Labour, and Welfare, Japan [H25-Shinko-Ippan-015]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ohyama Health Foundation; Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid (25461178) for Scientific Research (C) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), by a grant from the Ohyama Health Foundation (http://www.disclo-koeki.org/10a/01044/index.html) and by a Grant-in-Aid (H25-Shinko-Ippan-015) from the Ministry of Health, Labour, and Welfare, Japan (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Banerjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019280; Bao H, 2009, BIOINFORMATICS, V25, P1554, DOI 10.1093/bioinformatics/btp255; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Boes N, 2006, J BACTERIOL, V188, P6529, DOI 10.1128/JB.00308-06; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Cho YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081560; Choo SW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04061; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Iseman MD, 2008, AM J RESP CRIT CARE, V178, P999, DOI 10.1164/rccm.200808-1258ED; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joseph J, 2011, BIOINFORMATION, V6, P393, DOI 10.6026/97320630006393; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kim SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-21; Klepp LI, 2012, MICROBES INFECT, V14, P590, DOI 10.1016/j.micinf.2012.01.007; Klotz T, 1996, J UROLOGY, V155, P1488, DOI 10.1016/S0022-5347(01)66312-2; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Nakanaga K, 2014, J CLIN MICROBIOL, V52, P251, DOI 10.1128/JCM.01327-13; Nakanaga K, 2011, J CLIN MICROBIOL, V49, P613, DOI 10.1128/JCM.00817-10; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Otsuki T, 2012, J DERMATOL, V39, P569, DOI 10.1111/j.1346-8138.2011.01339.x; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Pawlik A, 2013, MOL MICROBIOL, V90, P612, DOI 10.1111/mmi.12387; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Primm TP, 2004, CLIN MICROBIOL REV, V17, P98, DOI 10.1128/CMR.17.1.98-106.2004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Shahidi M, 2010, INVEST OPHTH VIS SCI, V51, P4766, DOI 10.1167/iovs.09-4710; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki R, 2010, J BIOL CHEM, V285, P34279, DOI 10.1074/jbc.M110.156281; Villanueva A, 1997, CLIN INFECT DIS, V24, P1147, DOI 10.1086/513656; Wang W, 2004, J R SOC INTERFACE, V1, P109, DOI 10.1098/rsif.2004.0013	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114848	10.1371/journal.pone.0114848	http://dx.doi.org/10.1371/journal.pone.0114848			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503461	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700059
J	Sutela, S; Hahl, T; Tiimonen, H; Aronen, T; Ylioja, T; Laakso, T; Saranpaa, P; Chiang, V; Julkunen-Tiitto, R; Haggman, H				Sutela, Suvi; Hahl, Terhi; Tiimonen, Heidi; Aronen, Tuija; Ylioja, Tiina; Laakso, Tapio; Saranpaa, Pekka; Chiang, Vincent; Julkunen-Tiitto, Riitta; Haggman, Hely			Phenolic Compounds and Expression of 4CL Genes in Silver Birch Clones and Pt4CL1a Lines	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS PERTURBATIONS; COENZYME-A LIGASE; BETULA-PENDULA; 4-COUMARATE-COA LIGASE; SECONDARY CHEMISTRY; POPULUS-TRICHOCARPA; TRANSGENIC POPLARS; FIELD PERFORMANCE; SYSTEMS BIOLOGY; DOWN-REGULATION	A small multigene family encodes 4-coumarate:CoA ligases (4CLs) catalyzing the CoA ligation of hydroxycinnamic acids, a branch point step directing metabolites to a flavonoid or monolignol pathway. In the present study, we examined the effect of antisense Populus tremuloides 4CL (Pt4CL1) to the lignin and soluble phenolic compound composition of silver birch (Betula pendula) Pt4CL1a lines in comparison with non-transgenic silver birch clones. The endogenous expression of silver birch 4CL genes was recorded in the stems and leaves and also in leaves that were mechanically injured. In one of the transgenic Pt4CL1a lines, the ratio of syringyl (S) and guaiacyl (G) lignin units was increased. Moreover, the transcript levels of putative silver birch 4CL gene (Bp4CL1) were reduced and contents of cinnamic acid derivatives altered. In the other two Pt4CL1a lines changes were detected in the level of individual phenolic compounds. However, considerable variation was found in the transcript levels of silver birch 4CLs as well as in the concentration of phenolic compounds among the transgenic lines and non-transgenic clones. Wounding induced the expression of Bp4CL1 and Bp4CL2 in leaves in all clones and transgenic lines, whereas the transcript levels of Bp4CL3 and Bp4CL4 remained unchanged. Moreover, minor changes were detected in the concentrations of phenolic compounds caused by wounding. As an overall trend the wounding decreased the flavonoid content in silver birches and increased the content of soluble condensed tannins. The results indicate that by reducing the Bp4CL1 transcript levels lignin composition could be modified. However, the alterations found among the Pt4CL1a lines and the non-transgenic clones were within the natural variation of silver birches, as shown in the present study by the clonal differences in the transcripts levels of 4CL genes, soluble phenolic compounds and condensed tannins.	[Sutela, Suvi; Hahl, Terhi; Haggman, Hely] Univ Oulu, Dept Biol, Oulu, Finland; [Tiimonen, Heidi] Border & Coast Guard Acad, Finnish Border Guard, Imatra, Finland; [Aronen, Tuija] Finnish Forest Res Inst, Eastern Finland Reg Unit, Punkaharju Unit, Punkaharju, Finland; [Ylioja, Tiina; Laakso, Tapio; Saranpaa, Pekka] Finnish Forest Res Inst, Southern Finland Reg Unit, Vantaa Unit, FIN-01301 Vantaa, Finland; [Chiang, Vincent] N Carolina State Univ, Dept Forestry & Environm Resources, Forest Biotechnol Grp, Raleigh, NC 27695 USA; [Julkunen-Tiitto, Riitta] Univ Eastern Finland, Dept Biol, Joensuu, Finland	University of Oulu; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke); University of North Carolina; North Carolina State University; University of Eastern Finland	Sutela, S (corresponding author), Univ Oulu, Dept Biol, Oulu, Finland.	suvi.sutela@oulu.fi	Saranpaa, Pekka T/C-2114-2008; Julkunen-Tiitto, Riitta/GRR-9781-2022	Saranpaa, Pekka T/0000-0002-1129-2315; Aronen, Tuija/0000-0001-5442-5002; Ylioja, Tiina/0000-0002-8840-7504; Sutela, Suvi/0000-0003-0426-0718	Academy of Finland [104532]; Jenny and Antti Wihuri Foundation; Niemi Foundation; Biological Society of Finland Vanamo; Natural History Society of Oulu	Academy of Finland(Academy of Finland); Jenny and Antti Wihuri Foundation; Niemi Foundation; Biological Society of Finland Vanamo; Natural History Society of Oulu	The research was funded by the Academy of Finland (Project 104532 to HH), Jenny and Antti Wihuri Foundation, and Niemi Foundation (to SS) and by the Biological Society of Finland Vanamo and Natural History Society of Oulu (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold TA, 2008, AQUAT BOT, V89, P27, DOI 10.1016/j.aquabot.2008.02.001; ARONEN T, 1995, EUR J FOREST PATHOL, V25, P197; Aronen T., 2003, SUSTAINABLE FORESTRY, P149; Baraza E, 2004, CAN J BOT, V82, P357, DOI [10.1139/b04-004, 10.1139/B04-004]; Baraza E, 2010, ECOSCIENCE, V17, P156, DOI 10.2980/17-2-3286; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; BECKERANDRE M, 1991, J BIOL CHEM, V266, P8551; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Cabane M, 2012, ADV BOT RES, V61, P219, DOI 10.1016/B978-0-12-416023-1.00007-0; Chen HC, 2014, PLANT CELL, V26, P876, DOI 10.1105/tpc.113.119685; Chowdhury MEK, 2013, PLANT OMICS, V6, P254; Costa MA, 2005, PHYTOCHEMISTRY, V66, P2072, DOI 10.1016/j.phytochem.2005.06.022; de Bruxelles GL, 2001, CRIT REV PLANT SCI, V20, P487, DOI 10.1016/S0010-8545(02)00029-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Eyles A, 2010, NEW PHYTOL, V185, P893, DOI 10.1111/j.1469-8137.2009.03127.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gao H, 2012, J SYST EVOL, V50, P195, DOI 10.1111/j.1759-6831.2012.00187.x; Gui JS, 2011, PLANT PHYSIOL, V157, P574, DOI 10.1104/pp.111.178301; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamberger B, 2004, P NATL ACAD SCI USA, V101, P2209, DOI 10.1073/pnas.0307307101; HAUFFE KD, 1991, PLANT CELL, V3, P435, DOI 10.1105/tpc.3.5.435; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hikosaka K, 2005, ANN BOT-LONDON, V95, P1025, DOI 10.1093/aob/mci111; Hu WJ, 1999, NAT BIOTECHNOL, V17, P808, DOI 10.1038/11758; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; Jia CH, 2004, CHINESE SCI BULL, V49, P905, DOI 10.1360/03wc0529; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin XQ, 2012, BIOL PLANTARUM, V56, P261, DOI 10.1007/s10535-012-0085-3; Julkunen-Tiitto R, 2001, J CHEM ECOL, V27, P779, DOI 10.1023/A:1010358120482; Kajita S, 1996, PLANT CELL PHYSIOL, V37, P957, DOI 10.1093/oxfordjournals.pcp.a029045; Kajita S, 1997, PLANT PHYSIOL, V114, P871, DOI 10.1104/pp.114.3.871; Kao YY, 2002, PLANT PHYSIOL, V130, P796, DOI 10.1104/pp.006262; Keinanen M, 1999, ECOLOGY, V80, P1970, DOI 10.1890/0012-9658(1999)080[1970:TOIPMO]2.0.CO;2; Kitin P, 2010, PLANT PHYSIOL, V154, P887, DOI 10.1104/pp.110.156224; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar A, 2003, PLANT MOL BIOL, V51, P327, DOI 10.1023/A:1022004923982; Laitinen ML, 2000, J CHEM ECOL, V26, P1609, DOI 10.1023/A:1005582611863; Laitinen ML, 2005, J CHEM ECOL, V31, P697, DOI 10.1007/s10886-005-3539-7; Laitinen ML, 2004, OIKOS, V104, P316, DOI 10.1111/j.0030-1299.2004.12793.x; Lee D, 1997, PLANT CELL, V9, P1985, DOI 10.1105/tpc.9.11.1985; Lemmetyinen J, 2008, COMPENDIUM TRANSGENI, V9, P193; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Lin JS, 2013, PLANT J, V75, P781, DOI 10.1111/tpj.12238; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Muilenburg VL, 2013, TREES-STRUCT FUNCT, V27, P851, DOI 10.1007/s00468-013-0839-3; Nykanen H, 2004, OIKOS, V104, P247, DOI 10.1111/j.0030-1299.2004.12768.x; Pan X, 2013, MOL BIOL REP, V40, P2309, DOI 10.1007/s11033-012-2312-6; Pasonen HL, 2008, TREES-STRUCT FUNCT, V22, P413, DOI 10.1007/s00468-007-0202-7; Pasonen HL, 2009, PLANTA, V230, P973, DOI 10.1007/s00425-009-1005-4; Pasonen HL, 2005, SCAND J FOREST RES, V20, P385, DOI 10.1080/02827580500251432; Pasonen HL, 2004, THEOR APPL GENET, V109, P562, DOI 10.1007/s00122-004-1650-8; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rani A, 2009, FUNCT INTEGR GENOMIC, V9, P271, DOI 10.1007/s10142-008-0098-3; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; Seiwa K, 1999, ANN BOT-LONDON, V83, P355, DOI 10.1006/anbo.1998.0831; Seppanen SK, 2007, APPL SOIL ECOL, V36, P100, DOI 10.1016/j.apsoil.2006.12.002; Soltani BM, 2006, PLANTA, V224, P1226, DOI 10.1007/s00425-006-0296-y; Soltis DE, 2003, PLANT PHYSIOL, V132, P1790, DOI 10.1104/pp.103.022509; Souza CD, 2008, NEW PHYTOL, V179, P987, DOI 10.1111/j.1469-8137.2008.02534.x; Stout AT, 2014, BIOMASS BIOENERG, V68, P228, DOI 10.1016/j.biombioe.2014.06.008; Sun HY, 2013, BIOCHEM BIOPH RES CO, V430, P1151, DOI 10.1016/j.bbrc.2012.12.019; Sutela S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-124; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian XM, 2013, PLANT PHYSIOL BIOCH, V65, P111, DOI 10.1016/j.plaphy.2013.01.010; Tiimonen H, 2008, SILVAE GENET, V57, P235, DOI 10.1515/sg-2008-0036; Tiimonen H, 2005, PLANTA, V222, P699, DOI 10.1007/s00425-005-0002-5; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valjakka M, 2000, TREE PHYSIOL, V20, P607; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Vanholme R, 2012, PLANT CELL, V24, P3506, DOI 10.1105/tpc.112.102574; Vauramo S, 2006, APPL SOIL ECOL, V32, P338, DOI 10.1016/j.apsoil.2005.07.007; Vihervuori L, 2008, ENVIRON ENTOMOL, V37, P1582, DOI 10.1603/0046-225X-37.6.1582; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3	87	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114434	10.1371/journal.pone.0114434	http://dx.doi.org/10.1371/journal.pone.0114434			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502441	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000347146700023
J	Benn, A; Robinson, ESJ				Benn, Abigail; Robinson, Emma S. J.			Investigating Glutamatergic Mechanism in Attention and Impulse Control Using Rats in a Modified 5-Choice Serial Reaction Time Task	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NMDA RECEPTOR; BEHAVIORAL PHARMACOLOGY; PERFORMANCE DEFICITS; PHENCYCLIDINE; ANTAGONIST; KETAMINE; BLOCKADE; ACTIVATION; INHIBITION	The 5-choice serial reaction time task (5CSRTT) has been widely used to study attention and impulse control in rodents. In order to mimic cognitive impairments in psychiatry, one approach has been to use acute administration of NMDA antagonists. This disruption in glutamatergic transmission leads to impairments in accuracy, omissions, and premature responses although findings have been inconsistent. In this study, we further investigated glutamatergic mechanisms using a novel version of the 5CSRTT, which we have previously shown to be more sensitive to cognitive enhancers. We first investigated the effects of systemic treatment with NMDA antagonists. We also carried out a preliminary investigation using targeted medial prefrontal cortex infusions of a NMDA antagonist (MK801), mGluR2/ 3 antagonist (LY341495), and mGluR7 negative allosteric modulator (MMPIP). Acute systemic administration of the different NMDA antagonists had no specific effects on accuracy. At higher doses PCP, ketamine, and memantine, increased omissions and affected other measures suggesting a general disruption in task performance. Only MK801 increased premature responses, and reduced omissions at lower doses suggesting stimulant like effects. None of the NMDA antagonists affected accuracy or any other measures when tested using a short stimulus challenge. Infusions of MK801 had no effect on accuracy but increased premature responses following infralimbic, but not prelimbic infusion. LY341495 had no effects in either brain region but a decrease in accuracy was observed following prelimbic infusion of MMPIP. Contrary to our hypothesis, disruptions to glutamate transmission using NMDA antagonists did not induce any clear deficits in accuracy in this modified version of the 5CSRTT. We also found that the profile of effects for MK801 differed from those observed with PCP, ketamine, and memantine. The effects of MK801 in the infralimbic cortex add to the literature indicating this brain region and glutamate play an important role in impulse control.	[Benn, Abigail; Robinson, Emma S. J.] Univ Bristol, Dept Physiol & Pharmacol, Sch Med & Vet Sci, Bristol, Avon, England	University of Bristol	Benn, A (corresponding author), Univ Bristol, Dept Physiol & Pharmacol, Sch Med & Vet Sci, Bristol, Avon, England.	a.benn@bristol.ac.uk			Wellcome Trust [084621/Z/08/Z]; RCUK academic fellowship; Medical Research Council [G0700980] Funding Source: researchfish; MRC [G0700980] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); RCUK academic fellowship(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for this study was provided by the Wellcome Trust (www.wellcome.ac.uk, Reference no. 084621/Z/08/Z) with additional funding from an RCUK academic fellowship awarded to ESJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli L, 2011, NEUROSCIENCE, V185, P39, DOI 10.1016/j.neuroscience.2011.04.044; Agnoli L, 2013, NEUROPSYCHOPHARMACOL, V38, P701, DOI 10.1038/npp.2012.236; ALLEN RM, 1978, AM J PSYCHIAT, V135, P1081; Amitai N, 2007, PSYCHOPHARMACOLOGY, V193, P521, DOI 10.1007/s00213-007-0808-x; Amitai N, 2010, BIOL PSYCHIAT, V68, P5, DOI 10.1016/j.biopsych.2010.03.004; Amitai N, 2009, PSYCHOPHARMACOLOGY, V202, P275, DOI 10.1007/s00213-008-1246-0; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Barker GRI, 2008, J NEUROSCI, V28, P2837, DOI 10.1523/JNEUROSCI.4447-07.2008; Barnes SA, 2012, NEUROPHARMACOLOGY, V62, P1432, DOI 10.1016/j.neuropharm.2011.04.024; Baviera M, 2008, PSYCHOPHARMACOLOGY, V196, P269, DOI 10.1007/s00213-007-0959-9; BRESINK I, 1995, NEUROPHARMACOLOGY, V34, P533, DOI 10.1016/0028-3908(95)00017-Z; Campbell BM, 2006, NEUROSCIENCE, V137, P505, DOI 10.1016/j.neuroscience.2005.09.024; Carli M, 2006, NEUROPSYCHOPHARMACOL, V31, P757, DOI 10.1038/sj.npp.1300893; Carli M, 2011, PSYCHOPHARMACOLOGY, V214, P625, DOI 10.1007/s00213-010-2066-6; Carli M, 2011, PSYCHOPHARMACOLOGY, V214, P639, DOI 10.1007/s00213-010-2065-7; Chudasama Y, 2003, J NEUROSCI, V23, P5477; Chudasama Y, 2001, BEHAV NEUROSCI, V115, P417, DOI 10.1037/0735-7044.115.2.417; Dix S, 2010, PSYCHOPHARMACOLOGY, V212, P227, DOI 10.1007/s00213-010-1945-1; Fletcher PJ, 2011, NEUROPHARMACOLOGY, V61, P468, DOI 10.1016/j.neuropharm.2011.02.025; Gilmour G, 2009, PSYCHOPHARMACOLOGY, V205, P203, DOI 10.1007/s00213-009-1530-7; Hascup ER, 2010, J NEUROCHEM, V115, P1608, DOI 10.1111/j.1471-4159.2010.07066.x; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Higgins GA, 2005, PSYCHOPHARMACOLOGY, V179, P85, DOI 10.1007/s00213-005-2203-9; Higgins GA, 2003, NEUROPHARMACOLOGY, V44, P324, DOI 10.1016/S0028-3908(02)00402-1; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lahti AC, 2001, NEUROPSYCHOPHARMACOL, V25, P455, DOI 10.1016/S0893-133X(01)00243-3; Lustig C, 2013, NEUROSCI BIOBEHAV R, V37, P2099, DOI 10.1016/j.neubiorev.2012.05.009; McKenna BS, 2013, PSYCHIAT RES-NEUROIM, V212, P183, DOI 10.1016/j.pscychresns.2013.01.005; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Murphy ER, 2012, PSYCHOPHARMACOLOGY, V219, P401, DOI 10.1007/s00213-011-2572-1; Murphy ER, 2005, PSYCHOPHARMACOLOGY, V179, P99, DOI 10.1007/s00213-004-2068-3; NESTOR PG, 1990, SCHIZOPHR RES, V3, P329, DOI 10.1016/0920-9964(90)90018-3; Nicoletti E, 2011, NEUROPHARMACOLOGY, V60, P1017, DOI 10.1016/j.neuropharm.2010.10.022; Paine TA, 2009, NEUROPSYCHOPHARMACOL, V34, P2143, DOI 10.1038/npp.2009.40; Paine TA, 2009, NEUROPHARMACOLOGY, V56, P788, DOI 10.1016/j.neuropharm.2009.01.004; Paine TA, 2007, BIOL PSYCHIAT, V62, P687, DOI 10.1016/j.biopsych.2006.11.017; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; Pozzi L, 2011, NEUROSCIENCE, V176, P336, DOI 10.1016/j.neuroscience.2010.11.060; Quarta D, 2007, NEUROPHARMACOLOGY, V53, P421, DOI 10.1016/j.neuropharm.2007.05.023; Robbins TW, 2006, TRENDS PHARMACOL SCI, V27, P141, DOI 10.1016/j.tips.2006.01.009; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1028, DOI 10.1038/sj.npp.1301487; Robinson ESJ, 2012, PSYCHOPHARMACOLOGY, V219, P303, DOI 10.1007/s00213-011-2420-3; Sanchez-Roige S, 2012, PSYCHOPHARMACOLOGY, V219, P253, DOI 10.1007/s00213-011-2560-5; Smith JW, 2011, PSYCHOPHARMACOLOGY, V217, P255, DOI 10.1007/s00213-011-2277-5; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; Terry AV, 2012, BIOCHEM PHARMACOL, V83, P941, DOI 10.1016/j.bcp.2011.12.043; Thomson DM, 2011, PSYCHOPHARMACOLOGY, V213, P681, DOI 10.1007/s00213-010-2020-7; Tomlinson A, 2014, EUR NEUROPSYCHOPHARM, V24, P1371, DOI 10.1016/j.euroneuro.2014.04.008; van Enkhuizen J, 2014, BEHAV BRAIN RES, V261, P40, DOI 10.1016/j.bbr.2013.12.003; Young JW, 2013, BEHAV BRAIN RES, V240, P119, DOI 10.1016/j.bbr.2012.11.028; Young J, 2013, PHILOSOPHY OF TRAGEDY: FROM PLATO TO ZIZEK, P3	56	31	31	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115374	10.1371/journal.pone.0115374	http://dx.doi.org/10.1371/journal.pone.0115374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526617	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200024
J	Frees, AE; Rajaram, N; McCachren, SS; Fontanella, AN; Dewhirst, MW; Ramanujam, N				Frees, Amy E.; Rajaram, Narasimhan; McCachren, Samuel S., III; Fontanella, Andrew N.; Dewhirst, Mark W.; Ramanujam, Nimmi			Delivery-Corrected Imaging of Fluorescently-Labeled Glucose Reveals Distinct Metabolic Phenotypes in Murine Breast Cancer	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; HIGH LACTATE LEVELS; TUMOR HYPOXIA; BLOOD-FLOW; RAPAMYCIN INHIBITOR; NECK TUMORS; HEAD; OXYGEN; PET; VASCULATURE	When monitoring response to cancer therapy, it is important to differentiate changes in glucose tracer uptake caused by altered delivery versus a true metabolic shift. Here, we propose an optical imaging method to quantify glucose uptake and correct for in vivo delivery effects. Glucose uptake was measured using a fluorescent D-glucose derivative 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)Amino)-2-deoxy-D-glucose (2-NBDG) in mice implanted with dorsal skin flap window chambers. Additionally, vascular oxygenation (SO2) was calculated using only endogenous hemoglobin contrast. Results showed that the delivery factor proposed for correction, "R-D", reported on red blood cell velocity and injected 2-NBDG dose. Delivery-corrected 2-NBDG uptake (2-NBDG(60)/R-D) inversely correlated with blood glucose in normal tissue, indicating sensitivity to glucose demand. We further applied our method in metastatic 4T1 and nonmetastatic 4T07 murine mammary adenocarcinomas. The ratio 2-NBDG(60)/R-D was increased in 4T1 tumors relative to 4T07 tumors yet average SO2 was comparable, suggesting a shift toward a "Warburgian" (aerobic glycolysis) metabolism in the metastatic 4T1 line. In heterogeneous regions of both 4T1 and 4T07, 2-NBDG(60)/R-D increased slightly but significantly as vascular oxygenation decreased, indicative of the Pasteur effect in both tumors. These data demonstrate the utility of delivery-corrected 2-NBDG and vascular oxygenation imaging for differentiating metabolic phenotypes in vivo.	[Frees, Amy E.; Rajaram, Narasimhan; McCachren, Samuel S., III; Fontanella, Andrew N.; Ramanujam, Nimmi] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Dewhirst, Mark W.] Duke Univ, Med Ctr, Durham, NC USA	Duke University; Duke University	Frees, AE (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	amy.frees@duke.edu	Rajaram, Narasimhan/A-2249-2010; Dewhirst, Mark/Q-1302-2019; Ramanujam, Nimmi/AAA-7575-2021	Rajaram, Narasimhan/0000-0003-1224-8567; Dewhirst, Mark/0000-0003-3459-6546; Ramanujam, Nimmi/0000-0001-7319-8415; Martinez, Amy/0000-0002-8088-7398	National Science Foundation Graduate Research Fellowship Program; Department of Defense Era of Hope Scholar Awards [W81XWH-09-1-0410, W81XWH-05-10363]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Department of Defense Era of Hope Scholar Awards	This research was supported by generous funding from the National Science Foundation Graduate Research Fellowship Program (www.nsf.gov/grfp; AEF) and the Department of Defense Era of Hope Scholar Awards (http://cdmrp.army.mil/bcrp/era; W81XWH-09-1-0410; PI: N. Ramanujam and W81XWH-05-10363; PI: N. Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuzzi A, 2010, J THEOR BIOL, V262, P142, DOI 10.1016/j.jtbi.2009.09.024; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bollineni VR, 2013, J NUCL MED, V54, P1175, DOI 10.2967/jnumed.112.115014; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; Castell F, 2008, BRIT J CANCER, V98, P1597, DOI 10.1038/sj.bjc.6604330; EITZMAN D, 1992, J AM COLL CARDIOL, V20, P559, DOI 10.1016/0735-1097(92)90008-B; Epelbaum R, 2013, J NUCL MED, V54, P12, DOI 10.2967/jnumed.112.107466; Fontanella AN, 2013, MICROCIRCULATION, V20, P724, DOI 10.1111/micc.12072; GAILLARD WD, 1995, NEUROLOGY, V45, P1841, DOI 10.1212/WNL.45.10.1841; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gill EM, 2003, PHOTOCHEM PHOTOBIOL, V77, P653, DOI 10.1562/0031-8655(2003)077<0653:RBCAOT>2.0.CO;2; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; Heppner GH, 2000, BREAST CANCER RES, V2, P331; HLATKY L, 1988, J CELL PHYSIOL, V134, P167, DOI 10.1002/jcp.1041340202; Hoeben BAW, 2013, ACTA ONCOL, V52, P1257, DOI 10.3109/0284186X.2013.812799; Hudetz AG, 1997, MICROVASC RES, V54, P35, DOI 10.1006/mvre.1997.2023; Koolen BB, 2014, ACTA ONCOL, V53, P50, DOI 10.3109/0284186X.2013.783714; Maher JC, 2007, MOL CANCER THER, V6, P732, DOI 10.1158/1535-7163.MCT-06-0407; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091; Mankoff DA, 2009, CLIN CANCER RES, V15, P5294, DOI 10.1158/1078-0432.CCR-09-1448; Mees G, 2013, MOL IMAGING, V12, P49, DOI 10.2310/7290.2012.00020; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Millon SR, 2011, BREAST CANCER RES TR, V126, P55, DOI 10.1007/s10549-010-0884-1; Nitin N, 2009, INT J CANCER, V124, P2634, DOI 10.1002/ijc.24222; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Ohwada J, 2011, BIOORG MED CHEM LETT, V21, P1767, DOI 10.1016/j.bmcl.2011.01.065; Ostergaard L, 2013, CANCER RES, V73, P5618, DOI 10.1158/0008-5472.CAN-13-0964; Palmer GM, 2011, NAT PROTOC, V6, P1355, DOI 10.1038/nprot.2011.349; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Rajaram N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076524; Rajendran JG, 2005, RADIOL CLIN N AM, V43, P169, DOI 10.1016/j.rcl.2004.08.004; Russell J, 2009, INT J RADIAT ONCOL, V73, P1177, DOI 10.1016/j.ijrobp.2008.12.004; Schnell CR, 2008, CANCER RES, V68, P6598, DOI 10.1158/0008-5472.CAN-08-1044; Secomb TW, 2004, INT J RADIAT ONCOL, V59, P572, DOI 10.1016/j.ijrobp.2004.01.039; Sheth RA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3259364; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Specht JM, 2010, CLIN CANCER RES, V16, P2803, DOI 10.1158/1078-0432.CCR-10-0026; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; VAUPEL P, 1989, CANCER RES, V49, P6449; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vaupel PW, 2010, INT J HYPERTHER, V26, P211, DOI 10.3109/02656731003596259; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yamamoto T, 2008, TETRAHEDRON LETT, V49, P6876, DOI 10.1016/j.tetlet.2008.09.089; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z	59	17	17	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115529	10.1371/journal.pone.0115529	http://dx.doi.org/10.1371/journal.pone.0115529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526261	Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200032
J	Greenbaum, G; Templeton, AR; Zarmi, Y; Bar-David, S				Greenbaum, Gili; Templeton, Alan R.; Zarmi, Yair; Bar-David, Shirli			Allelic Richness following Population Founding Events - A Stochastic Modeling Framework Incorporating Gene Flow and Genetic Drift	PLOS ONE			English	Article							PER-GENERATION RULE; ONE-MIGRANT; NONEQUILIBRIUM MODELS; CONSERVATION; DIVERSITY; BOTTLENECKS; MANAGEMENT; NUMBER; EXTINCTION; NUCLEOTIDE	Allelic richness (number of alleles) is a measure of genetic diversity indicative of a population's long-term potential for adaptability and persistence. It is used less commonly than heterozygosity as a genetic diversity measure, partially because it is more mathematically difficult to take into account the stochastic process of genetic drift for allelic richness. This paper presents a stochastic model for the allelic richness of a newly founded population experiencing genetic drift and gene flow. The model follows the dynamics of alleles lost during the founder event and simulates the effect of gene flow on maintenance and recovery of allelic richness. The probability of an allele's presence in the population was identified as the relevant statistical property for a meaningful interpretation of allelic richness. A method is discussed that combines the probability of allele presence with a population's allele frequency spectrum to provide predictions for allele recovery. The model's analysis provides insights into the dynamics of allelic richness following a founder event, taking into account gene flow and the allele frequency spectrum. Furthermore, the model indicates that the "One Migrant per Generation" rule, a commonly used conservation guideline related to heterozygosity, may be inadequate for addressing preservation of diversity at the allelic level. This highlights the importance of distinguishing between heterozygosity and allelic richness as measures of genetic diversity, since focusing merely on the preservation of heterozygosity might not be enough to adequately preserve allelic richness, which is crucial for species persistence and evolution.	[Greenbaum, Gili; Zarmi, Yair] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, Midreshet Ben Gurion, Israel; [Greenbaum, Gili; Bar-David, Shirli] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Templeton, Alan R.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Templeton, Alan R.] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Templeton, Alan R.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel	Ben Gurion University; Ben Gurion University; Washington University (WUSTL); University of Haifa; University of Haifa	Greenbaum, G (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Dept Solar Energy & Environm Phys, Midreshet Ben Gurion, Israel.	gili.greenbaum@gmail.com	Templeton, Alan R./F-5963-2011; BAR-DAVID, SHIRLI/F-1512-2012	BAR-DAVID, SHIRLI/0000-0001-8103-041X; Templeton, Alan/0000-0002-0167-845X; Greenbaum, Gili/0000-0002-1631-8203	SIDEER (Swiss Institute for Dryland Environmental and Energy Research) Fund	SIDEER (Swiss Institute for Dryland Environmental and Energy Research) Fund	GG fellowship was supported by the 2010 SIDEER (Swiss Institute for Dryland Environmental and Energy Research) Fund for interdisciplinary research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F. W., 2012, CONSERV GENET; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Andras JP, 2011, MOL ECOL, V20, P2525, DOI 10.1111/j.1365-294X.2011.05115.x; [Anonymous], 2006, POPULATION GENETICS; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Caballero A, 2010, CONSERV GENET, V11, P409, DOI 10.1007/s10592-009-0020-0; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dewar RC, 2011, MOL ECOL, V20, P3156, DOI 10.1111/j.1365-294X.2011.05171.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EWENS WJ, 1964, GENETICS, V50, P891; Fisher RA, 1930, GENETICAL THEORY NAT; Foulley JL, 2006, LIVEST SCI, V101, P150, DOI 10.1016/j.livprodsci.2005.10.021; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; HILL WG, 1986, GENET RES, V48, P41, DOI 10.1017/S0016672300024642; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; JAMES JW, 1970, GENET RES, V16, P241, DOI 10.1017/S0016672300002500; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2010, DIVERS DISTRIB, V16, P65, DOI 10.1111/j.1472-4642.2009.00626.x; KIMURA M, 1969, GENETICS, V63, P701; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1964, GENETICS, V49, P561; Kimura M., 1971, THEORETICAL ASPECTS; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; LACY R C, 1987, Conservation Biology, V1, P143, DOI 10.1111/j.1523-1739.1987.tb00023.x; LEBERG PL, 1992, EVOLUTION, V46, P477, DOI 10.1111/j.1558-5646.1992.tb02053.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Marshall D. R., 1975, Crop genetic resources for today and tomorrow. Genetic variation in plant populations., P53; MARUYAMA T, 1985, GENETICS, V111, P675; MARUYAMA T, 1984, GENETICS, V108, P745; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Nachman MW, 2000, GENETICS, V156, P297; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; ROBERTSON A., 1960, PROC ROY SOC SER B BIOL SCI, V153, P234, DOI 10.1098/rspb.1960.0099; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Simianer H, 2005, J ANIM BREED GENET, V122, P177, DOI 10.1111/j.1439-0388.2005.00523.x; SPIETH PT, 1974, GENETICS, V78, P961; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; TEMPLETON AR, 1980, GENETICS, V94, P1011; Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003; Tracy LN, 2011, ANIM CONSERV, V14, P439, DOI 10.1111/j.1469-1795.2011.00448.x; Vogel F., 1997, HUMAN GENETICS PROBL; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Vucetich JA, 2000, ANIM CONSERV, V3, P261, DOI 10.1017/S1367943000000986; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; WATTERSON GA, 1984, THEOR POPUL BIOL, V26, P387, DOI 10.1016/0040-5809(84)90042-X; Weiser EL, 2013, CONSERV BIOL, V27, P335, DOI 10.1111/cobi.12011; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649; Wolfram S., 2003, MATH BOOK; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1921, GENETICS, V6, P111; ZENG ZB, 1990, THEOR POPUL BIOL, V37, P254, DOI 10.1016/0040-5809(90)90039-X	62	108	110	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115203	10.1371/journal.pone.0115203	http://dx.doi.org/10.1371/journal.pone.0115203			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526062	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200017
J	Kulangara, K; Yang, J; Chellappan, M; Yang, Y; Leong, KW				Kulangara, Karina; Yang, Jennifer; Chellappan, Malathi; Yang, Yong; Leong, Kam W.			Nanotopography Alters Nuclear Protein Expression, Proliferation and Differentiation of Human Mesenchymal Stem/Stromal Cells	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; A-TYPE LAMINS; RETINOBLASTOMA GENE; STROMAL CELLS; STEM-CELLS; IDENTIFICATION; MUTATIONS; LMNA; A/C	Mesenchymal stem/stromal cells respond to physical cues present in their microenvironment such as substrate elasticity, geometry, or topography with respect to morphology, proliferation, and differentiation. Although studies have demonstrated the role of focal adhesions in topography-mediated changes of gene expression, information linking substrate topography to the nucleus remains scarce. Here we show by two-dimensional gel electrophoresis and western blotting that A-type lamins and retinoblastoma protein are downregulated in mesenchymal stem/stromal cells cultured on 350 nm gratings compared to planar substrates; these changes lead to a decrease in proliferation and changes in differentiation potential.	[Kulangara, Karina; Yang, Jennifer; Chellappan, Malathi; Yang, Yong; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Leong, KW (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	kam.leong@duke.edu	, Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022; Leong, Kam/O-9302-2019	Leong, Kam/0000-0002-8133-4955	National Institutes of Health (NIH) [UH3TR000505, HL109442, AI096305]; Swiss National Science Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000505] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096305] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health (NIH) grants UH3TR000505, HL109442, and AI096305 (http//www.nih.gov/). KK received funding from the Swiss National Science Foundation (http//www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Bao LR, 2002, J VAC SCI TECHNOL B, V20, P2881, DOI 10.1116/1.1526355; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Caux F, 2003, J CLIN ENDOCR METAB, V88, P1006, DOI 10.1210/jc.2002-021506; Chalut KJ, 2010, SOFT MATTER, V6, P1675, DOI 10.1039/b921206j; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Friedman DB, 2004, PROTEOMICS, V4, P793, DOI 10.1002/pmic.200300635; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Osorio C, 2007, NEUROBIOL AGING, V28, P1853, DOI 10.1016/j.neurobiolaging.2006.08.011; OZAKI T, 1994, ONCOGENE, V9, P2649; Parker Carol E., 2005, V301, P117; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102	35	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114698	10.1371/journal.pone.0114698	http://dx.doi.org/10.1371/journal.pone.0114698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521962	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600008
J	Fisher, LR; Godfrey, MH; Owens, DW				Fisher, Leah R.; Godfrey, Matthew H.; Owens, David W.			Incubation Temperature Effects on Hatchling Performance in the Loggerhead Sea Turtle (Caretta caretta)	PLOS ONE			English	Article							CLIMATE-CHANGE; NEST TEMPERATURES; SNAPPING TURTLES; CHELONIA-MYDAS; GREEN TURTLES; PHENOTYPE; ENVIRONMENT; NORTHERN; RATIOS; FLUCTUATIONS	Incubation temperature has significant developmental effects on oviparous animals, including affecting sexual differentiation for several species. Incubation temperature also affects traits that can influence survival, a theory that is verified in this study for the Northwest Atlantic loggerhead sea turtle (Caretta caretta). We conducted controlled laboratory incubations and experiments to test for an effect of incubation temperature on performance of loggerhead hatchlings. Sixty-eight hatchlings were tested in 2011, and 31 in 2012, produced from eggs incubated at 11 different constant temperatures ranging from 27 degrees C to 33 degrees C. Following their emergence from the eggs, we tested righting response, crawling speed, and conducted a 24-hour long swim test. The results support previous studies on sea turtle hatchlings, with an effect of incubation temperature seen on survivorship, righting response time, crawling speed, change in crawl speed, and overall swim activity, and with hatchlings incubated at 27 degrees C showing decreased locomotor abilities. No hatchlings survived to be tested in both years when incubated at 32 degrees C and above. Differences in survivorship of hatchlings incubated at high temperatures are important in light of projected higher sand temperatures due to climate change, and could indicate increased mortality from incubation temperature effects.	[Fisher, Leah R.; Owens, David W.] Univ Charleston South Carolina, Coll Charleston, Charleston, SC 29424 USA; [Godfrey, Matthew H.] North Carolina Wildlife Resources Commiss, Beaufort, NC USA; [Godfrey, Matthew H.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA	College of Charleston; Duke University	Fisher, LR (corresponding author), Univ Charleston South Carolina, Coll Charleston, Charleston, SC 29424 USA.	lrfisher22@gmail.com			PADI Foundation [5040, 6344]; Lerner Gray Memorial Fund of the American Museum of Natural History; Charleston Scientific and Cultural Society; Slocum-Lunz Foundation; National Oceanic and Atmospheric Administration Section 6 cooperative research grant [NA10NMF4720035]	PADI Foundation; Lerner Gray Memorial Fund of the American Museum of Natural History; Charleston Scientific and Cultural Society; Slocum-Lunz Foundation; National Oceanic and Atmospheric Administration Section 6 cooperative research grant	This research was funded to LRF by the PADI Foundation (#5040, #6344; http://www.padifoundation.org/), the Lerner Gray Memorial Fund of the American Museum of Natural History (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships), the Charleston Scientific and Cultural Society (no website), the Slocum-Lunz Foundation (no website). The research was also funded in part to MHG by a National Oceanic and Atmospheric Administration Section 6 cooperative research grant (NA10NMF4720035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOBYN ML, 1994, CAN J ZOOL, V72, P28, DOI 10.1139/z94-005; Booth DT, 2013, MAR BIOL, V160, P127, DOI 10.1007/s00227-012-2070-y; Booth DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Booth DT, 2004, INT CONGR SER, V1275, P226, DOI 10.1016/j.ics.2004.08.057; Booth DT, 2001, AUST J ZOOL, V49, P389, DOI 10.1071/ZO01006; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Burgess EA, 2006, CORAL REEFS, V25, P341, DOI 10.1007/s00338-006-0116-7; Chu CT, 2008, AUST J ZOOL, V56, P57, DOI 10.1071/ZO08004; Conover David O., 2004, P11; Deeming D.C., 1991, P147, DOI 10.1017/CBO9780511585739.011; DeGregorio BA, 2011, CHELONIAN CONSERV BI, V10, P54, DOI 10.2744/CCB-0880.1; Delmas V, 2007, BIOL J LINN SOC, V91, P99, DOI 10.1111/j.1095-8312.2007.00780.x; Doody J. Sean, 1999, Chelonian Conservation and Biology, V3, P529; FOLEY AM, 1998, THESIS U S FLORIDA T; Freedberg S, 2004, EVOL ECOL RES, V6, P739; Fuentes M. M. P. B., 2009, Endangered Species Research, V9, P33, DOI 10.3354/esr00224; Glen F, 2004, GLOBAL CHANGE BIOL, V10, P2036, DOI 10.1111/j.1529-8817.2003.00865.x; Glen F, 2003, J MAR BIOL ASSOC UK, V83, P1183, DOI 10.1017/S0025315403008464h; Godfrey Matthew H., 1997, Chelonian Conservation and Biology, V2, P581; GYURIS E, 1994, CORAL REEFS, V13, P137, DOI 10.1007/BF00301189; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M., 2007, CLIMATE CHANGE GREAT, P465; Hanson J, 1998, CAN J ZOOL, V76, P1850, DOI 10.1139/cjz-76-10-1850; Harbour Jerry, 2009, BASICS PERFORMANCE M; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; HOSIER PE, 1981, ENVIRON CONSERV, V8, P158, DOI 10.1017/S0376892900027284; HUTCHISON VICTOR H., 1965, HERPETOLOGICA, V20, P233; Ischer T, 2009, MAR BIOL, V156, P1399, DOI 10.1007/s00227-009-1180-7; JANZEN FJ, 1993, PHYSIOL ZOOL, V66, P349, DOI 10.1086/physzool.66.3.30163697; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Layton J, 2011, THESIS U ALABAMA BIR; LeBlanc AM, 2012, CHELONIAN CONSERV BI, V11, P108, DOI 10.2744/CCB-0915.1; LIMPUS CJ, 2006, ROUNDTABLE MIGRATORY; Lohmann Kenneth J., 1997, P107; Marcovaldi MA, 1997, CAN J ZOOL, V75, P755, DOI 10.1139/z97-097; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; Maulany RI, 2012, MAR BIOL, V159, P2651, DOI 10.1007/s00227-012-2022-6; Maulany RI, 2012, COPEIA, P738, DOI 10.1643/CH-12-088; Micheli-Campbell MA, 2011, J ZOOL, V285, P266, DOI 10.1111/j.1469-7998.2011.00840.x; Micheli-Campbell MA, 2012, J ZOOL, V288, P143, DOI 10.1111/j.1469-7998.2012.00934.x; Miller J.D., 1985, Biology of Reptilia, V14, P269; MILLER J.D., 2003, LOGGERHEAD SEA TURTL, P125, DOI DOI 10.1086/431100; Mrosovsky N, 2002, CAN J ZOOL, V80, P2118, DOI 10.1139/Z02-204; MROSOVSKY N, 1988, CAN J ZOOL, V66, P661, DOI 10.1139/z88-098; O'Steen S, 1998, J EXP BIOL, V201, P439; Read T, 2012, AUST J ZOOL, V60, P402, DOI 10.1071/ZO12079; Reece SE, 2002, EVOL ECOL RES, V4, P737; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; Sandoval S, 2011, J THERM BIOL, V36, P138, DOI 10.1016/j.jtherbio.2010.12.007; Shine R, 1997, ECOLOGY, V78, P2559; Sim EL, 2014, COPEIA, P63, DOI 10.1643/CP-13-041; Steyermark AC, 2001, COPEIA, P1050, DOI 10.1643/0045-8511(2001)001[1050:BTAMIA]2.0.CO;2; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Wibbels T, 2003, CRC MAR BIOL SER, P103; WITHERINGTON BE, 1992, J HERPETOL, V26, P226, DOI 10.2307/1564869; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; Wood A, 2014, J EXP MAR BIOL ECOL, V451, P105, DOI 10.1016/j.jembe.2013.11.005; WYNEKEN J, 1992, COPEIA, P478, DOI 10.2307/1446208	59	56	57	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114880	10.1371/journal.pone.0114880	http://dx.doi.org/10.1371/journal.pone.0114880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517114	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600032
J	Kummell, SB; Frey, E				Kuemmell, Susanna B.; Frey, Eberhard			Range of Movement in Ray I of Manus and Pes and the Prehensility of the Autopodia in the Early Permian to Late Cretaceous Non-Anomodont Synapsida	PLOS ONE			English	Article							MARSUPIALS MAYULESTES-FEROX; PUCADELPHYS-ANDINUS; PALEOBIOLOGY; ANATOMY	The mobility of ray I was analysed in seventy-eight Early Permian to Late Cretaceous specimens of non-mammalian Synapsida and one extant mammal. In all non-mammaliamorph Synapsida investigated, ray I formed a digital arcade. The first phalanx was maximally extendable to the zero position in the metapodiophalangeal joint I. Metapodiale I was the functional equivalent to a basal phalanx of digits II-V. In contrast, there was no digital arcade in ray I in Mesozoic Mammaliamorpha. Phalanx 1 I was dorsally extendable and metapodiale I was functionally part of the metapodium. During the propulsion phase, autopodial rotation occurred in the majority of Synapsida with abducted limb posture. Regarding ray I, the reduction of autopodial rotation can be estimated, e. g., from the decrease of lateral rotation and medial abduction of the first phalanx in the metapodiophalangeal joint I. Autopodial rotation was high in Titanophoneus and reduced in derived Cynodontia. In Mammaliamorpha the mobility of the first ray suggests autopodial rolling in an approximately anterior direction. Most non-mammaliamorph Therapsida and probably some Mesozoic Mammaliamorpha had prehensile autopodia with an opposable ray I. In forms with a pronounced relief of the respective joints, ray I could be opposed to 90 degrees against ray III. A strong transverse arch in the row of distalia supported the opposition movement of ray I and resulted in a convergence of the claws of digits II-V just by flexing those digits. A tight articular coherence in the digital joints of digits II-V during strong flexion supported a firm grip capacity. Usually the grip capacity was more pronounced in the manus than in the pes. Prehensile autopodia of carnivorous Therapsida may have been utilized to hold prey while biting, thus helping to avoid fractures of the laterally compressed fangs.	[Kuemmell, Susanna B.] Univ Witten Herdecke, Inst Evolutionary Biol & Morphol, Ctr Biomed Educ & Res, Fac Hlth,Sch Med, Witten, Germany; [Frey, Eberhard] Staatl Museum Nat Kunde Karlsruhe, Karlsruhe, Germany	Witten Herdecke University	Kummell, SB (corresponding author), Univ Witten Herdecke, Inst Evolutionary Biol & Morphol, Ctr Biomed Educ & Res, Fac Hlth,Sch Med, Witten, Germany.	susanna.kuemmell@uni-wh.de			Rudolf Steiner-Fonds; Gemeinschaftsbank fur Leihen und Schenken; Cultura-Stiftung, Evidenz Stiftung and Mahle-Stiftung	Rudolf Steiner-Fonds; Gemeinschaftsbank fur Leihen und Schenken; Cultura-Stiftung, Evidenz Stiftung and Mahle-Stiftung	Rudolf Steiner-Fonds, Gemeinschaftsbank fur Leihen und Schenken, Cultura-Stiftung, Evidenz Stiftung and Mahle-Stiftung (SK). Center for Biomedical Education and Research, University Witten/Herdecke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Attenborough D, 1984, WUNDERWELT NATUR ERD; Attenborough D, 1990, WUNDERWELT NATUR KIN; Benninghoff A., 1994, ANATOMIE MAKROSKOPIS; Benninghoff A, 1957, LEHRBUCH ANATOMIE ME, VI; Boonstra L. D., 1964, Annals of the South African Museum, V48, P121; Boonstra L. D., 1966, Annals of the South African Museum, V50, P1; BOONSTRA LIEUWE DIRK, 1965, ANN S AFRICAN MUS, V48, P237; BRINKMAN D, 1980, CAN J ZOOL, V58, P2187, DOI 10.1139/z80-301; Camp C.L., 1956, MEM U CALIF, V13, P255; Campione NE, 2010, J VERTEBR PALEONTOL, V30, P724, DOI 10.1080/02724631003762914; Cartmill M., 1974, P45; Chudinov P.K., 1983, Trudy Paleontologicheskogo Instituta, V202, P1; Colbert E. H., 1948, Bulletin of the American Museum of Natural History, V89, P357; CRUICKSHANK AR, 1967, J ZOOL, V153, P163; De Valais S, 2009, ZOOTAXA, P1; FCAT, 1998, TERM AN INT AN TERM, P292; FOURIE H, 2001, THESIS U WITWATERSRA; Gand Georges, 2000, Palaeovertebrata (Montpellier), V29, P1; Granger W, 1930, B AM MUS NAT HIST, V56, P601; Grzimek B, 1987, GRZIMEKS ENZYKLOPADI, VI-V; Hu Yaoming, 1998, Vertebrata Palasiatica, V36, P102; Huttenlocker A, 2009, ZOOL J LINN SOC-LOND, V157, P865, DOI 10.1111/j.1096-3642.2009.00538.x; Jenkins F.A., 1971, B PEABODY MUS NAT HI, V36, P1, DOI DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0CO;2; Jenkins F.A. Jr., 1974, P85; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Kemp T.S., 1986, Journal of Vertebrate Paleontology, V6, P215; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kielan-Jaworowska Z, 2006, ACTA PALAEONTOL POL, V51, P393; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KING GM, 1985, ZOOL J LINN SOC-LOND, V84, P263, DOI 10.1111/j.1096-3642.1985.tb01801.x; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Krebs B, 1991, BERLINER GEOWISSEN A, V133, P5; Kuhne W.G., 1956, LIASSIC THERAPSID OL, P149; Kummell SB, 2009, THESIS WITTEN HERDEC; Kummell Susanna B., 2012, Palaeobiodiversity Palaeoenvironments, V92, P171, DOI 10.1007/s12549-012-0076-6; Kummer B, 2005, BIOMECHANIK FORM FUN; Leonardi G., 1994, ANNOTATED ATLAS S AM; Napier J. R., 1961, Symposia of the Zoological Society of London, P115; Napier J. R., 1993, HANDS; ORLOV Yu. A., 1958, TR PALEONTOL INST AKAD NAUK SSSR, V72, P1; Platzer W, 1999, DTV ATLAS ANATOMIE, V1; Rauber A, 1987, ANATOMIE MENSCHEN LE, VI; Romer Alfred S., 1944, BULL MUS COMP ZOOL HARVARD UNIV, V93, P465; Schilling N, 1999, Z SAUGETIERKD, V64, P129; Sereno Paul C., 2006, P315; Van Valkenburgh Blaire, 2002, Paleontological Society Papers, V8, P267; Voigt S, 2005, TETRAPODENICHNOFAUNA; WATSON D. M. S., 1931, PROC ZOOL SOC LONDON, V1931, P1163	50	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113911	10.1371/journal.pone.0113911	http://dx.doi.org/10.1371/journal.pone.0113911			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517726	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600011
J	Sullivan, SM; Coyle, D; Wells, G				Sullivan, Shannon M.; Coyle, Doug; Wells, George			What Guidance Are Researchers Given on How to Present Network Meta-Analyses to End-Users such as Policymakers and Clinicians? A Systematic Review	PLOS ONE			English	Review							CARE DECISION-MAKING; ISPOR TASK-FORCE; HEALTH-CARE	Introduction: Network meta-analyses (NMAs) are complex methodological approaches that may be challenging for non-technical end-users, such as policymakers and clinicians, to understand. Consideration should be given to identifying optimal approaches to presenting NMAs that help clarify analyses. It is unclear what guidance researchers currently have on how to present and tailor NMAs to different end-users. Methods: A systematic review of NMA guidelines was conducted to identify guidance on how to present NMAs. Electronic databases and supplementary sources were searched for NMA guidelines. Presentation format details related to sample formats, target audiences, data sources, analysis methods and results were extracted and frequencies tabulated. Guideline quality was assessed following criteria developed for clinical practice guidelines. Results: Seven guidelines were included. Current guidelines focus on how to conduct NMAs but provide limited guidance to researchers on how to best present analyses to different end-users. None of the guidelines provided reporting templates. Few guidelines provided advice on tailoring presentations to different end-users, such as policymakers. Available guidance on presentation formats focused on evidence networks, characteristics of individual trials, comparisons between direct and indirect estimates and assumptions of heterogeneity and/or inconsistency. Some guidelines also provided examples of figures and tables that could be used to present information. Conclusions: Limited guidance exists for researchers on how best to present NMAs in an accessible format, especially for non-technical end-users such as policymakers and clinicians. NMA guidelines may require further integration with end-users' needs, when NMAs are used to support healthcare policy and practice decisions. Developing presentation formats that enhance understanding and accessibility of NMAs could also enhance the transparency and legitimacy of decisions informed by NMAs.	[Sullivan, Shannon M.; Wells, George] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Coyle, Doug; Wells, George] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Sullivan, SM (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	ssullivan@ottawaheart.ca		Coyle, Doug/0000-0003-3492-2268	Canadian Institute of Health Research (CIHR) Drug Safety and Effectiveness Network [116573]	Canadian Institute of Health Research (CIHR) Drug Safety and Effectiveness Network(Canadian Institutes of Health Research (CIHR))	This research was supported through a grant from the Canadian Institute of Health Research (CIHR) Drug Safety and Effectiveness Network (Funding reference number - 116573). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid AS, 2012, RES SYNTH METHODS, V3, P71, DOI 10.1002/jrsm.51; Ades A, 2012, 7 NICE DSU; Akl EA, 2012, J CLIN EPIDEMIOL, V65, P268, DOI 10.1016/j.jclinepi.2011.08.001; [Anonymous], 2008, ASS IND COMP; Becker L, 2013, COMP MULTIPLE INTERV; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; CADTH Health Technology Assessment Report, 2009, IND EV IND TREATM CO; Canadian Agency for Drugs and Technologies in Health, 2013, GREY MATT PRACT SEAR; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chambers D, 2011, MILBANK Q, V89, P131, DOI 10.1111/j.1468-0009.2011.00622.x; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cochrane Collaboration, 2014, COCHR HDB SYST REV; Coleman CI, 2012, AHRQ PUBLICATION; Daniels N, 1997, PHILOS PUBLIC AFF, V26, P303, DOI 10.1111/j.1088-4963.1997.tb00082.x; Dias S., 2011, HETEROGENEITY SUBGRO; Dias S, 2011, 2 NICE DSU; Dias S, 2011, 4 NICE DSU; Dias S, 2011, 6 NICE DSU; Dias S, 2011, NICE DSU TECHNICAL S; Dias S, 2011, 3 NICE DSU; Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Fe RW, 2011, J CLIN EPIDEMIOL, V64, P1187, DOI 10.1016/j.jclinepi.2010.08.010; Guideline, 2014, EUNETHTA, P34; Haute Autorite de Sante (HAS), 2009, SUMM REP IND COMP ME; Hawkins N, 2012, VALUE HEALTH, V15, pA33, DOI 10.1016/j.jval.2012.03.186; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Innvaer Simon, 2002, J Health Serv Res Policy, V7, P239, DOI 10.1258/135581902320432778; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Martin A, 2013, VALUE HEALTH, V16, pA608, DOI 10.1016/j.jval.2013.08.1742; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murthy L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009401.pub2; Nikolakopoulou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086754; Pocock SJ, 2007, LANCET, V370, P2099, DOI 10.1016/S0140-6736(07)61898-4; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099682; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Straus SE, 2013, KNOWLEDGE TRANSLATION IN HEALTH CARE: MOVING FROM EVIDENCE TO PRACTICE, 2ND EDITION, P1, DOI 10.1002/9781118413555; Tan SH, 2014, J CLIN EPIDEMIOL, V67, P672, DOI 10.1016/j.jclinepi.2013.11.006; Tan SH, 2013, J HEALTH SERV RES PO, V18, P224, DOI 10.1177/1355819613498379; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222	47	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113277	10.1371/journal.pone.0113277	http://dx.doi.org/10.1371/journal.pone.0113277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517510	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600003
J	Beliveau, E; Lessard, V; Guillemette, G				Beliveau, Eric; Lessard, Vincent; Guillemette, Gaetan			STIM1 Positively Regulates the Ca2+ Release Activity of the Inositol 1,4,5-risphosphate Receptor in Bovine Aortic Endothelial Cells	PLOS ONE			English	Article							CALCIUM SENSOR STIM1; 1,4,5-TRISPHOSPHATE RECEPTOR; ACTIVATION; ENTRY; POLYCYSTIN-2; CHANNELS; ORAI1; WAVES	The endothelium is actively involved in many functions of the cardiovascular system, such as the modulation of arterial pressure and the maintenance of blood flow. These functions require a great versatility of the intracellular Ca2+ signaling that resides in the fact that different signals can be encoded by varying the frequency and the amplitude of the Ca2+ response. Cells use both extracellular and intracellular Ca2+ pools to modulate the intracellular Ca2+ concentration. In non-excitable cells, the inositol 1,4,5-trisphosphate receptor (IP3R), located on the endoplasmic reticulum (ER), is responsible for the release of Ca2+ from the intracellular store. The proteins STIM1 and STIM2 are also located on the ER and they are involved in the activation of a store-operated Ca2+ entry (SOCE). Due to their Ca2+ sensor property and their close proximity with IP(3)Rs on the ER, STIMs could modulate the activity of IP3R. In this study, we showed that STIM1 and STIM2 are expressed in bovine aortic endothelial cells and they both interact with IP3R. While STIM2 appears to play a minor role, STIM1 plays an important role in the regulation of agonist-induced Ca2+ mobilization in BAECs by a positive effect on both the SOCE and the IP3R-dependent Ca2+ release.	[Beliveau, Eric; Lessard, Vincent; Guillemette, Gaetan] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada.	gaetan.guillemette@usherbrooke.ca			Canadian Institutes of Health Research; Fondation des Maladies du Coeur du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation des Maladies du Coeur du Quebec	Funding from Canadian Institutes of Health Research (GG) and Fondation des Maladies du Coeur du Quebec (GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Antigny F, 2012, J BIOL CHEM, V287, P5917, DOI 10.1074/jbc.M111.295733; Antigny F, 2011, CELL CALCIUM, V49, P115, DOI 10.1016/j.ceca.2010.12.001; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Beliveau E, 2011, J CELL BIOCHEM, V112, P3722, DOI 10.1002/jcb.23301; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Briand SI, 1999, J CELL BIOCHEM, V75, P587, DOI 10.1002/(SICI)1097-4644(19991215)75:4<587::AID-JCB5>3.0.CO;2-Q; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Decuypere JP, 2010, CELL CALCIUM, V48, P161, DOI 10.1016/j.ceca.2010.08.003; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hirano K, 2009, J CELL BIOCHEM, V108, P499, DOI 10.1002/jcb.22279; Isshiki M, 1998, P NATL ACAD SCI USA, V95, P5009, DOI 10.1073/pnas.95.9.5009; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Lopez E, 2012, J PHYSIOL BIOCHEM, V68, P619, DOI 10.1007/s13105-012-0163-1; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Moccia Francesco, 2012, World J Biol Chem, V3, P127, DOI 10.4331/wjbc.v3.i7.127; Pani B, 2012, FRONT BIOSCI-LANDMRK, V17, P805, DOI 10.2741/3958; Sammels E, 2010, J BIOL CHEM, V285, P18794, DOI 10.1074/jbc.M109.090662; Santoso NG, 2011, CELL PHYSIOL BIOCHEM, V27, P715, DOI 10.1159/000330080; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Tran Q. -K., 2006, V176, P145; Tsai FC, 2014, NAT CELL BIOL, V16, P133, DOI 10.1038/ncb2906; Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605	36	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114718	10.1371/journal.pone.0114718	http://dx.doi.org/10.1371/journal.pone.0114718			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506690	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100024
J	Hotzel, MJ; Longo, C; Balcao, LF; Cardoso, CS; Costa, JHC				Hoetzel, Maria J.; Longo, Cibele; Balcao, Lucas F.; Cardoso, Clarissa S.; Costa, Joao H. C.			A Survey of Management Practices That Influence Performance and Welfare of Dairy Calves Reared in Southern Brazil	PLOS ONE			English	Article							LACTATION BIOLOGY SYMPOSIUM; FEEDING-BEHAVIOR; ANIMAL-WELFARE; MILK REPLACER; HERD REPLACEMENTS; EARLY SEPARATION; HOLSTEIN CALVES; CROSS-SUCKING; CALF; COLOSTRUM	Here we report dairy calf management practices used by 242 smallholder family farmers in the South of Brazil. Data were collected via a semi-structured questionnaire with farmers, inspection of the production environment and an indepth interview with a sample of 26 farmers. Herds had an average of 22.3 lactating cows and an average milk production of 12.7 L/cow/day. Calves were dehorned in 98% of the farms, with a hot iron in 95%. Male calves were castrated in 71% of the farms; methods were surgery (68%), emasculator (29%), or rubber rings (3%). No pain control was used for these interventions. In 51% of the farms all newborn male calves were reared, sold or donated to others; in 35% all newborn males were killed on the farm. Calves were separated from the dam up to 12 h after birth in 78% of the farms, and left to nurse colostrum from the dam without intervention in 55% of the farms. The typical amount of milk fed to calves was 4 L/day until a median age of 75 days. In 40% of the farms milk was provided in a bucket, in 49% with bottles, and in 11% calves suckled from a cow. Solid feeding in the milk-feeding period started at a median age of 10 days. Calves were housed individually in 70% of the farms; in 81% of the farms calves were housed in indoor pens, in 6% in outdoor hutches and in 13% they were kept on pasture. Diarrhoea was reported as the main cause of calf mortality in 71% of the farms. Farmers kept no records of calf disease, mortality, or use of medicines. Changing the scenario identified in this survey is essential to support the sustainable development of dairy production, an activity of great economic and social relevance for the region.	[Hoetzel, Maria J.; Longo, Cibele; Balcao, Lucas F.; Cardoso, Clarissa S.; Costa, Joao H. C.] Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada & Bem Estar Anim, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Hotzel, MJ (corresponding author), Univ Fed Santa Catarina, Dept Zootecnia & Desenvolvimento Rural, Lab Etol Aplicada & Bem Estar Anim, Florianopolis, SC, Brazil.	mjhotzel@cca.ufsc.br	Balcão, Lucas/F-2802-2017; Costa, Joao H. C./M-6660-2014; Costa, Joao H. C./ABD-4749-2021; Hötzel, Maria José/H-6975-2014; Cardoso, Clarissa Silva/J-7473-2018	Balcão, Lucas/0000-0002-9572-7039; Costa, Joao H. C./0000-0001-9311-4741; Costa, Joao H. C./0000-0001-9311-4741; Hötzel, Maria José/0000-0003-1034-3202; Cardoso, Clarissa Silva/0000-0002-4668-4052	MCT/CNPq/CT-Agronegocio/MAPA-SDC [505862/2008-5]; CNPq [562908/2010-2]; MEC/CAPES [23038.006958/2010-62]; CNPq (National Council for Scientific and Technological Development, Brazil); CAPES (Ministry of Education, Brazil)	MCT/CNPq/CT-Agronegocio/MAPA-SDC; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MEC/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding provided by MCT/CNPq/CT-Agronegocio/MAPA-SDC 40/2008, grant number 505862/2008-5, CNPq 22/2010 - Inter-institutional Network of the Agroecological Dairy Productive Chain, grant number 562908/2010-2, MEC/CAPES 029/2010, grant number 23038.006958/2010-62. MJH was supported by CNPq (National Council for Scientific and Technological Development, Brazil; http://www.cnpq.br/) CL, LFB and JHCC were supported by CAPES (Ministry of Education, Brazil; http://www.capes.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby MC, 2001, APPL ANIM BEHAV SCI, V74, P191, DOI 10.1016/S0168-1591(01)00171-X; AVMA, 2013, GUID EUTH ANIM 2013; Babu LK, 2004, APPL ANIM BEHAV SCI, V87, P177, DOI 10.1016/j.applanim.2004.01.006; Balcao LF, 2012, TIPOLOGIA ATIVIDADE; Balcao LF, 2011, 38 C BRAS MED VET FL; Ballou M. A., 2013, Professional Animal Scientist, V29, P116; Beam AL, 2009, J DAIRY SCI, V92, P3973, DOI 10.3168/jds.2009-2225; Bergman MA, 2014, J DAIRY SCI, V97, P4269, DOI 10.3168/jds.2013-7766; Borderas TF, 2009, J DAIRY SCI, V92, P2843, DOI 10.3168/jds.2008-1886; Cardoso C. S., 2014, 3 BRAZ C BIOET AN WE, P196; Cardoso CS, 2014, SUSTENTABILIDADE PEC; Chua B, 2002, J DAIRY SCI, V85, P360, DOI 10.3168/jds.S0022-0302(02)74082-4; Costa JHC, 2013, J DAIRY SCI, V96, P307, DOI 10.3168/jds.2012-5906; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Dos Santos OV, 2006, ESTUDO CADEIA LEITE; Duve LR, 2012, J DAIRY SCI, V95, P6571, DOI 10.3168/jds.2011-5170; EDWARDS SA, 1982, ANIM BEHAV, V30, P525, DOI 10.1016/S0003-3472(82)80065-1; Ellis KA, 2009, ANIM WELFARE, V18, P267; EPAGRI/CEPA, 2012, SINT AN AGR SANT CAT; Fernandes COM, 2012, PRODUCAO LEITE BASE, P335; Flower FC, 2003, ANIM WELFARE, V12, P339; Flower FC, 2001, APPL ANIM BEHAV SCI, V70, P275, DOI 10.1016/S0168-1591(00)00164-7; Franklin ST, 2003, J DAIRY SCI, V86, P2145, DOI 10.3168/jds.S0022-0302(03)73804-1; Fulwider WK, 2008, J DAIRY SCI, V91, P1686, DOI 10.3168/jds.2007-0631; Gaillard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090205; Gjerris M, 2011, J AGR ENVIRON ETHIC, V24, P331, DOI 10.1007/s10806-010-9270-6; Godden S, 2008, VET CLIN N AM-FOOD A, V24, P19, DOI 10.1016/j.cvfa.2007.10.005; Gottardo F, 2011, J DAIRY SCI, V94, P5724, DOI 10.3168/jds.2011-4443; Hammon HM, 2013, J ANIM SCI, V91, P685, DOI 10.2527/jas.2012-5758; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hoe FGH, 2006, J DAIRY SCI, V89, P2297, DOI 10.3168/jds.S0022-0302(06)72301-3; Hotzel MJ, 2013, J DAIRY SCI, V96, P1535, DOI 10.3168/jds.2012-5780; Hotzel MJ, 2014, DILEMMAS IN ANIMAL WELFARE, P67, DOI 10.1079/9781780642161.0067; Honorato LA, 2014, J DAIRY SCI, V97, P1319, DOI 10.3168/jds.2012-6532; IBGE, 2009, CENS AGR; Jensen MB, 2006, J DAIRY SCI, V89, P4778, DOI 10.3168/jds.S0022-0302(06)72527-9; Jensen MB, 2006, J DAIRY SCI, V89, P201, DOI 10.3168/jds.S0022-0302(06)72084-7; Jung J, 2001, APPL ANIM BEHAV SCI, V72, P201, DOI 10.1016/S0168-1591(01)00110-1; Khan MA, 2011, J DAIRY SCI, V94, P1071, DOI 10.3168/jds.2010-3733; Le Cozler Y, 2012, J AGR SCI-CAMBRIDGE, V150, P518, DOI 10.1017/S0021859612000032; Lidfors LM, 1996, APPL ANIM BEHAV SCI, V49, P269, DOI 10.1016/0168-1591(96)01053-2; Lopes F. C. F., 2010, MANUAL BOVINOCULTURA, P351; Lorenzon J, 2005, ESTUDO COMPARATIVO R, P4; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; McGuirk SM, 2004, VET CLIN N AM-FOOD A, V20, P593, DOI 10.1016/j.cvfa.2004.06.005; MDA, 2014, POL SET LEIT; Mello MA, 2003, BASE AGRICOLA OESTE, P15; Mellor DJ, 2004, VET J, V168, P118, DOI 10.1016/j.tvjl.2003.08.004; Mezzadri FP, 2013, CULTURA ANAL CONJUNT; Mior LC, 2010, COLOQUIO INT DESENVO, P487; Moallem U, 2010, J DAIRY SCI, V93, P2639, DOI 10.3168/jds.2009-3007; Morrison SJ, 2012, ANIMAL, V6, P909, DOI 10.1017/S1751731111002163; Morrison SJ, 2009, ANIMAL, V3, P1570, DOI 10.1017/S1751731109990437; Pettersson K, 2001, ACTA VET SCAND, V42, P465, DOI 10.1186/1751-0147-42-465; Poletto R., 2012, Animal Frontiers, V2, P22, DOI 10.2527/af.2012-0045; Rault JL, 2011, APPL ANIM BEHAV SCI, V135, P214, DOI 10.1016/j.applanim.2011.10.017; Robson C., 1993, REAL WORLD RES RESOU; Roth BA, 2009, APPL ANIM BEHAV SCI, V119, P143, DOI 10.1016/j.applanim.2009.03.004; Rushen J., 2008, WELFARE CATTLE, VVolume 5; SANTOS G. T., 2010, BOVINOCULTURA LEITEI, P47; Silva JCPM, 2011, MANEJO BEZERRAS LEIT; Sneddon J, 2010, J AGR ENVIRON ETHIC, V23, P371, DOI 10.1007/s10806-009-9216-z; Soberon F, 2013, J ANIM SCI, V91, P706, DOI 10.2527/jas.2012-5834; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Spers Renata Giovinazzo, 2013, Rev. Adm. (São Paulo), V48, P254, DOI 10.5700/rausp1086; Stafford KJ, 2011, APPL ANIM BEHAV SCI, V135, P226, DOI 10.1016/j.applanim.2011.10.018; Stanek S, 2014, J DAIRY SCI, V97, P3973, DOI 10.3168/jds.2013-7325; Trotz-Williams LA, 2008, J DAIRY SCI, V91, P3840, DOI 10.3168/jds.2007-0898; USDA, 2008, PART 3 REF DAIR CATT; Uys JL, 2011, J S AFR VET ASSOC, V82, P47; Vasseur E, 2012, ANIM WELFARE, V21, P77, DOI 10.7120/096272812799129439; Vasseur E, 2010, J DAIRY SCI, V93, P1307, DOI 10.3168/jds.2009-2429; Veissier I, 2013, APPL ANIM BEHAV SCI, V147, P11, DOI 10.1016/j.applanim.2013.05.002; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Vieira AD, 2012, J DAIRY SCI, V95, P3218, DOI 10.3168/jds.2011-4821; Vieira AD, 2010, J DAIRY SCI, V93, P3079, DOI 10.3168/jds.2009-2516; Vieira AD, 2008, APPL ANIM BEHAV SCI, V109, P180, DOI 10.1016/j.applanim.2007.03.006; von Keyserlingk MAG, 2013, J DAIRY SCI, V96, P5405, DOI 10.3168/jds.2012-6354; Von Keyserlingk MAG, 2010, 3 BOEHR ING EXP FOR, P7; Von Keyserlingk MAG, J AGR ENV ETHICS, DOI s10.1007/s10806-10014-19518-10807; Zucali M, 2013, ITAL J ANIM SCI, V12, DOI 10.4081/ijas.2013.e26	81	51	52	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114995	10.1371/journal.pone.0114995	http://dx.doi.org/10.1371/journal.pone.0114995			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506692	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100040
J	Barnes, AD; Emberson, RM; Krell, FT; Didham, RK				Barnes, Andrew D.; Emberson, Rowan M.; Krell, Frank-Thorsten; Didham, Raphael K.			The Role of Species Traits in Mediating Functional Recovery during Matrix Restoration	PLOS ONE			English	Article							DUNG BEETLE COMMUNITIES; FOREST FRAGMENTATION; HABITAT RESTORATION; ECOSYSTEM SERVICES; RESPONSE FUNCTIONS; LAND-USE; BIODIVERSITY; CONSEQUENCES; FRAMEWORK; ECOLOGY	Reversing anthropogenic impacts on habitat structure is frequently successful through restoration, but the mechanisms linking habitat change, community reassembly and recovery of ecosystem functioning remain unknown. We test for the influence of edge effects and matrix habitat restoration on the reassembly of dung beetle communities and consequent recovery of dung removal rates across tropical forest edges. Using path modelling, we disentangle the relative importance of community-weighted trait means and functional trait dispersion from total biomass effects on rates of dung removal. Community trait composition and biomass of dung beetle communities responded divergently to edge effects and matrix habitat restoration, yielding opposing effects on dung removal. However, functional dispersion-used in this study as a measure of niche complementarity-did not explain a significant amount of variation in dung removal rates across habitat edges. Instead, we demonstrate that the path to functional recovery of these altered ecosystems depends on the trait-mean composition of reassembling communities, over and above purely biomass-dependent processes that would be expected under neutral theory. These results suggest that any ability to manage functional recovery of ecosystems during habitat restoration will demand knowledge of species' roles in ecosystem processes.	[Barnes, Andrew D.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Barnes, Andrew D.] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Emberson, Rowan M.] Lincoln Univ, Dept Ecol, Lincoln, New Zealand; [Krell, Frank-Thorsten] Denver Museum Nat & Sci, Dept Zool, Denver, CO USA; [Didham, Raphael K.] CSIRO Land & Water Flagship, Ctr Environm & Life Sci, Floreat, WA, Australia; [Didham, Raphael K.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	University of Canterbury; University of Gottingen; Lincoln University - New Zealand; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia	Barnes, AD (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 1, New Zealand.	abarnes@gwdg.de	Barnes, Andrew/C-6643-2014; Krell, Frank-Thorsten/A-8633-2009; Didham, Raphael K/B-5953-2011; Barnes, Andrew/AAQ-9592-2020	Barnes, Andrew/0000-0002-6499-381X; Krell, Frank-Thorsten/0000-0001-6065-0812; Barnes, Andrew/0000-0002-6499-381X				Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Andresen E, 2003, ECOGRAPHY, V26, P87, DOI 10.1034/j.1600-0587.2003.03362.x; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Baker SC, 2006, J INSECT CONSERV, V10, P269, DOI 10.1007/s10841-006-0016-8; Barnes AD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6351; Barnes AD, 2014, BIOL CONSERV, V170, P28, DOI 10.1016/j.biocon.2013.12.006; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cadotte M, 2013, ECOL LETT, V16, P1234, DOI 10.1111/ele.12161; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chapman HM, 2004, ORYX, V38, P282, DOI 10.1017/S0030605304000511; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; Chown SL, 2002, COMP BIOCHEM PHYS B, V131, P587, DOI 10.1016/S1096-4959(02)00017-9; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Davis A. L. V., 2008, AFRICAN DUNG BEETLE; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ernest SKM, 2009, ECOL LETT, V12, P507, DOI 10.1111/j.1461-0248.2009.01305.x; Ewers RM, 2006, J APPL ECOL, V43, P527, DOI 10.1111/j.1365-2664.2006.01151.x; Fonseca CR, 2007, RESTOR ECOL, V15, P613, DOI 10.1111/j.1526-100X.2007.00273.x; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hubbell Stephen P., 2001, V32, pi; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2008, CONSERV BIOL, V22, P1288, DOI 10.1111/j.1523-1739.2008.00969.x; Laughlin DC, 2012, ECOL LETT, V15, P1291, DOI 10.1111/j.1461-0248.2012.01852.x; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Malmivaara-Lamsa M, 2008, SOIL BIOL BIOCHEM, V40, P1612, DOI 10.1016/j.soilbio.2008.01.013; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Moir ML, 2005, FOREST ECOL MANAG, V217, P294, DOI 10.1016/j.foreco.2005.06.012; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075819; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Quintero I, 2005, ECOLOGY, V86, P3303, DOI 10.1890/04-1960; R Development Core Team, 2013, LANG ENV STAT COMP; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Spector S, 2003, BIOTROPICA, V35, P394; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Tsbikae BP, 2008, ENVIRON ENTOMOL, V37, P431, DOI 10.1603/0046-225X(2008)37[431:TAOADB]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Watts CH, 2008, BIOL CONSERV, V141, P568, DOI 10.1016/j.biocon.2007.12.008; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Weiher E, 2011, PHILOS T R SOC B, V366, P2403, DOI 10.1098/rstb.2011.0056; Wu XW, 2011, ECOL MONOGR, V81, P313, DOI 10.1890/10-0808.1; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x	58	17	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115385	10.1371/journal.pone.0115385	http://dx.doi.org/10.1371/journal.pone.0115385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502448	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400092
J	Ghosh, R; Kumar, A; Vaziri, A				Ghosh, Ranajay; Kumar, Aloke; Vaziri, Ashkan			Type-IV Pilus Deformation Can Explain Retraction Behavior	PLOS ONE			English	Article							TWITCHING MOTILITY; NEISSERIA-GONORRHOEAE; BIOGENESIS; MOTOR; TRANSFORMATION; DYNAMICS; PROTEIN; GENE; DNA	Polymeric filament like type IV Pilus (TFP) can transfer forces in excess of 100 pN during their retraction before stalling, powering surface translocation(twitching). Single TFP level experiments have shown remarkable nonlinearity in the retraction behavior influenced by the external load as well as levels of PilT molecular motor protein. This includes reversal of motion near stall forces when the concentration of the PilT protein is loweblack significantly. In order to explain this behavior, we analyze the coupling of TFP elasticity and interfacial behavior with PilT kinetics. We model retraction as reaction controlled and elongation as transport controlled process. The reaction rates vary with TFP deformation which is modeled as a compound elastic body consisting of multiple helical strands under axial load. Elongation is controlled by monomer transport which suffer entrapment due to excess PilT in the cell periplasm. Our analysis shows excellent agreement with a host of experimental observations and we present a possible biophysical relevance of model parameters through a mechano-chemical stall force map.	[Ghosh, Ranajay; Vaziri, Ashkan] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Kumar, Aloke] Univ Alberta, Dept Mech Engn, Edmonton, AB, Canada	Northeastern University; University of Alberta	Vaziri, A (corresponding author), Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA.	vaziri@coe.neu.edu			United States National Science Foundation CMMI Grant [1149750]	United States National Science Foundation CMMI Grant	RG and AV were supported by United States National Science Foundation CMMI Grant-1149750. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Assalkhou R, 2007, MICROBIOL-SGM, V153, P1593, DOI 10.1099/mic.0.2006/004200-0; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crowther LJ, 2004, MOL MICROBIOL, V52, P67, DOI 10.1111/j.1365-2958.2003.03963.x; Drake SL, 1995, MOL MICROBIOL, V18, P975, DOI 10.1111/j.1365-2958.1995.18050975.x; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Jin F, 2011, P NATL ACAD SCI USA, V108, P12617, DOI 10.1073/pnas.1105073108; Linden M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021908; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Newton R. G., 1982, THEOR MATH PHYS+; Nivaskumar M, 2014, STRUCTURE, V22, P685, DOI 10.1016/j.str.2014.03.001; Park K, 2011, APPL MECH REV, V64, DOI 10.1115/1.4023110; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; Rudel T, 1995, NEISSERIA PILC PROTE; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	32	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114613	10.1371/journal.pone.0114613	http://dx.doi.org/10.1371/journal.pone.0114613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502696	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400040
J	McCormack, A; Edmondson-Jones, M; Mellor, D; Dawes, P; Munro, KJ; Moore, DR; Fortnum, H				McCormack, Abby; Edmondson-Jones, Mark; Mellor, Duane; Dawes, Piers; Munro, Kevin J.; Moore, David R.; Fortnum, Heather			Association of Dietary Factors with Presence and Severity of Tinnitus in a Middle-Aged UK Population	PLOS ONE			English	Article							HEARING-LOSS; RISK; PREVALENCE	Objective: The impact of dietary factors on tinnitus has received limited research attention, despite being a considerable concern among people with tinnitus and clinicians. The objective was to examine the link between dietary factors and presence and severity of tinnitus. Design: This study used the UK Biobank resource, a large cross-sectional study of adults aged 40-69. 171,722 eligible participants were asked questions specific to tinnitus (defined as noises such as ringing or buzzing in the head or ears). Dietary factors included portions of fruit and vegetables per day, weekly fish consumption (oily and non-oily), bread type, cups of caffeinated coffee per day, and avoidance of dairy, eggs, wheat and sugar. We controlled for lifestyle, noise exposure, hearing, personality and comorbidity factors. Results: Persistent tinnitus, defined as present at least a lot of the time, was elevated with increased: (i) fruit/vegetable intake (OR=1.01 per portion/day), (ii) bread (wholemeal/wholegrain, OR=1.07; other bread, 1.20) and (iii) dairy avoidance (OR=1.27). Persistent tinnitus was reduced with: (i) fish consumption (non-oily, OR=0.91; oily, 0.95), (ii) egg avoidance (OR=0.87) and (iii) caffeinated coffee consumption (OR=0.99 per cup/day). Reports of "bothersome'' tinnitus (moderate-severe handicap) increased with wholemeal/wholegrain bread intake (OR=0.86). Reports of less frequent transient tinnitus increased with dairy avoidance (OR=1.18) and decreased with caffeinated coffee (OR=0.98 per cup/day) and brown bread (OR=0.94). Conclusions: This is the first population study to report the association between dietary factors and tinnitus. Although individually dietary associations are mostly modest, particular changes in diet, such as switching between foodstuffs, may result in stronger associations. These findings offer insights into possible dietary associations with tinnitus, and this may be useful when discussing management options in combination with other lifestyle changes and therapies.	[McCormack, Abby; Edmondson-Jones, Mark; Fortnum, Heather] NIHR Nottingham, Hearing Biomed Res Unit, Nottingham, England; [Edmondson-Jones, Mark; Fortnum, Heather] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham NG7 2RD, England; [McCormack, Abby] MRC Inst Hearing Res, Nottingham, England; [Mellor, Duane] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England; [Dawes, Piers; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Munro, Kevin J.] Cent Manchester Univ Hosp, NHS Fdn Trust, Manchester Acad Hlth Sci, Manchester, Lancs, England; [Moore, David R.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University of Nottingham; University of Nottingham; University of Manchester; Oxford University Hospitals NHS Foundation Trust; University of Manchester; Cincinnati Children's Hospital Medical Center	Edmondson-Jones, M (corresponding author), NIHR Nottingham, Hearing Biomed Res Unit, 113 Ropewalk, Nottingham, England.	mark.edmondson-jones@nottingham.ac.uk	Mellor, Duane/Q-2184-2019; munro, kevin j/A-2899-2015; Mellor, Duane/H-1262-2012	munro, kevin j/0000-0001-6543-9098; Mellor, Duane/0000-0002-1369-3868; Dawes, Piers/0000-0003-3180-9884; Hunter, Abby/0000-0002-6533-6918	National Institute for Health Research; National Institute for Health Research (NIHR); Intramural Programme of the Medical Research Council [U135097130]; Medical Research Council [MC_qA137853] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Intramural Programme of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Nottingham Hearing Biomedical Research Unit is funded by the National Institute for Health Research. This paper presents independent research funded in part by the National Institute for Health Research (NIHR). This research was facilitated by the NIHR Manchester Biomedical Research Centre, and DRM was supported by the Intramural Programme of the Medical Research Council (Grant U135097130). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Cancado Trindade A.A., 2013, EJERCICIO FUNCION JU, V3rd, P1; Claire LS, 2010, INT J AUDIOL, V49, P24, DOI 10.3109/14992020903160884; Davis A, 2000, TINNITUS HDB, V1, P6; Dawes P., 2014, EAR HEARING; El Refaie A, 2004, INT J AUDIOL, V43, P410; Erlandsson SI, 2000, BRIT J AUDIOL, V34, P11, DOI 10.3109/03005364000000114; ERLANDSSON SI, 1992, AUDIOLOGY, V31, P168; Glicksman JT, 2014, AM J MED, V127, P739, DOI 10.1016/j.amjmed.2014.02.033; Gopinath B, 2011, J NUTR HEALTH AGING, V15, P896, DOI 10.1007/s12603-011-0119-0; Gopinath B, 2011, J NUTR, V141, P1355, DOI 10.3945/jn.111.138610; Gopinath B, 2010, J NUTR, V140, P2207, DOI 10.3945/jn.110.128462; Gopinath B, 2010, AM J CLIN NUTR, V92, P416, DOI 10.3945/ajcn.2010.29370; Hall D. A., 2013, Clinical Investigation, V3, P21, DOI 10.4155/cli.12.129; Hannaford PC, 2005, FAM PRACT, V22, P227, DOI 10.1093/fampra/cmi004; Hoare J, 2004, NATL DIET NUTR SURVE; Holgers KM, 2005, INT J AUDIOL, V44, P584, DOI 10.1080/14992020500190235; Houston DK, 1999, AM J CLIN NUTR, V69, P564; McCormack A, 2014, J PSYCHOSOM RES, V76, P56, DOI 10.1016/j.jpsychores.2013.08.018; McFerran D, 2013, FOOD DRINK TINNITUS; Shargorodsky J, 2010, OTOLARYNG HEAD NECK, V142, P231, DOI 10.1016/j.otohns.2009.10.049; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Spankovich C, 2011, J AM ACAD AUDIOL, V22, P49, DOI 10.3766/jaaa.22.1.6; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; Weber JH, 2008, Z PSYCHOSOM MED PSYC, V54, P227, DOI 10.13109/zptm.2008.54.3.227; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	27	28	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114711	10.1371/journal.pone.0114711	http://dx.doi.org/10.1371/journal.pone.0114711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503070	Green Published, Green Accepted, gold			2022-12-27	WOS:000346375400046
J	Miyata, K; Kudo, K				Miyata, Kohei; Kudo, Kazutoshi			Mutual Stabilization of Rhythmic Vocalization and Whole-Body Movement	PLOS ONE			English	Article							REDUCED TIMING VARIABILITY; AUDITORY-STIMULATION; PARKINSONS-DISEASE; PHASE-TRANSITIONS; STREET DANCERS; GAIT; INTERFERENCE; PERFORMANCE; ORGANIZATION; EXECUTION	The current study investigated the rhythmic coordination between vocalization and whole-body movement. Previous studies have reported that spatiotemporal stability in rhythmic movement increases when coordinated with a rhythmic auditory stimulus or other effector in a stable coordination pattern. Therefore, the present study conducted two experiments to investigate (1) whether there is a stable coordination pattern between vocalization and whole-body movement and (2) whether a stable coordination pattern reduces variability in whole-body movement and vocalization. In Experiment 1, two coordination patterns between vocalizations and whole-body movement (hip, knee, and ankle joint flexion-on-the-voice vs. joint extension-on-the-voice) in a standing posture were explored at movement frequencies of 80, 130, and 180 beats per minute. At higher movement frequencies, the phase angle in the extension-on-the-voice condition deviated from the intended phase angle. However, the angle of the flexion-on-the-voice was maintained even when movement frequency increased. These results suggest that there was a stable coordination pattern in the flexion-on-the-voice condition. In Experiment 2, variability in whole-body movement and voice-onset intervals was compared between two conditions: one related to tasks performed in the flexion-on-the-voice coordination (coordination condition) that was a stable coordination pattern, and the other related to tasks performed independently (control condition). The results showed that variability in whole-body movement and voice-onset intervals was smaller in the coordination condition than in the control condition. Overall, the present study revealed mutual stabilization between rhythmic vocalization and whole-body movement via coordination within a stable pattern, suggesting that coupled action systems can act as a single functional unit or coordinative structure.	[Miyata, Kohei; Kudo, Kazutoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	University of Tokyo	Miyata, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	still.kzn@gmail.com	Kudo, Kazutoshi/GVT-3733-2022	Kudo, Kazutoshi/0000-0002-3199-9449; Miyata, Kohei/0000-0002-5412-8240	Japanese Ministry of Education, Culture, Sports, Science and Technology [24650382]; Sasakawa Scientific Research Grant from The Japan Science Society [25-611]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Scientific Research Grant from The Japan Science Society	This research was supported by Grant-in-Aid for Challenging Exploratory Research (No. 24650382) awarded to KK from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/j-grantsinaid/03_keikaku/) and by the Sasakawa Scientific Research Grant (No. 25-611) awarded to MK from The Japan Science Society (http://www.jss.or.jp/ikusei/ sasakawa/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Batschelet E, 1981, CIRCULAR STAT BIOL; Bood RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070758; Buchanan JJ, 1997, BIOL CYBERN, V76, P257, DOI 10.1007/s004220050338; Drewing K, 2003, Q J EXP PSYCHOL-A, V56, P329, DOI 10.1080/02724980244000396; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Helmuth LL, 1996, J EXP PSYCHOL HUMAN, V22, P278, DOI 10.1037/0096-1523.22.2.278; HICKS RE, 1975, J COMP PHYSIOL PSYCH, V89, P50, DOI 10.1037/h0076385; Hiscock M, 1995, BRAIN COGNITION, V29, P307, DOI 10.1006/brcg.1995.1284; HISCOCK M, 1986, NEUROPSYCHOLOGIA, V24, P691, DOI 10.1016/0028-3932(86)90008-4; Hoffmann CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045206; INHOFF AW, 1990, BRAIN COGNITION, V13, P59, DOI 10.1016/0278-2626(90)90040-U; Kelso J.A.S., 1983, PRODUCTION SPEECH, P137, DOI [10.1007/978-1-4613-8202-7_7, DOI 10.1007/978-1-4613-8202-7_7]; KELSO JAS, 1990, ATTENTION PERFORM, V8, P139; KELSO JAS, 1991, EXP BRAIN RES, V85, P432; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kelso JAS, 1981, B PSYCHON SOC, V18; Kelso S., 1995, DYNAMIC PATTERNS SEL; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kugler P.N., 1980, ADV PSYCHOL, P3, DOI [10.1016/S0166-4115, DOI 10.1016/S0166-4115, 10.1016/S0166-4115(08)61936]; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Maitra KK, 2003, OTJR-OCCUP PART HEAL, V23, P35, DOI 10.1177/153944920302300105; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miura A, 2013, NEUROSCI LETT, V544, P157, DOI 10.1016/j.neulet.2013.04.005; Miura A, 2011, HUM MOVEMENT SCI, V30, P1260, DOI 10.1016/j.humov.2010.08.006; Muto T, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-58; Park JH, 2009, NEUROREHABILITATION, V25, P123, DOI 10.3233/NRE-2009-0507; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pellecchia GL, 2003, GAIT POSTURE, V18, P29, DOI 10.1016/S0966-6362(02)00138-8; Pellecchia GL, 2001, J MOTOR BEHAV, V33, P9, DOI 10.1080/00222890109601898; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Seyal M, 1999, CLIN NEUROPHYSIOL, V110, P424, DOI 10.1016/S1388-2457(98)00019-4; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Tokimura H, 1996, ANN NEUROL, V40, P628, DOI 10.1002/ana.410400413; Treffner P, 2002, HUM MOVEMENT SCI, V21, P641, DOI 10.1016/S0167-9457(02)00178-1; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	38	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115495	10.1371/journal.pone.0115495	http://dx.doi.org/10.1371/journal.pone.0115495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502730	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400094
J	Szelinger, S; Malenica, I; Corneveaux, JJ; Siniard, AL; Kurdoglu, AA; Ramsey, KM; Schrauwen, I; Trent, JM; Narayanan, V; Huentelman, MJ; Craig, DW				Szelinger, Szabolcs; Malenica, Ivana; Corneveaux, Jason J.; Siniard, Ashley L.; Kurdoglu, Ahmet A.; Ramsey, Keri M.; Schrauwen, Isabelle; Trent, Jeffrey M.; Narayanan, Vinodh; Huentelman, Matthew J.; Craig, David W.			Characterization of X Chromosome Inactivation Using Integrated Analysis of Whole-Exome and mRNA Sequencing	PLOS ONE			English	Article							MENTAL-RETARDATION; GENE-EXPRESSION; METHYLATION; FRAMEWORK; PATTERNS; GENOME; SEQ; IDENTIFICATION; DUPLICATION; ALIGNMENT	In females, X chromosome inactivation (XCI) is an epigenetic, gene dosage compensatory mechanism by inactivation of one copy of X in cells. Random XCI of one of the parental chromosomes results in an approximately equal proportion of cells expressing alleles from either the maternally or paternally inherited active X, and is defined by the XCI ratio. Skewed XCI ratio is suggestive of non-random inactivation, which can play an important role in X-linked genetic conditions. Current methods rely on indirect, semi-quantitative DNA methylation-based assay to estimate XCI ratio. Here we report a direct approach to estimate XCI ratio by integrated, family-trio based whole-exome and mRNA sequencing using phase-by-transmission of alleles coupled with allele-specific expression analysis. We applied this method to in silico data and to a clinical patient with mild cognitive impairment but no clear diagnosis or understanding molecular mechanism underlying the phenotype. Simulation showed that phased and unphased heterozygous allele expression can be used to estimate XCI ratio. Segregation analysis of the patient's exome uncovered a de novo, interstitial, 1.7 Mb deletion on Xp22.31 that originated on the paternally inherited X and previously been associated with heterogeneous, neurological phenotype. Phased, allelic expression data suggested an 83: 20 moderately skewed XCI that favored the expression of the maternally inherited, cytogenetically normal X and suggested that the deleterious affect of the de novo event on the paternal copy may be offset by skewed XCI that favors expression of the wild-type X. This study shows the utility of integrated sequencing approach in XCI ratio estimation.	[Szelinger, Szabolcs; Malenica, Ivana; Corneveaux, Jason J.; Siniard, Ashley L.; Kurdoglu, Ahmet A.; Ramsey, Keri M.; Schrauwen, Isabelle; Narayanan, Vinodh; Huentelman, Matthew J.; Craig, David W.] Translat Genom Res Inst, Ctr Rare Childhood Disorders, Phoenix, AZ 85004 USA; [Szelinger, Szabolcs] Arizona State Univ, Coll Liberal Arts & Sci, Mol & Cellular Biol Interdisciplinary Grad Progra, Tempe, AZ USA; [Schrauwen, Isabelle] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Trent, Jeffrey M.] Translat Genom Res Inst, Genet Basis Human Dis Div, Phoenix, AZ USA; [Narayanan, Vinodh] Barrow Neurol Inst, Phoenix, AZ 85013 USA	Translational Genomics Research Institute; Arizona State University; Arizona State University-Tempe; University of Antwerp; Translational Genomics Research Institute; Barrow Neurological Institute	Craig, DW (corresponding author), Translat Genom Res Inst, Ctr Rare Childhood Disorders, Phoenix, AZ 85004 USA.	dcraig@tgen.org	Malenica, Ivana/J-2007-2019; Craig, David Wesley/K-6961-2019; Schrauwen, Isabelle/H-5908-2019	Malenica, Ivana/0000-0002-7404-8088; Craig, David Wesley/0000-0003-2040-1955; Schrauwen, Isabelle/0000-0001-7310-6082; Narayanan, Vinodh/0000-0002-0658-3847	TGen's Salt River Project (SRP) Graduate Student Support Program; FWO Vlaanderen; Stardust Foundation; TGen Foundation	TGen's Salt River Project (SRP) Graduate Student Support Program; FWO Vlaanderen(FWO); Stardust Foundation; TGen Foundation	SS is supported by TGen's Salt River Project (SRP) Graduate Student Support Program; IS is supported by FWO Vlaanderen. This study was funded by The Stardust Foundation, and multiple anonymous private donors via the TGen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Biliya S, 2010, EXP BIOL MED, V235, P139, DOI 10.1258/ebm.2009.009251; Bittel DC, 2008, J MED GENET, V45, P309, DOI 10.1136/jmg.2007.055244; Bordes L, 2007, COMPUT STAT DATA AN, V51, P5429, DOI 10.1016/j.csda.2006.08.015; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desai V, 2011, CLIN GENET, V79, P176, DOI 10.1111/j.1399-0004.2010.01451.x; Disteche CM, 1999, P NATL ACAD SCI USA, V96, P14180, DOI 10.1073/pnas.96.25.14180; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Hardcastle TJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-135; Hunter DR, 2007, ANN STAT, V35, P224, DOI 10.1214/009053606000001118; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li F, 2010, EUR J MED GENET, V53, P93, DOI 10.1016/j.ejmg.2010.01.004; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Liu PF, 2011, HUM MOL GENET, V20, P1975, DOI 10.1093/hmg/ddr078; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mangs AH, 2007, CURR GENOMICS, V8, P129, DOI 10.2174/138920207780368141; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Morgan DJ, 2010, J NEUROCHEM, V113, P1275, DOI 10.1111/j.1471-4159.2010.06706.x; Orstavik KH, 2009, HUM GENET, V126, P363, DOI 10.1007/s00439-009-0670-5; Plenge RM, 2002, AM J HUM GENET, V71, P168, DOI 10.1086/341123; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROZOWSKY J, 2011, MOL SYSTEMS BIOL, V7, P1, DOI DOI 10.1038/MSB.2011.54; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Sun W, 2012, BIOMETRICS, V68, P1, DOI 10.1111/j.1541-0420.2011.01654.x; Swierczek SI, 2008, BLOOD, V112, P3186, DOI 10.1182/blood-2008-03-143925; Swierczek SI, 2012, BLOOD, V119, pE100, DOI 10.1182/blood-2011-11-390351; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Young JI, 2004, AM J HUM GENET, V74, P511, DOI 10.1086/382228; Zhang YC, 2013, MOL BIOL EVOL, V30, P2588, DOI 10.1093/molbev/mst148; Zhou YH, 2011, BIOINFORMATICS, V27, P2672, DOI 10.1093/bioinformatics/btr449	52	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113036	10.1371/journal.pone.0113036	http://dx.doi.org/10.1371/journal.pone.0113036			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503791	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400005
J	Videnska, P; Sedlar, K; Lukac, M; Faldynova, M; Gerzova, L; Cejkova, D; Sisak, F; Rychlik, I				Videnska, Petra; Sedlar, Karel; Lukac, Maja; Faldynova, Marcela; Gerzova, Lenka; Cejkova, Darina; Sisak, Frantisek; Rychlik, Ivan			Succession and Replacement of Bacterial Populations in the Caecum of Egg Laying Hens over Their Whole Life	PLOS ONE			English	Article							SEROVAR ENTERITIDIS INFECTION; SALMONELLA COLONIZATION; COMPETITIVE-EXCLUSION; MICROBIOTA; CHICKENS; DIVERSITY; COMMUNITY; BUTYRATE; CELLS	In this study we characterised the development of caecal microbiota in egg laying hens over their commercial production lifespan, from the day of hatching until 60 weeks of age. Using pyrosequencing of V3/V4 variable regions of 16S rRNA genes for microbiota characterisation, we were able to define 4 different stages of caecal microbiota development. The first stage lasted for the first week of life and was characterised by a high prevalence of Enterobacteriaceae (phylum Proteobacteria). The second stage lasted from week 2 to week 4 and was characterised by nearly an absolute dominance of Lachnospiraceae and Ruminococcaceae (both phylum Firmicutes). The third stage lasted from month 2 to month 6 and was characterised by the succession of Firmicutes at the expense of Bacteroidetes. The fourth stage was typical for adult hens in full egg production aged 7 months or more and was characterised by a constant ratio of Bacteroidetes and Firmicutes formed by equal numbers of the representatives of both phyla.	[Videnska, Petra; Lukac, Maja; Faldynova, Marcela; Gerzova, Lenka; Cejkova, Darina; Sisak, Frantisek; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic; [Sedlar, Karel] Brno Univ Technol, CS-61090 Brno, Czech Republic	Czech Veterinary Research Institute; Brno University of Technology	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	, Ivan/GPS-9674-2022; Cejkova, Darina/AAA-5820-2022; Sedlar, Karel/K-1120-2014	, Ivan/0000-0001-7995-6483; Cejkova, Darina/0000-0002-6989-6330; Sedlar, Karel/0000-0002-8269-4020	Czech Ministry of Education [MZE0002716202, CZ.1.05/2.1.00/01.0006-ED0006/01/01]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the projects MZE0002716202 and HealthyGut of the Czech Ministry of Agriculture and AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Callaway TR, 2009, POULTRY SCI, V88, P298, DOI 10.3382/ps.2008-00222; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cressman MD, 2010, APPL ENVIRON MICROB, V76, P6572, DOI 10.1128/AEM.00180-10; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Hoszowski A, 1997, COMP IMMUNOL MICROB, V20, P111, DOI 10.1016/S0147-9571(96)00042-2; Juricova H, 2013, APPL ENVIRON MICROB, V79, P745, DOI 10.1128/AEM.02628-12; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Methner U, 1999, INT J FOOD MICROBIOL, V49, P35, DOI 10.1016/S0168-1605(99)00051-3; Methner U, 1997, INT J FOOD MICROBIOL, V35, P223, DOI 10.1016/S0168-1605(96)01236-6; Nordentoft S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-187; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Videnska P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110076; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang JY, 2013, ANAEROBE, V23, P74, DOI 10.1016/j.anaerobe.2013.06.012; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	38	107	115	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115142	10.1371/journal.pone.0115142	http://dx.doi.org/10.1371/journal.pone.0115142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501990	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400075
J	Song, P; Wei, HH; Cao, ZY; Wang, P; Zhu, GP				Song, Ping; Wei, Huanhuan; Cao, Zhengyu; Wang, Peng; Zhu, Guoping			Single Arginine Mutation in Two Yeast Isocitrate Dehydrogenases: Biochemical Characterization and Functional Implication	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; COMPARTMENTAL LOCALIZATION; IDH1; 2-HYDROXYGLUTARATE; INSIGHTS; REVEAL	Isocitrate dehydrogenase ( IDH), a housekeeping gene, has drawn the attention of cancer experts. Mutation of the catalytic Arg132 residue of human IDH1 (HcIDH) eliminates the enzyme's wild-type isocitrate oxidation activity, but confer the mutant an ability of reducing alpha-ketoglutarate (alpha-KG) to 2-hydroxyglutarate (2-HG). To examine whether an analogous mutation in IDHs of other eukaryotes could cause similar effects, two yeast mitochondrial IDHs, Saccharomyces cerevisiae NADP+IDH1 (ScIDH1) and Yarrowia lipolytica NADP(+)-IDH (YIIDH), were studied. The analogous Arg residues (Arg148 of ScIDH1 and Arg141 of YIIDH) were mutated to His. The K-m values of ScIDH1 R148H and YIIDH R141H for isocitrate were determined to be 2.4-fold and 2.2-fold higher, respectively, than those of the corresponding wild-type enzymes. The catalytic efficiencies (k(cat)/K-m) of ScIDH1 R148H and YIIDH R141H for isocitrate oxidation were drastically reduced by 227-fold and 460-fold, respectively, of those of the wild-type enzymes. As expected, both ScIDH1 R148H and YIIDH R141H acquired the neomorphic activity of catalyzing alpha-KG to 2-HG, and the generation of 2-HG was confirmed using gas chromatography/time of flight-mass spectrometry (GC/TOF-MS). Kinetic analysis showed that ScIDH1 R148H and YIIDH R141H displayed 5.2-fold and 3.3-fold higher affinities, respectively, for alpha-KG than the HcIDH R132H mutant. The catalytic efficiencies of ScIDH1 R148H and YIIDH R141H for a-KG were 5.5-fold and 4.5-fold, respectively, of that of the HcIDH R132H mutant. Since the HcIDH Arg132 mutation is associated with the tumorigenesis, this study provides fundamental information for further research on the physiological role of this IDH mutation in vivo using yeast.	[Song, Ping; Wei, Huanhuan; Cao, Zhengyu; Wang, Peng; Zhu, Guoping] Anhui Normal Univ, Inst Mol Biol & Biotechnol, Wuhu 241000, Anhui, Peoples R China	Anhui Normal University	Wang, P (corresponding author), Anhui Normal Univ, Inst Mol Biol & Biotechnol, 1 Beijing East Rd, Wuhu 241000, Anhui, Peoples R China.	wangpeng1219@gmail.com; gpz1996@yahoo.com	Wang, Peng/I-8770-2018	Wang, Peng/0000-0002-5598-0996	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31170005, 31400003]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424110004]; Natural Science Foundation of Anhui Province of China [1308085QC67]; Provincial Project of Natural Science Research for Colleges and Universities of Anhul Province of China [KJ2013A128]	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Anhui Province of China(Natural Science Foundation of Anhui Province); Provincial Project of Natural Science Research for Colleges and Universities of Anhul Province of China	This research was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31170005, 31400003), Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424110004), the Natural Science Foundation of Anhui Province of China (1308085QC67), and the Provincial Project of Natural Science Research for Colleges and Universities of Anhul Province of China (KJ2013A128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen C, 2013, GENE DEV, V27, P1974, DOI 10.1101/gad.226613.113; Contreras-Shannon V, 2004, ARCH BIOCHEM BIOPHYS, V423, P235, DOI 10.1016/j.abb.2003.12.038; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Guaragnella N, 2014, FEMS YEAST RES, V14, P2, DOI 10.1111/1567-1364.12094; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2009, FREE RADICAL RES, V43, P165, DOI 10.1080/10715760802653661; Li X, 2013, APPL BIOCHEM BIOTECH, V171, P403, DOI 10.1007/s12010-013-0373-1; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Lu Q, 2008, ARCH BIOCHEM BIOPHYS, V472, P17, DOI 10.1016/j.abb.2008.01.025; Lu Q, 2010, ARCH BIOCHEM BIOPHYS, V493, P125, DOI 10.1016/j.abb.2009.10.011; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McCammon MT, 2003, ARCH BIOCHEM BIOPHYS, V419, P222, DOI 10.1016/j.abb.2003.08.022; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Pereira C, 2012, FEBS J, V279, P697, DOI 10.1111/j.1742-4658.2012.08477.x; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Shin SW, 2008, BIOCHEM BIOPH RES CO, V366, P1012, DOI 10.1016/j.bbrc.2007.12.067; Soundar S, 2006, J BIOL CHEM, V281, P21073, DOI 10.1074/jbc.M602956200; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yang ES, 2011, BMB REP, V44, P312, DOI 10.5483/BMBRep.2011.44.5.312; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	30	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115025	10.1371/journal.pone.0115025	http://dx.doi.org/10.1371/journal.pone.0115025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502799	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700085
J	Soubeyran, P; Bellera, C; Goyard, J; Heitz, D; Cure, H; Rousselot, H; Albrand, G; Servent, V; Saint Jean, O; van Praagh, I; Kurtz, JE; Perin, S; Verhaeghe, JL; Terret, C; Desauw, C; Girre, V; Mertens, C; Mathoulin-Pelissier, S; Rainfray, M				Soubeyran, Pierre; Bellera, Carine; Goyard, Jean; Heitz, Damien; Cure, Herve; Rousselot, Hubert; Albrand, Gilles; Servent, Veronique; Saint Jean, Olivier; van Praagh, Isabelle; Kurtz, Jean-Emmanuel; Perin, Stephane; Verhaeghe, Jean-Luc; Terret, Catherine; Desauw, Christophe; Girre, Veronique; Mertens, Cecile; Mathoulin-Pelissier, Simone; Rainfray, Muriel			Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; DETECTING FUNCTIONAL IMPAIRMENT; RIGHT PRESCREENING TOOL; ELDERS SURVEY-13; BREAST-CANCER; CHEMOTHERAPY TOXICITY; INTERNATIONAL-SOCIETY; 1ST-LINE CHEMOTHERAPY; ONCOLOGY SIOG; OPEN QUESTION	Background: Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify the best screening tool to identify older cancer patients requiring geriatric assessment by comparing the performance of two short assessment tools the G8 and the Vulnerable Elders Survey (VES-13). Patients and Methods: The diagnostic accuracy of the G8 and the (VES-13) were evaluated in a prospective cohort study of 1674 cancer patients accrued before treatment in 23 health care facilities. 1435 were eligible and evaluable. Outcome measures were multidimensional geriatric assessment (MGA), sensitivity (primary), specificity, negative and positive predictive values and likelihood ratios of the G8 and VES-13, and predictive factors of 1-year survival rate. Results: Patient median age was 78.2 years (70-98) with a majority of females (69.8%), various types of cancer including 53.9% breast, and 75.8% Performance Status 0-1. Impaired MGA, G8, and VES-13 were 80.2%, 68.4%, and 60.2%, respectively. Mean time to complete G8 or VES-13 was about five minutes. Reproducibility of the two questionnaires was good. G8 appeared more sensitive (76.5% versus 68.7%, P5 0.0046) whereas VES-13 was more specific (74.3% versus 64.4%, P<0.0001). Abnormal G8 score (HR = 2.72), advanced stage (HR = 3.30), male sex (HR = 2.69) and poor Performance Status (HR = 3.28) were independent prognostic factors of 1-year survival. Conclusion: With good sensitivity and independent prognostic value on 1-year survival, the G8 questionnaire is currently one of the best screening tools available to identify older cancer patients requiring geriatric assessment, and we believe it should be implemented broadly in daily practice. Continuous research efforts should be pursued to refine the selection process of older cancer patients before potentially life-threatening therapy.	[Soubeyran, Pierre; Mertens, Cecile] Ctr Comprehens Canc, Inst Bergonie, Dept Med Oncol, Bordeaux, France; [Soubeyran, Pierre; Mathoulin-Pelissier, Simone; Rainfray, Muriel] Univ Bordeaux, Bordeaux, France; [Bellera, Carine; Mathoulin-Pelissier, Simone] Ctr Comprehens Canc, Inst Bergonie, Clin & Epidemiol Res Unit, Bordeaux, France; [Bellera, Carine; Mathoulin-Pelissier, Simone] INSERM, U897, Ctr Invest Clin CIC1401, Inst Bergonie, Bordeaux, France; [Goyard, Jean; van Praagh, Isabelle] Ctr Jean Perrin, Oncogeriatr Coordinat Unit, Clermont Ferrand, France; [Heitz, Damien; Kurtz, Jean-Emmanuel] CHU Strasbourg, Hop Hautepierre, Oncol & Hematol Unit, F-67000 Strasbourg, France; [Cure, Herve; Perin, Stephane] Inst Jean Godinot, Geriatr Unit, Reims, France; [Rousselot, Hubert] Inst Cancerol Lorraine Alexis Vautrin, Canc Support Unit, Vandoeuvre Les Nancy, France; [Albrand, Gilles] Antoine Charial Hosp, Geriatr Evaluat & Management Unit, Lyon, France; [Servent, Veronique] Ctr Oscar Lambret, Breast Canc Unit, F-59020 Lille, France; [Saint Jean, Olivier] Hop Europeen Georges Pompidou, Internal Med Unit, Paris, France; [Verhaeghe, Jean-Luc] Inst Cancerol Lorraine Alexis Vautrin, Surg Oncol Unit, Vandoeuvre Les Nancy, France; [Terret, Catherine] Ctr Leon Berard, Med Oncol Unit, F-69373 Lyon, France; [Desauw, Christophe] Univ Catholique Lille, Hop St Vincent de Paul, Senol Unit, Lille, France; [Girre, Veronique] Ctr Hosp Dept, Oncol & Haematol Unit, La Roche Sur Yon, France; [Mertens, Cecile; Rainfray, Muriel] Ctr Hosp Univ Bordeaux, Dept Clin Gerontol, Bordeaux, France	UNICANCER; Centre Eugene Marquis; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Centre Eugene Marquis; Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Centre Jean Perrin; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UNICANCER; Institut Jean Godinot; UNICANCER; Institut de cancerologie de Lorraine (ICL); CHU Lyon; UNICANCER; Centre Oscar Lambret; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut de cancerologie de Lorraine (ICL); UNICANCER; Centre Leon Berard; Universite Catholique de Lille; CHD Vendee; CHU Bordeaux	Soubeyran, P (corresponding author), Ctr Comprehens Canc, Inst Bergonie, Dept Med Oncol, Bordeaux, France.	p.soubeyran@bordeaux.unicancer.fr	Soubeyran, Pierre-Louis/F-4523-2012; MATHOULIN-PELISSIER, Simone/T-2385-2019; Rainfray, Muriel/T-4880-2019; Kurtz, Jean-Emmanuel/R-3286-2016	Soubeyran, Pierre-Louis/0000-0003-3244-7299; Bellera, Carine/0000-0001-7926-4671	French National Cancer Institute (Institute National du Cancer); SIRIC BRIO (Site de Recherche Integree sur le Cancer - Bordeaux Recherche Integree Oncologie) [INCa-DGOS-Inserm 6046]	French National Cancer Institute (Institute National du Cancer); SIRIC BRIO (Site de Recherche Integree sur le Cancer - Bordeaux Recherche Integree Oncologie)	The ONCODAGE project was funded by the French National Cancer Institute (Institute National du Cancer; http://www.e-cancer.fr/) and SIRIC BRIO (Site de Recherche Integree sur le Cancer - Bordeaux Recherche Integree Oncologie; grant INCa-DGOS-Inserm 6046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaldriks AA, 2011, CRIT REV ONCOL HEMAT, V79, P205, DOI 10.1016/j.critrevonc.2010.05.009; Barber J H, 1980, J R Coll Gen Pract, V30, P49; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; Biganzoli L, 2013, ANN ONCOL, V24, P494, DOI 10.1093/annonc/mds331; Biganzoli L, 2012, LANCET ONCOL, V13, pE148, DOI 10.1016/S1470-2045(11)70383-7; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Caillet P, 2011, J CLIN ONCOL, V29, P3636, DOI 10.1200/JCO.2010.31.0664; Cigolle CT, 2007, ANN INTERN MED, V147, P156, DOI 10.7326/0003-4819-147-3-200708070-00004; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dale W, 2012, JNCI-J NATL CANCER I, V104, P581, DOI 10.1093/jnci/djs145; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Extermann M, 2009, CRIT REV ONCOL HEMAT, V69, P183; Extermann M, 2011, SIOG 10 PRIORITIES; Extermann M, 2007, J CLIN ONCOL, V25, P1824, DOI 10.1200/JCO.2007.10.6559; Extermann M, 2012, CANCER-AM CANCER SOC, V118, P3377, DOI 10.1002/cncr.26646; Falci C, 2010, J CLIN ONCOL, V28, pE665, DOI 10.1200/JCO.2010.30.5573; Gosney MA, 2005, LANCET ONCOL, V6, P790, DOI 10.1016/S1470-2045(05)70389-2; Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0; Hoppe S, 2013, J CLIN ONCOL, V31, P3877, DOI 10.1200/JCO.2012.47.7430; Hurria A, 2005, CANCER-AM CANCER SOC, V104, P1998, DOI 10.1002/cncr.21422; Hurria A, 2011, J CLIN ONCOL, V29, P3457, DOI 10.1200/JCO.2011.34.7625; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Kanesvaran R, 2011, J CLIN ONCOL, V29, P3620, DOI 10.1200/JCO.2010.32.0796; Kellen E, 2010, CRIT REV ONCOL HEMAT, V75, P243, DOI 10.1016/j.critrevonc.2009.12.002; Luce S, 2012, J GERIATR ONCOL, V3, P351, DOI 10.1016/j.jgo.2012.06.003; Luciani A, 2013, ANN ONCOL, V24, P469, DOI 10.1093/annonc/mds471; Luciani A, 2010, J CLIN ONCOL, V28, pE667, DOI 10.1200/JCO.2010.30.7199; Luciani A, 2010, J CLIN ONCOL, V28, P2046, DOI 10.1200/JCO.2009.25.9978; Maione P, 2005, J CLIN ONCOL, V23, P6865, DOI 10.1200/JCO.2005.02.527; Mathoulin-Pelissier S, 2013, LANCET ONCOL, V14, pE1, DOI 10.1016/S1470-2045(12)70554-5; McNeil C, 2013, JNCI-J NATL CANCER I, V105, P585, DOI 10.1093/jnci/djt104; Mitka M, 2003, JAMA-J AM MED ASSOC, V290, P27, DOI 10.1001/jama.290.1.27; Mohile SG, 2007, CANCER-AM CANCER SOC, V109, P802, DOI 10.1002/cncr.22495; Molina-Garrido MJ, 2011, CRIT REV ONCOL HEMAT, V79, P51, DOI 10.1016/j.critrevonc.2010.06.004; Muss HB, 2005, JAMA-J AM MED ASSOC, V293, P1073, DOI 10.1001/jama.293.9.1073; Overcash JA, 2006, CRIT REV ONCOL HEMAT, V59, P205, DOI 10.1016/j.critrevonc.2006.04.003; Owusu C, 2011, J GERIATR ONCOL, V2, P121, DOI 10.1016/j.jgo.2010.12.002; Pallis AG, 2010, EUR J CANCER, V46, P1019, DOI 10.1016/j.ejca.2010.01.006; Pottel L, 2012, J GERIATR ONCOL, V3, P24, DOI 10.1016/j.jgo.2011.11.006; Rodin MB, 2007, J CLIN ONCOL, V25, P1936, DOI 10.1200/JCO.2006.10.2954; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Slaets JPJ, 2006, MED CLIN N AM, V90, P593, DOI 10.1016/j.mcna.2006.05.008; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Wedding U, 2007, J CANCER RES CLIN, V133, P945, DOI 10.1007/s00432-007-0233-x	44	292	298	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115060	10.1371/journal.pone.0115060	http://dx.doi.org/10.1371/journal.pone.0115060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503576	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700088
J	Demion, M; Thireau, J; Gueffier, M; Finan, A; Khoueiry, Z; Cassan, C; Serafini, N; Aimond, F; Granier, M; Pasquie, JL; Launay, P; Richard, S				Demion, Marie; Thireau, Jerome; Gueffier, Melanie; Finan, Amanda; Khoueiry, Ziad; Cassan, Cecile; Serafini, Nicolas; Aimond, Franck; Granier, Mathieu; Pasquie, Jean-Luc; Launay, Pierre; Richard, Sylvain			Trpm4 Gene Invalidation Leads to Cardiac Hypertrophy and Electrophysiological Alterations	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; HEART-RATE-VARIABILITY; MYOCYTE HYPERPLASIA; ATRIAL; CONDUCTION; CARDIOMYOCYTES; MICE; OVEREXPRESSION; PROLIFERATION; HYPERTENSION	Rationale: TRPM4 is a non-selective Ca2+-activated cation channel expressed in the heart, particularly in the atria or conduction tissue. Mutations in the Trpm4 gene were recently associated with several human conduction disorders such as Brugada syndrome. TRPM4 channel has also been implicated at the ventricular level, in inotropism or in arrhythmia genesis due to stresses such as beta-adrenergic stimulation, ischemia-reperfusion, and hypoxia re-oxygenation. However, the physiological role of the TRPM4 channel in the healthy heart remains unclear. Objectives: We aimed to investigate the role of the TRPM4 channel on whole cardiac function with a Trpm4 gene knock-out mouse (Trpm4(-/-)) model. Methods and Results: Morpho-functional analysis revealed left ventricular (LV) eccentric hypertrophy in Trpm4(-/-)mice, with an increase in both wall thickness and chamber size in the adult mouse (aged 32 weeks) when compared to Trpm4(+/+) littermate controls. Immunofluorescence on frozen heart cryosections and qPCR analysis showed no fibrosis or cellular hypertrophy. Instead, cardiomyocytes in Trpm4(-/-) mice were smaller than Trpm4(+/+) with a higher density. Immunofluorescent labeling for phospho-histone H3, a mitosis marker, showed that the number of mitotic myocytes was increased 3-fold in the Trpm4(-/-) neonatal stage, suggesting hyperplasia. Adult Trpm4(-/-) mice presented multilevel conduction blocks, as attested by PR and QRS lengthening in surface ECGs and confirmed by intracardiac exploration. Trpm4(-/-) mice also exhibited Luciani-Wenckebach atrioventricular blocks, which were reduced following atropine infusion, suggesting paroxysmal parasympathetic overdrive. In addition, Trpm4(-/-) mice exhibited shorter action potentials in atrial cells. This shortening was unrelated to modifications of the voltage-gated Ca2+ or K+ currents involved in the repolarizing phase. Conclusions: TRPM4 has pleiotropic roles in the heart, including the regulation of conduction and cellular electrical activity which impact heart development.	[Demion, Marie; Thireau, Jerome; Gueffier, Melanie; Finan, Amanda; Khoueiry, Ziad; Cassan, Cecile; Aimond, Franck; Granier, Mathieu; Pasquie, Jean-Luc; Richard, Sylvain] Univ Montpellier 2, Univ Montpellier 1, INSERM U1046, Montpellier, France; [Serafini, Nicolas; Launay, Pierre] Univ Paris 07, INSERM U1149, Equipe Avenir, Paris, France; [Pasquie, Jean-Luc] CHRU Montpellier, Serv Cardiol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier	Launay, P (corresponding author), Univ Paris 07, INSERM U1149, Equipe Avenir, Paris, France.	pierre.launay@inserm.fr; sylvain.richard@inserm.fr	AIMOND, Franck/B-6024-2017; Launay, Pierre/AAH-7076-2019; marie, Demion/Q-8215-2016; Richard, Sylvain/C-9695-2016; Thireau, Jerome/C-5579-2016; SERAFINI, nicolas/S-5675-2019; Pasquié, Jean Luc/O-2216-2018	AIMOND, Franck/0000-0001-9124-0066; Thireau, Jerome/0000-0002-1641-5142; SERAFINI, nicolas/0000-0002-7440-4353; Pasquié, Jean Luc/0000-0003-3773-5804; Demion, Marie/0000-0003-4777-0654; Richard, Sylvain/0000-0001-9460-6705; Cassan, Cecile/0000-0003-2205-8222	Universite Montpellier; Agence Nationale de la Recherche ("Target channel'') [RPV09046FSA]; Agence Nationale de la Recherche ("Beat-genesis") [1128 03]; Region Languedoc-Roussillon (GEPETOS)	Universite Montpellier; Agence Nationale de la Recherche ("Target channel'')(French National Research Agency (ANR)); Agence Nationale de la Recherche ("Beat-genesis")(French National Research Agency (ANR)); Region Languedoc-Roussillon (GEPETOS)(Region Occitanie)	MD SR, grant from Universite Montpellier 2; PL MD SR, grant from Agence Nationale de la Recherche ("Target channel''; RPV09046FSA); SR, grant from Agence Nationale de la Recherche ("Beat-genesis" 2010 blanc 1128 03"); SR, grant from Region Languedoc-Roussillon (GEPETOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have	Abriel H, 2012, BIOCHEM PHARMACOL, V84, P873, DOI 10.1016/j.bcp.2012.06.021; Bagwe S, 2005, CIRCULATION, V112, P2245, DOI 10.1161/CIRCULATIONAHA.104.527325; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Brodde OE, 1999, PHARMACOL REV, V51, P651; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Burt R, 2013, CELL CALCIUM, V54, P193, DOI 10.1016/j.ceca.2013.06.003; Chang KTE, 2010, HUM PATHOL, V41, P1002, DOI 10.1016/j.humpath.2009.12.008; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; DESIMONE G, 1987, AM J CARDIOL, V60, P1317, DOI 10.1016/0002-9149(87)90614-X; Dhingra R, 2005, J AM COLL CARDIOL, V45, P685, DOI 10.1016/j.jacc.2004.11.046; Du Y, 2010, AM J PATHOL, V177, P1155, DOI 10.2353/ajpath.2010.090587; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Fauconnier J, 2010, PROG BIOPHYS MOL BIO, V103, P71, DOI 10.1016/j.pbiomolbio.2010.01.002; FERRANS VJ, 1987, Z KARDIOL, V76, P20; Gemel J, 2014, J MOL CELL CARDIOL, V76, P159, DOI 10.1016/j.yjmcc.2014.08.021; Guinamard R, 2004, J PHYSIOL-LONDON, V558, P75, DOI 10.1113/jphysiol.2004.063974; Guinamard R, 2002, J MEMBRANE BIOL, V188, P127, DOI 10.1007/s00232-001-0180-4; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Hof T, 2013, HEART RHYTHM, V10, P1683, DOI 10.1016/j.hrthm.2013.08.014; Just A, 2000, AM J PHYSIOL-REG I, V279, pR2214, DOI 10.1152/ajpregu.2000.279.6.R2214; Kreuzberg MM, 2006, TRENDS CARDIOVAS MED, V16, P266, DOI 10.1016/j.tcm.2006.05.002; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; LUTAS EM, 1985, HYPERTENSION, V7, P979, DOI 10.1161/01.HYP.7.6.979; Mansier P, 1996, CARDIOVASC RES, V31, P371; Mathar I, 2014, CIRC RES, V114, P283, DOI 10.1161/CIRCRESAHA.114.302835; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Mironov SL, 2011, J NEUROCHEM, V117, P295, DOI 10.1111/j.1471-4159.2011.07202.x; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Ng SY, 2010, AM J PHYSIOL-CELL PH, V299, pC1234, DOI 10.1152/ajpcell.00402.2009; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; OLIVETTI G, 1992, AM J PATHOL, V141, P227; Richard S, 2006, PROG BIOPHYS MOL BIO, V90, P118, DOI 10.1016/j.pbiomolbio.2005.05.005; Royuela M, 2003, EUR J HISTOCHEM, V47, P29; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sah R, 2013, CIRCULATION, V128, P101, DOI 10.1161/CIRCULATIONAHA.112.000768; Silverman ME, 2004, CIRCULATION, V110, P1162, DOI 10.1161/01.CIR.0000140669.35049.34; Simard C, 2013, J MOL CELL CARDIOL, V59, P11, DOI 10.1016/j.yjmcc.2013.01.019; Simard Christophe, 2012, Br J Pharmacol, V165, P2354, DOI 10.1111/j.1476-5381.2011.01715.x; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Stull LB, 2006, PFLUG ARCH EUR J PHY, V452, P140, DOI 10.1007/s00424-005-0020-y; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Thireau J, 2010, ENDOCRINOLOGY, V151, P1837, DOI 10.1210/en.2009-1184; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Tseng YT, 2001, FASEB J, V15, P1921, DOI 10.1096/fj.01-0151com; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Vanderbrink BA, 2000, J CARDIOVASC ELECTR, V11, P1270, DOI 10.1046/j.1540-8167.2000.01270.x; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; WANG J, 2013, PLOS GENET, V9, P70587, DOI DOI 10.1371/JOURNAL.PONE.0070587; Waters SB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00011; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9	59	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e115256	10.1371/journal.pone.0115256	http://dx.doi.org/10.1371/journal.pone.0115256			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531103	Green Published, gold			2022-12-27	WOS:000348845100046
J	Cagavi, E; Bartulos, O; Suh, CY; Sun, BN; Yue, ZC; Jiang, ZX; Yue, LX; Qyang, YB				Cagavi, Esra; Bartulos, Oscar; Suh, Carol Y.; Sun, Baonan; Yue, Zhichao; Jiang, Zhengxin; Yue, Lixia; Qyang, Yibing			Functional Cardiomyocytes Derived from Isl1 Cardiac Progenitors via Bmp4 Stimulation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SMOOTH-MUSCLE; CARDIOVASCULAR PROGENITORS; DEVELOPING HEART; DIFFERENTIATION; MULTIPOTENT; MOUSE; EXPRESSION; RENEWAL; PATHWAY	As heart failure due to myocardial infarction remains a leading cause of morbidity worldwide, cell-based cardiac regenerative therapy using cardiac progenitor cells (CPCs) could provide a potential treatment for the repair of injured myocardium. As adult CPCs may have limitations regarding tissue accessibility and proliferative ability, CPCs derived from embryonic stem cells (ESCs) could serve as an unlimited source of cells with high proliferative ability. As one of the CPCs that can be derived from embryonic stem cells, Isl1 expressing cardiac progenitor cells (Isl1-CPCs) may serve as a valuable source of cells for cardiac repair due to their high cardiac differentiation potential and authentic cardiac origin. In order to generate an unlimited number of Isl1-CPCs, we used a previously established an ESC line that allows for isolation of Isl1-CPCs by green fluorescent protein (GFP) expression that is directed by the mef2c gene, specifically expressed in the Isl1 domain of the anterior heart field. To improve the efficiency of cardiac differentiation of Isl1-CPCs, we studied the role of Bmp4 in cardiogenesis of Isl1-CPCs. We show an inductive role of Bmp directly on cardiac progenitors and its enhancement on early cardiac differentiation of CPCs. Upon induction of Bmp4 to Isl1-CPCs during differentiation, the cTnT+ cardiomyocyte population was enhanced 2.8 +/- 0.4 fold for Bmp4 treated CPC cultures compared to that detected for vehicle treated cultures. Both Bmp4 treated and untreated cardiomyocytes exhibit proper electrophysiological and calcium signaling properties. In addition, we observed a significant increase in Tbx5 and Tbx20 expression in differentiation cultures treated with Bmp4 compared to the untreated control, suggesting a link between Bmp4 and Tbx genes which may contribute to the enhanced cardiac differentiation in Bmp4 treated cultures. Collectively these findings suggest a cardiomyogenic role for Bmp4 directly on a pure population of Isl1 expressing cardiac progenitors, which could lead to enhancement of cardiac differentiation and engraftment, holding a significant therapeutic value for cardiac repair in the future.	[Cagavi, Esra; Bartulos, Oscar; Suh, Carol Y.; Jiang, Zhengxin; Qyang, Yibing] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Yale Cell Ctr,Sect Cardio, New Haven, CT 06510 USA; [Cagavi, Esra] Istanbul Medipol Univ, Sch Med, Dept Med Biol, Istanbul, Turkey; [Suh, Carol Y.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Sun, Baonan; Yue, Zhichao; Yue, Lixia] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT USA; [Qyang, Yibing] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Qyang, Yibing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA	Yale University; Istanbul Medipol University; Yale University; University of Connecticut; Yale University; Yale University	Qyang, YB (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr,Yale Cell Ctr,Sect Cardio, New Haven, CT 06510 USA.	yibing.qyang@yale.edu		Cagavi, Esra/0000-0002-7199-583X; Bartulos Encinas, Oscar/0000-0003-0790-8583; Jiang, Zhengxin/0000-0002-0338-1481	AHA [09SDG2080420]; Connecticut Stem Cell Program [09SCAYALE10, 10SCA35, 11SCB18]; NIH [1K02HL116705-01, UL1 RR024139, R01HL078960]; National Science Foundation [DGE-1122492]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116705, K02HL101990, R01HL078960] Funding Source: NIH RePORTER	AHA(American Heart Association); Connecticut Stem Cell Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by AHA 09SDG2080420 (http://www.heart.org/HEARTORG/), Connecticut Stem Cell Program 09SCAYALE10, 10SCA35, 11SCB18 (http://www.ct.gov/dph/cwp/view.asp?a=3142&q=389700), NIH 1K02HL116705-01 and NIH UL1 RR024139/CTSA Scholar Award (http://grants.nih.gov/grants/guide/index.html)(Y. Qyang), National Science Foundation Graduate Research Fellowship DGE-1122492 (http://www.nsfgrfp.org/)(C. Suh) and NIH R01HL078960 (http://grants.nih.gov/grants/guide/index.html)(L. Yue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee MO, 2013, P NATL ACAD SCI USA, V110, pE3281, DOI 10.1073/pnas.1303669110; Lee MY, 2011, BIOCHEM BIOPH RES CO, V416, P51, DOI 10.1016/j.bbrc.2011.10.140; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Mejia-Luna L, 2004, J PHYSIOL-LONDON, V559, P41, DOI 10.1113/jphysiol.2004.066852; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Musunuru K, 2010, ANNU REV CELL DEV BI, V26, P667, DOI 10.1146/annurev-cellbio-100109-103948; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nsair A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045603; Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; RUZICKA DL, 1988, J CELL BIOL, V107, P2575, DOI 10.1083/jcb.107.6.2575; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shen T, 2011, J CLIN INVEST, V110, DOI [10.1172/JCI59472.4640, DOI 10.1172/JCI59472.4640]; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Swapna I, 2012, P NATL ACAD SCI USA, V109, P16336, DOI 10.1073/pnas.1202818109; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	43	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e110752	10.1371/journal.pone.0110752	http://dx.doi.org/10.1371/journal.pone.0110752			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522363	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600001
J	Cheng, DS; Fei, Y; Liu, YM; Li, JH; Xue, Q; Wang, XX; Wang, NS				Cheng, Dongsheng; Fei, Yang; Liu, Yumei; Li, Junhui; Xue, Qin; Wang, Xiaoxia; Wang, Niansong			HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A Meta-Analysis	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; MICROVASCULAR COMPLICATIONS; HBA(1C) VARIABILITY; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; TYPE-2; NEPHROPATHY; PUBLICATION; ASSOCIATION; MORTALITY	Objective: To explore the association between glycated hemoglobin (A1C) variability and renal disease progression in patients with diabetes mellitus. Methods: A comprehensive search was performed using the PubMed and Embase databases (up to April 26, 2014). The hazard ratio (HR) was pooled per unit increase in the standard deviation of A1C (A1C-SD) to evaluate the dose-response relationship between A1C-SD and the risk of nephropathy. Results: Eight studies with a total of 17,758 subjects provided the HR for A1C-SD and were included in the final meta-analysis. The pooled HR results demonstrated that A1C-SD was significantly associated with the progression of renal status (HR for both T1DM and T2DM 1.43, 95% confidence interval [CI] 1.24-1.64; HR for T1DM 1.70, 95% CI 1.41-2.05; HR for T2DM 1.20, 95% CI 1.12-1.28). A1C-SD was significantly correlated with new-onset microalbuminuria (HR for T1DM 1.63, 95% CI 1.28-2.07; HR for T2DM 1.23, 95% CI 1.08-1.39). These outcomes were also supported in subgroup analyses. Furthermore, sensitivity analyses demonstrated that the results were robust. Conclusions: A1C variability is independently associated with the development of microalbuminuria and the progression of renal status in both type 1 and 2 diabetes patients. A standard method for measuring A1C variability is essential for further and deeper analyses. In addition, future studies should assess the effect of reducing A1C variability on nephropathy complication.	[Cheng, Dongsheng; Fei, Yang; Liu, Yumei; Li, Junhui; Xue, Qin; Wang, Xiaoxia; Wang, Niansong] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University	Wang, NS (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai 200233, Peoples R China.	wangniansong2012@163.com			Project of National Nature Science Foundation of China [81270824]; Shanghai Science and Technology Project [11DZ1921904, 11410708500]	Project of National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Project	This research is supported by grants from the Project of National Nature Science Foundation of China (81270824), Shanghai Science and Technology Project (11DZ1921904 and 11410708500). The funders played no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cavalot F, 2013, DIABETES OBES METAB, V15, pS3; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu CC, 2012, DIABETOLOGIA, V55, P3163, DOI 10.1007/s00125-012-2700-4; Kilpatrick ES, 2008, DIABETES CARE, V31, P2198, DOI 10.2337/dc08-0864; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kilpatrick ES, 2009, DIABETES CARE, V32, P1901, DOI [10.2337/dc09-0109, 10.2337/dc09-1231]; Lin CC, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.015; Luk AOY, 2013, DIABETES-METAB RES, V29, P384, DOI 10.1002/dmrr.2404; Marcovecchio ML, 2011, DIABETES CARE, V34, P1011, DOI 10.2337/dc10-2028; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45; Muggeo M, 1997, CIRCULATION, V96, P1750, DOI 10.1161/01.CIR.96.6.1750; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Penno G, 2013, DIABETES CARE, V36, P2301, DOI 10.2337/dc12-2264; Raman S, 2011, AM DIAB ASS ADA 71 S; Rodriguez-Segade S, 2012, DIABETIC MED, V29, P1562, DOI 10.1111/j.1464-5491.2012.03767.x; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Siegelaar SE, 2009, DIABETOLOGIA, V52, P2229, DOI 10.1007/s00125-009-1473-x; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sugawara A, 2012, DIABETOLOGIA, V55, P2128, DOI 10.1007/s00125-012-2572-7; Tonna S, 2010, NAT REV NEPHROL, V6, P332, DOI 10.1038/nrneph.2010.55; Waden J, 2009, DIABETES, V58, P2649, DOI 10.2337/db09-0693; Wells G.A., NEWCASTLE OTTAWA SCA	30	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115509	10.1371/journal.pone.0115509	http://dx.doi.org/10.1371/journal.pone.0115509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521346	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600052
J	Loizides-Mangold, U; Clement, S; Alfonso-Garcia, A; Branche, E; Conzelmann, S; Parisot, C; Potma, EO; Riezman, H; Negro, F				Loizides-Mangold, Ursula; Clement, Sophie; Alfonso-Garcia, Alba; Branche, Emilie; Conzelmann, Stephanie; Parisot, Clotilde; Potma, Eric O.; Riezman, Howard; Negro, Francesco			HCV 3a Core Protein Increases Lipid Droplet Cholesteryl Ester Content via a Mechanism Dependent on Sphingolipid Biosynthesis	PLOS ONE			English	Article							C VIRUS-INFECTION; TRIGLYCERIDE TRANSFER PROTEIN; ACTIVATED-RECEPTOR-ALPHA; CHRONIC HEPATITIS-C; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; MASS-SPECTROMETRY; TRANSGENIC MICE; IN-VITRO; STEATOSIS	Hepatitis C virus (HCV) infected patients often develop steatosis and the HCV core protein alone can induce this phenomenon. To gain new insights into the pathways leading to steatosis, we performed lipidomic profiling of HCV core protein expressing-Huh-7 cells and also assessed the lipid profile of purified lipid droplets isolated from HCV 3a core expressing cells. Cholesteryl esters, ceramides and glycosylceramides, but not triglycerides, increased specifically in cells expressing the steatogenic HCV 3a core protein. Accordingly, inhibitors of cholesteryl ester biosynthesis such as statins and acyl-CoA cholesterol acyl transferase inhibitors prevented the increase of cholesteryl ester production and the formation of large lipid droplets in HCV core 3a-expressing cells. Furthermore, inhibition of de novo sphingolipid biosynthesis by myriocin - but not of glycosphingolipid biosynthesis by miglustat - affected both lipid droplet size and cholesteryl ester level. The lipid profile of purified lipid droplets, isolated from HCV 3a core-expressing cells, confirmed the particular increase of cholesteryl ester. Thus, both sphingolipid and cholesteryl ester biosynthesis are affected by the steatogenic core protein of HCV genotype 3a. These results may explain the peculiar lipid profile of HCV-infected patients with steatosis.	[Clement, Sophie; Branche, Emilie; Conzelmann, Stephanie; Parisot, Clotilde; Negro, Francesco] Univ Geneva, Sch Med, Univ Hosp, Div Clin Pathol, CH-1211 Geneva, Switzerland; [Negro, Francesco] Univ Geneva, Sch Med, Univ Hosp, Div Gastroenterol, CH-1211 Geneva, Switzerland; [Negro, Francesco] Univ Geneva, Sch Med, Univ Hosp, Div Hepatol, CH-1211 Geneva, Switzerland; [Loizides-Mangold, Ursula; Riezman, Howard] Univ Geneva, Dept Biochem, NCCR Chem Biol, CH-1211 Geneva, Switzerland; [Alfonso-Garcia, Alba; Potma, Eric O.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of California System; University of California Irvine	Negro, F (corresponding author), Univ Geneva, Sch Med, Univ Hosp, Div Clin Pathol, CH-1211 Geneva, Switzerland.	francesco.negro@hcuge.ch	Loizides-Mangold, Ursula/I-9061-2014	Loizides-Mangold, Ursula/0000-0001-9233-2974; Riezman, Howard/0000-0003-4680-9422; Alfonso-Garcia, Alba/0000-0002-6748-3751	University of Geneva; Swiss National Science Foundation; NCCR Chemical Biology and SystemsX.ch; SNSF [314730-130498, 314730-146991]; FLAGS Foundation; Balsells Fellowship Program	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology and SystemsX.ch; SNSF(Swiss National Science Foundation (SNSF)); FLAGS Foundation; Balsells Fellowship Program	This work was supported by the University of Geneva; by the Swiss National Science Foundation (SNSF, http://www.snf.ch); the NCCR Chemical Biology and SystemsX.ch (http://www.systemsx.ch) evaluated by the SNSF to HR; by the SNSF (grants 314730-130498 and 314730-146991) to FN; by the FLAGS Foundation to SC and FN; and by the Balsells Fellowship Program to EOP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287; [Anonymous], 2014, HEPATOLOGY; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Binns D, 2006, J CELL BIOL, V173, P719, DOI 10.1083/jcb.200511125; Birnbaum Y, 2014, CARDIOVASC DRUG THER, V28, P447, DOI 10.1007/s10557-014-6546-5; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Clement S, 2008, HEPATOLOGY, V48, P799, DOI 10.1002/hep.22404; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; De Gottardi A, 2006, ALIMENT PHARM THER, V23, P107, DOI 10.1111/j.1365-2036.2006.02729.x; Dharancy S, 2005, GASTROENTEROLOGY, V128, P334, DOI 10.1053/j.gastro.2004.11.016; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Forde KA, 2009, WORLD J GASTROENTERO, V15, P5020, DOI 10.3748/wjg.15.5020; Goswami R, 2005, J NEUROSCI RES, V81, P541, DOI 10.1002/jnr.20550; Grebely J, 2011, SEMIN LIVER DIS, V31, P331, DOI 10.1055/s-0031-1297922; Guan XL, 2010, METHOD ENZYMOL, V470, P369, DOI 10.1016/S0076-6879(10)70015-X; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603; Kim SS, 2007, GASTROENTEROLOGY, V132, P311, DOI 10.1053/j.gastro.2006.10.032; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Loizides-Mangold U, 2012, J LIPID RES, V53, P1522, DOI 10.1194/jlr.M025692; Machado MV, 2011, J GASTROEN HEPATOL, V26, P1361, DOI 10.1111/j.1440-1746.2011.06801.x; McPherson S, 2008, J HEPATOL, V49, P1046, DOI 10.1016/j.jhep.2008.06.022; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Mirandola S, 2006, GASTROENTEROLOGY, V130, P1661, DOI 10.1053/j.gastro.2006.02.035; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Moriya K, 2001, BIOCHEM BIOPH RES CO, V281, P1207, DOI 10.1006/bbrc.2001.4523; MURATA T, 1973, ANAL CHEM, V45, P1816, DOI 10.1021/ac60333a032; Nakamuta M, 2009, INT J MOL MED, V24, P825, DOI 10.3892/ijmm_00000299; Naples M, 2008, ATHEROSCLEROSIS, V198, P94, DOI 10.1016/j.atherosclerosis.2007.11.003; Nelson A, 2009, J CLIN GASTROENTEROL, V43, P990, DOI 10.1097/MCG.0b013e31819c392e; O'Leary JG, 2007, HEPATOLOGY, V45, P895, DOI 10.1002/hep.21554; Oem JK, 2008, J GEN VIROL, V89, P1225, DOI 10.1099/vir.0.83491-0; Perlemuter G, 2002, FASEB J, V16, P185, DOI 10.1096/fj.01-0396com; Peyrou M, 2013, J HEPATOL, V59, P420, DOI 10.1016/j.jhep.2013.04.012; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Qiang G, 2009, VIRUS RES, V139, P127, DOI 10.1016/j.virusres.2008.10.008; Rabionet M, 2013, J LIPID RES, V54, P3312, DOI 10.1194/jlr.M040097; Read SA, 2014, J GEN VIROL, V95, P1900, DOI 10.1099/vir.0.065300-0; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schrader M, 2001, J HISTOCHEM CYTOCHEM, V49, P1421, DOI 10.1177/002215540104901110; Serfaty L, 2001, J HEPATOL, V34, P428, DOI 10.1016/S0168-8278(00)00036-2; Sezaki H, 2009, INTERVIROLOGY, V52, P43, DOI 10.1159/000213504; Sugiyama K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094460; Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yamaguchi A, 2005, DIGEST DIS SCI, V50, P1361, DOI 10.1007/s10620-005-2788-1; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008	61	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115309	10.1371/journal.pone.0115309	http://dx.doi.org/10.1371/journal.pone.0115309			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522003	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600033
J	Nasel, C; Kalcher, K; Boubela, R; Moser, E				Nasel, Christian; Kalcher, Klaudius; Boubela, Roland; Moser, Ewald			Improved Quantification of Cerebral Hemodynamics Using Individualized Time Thresholds for Assessment of Peak Enhancement Parameters Derived from Dynamic Susceptibility Contrast Enhanced Magnetic Resonance Imaging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; BLOOD-FLOW; PERFUSION; STROKE; MISMATCH; REPERFUSION; DIFFUSION; MAPS	Purpose: Assessment of cerebral ischemia often employs dynamic susceptibility contrast enhanced magnetic resonance imaging (DSC-MRI) with evaluation of various peak enhancement time parameters. All of these parameters use a single time threshold to judge the maximum tolerable peak enhancement delay that is supposed to reliably differentiate sufficient from critical perfusion. As the validity of this single threshold approach still remains unclear, in this study, (1) the definition of a threshold on an individual patient-basis, nevertheless (2) preserving the comparability of the data, was investigated. Methods: The histogram of time-to-peak (TTP) values derived from DSC-MRI, the so-called TTP-distribution curve (TDC), was modeled using a double-Gaussian model in 61 patients without severe cerebrovascular disease. Particular modelbased zf-scores were used to describe the arterial, parenchymal and venous bolustransit phase as time intervals I-a,I-p,I-v. Their durations (delta I-a,I-p,I-v), were then considered as maximum TTP-delays of each phase. Results: Mean-R2 for the model-fit was 0.967. Based on the generic zf-scores the proposed bolus transit phases could be differentiated. The I-p-interval reliably depicted the parenchymal bolus-transit phase with durations of 3.4 s-10.1 s (median = 4.3s), where an increase with age was noted (similar to 30 ms/year). Conclusion: Individual threshold-adjustment seems rational since regular bolustransit durations in brain parenchyma obtained from the TDC overlap considerably with recommended critical TTP-thresholds of 4 s-8 s. The parenchymal transit time derived from the proposed model may be utilized to individually correct TTP-thresholds, thereby potentially improving the detection of critical perfusion.	[Nasel, Christian] Karl Landsteiner Univ Hlth Sci, Univ Hosp Tulln, Dept Radiol, Tulln, Austria; [Nasel, Christian; Kalcher, Klaudius; Boubela, Roland; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Nasel, Christian; Kalcher, Klaudius; Boubela, Roland; Moser, Ewald] Med Univ Vienna, MR Ctr Excellence, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Nasel, C (corresponding author), Karl Landsteiner Univ Hlth Sci, Univ Hosp Tulln, Dept Radiol, Tulln, Austria.	christian.nasel@meduniwien.ac.at	Moser, Ewald/B-3666-2013	Moser, Ewald/0000-0001-8278-9583; Nasel, Christian/0000-0002-1418-7924; Boubela, Roland/0000-0002-2870-0282; Kalcher, Klaudius/0000-0003-4558-7987				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Carroll TJ, 2002, J CEREBR BLOOD F MET, V22, P1149, DOI 10.1097/00004647-200209000-00013; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Forkert ND, 2013, AM J NEURORADIOL, V34, P1697, DOI 10.3174/ajnr.A3460; FRALEY C, 2006, 504 U WASH DEP STAT; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Grun B, 2008, J STAT SOFTW, V28, P1; Hales PW, 2014, J CEREBR BLOOD F MET, V34, P776, DOI 10.1038/jcbfm.2014.17; Ibaraki Masanobu, 2005, Magn Reson Med Sci, V4, P27, DOI 10.2463/mrms.4.27; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; Kane I, 2007, STROKE, V38, P3158, DOI 10.1161/STROKEAHA.107.483842; Krayenbuahl HA., 1982, CEREBRAL ANGIOGRAPHY; Kreitner KF, 2005, ROFO-FORTSCHR RONTG, V177, P646, DOI 10.1055/s-2005-858091; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Ma H, 2012, INT J STROKE, V7, P74, DOI 10.1111/j.1747-4949.2011.00730.x; Nasel C, 2000, AM J NEURORADIOL, V21, P1195; Nasel C, 2005, EUR J RADIOL, V55, P219, DOI 10.1016/j.ejrad.2004.11.008; Nasel C, 2004, AM J NEURORADIOL, V25, P945; Nasel C, 2001, AM J NEURORADIOL, V22, P1056; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Perthen JE, 2002, MAGN RESON MED, V47, P61, DOI 10.1002/mrm.10020; R Core Team, 2018, R LANG ENV STAT COMP; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Shih LC, 2003, STROKE, V34, P1425, DOI 10.1161/01.STR.0000072998.70087.E9; Sobesky J, 2004, STROKE, V35, P2843, DOI 10.1161/01.STR.0000147043.29399.f6; Thijs VN, 2004, STROKE, V35, P94, DOI 10.1161/01.STR.0000106136.15163.73; WICHURA MJ, 1988, J R STAT SOC C-APPL, V37, P477, DOI 10.2307/2347330; Yamada K, 2002, STROKE, V33, P87, DOI 10.1161/hs0102.101893; Zaro-Weber O, 2010, STROKE, V41, P2817, DOI 10.1161/STROKEAHA.110.594432; Zaro-Weber O, 2009, STROKE, V40, P2413, DOI 10.1161/STROKEAHA.108.540914	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114999	10.1371/journal.pone.0114999	http://dx.doi.org/10.1371/journal.pone.0114999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521121	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600014
J	Giusca, S; Kelle, S; Nagel, E; Buss, SJ; Puntmann, V; Wellnhofer, E; Fleck, E; Katus, HA; Korosoglou, G				Giusca, Sorin; Kelle, Sebastian; Nagel, Eike; Buss, Sebastian Johannes; Puntmann, Valentina; Wellnhofer, Ernst; Fleck, Eckart; Katus, Hugo Albert; Korosoglou, Grigorios			Ischemic Burden and Clinical Outcome: Is One 'Culprit' Ischemic Segment by Dobutamine Stress Magnetic Resonance Predictive?	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; ACUTE MYOCARDIAL-INFARCTION; OPTIMAL MEDICAL THERAPY; PROGNOSTIC VALUE; WALL-MOTION; EXERCISE ECHOCARDIOGRAPHY; DIAGNOSTIC PERFORMANCE; CONSECUTIVE PATIENTS; HEART-DISEASE	Aims: We sought to evaluate the impact of ischemic burden for the prediction of hard cardiac events (cardiac death or nonfatal myocardial infarction) in patients with known or suspected CAD who undergo dobutamine stress cardiac magnetic resonance imaging (DCMR) Methods: We included 3166 patients (pts.), mean age 63 +/- 12 years, 27% female, who underwent DCMR in 3 tertiary cardiac centres (University Hospital Heildelberg, German Heart Institute and Kings College London). Pts. were separated in groups based on the number of ischemic segments by wall motion abnormalities (WMA) as follows: 1. no ischemic segment, 2. one ischemic segment, 3. two ischemic segments and 4. >= three ischemic segments. Cardiac death and nonfatal myocardial infarction were registered as hard cardiac events. Pts. with an "early" revascularization procedure (in the first three months after DCMR) were not included in the final survival analysis. Results: Pts. were followed for a median of 3.1 years (iqr 2-4.5 years). 187 (5.9%) pts. experienced hard cardiac events. 2349 (74.2%) had no inducible ischemia, 189 (6%) had ischemia in 1 segment, 292 (9.2%) in 2 segments and 336 (10.6%) >= 3 segments. Patients with only 1 ischemic segment showed a high rate of hard cardiac events of similar to 6% annually, which was 10-fold higher compared to those without ischemia (0.6% annually, p < 0.001) but similar to those with 2 and >= 3ischemic segments (similar to 5.5% and similar to 7%, p=NS). Conclusions: The presence of inducible ischemia even in a single 'culprit' myocardial segment during DCMR is enough to predict hard cardiac events in patients with known or suspected CAD.	[Giusca, Sorin; Buss, Sebastian Johannes; Katus, Hugo Albert; Korosoglou, Grigorios] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Kelle, Sebastian; Wellnhofer, Ernst; Fleck, Eckart] German Heart Inst, Dept Internal Med Cardiol, Berlin, Germany; [Nagel, Eike; Puntmann, Valentina] Kings Coll London, Div Imaging Sci, London, England	Ruprecht Karls University Heidelberg; German Heart Center Berlin; University of London; King's College London	Korosoglou, G (corresponding author), Heidelberg Univ, Dept Cardiol, Bergheimer Str 58, Heidelberg, Germany.	gkorosoglou@hotmail.com	Nagel, Eike/C-6903-2008; Kelle, Sebastian/ABH-7348-2020; Wellnhofer, Ernst/L-1829-2015; Puntmann, Valentina/J-4868-2014	Nagel, Eike/0000-0002-6044-950X; Wellnhofer, Ernst/0000-0003-4517-5149; Kelle, Sebastian/0000-0001-8105-6599; Puntmann, Valentina/0000-0002-6044-7002				Bikiri E, 2014, INT J CARDIOL, V171, P153, DOI 10.1016/j.ijcard.2013.11.038; Bodi V, 2009, HEART, V95, P49, DOI 10.1136/hrt.2007.139683; Brener SJ, 2000, AM HEART J, V139, P476, DOI 10.1016/S0002-8703(00)90091-7; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Davies RF, 1997, CIRCULATION, V95, P2037, DOI 10.1161/01.CIR.95.8.2037; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Elsman P, 2006, AM J CARDIOL, V97, P1137, DOI 10.1016/j.amjcard.2005.11.027; Gebker R, 2010, HEART, V96, P616, DOI 10.1136/hrt.2009.175521; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hachamovitch R, 1998, CIRCULATION, V97, P535; Heijenbrok-Kal MH, 2007, AM HEART J, V154, P415, DOI 10.1016/j.ahj.2007.04.061; Hundley WG, 2002, CIRCULATION, V106, P2328, DOI 10.1161/01.CIR.0000036017.46437.02; Karha J, 2003, AM J CARDIOL, V92, P913, DOI 10.1016/S0002-9149(03)00969-X; Kelle S, 2013, J AM COLL CARDIOL, V61, P2310, DOI 10.1016/j.jacc.2013.02.063; Kelle S, 2011, JACC-CARDIOVASC IMAG, V4, P161, DOI 10.1016/j.jcmg.2010.11.012; KLEIN LW, 1986, AM J CARDIOL, V58, P42, DOI 10.1016/0002-9149(86)90238-9; Korosoglou G, 2004, J AM SOC ECHOCARDIOG, V17, P1, DOI 10.1016/j.echo.2003.08.004; Korosoglou G, 2010, J AM COLL CARDIOL, V56, P1225, DOI 10.1016/j.jacc.2010.06.020; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Lipinski MJ, 2013, J AM COLL CARDIOL, V62, P826, DOI 10.1016/j.jacc.2013.03.080; Marwick TH, 1997, J AM COLL CARDIOL, V30, P83, DOI 10.1016/S0735-1097(97)00148-4; Marwick TH, 2001, CIRCULATION, V103, P2566; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Nagel E, 1999, CIRCULATION, V99, P763, DOI 10.1161/01.CIR.99.6.763; Nandalur KR, 2007, J AM COLL CARDIOL, V50, P1343, DOI 10.1016/j.jacc.2007.06.030; Schinkel AFL, 2003, EUR HEART J, V24, P789, DOI 10.1016/S0195-668X(02)00634-6; Shah R, 2013, CIRCULATION, V128, P605, DOI 10.1161/CIRCULATIONAHA.113.001430; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Shaw LJ, 2012, AM HEART J, V164, P243, DOI 10.1016/j.ahj.2012.05.018; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115182	10.1371/journal.pone.0115182	http://dx.doi.org/10.1371/journal.pone.0115182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517506	gold, Green Submitted, Green Published			2022-12-27	WOS:000347215600050
J	Shin, S; Ahnert, SE; Park, J				Shin, Seungkyu; Ahnert, Sebastian E.; Park, Juyong			Ranking Competitors Using Degree-Neutralized Random Walks	PLOS ONE			English	Article							CENTRALITY	Competition is ubiquitous in many complex biological, social, and technological systems, playing an integral role in the evolutionary dynamics of the systems. It is often useful to determine the dominance hierarchy or the rankings of the components of the system that compete for survival and success based on the outcomes of the competitions between them. Here we propose a ranking method based on the random walk on the network representing the competitors as nodes and competitions as directed edges with asymmetric weights. We use the edge weights and node degrees to define the gradient on each edge that guides the random walker towards the weaker (or the stronger) node, which enables us to interpret the steady-state occupancy as the measure of the node's weakness (or strength) that is free of unwarranted degree-induced bias. We apply our method to two real-world competition networks and explore the issues of ranking stabilization and prediction accuracy, finding that our method outperforms other methods including the baseline win-loss differential method in sparse networks.	[Shin, Seungkyu; Park, Juyong] Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Taejon 305701, South Korea; [Ahnert, Sebastian E.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Korea Advanced Institute of Science & Technology (KAIST); University of Cambridge	Park, J (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Culture Technol, Taejon 305701, South Korea.	juyongp@kaist.ac.kr	Park, Juyong/I-2290-2012		National Research Foundation - Korean Government [NRF-20100004910, NRF-2010-330-B00028]; IT R&D program of Ministry of Science, ICT and Future Planning/Korea Evaluation Institute of Industrial Technology [MSIP/KEIT10045459]; Brain Korea 21 Plus Postgraduate Organization for Content Science	National Research Foundation - Korean Government(Korean Government); IT R&D program of Ministry of Science, ICT and Future Planning/Korea Evaluation Institute of Industrial Technology; Brain Korea 21 Plus Postgraduate Organization for Content Science	SS and JP were supported by the National Research Foundation funded by the Korean Government (NRF-20100004910 and NRF-2010-330-B00028, http://www.nrf.re.kr/nrf_eng_cms/), IT R&D program of Ministry of Science, ICT and Future Planning/Korea Evaluation Institute of Industrial Technology (MSIP/KEIT10045459, http://english.msip.go.kr/index.do), and Brain Korea 21 Plus Postgraduate Organization for Content Science (http://http://content.kaist.ac.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balinski Michel, 2010, MAJORITY JUDGMENT ME; Bremaud P., 1975, MARKOV CHAINS GIBBS, V19, P91, DOI DOI 10.1007/978-1-4757-3124-8; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Colley WN, 2002, THESIS PRINCETON U; Darwin C, 2013, ORIGIN SPECIES; Drossel B, 2001, ADV PHYS, V50, P209, DOI 10.1080/00018730110041365; EFRON B, 1979, SIAM REV, V21, P460, DOI 10.1137/1021092; Freeman L., 2004, DEV SOCIAL NETWORK A; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kauffman S.A., 1993, ORIGINS ORDER; Newman M., 1999, MONTE CARLO METHODS; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Park J, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10014; Park J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06212; Stefani RT, 1997, J APPL STAT, V24, P635, DOI 10.1080/02664769723387; Wasserman S, 1994, SOCIAL NETWORK ANAL; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572	20	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113685	10.1371/journal.pone.0113685	http://dx.doi.org/10.1371/journal.pone.0113685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517977	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600007
J	Suzuki, Y; Konno, U; Fukuda, A; Komatsu, DD; Hirota, A; Watanabe, K; Togo, Y; Morikawa, N; Hagiwara, H; Aosai, D; Iwatsuki, T; Tsunogai, U; Nagao, S; Ito, K; Mizuno, T				Suzuki, Yohey; Konno, Uta; Fukuda, Akari; Komatsu, Daisuke D.; Hirota, Akinari; Watanabe, Katsuaki; Togo, Yoko; Morikawa, Noritoshi; Hagiwara, Hiroki; Aosai, Daisuke; Iwatsuki, Teruki; Tsunogai, Urumu; Nagao, Seiya; Ito, Kazumasa; Mizuno, Takashi			Biogeochemical Signals from Deep Microbial Life in Terrestrial Crust	PLOS ONE			English	Article							ANAEROBIC OXIDATION; TONO AREA; HYDROGEN; GROUNDWATER; FRACTURE; METHANE; CARBON; TEMPERATURE; ECOSYSTEMS; ISOTOPES	In contrast to the deep subseafloor biosphere, a volumetrically vast and stable habitat for microbial life in the terrestrial crust remains poorly explored. For the long-term sustainability of a crustal biome, high-energy fluxes derived from hydrothermal circulation and water radiolysis in uranium-enriched rocks are seemingly essential. However, the crustal habitability depending on a low supply of energy is unknown. We present multi-isotopic evidence of microbially mediated sulfate reduction in a granitic aquifer, a representative of the terrestrial crust habitat. Deep meteoric groundwater was collected from underground boreholes drilled into Cretaceous Toki granite (central Japan). A large sulfur isotopic fractionation of 20-60% diagnostic to microbial sulfate reduction is associated with the investigated groundwater containing sulfate below 0.2 mM. In contrast, a small carbon isotopic fractionation (<30 parts per thousand) is not indicative of methanogenesis. Except for 2011, the concentrations of H-2 ranged mostly from 1 to 5 nM, which is also consistent with an aquifer where a terminal electron accepting process is dominantly controlled by ongoing sulfate reduction. High isotopic ratios of mantle-derived He-3 relative to radiogenic He-4 in groundwater and the flux of H-2 along adjacent faults suggest that, in addition to low concentrations of organic matter (<70 mu M), H-2 from deeper sources might partly fuel metabolic activities. Our results demonstrate that the deep biosphere in the terrestrial crust is metabolically active and playing a crucial role in the formation of reducing groundwater even under low-energy fluxes.	[Suzuki, Yohey; Watanabe, Katsuaki] Univ Tokyo, Grad Sch Sci, Dept Plant Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Yohey; Konno, Uta; Fukuda, Akari; Hirota, Akinari; Togo, Yoko; Morikawa, Noritoshi; Ito, Kazumasa] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan; [Komatsu, Daisuke D.; Tsunogai, Urumu] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Fukuda, Akari; Hagiwara, Hiroki; Aosai, Daisuke; Iwatsuki, Teruki; Mizuno, Takashi] Japan Atom Energy Agcy, Mizunami, Gifu 5096132, Japan; [Nagao, Seiya] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Nagoya University; Japan Atomic Energy Agency; Kanazawa University	Suzuki, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Plant Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yohey-suzuki@eps.s.u-tokyo.ac.jp	Togo, Yoko/M-3411-2018; Tsunogai, Urumu/C-8303-2011; Morikawa, Noritoshi/L-9386-2016	Togo, Yoko/0000-0001-8353-4953; Tsunogai, Urumu/0000-0002-1517-3284; Morikawa, Noritoshi/0000-0002-7179-6769; Mizuno, Takashi/0000-0002-7338-1487	Secretariat of Nuclear Regulation Authority (Secretariat of NRA), Japan	Secretariat of Nuclear Regulation Authority (Secretariat of NRA), Japan	The main part of this research project has been conducted as the regulatory supporting research funded by the Secretariat of Nuclear Regulation Authority (Secretariat of NRA), Japan. The funders supervised study design and approved this work for publication.	Anderson RT, 1998, SCIENCE, V281, P976, DOI 10.1126/science.281.5379.976; [Anonymous], 2006, GWB ESSENTIALS GUIDE; Apps JA, 1993, 1570 US GEOL SURV; Banwart S, 1996, J CONTAM HYDROL, V21, P115, DOI 10.1016/0169-7722(95)00037-2; Bottrell SH, 2000, CHEM GEOL, V169, P461, DOI 10.1016/S0009-2541(00)00222-9; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Chapelle F, 2001, GROUND WATER MICROBI; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Gascoyne M, 1997, J GEOPHYS RES-SOL EA, V102, P573, DOI 10.1029/96JB02857; HARVEY RW, 1989, ENVIRON SCI TECHNOL, V23, P51, DOI 10.1021/es00178a005; Hasegawa T, 2010, RES DEV GROUNDWAT 12; Hoehler TM, 1998, GEOCHIM COSMOCHIM AC, V62, P1745, DOI 10.1016/S0016-7037(98)00106-9; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Hoek J, 2006, GEOCHIM COSMOCHIM AC, V70, P5831, DOI 10.1016/j.gca.2006.07.031; Iizuka T, 2007, PRECAMBRIAN RES, V153, P179, DOI 10.1016/j.precamres.2006.11.017; Iwatsuki T, 2005, APPL GEOCHEM, V20, P2283, DOI 10.1016/j.apgeochem.2005.09.002; Iwatsuki T, 2002, APPL GEOCHEM, V17, P1241, DOI 10.1016/S0883-2927(01)00129-9; JOHNSON JW, 1992, COMPUT GEOSCI-UK, V18, P899, DOI 10.1016/0098-3004(92)90029-Q; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Konno U, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026115; Kunimaru T, 2012, MIZUNAMI UNDERGROUND, P2012; Larowe DE, 2008, GEOBIOLOGY, V6, P436, DOI 10.1111/j.1472-4669.2008.00170.x; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Metcalfe R, 2006, GEOCHEM-EXPLOR ENV A, V6, P13, DOI 10.1144/1467-7873/05-080; Mizuno Takashi, 2013, Transactions of the Atomic Energy Society of Japan, V12, P89, DOI 10.3327/taesj.J12.008; Morikawa N, 2004, LIMNOLOGY, V5, P61, DOI 10.1007/s10201-004-0118-5; Morikawa N, 2008, GEOCHEM J, V42, P61, DOI 10.2343/geochemj.42.61; Nagao S, 2003, WATER RES, V37, P4159, DOI 10.1016/S0043-1354(03)00377-4; Niwa M, 2011, PURE APPL GEOPHYS, V168, P887, DOI 10.1007/s00024-010-0167-0; OHMOTO H, 1982, GEOCHIM COSMOCHIM AC, V46, P1727, DOI 10.1016/0016-7037(82)90113-2; Parkhurst D.L, 1999, WATER RESOUR INVESTI; PARSONS B, 1982, J GEOPHYS RES, V87, P289, DOI 10.1029/JB087iB01p00289; Pedersen K, 2012, FEMS MICROBIOL ECOL, V81, P217, DOI 10.1111/j.1574-6941.2012.01370.x; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; RYE RO, 1981, GEOCHIM COSMOCHIM AC, V45, P1941, DOI 10.1016/0016-7037(81)90024-7; STEVENS TO, 1995, SCIENCE, V270, P450, DOI 10.1126/science.270.5235.450; Suzuki Y, 2002, NATURE, V419, P134, DOI 10.1038/419134a; Tsunogai U, 2000, GEOCHIM COSMOCHIM AC, V64, P2439, DOI 10.1016/S0016-7037(00)00374-4; Wang GZ, 2008, GEOCHIM COSMOCHIM AC, V72, P3479, DOI 10.1016/j.gca.2008.04.024; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	43	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113063	10.1371/journal.pone.0113063	http://dx.doi.org/10.1371/journal.pone.0113063			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517230	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600001
J	Wang, SK; Ma, W; Wang, SM; Yi, XR; Jia, HY; Xue, FZ				Wang, Shu-Kang; Ma, Wei; Wang, Shumei; Yi, Xiang-Ren; Jia, Hong-Ying; Xue, Fuzhong			Obesity and Its Relationship with Hypertension among Adults 50 Years and Older in Jinan, China	PLOS ONE			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; METABOLIC RISK; BLOOD-PRESSURE; PREVALENCE; HEALTH; ASSOCIATION; POPULATION	Background: The relationship between obesity and hypertension varies with geographical area, race and definitions of obesity. Our study aimed to investigate the prevalence of obesity using standard Chinese criteria based on the body mass index (BMI) and the waist circumference (WC) and to examine the association between obesity and hypertension among middle-aged and elderly people in Jinan city. Methods: This cross-sectional study examined 1,870 subjects from the blocks randomly selected from among the 6 communities of Jinan, China in 2011-2012. The Student's t-test was used to compare numerical data, and the chi(2) test was used to compare categorical data. Multivariate logistic regression analyses were performed to assess the effects of general and central obesity on hypertension after adjusting for age or for education level, smoking, alcohol consumption, and continuous age. Results: The prevalence of general obesity among people age 50 years and older was 21.1% (17.0% for males and 23.1% for females), and the prevalence of central obesity was 77.8% for men and 78.7% for women. For men, compared with a normal BMI, the ORs and 95% CIs for overweight and general obesity were 1.853 (1.252, 2.744) and 3.422 (1.894, 6.182), respectively, after adjusting for age, smoking, alcohol consumption and educational level. Compared with a normal WC, the ORs and 95% CIs for central obesity were 2.334 (1.573, 3.465) and 2.318 (1.544, 3.479), respectively, for men. For women, compared with a normal BMI, the ORs and 95% CIs were 1.942 (1.473, 2.599) and 4.011 (2.817, 5.712), respectively, after adjusting for age, smoking, alcohol consumption and educational level. Compared with a normal WC, the ORs and 95% CIs for central obesity were 2.488 (1.865, 3.319) and 2.379 (1.773, 3.192), respectively, for women. Conclusions: The relationship between hypertension and general obesity was stronger than the relationship between hypertension and either overweight or central obesity in both genders.	[Wang, Shu-Kang; Ma, Wei; Wang, Shumei; Xue, Fuzhong] Shandong Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yi, Xiang-Ren] Shandong Univ, Coll Phys Educ, Jinan 250100, Peoples R China; [Jia, Hong-Ying] Shandong Univ, Hosp 2, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Xue, FZ (corresponding author), Shandong Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Ma, Wei/L-2374-2019; Ma, Wei/C-4748-2019; Xue, Fuzhong/AAG-4808-2020	Ma, Wei/0000-0002-8092-3280; Ma, Wei/0000-0002-8092-3280; Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Fund of China [81102191]; Independent Innovation Foundation of Shandong University [2012JC035]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by grants from the National Natural Science Fund (No. 81102191) of China and the Independent Innovation Foundation of Shandong University 2012JC035.	[Anonymous], 1995, WHO TECH REP SER, V854, P1; Bosy-Westphal A, 2006, INT J OBESITY, V30, P475, DOI 10.1038/sj.ijo.0803144; Canoy D, 2007, CIRCULATION, V116, P2933, DOI 10.1161/CIRCULATIONAHA.106.673756; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chen Jie, 2005, Zhonghua Yi Xue Za Zhi, V85, P2830; Chen TJ, 2011, ACTA PAEDIATR, V100, P1583, DOI 10.1111/j.1651-2227.2011.02397.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coorperative Meta-analysis Group of China Obesity Task Force, 2003, CHIN J EPIDEMIOL, V23, P5; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004138; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Harris MM, 2000, OBES RES, V8, P516, DOI 10.1038/oby.2000.64; He M, 2001, INT J OBESITY, V25, P748, DOI 10.1038/sj.ijo.0801612; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; HUANG ZD, 1994, J HYPERTENS, V12, P1103; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Jiang Yong, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P816; Ladabaum U, 2014, AM J MED, V14, P00191; Lear SA, 2007, OBESITY, V15, P2817, DOI 10.1038/oby.2007.334; Lear SA, 2007, AM J CLIN NUTR, V86, P353, DOI 10.1093/ajcn/86.2.353; Lopatynski Jerzy, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P413; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oda E, 2009, INTERNAL MED, V48, P497, DOI 10.2169/internalmedicine.48.1765; Pajunen P, 2011, OBESITY, V19, P848, DOI 10.1038/oby.2010.236; Park JK, 2013, HYPERTENS RES, V36, P444, DOI 10.1038/hr.2012.194; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Salvetti G, 2008, OBES METAB-MILAN, V4, P202; Shidfar F, 2012, CARDIOVASC J AFR, V23, P442, DOI 10.5830/CVJA-2012-038; Wakabayashi I, 2012, GENDER MED, V9, P267, DOI 10.1016/j.genm.2012.05.004; World Health Organization,, 1998, WHO TECHN REP SER; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhai Yi, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P621; Zhang YX, 2013, ANN HUM BIOL, V40, P294, DOI 10.3109/03014460.2013.772654; Zhou B., 2002, ZHONGHUA LIU XING BI, V1, P5	36	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114424	10.1371/journal.pone.0114424	http://dx.doi.org/10.1371/journal.pone.0114424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517735	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600019
J	Flego, A; Herbert, J; Waters, E; Gibbs, L; Swinburn, B; Reynolds, J; Moodie, M				Flego, Anna; Herbert, Jessica; Waters, Elizabeth; Gibbs, Lisa; Swinburn, Boyd; Reynolds, John; Moodie, Marj			Jamie's Ministry of Food: Quasi-Experimental Evaluation of Immediate and Sustained Impacts of a Cooking Skills Program in Australia	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CHRONIC DISEASES; VEGETABLE INTAKE; FAMILY DINNER; DIET QUALITY; BODY-WEIGHT; RISK; OBESITY; PREVENTION; FRUIT	Objective: To evaluate the immediate and sustained effectiveness of the first Jamie's Ministry of Food Program in Australia on individuals' cooking confidence and positive cooking/eating behaviours. Methods: A quasi-experimental repeated measures design was used incorporating a wait-list control group. A questionnaire was developed and administered at baseline (T1), immediately post program (T2) and 6 months post completion (T3) for participants allocated to the intervention group, while wait -list controls completed it 10 weeks prior to program commencement (T1) and just before program commencement (T2). The questionnaire measured: participants' confidence to cook, the frequency of cooking from basic ingredients, and consumption of vegetables, vegetables with the main meal, fruit, ready-made meals and takeaway. Analysis used a linear mixed model approach for repeated measures using all available data to determine mean differences within and between groups over time. Subjects: All adult participants (>= 18 years) who registered and subsequently participated in the program in Ipswich, Queensland, between late November 2011-December 2013, were invited to participate. Results: In the intervention group: 694 completed T1, 383 completed T1 and T2 and 214 completed T1, T2 and T3 assessments. In the wait-list group: 237 completed T1 and 149 completed T1 and T2 assessments. Statistically significant increases within the intervention group (P<0.001) and significant group*time interaction effects (P<0.001) were found in all cooking confidence measures between T1 and T2 as well as cooking from basic ingredients, frequency of eating vegetables with the main meal and daily vegetable intake (0.52 serves/day increase). Statistically significant increases at T2 were sustained at 6 months post program in the intervention group. Conclusions: Jamie's Ministry of Food Program, Australia improved individuals' cooking confidence and cooking/eating behaviours contributing to a healthier diet and is a promising community-based strategy to influence diet quality.	[Flego, Anna; Herbert, Jessica; Moodie, Marj] Deakin Univ, Fac Hlth, Deakin Hlth Econ, Melbourne, Vic, Australia; [Waters, Elizabeth; Gibbs, Lisa] Univ Melbourne, Jack Brockhoff Child Hlth & Wellbeing Program, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Swinburn, Boyd] Deakin Univ, Fac Hlth, WHO, Collaborating Ctr Obes Prevent, Melbourne, Vic, Australia; [Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Reynolds, John] Deakin Univ, Fac Hlth, Biostat Unit, Melbourne, Vic, Australia	Deakin University; University of Melbourne; Deakin University; World Health Organization; University of Auckland; Deakin University	Flego, A (corresponding author), Deakin Univ, Fac Hlth, Deakin Hlth Econ, Melbourne, Vic, Australia.	anna.flego@deakin.edu.au	Reynolds, John/D-2591-2013	Reynolds, John/0000-0002-8825-8625; Moodie, Marjory/0000-0001-6890-5250; Gibbs, Lisa/0000-0001-9702-6896; Flego, Anna/0000-0001-7409-8192	JMOF program, Ipswich	JMOF program, Ipswich	This evaluation was jointly commissioned by the Queensland Government and The Good Foundation, co-funders of the JMOF program, Ipswich. Whilst the project funders were involved in initial discussions around study design, they had no role in data collection and analysis, decision to publish or preparation of the manuscript.	Agudo A., 2004, MEASURING INTAKE FRU; Arem H, 2013, JNCI-J NATL CANCER I, V105, P1298, DOI 10.1093/jnci/djt185; Asif Mohammad, 2014, J Educ Health Promot, V3, P1, DOI 10.4103/2277-9531.127541; Australian Institute of Health and Welfare, 2012, AUSTR HLTH 2012; Backholer K, 2012, AUST NZ J PUBL HEAL, V36, P557, DOI 10.1111/j.1753-6405.2012.00885.x; Bambra CL, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-16; Barton KL, 2011, J HUM NUTR DIET; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Cadilhac D, 2009, HLTH EC BENEFITS RED; Caraher M., 1999, British Food Journal, V101, P590, DOI 10.1108/00070709910288289; Chang MW, 2008, J AM DIET ASSOC, V108, P1023, DOI 10.1016/j.jada.2008.03.004; Condrasky M, 2006, J NUTR EDUC BEHAV, V38, P324, DOI 10.1016/j.jneb.2006.04.005; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Flego A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-411; Flynn MM, 2013, J HUNGER ENVIRON NUT, V8, P73, DOI 10.1080/19320248.2012.758066; Garcia A., 2013, P 11 INT C VIBR PROB, P1; Gillman MW, 2000, ARCH FAM MED, V9, P235, DOI 10.1001/archfami.9.3.235; Gough B, 2006, SOC SCI MED, V62, P387, DOI 10.1016/j.socscimed.2005.05.032; Hartmann C, 2013, APPETITE, V65, P125, DOI 10.1016/j.appet.2013.01.016; Hawkes C, 2013, OBES REV, V14, P159, DOI 10.1111/obr.12098; Herbert J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1161; Jamie Oliver Food Foundation UK, 2014, JAM MIN FOOD; Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059; Jennings A, 2011, J NUTR, V141, P453, DOI 10.3945/jn.110.131441; Keller Heather H., 2004, Journal of Nutrition for the Elderly, V24, P71, DOI 10.1300/J052v24n01_06; Lal A, 2012, AUST NZ J PUBL HEAL, V36, P550, DOI 10.1111/j.1753-6405.2012.00931.x; Larsson SC, 2014, ATHEROSCLEROSIS, V233, P27, DOI 10.1016/j.atherosclerosis.2013.11.072; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Office of Economic and Statistical Research, 2011, QUEENSL REG PROF IPS; Pomerleau J, 2005, J NUTR, V135, P2486, DOI 10.1093/jn/135.10.2486; Queensland Health, 2012, SELF REP HLTH STAT 2; Queensland Health, 2011, SELF REP HLTH STAT 2; Queensland Health, 2009, SELF REP AD HLTH STA; Rees R., 2012, COMMUNITIES COOK SYS; Reicks M, 2014, J NUTR ED BEHAV; Roark RA, 2013, PUBLIC HEALTH NUTR, V16, P2, DOI 10.1017/S1368980012000985; Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164; Soliah LL, 2012, AM J LIFESTYLE MED, V6, P152, DOI 10.1177/1559827611426394; Swinburn B, 2007, AUST NZ J PUBL HEAL, V31, P305, DOI 10.1111/j.1753-6405.2007.00075.x; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; van der Horst KD, 2011, PUBLIC HEALTH NUTR, V14, P239, DOI 10.1017/S1368980010002624; von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7; Winkler E, 2010, J AM DIET ASSOC, V110, pS52, DOI 10.1016/j.jada.2010.03.007; Woodruff SJ, 2010, EUR J CLIN NUTR, V64, P454, DOI 10.1038/ejcn.2010.14; Woodside JV, 2013, P NUTR SOC, V72, P399, DOI 10.1017/S0029665113003029; Wrieden WL, 2007, PUBLIC HEALTH NUTR, V10, P203, DOI 10.1017/S1368980007246658	48	48	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114673	10.1371/journal.pone.0114673	http://dx.doi.org/10.1371/journal.pone.0114673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514531	Green Published, gold			2022-12-27	WOS:000349146300019
J	De Rosis, A				De Rosis, Alessandro			Fluid Forces Enhance the Performance of an Aspirant Leader in Self-Organized Living Groups	PLOS ONE			English	Article							LATTICE-BOLTZMANN; DECISION-MAKING; FLAPPING WINGS; ANIMAL GROUPS; FISH; DYNAMICS; INFORMATION; FLOCKS; MODEL; COMPROMISE	In this paper, the performance of an individual aiming at guiding a self-organized group is numerically investigated. A collective behavioural model is adopted, accounting for the mutual repulsion, attraction and orientation experienced by the individuals. Moreover, these represent a set of solid particles which are supposed to be immersed in a fictitious viscous fluid. In particular, the lattice Boltzmann and Immersed boundary methods are used to predict the fluid dynamics, whereas the effect of the hydrodynamic forces on particles is accounted for by solving the equation of the solid motion through the time discontinuous Galerkin scheme. Numerical simulations are carried out by involving the individuals in a dichotomous process. On the one hand, an aspirant leader (AL) additional individual is added to the system. AL is forced to move along a prescribed direction which intersects the group. On the other hand, these tend to depart from an obstacle represented by a rotating lamina which is placed in the fluid domain. A numerical campaign is carried out by varying the fluid viscosity and, as a consequence, the hydrodynamic field. Moreover, scenarios characterized by different values of the size of the group are investigated. In order to estimate the AL's performance, a proper parameter is introduced, depending on the number of individuals following AL. Present findings show that the sole collective behavioural equations are insufficient to predict the AL's performance, since the motion is drastically affected by the presence of the surrounding fluid. With respect to the existing literature, the proposed numerical model is enriched by accounting for the presence of the encompassing fluid, thus computing the hydrodynamic forces arising when the individuals move.	Univ Bologna, Dept Agr Sci, Bologna, Italy	University of Bologna	De Rosis, A (corresponding author), Univ Bologna, Dept Agr Sci, Bologna, Italy.	alessandro.derosis@unibo.it	De Rosis, Alessandro/P-8252-2019; De Rosis, Alessandro/U-2129-2018	De Rosis, Alessandro/0000-0002-4493-365X; De Rosis, Alessandro/0000-0002-4493-365X				Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2010, J R SOC INTERFACE, V7, P1441, DOI 10.1098/rsif.2010.0175; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; BENZI R, 1992, PHYS REP, V222, P145, DOI 10.1016/0370-1573(92)90090-M; BHATNAGAR PL, 1954, PHYS REV, V94, P511, DOI 10.1103/PhysRev.94.511; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Bode NWF, 2011, J R SOC INTERFACE, V8, P301, DOI 10.1098/rsif.2010.0397; Camperi M, 2012, INTERFACE FOCUS, V2, P715, DOI 10.1098/rsfs.2012.0026; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUDY BEHAV, V32; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; De Rosis A, 2014, J SCI COMPUTING; De Rosis A, 2014, ADV WATER RESOUR, V73, P97, DOI 10.1016/j.advwatres.2014.07.004; De Rosis A, 2014, ADV WATER RESOUR, V73, P55, DOI 10.1016/j.advwatres.2014.07.003; De Rosis A, 2014, PHYSICA A, V414, P329, DOI 10.1016/j.physa.2014.07.062; De Rosis A, 2014, J FLUID STRUCT, V49, P516, DOI 10.1016/j.jfluidstructs.2014.05.010; De Rosis A, 2014, PHYSICA A, V410, P276, DOI 10.1016/j.physa.2014.05.041; De Rosis A, 2014, COMPUT STRUCT, V138, P24, DOI 10.1016/j.compstruc.2014.02.007; De Rosis A, 2014, ADV WATER RESOUR, V65, P18, DOI 10.1016/j.advwatres.2014.01.003; De Rosis A, 2014, J FLUID STRUCT, V45, P202, DOI 10.1016/j.jfluidstructs.2013.12.009; Fadlun EA, 2000, J COMPUT PHYS, V161, P35, DOI 10.1006/jcph.2000.6484; Felippa CA, 2005, COMPUT METHOD APPL M, V194, P2285, DOI 10.1016/j.cma.2004.07.035; Filippova O, 1997, COMPUT FLUIDS, V26, P697, DOI 10.1016/S0045-7930(97)00009-1; Franks NR, 2002, PHILOS T R SOC B, V357, P1567, DOI 10.1098/rstb.2002.1066; Garay J, 2009, J THEOR BIOL, V257, P45, DOI 10.1016/j.jtbi.2008.11.010; Garcea G, 2009, INT J SOLIDS STRUCT, V46, P377, DOI 10.1016/j.ijsolstr.2008.08.038; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hemelrijk C, 2014, INCREASED EFFICIENCY; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; HIGUERA FJ, 1989, EUROPHYS LETT, V9, P345, DOI 10.1209/0295-5075/9/4/008; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Jeschke JM, 2005, OIKOS, V111, P547; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Kolpas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058525; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; KRAUSE J, 1995, ANIM BEHAV, V50, P465, DOI 10.1006/anbe.1995.0260; Krause J, 2002, LIVING GROUPS; Kunz H., 2006, P 10 INT C ART INT L; Leonard NE, 2012, P NATL ACAD SCI USA, V109, P227, DOI 10.1073/pnas.1118318108; LINDAUER M, 1957, NATURE, V179, P63, DOI 10.1038/179063a0; Mancuso M, 2003, COMPUT MECH, V32, P154, DOI 10.1007/s00466-003-0469-5; Mancuso M, 2006, COMPUT METHOD APPL M, V195, P6391, DOI 10.1016/j.cma.2006.01.004; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Mei RW, 1999, J COMPUT PHYS, V155, P307, DOI 10.1006/jcph.1999.6334; Mei RW, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041203; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Nabet B, 2009, J NONLINEAR SCI, V19, P399, DOI 10.1007/s00332-008-9038-6; Perez-Escudero A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002282; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; Pitcher T. J., 1983, PREDATORS PREY FISHE, P193; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077589; Polverino G, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/4/044001; Radakov D. V., 1973, SCH ECOLOGY FISH; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V53, P417, DOI 10.1007/s00265-003-0598-z; Succi S, 2001, LATTICE BOLTZMANN EQ, P290; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Wu J, 2009, J COMPUT PHYS, V228, P1963, DOI 10.1016/j.jcp.2008.11.019; Zheng M, 2005, J THEOR BIOL, V235, P153, DOI 10.1016/j.jtbi.2004.12.025	65	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114687	10.1371/journal.pone.0114687	http://dx.doi.org/10.1371/journal.pone.0114687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25501965	Green Published, gold			2022-12-27	WOS:000346607100018
J	Orlowski, G; Karg, J; Karg, G				Orlowski, Grzegorz; Karg, Jerzy; Karg, Grzegorz			Functional Invertebrate Prey Groups Reflect Dietary Responses to Phenology and Farming Activity and Pest Control Services in Three Sympatric Species of Aerially Foraging Insectivorous Birds	PLOS ONE			English	Article							SWALLOWS HIRUNDO-RUSTICA; BARN SWALLOWS; AGRICULTURAL LANDSCAPES; INSECT PESTS; ABUNDANCE; FOOD; BIODIVERSITY; DIVERSITY; SPILLOVER; PASSERINE	Farming activity severely impacts the invertebrate food resources of farmland birds, with direct mortality to populations of above-ground arthropods thorough mechanical damage during crop harvests. In this study we assessed the effects of phenological periods, including the timing of harvest, on the composition and biomass of prey consumed by three species of aerial insectivorous birds. Common Swifts Apus apus, Barn Swallows Hirundo rustica and House Martins Delichon urbica breed sympatrically and most of their diet is obtained from agricultural sources of invertebrate prey, especially from oil-seed rape crops. We categorized invertebrate prey into six functional groups, including oil-seed rape pests; pests of other arable crops; other crop-provisioned taxa; coprophilous taxa; and taxa living in non-crop and mixed crop/non-crop habitats. Seasonality impacted functional groups differently, but the general direction of change (increase/decrease) of all groups was consistent as indexed by prey composition of the three aerial insectivores studied here. After the oil-seed rape crop harvest (mid July), all three species exhibited a dietary shift from oil-seed rape insect pests to other aerial invertebrate prey groups. However, Common Switfts also consumed a relative large quantity of oil-seed rape insect pests in the late summer (August), suggesting that they could reduce pest insect emigration beyond the host plant/crop. Since these aerially foraging insectivorous birds operate in specific conditions and feed on specific pest resources unavailable to foliage/ground foraging avian predators, our results suggest that in some crops like oil-seed rape cultivations, the potential integration of the insectivory of aerial foraging birds into pest management schemes might provide economic benefits. We advise further research into the origin of airborne insects and the role of aerial insectivores as agents of the biological control of crop insect pests, especially the determination of depredation rates and the cascading effects of insectivory on crop damage and yield.	[Orlowski, Grzegorz; Karg, Grzegorz] Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland; [Karg, Jerzy] Univ Zielona Gora, Fac Biol Sci, Nat Conservat Dept, Zielona Gora, Poland	Polish Academy of Sciences; University of Zielona Gora	Orlowski, G (corresponding author), Polish Acad Sci, Inst Agr & Forest Environm, Poznan, Poland.	orlog@poczta.onet.pl		Orlowski, Grzegorz/0000-0001-9431-6521				Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; [Anonymous], ROCZ AKAD ROL POZ; Bell JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054202; Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bhar R., 1998, CONSERV ECOL, V2, P3; BRYANT DM, 1982, ANIM BEHAV, V30, P845, DOI 10.1016/S0003-3472(82)80158-9; BRYANT DM, 1973, J ANIM ECOL, V42, P539, DOI 10.2307/3123; Cramp S, 1998, COMPLETE BIRDS W PAL; DABROWSKA-PROT E, 1976, Polish Ecological Studies, V2, P87; Evans KL, 2007, AGR ECOSYST ENVIRON, V122, P267, DOI 10.1016/j.agee.2007.01.015; Evans KL, 2003, BIRD STUDY, V50, P8, DOI 10.1080/00063650309461284; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; FERGUSON AW, 1999, ASP APPL BIOL, V53, P1; Fuentes-Montemayor E, 2013, AGR ECOSYST ENVIRON, V172, P6, DOI 10.1016/j.agee.2013.03.019; Gagic V, 2011, P ROY SOC B-BIOL SCI, V278, P2946, DOI 10.1098/rspb.2010.2645; Gamez-Virues S, 2007, AUST J ENTOMOL, V46, P325, DOI 10.1111/j.1440-6055.2007.00608.x; Gruebler MU, 2008, AGR ECOSYST ENVIRON, V123, P75, DOI 10.1016/j.agee.2007.05.001; Gruebler MU, 2010, J APPL ECOL, V47, P1340, DOI 10.1111/j.1365-2664.2010.01873.x; Henderson I, 2007, BIRD STUDY, V54, P371, DOI 10.1080/00063650709461497; Holland J, 2000, AGR ECOSYST ENVIRON, V78, P115, DOI 10.1016/S0167-8809(99)00123-1; Holland JM, 2006, ANN APPL BIOL, V148, P49, DOI 10.1111/j.1744-7348.2006.00039.x; JOHNSTON RD, 1993, FUNCT ECOL, V7, P255, DOI 10.2307/2390203; Jones GA, 2005, CONSERV BIOL, V19, P1234, DOI 10.1111/j.1523-1739.2005.00211.x; KARG J, 1975, Polish Ecological Studies, V1, P149; KARG J, 1980, Polish Ecological Studies, V6, P345; Kedziora A, 2012, BIODIVERSITY ENRICHMENT IN A DIVERSE WORLD, P281, DOI 10.5772/48653; Kelly JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076616; Kirk David A., 1996, Current Ornithology, V13, P175; Kochman J., 1985, PORADNIK OCHRONY ROS; KOZENA I, 1983, FOLIA ZOOL, V32, P41; Kragten S, 2011, BIRD CONSERV INT, V21, P1, DOI 10.1017/S0959270910000079; Kunz TH, 2008, INTEGR COMP BIOL, V48, P1, DOI [10.1093/icb/icn030, 10.1093/icb/icn037]; LACK D, 1955, J ANIM ECOL, V24, P120, DOI 10.2307/1882; Martin EA, 2013, P NATL ACAD SCI USA, V110, P5534, DOI 10.1073/pnas.1215725110; MOLLER AP, 1987, ANIM BEHAV, V35, P819, DOI 10.1016/S0003-3472(87)80118-5; Moller AP, 2001, J APPL ECOL, V38, P378, DOI 10.1046/j.1365-2664.2001.00593.x; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Moonen AC, 2008, AGR ECOSYST ENVIRON, V127, P7, DOI 10.1016/j.agee.2008.02.013; Nocera JJ, 2012, P ROY SOC B-BIOL SCI, V279, P3114, DOI 10.1098/rspb.2012.0445; Orlowski G, 2013, BIRD STUDY, V60, P475, DOI 10.1080/00063657.2013.839622; Orlowski G, 2013, BIRD STUDY, V60, P111, DOI 10.1080/00063657.2012.748717; Orlowski G, 2011, CENT EUR J BIOL, V6, P1023, DOI 10.2478/s11535-011-0070-4; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ryszkowski L., 1992, Ekologia Polska, V39, P171; RYSZKOWSKI L, 1977, EKOL POL-POL J ECOL, V25, P501; RYSZKOWSKI L, 1993, LANDSCAPE ECOLOGY AND AGROECOSYSTEMS, P71; Schneider G, 2013, BASIC APPL ECOL, V14, P614, DOI 10.1016/j.baae.2013.08.008; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Shortall CR, 2009, INSECT CONSERV DIVER, V2, P251, DOI 10.1111/j.1752-4598.2009.00062.x; SPJOTVOLL E, 1973, J AM STAT ASSOC, V68, P975, DOI 10.2307/2284534; StatSoft, 2006, STAT DAT AN SOFTW SY; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Threlfall CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038800; Tscharntke T, 2005, ANN ZOOL FENN, V42, P421; Turner A., 2006, BARN SWALLOW; Turner A. K., 1980, THESIS U STIRLING ST; TURNER AK, 1982, ANIM BEHAV, V30, P862, DOI 10.1016/S0003-3472(82)80160-7; TURNER AK, 1982, J ANIM ECOL, V51, P29, DOI 10.2307/4308; Vickery JA, 2009, AGR ECOSYST ENVIRON, V133, P1, DOI 10.1016/j.agee.2009.05.012; Waugh DR, 1978, THESIS U STIRLING ST; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Whitaker DM, 2000, CAN J ZOOL, V78, P740, DOI 10.1139/cjz-78-5-740; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Zaller JG, 2008, BASIC APPL ECOL, V9, P682, DOI 10.1016/j.baae.2007.10.004	65	19	21	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114906	10.1371/journal.pone.0114906	http://dx.doi.org/10.1371/journal.pone.0114906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506696	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100032
J	Alcolea, PJ; Alonso, A; Garcia-Tabares, F; Torano, A; Larraga, V				Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Torano, Alfredo; Larraga, Vicente			An Insight into the Proteome of Crithidia fasciculata Choanomastigotes as a Comparative Approach to Axenic Growth, Peanut Lectin Agglutination and Differentiation of Leishmania spp. Promastigotes	PLOS ONE			English	Article							GENE-EXPRESSION; TRYPANOSOMA-BRUCEI; VISCERAL LEISHMANIASIS; INFANTUM PROMASTIGOTES; LIFE-CYCLE; KINASE-C; GENOME; DNA; PROTEINS; STAGE	The life cycle of the trypanosomatid Crithidia fasciculata is monogenetic, as the unique hosts of these parasites are different species of culicids. The comparison of these non-pathogenic microorganisms evolutionary close to other species of trypanosomatids that develop digenetic life cycles and cause chronic severe sickness to millions of people worldwide is of outstanding interest. A ground-breaking analysis of differential protein abundance in Crithidia fasciculata is reported herein. The comparison of the outcome with previous gene expression profiling studies developed in the related human pathogens of the genus Leishmania has revealed substantial differences between the motile stages of these closely related organisms in abundance of proteins involved in catabolism, redox homeostasis, intracellular signalling, and gene expression regulation. As L. major and L. infantum agglutinate with peanut lectin and non-agglutinating parasites are more infective, the agglutination properties were evaluated in C. fasciculata. The result is that choanomastigotes are able to agglutinate with peanut lectin and a non-agglutinating subpopulation can be also isolated. As a difference with L. infantum, the non-agglutinating subpopulation over-expresses the whole machinery for maintenance of redox homeostasis and the translation factors eIF5a, EF1 alpha and EF2, what suggests a relationship between the lack of agglutination and a differentiation process.	[Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Larraga, Vicente] CSIC, Dept Mol Microbiol & Biol Infect, Ctr Invest Biol, Madrid, Spain; [Alcolea, Pedro J.; Alonso, Ana; Garcia-Tabares, Francisco; Larraga, Vicente] CSIC, Serv Prote & Genom, Ctr Invest Biol, Madrid, Spain; [Torano, Alfredo] Inst Salud Carlos III, Serv Inmunol, Ctr Nacl Microbiol Virol & Inmunol Sanitarias, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Instituto de Salud Carlos III	Alcolea, PJ (corresponding author), CSIC, Dept Mol Microbiol & Biol Infect, Ctr Invest Biol, Madrid, Spain.	pjalcolea@cib.csic.es	Alcolea Alcolea, Pedro José/O-5654-2016	Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Larraga, Vicente/0000-0003-1260-7400; Alonso Ayala, Ana Maria/0000-0002-1228-7331	Spanish Ministry of Science, MICINN [AGL2010-21806-C02-01]; RICET (RETICS-FIS, FEDER) collaborative network grant; Fundacion Ramon Areces contract [050204100014/OTT, 20100338]	Spanish Ministry of Science, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RICET (RETICS-FIS, FEDER) collaborative network grant; Fundacion Ramon Areces contract	PA thanks CENTRO DE INVESTIGACIONES BIOLOGICAS CSIC for two contracts of employment at a position included in the A1 group (respectively developed from January 16th to July 23rd 2008 and from October 16th 2008 to April 15th 2009). AA thanks CSIC for the Ph.D. contract 5072160068 W0SC000077 within the A1 group. This work has been partially defrayed by the grant AGL2010-21806-C02-01 (Spanish Ministry of Science, MICINN), RICET (RETICS-FIS, FEDER) collaborative network grant and the Fundacion Ramon Areces contract 050204100014/OTT code 20100338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; Alcolea PJ, 2011, INT MICROBIOL, V14, P1, DOI 10.2436/20.1501.01.129; Alcolea PJ, 2011, J EUKARYOT MICROBIOL, V58, P352, DOI 10.1111/j.1550-7408.2011.00549.x; Alcolea PJ, 2010, INT J PARASITOL, V40, P1497, DOI 10.1016/j.ijpara.2010.05.013; Alcolea Pedro J, 2010, BMC Genomics, V11, P31, DOI 10.1186/1471-2164-11-31; Alcolea PJ, 2009, GENOMICS, V93, P551, DOI 10.1016/j.ygeno.2009.01.007; Almeida R, 2004, MOL BIOCHEM PARASIT, V136, P87, DOI 10.1016/j.molbiopara.2004.03.004; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Calderon-Arguedas Olger, 2006, Parasitologia Latinoamericana, V61, P32; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; Chevalier N, 2000, EUR J BIOCHEM, V267, P1464, DOI 10.1046/j.1432-1327.2000.01145.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Day BJ, 2009, BIOCHEM PHARMACOL, V77, P285, DOI 10.1016/j.bcp.2008.09.029; Depledge DP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000476; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gualdron-Lopez M, 2013, BBA-MOL CELL RES, V1833, P3076, DOI 10.1016/j.bbamcr.2013.08.008; Gupta N, 1999, ACTA TROP, V73, P121, DOI 10.1016/S0001-706X(99)00020-0; Holzer TR, 2006, MOL BIOCHEM PARASIT, V146, P198, DOI 10.1016/j.molbiopara.2005.12.009; Hughes Austin L., 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-15; IBRAHIM EA, 1987, ACTA TROP, V44, P13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4; Maslov DA, 2001, MEM I OSWALDO CRUZ, V96, P397, DOI 10.1590/S0074-02762001000300021; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MOCHLYROSEN D, 1991, J BIOL CHEM, V266, P14866; Olsen OW, 1974, ANIMAL PARASITES LIF; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Parsons M, 2004, MOL MICROBIOL, V53, P717, DOI 10.1111/j.1365-2958.2004.04203.x; Perez-Castineira JR, 2002, BIOCHEM BIOPH RES CO, V294, P567, DOI 10.1016/S0006-291X(02)00517-X; Ramiro MJ, 2003, VACCINE, V21, P2474, DOI 10.1016/S0264-410X(03)00032-X; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Rastrojo A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-223; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Saxena A, 2003, MOL BIOCHEM PARASIT, V129, P103, DOI 10.1016/S0166-6851(03)00100-2; SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4; Schneider P, 1996, BIOCHEM J, V313, P963, DOI 10.1042/bj3130963; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Tetaud E, 1998, MOL BIOCHEM PARASIT, V96, P111, DOI 10.1016/S0166-6851(98)00120-0; VICKERMAN K, 1994, INT J PARASITOL, V24, P1317, DOI 10.1016/0020-7519(94)90198-8; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Warburg O, 1942, BIOCHEM Z, V310, P384; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WHO, 2010, CONTR LEISHM	50	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113837	10.1371/journal.pone.0113837	http://dx.doi.org/10.1371/journal.pone.0113837			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503511	Green Published, gold			2022-12-27	WOS:000347146700010
J	Schnitzler, A; Woimant, F; Tuppin, P; de Peretti, C				Schnitzler, Alexis; Woimant, France; Tuppin, Philippe; de Peretti, Christine			Prevalence of Self-Reported Stroke and Disability in the French Adult Population: A Transversal Study	PLOS ONE			English	Article							NURSING-HOME; YOUNG-ADULTS; AGE; EPIDEMIOLOGY; MORTALITY; BURDEN; GENDER; TRENDS	In France, the prevalence of stroke and the level of disability of stroke survivors are little known. The aim of this study was to evaluate functional limitations in adults at home and in institutions, with and without self-reported stroke. A survey named "the Disability Health survey'' was carried out in people's homes (DHH) and in institutions (DHI). Medical history and functional level (activities-of-daily-living, ADL and instrumented-activities-of-daily-living IADL) were collected through interviews. The modified Rankin score (mRS) and the level of dependence and disability were compared between participants with and without stroke. 33896 subjects responded. The overall prevalence of stroke was 1.6% (CI95% [1.4%-1.7%]). The mRS was over 2 for 34.4% of participants with stroke (28.7% of participants at home and 87.8% of participants in institutions) versus respectively 3.9%, 3.1% and 71.6% without stroke. Difficulty washing was the most frequently reported ADL for those with stroke (30.6% versus 3% for those without stroke). Difficulty with ADL and IADL increased with age but the relative risk was higher below the age of 60 (17 to 25) than over 85 years (1.5 to 2.2), depending on the ADL. In the overall population, 22.6% of those confined to bed or chair reported a history of stroke. These results thus demonstrate a high national prevalence of stroke. Older people are highly dependent, irrespective of stroke history and the relative risk of dependence in young subjects with a history of stroke is high compared with those without.	[Schnitzler, Alexis] Univ Versailles St Quentin EA 4497, Hop Raymond Poincare, Assistance Publ Hop Paris, Phys Med & Rehabil Dept, Garches, France; [Woimant, France] Agence Reg Sante Ile France, Paris, France; [Woimant, France] Caisse Natl Assurance Malad Travailleurs Salaries, Paris, France; [de Peretti, Christine] Inst Veille Sanit, St Maurice, France; [Woimant, France] Hop Lariboisiere, Assistance Publ Hop Paris, F-75475 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Schnitzler, A (corresponding author), Univ Versailles St Quentin EA 4497, Hop Raymond Poincare, Assistance Publ Hop Paris, Phys Med & Rehabil Dept, Garches, France.	alexis.schnitzler@rpc.aphp.fr	Schnitzler, Alfons/Q-5520-2019	Schnitzler, Alfons/0000-0002-6414-7939				Bejot Y, 2009, EUR J NEUROL, V16, P324, DOI 10.1111/j.1468-1331.2008.02415.x; Bejot Y, 2010, CEREBROVASC DIS, V30, P346, DOI 10.1159/000319569; Black-Schaffer Randie M, 2004, Top Stroke Rehabil, V11, P23; Brown RD, 1999, STROKE, V30, P924, DOI 10.1161/01.STR.30.5.924; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Bruno A, 2010, STROKE, V41, P1048, DOI 10.1161/STROKEAHA.109.571562; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; De Peretti C, 2012, B EPIDEMIOLOGIQUE HE; Engstad T, 2000, STROKE, V31, P1602, DOI 10.1161/01.STR.31.7.1602; Fearon P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub3; Feigin VL, 2010, NEUROLOGY, V75, P1597, DOI 10.1212/WNL.0b013e3181fb44b3; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fisher RJ, 2011, STROKE, V42, P1392, DOI 10.1161/STROKEAHA.110.606285; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; JORGENSEN HS, 1995, STROKE, V26, P1178, DOI 10.1161/01.STR.26.7.1178; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Leys D, 2002, NEUROLOGY, V59, P26, DOI 10.1212/WNL.59.1.26; Mishra NK, 2010, STROKE, V41, P2840, DOI 10.1161/STROKEAHA.110.586206; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; Palazzo C, 2013, PLOS ONE, V7; Peretti C. de, 2010, Bulletin Epidemiologique Hebdomadaire, P501; Rousseaux M., 2009, Annals of Physical and Rehabilitation Medicine, V52, P224, DOI 10.1016/j.rehab.2009.01.002; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; World Health Organization, WORLD HLTH STAT; Zhang YN, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/436125	29	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115375	10.1371/journal.pone.0115375	http://dx.doi.org/10.1371/journal.pone.0115375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521057	Green Published, gold			2022-12-27	WOS:000348845600038
J	Cristia, A; Minagawa, Y; Dupoux, E				Cristia, Alejandrina; Minagawa, Yasuyo; Dupoux, Emmanuel			Responses to Vocalizations and Auditory Controls in the Human Newborn Brain	PLOS ONE			English	Article							SPEECH; LANGUAGE; INFANTS; SOUNDS; DISCRIMINATION; SPECIALIZATION; SENSITIVITY; EMERGENCE; MONKEYS; BIRTH	In the adult brain, speech can recruit a brain network that is overlapping with, but not identical to, that involved in perceiving non-linguistic vocalizations. Using the same stimuli that had been presented to human 4-month-olds and adults, as well as adult macaques, we sought to shed light on the cortical networks engaged when human newborns process diverse vocalization types. Near infrared spectroscopy was used to register the response of 40 newborns' perisylvian regions when stimulated with speech, human and macaque emotional vocalizations, as well as auditory controls where the formant structure was destroyed but the long-term spectrum was retained. Left fronto-temporal and parietal regions were significantly activated in the comparison of stimulation versus rest, with unclear selectivity in cortical activation. These results for the newborn brain are qualitatively and quantitatively compared with previous work on newborns, older human infants, adult humans, and adult macaques reported in previous work.	[Cristia, Alejandrina; Dupoux, Emmanuel] PSL Res Univ, Ecole Normale Super, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist,ENS,EHESS,CNRS, Paris, France; [Minagawa, Yasuyo] Keio Univ, Fac Letters, Dept Psychol, Tokyo, Japan	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Keio University	Cristia, A (corresponding author), PSL Res Univ, Ecole Normale Super, Dept Etud Cognit, Lab Sci Cognit & Psycholinguist,ENS,EHESS,CNRS, Paris, France.	alecristia@gmail.com	Cristia, Alejandrina/H-2768-2019	Cristia, Alejandrina/0000-0003-2979-4556	Agence Nationale pour la Recherche [ANR-09-BLAN-0327 SOCODEV, ANR-2010-BLAN-1901-1 BOOTLANG]; Ile-de-France (NERF); Ecole de Neurosciences de Paris; Fyssen Foundation; Fondation de France	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Ile-de-France (NERF); Ecole de Neurosciences de Paris; Fyssen Foundation; Fondation de France(Fondation de France)	This work was supported by two grants from the Agence Nationale pour la Recherche (grant number ANR-09-BLAN-0327 SOCODEV and ANR-2010-BLAN-1901-1 BOOTLANG), funding from Ile-de-France (NERF), the Ecole de Neurosciences de Paris, the Fyssen Foundation, and Fondation de France. We are grateful for the institutional support of ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL*, and the Hopital Cochin (Maternite Port-Royale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Arimitsu T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00202; Belin P, 2006, PHILOS T R SOC B, V361, P2091, DOI 10.1098/rstb.2006.1933; Blasi A, 2007, PHYS MED BIOL, V52, P6849, DOI 10.1088/0031-9155/52/23/005; Cristia A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058906; Everdell NL, 2005, PEDIATR NEPHROL, V20, P636, DOI 10.1007/s00467-004-1785-5; Gervain Judit, 2008, Proc Natl Acad Sci U S A, V105, P14222, DOI 10.1073/pnas.0806530105; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Joly O, 2012, NEUROIMAGE, V62, P1376, DOI 10.1016/j.neuroimage.2012.05.070; Kotilahti K, 2010, HUM BRAIN MAPP, V31, P595, DOI 10.1002/hbm.20890; Lloyd-Fox S, 2012, SOC NEUROSCI-UK, V7, P317, DOI 10.1080/17470919.2011.614696; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; May L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00222; Minagawa-Kawai Y, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00170; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Minagawa-Kawai Y, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00135; Minagawa-Kawai Y, 2011, CEREB CORTEX, V21, P254, DOI 10.1093/cercor/bhq082; Nishida T, 2008, NEUROSCI LETT, V443, P23, DOI 10.1016/j.neulet.2008.07.035; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Pollard KS, 2005, STAT BIOL HEALTH, P249; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Ramus F., 2002, ANN REV LANGUAGE ACQ, V2, P85, DOI [10.1075/arla.2.05ram, DOI 10.1075/ARLA.2.05RAM]; Sato H, 2012, HUM BRAIN MAPP, V33, P2092, DOI 10.1002/hbm.21350; Scott LS, 2007, CURR DIR PSYCHOL SCI, V16, P197, DOI 10.1111/j.1467-8721.2007.00503.x; Shukla M, 2006, THESIS INT SCH ADV S; Shultz S, 2014, DEVELOPMENTAL SCI, V17; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vouloumanos A, 2010, CHILD DEV, V81, P517, DOI 10.1111/j.1467-8624.2009.01412.x; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	33	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115162	10.1371/journal.pone.0115162	http://dx.doi.org/10.1371/journal.pone.0115162			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517997	Green Submitted, gold, Green Published			2022-12-27	WOS:000347215600047
J	Rabhi, KK; Esancy, K; Voisin, A; Crespin, L; Le Corre, J; Tricoire-Leignel, H; Anton, S; Gadenne, C				Rabhi, Kaouther K.; Esancy, Kali; Voisin, Anouk; Crespin, Lucille; Le Corre, Julie; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe			Unexpected Effects of Low Doses of a Neonicotinoid Insecticide on Behavioral Responses to Sex Pheromone in a Pest Insect	PLOS ONE			English	Article							BLACK CUTWORM MOTH; GREEN PEACH APHID; ASIAN CORN-BORER; INDUCED HORMESIS; PARASITOID WASP; ACUTE TOXICITY; SUBLETHAL; REPRODUCTION; HONEYBEE; EXPOSURE	In moths, which include many agricultural pest species, males are attracted by female-emitted sex pheromones. Although integrated pest management strategies are increasingly developed, most insect pest treatments rely on widespread use of neurotoxic chemicals, including neonicotinoid insecticides. Residual accumulation of low concentrations of these insecticides in the environment is known to be harmful to beneficial insects such as honey bees. This environmental stress probably acts as an "info-disruptor'' by modifying the chemical communication system, and therefore decreases chances of reproduction in target insects that largely rely on olfactory communication. However, low doses of pollutants could on the contrary induce adaptive processes in the olfactory pathway, thus enhancing reproduction. Here we tested the effects of acute oral treatments with different low doses of the neonicotinoid clothianidin on the behavioral responses to sex pheromone in the moth Agrotis ipsilon using wind tunnel experiments. We show that low doses of clothianidin induce a biphasic effect on pheromone-guided behavior. Surprisingly, we found a hormetic-like effect, improving orientation behavior at the LD20 dose corresponding to 10 ng clothianidin. On the contrary, a negative effect, disturbing orientation behavior, was elicited by a treatment with a dose below the LD0 dose corresponding to 0.25 ng clothianidin. No clothianidin effect was observed on behavioral responses to plant odor. Our results indicate that risk assessment has to include unexpected effects of residues on the life history traits of pest insects, which could then lead to their adaptation to environmental stress.	[Rabhi, Kaouther K.; Esancy, Kali; Voisin, Anouk; Crespin, Lucille; Le Corre, Julie; Tricoire-Leignel, Helene; Anton, Sylvia; Gadenne, Christophe] Univ Angers, INRA, Neuroethol RCIM, SFR QUASAV 4207,UPRES EA USC INRA 2647 1330, F-49071 Beaucouze, France	INRAE; Universite d'Angers	Gadenne, C (corresponding author), Univ Angers, INRA, Neuroethol RCIM, SFR QUASAV 4207,UPRES EA USC INRA 2647 1330, 42 Rue Georges Morel, F-49071 Beaucouze, France.	christophe.gadenne@angers.inra.fr	Tricoire-Leignel, Hélène/ABG-2320-2020	Tricoire-Leignel, Hélène/0000-0002-2881-2962	French National Funding Agency [ANR-12 ADAP-0012-01]; Region Pays de la Loire; Fulbright grant	French National Funding Agency; Region Pays de la Loire(Region Pays de la Loire); Fulbright grant	This work was supported by French National Funding Agency grant ANR-12 ADAP-0012-01 to H.T.-L., S.A., C.G. and a PhD grant to K.K.R., by the "Region Pays de la Loire" to S.A. and C.G. and by a Fulbright grant to K.E.	Ahmad S, 2013, INT J TROP INSECT SC, V33, P264, DOI 10.1017/S1742758413000246; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Anton S, 2007, ENTOMOL EXP APPL, V123, P1, DOI 10.1111/j.1570-7458.2007.00516.x; Anton S, 2011, P NATL ACAD SCI USA, V108, P3401, DOI 10.1073/pnas.1008840108; Bao HB, 2009, PEST MANAG SCI, V65, P170, DOI 10.1002/ps.1664; Barbieri RF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2157; Barrozo RB, 2010, J EXP BIOL, V213, P2933, DOI 10.1242/jeb.043430; Bues R., 1974, ANN ZOOL ECOL ANIM, V2, P79; Calabrese EJ, 2009, ARCH TOXICOL, V83, P203, DOI 10.1007/s00204-009-0412-4; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Calabrese EJ, 2001, TOXICOL SCI, V62, P330, DOI 10.1093/toxsci/62.2.330; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Cutler GC, 2009, PEST MANAG SCI, V65, P205, DOI 10.1002/ps.1669; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Delpuech JM, 2005, ARCH ENVIRON CON TOX, V49, P186, DOI 10.1007/s00244-004-0158-1; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; GADENNE C, 1993, EXPERIENTIA, V49, P721, DOI 10.1007/BF01923960; Gemeno C, 1998, J CHEM ECOL, V24, P999, DOI 10.1023/A:1022398318465; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Guedes NMP, 2010, J APPL ENTOMOL, V134, P142, DOI 10.1111/j.1439-0418.2009.01462.x; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; HARDIN MR, 1995, CROP PROT, V14, P3, DOI 10.1016/0261-2194(95)91106-P; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hu XP, 1998, J APPL ENTOMOL, V122, P37, DOI 10.1111/j.1439-0418.1998.tb01458.x; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Komeza N, 2001, ARCH ENVIRON CON TOX, V41, P436, DOI 10.1007/s002440010269; Kullik SA, 2011, J ECON ENTOMOL, V104, P484, DOI 10.1603/EC10360; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P671, DOI 10.1016/S0028-3908(99)00170-7; Laurino D, 2013, B INSECTOL, V66, P119; Laurino D, 2011, B INSECTOL, V64, P107; Li J, 2010, INSECT BIOCHEM MOLEC, V40, P17, DOI 10.1016/j.ibmb.2009.12.003; LINN C, 1985, PESTIC SCI, V16, P445; LINN CE, 1984, ARCH INSECT BIOCHEM, V1, P331, DOI 10.1002/arch.940010405; Lurling M, 2007, TRENDS ECOL EVOL, V22, P374, DOI 10.1016/j.tree.2007.04.002; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Miao J, 2014, PEST MANAG SCI, V70, P55, DOI 10.1002/ps.3523; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Morse JG, 1998, HUM EXP TOXICOL, V17, P266, DOI 10.1191/096032798678908738; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Picimbon JF, 1997, J CHEM ECOL, V23, P211, DOI 10.1023/B:JOEC.0000006355.13207.91; Rings RW, 1974, OHIO AGR RES DEV CTR, P1; ROELOFS WL, 1995, P NATL ACAD SCI USA, V92, P44, DOI 10.1073/pnas.92.1.44; Saber M, 2013, CROP PROT, V43, P14, DOI 10.1016/j.cropro.2012.09.011; Saveer AM, 2012, P ROY SOC B-BIOL SCI, V279, P2314, DOI 10.1098/rspb.2011.2710; Shi XB, 2011, PEST MANAG SCI, V67, P1528, DOI 10.1002/ps.2207; Sohrabi F, 2011, CROP PROT, V30, P1190, DOI 10.1016/j.cropro.2011.05.004; Sokal R.R., 2012, BIOMETRY; Suckling DM, 2014, PEST MANAG SCI, V70, P179, DOI 10.1002/ps.3670; Taillebois E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096669; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; Thany SH, 2005, GENE, V344, P125, DOI 10.1016/j.gene.2004.09.010; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Wei H, 2004, PESTIC BIOCHEM PHYS, V80, P12, DOI 10.1016/j.pestbp.2004.05.001; Yu YS, 2010, PESTIC BIOCHEM PHYS, V98, P238, DOI 10.1016/j.pestbp.2010.06.013; Zhou HC, 2005, J CHEM ECOL, V31, P1645, DOI 10.1007/s10886-005-5804-1	62	30	35	0	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114411	10.1371/journal.pone.0114411	http://dx.doi.org/10.1371/journal.pone.0114411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517118	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600016
J	Si, MR; Long, MX; Chaudhry, MT; Xu, YX; Zhang, P; Zhang, L; Shen, XH				Si, Meiru; Long, Mingxiu; Chaudhry, Muhammad Tausif; Xu, Yixiang; Zhang, Pan; Zhang, Lei; Shen, Xihui			Functional Characterization of Corynebacterium glutamicum Mycothiol S-Conjugate Amidase	PLOS ONE			English	Article							N-ACETYL-1-D-MYO-INOSITYL-2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE DEACETYLASE MSHB; MYCOBACTERIUM-SMEGMATIS MUTANTS; SIGMA-FACTOR SIGH; BIOSYNTHESIS; TUBERCULOSIS; GENE; IDENTIFICATION; DETOXIFICATION; INHIBITORS; COFACTOR	The present study focuses on the genetic and biochemical characterization of mycothiol S-conjugate amidase (Mca) of Corynebacterium glutamicum. Recombinant C. glutamicum Mca was heterologously expressed in Escherichia coli and purified to apparent homogeneity. The molecular weight of native Mca protein determined by gel filtration chromatography was 35 kDa, indicating that Mca exists as monomers in the purification condition. Mca showed amidase activity with mycothiol S-conjugate of monobromobimane (MSmB) in vivo while mca mutant lost the ability to cleave MSmB. In addition, Mca showed limited deacetylase activity with N-acetyl-D-glucosamine (GlcNAc) as substrate. Optimum pH for amidase activity was between 7.5 and 8.5, while the highest activity in the presence of Zn2+ confirmed Mca as a zinc metalloprotein. Amino acid residues conserved among Mca family members were located in C. glutamicum Mca and site-directed mutagenesis of these residues indicated that Asp14, Tyr137, His139 and Asp141 were important for activity. The mca deletion mutant showed decreased resistance to antibiotics, alkylating agents, oxidants and heavy metals, and these sensitive phenotypes were recovered in the complementary strain to a great extent. The physiological roles of Mca in resistance to various toxins were further supported by the induced expression of Mca in C. glutamicum under various stress conditions, directly under the control of the stress-responsive extracytoplasmic function-sigma (ECF-s) factor SigH.	[Si, Meiru; Xu, Yixiang; Zhang, Pan; Zhang, Lei; Shen, Xihui] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Si, Meiru; Xu, Yixiang; Zhang, Pan; Zhang, Lei; Shen, Xihui] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Long, Mingxiu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Chaudhry, Muhammad Tausif] Pakistan Council Sci & Ind Res, Natl Phys & Stand Lab, Environm Analyt Lab, Islamabad, Pakistan	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; National Physical & Standards Laboratory (NPSL); PCSIR Laboratories Complex	Shen, XH (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	xihuishen@nwsuaf.edu.cn			National High Technology Research and Development Program of China (863 program) [2013AA102802]; National Natural Science Foundation of China [31270078, 31170100, 31170121]; Key Science and Technology R&D Program of Shaanxi Province, China [2014K02-12-01]; State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences [SKLMR-20120601]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology R&D Program of Shaanxi Province, China; State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences	This work was supported by the National High Technology Research and Development Program of China (863 program, grant 2013AA102802), National Natural Science Foundation of China (Nos. 31270078, 31170100 and 31170121), Key Science and Technology R&D Program of Shaanxi Province, China (2014K02-12-01) and the Opening Project of State Key Laboratory of Microbial Resource, Institute of Microbiology, Chinese Academy of Sciences (No. SKLMR-20120601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belyaeva EA, 2008, TOXICOL APPL PHARM, V231, P34, DOI 10.1016/j.taap.2008.03.017; Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x; Busche T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-445; Ehira S, 2009, J BACTERIOL, V191, P2964, DOI 10.1128/JB.00112-09; Fahey RC, 2001, ANNU REV MICROBIOL, V55, P333, DOI 10.1146/annurev.micro.55.1.333; Feng J, 2006, J BIOL CHEM, V281, P10778, DOI 10.1074/jbc.M513192200; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Huang XY, 2011, J BIOL CHEM, V286, P20275, DOI 10.1074/jbc.M111.234229; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Koledin T, 2002, ARCH MICROBIOL, V178, P331, DOI 10.1007/s00203-002-0462-y; Li M, 2007, ARCH BIOCHEM BIOPHYS, V458, P220, DOI 10.1016/j.abb.2006.12.010; Liu YB, 2013, ARCH MICROBIOL, V195, P419, DOI 10.1007/s00203-013-0889-3; Maynes JT, 2003, J BIOL CHEM, V278, P47166, DOI 10.1074/jbc.M308914200; Miller JH, 1992, SHORT COURSE BACTERI, V1; Nan BY, 2006, BBA-PROTEINS PROTEOM, V1764, P839, DOI 10.1016/j.bbapap.2005.10.023; Nan BY, 2010, MOL MICROBIOL, V75, P1484, DOI 10.1111/j.1365-2958.2010.07069.x; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; NEWTON GL, 1995, METHOD ENZYMOL, V251, P148, DOI 10.1016/0076-6879(95)51118-0; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Newton GL, 1999, BIOCHEM BIOPH RES CO, V255, P239, DOI 10.1006/bbrc.1999.0156; Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n; Nicholas GM, 2003, BIOORGAN MED CHEM, V11, P601, DOI 10.1016/S0968-0896(02)00345-0; Nicholas GM, 2002, BIOORG MED CHEM LETT, V12, P2487, DOI 10.1016/S0960-894X(02)00385-2; Nicholas GM, 2001, ORG LETT, V3, P1543, DOI 10.1021/ol015845+; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Park JH, 2008, MOL MICROBIOL, V68, P861, DOI 10.1111/j.1365-2958.2008.06191.x; Rawat M, 2004, J BACTERIOL, V186, P6050, DOI 10.1128/jb.186.18.6050-6058.2004; Rawat M, 2003, MICROBIOL-SGM, V149, P1341, DOI 10.1099/mic.0.26084-0; Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Shen XH, 2005, APPL ENVIRON MICROB, V71, P3442, DOI 10.1128/AEM.71.7.3442-3452.2005; Si MR, 2014, APPL ENVIRON MICROB, V80, P1750, DOI 10.1128/AEM.03654-13; Smirnova GV, 2000, FREE RADICAL BIO MED, V28, P1009, DOI 10.1016/S0891-5849(99)00256-7; Steffek M, 2003, BIOCHEMISTRY-US, V42, P12067, DOI 10.1021/bi030080u; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005	38	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115075	10.1371/journal.pone.0115075	http://dx.doi.org/10.1371/journal.pone.0115075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514023	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300032
J	Morgan, AP; Crowley, JJ; Nonneman, RJ; Quackenbush, CR; Miller, CN; Ryan, AK; Bogue, MA; Paredes, SH; Yourstone, S; Carroll, IM; Kawula, TH; Bower, MA; Sartor, RB; Sullivan, PF				Morgan, Andrew P.; Crowley, James J.; Nonneman, Randal J.; Quackenbush, Corey R.; Miller, Cheryl N.; Ryan, Allison K.; Bogue, Molly A.; Paredes, Sur Herrera; Yourstone, Scott; Carroll, Ian M.; Kawula, Thomas H.; Bower, Maureen A.; Sartor, R. Balfour; Sullivan, Patrick F.			The Antipsychotic Olanzapine Interacts with the Gut Microbiome to Cause Weight Gain in Mouse	PLOS ONE			English	Article							INSULIN-RESISTANCE; FAT DEPOSITION; BODY-WEIGHT; SCHIZOPHRENIA; DRUGS; SEQUENCES; ECOLOGY; OBESITY	The second-generation antipsychotic olanzapine is effective in reducing psychotic symptoms but can cause extreme weight gain in human patients. We investigated the role of the gut microbiota in this adverse drug effect using a mouse model. First, we used germ-free C57BL/6J mice to demonstrate that gut bacteria are necessary and sufficient for weight gain caused by oral delivery of olanzapine. Second, we surveyed fecal microbiota before, during, and after treatment and found that olanzapine potentiated a shift towards an "obesogenic'' bacterial profile. Finally, we demonstrated that olanzapine has antimicrobial activity in vitro against resident enteric bacterial strains. These results collectively provide strong evidence for a mechanism underlying olanzapine-induced weight gain in mouse and a hypothesis for clinical translation in human patients.	[Morgan, Andrew P.; Crowley, James J.; Nonneman, Randal J.; Quackenbush, Corey R.; Ryan, Allison K.; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Miller, Cheryl N.; Kawula, Thomas H.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Paredes, Sur Herrera; Yourstone, Scott] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Carroll, Ian M.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Morgan, Andrew P.; Paredes, Sur Herrera; Yourstone, Scott] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC USA; [Bogue, Molly A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Bower, Maureen A.; Sartor, R. Balfour] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sullivan, PF (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA.	pfsulliv@med.unc.edu	Miller, Cheryl/M-7133-2019; Miller, Cheryl N/M-7579-2019; Paredes, Sur Herrera/I-8617-2019	Miller, Cheryl N/0000-0003-3665-704X; Paredes, Sur Herrera/0000-0001-9246-8337; Morgan, Andrew Parker/0000-0003-1942-4543; Crowley, James/0000-0001-9051-1557	National Institute of Mental Health [R21MH097173, K01MH094406]; National Institute of Diabetes, Digestive and Kidney Diseases [P30DK034987, P40OD010995, P30DK056350]; National Institute of General Medical Sciences [T32GM067553, T32GM008719]; Howard Hughes Medical Institute International Student Research Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, T32GM067553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH094406, F30MH103925, R21MH097173] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: National Institute of Mental Health #R21MH097173 (JJC, PFS), #K01MH094406 (JJC); National Institute of Diabetes, Digestive and Kidney Diseases #P30DK034987, P40OD010995, P30DK056350 (RBS); National Institute of General Medical Sciences #T32GM067553, T32GM008719 (APM); and Howard Hughes Medical Institute International Student Research Fellowship (SHP). URLs: NIMH http://www.nimh.nih.gov/; NIDDK http://www.niddk. nih.gov/; NIGMS http://www.nigms.nih.gov/; HHMI https://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2011, LANCET, V377, P611, DOI 10.1016/S0140-6736(11)60211-0; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Callaghan JT, 1999, CLIN PHARMACOKINET, V37, P177, DOI 10.2165/00003088-199937030-00001; Campbell JH, 2012, ISME J, V6, P2033, DOI 10.1038/ismej.2012.54; Capasso RM, 2008, SCHIZOPHR RES, V98, P287, DOI 10.1016/j.schres.2007.10.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carroll IM, 2009, MAMM GENOME, V20, P395, DOI 10.1007/s00335-009-9204-7; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Davey KJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.83; Davey KJ, 2012, PSYCHOPHARMACOLOGY, V221, P155, DOI 10.1007/s00213-011-2555-2; Farwell WR, 2004, J GEN INTERN MED, V19, P1200, DOI 10.1111/j.1525-1497.2004.40126.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Foley DL, 2011, ARCH GEN PSYCHIAT, V68, P609, DOI 10.1001/archgenpsychiatry.2011.2; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Jenkins AJ, 1998, J ANAL TOXICOL, V22, P605, DOI 10.1093/jat/22.7.605; Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413; KRISTIANSEN JEH, 1979, ACTA PATH MICRO IM B, V87, P317; Leslie WS, 2007, QJM-INT J MED, V100, P395, DOI 10.1093/qjmed/hcm044; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lieberman JA, 2006, ARCH GEN PSYCHIAT, V63, P1069, DOI 10.1001/archpsyc.63.10.1069; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; Minet-Ringuet J, 2006, APPETITE, V46, P254, DOI 10.1016/j.appet.2006.01.008; Nixon JP, 2010, OBESITY, V18, P1652, DOI 10.1038/oby.2009.471; Perry PJ, 2001, J CLIN PSYCHOPHARM, V21, P14, DOI 10.1097/00004714-200102000-00004; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Teff KL, 2013, DIABETES, V62, P3232, DOI 10.2337/db13-0430; Thorsing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064518; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Venables WN., 2002, MODERN APPL STAT S 4; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Wang CJ, 2006, BIOL PSYCHIAT, V60, P1309, DOI 10.1016/j.biopsych.2006.03.014; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163; Zhang G, 2007, J CHROMATOGR B, V858, P276, DOI 10.1016/j.jchromb.2007.08.007; Zhang ZJ, 2004, BRIT J PSYCHIAT, V184, P58, DOI 10.1192/bjp.184.1.58	58	103	105	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115225	10.1371/journal.pone.0115225	http://dx.doi.org/10.1371/journal.pone.0115225			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506936	Green Submitted, gold, Green Published			2022-12-27	WOS:000346607100063
J	Francis, B; Lane, S; Pirmohamed, M; Jorgensen, A				Francis, Ben; Lane, Steven; Pirmohamed, Munir; Jorgensen, Andrea			A Review of A Priori Regression Models for Warfarin Maintenance Dose Prediction	PLOS ONE			English	Review							DOSING ALGORITHMS; PHARMACOGENETIC ALGORITHMS; ORAL ANTICOAGULATION; CYP2C9 GENOTYPES; RANDOMIZED-TRIAL; CLINICAL FACTORS; THERAPY; VKORC1; CHILDREN; AGE	A number of a priori warfarin dosing algorithms, derived using linear regression methods, have been proposed. Although these dosing algorithms may have been validated using patients derived from the same centre, rarely have they been validated using a patient cohort recruited from another centre. In order to undertake external validation, two cohorts were utilised. One cohort formed by patients from a prospective trial and the second formed by patients in the control arm of the EUPACT trial. Of these, 641 patients were identified as having attained stable dosing and formed the dataset used for validation. Predicted maintenance doses from six criterion fulfilling regression models were then compared to individual patient stable warfarin dose. Predictive ability was assessed with reference to several statistics including the R-square and mean absolute error. The six regression models explained different amounts of variability in the stable maintenance warfarin dose requirements of the patients in the two validation cohorts; adjusted R-squared values ranged from 24.2% to 68.6%. An overview of the summary statistics demonstrated that no one dosing algorithm could be considered optimal. The larger validation cohort from the prospective trial produced more consistent statistics across the six dosing algorithms. The study found that all the regression models performed worse in the validation cohort when compared to the derivation cohort. Further, there was little difference between regression models that contained pharmacogenetic coefficients and algorithms containing just non-pharmacogenetic coefficients. The inconsistency of results between the validation cohorts suggests that unaccounted population specific factors cause variability in dosing algorithm performance. Better methods for dosing that take into account inter- and intraindividual variability, at the initiation and maintenance phases of warfarin treatment, are needed.	[Francis, Ben; Lane, Steven; Jorgensen, Andrea] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Pirmohamed, Munir] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Francis, B (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	b.r.francis@liv.ac.uk	Pirmohamed, Munir/H-6004-2011	Pirmohamed, Munir/0000-0002-7534-7266; Francis, Ben/0000-0002-2130-5976	EU commission; Department of Health; MRC [MR/L006758/1] Funding Source: UKRI; Medical Research Council [MR/L006758/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10064] Funding Source: researchfish	EU commission(European CommissionEuropean Commission Joint Research Centre); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors wish to thank the authors of the EU-PACT trial manuscript, especially Girvan Burnside for his kind help with the EU-PACT trial data and the EU commission for funding the EU-PACT trial.; Similarly we also would like to thank the Department of Health for funding the Liverpool prospective study. As well as Anita Hanson for her helpful assistance with the ethics statement for the Liverpool prospective study.	Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Anderson JL, 2012, CIRCULATION, V125, P1997, DOI 10.1161/CIRCULATIONAHA.111.070920; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; Chen JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105250; Do EJ, 2012, PHARMACOGENOMICS J, V12, P417, DOI 10.1038/tpj.2011.18; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Greenway A, 2009, THROMB HAEMOSTASIS, V102, P159, DOI 10.1160/TH09-01-0056; Hamberg AK, 2007, CLIN PHARMACOL THER, V81, P529, DOI 10.1038/sj.clpt.6100084; Hamberg AK, 2010, CLIN PHARMACOL THER, V87, P727, DOI 10.1038/clpt.2010.37; Hamberg AK, 2013, EUR J CLIN PHARMACOL, V69, P1275, DOI 10.1007/s00228-012-1466-4; Hawcutt DB, 2014, PHARMACOGENOMICS J; Hillman MA, 2005, CLIN MED RES, V3, P137, DOI 10.3121/cmr.3.3.137; Horne BD, 2012, THROMB HAEMOSTASIS, V107, P232, DOI 10.1160/TH11-06-0388; Johnson EG, 2011, MOL DIAGN THER, V15, P255, DOI 10.2165/11594390-000000000-00000; Jorgensen AL, 2009, PHARMACOGENET GENOM, V19, P800, DOI 10.1097/FPC.0b013e3283317ab5; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Kimmel SE, 2008, EXPERT OPIN PHARMACO, V9, P677, DOI 10.1517/14656566.9.5.677; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Krajiova L, 2014, EUR J HAEMATOL; Kulkarni UP, 2008, BRIT J CLIN PHARMACO, V65, P787, DOI 10.1111/j.1365-2125.2008.03113.x; Kumar DK, 2014, EUR J CLIN PHARMACOL, V70, P47, DOI 10.1007/s00228-013-1581-x; Lala Mallika, 2013, J Pediatr Pharmacol Ther, V18, P209, DOI 10.5863/1551-6776-18.3.209; Lane S, 2012, BRIT J CLIN PHARMACO, V73, P66, DOI 10.1111/j.1365-2125.2011.04051.x; Le Gal G, 2010, J THROMB HAEMOST, V8, P90, DOI 10.1111/j.1538-7836.2009.03676.x; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Linder MW, 2009, CLIN CHEM, V55, P1861, DOI 10.1373/clinchem.2009.125898; Lou Ying, 2014, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V31, P367, DOI 10.3760/cma.j.issn.1003-9406.2014.03.024; Marin-Leblanc M, 2012, PHARMACOGENOMICS, V13, P21, DOI [10.2217/PGS.11.120, 10.2217/pgs.11.120]; Moreau C, 2011, J THROMB HAEMOST, V9, P711, DOI 10.1111/j.1538-7836.2011.04213.x; Perini JA, 2008, CLIN PHARMACOL THER, V84, P722, DOI 10.1038/clpt.2008.166; Perlstein TS, 2012, THROMB HAEMOSTASIS, V107, P59, DOI 10.1160/TH11-08-0568; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Pirmohamed M, 2006, BRIT J CLIN PHARMACO, V62, P509, DOI 10.1111/j.1365-2125.2006.02806.x; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; QURESHI GD, 1981, ARCH INTERN MED, V141, P507, DOI 10.1001/archinte.141.4.507; Roper N, 2010, J MOL DIAGN, V12, P283, DOI 10.2353/jmoldx.2010.090110; Schelleman H, 2008, CLIN PHARMACOL THER, V84, P332, DOI 10.1038/clpt.2008.101; Sconce EA, 2005, BLOOD, V106, P2329, DOI 10.1182/blood-2005-03-1108; Scott SA, 2012, PHARMACOGENOMICS, V13, P297, DOI [10.2217/PGS.11.156, 10.2217/pgs.11.156]; Shaw K, 2014, PEDIATR BLOOD CANCER, V61, P1055, DOI 10.1002/pbc.24932; Solomon I, 2004, ISR MED ASSOC J, V6, P732; van Schie RMF, 2009, PHARMACOGENOMICS, V10, P1687, DOI [10.2217/pgs.09.125, 10.2217/PGS.09.125]; Wadelius M, 2007, PHARMACOGENOMICS J, V7, P99, DOI 10.1038/sj.tpj.6500417; Wadelius M, 2009, BLOOD, V113, P784, DOI 10.1182/blood-2008-04-149070; Zhu Y, 2007, CLIN CHEM, V53, P1199, DOI 10.1373/clinchem.2006.078139	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114896	10.1371/journal.pone.0114896	http://dx.doi.org/10.1371/journal.pone.0114896			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501765	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400061
J	Sato, Y; Inoue, M; Yoshizawa, T; Yamagata, K				Sato, Yoshifumi; Inoue, Masahiro; Yoshizawa, Tatsuya; Yamagata, Kazuya			Moderate Hypoxia Induces beta-Cell Dysfunction with HIF-1-Independent Gene Expression Changes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INSULIN-SECRETION; TUMOR HYPOXIA; APOPTOSIS; ACTIVATION; FAILURE; PROLIFERATION; PROGRESSION; HOMEOSTASIS; REGULATOR	Pancreatic beta-cell failure is central to the development and progression of type 2 diabetes. We recently demonstrated that beta-cells become hypoxic under high glucose conditions due to increased oxygen consumption and that the pancreatic islets of diabetic mice but not those of control mice are moderately hypoxic. However, the impact of moderate hypoxia on beta-cell number and function is unknown. In the present study, moderate hypoxia induced a hypoxic response in MIN6 cells, as evidenced by increased levels of HIF-1 alpha protein and target genes. Under these conditions, a selective downregulation of Mafa, Pdx1, Slc2a2, Ndufa5, Kcnj11, Ins1, Wfs1, Foxa2, and Neurod1, which play important roles in beta-cells, was also observed in both MIN6 cells and isolated pancreatic islets. Consistent with the altered expression of these genes, abnormal insulin secretion was detected in hypoxic MIN6 cells. Most of the hypoxia-induced gene downregulation in MIN6 cells was not affected by the suppression of HIF-1 alpha, suggesting a HIF-1-independent mechanism. Moderate hypoxia also induced apoptosis in MIN6 cells. These results suggest that hypoxia is a novel stressor of beta-cells and that hypoxic stress may play a role in the deterioration of beta-cell function.	[Sato, Yoshifumi; Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto, Japan; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka, Japan	Kumamoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Yamagata, K (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Med Biochem, Kumamoto, Japan.	k-yamaga@kumamoto-u.ac.jp	Sato, Yoshifumi/GYQ-7230-2022	Yoshizawa, Tatsuya/0000-0002-5728-1996; Sato, Yoshifumi/0000-0003-0697-1476	Banyu Life Science Foundation International; Takeda Science Foundation; Novo Nordisk Insulin Research Foundation	Banyu Life Science Foundation International(Banyu Life Science Foundation International); Takeda Science Foundation(Takeda Science Foundation (TSF)); Novo Nordisk Insulin Research Foundation	This work was supported by a Grant-in-Aid for Young Scientists (B), a Grant-in-Aid for Scientific Research (B), a grant from Banyu Life Science Foundation International, a grant from Takeda Science Foundation, and a grant from Novo Nordisk Insulin Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Endo H, 2007, CANCER RES, V67, P8095, DOI 10.1158/0008-5472.CAN-06-3389; Fujimoto K, 2010, J CLIN INVEST, V120, P4031, DOI 10.1172/JCI44011; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Halban PA, 2014, J CLIN ENDOCR METAB, V99, P1983, DOI 10.1210/jc.2014-1425; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Li XQ, 2006, DIABETES, V55, P2965, DOI 10.2337/db06-0733; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Melvin A, 2012, CELL SIGNAL, V24, P35, DOI 10.1016/j.cellsig.2011.08.019; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Peralta S, 2014, HUM MOL GENET, V23, P1399, DOI 10.1093/hmg/ddt526; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Puri S, 2013, GENE DEV, V27, P2563, DOI 10.1101/gad.227785.113; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Samoszuk MK, 2004, J HISTOCHEM CYTOCHEM, V52, P837, DOI 10.1369/jhc.4B6248.2004; Sato Y, 2012, J BIOL CHEM, V287, P23236, DOI 10.1074/jbc.M112.368779; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Wu MZ, 2011, MOL CELL, V43, P811, DOI 10.1016/j.molcel.2011.07.012; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	49	31	35	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114868	10.1371/journal.pone.0114868	http://dx.doi.org/10.1371/journal.pone.0114868			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503986	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400057
J	Gordian, E; Li, J; Pevzner, Y; Mediavilla-Varela, M; Luddy, K; Ohaegbulam, K; Daniel, KG; Haura, EB; Munoz-Antonia, T				Gordian, Edna; Li, Jiannong; Pevzner, Yuri; Mediavilla-Varela, Melanie; Luddy, Kimberly; Ohaegbulam, Kim; Daniel, Kenyon G.; Haura, Eric B.; Munoz-Antonia, Teresita			Transforming Growth Factor beta Signaling Overcomes Dasatinib Resistance in Lung Cancer	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; TGF-BETA; EPITHELIAL-CELLS; RECEPTOR KINASE; BREAST-CANCER; I RECEPTOR; PHASE-II; APOPTOSIS; EXPRESSION; INVASION	Lung cancer is the second most common cancer and the leading cause of cancer-related deaths. Despite recent advances in the development of targeted therapies, patients with advanced disease remain incurable, mostly because metastatic non-small cell lung carcinomas (NSCLC) eventually become resistant to tyrosine kinase inhibitors (TKIs). Kinase inhibitors have the potential for target promiscuity because the kinase super family is the largest family of druggable genes that binds to a common substrate (ATP). As a result, TKIs often developed for a specific purpose have been found to act on other targets. Drug affinity chromatography has been used to show that dasatinib interacts with the TGF beta type I receptor (T beta R-I), a serine-threonine kinase. To determine the potential biological relevance of this association, we studied the combined effects of dasatinib and TGFb on lung cancer cell lines. We found that dasatinib treatment alone had very little effect; however, when NSCLC cell lines were treated with a combination of TGF beta and dasatinib, apoptosis was induced. Combined TGF beta-1 + dasatinib treatment had no effect on the activity of Smad2 or other non-canonical TGF beta intracellular mediators. Interestingly, combined TGFb and dasatinib treatment resulted in a transient increase in p-Smad3 (seen after 3 hours). In addition, when NSCLC cells were treated with this combination, the pro-apoptotic protein BIM was up-regulated. Knockdown of the expression of Smad3 using Smad3 siRNA also resulted in a decrease in BIM protein, suggesting that TGF beta-1 + dasatinib- induced apoptosis is mediated by Smad3 regulation of BIM. Dasatinib is only effective in killing EGFR mutant cells, which is shown in only 10% of NSCLCs. Therefore, the observation that wild-type EGFR lung cancers can be manipulated to render them sensitive to killing by dasatinib could have important implications for devising innovative and potentially more efficacious treatment strategies for this disease.	[Gordian, Edna; Munoz-Antonia, Teresita] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Li, Jiannong; Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA; [Pevzner, Yuri; Daniel, Kenyon G.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Mediavilla-Varela, Melanie] H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA; [Luddy, Kimberly] H Lee Moffitt Canc Ctr & Res Inst, Canc Imaging & Metab Program, Tampa, FL 33612 USA; [Ohaegbulam, Kim] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Yeshiva University; Albert Einstein College of Medicine	Munoz-Antonia, T (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA.	teresita.Antonia@moffitt.org		Luddy, Kimberly/0000-0002-5172-221X	National Institutes of Health SPORE [P50 CA119997-02-S2]; NATIONAL CANCER INSTITUTE [P50CA119997] Funding Source: NIH RePORTER	National Institutes of Health SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health SPORE Grant P50 CA119997-02-S2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SUIT 2012 DESM MOL D; [Anonymous], 2013, SCHROD REL 2013 1 SI; [Anonymous], 2012, SUIT 2012 SCHROD SUI; [Anonymous], 2012, EP; [Anonymous], 2012, LIGPREP; [Anonymous], 2013, SCHROD REL 2013 1 MA; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boulay JL, 2003, INT J CANCER, V104, P446, DOI 10.1002/ijc.10908; Buettner R, 2008, MOL CANCER RES, V6, P1766, DOI 10.1158/1541-7786.MCR-08-0169; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DiVito KA, 2010, PIGM CELL MELANOMA R, V23, P795, DOI 10.1111/j.1755-148X.2010.00758.x; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Guerrouahen BS, 2010, CLIN CANCER RES, V16, P1149, DOI 10.1158/1078-0432.CCR-09-2416; Ha Thi Huyen Trang, 2013, Biochim Biophys Acta, V1830, P3584, DOI 10.1016/j.bbagen.2013.03.006; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Johnson ML, 2011, J THORAC ONCOL, V6, P1128, DOI 10.1097/JTO.0b013e3182161508; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Lin S, 2011, J BIOL CHEM, V286, P44023, DOI 10.1074/jbc.M111.265397; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nakagawa T, 2013, CANCER RES, V73, P2428, DOI 10.1158/0008-5472.CAN-12-3479; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Ohgushi M, 2005, MOL CELL BIOL, V25, P10017, DOI 10.1128/MCB.25.22.10017-10028.2005; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Saitoh M, 1996, J BIOL CHEM, V271, P2769, DOI 10.1074/jbc.271.5.2769; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Ungefroren H, 2011, CURR CANCER DRUG TAR, V11, P524, DOI 10.2174/156800911795538075; Wildey GM, 2003, J BIOL CHEM, V278, P18069, DOI 10.1074/jbc.M211958200; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrighton KH, 2006, J BIOL CHEM, V281, P38365, DOI 10.1074/jbc.M607246200; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Zhang ZF, 2010, ONCOTARGET, V1, P497	60	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114131	10.1371/journal.pone.0114131	http://dx.doi.org/10.1371/journal.pone.0114131			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501935	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700015
J	Li, YY; Wen, HY; Chen, LQ; Yin, TT				Li, Yuanyuan; Wen, Hongyu; Chen, Longqian; Yin, Tingting			Succession of Bacterial Community Structure and Diversity in Soil along a Chronosequence of Reclamation and Re-Vegetation on Coal Mine Spoils in China	PLOS ONE			English	Article							MICROBIAL COMMUNITY; RESTORATION; RECOVERY; DISTRIBUTIONS; DISTURBANCE; SEQUENCES; PATTERNS; IMPACT; CARBON	The growing concern about the effectiveness of reclamation strategies has motivated the evaluation of soil properties following reclamation. Recovery of belowground microbial community is important for reclamation success, however, the response of soil bacterial communities to reclamation has not been well understood. In this study, PCR-based 454 pyrosequencing was applied to compare bacterial communities in undisturbed soils with those in reclaimed soils using chronosequences ranging in time following reclamation from 1 to 20 year. Bacteria from the Proteobacteria, Chloroflexi, Actinobacteria, Acidobacteria, Planctomycetes and Bacteroidetes were abundant in all soils, while the composition of predominant phyla differed greatly across all sites. Long-term reclamation strongly affected microbial community structure and diversity. Initial effects of reclamation resulted in significant declines in bacterial diversity indices in younger reclaimed sites (1, 8-year-old) compared to the undisturbed site. However, bacterial diversity indices tended to be higher in older reclaimed sites (15, 20-year-old) as recovery time increased, and were more similar to predisturbance levels nearly 20 years after reclamation. Bacterial communities are highly responsive to soil physicochemical properties (pH, soil organic matter, Total N and P), in terms of both their diversity and community composition. Our results suggest that the response of soil microorganisms to reclamation is likely governed by soil characteristics and, indirectly, by the effects of vegetation restoration. Mixture sowing of gramineae and leguminosae herbage largely promoted soil geochemical conditions and bacterial diversity that recovered to those of undisturbed soil, representing an adequate solution for soil remediation and sustainable utilization for agriculture. These results confirm the positive impacts of reclamation and vegetation restoration on soil microbial diversity and suggest that the most important phase of microbial community recovery occurs between 15 and 20 years after reclamation.	[Li, Yuanyuan; Chen, Longqian] China Univ Min & Technol, Sch Environm Sci & Spatial Informat, Jiangsu Key Lab Resources & Environm Informat Eng, Xuzhou, Peoples R China; [Wen, Hongyu; Yin, Tingting] Jiangsu Normal Univ, Sch Life Sci, Xuzhou, Peoples R China; [Chen, Longqian] Univ Malaya, Fac Built Environm, Kuala Lumpur, Malaysia	China University of Mining & Technology; Jiangsu Normal University; Universiti Malaya	Chen, LQ (corresponding author), China Univ Min & Technol, Sch Environm Sci & Spatial Informat, Jiangsu Key Lab Resources & Environm Informat Eng, Xuzhou, Peoples R China.	longqianchencumt@163.com	li, yuanyuan/GZA-4435-2022		National Natural Science Foundation of China [51174207]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions [SZBF2011-6-B35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (51174207) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (SZBF2011-6-B35, http://www.nsfc.gov.cn/; http://www.nsfc.gov.cn/nsfc/cen/00/download.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Afrasayab S., 2002, PAK J BIOL SCI, V5, P792, DOI [10.3923/pjbs.2002.792.797, DOI 10.3923/PJBS.2002.792.797]; Anderson JD, 2008, APPL SOIL ECOL, V40, P387, DOI 10.1016/j.apsoil.2008.06.008; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Bastida F, 2013, SOIL BIOL BIOCHEM, V65, P12, DOI 10.1016/j.soilbio.2013.04.022; Bremner J.M., 1965, METHODS SOIL ANAL 2, P1149, DOI DOI 10.2134/AGRONMONOGR9.2.C32; Cabrera-Rubio R, 2012, AM J CLIN NUTR, V96, P544, DOI 10.3945/ajcn.112.037382; CARSON PL, 1980, N DAK AGR EXP STA BU, P17; Chen LX, 2013, ENVIRON MICROBIOL, V15, P2431, DOI 10.1111/1462-2920.12114; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Dangi SR, 2012, SOIL SCI SOC AM J, V76, P915, DOI 10.2136/sssaj2011.0288; Dimitriu PA, 2010, SOIL BIOL BIOCHEM, V42, P2289, DOI 10.1016/j.soilbio.2010.09.001; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Frost SM, 2001, ARID LAND RES MANAG, V15, P3, DOI 10.1080/15324980119429; Gasch C, 2014, APPL SOIL ECOL, V76, P102, DOI 10.1016/j.apsoil.2013.12.012; Hahn AS, 2013, PLANT SOIL, V363, P331, DOI 10.1007/s11104-012-1306-4; Harris J.A., 1996, LAND RESTORATION REC; Huang LN, 2011, APPL ENVIRON MICROB, V77, P5540, DOI 10.1128/AEM.02458-10; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ingram LJ, 2005, SOIL SCI SOC AM J, V69, P1737, DOI 10.2136/sssaj2004.0371; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jiang XT, 2013, MICROB ECOL, V66, P96, DOI 10.1007/s00248-013-0238-8; Keil D, 2011, FEMS MICROBIOL ECOL, V77, P95, DOI 10.1111/j.1574-6941.2011.01091.x; Kolton M, 2011, APPL ENVIRON MICROB, V77, P4924, DOI 10.1128/AEM.00148-11; Kuffner M, 2012, FEMS MICROBIOL ECOL, V82, P551, DOI 10.1111/j.1574-6941.2012.01420.x; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leps J., 2005, AUSTRAL ECOL, V86, P6, DOI [10.1890/0012-9623(2005)86[6a:MAOEDU]2.0.CO;2, DOI 10.1111/J.1442-9993.2005.01433.X]; Lewis DE, 2012, MICROB ECOL, V64, P738, DOI 10.1007/s00248-012-0020-3; Lewis DE, 2010, MICROB ECOL, V59, P710, DOI 10.1007/s00248-009-9621-x; Li JG, 2014, GEODERMA, V226, P130, DOI 10.1016/j.geoderma.2014.02.003; Li JW, 2010, GEODERMA, V156, P60, DOI 10.1016/j.geoderma.2010.01.008; Li YY, 2014, J MICROBIOL BIOTECHN, V24, P313, DOI 10.4014/jmb.1309.09001; Mummey DL, 2002, SOIL BIOL BIOCHEM, V34, P1717, DOI 10.1016/S0038-0717(02)00158-X; Munshower FF., 1994, PRACTICAL HDB DISTUR; Nelson D. W., 1982, METHODS SOIL ANAL 2; [潘平 Pang Ping], 2003, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V20, P697; Poncelet DM, 2014, ENVIRON MONIT ASSESS, V186, P1917, DOI 10.1007/s10661-013-3505-8; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Rana S., 2007, 30 YEARS SMCRA, P653, DOI [DOI 10.21000/JASMR07010653, 10.21000/JASMR07010653]; Rastogi G, 2010, MICROB ECOL, V59, P94, DOI 10.1007/s00248-009-9598-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sheik CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040059; Sheoran V., 2010, INT J SOIL SEDIMENT, V3, P1; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Sun YG, 2011, CHINESE GEOGR SCI, V21, P403, DOI 10.1007/s11769-011-0482-0; Tait E, 2007, J EXP MAR BIOL ECOL, V342, P138, DOI 10.1016/j.jembe.2006.10.024; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wang L.P., 2009, INT J MIN SCI TECHNO, V19, P479, DOI [10.1016/S1674-5264(09)60089-2, DOI 10.1016/S1674-5264(09)60089-2]; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wick A.F., 2007, THESIS U WYOMING LAR; [武瑞平 WU Rui-ping], 2009, [农业环境科学学报, Journal of Agro-Environment Science], V28, P1855; Xiao R, 2011, CONT SHELF RES, V31, P739, DOI 10.1016/j.csr.2011.01.013; Xu QF, 2010, J SOIL SEDIMENT, V10, P255, DOI 10.1007/s11368-009-0100-2; Ye RW, 2001, CURR OPIN MICROBIOL, V4, P307, DOI 10.1016/S1369-5274(00)00208-3; Zhao ZQ, 2012, ECOL ENG, V44, P147, DOI 10.1016/j.ecoleng.2012.03.018	58	37	40	9	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115024	10.1371/journal.pone.0115024	http://dx.doi.org/10.1371/journal.pone.0115024			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502754	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700084
J	Rauch, AV; ter Horst, L; Paul, VG; Bauer, J; Dannlowski, U; Konrad, C; Ohrmann, P; Kugel, H; Egloff, B; Arolt, V; Suslow, T				Rauch, Astrid Veronika; ter Horst, Lena; Paul, Victoria Gabriele; Bauer, Jochen; Dannlowski, Udo; Konrad, Carsten; Ohrmann, Patricia; Kugel, Harald; Egloff, Boris; Arolt, Volker; Suslow, Thomas			Influence of Repressive Coping Style on Cortical Activation during Encoding of Angry Faces	PLOS ONE			English	Article							VIGILANCE-AVOIDANCE THEORY; COGNITIVE AVOIDANCE; INDIVIDUAL-DIFFERENCES; EMOTIONAL MEMORY; HORMONAL CYCLE; TERM-MEMORY; FMRI; INFORMATION; THREAT; PERCEPTION	Background: Coping plays an important role for emotion regulation in threatening situations. The model of coping modes designates repression and sensitization as two independent coping styles. Repression consists of strategies that shield the individual from arousal. Sensitization indicates increased analysis of the environment in order to reduce uncertainty. According to the discontinuity hypothesis, repressors are sensitive to threat in the early stages of information processing. While repressors do not exhibit memory disturbances early on, they manifest weak memory for these stimuli later. This study investigates the discontinuity hypothesis using functional magnetic resonance imaging (fMRI). Methods: Healthy volunteers (20 repressors and 20 sensitizers) were selected from a sample of 150 students on the basis of the Mainz Coping Inventory. During the fMRI experiment, subjects evaluated and memorized emotional and neutral faces. Subjects performed two sessions of face recognition: immediately after the fMRI session and three days later. Results: Repressors exhibited greater activation of frontal, parietal and temporal areas during encoding of angry faces compared to sensitizers. There were no differences in recognition of facial emotions between groups neither immediately after exposure nor after three days. Conclusions: The fMRI findings suggest that repressors manifest an enhanced neural processing of directly threatening facial expression which confirms the assumption of hyper-responsivity to threatening information in repression in an early processing stage. A discrepancy was observed between high neural activation in encoding-relevant brain areas in response to angry faces in repressors and no advantage in subsequent memory for these faces compared to sensitizers.	[Rauch, Astrid Veronika; ter Horst, Lena; Paul, Victoria Gabriele; Bauer, Jochen; Ohrmann, Patricia; Arolt, Volker] Univ Munster, Dept Psychiat, Munster, Germany; [Dannlowski, Udo; Konrad, Carsten] Univ Marburg, Dept Psychiat, Marburg, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, Munster, Germany; [Egloff, Boris] Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany; [Suslow, Thomas] Univ Leipzig, Dept Psychosomat Med, D-04109 Leipzig, Germany	University of Munster; Philipps University Marburg; University of Munster; Johannes Gutenberg University of Mainz; Leipzig University	Rauch, AV (corresponding author), Univ Munster, Dept Psychiat, Munster, Germany.	rauchast@ukmuenster.de	Egloff, Boris/G-2503-2013; Bauer, Jochen/AAW-4539-2021	Egloff, Boris/0000-0002-5736-9912; Bauer, Jochen/0000-0001-9345-2126; Suslow, Thomas/0000-0003-4560-0555; Kugel, Harald/0000-0002-4349-1984; Dannlowski, Udo/0000-0002-0623-3759	Deutsche Forschungsgemeinschaft (DFG) [RA 2009/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The Deutsche Forschungsgemeinschaft (DFG) supported part of this research (RA 2009/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andreano JM, 2008, PSYCHONEUROENDOCRINO, V33, P874, DOI 10.1016/j.psyneuen.2008.03.009; [Anonymous], 2007, COMPUTER SOFTWARE; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; BAUMEISTER RF, 1992, J PERS SOC PSYCHOL, V62, P851, DOI 10.1037/0022-3514.62.5.851; Beck A, 1987, BDI BECK DEPRESSION; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Blasi G, 2009, BIOL PSYCHIAT, V66, P847, DOI 10.1016/j.biopsych.2009.06.017; Cutler SE, 1996, J PERS, V64, P379, DOI 10.1111/j.1467-6494.1996.tb00515.x; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Derakshan N, 2001, ANXIETY STRESS COPIN, V14, P285, DOI 10.1080/10615800108248358; Derakshan N, 2007, COGNITION EMOTION, V21, P1585, DOI 10.1080/02699930701499857; Egloff B, 1998, DIAGNOSTICA, V44, P189; Ekman P., 1984, APPROACHES EMOTION, V3, P344; Ekman P., 1976, PICTURES FACIAL AFFE; Fajkowska M, 2011, PERS INDIV DIFFER, V50, P961, DOI 10.1016/j.paid.2010.11.023; Fischer H, 2007, EMOTION, V7, P767, DOI 10.1037/1528-3542.7.4.767; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Fujiwara E, 2008, COGN AFFECT BEHAV NE, V8, P254, DOI 10.3758/CABN.8.3.254; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Hautzinger M, 1994, BECK DEPRESSIONS INV; Hock M, 1996, J PERS SOC PSYCHOL, V70, P1052, DOI 10.1037/0022-3514.70.5.1052; Hock M, 2004, EMOTION, V4, P65, DOI 10.1037/1528-3542.4.1.65; Ino T, 2010, BRAIN IMAGING BEHAV, V4, P55, DOI 10.1007/s11682-009-9085-0; Izard C. E., 1991, PSYCHOL EMOTIONS; Jackson MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003536; Keightley ML, 2011, SOC COGN AFFECT NEUR, V6, P24, DOI 10.1093/scan/nsq003; KOCHUNOV P, 2003, TALAIRACH DAEMON CLI; Kohlmann CW, 1996, PSYCHOL HEALTH, V11, P371, DOI 10.1080/08870449608400265; Krohne H. W. E., 1993, ATTENTION AVOIDANCE; Krohne HW, 2008, J RES PERS, V42, P1572, DOI 10.1016/j.jrp.2008.07.015; Krohne HW, 2000, COGNITIVE THER RES, V24, P297, DOI 10.1023/A:1005511320194; KROHNE HW, 1989, ADV BEHAV RES THER, V11, P235, DOI 10.1016/0146-6402(89)90027-1; Lambie JA, 2002, PSYCHOL REV, V109, P219, DOI 10.1037//0033-295X.109.2.219; Laux L., 1981, STATE TRAIT ANGSTINV; Lazarus R.S., 1984, EMOTION ADAPTATION; Lehrl S., 1999, MEHRFACHWAHL WORTSCH; Leube DT, 2001, NEUROREPORT, V12, P2773, DOI 10.1097/00001756-200108280-00035; Lundqvist D., 1998, KAROLINSKA DIRECTED; Murty VP, 2010, NEUROPSYCHOLOGIA, V48, P3459, DOI 10.1016/j.neuropsychologia.2010.07.030; Myers L, 2004, COGNITION EMOTION, V18, P495, DOI 10.1080/02699930341000419; Myers LB, 1998, J ABNORM PSYCHOL, V107, P141, DOI 10.1037/0021-843X.107.1.141; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Paul VG, 2012, SOC COGN AFFECT NEUR, V7, P980, DOI 10.1093/scan/nsr080; Pennebaker JW, 1993, INHIBITION PSYCHOSOM, P146; Peters JH, 2012, J PERS SOC PSYCHOL, V102, P200, DOI 10.1037/a0026080; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Rauch AV, 2007, CEREB CORTEX, V17, P2526, DOI 10.1093/cercor/bhl158; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Rohrmann S, 2002, PSYCHOL HEALTH, V17, P583, DOI 10.1080/08870440290025795; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sander K, 2003, COGNITIVE BRAIN RES, V16, P441, DOI 10.1016/S0926-6410(03)00059-4; Schimmack U, 1997, J PERS SOC PSYCHOL, V73, P1064, DOI 10.1037/0022-3514.73.5.1064; Schwerdtfeger A, 2010, PSYCHOPHYSIOLOGY, V47, P786, DOI 10.1111/j.1469-8986.2010.00965.x; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Sergerie K, 2006, J COGNITIVE NEUROSCI, V18, P1359, DOI 10.1162/jocn.2006.18.8.1359; Shimamura AP, 2006, PSYCHON B REV, V13, P217, DOI 10.3758/BF03193833; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Tewes U, 1991, HDB TESTANWEISUNG	62	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e112398	10.1371/journal.pone.0112398	http://dx.doi.org/10.1371/journal.pone.0112398			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25502775	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700004
J	Liu, F; Jiao, AX; Wu, XR; Zhao, W; Yin, QQ; Qi, H; Jiao, WW; Xiao, J; Sun, L; Shen, C; Tian, JL; Shen, D; Jacqz-Aigrain, E; Shen, AD				Liu, Fang; Jiao, An-xia; Wu, Xi-rong; Zhao, Wei; Yin, Qing-qin; Qi, Hui; Jiao, Wei-wei; Xiao, Jing; Sun, Lin; Shen, Chen; Tian, Jian-ling; Shen, Dan; Jacqz-Aigrain, Evelyne; Shen, A-dong			Impact of Glutathione S-Transferase M1 and T1 on Anti-Tuberculosis Drug-Induced Hepatotoxicity in Chinese Pediatric Patients	PLOS ONE			English	Article							GSTT1 GENETIC POLYMORPHISMS; CYP2E1 POLYMORPHISMS; ADVERSE-REACTIONS; NULL MUTATIONS; GSTM1; LIVER; RISK; NAT2; SUSCEPTIBILITY; HEPATITIS	Background: Anti-tuberculosis drug induced hepatotoxicity (ATDH) is a major adverse drug reaction associated for anti-tuberculosis therapy. The glutathione Stransferases (GST) plays a crucial role in the detoxification of hepatotoxic metabolites of anti-tuberculosis drugs. An association between GSTM1/GSTT1 null mutations and increased risk of ATDH has been demonstrated in adults. Given the ethnic differences and developmental changes, our study aims to investigate the potential impacts of GSTM1/GSTT1genotypes on the development of ATDH in Han Chinese children treated with anti-tuberculosis therapy. Methods: Children receiving anti-tuberculosis therapy with or without evidence of ATDH were considered as the cases or controls, respectively. The GSTM1 and GSTT1 genotyping were performed using the polymerase chain reaction. Results: One hundred sixty-three children (20 cases and 143 controls) with a mean age of 4.7 years (range: 2 months-14.1 years) were included. For the GSTM1, 14 (70.0%) cases and 96 (67.1%) controls had homozygous null mutations. For the GSTT1, 13 (65.0%) cases and 97 (67.8%) controls had homozygous null mutations. Neither the GSTM1, nor the GSTT1 polymorphism was significantly correlated with the occurrence of ATHD. Conclusion: Ourresults did not support the GSTM1 and GSTT1 polymorphisms as the predictors of ADTH in Chinese Han children treated with anti-tuberculosis drugs. An age-related association between pharmacogenetics and ATHD need to be confirmed in the further study.	[Liu, Fang; Jiao, An-xia; Wu, Xi-rong; Yin, Qing-qin; Qi, Hui; Jiao, Wei-wei; Xiao, Jing; Sun, Lin; Shen, Chen; Tian, Jian-ling; Shen, Dan; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China; [Liu, Fang; Jiao, An-xia; Wu, Xi-rong; Yin, Qing-qin; Qi, Hui; Jiao, Wei-wei; Xiao, Jing; Sun, Lin; Shen, Chen; Tian, Jian-ling; Shen, Dan; Shen, A-dong] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Zhao, Wei] Shandong Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Jinan 250100, Shandong, Peoples R China; [Zhao, Wei; Jacqz-Aigrain, Evelyne] Hop Robert Debre, AP HP, Dept Pediat Pharmacol & Pharmacogenet, F-75019 Paris, France; [Zhao, Wei; Jacqz-Aigrain, Evelyne] INSERM, Clin Invest Ctr CIC1426, Paris, France; [Zhao, Wei; Jacqz-Aigrain, Evelyne] Univ Paris Diderot, EA7323, Paris, France	Capital Medical University; Capital Medical University; Shandong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Shen, AD (corresponding author), Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China.	shenad16@hotmail.com	孙, 琳/HGE-6966-2022; zhao, wei/D-3322-2011; shen, chen/AAC-2458-2020; Jacqz-Aigrain, Evelyne/AAW-7089-2021	zhao, wei/0000-0002-1830-338X; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067	National Natural Science Foundation of China [81271889]; Beijing Natural Science Foundation [7121007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China (No. 81271889), and Beijing Natural Science Foundation (No. 7121007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker ML, 2010, PHARMACOGENOMICS, V11, P1591, DOI [10.2217/pgs.10.175, 10.2217/PGS.10.146]; BENICHOU C, 1990, J HEPATOL, V11, P272; Buchard A, 2007, J MOL DIAGN, V9, P612, DOI 10.2353/jmoldx.2007.070030; *CENT EUR J PUBL H, 2010, WHO GLOBAL TUBERCULO, V18, P237; Chatterjee S, 2010, J CLIN PHARM THER, V35, P465, DOI 10.1111/j.1365-2710.2009.01101.x; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Teixeira RLD, 2011, MEM I OSWALDO CRUZ, V106, P716, DOI 10.1590/S0074-02762011000600011; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; GARIBALDI RA, 1972, AM REV RESPIR DIS, V106, P357, DOI 10.1164/arrd.1972.106.3.357; Gupta VH, 2013, ANN HEPATOL, V12, P959, DOI 10.1016/S1665-2681(19)31302-X; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2014, J CHIN MED ASSOC, V77, P169, DOI 10.1016/j.jcma.2014.01.010; Johnsrud EK, 2003, J PHARMACOL EXP THER, V307, P402, DOI 10.1124/jpet.102.053124; Kim SH, 2010, TUBERCULOSIS, V90, P39, DOI 10.1016/j.tube.2009.12.001; Lee SW, 2010, INT J TUBERC LUNG D, V14, P622; Leiro V, 2008, LIVER INT, V28, P835, DOI 10.1111/j.1478-3231.2008.01700.x; Li C, 2013, EUR J CLIN MICROBIOL, V32, P859, DOI 10.1007/s10096-013-1831-y; Maria VAJ, 1997, HEPATOLOGY, V26, P664, DOI 10.1053/jhep.1997.v26.pm0009303497; Monteiro TP, 2012, J CLIN PHARM THER, V37, P712, DOI 10.1111/j.1365-2710.2012.01368.x; Neville KA, 2011, PEDIATR ANESTH, V21, P255, DOI 10.1111/j.1460-9592.2011.03533.x; Nolan CM, 1999, JAMA-J AM MED ASSOC, V281, P1014, DOI 10.1001/jama.281.11.1014; Ramachandran G, 2011, INDIAN J PEDIATR, V78, P435, DOI 10.1007/s12098-010-0304-x; Rana SV, 2014, J CLIN PHARM THER, V39, P91, DOI 10.1111/jcpt.12105; Roy B, 2001, J GASTROEN HEPATOL, V16, P1033, DOI 10.1046/j.1440-1746.2001.02585.x; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sharifzadeh M, 2005, PHARMACOL RES, V51, P353, DOI 10.1016/j.phrs.2004.10.009; Sharma SK, 2004, INFECT GENET EVOL, V4, P167, DOI 10.1016/j.meegid.2003.01.001; SINGH J, 1995, POSTGRAD MED J, V71, P359, DOI 10.1136/pgmj.71.836.359; Singla N, 2014, TUBERCULOSIS, V94, P293, DOI 10.1016/j.tube.2014.02.003; Sun HY, 2009, J FORMOS MED ASSOC, V108, P102, DOI 10.1016/S0929-6646(09)60040-1; Tang SW, 2012, J CLIN PHARM THER, V37, P588, DOI 10.1111/j.1365-2710.2012.01334.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Uetrecht J, 2013, PHARMACOL REV, V65, P779, DOI 10.1124/pr.113.007450; Verhagen LM, 2014, PHARMACOGENOMICS, V15, P285, DOI 10.2217/pgs.13.230; Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; Wang T, 2010, J INT MED RES, V38, P977, DOI 10.1177/147323001003800324; Xiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085905; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	39	11	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115410	10.1371/journal.pone.0115410	http://dx.doi.org/10.1371/journal.pone.0115410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525805	gold, Green Submitted, Green Published			2022-12-27	WOS:000347186200026
J	Renwick, J; McNally, P; John, B; DeSantis, T; Linnane, B; Murphy, P				Renwick, Julie; McNally, Paul; John, Bettina; DeSantis, Todd; Linnane, Barry; Murphy, Philip		SHIELD CF	The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life	PLOS ONE			English	Editorial Material							DIVERSITY; BACTERIA; INFECTIONS; GREENGENES; NOV.	Background: Molecular techniques have uncovered vast numbers of organisms in the cystic fibrosis (CF) airways, the clinical significance of which is yet to be determined. The aim of this study was to describe and compare the microbial communities of the lower airway of clinically stable children with CF and children without CF. Methods: Bronchoalveolar lavage (BAL) fluid and paired oropharyngeal swabs from clinically stable children with CF (n=13) and BAL from children without CF (n=9) were collected. DNA was isolated, the 16S rRNA regions amplified, fragmented, biotinylated and hybridised to a 16S rRNA microarray. Patient medical and demographic information was recorded and standard microbiological culture was performed. Results: A diverse bacterial community was detected in the lower airways of children with CF and children without CF. The airway microbiome of clinically stable children with CF and children without CF were significantly different as measured by Shannon's Diversity Indices (p=0.001; t test) and Principle coordinate analysis (p=0.01; Adonis test). Overall the CF airway microbial community was more variable and had a less even distribution than the microbial community in the airways of children without CF. We highlighted several bacteria of interest, particularly Prevotella veroralis, CW040 and a Corynebacterium, which were of significantly differential abundance between the CF and non-CF lower airways. Both Pseudomonas aeruginosa and Streptococcus pneumoniae culture abundance were found to be associated with CF airway microbial community structure. The CF upper and lower airways were found to have a broadly similar microbial milieu. Conclusion: The microbial communities in the lower airways of stable children with CF and children without CF show significant differences in overall diversity. These discrepancies indicate a disruption of the airway microflora occurring early in life in children with CF.	[Renwick, Julie; Murphy, Philip] Univ Dublin Trinity Coll, Dept Clin Microbiol, Dublin 2, Ireland; [Renwick, Julie; McNally, Paul; Linnane, Barry; Murphy, Philip] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland; [Renwick, Julie; Murphy, Philip] Tallaght Hosp, Natl Childrens Hosp, Dublin, Ireland; [John, Bettina; DeSantis, Todd] Second Genome, San Francisco, CA USA; [Linnane, Barry] Hosp Limerick, Limerick, Ireland; [Linnane, Barry] Univ Limerick, Grad Entry Med Sch, Ctr Intervent Infect Inflammat & Immun 4i, Limerick, Ireland	Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Trinity College Dublin; University of Limerick	Renwick, J (corresponding author), Univ Dublin Trinity Coll, Dept Clin Microbiol, Dublin 2, Ireland.	jsrenwick@gmail.com	Elnazir, Basil/N-8418-2019; McNally, Paul/I-3151-2013; McNally, Paul/AAL-4407-2021	McNally, Paul/0000-0001-7102-1712; McNally, Paul/0000-0001-7102-1712				Bittar F, 2010, EMERG INFECT DIS, V16, P1231, DOI 10.3201/eid1608.100193; Blainey PC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004458; Charlson ES, 2011, AM J RESP CRIT CARE, DOI 201104-06550Cv2; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Downes J, 2008, INT J SYST EVOL MICR, V58, P1788, DOI 10.1099/ijs.0.65656-0; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Klepac-Ceraj V, 2010, ENV MICROBIOL; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; O'Connell HA, 2006, APPL ENVIRON MICROB, V72, P5013, DOI 10.1128/AEM.02474-05; Rigsbee L, 2012, AM J GASTROENTEROL; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sibley CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022702; Stressmann FA, 2012, THORAX; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Tunney MM, 2011, THORAX, V66, P579, DOI 10.1136/thx.2010.137281; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Weigel LM, 2007, ANTIMICROB AGENTS CH, V51, P231, DOI 10.1128/AAC.00576-06; Whiteson KL, 2014, AM J RESP CRIT CARE, V189, P1309, DOI 10.1164/rccm.201312-2129PP; Whiteson KL, 2014, AM J RESP CRIT CARE; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	35	48	48	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e109798	10.1371/journal.pone.0109798	http://dx.doi.org/10.1371/journal.pone.0109798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526264	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200065
J	Clark, B; Costa, VP; O'Brien, BJ; Guglielmo, LG; Paton, CD				Clark, Bradley; Costa, Vitor P.; O'Brien, Brendan J.; Guglielmo, Luiz G.; Paton, Carl D.			Effects of a Seven Day Overload-Period of High-Intensity Training on Performance and Physiology of Competitive Cyclists	PLOS ONE			English	Article							TIME-TRIAL PERFORMANCE; IMPROVES PERFORMANCE; POWER OUTPUT; INTERVAL; ADAPTATIONS; PERIODIZATION; EFFICIENCY; VOLUME; TOUR	Objectives: Competitive endurance athletes commonly undertake periods of overload training in the weeks prior to major competitions. This investigation examined the effects of two seven-day high-intensity overload training regimes (HIT) on performance and physiological characteristics of competitive cyclists. Design: The study was a matched groups, controlled trial. Methods: Twenty-eight male cyclists (mean +/- SD, Age: 33 +/- 10 years, Mass 74 +/- 7 kg, VO2 peak 4.7 +/- 0.5 L center dot min(-1)) were assigned to a control group or one of two training groups for seven consecutive days of HIT. Before and after training cyclists completed an ergometer based incremental exercise test and a 20-km time-trial. The HIT sessions were,120 minutes in duration and consisted of matched volumes of 5, 10 and 20 second (short) or 15, 30 and 45 second (long) maximal intensity efforts. Results: Both the short and long HIT regimes led to significant (p<0.05) gains in time trial performance compared to the control group. Relative to the control group, the mean changes (+/- 90% confidence limits) in time-trial power were 8.2% +/- 3.8% and 10.4% +/- 4.3% for the short and long HIT regimes respectively; corresponding increases in peak power in the incremental test were 5.5% +/- 2.7% and 9.5% +/- 2.5%. Both HIT (short vs long) interventions led to non-significant (p. 0.05) increases (mean +/- SD) in VO2 peak (2.3% +/- 4.7% vs 3.5% +/- 6.2%), lactate threshold power (3.6% +/- 3.5% vs 2.9% +/- 5.3%) and gross efficiency (3.2% +/- 2.4% vs 5.1% +/- 3.9%) with only small differences between HIT regimes. Conclusions: Seven days of overload HIT induces substantial enhancements in time-trial performance despite non-significant increases in physiological measures with competitive cyclists.	[Clark, Bradley; O'Brien, Brendan J.] Federat Univ, Sch Hlth Sci, Ballarat, Vic, Australia; [Costa, Vitor P.; Guglielmo, Luiz G.] Univ Fed Santa Catarina, Phys Effort Lab, Florianopolis, SC, Brazil; [Paton, Carl D.] Eastern Inst Technol, Fac Hlth & Sport Sci, Hawkes Bay, New Zealand	Federation University Australia; Universidade Federal de Santa Catarina (UFSC); Eastern Institute of Technology	Paton, CD (corresponding author), Eastern Inst Technol, Fac Hlth & Sport Sci, Hawkes Bay, New Zealand.	cpaton@eit.ac.nz	Guglielmo, Luiz Guilherme GA Antonacci/I-1160-2015; Costa, Vitor Pereira/ABG-1056-2021; Costa, Vitor Pereira/N-8419-2016; Paton, Carl/H-3332-2019	Guglielmo, Luiz Guilherme GA Antonacci/0000-0001-6757-5050; Costa, Vitor Pereira/0000-0001-9146-6858; Costa, Vitor Pereira/0000-0001-9146-6858; Paton, Carl/0000-0002-7418-7213; O'Brien, Brendan/0000-0002-6371-1796; Clark, Bradley/0000-0003-2277-0463	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Dr. Costa would like to acknowledge and thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the travel scholarship which enabled his participation in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breil FA, 2010, EUR J APPL PHYSIOL, V109, P1077, DOI 10.1007/s00421-010-1455-1; Cohen J., 1986, STAT POWER ANAL BEHA; Creer AR, 2004, INT J SPORTS MED, V25, P92; Ebert TR, 2006, INT J SPORT PHYSIOL, V1, P324, DOI 10.1123/ijspp.1.4.324; Gross M, 2007, MED SCI SPORT EXER, V39, P1666, DOI 10.1249/mss.0b013e3180cac209; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Hamilton RJ, 2006, INTJ SPORT PHYSIOL, V1, P40, DOI 10.1123/ijspp.1.1.40; Hopker J, 2010, APPL PHYSIOL NUTR ME, V35, P17, DOI 10.1139/H09-124; Hopkins WG, 2006, SPORTSCIENCE, V10, P46; HOROWITZ JF, 1994, INT J SPORTS MED, V15, P152, DOI 10.1055/s-2007-1021038; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Laursen PB, 2005, J STRENGTH COND RES, V19, P527; Laursen PB, 2002, CAN J APPL PHYSIOL, V27, P336, DOI 10.1139/h02-019; Laursen PB, 2002, MED SCI SPORT EXER, V34, P1801, DOI 10.1097/00005768-200211000-00017; Lindsay FH, 1996, MED SCI SPORT EXER, V28, P1427, DOI 10.1097/00005768-199611000-00013; Lucia A, 2004, BRIT J SPORT MED, V38, P636, DOI 10.1136/bjsm.2003.008490; Meeusen R, 2006, EUR J SPORT SCI, V6, P1, DOI 10.1080/17461390600617717; Paton CD, 2006, EUR J SPORT SCI, V6, P25, DOI 10.1080/17461390500422796; Paton CD, 2005, J STRENGTH COND RES, V19, P826; Paton CD, 2004, SPORTSCIENCE, V8, P25; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P327, DOI 10.1111/sms.12016; Ronnestad BR, 2014, SCAND J MED SCI SPOR, V24, P34, DOI 10.1111/j.1600-0838.2012.01485.x; Ross A, 2001, SPORTS MED, V31, P1063, DOI 10.2165/00007256-200131150-00003; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Seiler S, 2013, SCAND J MED SCI SPOR, V23, P74, DOI 10.1111/j.1600-0838.2011.01351.x; Stepto NK, 1999, MED SCI SPORT EXER, V31, P736, DOI 10.1097/00005768-199905000-00018; WestgarthTaylor C, 1997, EUR J APPL PHYSIOL O, V75, P298, DOI 10.1007/s004210050164; Weston AR, 1997, EUR J APPL PHYSIOL O, V75, P7	29	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115308	10.1371/journal.pone.0115308	http://dx.doi.org/10.1371/journal.pone.0115308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521824	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600032
J	Noble, JM; Scarmeas, N; Celenti, RS; Elkind, MSV; Wright, CB; Schupf, N; Papapanou, PN				Noble, James M.; Scarmeas, Nikolaos; Celenti, Romanita S.; Elkind, Mitchell S. V.; Wright, Clinton B.; Schupf, Nicole; Papapanou, Panos N.			Serum IgG Antibody Levels to Periodontal Microbiota Are Associated with Incident Alzheimer Disease	PLOS ONE			English	Article							CEREBROVASCULAR REACTIVITY; ACTINOMYCES-NAESLUNDII; EUBACTERIUM-NODATUM; ORAL-HEALTH; RISK; INFECTIONS; BACTERIA; RESPONSES; DEMENTIA; MARKERS	Background: Periodontitis and Alzheimer disease (AD) are associated with systemic inflammation. This research studied serum IgG to periodontal microbiota as possible predictors of incident AD. Methods: Using a case-cohort study design, 219 subjects (110 incident AD cases and 109 controls without incident cognitive impairment at last follow-up), matched on race-ethnicity, were drawn from the Washington Heights-Inwood Columbia Aging Project (WHICAP), a cohort of longitudinally followed northern Manhattan residents aged >65 years. Mean follow-up was five years (SD 2.6). In baseline sera, serum IgG levels were determined for bacteria known to be positively or negatively associated with periodontitis (Porphyromonas gingivalis, Tannerella forsythia, Actinobacillus actinomycetemcomitans Y4, Treponema denticola, Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii genospecies-2). In all analyses, we used antibody threshold levels shown to correlate with presence of moderate-severe periodontitis. Results: Mean age was 72 years (SD 6.9) for controls, and 79 years (SD 4.6) for cases (p<0.001). Non-Hispanic Whites comprised 26%, non-Hispanic Blacks 27%, and Hispanics 48% of the sample. In a model adjusting for baseline age, sex, education, diabetes mellitus, hypertension, smoking, prior history of stroke, and apolipoprotein E genotype, high anti-A. naeslundii titer (>640 ng/ml, present in 10% of subjects) was associated with increased risk of AD (HR=2.0, 95% CI: 1.1-3.8). This association was stronger after adjusting for other significant titers (HR=3.1, 95% CI: 1.5-6.4). In this model, high anti-E. nodatum IgG (>1755 ng/ml; 19% of subjects) was associated with lower risk of AD (HR50.5, 95% CI: 0.2-0.9). Conclusions: Serum IgG levels to common periodontal microbiota are associated with risk for developing incident AD.	[Noble, James M.; Scarmeas, Nikolaos; Schupf, Nicole] Columbia Univ, Taub Inst Alzheimer Dis & Aging Brain, New York, NY 10027 USA; [Noble, James M.; Scarmeas, Nikolaos; Elkind, Mitchell S. V.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Scarmeas, Nikolaos] Univ Athens, Dept Social Med Psychiat & Neurol, Athens 11528, Greece; [Celenti, Romanita S.; Papapanou, Panos N.] Columbia Univ, Coll Dent Med, Div Periodont, Sect Oral & Diagnost Sci, New York, NY USA; [Elkind, Mitchell S. V.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Wright, Clinton B.] Univ Miami, Evelyn F McKnight Brain Inst, Dept Neurol, Miami, FL USA; [Wright, Clinton B.] Univ Miami, Evelyn F McKnight Brain Inst, Dept Epidemiol & Publ Hlth Sci, Miami, FL USA; [Wright, Clinton B.] Univ Miami, Leonard M Miller Sch Med, Neurosci Program, Miami, FL USA	Columbia University; Columbia University; National & Kapodistrian University of Athens; Columbia University; Columbia University; University of Miami; University of Miami; University of Miami	Noble, JM (corresponding author), Columbia Univ, Taub Inst Alzheimer Dis & Aging Brain, New York, NY 10027 USA.	jn2054@columbia.edu	Noble, James McCallum/AAA-4218-2020; Scarmeas, Nikolaos/AAD-2512-2020; Scarmeas, Nikolaos/AAD-2517-2020	Noble, James McCallum/0000-0003-0648-6702; Scarmeas, Nikolaos/0000-0001-6453-8908; Scarmeas, Nikolaos/0000-0001-6453-8908; Papapanou, Panos N./0000-0002-6538-3618	Taub Institute for Alzheimer Disease and the Aging Brain; National Institutes of Health [R56 DE022568, R01 AG037212, UL1 TR000040]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R56DE022568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037212] Funding Source: NIH RePORTER	Taub Institute for Alzheimer Disease and the Aging Brain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a pilot grant from the Taub Institute for Alzheimer Disease and the Aging Brain, and the National Institutes of Health (R56 DE022568, R01 AG037212, and UL1 TR000040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Beck JD, 2006, COMMUNITY DENT ORAL, V34, P1, DOI 10.1111/j.1600-0528.2006.00252.x; Beck JD, 2005, J PERIODONTOL, V76, P2089, DOI 10.1902/jop.2005.76.11-S.2089; Brailsford SR, 1998, CARIES RES, V32, P100, DOI 10.1159/000016438; Bretz WA, 2005, J AM GERIATR SOC, V53, P1532, DOI 10.1111/j.1532-5415.2005.53468.x; Cheng D, 2011, DEMENT GERIATR COGN, V31, P424, DOI 10.1159/000324134; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Demmer RT, 2010, PERIODONTOL 2000, V53, P28, DOI 10.1111/j.1600-0757.2009.00326.x; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dye BA, 2012, PERIODONTOL 2000, V58, P10, DOI 10.1111/j.1600-0757.2011.00413.x; Dye BA, 2009, J PERIODONTOL, V80, P634, DOI 10.1902/jop.2009.080474; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Ford PJ, 2007, J DENT RES, V86, P35, DOI 10.1177/154405910708600105; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Gurland BJ, 1999, INT J GERIATR PSYCH, V14, P481, DOI 10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.3.CO;2-X; Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x; Haffajee AD, 2009, J PERIODONTAL RES, V44, P511, DOI 10.1111/j.1600-0765.2008.01154.x; Heller D, 2012, ARCH ORAL BIOL, V57, P973, DOI 10.1016/j.archoralbio.2012.02.003; Helzner EP, 2008, NEUROLOGY, V71, P1489, DOI 10.1212/01.wnl.0000334278.11022.42; HILL GB, 1987, J CLIN MICROBIOL, V25, P1540, DOI 10.1128/JCM.25.8.1540-1545.1987; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Johansson A, 2005, CEREBROVASC DIS, V20, P226, DOI 10.1159/000087703; Kamer AR, 2009, J NEUROIMMUNOL, V216, P92, DOI 10.1016/j.jneuroim.2009.08.013; Kishi M, 2010, J MED MICROBIOL, V59, P1354, DOI 10.1099/jmm.0.020636-0; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kulekci G, 2007, ANAEROBE; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702; Noble JM, 2009, J NEUROL NEUROSUR PS, V80, P1206, DOI 10.1136/jnnp.2009.174029; Noble JM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0384-x; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Papapanou PN, 2004, J CLIN PERIODONTOL, V31, P985, DOI 10.1111/j.1600-051X.2004.00599.x; Papapanou PN, 2001, J CLIN PERIODONTOL, V28, P103, DOI 10.1034/j.1600-051x.2001.280116.x; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Peyyala R, 2013, J DENT RES, V92, P235, DOI 10.1177/0022034512472508; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Pussinen PJ, 2004, STROKE, V35, P2020, DOI 10.1161/01.STR.0000136148.29490.fe; Reitz C, 2007, ARCH NEUROL-CHICAGO, V64, P1734, DOI 10.1001/archneur.64.12.1734; Sakellari D, 1997, ORAL MICROBIOL IMMUN, V12, P303, DOI 10.1111/j.1399-302X.1997.tb00395.x; Sato T, 2012, ARCH ORAL BIOL, V57, P1522, DOI 10.1016/j.archoralbio.2012.07.012; Silvestrini M, 2006, STROKE, V37, P1010, DOI 10.1161/01.STR.0000206439.62025.97; Stein PS, 2012, ALZHEIMERS DEMENT, V8, P196, DOI 10.1016/j.jalz.2011.04.006; Stewart R, 2008, PSYCHOSOM MED, V70, P936, DOI 10.1097/PSY.0b013e3181870aec; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Tanner A, 1998, J CLIN PERIODONTOL, V25, P85, DOI 10.1111/j.1600-051X.1998.tb02414.x; Thorstensson H, 2010, GERODONTOLOGY, V27, P19, DOI 10.1111/j.1741-2358.2009.00297.x; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Vicenzini E, 2007, EUR NEUROL, V58, P84, DOI 10.1159/000103642; Vlachojannis C, 2010, J CLIN PERIODONTOL, V37, P685, DOI 10.1111/j.1600-051X.2010.01592.x	58	114	120	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114959	10.1371/journal.pone.0114959	http://dx.doi.org/10.1371/journal.pone.0114959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522313	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600011
J	Dechmann, DKN; Wikelski, M; Varga, K; Yohannes, E; Fiedler, W; Safi, K; Burkhard, WD; O'Mara, MT				Dechmann, Dina K. N.; Wikelski, Martin; Varga, Katarina; Yohannes, Elisabeth; Fiedler, Wolfgang; Safi, Kamran; Burkhard, Wolf-Dieter; O'Mara, M. Teague			Tracking Post-Hibernation Behavior and Early Migration Does Not Reveal the Expected Sex-Differences in a "Female-Migrating'' Bat	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; NYCTALUS-NOCTULA; INSECTIVOROUS BAT; FORAGING BEHAVIOR; HABITAT USE; INDIVIDUAL SPECIALIZATION; TADARIDA-BRASILIENSIS; FLIGHT PERFORMANCE; LASIURUS-CINEREUS; MYOTIS-LUCIFUGUS	Long-distance migration is a rare phenomenon in European bats. Genetic analyses and banding studies show that females can cover distances of up to 1,600 km, whereas males are sedentary or migrate only short distances. The onset of this sex-biased migration is supposed to occur shortly after rousing from hibernation and when the females are already pregnant. We therefore predicted that the sexes are exposed to different energetic pressures in early spring, and this should be reflected in their behavior and physiology. We investigated this in one of the three Central European long-distance migrants, the common noctule (Nyctalus noctula) in Southern Germany recording the first individual partial migration tracks of this species. In contrast to our predictions, we found no difference between male and female home range size, activity, habitat use or diet. Males and females emerged from hibernation in similar body condition and mass increase rate was the same in males and females. We followed the first migration steps, up to 475 km, of radio-tagged individuals from an airplane. All females, as well as some of the males, migrated away from the wintering area in the same northeasterly direction. Sex differences in long-distance migratory behavior were confirmed through stable isotope analysis of hair, which showed greater variation in females than in males. We hypothesize that both sexes faced similarly good conditions after hibernation and fattened at maximum rates, thus showing no differences in their local behavior. Interesting results that warrant further investigation are the better initial condition of the females and the highly consistent direction of the first migratory step in this	[Dechmann, Dina K. N.; Wikelski, Martin; Fiedler, Wolfgang; Safi, Kamran; O'Mara, M. Teague] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Dechmann, Dina K. N.; Wikelski, Martin; Varga, Katarina; Yohannes, Elisabeth; Fiedler, Wolfgang; Safi, Kamran; O'Mara, M. Teague] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Dechmann, Dina K. N.; Wikelski, Martin; O'Mara, M. Teague] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Max Planck Society; University of Konstanz; Smithsonian Institution; Smithsonian Tropical Research Institute	Dechmann, DKN (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Am Obstberg 1, D-78315 Radolfzell am Bodensee, Germany.	ddechmann@om.mpg.de	O'Mara, M. Teague/J-6090-2012; Fiedler, Wolfgang/AAG-4510-2021; Safi, Kamran/B-2079-2008	O'Mara, M. Teague/0000-0002-6951-1648; Fiedler, Wolfgang/0000-0003-1082-4161; Safi, Kamran/0000-0002-8418-6759				ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Alerstam T, 2009, J THEOR BIOL, V258, P530, DOI 10.1016/j.jtbi.2009.01.020; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; BARCLAY RMR, 1989, BEHAV ECOL SOCIOBIOL, V24, P31, DOI 10.1007/BF00300115; BECK A, 1995, MYOTIS, V32, P109; Berthold P, 2001, BIRD MIGRATION GEN S, P89; Best TL, 2003, SOUTHWEST NAT, V48, P590, DOI 10.1894/0038-4909(2003)048<0590:SFROMF>2.0.CO;2; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Catry Paulo, 2005, P351; Cryan PM, 2012, J MAMMAL, V93, P381, DOI 10.1644/11-MAMM-S-162.1; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Dietz M, 2006, J COMP PHYSIOL B, V176, P223, DOI 10.1007/s00360-005-0043-x; Durell SEALD, 2000, WADER STUDY GROUP B, V100, P35; Dzal YA, 2012, J COMP PHYS B; Fleming TH, 2003, BAT ECOLOGY, P156; GEBHARD J, 1997, FLEDERMAUSE; GLOOR S, 1995, MYOTIS, V32, P231; Guglielmo CG, 2010, INTEGR COMP BIOL, V50, P336, DOI 10.1093/icb/icq097; Haussler U, 2003, SAUGETIERE BADENWURT, P591; Hedenstrom A, 2007, SCIENCE, V316, P894, DOI 10.1126/science.1142281; Hedenstrom A, 2009, J MAMMAL, V90, P1298, DOI 10.1644/09-MAMM-S-075R2.1; Heise G., 1989, NYCTALUS, V3, P17; Holland RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001676; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Jonasson KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021061; JONES G, 1995, J ZOOL, V237, P303, DOI 10.1111/j.1469-7998.1995.tb02764.x; Kolb A, 1955, SAUGETIERKUNDLICHE M, V3, P176; KURTA A, 1990, J MAMMAL, V71, P59, DOI 10.2307/1381316; KURTA A, 1987, PHYSIOL ZOOL, V60, P386, DOI 10.1086/physzool.60.4.30157900; Lam MMY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083452; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; McGuire LP, 2013, J EXP BIOL, V216, P800, DOI 10.1242/jeb.072868; McGuire LP, 2009, J MAMMAL, V90, P1290, DOI 10.1644/09-MAMM-S-084R.1; McWilliams Scott R., 2005, P67; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; O'Mara MT, 2014, METHODS ECOL EVOL, V5, P311, DOI 10.1111/2041-210X.12172; O'SHEA T J, 1976, Southwestern Naturalist, V21, P321, DOI 10.2307/3669717; Petit E, 1999, P ROY SOC B-BIOL SCI, V266, P1717, DOI 10.1098/rspb.1999.0837; Petit E, 2000, MOL ECOL, V9, P683, DOI 10.1046/j.1365-294x.2000.00896.x; Petit E, 2001, EVOLUTION, V55, P635, DOI 10.1554/0014-3820(2001)055[0635:SBDIAM]2.0.CO;2; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; Popa-Lisseanu AG, 2009, J MAMMAL, V90, P1283, DOI 10.1644/09-MAMM-S-130R2.1; Privat KL, 2007, J ARCHAEOL SCI, V34, P1197, DOI 10.1016/j.jas.2006.10.008; Raikow DF, 2011, ECOL APPL, V21, P983, DOI 10.1890/09-1504.1; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rubin Esther S., 2005, P379; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; Safi K, 2007, BIOL CONSERV, V137, P28, DOI 10.1016/j.biocon.2007.01.011; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; Scott JE, 2006, J HUM EVOL, V51, P422, DOI 10.1016/j.jhevol.2006.06.001; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Shiel CB, 1999, J ZOOL, V249, P347, DOI 10.1111/j.1469-7998.1999.tb00770.x; Shine R, 2002, OECOLOGIA, V133, P45, DOI 10.1007/s00442-002-1012-7; Stevens RD, 2013, ACTA CHIROPTEROL, V15, P163, DOI 10.3161/150811013X667966; van Toor ML, 2011, ANIM CONSERV, V14, P512, DOI 10.1111/j.1469-1795.2011.00454.x; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Voigt CC, 2012, P ROY SOC B-BIOL SCI, V279, P3772, DOI 10.1098/rspb.2012.0902; Voigt CC, 2012, J COMP PHYSIOL B, V182, P415, DOI 10.1007/s00360-011-0627-6; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; Waters D, 1999, J ZOOL, V249, P173, DOI 10.1111/j.1469-7998.1999.tb00755.x; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; WILLIAMS TC, 1973, J MAMMAL, V54, P807, DOI 10.2307/1379076; Willis CKR, 2006, NATURWISSENSCHAFTEN, V93, P80, DOI 10.1007/s00114-005-0063-0; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	70	18	18	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114810	10.1371/journal.pone.0114810	http://dx.doi.org/10.1371/journal.pone.0114810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517947	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600029
J	Gallo, I; Rattazzi, L; Piras, G; Gobbetti, T; Panza, E; Perretti, M; Dalley, JW; D'Acquisto, F				Gallo, Irene; Rattazzi, Lorenza; Piras, Giuseppa; Gobbetti, Thomas; Panza, Elisabetta; Perretti, Mauro; Dalley, Jeffrey W.; D'Acquisto, Fulvio			Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-Related Disorders	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SPECIES-TYPICAL BEHAVIORS; INNATE IMMUNE RECOGNITION; MURINE MICROGLIAL CELLS; CHEMOTACTIC PEPTIDE; ENVIRONMENTAL ENRICHMENT; PLASMA-CORTICOSTERONE; DENDRITIC CELLS; GUT MICROBIOTA; BINDING-SITES	Formyl peptide receptors (FPR) belong to a family of sensors of the immune system that detect microbe-associated molecules and inform various cellular and sensorial mechanisms to the presence of pathogens in the host. Here we demonstrate that Fpr2/3-deficient mice show a distinct profile of behaviour characterised by reduced anxiety in the marble burying and light-dark box paradigms, increased exploratory behaviour in an open-field, together with superior performance on a novel object recognition test. Pharmacological blockade with a formyl peptide receptor antagonist, Boc2, in wild type mice reproduced most of the behavioural changes observed in the Fpr2/3(-/)-mice, including a significant improvement in novel object discrimination and reduced anxiety in a light/dark shuttle test. These effects were associated with reduced FPR signalling in the gut as shown by the significant reduction in the levels of p-p38. Collectively, these findings suggest that homeostatic FPR signalling exerts a modulatory effect on anxiety-like behaviours. These findings thus suggest that therapies targeting FPRs may be a novel approach to ameliorate behavioural abnormalities present in neuropsychiatric disorders at the cognitive-emotional interface.	[Gallo, Irene; Rattazzi, Lorenza; Piras, Giuseppa; Gobbetti, Thomas; Perretti, Mauro; D'Acquisto, Fulvio] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Panza, Elisabetta] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Dalley, Jeffrey W.] Univ Cambridge, Dept Psychol, Cambridge, England; [Dalley, Jeffrey W.] Univ Cambridge, Dept Psychiat, Cambridge, England	University of London; Queen Mary University London; University of Naples Federico II; University of Cambridge; University of Cambridge	D'Acquisto, F (corresponding author), Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England.	F.Dacquisto@qmul.ac.uk	D'Acquisto, Fulvio/E-7204-2018	D'Acquisto, Fulvio/0000-0002-4513-1608; Dalley, Jeffrey/0000-0002-2282-3660				Alam A, 2014, MUCOSAL IMMUNOL, V7, P645, DOI 10.1038/mi.2013.84; Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Anton P, 1998, GUT, V42, P374, DOI 10.1136/gut.42.3.374; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aoki M, 2010, ZOOL SCI, V27, P783, DOI 10.2108/zsj.27.783; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Barr JL, 2011, NEUROSCIENCE, V182, P105, DOI 10.1016/j.neuroscience.2011.03.020; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Carpenter AC, 2012, DEV NEUROSCI-BASEL, V34, P250, DOI 10.1159/000336824; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2007, J IMMUNOL, V178, P1759, DOI 10.4049/jimmunol.178.3.1759; Christakis DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00546; CONDO GT, 1991, PHYS REV D, V43, P2787, DOI 10.1103/PhysRevD.43.2787; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Costa-Pinto FA, 2010, NEUROIMMUNOMODULAT, V17, P196, DOI 10.1159/000258722; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cui YH, 2002, NEUROBIOL DIS, V10, P366, DOI 10.1006/nbdi.2002.0517; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; De Palma G, 2014, J PHYSL; Deacon RMJ, 2005, BEHAV BRAIN RES, V156, P241, DOI 10.1016/j.bbr.2004.05.027; Deacon RMJ, 2002, BEHAV BRAIN RES, V132, P203, DOI 10.1016/S0166-4328(01)00401-6; Deacon RMJ, 2006, NAT PROTOC, V1, P122, DOI 10.1038/nprot.2006.20; Derian CK, 1996, BIOCHEMISTRY-US, V35, P1265, DOI 10.1021/bi952087k; Dufton N, 2010, PHARMACOL THERAPEUT, V127, P175, DOI 10.1016/j.pharmthera.2010.04.010; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Fediuc S, 2006, J APPL PHYSIOL, V100, P1867, DOI 10.1152/japplphysiol.01416.2005; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Ganella DE, 2014, BRIT J PHARMACOL, V171, P4556, DOI 10.1111/bph.12643; Gao JL, 2011, BEHAV GENET, V41, P724, DOI 10.1007/s10519-011-9467-0; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gemperle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050195; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Ihara S, 2013, NEUROSCIENCE, V254, P45, DOI 10.1016/j.neuroscience.2013.08.063; Jahng JW, 2011, HORM BEHAV, V59, P213, DOI 10.1016/j.yhbeh.2010.11.010; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kedia S, 2014, J NEUROSCI METHODS; Keitoku M, 1997, J MOL CELL CARDIOL, V29, P881, DOI 10.1006/jmcc.1996.0291; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lim H, 2012, BIOMOL THER, V20, P418, DOI 10.4062/biomolther.2012.20.4.418; Luisi R, 2009, J NEUROCHEM, V109, P168, DOI 10.1111/j.1471-4159.2009.05945.x; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Marquez C, 2006, BEHAV BRAIN RES, V168, P13, DOI 10.1016/j.bbr.2005.10.004; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Miceli F, 2009, NEUROBIOL DIS, V34, P501, DOI 10.1016/j.nbd.2009.03.009; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Mou HW, 2012, INFLAMMATION, V35, P656, DOI 10.1007/s10753-011-9358-9; Munger SD, 2009, NATURE, V459, P521, DOI 10.1038/459521a; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Onnela JP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036106; Panaro MA, 2006, IMMUNOPHARM IMMUNOT, V28, P103, DOI 10.1080/08923970600625975; Park S, 2014, BIOCHEM BIOPH RES CO, V450, P13, DOI 10.1016/j.bbrc.2014.05.049; PELLOW S, 1985, PHYSIOL BEHAV, V35, P587, DOI 10.1016/0031-9384(85)90145-3; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Rane MJ, 1997, J IMMUNOL, V159, P5070; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saigo M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.091601; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Santos-Soto IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081459; Sato AK, 2006, CURR OPIN BIOTECH, V17, P638, DOI 10.1016/j.copbio.2006.10.002; Sato T, 2010, FORENSIC SCI INT, V194, P77, DOI 10.1016/j.forsciint.2009.10.014; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Spurr L, 2011, INT IMMUNOPHARMACOL, V11, P55, DOI 10.1016/j.intimp.2010.10.006; Stenfeldt AL, 2007, INFLAMMATION, V30, P224, DOI 10.1007/s10753-007-9040-4; Strohle A, 2003, PHARMACOPSYCHIATRY, V36, pS207; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Sutton LM, 2013, HUM MOL GENET, V22, P452, DOI 10.1093/hmg/dds441; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; van Gaalen MM, 2002, GENES BRAIN BEHAV, V1, P174, DOI 10.1034/j.1601-183X.2002.10305.x; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang QS, 2012, BEHAV BRAIN RES, V230, P167, DOI 10.1016/j.bbr.2012.01.051; Wentworth CC, 2011, J BIOL CHEM, V286, P38448, DOI 10.1074/jbc.M111.268938; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	90	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114626	10.1371/journal.pone.0114626	http://dx.doi.org/10.1371/journal.pone.0114626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517119	Green Submitted, Green Published, gold			2022-12-27	WOS:000347215600024
J	Mukai, K; Komatsu, E; Nakajima, Y; Urai, T; Nasruddin; Sugama, J; Nakatani, T				Mukai, Kanae; Komatsu, Emi; Nakajima, Yukari; Urai, Tamae; Nasruddin; Sugama, Junko; Nakatani, Toshio			The Effect of 17 beta-Estradiol on Cutaneous Wound Healing in Protein-Malnourished Ovariectomized Female Mouse Model	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; ALTERNATIVE ACTIVATION; INFLAMMATORY RESPONSES; AGED HUMANS; ESTROGEN; MICE; MACROPHAGES; SUPPLEMENTATION; MALNUTRITION; ALTERS	Cutaneous wound healing is delayed by protein malnutrition (PM). On the other hand, estrogen promotes cutaneous wound healing by its anti-inflammatory and cell proliferation effects. Therefore, we hypothesized that estrogen administration in protein-malnourished ovariectomized (OVX) female mice might improve the inflammatory response and promote cutaneous wound healing as well as normal nutrition. To test this hypothesis, we used full-thickness excisional wounds in Control SHAM, PM SHAM, PM OVX and PM OVX+17 beta-estradiol mice. The Control diet included 200 g/kg protein and the PM diet included 30 g/kg protein. The ratio of wound area in the Control SHAM group was significantly smaller than those in the three PM groups. In addition, microscopic findings also showed that the ratio of collagen fibers, the ratio of myofibroblasts and the number of new blood vessels in the Control SHAM group were significantly greater than those in the three PM groups. However, the number of Ym1-positive cells as an anti-inflammatory M2-like macrophage marker in the PM OVX+17 beta-estradiol group was significantly higher than those in the other three groups. These results indicate that the appearance of anti-inflammatory M2-like macrophages was promoted by estrogen administration; however, it could not promote cutaneous wound healing upon a low-protein diet. Therefore, it may be confirmed that nutrition is more important for promoting cutaneous wound healing than estrogen administration.	[Mukai, Kanae; Komatsu, Emi; Nakajima, Yukari; Urai, Tamae; Nasruddin] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Dept Clin Nursing, Kanazawa, Ishikawa, Japan; [Sugama, Junko; Nakatani, Toshio] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Nakatani, T (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan.	nakatosi@staff.kanazawa-u.ac.jp	, Nasruddin/P-1610-2019; 中谷, 壽男/C-3220-2015	, Nasruddin/0000-0002-0872-6282; 中谷, 壽男/0000-0003-4949-5123	JSPS KAKENHI [25293430]; Kanazawa University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kanazawa University	All of this work was supported by JSPS KAKENHI (Grant Number 25293430 to T. Nakatani) and research funding from Kanazawa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RE, 1998, ARCH SURG-CHICAGO, V133, P1002, DOI 10.1001/archsurg.133.9.1002; [Anonymous], 2007, DERMATOTOXICOLOGY, DOI DOI 10.1201/9781420009774.CH33; Ansell DM, 2014, WOUND REPAIR REGEN, V22, P281, DOI 10.1111/wrr.12148; Ashcroft GS, 2003, J CLIN INVEST, V111, P1309, DOI 10.1172/KCO200316288; Ashcroft GS, 1997, CELL TISSUE RES, V290, P581, DOI 10.1007/s004410050963; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Ashcroft GS, 1998, LAB INVEST, V78, P47; Brufani M, 2009, MOL PHARMACEUT, V6, P543, DOI 10.1021/mp800206b; Chandra Ranjit Kumar, 1997, American Journal of Clinical Nutrition, V66, p460S; CHANDRA RK, 1992, J NUTR, V122, P597, DOI 10.1093/jn/122.suppl_3.597; Emmerson E, 2009, ENDOCRINOLOGY, V150, P2749, DOI 10.1210/en.2008-1569; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hardman MJ, 2008, ENDOCRINOLOGY, V149, P551, DOI 10.1210/en.2007-1042; Herrick S, 1997, LAB INVEST, V77, P281; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Izawa S, 2006, CLIN NUTR, V25, P962, DOI 10.1016/j.clnu.2006.05.006; Langemo D, 2006, ADV SKIN WOUND CARE, V19, P303; Langemo D, 2006, ADV SKIN WOUND CARE, V19, P300; Langemo Diane, 2006, Adv Skin Wound Care, V19, P297, DOI 10.1097/00129334-200607000-00007; Li J, 2002, J NUTR, V132, P3286, DOI 10.1093/jn/132.11.3286; Lim Y, 2006, J NUTR BIOCHEM, V17, P328, DOI 10.1016/j.jnutbio.2005.08.004; Lima FD, 2013, EUR J NUTR, V52, P1343, DOI 10.1007/s00394-012-0443-0; Lochs H, 2006, CLIN NUTR, V25, P180, DOI 10.1016/j.clnu.2006.02.007; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mercado AM, 2002, J NEUROIMMUNOL, V129, P74, DOI 10.1016/S0165-5728(02)00174-1; Mukai K, 2014, J HORM; Mukai K, 2014, J HORM, DOI 10.1371/journal.pone.0115564; Mukai K, 2016, INT WOUND J, V13, P636, DOI 10.1111/iwj.12336; Otranto M, 2009, APPL PHYSIOL NUTR ME, V34, P1023, DOI 10.1139/H09-100; Routley CE, 2009, WOUND REPAIR REGEN, V17, P42, DOI 10.1111/j.1524-475X.2008.00440.x; Sgonc R, 2013, GERONTOLOGY, V59, P159, DOI 10.1159/000342344; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Sindrilaru A, 2013, ADV WOUND CARE, V2, P357, DOI 10.1089/wound.2012.0407; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Tsuda K, 2010, INT WOUND J, V7, P135, DOI 10.1111/j.1742-481X.2010.00674.x	39	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115564	10.1371/journal.pone.0115564	http://dx.doi.org/10.1371/journal.pone.0115564			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25518000	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600071
J	Veenith, TV; Mada, M; Carter, E; Grossac, J; Newcombe, V; Outtrim, J; Lupson, V; Nallapareddy, S; Williams, GB; Sheriff, S; Menon, DK; Maudsley, AA; Coles, JP				Veenith, Tonny V.; Mada, Marius; Carter, Eleanor; Grossac, Julia; Newcombe, Virginia; Outtrim, Joanne; Lupson, Victoria; Nallapareddy, Sridhar; Williams, Guy B.; Sheriff, Sulaiman; Menon, David K.; Maudsley, Andrew A.; Coles, Jonathan P.			Comparison of Inter Subject Variability and Reproducibility of Whole Brain Proton Spectroscopy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYLASPARTATE; INJURY; METABOLITES; CHOLINE; ROBUST; NEURODEGENERATION; OPTIMIZATION; REGISTRATION; QUANTITATION	The aim of these studies was to provide reference data on intersubject variability and reproducibility of metabolite ratios for Choline/Creatine (Cho/Cr), N-acetyl aspartate/Choline (NAA/Cho) and N-acetyl aspartate/Creatine (NAA/Cr), and individual signal-intensity normalised metabolite concentrations of NAA, Cho and Cr. Healthy volunteers underwent imaging on two occasions using the same 3T Siemens Verio magnetic resonance scanner. At each session two identical Metabolic Imaging and Data Acquisition Software (MIDAS) sequences were obtained along with standard structural imaging. Metabolite maps were created and regions of interest applied in normalised space. The baseline data from all 32 volunteers were used to calculate the intersubject variability, while within session and between session reproducibility were calculated from all the available data. The reproducibility of measurements were used to calculate the overall and within session 95% prediction interval for zero change. The within and between session reproducibility data were lower than the values for intersubject variability, and were variable across the different brain regions. The within and between session reproducibility measurements were similar for Cho/Cr, NAA/Choline, Cho and Cr (11.8%, 11.4%, 14.3 and 10.6% vs. 11.9%, 11.4%, 13.5% and 10.5% respectively), but for NAA/Creatine and NAA between session reproducibility was lower (9.3% and 9.1% vs. 10.1% and 9.9%; p<0.05). This study provides additional reference data that can be utilised in interventional studies to quantify change within a single imaging session, or to assess the significance of change in longitudinal studies of brain injury and disease.	[Veenith, Tonny V.] Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Dept Crit Care Med, Birmingham B15 2TH, W Midlands, England; [Veenith, Tonny V.; Carter, Eleanor; Grossac, Julia; Newcombe, Virginia; Outtrim, Joanne; Nallapareddy, Sridhar; Menon, David K.; Coles, Jonathan P.] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Mada, Marius; Lupson, Victoria; Williams, Guy B.] Univ Cambridge, Wolfson Brain Imaging Ctr, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Sheriff, Sulaiman; Maudsley, Andrew A.] Univ Miami, Miller Sch Med, Dept Radiol, Miami, FL 33136 USA	University of Birmingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Miami	Coles, JP (corresponding author), Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0QQ, England.	jpc44@wbic.cam.ac.uk	Veenith, Tonny/A-9948-2010; Veenith, Tonny/AAI-3067-2020	Veenith, Tonny/0000-0002-4125-8804; Veenith, Tonny/0000-0002-4125-8804; Williams, Guy/0000-0001-5223-6654; Maudsley, Andrew/0000-0001-7653-3063; Outtrim, Joanne/0000-0001-8118-6430; Newcombe, Virginia/0000-0001-6044-9035; Coles, Jonathan/0000-0003-4013-679X	National Institute of Academic Anaesthesia; Raymond Beverly Sackler studentship; NIHR academic clinical fellowship; Wellcome trust project grant; NIHR Senior Investigator Award; Medical Research Council (UK) Program Grant [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at Cambridge; UK Department of Health; Academy of Medical Sciences (AMS) [AMS-CSF4-Newcombe] Funding Source: researchfish; Medical Research Council [G0001354, G0001354B, G1000183B, G0600986, G0001237, G9439390] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10090, NF-SI-0508-10327, ACF-2009-14-007] Funding Source: researchfish; MRC [G0001237, G9439390, G0600986] Funding Source: UKRI	National Institute of Academic Anaesthesia; Raymond Beverly Sackler studentship; NIHR academic clinical fellowship; Wellcome trust project grant(Wellcome Trust); NIHR Senior Investigator Award; Medical Research Council (UK) Program Grant; UK National Institute of Health Research Biomedical Research Centre at Cambridge(National Institute for Health Research (NIHR)); UK Department of Health; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TV Veenith was supported by clinical research training fellowship from the National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship. VFJN is supported by an NIHR academic clinical fellowship. JPC was supported by Wellcome trust project grant. DKM is supported by an NIHR Senior Investigator Award. This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects (G9439390 ID 65883)), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P799, DOI 10.1016/0730-725X(93)90197-L; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Ebel A, 2001, MAGNET RESON MED, V46, P1072, DOI 10.1002/mrm.1301; Ebel A, 2001, MAGNET RESON MED, V46, P706, DOI 10.1002/mrm.1249; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gonen O, 2000, NEUROLOGY, V54, P15, DOI 10.1212/WNL.54.1.15; Govind V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035607; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Klein J, 2000, J NEURAL TRANSM, V107, P1027, DOI 10.1007/s007020070051; Kraguljac NV, 2012, PSYCHIAT RES-NEUROIM, V203, P111, DOI 10.1016/j.pscychresns.2012.02.003; Langer DL, 2007, MAGN RESON MED, V58, P666, DOI 10.1002/mrm.21351; Li BSY, 2002, MAGNET RESON MED, V47, P439, DOI 10.1002/mrm.10081; Ruiz-Pena JL, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-8; Maudsley AA, 2006, NMR BIOMED, V19, P492, DOI 10.1002/nbm.1025; Maudsley AA, 2012, NMR BIOMED, V25, P580, DOI 10.1002/nbm.1775; Maudsley AA, 2010, NMR BIOMED, V23, P251, DOI 10.1002/nbm.1445; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; MAUDSLEY AA, 1994, MAGN RESON MED, V31, P589, DOI 10.1002/mrm.1910310603; Miller BL, 1996, LIFE SCI, V58, P1929, DOI 10.1016/0024-3205(96)00182-8; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Price SJ, 2011, BRIT J RADIOL, V84, pS159, DOI 10.1259/bjr/26838774; Saunders DE, 1999, JMRI-J MAGN RESON IM, V9, P711, DOI 10.1002/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.3.CO;2-V; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Steen RG, 2005, NEUROPSYCHOPHARMACOL, V30, P1949, DOI 10.1038/sj.npp.1300850; Szulc A, 2012, CURR MED CHEM; Tumati S, 2013, NEUROSCI BIOBEHAV RE; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Watanabe T, 2012, NEUROBIOL LEARN MEM, V97, P289, DOI 10.1016/j.nlm.2012.01.006; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wylezinska M, 2003, NEUROLOGY, V60, P1949, DOI 10.1212/01.WNL.0000069464.22267.95	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115304	10.1371/journal.pone.0115304	http://dx.doi.org/10.1371/journal.pone.0115304			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517503	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600058
J	Zhu, YN; Yu, H; Wang, W; Gong, XH; Yao, K				Zhu, Yanan; Yu, Hao; Wang, Wei; Gong, Xiaohua; Yao, Ke			A Novel GJA8 Mutation (p.V44A) Causing Autosomal Dominant Congenital Cataract	PLOS ONE			English	Article							GAP-JUNCTIONS; CONNEXIN HEMICHANNELS; LENS DEVELOPMENT; CHINESE FAMILY; CALCIUM; NUCLEAR; CHANNELS; PROTEIN	Purpose: To examine the mechanism by which a novel connexin 50 (Cx50) mutation, Cx50 V44A, in a Chinese family causes suture-sparing autosomal dominant congenital nuclear cataracts. Methods: Family history and clinical data were recorded and direct gene sequencing was used to identify the disease-causing mutation. The Cx50 gene was cloned from a human lens cDNA library. Connexin protein distributions were assessed by fluorescence microscopy. Hemichannel functions were analyzed by dye uptake assay. Formation of functional channels was assessed by dye transfer experiments. Results: Direct sequencing of the candidate GJA8 gene revealed a novel c. 131T>C transition in exon 2, which cosegregated with the disease in the family and resulted in the substitution of a valine residue with alanine at codon 44 (p. V44A) in the extracellular loop 1 of the Cx50 protein. Both Cx50 and Cx50V44A formed functional gap junctions, as shown by the neurobiotin transfer assay. However, unlike wild-type Cx50, Cx50V44A was unable to form open hemichannels in dye uptake experiments. Conclusion: This work identified a unique congenital cataract in the Chinese population, caused by the novel mutation Cx50V44A, and it showed that the V44A mutation specifically impairs the gating of the hemichannels but not the gap junction channels. The dysfunctional hemichannels resulted in the development of human congenital cataracts.	[Zhu, Yanan; Wang, Wei; Yao, Ke] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Yanan; Wang, Wei; Yao, Ke] Key Lab Ophthalmol Zhejiang Prov, Wenzhou, Peoples R China; [Yu, Hao] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Neurobiol Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA	Zhejiang University; Zhejiang University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Yao, K (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	Key Program of National Natural Science Foundation of China [81130018]; National Natural Science Foundation of China [81371001]; National Twelfth Five-Year Plan Foundation of China [2012BAI08B01]; Zhejiang Key Laboratory Fund of China [2011E10006]; Fundamental Research Funds for the Central Universities [2014FZA7003]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Twelfth Five-Year Plan Foundation of China; Zhejiang Key Laboratory Fund of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Key Program of National Natural Science Foundation of China (Grant No. 81130018), National Natural Science Foundation of China (Grant No. 81371001), National Twelfth Five-Year Plan Foundation of China (Grant No. 2012BAI08B01), Zhejiang Key Laboratory Fund of China (Grant No. 2011E10006) and the Fundamental Research Funds for the Central Universities (Grant No. 2014FZA7003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, J MED GENET, V45, P155, DOI 10.1136/jmg.2007.051029; Banks EA, 2009, J CELL SCI, V122, P378, DOI 10.1242/jcs.034124; Beahm DL, 2002, BIOPHYS J, V82, P2016, DOI 10.1016/S0006-3495(02)75550-1; Beyer EC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00020; Bruzzone S, 2001, J BIOL CHEM, V276, P48300, DOI 10.1074/jbc.M107308200; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; DeRosa AM, 2009, EXP CELL RES, V315, P1063, DOI 10.1016/j.yexcr.2009.01.017; Devi RR, 2006, MOL VIS, V12, P190; DUNCAN G, 1984, CIBA F SYMP, V106, P132; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Ferrini W, 2004, INVEST OPHTH VIS SCI, V45, P1436, DOI 10.1167/iovs.03-0760; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Gao JY, 2004, J GEN PHYSIOL, V124, P289, DOI 10.1085/jgp.200409121; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Hunter AW, 2003, CELL COMMUN ADHES, V10, P211, DOI 10.1080/714040429; Jiang JX, 2010, CURR MOL MED, V10, P851; Kalvelyte A, 2003, BIOCHEM PHARMACOL, V66, P1661, DOI 10.1016/S0006-2952(03)00540-9; Li JY, 2013, MOL VIS, V19, P767; Lin Ying, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P59; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MAURER P, 1987, PFLUG ARCH EUR J PHY, V409, P394, DOI 10.1007/BF00583793; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Pocrnich CE, 2012, GRAEF ARCH CLIN EXP, V250, P515, DOI 10.1007/s00417-011-1871-x; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Reis LM, 2013, HUM GENET, V132, P761, DOI 10.1007/s00439-013-1289-0; Ren Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074732; Rubinos C, 2014, AM J PHYSIOL-CELL PH, V306, pC212, DOI 10.1152/ajpcell.00098.2013; Santana A, 2011, ARQ BRAS OFTALMOL, V74, P136, DOI 10.1590/S0004-27492011000200016; Thomas BC, 2008, INVEST OPHTH VIS SCI, V49, P2549, DOI 10.1167/iovs.07-1658; Valiunas V, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00075; Vanita V, 2008, MOL VIS, V14, P323; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Xia CH, 2006, DEVELOPMENT, V133, P2033, DOI 10.1242/dev.02361; Xu XR, 1999, INVEST OPHTH VIS SCI, V40, P1844; Yao K, 2011, HUM MUTAT, V32, P1367, DOI 10.1002/humu.21552; Zhang XR, 2006, BIOL CHEM, V387, P595, DOI 10.1515/BC.2006.076; Zhu YA, 2010, MOL VIS, V16, P2347	40	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115406	10.1371/journal.pone.0115406	http://dx.doi.org/10.1371/journal.pone.0115406			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517998	Green Published, gold			2022-12-27	WOS:000347215600063
J	Liu, W; Wang, JY; Wang, TJ; Xie, HW				Liu, Wei; Wang, Jianying; Wang, Tengjiao; Xie, Hongwei			Construction and Analyses of Human Large-Scale Tissue Specific Networks	PLOS ONE			English	Article								Construction and analyses of tissue specific networks is crucial to unveil the function and organizational structure of biological systems. As a direct method to detect protein dynamics, human proteome-wide expression data provide an valuable resource to investigate the tissue specificity of proteins and interactions. By integrating protein expression data with large-scale interaction network, we constructed 30 tissue/cell specific networks in human and analyzed their properties and functions. Rather than the tissue specificity of proteins, we mainly focused on the tissue specificity of interactions to distill tissue specific networks. Through comparing our tissue specific networks with those inferred from gene expression data, we found our networks have larger scales and higher reliability. Furthermore, we investigated the similar extent of multiple tissue specific networks, which proved that tissues with similar functions tend to contain more common interactions. Finally, we found that the tissue specific networks differed from the static network in multiple topological properties. The proteins in tissue specific networks are interacting looser and the hubs play more important roles than those in the static network.	[Liu, Wei; Wang, Tengjiao; Xie, Hongwei] Natl Univ Def Technol, Coll Mech & Elect Engn & Automat, Changsha, Hunan, Peoples R China; [Wang, Jianying] Affiliated Hosp Mil Med Sci, Beijing, Peoples R China		Liu, W (corresponding author), Natl Univ Def Technol, Coll Mech & Elect Engn & Automat, Changsha, Hunan, Peoples R China.	angel_nudt@126.com	wang, tengjiao/E-2118-2015	wang, tengjiao/0000-0002-7790-7407	International Cooperation Project [2014DFB30010]; Chinese National Key Program of Basic Research [31171266]	International Cooperation Project; Chinese National Key Program of Basic Research	This work was supported by International Cooperation Project (2014DFB30010) and Chinese National Key Program of Basic Research (31171266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Emig D, 2011, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2011-5; Emig D, 2011, J PROTEOME RES, V10, P1893, DOI 10.1021/pr101132h; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Koyuturk M, 2010, WIRES SYST BIOL MED, V2, P277, DOI 10.1002/wsbm.61; Lopes TJS, 2011, BIOINFORMATICS, V27, P2414, DOI 10.1093/bioinformatics/btr414; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Schaefer MH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002860; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Zhu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025394	19	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115074	10.1371/journal.pone.0115074	http://dx.doi.org/10.1371/journal.pone.0115074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513809	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300031
J	Chi, NF; Liu, HL; Yang, JT; Lin, JR; Liao, SL; Peng, BH; Lee, YT; Lee, TH				Chi, Nai-Fang; Liu, Ho-Ling; Yang, Jen-Tsung; Lin, Jr-Rung; Liao, Shu-Li; Peng, Bo-Han; Lee, Yen-Tung; Lee, Tsong-Hai			Neuroprotective Mechanism of BNG-1 against Focal Cerebral Ischemia: A Neuroimaging and Neurotrophin Study	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SCUTELLARIA-BAICALENSIS; DIFFUSION-PERFUSION; ACUTE STROKE; BLOOD-FLOW; IN-VIVO; RATS; BRAIN; EXPRESSION; HYPERPERFUSION	BNG-1 is a herb complex used in traditional Chinese medicine to treat stroke. In this study, we attempted to identify the neuroprotective mechanism of BNG-1 by using neuroimaging and neurotrophin analyses of a stroke animal model. Rats were treated with either saline or BNG-1 for 7 d after 60-min middle cerebral artery occlusion by filament model. The temporal change of magnetic resonance (MR) imaging of brain was studied using a 7 Tesla MR imaging (MRI) system and the temporal expressions of neurotrophin-3 (NT-3), brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF) in brain were analyzed before operation and at 4 h, 2 d, and 7 d after operation. Compared with the saline group, the BNG-1 group exhibited a smaller infarction volume in the cerebral cortex in T2 image from as early as 4 h to 7 d, less edema in the cortex in diffusion weighted image from 2 to 7 d, earlier reduction of postischemic hyperperfusion in both the cortex and striatum in perfusion image at 4 h, and earlier normalization of the ischemic pattern in the striatum in susceptibility weighted image at 2 d. NT-3 and BDNF levels were higher in the BNG-1 group than the saline group at 7 d. We concluded that the protective effect of BNG-1 against cerebral ischemic injury might act through improving cerebral hemodynamics and recovering neurotrophin generation.	[Chi, Nai-Fang] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan; [Chi, Nai-Fang] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Liu, Ho-Ling] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Yang, Jen-Tsung] Chiayi Chang Gung Mem Hosp, Dept Neurosurg, Chiayi, Taiwan; [Yang, Jen-Tsung] Chang Gung Univ, Coll Med, Dept Neurosurg, Taoyuan, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Liao, Shu-Li] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Tradit Chinese Med, Taoyuan, Taiwan; [Peng, Bo-Han] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Tradit Chinese Med, Taoyuan, Taiwan; [Lee, Yen-Tung] En Chu Kong Hosp, Dept Tradit Chinese Med, New Taipei City, Taiwan; [Lee, Tsong-Hai] Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Taipei Medical University; Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; En Chu Kong Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, TH (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Stroke Ctr, Taoyuan, Taiwan.	thlee@adm.cgmh.org.tw	Chi, Nai-Fang/G-3561-2016; Chi, Nai-Fang/E-2851-2017	Chi, Nai-Fang/0000-0002-2204-4923; Chi, Nai-Fang/0000-0002-2204-4923; Lin, Jr-Rung/0000-0002-8522-6601	National Science Council, Taiwan [NSC 97-2314-B-182A-049, NSC 98-2314-B-182-054, NSC 99-2628-B-182-027, 103-2314-B-182A-030-MY2]; Chang Gung Memorial Hospital Medical Research Project, Taiwan (Animal Molecular Imaging Center) [CMRPG340203]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital Medical Research Project, Taiwan (Animal Molecular Imaging Center)	This work was supported by the National Science Council, Taiwan (NSC 97-2314-B-182A-049, NSC 98-2314-B-182-054, NSC 99-2628-B-182-027, 103-2314-B-182A-030-MY2) and Chang Gung Memorial Hospital Medical Research Project, Taiwan (Animal Molecular Imaging Center CMRPG340203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, NEW ENGLAND J MED, V333, P1581; Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; Bereczki D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000480.pub2; Bonoczk Peter, 2002, Eur J Ultrasound, V15, P85, DOI 10.1016/S0929-8266(02)00006-X; Chan S, 2011, CURR OPIN PHARMACOL, V11, P720, DOI 10.1016/j.coph.2011.09.002; Cheng FC, 2005, AM J CHINESE MED, V33, P61, DOI 10.1142/S0192415X05002667; Geisler BS, 2006, STROKE, V37, P1778, DOI 10.1161/01.STR.0000226738.97426.6f; Jeong JC, 2005, J ETHNOPHARMACOL, V98, P259, DOI 10.1016/j.jep.2004.12.034; Kidwell CS, 2001, NEUROLOGY, V57, P2015, DOI 10.1212/WNL.57.11.2015; Kim YO, 2001, J ETHNOPHARMACOL, V77, P183, DOI 10.1016/S0378-8741(01)00283-5; Lee JT, 2014, NEUROSCIENCE, V257, P31, DOI 10.1016/j.neuroscience.2013.10.066; Lee TH, 2004, J NEUROSCI RES, V76, P705, DOI 10.1002/jnr.20097; Lee TH, 1998, STROKE, V29, P1687, DOI 10.1161/01.STR.29.8.1687; LEE TH, 1994, STROKE, V25, P1425, DOI 10.1161/01.STR.25.7.1425; Lee TH, 2008, BRAIN RES, V1187, P1, DOI 10.1016/j.brainres.2007.09.078; Lee TH, 2011, EXP NEUROL, V227, P314, DOI 10.1016/j.expneurol.2010.12.003; Li RL, 2010, CURR NEUROVASC RES, V7, P213, DOI 10.2174/156720210792231796; Lin TN, 2002, STROKE, V33, P2985, DOI 10.1161/01.STR.0000037675.97888.9D; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Lu ZF, 2010, J ASIAN NAT PROD RES, V12, P265, DOI 10.1080/10286021003689791; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Mao QQ, 2010, J ETHNOPHARMACOL, V131, P182, DOI 10.1016/j.jep.2010.06.019; Marchal G, 1996, BRAIN, V119, P409, DOI 10.1093/brain/119.2.409; Medina AE, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00021; Oliveira GB, 2014, BRAIN RES, V1561, P23, DOI 10.1016/j.brainres.2014.03.005; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Park JS, 2012, J PHARMACOL EXP THER, V341, P59, DOI 10.1124/jpet.111.189035; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; Shin JW, 2012, AM J CHINESE MED, V40, P85, DOI 10.1142/S0192415X12500073; Tanabe H, 2006, PHYTOMEDICINE, V13, P334, DOI 10.1016/j.phymed.2005.02.001; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Xu XL, 2008, PHYTOTHER RES, V22, P389, DOI 10.1002/ptr.2332; Yan BC, 2014, J NEUROSCI RES, V92, P795, DOI 10.1002/jnr.23360; Ye RD, 2011, NEUROPHARMACOLOGY, V61, P815, DOI 10.1016/j.neuropharm.2011.05.029; Yin YY, 2010, AM J CHINESE MED, V38, P517, DOI 10.1142/S0192415X10008020; Yu XQ, 2008, LIFE SCI, V82, P68, DOI 10.1016/j.lfs.2007.10.019; Zhang L, 2009, YAKUGAKU ZASSHI, V129, P855, DOI 10.1248/yakushi.129.855	39	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114909	10.1371/journal.pone.0114909	http://dx.doi.org/10.1371/journal.pone.0114909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506838	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100033
J	Dubchak, I; Balasubramanian, S; Wang, S; Meyden, C; Sulakhe, D; Poliakov, A; Bornigen, D; Xie, BQ; Taylor, A; Ma, JZ; Paciorkowski, AR; Mirzaa, GM; Dave, P; Agam, G; Xu, JB; Al-Gazali, L; Mason, CE; Ross, ME; Maltsev, N; Gilliam, TC				Dubchak, Inna; Balasubramanian, Sandhya; Wang, Sheng; Meyden, Cem; Sulakhe, Dinanath; Poliakov, Alexander; Boernigen, Daniela; Xie, Bingqing; Taylor, Andrew; Ma, Jianzhu; Paciorkowski, Alex R.; Mirzaa, Ghayda M.; Dave, Paul; Agam, Gady; Xu, Jinbo; Al-Gazali, Lihadh; Mason, Christopher E.; Ross, M. Elizabeth; Maltsev, Natalia; Gilliam, T. Conrad			An Integrative Computational Approach for Prioritization of Genomic Variants	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; NEURAL-TUBE DEFECTS; VITAMIN B-12 RECEPTOR; GENE PRIORITIZATION; INTERACTION NETWORKS; PATHWAY GENES; DATABASE; CUBILIN; VISTA; ASSOCIATION	An essential step in the discovery of molecular mechanisms contributing to disease phenotypes and efficient experimental planning is the development of weighted hypotheses that estimate the functional effects of sequence variants discovered by high-throughput genomics. With the increasing specialization of the bioinformatics resources, creating analytical workflows that seamlessly integrate data and bioinformatics tools developed by multiple groups becomes inevitable. Here we present a case study of a use of the distributed analytical environment integrating four complementary specialized resources, namely the Lynx platform, VISTA RViewer, the Developmental Brain Disorders Database (DBDB), and the RaptorX server, for the identification of high-confidence candidate genes contributing to pathogenesis of spina bifida. The analysis resulted in prediction and validation of deleterious mutations in the SLC19A placental transporter in mothers of the affected children that causes narrowing of the outlet channel and therefore leads to the reduced folate permeation rate. The described approach also enabled correct identification of several genes, previously shown to contribute to pathogenesis of spina bifida, and suggestion of additional genes for experimental validations. The study demonstrates that the seamless integration of bioinformatics resources enables fast and efficient prioritization and characterization of genomic factors and molecular networks contributing to the phenotypes of interest.	[Dubchak, Inna] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Dubchak, Inna; Poliakov, Alexander] Dept Energy Joint Genome Inst, Walnut Creek, CA USA; [Balasubramanian, Sandhya; Sulakhe, Dinanath; Boernigen, Daniela; Xie, Bingqing; Taylor, Andrew; Maltsev, Natalia; Gilliam, T. Conrad] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Wang, Sheng; Boernigen, Daniela; Ma, Jianzhu; Xu, Jinbo] Toyota Technol Inst, Chicago, IL USA; [Meyden, Cem; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Meyden, Cem; Mason, Christopher E.] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Meyden, Cem; Mason, Christopher E.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Sulakhe, Dinanath; Dave, Paul; Maltsev, Natalia; Gilliam, T. Conrad] Univ Chicago, Argonne Natl Lab, Computat Inst, Chicago, IL 60637 USA; [Xie, Bingqing; Agam, Gady] IIT, Dept Comp Sci, Chicago, IL 60616 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Paciorkowski, Alex R.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Mirzaa, Ghayda M.] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Mirzaa, Ghayda M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Ross, M. Elizabeth] Weill Cornell Med Coll, Lab Neurogenet & Dev, New York, NY USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Chicago; Toyota Technological Institute - Chicago; Cornell University; Cornell University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Illinois Institute of Technology; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United Arab Emirates University; Cornell University	Dubchak, I (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA.	ildubchak@lbl.gov; maltsev@uchicago.edu	Mason, Christopher/HCH-3977-2022; Wang, Sheng/H-5989-2018; Wang, Sheng/O-3465-2015; Ma, Jianzhu/AAV-1904-2020	Wang, Sheng/0000-0003-4210-1670; Wang, Sheng/0000-0003-4210-1670; Meydan, Cem/0000-0002-0663-6216	National Heart, Lung and Blood Institute, National Institutes of Health [R01GM081080A]; Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; National Institute of Neurological Disorders and Stroke, National Institutes of Health [2R01NS050375-06]; National Institutes of Health (NIH) [R01HG006798, R01NS076465]; Irma T. Hirschl Charitable Trust; STARR Consortium [I7-A765]; Monique Weill-Caulier Charitable Trust; Mr. and Ms. Lawrence Hilibrand and the Boler Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465, R01NS050375] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Charitable Trust; STARR Consortium; Monique Weill-Caulier Charitable Trust; Mr. and Ms. Lawrence Hilibrand and the Boler Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	ID was partially supported by National Heart, Lung and Blood Institute, National Institutes of Health, Grant R01GM081080A. The work conducted by the United States Department of Energy Joint Genome Institute is supported by the Office of Science of the United States Department of Energy under Contract No. (DE-AC02-05CH11231); SB and NM were partially supported by National Institute of Neurological Disorders and Stroke, National Institutes of Health, Grant 2R01NS050375-06. The University of Chicago component of the project is grateful to Mr. and Ms. Lawrence Hilibrand and the Boler Family Foundation for their generous support of the project. This work was also supported with funding from the National Institutes of Health (NIH), including R01HG006798, R01NS076465, as well as funds from the Irma T. Hirschl and Monique Weill-Caulier Charitable Trusts and the STARR Consortium (I7-A765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Aminoff M, 1999, NAT GENET, V21, P309, DOI 10.1038/6831; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Boucher Benjamin, 2013, Frontiers in Genetics, V4, P290, DOI 10.3389/fgene.2013.00290; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; Brudno M, 2007, NUCLEIC ACIDS RES, V35, pW669, DOI 10.1093/nar/gkm279; Burzynski GM, 2012, GENOME RES, V22, P2278, DOI 10.1101/gr.139717.112; Calabrese C, 2014, BIOINFORMATICS; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chandler AL, 2012, BIRTH DEFECTS RES A, V94, P864, DOI 10.1002/bdra.23068; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; Copp AJ, 2013, WIRES DEV BIOL, V2, P213, DOI 10.1002/wdev.71; Cordero F, 2012, CURR TOP MED CHEM, V12, P1320, DOI 10.2174/156802612801319007; Doolin MT, 2002, AM J HUM GENET, V71, P1222, DOI 10.1086/344209; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franke B, 2009, BIRTH DEFECTS RES A, V85, P216, DOI 10.1002/bdra.20556; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Green Ridgely Fisk, 2013, Frontiers in Genetics, V4, P223, DOI 10.3389/fgene.2013.00223; Hamilton NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055434; Hong HX, 2013, SCI CHINA LIFE SCI, V56, P110, DOI 10.1007/s11427-013-4439-7; Infante CR, 2013, DEV BIOL, V374, P234, DOI 10.1016/j.ydbio.2012.11.017; Jager M, 2014, HUM MUTAT, V35, P548, DOI 10.1002/humu.22531; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Konneker T, 2008, AM J MED GENET B, V147B, P671, DOI 10.1002/ajmg.b.30802; Kozyraki R, 1999, NAT MED, V5, P656, DOI 10.1038/9504; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Li Xin, 2013, Frontiers in Genetics, V4, P67, DOI 10.3389/fgene.2013.00067; Liu J, 2014, J NEUROL SCI, V337, P61, DOI 10.1016/j.jns.2013.11.017; Lukashin I, 2011, BIOINFORMATICS, V27, P2595, DOI 10.1093/bioinformatics/btr440; Ma JZ, 2012, BIOINFORMATICS, V28, pI59, DOI 10.1093/bioinformatics/bts213; Marini NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028408; Matherly LH, 2008, VITAM HORM, V79, P145, DOI 10.1016/S0083-6729(08)00405-6; Mirzaa GM, 2014, AM J MED GENET A, V164, P1503, DOI 10.1002/ajmg.a.36517; Mirzaa GM, 2014, AM J MED GENET A; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; Morin I, 2003, MOL GENET METAB, V79, P197, DOI 10.1016/S1096-7192(03)00086-6; Narlikar L, 2010, GENOME RES, V20, P381, DOI 10.1101/gr.098657.109; Nitsch D, 2011, NUCLEIC ACIDS RES, V39, pW334, DOI 10.1093/nar/gkr289; Padmanabhan Rengasamy, 2006, Congenital Anomalies, V46, P55, DOI 10.1111/j.1741-4520.2006.00104.x; Pastrello C, 2014, BIOCHEM BIOPH RES CO, V445, P757, DOI 10.1016/j.bbrc.2014.01.151; Peng J, 2011, PROTEINS, V79, P1930, DOI 10.1002/prot.23016; Rady PL, 2001, MOL GENET METAB, V73, P285, DOI 10.1006/mgme.2001.3197; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Ross ME, 2010, WIRES SYST BIOL MED, V2, P471, DOI 10.1002/wsbm.72; Seoane JA, 2013, CURR TOP MED CHEM, V13, P591; Sifrim A, 2013, NAT METHODS, V10, P1083, DOI [10.1038/NMETH.2656, 10.1038/nmeth.2656]; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Sulakhe D, 2014, NUCLEIC ACIDS RES, V42, pD1007, DOI 10.1093/nar/gkt1166; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wahlstedt-Froberg V, 2003, PEDIATR NEPHROL, V18, P417, DOI 10.1007/s00467-003-1128-y; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Wang Shuoguo, 2013, Genomics & Informatics, V11, P191, DOI 10.5808/GI.2013.11.4.191; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Whitehead VM, 2006, BRIT J HAEMATOL, V134, P125, DOI 10.1111/j.1365-2141.2006.06133.x; Wu JX, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004237; Xie B, 2012, PREDICTION CANDIDATE; Yao J, 2014, BIOINFORMATICS	69	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114903	10.1371/journal.pone.0114903	http://dx.doi.org/10.1371/journal.pone.0114903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506935	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100031
J	Rostoker, G; Griuncelli, M; Loridon, C; Magna, T; Janklewicz, P; Drahi, G; Dahan, H; Cohen, Y				Rostoker, Guy; Griuncelli, Mireille; Loridon, Christelle; Magna, Theophile; Janklewicz, Philippe; Drahi, Gilles; Dahan, Herve; Cohen, Yves			Maximal Standard Dose of Parenteral Iron for Hemodialysis Patients: An MRI-Based Decision Tree Learning Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ANEMIA MANAGEMENT; SUPPLEMENTATION; OVERLOAD; OUTCOMES; MORTALITY; PATTERNS; TIME	Background and Objectives: Iron overload used to be considered rare among hemodialysis patients after the advent of erythropoesis-stimulating agents, but recent MRI studies have challenged this view. The aim of this study, based on decision-tree learning and on MRI determination of hepatic iron content, was to identify a noxious pattern of parenteral iron administration in hemodialysis patients. Design, Setting, Participants and Measurements: We performed a prospective cross-sectional study from 31 January 2005 to 31 August 2013 in the dialysis centre of a French community-based private hospital. A cohort of 199 fit hemodialysis patients free of overt inflammation and malnutrition were treated for anemia with parenteral iron-sucrose and an erythropoesis-stimulating agent (darbepoetin), in keeping with current clinical guidelines. Patients had blinded measurements of hepatic iron stores by means of T1 and T2* contrast MRI, without gadolinium, together with CHi-squared Automatic Interaction Detection (CHAID) analysis. Results: The CHAID algorithm first split the patients according to their monthly infused iron dose, with a single cutoff of 250 mg/month. In the node comprising the 88 hemodialysis patients who received more than 250 mg/month of IV iron, 78 patients had iron overload on MRI (88.6%, 95% CI: 80% to 93%). The odds ratio for hepatic iron overload on MRI was 3.9 (95% CI: 1.81 to 8.4) with >250 mg/month of IV iron as compared to <250 mg/month. Age, gender (female sex) and the hepcidin level also influenced liver iron content on MRI. Conclusions: The standard maximal amount of iron infused per month should be lowered to 250 mg in order to lessen the risk of dialysis iron overload and to allow safer use of parenteral iron products.	[Rostoker, Guy; Griuncelli, Mireille; Loridon, Christelle; Magna, Theophile] Gen Sante, Hop Prive Claude Galien, Div Nephrol & Dialysis, F-91480 Quincy Sous Senart, France; [Janklewicz, Philippe; Drahi, Gilles; Dahan, Herve; Cohen, Yves] Gen Sante, Div Radiol, Hop Prive Claude Galien, F-91480 Quincy Sous Senart, France		Rostoker, G (corresponding author), Gen Sante, Hop Prive Claude Galien, Div Nephrol & Dialysis, 20 Route Boussy, F-91480 Quincy Sous Senart, France.	rostotom@orange.fr	Rostoker, Guy/K-1432-2019	Rostoker, Guy/0000-0002-4383-3825	not-for-profit Physicians' Association of Claude Galien Hospital (Association Quincy Recherche Clinique et Therapeutique (QRCT)), Hopital Prive Claude Galien and Generale de Sante	not-for-profit Physicians' Association of Claude Galien Hospital (Association Quincy Recherche Clinique et Therapeutique (QRCT)), Hopital Prive Claude Galien and Generale de Sante	This study was sponsored by the not-for-profit Physicians' Association of Claude Galien Hospital (Association Quincy Recherche Clinique et Therapeutique (QRCT)), Hopital Prive Claude Galien and Generale de Sante. The aim of the QRCT Association is to promote clinical, epidemiological and cognitive research at Claude Galien Hospital. QRCT paid for the software license of SPSS decision learning trees from IBM Bois-Colombes, France and for computers (iMac OS X).	ALI M, 1982, LANCET, V1, P652; [Anonymous], 2014, KDIGO CONTR C IR MAN; [Anonymous], 2006, AN MAN PEOP CHRON KI; Bailie GR, 2015, KIDNEY INT, V87, P162, DOI 10.1038/ki.2014.275; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Barton JC., 2010, HDB IRON OVERLOAD DI; Besarab A, 2010, NAT REV NEPHROL, V6, P699, DOI 10.1038/nrneph.2010.139; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Canavese C, 2004, KIDNEY INT, V65, P1091, DOI 10.1111/j.1523-1755.2004.00480.x; Eduardo Toblli Jorge, 2012, Inflammation & Allergy Drug Targets, V11, P66; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Ferrari P, 2011, CLIN J AM SOC NEPHRO, V6, P77, DOI 10.2215/CJN.04190510; Fishbane S, 2014, NEPHROL DIAL TRANSPL, V29, P255, DOI 10.1093/ndt/gft269; Freburger JK, 2012, AM J MED, V125, P906, DOI 10.1016/j.amjmed.2012.03.011; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gandon Y, 2004, LANCET, V363, P357, DOI 10.1016/S0140-6736(04)15436-6; Ghoti H, 2012, EUR J HAEMATOL, V89, P87, DOI 10.1111/j.1600-0609.2012.01783.x; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KDOQI, 2006, Am J Kidney Dis, V47, pS16; Locatelli F, 2013, NEPHROL DIAL TRANSPL, V28, P1346, DOI 10.1093/ndt/gft033; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Moisen G. G., 2008, ENCY ECOLOGY, V1, P582; Pisoni RL, 2012, AM J KIDNEY DIS, V60, P160, DOI 10.1053/j.ajkd.2012.04.001; Rostoker G, 2012, AM J MED, V125, P991, DOI 10.1016/j.amjmed.2012.01.015; Sheskin D. J., 2007, HDB PARAMETRIC NONPA; Vaziri ND, 2012, AM J MED, V125, P951, DOI 10.1016/j.amjmed.2012.02.009; Yamamoto H, 2011, SEMIN DIALYSIS, V24, P269, DOI 10.1111/j.1525-139X.2011.00938.x	29	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115096	10.1371/journal.pone.0115096	http://dx.doi.org/10.1371/journal.pone.0115096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506921	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100050
J	Ruggirello, M; Dolci, P; Cocolin, L				Ruggirello, Marianna; Dolci, Paola; Cocolin, Luca			Detection and Viability of Lactococcus lactis throughout Cheese Ripening	PLOS ONE			English	Article							CULTURE-INDEPENDENT METHODS; CARBOHYDRATE STARVATION; MICROBIAL DIVERSITY; ACID BACTERIA; PCR-DGGE; IDENTIFICATION; LACTOBACILLUS; EXTRACTION; STRATEGIES; DYNAMICS	Recent evidences highlighted the presence of Lactococcus lactis during late cheese ripening. For this reason, the role of this microorganism, well known as dairy starter, should be reconsidered throughout cheese manufacturing and ripening. Thus, the main objective of this study was to develop a RT-qPCR protocol for the detection, quantification and determination of the viability of L. lactis in ripened cheese samples by direct analysis of microbial nucleic acids. Standard curves were constructed for the specific quantification of L. lactis in cheese matrices and good results in terms of selectivity, correlation coefficient and efficiency were obtained. Thirty-three ripened cheeses were analyzed and, on the basis of RNA analysis, twelve samples showed 10(6) to 10(8) CFU of L. lactis per gram of product, thirteen from 10(3) to 10(5) CFU/g, and in eight cheeses, L. lactis was not detected. Traditional plating on M17 medium led to loads ranging from 10(5) to 10(9) CFU/g, including the cheese samples where no L. lactis was found by RT-qPCR. From these cheeses, none of the colonies isolated on M17 medium was identified as L. lactis species. These data could be interpreted as a lack of selectivity of M17 medium where colony growth is not always related to lactococcal species. At the same time, the absence or low abundance of L. lactis isolates on M17 medium from cheese where L. lactis was detected by RT-qPCR support the hypothesis that L. lactis starter populations are mainly present in viable but not culturable state during ripening and, for this reason, culture-dependent methods have to be supplemented with direct analysis of cheese.	[Ruggirello, Marianna; Dolci, Paola; Cocolin, Luca] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy	University of Turin	Dolci, P (corresponding author), Univ Turin, Dipartimento Sci Agr Forestali & Alimentari, Grugliasco, Italy.	paola.dolci@unito.it	Cocolin, Luca/H-5091-2012	Cocolin, Luca/0000-0003-4799-7074; DOLCI, Paola/0000-0003-1847-2367				Achilleos C, 2013, FOOD MICROBIOL, V36, P286, DOI 10.1016/j.fm.2013.06.024; Beresford TP, 2001, INT DAIRY J, V11, P259, DOI 10.1016/S0958-6946(01)00056-5; Cocolin L, 2001, APPL ENVIRON MICROB, V67, P5113, DOI 10.1128/AEM.67.11.5113-5121.2001; Corroler D, 1998, APPL ENVIRON MICROB, V64, P4729; Cretenet M, 2011, APPL ENVIRON MICROB, V77, P247, DOI 10.1128/AEM.01174-10; Desfosses-Foucault E, 2013, INT J FOOD MICROBIOL, V166, P117, DOI 10.1016/j.ijfoodmicro.2013.06.022; Dolci P, 2010, INT J FOOD MICROBIOL, V143, P71, DOI 10.1016/j.ijfoodmicro.2010.07.007; Ercolini D, 2004, J MICROBIOL METH, V56, P297, DOI 10.1016/j.mimet.2003.11.006; FEIRTAG JM, 1987, J DAIRY SCI, V70, P1779, DOI 10.3168/jds.S0022-0302(87)80214-X; Florez AB, 2006, INT J FOOD MICROBIOL, V110, P165, DOI 10.1016/j.ijfoodmicro.2006.04.016; Fortina MG, 2003, FOOD MICROBIOL, V20, P397, DOI 10.1016/S0740-0020(02)00149-1; Ganesan B, 2007, APPL ENVIRON MICROB, V73, P2498, DOI 10.1128/AEM.01832-06; Jany JL, 2008, FOOD MICROBIOL, V25, P839, DOI 10.1016/j.fm.2008.06.003; JENSEN MA, 1993, APPL ENVIRON MICROB, V59, P945, DOI 10.1128/AEM.59.4.945-952.1993; Ke DB, 2000, J BACTERIOL, V182, P6913, DOI 10.1128/JB.182.24.6913-6920.2000; Mertens K, 2014, INT J FOOD MICROBIOL, V170, P29, DOI 10.1016/j.ijfoodmicro.2013.10.022; Ndoye B, 2011, DAIRY SCI TECHNOL, V91, P495, DOI 10.1007/s13594-011-0031-8; Neviani E, 2009, FOOD MICROBIOL, V26, P240, DOI 10.1016/j.fm.2009.01.004; Rantsiou K, 2008, INT J FOOD MICROBIOL, V126, P36, DOI 10.1016/j.ijfoodmicro.2008.04.031; Stuart MR, 1999, APPL ENVIRON MICROB, V65, P665; Taibi A, 2011, INT J FOOD MICROBIOL, V146, P263, DOI 10.1016/j.ijfoodmicro.2011.02.034; Temmerman R, 2004, TRENDS FOOD SCI TECH, V15, P348, DOI 10.1016/j.tifs.2003.12.007; Ulve VM, 2008, J APPL MICROBIOL, V105, P1327, DOI 10.1111/j.1365-2672.2008.03869.x; Ventura M, 2003, APPL ENVIRON MICROB, V69, P6908, DOI 10.1128/AEM.69.11.6908-6922.2003	24	28	28	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114280	10.1371/journal.pone.0114280	http://dx.doi.org/10.1371/journal.pone.0114280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25503474	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100009
J	Haggerty, TJ; Dunn, IS; Rose, LB; Newton, EE; Pandolfi, F; Kurnick, JT				Haggerty, Timothy J.; Dunn, Ian S.; Rose, Lenora B.; Newton, Estelle E.; Pandolfi, Franco; Kurnick, James T.			Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells	PLOS ONE			English	Article							PHASE-II TRIAL; ANTITUMOR-ACTIVITY; BRAF INHIBITION; DOWN-MODULATION; HSP90 INHIBITOR; B-RAF; CANCER; IMMUNOTHERAPY; CHAPERONE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN	In an effort to enhance antigen-specific T cell recognition of cancer cells, we have examined numerous modulators of antigen-expression. In this report we demonstrate that twelve different Hsp90 inhibitors (iHsp90) share the ability to increase the expression of differentiation antigens and MHC Class I antigens. These iHsp90 are active in several molecular and cellular assays on a series of tumor cell lines, including eleven human melanomas, a murine B16 melanoma, and two human glioma-derived cell lines. Intra-cytoplasmic antibody staining showed that all of the tested iHsp90 increased expression of the melanocyte differentiation antigens Melan-A/MART-1, gp100, and TRP-2, as well as MHC Class I. The gliomas showed enhanced gp100 and MHC staining. Quantitative analysis of mRNA levels showed a parallel increase in message transcription, and a reporter assay shows induction of promoter activity for Melan-A/MART-1 gene. In addition, iHsp90 increased recognition of tumor cells by T cells specific for Melan-A/MART-1. In contrast to direct Hsp90 client proteins, the increased levels of full-length differentiation antigens that result from iHsp90 treatment are most likely the result of transcriptional activation of their encoding genes. In combination, these results suggest that iHsp90 improve recognition of tumor cells by T cells specific for a melanoma-associated antigen as a result of increasing the expressed intracellular antigen pool available for processing and presentation by MHC Class I, along with increased levels of MHC Class I itself. As these Hsp90 inhibitors do not interfere with T cell function, they could have potential for use in immunotherapy of cancer.	[Haggerty, Timothy J.; Dunn, Ian S.; Rose, Lenora B.; Newton, Estelle E.; Kurnick, James T.] CytoCure LLC, Beverly, MA USA; [Haggerty, Timothy J.; Kurnick, James T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA USA; [Pandolfi, Franco] Catholic Univ, Dept Internal Med, Rome, Italy	Harvard University; Harvard Medical School; Massachusetts General Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Pandolfi, F (corresponding author), Catholic Univ, Dept Internal Med, Rome, Italy.	pandolfi@rm.unicatt.it	Pandolfi, Franco/D-3025-2011; Kurnick, James/GRO-3944-2022	Pandolfi, Franco/0000-0003-3516-3961	National Institutes of Health [CA-165553]; International Cancer Research Scholarship; NATIONAL CANCER INSTITUTE [R43CA165553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Cancer Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were supported in part by a grant from the National Institutes of Health, CA-165553 (TJH, ISD, EEN, LBR, JTK), and by an International Cancer Research Scholarship to JTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2010, ONCOL REP, V23, P1709, DOI 10.3892/or_00000815; Bae J, 2007, J IMMUNOL, V178, P7730, DOI 10.4049/jimmunol.178.12.7730; Bai L, 2011, APOPTOSIS, V16, P45, DOI 10.1007/s10495-010-0542-4; Banerji U, 2008, MOL CANCER THER, V7, P737, DOI 10.1158/1535-7163.MCT-08-0145; Brandt GEL, 2008, J MED CHEM, V51, P6495, DOI 10.1021/jm8007486; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Castilleja A, 2001, MOL CELL BIOCHEM, V217, P21, DOI 10.1023/A:1007267814251; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn IS, 2007, J IMMUNOL, V179, P2134, DOI 10.4049/jimmunol.179.4.2134; Durda PJ, 2003, MOL CANCER RES, V1, P411; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Fox BA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-214; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Haggerty TJ, 2012, ASSAY DRUG DEV TECHN, V10, P187, DOI 10.1089/adt.2011.0379; Haggerty TJ, 2011, CANCER IMMUNOL IMMUN, V60, P133, DOI 10.1007/s00262-010-0926-x; Hishii M, 1999, CLIN EXP IMMUNOL, V116, P388; Hishii M, 1997, P NATL ACAD SCI USA, V94, P1378, DOI 10.1073/pnas.94.4.1378; Houlihan JL, 2009, J IMMUNOL, V182, P7451, DOI 10.4049/jimmunol.0804296; Hurwitz AA, 2004, METH MOLEC MED, V102, P421; Kono M, 2006, MOL CANCER RES, V4, P779, DOI 10.1158/1541-7786.MCR-06-0077; Kurnick JT, 2001, J IMMUNOL, V167, P1204, DOI 10.4049/jimmunol.167.3.1204; Kurnick JT, 2013, INT TRENDS IMMUNOLOG, V1, P5; Li YY, 2009, DRUG RESIST UPDATE, V12, P17, DOI 10.1016/j.drup.2008.12.002; Lundgren K, 2009, MOL CANCER THER, V8, P921, DOI 10.1158/1535-7163.MCT-08-0758; Maus MV, 2014, CLIN CANCER RES, V20, P3899, DOI 10.1158/1078-0432.CCR-14-0721; Mehta PP, 2011, CANCER LETT, V300, P30, DOI 10.1016/j.canlet.2010.09.002; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Pacey S, 2012, INVEST NEW; Pandolfi F, 2008, INT J IMMUNOPATH PH, V21, P493, DOI 10.1177/039463200802100302; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Porter JR, 2010, CURR OPIN CHEM BIOL, V14, P412, DOI 10.1016/j.cbpa.2010.03.019; Rao A, 2012, CANCER RES, V72, P3196, DOI 10.1158/0008-5472.CAN-12-0538; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200; Sharma SV, 1998, ONCOGENE, V16, P2639, DOI 10.1038/sj.onc.1201790; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Shipp C, 2013, CELL STRESS CHAPERON, V18, P145, DOI 10.1007/s12192-012-0363-1; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; Tarhini AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087705; Tian ZQ, 2004, BIOORGAN MED CHEM, V12, P5317, DOI 10.1016/j.bmc.2004.07.053; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0; Yeh S, 2009, OPHTHALMOLOGY, V116, P981, DOI 10.1016/j.ophtha.2008.12.004; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532	59	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114506	10.1371/journal.pone.0114506	http://dx.doi.org/10.1371/journal.pone.0114506			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503774	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400032
J	Huang, SW; Wang, SF; Lin, YT; Yen, CH; Lee, CH; Wong, WW; Tsai, HC; Yang, CJ; Hu, BS; Lin, YH; Wang, CT; Wang, JJ; Hu, ZX; Kuritzkes, DR; Chen, YH; Chen, YMA				Huang, Szu-Wei; Wang, Sheng-Fan; Lin, Yu-Ting; Yen, Chia-Hung; Lee, Chih-Hao; Wong, Wing-Wai; Tsai, Hung-Chin; Yang, Chia-Jui; Hu, Bor-Shen; Lin, Yu-Huei; Wang, Chin-Tien; Wang, Jaang-Jiun; Hu, Zixin; Kuritzkes, Daniel R.; Chen, Yen-Hsu; Chen, Yi-Ming Arthur			Patients Infected with CRF07_BC Have Significantly Lower Viral Loads than Patients with HIV-1 Subtype B: Mechanism and Impact on Disease Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INJECTING DRUG-USERS; MOLECULAR EPIDEMIOLOGY; TAIWAN; PLASMA; INDIVIDUALS; TROPISM; REGION; DOMAIN; REPLICATION	The circulating recombinant form (CRF) 07_BC is the most prevalent HIV-1 strain among injection drug users (IDUs) in Taiwan. It contains a 7 amino-acid deletion in its p6(gag). We conducted a cohort study to compare viral loads and CD4 cell count changes between patients infected with subtype B and CRF07_BC and to elucidate its mechanism. Twenty-one patients infected with CRF07_BC and 59 patients with subtype B were selected from a cohort of 667 HIV-1/AIDS patients whom have been followed up for 3 years. Generalized estimated equation was used to analyze their clinical data and the results showed that patients infected with CRF07_BC had significantly lower viral loads (about 58,000 copies per ml less) than patients with subtype B infection (p=0.002). The replicative capacity of nine CRF07_BC and four subtype B isolates were compared and the results showed that the former had significantly lower replicative capacity than the latter although all of them were CCR5- tropic and non-syncytium inducing viruses. An HIV-1-NL4-3 mutant virus which contains a 7 amino-acid deletion in p6(gag) (designated as 7d virus) was generated and its live cycle was investigated. The results showed that 7d virus had significantly lower replication capacity, poorer protease-mediated processing and viral proteins production. Electron microscopic examination of cells infected with wild-type or 7d virus demonstrated that the 7d virus had poorer and slower viral maturation processes: more viruses attached to the cell membrane and higher proportion of immature virions outside the cells. The interaction between p6(gag) and Alix protein was less efficient in cells infected with 7d virus. In conclusion, patients infected with CRF07_BC had significantly lower viral loads than patients infected with subtype B and it may due to the deletion of 7 amino acids which overlaps with Alix protein-binding domain of the p6(gag).	[Huang, Szu-Wei; Wang, Sheng-Fan; Lin, Yu-Ting; Yen, Chia-Hung; Lee, Chih-Hao; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res CICAR, Kaohsiung, Taiwan; [Huang, Szu-Wei; Lee, Chih-Hao] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Sheng-Fan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Wong, Wing-Wai] Taipei Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Taipei, Taiwan; [Tsai, Hung-Chin] Kaohsiung Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Kaohsiung, Taiwan; [Yang, Chia-Jui] Far Eastern Mem Hosp, Dept Internal Med, Infect Dis Sect, New Taipei City, Taiwan; [Hu, Bor-Shen] Taipei City Hosp, Dept Internal Med, Infect Dis Sect, Taipei, Taiwan; [Lin, Yu-Huei] Taichung Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Taichung, Taiwan; [Wang, Chin-Tien] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wang, Jaang-Jiun] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA; [Wang, Jaang-Jiun] Emory Univ, Sch Med, Atlanta, GA USA; [Hu, Zixin; Kuritzkes, Daniel R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Hu, Zixin; Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Sepsis Res Ctr, Sch Med,Grad Inst Med, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Inst Med Res, Dept Microbiol, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan	Kaohsiung Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital; Far Eastern Memorial Hospital; Taipei City Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Children's Healthcare of Atlanta (CHOA); Emory University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chen, YMA (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res CICAR, Kaohsiung, Taiwan.	arthur@kmu.edu.tw	Wang, Sheng-Fan/ABA-7842-2020; Huang, Szu-Wei/AAT-1998-2020; HUANG, SZU-WEI/AAT-5153-2021	Wang, Sheng-Fan/0000-0002-8142-4707; Huang, Szu-Wei/0000-0002-3813-7737; Wang, Sheng-Fan/0000-0002-4183-3872; Yen, Chia-Hung/0000-0002-6939-5528; Chen, Yen-hsu/0000-0002-8667-4844	Republic of China (ROC) National Health Research Institutes [NHRI-EX103-10149SI]; Kaohsiung Medical University "Aim for the Top Universities Grant [KMU-TP103E02, KMU-TP103E20]	Republic of China (ROC) National Health Research Institutes; Kaohsiung Medical University "Aim for the Top Universities Grant	This research was supported by Republic of China (ROC) National Health Research Institutes [grant number NHRI-EX103-10149SI] and partially by Kaohsiung Medical University "Aim for the Top Universities Grant [grant number KMU-TP103E02, KMU-TP103E20]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HIV AIDS DAT; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chen SW, 2004, VIROLOGY, V318, P534, DOI 10.1016/j.virol.2003.08.043; Chen YJ, 2012, JAIDS-J ACQ IMM DEF, V59, P438, DOI 10.1097/QAI.0b013e3182454ea3; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Chen YMA, 2006, EMERG INFECT DIS, V12, P703, DOI 10.3201/eid1204.050762; Chen YMA, 2001, J ACQ IMMUN DEF SYND, V26, P274, DOI 10.1097/00126334-200103010-00011; Chiu HC, 2006, J GEN VIROL, V87, P2041, DOI 10.1099/vir.0.81601-0; FERRIS AL, 1990, VIROLOGY, V175, P456, DOI 10.1016/0042-6822(90)90430-Y; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hu DJ, 2001, AIDS, V15, P683, DOI 10.1097/00002030-200104130-00003; Hu ZX, 2006, J VIROL, V80, P7020, DOI 10.1128/JVI.02747-05; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; KARLSSON A, 1994, J CLIN MICROBIOL, V32, P364, DOI 10.1128/JCM.32.2.364-370.1994; Kittikraisak W, 2009, JAIDS-J ACQ IMM DEF, V51, P601, DOI 10.1097/QAI.0b013e3181a44700; Lin YT, 2007, J INFECT DIS, V195, P1283, DOI 10.1086/513437; Manders EMM, 1993, J MICROSCOPY, P8; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Morrison CS, 2010, AIDS, V24, P573, DOI 10.1097/QAD.0b013e32833433df; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nakagawa F, 2014, AIDS, V28, P1351, DOI 10.1097/QAD.0000000000000224; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; PARTIN K, 1990, J VIROL, V64, P3938, DOI 10.1128/JVI.64.8.3938-3947.1990; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Raugi DN, 2013, AIDS, V27, P2441, DOI 10.1097/QAD.0b013e328362e856; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Weber J, 2006, AIDS REV, V8, P60; Xin X, 1998, ARCH VIROL, V143, P85, DOI 10.1007/s007050050270; Yu XF, 1998, J VIROL, V72, P3412, DOI 10.1128/JVI.72.4.3412-3417.1998; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109821; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	47	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114441	10.1371/journal.pone.0114441	http://dx.doi.org/10.1371/journal.pone.0114441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502811	gold, Green Published			2022-12-27	WOS:000347146700026
J	Sangartit, W; Kukongviriyapan, U; Donpunha, W; Pakdeechote, P; Kukongviriyapan, V; Surawattanawan, P; Greenwald, SE				Sangartit, Weerapon; Kukongviriyapan, Upa; Donpunha, Wanida; Pakdeechote, Poungrat; Kukongviriyapan, Veerapol; Surawattanawan, Praphassorn; Greenwald, Stephen E.			Tetrahydrocurcumin Protects against Cadmium-Induced Hypertension, Raised Arterial Stiffness and Vascular Remodeling in Mice	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NITRIC-OXIDE PRODUCTION; NATIONAL-HEALTH; ANTIOXIDANT; CURCUMIN; TOXICITY; DYSFUNCTION; EXPRESSION; MECHANISM; BLOOD	Background: Cadmium (Cd) is a nonessential heavy metal, causing oxidative damage to various tissues and associated with hypertension. Tetrahydrocurcumin (THU), a major metabolite of curcumin, has been demonstrated to be an antioxidant, anti-diabetic, anti-hypertensive and anti-inflammatory agent. In this study, we investigated the protective effect of THU against Cd-induced hypertension, raised arterial stiffness and vascular remodeling in mice. Methods: Male ICR mice received CdCl2 (100 mg/l) via drinking water for 8 weeks. THU was administered intragastrically at dose of 50 or 100 mg/kg/day concurrently with Cd treatment. Results: Administration of CdCl2 significantly increased arterial blood pressure, blunted vascular responses to vasoactive agents, increased aortic stiffness, and induced hypertrophic aortic wall remodeling by increasing number of smooth muscle cells and collagen deposition, decreasing elastin, and increasing matrix metalloproteinase (MMP)-2 and MMP-9 levels in the aortic medial wall. Supplementation with THU significantly decreased blood pressure, improved vascular responsiveness, and reversed the structural and mechanical alterations of the aortas, including collagen and elastin deposition. The reduction on the adverse response of Cd treatment was associated with upregulated eNOS and downregulated iNOS protein expressions, increased nitrate/nitrite level, alleviated oxidative stress and enhanced antioxidant glutathione. Moreover, THU also reduced the accumulation of Cd in the blood and tissues. Conclusions: Our results suggest that THU ameliorates cadmium-induced hypertension, vascular dysfunction, and arterial stiffness in mice through enhancing NO bioavailability, attenuating oxidative stress, improving vascular remodeling and decreasing Cd accumulation in other tissues. THU has a beneficial effect in moderating the vascular alterations associated with Cd exposure.	[Sangartit, Weerapon; Kukongviriyapan, Upa; Donpunha, Wanida; Pakdeechote, Poungrat] Khon Kaen Univ, Fac Med, Dept Physiol, Khon Kaen 40002, Thailand; [Kukongviriyapan, Veerapol] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen 40002, Thailand; [Surawattanawan, Praphassorn] Govt Pharmaceut Org, Inst Res & Dev, Bangkok 10400, Thailand; [Greenwald, Stephen E.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Pathol Grp, London E1 1BB, England	Khon Kaen University; Khon Kaen University; University of London; Queen Mary University London	Kukongviriyapan, U (corresponding author), Khon Kaen Univ, Fac Med, Dept Physiol, Khon Kaen 40002, Thailand.	upa_ku@kku.ac.th	Greenwald, Stephen E/C-6928-2012	Sangartit, Weerapon/0000-0002-5058-2294; Greenwald, Stephen/0000-0002-8471-7070	Khon Kaen University Research Fund; Invitation Research Fund, Faculty of Medicine, Khon Kaen University; Thailand Research Fund; British Council PMI2, United Kingdom [Ref RC53]; Royal Golden Jubilee PhD Program [PHD/0292/2551]	Khon Kaen University Research Fund; Invitation Research Fund, Faculty of Medicine, Khon Kaen University; Thailand Research Fund(Thailand Research Fund (TRF)); British Council PMI2, United Kingdom; Royal Golden Jubilee PhD Program(Thailand Research Fund (TRF))	This work was supported by grants from the Khon Kaen University Research Fund, the Invitation Research Fund, Faculty of Medicine, Khon Kaen University, The Thailand Research Fund and the British Council PMI2 Connect Grant (Ref RC53), United Kingdom. WS was supported by a scholarship (PHD/0292/2551) from the Royal Golden Jubilee PhD Program, The Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2012, TOX PROF CADM, P1, DOI DOI 10.1039/C2EM30303E; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ali MS, 2009, PHARMAZIE, V64, P132, DOI 10.1691/ph.2008.8628; Alissa EM, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/870125; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castro MM, 2013, CURR DRUG TARGETS, V14, P335; Chauhan SD, 2003, FASEB J, V17, P773, DOI 10.1096/fj.02-0668fje; Cohen RD, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/185845; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Donpunha W, 2011, BIOMETALS, V24, P105, DOI 10.1007/s10534-010-9379-0; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Eum KD, 2008, SCI TOTAL ENVIRON, V407, P147, DOI 10.1016/j.scitotenv.2008.08.037; Eybl V, 2006, TOXICOLOGY, V225, P150, DOI 10.1016/j.tox.2006.05.011; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fowler BA, 2009, TOXICOL APPL PHARM, V238, P294, DOI 10.1016/j.taap.2009.05.004; Gaubin Y, 2000, BBA-MOL CELL RES, V1495, P4, DOI 10.1016/S0167-4889(99)00149-4; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Houston MC, 2007, ALTERN THER HEALTH M, V13, P128; Huang PL, 1998, AM J CARDIOL, V82, p57S, DOI 10.1016/S0002-9149(98)90437-4; Jackson ZS, 2002, CIRC RES, V90, P918, DOI 10.1161/01.RES.0000016481.87703.CC; Javanmard Shaghayegh Haghjooy, 2009, Pathophysiology, V16, P9, DOI 10.1016/j.pathophys.2008.11.003; Kirschvink N, 2005, TOXICOLOGY, V211, P36, DOI 10.1016/j.tox.2005.02.012; Kukongviriyapan U, 2014, NUTRIENTS, V6, P1194, DOI 10.3390/nu6031194; Kukongviriyapan U, 2012, CAN J PHYSIOL PHARM, V90, P1345, DOI [10.1139/Y2012-101, 10.1139/y2012-101]; Kundu S, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-19; Lambertucci RH, 2012, CELL PHYSIOL BIOCHEM, V30, P1169, DOI 10.1159/000343307; LANGEWOUTERS GJ, 1984, J BIOMECH, V17, P425, DOI 10.1016/0021-9290(84)90034-4; Lee BK, 2012, AM J IND MED, V55, P1060, DOI 10.1002/ajim.22078; Lee MY, 2008, ANTIOXID REDOX SIGN, V10, P1045, DOI 10.1089/ars.2007.1986; Lehoux S, 2004, CIRCULATION, V109, P1041, DOI 10.1161/01.CIR.0000115521.95662.7A; Lei J, 2013, NITRIC OXIDE-BIOL CH, V35, P175, DOI 10.1016/j.niox.2013.09.004; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Messner B, 2010, BIOMETALS, V23, P811, DOI 10.1007/s10534-010-9314-4; Murugan P, 2007, J ETHNOPHARMACOL, V113, P479, DOI 10.1016/j.jep.2007.07.004; Murugan P, 2006, BASIC CLIN PHARMACOL, V99, P122, DOI 10.1111/j.1742-7843.2006.pto_447.x; Nakmareong S, 2012, HYPERTENS RES, V35, P418, DOI 10.1038/hr.2011.180; Nakmareong S, 2011, N-S ARCH PHARMACOL, V383, P519, DOI 10.1007/s00210-011-0624-z; Nwokocha CR, 2013, CARDIOVASC TOXICOL, V13, P357, DOI 10.1007/s12012-013-9216-0; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; ONER G, 1995, BIOL TRACE ELEM RES, V48, P111, DOI 10.1007/BF02789083; OSAWA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1609, DOI 10.1271/bbb.59.1609; Ozturk IM, 2009, TOXICOL MECH METHOD, V19, P308, DOI 10.1080/15376510802662751; Pari L, 2005, J PHARM PHARM SCI, V8, P115; Portes E, 2007, TETRAHEDRON, V63, P9092, DOI 10.1016/j.tet.2007.06.085; Prozialeck WC, 2008, TOXICOL SCI, V102, P207, DOI 10.1093/toxsci/kfm263; Prozialeck WC, 2006, LIFE SCI, V79, P1493, DOI 10.1016/j.lfs.2006.05.007; Satarug S, 2005, TOXICOL LETT, V157, P57, DOI 10.1016/j.toxlet.2005.01.004; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Sompamit K, 2010, TOXICOL LETT, V198, P77, DOI 10.1016/j.toxlet.2010.04.007; Somparn P, 2007, BIOL PHARM BULL, V30, P74, DOI 10.1248/bpb.30.74; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Sugiyama Y, 1996, BIOCHEM PHARMACOL, V52, P519, DOI 10.1016/0006-2952(96)00302-4; Tandon SK, 2003, TOXICOL LETT, V145, P211, DOI 10.1016/S0378-4274(03)00265-0; Tellez-Plaza M, 2008, ENVIRON HEALTH PERSP, V116, P51, DOI 10.1289/ehp.10764; Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009; Tzotzes V, 2007, BIOMETALS, V20, P83, DOI 10.1007/s10534-006-9017-z; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; Watts SW, 2007, AM J PHYSIOL-HEART C, V292, pH2438, DOI 10.1152/ajpheart.00900.2006; Xu SP, 2006, CAN J CARDIOL, V22, P947, DOI 10.1016/S0828-282X(06)70314-2; Yeh TK, 2011, NANOTOXICOLOGY, V5, P91, DOI 10.3109/17435390.2010.502260; Yoopan N, 2008, TOXICOL LETT, V176, P157, DOI 10.1016/j.toxlet.2007.11.002; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176	63	39	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114908	10.1371/journal.pone.0114908	http://dx.doi.org/10.1371/journal.pone.0114908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502771	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700069
J	Anderson, DEJ; Glynn, JJ; Song, HK; Hinds, MT				Anderson, Deirdre E. J.; Glynn, Jeremy J.; Song, Howard K.; Hinds, Monica T.			Engineering an Endothelialized Vascular Graft: A Rational Approach to Study Design in a Non-Human Primate Model	PLOS ONE			English	Article							IN-VITRO ENDOTHELIALIZATION; FLUID SHEAR-STRESS; PROGENITOR CELLS; NEOINTIMAL HYPERPLASIA; GROWTH-FACTOR; EPTFE GRAFTS; INTIMAL HYPERPLASIA; THROMBUS FORMATION; OUTGROWTH CELLS; MECHANISMS	After many years of research, small diameter, synthetic vascular grafts still lack the necessary biologic integration to perform ideally in clinical settings. Endothelialization of vascular grafts has the potential to improve synthetic graft function, and endothelial outgrowth cells (EOCs) are a promising autologous cell source. Yet no work has established the link between endothelial cell functions and outcomes of implanted endothelialized grafts. This work utilized steady flow, oscillatory flow, and tumor necrosis factor stimulation to alter EOC phenotype and enable the formulation of a model to predict endothelialized graft performance. To accomplish this, EOC in vitro expression of coagulation and inflammatory markers was quantified. In parallel, in non-human primate (baboon) models, the platelet and fibrinogen accumulation on endothelialized grafts were quantified in an ex vivo shunt, or the tissue ingrowth on implanted grafts were characterized after 1mth. Oscillatory flow stimulation of EOCs increased in vitro coagulation markers and ex vivo platelet accumulation. Steady flow preconditioning did not affect platelet accumulation or intimal hyperplasia relative to static samples. To determine whether in vitro markers predict implant performance, a linear regression model of the in vitro data was fit to platelet accumulation data-correlating the markers with the thromboprotective performance of the EOCs. The model was tested against implant intimal hyperplasia data and found to correlate strongly with the parallel in vitro analyses. This research defines the effects of flow preconditioning on EOC regulation of coagulation in clinical vascular grafts through parallel in vitro, ex vivo, and in vivo analyses, and contributes to the translatability of in vitro tests to in vivo clinical graft performance.	[Anderson, Deirdre E. J.; Glynn, Jeremy J.; Hinds, Monica T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Song, Howard K.] Oregon Hlth & Sci Univ, Div Cardiothorac Surg, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Hinds, MT (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	hindsm@ohsu.edu		Glynn, Jeremy/0000-0003-1961-9121	National Institutes of Health (NIH) [R01HL095474, R01HL103728]; NIH grant for the operation of the Oregon National Primate Research Center [OD011092]; National Science Foundation [DGE-0925180]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095474, R01HL103728] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant for the operation of the Oregon National Primate Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by National Institutes of Health (NIH, http://www.nih.gov/) grants R01HL095474 and R01HL103728. It was also supported by NIH grant OD011092 for the operation of the Oregon National Primate Research Center and by National Science Foundation (www.nsf.gov) Graduate Research Fellowship DGE-0925180 for JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmann KA, 2011, TISSUE ENG PT A, V17, P2511, DOI [10.1089/ten.tea.2011.0055, 10.1089/ten.TEA.2011.0055]; Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z; Anderson DEJ, 2014, CELLS TISSU IN PRESS; Ankeny RF, 2013, TISSUE ENG PT A, V19, P1573, DOI [10.1089/ten.tea.2012.0300, 10.1089/ten.TEA.2012.0300]; BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brown MA, 2009, TISSUE ENG PT A, V15, P3575, DOI 10.1089/ten.TEA.2008.0444; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CADROY Y, 1989, J LAB CLIN MED, V113, P436; CADROY Y, 1990, BLOOD, V75, P2185; Chen CY, 1997, ANN VASC SURG, V11, P74, DOI 10.1007/s100169900013; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; CLOWES AW, 1985, AM J PATHOL, V118, P43; Dahl SLM, 2011, TRENDS CARDIOVAS MED, V21, P83, DOI 10.1016/j.tcm.2012.03.004; Deutsch M, 2009, J VASC SURG, V49, P352, DOI 10.1016/j.jvs.2008.08.101; Ensley AE, 2012, TISSUE ENG PT A, V18, P127, DOI [10.1089/ten.tea.2010.0290, 10.1089/ten.TEA.2010.0290]; Glynn J. J., 2013, TISSUE ENG B; Glynn JJ, 2014, TISSUE ENG A; GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047; HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595; Hinds MT, 2008, J BIOMED MATER RES A, V86A, P804, DOI 10.1002/jbm.a.31672; HOCH JR, 1995, J VASC SURG, V22, P51, DOI 10.1016/S0741-5214(95)70088-9; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; KRUPSKI WC, 1993, J VASC SURG, V17, P294, DOI 10.1016/0741-5214(93)90415-I; Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046; Lumsden AB, 1996, J VASC SURG, V24, P825, DOI 10.1016/S0741-5214(96)70019-8; Lund T, 2010, THROMB HAEMOSTASIS, V104, P582, DOI 10.1160/TH09-12-0854; Mazzolai L, 2011, J VASC RES, V48, P443, DOI 10.1159/000324844; McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039; Meier LA, 2014, J CARDIOVASC TRANSL; Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; Pearson JD, 1999, BEST PRACT RES CL HA, V12, P329, DOI 10.1053/beha.1999.0028; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; SCHNEIDER PA, 1989, J VASC SURG, V10, P75, DOI 10.1067/mva.1989.vs0100075; Stroncek JD, 2012, ACTA BIOMATER, V8, P201, DOI 10.1016/j.actbio.2011.09.002; Stroncek JD, 2011, TISSUE ENG PT A, V17, P2091, DOI [10.1089/ten.TEA.2010.0631, 10.1089/ten.tea.2010.0631]; Thebaud NB, 2010, ACTA BIOMATER, V6, P1437, DOI 10.1016/j.actbio.2009.11.012; TOREM S, 1988, J VASC SURG, V7, P172, DOI 10.1067/mva.1988.avs0070172; Vartanian KB, 2009, ENDOTHELIAL CELL FUN; Vartanian KB, 2010, AM J PHYSIOL-CELL PH, V298, pC333, DOI 10.1152/ajpcell.00340.2009; Walpoth BH, 2007, J THORAC CARDIOV SUR, V133, P1163, DOI 10.1016/j.jtcvs.2007.01.029; Wu KK, 1996, ANNU REV MED, V47, P315; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074; ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	48	68	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115163	10.1371/journal.pone.0115163	http://dx.doi.org/10.1371/journal.pone.0115163			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526637	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200015
J	Dankbaar, MEW; Stegers-Jager, KM; Baarveld, F; van Merrienboer, JJG; Norman, GR; Rutten, FL; van Saase, JLCM; Schuit, SCE				Dankbaar, Mary E. W.; Stegers-Jager, Karen M.; Baarveld, Frank; van Merrienboer, Jeroen J. G.; Norman, Geoff R.; Rutten, Frans L.; van Saase, Jan L. C. M.; Schuit, Stephanie C. E.			Assessing the Assessment in Emergency Care Training	PLOS ONE			English	Article							COMMUNICATION-SKILLS; CLINICAL SKILLS; PSYCHOMETRIC PROPERTIES; MEDICAL-EDUCATION; RATING FORMS; OSCE; PERFORMANCE; CHECKLISTS; RELIABILITY; VALIDATION	Objective: Each year over 1.5 million health care professionals attend emergency care courses. Despite high stakes for patients and extensive resources involved, little evidence exists on the quality of assessment. The aim of this study was to evaluate the validity and reliability of commonly used formats in assessing emergency care skills. Methods: Residents were assessed at the end of a 2-week emergency course; a subgroup was videotaped. Psychometric analyses were conducted to assess the validity and inter-rater reliability of the assessment instrument, which included a checklist, a 9-item competency scale and a global performance scale. Results: A group of 144 residents and 12 raters participated in the study; 22 residents were videotaped and re-assessed by 8 raters. The checklists showed limited validity and poor inter-rater reliability for the dimensions "correct'' and "timely'' (ICC=.30 and. 39 resp.). The competency scale had good construct validity, consisting of a clinical and a communication subscale. The internal consistency of the (sub)scales was high (alpha=.93/.91/.86). The inter-rater reliability was moderate for the clinical competency subscale (.49) and the global performance scale (.50), but poor for the communication subscale (.27). A generalizability study showed that for a reliable assessment 5-13 raters are needed when using checklists, and four when using the clinical competency scale or the global performance scale. Conclusions: This study shows poor validity and reliability for assessing emergency skills with checklists but good validity and moderate reliability with clinical competency or global performance scales. Involving more raters can improve the reliability substantially. Recommendations are made to improve this high stakes skill assessment.	[Dankbaar, Mary E. W.; Stegers-Jager, Karen M.; van Saase, Jan L. C. M.; Schuit, Stephanie C. E.] Erasmus Univ, Med Ctr Rotterdam, Rotterdam, Netherlands; [Baarveld, Frank; Rutten, Frans L.] Training Inst Family Practice SBOH, Utrecht, Netherlands; [Norman, Geoff R.] McMaster Univ, Hamilton, ON, Canada; [van Merrienboer, Jeroen J. G.] Maastricht Univ, Sch Hlth Profess Educ, NL-6200 MD Maastricht, Netherlands	Erasmus University Rotterdam; Erasmus MC; McMaster University; Maastricht University	Dankbaar, MEW (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Rotterdam, Netherlands.	m.dankbaar@erasmusmc.nl	van Merrienboer, Jeroen J.G./C-2051-2009; Stegers-Jager, Karen M/F-7565-2017	van Merrienboer, Jeroen J.G./0000-0002-5868-7031; Stegers-Jager, Karen M/0000-0003-2947-6099; Dankbaar, Mary E.W./0000-0003-0880-505X	Erasmus University Medical Center Rotterdam; TNO (the Dutch Ministry of Economic Affairs); SBOH	Erasmus University Medical Center Rotterdam; TNO (the Dutch Ministry of Economic Affairs); SBOH	This study was financed by the Erasmus University Medical Center Rotterdam, The Netherlands. Additional external funding for this study was received from TNO (the Dutch Ministry of Economic Affairs) (www.tno.nl) and SBOH (training institution for family practitioners) (www.sboh.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch R, 2012, MED TEACH, V34, P960, DOI 10.3109/0142159X.2012.703791; Boulet JR, 2003, ANESTHESIOLOGY, V99, P1270, DOI 10.1097/00000542-200312000-00007; Breedveld, 2009, RAPP WERKGR KWAL SEH; Cohen DS, 1996, ADV HEALTH SCI EDUC, V1, P209, DOI 10.1007/BF00162917; Cohen DS, 1996, ACAD MED, V71, pS87, DOI 10.1097/00001888-199601000-00052; Cook DA, 2013, ADV HLTH SCI ED THEO; David Streiner, 2008, HLTH MEASUREMENT SCA; Downing SM, 2004, MED EDUC, V38, P1006, DOI 10.1111/j.1365-2929.2004.01932.x; Elstein AS, 1978, MED PROBLEM SOLVING; Farmer Elizabeth A, 2005, Aust Fam Physician, V34, P1059; Flowerdew L, 2012, ANN EMERG MED, V59, P376, DOI 10.1016/j.annemergmed.2011.11.022; Govaerts MJB, 2002, ADV HEALTH SCI EDUC, V7, P133, DOI 10.1023/A:1015720302925; Hatala R, 2002, MED EDUC, V36, P160, DOI 10.1046/j.1365-2923.2002.01067.x; Hodges B, 1999, ACAD MED, V74, P1129, DOI 10.1097/00001888-199910000-00017; Hodges B, 1998, ACAD MED, V73, P910, DOI 10.1097/00001888-199808000-00019; House Joseph B, 2012, J Grad Med Educ, V4, P312, DOI 10.4300/JGME-D-11-00123.1; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Napier F, 2009, RESUSCITATION, V80, P1034, DOI 10.1016/j.resuscitation.2009.04.043; Norman G, 2013, BMJ-BRIT MED J, V324, P1560; Patricio MF, 2013, MED TEACH, V35, P503, DOI 10.3109/0142159X.2013.774330; Pell G, 2010, MED TEACH, V32, P802, DOI 10.3109/0142159X.2010.507716; Perkins GD, 2012, ANN INTERN MED, V157, P19, DOI 10.7326/0003-4819-157-1-201207030-00005; Perkins GD, 2001, RESUSCITATION, V50, P281, DOI 10.1016/S0300-9572(01)00434-8; Preston JL, 2009, AUST CRIT CARE, V22, P164, DOI 10.1016/j.aucc.2009.05.002; Ram P, 1999, MED EDUC, V33, P197, DOI 10.1046/j.1365-2923.1999.00280.x; Regehr G, 1998, ACAD MED, V73, P993, DOI 10.1097/00001888-199809000-00020; Reznick RK, 1998, ACAD MED, V73, pS97, DOI 10.1097/00001888-199810000-00058; Ringsted C, 2007, RESUSCITATION, V75, P153, DOI 10.1016/j.resuscitation.2007.03.003; Ringsted C, 2003, MED TEACH, V25, P654, DOI 10.1080/01421590310001605642; Schuwirth LWT, 2011, MED TEACH, V33, P783, DOI 10.3109/0142159X.2011.611022; Schuwirth LWT, 2003, MED EDUC, V37, P65, DOI 10.1046/j.1365-2923.37.s1.8.x; Swanson DB, 2013, TEACH LEARN MED, V25, pS17, DOI 10.1080/10401334.2013.842916; Tamblyn R, 2013, JAMA-J AM MED ASSOC, V298, P993; van Dalen J, 2002, MED EDUC, V36, P148, DOI 10.1046/j.1365-2923.2002.01066.x; VANDERVLEUTEN CPM, 1989, MED EDUC, V23, P290; Wass V, 2001, LANCET, V357, P945, DOI 10.1016/S0140-6736(00)04221-5; Wenghofer E, 2009, MED EDUC, V43, P1166, DOI 10.1111/j.1365-2923.2009.03534.x	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114663	10.1371/journal.pone.0114663	http://dx.doi.org/10.1371/journal.pone.0114663			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521702	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600006
J	Druckman, JN; Gilli, M; Klar, S; Robison, J				Druckman, James N.; Gilli, Mauro; Klar, Samara; Robison, Joshua			The Role of Social Context in Shaping Student-Athlete Opinions	PLOS ONE			English	Article							SENSITIVE QUESTIONS; IMPACT	How do student-athletes form opinions? This is a particularly important question given ongoing debates about whether student-athletes should be paid and/or allowed to unionize. These debates concern the rights and benefits accrued directly to student-athletes, and thus, understanding their attitudes is of obvious import. Yet, virtually no recent work has delved into how student-athletes form opinions on these issues. We fill this gap with a theoretical framework that predicts changes in social context alter opinions. This leads to the hypothesis that opinions will change once a student-athlete completes his/her career and finds him/herself in a distinct social network. We test the prediction with a survey, implemented in 2012, of one of the most notable athletic conferences in the National Collegiate Athletic Association (NCAA): the Big Ten. We find that post-career student-athletes demonstrate higher levels of support for pay for play and unionization. Our results suggest that studentathletes' opinions seem to depend on their extant social contexts. While our data, from 2012, neither speak to current opinions -given the quickly evolving landscape of college athletics - nor demonstrate what reforms may be "best," they do accentuate the power of social context in shaping student-athletes' attitudes.	[Druckman, James N.; Gilli, Mauro] Northwestern Univ, Dept Polit Sci, Evanston, IL 60208 USA; [Klar, Samara] Univ Arizona, Dept Polit Sci, Tucson, AZ USA; [Robison, Joshua] Aarhus Univ, Dept Polit Sci, Aarhus, Denmark	Northwestern University; University of Arizona; Aarhus University	Druckman, JN (corresponding author), Northwestern Univ, Dept Polit Sci, Evanston, IL 60208 USA.	druckman@northwestern.edu		Robison, Joshua/0000-0002-7472-2247				Alesia M, 2014, NCAA APPROACHING 1 B; [Anonymous], NY TIMES; Armour N, 2014, HUFFINGTON POST; Auerbach N, 2014, US TODAY; Bullock JG, 2011, CAMBRIDGE HDB EXPT P; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Couper M. P., 2008, DESIGNING EFFECTIVE; Fountain JJ, 2009, J ISS INERCOLL ATH, V2; Greenstein T, 2014, CHICAGO TRIBUNE; Gregory S, 2014, TIME MAGAZINE; Gregory S., 2013, TIME; Hayes C, 2014, FAT PROFITS NCAA WHI; Huckfeldt R.R., 1995, CITIZENS POLITICS SO; Klar S, 2014, AM J POLIT SCI, V58, P687, DOI 10.1111/ajps.12087; Matthes J, 2010, COMMUN RES, V37, P774, DOI 10.1177/0093650210362685; Mutz DC, 1998, IMPERSONAL INFLUENCE; Noelle-Neumann E, 1993, SPIRAL SILENCE OUR S; Prewitt Alex, 2014, WASHINGTON POST; Putterman A, 2014, DAILY NW; Ritter L. A., 2007, CONDUCTING ONLINE SU; Sakc A. L., 1988, Journal of Sport and Social Issues, V12, P1, DOI 10.1177/019372358801200101; Scheufele DA, 2000, INT J PUBLIC OPIN R, V12, P3, DOI 10.1093/ijpor/12.1.3; Schneider RG, 2001, COLL STUD J, V35, P44; SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Sinclair B., 2012, THE SOCIAL CITIZEN; Steinmetz S, 2014, WILEY SER SURV METH, P273; Tarm M, 2014, COLL ATHLETES CAN UN; Tomz M, 1999, CLARIFY VERSION 1 2; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Tourangeau R., 2000, PSYCHOL SURVEY RESPO; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Trahan K, 2014, US TODAY; Visser P. S, 2006, ADV EXPT SOCIAL PSYC; Visser PS, 2004, J PERS SOC PSYCHOL, V87, P779, DOI 10.1037/0022-3514.87.6.779	35	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115159	10.1371/journal.pone.0115159	http://dx.doi.org/10.1371/journal.pone.0115159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522052	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600021
J	Krishnan, A; Pramanik, GK; Revadi, SV; Venkateswaran, V; Borges, RM				Krishnan, Anusha; Pramanik, Gautam Kumar; Revadi, Santosh V.; Venkateswaran, Vignesh; Borges, Renee M.			High Temperatures Result in Smaller Nurseries which Lower Reproduction of Pollinators and Parasites in a Brood Site Pollination Mutualism	PLOS ONE			English	Article							FIG WASP COMMUNITY; FLOWERING ASYNCHRONY; CLIMATE-CHANGE; SEASONAL FLUCTUATIONS; YUCCA MOTH; HOST-PLANT; TRADE-OFF; SEED; EVOLUTIONARY; PHENOLOGY	In a nursery pollination mutualism, we asked whether environmental factors affected reproduction of mutualistic pollinators, non-mutualistic parasites and seed production via seasonal changes in plant traits such as inflorescence size and within-tree reproductive phenology. We examined seasonal variation in reproduction in Ficus racemosa community members that utilise enclosed inflorescences called syconia as nurseries. Temperature, relative humidity and rainfall defined four seasons: winter; hot days, cold nights; summer and wet seasons. Syconium volumes were highest in winter and lowest in summer, and affected syconium contents positively across all seasons. Greater transpiration from the nurseries was possibly responsible for smaller syconia in summer. The 3-5 degrees C increase in mean temperatures between the cooler seasons and summer reduced fig wasp reproduction and increased seed production nearly two-fold. Yet, seed and pollinator progeny production were never negatively related in any season confirming the mutualistic fig-pollinator association across seasons. Non-pollinator parasites affected seed production negatively in some seasons, but had a surprisingly positive relationship with pollinators in most seasons. While within-tree reproductive phenology did not vary across seasons, its effect on syconium inhabitants varied with season. In all seasons, within-tree reproductive asynchrony affected parasite reproduction negatively, whereas it had a positive effect on pollinator reproduction in winter and a negative effect in summer. Seasonally variable syconium volumes probably caused the differential effect of within-tree reproductive phenology on pollinator reproduction. Within-tree reproductive asynchrony itself was positively affected by intra-tree variation in syconium contents and volume, creating a unique feedback loop which varied across seasons. Therefore, nursery size affected fig wasp reproduction, seed production and within-tree reproductive phenology via the feedback cycle in this system. Climatic factors affecting plant reproductive traits cause biotic relationships between plants, mutualists and parasites to vary seasonally and must be accorded greater attention, especially in the context of climate change.	[Krishnan, Anusha; Venkateswaran, Vignesh; Borges, Renee M.] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Pramanik, Gautam Kumar] Johannes Gutenberg Univ Med Mainz, Inst Microscopy Anat & Neurobiol, Mainz, Germany; [Revadi, Santosh V.] Swedish Univ Agr Sci, Dept Plant Protect & Biol, Unit Chem Ecol, Alnarp, Sweden	Indian Institute of Science (IISC) - Bangalore; Johannes Gutenberg University of Mainz; Swedish University of Agricultural Sciences	Borges, RM (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	renee@ces.iisc.ernet.in	Venkateswaran, Vignesh/L-6002-2019; revadi, santosh/AAX-4341-2021	revadi, santosh/0000-0001-5647-3454	Ministry of Environment and Forests, Government of India	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India)	This research was funded by the Ministry of Environment and Forests, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKER CL, 1981, OECOLOGIA, V49, P96, DOI 10.1007/BF00376905; Al-Beidh Sarah, 2012, ISRN Zoology, P1; Al-Beidh S, 2012, OIKOS, V121, P1833, DOI 10.1111/j.1600-0706.2011.20179.x; Anstett MC, 1996, J EVOLUTION BIOL, V9, P417, DOI 10.1046/j.1420-9101.1996.9040417.x; AUGSPURGER CK, 1983, BIOTROPICA, V15, P257, DOI 10.2307/2387650; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Barrett LG, 2012, FUNCT ECOL, V26, P457, DOI 10.1111/j.1365-2435.2011.01940.x; BEATLEY JC, 1974, ECOLOGY, V55, P856, DOI 10.2307/1934421; BENTLEY BL, 1976, ECOLOGY, V57, P815, DOI 10.2307/1936195; Blatrix R, 2013, CR GEOSCI, V345, P306, DOI 10.1016/j.crte.2013.03.006; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P622, DOI 10.1007/BF01975679; BRONSTEIN JL, 1990, ECOLOGY, V71, P2145, DOI 10.2307/1938628; BRONSTEIN JL, 1988, BIOTROPICA, V20, P215, DOI 10.2307/2388236; Cardona W, 2013, BIOTROPICA, V45, P203, DOI 10.1111/j.1744-7429.2012.00901.x; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cook JM, 1996, J BIOGEOGR, V23, P487, DOI 10.1111/j.1365-2699.1996.tb00010.x; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; Dunn DW, 2008, J ANIM ECOL, V77, P927, DOI 10.1111/j.1365-2656.2008.01416.x; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; Dyer LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062528; Forrest JRK, 2015, OIKOS, V124, P4, DOI 10.1111/oik.01386; FRANK SA, 1989, EXPERIENTIA, V45, P674, DOI 10.1007/BF01975684; GADGIL S, 1983, J CLIMATOL, V3, P47, DOI 10.1002/joc.3370030105; GALIL J, 1968, ECOLOGY, V49, P259, DOI 10.2307/1934454; Gates DJ, 2012, AM J BOT, V99, P757, DOI 10.3732/ajb.1100472; Ghara M, 2014, ARTHROPOD-PLANT INTE, V8, P191, DOI 10.1007/s11829-014-9300-9; Ghara M, 2010, ECOL ENTOMOL, V35, P139, DOI 10.1111/j.1365-2311.2010.01176.x; Gorden NLS, 2013, AM J BOT, V100, P679, DOI 10.3732/ajb.1200460; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jevanandam N, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0041; Johansson J, 2013, GLOBAL CHANGE BIOL, V19, P197, DOI 10.1111/gcb.12006; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Joreskog KG, 2012, LISREL 9 1 WINDOWS; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; Kerdelhue C, 1996, OIKOS, V75, P3, DOI 10.2307/3546315; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; Krishnan A, 2014, J ECOL, V102, P1329, DOI 10.1111/1365-2745.12277; Kudo G, 2008, ECOLOGY, V89, P321, DOI 10.1890/06-2131.1; LAWRENCE PO, 1981, ANN ENTOMOL SOC AM, V74, P540, DOI 10.1093/aesa/74.6.540; Liu YZ, 2012, NEW PHYTOL, V195, P427, DOI 10.1111/j.1469-8137.2012.04178.x; Lombardero MJ, 2003, OIKOS, V102, P243, DOI 10.1034/j.1600-0706.2003.12599.x; Malizia LR, 2001, CONDOR, V103, P45, DOI 10.1650/0010-5422(2001)103[0045:SFOBFA]2.0.CO;2; Meindl GA, 2013, OECOLOGIA, V173, P1355, DOI 10.1007/s00442-013-2711-y; MITCHELL RJ, 1992, FUNCT ECOL, V6, P123, DOI 10.2307/2389745; Muniz DG, 2012, STUD NEOTROP FAUNA E, V47, P111, DOI 10.1080/01650521.2012.698932; Pagamas P, 2008, SCI HORTIC-AMSTERDAM, V117, P21, DOI 10.1016/j.scienta.2008.03.017; PATINO S, 1994, OECOLOGIA, V100, P13, DOI 10.1007/BF00317125; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; PITELKA LF, 1985, AM J BOT, V72, P311, DOI 10.2307/2443558; Pringle EG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001705; Proffit M, 2007, J ANIM ECOL, V76, P296, DOI 10.1111/j.1365-2656.2007.01213.x; Proffit M, 2009, ENTOMOL EXP APPL, V131, P46, DOI 10.1111/j.1570-7458.2009.00823.x; Raja S, 2015, ENTOMOL SCI, V18, P230, DOI 10.1111/ens.12100; Ramirez B, 1970, Evolution, Lancaster, Pa., V24, P680, DOI 10.1111/j.1558-5646.1970.tb01804.x; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Ranganathan Y, 2010, ENTOMOL EXP APPL, V137, P50, DOI 10.1111/j.1570-7458.2010.01038.x; Rico-Gray V, 2012, ARTHROPOD-PLANT INTE, V6, P289, DOI 10.1007/s11829-011-9170-3; Scaven VL, 2013, CURR ZOOL, V59, P418, DOI 10.1093/czoolo/59.3.418; Segraves KA, 2003, ECOLOGY, V84, P2943, DOI 10.1890/02-0619; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Suleman N, 2013, ECOL ENTOMOL, V38, P478, DOI 10.1111/een.12041; Suleman N, 2013, PLANT SYST EVOL, V299, P927, DOI 10.1007/s00606-013-0773-2; Ulian T, 2013, S AFR J BOT, V88, P278, DOI 10.1016/j.sajb.2013.08.006; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; VANALEBEEK FAN, 1993, ENTOMOL EXP APPL, V69, P21, DOI 10.1007/BF02380670; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Wang R-W, 2009, PLOS ONE, V4, P1; Wang RW, 2008, J ANIM ECOL, V77, P616, DOI 10.1111/j.1365-2656.2008.01359.x; Wang RW, 2008, SYMBIOSIS, V45, P113; Wang RW, 2011, J R SOC INTERFACE, V8, P1487, DOI 10.1098/rsif.2011.0063; Wang RW, 2010, ECOLOGY, V91, P1308, DOI 10.1890/09-1446.1; Wang RW, 2005, J INTEGR PLANT BIOL, V47, P144, DOI 10.1111/j.1744-7909.2005.00034.x; Warren RJ, 2014, GLOBAL CHANGE BIOL, V20, P466, DOI 10.1111/gcb.12407; WEST SA, 1994, P ROY SOC B-BIOL SCI, V258, P67, DOI 10.1098/rspb.1994.0143; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Young LW, 2004, J EXP BOT, V55, P485, DOI 10.1093/jxb/erh038	83	8	8	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115118	10.1371/journal.pone.0115118	http://dx.doi.org/10.1371/journal.pone.0115118			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521512	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600017
J	Zhao, LL; Yang, GS; Zhao, X				Zhao, Lili; Yang, Gongshe; Zhao, Xin			Rho-Associated Protein Kinases Play an Important Role in the Differentiation of Rat Adipose-Derived Stromal Cells into Cardiomyocytes In Vitro	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DEDIFFERENTIATED FAT-CELLS; STEM-CELLS; BEATING CARDIOMYOCYTES; CARDIAC-FUNCTION; TISSUE; DISEASE; ROCK	Adipose-derived stromal cells (ADSCs) represent a readily available abundant supply of mesenchymal stem cells and have the ability to differentiate into cardiomyocytes in mice and human, making ADSCs a promising source of cardiomyocytes for transplantation. However, there has been no report of differentiation of rat ADSCs into cardiomyocytes. In addition, signaling pathways in the differentiation process from ADSCs to cardiomyocytes are unknown. In this study, we first demonstrated that rat ADSCs spontaneously differentiated into cardiomyocytes in vitro, when cultured on a complete medium formulation MethoCult GF M3534. These differentiated cells possessed cardiomyocyte phenotype and expressed cardiac markers. Moreover, these cells showed open excitation-contracting coupling and Ca2+ transient and contracted spontaneously. The role of Rho-associated protein kinases (ROCKs) in the differentiation process was then studied by using ROCK-specific inhibitor Y-27632 and ROCK siRNAs. These agents changed the arrangement of cytoskeleton and diminished appearance of cardiomyocyte phenotype, accompanied by inhibition of c-Jun N-terminal kinase (JNK) phosphorylation and promotion of Akt phosphorylation. Collectively, this is the first study to demonstrate that rat ADSCs could spontaneously differentiate into cardiomyocytes in vitro and ROCKs play an important role in the differentiation of ADSCs into beating cardiomyocytes in conjunction of the PI3K/Akt pathway and the JNK pathway.	[Zhao, Lili; Yang, Gongshe; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332; Yang, Gongshe/0000-0003-2003-979X	China QianRen program	China QianRen program	This work was supported by the China QianRen program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader M, 2010, METHODS MOL BIOL, V597, P403, DOI 10.1007/978-1-60327-389-3_27; Bai XW, 2010, EUR HEART J, V31, P489, DOI 10.1093/eurheartj/ehp568; Castellani L, 2006, J BIOL CHEM, V281, P15249, DOI 10.1074/jbc.M601390200; Chen L, 2009, ENVIRON HEALTH PERSP, V117, P1124, DOI 10.1289/ehp.0800157; Choi YS, 2010, J CELL MOL MED, V14, P878, DOI 10.1111/j.1582-4934.2010.01009.x; Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077; Feng TS, 2010, STEM CELL REV REP, V6, P74, DOI 10.1007/s12015-010-9115-8; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Ishida H, 2011, AM J PHYSIOL-HEART C, V301, pH1531, DOI 10.1152/ajpheart.00216.2011; Jumabay M, 2010, CARDIOVASC RES, V85, P17, DOI 10.1093/cvr/cvp267; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Leobon B, 2009, CARDIOVASC RES, V83, P757, DOI 10.1093/cvr/cvp167; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Rai M, 2012, STEM CELLS DEV, V21, P54, DOI 10.1089/scd.2011.0326; Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X; Riazi AM, 2005, J BIOL CHEM, V280, P10716, DOI 10.1074/jbc.M500028200; Schenke-Layland K, 2009, J SURG RES, V153, P217, DOI 10.1016/j.jss.2008.03.019; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Shen JF, 2011, INT J ORAL SCI, V3, P117, DOI 10.4248/IJOS11044; Valina C, 2007, EUR HEART J, V28, P2667, DOI 10.1093/eurheartj/ehm426; VASILIEV JM, 1987, J CELL SCI, P1; Wang L, 2009, AM J PHYSIOL-HEART C, V297, pH1020, DOI 10.1152/ajpheart.01082.2008; Wei L, 2001, DEVELOPMENT, V128, P2953; Yamada Y, 2007, STEM CELLS, V25, P1326, DOI 10.1634/stemcells.2006-0588; Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841; Zhao LL, 2012, MOL BIOL REP, V39, P2585, DOI 10.1007/s11033-011-1011-z; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	32	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115191	10.1371/journal.pone.0115191	http://dx.doi.org/10.1371/journal.pone.0115191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522345	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600024
J	MacNeil, JE; Williams, RN				MacNeil, Jami E.; Williams, Rod N.			Effects of Timber Harvests and Silvicultural Edges on Terrestrial Salamanders	PLOS ONE			English	Article							SOUTHERN APPALACHIAN SALAMANDERS; MISSOURI OZARK FORESTS; PLETHODONTID SALAMANDERS; ABUNDANCE; AMPHIBIANS; MANAGEMENT; POPULATIONS; STANDS; PERSISTENCE; MOUNTAINS	Balancing timber production and conservation in forest management requires an understanding of how timber harvests affect wildlife species. Terrestrial salamanders are useful indicators of mature forest ecosystem health due to their importance to ecosystem processes and sensitivity to environmental change. However, the effects of timber harvests on salamanders, though often researched, are still not well understood. To further this understanding, we used artificial cover objects to monitor the relative abundance of terrestrial salamanders for two seasons (fall and spring) pre-harvest and five seasons post-harvest in six forest management treatments, and for three seasons post-harvest across the edge gradients of six recent clearcuts. In total, we recorded 19,048 encounters representing nine species of salamanders. We observed declines in mean encounters of eastern red-backed salamanders (Plethodon cinereus) and northern slimy salamanders (P. glutinosus) from pre-to post-harvest in group selection cuts and in clearcuts. However, we found no evidence of salamander declines at shelterwoods and forested sites adjacent to harvests. Edge effects induced by recent clearcuts influenced salamanders for approximately 20 m into the forest, but edge influence varied by slope orientation. Temperature, soil moisture, and canopy cover were all correlated with salamander counts. Our results suggest silvicultural techniques that remove the forest canopy negatively affect salamander relative abundance on the local scale during the years immediately following harvest, and that the depth of edge influence of clearcuts on terrestrial salamanders is relatively shallow (<20 m). Small harvests (<4 ha) and techniques that leave the forest canopy intact may be compatible with maintaining terrestrial salamander populations across a forested landscape. Our results demonstrate the importance of examining species-specific responses and monitoring salamanders across multiple seasons and years. Long-term monitoring will be necessary to understand the full impacts of forest management on terrestrial salamanders.	[MacNeil, Jami E.; Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	MacNeil, JE (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	jami.macneil@gmail.com			Indiana Department of Natural Resources Division of Forestry; Department of Forestry and Natural Resources, Purdue University	Indiana Department of Natural Resources Division of Forestry; Department of Forestry and Natural Resources, Purdue University	Funding was provided by the Indiana Department of Natural Resources Division of Forestry and the Department of Forestry and Natural Resources, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2010, SALAMANDERS US CANAD; Ash AN, 1997, CONSERV BIOL, V11, P983, DOI 10.1046/j.1523-1739.1997.96172.x; Ash AN, 1999, CONSERV BIOL, V13, P206, DOI 10.1046/j.1523-1739.1999.98257.x; ASH AN, 1994, CONSERV BIOL, V8, P300, DOI 10.1046/j.1523-1739.1994.08010300.x; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Biek R, 2002, NORTHWEST SCI, V76, P129; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bolen EG, 2003, WILDLIFE ECOLOGY MAN, P332; Bonin J., 1991, THESIS MCGILL U MONT; Brown JK, 1974, INT16 USDA FOR SERV; Burnham K. P., 1998, MODEL SELECTION INFE; BURTON TM, 1975, COPEIA, P541; BURY RB, 1988, MANAGEMENT AMPHIBIAN, P11; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Dale M.E., 1995, NE698 USDA FOR SERV; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; DEGRAAF RM, 1992, WILDLIFE SOC B, V20, P260; DeGraaf RM, 2002, FOREST SCI, V48, P351; Demaynadier PG, 1998, CONSERV BIOL, V12, P340, DOI 10.1046/j.1523-1739.1998.96412.x; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Duguay JP, 2002, FOREST SCI, V48, P331; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Fellers GM, 1994, MEASURING MONITORING, P149; Ford WM, 2002, FOREST ECOL MANAG, V155, P131, DOI 10.1016/S0378-1127(01)00553-9; Grialou JA, 2000, J WILDLIFE MANAGE, V64, P105, DOI 10.2307/3802979; Harpole DN, 1999, FOREST ECOL MANAG, V114, P349, DOI 10.1016/S0378-1127(98)00365-X; HEATWOLE H, 1962, ECOLOGY, V43, P460, DOI 10.2307/1933374; Herbeck LA, 1999, CONSERV BIOL, V13, P623, DOI 10.1046/j.1523-1739.1999.98097.x; Hines, 2006, PROGRAM PRESENCE VER; Hyde EJ, 2001, J WILDLIFE MANAGE, V65, P624, DOI 10.2307/3803013; JAEGER RG, 1980, COPEIA, P265, DOI 10.2307/1444003; KALB RA, 2013, HARDWOOD ECOSYSTEM E, V108, P36; Karraker NE, 2006, BIOL CONSERV, V131, P132, DOI 10.1016/j.biocon.2006.02.013; KESSLER WB, 1992, ECOL APPL, V2, P221, DOI 10.2307/1941856; Knapp SM, 2003, CONSERV BIOL, V17, P752, DOI 10.1046/j.1523-1739.2003.02061.x; Leopold A, 1930, GAME MANAGEMENT; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MacNeil JE, 2013, HERPETOL CO IN PRESS; Maser C., 1979, WILDLIFE HABITATS MA, P78; MATLACK GR, 1993, BIOL CONSERV, V66, P185, DOI 10.1016/0006-3207(93)90004-K; Morneault AE, 2004, FOREST ECOL MANAG, V199, P1, DOI 10.1016/j.foreco.2004.03.043; Moseley KR, 2009, ENVIRON MONIT ASSESS, V151, P425, DOI 10.1007/s10661-008-0286-6; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; National Drought Mitigation Center, US DROUGHT MON; Perry DA, 1998, ANNU REV ECOL SYST, V29, P435, DOI 10.1146/annurev.ecolsys.29.1.435; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; PETRANKA JW, 1994, FOREST ECOL MANAG, V67, P135, DOI 10.1016/0378-1127(94)90012-4; Petranka JW, 1999, CONSERV BIOL, V13, P203, DOI 10.1046/j.1523-1739.1999.97376.x; Popescu VD, 2012, FOREST ECOL MANAG, V270, P163, DOI 10.1016/j.foreco.2012.01.027; POUGH FH, 1987, FOREST ECOL MANAG, V20, P1, DOI 10.1016/0378-1127(87)90146-0; Renken RB, 2004, CONSERV BIOL, V18, P174, DOI 10.1111/j.1523-1739.2004.00312.x; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Roznik EA, 2012, J THERM BIOL, V37, P260, DOI 10.1016/j.jtherbio.2012.02.004; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; SHARITZ RR, 1992, ECOL APPL, V2, P226, DOI 10.2307/1941857; Summerville KS, 2009, FOREST ECOL MANAG, V259, P8, DOI 10.1016/j.foreco.2009.09.033; Temple SA, 1987, PREDATION TURTLE NES, V1987, P250; USDA Forest Service, 2007, USDA FOR SERV OV; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Willson John D., 2010, P229; Wyman RL, 1998, BIODIVERS CONSERV, V7, P641, DOI 10.1023/A:1008856402258; Zwolak R, 2009, FOREST ECOL MANAG, V258, P539, DOI 10.1016/j.foreco.2009.05.033	67	5	7	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114683	10.1371/journal.pone.0114683	http://dx.doi.org/10.1371/journal.pone.0114683			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517409	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600025
J	Wiseman, B; Kilburg, A; Chaptal, V; Reyes-Mejia, GC; Sarwan, J; Falson, P; Jault, JM				Wiseman, Benjamin; Kilburg, Arnaud; Chaptal, Vincent; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Falson, Pierre; Jault, Jean-Michel			Stubborn Contaminants: Influence of Detergents on the Purity of the Multidrug ABC Transporter BmrA	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MEMBRANE-PROTEIN CRYSTALLIZATION; SIZE-EXCLUSION CHROMATOGRAPHY; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ATP-BINDING; STRUCTURAL-ANALYSIS; ACRB CONTAMINATION; PURIFICATION; SOFTWARE	Despite the growing interest in membrane proteins, their crystallization remains a major challenge. In the course of a crystallographic study on the multidrug ATP-binding cassette transporter BmrA, mass spectral analyses on samples purified with six selected detergents revealed unexpected protein contamination visible for the most part on overloaded SDS-PAGE. A major contamination from the outer membrane protein OmpF was detected in purifications with Foscholine 12 (FC12) but not with Lauryldimethylamine-N-oxide (LDAO) or any of the maltose-based detergents. Consequently, in the FC12 purified BmrA, OmpF easily crystallized over BmrA in a new space group, and whose structure is reported here. We therefore devised an optimized protocol to eliminate OmpF during the FC12 purification of BmrA. On the other hand, an additional band visible at similar to 110 kDa was detected in all samples purified with the maltose-based detergents. It contained AcrB that crystallized over BmrA despite its trace amounts. Highly pure BmrA preparations could be obtained using either a Delta acrAB E. coli strain and n-dodecyl-beta-D-maltopyranoside, or a classical E. coli strain and lauryl maltose neopentyl glycol for the overexpression and purification, respectively. Overall our results urge to incorporate a proteomics-based purity analysis into quality control checks prior to commencing crystallization assays of membrane proteins that are notoriously arduous to crystallize. Moreover, the strategies developed here to selectively eliminate obstinate contaminants should be applicable to the purification of other membrane proteins overexpressed in E. coli.	[Wiseman, Benjamin; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Jault, Jean-Michel] Univ Grenoble Alpes, Inst Biol Struct, F-38000 Grenoble, France; [Wiseman, Benjamin; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Jault, Jean-Michel] CEA Grenoble, DSV, IBS, F-38000 Grenoble, France; [Wiseman, Benjamin; Reyes-Mejia, Gina Catalina; Sarwan, Jonathan; Jault, Jean-Michel] CNRS, IBS, UMR5075, F-38000 Grenoble, France; [Kilburg, Arnaud; Chaptal, Vincent; Falson, Pierre] Univ Lyon 1, Inst Biol & Chim Prot, Drug Resistance Mech & Modulat Team, CNRS,UMR5086, F-69367 Lyon, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Falson, P (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, 6 Rue Jules Horowitz, F-38000 Grenoble, France.	pierre.falson@ibcp.fr; jean-michel.jault@ibcp.fr	jault, jean-michel/G-2086-2012	jault, jean-michel/0000-0003-1743-2777; Wiseman, Benjamin/0000-0002-2994-5839; chaptal, vincent/0000-0003-2603-0294; Falson, Pierre/0000-0002-9760-4577	Ligue Contre le Cancer; region Rhone-Alpes; Ligue Nationale Contre le Cancer;  [ANR-EMMA-10-049-01];  [ANR-13-BSV5-0001-01];  [ANR-09-PIRI-0002-01];  [ANR-14-CE09-0024]	Ligue Contre le Cancer(Ligue nationale contre le cancer); region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); ; ; ; 	PF was supported by the Ligue Contre le Cancer and by ANR-EMMA-10-049-01 and ANR-13-BSV5-0001-01. JMJ and PF were supported by the ANR-09-PIRI-0002-01 and the ANR-14-CE09-0024. Arnaud Kilburg is a recipient of a doctoral fellowship from 'region Rhone-Alpes' and Jonathan Sarwan was a recipient of a doctoral fellowship from the Ligue Nationale Contre le Cancer; their financial support is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Arachea BT, 2012, PROTEIN EXPRES PURIF, V86, P12, DOI 10.1016/j.pep.2012.08.016; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boncoeur E, 2012, BIOCHEMISTRY-US, V51, P7755, DOI 10.1021/bi300762p; Camara-Artigas A, 2006, ACTA CRYSTALLOGR F, V62, P1087, DOI 10.1107/S174430910604200X; Caylor CL, 1999, PROTEINS, V36, P270, DOI 10.1002/(SICI)1097-0134(19990815)36:3<270::AID-PROT2>3.3.CO;2-E; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chung KY, 2012, J BIOL CHEM, V287, P36305, DOI 10.1074/jbc.M112.406371; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Galian C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019677; Glover CAP, 2011, J STRUCT BIOL, V176, P419, DOI 10.1016/j.jsb.2011.09.005; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hohl M, 2012, NAT STRUCT MOL BIOL; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Jin MS, 2012, NATURE; Kang HJ, 2013, INT J BIOCHEM CELL B, V45, P636, DOI 10.1016/j.biocel.2012.12.018; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kefala G, 2010, PROTEIN SCI, V19, P1117, DOI 10.1002/pro.369; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Lohkamp B, 2008, ACTA CRYSTALLOGR D, V64, P407, DOI 10.1107/S0907444908001091; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Morales R, 2006, STRUCTURE, V14, P601, DOI 10.1016/j.str.2005.12.012; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Orelle C, 2008, BIOCHEMISTRY-US, V47, P2404, DOI 10.1021/bi702303s; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Panwar P, 2012, ACTA CRYSTALLOGR D, V68, P1272, DOI 10.1107/S090744491202639X; Parcej D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067112; Pollock NL, 2014, BBA-BIOMEMBRANES, V1838, P134, DOI 10.1016/j.bbamem.2013.09.001; Psakis G, 2009, J STRUCT BIOL, V166, P107, DOI 10.1016/j.jsb.2008.12.007; Raman P, 2006, CELL MOL LIFE SCI, V63, P36, DOI 10.1007/s00018-005-5350-6; Ravaud S, 2006, BIOCHEM J, V395, P345, DOI 10.1042/BJ20051719; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Steinfels E, 2002, BBA-BIOMEMBRANES, V1565, P1, DOI 10.1016/S0005-2736(02)00515-1; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Veesler D, 2008, ACTA CRYSTALLOGR F, V64, P880, DOI 10.1107/S1744309108028248; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08	53	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114864	10.1371/journal.pone.0114864	http://dx.doi.org/10.1371/journal.pone.0114864			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517996	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600031
J	Brummett, BH; Babyak, MA; Williams, RB; Harris, KM; Jiang, R; Kraus, WE; Singh, A; Costa, PT; Georgiades, A; Siegler, IC				Brummett, Beverly H.; Babyak, Michael A.; Williams, Redford B.; Harris, Kathleen Mullan; Jiang, Rong; Kraus, William E.; Singh, Abanish; Costa, Paul T.; Georgiades, Anastasia; Siegler, Ilene C.			A Putatively Functional Polymorphism in the HTR2C Gene is Associated with Depressive Symptoms in White Females Reporting Significant Life Stress	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; HUMAN 5-HT2C RECEPTOR; SEROTONIN 2C RECEPTOR; CORTISOL RESPONSES; GENDER; CYS23SER; EXPOSURE	Psychosocial stress is well known to be positively associated with subsequent depressive symptoms. Cortisol response to stress may be one of a number of biological mechanisms that links psychological stress to depressive symptoms, although the precise causal pathway remains unclear. Activity of the x-linked serotonin 5-HTR2C receptor has also been shown to be associated with depression and with clinical response to antidepressant medications. We recently demonstrated that variation in a single nucleotide polymorphism on the HTR2C gene, rs6318 (Ser23Cys), is associated with different cortisol release and short-term changes in affect in response to a series of stress tasks in the laboratory. Based on this observation, we decided to examine whether rs6318 might moderate the association between psychosocial stress and subsequent depressive symptoms. In the present study we use cross-sectional data from a large population-based sample of young adult White men (N=2,366) and White women (N=2,712) in the United States to test this moderation hypothesis. Specifically, we hypothesized that the association between self-reported stressful life events and depressive symptoms would be stronger among homozygous Ser23 C females and hemizygous Ser23 C males than among Cys23 G carriers. In separate within-sex analyses a genotype-by-life stress interaction was observed for women (p=.022) but not for men (p=.471). Homozygous Ser23 C women who reported high levels of life stress had depressive symptom scores that were about 0.3 standard deviations higher than female Cys23 G carriers with similarly high stress levels. In contrast, no appreciable difference in depressive symptoms was observed between genotypes at lower levels of stress. Our findings support prior work that suggests a functional SNP on the HTR2C gene may confer an increased risk for depressive symptoms in White women with a history of significant life stress.	[Brummett, Beverly H.; Babyak, Michael A.; Williams, Redford B.; Jiang, Rong; Singh, Abanish; Costa, Paul T.; Georgiades, Anastasia; Siegler, Ilene C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA; [Harris, Kathleen Mullan] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Harris, Kathleen Mullan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Kraus, William E.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Kraus, William E.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Brummett, BH (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	brummett@duke.edu	Costa, Paul/AAH-6594-2019	Costa, Paul/0000-0003-4375-1712	National Heart Lung and Blood Institute [P01-HL036587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036587] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the the grant from the National Heart Lung and Blood Institute P01-HL036587. Redford Williams is the Principal Investigator on this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaver KM, 2012, AM J ORTHOPSYCHIAT, V82, P260, DOI 10.1111/j.1939-0025.2012.01148.x; Blazer DG, 1998, PSYCHOL MED, V28, P1311, DOI 10.1017/S0033291798007648; Brummett BH, 2008, BEHAV GENET, V38, P476, DOI 10.1007/s10519-008-9219-y; Brummett BH, 2008, BIOL PSYCHOL, V78, P200, DOI 10.1016/j.biopsycho.2008.03.002; Brummett BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082781; Brummett BH, 2012, BIOL PSYCHOL, V89, P94, DOI 10.1016/j.biopsycho.2011.09.013; Brummett BH, BIOL PSYCHO IN PRESS; Cooke BM, 2014, HORM BEHAV, V65, P416, DOI 10.1016/j.yhbeh.2014.03.004; Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5; Drago A, 2009, AM J MED GENET B, V150B, P601, DOI 10.1002/ajmg.b.30864; Ensel W, 1996, MEASURING DEPRESSION, P51; Fentress HM, 2005, PHARMACOGENOMICS J, V5, P244, DOI 10.1038/sj.tpj.6500315; GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467; Halligan SL, 2004, BIOL PSYCHIAT, V55, P376, DOI 10.1016/j.biopsych.2003.09.013; Harris CM, 2009, NATL LONGITUDINAL ST; Heim Christine, 2002, Semin Clin Neuropsychiatry, V7, P147, DOI 10.1053/scnp.2002.33127; Heisler LK, 2007, J NEUROSCI, V27, P6956, DOI 10.1523/JNEUROSCI.2584-06.2007; Herbert J, 2013, PSYCHOL MED, V43, P449, DOI 10.1017/S0033291712000955; Jahnsen JA, 2012, EUR J PHARMACOL, V684, P44, DOI 10.1016/j.ejphar.2012.03.043; Kidd T, 2014, BIOL PSYCHOL, V99, P34, DOI 10.1016/j.biopsycho.2014.02.010; Lerer B, 2001, VARIABILITY 5 HT2C R; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Lowry CA, 2002, J NEUROENDOCRINOL, V14, P911, DOI 10.1046/j.1365-2826.2002.00861.x; Mickey BJ, 2012, J NEUROSCI, V32, P9344, DOI 10.1523/JNEUROSCI.1260-12.2012; Netherton C, 2004, PSYCHONEUROENDOCRINO, V29, P125, DOI 10.1016/S0306-4530(02)00150-6; Okada M, 2004, MOL PSYCHIATR, V9, P55, DOI 10.1038/sj.mp.4001357; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Turner R, 1995, CHECKLIST MEASURMENT, P29	31	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114451	10.1371/journal.pone.0114451	http://dx.doi.org/10.1371/journal.pone.0114451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514629	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300012
J	Delvendahl, I; Gattinger, N; Berger, T; Gleich, B; Siebner, HR; Mall, V				Delvendahl, Igor; Gattinger, Norbert; Berger, Thomas; Gleich, Bernhard; Siebner, Hartwig R.; Mall, Volker			The Role of Pulse Shape in Motor Cortex Transcranial Magnetic Stimulation Using Full-Sine Stimuli	PLOS ONE			English	Article							INPUT-OUTPUT CURVE; CORTICAL EXCITABILITY; CURRENT DIRECTION; WAVE-FORMS; I-WAVES; RTMS; THRESHOLDS; EXCITATION; ACTIVATION; FREQUENCY	A full-sine (biphasic) pulse waveform is most commonly used for repetitive transcranial magnetic stimulation (TMS), but little is known about how variations in duration or amplitude of distinct pulse segments influence the effectiveness of a single TMS pulse to elicit a corticomotor response. Using a novel TMS device, we systematically varied the configuration of full-sine pulses to assess the impact of configuration changes on resting motor threshold (RMT) as measure of stimulation effectiveness with single-pulse TMS of the non-dominant motor hand area (M1). In young healthy volunteers, we (i) compared monophasic, half-sine, and full-sine pulses, (ii) applied two-segment pulses consisting of two identical half-sines, and (iii) manipulated amplitude, duration, and current direction of the first or second full-sine pulse half-segments. RMT was significantly higher using half-sine or monophasic pulses compared with full-sine. Pulses combining two half-sines of identical polarity and duration were also characterized by higher RMT than full-sine stimuli resulting. For full-sine stimuli, decreasing the amplitude of the half-segment inducing posterior-anterior oriented current in M1 resulted in considerably higher RMT, whereas varying the amplitude of the half-segment inducing anterior-posterior current had a smaller effect. These findings provide direct experimental evidence that the pulse segment inducing a posterior-anterior directed current in M1 contributes most to corticospinal pathway excitation. Preferential excitation of neuronal target cells in the posterior-anterior segment or targeting of different neuronal structures by the two half-segments can explain this result. Thus, our findings help understanding the mechanisms of neural stimulation by full-sine TMS.	[Delvendahl, Igor] Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Gattinger, Norbert; Gleich, Bernhard] Tech Univ Munich, IMETUM, Zent Inst Med Tech, Garching, Germany; [Berger, Thomas] Univ Med Ctr Freiburg, Dept Pediat & Adolescent Med, Freiburg, Germany; [Siebner, Hartwig R.] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark; [Siebner, Hartwig R.] Univ Copenhagen, Hvidovre Hosp, Dept Neurol, Copenhagen, Denmark; [Mall, Volker] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany	Leipzig University; Technical University of Munich; University of Freiburg; University of Copenhagen; University of Copenhagen; Technical University of Munich	Mall, V (corresponding author), Univ Leipzig, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany.	volker.mall@tum.de	Gleich, Bernhard/D-4803-2009; Berger, Thomas U/HGA-3594-2022; Delvendahl, Igor/A-7176-2013; Siebner, Hartwig R/G-4052-2016	Gleich, Bernhard/0000-0002-0574-7678; Delvendahl, Igor/0000-0002-6151-2363; 	Grant of Excellence "ContAct" from Lundbeckfonden [R59 A5399]; German Research Foundation [DFG MA 3306/4-1]; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish	Grant of Excellence "ContAct" from Lundbeckfonden; German Research Foundation(German Research Foundation (DFG)); Lundbeck Foundation(Lundbeckfonden)	HRS was supported by a Grant of Excellence "ContAct" from Lundbeckfonden (R59 A5399); VM was supported by a grant from the German Research Foundation (DFG MA 3306/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai N, 2005, CLIN NEUROPHYSIOL, V116, P605, DOI 10.1016/j.clinph.2004.09.020; Arai N, 2007, CLIN NEUROPHYSIOL, V118, P2227, DOI 10.1016/j.clinph.2007.07.006; Awiszus F, 2003, CLIN NEUROPHYSIOL, P5613; BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005; Barker AT, 1991, ELECTROENCEPHALOGR S, P43227; Brockhardt, 2011, TMS MOTOR THRESHOLD; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; CLAUS D, 1990, ELECTROEN CLIN NEURO, V75, P342, DOI 10.1016/0013-4694(90)90112-W; Clay JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045983; COHEN LG, 1990, ELECTROEN CLIN NEURO, V75, P350, DOI 10.1016/0013-4694(90)90113-X; Corthout E, 2001, EXP BRAIN RES, V141, P128, DOI 10.1007/s002210100860; Delvendahl I, 2014, BRAIN STIMUL, V7, P49, DOI 10.1016/j.brs.2013.08.002; Di Lazzaro V, 2001, EXP BRAIN RES, V138, P268; Di Lazzaro V, 2001, EXP BRAIN RES, V141, P121; Di Lazzaro V, 2013, FRONT NEURAL CIRCUIT, V718; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; EPSTEIN CM, 1990, NEUROLOGY, V40, P666, DOI 10.1212/WNL.40.4.666; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fox PT, 2004, HUM BRAIN MAPP, V22, P1, DOI 10.1002/hbm.20006; Gattinger N, 2012, IEEE T BIO-MED ENG, V59, P1962, DOI 10.1109/TBME.2012.2195180; George MS, 2009, BRAIN STIMUL, V2, P14, DOI 10.1016/j.brs.2008.06.001; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; JALINOUS R, 1991, J CLIN NEUROPHYSIOL, V8, P10, DOI 10.1097/00004691-199101000-00004; Jung NH, 2012, BMC NEUROSCI, V13139; Jung NH, 2010, BRAIN STIMUL, V3, P87, DOI 10.1016/j.brs.2009.10.003; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kammer T, 2007, NEUROIMAGE, V36, P313, DOI 10.1016/j.neuroimage.2007.03.001; Kammer T, 2010, CLIN NEUROPHYSIOL, V121, P376, DOI 10.1016/j.clinph.2009.12.002; Laakso I, 2014, PHYS MED BIOL, V59, P203, DOI 10.1088/0031-9155/59/1/203; Maccabee PJ, 1998, J PHYSIOL-LONDON, V513, P571, DOI 10.1111/j.1469-7793.1998.571bb.x; Moller C, 2009, CLIN NEUROPHYSIOL, V120, P1003, DOI 10.1016/j.clinph.2009.03.001; Niehaus L, 2000, CLIN NEUROPHYSIOL, V111, P75, DOI 10.1016/S1388-2457(99)00198-4; Pechmann A, 2012, BRAIN STIMUL, V5, P148, DOI 10.1016/j.brs.2011.02.006; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Peterchev AV, 2008, IEEE T BIO-MED ENG, V55, P257, DOI 10.1109/TBME.2007.900540; Peterchev AV, 2013, CLIN NEUROPHYSIOL, V124, P1364, DOI 10.1016/j.clinph.2013.01.011; Ridding MC, 1997, ELECTROMYOGR MOTOR C, V105, P340, DOI 10.1016/S0924-980X(97)00041-6; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Salvador R, 2011, CLIN NEUROPHYSIOL, V122, P748, DOI 10.1016/j.clinph.2010.09.022; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Silbert BI, 2013, CLIN NEUROPHYSIOL, V124, P708, DOI 10.1016/j.clinph.2012.09.018; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Sommer M, 2013, BRAIN STIMUL, V6, P363, DOI 10.1016/j.brs.2012.07.003; Tings T, 2005, EXP BRAIN RES, V164, P323, DOI 10.1007/s00221-005-2253-6; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Weyh T, 2005, CLIN NEUROPHYSIOL, V116, P1477, DOI 10.1016/j.clinph.2005.02.002; Ziemann U, 2000, J CLIN NEUROPHYSIOL, V17, P397, DOI 10.1097/00004691-200007000-00005; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	54	18	18	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115247	10.1371/journal.pone.0115247	http://dx.doi.org/10.1371/journal.pone.0115247			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514673	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300045
J	Ko, WC; Liu, CL; Lee, JJ; Liu, TP; Yang, PS; Hsu, YC; Cheng, SP				Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Hsu, Yi-Chiung; Cheng, Shih-Ping			Negative Association between Serum Parathyroid Hormone Levels and Urinary Perchlorate, Nitrate, and Thiocyanate Concentrations in US Adults: The National Health and Nutrition Examination Survey 2005-2006	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; 25-HYDROXYVITAMIN D; RECEPTOR; SMOKING; DISEASE; EXPOSURE; RELEASE; DIETARY; GLANDS; GENDER	Objectives: Perchlorate, nitrate, and thiocyanate are well-known inhibitors of the sodium-iodide symporter and may disrupt thyroid function. This exploratory study investigated the association among urinary perchlorate, nitrate, and thiocyanate concentrations and parathyroid hormone (PTH) levels in the general U.S. population. Methods: We analyzed data on 4265 adults (aged 20 years and older) from the National Health and Nutrition Examination Survey in 2005 through 2006 to evaluate the relationship among urinary perchlorate, nitrate, and thiocyanate concentration and PTH levels and the presence of hyperparathyroidism cross-sectionally. Results: The geometric means and 95% confidence interval (95% CI) concentrations of urinary perchlorate, nitrate, and thiocyanate were 3.38 (3.15-3.62), 40363 (37512-43431), and 1129 (1029-1239) ng/mL, respectively. After adjusting for confounding variables and sample weights, creatinine-corrected urinary perchlorate was negatively associated with serum PTH levels in women (P=0.001), and creatinine-corrected urinary nitrate and thiocyanate were negatively associated with serum PTH levels in both sex groups (P=0.001 and P<0.001 for men, P=0.018 and P<0.001 for women, respectively). Similar results were obtained from sensitivity analyses performed for exposure variables unadjusted for creatinine with urinary creatinine added as a separate covariate. There was a negative relationship between hyperparathyroidism and urinary nitrate and thiocyanate [odds ratio (95% CI)=0.77 (0.60-0.98) and 0.69 (0.61-0.79), respectively]. Conclusions: A higher urinary concentration of perchlorate, nitrate, and thiocyanate is associated with lower serum PTH levels. Future studies are needed to determine the pathophysiological background of the observation.	[Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Cheng, Shih-Ping] MacKay Mem Hosp, Dept Surg, Taipei, Taiwan; [Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Cheng, Shih-Ping] Mackay Med Coll, Taipei, Taiwan; [Ko, Wen-Ching; Liu, Chien-Liang; Lee, Jie-Jen; Liu, Tsang-Pai; Yang, Po-Sheng; Cheng, Shih-Ping] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Lee, Jie-Jen; Yang, Po-Sheng; Cheng, Shih-Ping] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan; [Lee, Jie-Jen; Yang, Po-Sheng; Cheng, Shih-Ping] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Hsu, Yi-Chiung] Acad Sinica, Inst Stat, Taipei 115, Taiwan	Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Taipei Medical University; Taipei Medical University; Academia Sinica - Taiwan	Cheng, SP (corresponding author), MacKay Mem Hosp, Dept Surg, Taipei, Taiwan.	surg.mmh@gmail.com	Cheng, Shih-Ping/Q-3014-2018	Cheng, Shih-Ping/0000-0002-6301-5096	Ministry of Science and Technology of Taiwan [MOST 103-2314-B-195-004]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by research grant from the Ministry of Science and Technology of Taiwan (MOST 103-2314-B-195-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafez AM, 2014, J ENDOCRINOL INVEST, V37, P455, DOI 10.1007/s40618-013-0043-8; Amstrup AK, 2010, CALCIFIED TISSUE INT, V87, P406, DOI 10.1007/s00223-010-9416-6; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basile C, 2006, NEPHROL DIAL TRANSPL, V21, P968, DOI 10.1093/ndt/gfi311; Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214; Brown JM, 2014, HYPERTENSION, V63, P273, DOI 10.1161/HYPERTENSIONAHA.113.01910; Canadillas S, 2010, AM J PHYSIOL-RENAL, V298, pF1197, DOI 10.1152/ajprenal.00529.2009; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chang WH, 1997, AM J PHYSIOL-ENDOC M, V273, pE880, DOI 10.1152/ajpendo.1997.273.5.E880; Cheng SP, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/709024; Cheng SP, 2011, J SURG RES, V168, P82, DOI 10.1016/j.jss.2009.07.034; Cheng SP, 2011, MED HYPOTHESES, V76, P94, DOI 10.1016/j.mehy.2010.08.039; Cozzolino M, 2009, INT J ARTIF ORGANS, V32, P75, DOI 10.1177/039139880903200203; Fischer E, 2014, J CLIN ENDOCR METAB, V99, P965, DOI 10.1210/jc.2013-3214; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Goodman WG, 2008, KIDNEY INT, V74, P276, DOI 10.1038/sj.ki.5002287; Kritchevsky SB, 2012, J CLIN ENDOCR METAB, V97, P4156, DOI 10.1210/jc.2012-1551; LEWITUS Z, 1962, ENDOCRINOLOGY, V70, P295, DOI 10.1210/endo-70-3-295; Meir T, 2009, AM J PHYSIOL-RENAL, V297, pF1192, DOI 10.1152/ajprenal.00360.2009; Mervish N, 2012, J EXPO SCI ENV EPID, V22, P212, DOI 10.1038/jes.2011.44; Miller BS, 2008, WORLD J SURG, V32, P795, DOI 10.1007/s00268-007-9427-2; Murray CW, 2008, J EXPO SCI ENV EPID, V18, P571, DOI 10.1038/sj.jes.7500648; Paik JM, 2012, OSTEOPOROSIS INT, V23, P1727, DOI 10.1007/s00198-011-1776-x; Rapuri PB, 2000, BONE, V27, P429, DOI 10.1016/S8756-3282(00)00341-0; Rejnmark L, 2011, CLIN ENDOCRINOL, V74, P37, DOI 10.1111/j.1365-2265.2010.03894.x; RIDEFELT P, 1995, SURGERY, V117, P56, DOI 10.1016/S0039-6060(05)80230-2; RIDEFELT P, 1992, BIOCHEM BIOPH RES CO, V186, P556, DOI 10.1016/S0006-291X(05)80844-7; Rossi GP, 2012, HYPERTENSION, V60, P431, DOI 10.1161/HYPERTENSIONAHA.112.195891; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Scherer G, 2006, EXP TOXICOL PATHOL, V58, P101, DOI 10.1016/j.etp.2006.07.001; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P3245, DOI 10.1097/01.ASN.0000101240.47747.7F; Srinivasan A, 2009, INT J ENV RES PUB HE, V6, P1418, DOI 10.3390/ijerph6041418; Steinmaus C, 2013, ENVIRON RES, V123, P17, DOI 10.1016/j.envres.2013.01.005; Suh M, 2014, J EXPO SCI ENV EPID, V24, P579, DOI 10.1038/jes.2013.67; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; Tripepi G, 2012, J NEPHROL, V25, P75, DOI 10.5301/JN.2011.7740; Ward MH, 2010, EPIDEMIOLOGY, V21, P389, DOI 10.1097/EDE.0b013e3181d6201d; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; Wolff J, 1998, PHARMACOL REV, V50, P89; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Zhao GX, 2010, J HYPERTENS, V28, P1821, DOI 10.1097/HJH.0b013e32833bc5b4	41	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115245	10.1371/journal.pone.0115245	http://dx.doi.org/10.1371/journal.pone.0115245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514572	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300044
J	Zhang, H; Shao, Z; Alibin, CP; Acosta, C; Anderson, HD				Zhang, Haining; Shao, Zongjun; Alibin, Caroline P.; Acosta, Crystal; Anderson, Hope D.			Liganded Peroxisome Proliferator-Activated Receptors (PPARs) Preserve Nuclear Histone Deacetylase 5 Levels in Endothelin-Treated Sprague-Dawley Rat Cardiac Myocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; NATRIURETIC-PEPTIDE GENE; MEF2 TRANSCRIPTION FACTOR; HYPERTROPHY IN-VITRO; CARDIOMYOCYTE HYPERTROPHY; DEPENDENT ACTIVATION; GAMMA; EXPRESSION; DIFFERENTIATION; SUPPRESSION	Ligand activation of peroxisome proliferator-activated receptors (PPARs) prevents cardiac myocyte hypertrophy, and we previously reported that diacylglycerol kinase zeta (DGK zeta) is critically involved. DGK zeta is an intracellular lipid kinase that catalyzes phosphorylation of diacylglycerol; by attenuating DAG signaling, DGK zeta suppresses protein kinase C (PKC) and G-protein signaling. Here, we investigated how PPAR-DGK zeta signaling blocks activation of the hypertrophic gene program. We focused on export of histone deacetylase 5 (HDAC5) from the nucleus, a key event during hypertrophy, since crosstalk occurs between PPARs and other members of the HDAC family. Using cardiac myocytes isolated from Sprague-Dawley rats, we determined that liganded PPARs disrupt endothelin-1 (ET1)-induced nuclear export of HDAC5 in a manner that is dependent on DGK zeta. When DGK zeta-mediated PKC inhibition was circumvented using a constitutively-active PKC epsilon mutant, PPARs failed to block ET1-induced nuclear retention of HDAC5. Liganded PPARs also prevented (i) activation of protein kinase D (the downstream effector of PKC), (ii) HDAC5 phosphorylation at 14-3-3 protein chaperone binding sites (serines 259 and 498), and (iii) physical interaction between HDAC5 and 14-3-3, all of which are consistent with blockade of nucleo-cytoplasmic shuttling of HDAC5. Finally, the ability of PPARs to prevent neutralization of HDAC5 activity was associated with transcriptional repression of hypertrophic genes. This occurred by first, reduced MEF2 transcriptional activity and second, augmented deacetylation of histone H3 associated with hypertrophic genes expressing brain natriuretic peptide, beta-myosin heavy chain, skeletal muscle alpha-actin, and cardiac muscle alpha-actin. Our findings identify spatial regulation of HDAC5 as a target for liganded PPARs, and to our knowledge, are the first to describe a mechanistic role for nuclear DGK zeta in cardiac myocytes. In conclusion, these results implicate modulation of HDAC5 as a mechanism by which liganded PPARs suppress the hypertrophic gene program.	[Zhang, Haining; Shao, Zongjun; Alibin, Caroline P.; Acosta, Crystal; Anderson, Hope D.] St Boniface Gen Hosp, Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB R2H 2A6, Canada; [Acosta, Crystal] Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0W3, Canada; [Anderson, Hope D.] Univ Manitoba, Fac Hlth Sci, Coll Pharm, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba	Anderson, HD (corresponding author), St Boniface Gen Hosp, Res Ctr, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB R2H 2A6, Canada.	handerson@sbrc.ca		Anderson, Hope/0000-0001-6570-6678	Canadian Institutes of Health Research [MOP114888]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by an operating grant awarded to HDA from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca, Grant Number: MOP114888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibin CP, 2008, J BIOL CHEM, V283, P10707, DOI 10.1074/jbc.M800035200; Anderson HDI, 2004, J BIOL CHEM, V279, P9287, DOI 10.1074/jbc.M309227200; Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771; Asakawa M, 2002, CIRCULATION, V105, P1240, DOI 10.1161/hc1002.105225; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bonofiglio D, 2008, ENDOCR-RELAT CANCER, V15, P545, DOI 10.1677/ERC-07-0272; Bonofiglio D, 2009, BREAST CANCER RES TR, V113, P423, DOI 10.1007/s10549-008-9944-1; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chung SS, 2006, BIOCHEM BIOPH RES CO, V348, P253, DOI 10.1016/j.bbrc.2006.07.048; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI DOI 10.1074/mcp.M110.004317; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Huang YS, 2011, CARDIOVASC RES, V90, P267, DOI 10.1093/cvr/cvq401; Irukayama-Tomobe Y, 2004, CIRCULATION, V109, P904, DOI 10.1161/01.CIR.0000112596.06954.00; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaneda R, 2005, CIRC RES, V97, P210, DOI 10.1161/01.RES.0000176028.18423.07; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Kuwahara K, 2001, MOL CELL BIOL, V21, P2085, DOI 10.1128/MCB.21.6.2085-2097.2001; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; LaPointe MC, 2005, PEPTIDES, V26, P944, DOI 10.1016/j.peptides.2004.08.028; Lee KC, 2001, TRENDS ENDOCRIN MET, V12, P191, DOI 10.1016/S1043-2760(01)00392-7; Lee KS, 2009, J CELL BIOCHEM, V106, P823, DOI 10.1002/jcb.22038; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Liang FQ, 2003, ENDOCRINOLOGY, V144, P4187, DOI 10.1210/en.2002-0217; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mathiyalagan P, 2014, CARDIOVASC RES, V103, P7, DOI 10.1093/cvr/cvu122; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Sheng L, 2008, CLIN EXP HYPERTENS, V30, P109, DOI 10.1080/10641960801945840; Takahashi H, 2005, CIRCULATION, V111, P1510, DOI 10.1161/01.CIR.0000159339.00703.22; Takahashi H, 2004, EUR J CLIN INVEST, V34, P85, DOI 10.1111/j.1365-2362.2004.01304.x; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang WM, 2011, J BIOL CHEM, V286, P40974, DOI 10.1074/jbc.M111.290874; WOTTON D, 1993, J BIOL CHEM, V268, P17975; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	49	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115258	10.1371/journal.pone.0115258	http://dx.doi.org/10.1371/journal.pone.0115258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514029	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300048
J	Haring, B; von Ballmoos, MCW; Appel, LJ; Sacks, FM				Haring, Bernhard; von Ballmoos, Moritz C. Wyler; Appel, Lawrence J.; Sacks, Frank M.			Healthy Dietary Interventions and Lipoprotein (a) Plasma Levels: Results from the Omni Heart Trial	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; APOLIPOPROTEIN-C-III; BLOOD-PRESSURE; SOY PROTEIN; MONOUNSATURATED FAT; RISK; LIPIDS; DISEASE; ISOFLAVONES; METABOLISM	Background: Increased lipoprotein(a) [Lp(a)] levels are associated with atherosclerotic cardiovascular disease. Studies of dietary interventions on changes in Lp(a) are sparse. We aimed to compare the effects of three healthy dietary interventions differing in macronutrient content on Lp(a) concentration. Methods: Secondary analysis of a randomized, 3-period crossover feeding study including 155 (89 blacks; 66 whites) individuals. Participants were given DASH-type healthy diets rich in carbohydrates [Carb], in protein [Prot] or in unsaturated fat [Unsat Fat] for 6 weeks each. Plasma Lp(a) concentration was assessed at baseline and after each diet. Results: Compared to baseline, all interventional diets increased mean Lp(a) by 2 to 5 mg/dl. Unsat Fat increased Lp(a) less than Prot with a difference of 1.0 mg/dl (95% CI, 20.5, 2.5; p=0.196) in whites and 3.7 mg/dl (95% CI, 2.4, 5.0; p<0.001) in blacks (p-value between races=0.008); Unsat Fat increased Lp(a) less than Carb with a difference of 20.6 mg/dl, 95% CI, -2.1, 0.9; p=0.441) in whites and -1.5 mg/dl (95% CI, -0.2, 22.8; p=0.021) in blacks (p-value between races=0.354). Prot increased Lp(a) more than Carb with a difference of 0.4 mg/dl (95% CI, -1.1, 1.9; p=0.597) in whites and 2.2 mg/dl (95% CI, 0.9, 3.5; p=0.001) in blacks (p-value between races=0.082). Conclusion: Diets high in unsaturated fat increased Lp(a) levels less than diets rich in carbohydrate or protein with greater changes in blacks than whites. Our results suggest that substitutions with dietary mono-and polyunsaturated fatty acids in healthy diets may be preferable over protein or carbohydrates with regards to Lp(a).	[Haring, Bernhard] Univ Wurzburg, Comprehens Heart Failure Ctr, Dept Internal Med 1, Bavaria, Germany; [von Ballmoos, Moritz C. Wyler] Froedtert Mem Hosp, Dept Cardiothorac Surg, Milwaukee, WI USA; [von Ballmoos, Moritz C. Wyler] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Appel, Lawrence J.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Sacks, Frank M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	University of Wurzburg; Medical College of Wisconsin; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health	Haring, B (corresponding author), Univ Wurzburg, Comprehens Heart Failure Ctr, Dept Internal Med 1, Bavaria, Germany.	Haring_B@ukw.de	Appel, Larry/GLT-2608-2022; Reardon, Michael/ABF-8880-2021		National Institutes of Health [HL67098, DK63214, HL68712, RR02635]; German Research Foundation (DFG); University of Wuerzburg; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL068712, R01HL067098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK063214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for the Omni Heart Trial was provided through grants HL67098, DK63214, HL68712, and RR02635 from the National Institutes of Health. The following companies donated food: The Almond Board, International Tree Nut Council, Olivio Premium Products Inc, and The Peanut Institute. Open Access publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funding sources had no role in study design; collection, analysis, and interpretation of data; in writing the report; and in the decision to submit the article for publication.	Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Banerjee D, 2011, J LIPIDS, V2011, DOI 10.1155/2011/291954; Berglund L, 2007, AM J CLIN NUTR, V86, P1611; BOOMSMA DI, 1993, ATHEROSCLEROSIS, V99, P23, DOI 10.1016/0021-9150(93)90047-X; BROUSSEAU ME, 1995, J NUTR, V125, P425; BROUSSEAU ME, 1994, ATHEROSCLEROSIS, V106, P109, DOI 10.1016/0021-9150(94)90087-6; Carey VJ, 2005, CLIN TRIALS, V2, P529, DOI 10.1191/1740774505cn123oa; Crouse JR, 1999, ARCH INTERN MED, V159, P2070, DOI 10.1001/archinte.159.17.2070; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Frank S, 1996, EUR J CLIN INVEST, V26, P109, DOI 10.1046/j.1365-2362.1996.112255.x; Furtado JD, 2010, AM J CLIN NUTR, V92, P714, DOI 10.3945/ajcn.2009.28532; Genser B, 2011, CLIN LAB, V57, P143; Ginsberg HN, 1998, ARTERIOSCL THROM VAS, V18, P441, DOI 10.1161/01.ATV.18.3.441; Jenkins DJA, 2002, AM J CLIN NUTR, V76, P365, DOI 10.1093/ajcn/76.2.365; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kostner GM, 1997, CLIN GENET, V52, P347; Kostner Karam M, 2004, Semin Vasc Med, V4, P211, DOI 10.1055/s-2004-835380; KREMPLER F, 1980, J CLIN INVEST, V65, P1483, DOI 10.1172/JCI109813; Kronenberg F, 1996, CRIT REV CL LAB SCI, V33, P495, DOI 10.3109/10408369609080056; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Meinertz H, 2002, ARTERIOSCL THROM VAS, V22, P312, DOI 10.1161/hq0202.103998; NESTEL P, 1992, J LIPID RES, V33, P1029; Nilausen K, 1999, AM J CLIN NUTR, V69, P419; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Ohira T, 2006, STROKE, V37, P1407, DOI 10.1161/01.STR.0000222666.21482.b6; RADER DJ, 1993, J CLIN INVEST, V91, P443, DOI 10.1172/JCI116221; Sacks FM, 2006, CIRCULATION, V113, P1034, DOI 10.1161/CIRCULATIONAHA.106.171052; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SEED M, 1993, ATHEROSCLEROSIS, V101, P61, DOI 10.1016/0021-9150(93)90102-Z; Shin MJ, 2007, AM J CLIN NUTR, V85, P1527, DOI 10.1093/ajcn/85.6.1527; Su WF, 1998, J CLIN ENDOCR METAB, V83, P3267, DOI 10.1210/jc.83.9.3267; Teede HJ, 2001, J CLIN ENDOCR METAB, V86, P3053, DOI 10.1210/jc.86.7.3053; THOLSTRUP T, 1995, J LIPID RES, V36, P1447	34	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114859	10.1371/journal.pone.0114859	http://dx.doi.org/10.1371/journal.pone.0114859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506933	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100027
J	Jeraldo, P; Kalari, K; Chen, XF; Bhavsar, J; Mangalam, A; White, B; Nelson, H; Kocher, JP; Chia, N				Jeraldo, Patricio; Kalari, Krishna; Chen, Xianfeng; Bhavsar, Jaysheel; Mangalam, Ashutosh; White, Bryan; Nelson, Heidi; Kocher, Jean-Pierre; Chia, Nicholas			IM-TORNADO: A Tool for Comparison of 16S Reads from Paired-End Libraries	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; MICROBIAL COMMUNITIES; DIVERSITY; INSIGHTS; DATABASE; FASTER	Motivation: 16S rDNA hypervariable tag sequencing has become the de facto method for accessing microbial diversity. Illumina paired-end sequencing, which produces two separate reads for each DNA fragment, has become the platform of choice for this application. However, when the two reads do not overlap, existing computational pipelines analyze data from read separately and underutilize the information contained in the paired-end reads. Results: We created a workflow known as Illinois Mayo Taxon Organization from RNA Dataset Operations (IM-TORNADO) for processing non-overlapping reads while retaining maximal information content. Using synthetic mock datasets, we show that the use of both reads produced answers with greater correlation to those from full length 16S rDNA when looking at taxonomy, phylogeny, and beta-diversity. Availability and Implementation: IM-TORNADO is freely available at http://sourceforge.net/projects/imtornado and produces BIOM format output for cross compatibility with other pipelines such as QIIME, mothur, and phyloseq.	[Jeraldo, Patricio; Nelson, Heidi; Chia, Nicholas] Mayo Clin, Dept Surg, Rochester, MN 55902 USA; [Jeraldo, Patricio; White, Bryan; Chia, Nicholas] Univ Illinois, Inst Genom Biol, Urbana, IL USA; [Kalari, Krishna; Chen, Xianfeng; Bhavsar, Jaysheel; Kocher, Jean-Pierre] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Mangalam, Ashutosh] Mayo Clin, Dept Immunol, Rochester, MN USA; [White, Bryan] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Chia, Nicholas] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic; University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic	Chia, N (corresponding author), Mayo Clin, Dept Surg, Rochester, MN 55902 USA.	chia.nicholas@mayo.edu	Chen, Xianfeng/ABG-8256-2021; Jeraldo, Patricio/H-8178-2019; Mangalam, Ashutosh/I-8565-2017	Jeraldo, Patricio/0000-0003-0282-4217; Mangalam, Ashutosh/0000-0002-9926-2531; Kalari, Krishna/0000-0001-8944-8378; Chia, Nicholas/0000-0001-9652-691X	Mayo Clinic Center for Individualized Medicine Microbiome Program; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL CANCER INSTITUTE [R01CA179243] Funding Source: NIH RePORTER	Mayo Clinic Center for Individualized Medicine Microbiome Program; Mayo-Illinois Strategic Alliance for Technology-Based Healthcare; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Mayo Clinic Center for Individualized Medicine Microbiome Program. PJ was funded by the Mayo-Illinois Strategic Alliance for Technology-Based Healthcare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di Rienzi Sara C, 2013, Elife, V2, pe01102, DOI 10.7554/eLife.01102; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Kang SS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-36; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lie AAY, 2014, APPL ENVIRON MICROB, V80, P4363, DOI 10.1128/AEM.00057-14; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miller CS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056018, 10.1371/journal.pone.0081692]; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipos M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015220; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Walther-Antonio MRS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098514; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	45	73	73	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114804	10.1371/journal.pone.0114804	http://dx.doi.org/10.1371/journal.pone.0114804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506826	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100025
J	Genuis, SJ; Liu, YN; Genuis, QIT; Martin, JW				Genuis, Stephen J.; Liu, Yanna; Genuis, Quentin I. T.; Martin, Jonathan W.			Phlebotomy Treatment for Elimination of Perfluoroalkyl Acids in a Highly Exposed Family: A Retrospective Case-Series	PLOS ONE			English	Article							PERFLUOROOCTANE SULFONATE; HALF-LIFE; SERUM; BLOOD; WOMEN; PFOA; PERFLUOROHEXANESULFONATE; PERFLUOROCHEMICALS; ASSOCIATION; POPULATION	Background: Perfluoroalkyl acids (PFAAs) are a family of commonly used synthetic chemicals that have become widespread environmental contaminants. In human serum, perfluorohexane sulfonate (PFHxS), perflurooctane sulfonate (PFOS), and perfluorooctanoate (PFOA) are most frequently detected, in part owing to their long elimination half-lives of between 3.8 yrs (PFOA) and 8.5 yrs (PFHxS). These PFAAs also cross the placenta and have been associated with developmental toxicity, and some are considered likely human carcinogens. Interventions to eliminate PFAAs in highly contaminated individuals would reduce future health risks, but minimal research has been conducted on methods to facilitate accelerated human clearance of these persistent substances. Methods: Six patients with elevated serum concentrations from a single family were treated by intermittent phlebotomy over a 4-5 year period at intervals similar to, or less frequent than what is done for routine blood donation at Canadian Blood Services. The apparent elimination half-life (HLapp) for PFHxS, PFOS, and PFOA in this treated population was calculated in each patient and compared to the intrinsic elimination half-lives (HLin) from a literature reference population of untreated fluorochemical manufacturing plant retirees (n=26, age >55 yrs). Results: For all three PFAAs monitored during phlebotomy, HLapp in each of the family members (except the mother, who had a low rate of venesection) was significantly shorter than the geometric mean HL measured in the reference population, and in some cases were even shorter compared to the fastest eliminator in the reference population. Conclusion: This study suggests significantly accelerated PFAA clearance with regular phlebotomy treatment, but the small sample size and the lack of controls in this clinical intervention precludes drawing firm conclusions. Given the minimal risks of intermittent phlebotomy, this may be an effective and safe clinical intervention to diminish the body burden of PFAAs in highly exposed people.	[Genuis, Stephen J.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Liu, Yanna; Martin, Jonathan W.] Univ Alberta, Dept Lab Med & Pathol, Div Analyt & Environm Toxicol, Edmonton, AB, Canada; [Genuis, Quentin I. T.] Univ Alberta, Fac Med & Dent, MD Program, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Genuis, SJ (corresponding author), Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.	sgenuis@ualberta.ca	Martin, Jonathan W/J-3824-2013	Martin, Jonathan W/0000-0001-6265-4294	China Scholarship Council	China Scholarship Council(China Scholarship Council)	The authors would like to thank Dr. Detlef Birkholz at the 'Centre of Excellence' at ALS Environmental for his expert assistance in laboratory testing. Yanna Liu acknowledges stipend support from the China Scholarship Council.	Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; [Anonymous], 2012, 4 NHANES; Arbuckle TE, 2014, ENVIRON INT, V68, P55, DOI 10.1016/j.envint.2014.02.010; Beesoon S, 2012, ENVIRON SCI TECHNOL, V46, P12960, DOI 10.1021/es3034654; Beesoon S, 2011, ENVIRON HEALTH PERSP, V119, P1659, DOI 10.1289/ehp.1003265; Centers for Disease Control and Prevention, 2013, 4 CDCP; Chen MH, 2013, EPIDEMIOLOGY, V24, P800, DOI 10.1097/EDE.0b013e3182a6dd46; Corsini E, 2014, TOXICOLOGY LETT; DeWitt JC, 2012, TOXICOL PATHOL, V40, P300, DOI 10.1177/0192623311428473; Doherty Steven, 2005, Emerg Med Australas, V17, P314, DOI 10.1111/j.1742-6723.2005.00752.x; Ducatman AM, 2012, COMMUNICATION; Frisbee SJ, 2009, ENVIRON HEALTH PERSP, V117, P1873, DOI 10.1289/ehp.0800379; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; Genuis SJ, 2008, PUBLIC HEALTH, V122, P671, DOI 10.1016/j.puhe.2008.04.002; Genuis SJ, 2010, PUBLIC HEALTH, V124, P367, DOI 10.1016/j.puhe.2010.03.002; Genuis SJ, 2013, ISRN TOXICOLOGY; Genuis SK, 2006, J EVAL CLIN PRACT, V12, P49, DOI 10.1111/j.1365-2753.2005.00608.x; Genuis SJ, 2011, HUM EXP TOXICOL, V30, P3, DOI 10.1177/0960327110368417; Glynn A, 2012, ENVIRON SCI TECHNOL, V46, P9071, DOI 10.1021/es301168c; GREENBLATT DJ, 1985, ANNU REV MED, V36, P421; Gregoraszczuk EL, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/828532; Hanssen L, 2010, J ENVIRON MONITOR, V12, P1355, DOI 10.1039/b924420d; Harada K, 2005, ENVIRON RES, V99, P253, DOI 10.1016/j.envres.2004.12.003; Health Canada, 2013, 2 HLTH CAN; Hu WY, 2003, COMP BIOCHEM PHYS C, V135, P77, DOI 10.1016/S1532-0456(03)00043-7; Huang QY, 2013, TOXICOL LETT, V223, P211, DOI 10.1016/j.toxlet.2013.09.002; Jandacek RJ, 2013, SCI WORLD J, DOI 10.1155/2013/205621; JOHNSON JD, 1984, FUND APPL TOXICOL, V4, P972, DOI 10.1016/0272-0590(84)90235-5; Jones PD, 2003, ENVIRON TOXICOL CHEM, V22, P2639, DOI 10.1897/02-553; Kaneko T, 2000, TOXICOLOGY, V143, P203, DOI 10.1016/S0300-483X(99)00170-5; Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491; Kjeldsen LS, 2013, PERFLUORINATED COMPO; Klaunig JE, 2012, REPROD TOXICOL, V33, P410, DOI 10.1016/j.reprotox.2011.10.014; Kleszczynski K, 2009, TOXICOL APPL PHARM, V235, P182, DOI 10.1016/j.taap.2008.11.021; Knox SS, 2011, J CLIN ENDOCR METAB, V96, P1747, DOI 10.1210/jc.2010-2401; Kwadijk CJ, 2014, ENV TOXICOLOGY CHEM; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lee DH, 2012, ENVIRON INT, V47, P115, DOI 10.1016/j.envint.2012.06.009; Lee I, 2013, NEUROTOXICOLOGY; Lim JS, 2008, DIABETES CARE, V31, P1802, DOI 10.2337/dc08-0850; Lorber M, 2011, ORGANOHALOGEN COMPOU, V73, P943; Louis GMB, 2012, EPIDEMIOLOGY, V23, P799, DOI 10.1097/EDE.0b013e31826cc0cf; Martin JW, 2010, J ENVIRON MONITOR, V12, P1979, DOI 10.1039/c0em00295j; Nakayama Shoji, 2005, Environ Sci, V12, P293; Nicole W, 2013, ENVIRON HEALTH PERSP, V121, pA340, DOI 10.1289/ehp.121-A340; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Organisation for Economic Co-operation and Development, 2002, HAZ ASS PERFL SULF I; Ritter R, 2011, ENVIRON HEALTH PERSP, V119, P225, DOI 10.1289/ehp.1002211; Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x; Shi ZM, 2007, TOXICOL SCI, V98, P206, DOI 10.1093/toxsci/kfm070; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P229, DOI 10.1289/ehp.0900940; Tian MP, 2012, TOXICOLOGY, V296, P48, DOI 10.1016/j.tox.2012.03.003; Vallianatos EG, 2014, POISON SPRING, P1; Wong F, 2014, ENVIRON SCI TECHNOL, V48, P8807, DOI 10.1021/es500796y; Wu KS, 2012, ENVIRON INT, V48, P1, DOI 10.1016/j.envint.2012.06.018; Zhang YF, 2013, ENVIRON SCI TECHNOL, V47, P10619, DOI 10.1021/es401905e	56	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114295	10.1371/journal.pone.0114295	http://dx.doi.org/10.1371/journal.pone.0114295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504057	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400025
J	Hero, JM; Butler, SA; Lollback, GW; Castley, JG				Hero, Jean-Marc; Butler, Sarah A.; Lollback, Gregory W.; Castley, James G.			Determinants of Tree Assemblage Composition at the Mesoscale within a Subtropical Eucalypt Forest	PLOS ONE			English	Article							VEGETATION-ENVIRONMENT RELATIONSHIPS; PLANT DIVERSITY PATTERNS; RAIN-FOREST; SPECIES-RICHNESS; HABITAT ASSOCIATIONS; NORTHERN-TERRITORY; SPATIAL PREDICTION; FUNCTIONAL TRAITS; LIFE FORMS; SOIL	A variety of environmental processes, including topography, edaphic and disturbance factors can influence vegetation composition. The relative influence of these patterns has been known to vary with scale, however, few studies have focused on environmental drivers of composition at the mesoscale. This study examined the relative importance of topography, catchment flow and soil in influencing tree assemblages in Karawatha Forest Park; a South-East Queensland subtropical eucalypt forest embedded in an urban matrix that is part of the Terrestrial Ecosystem Research Network South-East Queensland Peri-urban SuperSite. Thirty-three LTER plots were surveyed at the mesoscale (909 ha), where all woody stems >= 1.3 m high rooted within plots were sampled. Vegetation was divided into three cohorts: small (>= 1-10 cm DBH), intermediate (>= 10-30 cm DBH), and large (>= 30 cm DBH). Plot slope, aspect, elevation, catchment area and location and soil chemistry and structure were also measured. Ordinations and smooth surface modelling were used to determine drivers of vegetation assemblage in each cohort. Vegetation composition was highly variable among plots at the mesoscale (plots systematically placed at 500 m intervals). Elevation was strongly related to woody vegetation composition across all cohorts (R-2: 0.69-0.75). Other topographic variables that explained a substantial amount of variation in composition were catchment area (R-2: 0.43-0.45) and slope (R-2: 0.23-0.61). Soil chemistry (R-2: 0.09-0.75) was also associated with woody vegetation composition. While species composition differed substantially between cohorts, the environmental variables explaining composition did not. These results demonstrate the overriding importance of elevation and other topographic features in discriminating tree assemblage patterns irrespective of tree size. The importance of soil characteristics to tree assemblages was also influenced by topography, where ridge top sites were typically drier and had lower soil nutrient levels than riparian areas.	[Hero, Jean-Marc; Butler, Sarah A.; Lollback, Gregory W.; Castley, James G.] Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast, Qld 4222, Australia	Griffith University	Lollback, GW (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast, Qld 4222, Australia.	g.lollback@griffith.edu.au	Castley, James Guy/A-7056-2010	Castley, James Guy/0000-0002-8418-5828	Brisbane City Council; Griffith University; SEQ Catchments; TERN Australian SuperSite Network	Brisbane City Council; Griffith University(Griffith University); SEQ Catchments; TERN Australian SuperSite Network	Funded by the Brisbane City Council, Griffith University, SEQ Catchments and TERN Australian SuperSite Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar FC, 2013, J VEG SCI, V24, P628, DOI 10.1111/jvs.12009; Austin MP, 2009, J ECOL, V97, P496, DOI 10.1111/j.1365-2745.2009.01494.x; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; AUSTIN MP, 1985, ANNU REV ECOL SYST, V16, P39, DOI 10.1146/annurev.es.16.110185.000351; AUSTIN MP, 1989, VEGETATIO, V83, P35, DOI 10.1007/BF00031679; Australian Biological Resources Study, 2000, FLOR AUSTR, V17a; Australian Biological Resources Study, 1995, FLORA AUSTR, V16; Austrheim G, 2002, PLANT ECOL, V161, P193, DOI 10.1023/A:1020315718720; Bale CL, 1998, FOREST ECOL MANAG, V110, P363, DOI 10.1016/S0378-1127(98)00300-4; BASNET K, 1992, BIOTROPICA, V24, P31, DOI 10.2307/2388471; Batek MJ, 1999, J BIOGEOGR, V26, P397, DOI 10.1046/j.1365-2699.1999.00292.x; Battaglia M, 1996, OECOLOGIA, V108, P518, DOI 10.1007/BF00333729; Beerling DJ, 1997, GLOBAL ECOL BIOGEOGR, V6; Bhattarai KR, 2003, GLOBAL ECOL BIOGEOGR, V12, P327, DOI 10.1046/j.1466-822X.2003.00044.x; Bledsoe BP, 2000, WETLANDS, V20, P126, DOI 10.1672/0277-5212(2000)020[0126:VAHAEG]2.0.CO;2; Catterall CP, 2001, AUSTRAL ECOL, V26, P56, DOI 10.1111/j.1442-9993.2001.01074.pp.x; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; COLLINS SL, 1991, ECOLOGY, V72, P654, DOI 10.2307/2937205; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; de Castilho CV, 2010, BIOTROPICA, V42, P95, DOI 10.1111/j.1744-7429.2009.00543.x; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Debski I, 2000, J TROP ECOL, V16, P387, DOI 10.1017/S0266467400001474; Egan JL, 1996, AUST SYST BOT, V9, P205, DOI 10.1071/SB9960205; Eisenlohr PV, 2013, BIODIVERS CONSERV, V22, P2767, DOI 10.1007/s10531-013-0553-x; Eiserhardt WL, 2011, ANN BOT-LONDON, V108, P1391, DOI 10.1093/aob/mcr146; Fensham RJ, 2012, ECOL APPL, V22, P894, DOI 10.1890/11-1123.1; FENSHAM RJ, 1992, AUST J BOT, V40, P311, DOI 10.1071/BT9920311; Flora of Australia, 1981, FLOR AUSTR, V16; Garden JG, 2007, AUSTRAL ECOL, V32, P669, DOI 10.1111/j.1442-9993.2007.01750.x; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Hager Tim, 2010, Cunninghamia, V11, P425; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hero JM, 2013, FOREST ECOL MANAG, V310, P547, DOI 10.1016/j.foreco.2013.08.062; Hero Jean-Marc, 2010, Australian Zoologist, V35, P216; Horton BM, 2013, FOREST ECOL MANAG, V302, P329, DOI 10.1016/j.foreco.2013.04.006; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Hutchinson TF, 1999, PLANT ECOL, V144, P177, DOI 10.1023/A:1009804020976; Kalra Y. P., 1991, Information Report - Northwest Region, Forestry Canada; Kooyman R, 2010, J ECOL, V98, P517, DOI 10.1111/j.1365-2745.2010.01642.x; Kordas G, 1993, VEGETATION KARAWATHA; Lai JS, 2013, OIKOS, V122, P1636, DOI 10.1111/j.1600-0706.2013.00436.x; Leathwick JR, 2001, FUNCT ECOL, V15, P233, DOI 10.1046/j.1365-2435.2001.00504.x; Ledo A, 2013, J VEG SCI, V24, P1086, DOI 10.1111/jvs.12023; Legendre P., 2012, NUMERICAL ECOLOGY; Liu XP, 2012, ECOL ENG, V49, P193, DOI 10.1016/j.ecoleng.2012.06.040; Magnusson WE, 2013, BIODIVERSITY INTEGRA; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Mark AF, 2000, ARCT ANTARCT ALP RES, V32, P240, DOI 10.2307/1552522; Moeslund JE, 2013, NORD J BOT, V31, P129, DOI 10.1111/j.1756-1051.2013.00082.x; Nagy L., 2003, ALPINE BIODIVERSITY; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Neave HM, 1998, FOREST ECOL MANAG, V106, P259, DOI 10.1016/S0378-1127(97)00318-6; Nzegbule EC, 2013, TROP ECOL, V54, P205; O'Grady AP, 2000, AUST J BOT, V48, P629, DOI 10.1071/BT99022; Oksanen J., 2020, VEGAN COMMUNITY ECOL; OLIVEIRAFILHO AT, 1994, J TROP ECOL, V10, P483, DOI 10.1017/S0266467400008178; Olvera-Vargas M, 2010, PLANT ECOL, V211, P321, DOI 10.1007/s11258-010-9792-z; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; Pekin BK, 2012, AUSTRAL ECOL, V37, P330, DOI 10.1111/j.1442-9993.2011.02280.x; Pekin BK, 2009, FOREST ECOL MANAG, V258, P2136, DOI 10.1016/j.foreco.2009.08.013; Pollock LJ, 2012, ECOGRAPHY, V35, P716, DOI 10.1111/j.1600-0587.2011.07085.x; Queensland Herbarium, 2001, KEY EUC GREAT BRISB; R Core Team, 2021, R LANGUAGE ENV STAT; Rayment G.E., 1992, AUSTR LAB HDB SOIL W; Sanchez M, 2013, FLORA, V208, P184, DOI 10.1016/j.flora.2013.03.002; Siefert A, 2012, J VEG SCI, V23, P942, DOI 10.1111/j.1654-1103.2012.01401.x; Sklenar Petr, 2001, Diversity and Distributions, V7, P113, DOI 10.1046/j.1472-4642.2001.00101.x; Sukri RS, 2012, BIOTROPICA, V44, P595, DOI 10.1111/j.1744-7429.2011.00837.x; TITUS HJ, 1990, B TORREY BOT CLUB, V117, P429, DOI 10.2307/2996840; Vlam M, 2014, FOREST ECOL MANAG, V312, P108, DOI 10.1016/j.foreco.2013.10.016; Wardell-Johnson Grant W., 2007, Pacific Conservation Biology, V13, P47; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Williams RJ, 1999, AUST J ECOL, V24, P50, DOI 10.1046/j.1442-9993.1999.00946.x; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Wills KE, 2008, AUST J BOT, V56, P422, DOI 10.1071/BT07150; Zhang JT, 2013, MT RES DEV, V33, P170, DOI 10.1659/MRD-JOURNAL-D-11-00042.1	78	2	2	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114994	10.1371/journal.pone.0114994	http://dx.doi.org/10.1371/journal.pone.0114994			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501866	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400067
J	King, LY; Johnson, KB; Zheng, H; Wei, L; Gudewicz, T; Hoshida, Y; Corey, KE; Ajayi, T; Ufere, N; Baumert, TF; Chan, AT; Tanabe, KK; Fuchs, BC; Chung, RT				King, Lindsay Y.; Johnson, Kara B.; Zheng, Hui; Wei, Lan; Gudewicz, Thomas; Hoshida, Yujin; Corey, Kathleen E.; Ajayi, Tokunbo; Ufere, Nneka; Baumert, Thomas F.; Chan, Andrew T.; Tanabe, Kenneth K.; Fuchs, Bryan C.; Chung, Raymond T.			Host Genetics Predict Clinical Deterioration in HCV-Related Cirrhosis	PLOS ONE			English	Article							THAN-G POLYMORPHISM; GROWTH-FACTOR GENE; HEPATOCELLULAR-CARCINOMA; FUNCTIONAL POLYMORPHISM; RISK; PROGRESSION; EXPRESSION; SIGNATURE; RS738409; FIBROSIS	Single nucleotide polymorphisms (SNPs) in the epidermal growth factor (EGF, rs4444903), patatin-like phospholipase domain-containing protein 3 (PNPLA3, rs738409) genes, and near the interleukin-28B (IL28B, rs12979860) gene are linked to treatment response, fibrosis, and hepatocellular carcinoma (HCC) in chronic hepatitis C. Whether these SNPs independently or in combination predict clinical deterioration in hepatitis C virus (HCV)-related cirrhosis is unknown. We genotyped SNPs in EGF, PNPLA3, and IL28B from liver tissue from 169 patients with biopsy-proven HCV cirrhosis. We estimated risk of clinical deterioration, defined as development of ascites, encephalopathy, variceal hemorrhage, HCC, or liver-related death using Cox proportional hazards modeling. During a median follow-up of 6.6 years, 66 of 169 patients experienced clinical deterioration. EGF non-AA, PNPLA3 non-CC, and IL28B non-CC genotypes were each associated with increased risk of clinical deterioration in age, sex, and race-adjusted analysis. Only EGF non-AA genotype was independently associated with increased risk of clinical deterioration (hazard ratio [HR] 2.87; 95% confidence interval [CI] 1.31-6.25) after additionally adjusting for bilirubin, albumin, and platelets. Compared to subjects who had 0-1 unfavorable genotypes, the HR for clinical deterioration was 1.79 (95% CI 0.96-3.35) for 2 unfavorable genotypes and 4.03 (95% CI 2.13-7.62) for unfavorable genotypes for all three loci (P-trend<0.0001). In conclusion, among HCV cirrhotics, EGF non-AA genotype is independently associated with increased risk for clinical deterioration. Specific PNPLA3 and IL28B genotypes also appear to be associated with clinical deterioration. These SNPs have potential to identify patients with HCV-related cirrhosis who require more intensive monitoring for decompensation or future therapies preventing disease progression.	[King, Lindsay Y.; Johnson, Kara B.; Corey, Kathleen E.; Chan, Andrew T.; Chung, Raymond T.] Massachusetts Gen Hosp, Ctr Liver, Gastrointestinal Div, Boston, MA 02114 USA; [King, Lindsay Y.; Johnson, Kara B.; Corey, Kathleen E.; Ufere, Nneka; Chan, Andrew T.; Chung, Raymond T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Wei, Lan; Tanabe, Kenneth K.; Fuchs, Bryan C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Gudewicz, Thomas] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zheng, Hui] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [King, Lindsay Y.; Johnson, Kara B.; Zheng, Hui; Wei, Lan; Gudewicz, Thomas; Corey, Kathleen E.; Ufere, Nneka; Baumert, Thomas F.; Chan, Andrew T.; Tanabe, Kenneth K.; Fuchs, Bryan C.; Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA; [Hoshida, Yujin] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Ajayi, Tokunbo] North Shore Med Ctr, Dept Med, Salem, MA USA; [Baumert, Thomas F.] Univ Strasbourg, INSERM, U1110, Strasbourg, France	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chung, RT (corresponding author), Massachusetts Gen Hosp, Ctr Liver, Gastrointestinal Div, Boston, MA 02114 USA.	rtchung@partners.org	Chan, Andrew T/P-8293-2014; Baumert, Thomas/ABF-4718-2020; Ufere, Nneka/AAB-2660-2022; Hoshida, Yujin/R-7513-2019	Chan, Andrew T/0000-0001-7284-6767; Baumert, Thomas/0000-0002-8864-2168; Ufere, Nneka/0000-0001-8255-9374; 	National Institutes of Health [DK078772, T32DK007191, DK098311]; National Cancer Institute [CA140861]; NATIONAL CANCER INSTITUTE [K01CA140861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311, K23DK099422, R01DK099558, T32DK007191, K24DK078772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health DK078772 (RC), National Cancer Institute CA140861 (BF), National Institutes of Health T32DK007191 (LK and KJ), National Institutes of Health DK098311 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; [Anonymous], 1997, HEPATOLOGY, V26, pS2; [Anonymous], WHO TECHN REP SER, V889, P64; Charlton M, 2001, AM J TRANSPLANT, V1, P197, DOI 10.1034/j.1600-6143.2001.001003197.x; Cmet S, 2012, CLIN EXP IMMUNOL, V167, P296, DOI 10.1111/j.1365-2249.2011.04497.x; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Diao JY, 2012, J VIROL, V86, P10935, DOI 10.1128/JVI.00750-12; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Falleti E, 2012, CYTOKINE, V57, P68, DOI 10.1016/j.cyto.2011.10.018; Falleti E, 2011, J CLIN IMMUNOL, V31, P891, DOI 10.1007/s10875-011-9547-1; Fuchs BC, 2013, HEPATOLOGY; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2010, GASTROENTEROLOGY, V138, P136, DOI 10.1053/j.gastro.2009.09.007; Guyot E, 2013, J HEPATOL, V58, P312, DOI 10.1016/j.jhep.2012.09.036; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Noureddin M, 2013, HEPATOLOGY; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Tanabe KK, 2008, JAMA-J AM MED ASSOC, V299, P53, DOI 10.1001/jama.2007.65; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Trepo E, 2013, HEPATOLOGY; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Yang ZP, 2012, GENET TEST MOL BIOMA, V16, P1086, DOI 10.1089/gtmb.2012.0050; Zhong JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032159; Zona L, 2013, CELL HOST MICROBE, V13, P302, DOI 10.1016/j.chom.2013.02.006	28	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114747	10.1371/journal.pone.0114747	http://dx.doi.org/10.1371/journal.pone.0114747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504078	gold, Green Published			2022-12-27	WOS:000346375400049
J	Zhong, X; Xu, HT; Chen, DK; Zhou, HJ; Hu, X; Cheng, G				Zhong, Xue; Xu, Hongtao; Chen, Dongke; Zhou, Haijian; Hu, Xin; Cheng, Gang			First Emergence of acrAB and oqxAB Mediated Tigecycline Resistance in Clinical Isolates of Klebsiella pneumoniae Pre-Dating the Use of Tigecycline in a Chinese Hospital	PLOS ONE			English	Article							EFFLUX PUMP ACRAB; ACINETOBACTER-BAUMANNII; MULTIDRUG-RESISTANCE; RAMA; EXPRESSION; SUSCEPTIBILITY; MECHANISMS; SOXS	Tigecycline is one of the few therapeutic options for treating infections caused by some multi-drug resistant pathogens, such as Klebsiella pneumoniae. However, tigecycline-resistant K. pneumoniae has been discovered recently in China. From 2009 to 2013, nine tigecycline-resistant K. pneumoniae isolates were identified in our hospital. Six of nine strains were identified before using tigecycline. To investigate the efflux-mediated resistance mechanisms of K. pneumoniae, the expression of efflux pump genes (acrA, acrB, tolC, oqxA and oqxB) and pump regulators (acrR, marA, soxS, rarA, rob and ramA) were examined by real-time RTPCR. Molecular typing of the tigecycline resistant strains was performed. ST11 was the predominant clone of K. pneumoniae strains, while ST1414 and ST1415 were novel STs. Efflux pump inhibitor (EPI)-carbonyl cyanide chlorophenylhydrazone (CCCP) was able to reverse the resistance patterns of 5 resistant K. pneumoniae strains. In comparison with strain A111, a tigecycline-susceptible strain (negative control), we found that the expression levels of efflux pump genes and pump regulators were higher in a majority of resistant strains. Higher expression levels of regulators rarA (2.41-fold, 9.55-fold, 28.44-fold and 18.31-fold, respectively) and pump gene oqxB (3.87-fold, 31.96-fold, 50.61-fold and 29.45-fold, respectively) were observed in four tigecycline resistant strains (A363, A361, A368, A373, respectively). Increased expression of acrB was associated with ramA and marA expression. To our knowledge, studies on tigecycline resistance mechanism in K. pneumoniae are limited especially in China. In our study, we found that both efflux pump AcrAB-TolC and OqxAB contributed to tigecycline resistance in K. pneumoniae isolates.	[Zhong, Xue; Cheng, Gang] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Shenyang, Liaoning, Peoples R China; [Zhong, Xue; Hu, Xin] Beijing Hosp, Dept Pharm, Beijing, Peoples R China; [Xu, Hongtao; Chen, Dongke] Beijing Hosp, Dept Clin Lab, Beijing, Peoples R China; [Zhou, Haijian] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Haijian] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Shenyang Pharmaceutical University; Beijing Hospital; Beijing Hospital; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Cheng, G (corresponding author), Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Shenyang, Liaoning, Peoples R China.	chenggang63@hotmail.com						Bratu S, 2009, J ANTIMICROB CHEMOTH, V64, P278, DOI 10.1093/jac/dkp186; Deng M., 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10. 1128/AAC. 01727-13 24165187; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Hasdemir UO, 2004, J CLIN MICROBIOL, V42, P2701, DOI 10.1128/JCM.42.6.2701-2706.2004; Hornsey M, 2010, INT J ANTIMICROB AG, V35, P478, DOI 10.1016/j.ijantimicag.2010.01.011; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Kuo HY, 2012, INT J ANTIMICROB AG, V39, P33, DOI 10.1016/j.ijantimicag.2011.08.016; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Perez A, 2012, ANTIMICROB AGENTS CH, V56, P6256, DOI 10.1128/AAC.01085-12; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Reid GE, 2007, PHARMACOTHERAPY, V27, P1198, DOI 10.1592/phco.27.8.1198; Rosenblum R, 2011, INT J ANTIMICROB AG, V38, P39, DOI 10.1016/j.ijantimicag.2011.02.012; Roy S, 2013, J ANTIMICROB CHEMOTH, V68, P1036, DOI 10.1093/jac/dks535; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Ruzin A, 2008, ANTIMICROB AGENTS CH, V52, P3430, DOI 10.1128/AAC.00591-08; Sheng ZK, 2014, ANTIMICROB AGENTS CH, V58, P6982, DOI 10.1128/AAC.03808-14; Stein GE, 2013, DIAGN MICR INFEC DIS, V75, P331, DOI 10.1016/j.diagmicrobio.2012.12.004; Sun Y, 2013, INT J ANTIMICROB AG, V41, P110, DOI 10.1016/j.ijantimicag.2012.09.005; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4450, DOI 10.1128/AAC.00456-12; Veleba M, 2012, ANTIMICROB AGENTS CH, V56, P4466, DOI 10.1128/AAC.06224-11	21	58	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115185	10.1371/journal.pone.0115185	http://dx.doi.org/10.1371/journal.pone.0115185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503276	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400080
J	Isipradit, S; Sirimaharaj, M; Charukamnoetkanok, P; Thonginnetra, O; Wongsawad, W; Sathornsumetee, B; Somboonthanakij, S; Soomsawasdi, P; Jitawatanarat, U; Taweebanjongsin, W; Arayangkoon, E; Arame, P; Kobkoonthon, C; Pangputhipong, P				Isipradit, Saichin; Sirimaharaj, Maytinee; Charukamnoetkanok, Puwat; Thonginnetra, Oraorn; Wongsawad, Warapat; Sathornsumetee, Busaba; Somboonthanakij, Sudawadee; Soomsawasdi, Piriya; Jitawatanarat, Umapond; Taweebanjongsin, Wongsiri; Arayangkoon, Eakkachai; Arame, Punyawee; Kobkoonthon, Chinsuchee; Pangputhipong, Pannet			The First Rapid Assessment of Avoidable Blindness (RAAB) in Thailand	PLOS ONE			English	Article							CATARACT BLINDNESS; VISUAL IMPAIRMENT; GLOBAL BLINDNESS; LOW-VISION; PREVALENCE; POPULATION; DISTRICT	Background: The majority of vision loss is preventable or treatable. Population surveys are crucial for planning, implementation, and monitoring policies and interventions to eliminate avoidable blindness and visual impairments. This is the first rapid assessment of avoidable blindness (RAAB) study in Thailand. Methods: A cross-sectional study of a population in Thailand age 50 years old or over aimed to assess the prevalence and causes of blindness and visual impairments. Using the Thailand National Census 2010 as the sampling frame, a stratified four-stage cluster sampling based on a probability proportional to size was conducted in 176 enumeration areas from 11 provinces. Participants received comprehensive eye examination by ophthalmologists. Results: The age and sex adjusted prevalence of blindness (presenting visual acuity (VA),<20/400), severe visual impairment(VA, <20/200 but >= 20/400), and moderate visual impairment (VA <20/70 but >= 20/200) were 0.6% (95% CI: 0.5-0.8), 1.3% (95% CI: 1.0-1.6), 12.6% (95% CI: 10.8-14.5). There was no significant difference among the four regions of Thailand. Cataract was the main cause of vision loss accounted for 69.7% of blindness. Cataract surgical coverage in persons was 95.1% for cut off VA of 20/400. Refractive errors, diabetic retinopathy, glaucoma, and corneal opacities were responsible for 6.0%, 5.1%, 4.0%, and 2.0% of blindness respectively. Conclusion: Thailand is on track to achieve the goal of VISION 2020. However, there is still much room for improvement. Policy refinements and innovative interventions are recommended to alleviate blindness and visual impairments especially regarding the backlog of blinding cataract, management of non-communicative, chronic, age-related eye diseases such as glaucoma, age-related macular degeneration, and diabetic retinopathy, prevention of childhood blindness, and establishment of a robust eye health information system.	[Isipradit, Saichin; Sirimaharaj, Maytinee; Charukamnoetkanok, Puwat; Thonginnetra, Oraorn; Wongsawad, Warapat; Sathornsumetee, Busaba; Somboonthanakij, Sudawadee; Soomsawasdi, Piriya; Jitawatanarat, Umapond; Taweebanjongsin, Wongsiri; Arayangkoon, Eakkachai; Arame, Punyawee; Kobkoonthon, Chinsuchee; Pangputhipong, Pannet] Mettapracharak Wat Rai Khing Hosp, Sampran 73210, Nakornprathom, Thailand		Charukamnoetkanok, P (corresponding author), Mettapracharak Wat Rai Khing Hosp, 52 Moo 2 Rai Khing, Sampran 73210, Nakornprathom, Thailand.	drpuwat@yahoo.com			Department of Medical Services, Ministry of Public Health, Kingdom of Thailand	Department of Medical Services, Ministry of Public Health, Kingdom of Thailand	This work was supported by the Department of Medical Services, Ministry of Public Health, Kingdom of Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amansakhatov S, 2002, BRIT J OPHTHALMOL, V86, P1207, DOI 10.1136/bjo.86.11.1207; Bachani D, 2000, Indian J Public Health, V44, P82; Bastawrous A, 2012, OPHTHALMOLOGY, V119, P432, DOI 10.1016/j.ophtha.2011.11.014; Beltranena F, 2007, OPHTHALMOLOGY, V114, P1558, DOI 10.1016/j.ophtha.2006.11.015; Casson RJ, 2007, OPHTHALMOLOGY, V114, P2302, DOI 10.1016/j.ophtha.2007.02.004; Chou R, 2009, ANN INTERN MED, V151, P44, DOI 10.7326/0003-4819-151-1-200907070-00008; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Foster A, 2001, BRIT J OPHTHALMOL, V85, P635, DOI 10.1136/bjo.85.6.635; Frick KD, 2003, AM J OPHTHALMOL, V135, P471, DOI 10.1016/S0002-9394(02)02110-4; Haider S, 2003, OPHTHALMIC EPIDEMIOL, V10, P249, DOI 10.1076/opep.10.4.249.15907; Jenchitr W, 2007, THAI J PUB HLTH OPHT, V21, P11; Konyama K, 1998, Community Eye Health, V11, P19; Kuper Hannah, 2006, Community Eye Health, V19, P68; Limburg H, 1998, Ophthalmic Epidemiol, V5, P211, DOI 10.1076/opep.5.4.211.4193; Limburg H, 1996, BRIT J OPHTHALMOL, V80, P951, DOI 10.1136/bjo.80.11.951; Limburg H, 1997, INT J EPIDEMIOL, V26, P1049, DOI 10.1093/ije/26.5.1049; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Nirmalan PK, 2005, INVEST OPHTH VIS SCI, V46, P2308, DOI 10.1167/iovs.04-0830; Pararajasegaram R, 2011, COMMUNICATION; Saw SM, 2003, BRIT J OPHTHALMOL, V87, P1075, DOI 10.1136/bjo.87.9.1075; Schwab L, 2007, EYE CARE DEV NATIONS, P235; Smith AF, 1996, BRIT J OPHTHALMOL, V80, P276, DOI 10.1136/bjo.80.4.276; West S, 2001, B WORLD HEALTH ORGAN, V79, P244; WHO Programme for the Prevention of Blindness, 1990, WHOPBL9018; Wong TY, 2008, AM J OPHTHALMOL, V146, P656, DOI 10.1016/j.ajo.2008.07.048; World Health Organization, 2013, UN EYE HLTH GLOB ACT; Wu Min, 2007, Community Eye Health, V20, P10; Zainal M, 2002, BRIT J OPHTHALMOL, V86, P951, DOI 10.1136/bjo.86.9.951; Zheng YF, 2011, OPHTHALMOLOGY, V118, P1798, DOI 10.1016/j.ophtha.2011.02.014	32	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114245	10.1371/journal.pone.0114245	http://dx.doi.org/10.1371/journal.pone.0114245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502762	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700017
J	Moens, LN; Falk-Sorqvist, E; Asplund, AC; Bernatowska, E; Smith, CIE; Nilsson, M				Moens, Lotte N.; Falk-Sorqvist, Elin; Asplund, A. Charlotta; Bernatowska, Ewa; Smith, C. I. Edvard; Nilsson, Mats			Diagnostics of Primary Immunodeficiency Diseases: A Sequencing Capture Approach	PLOS ONE			English	Article							IMMUNE-DEFICIENCY; MUTATIONS; GLYCOSYLATION; DESIGN; PROBES	Primary Immunodeficiencies (PID) are genetically inherited disorders characterized by defects of the immune system, leading to increased susceptibility to infection. Due to the variety of clinical symptoms and the complexity of current diagnostic procedures, accurate diagnosis of PID is often difficult in daily clinical practice. Thanks to the advent of "next generation'' sequencing technologies and target enrichment methods, the development of multiplex diagnostic assays is now possible. In this study, we applied a selector-based target enrichment assay to detect disease-causing mutations in 179 known PID genes. The usefulness of this assay for molecular diagnosis of PID was investigated by sequencing DNA from 33 patients, 18 of which had at least one known causal mutation at the onset of the experiment. We were able to identify the disease causing mutations in 60% of the investigated patients, indicating that the majority of PID cases could be resolved using a targeted sequencing approach. Causal mutations identified in the unknown patient samples were located in STAT3, IGLL1, RNF168 and PGM3. Based on our results, we propose a stepwise approach for PID diagnostics, involving targeted resequencing, followed by whole transcriptome and/or whole genome sequencing if causative variants are not found in the targeted exons.	[Moens, Lotte N.; Falk-Sorqvist, Elin; Nilsson, Mats] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Asplund, A. Charlotta; Smith, C. I. Edvard] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Huddinge, Sweden; [Bernatowska, Ewa] Childrens Mem Hlth Inst, Dept Clin Immunol, Warsaw, Poland; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital; Children's Memorial Health Institute; Stockholm University	Smith, CIE (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Huddinge, Sweden.	edvard.smith@ki.se; mats.nilsson@scilifelab.se		SMITH, C. I. Edvard/0000-0003-1907-3392; Bernatowska, Ewa/0000-0002-0125-266X	FP7 project "European Genetic Disease Diagnostics''; EURO-GENE-SCAN [Health-F5-2008-223293]	FP7 project "European Genetic Disease Diagnostics''; EURO-GENE-SCAN	This study was funded by the FP7 project "European Genetic Disease Diagnostics'', with the acronym "EURO-GENE-SCAN'' (project number Health-F5-2008-223293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Berglof A, 2013, EXPERT REV CLIN IMMU, V9, P1205, DOI 10.1586/1744666X.2013.850030; Blundred RM, 2011, EXPERT REV CLIN IMMU, V7, P169, DOI [10.1586/ECI.10.93, 10.1586/eci.10.93]; Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111; Bonilla FA, 2005, ANN ALLERG ASTHMA IM, V94, pS1, DOI 10.1016/S1081-1206(10)61142-8; Dahl F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni070; Desai AN, 2012, CLIN GENET, V81, P503, DOI 10.1111/j.1399-0004.2012.01865.x; Etzioni A, 2014, PRIMARY IMMUNODEFICIENCY DISORDERS: A HISTORIC AND SCIENTIFIC PERSPECTIVE, P1; Evans BJ, 2013, GENET MED, V15, P915, DOI 10.1038/gim.2013.135; Freeman A., 2014, PRIMARY IMMUNODEFICI, P489; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; McCusker C., 2011, ALLERGY ASTHMA CL IM, V7, pS11, DOI [DOI 10.1186/1710-1492-7-S1-S11, 10.1186/1710-1492-7-S1-S11]; Nijman IJ, 2014, J ALLERGY CLIN IMMUN, V133, P529, DOI 10.1016/j.jaci.2013.08.032; Oliveira JB, 2010, J ALLERGY CLIN IMMUN, V125, pS297, DOI 10.1016/j.jaci.2009.08.043; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Shehata N, 2010, TRANSFUS MED REV, V24, pS28, DOI 10.1016/j.tmrv.2009.09.011; Stenberg J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-229; Stenberg J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni071; Stenberg J, 2009, BIOINFORMATICS, V25, P666, DOI 10.1093/bioinformatics/btp001; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Valencia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053083; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weiss MM, 2013, HUM MUTAT, V34, P1313, DOI 10.1002/humu.22368; Yu B, 2014, METHODS MOL BIOL, V1168, P195, DOI 10.1007/978-1-4939-0847-9_11; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	25	57	57	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114901	10.1371/journal.pone.0114901	http://dx.doi.org/10.1371/journal.pone.0114901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502423	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700066
J	Moonens, K; De Kerpel, M; Coddens, A; Cox, E; Pardon, E; Remaut, H; De Greve, H				Moonens, Kristof; De Kerpel, Maia; Coddens, Annelies; Cox, Eric; Pardon, Els; Remaut, Han; De Greve, Henri			Nanobody Mediated Inhibition of Attachment of F18 Fimbriae Expressing Escherichia coli	PLOS ONE			English	Article							DOMAIN ANTIBODY FRAGMENTS; URINARY-TRACT-INFECTIONS; GALABIOSE DERIVATIVES; FIMH ANTAGONISTS; EDEMA DISEASE; F107 FIMBRIAE; ADHESIN FEDF; PIGS; RECEPTOR; BINDING	Post-weaning diarrhea and edema disease caused by F18 fimbriated E. coli are important diseases in newly weaned piglets and lead to severe production losses in farming industry. Protective treatments against these infections have thus far limited efficacy. In this study we generated nanobodies directed against the lectin domain of the F18 fimbrial adhesin FedF and showed in an in vitro adherence assay that four unique nanobodies inhibit the attachment of F18 fimbriated E. coli bacteria to piglet enterocytes. Crystallization of the FedF lectin domain with the most potent inhibitory nanobodies revealed their mechanism of action. These either competed with the binding of the blood group antigen receptor on the FedF surface or induced a conformational change in which the CDR3 region of the nanobody displaces the D ''-E loop adjacent to the binding site. This D ''-E loop was previously shown to be required for the interaction between F18 fimbriated bacteria and blood group antigen receptors in a membrane context. This work demonstrates the feasibility of inhibiting the attachment of fimbriated pathogens by employing nanobodies directed against the adhesin domain.	[Moonens, Kristof; De Kerpel, Maia; Pardon, Els; Remaut, Han; De Greve, Henri] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Moonens, Kristof; De Kerpel, Maia; Pardon, Els; Remaut, Han; De Greve, Henri] Vrije Univ Brussel, Struct Biol Brussels, B-1050 Brussels, Belgium; [Coddens, Annelies; Cox, Eric] Univ Ghent, Fac Vet Med, Dept Vet Immunol, B-9820 Merelbeke, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Ghent University	De Greve, H (corresponding author), VIB, Struct Biol Res Ctr, Brussels, Belgium.	hdegreve@vub.ac.be		Pardon, Els/0000-0002-2466-0172; Cox, Eric/0000-0003-4281-2990; Remaut, Han/0000-0002-9775-4102	VIB Young PI project; Odysseus program of the FWO-Vlaanderen; Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office [7/40]; FWO [G030411N]; Hercules Foundation [UABR/09/005]	VIB Young PI project; Odysseus program of the FWO-Vlaanderen; Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office; FWO(FWO); Hercules Foundation	K.M. was a doctoral fellow of the Fonds voor Wetenschappelijk Onderzoek (FWO) - Vlaanderen. H.R. is supported by a VIB Young PI project grant and the Odysseus program of the FWO-Vlaanderen. E.P. is supported by grant 7/40 of the Interuniversity Attraction Poles (IAP) Program of the Belgian Science Policy Office. The authors are grateful to the beamline staff of the Swiss Light Source (SLS; Switzerland), Diamond Light Source (England) and Soleil (France) for support with data collection and processing. This research was granted by FWO project G030411N and equipment grant UABR/09/005 from the Hercules Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARRETT TJ, 1989, J INFECT DIS, V159, P774, DOI 10.1093/infdis/159.4.774; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Bertschinger H. U., 1994, P193; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Busch A, 2012, PHILOS T R SOC B, V367, P1112, DOI 10.1098/rstb.2011.0206; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Coddens A, 2009, J BIOL CHEM, V284, P9713, DOI 10.1074/jbc.M807866200; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cusumano CK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003021; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; De Kerpel M, 2006, ACTA CRYSTALLOGR F, V62, P1278, DOI 10.1107/S1744309106049281; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairbrother J. M., 2006, DIS SWINE, P649; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; IMBERECHTS H, 1992, INFECT IMMUN, V60, P1963, DOI 10.1128/IAI.60.5.1963-1971.1992; IMBERECHTS H, 1994, VET MICROBIOL, V40, P219, DOI 10.1016/0378-1135(94)90111-2; Jiang XH, 2012, J MED CHEM, V55, P4700, DOI 10.1021/jm300192x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x; Klein T, 2010, J MED CHEM, V53, P8627, DOI 10.1021/jm101011y; Lo AWH, 2013, CURR OPIN MICROBIOL, V16, P85, DOI 10.1016/j.mib.2013.02.003; Melkebeek V, 2013, VET IMMUNOL IMMUNOP, V152, P37, DOI 10.1016/j.vetimm.2012.09.024; Moonens K, 2012, MOL MICROBIOL, V86, P82, DOI 10.1111/j.1365-2958.2012.08174.x; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ohlsson J, 2002, CHEMBIOCHEM, V3, P772, DOI 10.1002/1439-7633(20020802)3:8<772::AID-CBIC772>3.0.CO;2-8; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; Reineck P, 2010, ELECTROPHORESIS, V31, P279, DOI 10.1002/elps.200900505; Salminen A, 2007, J ANTIMICROB CHEMOTH, V60, P495, DOI 10.1093/jac/dkm251; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Schwardt O, 2011, BIOORGAN MED CHEM, V19, P6454, DOI 10.1016/j.bmc.2011.08.057; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; Smeds A, 2001, INFECT IMMUN, V69, P7941, DOI 10.1128/IAI.69.12.7941-7945.2001; Tiels P, 2005, VET MICROBIOL, V110, P277, DOI 10.1016/j.vetmic.2005.08.004; Van den Broeck W, 1999, INFECT IMMUN, V67, P520, DOI 10.1128/IAI.67.2.520-526.1999; Verdonck F, 2007, VET IMMUNOL IMMUNOP, V120, P69, DOI 10.1016/j.vetimm.2007.06.018; Virdi V, 2013, P NATL ACAD SCI USA, V110, P11809, DOI 10.1073/pnas.1301975110; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	48	17	20	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114691	10.1371/journal.pone.0114691	http://dx.doi.org/10.1371/journal.pone.0114691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502211	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700043
J	Otto, CC; Koehl, JL; Solanky, D; Haydel, SE				Otto, Caitlin C.; Koehl, Jennifer L.; Solanky, Dipesh; Haydel, Shelley E.			Metal Ions, Not Metal-Catalyzed Oxidative Stress, Cause Clay Leachate Antibacterial Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; ACID RESISTANCE; CADMIUM TOXICITY; SILVER IONS; IRON; SUPEROXIDE; COPPER; PH	Aqueous leachates prepared from natural antibacterial clays, arbitrarily designated CB-L, release metal ions into suspension, have a low pH (3.4-5), generate reactive oxygen species (ROS) and H2O2 , and have a high oxidation-reduction potential. To isolate the role of pH in the antibacterial activity of CB clay mixtures, we exposed three different strains of Escherichia coli O157:H7 to 10% clay suspensions. The clay suspension completely killed acid-sensitive and acid-tolerant E. coli O157: H7 strains, whereas incubation in a low-pH buffer resulted in a minimal decrease in viability, demonstrating that low pH alone does not mediate antibacterial activity. The prevailing hypothesis is that metal ions participate in redox cycling and produce ROS, leading to oxidative damage to macromolecules and resulting in cellular death. However, E. coli cells showed no increase in DNA or protein oxidative lesions and a slight increase in lipid peroxidation following exposure to the antibacterial leachate. Further, supplementation with numerous ROS scavengers eliminated lipid peroxidation, but did not rescue the cells from CB-L-mediated killing. In contrast, supplementing CB-L with EDTA, a broad-spectrum metal chelator, reduced killing. Finally, CB-L was equally lethal to cells in an anoxic environment as compared to the aerobic environment. Thus, ROS were not required for lethal activity and did not contribute to toxicity of CB-L. We conclude that clay-mediated killing was not due to oxidative damage, but rather, was due to toxicity associated directly with released metal ions.	[Otto, Caitlin C.; Koehl, Jennifer L.; Solanky, Dipesh; Haydel, Shelley E.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85004 USA; [Haydel, Shelley E.] Arizona State Univ, Biodesign Inst Ctr Infect Dis & Vaccinol, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Haydel, SE (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85004 USA.	Shelley.Haydel@asu.edu		Haydel, Shelley/0000-0001-5542-5469	NIH National Center for Complementary and Alternative Medicine [AT004690]; Arizona Board of Regents Doctoral Research Grant; Science Foundation Arizona; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004690] Funding Source: NIH RePORTER	NIH National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Arizona Board of Regents Doctoral Research Grant; Science Foundation Arizona; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This research was supported by Public Health Service grant AT004690 awarded to SEH from the NIH National Center for Complementary and Alternative Medicine and an Arizona Board of Regents Doctoral Research Grant awarded to CCO. CCO was also partially supported by a graduate research fellowship from Science Foundation Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg E, 1996, INT J MINER PROCESS, V46, P73, DOI 10.1016/0301-7516(95)00058-5; ARIFOGLU M, 1992, TEXT RES J, V62, P94, DOI 10.1177/004051759206200206; AVERILLBATES DA, 1994, ARCH BIOCHEM BIOPHYS, V312, P52, DOI 10.1006/abbi.1994.1279; Berry ED, 2000, APPL ENVIRON MICROB, V66, P1493, DOI 10.1128/AEM.66.4.1493-1498.2000; Bird LJ, 2013, APPL ENVIRON MICROB, V79, P3619, DOI 10.1128/AEM.03944-12; Borda MJ, 2001, ASTROBIOLOGY, V1, P283, DOI 10.1089/15311070152757474; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cervantes-Cervantes MP, 2005, BIOL TRACE ELEM RES, V103, P229, DOI 10.1385/BTER:103:3:229; Chung HJ, 2006, COMPR REV FOOD SCI F, V5, P52, DOI 10.1111/j.1541-4337.2006.00002.x; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5; Cunningham TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009456; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Freeman JL, 2005, APPL ENVIRON MICROB, V71, P8627, DOI 10.1128/AEM.71.12.8627-8633.2005; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Geslin C, 2001, RES MICROBIOL, V152, P901, DOI 10.1016/S0923-2508(01)01273-6; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; Grant Chris M, 2008, J Biol, V7, P1, DOI 10.1186/jbiol63; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Harris D. C., 2010, QUANTITATIVE CHEM AN; Haydel SE, 2008, J ANTIMICROB CHEMOTH, V61, P353, DOI 10.1093/jac/dkm468; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jayasena T, 2007, NEUROSCI RES, V57, P454, DOI 10.1016/j.neures.2006.12.004; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Lloyd DR, 1998, CHEM RES TOXICOL, V11, P420, DOI 10.1021/tx970156l; Lopez E, 2006, FREE RADICAL BIO MED, V40, P940, DOI 10.1016/j.freeradbiomed.2005.10.062; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; McCormick ML, 1998, J BACTERIOL, V180, P622, DOI 10.1128/JB.180.3.622-625.1998; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Otto CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064068; Otto CC, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-26; Pacheco CC, 2008, ARCH MICROBIOL, V189, P271, DOI 10.1007/s00203-007-0316-8; Popat SC, 2009, ENVIRON SCI TECHNOL, V43, P7856, DOI 10.1021/es901305x; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rowbury RJ, 1999, FEMS MICROBIOL LETT, V174, P49, DOI 10.1016/S0378-1097(99)00120-2; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Rui B, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-122; Sandrin TR, 2002, ENVIRON TOXICOL CHEM, V21, P2075, DOI 10.1897/1551-5028(2002)021<2075:EOPOCT>2.0.CO;2; SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4; Slauch JM, 2011, MOL MICROBIOL, V80, P580, DOI 10.1111/j.1365-2958.2011.07612.x; Small PLC, 1998, TRENDS MICROBIOL, V6, P214, DOI 10.1016/S0966-842X(98)01285-2; STIM KP, 1993, J BACTERIOL, V175, P1221, DOI 10.1128/JB.175.5.1221-1234.1993; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Toyokuni S, 1997, LAB INVEST, V76, P365; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; Waterman SR, 1998, APPL ENVIRON MICROB, V64, P3882; Williams LB, 2011, ENVIRON SCI TECHNOL, V45, P3768, DOI 10.1021/es1040688; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X	63	16	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115172	10.1371/journal.pone.0115172	http://dx.doi.org/10.1371/journal.pone.0115172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502790	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700096
J	Sverdrup-Thygeson, A; Sogaard, G; Rusch, GM; Barton, DN				Sverdrup-Thygeson, Anne; Sogaard, Gunnhild; Rusch, Graciela M.; Barton, David N.			Spatial Overlap between Environmental Policy Instruments and Areas of High Conservation Value in Forest	PLOS ONE			English	Article							NORTHERN EUROPE; BIODIVERSITY; WOOD; RETENTION; INVENTORY	In order to safeguard biodiversity in forest we need to know how forest policy instruments work. Here we use a nationwide network of 9400 plots in productive forest to analyze to what extent large-scale policy instruments, individually and together, target forest of high conservation value in Norway. We studied both instruments working through direct regulation; Strict Protection and Landscape Protection, and instruments working through management planning and voluntary schemes of forest certification; Wilderness Area and Mountain Forest. As forest of high conservation value (HCV-forest) we considered the extent of 12 Biodiversity Habitats and the extent of Old-Age Forest. We found that 22% of productive forest area contained Biodiversity Habitats. More than 70% of this area was not covered by any large-scale instruments. Mountain Forest covered 23%, while Strict Protection and Wilderness both covered 5% of the Biodiversity Habitat area. A total of 9% of productive forest area contained Old-Age Forest, and the relative coverage of the four instruments was similar as for Biodiversity Habitats. For all instruments, except Landscape Protection, the targeted areas contained significantly higher proportions of HCV-forest than areas not targeted by these instruments. Areas targeted by Strict Protection had higher proportions of HCV-forest than areas targeted by other instruments, except for areas targeted by Wilderness Area which showed similar proportions of Biodiversity Habitats. There was a substantial amount of spatial overlap between the policy tools, but no incremental conservation effect of overlapping instruments in terms of contributing to higher percentages of targeted HCV-forest. Our results reveal that although the current policy mix has an above average representation of forest of high conservation value, the targeting efficiency in terms of area overlap is limited. There is a need to improve forest conservation and a potential to cover this need by better targeting high conservation value areas.	[Sverdrup-Thygeson, Anne] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Sverdrup-Thygeson, Anne; Barton, David N.] Norwegian Inst Nat Res NINA, Oslo, Norway; [Sogaard, Gunnhild] Norwegian Forest & Landscape Inst, As, Norway; [Rusch, Graciela M.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Norwegian University of Life Sciences; Norwegian Institute Nature Research; The Norwegian Forest & Landscape Institute; Norwegian Institute Nature Research	Sverdrup-Thygeson, A (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.	anne.sverdrup-thygeson@nmbu.no	Sverdrup-Thygeson, Anne/I-2902-2017; Sverdrup-Thygeson, Anne/AAW-7779-2021	Sverdrup-Thygeson, Anne/0000-0002-3122-2250; Rusch, Graciela/0000-0003-3769-8345	European Union [244065]	European Union(European Commission)	The POLICYMIX project (http://policymix.nina.no) has received funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 244065. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Barton DN, 2012, ASSESSMENT EXISTING; Bollandsas OM, 2004, NULLOMRADER SKOGBRUK; Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930; Directorate for Nature Management, 2010, NAT NORG 2010; Directorate for Nature Management, 1995, 61995 DN; Djupstrom LB, 2008, FOREST ECOL MANAG, V255, P3340, DOI 10.1016/j.foreco.2008.02.015; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fedrowitz K, 2014, J APPL ECOL, V51, P1669, DOI 10.1111/1365-2664.12289; Framstad E, 2010, 535 NINA; Gjerde I, 2010, NORWEGIAN FOREST HAB; Gjerde I, 2007, BIOL CONSERV, V137, P549, DOI 10.1016/j.biocon.2007.03.007; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; Johansson T, 2013, FOREST ECOL MANAG, V303, P98, DOI 10.1016/j.foreco.2013.04.012; Kouki J, 2012, DIVERS DISTRIB, V18, P348, DOI 10.1111/j.1472-4642.2011.00839.x; Living Forests, 2007, LIV FOR STAND SUST F; Lovdata, 2006, 61995 DIR NAT MAN; Magnusson M, 2014, SCAND J FOREST RES, V29, P455, DOI 10.1080/02827581.2014.919353; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Nilsen J-EO, 2010, DATAGRUNNLAGET NATUR; Norwegian Agricultural Authority Directorate for Nature Management, 2010, SKOGS HENSYN INNGR N; Norwegian Environment Agency, 2014, M137 NORW ENV AG; R Core Team, 2021, R LANGUAGE ENV STAT; Rietbergen-McCracken J., 2007, HIGH CONSERVATION VA; Ring I, 2011, 22011 UFZ LEIPZ HELM; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Skjeggedal T, 2005, INNGREPSFRIE NATUROM; Sogaard G., 2012, EFFEKTER ULIKE MILJO; Storaunet KO, 2011, MENGDE UTVIKLING DOD; Sverdrup-Thygeson A, 2009, MILJOREGISTRERING SK; Sverdrup-Thygeson A, 2008, SCAND J FOREST RES, V23, P236, DOI 10.1080/02827580802158228; Sverdrup-Thygeson A, 2014, FOREST ECOL MANAG, V330, P8, DOI 10.1016/j.foreco.2014.06.036; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; The Office of the Auditor General of Norway, 2012, DOKUMENT, V3, P17; Timonen J, 2010, SCAND J FOREST RES, V25, P309, DOI 10.1080/02827581.2010.497160	37	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115001	10.1371/journal.pone.0115001	http://dx.doi.org/10.1371/journal.pone.0115001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502238	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000347146700080
J	Ahmad, J; Mohyud-Din, ST				Ahmad, Jamshad; Mohyud-Din, Syed Tauseef			An Efficient Algorithm for Some Highly Nonlinear Fractional PDEs in Mathematical Physics	PLOS ONE			English	Editorial Material							VARIATIONAL ITERATION METHOD; DIFFERENTIAL-EQUATIONS; NUMERICAL-SOLUTION; TRANSFORM	In this paper, a fractional complex transform (FCT) is used to convert the given fractional partial differential equations (FPDEs) into corresponding partial differential equations (PDEs) and subsequently Reduced Differential Transform Method (RDTM) is applied on the transformed system of linear and nonlinear time-fractional PDEs. The results so obtained are re-stated by making use of inverse transformation which yields it in terms of original variables. It is observed that the proposed algorithm is highly efficient and appropriate for fractional PDEs and hence can be extended to other complex problems of diversified nonlinear nature.	[Ahmad, Jamshad; Mohyud-Din, Syed Tauseef] HITEC Univ, Fac Sci, Dept Math, Taxila, Pakistan	NITEC University	Ahmad, J (corresponding author), HITEC Univ, Fac Sci, Dept Math, Taxila, Pakistan.	jamshadahmadm@gmail.com						Abbasbandy S, 2007, J COMPUT APPL MATH, V207, P59, DOI 10.1016/j.cam.2006.07.012; Abbasbandy S, 2007, INT J NUMER METH ENG, V70, P876, DOI 10.1002/nme.1924; Arikoglu A, 2007, CHAOS SOLITON FRACT, V34, P1473, DOI 10.1016/j.chaos.2006.09.004; Bildik N, 2006, INT J NONLIN SCI NUM, V7, P65; FORNBERG B, 1978, PHILOS T R SOC A, V289, P373, DOI 10.1098/rsta.1978.0064; He B, 2010, APPL MATH COMPUT, V217, P1976, DOI 10.1016/j.amc.2010.06.055; Jang MJ, 2006, APPL MATH COMPUT, V181, P767; Jumarie G, 2006, COMPUT MATH APPL, V51, P1367, DOI 10.1016/j.camwa.2006.02.001; Kurnaz A, 2005, INT J COMPUT MATH, V82, P709, DOI 10.1080/00207160512331329050; Li ZB, 2010, MATH COMPUT APPL, V15, P970, DOI 10.3390/mca15050970; Matinfar M, 2010, APPL APPL MATH, V5, P70; Merdan Mehmet, 2011, Mathematical & Computational Applications, V16, P761; Mohyud-Din S., 2010, WORLD APPL SCI J, V11, P622; Mohyud-Din ST, 2009, COMMUN KOREAN MATH S, V24, P605, DOI 10.4134/CKMS.2009.24.4.605; Momani S, 2005, APPL MATH COMPUT, V162, P1351, DOI 10.1016/j.amc.2004.03.014; Noor MA, 2008, ACTA APPL MATH, V104, P257, DOI 10.1007/s10440-008-9255-x; Odibat Z, 2007, PHYS LETT A, V369, P349, DOI 10.1016/j.physleta.2007.05.002; OLVER PJ, 1977, J MATH PHYS, V18, P1212, DOI 10.1063/1.523393; Rawashdeh, 2013, J APPL MATH BIONORFO, V3, P1; Soliman AA, 2006, CHAOS SOLITON FRACT, V29, P294, DOI 10.1016/j.chaos.2005.08.054; Sweilam NH, 2007, CHAOS SOLITON FRACT, V32, P145, DOI 10.1016/j.chaos.2005.11.028; Wazwaz AM, 2007, COMMUN NONLINEAR SCI, V12, P1395, DOI 10.1016/j.cnsns.2005.11.007; WHITHAM GB, 1967, PROC R SOC LON SER-A, V299, P6, DOI 10.1098/rspa.1967.0119; Yildirim A, 2009, ADV WATER RESOUR, V32, P1711, DOI 10.1016/j.advwatres.2009.09.003; Zhou J.K., 1986, DIFFERENTIAL TRANSFO; 何吉欢, 1999, [科技通报, Bulletin of Science and Technology], V15, P86	26	9	9	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e109127	10.1371/journal.pone.0109127	http://dx.doi.org/10.1371/journal.pone.0109127			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525804	Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200064
J	Boivin, F; Simard, A; Peres-Neto, P				Boivin, Frederic; Simard, Anouk; Peres-Neto, Pedro			Can Wide Consultation Help with Setting Priorities for Large-Scale Biodiversity Monitoring Programs?	PLOS ONE			English	Editorial Material							CLIMATE-CHANGE; CONSERVATION; MANAGEMENT; SCIENCE; NEEDS	Climate and other global change phenomena affecting biodiversity require monitoring to track ecosystem changes and guide policy and management actions. Designing a biodiversity monitoring program is a difficult task that requires making decisions that often lack consensus due to budgetary constrains. As monitoring programs require long-term investment, they also require strong and continuing support from all interested parties. As such, stakeholder consultation is key to identify priorities and make sound design decisions that have as much support as possible. Here, we present the results of a consultation conducted to serve as an aid for designing a large-scale biodiversity monitoring program for the province of Quebec (Canada). The consultation took the form of a survey with 13 discrete choices involving tradeoffs in respect to design priorities and 10 demographic questions (e.g., age, profession). The survey was sent to thousands of individuals having expected interests and knowledge about biodiversity and was completed by 621 participants. Overall, consensuses were few and it appeared difficult to create a design fulfilling the priorities of the majority. Most participants wanted 1) a monitoring design covering the entire territory and focusing on natural habitats; 2) a focus on species related to ecosystem services, on threatened and on invasive species. The only demographic characteristic that was related to the type of prioritization was the declared level of knowledge in biodiversity (null to high), but even then the influence was quite small.	[Boivin, Frederic; Peres-Neto, Pedro] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada; [Simard, Anouk] Minist Forets Faune & Parcs, Quebec City, PQ, Canada	University of Quebec; University of Quebec Montreal	Boivin, F (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada.	fredboivin@gmail.com		Peres Neto, Pedro/0000-0002-5629-8067				Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Boutin S, 2009, FOREST ECOL MANAG, V258, pS168, DOI 10.1016/j.foreco.2009.08.024; Brown G, 2004, APPL GEOGR, V24, P161, DOI 10.1016/j.apgeog.2004.03.006; Caughlan L., 2001, ECOL INDIC, V1, DOI [10.1016/S1470-160X(01)00015-2, DOI 10.1016/S1470-160X(01)00015-2]; Convention on Biological Diversity (CBD), 2010, GLOB BIOD OUTL; Couillard L, 1986, VEEGEETATION MILIEUX; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2012, MULTIVARIATE PARTITI; Duarte LDS, 2012, ECOGRAPHY, V35, P952, DOI 10.1111/j.1600-0587.2011.07193.x; Geupel GR, 2011, TRENDS ECOL EVOL, V26, P107, DOI 10.1016/j.tree.2010.11.007; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Haughland DL, 2010, TRENDS ECOL EVOL, V25, P199, DOI 10.1016/j.tree.2009.11.005; Human BA, 2010, MAR POLICY, V34, P645, DOI 10.1016/j.marpol.2009.12.003; Jiguet F, 2012, ACTA OECOL, V44, P58, DOI 10.1016/j.actao.2011.05.003; Legg CJ, 2006, J ENVIRON MANAGE, V78, P194, DOI 10.1016/j.jenvman.2005.04.016; Lepetz V, 2009, BIODIVERS CONSERV, V18, P3185, DOI 10.1007/s10531-009-9636-0; Lindenmayer DB, 2013, FRONT ECOL ENVIRON, V11, P549, DOI 10.1890/120220; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Lindenmayer DB, 2010, TRENDS ECOL EVOL, V25, P200, DOI 10.1016/j.tree.2009.11.006; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maddock AH, 2000, BIODIVERS CONSERV, V9, P1153, DOI 10.1023/A:1008992602151; MDDEP, 2013, REG AIR PROT; Montoya JM, 2010, PHILOS T R SOC B, V365, P2013, DOI 10.1098/rstb.2010.0114; MRNF, 2012, RESS IND FOR; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; R Core Team, 2021, R LANGUAGE ENV STAT; Rudd MA, 2014, BIOSCIENCE, V64, P219, DOI 10.1093/biosci/bit035; Rudd MA, 2013, MAR POLICY, V39, P101, DOI 10.1016/j.marpol.2012.09.004; Rudd MA, 2011, CONSERV BIOL, V25, P1165, DOI 10.1111/j.1523-1739.2011.01772.x; Rudd MA, 2011, CONSERV BIOL, V25, P476, DOI 10.1111/j.1523-1739.2010.01625.x; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; Schmeller DS, 2009, CONSERV BIOL, V23, P307, DOI 10.1111/j.1523-1739.2008.01125.x; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Tardif B., 2005, ATLAS BIODIVERSITE Q; Watson I, 2004, AUSTRAL ECOL, V29, P16, DOI 10.1111/j.1442-9993.2004.01350.x; Xenopoulos MA, 2005, GLOBAL CHANGE BIOL, V11, P1557, DOI 10.1111/j.1365-2486.2005.001008.x; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zarraga A, 2011, STUD CLASS DATA ANAL, P505, DOI 10.1007/978-3-642-11363-5_57	48	0	0	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e113905	10.1371/journal.pone.0113905	http://dx.doi.org/10.1371/journal.pone.0113905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525798	Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200069
J	Kochemazov, S; Semenov, A				Kochemazov, Stepan; Semenov, Alexander			Using Synchronous Boolean Networks to Model Several Phenomena of Collective Behavior	PLOS ONE			English	Article							THRESHOLD MODELS; ALGORITHM; DYNAMICS	In this paper, we propose an approach for modeling and analysis of a number of phenomena of collective behavior. By collectives we mean multi-agent systems that transition from one state to another at discrete moments of time. The behavior of a member of a collective (agent) is called conforming if the opinion of this agent at current time moment conforms to the opinion of some other agents at the previous time moment. We presume that at each moment of time every agent makes a decision by choosing from the set {0,1} (where 1-decision corresponds to action and 0-decision corresponds to inaction). In our approach we model collective behavior with synchronous Boolean networks. We presume that in a network there can be agents that act at every moment of time. Such agents are called instigators. Also there can be agents that never act. Such agents are called loyalists. Agents that are neither instigators nor loyalists are called simple agents. We study two combinatorial problems. The first problem is to find a disposition of instigators that in several time moments transforms a network from a state where the majority of simple agents are inactive to a state with the majority of active agents. The second problem is to find a disposition of loyalists that returns the network to a state with the majority of inactive agents. Similar problems are studied for networks in which simple agents demonstrate the contrary to conforming behavior that we call anticonforming. We obtained several theoretical results regarding the behavior of collectives of agents with conforming or anticonforming behavior. In computational experiments we solved the described problems for randomly generated networks with several hundred vertices. We reduced corresponding combinatorial problems to the Boolean satisfiability problem (SAT) and used modern SAT solvers to solve the instances obtained.	[Kochemazov, Stepan; Semenov, Alexander] ISDCT SB RAS, Irkutsk, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Matrosov Institute for System Dynamics & Control Theory SB RAS	Semenov, A (corresponding author), ISDCT SB RAS, Irkutsk, Russia.	biclop.rambler@yandex.ru	Semenov, Alexander/R-3844-2016; Kochemazov, Stepan E./M-4029-2015	Semenov, Alexander/0000-0001-6172-4801; Kochemazov, Stepan E./0000-0003-2848-5786	Siberian Branch of the Russian Academy of Sciences in the Framework of the Interdisciplinary Integration Project "Differential-Discrete and Integrodifferential Equations. Application to Problems of Natural Sciences" [80]; Russian Foundation for Basic Research [14-07-00403, 14-07-31172mol]; Council at the President of the Russian Federation for the State Maintenance of the Leading Scientific Schools [5007.2014.9]	Siberian Branch of the Russian Academy of Sciences in the Framework of the Interdisciplinary Integration Project "Differential-Discrete and Integrodifferential Equations. Application to Problems of Natural Sciences"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Council at the President of the Russian Federation for the State Maintenance of the Leading Scientific Schools	This work was partially supported by the Siberian Branch of the Russian Academy of Sciences in the Framework of the Interdisciplinary Integration Project No. 80 "Differential-Discrete and Integrodifferential Equations. Application to Problems of Natural Sciences", the Russian Foundation for Basic Research (projects No. 14-07-00403 and 14-07-31172mol) and the Council at the President of the Russian Federation for the State Maintenance of the Leading Scientific Schools (project No. 5007.2014.9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asin R, 2011, CONSTRAINTS, V16, P195, DOI 10.1007/s10601-010-9105-0; Bailleux O, 2003, LECT NOTES COMPUT SC, V2833, P108; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batcher K. E., 1968, P AFIPS SPRING JOINT, V32, P307, DOI DOI 10.1145/1468075.1468121; BRAUN N, 1995, RATION SOC, V7, P167, DOI 10.1177/1043463195007002005; Breer VV, 2012, AUTOMAT REM CONTR+, V73, P1680, DOI 10.1134/S0005117912100086; Chiang YS, 2007, J MATH SOCIOL, V31, P47, DOI 10.1080/00222500601013536; Chwe MSY, 1999, AM J SOCIOL, V105, P128, DOI 10.1086/210269; Cook SA, 1971, P 3 ANN ACM S THEOR, P151, DOI DOI 10.1145/800157.805047; Cormen Thomas H., 2009, INTRO ALGORITHMS; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dubrova E, 2005, IEEE IC CAD, P479, DOI 10.1109/ICCAD.2005.1560115; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Een N, 2006, BOOLEAN MODELING COM, V2, P1; [ЕВДОКИМОВ Александр Андреевич Evdokimov A.A.], 2011, [Вычислительные технологии, Vychislitel'nye tekhnologii], V16, P30; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Giunchiglia E, 2009, FRONT ARTIF INTEL AP, V185, P761, DOI 10.3233/978-1-58603-929-5-761; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRANOVETTER M, 1983, J MATH SOCIOL, V9, P165, DOI 10.1080/0022250X.1983.9989941; GRANOVETTER M, 1986, J ECON BEHAV ORGAN, V7, P83, DOI 10.1016/0167-2681(86)90023-5; Guo WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094258; Janota M, 2011, LECT NOTES COMPUT SC, V6695, P230; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Marques-Silva J, 2007, LECT NOTES COMPUT SC, V4741, P483; Marques-Silva J, 2009, FRONT ARTIF INTEL AP, V185, P131, DOI 10.3233/978-1-58603-929-5-131; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Novikov D., 2013, THEORY CONTROL ORG; Novikov D., 2014, REFLEXION CONTROL MA; Prestwich S, 2009, FRONT ARTIF INTEL AP, V185, P75, DOI 10.3233/978-1-58603-929-5-75; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Sinz C, 2005, LECT NOTES COMPUT SC, V3709, P827, DOI 10.1007/11564751_73; SOLOMONOFF RAY, 1951, BULL MATH BIOPHYS, V13, P107, DOI 10.1007/BF02478357; Tseitin Grigori S, 1983, AUTOMATION REASONING, P466, DOI [DOI 10.1007/978-3-642-81955-1_28, 10.1007/978-3-642-81955-1_28]; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	36	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115156	10.1371/journal.pone.0115156	http://dx.doi.org/10.1371/journal.pone.0115156			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526612	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200014
J	Rajashekar, R; Liebl, D; Chikkaballi, D; Liss, V; Hensel, M				Rajashekar, Roopa; Liebl, David; Chikkaballi, Deepak; Liss, Viktoria; Hensel, Michael			Live Cell Imaging Reveals Novel Functions of Salmonella enterica SPI2-T3SS Effector Proteins in Remodeling of the Host Cell Endosomal System	PLOS ONE			English	Article							III SECRETION SYSTEM; PATHOGENICITY ISLAND 2; LYSOSOMAL MEMBRANE-GLYCOPROTEINS; EPITHELIAL-CELLS; INTRACELLULAR SALMONELLA; ESCHERICHIA-COLI; TRANSLOCATED EFFECTORS; FILAMENTOUS STRUCTURES; TYPHIMURIUM; TRAFFICKING	Intracellular Salmonella enterica induce a massive remodeling of the endosomal system in infected host cells. One dramatic consequence of this interference is the induction of various extensive tubular aggregations of membrane vesicles, and tubules positive for late endosomal/lysosomal markers are referred to as Salmonella-induced filaments or SIF. SIF are highly dynamic in nature with extension and collapse velocities of 0.4-0.5 mm x sec(-1). The induction of SIF depends on the function of the Salmonella Pathogenicity Island 2 (SPI2) encoded type III secretion system (T3SS) and a subset of effector proteins. In this study, we applied live cell imaging and electron microscopy to analyze the role of individual effector proteins in SIF morphology and dynamic properties of SIF. SIF in cells infected with sifB, sseJ, sseK1, sseK2, sseI, sseL, sspH1, sspH2, slrP, steC, gogB or pipB mutant strains showed a morphology and dynamics comparable to SIF induced by WT Salmonella. SIF were absent in cells infected with the sifA-deficient strain and live cell analyses allowed tracking of the loss of the SCV membrane of intracellular sifA Salmonella. In contrast to analyses in fixed cells, in living host cells SIF induced by sseF- or sseG-deficient strains were not discontinuous, but rather continuous and thinner in diameter. A very dramatic phenotype was observed for the pipB2-deficient strain that induced very bulky, non-dynamic aggregations of membrane vesicles. Our study underlines the requirement of the study of Salmonella-host interaction in living systems and reveals new phenotypes due to the intracellular activities of Salmonella.	[Rajashekar, Roopa; Liebl, David; Chikkaballi, Deepak; Hensel, Michael] Univ Klinikum Erlangen, Mikrobiol Inst, Erlangen, Germany; [Liebl, David] EMBL Heidelberg, Cell Biol & Biophys Unit, Heidelberg, Germany; [Chikkaballi, Deepak; Liss, Viktoria; Hensel, Michael] Univ Osnabruck, Abt Mikrobiol, Osnabruck, Germany	University of Erlangen Nuremberg; European Molecular Biology Laboratory (EMBL); University Osnabruck	Hensel, M (corresponding author), Univ Klinikum Erlangen, Mikrobiol Inst, Erlangen, Germany.	Michael.Hensel@biologie.uni-osnabrueck.de	Liebl, David/AFJ-1224-2022; Liebl, David/AAF-4479-2022; Chikkaballi, Deepak/AAB-2775-2021	Liss, Viktoria/0000-0002-1304-2512; C A, Deepak/0000-0001-7835-5790; Hensel, Michael/0000-0001-6604-6253; Liebl, David/0000-0002-1899-7713	Deutsche Forschungsgemeinschaft [HE1964/17-1, HE1964/18-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft as project grant HE1964/17-1 and continued by grant HE1964/18-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Drecktrah D, 2008, TRAFFIC, V9, P2117, DOI 10.1111/j.1600-0854.2008.00830.x; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; GARCIADELPORTILLO F, 1993, P NATL ACAD SCI USA, V90, P10544, DOI 10.1073/pnas.90.22.10544; Guy RL, 2000, MOL MICROBIOL, V37, P1417, DOI 10.1046/j.1365-2958.2000.02092.x; Halici S, 2008, INFECT IMMUN, V76, P4924, DOI 10.1128/IAI.00531-08; Hansen-Wester I, 2002, INFECT IMMUN, V70, P1403, DOI 10.1128/IAI.70.3.1403-1409.2002; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Knodler LA, 2005, INFECT IMMUN, V73, P7027, DOI 10.1128/IAI.73.10.7027-7031.2005; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.e05-04-0367; Knodler LA, 2003, MOL MICROBIOL, V49, P685, DOI 10.1046/j.1365-2958.2003.03598.x; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Kuhle V, 2004, TRAFFIC, V5, P356, DOI 10.1111/j.1398-9219.2004.00179.x; Kuhle V, 2002, CELL MICROBIOL, V4, P813, DOI 10.1046/j.1462-5822.2002.00234.x; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Mota LJ, 2009, CELL MICROBIOL, V11, P1236, DOI 10.1111/j.1462-5822.2009.01329.x; Murk JLAN, 2003, J MICROSC-OXFORD, V212, P81, DOI 10.1046/j.1365-2818.2003.01238.x; Odendall C, 2012, CELL HOST MICROBE, V12, P657, DOI 10.1016/j.chom.2012.09.011; Ohlson MB, 2005, INFECT IMMUN, V73, P6249, DOI 10.1128/IAI.73.10.6249-6259.2005; Rajashekar R, 2008, TRAFFIC, V9, P2100, DOI 10.1111/j.1600-0854.2008.00821.x; Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sambrook J, 1989, MOL CLONING LAB MANU; Schroeder N, 2011, TRENDS MICROBIOL, V19, P268, DOI 10.1016/j.tim.2011.01.006; Schroeder N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001002; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Stein MA, 1996, MOL MICROBIOL, V20, P151, DOI 10.1111/j.1365-2958.1996.tb02497.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Valdivia RH, 1996, MOL MICROBIOL, V22, P367, DOI 10.1046/j.1365-2958.1996.00120.x; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wild Jadwiga, 2004, Methods Mol Biol, V267, P155; Zhang YY, 2013, NANOSCALE, V5, P9296, DOI 10.1039/c3nr01550e	44	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115423	10.1371/journal.pone.0115423	http://dx.doi.org/10.1371/journal.pone.0115423			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522146	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600046
J	Alonso, AN; Perry, KJ; Regeimbal, JM; Regan, PM; Higgins, DE				Alonso, Almaris N.; Perry, Kyle J.; Regeimbal, James M.; Regan, Patrick M.; Higgins, Darren E.			Identification of Listeria monocytogenes Determinants Required for Biofilm Formation	PLOS ONE			English	Article							ALANYL-LIPOTEICHOIC ACID; MARINER-BASED TRANSPOSON; BACILLUS-SUBTILIS; VIRULENCE; MUTAGENESIS; EXPRESSION; HEMOLYSIN; SURFACES; SYSTEM; GROWTH	Listeria monocytogenes is a Gram-positive, food-borne pathogen of humans and animals. L. monocytogenes is considered to be a potential public health risk by the U.S. Food and Drug Administration (FDA), as this bacterium can easily contaminate ready-to-eat (RTE) foods and cause an invasive, life-threatening disease (listeriosis). Bacteria can adhere and grow on multiple surfaces and persist within biofilms in food processing plants, providing resistance to sanitizers and other antimicrobial agents. While whole genome sequencing has led to the identification of biofilm synthesis gene clusters in many bacterial species, bioinformatics has not identified the biofilm synthesis genes within the L. monocytogenes genome. To identify genes necessary for L. monocytogenes biofilm formation, we performed a transposon mutagenesis library screen using a recently constructed Himar1 mariner transposon. Approximately 10,000 transposon mutants within L. monocytogenes strain 10403S were screened for biofilm formation in 96-well polyvinyl chloride (PVC) microtiter plates with 70 Himar1 insertion mutants identified that produced significantly less biofilms. DNA sequencing of the transposon insertion sites within the isolated mutants revealed transposon insertions within 38 distinct genetic loci. The identification of mutants bearing insertions within several flagellar motility genes previously known to be required for the initial stages of biofilm formation validated the ability of the mutagenesis screen to identify L. monocytogenes biofilm-defective mutants. Two newly identified genetic loci, dltABCD and phoPR, were selected for deletion analysis and both Delta dltABCD and Delta phoPR bacterial strains displayed biofilm formation defects in the PVC microtiter plate assay, confirming these loci contribute to biofilm formation by L. monocytogenes.	[Alonso, Almaris N.; Perry, Kyle J.; Regeimbal, James M.; Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Alonso, Almaris N.; Regan, Patrick M.] US FDA, Winchester Engn & Analyt Ctr, Winchester, MA 01890 USA	Harvard University; Harvard Medical School; US Food & Drug Administration (FDA)	Alonso, AN (corresponding author), US FDA, Ctr Tobacco Prod, Off Sci, 10903 New Hampshire Ave,Bldg 32,Rm 5160, Silver Spring, MD 20993 USA.	Almaris.Alonso@fda.hhs.gov; dhiggins@hms.harvard.edu			United States Public Health Service Grant from the National Institutes of Health [AI53669]; FDA Office of Regulatory Affairs, Division of Field Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053669] Funding Source: NIH RePORTER	United States Public Health Service Grant from the National Institutes of Health; FDA Office of Regulatory Affairs, Division of Field Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Public Health Service Grant AI53669 from the National Institutes of Health (DEH) and has been funded in part by the FDA Office of Regulatory Affairs, Division of Field Science (ANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Alonso A.N., 2008, BIOFILMS, V5, P1, DOI [10.1017/S1479050508002238, DOI 10.1017/S1479050508002238]; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Blackman IC, 1996, J FOOD PROTECT, V59, P827, DOI 10.4315/0362-028X-59.8.827; Borucki MK, 2003, APPL ENVIRON MICROB, V69, P7336, DOI 10.1128/AEM.69.12.7336-7342.2003; Chang YH, 2012, APPL MICROBIOL BIOT, V93, P2051, DOI 10.1007/s00253-011-3719-z; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Doyle M.P., 2013, FOOD MICROBIOLOGY FU; GAILLARD JL, 1986, INFECT IMMUN, V52, P50, DOI 10.1128/IAI.52.1.50-55.1986; Ghannoum M., 2004, MICROBIAL BIOFILMS; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Heilmann C., 2010, BACTERIAL SIGNALING, P7; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kocan M, 2006, J BACTERIOL, V188, P724, DOI 10.1128/JB.188.2.724-732.2006; Lemon KP, 2007, J BACTERIOL, V189, P4418, DOI 10.1128/JB.01967-06; McCollum JT, 2013, NEW ENGL J MED, V369, P944, DOI 10.1056/NEJMoa1215837; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Moretro T., 2004, Biofilms, V1, P107, DOI 10.1017/S1479050504001322; Ouyang Y, 2012, J BIOTECH RES, V4, P13; Perry KJ, 2013, J BACTERIOL, V195, P3331, DOI 10.1128/JB.00210-13; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Pragai Z, 2004, J BACTERIOL, V186, P1182, DOI 10.1128/JB.186.4.1182-1190.2004; Prouty AM, 2003, INFECT IMMUN, V71, P7154, DOI 10.1128/IAI.71.12.7154-7158.2003; Saar-Dover R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002891; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Sun YC, 2009, FEMS MICROBIOL LETT, V290, P85, DOI 10.1111/j.1574-6968.2008.01409.x; Tsai HN, 2003, APPL ENVIRON MICROB, V69, P6943, DOI 10.1128/AEM.69.11.6943-6945.2003; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wassinger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070448; Wingender J., 1999, MICROBIAL EXTRACELLU; Young JM, 2012, ENVIRON MICROBIOL, V14, P594, DOI 10.1111/j.1462-2920.2011.02596.x; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09; Zhu XN, 2011, FOODBORNE PATHOG DIS, V8, P495, DOI 10.1089/fpd.2010.0697; ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7	36	44	46	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113696	10.1371/journal.pone.0113696	http://dx.doi.org/10.1371/journal.pone.0113696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517120	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600008
J	Silveira, JW; Issy, AC; Castania, VA; Salmon, CEG; Nogueira-Barbosa, MH; Guimaraes, FS; Defino, HLA; Del Bel, E				Silveira, Joao W.; Issy, Ana Carolina; Castania, Vitor A.; Salmon, Carlos E. G.; Nogueira-Barbosa, Marcello H.; Guimaraes, Francisco S.; Defino, Helton L. A.; Del Bel, Elaine			Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration	PLOS ONE			English	Article							LOW-BACK-PAIN; MULTIPLE-SCLEROSIS; CONTROLLED-TRIAL; CONSTITUENT CANNABIDIOL; INFLAMMATORY CYTOKINES; PLANT CANNABINOIDS; ANTITUMOR-ACTIVITY; NEUROPATHIC PAIN; NUCLEUS PULPOSUS; NEEDLE PUNCTURE	Disc degeneration is a multifactorial process that involves hypoxia, inflammation, neoinnervation, accelerated catabolism, and reduction in water and glycosaminoglycan content. Cannabidiol is the main non-psychotropic component of the Cannabis sativa with protective and anti-inflammatory properties. However, possible therapeutic effects of cannabidiol on intervertebral disc degeneration have not been investigated yet. The present study investigated the effects of cannabidiol intradiscal injection in the coccygeal intervertebral disc degeneration induced by the needle puncture model using magnetic resonance imaging (MRI) and histological analyses. Disc injury was induced in the tail of male Wistar rats via a single needle puncture. The discs selected for injury were punctured percutaneously using a 21-gauge needle. MRI and histological evaluation were employed to assess the results. The effects of intradiscal injection of cannabidiol (30, 60 or 120 nmol) injected immediately after lesion were analyzed acutely (2 days) by MRI. The experimental group that received cannabidiol 120 nmol was resubmitted to MRI examination and then to histological analyses 15 days after lesion/cannabidiol injection. The needle puncture produced a significant disc injury detected both by MRI and histological analyses. Cannabidiol significantly attenuated the effects of disc injury induced by the needle puncture. Considering that cannabidiol presents an extremely safe profile and is currently being used clinically, these results suggest that this compound could be useful in the treatment of intervertebral disc degeneration.	[Silveira, Joao W.; Issy, Ana Carolina; Castania, Vitor A.; Del Bel, Elaine] Univ Sao Paulo, NAPNA, Sch Dent, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, Brazil; [Salmon, Carlos E. G.] Univ Sao Paulo, Dept Phys Philosophy, Ribeirao Preto, Brazil; [Salmon, Carlos E. G.] Univ Sao Paulo, Sch Sci, Ribeirao Preto, Brazil; [Nogueira-Barbosa, Marcello H.] Univ Sao Paulo, Sch Med, Div Radiol, Ribeirao Preto, Brazil; [Guimaraes, Francisco S.] Univ Sao Paulo, NAPNA, Sch Med, Dept Pharmacol, Ribeirao Preto, Brazil; [Defino, Helton L. A.] Univ Sao Paulo, Locomotor Apparat, Sch Med, Dept Biomech Med & Rehabil, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Del Bel, E (corresponding author), Univ Sao Paulo, NAPNA, Sch Dent, Dept Morphol Physiol & Basic Pathol, Ribeirao Preto, Brazil.	eadelbel@forp.usp.br	Guimaraes, Francisco Silveira/C-1059-2012; Issy, Ana Carolina/V-8077-2019; Del Bel, Elaine A/E-2308-2012; Del Bel, Elaine/ABH-1331-2020; Nogueira-Barbosa, Marcello H/D-7681-2012; Issy, Ana C/K-1878-2012; Salmon, Carlos Ernesto Garrido/C-6326-2012; Defino, Helton/O-1928-2013	Guimaraes, Francisco Silveira/0000-0003-4092-7778; Del Bel, Elaine A/0000-0002-4158-7376; Del Bel, Elaine/0000-0003-3483-8074; Nogueira-Barbosa, Marcello H/0000-0002-7436-5315; Salmon, Carlos Ernesto Garrido/0000-0003-1441-1524; Defino, Helton/0000-0003-4274-0130	CAPES/PNPD, Brazil	CAPES/PNPD, Brazil	This research was supported by CAPES/PNPD, Brazil. The equipment and drugs used in this work were acquired from FAPESP, CNPq, and CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2003, SPINE, V28, pS86, DOI 10.1097/00007632-200308011-00015; Bisogno T, 2001, EUR J BIOCHEM, V268, P1982, DOI 10.1046/j.1432-1327.2001.02072.x; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Brady CM, 2004, MULT SCLER J, V10, P425, DOI 10.1191/1352458504ms1063oa; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Buttermann Glenn R, 2004, Spine J, V4, P495, DOI 10.1016/j.spinee.2004.03.024; CARLINI EA, 1981, J CLIN PHARMACOL, V21, pS417, DOI 10.1002/j.1552-4604.1981.tb02622.x; Carragee EJ, 2011, SPINE J, V11, P97, DOI 10.1016/j.spinee.2011.01.015; Carrier EJ, 2006, P NATL ACAD SCI USA, V103, P7895, DOI 10.1073/pnas.0511232103; Chou R, 2009, SPINE, V34, P1078, DOI 10.1097/BRS.0b013e3181a103b1; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Costa B, 2004, N-S ARCH PHARMACOL, V369, P294, DOI 10.1007/s00210-004-0871-3; Costa B, 2007, EUR J PHARMACOL, V556, P75, DOI 10.1016/j.ejphar.2006.11.006; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; CUNHA JM, 1980, PHARMACOLOGY, V21, P175, DOI 10.1159/000137430; Grava ALD, 2012, EUR SPINE J, V21, P537, DOI 10.1007/s00586-011-2027-8; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Durst R, 2007, AM J PHYSIOL-HEART C, V293, pH3602, DOI 10.1152/ajpheart.00098.2007; El-Remessy AB, 2006, AM J PATHOL, V168, P235, DOI 10.2353/ajpath.2006.050500; Esposito G, 2007, BRIT J PHARMACOL, V151, P1272, DOI 10.1038/sj.bjp.0707337; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Fouad AA, 2011, EUR J PHARMACOL, V670, P216, DOI 10.1016/j.ejphar.2011.08.048; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; Guimaraes FS, 2006, PSYCHOPHARMACOLOGY B, V100, P558; Hampson AJ, 1998, P NATL ACAD SCI USA, V95, P8268, DOI 10.1073/pnas.95.14.8268; Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9; Issy AC, 2013, BRAZ J MED BIOL RES, V46, P235, DOI 10.1590/1414-431X20122429; Izzo AA, 2009, TRENDS PHARMACOL SCI, V30, P515, DOI 10.1016/j.tips.2009.07.006; Khot A, 2004, SPINE, V29, P833, DOI 10.1097/00007632-200404150-00002; Kozela E, 2010, J BIOL CHEM, V285, P1616, DOI 10.1074/jbc.M109.069294; Kwiatkoski M, 2012, NEUROTOX RES, V21, P271, DOI 10.1007/s12640-011-9273-8; Lee S, 2009, CLIN BIOCHEM, V42, P1504, DOI 10.1016/j.clinbiochem.2009.06.017; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Ludwinski FE, 2013, REGEN MED, V8, P75, DOI [10.2217/RME.12.108, 10.2217/rme.12.108]; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; Mechoulam R, 2002, CHEM PHYS LIPIDS, V121, P35, DOI 10.1016/S0009-3084(02)00144-5; Mechoulam R, 2007, CHEM BIODIVERS, V4, P1678, DOI 10.1002/cbdv.200790147; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Moreira FA, 2006, PROG NEURO-PSYCHOPH, V30, P1466, DOI 10.1016/j.pnpbp.2006.06.004; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V50, P1368, DOI 10.1016/j.freeradbiomed.2011.02.021; Napimoga MH, 2009, INT IMMUNOPHARMACOL, V9, P216, DOI 10.1016/j.intimp.2008.11.010; Norcross JP, 2003, J ORTHOPAED RES, V21, P183, DOI 10.1016/S0736-0266(02)00098-0; PEARCE RH, 1991, J RHEUMATOL, V18, P42; Perez Matheus, 2013, Tropical Medicine & International Health, V18, P3424, DOI 10.1111/ejn.12341; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Rock EM, 2008, PSYCHOPHARMACOLOGY, V196, P389, DOI 10.1007/s00213-007-0970-1; Rog DJ, 2005, NEUROLOGY, V65, P812, DOI 10.1212/01.wnl.0000176753.45410.8b; SCHIEBLER ML, 1991, SPINE, V16, P635, DOI 10.1097/00007632-199106000-00007; SIMMONS JW, 1992, SPINE, V17, pS172, DOI 10.1097/00007632-199206001-00019; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558; Sun Z, 2013, MED HYPOTHESES, V81, P477, DOI 10.1016/j.mehy.2013.06.014; Sun Z, 2013, INT J CLIN EXP PATHO, V6, P1009; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; Thompson JP, 1988, T ORTHOP RES SOC, V13, P1; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Wei A, 2009, INT J BIOL SCI, V5, P388; Zajicek J, 2003, LANCET, V362, P1517, DOI 10.1016/S0140-6736(03)14738-1; Zhang YJ, 2008, AM J PHYS MED REHAB, V87, P694, DOI 10.1097/PHM.0b013e31817c1945; Zuardi AW, 2009, J PSYCHOPHARMACOL, V23, P979, DOI 10.1177/0269881108096519	62	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113161	10.1371/journal.pone.0113161	http://dx.doi.org/10.1371/journal.pone.0113161			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517414	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600002
J	Lo, KL; Wang, LC; Chen, IJ; Liu, YC; Chung, MC; Lo, WS				Lo, Kuan-Lin; Wang, Long-Chi; Chen, I-Ju; Liu, Yu-Chen; Chung, Mei-Chu; Lo, Wan-Sheng			Transcriptional Consequence and Impaired Gametogenesis with High-Grade Aneuploidy in Arabidopsis thaliana	PLOS ONE			English	Article							GENE BALANCE HYPOTHESIS; TERTIARY TRISOMICS; CHROMOSOMAL INSTABILITY; PLANT-MITOCHONDRIA; TETRAD ANALYSIS; AURORA KINASES; CELL-DIVISION; DOWN-SYNDROME; COPY-NUMBER; T-DNA	Aneuploidy features a numerical chromosome variant that the number of chromosomes in the nucleus of a cell is not an exact multiple of the haploid number, which may have an impact on morphology and gene expression. Here we report a tertiary trisomy uncovered by characterizing a T-DNA insertion mutant (aur2-1/+) in the Arabidopsis (Arabidopsis thaliana) AURORA2 locus. Whole-genome analysis with DNA tiling arrays revealed a chromosomal translocation linked to the aur2-1 allele, which collectively accounted for a tertiary trisomy 2. Morphologic, cytogenetic and genetic analyses of aur2-1 progeny showed impaired male and female gametogenesis to various degrees and a tight association of the aur2-1 allele with the tertiary trisomy that was preferentially inherited. Transcriptome analysis showed overlapping and distinct gene expression profiles between primary and tertiary trisomy 2 plants, particularly genes involved in response to stress and various types of external and internal stimuli. Additionally, transcriptome and gene ontology analyses revealed an overrepresentation of nuclear-encoded organelle-related genes functionally involved in plastids, mitochondria and peroxisomes that were differentially expressed in at least three if not all Arabidopsis trisomics. These observations support a previous hypothesis that aneuploid cells have higher energy requirement to overcome the detrimental effects of an unbalanced genome. Moreover, our findings extend the knowledge of the complex nature of the T-DNA insertion event influencing plant genomic integrity by creating high-grade trisomy. Finally, gene expression profiling results provide useful information for future research to compare primary and tertiary trisomics for the effects of aneuploidy on plant cell physiology.	[Lo, Kuan-Lin; Chen, I-Ju; Liu, Yu-Chen; Chung, Mei-Chu; Lo, Wan-Sheng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Long-Chi] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University	Lo, WS (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	sunnylo@gate.sinica.edu.tw	liu, yuchen/GYQ-6286-2022		Ministry of Science and Technology (NSC) [101-2311-B-001-029-MY3]; Institute of Plant and Microbial Biology, Academia Sinica, Taiwan	Ministry of Science and Technology (NSC); Institute of Plant and Microbial Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This research was funded in part by grants from the Ministry of Science and Technology (NSC 101-2311-B-001-029-MY3) and Institute of Plant and Microbial Biology, Academia Sinica, Taiwan, to WSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla E. R, 2010, ARABIDOPSIS BOOK, V8, pe0127, DOI [DOI 10.1199/TAB.0127, 10.1199/tab.0127]; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Birchler JA, 2014, METHODS MOL BIOL, V1112, P25, DOI 10.1007/978-1-62703-773-0_2; Birchler JA, 2010, NEW PHYTOL, V186, P54, DOI 10.1111/j.1469-8137.2009.03087.x; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Braddock SR, 2000, AM J MED GENET, V92, P311, DOI 10.1002/1096-8628(20000619)92:5<311::AID-AJMG4>3.0.CO;2-7; Cai XW, 2007, CURR GENOMICS, V8, P151, DOI 10.2174/138920207780833847; Cataldo AM, 2003, J NEUROSCI, V23, P6788; CHAN CSM, 1993, GENETICS, V135, P677; Chang YC, 2009, J AM SOC HORTIC SCI, V134, P567, DOI 10.21273/JASHS.134.5.567; Chen YCS, 1996, DEVELOPMENT, V122, P3243; Chung MC, 2008, THEOR APPL GENET, V116, P745, DOI 10.1007/s00122-007-0705-z; Copenhaver GP, 2000, PLANT PHYSIOL, V124, P7, DOI 10.1104/pp.124.1.7; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eberhard S, 2002, PLANT J, V31, P149, DOI 10.1046/j.1365-313X.2002.01340.x; Fan LM, 2001, J EXP BOT, V52, P1603, DOI 10.1093/jexbot/52.361.1603; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huettel B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000226; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KHUSH GS, 1967, CAN J GENET CYTOL, V9, P610, DOI 10.1139/g67-066; KOORNNEEF M, 1983, GENETICA, V61, P41, DOI 10.1007/BF00563230; Koornneef M, 2003, CHROMOSOME RES, V11, P183, DOI 10.1023/A:1022827624082; Kosterin OE, 2009, EUPHYTICA, V166, P109, DOI 10.1007/s10681-008-9843-x; KUMAR RS, 1985, CYTOLOGIA, V50, P433, DOI 10.1508/cytologia.50.433; LADIZINSKY G, 1990, EUPHYTICA, V51, P179; Law SR, 2012, PLANT PHYSIOL, V158, P1610, DOI 10.1104/pp.111.192351; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Makarevitch I, 2010, PLANT PHYSIOL, V152, P927, DOI 10.1104/pp.109.150466; Manchado E, 2012, CELL DEATH DIFFER, V19, P369, DOI 10.1038/cdd.2011.197; MATZKE MA, 1994, MOL GEN GENET, V245, P471, DOI 10.1007/BF00302260; Matzke MA, 2003, TRENDS GENET, V19, P253, DOI 10.1016/S0168-9525(03)00057-X; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; OHBA T, 1995, PLANT J, V7, P157, DOI 10.1046/j.1365-313X.1995.07010157.x; Oromendia AB, 2014, DIS MODEL MECH, V7, P15, DOI 10.1242/dmm.013391; Oromendia AB, 2012, GENE DEV, V26, P2696, DOI 10.1101/gad.207407.112; Papp I, 1996, PLANT J, V10, P469, DOI 10.1046/j.1365-313X.1996.10030469.x; Park SK, 1998, DEVELOPMENT, V125, P3789; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Pogson BJ, 2008, TRENDS PLANT SCI, V13, P602, DOI 10.1016/j.tplants.2008.08.008; PREUSS D, 1994, SCIENCE, V264, P1458, DOI 10.1126/science.8197459; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; SEARS LMS, 1970, CAN J GENET CYTOL, V12, P217, DOI 10.1139/g70-032; Sheltzer JM, 2013, CANCER RES, V73, P6401, DOI 10.1158/0008-5472.CAN-13-0749; Sheltzer JM, 2012, P NATL ACAD SCI USA, V109, P12644, DOI 10.1073/pnas.1209227109; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Sheltzer JM, 2011, SCIENCE, V333, P1026, DOI 10.1126/science.1206412; Siegel JJ, 2012, ANNU REV CELL DEV BI, V28, P189, DOI 10.1146/annurev-cellbio-101011-155807; Singh RJ., 1993, PLANT CYTOGENETICS; STANDRING LS, 1990, EUPHYTICA, V47, P71, DOI 10.1007/BF00040366; Storchova Z, 2012, ANEUPLOIDY HLTH DIS; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Van Damme D, 2011, PLANT CELL, V23, P4013, DOI 10.1105/tpc.111.089565; Vizir IY, 1999, J HERED, V90, P412, DOI 10.1093/jhered/90.3.412; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032	70	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114617	10.1371/journal.pone.0114617	http://dx.doi.org/10.1371/journal.pone.0114617			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514186	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300017
J	Fu, JY; Han, BY; Xiao, Q				Fu, Jian-Yu; Han, Bao-Yu; Xiao, Qiang			Mitochondrial COI and 16sRNA Evidence for a Single Species Hypothesis of E-vitis, J-formosana and E-onukii in East Asia	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; LEAFHOPPER; CICADELLIDAE; PHYLOGENY; HEMIPTERA; TEA; ALEYRODIDAE; APHELINIDAE; HYMENOPTERA; EVOLUTION	Tea green leafhopper is one of the most damaging tea pests in main tea production regions of East Asia. For lack of recognized morphological characters, the dominant species of tea green leafhoppers in Mainland China, Taiwan and Japan have always been named as Empoasca vitis Gothe, Jacobiasca formosana Paoli and Empoasca onukii MATSUDA, respectively. Furthermore, nothing is known about the genetic relationships among them. In this study, we collected six populations from Mainland China, four populations from Japan and one population from Taiwan, and examined the genetic distances in the COI and 16sRNA regions of mtDNA among them. The results showed that the genetic distances based on single gene or the combined sequences among eleven leafhopper populations were 0.3-1.2%, which were all less than the species boundary of 2%. Moreover, there were at least two haplotypes shared by two distinct populations from different regions. The phylogenetic analysis based on single gene or combined sets also supported that tea green leafhoppers from Mainland China, Taiwan and Japan were closely related to each other, and there were at least two specimens from different regions clustered ahead of those from the same region. Therefore, we propose that the view of recognizing the dominant species of tea green leafhoppers in three adjacent tea production regions of East Asia as different species is unreliable or questionable and suggest that they are a single species.	[Fu, Jian-Yu; Xiao, Qiang] Chinese Acad Agr Sci, Minist Agr, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China; [Fu, Jian-Yu] Chinese Acad Agr Sci, Grad Sch, Beijing 100081, Peoples R China; [Han, Bao-Yu] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou 310018, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; China Jiliang University	Fu, JY (corresponding author), Chinese Acad Agr Sci, Minist Agr, Tea Res Inst, Key Lab Tea Plants Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China.	mybatigoal@mail.tricaas.com; han-insect@263.net			National Natural Science Foundation of China [31470693, 31100503]; Zhejiang Province [2013C32086]; Fundamental Research Funds of National Nonprofit Research Institute for Tea Research Institute, CAAS [0032014014]; Natural Science Foundation of Zhejiang province, China [Y3080150]; Fundamental Research Funds of National Science and Technology [2013FY113200]; Key Innovation Team of Zhejiang Province [2011R09027-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province; Fundamental Research Funds of National Nonprofit Research Institute for Tea Research Institute, CAAS; Natural Science Foundation of Zhejiang province, China(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds of National Science and Technology; Key Innovation Team of Zhejiang Province	This work was supported by the National Natural Science Foundation of China (31470693, 31100503), the public technology application research of Zhejiang Province (2013C32086), the Fundamental Research Funds of National Nonprofit Research Institute for Tea Research Institute, CAAS, (0032014014), the Natural Science Foundation of Zhejiang province, China (Y3080150), the Fundamental Research Funds of National Science and Technology (2013FY113200), and the Key Innovation Team of Zhejiang Province (Grant No. 2011R09027-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boykin LM, 2006, B ENTOMOL RES, V96, P457, DOI 10.1079/BER2006438; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Castalanelli MA, 2012, B ENTOMOL RES, V102, P17, DOI 10.1017/S0007485311000319; Cho JY, 2007, BIOSCI BIOTECH BIOCH, V71, P1476, DOI 10.1271/bbb.60708; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Dietrich CH, 1997, MOL PHYLOGENET EVOL, V8, P139, DOI 10.1006/mpev.1997.0415; FANG QQ, 1993, MOL PHYLOGENET EVOL, V2, P119, DOI 10.1006/mpev.1993.1012; Fu JY, 2005, B SCI TECHNOL, V5, P550; Ge ZLZ (, 1988, J TEA BUSINESS, P15; Hazarika LK, 2009, ANNU REV ENTOMOL, V54, P267, DOI 10.1146/annurev.ento.53.103106.093359; Hicks AL, 1996, P ENTOMOL SOC WASH, V98, P145; Jin Miao, 2007, Acta Ecologica Sinica, V27, P3973, DOI 10.1016/S1872-2032(07)60083-3; Johnson DG, 2005, ANN ENTOMOL SOC AM, V98, P165, DOI 10.1603/0013-8746(2005)098[0165:POLSEE]2.0.CO;2; Li Le, 2013, Chinese Journal of Applied Entomology, V50, P675, DOI 10.7679/j.issn.2095-1353.2013.095; Lozier JD, 2009, B ENTOMOL RES, V99, P83, DOI 10.1017/S0007485308006147; Matsuda R., 1952, Oyo-Kontyu Tokyo, V8, P19; Mochizuki M., 1994, Bulletin of the National Research Institute of Vegetables, Ornamental Plants and Tea. Series B, P29; Monti MM, 2005, B ENTOMOL RES, V95, P401, DOI 10.1079/BER2005371; Mu D, 2012, INSECT SCI, V19, P229, DOI 10.1111/j.1744-7917.2011.01476.x; Oman P. W., 1990, Leafhoppers (Cicadellidae): A bibliography, generic check-list and index to the world literature 1956-1985.; Paoli G, 1932, MEMORIES ITALIA ENTO, P109; Polaszek A, 2004, ZOOL SCR, V33, P403, DOI 10.1111/j.0300-3256.2004.00161.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith PT, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.41; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zhang HH, 2004, TEA PESTS NONPOLLUTI, P3; Zhao DongXiang, 2000, Journal of Tea Science, V20, P101	31	23	33	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115259	10.1371/journal.pone.0115259	http://dx.doi.org/10.1371/journal.pone.0115259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506929	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100066
J	Gilbert, M; Koel, BF; Bestebroer, TM; Lewis, NS; Smith, DJ; Fouchier, RAM				Gilbert, Martin; Koel, Bjorn F.; Bestebroer, Theo M.; Lewis, Nicola S.; Smith, Derek J.; Fouchier, Ron A. M.			Serological Evidence for Non-Lethal Exposures of Mongolian Wild Birds to Highly Pathogenic Avian Influenza H5N1 Virus	PLOS ONE			English	Article							A VIRUSES; EXPERIMENTAL-INFECTION; MIGRATORY WATERFOWL; GENETIC EVOLUTION; NORTHERN EUROPE; ASIAN LINEAGE; HONG-KONG; ANTIBODIES; GEESE; DUCKS	Surveillance for highly pathogenic avian influenza viruses (HPAIV) in wild birds is logistically demanding due to the very low rates of virus detection. Serological approaches may be more cost effective as they require smaller sample sizes to identify exposed populations. We hypothesized that antigenic differences between classical Eurasian H5 subtype viruses (which have low pathogenicity in chickens) and H5N1 viruses of the Goose/Guangdong/96 H5 lineage (which are HPAIV) may be used to differentiate populations where HPAIVs have been circulating, from those where they have not. To test this we performed hemagglutination inhibition assays to compare the reactivity of serum samples from wild birds in Mongolia (where HPAIV has been circulating, n= 1,832)and Europe (where HPAIV has been rare or absent, n=497) to a panel of reference viruses including classical Eurasian H5 (of low pathogenicity), and five HPAIV H5N1 antigens of the Asian lineage A/Goose/Guangdong/1/96. Antibody titres were detected against at least one of the test antigens for 182 Mongolian serum samples (total seroprevalence of 0.10, n=1,832, 95% adjusted Wald confidence limits of 0.09-0.11) and 25 of the European sera tested (total seroprevalence of 0.05, n=497, 95% adjusted Wald confidence limits of 0.03-0.07). A bias in antibody titres to HPAIV antigens was found in the Mongolian sample set (22/182) that was absent in the European sera (0/25). Although the interpretation of serological data from wild birds is complicated by the possibility of exposure to multiple strains, and variability in the timing of exposure, these findings suggest that a proportion of the Mongolian population had survived exposure to HPAIV, and that serological assays may enhance the targeting of traditional HPAIV surveillance toward populations where isolation of HPAIV is more likely.	[Gilbert, Martin] Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA; [Gilbert, Martin] Univ Glasgow, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Koel, Bjorn F.; Bestebroer, Theo M.; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, NL-3015 GE Rotterdam, Netherlands; [Lewis, Nicola S.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Wildlife Conservation Society; University of Glasgow; Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Gilbert, M (corresponding author), Wildlife Conservat Soc, 2300 Southern Blvd, Bronx, NY 10460 USA.	mgilbert@wcs.org	Smith, Derek/Z-3075-2019; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Gilbert, Martin/0000-0002-9930-4383	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH); Department of Health and Human Services [HHSN266200700007C, HHSN266200700010C]; Biotechnology and Biological Sciences Research Council [BB/F016786/1]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this work was provided by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), and the Department of Health and Human Services under contracts HHSN266200700007C and HHSN266200700010C. Further support was provided through a doctoral training grant to MG by the Biotechnology and Biological Sciences Research Council (BB/F016786/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berhane Y, 2010, AVIAN DIS, V54, P548, DOI 10.1637/8841-040309-Reg.1; Berhane Y, 2014, J WILDLIFE DIS, V50, P84, DOI 10.7589/2012-09-237; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; *BRIT TRUST ORN, 2012, MIGRATION MAPPING TO; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Brown JD, 2010, J WILDLIFE DIS, V46, P896, DOI 10.7589/0090-3558-46.3.896; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; Daly JM, 1996, J GEN VIROL, V77, P661, DOI 10.1099/0022-1317-77-4-661; Dowdle W.A., 1979, DIAGNOSTIC PROCEDURE, V5th ed., P585; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; *EMPR, 2012, H5N1 HPAI GLOBAL OVE, P1; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Fransson T., 2010, EURING LIST LONGEVIT; Gilbert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044097; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Hall JS, 2011, INFLUENZA OTHER RESP, V5, P365, DOI 10.1111/j.1750-2659.2011.00238.x; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoye BJ, 2010, EMERG INFECT DIS, V16, P1827, DOI 10.3201/eid1612.100589; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Ishtiaq F, 2012, J WILDLIFE DIS, V48, P768, DOI 10.7589/0090-3558-48.3.768; Kalthoff D, 2008, EMERG INFECT DIS, V14, P1267, DOI 10.3201/eid1408.080078; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Kwon YK, 2010, VET PATHOL, V47, P495, DOI 10.1177/0300985809359602; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Nemeth NM, 2013, VET PATHOL, V50, P961, DOI 10.1177/0300985813490758; Sakoda Y, 2010, VIROLOGY, V406, P88, DOI 10.1016/j.virol.2010.07.007; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; UNDERWOOD PA, 1982, J GEN VIROL, V62, P153, DOI 10.1099/0022-1317-62-1-153; Wallensten A, 2006, VACCINE, V24, P6734, DOI 10.1016/j.vaccine.2006.05.057; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; *WHO, 2011, UPDATED UNIFIED NOME	38	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e113569	10.1371/journal.pone.0113569	http://dx.doi.org/10.1371/journal.pone.0113569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502318	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000346607100006
J	Rizk, SM; El-Maraghy, SA; Nassar, NN				Rizk, Sherine M.; El-Maraghy, Shohda A.; Nassar, Noha N.			A Novel Role for SIRT-1 in L-Arginine Protection against STZ Induced Myocardial Fibrosis in Rats	PLOS ONE			English	Article							NF-KAPPA-B; TRANSFORMING GROWTH FACTOR-BETA(1); INSULIN-RESISTANCE; TNF-ALPHA; DIABETIC CARDIOMYOPATHY; CARDIAC FIBROBLASTS; COLLAGEN PRODUCTION; INDUCED APOPTOSIS; END-PRODUCTS; FAS LIGAND	Background: L-arginine (L-ARG) effectively protects against diabetic impediments. In addition, silent information regulator (SIRT-1) activators are emerging as a new clinical concept in treating diabetic complications. Accordingly, this study aimed at delineating a role for SIRT-1 in mediating L-ARG protection against streptozotocin (STZ) induced myocardial fibrosis. Methods: Male Wistar rats were allocated into five groups; (i) normal control rats received 0.1 M sodium citrate buffer (pH 4.5); (ii) STZ at the dose of 60 mg/kg dissolved in 0.1 M sodium citrate buffer (pH 4.5); (iii) STZ + sirtinol (Stnl; specific inhibitor of SIRT-1; 2 mg/Kg, i.p.); (iv) STZ + L-ARG given in drinking water (2.25%) or (v) STZ + L-ARG + Stnl. Results: L-ARG increased myocardial SIRT-1 expression as well as its protein content. The former finding was paralleled by L-ARG induced reduction in myocardial fibrotic area compared to STZ animals evidenced histopathologically. The reduction in the fibrotic area was accompanied by a decline in fibrotic markers as evident by a decrease in expression of collagen-1 along with reductions in myocardial TGF-beta, fibronectin, CTGF and BNP expression together with a decrease in TGF-beta and hydroxyproline contents. Moreover, L-ARG increased MMP-2 expression in addition to its protein content while decreasing expression of PAI-1. Finally, L-ARG protected against myocardial cellular death by reduction in NF kappa-B mRNA as well as TNF-alpha level in association with decline in Casp-3 and FAS expressions andCasp-3protein content in addition to reduction of FAS positive cells. However, co-administration of L-ARG and Stnl diminished the protective effect of L-ARG against STZ induced myocardial fibrosis. Conclusion: Collectively, these findings associate a role for SIRT-1 in L-ARG defense against diabetic cardiac fibrosis via equilibrating the balance between profibrotic and antifibrotic mediators.	[Rizk, Sherine M.; El-Maraghy, Shohda A.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Nassar, Noha N.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Nassar, NN (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	noha.nnassar@pharma.cu.edu.eg						Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Baker BJ, 2010, GLIA, V58, P1082, DOI 10.1002/glia.20989; Bergman MR, 2007, AM J PHYSIOL-HEART C, V292, pH1847, DOI 10.1152/ajpheart.00434.2006; BISSE E, 1985, J CHROMATOGR, V344, P81, DOI 10.1016/S0378-4347(00)82009-5; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Ortiz MD, 2013, NEUROCHEM RES, V38, P2570, DOI 10.1007/s11064-013-1172-3; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Gray S, 2011, TRENDS ENDOCRIN MET, V22, P394, DOI 10.1016/j.tem.2011.05.001; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315; Hernandez-Jimenez M, 2013, STROKE, V44, P2333, DOI 10.1161/STROKEAHA.113.001715; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Hutchinson KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072080; Huynh K, 2010, DIABETES, V59, P1512, DOI 10.2337/db09-1456; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; James LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070441; Jesmin S, 2005, MOL CELL BIOCHEM, V272, P63, DOI 10.1007/s11010-005-7635-3; Kain V, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-82; Kar Manoj, 1999, Indian Journal of Experimental Biology, V37, P190; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Kiener PA, 1997, J IMMUNOL, V159, P1594; Kohda Y, 2008, J TOXICOL SCI, V33, P459, DOI 10.2131/jts.33.459; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Lee YJ, 2001, ONCOGENE, V20, P1476, DOI 10.1038/sj.onc.1204225; Lijnen P, 2002, METHOD FIND EXP CLIN, V24, P333, DOI 10.1358/mf.2002.24.6.693065; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Liu CT, 2005, NUTRITION, V21, P615, DOI 10.1016/j.nut.2004.09.020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miguel-Carrasco JL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/726940; Luo L, 2013, J SURG RES, V179, pE255, DOI 10.1016/j.jss.2012.02.059; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Mendez JD, 2006, BIOMED PHARMACOTHER, V60, P26, DOI 10.1016/j.biopha.2005.08.004; Mohan IK, 1998, FREE RADICAL BIO MED, V25, P757, DOI 10.1016/S0891-5849(98)00129-4; Nagaya N, 2001, AM J RESP CRIT CARE, V163, P887, DOI 10.1164/ajrccm.163.4.2007116; Nelson DP, 2000, J CLIN INVEST, V105, P1199, DOI 10.1172/JCI8212; Pai MH, 2010, BRIT J NUTR, V104, P686, DOI 10.1017/S000711451000111X; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Perez Gutierrez RM, 2014, PHARM BIOL, P1; Petrov VV, 2002, HYPERTENSION, V39, P258, DOI 10.1161/hy0202.103268; Piatti P, 2001, DIABETES CARE, V24, P875, DOI 10.2337/diacare.24.5.875; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pulla VK, 2012, EXPERT OPIN THER TAR, V16, P819, DOI 10.1517/14728222.2012.703656; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sklavounou E, 2006, BIOCHEM BIOPH RES CO, V347, P420, DOI 10.1016/j.bbrc.2006.06.087; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Suboj P, 2012, EUR J PHARM SCI, V45, P581, DOI 10.1016/j.ejps.2011.12.012; Szulinska M, 2014, EUR REV MED PHARMACO, V18, P575; Takahashi T, 2007, INT HEART J, V48, P637, DOI 10.1536/ihj.48.637; Tan BE, 2012, FRONT BIOSCI-LANDMRK, V17, P2237, DOI 10.2741/4047; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang WR, 2013, EXP CELL RES, V319, P1523, DOI 10.1016/j.yexcr.2013.04.007; Wang WR, 2013, APOPTOSIS, V18, P689, DOI 10.1007/s10495-013-0833-7; Way KJ, 2002, DIABETES, V51, P2709, DOI 10.2337/diabetes.51.9.2709; Westermann D, 2007, DIABETES, V56, P641, DOI 10.2337/db06-1163; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010; Yang JH, 2011, ARCH MED RES, V42, P354, DOI 10.1016/j.arcmed.2011.07.005; Yang Y, 2013, FREE RADICAL BIO MED, V65, P667, DOI 10.1016/j.freeradbiomed.2013.07.007; Zagotta I, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/793525; Zhang L, 2008, DIABETES, V57, P2158, DOI 10.2337/db08-0140	68	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114560	10.1371/journal.pone.0114560	http://dx.doi.org/10.1371/journal.pone.0114560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501750	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400036
J	Ratnam, J; Zdrazil, B; Digles, D; Cuadrado-Rodriguez, E; Neefs, JM; Tipney, H; Siebes, R; Waagmeester, A; Bradley, G; Chau, CH; Richter, L; Brea, J; Evelo, CT; Jacoby, E; Senger, S; Loza, MI; Ecker, GF; Chichester, C				Ratnam, Joseline; Zdrazil, Barbara; Digles, Daniela; Cuadrado-Rodriguez, Emiliano; Neefs, Jean-Marc; Tipney, Hannah; Siebes, Ronald; Waagmeester, Andra; Bradley, Glyn; Chau, Chau Han; Richter, Lars; Brea, Jose; Evelo, Chris T.; Jacoby, Edgar; Senger, Stefan; Isabel Loza, Maria; Ecker, Gerhard F.; Chichester, Christine			The Application of the Open Pharmacological Concepts Triple Store (Open PHACTS) to Support Drug Discovery Research	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; CHEMICAL ENTITIES; GENE ONTOLOGY; HYP MICE; DATABASE; CANCER; PROTEIN; IDENTIFICATION; EXPRESSION	Integration of open access, curated, high-quality information from multiple disciplines in the Life and Biomedical Sciences provides a holistic understanding of the domain. Additionally, the effective linking of diverse data sources can unearth hidden relationships and guide potential research strategies. However, given the lack of consistency between descriptors and identifiers used in different resources and the absence of a simple mechanism to link them, gathering and combining relevant, comprehensive information from diverse databases remains a challenge. The Open Pharmacological Concepts Triple Store (Open PHACTS) is an Innovative Medicines Initiative project that uses semantic web technology approaches to enable scientists to easily access and process data from multiple sources to solve real-world drug discovery problems. The project draws together sources of publicly-available pharmacological, physicochemical and biomolecular data, represents it in a stable infrastructure and provides well-defined information exploration and retrieval methods. Here, we highlight the utility of this platform in conjunction with workflow tools to solve pharmacological research questions that require interoperability between target, compound, and pathway data. Use cases presented herein cover 1) the comprehensive identification of chemical matter for a dopamine receptor drug discovery program 2) the identification of compounds active against all targets in the Epidermal growth factor receptor (ErbB) signaling pathway that have a relevance to disease and 3) the evaluation of established targets in the Vitamin D metabolism pathway to aid novel Vitamin D analogue design. The example workflows presented illustrate how the Open PHACTS Discovery Platform can be used to exploit existing knowledge and generate new hypotheses in the process of drug discovery.	[Ratnam, Joseline; Cuadrado-Rodriguez, Emiliano; Brea, Jose; Isabel Loza, Maria] Univ Santiago de Compostela, Grp BioFarma USEF, Dept Farmacol, Santiago De Compostela 15782, Spain; [Zdrazil, Barbara; Digles, Daniela; Richter, Lars; Ecker, Gerhard F.] Univ Vienna, Dept Pharmaceut Chem, A-1090 Vienna, Austria; [Neefs, Jean-Marc; Jacoby, Edgar] Janssen Res & Dev, Beerse, Belgium; [Chichester, Christine] Swiss Inst Bioinformat, CALIPHO Grp, CH-1211 Geneva 4, Switzerland; [Tipney, Hannah; Bradley, Glyn; Chau, Chau Han; Senger, Stefan] GSK Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Siebes, Ronald] Vrije Univ Amsterdam, Fac Sci, Div Math & Comp Sci, NL-1081 HV Amsterdam, Netherlands; [Waagmeester, Andra; Evelo, Chris T.] Maastricht Univ, Dept Bioinformat BiGCaT, NL-6200 MD Maastricht, Netherlands	Universidade de Santiago de Compostela; University of Vienna; Johnson & Johnson; Janssen Pharmaceuticals; Swiss Institute of Bioinformatics; GlaxoSmithKline; Vrije Universiteit Amsterdam; Maastricht University	Ratnam, J (corresponding author), Univ Santiago de Compostela, Grp BioFarma USEF, Dept Farmacol, Campus Univ Sur S-N, Santiago De Compostela 15782, Spain.	joselinepriya.ratnam@usc.es	Brea, Jose/ABH-3260-2020; Digles, Daniela/GRF-4866-2022; Richter, Lars/D-3426-2017; Evelo, Chris TA/D-2914-2009; Zdrazil, Barbara/F-1021-2013	Digles, Daniela/0000-0001-5934-3559; Richter, Lars/0000-0002-9417-9042; Evelo, Chris TA/0000-0002-5301-3142; Zdrazil, Barbara/0000-0001-9395-1515; Loza Garcia, Maria Isabel/0000-0003-4730-0863; Brea, Jose/0000-0002-5523-1979; Ecker, Gerhard/0000-0003-4209-6883; Waagmeester, Andra/0000-0001-9773-4008; Senger, Stefan/0000-0002-7188-9607	Innovative Medicines Initiative Joint Undertaking [115191]; European Union's Seventh Framework Programme (FP7); EFPIA (European Federation of Pharmaceutical Industries and Associations) companies	Innovative Medicines Initiative Joint Undertaking; European Union's Seventh Framework Programme (FP7); EFPIA (European Federation of Pharmaceutical Industries and Associations) companies	This work received support from the Innovative Medicines Initiative Joint Undertaking (http://www.imi.europa.eu) under grant agreement no. 115191, the resources of which were composed of a financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013). Co-authors Jean-Marc Neefs and Edgar Jacoby are employed by Janssen Research & Development. Co-authors Hannah Tipney, Glyn Bradley, Chau Han Chau and Stefan Senger are employed by GSK Medicines Research Centre. This study was funded, in part, by an in-kind contribution from EFPIA (European Federation of Pharmaceutical Industries and Associations) companies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, 2010, PIP PIL; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson MG, 2006, CANCER CHEMOTH PHARM, V57, P234, DOI 10.1007/s00280-005-0059-7; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Asano L, 2013, FEBS LETT, V587, P957, DOI 10.1016/j.febslet.2013.02.028; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azzaoui K, 2013, DRUG DISCOV TODAY, V18, P843, DOI 10.1016/j.drudis.2013.05.008; Baeke F, 2007, NUTR RES REV, V20, P106, DOI 10.1017/S0954422407742713; Bai XY, 2007, ENDOCRINOLOGY, V148, P4974, DOI 10.1210/en.2007-0243; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; Bender A, 2007, COMB CHEM HIGH T SCR, V10, P719, DOI 10.2174/138620707782507313; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280; Blach-Olszewska Zofia, 2007, Neuropsychiatr Dis Treat, V3, P365; Boehm MF, 1999, CHEM BIOL, V6, P265, DOI 10.1016/S1074-5521(99)80072-6; BROWN A, 2008, LANDSCOPE, V23, P29; Chen B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-255; Chichester C, 2011, COLLABORATIVE COMPUT, P453; CIVELLI O, 1993, ANNU REV PHARMACOL, V33, P281, DOI 10.1146/annurev.pa.33.040193.001433; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Fleet J. C., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P336; Fleet JC, 2008, MOL ASPECTS MED, V29, P388, DOI 10.1016/j.mam.2008.07.003; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Gondi CS, 2009, INT J ONCOL, V35, P257, DOI 10.3892/ijo_00000335; Gray AJG, 2014, SEMANT WEB, V5, P101, DOI 10.3233/SW-2012-0088; Gregori-Puigjane E, 2012, P NATL ACAD SCI USA, V109, P11178, DOI 10.1073/pnas.1204524109; Hardy B, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-7; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hettne KM, 2010, J CHEMINFORMATICS, V2, DOI [10.1186/1758-2946-2-3, 10.1186/1758-2946-2-4]; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; HOLICK MF, 1971, P NATL ACAD SCI USA, V68, P803, DOI 10.1073/pnas.68.4.803; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Larriba MJ, 2010, J STEROID BIOCHEM, V121, P106, DOI 10.1016/j.jsbmb.2010.01.014; Larriba MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010221; Larriba MJ, 2009, CARCINOGENESIS, V30, P1459, DOI 10.1093/carcin/bgp140; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kedjouar B, 2004, J BIOL CHEM, V279, P34048, DOI 10.1074/jbc.M405230200; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Lanfear J, 2002, NAT REV DRUG DISCOV, V1, P479, DOI 10.1038/nrd832; Loizou A, 2014, J WEB SEM UNPUB  JUN; Luo W, 2013, J STEROID BIOCHEM, V136, P252, DOI 10.1016/j.jsbmb.2012.09.031; Ma YF, 2006, J CLIN INVEST, V116, P892, DOI 10.1172/JCI25901; Mathieu C, 2002, TRENDS MOL MED, V8, P174, DOI 10.1016/S1471-4914(02)02294-3; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Perakyla M, 2005, MOL ENDOCRINOL, V19, P2060, DOI 10.1210/me.2004-0417; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Ridolfi E, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/939786; ROY S, 1994, ENDOCRINOLOGY, V134, P1761, DOI 10.1210/en.134.4.1761; Saito N, 2009, BIOORGAN MED CHEM, V17, P4296, DOI 10.1016/j.bmc.2009.05.032; Samwald M, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-19; Seeman Philip, 2010, Clin Schizophr Relat Psychoses, V4, P56, DOI 10.3371/CSRP.4.1.5; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Swann SL, 2002, J AM CHEM SOC, V124, P13795, DOI 10.1021/ja0268377; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhou XM, 1999, J MED CHEM, V42, P3539, DOI 10.1021/jm980736v	68	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115460	10.1371/journal.pone.0115460	http://dx.doi.org/10.1371/journal.pone.0115460			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522365	gold, Green Submitted, Green Published			2022-12-27	WOS:000348845600049
J	Heurich, M; Hilger, A; Kuchenhoff, H; Andren, H; Bufka, L; Krofel, M; Mattisson, J; Odden, J; Persson, J; Rauset, GR; Schmidt, K; Linnell, JDC				Heurich, Marco; Hilger, Anton; Kuechenhoff, Helmut; Andren, Henrik; Bufka, Ludek; Krofel, Miha; Mattisson, Jenny; Odden, John; Persson, Jens; Rauset, Geir R.; Schmidt, Krzysztof; Linnell, John D. C.			Activity Patterns of Eurasian Lynx Are Modulated by Light Regime and Individual Traits over a Wide Latitudinal Range	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; DEER CAPREOLUS-CAPREOLUS; ROE DEER; NATIONAL-PARK; HOME-RANGE; RED DEER; CIRCADIAN ACTIVITY; MOVEMENT PATTERNS; TROPHIC CASCADE; BEHAVIOR	The activity patterns of most terrestrial animals are regarded as being primarily influenced by light, although other factors, such as sexual cycle and climatic conditions, can modify the underlying patterns. However, most activity studies have been limited to a single study area, which in turn limit the variability of light conditions and other factors. Here we considered a range of variables that might potentially influence the activity of a large carnivore, the Eurasian lynx, in a network of studies conducted with identical methodology in different areas spanning latitudes from 49 degrees 7'N in central Europe to 70 degrees 00'N in northern Scandinavia. The variables considered both light conditions, ranging from a day with a complete day-night cycle to polar night and polar day, as well as individual traits of the animals. We analysed activity data of 38 individual free-ranging lynx equipped with GPS-collars with acceleration sensors, covering more than 11,000 lynx days. Mixed linear additive models revealed that the lynx activity level was not influenced by the daily daylight duration and the activity pattern was bimodal, even during polar night and polar day. The duration of the active phase of the activity cycle varied with the widening and narrowing of the photoperiod. Activity varied significantly with moonlight. Among adults, males were more active than females, and subadult lynx were more active than adults. In polar regions, the amplitude of the lynx daily activity pattern was low, likely as a result of the polycyclic activity pattern of their main prey, reindeer. At lower latitudes, the basic lynx activity pattern peaked during twilight, corresponding to the crepuscular activity pattern of the main prey, roe deer. Our results indicated that the basic activity of lynx is independent of light conditions, but is modified by both individual traits and the activity pattern of the locally most important prey.	[Heurich, Marco] Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany; [Heurich, Marco] Univ Freiburg, Chair Wildlife Ecol & Management, D-79106 Freiburg, Germany; [Hilger, Anton; Kuechenhoff, Helmut] Univ Munich, Stat Consulting Unit, Dept Stat, Munich, Germany; [Andren, Henrik; Persson, Jens; Rauset, Geir R.] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Bufka, Ludek] Sumava Natl Pk Adm, Dept Res & Nat Protect, Kasperske Hory, Czech Republic; [Krofel, Miha] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Mattisson, Jenny; Odden, John; Linnell, John D. C.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Schmidt, Krzysztof] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland	University of Freiburg; University of Munich; Swedish University of Agricultural Sciences; University of Ljubljana; Norwegian Institute Nature Research; Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences	Heurich, M (corresponding author), Bavarian Forest Natl Pk, Dept Conservat & Res, Grafenau, Germany.	marco.heurich@npv-bw.bayern.de	Schmidt, Krzysztof/L-6437-2013; Krofel, Miha/I-4495-2019; Andrén, Henrik/C-8995-2015; Linnell, John/V-4177-2019; Rauset, Geir Rune/F-8961-2016; Rauset, Geir Rune/AAF-5435-2021; Odden, John/F-6088-2019; Mattisson, Jenny/X-4750-2019; Heurich, Marco/O-4653-2014	Krofel, Miha/0000-0002-2010-5219; Linnell, John/0000-0002-8370-5633; Rauset, Geir Rune/0000-0002-6345-3029; Rauset, Geir Rune/0000-0002-6345-3029; Odden, John/0000-0002-6275-8648; Mattisson, Jenny/0000-0001-6032-5307; Heurich, Marco/0000-0003-0051-2930; Persson, Jens/0000-0003-1405-7561; Kuchenhoff, Helmut/0000-0002-6372-2487; Andren, Henrik/0000-0002-5616-2426; Schmidt, Krzysztof/0000-0002-9043-291X	EU; Bavarian Forest National Park Administration; Swedish Environmental Protection Agency; Norwegian Environmental agency; Research Council of Norway; Nature Protection Divisions of the County Governor's Offices in Finnmark; Troms; Buskerud; Oppland; Telemark; Vestfold (Norway); Reindeer Development Fund in Norway; Carnivore Management Boards in regions 2, 3 and 8 (Norway); World Wide Fund for Nature (Sweden); Swedish Research Council; private foundation Marie-Claire Cronstedts Stiftelse	EU(European Commission); Bavarian Forest National Park Administration; Swedish Environmental Protection Agency; Norwegian Environmental agency; Research Council of Norway(Research Council of Norway); Nature Protection Divisions of the County Governor's Offices in Finnmark; Troms; Buskerud; Oppland; Telemark; Vestfold (Norway); Reindeer Development Fund in Norway; Carnivore Management Boards in regions 2, 3 and 8 (Norway); World Wide Fund for Nature (Sweden); Swedish Research Council(Swedish Research CouncilEuropean Commission); private foundation Marie-Claire Cronstedts Stiftelse	Financial support was provided by the EU program Interreg IV (Ziel 3), the Bavarian Forest National Park Administration, the Swedish Environmental Protection Agency, the Norwegian Environmental agency, the Research Council of Norway, the Nature Protection Divisions of the County Governor's Offices in Finnmark, Troms, Buskerud, Oppland, Telemark and Vestfold (Norway), the Reindeer Development Fund in Norway, the Carnivore Management Boards in regions 2, 3 and 8 (Norway), the World Wide Fund for Nature (Sweden), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) and the private foundation Marie-Claire Cronstedts Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale SB, 2009, ISR J ECOL EVOL, V55, P315, DOI 10.1560/IJEE.55.4.315; Andren H, 2006, BIOL CONSERV, V131, P23, DOI 10.1016/j.biocon.2006.01.025; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; Arnemo JM, 2011, BIOMEDICAL PROTOCOL; ASCHOFF J, 1954, NATURWISSENSCHAFTEN, V41, P49, DOI 10.1007/BF00634164; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beltran J, 1988, THESIS U SEVILLE; BELTRAN JF, 1994, J MAMMAL, V75, P382, DOI 10.2307/1382557; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOWDEN J, 1973, B ENTOMOL RES, V63, P129, DOI 10.1017/S0007485300050938; Breitenmoser U., 2008, LUCHS GROSSRAUBTIER; Broekhuis F, 2014, BEHAV ECOL, V25, P1268, DOI 10.1093/beheco/aru122; CEDERLUND G, 1989, HOLARCTIC ECOL, V12, P39; Curio E., 1976, ETHOLOGY PREDATION; Daan Serge, 2001, Handbook of Behavioral Neurobiology, V12, P7; Davidson AJ, 2003, CURR OPIN NEUROBIOL, V13, P765, DOI 10.1016/j.conb.2003.10.011; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Fahrmeir L., 2013, REGRESSION, DOI DOI 10.1007/978-3-642-34333-9; GEORGII B, 1983, OECOLOGIA, V58, P238, DOI 10.1007/BF00399224; Gerkema MP, 2013, P ROYAL SOC B, V280; Guillet C, 1996, WILDLIFE BIOL, V2, P107, DOI 10.2981/wlb.1996.039; Harmsen BJ, 2011, MAMM BIOL, V76, P320, DOI 10.1016/j.mambio.2010.08.007; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Heurich M, 2011, 12 INT FACHT FRAG VE, P142; Jedrzejewski W, 2002, ANN ZOOL FENN, V39, P29; Kamler JF, 2007, J MAMMAL, V88, P508, DOI 10.1644/06-MAMM-A-169R.1; KITCHENER A., 1991, NATURAL HIST WILD CA; Kolbe JA, 2007, J WILDLIFE MANAGE, V71, P1607, DOI 10.2193/2005-727; Krofel M, 2014, EUR J WILDLIFE RES, V60, P11, DOI 10.1007/s10344-013-0745-4; Krofel M, 2013, ECOL RES, V28, P103, DOI 10.1007/s11284-012-1005-x; Krofel M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1297, DOI 10.1007/s00265-012-1384-6; Krop-Benesch A, 2011, ACTIVITY PATTERN USE, P139; Krop-Benesch A, 2012, ITALIAN J ZOOLOGY, V80, P1; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; Linnell JDC, 2010, ENVIRON MANAGE, V45, P1142, DOI 10.1007/s00267-010-9455-9; Loe LE, 2007, OECOLOGIA, V152, P617, DOI 10.1007/s00442-007-0681-7; Lottker P, 2009, WILDLIFE BIOL, V15, P425, DOI 10.2981/08-014; Lu WQ, 2010, CURR BIOL, V20, P533, DOI 10.1016/j.cub.2010.01.042; Lucherini M, 2009, J MAMMAL, V90, P1404, DOI 10.1644/09-MAMM-A-002R.1; Manfredi C, 2011, MAMM BIOL, V76, P313, DOI 10.1016/j.mambio.2011.01.009; Mattisson J, 2011, BIOL CONSERVATION; Mattisson J, 2011, CAN J ZOOL, V89, P79, DOI 10.1139/Z10-097; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Molinari-Jobin A, 2002, WILDLIFE BIOL, V8, P109, DOI 10.2981/wlb.2002.015; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Okarma H, 1997, ACTA THERIOL, V42, P203, DOI 10.4098/AT.arch.97-22; Packer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022285; Pagon N, 2013, CHRONOBIOL INT, P1; PALOMARES F, 1988, J MAMMAL, V69, P635, DOI 10.2307/1381362; Podolski I, 2013, WILDLIFE BIOL, V19, P69, DOI 10.2981/12-049; R Core Team, 2021, R LANGUAGE ENV STAT; Ray RR, 2014, ANIM BIODIV CONSERV, V37, P77; Reinhardt I, 1999, Z SAUGETIERKD, V64, P65; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Rockhill AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069213; Samelius G, 2012, J ZOOL, V286, P120, DOI 10.1111/j.1469-7998.2011.00857.x; Schaller GB, 1972, WILDLIFE BEHAV ECOLO; Schmidt K, 1997, ACTA THERIOL, V42, P289, DOI 10.4098/AT.arch.97-30; Schmidt K, 1999, J ZOOL, V249, P417, DOI 10.1017/S0952836999009851; Schmidt K, 2008, ACTA THERIOL, V53, P1, DOI 10.1007/BF03194274; Sunquist ME, 2002, WILD CATS WORLD; Theuerkauf J, 2003, J MAMMAL, V84, P243, DOI 10.1644/1545-1542(2003)084<0243:DPADOW>2.0.CO;2; Theuerkauf J, 2008, FOREST ECOL MANAG, V256, P1325, DOI 10.1016/j.foreco.2008.06.030; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Vogt K, 2014, BEHAV PROCESS, V106, P98, DOI 10.1016/j.beproc.2014.04.017; Wilson DE., 2015, HDB MAMMALS WORLD; Wolfl M, 1996, ACTA THERIOL, V41, P443; Wolfl M, 2001, ACTA THERIOL, V46, P181, DOI 10.1007/BF03192427; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zimmermann F, 2007, ORYX, V41, P358, DOI 10.1017/S0030605307000712	75	51	51	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114143	10.1371/journal.pone.0114143	http://dx.doi.org/10.1371/journal.pone.0114143			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517902	gold, Green Accepted, Green Published			2022-12-27	WOS:000347215600012
J	Kuhn, S; Brick, TR; Muller, BCN; Gallinat, J				Kuehn, Simone; Brick, Timothy R.; Mueller, Barbara C. N.; Gallinat, Juergen			Is This Car Looking at You? How Anthropomorphism Predicts Fusiform Face Area Activation when Seeing Cars	PLOS ONE			English	Article							HUMAN EXTRASTRIATE CORTEX; PERCEPTION; EXPERTISE	Anthropomorphism encompasses the attribution of human characteristics to non-living objects. In particular the human tendency to see faces in cars has long been noticed, yet its neural correlates are unknown. We set out to investigate whether the fusiform face area (FFA) is associated with seeing human features in car fronts, or whether, the higher-level theory of mind network (ToM), namely temporoparietal junction (TPJ) and medial prefrontal cortex (MPFC) show a link to anthropomorphism. Twenty participants underwent fMRI scanning during a passive car-front viewing task. We extracted brain activity from FFA, TPJ and MPFC. After the fMRI session participants were asked to spontaneously list adjectives that characterize each car front. Five raters judged the degree to which each adjective can be applied as a characteristic of human beings. By means of linear mixed models we found that the implicit tendency to anthropomorphize individual car fronts predicts FFA, but not TPJ or MPFC activity. The results point to an important role of FFA in the phenomenon of ascribing human attributes to non-living objects. Interestingly, brain regions that have been associated with thinking about beliefs and mental states of others (TPJ, MPFC) do not seem to be related to anthropomorphism of car fronts.	[Kuehn, Simone; Brick, Timothy R.] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Mueller, Barbara C. N.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6500 HE Nijmegen, Netherlands; [Mueller, Barbara C. N.] Univ Munich, Dept Psychol, D-80802 Munich, Germany; [Gallinat, Juergen] Charite, Clin Psychiat & Psychotherapy, D-10115 Berlin, Germany; [Gallinat, Juergen] Univ Clin Hamburg Eppendorf, Clin & Policlin Psychiat & Psychotherapy, D-20246 Hamburg, Germany	Max Planck Society; Radboud University Nijmegen; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kuhn, S (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Lentzeallee 94, D-14195 Berlin, Germany.	kuehn@mpib-berlin.mpg.de	, Barbara/O-4912-2019; Kuehn, Simone/P-6145-2014; Brick, Timothy/C-9966-2015	, Barbara/0000-0003-1812-8531; Brick, Timothy/0000-0002-3339-9279; Kuhn, Simone/0000-0001-6823-7969				Bates D, 2012, LME4 LINEAR MIXED EF; Brass M, 2009, PHILOS T R SOC B, V364, P2359, DOI 10.1098/rstb.2009.0066; Brett M, 2002, PRESENTED AT THE 8TH; CORTI FJ, 2000, SYST BIOL, V49, P740, DOI DOI 10.1080/106351500750049806; Cullen H, 2014, SOC COGN AFFECT NEUR, V9, P1276, DOI 10.1093/scan/nst109; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Epley N, 2008, PSYCHOL SCI, V19, P114, DOI 10.1111/j.1467-9280.2008.02056.x; Farah M, 1998, PSYCHOL REV; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Guthrie S., 1993, FACES IN THE CLOUDS; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; MCGUGIN RW, 2012, HIGH RESOLUTION IMAG; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Satterthwaite FE, 1946, BIOMETRICS B; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Waytz A, 2010, PERSPECT PSYCHOL SCI, V5, P219, DOI 10.1177/1745691610369336; Windhager S, 2008, HUM NATURE-INT BIOS, V19, P331, DOI 10.1007/s12110-008-9047-z; Windhager S, 2012, EVOL HUM BEHAV, V33, P109, DOI 10.1016/j.evolhumbehav.2011.06.003; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075	29	19	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113885	10.1371/journal.pone.0113885	http://dx.doi.org/10.1371/journal.pone.0113885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517511	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600010
J	Wu, JY; Ding, ST; Li, QJ; Zhao, ZR; Sun, BN				Wu, Jing-Yu; Ding, Su-Ting; Li, Qi-Jia; Zhao, Zhen-Rui; Sun, Bai-Nian			First Occurrence of Platycladus from the Upper Miocene of Southwest China and Its Phytogeographic Implications	PLOS ONE			English	Article							ASIAN MONSOON; CUPRESSACEAE; OLIGOCENE; CLIMATE; CALOCEDRUS; PHYLOGENY; EVOLUTION; SEQUENCES; PLIOCENE; FOLIAGE	Platycladus Spach is native to Central China, but its natural occurrences are very difficult to establish. According to molecular phylogenetic data, this genus might have originated since the Oligocene, but no fossil record has been reported. Here, we describe eight foliage branches from the upper Miocene in western Yunnan, Southwest China as a new species, P. yunnanensis sp. nov., which is characterized by foliage branches spread in flattened sprays, and leaves decussate, imbricate, scale-like and dimorphic. The leaves are amphistomatic, and the stomata are elliptical or oblong, haplocheilic, and monocyclic type. Based on a detailed comparison with the extant genera of Cupressaceae sensu lato, our fossils are classified into the genus Platycladus. The occurrence of P. yunnanensis sp. nov. indicates that this genus had a more southernly natural distribution in the late Miocene than at present. Molecular phylogeny and fossil records support a pre-Oligocene common ancestor for the genera Platycladus, Microbiota and Calocedrus. The separation of the three taxa was most likely caused by the arid belt across Central China during the Oligocene. In addition, the cooling down of the global temperature and the strengthening of Asian monsoon since the Miocene will further promote the migration of these genera.	[Wu, Jing-Yu; Ding, Su-Ting; Li, Qi-Jia; Zhao, Zhen-Rui; Sun, Bai-Nian] Lanzhou Univ, Sch Earth Sci, Key Lab Mineral Resources Western China Gansu Pro, Lanzhou 730000, Peoples R China; [Wu, Jing-Yu; Ding, Su-Ting; Li, Qi-Jia; Zhao, Zhen-Rui; Sun, Bai-Nian] Lanzhou Univ, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Wu, Jing-Yu] Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Palaeobiol & Stratig, Nanjing 210008, Jiangsu, Peoples R China	Lanzhou University; Lanzhou University; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Wu, JY (corresponding author), Lanzhou Univ, Sch Earth Sci, Key Lab Mineral Resources Western China Gansu Pro, Lanzhou 730000, Peoples R China.	jywu@lzu.edu.cn	Wu, Jingyu/HHR-9058-2022		National Natural Science Foundation of China [41302009, 41172021, 41271024]; NSFC-RFBR [413111050]; China Postdoctoral Science Foundation [2011M500960]; Foundation of the State Key Laboratory of Paleobiology and Stratigraphy; Nanjing Institute of Geology and Paleontology; Chinese Academy of Sciences [133102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-RFBR; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of the State Key Laboratory of Paleobiology and Stratigraphy; Nanjing Institute of Geology and Paleontology; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (41302009, 41172021, 41271024), the NSFC-RFBR (413111050), the China Postdoctoral Science Foundation (2011M500960), and the Foundation of the State Key Laboratory of Paleobiology and Stratigraphy, Nanjing Institute of Geology and Paleontology, Chinese Academy of Sciences (133102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], [No title captured]; Blokhina Nadezhda I., 2011, Acta Palaeobotanica, V51, P19; BRUNSFELD SJ, 1994, SYST BOT, V19, P253, DOI 10.2307/2419600; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen CH, 2009, BOT STUD, V50, P425; Chen W, 2000, ACTA BOT YUNNANICA, V23, P189; Clift PD, 2008, NAT GEOSCI, V1, P875, DOI 10.1038/ngeo351; Dettman DL, 2001, GEOLOGY, V29, P31, DOI 10.1130/0091-7613(2001)029<0031:SSIEFA>2.0.CO;2; Farjon A., 2005, MONOGRAPH CUPRESSACE, P1; Fu L., 1999, FLORA CHINA, P62; Gadek PA, 2000, AM J BOT, V87, P1044, DOI 10.2307/2657004; Ge H.-R., 1999, CENOZOIC COAL BEARIN, P1; [郭双兴 Guo Shuangxing], 2011, [古生物学报, Acta Palaeontologica Sinica], V50, P353; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; He WL, 2012, REV PALAEOBOT PALYNO, V176, P24, DOI 10.1016/j.revpalbo.2012.03.013; Kvacek Z, 2000, INT J PLANT SCI, V161, P331, DOI 10.1086/314245; Little DP, 2004, AM J BOT, V91, P1872, DOI 10.3732/ajb.91.11.1872; LIU TS, 1993, GLOBAL PLANET CHANGE, V7, P119; Mao KS, 2012, P NATL ACAD SCI USA, V109, P7793, DOI 10.1073/pnas.1114319109; Shi GL, 2012, AM J BOT, V99, P108, DOI 10.3732/ajb.1100331; Shi GL, 2011, REV PALAEOBOT PALYNO, V166, P325, DOI 10.1016/j.revpalbo.2011.06.005; Shi GL, 2010, REV PALAEOBOT PALYNO, V161, P179, DOI 10.1016/j.revpalbo.2010.04.002; Sun XJ, 2005, PALAEOGEOGR PALAEOCL, V222, P181, DOI 10.1016/j.palaeo.2005.03.005; WILSON ERNEST H., 1926, JOUR ARNOLD ARBORETUM, V7, P37; Working Group on Copper Geology of the Zhongtiao Mountains, 1978, COPPER GEOLOGY ZHONG, P1; Wu JY, 2009, REV PALAEOBOT PALYNO, V155, P32, DOI 10.1016/j.revpalbo.2008.12.015; Xia K, 2009, PALAEOGEOGR PALAEOCL, V276, P80, DOI 10.1016/j.palaeo.2009.02.024; Xing YW, 2012, PALAEOGEOGR PALAEOCL, V358, P19, DOI 10.1016/j.palaeo.2012.07.011; Xu JX, 2008, REV PALAEOBOT PALYNO, V148, P36, DOI 10.1016/j.revpalbo.2007.08.004; Yang ZY, 2012, MOL PHYLOGENET EVOL, V64, P452, DOI 10.1016/j.ympev.2012.05.004; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; [张仲石 Zhang Zhongshi], 2005, [第四纪研究, Quaternary Sciences], V25, P523; Zheng HB, 2004, GLOBAL PLANET CHANGE, V41, P147, DOI 10.1016/j.gloplacha.2004.01.003; Zhu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056489; Zhuo WR., 1990, YUNNAN GEOL, V9, P321	37	4	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115141	10.1371/journal.pone.0115141	http://dx.doi.org/10.1371/journal.pone.0115141			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517767	Green Submitted, gold, Green Published			2022-12-27	WOS:000347215600044
J	Gan, L; Jiang, WD; Wu, P; Liu, Y; Jiang, J; Li, SH; Tang, L; Kuang, SY; Feng, L; Zhou, XQ				Gan, Lu; Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Tang, Ling; Kuang, Sheng-Yao; Feng, Lin; Zhou, Xiao-Qiu			Flesh Quality Loss in Response to Dietary Isoleucine Deficiency and Excess in Fish: A Link to Impaired Nrf2-Dependent Antioxidant Defense in Muscle	PLOS ONE			English	Article							CARP CTENOPHARYNGODON-IDELLA; TROUT ONCORHYNCHUS-MYKISS; ALPHA-TOCOPHERYL ACETATE; SALMON SALMO-SALAR; OXIDATIVE STRESS; ENZYME-ACTIVITIES; GRASS CARP; HOLDING CAPACITY; ATLANTIC SALMON; FILLET QUALITY	The present study explored the impact of dietary isoleucine (Ile) on fish growth and flesh quality and revealed a possible role of muscle antioxidant defense in flesh quality in relation to dietary Ile. Grass carp (weighing 256.8 +/- 3.5 g) were fed diets containing six graded levels of Ile (3.8, 6.6, 9.3, 12.5, 15.2 and 18.5 g/kg) for eight weeks. The results indicated that compared with Ile deficiency (3.8 g/kg diets) and excess (18.5 g/kg diets) groups, 9.3-15.2 g Ile/kg diet supplementations promoted fish growth and muscle fat deposition, whereas 6.6-15.2 g Ile/kg diets supplementation enhanced muscle nutrients (protein and total EAAs) deposition. Furthermore, muscle shear force, pH value, and hydroxyproline concentration were improved by 9.3-12.5, 9.3 and 9.3 g Ile/kg diet supplementations, respectively. However, muscle cooking loss, lactate content, and activities of cathepsin B and L were decreased by 6.6-15.2, 9.3-12.5, 9.3-12.5 and 9.3-15.2 g Ile/kg diet supplementations, respectively. Additionally, 6.6-15.2 and 6.6-12.5 g Ile/kg diet supplementations attenuated malondialdehyde and protein carbonyl contents, respectively. The activities of copper/zinc superoxide dismutase (Cu/Zn-SOD) and glutathione peroxidase (GPx), and glutathione content were enhanced by 6.6-9.3, 6.6-12.5 and 6.6-15.2 g Ile/kg diet supplementations, respectively. Moreover, the relative mRNA expressions of antioxidant enzymes, including Cu/Zn-SOD (6.6-12.5 g/kg diets) and GPx (12.5 g/kg diets), as well as antioxidant-related signaling molecules, including NF-E2-related factor 2 (Nrf2) (6.6-12.5 g/kg diets), target of rapamycin (6.6-12.5 g/kg diets), ribosomal S6 protein kinase 1 (9.3-12.5 g/kg diets) and casein kinase 2 (6.6-12.5 g/kg diets), were up-regulated when Ile diet supplementations were administered at these levels, respectively, whereas the relative mRNA expression of Kelch-like ECH-associated protein 1 was downregulated with 9.3 g Ile/kg diet supplementations. Collectively, the present study indicated that optimum isoleucine improved flesh quality, partly due to the activation of antioxidant defense through the Nrf2 signaling pathway.	[Gan, Lu; Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Li, Shu-Hong; Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China; [Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, Fish Nutr & Safety Prod Univ Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Jiang, Wei-Dan; Wu, Pei; Liu, Yang; Jiang, Jun; Feng, Lin; Zhou, Xiao-Qiu] Sichuan Agr Univ, China Minist Educ, Key Lab Anim Disease Resistance Nutr, Chengdu, Sichuan, Peoples R China; [Tang, Ling; Kuang, Sheng-Yao] Sichuan Acad Anim Sci, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Feng, L (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu, Sichuan, Peoples R China.	fenglin@sicau.edu.cn; xqzhouqq@tom.com	liu, yang/HHY-8583-2022; jiang, jun/GWC-9329-2022; Jun, Jiang/CAE-8962-2022		National Department Public Benefit Research Foundation (Agriculture) of China [201003020]; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China [2012NC0007]; Science and Technology Support Program of Sichuan Province [2014NZ0003]; National 973 Project [2014CB138600]	National Department Public Benefit Research Foundation (Agriculture) of China; Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China; Science and Technology Support Program of Sichuan Province; National 973 Project(National Basic Research Program of China)	This research was financially supported by the National Department Public Benefit Research Foundation (Agriculture) of China (201003020), Major Scientific and Technological Achievement Transformation Project of Sichuan Province of China (2012NC0007), Science and Technology Support Program of Sichuan Province (2014NZ0003) and National 973 Project (2014CB138600). The authors would like to thank the personnel of these teams for their kind assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2004, COMP BIOCHEM PHYS A, V138, P405, DOI 10.1016/j.cbpb.2004.05.013; Acerete L, 2004, AQUACULTURE, V237, P167, DOI 10.1016/j.aquaculture.2004.03.018; Acerete L, 2009, AQUACULTURE, V287, P139, DOI 10.1016/j.aquaculture.2008.10.012; Ahmed I, 2006, BRIT J NUTR, V96, P450, DOI 10.1079/BJN20061845; Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002; Bahuaud D, 2010, FOOD CHEM, V118, P602, DOI 10.1016/j.foodchem.2009.05.028; Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Bliesath J, 2012, CANCER LETT, V322, P113, DOI 10.1016/j.canlet.2012.02.032; Bridi R, 2003, INT J DEV NEUROSCI, V21, P327, DOI 10.1016/S0736-5748(03)00074-1; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Chen GF, 2012, BRIT J NUTR, V108, P195, DOI 10.1017/S0007114511005459; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Dalton TP, 2000, BIOCHEM BIOPH RES CO, V279, P324, DOI 10.1006/bbrc.2000.3930; Ayala MD, 2011, LWT-FOOD SCI TECHNOL, V44, P1098, DOI 10.1016/j.lwt.2010.09.014; Enser M, 1996, MEAT SCI, V42, P443, DOI 10.1016/0309-1740(95)00037-2; FAO, 2011, FAOSTAT AGR; FAUCONNEAU B, 1995, AQUACULTURE, V129, P265, DOI 10.1016/0044-8486(94)00309-C; Hosseini SV, 2010, FOOD CHEM, V118, P341, DOI 10.1016/j.foodchem.2009.04.131; Huang HM, 2004, FREE RADICAL BIO MED, V37, P1779, DOI 10.1016/j.freeradbiomed.2004.08.001; Iles KE, 2005, FREE RADICAL BIO MED, V38, P547, DOI 10.1016/j.freeradbiomed.2004.11.012; Jiang WD, 2010, FOOD CHEM, V120, P692, DOI 10.1016/j.foodchem.2009.10.062; Johnston IA, 1999, AQUACULTURE, V177, P99, DOI 10.1016/S0044-8486(99)00072-1; Johnston IA, 2006, AQUACULTURE, V256, P323, DOI 10.1016/j.aquaculture.2006.02.048; KANETO A, 1972, ENDOCRINOLOGY, V91, P691, DOI 10.1210/endo-91-3-691; Khan MA, 2004, AQUAC RES, V35, P1277, DOI 10.1111/j.1365-2109.2004.01150.x; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Kong FB, 2008, LWT-FOOD SCI TECHNOL, V41, P1210, DOI 10.1016/j.lwt.2007.07.020; Lai CC, 1996, J MOL CELL CARDIOL, V28, P1157, DOI 10.1006/jmcc.1996.0106; Lambertucci RH, 2007, MECH AGEING DEV, V128, P267, DOI 10.1016/j.mad.2006.12.006; Larsson T, 2014, AQUACULTURE, V426, P288, DOI 10.1016/j.aquaculture.2014.01.034; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Li X., 2013, J APPL MATH, P1; Lin YH, 2013, AQUACULTURE, V380, P47, DOI 10.1016/j.aquaculture.2012.11.034; Liu DS, 2013, FOOD CHEM, V140, P105, DOI 10.1016/j.foodchem.2013.02.034; Losada V, 2005, FOOD CHEM, V93, P619, DOI 10.1016/j.foodchem.2004.09.041; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; Mercado N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088168; Mohammadzadeh M, 2012, CELL STRESS CHAPERON, V17, P553, DOI 10.1007/s12192-012-0331-9; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Obernier JA, 2006, ILAR J, V47, P364, DOI 10.1093/ilar.47.4.364; OFSTAD R, 1993, FOOD STRUCT, V12, P163; Okouchi M, 2006, CURR NEUROVASC RES, V3, P249, DOI 10.2174/156720206778792876; Olsen RE, 1998, AQUACULT NUTR, V4, P13, DOI 10.1046/j.1365-2095.1998.00099.x; Olsson GB, 2003, LEBENSM-WISS TECHNOL, V36, P125, DOI 10.1016/S0023-6438(02)00205-0; Periago Ma.J., 2005, Aquaculture, V249, P175, DOI 10.1016/j.aquaculture.2005.02.047; Peso-Echarri P, 2012, FOOD CHEM, V135, P699, DOI 10.1016/j.foodchem.2012.05.033; Poli BM, 2005, AQUACULT INT, V13, P29, DOI 10.1007/s10499-004-9035-1; Rodehutscord M, 1997, J NUTR, V127, P1166, DOI 10.1093/jn/127.6.1166; Seiliez I, 2008, AM J PHYSIOL-REG I, V295, pR329, DOI 10.1152/ajpregu.00146.2008; [尚晓迪 SHANG Xiao-di], 2009, [水产学报, Journal of Fisheries of China], V33, P813; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Talbott S., 2006, ANN M INT SOC SPORTS; Tang QQ, 2013, BIOL TRACE ELEM RES, V155, P370, DOI 10.1007/s12011-013-9785-6; Tokur B, 2007, FOOD CHEM, V104, P754, DOI 10.1016/j.foodchem.2006.12.033; Wu T, 2008, FOOD CHEM, V110, P647, DOI 10.1016/j.foodchem.2008.02.058; Wu Y.P., 2014, AQUAC RES; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zhang Xiao-dong, 2007, Journal of Zhejiang University-Science B, V8, P680, DOI 10.1631/jzus.2007.B0680; Zhou QC, 2012, AQUACULTURE, V350, P175, DOI 10.1016/j.aquaculture.2012.03.042	61	30	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115129	10.1371/journal.pone.0115129	http://dx.doi.org/10.1371/journal.pone.0115129			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514235	gold, Green Submitted, Green Published			2022-12-27	WOS:000349146300034
J	Prehna, G; Ramirez, BE; Lovering, AL				Prehna, Gerd; Ramirez, Benjamin E.; Lovering, Andrew L.			The Lifestyle Switch Protein Bd0108 of Bdellovibrio bacteriovorus Is an Intrinsically Disordered Protein	PLOS ONE			English	Article							NMR CHEMICAL-SHIFTS; IV PILI; STRUCTURE PREDICTION; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; DIVERSE BACTERIA; DOMAIN; SERVER; GENE; SPECTROSCOPY	Bdellovibrio bacteriovorus is a delta-proteobacterium that preys upon Salmonella spp., E. coli, and other Gram-negative bacteria. Bdellovibrio can grow axenically (host-independent, HI, rare and mutation-driven) or subsist via a predatory lifecycle (host-dependent, HD, the usual case). Upon contact with prey, B. bacteriovorus enters the host periplasm from where it slowly drains the host cytosol of nutrients for its own replication. At the core of this mechanism is a retractile pilus, whose architecture is regulated by the protein Bd0108 and its interaction with the neighboring gene product Bd0109. Deletion of bd0108 results in negligible pilus formation, whereas an internal deletion (the one that instigates host-independence) causes mis-regulation of pilus length. These mutations, along with a suite of naturally occurring bd0108 mutant strains, act to control the entry to HI growth. To further study the molecular mechanism of predatory regulation, we focused on the apparent lifecycle switch protein Bd0108. Here we characterize the solution structure and dynamics of Bd0108 using nuclear magnetic resonance (NMR) spectroscopy complemented with additional biophysical methods. We then explore the interaction between Bd0108 and Bd0109 in detail utilizing isothermal titration calorimetry (ITC) and NMR spectroscopy. Together our results demonstrate that Bd0108 is an intrinsically disordered protein (IDP) and that the interaction with Bd0109 is of low affinity. Furthermore, we observe that Bd0108 retains an IDP nature while binding Bd0109. From our data we conclude that Bdellovibrio bacteriovorus utilizes an intrinsically disordered protein to regulate its pilus and control predation signaling.	[Prehna, Gerd; Ramirez, Benjamin E.] Univ Illinois, Struct Biol Ctr, Res Resources Ctr, Chicago, IL USA; [Prehna, Gerd] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Ramirez, Benjamin E.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Lovering, Andrew L.] Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Birmingham	Lovering, AL (corresponding author), Univ Birmingham, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	a.lovering@bham.ac.uk		Prehna, Gerd/0000-0001-5539-7533; Lovering, Andrew/0000-0002-1856-7975	EMBO Young Investigator Award; BBSRC [BB/J015229/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015229/1] Funding Source: researchfish	EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an EMBO Young Investigator Award to ALL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Baer ML, 2004, INT J SYST EVOL MICR, V54, P1011, DOI 10.1099/ijs.0.02458-0; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Capeness MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079759; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COTTER TW, 1992, J BACTERIOL, V174, P6018, DOI 10.1128/JB.174.19.6018-6024.1992; Crossman LC, 2013, ISME J, V7, P148, DOI 10.1038/ismej.2012.90; Daithankar VN, 2010, BIOCHEMISTRY-US, V49, P6737, DOI 10.1021/bi100912m; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferguson MA, 2014, APPL ENV MICROBIOL; Forman-Kay JD, 2013, STRUCTURE, V21, P1492, DOI 10.1016/j.str.2013.08.001; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Hobley L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-670; HOENIGER JF, 1972, CAN J MICROBIOL, V18, P87, DOI 10.1139/m72-014; Jackson AP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-584; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Kadouri DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063397; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Lambert C, 2006, CURR OPIN MICROBIOL, V9, P639, DOI 10.1016/j.mib.2006.10.002; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; Martin MO, 2002, J MOL MICROB BIOTECH, V4, P467; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Milner DS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004253; Minet AD, 1999, J CELL SCI, V112, P2019; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Morehouse KA, 2011, J BACTERIOL, V193, P932, DOI 10.1128/JB.00941-10; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Passerini A, 2011, NUCLEIC ACIDS RES, V39, pW288, DOI 10.1093/nar/gkr365; Pasternak Z, 2014, ISME J, V8, P625, DOI 10.1038/ismej.2013.164; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Phulera S, 2013, BIOCHEMISTRY-US, V52, P4056, DOI 10.1021/bi400191z; Prehna G, 2012, J BIOL CHEM, V287, P32324, DOI 10.1074/jbc.M112.357210; Prehna G, 2012, STRUCTURE, V20, P1154, DOI 10.1016/j.str.2012.04.014; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Reichmann D, 2013, CURR OPIN STRUC BIOL, V23, P436, DOI 10.1016/j.sbi.2013.02.006; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; RITTENBERG GM, 1979, CT-J COMPUT TOMOGR, V3, P140, DOI 10.1016/0149-936X(79)90005-5; Roschanski N, 2011, J BACTERIOL, V193, P1745, DOI 10.1128/JB.01343-10; Roux N, 2012, RES MICROBIOL, V163, P659, DOI 10.1016/j.resmic.2012.10.015; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Serre L, 2004, J MOL BIOL, V339, P161, DOI 10.1016/j.jmb.2004.03.022; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Sockett RE, 2009, ANNU REV MICROBIOL, V63, P523, DOI 10.1146/annurev.micro.091208.073346; Soranno A, 2014, P NATL ACAD SCI USA, V111, P4874, DOI 10.1073/pnas.1322611111; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TUDOR JJ, 1990, J BACTERIOL, V172, P2421, DOI 10.1128/jb.172.5.2421-2426.1990; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wurtzel O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015628; Youderian P, 2007, GENETICS, V177, P557, DOI 10.1534/genetics.107.076182; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	74	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115390	10.1371/journal.pone.0115390	http://dx.doi.org/10.1371/journal.pone.0115390			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514156	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300057
J	Thomas, A; Hanel, B; Marott, JL; Buchvald, F; Mortensen, J; Nielsen, KG				Thomas, Astrid; Hanel, Birgitte; Marott, Jacob L.; Buchvald, Frederik; Mortensen, Jann; Nielsen, Kim G.			The Single-Breath Diffusing Capacity of CO and NO in Healthy Children of European Descent	PLOS ONE			English	Article							LUNG MEMBRANE CONDUCTANCE; HIGH-ALTITUDE NEWCOMERS; CAPILLARY BLOOD-VOLUME; CARBON-MONOXIDE; NITRIC-OXIDE; REFERENCE VALUES; HYPERTENSION; EQUATIONS; GASES; RATIO	Rationale: The diffusing capacity (D-L) of the lung can be divided into two components: the diffusing capacity of the alveolar membrane (Dm) and the pulmonary capillary volume (Vc). D-L is traditionally measured using a single-breath method, involving inhalation of carbon monoxide, and a breath hold of 8-10 seconds (D-L,(CO)). This method does not easily allow calculation of Dm and Vc. An alternative single-breath method (D-L,(CO),(NO)), involving simultaneous inhalation of carbon monoxide and nitric oxide, and traditionally a shorter breath hold, allows calculation of Dm and Vc and the D-L,(NO)/D-L,(CO) ratio in a single respiratory maneuver. The clinical utility of Dm, Vc, and D-L,(NO)/D-L,(CO) in the pediatric age range is currently unknown but also restricted by lack of reference values. Objectives: The aim of this study was to establish reference ranges for the outcomes of D-L,(CO),(NO) with a 5 second breath hold, including the calculated outcomes Dm, Vc, and the D-L,(NO)/D-L,(CO) ratio, as well as to establish reference values for the outcomes of the traditional D-L,(CO) method, with a 10 second breath hold in children. Methods: D-L,(CO),(NO) and D-L,(CO) were measured in healthy children, of European descent, aged 5-17 years using a Jaeger Masterscreen PFT. The data were analyzed using the Generalized Additive Models for Location Scale and Shape (GAMLSS) statistical method. Measurements and Main Results: A total of 326 children were eligible for diffusing capacity measurements, resulting in 312 measurements of D-L,(CO),(NO) and 297 of D-L,(CO), respectively. Reference equations were established for the outcomes of D-L,(CO),(NO) and D-L,(CO), including the calculated values: Vc, Dm, and the D-L,(NO)/D-L,(CO) ratio. Conclusion: These reference values are based on the largest sample of children to date and may provide a basis for future studies of their clinical utility in differentiating between alterations in the pulmonary circulation and changes in the alveolar membrane in pediatric patients.	[Thomas, Astrid; Hanel, Birgitte; Buchvald, Frederik; Nielsen, Kim G.] Univ Copenhagen, Rigshosp, Danish PCD & ChILD Ctr, CF Ctr Copenhagen,Pediat Pulm Serv,Dept Pediat &, DK-2100 Copenhagen, Denmark; [Marott, Jacob L.] Frederiksberg Univ Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Mortensen, Jann] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nielsen, KG (corresponding author), Univ Copenhagen, Rigshosp, Danish PCD & ChILD Ctr, CF Ctr Copenhagen,Pediat Pulm Serv,Dept Pediat &, DK-2100 Copenhagen, Denmark.	kgn@dadlnet.dk	Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449; Mortensen, Jann/0000-0002-1399-8995	Dagmar Marshalls Foundation; Carpenter Johannes Foghs Foundation; John and Birthe Meyer Foundation; Director Jacob Madsens Foundation; Aase and Ejnar Danielsens Foundation	Dagmar Marshalls Foundation; Carpenter Johannes Foghs Foundation; John and Birthe Meyer Foundation; Director Jacob Madsens Foundation; Aase and Ejnar Danielsens Foundation	Dagmar Marshalls Foundation URL: N/A, Carpenter Johannes Foghs Foundation http://www.fogfond.dk, Aase and Ejnar Danielsens Foundation http://www.danielsensfond.dk, The John and Birthe Meyer Foundation URL: N/A, Director Jacob Madsens Foundation URL: N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; Borland C, 1996, THORAX, V51, P855, DOI 10.1136/thx.51.8.855; BORLAND CDR, 1989, EUR RESPIR J, V2, P56; Borland CDR, 2010, J APPL PHYSIOL, V108, P1052, DOI 10.1152/japplphysiol.00904.2009; Cook RD, 1982, RESIDUALS INFLUENCE; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Cotes JE, 1993, LUNG FUNCTION ASSESS, Vxi; Cotes JE, 2006, LUNG FUNCTION PHYSL, Vxi; Dressel H, 2008, CHEST, V133, P1149, DOI 10.1378/chest.07-2388; Dressel Holger, 2009, BMC Pulm Med, V9, P30, DOI 10.1186/1471-2466-9-30; Forster R.E., 1987, HDB PHYSL RESP SYSTE, P71; Fox Jr J., 2015, APPL REGRESSION ANAL; Glenet SN, 2007, J PHYSIOL-LONDON, V582, P767, DOI 10.1113/jphysiol.2007.133405; GUENARD H, 1987, RESP PHYSIOL, V70, P113, DOI 10.1016/S0034-5687(87)80036-1; Hector Dearton Thomas, 2013, BUSINESS TODAY; Hughes JMB, 2013, J APPL PHYSIOL, V115, P153, DOI 10.1152/japplphysiol.00581.2013; Hughes JMB, 2013, EUR RESPIR J, V41, P453, DOI 10.1183/09031936.00082112; JONES RS, 1961, Q J EXP PHYSIOL CMS, V46, P131, DOI 10.1113/expphysiol.1961.sp001525; Kim YJ, 2011, PEDIAT PULMONOLOGY, P469; Kim YJ, 2011, PEDIAT PULMONOLOGY; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Krogh M, 1915, J PHYSIOL-LONDON, V49, P271; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martinot JB, 2013, J APPL PHYSIOL, V115, P157, DOI 10.1152/japplphysiol.01455.2012; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Neas LM, 1996, AM J RESP CRIT CARE, V153, P656, DOI 10.1164/ajrccm.153.2.8564114; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; Phansalkar AR, 2004, AM J RESP CRIT CARE, V169, P1034, DOI 10.1164/rccm.200309-1287OC; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rouatbi S, 2006, REV MAL RESPIR, V23, P211, DOI 10.1016/S0761-8425(06)71570-4; Rouatbi S, 2014, EGYPT J CHEST DIS TU, V63, P705, DOI 10.1016/j.ejcdt.2014.02.007; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; Royston P, 2000, STAT MED, V19, P2943, DOI 10.1002/1097-0258(20001115)19:21<2943::AID-SIM559>3.0.CO;2-5; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van der Lee I, 2006, CHEST, V129, P378, DOI 10.1378/chest.129.2.378; van der Lee I, 2009, RESP MED, V103, P1892, DOI 10.1016/j.rmed.2009.06.005; VONWESTERNHAGEN F, 1978, LUNG, V154, P289; Welsch R, 1980, REGRESSION DIAGNOSTI; Williams D, 1987, APPL STAT, P181; Zavorsky GS, 2010, ACTA PHYSIOL, V198, P499, DOI 10.1111/j.1748-1716.2009.02059.x; Zavorsky GS, 2013, RESP PHYSIOL NEUROBI, V186, P103, DOI 10.1016/j.resp.2013.01.001	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113177	10.1371/journal.pone.0113177	http://dx.doi.org/10.1371/journal.pone.0113177			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514246	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300002
J	Verzola, D; Ratto, E; Villaggio, B; Parodi, EL; Pontremoli, R; Garibotto, G; Viazzi, F				Verzola, Daniela; Ratto, Elena; Villaggio, Barbara; Parodi, Emanuele Luigi; Pontremoli, Roberto; Garibotto, Giacomo; Viazzi, Francesca			Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; POST-HOC ANALYSIS; ENDOTHELIAL DYSFUNCTION; GLOMERULAR HYPERTENSION; MILD HYPERURICEMIA; NAD(P)H OXIDASE; RENAL OUTCOMES; PROLIFERATION; EXPRESSION; INFLAMMATION	Mild hyperuricemia has been linked to the development and progression of tubulointerstitial renal damage. However the mechanisms by which uric acid may cause these effects are poorly explored. We investigated the effect of uric acid on apoptosis and the underlying mechanisms in a human proximal tubule cell line (HK-2). Increased uric acid concentration decreased tubule cell viability and increased apoptotic cells in a dose dependent manner (up to a 7-fold increase, p<0.0001). Uric acid up-regulated Bax (+60% with respect to Ctrl; p<0.05) and down regulated X-linked inhibitor of apoptosis protein. Apoptosis was blunted by Caspase-9 but not Caspase-8 inhibition. Uric acid induced changes in the mitochondrial membrane, elevations in reactive oxygen species and a pronounced up-regulation of NOX 4 mRNA and protein (p<0.05). In addition, both reactive oxygen species production and apoptosis was prevented by the NADPH oxidase inhibitor DPI as well as by Nox 4 knockdown. URAT 1 transport inhibition by probenecid and losartan and its knock down by specific siRNA, blunted apoptosis, suggesting a URAT 1 dependent cell death. In summary, our data show that uric acid increases the permissiveness of proximal tubule kidney cells to apoptosis by triggering a pathway involving NADPH oxidase signalling and URAT 1 transport. These results might explain the chronic tubulointerstitial damage observed in hyperuricaemic states and suggest that uric acid transport in tubular cells is necessary for urate-induced effects.	[Verzola, Daniela; Villaggio, Barbara; Parodi, Emanuele Luigi; Pontremoli, Roberto; Garibotto, Giacomo; Viazzi, Francesca] Univ Genoa, Genoa, Italy; [Verzola, Daniela; Villaggio, Barbara; Parodi, Emanuele Luigi; Pontremoli, Roberto; Garibotto, Giacomo; Viazzi, Francesca] IRCCS Azienda Ospedaliera Univ San Martino IST, Ist Nazl Ric Cancro, Dept Internal Med, Genoa, Italy; [Ratto, Elena] IRCCS Azienda Ospedaliera Univ San Martino IST, Ist Nazl Ric Cancro, Clin Nefrol Dialisi & Trapianto, Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST	Viazzi, F (corresponding author), Univ Genoa, Genoa, Italy.	francesca.viazzi@unige.it	Viazzi, Francesca/AAB-2479-2019; Verzola, Daniela/U-2761-2019; Garibotto, Giacomo/AAB-1190-2019	Garibotto, Giacomo/0000-0001-6432-2429; VERZOLA, Daniela/0000-0002-2790-5876; Viazzi, Francesca/0000-0003-4219-7043; Parodi, Emanuele Luigi/0000-0002-7365-7287	Italian Ministero della Salute (Bando Giovane Ricercatore) [CUP G35J11000130001]	Italian Ministero della Salute (Bando Giovane Ricercatore)	This work was, in part, supported by grants from the Italian Ministero della Salute (Bando Giovane Ricercatore 2008, CUP G35J11000130001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Capellino S, 2008, CLIN EXP RHEUMATOL, V26, P903; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Feig DI, 2006, J AM SOC NEPHROL, V17, pS69, DOI 10.1681/ASN.2005121331; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; Han HJ, 2007, AM J PHYSIOL-RENAL, V292, pF373, DOI 10.1152/ajprenal.00104.2006; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hoieggen A, 2004, KIDNEY INT, V65, P1041, DOI 10.1111/j.1523-1755.2004.00484.x; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Jalal DI, 2010, NEPHROL DIAL TRANSPL, V25, P1865, DOI 10.1093/ndt/gfp740; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2005, AM J NEPHROL, V25, P425, DOI 10.1159/000087713; Lhotta K, 1998, NEPHRON, V79, P340, DOI 10.1159/000045060; Liu YH, 2009, KIDNEY INT, V76, P1125, DOI 10.1038/ki.2009.352; Lodha S, 2002, MOL MED, V8, P830, DOI 10.1007/BF03402088; Miao Y, 2011, HYPERTENSION, V58, P2, DOI 10.1161/HYPERTENSIONAHA.111.171488; Miyazaki H, 2004, TRENDS PHARMACOL SCI, V25, P654, DOI 10.1016/j.tips.2004.10.006; Morais C, 2005, NEPHROL DIAL TRANSPL, V20, P50, DOI 10.1093/ndt/gfh561; New DD, 2012, AM J PHYSIOL-CELL PH, V302, pC122, DOI 10.1152/ajpcell.00141.2011; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Nieto FJ, 2000, ATHEROSCLEROSIS, V148, P131, DOI 10.1016/S0021-9150(99)00214-2; Obermayr RP, 2008, J AM SOC NEPHROL, V19, P2407, DOI 10.1681/ASN.2008010080; Ohno I, 2001, NEPHRON, V87, P333, DOI 10.1159/000045939; Ortiz A, 2000, KIDNEY INT, V58, P467, DOI 10.1046/j.1523-1755.2000.00188.x; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Quan H, 2011, CELL PHYSIOL BIOCHEM, V27, P91, DOI 10.1159/000325209; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Sanchez-Lozada LG, 2008, NEPHROL DIAL TRANSPL, V23, P1179, DOI 10.1093/ndt/gfm783; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Sanchez-Lozada LG, 2005, KIDNEY INT, V67, P237, DOI 10.1111/j.1523-1755.2005.00074.x; Sanchez-Nino MD, 2010, KIDNEY INT, V78, P737, DOI 10.1038/ki.2010.270; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Schreck C, 2011, AM J PHYSIOL-REG I, V300, pR1023, DOI 10.1152/ajpregu.00618.2010; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Smink PA, 2012, J HYPERTENS, V30, P1022, DOI 10.1097/HJH.0b013e32835200f9; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Syrjanen J, 2000, NEPHROL DIAL TRANSPL, V15, P34, DOI 10.1093/ndt/15.1.34; Tsuda H, 2012, BIOCHEM BIOPH RES CO, V427, P266, DOI 10.1016/j.bbrc.2012.09.032; Viazzi F, 2007, AM J HYPERTENS, V20, P1276, DOI 10.1016/j.amjhyper.2007.08.010; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	53	83	88	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115210	10.1371/journal.pone.0115210	http://dx.doi.org/10.1371/journal.pone.0115210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514209	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300042
J	Deasy, C; Coughlan, B; Pironom, J; Jourdan, D; Mannix-McNamara, P				Deasy, Christine; Coughlan, Barry; Pironom, Julie; Jourdan, Didier; Mannix-McNamara, Patricia			Psychological Distress and Coping amongst Higher Education Students: A Mixed Method Enquiry	PLOS ONE			English	Article							NURSING-STUDENTS; UNIVERSITY-STUDENTS; PERCEIVED STRESS; COLLEGE-STUDENTS; SOCIAL SUPPORT; MENTAL-HEALTH; PREDICTING STRESS; BURNOUT BEGIN; DEPRESSION; TEACHERS	Background: Psychological distress among higher education students is of global concern. Students on programmes with practicum components such as nursing and teacher education are exposed to additional stressors which may further increase their risk for psychological distress. The ways in which these students cope with distress has potential consequences for their health and academic performance. An in-depth understanding of how nursing/midwifery and teacher education students experience psychological distress and coping is necessary to enable higher education providers to adequately support these students. Methods: This mixed method study was employed to establish self-reported psychological distress (General Health Questionnaire), coping processes (Ways of Coping Questionnaire) and lifestyle behaviour (Lifestyle Behaviour Questionnaire) of a total sample (n = 1557) of undergraduate nursing/midwifery and teacher education students in one university in Ireland. Individual interviews (n=59) provided an in-depth understanding of students experiences of psychological distress and coping. Results: A significant percentage (41.9%) of respondents was psychologically distressed. The factors which contributed to their distress, included study, financial, living and social pressures. Students used varied coping strategies including seeking social support, problem solving and escape avoidance. The positive relationship between elevated psychological distress and escape avoidance behaviours including substance use (alcohol, tobacco and cannabis) and unhealthy diet is of particular concern. Statistically significant relationships were identified between "escape-avoidance" and gender, age, marital status, place of residence, programme/year of study and lifestyle behaviours such as diet, substance use and physical inactivity. Conclusion: The paper adds to existing research by illuminating the psychological distress experienced by undergraduate nursing/midwifery and teacher education students. It also identifies their distress, maladaptive coping and the relationship to their lifestyle behaviours. The findings can inform strategies to minimise student distress and maladaptive coping during college and in future professional years.	[Deasy, Christine] Univ Limerick, Dept Nursing & Midwifery, Limerick, Ireland; [Coughlan, Barry] Univ Limerick, Dept Psychol, Limerick, Ireland; [Pironom, Julie; Jourdan, Didier] Univ Blaise Pascal, ACTe, ESPE Clermont Auvergne, Clermont Ferrand, France; [Mannix-McNamara, Patricia] Univ Limerick, Dept Educ & Profess Studies, Limerick, Ireland	University of Limerick; University of Limerick; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); University of Limerick	Deasy, C (corresponding author), Univ Limerick, Dept Nursing & Midwifery, Limerick, Ireland.	Christine.deasy@ul.ie	coughlan, barry/ABF-5779-2021; Mannix-McNamara, Patricia/AAY-5739-2021; Deasy, Christine/D-9369-2017	Mannix-McNamara, Patricia/0000-0002-3011-0177; Deasy, Christine/0000-0003-3842-2260; Coughlan, Barry/0000-0003-4349-7646				Adams TB, 2008, J AM COLL HEALTH, V56, P657, DOI 10.3200/JACH.56.6.657-664; Barlow DH, 2005, CENGAGE LEARNING; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Biro E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-871; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Burnard P, 2007, NURS EDUC TODAY, V27, P808, DOI 10.1016/j.nedt.2006.11.002; Butler AB, 2010, J OCCUP HEALTH PSYCH, V15, P291, DOI 10.1037/a0019822; Chambers G., 2000, J EDUC TEACHING, V26, P25, DOI DOI 10.1080/02607470050007110; Chan D.W., 2002, EDUC PSYCHOL-UK, V22, P557, DOI [10.1080/0144341022000023635, DOI 10.1080/0144341022000023635]; Chao RCL, 2012, J COLL COUNS, V15, P5, DOI 10.1002/j.2161-1882.2012.00002.x; Chaplain RP, 2008, EDUC PSYCHOL-UK, V28, P195, DOI 10.1080/01443410701491858; Childs E, 2011, ALCOHOL CLIN EXP RES, V35, P1794, DOI 10.1111/j.1530-0277.2011.01522.x; Cilingir D, 2011, INT J NURS PRACT, V17, P486, DOI 10.1111/j.1440-172X.2011.01965.x; Connor-Smith JK, 2007, J PERS SOC PSYCHOL, V93, P1080, DOI 10.1037/0022-3514.93.6.1080; Creswell J.W., 2007, DESIGNING CONDUCTING; David K, 2004, STUD HIGH EDUC, V29, P165, DOI 10.1080/0307507042000190778; Dooley B.A., 2012, MY WORLD SURVEY NATL; Dooris M, 2001, HLTH ED, V101, P51, DOI [10.1108/, DOI 10.1108/09654280110384108]; Dooris M, 2010, HEALTH PROMOT INT, V25, P94, DOI 10.1093/heapro/daq015; Drapeau A, 2012, MENTAL ILLNESSES UND, P105, DOI DOI 10.5772/30872; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; El Ansari W, 2010, INT J ENV RES PUB HE, V7, P509, DOI 10.3390/ijerph7020509; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Gardner S, 2010, AUSTR J TEACHER ED, DOI 10.14221/ajte.2010v35n8.2; GOLD Y, 1985, EDUCATION, V105, P254; Goldberg D., 1981, GHQ 28; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Gustems-Carnicer J, 2013, EUR J PSYCHOL EDUC, V28, P1127, DOI 10.1007/s10212-012-0158-x; Harmon D, 2011, 4 HLTH ED AUTH; Hope A., 2015, COLL LIFESTYLE ATTIT; Horwitz AV, 2007, HEALTH-LONDON, V11, P273, DOI 10.1177/1363459307077541; Houghton F, 2010, IRISH J APPL SOC STU, V10, P1; Hudd S.S., 2000, COLL STUD J, V34, P217, DOI DOI 10.1037/A0018745; Humphris Gerry, 2002, Eur J Dent Educ, V6, P22, DOI 10.1034/j.1600-0579.2002.060105.x; Ilhan MN, 2008, J ADV NURS, V61, P100, DOI 10.1111/j.1365-2648.2007.04476.x; Iwasaki Y, 2003, ANXIETY STRESS COPIN, V16, P31, DOI 10.1080/1061580021000057022; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Jones MC, 2000, J ADV NURS, V32, P66, DOI 10.1046/j.1365-2648.2000.01421.x; Kember D, 2006, STUD HIGH EDUC, V31, P185, DOI 10.1080/03075070600572074; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus R. S., 1988, MANUAL WAYS COPING Q; Lindsay ED, 2010, AUSTRALAS J ENG ED, V16, P167; Luo Y, 2009, NURS EDUC TODAY, V29, P5, DOI 10.1016/j.nedt.2008.05.019; MacGeorge EL, 2005, COMMUN EDUC, V54, P365, DOI 10.1080/03634520500442236; Mapfumo JS, 2012, S AFR J EDUC, V32, P155, DOI 10.15700/saje.v32n2a601; Mearns J, 2003, ANXIETY STRESS COPIN, V16, P71, DOI 10.1080/1061580021000057040; Montgomery L, 2012, ASBBS C P, V19, P974; Morrison R, 2005, J CLIN PSYCHOL, V61, P447, DOI 10.1002/jclp.20021; Murray-Harvey R, 2001, TEACHER ED, V37, P117, DOI DOI 10.1080/08878730109555286; Nerdrum P., 2006, J EDUC RES, V50, P95, DOI [10.1080/00313830500372075, DOI 10.1080/00313830500372075]; Newell R., 2006, RES EVIDENCE BASED P; Nguyen-Michel ST, 2006, STRESS HEALTH, V22, P179, DOI 10.1002/smi.1094; Pabiton CP., 2007, PHILIPPINE J COUNS C, V6, P78; Pommier J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-43; Pryjmachuk S, 2008, MIDWIFERY, V24, P108, DOI 10.1016/j.midw.2006.07.006; Pryjmachuk S, 2007, BRIT J HEALTH PSYCH, V12, P125, DOI 10.1348/135910706X98524; Pulido-Martos M, 2012, INT NURS REV, V59, P15, DOI 10.1111/j.1466-7657.2011.00939.x; Rapley T.J., 2001, QUAL RES, V1, P303, DOI DOI 10.1177/146879410100100303; Reeve KL, 2013, NURS EDUC TODAY, V33, P419, DOI 10.1016/j.nedt.2012.11.009; Rella S, 2009, J NURS MANAGE, V17, P886, DOI 10.1111/j.1365-2834.2008.00883.x; Ridner SH, 2004, J ADV NURS, V45, P536, DOI 10.1046/j.1365-2648.2003.02938.x; Robotham D, 2006, J FURTH HIGH EDUC, V30, P107, DOI 10.1080/03098770600617513; *ROYAL COLL PSYCH, 2003, CR112 ROYAL COLL PSY; Royal College of Psychiatrists, 2017, MENT HLTH STUD HIGH; Saias T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-256; Stallman HM, 2008, AUST FAM PHYSICIAN, V37, P673; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stixrud WR, 2012, J MANAG EDUC, V36, P135, DOI 10.1177/1052562911430317; Sun J, 2011, HEALTH EDUC, V111, P133, DOI 10.1108/09654281111108544; Tavolacci MP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-724; Timmins F, 2011, J PSYCHIATR MENT HLT, V18, P758, DOI 10.1111/j.1365-2850.2011.01780.x; Timmins F, 2002, NURS EDUC TODAY, V22, P203, DOI 10.1054/nedt.2001.0698; Tully A, 2004, J Psychiatr Ment Health Nurs, V11, P43, DOI 10.1111/j.1365-2850.2004.00682.x; Vaez M, 2008, SOC BEHAV PERSONAL, V36, P183, DOI 10.2224/sbp.2008.36.2.183; Vazquez FL, 2012, J AM COLL HEALTH, V60, P219, DOI 10.1080/07448481.2011.587485; Verger P, 2009, SOC PSYCH PSYCH EPID, V44, P643, DOI 10.1007/s00127-008-0486-y; Watson R, 2009, J CLIN NURS, V18, P270, DOI 10.1111/j.1365-2702.2008.02555.x; Wheaton B, 2007, HEALTH-LONDON, V11, P303, DOI 10.1177/1363459307077545; Wichianson JR, 2009, STRESS HEALTH, V25, P235, DOI 10.1002/smi.1242	80	131	134	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115193	10.1371/journal.pone.0115193	http://dx.doi.org/10.1371/journal.pone.0115193			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506825	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100057
J	Hayden, TA; Holbrook, CM; Fielder, DG; Vandergoot, CS; Bergstedt, RA; Dettmers, JM; Krueger, CC; Cooke, SJ				Hayden, Todd A.; Holbrook, Christopher M.; Fielder, David G.; Vandergoot, Christopher S.; Bergstedt, Roger A.; Dettmers, John M.; Krueger, Charles C.; Cooke, Steven J.			Acoustic Telemetry Reveals Large-Scale Migration Patterns of Walleye in Lake Huron	PLOS ONE			English	Article							FRESH-WATER FISHES; GREAT-LAKES; STIZOSTEDION-VITREUM; CHINOOK SALMON; MOVEMENT; ERIE; POPULATION; SURVIVAL; MARK; MODELS	Fish migration in large freshwater lacustrine systems such as the Laurentian Great Lakes is not well understood. The walleye (Sander vitreus) is an economically and ecologically important native fish species throughout the Great Lakes. In Lake Huron walleye has recently undergone a population expansion as a result of recovery of the primary stock, stemming from changing food web dynamics. During 2011 and 2012, we used acoustic telemetry to document the timing and spatial scale of walleye migration in Lake Huron and Saginaw Bay. Spawning walleye (n=199) collected from a tributary of Saginaw Bay were implanted with acoustic tags and their migrations were documented using acoustic receivers (n=140) deployed throughout U.S. nearshore waters of Lake Huron. Three migration pathways were described using multistate mark-recapture models. Models were evaluated using the Akaike Information Criterion. Fish sex did not influence migratory behavior but did affect migration rate and walleye were detected on all acoustic receiver lines. Most (95%) tagged fish migrated downstream from the riverine tagging and release location to Saginaw Bay, and 37% of these fish emigrated from Saginaw Bay into Lake Huron. Remarkably, 8% of walleye that emigrated from Saginaw Bay were detected at the acoustic receiver line located farthest from the release location more than 350 km away. Most (64%) walleye returned to the Saginaw River in 2012, presumably for spawning. Our findings reveal that fish from this stock use virtually the entirety of U.S. nearshore waters of Lake Huron.	[Hayden, Todd A.; Dettmers, John M.] Great Lakes Fishery Commiss, Ann Arbor, MI 48105 USA; [Hayden, Todd A.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Holbrook, Christopher M.; Bergstedt, Roger A.] US Geol Survey, Hammond Bay Biol Stn, Millersburg, MI 49759 USA; [Fielder, David G.] Michigan Dept Nat Resources, Alpena, MI 49707 USA; [Vandergoot, Christopher S.] Ohio Dept Nat Resources, Sandusky Fish Res Unit, Sandusky, OH 44870 USA; [Krueger, Charles C.] Michigan State Univ, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48823 USA	Carleton University; United States Department of the Interior; United States Geological Survey; Ohio Department of Natural Resources; Michigan State University	Hayden, TA (corresponding author), Great Lakes Fishery Commiss, 2100 Commonwealth Blvd Ste 100, Ann Arbor, MI 48105 USA.	thayden@usgs.gov	Cooke, Steven J/F-4193-2010	Cooke, Steven J/0000-0002-5407-0659	Great Lakes Fishery Commission [GL-00E23010-3]; Canada Research Chairs Program; Natural Sciences and Engineering Research Council of Canada	Great Lakes Fishery Commission; Canada Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was funded by the Great Lakes Fishery Commission (http://www.glfc.org) by way of Great Lakes Restoration Initiative appropriations (GL-00E23010-3), Canada Research Chairs Program (SC), and the Natural Sciences and Engineering Research Council of Canada (SC).	BALDWIN NS, 1962, TECHNICAL REPORT NO; Barton BA, 2011, BIOLOGY, MANAGEMENT, AND CULTURE OF WALLEYE AND SAUGER, P199; BENCE JR, 2008, GREAT LAKES FISH COM, V801; Bowlby JN, 2011, AQUAT ECOSYST HEALTH, V14, P56, DOI 10.1080/14634988.2011.548298; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 2002, MODEL SELECTION AND; BURNHAM KP, 1987, DESIGN AND ANALYSIS; Cooke S.J., 2013, ANIMAL BIOTELEMETRY, V1, P1, DOI DOI 10.1186/2050-3385-1-5; COOKE SJ, 2011, TECHNICAL REPORT; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P11, DOI 10.1007/s11160-010-9184-4; CROWE WALTER R., 1962, TRANS AMER FISH SOC, V91, P350, DOI 10.1577/1548-8659(1962)91[350:HBIW]2.0.CO;2; DEMPSEY D, 2001, RUIN AND RECOVERY MI; Dettmers JM, 2012, FISHERIES, V37, P495, DOI 10.1080/03632415.2012.731875; DINGLE H, 1996, MIGRATION THE BIOLOG; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Fielder DG, 2007, J GREAT LAKES RES, V33, P118, DOI 10.3394/0380-1330(2007)33[118:EAECST]2.0.CO;2; FIELDER DG, 2014, FISHERIES DIVISION R; FIELDER DG, 2014, 31 YEARS OF TAG RETU; FIELDER DG, 2014, REPORT; FULLER K, 2002, THE GREAT LAKES AN E, P1; GOWAN C, 1994, CAN J FISH AQUAT SCI, V51, P2626, DOI 10.1139/f94-262; Hanson K. C., 2008, REV FISH SCI, V16, P421, DOI DOI 10.1080/10641260802013866; Hayden TA, 2011, J GREAT LAKES RES, V37, P691, DOI 10.1016/j.jglr.2011.08.012; Henderson BA, 1996, CAN J FISH AQUAT SCI, V53, P127, DOI 10.1139/cjfas-53-1-127; HESTBECK JB, 1991, ECOLOGY, V72, P523, DOI 10.2307/2937193; HILE R, 1959, RESEARCH REPORT 51; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Jackson CH, 2011, J STAT SOFTW, V38, P1; Johnson JE, 2010, N AM J FISH MANAGE, V30, P518, DOI 10.1577/M09-094.1; Kershner MW, 1999, CAN J FISH AQUAT SCI, V56, P527, DOI 10.1139/cjfas-56-4-527; LAAKE J, 2013, PROGRAM MARK A GENTL; Landsman SJ, 2011, J GREAT LAKES RES, V37, P365, DOI 10.1016/j.jglr.2011.03.003; Lucas M. C., 2001, MIGRATION OF FRESHWA; Lucas MC, 2000, FISH FISH, V1, P283, DOI 10.1046/j.1467-2979.2000.00028.x; Madenjian CP, 2008, N AM J FISH MANAGE, V28, P263, DOI 10.1577/M07-012.1; Madenjian CP, 1998, CAN J FISH AQUAT SCI, V55, P1085, DOI 10.1139/cjfas-55-5-1085; Manly B.F.J., 1968, T SOC BRIT ENTOMOLOG, V18, P81; McParland TL, 1999, T AM FISH SOC, V128, P1055, DOI 10.1577/1548-8659(1999)128&lt;1055:GPSAMS&gt;2.0.CO;2; Melnychuk MC, 2012, TELEMETRY TECHNIQUES: A USER GUIDE FOR FISHERIES RESEARCH, P339; Pangle KL, 2010, CAN J FISH AQUAT SCI, V67, P1475, DOI 10.1139/F10-076; Peake S, 2000, CAN J ZOOL, V78, P1686, DOI 10.1139/cjz-78-9-1686; Perry RW, 2010, N AM J FISH MANAGE, V30, P142, DOI 10.1577/M08-200.1; Pincock D.G., 2009, DETECTION PERFORMANC; R Core Team, 2021, R LANGUAGE ENV STAT; SCHNEIDER JC, 1977, J FISH RES BOARD CAN, V34, P1878, DOI 10.1139/f77-254; Seber G. A. F., 1982, THE ESTIMATION OF AN; Skalski JR, 2001, CAN J FISH AQUAT SCI, V58, P1987, DOI 10.1139/cjfas-58-10-1987; SPANGLER GR, 1977, J FISH RES BOARD CAN, V34, P1839, DOI 10.1139/f77-250; STEPHEN C, 2013, THE STATUS OF LAKE H, P21; Stepien CA, 2009, MOL ECOL, V18, P3411, DOI 10.1111/j.1365-294X.2009.04291.x; Stepien CA, 2012, T AM FISH SOC, V141, P660, DOI 10.1080/00028487.2012.683474; Tanner HA, 2002, SUSTAINING NORTH AMERICAN SALMON: PERSPECTIVES ACROSS REGIONS AND DISCIPLINES, P139; Vandergoot CS, 2011, N AM J FISH MANAGE, V31, P914, DOI 10.1080/02755947.2011.629717; Wang HY, 2007, T AM FISH SOC, V136, P539, DOI 10.1577/T06-012.1; White GC, 2006, J WILDLIFE MANAGE, V70, P1521, DOI 10.2193/0022-541X(2006)70[1521:MSMATE]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zhao YM, 2011, N AM J FISH MANAGE, V31, P379, DOI 10.1080/02755947.2011.571516	58	73	74	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114833	10.1371/journal.pone.0114833	http://dx.doi.org/10.1371/journal.pone.0114833			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506913	gold, Green Published			2022-12-27	WOS:000346607100026
J	Li, SY; Suyou, LT; Chen, J; Mamuti, M; Liu, JH; Shan, Z; Wang, CY; Fan, SW; Zhao, FD				Li Sheng-yun; Suyou Letu; Chen Jian; Mamuti, Maiwulanjiang; Liu Jun-hui; Shan Zhi; Wang Chong-yan; Fan Shunwu; Zhao, Fengdong			Comparison of Modic Changes in the Lumbar and Cervical Spine, in 3167 Patients with and without Spinal Pain	PLOS ONE			English	Article							DISC-DEGENERATION; MARROW CHANGES; END-PLATES; LOW-BACK; PREVALENCE; ASSOCIATION; CLASSIFICATION; STRENGTH	Background Context: There are few comparisons of Modic changes (MCs) in the lumbar and cervical spine. Purpose: Compare the prevalence of MCs in the lumbar and cervical spine, and determine how MC prevalence depends on spinal pain, age, disc degeneration, spinal level, and the presence or absence of kyphosis. Study Design: Retrospective clinical survey. Materials and Methods: Magnetic resonance images (MRIs) were compared from five patient groups: 1. 1223 patients with low-back pain/radiculopathy only; 2. 1023 patients with neck pain/radiculopathy only; 3. 497 patients with concurrent low-back and neck symptoms; 4. 304 asymptomatic subjects with lumbar MRIs; and 5. 120 asymptomatic subjects with cervical MRIs. Results: The prevalence of MCs was higher in those with spinal pain than in those without, both in the lumbar spine (21.0% vs 10.5%) and cervical spine (8.8% vs 3.3%). Type II MCs were most common and Type III were least common in all groups. The prevalence of lumbar MCs in people with back pain was little affected by the presence of concurrent neck pain, and the same was true for the prevalence of cervical MCs in people with neck pain with or without concurrent back pain. When symptomatic patients were reclassified into two groups (back pain, neck pain), the prevalence of lumbar MCs in people with back pain was greater than that of cervical MCs in people with neck pain. The prevalence of lumbar and cervical MCs increased with age, disc degeneration, (descending) spinal level, and increased kyphosis. Conclusions: There is a significantly higher prevalence of MCs in patients with back and neck pain. The reported association with increased kyphosis (flat back) is novel.	[Li Sheng-yun; Suyou Letu; Chen Jian; Mamuti, Maiwulanjiang; Liu Jun-hui; Shan Zhi; Wang Chong-yan; Fan Shunwu; Zhao, Fengdong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang University	Zhao, FD (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Orthopaed, Hangzhou 310016, Zhejiang, Peoples R China.	zhaodong68@hotmail.com			National Natural Science Foundation of China [31270997, 81171739]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partially supported by the National Natural Science Foundation of China (31270997 and 81171739). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; BORDEN AGB, 1960, RADIOLOGY, V74, P806, DOI 10.1148/74.5.806; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; CROCK HV, 1986, SPINE, V11, P650, DOI 10.1097/00007632-198607000-00028; DEROOS A, 1987, AM J ROENTGENOL, V149, P531, DOI 10.2214/ajr.149.3.531; HANSSON T, 1981, SPINE, V6, P375, DOI 10.1097/00007632-198107000-00008; Holm S, 2004, J SPINAL DISORD TECH, V17, P64, DOI 10.1097/00024720-200402000-00012; Hutton MJ, 2011, SPINE, V36, P2304, DOI 10.1097/BRS.0b013e31821604b6; Jones A, 2005, SPINE, V30, P187; Karchevsky M, 2005, SKELETAL RADIOL, V34, P125, DOI 10.1007/s00256-004-0886-3; Kuisma M, 2007, SPINE, V32, P1116, DOI 10.1097/01.brs.0000261561.12944.ff; Mann E, 2014, EUR SPINE J, V23, P584, DOI 10.1007/s00586-013-2882-6; Mann E, 2011, SPINE, V36, P1081, DOI 10.1097/BRS.0b013e3181ef6a1e; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Peterson CK, 2007, J MANIP PHYSIOL THER, V30, P5, DOI 10.1016/j.jmpt.2006.11.013; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Przybyla AS, 2007, SPINE, V32, P1612, DOI 10.1097/BRS.0b013e318074c40b; Schmid G, 2004, RADIOLOGY, V231, P352, DOI 10.1148/radiol.2312021708; SUZUKI N, 1983, SPINE, V8, P69, DOI 10.1097/00007632-198301000-00012; Vital JM, 2003, SPINE, V28, P715; Wang YXJ, 2011, MED HYPOTHESES, V77, P18, DOI 10.1016/j.mehy.2011.03.014; Wang Y, 2012, SPINE, V37, P1490, DOI 10.1097/BRS.0b013e3182608ac4; Wang Y, 2012, SPINE, V37, P1432, DOI 10.1097/BRS.0b013e31824dd20a; Wang Y, 2012, SPINE J, V12, P411, DOI 10.1016/j.spinee.2012.03.026; Wu HL, 2012, SPINE, V37, P1958, DOI 10.1097/BRS.0b013e31825bfb85	28	16	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114993	10.1371/journal.pone.0114993	http://dx.doi.org/10.1371/journal.pone.0114993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506944	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100039
J	Yuan, LH; Zhang, XJ; Li, LM; Jiang, HY; Chen, JP				Yuan, Lihong; Zhang, Xiujuan; Li, Linmiao; Jiang, Haiying; Chen, Jinping			High-Throughput Sequencing of MicroRNA Transcriptome and Expression Assay in the Sturgeon, Acipenser schrenckii	PLOS ONE			English	Article							RNA-SEQ; DUPLICATION EVENTS; IDENTIFICATION; GENERATION; GENOMICS; TARGETS; DIFFERENTIATION; NORMALIZATION; KARYOTYPES; EVOLUTION	Sturgeons are considered as living fossils and have very high evolutionary, economical and conservation values. The multiploidy of sturgeon that has been caused by chromosome duplication may lead to the emergence of new microRNAs ( miRNAs) involved in the ploidy and physiological processes. In the present study, we performed the first sturgeon miRNAs analysis by RNA-seq high-throughput sequencing combined with expression assay of microarray and real-time PCR, and aimed to discover the sturgeon-specific miRNAs, confirm the expressed pattern of miRNAs and illustrate the potential role of miRNAs-targets on sturgeon biological processes. A total of 103 miRNAs were identified, including 58 miRNAs with strongly detected signals ( signal >500 and P <= 0.01), which were detected by microarray. Real-time PCR assay supported the expression pattern obtained by microarray. Moreover, co-expression of 21 miRNAs in all five tissues and tissue-specific expression of 16 miRNAs implied the crucial and particular function of them in sturgeon physiological processes. Target gene prediction, especially the enriched functional gene groups (369 GO terms) and pathways (37 KEGG) regulated by 58 miRNAs (P<0.05), illustrated the interaction of miRNAs and putative mRNAs, and also the potential mechanism involved in these biological processes. Our new findings of sturgeon miRNAs expand the public database of transcriptome information for this species, contribute to our understanding of sturgeon biology, and also provide invaluable data that may be applied in sturgeon breeding.	[Yuan, Lihong; Zhang, Xiujuan; Li, Linmiao; Jiang, Haiying; Chen, Jinping] South China Inst Endangered Animals, Guangdong Entomol Inst, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Chen, JP (corresponding author), South China Inst Endangered Animals, Guangdong Entomol Inst, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China.	chenjp@gdei.gd.cn			Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences [rcjj201402]; Innovative Talent Fund of Guangdong Entomological Institute [GDEI-cxrc2013]; National Natural Science Fund of China [31301012]; Guangzhou Pearl River Scientific and Technological New Star Project [2012J2200003]	Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences; Innovative Talent Fund of Guangdong Entomological Institute; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Guangzhou Pearl River Scientific and Technological New Star Project	This work was funded by grants awarded to LH.Y under the Outstanding Youth Science and Technology Talent Fund of Guangdong Academy of Sciences (rcjj201402) and the Innovative Talent Fund of Guangdong Entomological Institute (GDEI-cxrc2013). LH.Y is supported by the National Natural Science Fund of China (31301012) and the Guangzhou Pearl River Scientific and Technological New Star Project (2012J2200003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bemis WE, 1997, STURGEON BIODIVERSIT, V17, P5; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; BIRSTEIN VJ, 1987, GENETICA, V72, P3, DOI 10.1007/BF00126973; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chen MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076120; Chen P, 2013, P NATL ACAD SCI USA, V110, P11511, DOI 10.1073/pnas.1310144110; Chiba Y, 2010, J PHARMACOL SCI, V114, P264, DOI 10.1254/jphs.10R10FM; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fontana F, 2008, GENOME, V51, P113, DOI [10.1139/G07-112, 10.1139/g07-112]; Fontana F, 2008, GENETICA, V132, P281, DOI 10.1007/s10709-007-9171-4; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hudish LI, 2013, DEV CELL, V27, P387, DOI 10.1016/j.devcel.2013.10.015; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kalimutho M, 2011, J GASTROENTEROL, V46, P1391, DOI 10.1007/s00535-011-0456-0; Karaayvaz M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.193; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leary S, 2013, AVMA GUIDELINES EUTH; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ludwig A, 2001, GENETICS, V158, P1203; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Persengiev S, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.03.014; Rao PK, 2010, FASEB J, V24, P3427, DOI 10.1096/fj.09-150698; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Tarailo-Graovac M, 2009, CURRENT PROTOCOLS BI, V25; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-140; Wu J, 2014, REPROD DOMEST ANIM, V49, P32, DOI 10.1111/rda.12217; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Yin D, 2013, ONCOGENE, V32, P1155, DOI 10.1038/onc.2012.132	45	16	16	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115251	10.1371/journal.pone.0115251	http://dx.doi.org/10.1371/journal.pone.0115251			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506840	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100065
J	Sabol, M; Trnski, D; Uzarevic, Z; Ozretic, P; Musani, V; Rafaj, M; Cindric, M; Levanat, S				Sabol, Maja; Trnski, Diana; Uzarevic, Zvonimir; Ozretic, Petar; Musani, Vesna; Rafaj, Maja; Cindric, Mario; Levanat, Sonja			Combination of Cyclopamine and Tamoxifen Promotes Survival and Migration of MCF-7 Breast Cancer Cells - Interaction of Hedgehog-Gli and Estrogen Receptor Signaling Pathways	PLOS ONE			English	Article							SONIC-HEDGEHOG; THERAPEUTIC TARGET; POOR-PROGNOSIS; EXPRESSION; PROTEIN; PROHIBITIN; ALPHA; PROLIFERATION; ACTIVATION; DNA	Hedgehog-Gli (Hh-Gli) signaling pathway is one of the new molecular targets found upregulated in breast tumors. Estrogen receptor alpha (ER alpha) signaling has a key role in the development of hormone-dependent breast cancer. We aimed to investigate the effects of inhibiting both pathways simultaneously on breast cancer cell survival and the potential interactions between these two signaling pathways. ER-positive MCF-7 cells show decreased viability after treatment with cyclopamine, a Hh-Gli pathway inhibitor, as well as after tamoxifen (an ER alpha inhibitor) treatment. Simultaneous treatment with cyclopamine and tamoxifen on the other hand, causes short-term survival of cells, and increased migration. We found upregulated Hh-Gli signaling under these conditions and protein profiling revealed increased expression of proteins involved in cell proliferation and migration. Therefore, even though Hh-Gli signaling seems to be a good potential target for breast cancer therapy, caution must be advised, especially when combining therapies. In addition, we also show a potential direct interaction between the Shh protein and ER alpha in MCF-7 cells. Our data suggest that the Shh protein is able to activate ER alpha independently of the canonical Hh-Gli signaling pathway. Therefore, this may present an additional boost for ER-positive cells that express Shh, even in the absence of estrogen.	[Sabol, Maja; Trnski, Diana; Ozretic, Petar; Musani, Vesna; Rafaj, Maja; Cindric, Mario; Levanat, Sonja] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Uzarevic, Zvonimir] Josip Juraj Strossmayer Univ Osijek, Fac Educ, Osijek, Croatia	Rudjer Boskovic Institute; University of JJ Strossmayer Osijek	Levanat, S (corresponding author), Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia.	levanat@irb.hr	Sabol, Maja/G-4177-2011; Užarević, Zvonimir/AAC-8963-2021; Trnski, Diana/N-6816-2015; Musani, Vesna/K-7972-2019; Ozretić, Petar/G-5189-2014	Sabol, Maja/0000-0001-6968-2327; Ozretić, Petar/0000-0001-9757-6636; Musani, Vesna/0000-0001-9927-3727; Uzarevic, Zvonimir/0000-0001-9543-321X; Trnski, Diana/0000-0003-2441-8439	Croatian Ministry of Science, Education and Sports [098-0982464-2461]; European Union [316289 - InnoMol, FP7-REGPOT-2012-2013-1]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); European Union(European Commission)	This work was supported by funds from the Croatian Ministry of Science, Education and Sports, Grant No. 098-0982464-2461, and the European Union's Seventh Framework Programme for Research and Technological Development under grant agreement No. 316289 - InnoMol, FP7-REGPOT-2012-2013-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Antonioli P, 2009, J CHROMATOGR A, V1216, P3606, DOI 10.1016/j.chroma.2008.11.053; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Chang-Claude J, 2003, INT J CANCER, V103, P779, DOI 10.1002/ijc.10889; CHE J, 2013, ONCOL LETT; Chu YW, 1996, AM J PATHOL, V148, P63; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Cui W, 2010, CANCER SCI, V101, P927, DOI 10.1111/j.1349-7006.2010.01495.x; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Fillies T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-10; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Guay J, 1997, J CELL SCI, V110, P357; Hatsell SJ, 2006, DEVELOPMENT, V133, P3661, DOI 10.1242/dev.02542; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Hu WG, 2007, ACTA PHARMACOL SIN, V28, P1224, DOI 10.1111/j.1745-7254.2007.00620.x; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Jinawath A, 2007, J CANCER RES CLIN, V133, P271, DOI 10.1007/s00432-006-0166-9; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Kameda C, 2010, BRIT J CANCER, V102, P738, DOI 10.1038/sj.bjc.6605517; Koga K, 2008, ANTICANCER RES, V28, P731; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Kwon SM, 2010, J ENDODONT, V36, P1332, DOI 10.1016/j.joen.2010.04.010; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Leovic D, 2012, HEAD NECK-J SCI SPEC, V34, P104, DOI 10.1002/hed.21696; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maurac I, 2012, INT J GYNECOL PATHOL, V31, P264, DOI 10.1097/PGP.0b013e31823b6f0f; Mazumdar M, 2010, CANCER RES, V70, DOI 10.1158/1538-7445.AM10-2940; Mimeault M, 2006, INT J CANCER, V118, P1022, DOI 10.1002/ijc.21440; Mimeault M, 2010, MOL CANCER THER, V9, P617, DOI 10.1158/1535-7163.MCT-09-1013; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Panfoli I, 2012, EXPERT REV PROTEOMIC, V9, P627, DOI [10.1586/epr.12.63, 10.1586/EPR.12.63]; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Sabol M, 2012, INT J ONCOL, V41, P1411, DOI 10.3892/ijo.2012.1554; Shaw G, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Sievers C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012735; Sinha S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-84; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Sun Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-137; Teh MT, 2002, CANCER RES, V62, P4773; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; White SR, 2005, AM J RESP CELL MOL, V32, P301, DOI 10.1165/rcmb.2004-0118OC; Wicking C, 1998, ONCOGENE, V16, P1091, DOI 10.1038/sj.onc.1201644; Wolf I, 2007, BREAST CANCER RES TR, V105, P139, DOI 10.1007/s10549-006-9440-4; Xie JW, 1997, CANCER RES, V57, P2369; Xu ZB, 2011, SCI CHINA LIFE SCI, V54, P121, DOI 10.1007/s11427-010-4130-1; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3; Zhao JY, 2010, BREAST CANCER RES TR, V119, P39, DOI 10.1007/s10549-009-0323-3	56	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114510	10.1371/journal.pone.0114510	http://dx.doi.org/10.1371/journal.pone.0114510			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503972	gold, Green Published			2022-12-27	WOS:000346375400033
J	Schofield, AJ; Kingdom, FAA				Schofield, Andrew J.; Kingdom, Frederick A. A.			Texture Variations Suppress Suprathreshold Brightness and Colour Variations	PLOS ONE			English	Article							CHROMOLUMINANCE PATTERNS; RED-GREEN; LUMINANCE; CONTRAST; MECHANISMS; SENSITIVITY; LIGHTNESS; CONE; INFORMATION; ADAPTATION	Discriminating material changes from illumination changes is a key function of early vision. Luminance cues are ambiguous in this regard, but can be disambiguated by co-incident changes in colour and texture. Thus, colour and texture are likely to be given greater prominence than luminance for object segmentation, and better segmentation should in turn produce stronger grouping. We sought to measure the relative strengths of combined luminance, colour and texture contrast using a suprathreshhold, psychophysical grouping task. Stimuli comprised diagonal grids of circular patches bordered by a thin black line and contained combinations of luminance decrements with either violet, red, or texture increments. There were two tasks. In the Separate task the different cues were presented separately in a two-interval design, and participants indicated which interval contained the stronger orientation structure. In the Combined task the cues were combined to produce competing orientation structure in a single image. Participants had to indicate which orientation, and therefore which cue was dominant. Thus we established the relative grouping strength of each cue pair presented separately, and compared this to their relative grouping strength when combined. In this way we observed suprathreshold interactions between cues and were able to assess cue dominance at ecologically relevant signal levels. Participants required significantly more luminance and colour compared to texture contrast in the Combined compared to Separate conditions (contrast ratios differed by about 0.1 log units), showing that suprathreshold texture dominates colour and luminance when the different cues are presented in combination.	[Schofield, Andrew J.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Kingdom, Frederick A. A.] McGill Univ, Dept Ophthalmol, McGill Vis Res, Montreal, PQ H3A 2T5, Canada	University of Birmingham; McGill University	Schofield, AJ (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	a.j.schofield@bham.ac.uk		Schofield, Andrew J./0000-0002-0589-4678	Canadian Institute of Health Research [MOP 82755, MOP 123349]; Engineering and Physical Sciences Research Council [EP/F026269/1]; Royal Society Travel grant; EPSRC [EP/F026269/1] Funding Source: UKRI	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Travel grant(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Canadian Institute of Health Research (www.cihr-irsc.gc.ca/e/193.html) grants MOP 82755 and MOP 123349 awarded to FK and Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant (EP/F026269/1) and a Royal Society (www.royalsociety.org) Travel grant to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson E. H, 1995, CHECKER SHADOW ILLUS; Amano K, 2014, J OPT SOC AM A, V31, pA254, DOI 10.1364/JOSAA.31.00A254; CHAPARRO A, 1994, VISION RES, V34, P751, DOI 10.1016/0042-6989(94)90214-3; Chen CC, 2000, VISION RES, V40, P773, DOI 10.1016/S0042-6989(99)00227-8; Chen CC, 2000, VISION RES, V40, P789, DOI 10.1016/S0042-6989(99)00228-X; Clery S, 2013, J VISION, V13, DOI 10.1167/13.5.16; COLE GR, 1993, J OPT SOC AM A, V10, P38, DOI 10.1364/JOSAA.10.000038; COLE GR, 1990, J OPT SOC AM A, V7, P128, DOI 10.1364/JOSAA.7.000128; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; Georgeson MA, 2002, SPATIAL VISION, V16, P59, DOI 10.1163/15685680260433913; GILCHRIST AL, 1988, PERCEPT PSYCHOPHYS, V43, P415, DOI 10.3758/BF03207877; GILCHRIST AL, 1977, SCIENCE, V195, P185, DOI 10.1126/science.831266; GUR M, 1992, VISION RES, V32, P1253, DOI 10.1016/0042-6989(92)90220-D; Johnson AP, 2005, J OPT SOC AM A, V22, P2050, DOI 10.1364/JOSAA.22.002050; Kingdom FAA, 2004, PERCEPTION, V33, P907, DOI 10.1068/p5264; Kingdom FAA, 2006, SPATIAL VISION, V19, P147, DOI 10.1163/156856806776923461; Kingdom FAA, 2005, VISION RES, V45, P1425, DOI 10.1016/j.visres.2004.11.023; Kingdom FAA, 2003, NAT NEUROSCI, V6, P641, DOI 10.1038/nn1060; Kingdom FAA, 2008, VISION RES, V48, P2090, DOI 10.1016/j.visres.2008.03.020; Kingdom FAA, 2014, VISION RES, V95, P36, DOI 10.1016/j.visres.2013.12.004; Kingdom FAA, 2010, J VISION, V10, DOI 10.1167/10.10.13; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; LANDY MS, 1991, VISION RES, V31, P679, DOI 10.1016/0042-6989(91)90009-T; Lovell PG, 2005, J OPT SOC AM A, V22, P2060, DOI 10.1364/JOSAA.22.002060; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Mamassian P, 2001, VISION RES, V41, P2653, DOI 10.1016/S0042-6989(01)00147-X; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; MULLEN KT, 1994, J OPT SOC AM A, V11, P3136, DOI 10.1364/JOSAA.11.003136; NOORLANDER C, 1983, J OPT SOC AM, V73, P1533, DOI 10.1364/JOSA.73.001533; Parraga CA, 2002, CURR BIOL, V12, P483, DOI 10.1016/S0960-9822(02)00718-2; Prins N, 2009, PALMEDES MATLAB ROUT; Regan BC, 1997, DOC OPHTH P, V59, P261; RUBIN JM, 1982, BIOL CYBERN, V45, P215, DOI 10.1007/BF00336194; Sankeralli MJ, 1997, J OPT SOC AM A, V14, P906; Schofield AJ, 1999, VISION RES, V39, P2697, DOI 10.1016/S0042-6989(98)00284-3; Schofield AJ, 2006, VISION RES, V46, P3462, DOI 10.1016/j.visres.2006.03.014; Schofield AJ, 2010, J VISION, V10, DOI 10.1167/10.9.2; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; STROMEYER CF, 1985, VISION RES, V25, P219, DOI 10.1016/0042-6989(85)90116-6; SWITKES E, 1988, J OPT SOC AM A, V5, P1149, DOI 10.1364/JOSAA.5.001149	42	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114803	10.1371/journal.pone.0114803	http://dx.doi.org/10.1371/journal.pone.0114803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502555	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000346375400055
J	Dona, F; Houseley, J				Dona, Federico; Houseley, Jonathan			Unexpected DNA Loss Mediated by the DNA Binding Activity of Ribonuclease A	PLOS ONE			English	Article							BOVINE PANCREATIC RIBONUCLEASE; EMBRYONIC STEM-CELLS; PERICENTRIC HETEROCHROMATIN; SATELLITE REPEATS; MOUSE DEVELOPMENT; TRANSCRIPTION; METHYLATION; MECHANISM; PATHWAY	Ribonuclease A (RNase A) is widely used in molecular biology research both for analytical assays and for nucleic acid preparation. The catalytic mechanism of RNase A is well understood and absolutely precludes activity on DNA; however anecdotal reports of DNA degradation by RNase A are not uncommon. Here we describe a mechanism by which RNase A treatment can lead to apparent DNA degradation. This results from the surprising finding that RNase A remains functional in a phenol: chloroform mixture, to our knowledge the only enzyme that survives this highly denaturing solvent environment. Although RNase A does not cleave the DNA backbone it is capable of binding to DNA, forming stable RNase ADNA complexes that partition to the interphase or organic phase during phenol: chloroform purification. The unexpected survival of the RNase A DNA-binding activity in phenol means that these complexes are not dissolved and a substantial amount of RNase A- bound DNA is permanently removed from the aqueous phase and lost on phase separation. This effect will impact DNA recovery from multiple procedures and is likely to represent a source of sequence bias in genome- wide studies. Our results also indicate that the results of analytical studies performed using RNase A must be considered with care.	[Dona, Federico; Houseley, Jonathan] Babraham Inst, Epigenet Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Houseley, J (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	jon.houseley@babraham.ac.uk	Houseley, Jon/AAF-7409-2021	Dona, Federico/0000-0002-4232-4762; Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust [088335]; scholarship of the Leonardo da Vinci project Unipharma-Graduates 9 coordinated by Sapienza University of Rome; BBSRC [BBS/E/B/000C0401, BBS/E/B/0000H247] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0401, BBS/E/B/0000H247] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); scholarship of the Leonardo da Vinci project Unipharma-Graduates 9 coordinated by Sapienza University of Rome; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Wellcome Trust [grant number 088335], FD was partially supported by a scholarship of the Leonardo da Vinci project Unipharma-Graduates 9 coordinated by Sapienza University of Rome. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BenoreParsons M, 1997, BIOTECHNIQUES, V23, P128, DOI 10.2144/97231st04; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; FELSENFELD G, 1963, P NATL ACAD SCI USA, V50, P644, DOI 10.1073/pnas.50.4.644; FINDLAY D, 1961, NATURE, V190, P781, DOI 10.1038/190781a0; GAUBATZ JW, 1990, J BIOL CHEM, V265, P17753; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; GUTTE B, 1969, J AM CHEM SOC, V91, P501, DOI 10.1021/ja01030a050; HIRSCHMANN R, 1969, J AM CHEM SOC, V91, P507, DOI 10.1021/ja01030a055; Hsieh CL, 2011, NUCLEIC ACIDS RES, V39, P4048, DOI 10.1093/nar/gkq1338; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; Jones W, 1920, AM J PHYSIOL, V52, P203, DOI 10.1152/ajplegacy.1920.52.1.203; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; KARTHA G, 1967, NATURE, V213, P862, DOI 10.1038/213862a0; KUNITZ M., 1940, JOUR GEN PHYSIOL, V24, P15, DOI 10.1085/jgp.24.1.15; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MOORE S, 1973, SCIENCE, V180, P458, DOI 10.1126/science.180.4085.458; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Richards F M, 1972, Science, V178, P492, DOI 10.1126/science.178.4060.492; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; Sambrook J, 2001, MOL CLONING LAB MANU, V3rd; SAUNDERS M, 1957, J AM CHEM SOC, V79, P3289, DOI 10.1021/ja01569a083; UDGAONKAR JB, 1988, NATURE, V335, P694, DOI 10.1038/335694a0; WYCKOFF HW, 1967, J BIOL CHEM, V242, P3984	30	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115008	10.1371/journal.pone.0115008	http://dx.doi.org/10.1371/journal.pone.0115008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502562	Green Published, gold			2022-12-27	WOS:000347146700082
J	Vent-Schmidt, J; Waltz, X; Romana, M; Hardy-Dessources, MD; Lemonne, N; Billaud, M; Etienne-Julan, M; Connes, P				Vent-Schmidt, Jens; Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Lemonne, Nathalie; Billaud, Marie; Etienne-Julan, Maryse; Connes, Philippe			Blood Thixotropy in Patients with Sickle Cell Anaemia: Role of Haematocrit and Red Blood Cell Rheological Properties	PLOS ONE			English	Article							AGGREGATE STRENGTH; ALPHA-THALASSEMIA; DEFORMABILITY; EVOLUTION; DISEASE; CRISIS; RISK	We compared the blood thixotropic/shear-thinning properties and the red blood cells' (RBC) rheological properties between a group of patients with sickle cell anaemia (SS) and healthy individuals (AA). Blood thixotropy was determined by measuring blood viscosity with a capillary viscometer using a "loop" protocol: the shear rate started at 1 s(-1) and increased progressively to 922 s(-1) and then redecreased to the initial shear rate. Measurements were performed at native haematocrit for the two groups and at 25% and 40% haematocrit for the AA and SS individuals, respectively. RBC deformability was determined by ektacytometry and RBC aggregation properties by laser backscatter versus time. AA at native haematocrit had higher blood thixotropic index than SS at native haematocrit and AA at 25% haematocrit. At 40% haematocrit, SS had higher blood thixotropic index than AA. While RBC deformability and aggregation were lower in SS than in AA, the strength of RBC aggregates was higher in the former population. Our results showed that 1) anaemia is the main modulator of blood thixtropy and 2) the low RBC deformability and high RBC aggregates strength cause higher blood thixotropy in SS patients than in AA individuals at 40% haematocrit, which could impact blood flow in certain vascular compartments.	[Vent-Schmidt, Jens; Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Etienne-Julan, Maryse; Connes, Philippe] CHU Pointe A Pitre, Hop Ricou, Inserm UMR 1134, Pointe A Pitre 97157, Guadeloupe, France; [Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Etienne-Julan, Maryse; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, F-75015 Paris, France; [Waltz, Xavier] French West Indies & Guiana Univ, Dept Physiol, Lab ACTES EA 3596, Pointe A Pitre, Guadeloupe, France; [Lemonne, Nathalie; Billaud, Marie; Etienne-Julan, Maryse] CHU Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre 97157, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France; [Connes, Philippe] Univ Lyon 1, Lab CRIS EA647, F-69100 Villeurbanne, France	CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Institut Universitaire de France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Connes, P (corresponding author), CHU Pointe A Pitre, Hop Ricou, Inserm UMR 1134, Pointe A Pitre 97157, Guadeloupe, France.	pconnes@yahoo.fr	, Hardy-dessources/K-9189-2017; WALTZ, Xavier/M-3606-2016; Romana, Marc/K-6442-2017; Connes, Philippe/J-7835-2019	, Hardy-dessources/0000-0003-0861-3648; WALTZ, Xavier/0000-0002-0838-290X; Romana, Marc/0000-0002-8715-9836; Connes, Philippe/0000-0002-9232-0268; ETIENNE-JULAN, Maryse/0000-0003-1339-6545				BALLAS SK, 1988, BLOOD, V72, P1216; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; BALLAS SK, 1991, AM J HEMATOL, V36, P122, DOI 10.1002/ajh.2830360211; BARBEE JH, 1971, MICROVASC RES, V3, P6, DOI 10.1016/0026-2862(71)90002-1; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435; CHIEN S, 1970, J CLIN INVEST, V49, P623, DOI 10.1172/JCI106273; CLARK MR, 1980, J CLIN INVEST, V65, P189, DOI 10.1172/JCI109650; Connes P, 2014, BRIT J HAEMATOL, V165, P564, DOI 10.1111/bjh.12786; Connes P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079680; DINTENFASS L, 1962, Sogo Rinsho, V11, P233; EMBURY SH, 1984, J CLIN INVEST, V73, P116, DOI 10.1172/JCI111181; Franco M, 2013, BLOOD, V121, P546, DOI 10.1182/blood-2012-07-442467; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Hierso R, 2014, BRIT J HAEMATOL, V166, P601, DOI 10.1111/bjh.12912; Lamarre Y, 2014, CLIN HEMORHEOL MICRO, V57, P63, DOI 10.3233/CH-131772; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; LANDE WM, 1988, BLOOD, V72, P2056; Lemaire C, 2013, CLIN HEMORHEOL MICRO, V55, P205, DOI 10.3233/CH-2012-1622; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; MOHANDAS N, 1989, ANN NY ACAD SCI, V565, P327, DOI 10.1111/j.1749-6632.1989.tb24180.x; NASH GB, 1986, BLOOD, V67, P110; Stuart J, 1987, Baillieres Clin Haematol, V1, P747, DOI 10.1016/S0950-3536(87)80023-9; Thurston GB, 2004, CLIN HEMORHEOL MICRO, V30, P83; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Vaya A, 2014, CLIN HEMORHEOL MICRO; Vaya A, 2013, CLIN HEMORHEOL MICRO; Waltz X, 2012, CLIN HEMORHEOL MICRO, V52, P15, DOI 10.3233/CH-2012-1540	30	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114412	10.1371/journal.pone.0114412	http://dx.doi.org/10.1371/journal.pone.0114412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502228	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700022
J	Lynch, TP; Morello, EB; Evans, K; Richardson, AJ; Rochester, W; Steinberg, CR; Roughan, M; Thompson, P; Middleton, JF; Feng, M; Sherrington, R; Brando, V; Tilbrook, B; Ridgway, K; Allen, S; Doherty, P; Hill, K; Moltmann, TC				Lynch, Tim P.; Morello, Elisabetta B.; Evans, Karen; Richardson, Anthony J.; Rochester, Wayne; Steinberg, Craig R.; Roughan, Moninya; Thompson, Peter; Middleton, John F.; Feng, Ming; Sherrington, Robert; Brando, Vittorio; Tilbrook, Bronte; Ridgway, Ken; Allen, Simon; Doherty, Peter; Hill, Katherine; Moltmann, Tim C.			IMOS National Reference Stations: A Continental-Wide Physical, Chemical and Biological Coastal Observing System	PLOS ONE			English	Article							PHYTOPLANKTON	Sustained observations allow for the tracking of change in oceanography and ecosystems, however, these are rare, particularly for the Southern Hemisphere. To address this in part, the Australian Integrated Marine Observing System (IMOS) implemented a network of nine National Reference Stations (NRS). The network builds on one long-term location, where monthly water sampling has been sustained since the 1940s and two others that commenced in the 1950s. In-situ continuously moored sensors and an enhanced monthly water sampling regime now collect more than 50 data streams. Building on sampling for temperature, salinity and nutrients, the network now observes dissolved oxygen, carbon, turbidity, currents, chlorophyll a and both phytoplankton and zooplankton. Additional parameters for studies of ocean acidification and bio-optics are collected at a sub-set of sites and all data is made freely and publically available. Our preliminary results demonstrate increased utility to observe extreme events, such as marine heat waves and coastal flooding; rare events, such as plankton blooms; and have, for the first time, allowed for consistent continental scale sampling and analysis of coastal zooplankton and phytoplankton communities. Independent water sampling allows for cross validation of the deployed sensors for quality control of data that now continuously tracks daily, seasonal and annual variation. The NRS will provide multi-decadal time series, against which more spatially replicated short-term studies can be referenced, models and remote sensing products validated, and improvements made to our understanding of how large-scale, long-term change and variability in the global ocean are affecting Australia's coastal seas and ecosystems. The NRS network provides an example of how a continental scaled observing systems can be developed to collect observations that integrate across physics, chemistry and biology.	[Lynch, Tim P.; Evans, Karen; Thompson, Peter; Sherrington, Robert; Tilbrook, Bronte; Ridgway, Ken; Allen, Simon] CSIRO, Oceans & Atmosphere, Hobart, Tas 7001, Australia; [Morello, Elisabetta B.; Richardson, Anthony J.; Rochester, Wayne] CSIRO, Oceans & Atmosphere, Brisbane, Qld 4102, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, St Lucia, Qld 4072, Australia; [Steinberg, Craig R.; Doherty, Peter] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Roughan, Moninya] Univ New S Wales, Sch Math, Sydney, NSW 2052, Australia; [Middleton, John F.] South Australian Res & Dev Inst, Urrbrae, SA 5022, Australia; [Feng, Ming] CSIRO, Oceans & Atmosphere, Wembly, WA 6014, Australia; [Brando, Vittorio] CSIRO, Land & Water, Canberra, ACT 2601, Australia; [Hill, Katherine; Moltmann, Tim C.] Univ Tasmania, Integrated Marine Observ Syst, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Australian Institute of Marine Science; University of New South Wales Sydney; South Australian Research & Development Institute (SARDI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania	Lynch, TP (corresponding author), CSIRO, Oceans & Atmosphere, GPO Box 1538, Hobart, Tas 7001, Australia.	Tim.Lynch@csiro.au	Lynch, Tim P/A-1463-2012; Rochester, Wayne A/K-1569-2018; Ridgway, Ken/AAA-4040-2019; Brando, Vittorio E/A-1321-2008; Richardson, Anthony J/B-3649-2010; Roughan, Moninya/B-5563-2009; Thompson, Peter A/A-2361-2012; Tilbrook, Bronte/W-4007-2019; Feng, Ming/F-5411-2010; evans, karen/D-7110-2012; Doherty, Peter J/K-5211-2015; Tilbrook, Bronte/A-1522-2012	Rochester, Wayne A/0000-0002-7315-9341; Brando, Vittorio E/0000-0002-2193-5695; Richardson, Anthony J/0000-0002-9289-7366; Roughan, Moninya/0000-0003-3825-7533; Thompson, Peter A/0000-0002-9504-5433; Tilbrook, Bronte/0000-0001-9385-3827; Feng, Ming/0000-0002-2855-7092; Doherty, Peter J/0000-0001-6863-0533; Tilbrook, Bronte/0000-0001-9385-3827; Moltmann, Tim/0000-0002-7060-2117; Evans, Karen/0000-0003-2205-4264	Australian Government through the National Collaborative Research Infrastructure Strategy; Education Investment Fund; Collaborative Research Infrastructure Scheme	Australian Government through the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Education Investment Fund; Collaborative Research Infrastructure Scheme	Funding for the development of the extended NRS described here was provided by the Australian Government through the National Collaborative Research Infrastructure Strategy (2007-2011), the Education Investment Fund (2009-2013) and the Collaborative Research Infrastructure Scheme (2013-2014). Co-investment has been provided by the Queensland and New South Wales State Government, the Northern Territory Government, the Commonwealth Science and Industry Research Organisation, the Australian Institute of Marine Science, the Sydney Institute of Marine Science and the South Australian Research and Development Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Australian Bureau of Statistics, 2019, 3101 0 AUSTR DEM STA; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BURFORD MA, 1995, MAR ECOL PROG SER, V118, P255, DOI 10.3354/meps118255; BUSALACCHI A, 2010, ESA PUBLICATION WPP, V2, P10, DOI DOI 10.5270/OCEANOBS09.PP.10; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dexter P., 2010, TROUBLED WATERS OCEA, P161; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; DUARTE CM, 1992, NATURE, V356, P190, DOI 10.1038/356190a0; Feng M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01277; Findlay CS, 2000, MAR MICROPALEONTOL, V40, P417, DOI 10.1016/S0377-8398(00)00046-3; FREELAND H, 2010, ESA PUBLICATION WPP, V2; Geoscience Australia, 2004, GEODATA COAST 100K 2; Glenn S.M., 2000, OCEANOGRAPHY, V13, P24, DOI [10.5670/oceanog.2000.50, DOI 10.5670/OCEANOG.2000.50]; GREGG WW, 2007, DEEP SEA RES 2, V54, P1; GRIFFIN DA, 2004, DECADE SST SATELLITE; GUNN JJ, 2010, ESA PUBLICATION WPP, V2, P20, DOI DOI 10.5270/OCEANOBS09.PP.20; HALLEGRAEFF GM, 1993, AUST J MAR FRESH RES, V44, P325; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hayes D., 2005, COLLATION ANAL OCEAN; HEREDIA PC, 2014, J GEOPHYS RES-OCEANS, P119; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hill K, 2010, MAR TECHNOL SOC J, V44, P65, DOI 10.4031/MTSJ.44.6.13; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEQUERE C, 2010, ESA PUBLICATION WPP, V2, DOI DOI 10.5270/OCEANOBS09.CWP.56; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; LYNCH T, 2010, ESA PUBLICATION WPP, V2, DOI DOI 10.5270/OCEANOBS09; LYNCH TP, 2011, SCI RATIONALE IMPLEM; Morello Elisabetta B., 2014, Methods in Oceanography, V9, P17, DOI 10.1016/j.mio.2014.09.001; Oke PR, 2012, J MARINE SYST, V105, P30, DOI 10.1016/j.jmarsys.2012.05.009; Pearce A, 2007, MAR FRESHWATER RES, V58, P914, DOI 10.1071/MF07082; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poulter B, 2014, NATURE, V509, P600, DOI 10.1038/nature13376; REVELANTE N, 1982, J PLANKTON RES, V4, P47, DOI 10.1093/plankt/4.1.47; Richardson AJ, 2008, SCIENCE, V320, P1294, DOI 10.1126/science.1156129; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Ridgway KR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001921; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Solomon D.Q.S., 2007, CONTRIBUTION WORKING; Southward AJ, 2005, ADV MAR BIOL, V47, P1; SWADLING KM, 2013, AUSTRALIAN MARINE ZO; Taylor F.J.R., 1976, BIBLIOTHECA BOT, V132, P1; Thompson P. A., 2011, Journal of the Royal Society of Western Australia, V94, P161; Thompson PA, 2011, DEEP-SEA RES PT II, V58, P645, DOI 10.1016/j.dsr2.2010.10.003; Thompson PA, 2009, MAR ECOL PROG SER, V394, P1, DOI 10.3354/meps08297; UNESCO, 2005, 148 UNESCO GOOS; van den Honert RC, 2011, WATER-SUI, V3, P1149, DOI 10.3390/w3041149; Wilson D, 2009, OCEANS-IEEE, P2643; WOOD E. J. F., 1954, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V5, P171; J GEO RES; [No title captured], DOI DOI 10.5270/OCEANOBS09.CWP.17	53	56	56	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113652	10.1371/journal.pone.0113652	http://dx.doi.org/10.1371/journal.pone.0113652			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517905	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600005
J	Shen, SC; Shen, CI; Lin, H; Chen, CJ; Chang, CY; Chen, SM; Lee, HC; Lai, PS; Su, HL				Shen, Shih-Cheng; Shen, Ching-I; Lin, Ho; Chen, Chun-Jung; Chang, Chia-Yu; Chen, Sheng-Mei; Lee, Hsiu-Chin; Lai, Ping-Shan; Su, Hong-Lin			Susceptibility of Human Embryonic Stem Cell-Derived Neural Cells to Japanese Encephalitis Virus Infection	PLOS ONE			English	Article							NEURONAL PROGENITOR CELLS; GLIAL ACTIVATION; RAT-BRAIN; DIFFERENTIATION; VIMENTIN; DEATH; PATHOGENESIS; CONTRIBUTES; FEATURES; TROPISM	Pluripotent human embryonic stem cells (hESCs) can be efficiently directed to become immature neuroepithelial precursor cells (NPCs) and functional mature neural cells, including neurotransmitter-secreting neurons and glial cells. Investigating the susceptibility of these hESCs-derived neural cells to neurotrophic viruses, such as Japanese encephalitis virus (JEV), provides insight into the viral cell tropism in the infected human brain. We demonstrate that hESC-derived NPCs are highly vulnerable to JEV infection at a low multiplicity of infection (MOI). In addition, glial fibrillary acid protein (GFAP)-expressing glial cells are also susceptible to JEV infection. In contrast, only a few mature neurons were infected at MOI 10 or higher on the third day post-infection. In addition, functional neurotransmitter-secreting neurons are also resistant to JEV infection at high MOI. Moreover, we discover that vimentin intermediate filament, reported as a putative neurovirulent JEV receptor, is highly expressed in NPCs and glial cells, but not mature neurons. These results indicate that the expression of vimentin in neural cells correlates to the cell tropism of JEV. Finally, we further demonstrate that membranous vimentin is necessary for the susceptibility of hESC-derived NPCs to JEV infection.	[Shen, Shih-Cheng; Lin, Ho; Chen, Sheng-Mei; Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Shen, Ching-I; Lai, Ping-Shan] Natl Chung Hsing Univ, Dept Chem, Taichung 40227, Taiwan; [Chen, Chun-Jung] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chen, Chun-Jung] Tunghai Univ, Ctr Gen Educ, Taichung 40704, Taiwan; [Chen, Chun-Jung] Hung Kuang Univ, Grad Sch Nursing, Taichung, Taiwan; [Chang, Chia-Yu; Lee, Hsiu-Chin] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Tunghai University; Hungkuang University; National Chung Hsing University	Su, HL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Agr Biotechnol Ctr, Taichung 40227, Taiwan.	suhonglin@nchu.edu.tw		Lin, Ho/0000-0001-7849-9137	National Science Council of Taiwan (NSC) [101-2811-B-005-015-MY3, 102-2628-B-005-007-MY3]; Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU) [1017604, 1027607]; Ministry of Education, Taiwan, Republic of China, under the ATU plan	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU); Ministry of Education, Taiwan, Republic of China, under the ATU plan	This work was supported by grants from the National Science Council of Taiwan (NSC 101-2811-B-005-015-MY3 and 102-2628-B-005-007-MY3) and the Taichung Veterans General Hospital/National Chung Hsing University Joint Research Program (TCVGH-NCHU 1017604 and 1027607). This research was also funded in part by the Ministry of Education, Taiwan, Republic of China, under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bramanti Vincenzo, 2010, Front Biosci (Schol Ed), V2, P558; Chen CJ, 2010, J GEN VIROL, V91, P1028, DOI 10.1099/vir.0.013565-0; Chen SM, 2013, CELL TRANSPLANT, DOI [10. 3727/ 096368913X096675179, DOI 10.3727/096368913X096675179]; Cheng EH, 2008, REPROD BIOMED ONLINE, V17, P436, DOI 10.1016/S1472-6483(10)60229-5; Cho MS, 2008, NAT PROTOC, V3, P1888, DOI 10.1038/nprot.2008.188; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Das S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017225; DESAI A, 1995, ACTA NEUROPATHOL, V89, P368, DOI 10.1007/BF00309631; Dhara SK, 2008, J CELL BIOCHEM, V105, P633, DOI 10.1002/jcb.21891; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; HOULE J, 1983, DEV BRAIN RES, V9, P189, DOI 10.1016/0165-3806(83)90051-2; ISHII T, 1977, ACTA NEUROPATHOL, V38, P181, DOI 10.1007/BF00688063; JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510; Kaushik DK, 2011, FRONT BIOSCI-LANDMRK, V16, P2187, DOI 10.2741/3847; KIMURAKURODA J, 1993, ARCH VIROL, V130, P477, DOI 10.1007/BF01309676; Kumar S, 2009, BRAIN RES, V1268, P135, DOI 10.1016/j.brainres.2009.02.051; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x; Lin YL, 1996, VIRUS RES, V44, P45, DOI 10.1016/0168-1702(96)01343-3; LUKAS Z, 1989, HISTOCHEM J, V21, P693, DOI 10.1007/BF01002834; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; OGATA A, 1991, J VIROL, V65, P880, DOI 10.1128/JVI.65.2.880-886.1991; Raung SL, 2007, NEUROSCI LETT, V419, P263, DOI 10.1016/j.neulet.2007.04.036; Riaz SS, 2004, DEV BRAIN RES, V153, P39, DOI 10.1016/j.devbrainres.2004.07.006; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SCHNITZER J, 1984, DEV BRAIN RES, V15, P21, DOI 10.1016/0165-3806(84)90136-6; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712; Solomon T, 2004, ARCH VIROL, P161; Solomon T, 2002, CURR TOP MICROBIOL, V267, P171; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Su CM, 2001, VIROLOGY, V286, P206, DOI 10.1006/viro.2001.0986; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Thongtan T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/890586; Tsueng G, 2011, J VIROL, V85, P5718, DOI 10.1128/JVI.02261-10; Wilson PG, 2006, STEM CELL REV, V2, P67, DOI 10.1385/SCR:2:1:67	43	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114990	10.1371/journal.pone.0114990	http://dx.doi.org/10.1371/journal.pone.0114990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517725	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600035
J	Surma, S; Pakhomov, EA; Pitcher, TJ				Surma, Szymon; Pakhomov, Evgeny A.; Pitcher, Tony J.			Effects of Whaling on the Structure of the Southern Ocean Food Web: Insights on the "Krill Surplus'' from Ecosystem Modelling	PLOS ONE			English	Article							SEA-ICE EXTENT; ROSS SEA; WHALES; COMPETITION; INCREASES; SHETLAND; REVEALS; GEORGIA; DECLINE; BIOMASS	The aim of this study was to examine the ecological plausibility of the "krill surplus'' hypothesis and the effects of whaling on the Southern Ocean food web using mass-balance ecosystem modelling. The depletion trajectory and unexploited biomass of each rorqual population in the Antarctic was reconstructed using yearly catch records and a set of species-specific surplus production models. The resulting estimates of the unexploited biomass of Antarctic rorquals were used to construct an Ecopath model of the Southern Ocean food web existing in 1900. The rorqual depletion trajectory was then used in an Ecosim scenario to drive rorqual biomasses and examine the "krill surplus'' phenomenon and whaling effects on the food web in the years 1900-2008. An additional suite of Ecosim scenarios reflecting several hypothetical trends in Southern Ocean primary productivity were employed to examine the effect of bottom-up forcing on the documented krill biomass trend. The output of the Ecosim scenarios indicated that while the "krill surplus'' hypothesis is a plausible explanation of the biomass trends observed in some penguin and pinniped species in the mid-20th century, the excess krill biomass was most likely eliminated by a rapid decline in primary productivity in the years 1975-1995. Our findings suggest that changes in physical conditions in the Southern Ocean during this time period could have eliminated the ecological effects of rorqual depletion, although the mechanism responsible is currently unknown. Furthermore, a decline in iron bioavailability due to rorqual depletion may have contributed to the rapid decline in overall Southern Ocean productivity during the last quarter of the 20th century. The results of this study underscore the need for further research on historical changes in the roles of top-down and bottom-up forcing in structuring the Southern Ocean food web.	[Surma, Szymon; Pitcher, Tony J.] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Pakhomov, Evgeny A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Surma, S (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	s.surma@fisheries.ubc.ca	Surma, Szymon/GOG-9811-2022	Surma, Szymon/0000-0002-0236-6757				Ainley D, 2007, ANTARCT SCI, V19, P283, DOI 10.1017/S095410200700051X; Ainley DG, 2006, ECOLOGY, V87, P2080, DOI 10.1890/0012-9658(2006)87[2080:CAPACR]2.0.CO;2; Ainley DG, 2009, MAR MAMMAL SCI, V26, P1; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2014, TRENDS ECOL EVOL, V29, P309, DOI 10.1016/j.tree.2014.03.011; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Ballance LT, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P215; Boyce DG, 2014, PROG OCEANOGR, V122, P163, DOI 10.1016/j.pocean.2014.01.004; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Branch TA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P262; Brierley A.S., 1999, CCAMLR Science, V6, P47; Christensen LB, 2006, FISHERIES CTR RES RE, V14, P1; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Cornejo-Donoso J, 2008, ECOL MODEL, V218, P1, DOI 10.1016/j.ecolmodel.2008.06.011; Croll DA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P202; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; de la Mare WK, 2009, CLIMATIC CHANGE, V92, P461, DOI 10.1007/s10584-008-9473-2; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; FRASER WR, 1992, POLAR BIOL, V11, P525; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hucke-Gaete R, 2004, POLAR BIOL, V27, P304, DOI 10.1007/s00300-003-0587-8; LAWS RM, 1977, PHILOS T ROY SOC B, V279, P81, DOI 10.1098/rstb.1977.0073; Leaper R, 2008, SC60 IWC SCI COMM; Lee CS, 2011, J SPINAL DISORD TECH, V24, P183, DOI 10.1097/BSD.0b013e3181eb5214; Lynch HJ, 2014, AUK, V131, P457, DOI 10.1642/AUK-14-31.1; Micol T, 2001, POLAR BIOL, V24, P175, DOI 10.1007/s003000000193; Mori M, 2006, CCAMLR SCI, V13, P217; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nicol S, 2007, ANTARCT SCI, V19, P291, DOI 10.1017/S0954102007000491; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Pinkerton MH, 2010, CCAMLR SCI, V17, P1; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; Ruegg KC, 2010, MOL ECOL, V19, P281, DOI 10.1111/j.1365-294X.2009.04447.x; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Smetacek V., 2008, IMPACTS GLOBAL WARMI, P45; Smith WO, 2014, GEOPHYS RES LETT, V41, P1624, DOI 10.1002/2014GL059311; Trathan PN, 2012, ECOGRAPHY, V35, P983, DOI 10.1111/j.1600-0587.2012.07330.x; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Williams TM, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P191	43	26	27	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114978	10.1371/journal.pone.0114978	http://dx.doi.org/10.1371/journal.pone.0114978			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517505	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600034
J	Sandberg, CJ; Vik-Mo, EO; Behnan, J; Helseth, E; Langmoen, IA				Sandberg, Cecilie Jonsgar; Vik-Mo, Einar O.; Behnan, Jinan; Helseth, Eirik; Langmoen, Iver A.			Transcriptional Profiling of Adult Neural Stem-Like Cells from the Human Brain	PLOS ONE			English	Article							PROGENITOR CELLS; SUBVENTRICULAR ZONE; IMMUNOHISTOCHEMICAL ANALYSIS; PROSPECTIVE IDENTIFICATION; NEUROTROPHIN RECEPTOR; HEMATOPOIETIC STEM; SELF-RENEWAL; EXPRESSION; FAMILY; SLITRK	There is a great potential for the development of new cell replacement strategies based on adult human neural stem-like cells. However, little is known about the hierarchy of cells and the unique molecular properties of stem-and progenitor cells of the nervous system. Stem cells from the adult human brain can be propagated and expanded in vitro as free floating neurospheres that are capable of self-renewal and differentiation into all three cell types of the central nervous system. Here we report the first global gene expression study of adult human neural stem-like cells originating from five human subventricular zone biopsies (mean age 42, range 33-60). Compared to adult human brain tissue, we identified 1,189 genes that were significantly up-and downregulated in adult human neural stem-like cells (1% false discovery rate). We found that adult human neural stem-like cells express stem cell markers and have reduced levels of markers that are typical of the mature cells in the nervous system. We report that the genes being highly expressed in adult human neural stem-like cells are associated with developmental processes and the extracellular region of the cell. The calcium signaling pathway and neuroactive ligand-receptor interactions are enriched among the most differentially regulated genes between adult human neural stem-like cells and adult human brain tissue. We confirmed the expression of 10 of themost up-regulated genes in adult human neural stem-like cells in an additional sample set that included adult human neural stem-like cells (n=6), foetal human neural stem cells (n=1) and human brain tissues (n=12). The NGFR, SLITRK6 and KCNS3 receptors were further investigated by immunofluorescence and shown to be heterogeneously expressed in spheres. These receptors could potentially serve as new markers for the identification and characterisation of neural stem-and progenitor cells or as targets for manipulation of cellular fate.	[Sandberg, Cecilie Jonsgar; Vik-Mo, Einar O.; Behnan, Jinan; Helseth, Eirik; Langmoen, Iver A.] Oslo Univ Hosp, Vilhelm Magnus Lab, Inst Surg Res, Oslo, Norway; [Sandberg, Cecilie Jonsgar; Vik-Mo, Einar O.; Behnan, Jinan; Helseth, Eirik; Langmoen, Iver A.] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Langmoen, Iver A.] Oslo Univ Hosp, Canc Stem Cell Innovat Ctr CAST, Oslo, Norway; [Langmoen, Iver A.] Univ Oslo, Oslo, Norway; [Langmoen, Iver A.] Oslo Univ Hosp, Norwegian Stem Cell Ctr, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Sandberg, CJ (corresponding author), Oslo Univ Hosp, Vilhelm Magnus Lab, Inst Surg Res, Oslo, Norway.	cesandbe@medisin.uio.no	Behnan, Jinan/C-9263-2009; Helseth, Eirik/AAH-2466-2020	Behnan, Jinan/0000-0001-5780-0971; Vik-Mo, Einar Osland/0000-0001-8303-4123				Aruga J, 2003, GENE, V315, P87, DOI 10.1016/S0378-1119(03)00715-7; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cai JL, 2006, STEM CELLS DEV, V15, P232, DOI 10.1089/scd.2006.15.232; Carpentino JE, 2009, CANCER RES, V69, P8208, DOI 10.1158/0008-5472.CAN-09-1132; Chen Y, 2009, J INT MED RES, V37, P281, DOI 10.1177/147323000903700201; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dutta S, 2013, CNS NEUROSCI THER, V19, P5, DOI 10.1111/cns.12027; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Giebel B, 2008, BIOL CHEM, V389, P813, DOI 10.1515/BC.2008.092; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kukekov VG, 1999, EXP NEUROL, V156, P333, DOI 10.1006/exnr.1999.7028; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; Marei HES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033542; Milde T, 2007, LEUKEMIA, V21, P824, DOI 10.1038/sj.leu.2404525; Milward EA, 1997, J NEUROSCI RES, V50, P862, DOI 10.1002/(SICI)1097-4547(19971201)50:5<862::AID-JNR22>3.0.CO;2-1; Moe MC, 2005, NEUROSURGERY, V56, P1182, DOI 10.1227/01.NEU.0000159881.09663.6D; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Murrell W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071334; Nash B, 2014, INT REV NEUROBIOL, V118, P105, DOI 10.1016/B978-0-12-801284-0.00005-1; Olstorn H, 2011, NEUROSURGERY, V68, P213, DOI 10.1227/NEU.0b013e3181fd2c11; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Petratos S, 2004, GLIA, V48, P64, DOI 10.1002/glia.20056; Rahman M, 2011, NEUROSURGERY, V68, P531, DOI 10.1227/NEU.0b013e3181ff9eb5; Rector Kyle, 2013, Methods Mol Biol, V976, P1, DOI 10.1007/978-1-62703-317-6_1; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sandberg CJ, 2013, EXP CELL RES, V319, P2230, DOI 10.1016/j.yexcr.2013.06.004; Singh SK, 2003, CANCER RES, V63, P5821; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tonchev AB, 2005, J NEUROSCI RES, V81, P776, DOI 10.1002/jnr.20604; Valyi-Nagy K, 2012, MOL VIS, V18, P588; van Strien ME, 2014, STEM CELL TRANSL MED, V3, P470, DOI 10.5966/sctm.2013-0038; Vik-Mo EO, 2011, EXP CELL RES, V317, P1049, DOI 10.1016/j.yexcr.2010.12.022; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010; Westerlund U, 2003, EXP CELL RES, V289, P378, DOI 10.1016/S0014-4827(03)00291-X; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xue LP, 2014, CELL BIOCHEM BIOPHYS, V70, P1609, DOI 10.1007/s12013-014-0103-5	57	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114739	10.1371/journal.pone.0114739	http://dx.doi.org/10.1371/journal.pone.0114739			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514637	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300020
J	Estan, MC; Calvino, E; Calvo, S; Guillen-Guio, B; Boyano-Adanez, MD; de Blas, E; Rial, E; Aller, P				Cristina Estan, Maria; Calvino, Eva; Calvo, Susana; Guillen-Guio, Beatriz; del Carmen Boyano-Adanez, Maria; de Blas, Elena; Rial, Eduardo; Aller, Patricio			Apoptotic Efficacy of Etomoxir in Human Acute Myeloid Leukemia Cells. Cooperation with Arsenic Trioxide and Glycolytic Inhibitors, and Regulation by Oxidative Stress and Protein Kinase Activities	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; FATTY-ACID OXIDATION; ENERGY-METABOLISM; LEVEL; 2-DEOXYGLUCOSE; GLUTATHIONE; ACTIVATION; LONIDAMINE; DEPLETION; GROWTH	Fatty acid synthesis and oxidation are frequently exacerbated in leukemia cells, and may therefore represent a target for therapeutic intervention. In this work we analyzed the apoptotic and chemo-sensitizing action of the fatty acid oxidation inhibitor etomoxir in human acute myeloid leukemia cells. Etomoxir caused negligible lethality at concentrations up to 100 mu M, but efficaciously cooperated to cause apoptosis with the anti-leukemic agent arsenic trioxide (ATO, Trisenox), and with lower efficacy with other anti-tumour drugs (etoposide, cisplatin), in HL60 cells. Etomoxir-ATO cooperation was also observed in NB4 human acute promyelocytic cells, but not in normal (non-tumour) mitogen-stimulated human peripheral blood lymphocytes. Biochemical determinations in HL60 cells indicated that etomoxir (25-200 mu M) dose-dependently inhibited mitochondrial respiration while slightly stimulating glycolysis, and only caused marginal alterations in total ATP content and adenine nucleotide pool distribution. In addition, etomoxir caused oxidative stress (increase in intracellular reactive oxygen species accumulation, decrease in reduced glutathione content), as well as pro-apoptotic LKB-1/AMPK pathway activation, all of which may in part explain the chemo-sensitizing capacity of the drug. Etomoxir also cooperated with glycolytic inhibitors (2-deoxy-D-glucose, lonidamine) to induce apoptosis in HL60 cells, but not in NB4 cells. The combined etomoxir plus 2-deoxy-D-glucose treatment did not increase oxidative stress, caused moderate decrease in net ATP content, increased the AMP/ATP ratio with concomitant drop in energy charge, and caused defensive Akt and ERK kinase activation. Apoptosis generation by etomoxir plus 2-deoxy-D-glucose was further increased by co-incubation with ATO, which is apparently explained by the capacity of ATO to attenuate Akt and ERK activation. In summary, co-treatment with etomoxir may represent an interesting strategy to increase the apoptotic efficacy of ATO and (with some limitations) 2-deoxy-D-glucose which, although clinically important anti-tumour agents, exhibit low efficacy in monotherapy.	[Cristina Estan, Maria; Calvino, Eva; Calvo, Susana; Guillen-Guio, Beatriz; de Blas, Elena; Rial, Eduardo; Aller, Patricio] CSIC, Ctr Invest Biol, Madrid, Spain; [Calvo, Susana; del Carmen Boyano-Adanez, Maria] Univ Alcala, Dept Biol Sistemas, Fac Med & Ciencies Salud, Unidad Bioquim & Biol Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Universidad de Alcala	Rial, E (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid, Spain.	rial@cib.csic.es; aller@cib.csic.es	Calviño, Eva/H-9219-2015; Rial, Eduardo/A-4242-2008	Rial, Eduardo/0000-0001-8634-8902; Calvino Vanegas, Eva/0000-0003-0316-3035; Guillen-Guio, Beatriz/0000-0002-3703-1738	Spanish Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Direccion General de Investigacion [SAF2010-20256]; Comunidad de Madrid [S2010/BMD-2402]; Consejo Superior de Investigaciones Cientificas	Spanish Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); Consejo Superior de Investigaciones Cientificas	This work was supported by grant SAF2010-20256 (to P.A.) from the Spanish Ministerio de Ciencia e Innovacion, Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, Direccion General de Investigacion (http://www.mineco.gob.es/portal/site/mineco/idi), and by Grant S2010/BMD-2402 (to E.R.) from the Comunidad de Madrid (https://www.madrimasd.org). M.C.E. is the recipient of a JAE-Predoc fellowship from the Consejo Superior de Investigaciones Cientificas (http://www.csic.es/web/ guest/programa-jae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELALEEM S, 1994, HORM METAB RES, V26, P88, DOI 10.1055/s-2007-1000779; Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Amadori S, 2005, CURR MED RES OPIN, V21, P403, DOI 10.1185/030079904X20349; Breccia M, 2012, EXPERT OPIN PHARMACO, V13, P1031, DOI 10.1517/14656566.2012.677436; Cabrero A, 2002, J BIOL CHEM, V277, P10100, DOI 10.1074/jbc.M110321200; Calvino E, 2014, J PHARMACOL EXP THER, V348, P324, DOI 10.1124/jpet.113.206714; Calvino E, 2011, BIOCHEM PHARMACOL, V82, P1619, DOI 10.1016/j.bcp.2011.08.017; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Estan MC, 2012, BIOCHEM PHARMACOL, V84, P1604, DOI 10.1016/j.bcp.2012.09.022; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; DEKORTE D, 1985, ANAL BIOCHEM, V147, P197, DOI 10.1016/0003-2697(85)90028-4; Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451; Diaz Zuanel, 2005, Blood, V105, P1237; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fantin VR, 2006, ONCOGENE, V25, P4787, DOI 10.1038/sj.onc.1209599; Galan A, 2000, J BIOL CHEM, V275, P11418, DOI 10.1074/jbc.275.15.11418; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Holubarsch CJF, 2007, CLIN SCI, V113, P205, DOI 10.1042/CS20060307; Hubinger A, 1997, HORM METAB RES, V29, P436, DOI 10.1055/s-2007-979072; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Ko YH, 2012, J BIOENERG BIOMEMBR, V44, P163, DOI 10.1007/s10863-012-9417-4; Kritharis A, 2013, ANN HEMATOL, V92, P719, DOI 10.1007/s00277-013-1707-3; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; LANOTTE M, 1991, BLOOD, V77, P1080; Li JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074623; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Merrill CL, 2002, TOXICOL SCI, V68, P93, DOI 10.1093/toxsci/68.1.93; Miller WH, 2002, CANCER RES, V62, P3893; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Sanchez Y, 2008, INT J CANCER, V123, P1205, DOI 10.1002/ijc.23639; Sanchez Y, 2010, J PHARMACOL EXP THER, V335, P114, DOI 10.1124/jpet.110.168344; Scotland S, 2013, LEUKEMIA, V27, P2129, DOI 10.1038/leu.2013.107; Suganuma K, 2010, LEUKEMIA LYMPHOMA, V51, P2112, DOI 10.3109/10428194.2010.512966; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Troyano A, 2001, J BIOL CHEM, V276, P47107, DOI 10.1074/jbc.M104516200; Tsunekawa-Imai N, 2013, LEUKEMIA RES, V37, P1132, DOI 10.1016/j.leukres.2013.05.017; Vickers AEM, 2006, TOXICOL IN VITRO, V20, P1173, DOI 10.1016/j.tiv.2006.01.021; Xi HB, 2013, BIOCHEM PHARMACOL, V85, P1463, DOI 10.1016/j.bcp.2013.02.037; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; Yi J, 2002, APOPTOSIS, V7, P209, DOI 10.1023/A:1015331229263; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	50	32	34	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115250	10.1371/journal.pone.0115250	http://dx.doi.org/10.1371/journal.pone.0115250			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506699	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100064
J	Giannini, M; Giannaccini, M; Sibillano, T; Giannini, C; Liu, D; Wang, ZG; Bau, A; Dente, L; Cuschieri, A; Raffa, V				Giannini, Marianna; Giannaccini, Martina; Sibillano, Teresa; Giannini, Cinzia; Liu, Dun; Wang, Zhigang; Bau, Andrea; Dente, Luciana; Cuschieri, Alfred; Raffa, Vittoria			Sheets of Vertically Aligned BaTiO3 Nanotubes Reduce Cell Proliferation but Not Viability of NIH-3T3 Cells	PLOS ONE			English	Article							PIEZOELECTRIC CERAMIC IMPLANTS; BARIUM-TITANATE; IN-VITRO; SURFACE-ROUGHNESS; CALCIUM-PHOSPHATE; ADHESION; GROWTH; DIFFERENTIATION; HYDROXYAPATITE; NANOPARTICLES	All biomaterials initiate a tissue response when implanted in living tissues. Ultimately this reaction causes fibrous encapsulation and hence isolation of the material, leading to failure of the intended therapeutic effect of the implant. There has been extensive bioengineering research aimed at overcoming or delaying the onset of encapsulation. Nanotechnology has the potential to address this problem by virtue of the ability of some nanomaterials to modulate interactions with cells, thereby inducing specific biological responses to implanted foreign materials. To this effect in the present study, we have characterised the growth of fibroblasts on nano-structured sheets constituted by BaTiO3, a material extensively used in biomedical applications. We found that sheets of vertically aligned BaTiO3 nanotubes inhibit cell cycle progression - without impairing cell viability - of NIH-3T3 fibroblast cells. We postulate that the 3D organization of the material surface acts by increasing the availability of adhesion sites, promoting cell attachment and inhibition of cell proliferation. This finding could be of relevance for biomedical applications designed to prevent or minimize fibrous encasement by uncontrolled proliferation of fibroblastic cells with loss of material-tissue interface underpinning long-term function of implants.	[Giannini, Marianna; Giannaccini, Martina; Cuschieri, Alfred; Raffa, Vittoria] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy; [Sibillano, Teresa; Giannini, Cinzia] CNR, Inst Crystallog, I-70126 Bari, Italy; [Liu, Dun; Wang, Zhigang; Cuschieri, Alfred; Raffa, Vittoria] Univ Dundee, Inst Med Sci & Technol, Dundee, Scotland; [Bau, Andrea; Dente, Luciana; Raffa, Vittoria] Univ Pisa, Dept Biol, Pisa, Italy	Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); University of Dundee; University of Pisa	Giannini, M (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy.	marianna.giannini@sssup.it	Cuschieri, Alfred/O-4092-2019; Wang, Zhigang/A-5197-2013	Cuschieri, Alfred/0000-0003-0764-5947; Wang, Zhigang/0000-0001-8309-7888; GIANNINI, CINZIA/0000-0003-0983-2885; DENTE, LUCIANA/0000-0002-9617-0922; RAFFA, VITTORIA/0000-0002-4289-9937; GIANNACCINI, Martina/0000-0002-8485-1018	FIRB-MIUR - Italian Ministry of Education, Universities and Research [RBAP114AMK_006]; Italian MoH/Regione Toscana [RF-2009-1535329]; EPSRC [EP/H010033/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H010033/1] Funding Source: researchfish	FIRB-MIUR - Italian Ministry of Education, Universities and Research; Italian MoH/Regione Toscana; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by: FIRB-MIUR "Rete integrata per la Nano Medicina (RINAME)'', code RBAP114AMK_006, funded by Italian Ministry of Education, Universities and Research (http://www.istruzione.it/), to M. Saviano and D. Gatteschi; and "Single incision laparoscopy surgery study (SILS)'', project, code RF-2009-1535329, funded by Italian MoH/Regione Toscana, http://ricerca.cbim.it/index.html, to V. Raffa and A. Cuschieri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bacakova L, 2004, PHYSIOL RES, V53, pS35; Baxter FR, 2010, ANN BIOMED ENG, V38, P2079, DOI 10.1007/s10439-010-9977-6; Baxter FR, 2009, J MATER SCI-MATER M, V20, P1697, DOI 10.1007/s10856-009-3734-0; Beloti MM, 2006, J BIOMED MATER RES A, V79A, P282, DOI 10.1002/jbm.a.30801; Chen YY, 2009, INORG CHEM, V48, P681, DOI 10.1021/ic8018887; Ciofani G, 2010, NANOSCALE RES LETT, V5, P1093, DOI 10.1007/s11671-010-9607-0; CRAWFORD GP, 1992, J CHEM PHYS, V96, P7788, DOI 10.1063/1.462376; Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191; Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5; Feng JQ, 1997, BIOMATERIALS, V18, P1531, DOI 10.1016/S0142-9612(97)00087-2; Gimenes R, 2004, P SOC PHOTO-OPT INS, V5385, P539, DOI 10.1117/12.548647; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hwang KS, 2002, J MATER SCI-MATER M, V13, P133, DOI 10.1023/A:1013671526975; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019; Li ZS, 2009, ACTA BIOMATER, V5, P2189, DOI 10.1016/j.actbio.2009.02.013; Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2; Massafera MP, 2011, ELECTROANAL, V23, P2534, DOI 10.1002/elan.201100239; Nagata H, 2003, JPN J APPL PHYS 1, V42, P7401, DOI 10.1143/JJAP.42.7401; PARK JB, 1980, J BIOMED MATER RES, V14, P269, DOI 10.1002/jbm.820140308; PARK JB, 1981, J BIOMED MATER RES, V15, P103, DOI 10.1002/jbm.820150114; Park YJ, 2002, BIOMATERIALS, V23, P3859, DOI 10.1016/S0142-9612(02)00123-0; Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Song HJ, 2007, MATER LETT, V61, P3473, DOI 10.1016/j.matlet.2006.11.100; Wada S, 2007, J KOREAN PHYS SOC, V51, P874, DOI 10.3938/jkps.51.874; Wang ZG, 2013, INT J MOL SCI, V14, P9111, DOI 10.3390/ijms14059111; Zagar K, 2011, MATER RES BULL, V46, P366, DOI 10.1016/j.materresbull.2010.12.012; Zagar K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/38/385501	30	1	2	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115183	10.1371/journal.pone.0115183	http://dx.doi.org/10.1371/journal.pone.0115183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506693	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100056
J	Jayawardhana, J; Bradford, WD; Jones, W; Nietert, PJ; Silvestri, G				Jayawardhana, Jayani; Bradford, W. David; Jones, Walter; Nietert, Paul J.; Silvestri, Gerard			Master Settlement Agreement (MSA) Spending and Tobacco Control Efforts	PLOS ONE			English	Article							STATES ALLOCATIONS	We investigate whether the distributions to the states from the Tobacco Master Settlement Agreement (MSA) in 1998 is associated with stronger tobacco control efforts. We use state level data from 50 states and the District of Columbia from four time periods post MSA (1999, 2002, 2004, and 2006) for the analysis. Using fixed effect regression models, we estimate the relationship between MSA disbursements and a new aggregate measure of strength of state tobacco control known as the Strength of Tobacco Control (SoTC) Index. Results show an increase of $1 in the annual per capita MSA disbursement to a state is associated with a decrease of -0.316 in the SoTC mean value, indicating higher MSA payments were associated with weaker tobacco control measures within states. In order to achieve the initial objectives of the MSA payments, policy makers should focus on utilizing MSA payments strictly on tobacco control activities across states.	[Jayawardhana, Jayani] Univ Georgia, Coll Publ Hlth, Dept Hlth Policy & Management, Athens, GA 30602 USA; [Bradford, W. David] Univ Georgia, Sch Publ & Int Affairs, Dept Publ Adm & Policy, Athens, GA 30602 USA; [Jones, Walter] Med Univ S Carolina, Charleston, SC 29425 USA; [Nietert, Paul J.; Silvestri, Gerard] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Medical University of South Carolina; Medical University of South Carolina	Jayawardhana, J (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Hlth Policy & Management, Athens, GA 30602 USA.	jayaward@uga.edu		Nietert, Paul/0000-0002-3933-4986	Department of Defense [W81XWH-05-1-0378]; South Carolina Clinical & Translational Research Institute, Medical University of South Carolina's CTSA, NIH/NCRR Grant [UL1RR029882]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); South Carolina Clinical & Translational Research Institute, Medical University of South Carolina's CTSA, NIH/NCRR Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was supported in part by a contract from the Department of Defense (No. W81XWH-05-1-0378) and the South Carolina Clinical & Translational Research Institute, Medical University of South Carolina's CTSA, NIH/NCRR Grant Number UL1RR029882. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Austin-Lane Joy, 2004, Health Promot Pract, V5, p46S; Chaloupka FJ, 2000, HANDB ECON, V17, P1539; Hero RE, 1996, AM J POLIT SCI, V40, P851, DOI 10.2307/2111798; Jemal A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-512; Michigan in Brief, 2002, TOB SETT; National Association of State Budget Officers, 2013, UPD TOB MAST SETT AG; National Cancer Institute, 2009, STAT CANC LEG DAT PR; National Cancer Institute, 2006, TOB CONTR MON, V17, P402; National Conference of State Legislatures, 2012, HLTH CAR DISC PLANS; Redhead CS, 1999, OVERVIEW IMPLEMENTAT; Schroeder SA, 2004, NEW ENGL J MED, V350, P293, DOI 10.1056/NEJMsr031421; Sloan FA, 2005, J HEALTH POLIT POLIC, V30, P643, DOI 10.1215/03616878-30-4-643; Sloan FA, 2005, HEALTH AFFAIR, V24, P220, DOI 10.1377/hlthaff.24.1.220; Stillman F, 1999, EVALUATION REV, V23, P259, DOI 10.1177/0193841X9902300301; U.S. General Accounting Office, 2001, TOB SETTL STAT US MA; Ward J, 2002, LOCAL GOVT THINK STA; WARNER KE, 2005, POLICY CHALLENGES MO, P99; York NL, 2010, J RURAL HEALTH, V26, P120, DOI 10.1111/j.1748-0361.2010.00273.x	19	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114706	10.1371/journal.pone.0114706	http://dx.doi.org/10.1371/journal.pone.0114706			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506827	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100021
J	Letz, S; Haag, C; Schulze, E; Frank-Raue, K; Raue, F; Hofner, B; Mayr, B; Schofl, C				Letz, Saskia; Haag, Christine; Schulze, Egbert; Frank-Raue, Karin; Raue, Friedhelm; Hofner, Benjamin; Mayr, Bernhard; Schoefl, Christof			Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia	PLOS ONE			English	Article							PARATHYROID-HORMONE; ACTIVATING MUTATIONS; CA2+-SENSING RECEPTOR; CA2+ RECEPTOR; PHENOTYPES; SECRETION; DOMAIN; IDENTIFICATION; TRANSDUCTION; ANTAGONISTS	Introduction: Activating calcium sensing receptor (CaSR) mutations cause autosomal dominant hypocalcemia (ADH) characterized by low serum calcium, inappropriately low PTH and relative hypercalciuria. Four activating CaSR mutations cause additional renal wasting of sodium, chloride and other salts, a condition called Bartter syndrome (BS) type 5. Until today there is no specific medical treatment for BS type 5 and ADH. We investigated the effects of different allosteric CaSR antagonists (calcilytics) on activating CaSR mutants. Methods: All 4 known mutations causing BS type 5 and five ADH mutations were expressed in HEK 293T cells and receptor signalling was studied by measurement of intracellular free calcium in response to extracellular calcium ([Ca2+](o)). To investigate the effect of calcilytics, cells were stimulated with 3 mM [Ca2+](o) in the presence or absence of NPS-2143, ATF936 or AXT914. Results: All BS type 5 and ADH mutants showed enhanced signalling activity to [Ca2+](o) with left shifted dose response curves. In contrast to the amino alcohol NPS-2143, which was only partially effective, the quinazolinone calcilytics ATF936 and AXT914 significantly mitigated excessive cytosolic calcium signalling of all BS type 5 and ADH mutants studied. When these mutants were co-expressed with wild-type CaSR to approximate heterozygosity in patients, ATF936 and AXT914 were also effective on all mutants. Conclusion: The calcilytics ATF936 and AXT914 are capable of attenuating enhanced cytosolic calcium signalling activity of CaSR mutations causing BS type 5 and ADH. Quinazolinone calcilytics might therefore offer a novel treatment option for patients with activating CaSR mutations.	[Letz, Saskia; Mayr, Bernhard; Schoefl, Christof] Univ Klinikum Erlangen, Dept Med 1, Div Endocrinol & Diabet, Erlangen, Germany; [Hofner, Benjamin] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Schofl, C (corresponding author), Univ Klinikum Erlangen, Dept Med 1, Div Endocrinol & Diabet, Erlangen, Germany.	christof.schoefl@uk-erlangen.de	Mayr, Bernhard M/F-6936-2012; Hofner, Benjamin/AGN-7505-2022; Raue, Friedhelm/AAC-4405-2020; Raue, Friedhelm/ABD-6150-2021	Mayr, Bernhard M/0000-0002-8973-4494; Hofner, Benjamin/0000-0003-2810-3186; Raue, Friedhelm/0000-0002-7700-1648	Friedrich-Alexander University Erlangen-Nuremberg [AZ 08.12.18.1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Friedrich-Alexander University Erlangen-Nuremberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Christof Schofl was supported by institutional grants from the Friedrich-Alexander University Erlangen-Nuremberg (AZ 08.12.18.1). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Caltabiano S, 2009, J BONE MINER RES  S1, V24; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Egbuna OI, 2008, BEST PRACT RES CL RH, V22, P129, DOI 10.1016/j.berh.2007.11.006; Fitzpatrick L, 2009, J BONE MINER RES S1, V24; Gonzales MC, 2013, ENDOCR PRACT, V19, pE24, DOI 10.4158/EP12132.CR; Gowen M, 2000, J CLIN INVEST, V105, P1595, DOI 10.1172/JCI9038; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2007, J CELL MOL MED, V11, P908, DOI 10.1111/j.1582-4934.2007.00096.x; Hu JX, 2005, J BIOL CHEM, V280, P5113, DOI 10.1074/jbc.M413403200; Hu JX, 2004, J BONE MINER RES, V19, P578, DOI 10.1359/JBMR.040106; John MR, 2014, BONE, V64, P204, DOI 10.1016/j.bone.2014.04.015; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Letz S, 2010, J CLIN ENDOCR METAB, V95, pE229, DOI 10.1210/jc.2010-0651; Lia-Baldini AS, 2013, EUR J ENDOCRINOL, V168, pK27, DOI 10.1530/EJE-12-0714; Lienhardt A, 2001, J CLIN ENDOCR METAB, V86, P5313, DOI 10.1210/jc.86.11.5313; Liu XL, 2013, MOL NEUROBIOL, V48, P590, DOI 10.1007/s12035-013-8448-0; MacLeod RJ, 2013, BEST PRACT RES CL EN, V27, P385, DOI 10.1016/j.beem.2013.05.005; Magno AL, 2011, ENDOCR REV, V32, P3, DOI 10.1210/er.2009-0043; Milliken GA., 1990, TECHNOMETRICS, V32, P219, DOI [10.1080/00401706.1990.10484638, DOI 10.1080/00401706.1990.10484638]; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Park SY, 2013, CLIN ENDOCRINOL, V78, P687, DOI 10.1111/cen.12056; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; Raue F, 2011, CLIN ENDOCRINOL, V75, P760, DOI 10.1111/j.1365-2265.2011.04142.x; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Rus R, 2008, J CLIN ENDOCR METAB, V93, P4797, DOI 10.1210/jc.2008-1076; Sayer JA, 2003, CLIN ENDOCRINOL, V59, P419, DOI 10.1046/j.1365-2265.2003.01869.x; Szczawinska D, 2014, J CLIN ENDOCRINOL ME; Theman TA, 2009, J BONE MINER RES, V24, P964, DOI 10.1359/JBMR.081233; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Vezzoli G, 2006, J NEPHROL, V19, P525; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Widler L, 2011, FUTURE MED CHEM, V3, P535, DOI [10.4155/FMC.11.17, 10.4155/fmc.11.17]; Zhao XM, 1999, FEBS LETT, V448, P180, DOI 10.1016/S0014-5793(99)00368-3	36	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115178	10.1371/journal.pone.0115178	http://dx.doi.org/10.1371/journal.pone.0115178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506941	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100055
J	Onken, MD; Li, JM; Cooper, JA				Onken, Michael D.; Li, Jinmei; Cooper, John A.			Uveal Melanoma Cells Utilize a Novel Route for Transendothelial Migration	PLOS ONE			English	Article							COLLABORATIVE OCULAR MELANOMA; VASCULOGENIC MIMICRY; ENDOTHELIAL BARRIER; EXPRESSION; MELANOGENESIS; MECHANISMS; TRANSMIGRATION; PLASTICITY; INHIBITORS; LEUKOCYTES	Uveal melanoma arises in the eye, and it spreads to distant organs in almost half of patients, leading to a fatal outcome. To metastasize, uveal melanoma cells must transmigrate into and out of the microvasculature, crossing the monolayer of endothelial cells that separates the vessel lumen from surrounding tissues. We investigated how human uveal melanoma cells cross the endothelial cell monolayer, using a cultured cell system with primary human endothelial cell monolayers on hydrogel substrates. We found that uveal melanoma cells transmigrate by a novel and unexpected mechanism. Uveal melanoma cells intercalate into the endothelial cell monolayer and flatten out, assuming a shape and geometry similar to those of endothelial cells in the monolayer. After an extended period of time in the intercalated state, the uveal melanoma cells round up and migrate underneath the monolayer. VCAM is present on endothelial cells, and anti-VCAM antibodies slowed the process of intercalation. Depletion of BAP1, a known suppressor of metastasis in patients, increased the amount of transmigration of uveal melanoma cells in transwell assays; but BAP1 depletion did not affect the rate of intercalation, based on movies of living cells. Our results reveal a novel route of transendothelial migration for uveal melanoma cells, and they provide insight into the mechanism by which loss of BAP1 promotes metastasis.	[Onken, Michael D.; Li, Jinmei; Cooper, John A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Onken, MD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	mdonken@wustl.edu	Onken, Michael D/H-5620-2013; Cooper, John/D-4448-2014	Onken, Michael D/0000-0003-4082-1105; Cooper, John/0000-0002-0933-4571	National Institute of Health [GM38542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038542] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM38542 from the National Institute of Health (http://grants.nih.gov) to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert DM, 1998, AM J OPHTHALMOL, V125, P745; Anastassiou G, 2002, EXP EYE RES, V74, P423, DOI 10.1006/exer.2002.1140; Baker JKL, 2001, MELANOMA RES, V11, P265, DOI 10.1097/00008390-200106000-00008; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Callejo SA, 2007, EYE, V21, P752, DOI 10.1038/sj.eye.6702322; Clarijs R, 2001, INVEST OPHTH VIS SCI, V42, P1422; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Fazakas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020758; Folberg R, 2006, AM J PATHOL, V169, P1376, DOI 10.2353/ajpath.2006.060223; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; Keilholz U, 2004, CLIN CANCER RES, V10, P1605, DOI 10.1158/1078-0432.CCR-0610-3; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Mazzini C, 2014, CANCERS, V6, P323, DOI 10.3390/cancers6010323; Mihic-Probst D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033571; Mooren OL, 2014, MOL BIOL CELL; Mukherjee S, 2014, PLOS ONE IN PRESS; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Onken MD, 2004, CANCER RES, V64, P7205, DOI 10.1158/0008-5472.CAN-04-1750; Onken MD, 2014, CYTOSKELETO IN PRESS; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Sage PT, 2009, FRONT BIOSCI-LANDMRK, V14, P5066, DOI 10.2741/3587; Singh AD, 2005, OPHTHALMOL CLIN N AM, V18, pviii; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Stroka KM, 2011, CELL MOL BIOENG, V4, P9, DOI 10.1007/s12195-010-0142-y; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Willson JKV, 2001, ARCH OPHTHALMOL-CHIC, V119, P670; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Woodward JKL, 2005, EYE, V19, P342, DOI 10.1038/sj.eye.6701471; Yonekawa Y, 2012, HEMATOL ONCOL CLIN N, V26, P1169, DOI 10.1016/j.hoc.2012.08.004; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109	40	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115472	10.1371/journal.pone.0115472	http://dx.doi.org/10.1371/journal.pone.0115472			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506912	gold, Green Published			2022-12-27	WOS:000346607100078
J	Song, H; Fares, M; Maguire, KR; Siden, A; Potacova, Z				Song, Hairong; Fares, Mona; Maguire, Kim R.; Siden, Ake; Potacova, Zuzana			Cytotoxic Effects of Tetracycline Analogues (Doxycycline, Minocycline and COL-3) in Acute Myeloid Leukemia HL-60 Cells	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; PROSTATE-CANCER; NONANTIBIOTIC PROPERTIES; DNA-DAMAGE; APOPTOSIS; INHIBITION; PROTEIN; PROLIFERATION; METASTASIS; LINES	Tetracycline analogues (TCNAs) have been shown to inhibit matrix metalloproteinases and to induce apoptosis in several cancer cell types. In the present study, the cytotoxic effects of TCNAs doxycycline (DOXY), minocycline (MINO) and chemically modified tetracycline-3 (COL-3) were investigated in the human acute myeloid leukemia HL-60 cell line. Cells were incubated with TCNAs in final concentrations of 0.5-100 mu g/ml for 24 h. Viability of the leukemic cells was inhibited in a concentration-dependent manner using resazurin assay. The estimated IC50s were 9.2 mu g/ml for DOXY, 9.9 mu g/ml for MINO and 1.3 mu g/ml for COL-3. All three TCNAs induced potent cytotoxic effects and cell death. Apoptosis, which was assessed by morphological changes and annexin V positivity, was concentration- and time-dependent following incubation with any one of the drugs. TCNAs induced DNA double strand breaks soon after treatment commenced as detected by gamma H2AX and western blot. The loss of mitochondrial membrane potential (Delta psi m), caspase activation and cleavage of PARP and Bcl-2 were observed; however, the sequence of events differed among the drugs. Pancaspase inhibitor Z-VAD-FMK improved survival of TCNAs-treated cells and decreased TCNAs-induced apoptosis. In summary, we demonstrated that TCNAs had a cytotoxic effect on the HL-60 leukemic cell line. Apoptosis was induced via mitochondria-mediated and caspase-dependent pathways in HL-60 cells by all three TCNAs. COL-3 exerted the strongest anti-proliferative and pro-apoptotic effects in concentrations that have been achieved in human plasma in reported clinical trials. These results indicate that there is a therapeutic potential of TCNAs in leukemia.	[Song, Hairong; Fares, Mona; Maguire, Kim R.; Potacova, Zuzana] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Clin Res Ctr Novum,Dept Lab Med, Stockholm, Sweden; [Siden, Ake] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Potacova, Z (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Clin Res Ctr Novum,Dept Lab Med, Stockholm, Sweden.	zuzana.potacova@ki.se			Swedish Childhood Cancer Foundation [PROJ04/085, PROJ04/098, PROJ06/121]	Swedish Childhood Cancer Foundation(European Commission)	This study was supported by grants from the Swedish Childhood Cancer Foundation ( PROJ04/085, PROJ04/098, PROJ06/121); http://www.barncancerfonden.se. COL-3 was generously provided by CollaGenex Pharmaceuticals Inc and Galderma R & D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Bachur NR, 1989, CANC MANAGEMENT MAN, P125; Belizario JE, 2007, BRAZ J MED BIOL RES, V40, P1011, DOI 10.1590/S0100-879X2006005000109; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Dalm D, 2010, J MOL BIOL, V398, P83, DOI 10.1016/j.jmb.2010.02.049; DALTON WT, 1988, BLOOD, V71, P242; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dezube BJ, 2006, J CLIN ONCOL, V24, P1389, DOI 10.1200/JCO.2005.04.2614; Fletcher A, 2011, LEUKEMIAS: PRINCIPLES AND PRACTICE OF THERAPY, P17; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Howlader N, 2009, J NATL CANCER I, V101, P533, DOI 10.1093/jnci/djn517; Juliusson G, 2012, BLOOD, V119, P3890, DOI 10.1182/blood-2011-12-379008; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Lichtman MA, 2013, BLOOD CELL MOL DIS, V50, P119, DOI 10.1016/j.bcmd.2012.10.005; Liu J, 1999, BIOCHEM BIOPH RES CO, V260, P562, DOI 10.1006/bbrc.1999.0929; Lokeshwar BL, 1999, ANN NY ACAD SCI, V878, P271, DOI 10.1111/j.1749-6632.1999.tb07690.x; Lokeshwar BL, 2002, INT J CANCER, V98, P297, DOI 10.1002/ijc.10168; Mouratidis PXE, 2007, INT J CANCER, V120, P743, DOI 10.1002/ijc.22303; Nelson M L, 1998, Adv Dent Res, V12, P5; Noble W, 2009, PRION, V3, P78, DOI 10.4161/pri.3.2.8820; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Onoda T, 2004, J LAB CLIN MED, V143, P207, DOI 10.1016/j.lab.2003.12.012; Pollyea DA, 2011, BRIT J HAEMATOL, V152, P524, DOI 10.1111/j.1365-2141.2010.08470.x; Pourgholami MH, 2012, GYNECOL ONCOL, V125, P433, DOI 10.1016/j.ygyno.2012.01.006; Sagar J, 2010, ANTI-CANCER AGENT ME, V10, P556, DOI 10.2174/187152010793498645; Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004; Seftor REB, 1998, CLIN EXP METASTAS, V16, P217, DOI 10.1023/A:1006588708131; Selzer MG, 1999, ANN NY ACAD SCI, V878, P678, DOI 10.1111/j.1749-6632.1999.tb07760.x; SEN S, 1993, LEUKEMIA RES, V17, P639, DOI 10.1016/0145-2126(93)90068-V; Shieh JM, 2010, BRIT J PHARMACOL, V160, P1171, DOI 10.1111/j.1476-5381.2010.00746.x; Smith K, 2005, CLIN THER, V27, P1329, DOI 10.1016/j.clinthera.2005.09.005; Swerdlow SH, 2008, WHO CLASSIFICATION T; Syed S, 2004, CLIN CANCER RES, V10, P6512, DOI 10.1158/1078-0432.CCR-04-0804; Tolomeo M, 2001, BRIT J PHARMACOL, V133, P306, DOI 10.1038/sj.bjp.0704068; VANDENBOGERT C, 1985, LEUKEMIA RES, V9, P617, DOI 10.1016/0145-2126(85)90142-0; VANDENBOGERT C, 1986, CANCER RES, V46, P3283; Wang JYJ, 2001, ACTA ONCOL, V40, P689; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006	43	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114457	10.1371/journal.pone.0114457	http://dx.doi.org/10.1371/journal.pone.0114457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502932	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100014
J	Wang, HB; Zhang, JQ; Lv, GY; Ma, JB; Ma, PK; Du, GY; Wang, ZL; Tian, JW; Fang, WS; Fu, FH				Wang, Hongbo; Zhang, Jianqiao; Lv, Guangyao; Ma, Jinbo; Ma, Pengkai; Du, Guangying; Wang, Zongliang; Tian, Jingwei; Fang, Weishuo; Fu, Fenghua			Preparation, Pharmacokinetics, Biodistribution, Antitumor Efficacy and Safety of Lx2-32c-Containing Liposome	PLOS ONE			English	Article							HYDROPHOBIC DRUG-DELIVERY; IN-VITRO; PHASE-I; PACLITAXEL FORMULATION; COMPLEMENT ACTIVATION; CREMOPHOR-EL; DOXORUBICIN; CANCER; HYPERSENSITIVITY; ENCAPSULATION	Lx2-32c is a novel taxane that has been demonstrated to have robust antitumor activity against different types of tumors including several paclitaxel-resistant neoplasms. Since the delivery vehicles for taxane, which include cremophor EL, are all associated with severe toxic effects, liposome-based Lx2-32c has been developed. In the present study, the pharmacokinetics, biodistribution, antitumor efficacy and safety characteristics of liposome-based Lx2-32c were explored and compared with those of cremophor-based Lx2-32c. The results showed that liposome-based Lx2-32c displayed similar antitumor effects to cremophor-based Lx2-32c, but with significantly lower bone marrow toxicity and cardiotoxicity, especially with regard to the low ratio of hypersensitivity reaction. In comparing these two delivery modalities, targeting was superior using the Lx2-32c liposome formulation; it achieved significantly higher uptake in tumor than in bone marrow and heart. Our data thus suggested that the Lx2-32c liposome was a novel alternative formulation with comparable antitumor efficacy and a superior safety profiles to cremophor-based Lx2-32c, which might be related to the improved pharmacokinetic and biodistribution characteristics. In conclusion, the Lx2-32c liposome could be a promising alternative formulation for further development.	[Wang, Hongbo; Zhang, Jianqiao; Lv, Guangyao; Ma, Pengkai; Du, Guangying; Wang, Zongliang; Tian, Jingwei; Fu, Fenghua] Yantai Univ, Sch Pharm, Minist Educ China, Key Lab Mol Pharmacol & Drug Evaluat, Yantai, Peoples R China; [Fang, Weishuo] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Fang, Weishuo] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ma, Jinbo] Binzhou Med Coll, Dept Clin Med, Yantai, Peoples R China; [Tian, Jingwei] Luye Pharma Grp Ltd, State Key Lab Long Acting & Targeting Drug Delive, Yantai, Peoples R China	Ministry of Education, China; Yantai University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Binzhou Medical University	Wang, HB (corresponding author), Yantai Univ, Sch Pharm, Minist Educ China, Key Lab Mol Pharmacol & Drug Evaluat, Yantai, Peoples R China.	hongbowangyt@gmail.com; fufenghua@sohu.com	Tian, Jingwei/GPJ-9819-2022; Wang, Hongbo/AHC-7831-2022; 王, 洪波/A-6767-2019	Wang, Hongbo/0000-0001-8530-2339; 王, 洪波/0000-0001-8530-2339; Lv, Guang yao/0000-0002-6726-3089; Fang, Weishuo/0000-0002-0972-0640; qiao, jian/0000-0002-4941-7013	Taishan Scholar Project, Technology Development Program Projects of Shandong Province [2011YD18075]; Startup Project of Doctor scientific research in Yantai University [YX11B31, YX13B29]; National Natural Science Foundation of China [81202038, 30930108]; MOST Grant [2012ZX09103101-054]; State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.)	Taishan Scholar Project, Technology Development Program Projects of Shandong Province; Startup Project of Doctor scientific research in Yantai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST Grant; State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.)	This study was supported by the Taishan Scholar Project, Technology Development Program Projects of Shandong Province (2011YD18075), Startup Project of Doctor scientific research in Yantai University (YX11B31 and YX13B29), National Natural Science Foundation of China (No. 81202038 and 30930108) and MOST Grant (No. 2012ZX09103101-054). State Key Laboratory of Long-acting and Targeting Drug Delivery Technologies (Luye Pharma Group Ltd.) provided support in the form of a salary for author JT. The Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adams J. D., 1992, J NATL CANC I MONOGR, P141; Chu Z, 2008, ANTI-CANCER DRUG, V19, P275, DOI 10.1097/CAD.0b013e3282f3fd2e; Crosasso P, 2000, J CONTROL RELEASE, V63, P19, DOI 10.1016/S0168-3659(99)00166-2; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; FORSSEN EA, 1983, CANCER TREAT REP, V67, P481; Hamaguchi T, 2007, BRIT J CANCER, V97, P170, DOI 10.1038/sj.bjc.6603855; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; MADHAVAN S, 1995, J NATL CANCER I, V87, P1556, DOI 10.1093/jnci/87.20.1556; Mita AC, 2007, CLIN CANCER RES, V13, P3293, DOI 10.1158/1078-0432.CCR-06-2496; Phillips WT, 2002, J PHARMACOL EXP THER, V303, P11, DOI 10.1124/jpet.102.037119; ROSA P, 1983, PHARMACOLOGY, V26, P221, DOI 10.1159/000137805; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; Rowinsky M, 1997, ANNU REV MED, V48, P353; Sadzuka Y, 2002, TOXICOL LETT, V126, P83, DOI 10.1016/S0378-4274(01)00447-7; Stenner-Liewen F, 2006, CHIRURG, V77, P1118, DOI 10.1007/s00104-006-1262-8; Straub JA, 2005, PHARM RES-DORDR, V22, P347, DOI 10.1007/s11095-004-1871-1; Szebeni J, 1998, JNCI-J NATL CANCER I, V90, P300, DOI 10.1093/jnci/90.4.300; Wang H. B., 2014, SCI REPORTS, V4; Wang HB, 2008, CANCER LETT, V268, P89, DOI 10.1016/j.canlet.2008.03.051; Wang HB, 2013, MOL MED REP, V7, P947, DOI 10.3892/mmr.2013.1264; Wang L, 2007, BIOORG MED CHEM LETT, V17, P3191, DOI 10.1016/j.bmcl.2007.03.026; Weiszhar Z, 2012, EUR J PHARM SCI, V45, P492, DOI 10.1016/j.ejps.2011.09.016; Working PK, 1999, J PHARMACOL EXP THER, V289, P1128; Wyld L, 2007, EUR J CANCER, V43, P2253, DOI 10.1016/j.ejca.2007.07.035; Yang A-z, 2006, B CHIN CANC, V15, P862; Ye L, 2013, FOOD CHEM TOXICOL, V52, P200, DOI 10.1016/j.fct.2012.11.004; Zhang JA, 2005, EUR J PHARM BIOPHARM, V59, P177, DOI 10.1016/j.ejpb.2004.06.009; Zhou Q, 2012, BIOL PHARM BULL, V35, P2170, DOI 10.1248/bpb.b12-00513	29	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114688	10.1371/journal.pone.0114688	http://dx.doi.org/10.1371/journal.pone.0114688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506928	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100019
J	Hwang, BG; Ahn, S; Lee, SJ				Hwang, Bae Geun; Ahn, Sungsook; Lee, Sang Joon			Use of Gold Nanoparticles to Detect Water Uptake in Vascular Plants	PLOS ONE			English	Article							REFILLING PROCESS; EMBOLISM REPAIR; SAP FLOW; XYLEM; DYNAMICS; VESSELS; ROOTS; MAIZE	Direct visualization of water-conducting pathways and sap flows in xylem vessels is important for understanding the physiology of vascular plants and their sap ascent. Gold nanoparticles (AuNPs) combined with synchrotron X-ray imaging technique is a new promising tool for investigating plant hydraulics in opaque xylem vessels of vascular plants. However, in practical applications of AuNPs for real-time quantitative visualization of sap flows, their interaction with a vascular network needs to be verified in advance. In this study, the effect of AuNPs on the water-refilling function of xylem vessels is experimentally investigated with three monocot species. Discrepancy in the water uptakes starts to appear at about 20 min to 40 min after the supply of AuNP solution to the test plant by the possible gradual accumulation of AuNPs on the internal structures of vasculature. However conclusively, it is observed that the water-refilling speeds in individual xylem vessels are virtually unaffected by hydrophilically surface-modified AuNPs (diameter similar to 20 nm). Therefore, the AuNPs can be effectively used as flow tracers in the xylem vessels in the first 20 similar to 30 min without any physiological barrier. As a result, AuNPs are found to be useful for visualizing various fluid dynamic phenomena occurring in vascular plants.	[Hwang, Bae Geun; Lee, Sang Joon] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Ctr Biofluid & Biomim Res, Pohang 790784, Gyeongbuk, South Korea; [Ahn, Sungsook] Pohang Univ Sci & Technol POSTECH, Ctr Biofluid & Biomim Res, Pohang 790784, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Ctr Biofluid & Biomim Res, San31, Pohang 790784, Gyeongbuk, South Korea.	sjlee@postech.ac.kr	Lee, Sang Joon/AAG-2448-2019		National Research Foundation of Korea - Korea government (MSIP) [2008-0061991]	National Research Foundation of Korea - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) grant funded by the Korea government (MSIP) (No. 2008-0061991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Ahn S, 2011, BIOMATERIALS, V32, P7191, DOI 10.1016/j.biomaterials.2011.05.023; Ahn S, 2010, ACS NANO, V4, P3753, DOI 10.1021/nn1003293; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Fouras A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783978; Gasco A, 2006, PLANT CELL ENVIRON, V29, P1946, DOI 10.1111/j.1365-3040.2006.01570.x; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Im KS, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711372; Kaufmann I, 2009, NEW PHYTOL, V184, P245, DOI 10.1111/j.1469-8137.2009.02919.x; Kim HK, 2010, NEW PHYTOL, V188, P1085, DOI 10.1111/j.1469-8137.2010.03424.x; Lee SJ, 2013, PLANTA, V238, P307, DOI 10.1007/s00425-013-1889-x; Lee SJ, 2010, BIOSENS BIOELECTRON, V25, P1571, DOI 10.1016/j.bios.2009.11.010; Lee SJ, 2008, ANN BOT-LONDON, V101, P595, DOI 10.1093/aob/mcm312; Lee SJ, 2003, J APPL PHYS, V94, P3620, DOI 10.1063/1.1599981; NIST, XRAY MASS ATT COEFF; Sano Y, 2005, TREE PHYSIOL, V25, P269, DOI 10.1093/treephys/25.3.269; Scheenen TWJ, 2007, PLANT PHYSIOL, V144, P1157, DOI [10.1104/pp.106.089250, 10.1104/PP.106.089250]; Shane MW, 2000, ANN BOT-LONDON, V85, P613, DOI 10.1006/anbo.2000.1113; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Wyss HM, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061402; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	21	4	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114902	10.1371/journal.pone.0114902	http://dx.doi.org/10.1371/journal.pone.0114902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502567	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700067
J	Jahandideh, F; Majumder, K; Chakrabarti, S; Morton, JS; Panahi, S; Kaufman, S; Davidge, ST; Wu, JP				Jahandideh, Forough; Majumder, Kaustav; Chakrabarti, Subhadeep; Morton, Jude S.; Panahi, Sareh; Kaufman, Susan; Davidge, Sandra T.; Wu, Jianping			Beneficial Effects of Simulated Gastro-Intestinal Digests of Fried Egg and Its Fractions on Blood Pressure, Plasma Lipids and Oxidative Stress in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							LONG-TERM INTAKE; WHITE HYDROLYSATE; ANTIOXIDANT ACTIVITY; VASCULAR REACTIVITY; MESENTERIC-ARTERIES; VIRGIN OLIVE; SERUM-LIPIDS; PEPTIDES; DIET; CHEMISTRY	Background: We have previously characterized several antihypertensive peptides in simulated digests of cooked eggs and showed blood pressure lowering property of fried whole egg digest. However, the long-term effects of this hydrolysate and its fractions on blood pressure are not known. Therefore, the objectives of the study were to determine the effects of long term administration of fried whole egg hydrolysate and its fractions (i.e. egg white and egg yolk) on regulation of blood pressure and associated factors in cardiovascular disease such as plasma lipid profile and tissue oxidative stress. Methods and Results: We used spontaneously hypertensive rats (SHR), an animal model of essential hypertension. Hydrolysates of fried egg and its fractions were prepared by simulated gastro-intestinal digestion with pepsin and pancreatin. 16-17 week old male SHRs were orally administered fried whole egg hydrolysate, non-hydrolyzed fried whole egg, egg white hydrolysate or egg yolk hydrolysates (either defatted, or not) daily for 18 days. Blood pressure (BP) and heart rate were monitored by telemetry. Animals were sacrificed at the end of the treatment for vascular function studies and evaluating plasma lipid profile and tissue oxidative stress. BP was reduced by feeding fried whole egg hydrolysate but not by the nonhydrolyzed product suggesting a critical role for in vitro digestion in releasing anti-hypertensive peptides. Egg white hydrolysate and defatted egg yolk hydrolysate (but not egg yolk hydrolysate) also had similar effects. Reduction in BP was accompanied by the restoration of nitric oxide (NO) dependent vasorelaxation and reduction of plasma angiotensin II. Fried whole egg hydrolysate also reduced plasma levels of triglyceride although it was increased by the non-hydrolyzed sample. Additionally the hydrolyzed preparations attenuated tissue oxidative stress. Conclusion: Our results demonstrate that fried egg hydrolysates exert antihypertensive effects, improve plasma lipid profile and attenuate tissue oxidative stress in vivo.	[Jahandideh, Forough; Majumder, Kaustav; Chakrabarti, Subhadeep; Panahi, Sareh; Wu, Jianping] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Kaufman, Susan; Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Kaufman, Susan; Davidge, Sandra T.; Wu, Jianping] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Morton, Jude S.; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wu, JP (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	jwu3@ualberta.ca	Jahandideh, Forough/M-4648-2019; Wu, Jian/AAU-5221-2020; Chakrabarti, Subhadeep/AAD-1078-2022; Wu, Jian/AAU-5221-2020	Jahandideh, Forough/0000-0001-9731-0854; Wu, Jian/0000-0001-9933-7364; Majumder, Kaustav/0000-0003-2094-7835; Davidge, Sandra/0000-0002-5559-4905; Wu, Jian/0000-0002-3394-1507	Egg Farmers of Canada (EFC); Egg Farmers of Alberta (EFA); Natural Sciences and Engineering Research Council (NSERC) of Canada	Egg Farmers of Canada (EFC); Egg Farmers of Alberta (EFA); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by grants from Egg Farmers of Canada (EFC), Egg Farmers of Alberta (EFA), and Natural Sciences and Engineering Research Council (NSERC) of Canada to J. Wu. S. T. Davidge is a Canada Research Chair in women's cardiovascular health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anton M, 2003, FOOD CHEM, V83, P175, DOI 10.1016/S0308-8146(03)00060-8; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bolterman RJ, 2005, HYPERTENSION, V46, P943, DOI 10.1161/01.HYP.0000174602.59935.d5; Boon CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055908; Chen C, 2012, AMINO ACIDS, V43, P457, DOI 10.1007/s00726-011-1102-0; Chockalingam A, 2008, CAN J CARDIOL, V24, P441, DOI 10.1016/S0828-282X(08)70617-2; Cohn JS, 2010, NUTRIENTS, V2, P116, DOI 10.3390/nu2020116; Cooke CLM, 2003, CARDIOVASC RES, V60, P635, DOI 10.1016/j.cardiores.2003.08.011; CURTIS KJ, 1978, J PHYSIOL-LONDON, V274, P409, DOI 10.1113/jphysiol.1978.sp012156; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; Duan X, 2014, J AGR FOOD CHEM; Erdmann K, 2008, J NUTR BIOCHEM, V19, P643, DOI 10.1016/j.jnutbio.2007.11.010; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Giachini FRC, 2008, EXPERT OPIN THER TAR, V12, P327, DOI 10.1517/14728222.12.3.327; Hermansen K, 2000, BRIT J NUTR, V83, pS113; Herrera MD, 2001, BRIT J NUTR, V86, P349, DOI 10.1079/BJN2001397; Huang W, 2010, J AGR FOOD CHEM; Kawase M, 2000, J DAIRY SCI, V83, P255, DOI 10.3168/jds.S0022-0302(00)74872-7; Khanna A, 2008, CURR OPIN NEPHROL HY, V17, P477, DOI 10.1097/MNH.0b013e3283069d72; KINGSLEY TR, 1988, LIPIDS, V23, P564, DOI 10.1007/BF02535598; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Majumder K, 2013, J AGR FOOD CHEM; Majumder K, 2009, J AGR FOOD CHEM, V57, P471, DOI 10.1021/jf8028557; Majumder K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082829; Majumder K, 2013, J FUNCT FOODS, V5, P187, DOI 10.1016/j.jff.2012.10.004; Majumder K, 2011, FOOD CHEM, V126, P1614, DOI 10.1016/j.foodchem.2010.12.039; Manso MA, 2008, FOOD CHEM, V109, P361, DOI 10.1016/j.foodchem.2007.12.049; Matoba N, 1999, FEBS LETT, V452, P181, DOI 10.1016/S0014-5793(99)00587-6; Miguel M, 2005, BRIT J NUTR, V94, P731, DOI 10.1079/BJN20051570; Miguel M, 2006, J NUTR, V136, P1457, DOI 10.1093/jn/136.6.1457; Miguel M, 2006, LIFE SCI, V78, P2960, DOI 10.1016/j.lfs.2005.11.025; Milanovic JG, 2010, J HYPERTENS, V28, pE500; Mine Y, 2007, CURR PHARM DESIGN, V13, P875, DOI 10.2174/138161207780414278; Miura K, 2013, J HYPERTENS, V31, P1144, DOI 10.1097/HJH.0b013e3283604016; Moser Marvin, 2007, J Clin Hypertens (Greenwich), V9, P316, DOI 10.1111/j.1524-6175.2007.07152.x; Nimalaratne C, 2011, FOOD CHEM, V129, P155, DOI 10.1016/j.foodchem.2011.04.058; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003; Palacios LE, 2005, J AM OIL CHEM SOC, V82, P571, DOI 10.1007/s11746-005-1111-4; Pannirselvam M, 2005, BRIT J PHARMACOL, V144, P953, DOI 10.1038/sj.bjp.0706121; Pennathur S, 2007, ANTIOXID REDOX SIGN, V9, P955, DOI 10.1089/ars.2007.1595; Perona JS, 2004, CLIN NUTR, V23, P1113, DOI 10.1016/j.clnu.2004.02.004; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; Rawendra RDS, 2013, J PROTEOMICS, V94, P359, DOI 10.1016/j.jprot.2013.10.006; Remanan MK, 2014, FOOD FUNCT, V5, P1464, DOI 10.1039/c4fo00204k; Rodriguez-Mateos A, 2013, AM J CLIN NUTR, V98, P1179, DOI 10.3945/ajcn.113.066639; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Shahidi F, 2008, J AOAC INT, V91, P914; Shen SW, 2010, J AGR FOOD CHEM, V58, P7664, DOI 10.1021/jf101323y; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; TRIPPODO NC, 1981, CIRC RES, V48, P309, DOI 10.1161/01.RES.48.3.309; Xiong X, 2001, HYPERTENS PREGNANCY, V20, P1; Yang F, 2012, LIPIDS, V47, P269, DOI 10.1007/s11745-011-3646-x; Yoshii H, 2001, COMP BIOCHEM PHYS C, V128, P27, DOI 10.1016/S1532-0456(00)00172-1; Yu ZP, 2011, J SCI FOOD AGR, V91, P921, DOI 10.1002/jsfa.4266; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	56	26	28	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115006	10.1371/journal.pone.0115006	http://dx.doi.org/10.1371/journal.pone.0115006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502445	gold, Green Published			2022-12-27	WOS:000347146700081
J	Chaires, JB; Trent, JO; Gray, RD; Dean, WL; Buscaglia, R; Thomas, SD; Miller, DM				Chaires, Jonathan B.; Trent, John O.; Gray, Robert D.; Dean, William L.; Buscaglia, Robert; Thomas, Shelia D.; Miller, Donald M.			An Improved Model for the hTERT Promoter Quadruplex	PLOS ONE			English	Article							TELOMERIC DNA; CORE PROMOTER; MUTATIONS; CANCER; REGION; SEQUENCE; CELLS; ACID; TRANSCRIPTION; MELANOMA	Mutations occur at four specific sites in the hTERT promoter in >75% of glioblastomas and melanomas, but the mechanism by which the mutations affect gene expression remains unexplained. We report biophysical computational studies that show that the hTERT promoter sequence forms a novel G-quadruplex structure consisting of three contiguous, stacked parallel quadruplexes. The reported hTERT mutations map to the central quadruplex within this structure, and lead to an alteration of its hydrodynamic properties and stability.	[Chaires, Jonathan B.; Trent, John O.; Gray, Robert D.; Dean, William L.; Buscaglia, Robert; Thomas, Shelia D.; Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA	University of Louisville	Chaires, JB (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40292 USA.	j.chaires@louisville.edu		Chaires, Jonathan/0000-0001-5477-945X; trent, John/0000-0002-7346-4231	NIH [CA35635, GM077422, 1P30GM106396-01]; James Graham Brown Foundation; NATIONAL CANCER INSTITUTE [R01CA035635] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077422, P30GM106396] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James Graham Brown Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants CA35635 (JBC), GM077422 (JBC & JOT) and 1P30GM106396-01 (DMM) and by the James Graham Brown Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Corey DR, 2009, CHEM BIOL, V16, P1219, DOI 10.1016/j.chembiol.2009.12.001; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dailey MM, 2010, NUCLEIC ACIDS RES, V38, P4877, DOI 10.1093/nar/gkq166; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Jameson D. M., 2014, INTRO FLUORESCENCE; Kan ZY, 2007, NUCL ACIDS RES; Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Lam EYN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2792; Le HT, 2013, TOP CURR CHEM, V330, P179, DOI 10.1007/128_2012_351; Lim KW, 2010, J AM CHEM SOC, V132, P12331, DOI 10.1021/ja101252n; Micheli E, 2010, BIOPHYS CHEM, V153, P43, DOI 10.1016/j.bpc.2010.10.003; Montanaro L, 1979, Methods Enzymol, V60, P712; MURCHIE AIH, 1992, NUCLEIC ACIDS RES, V20, P49, DOI 10.1093/nar/20.1.49; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Nygren J, 1998, BIOPOLYMERS, V46, P39, DOI 10.1002/(SICI)1097-0282(199807)46:1<39::AID-BIP4>3.0.CO;2-Z; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Palumbo SL, 2008, NUCL ACIDS RES; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Xing MZ, 2014, J CLIN ONCOL, V32, P2718, DOI 10.1200/JCO.2014.55.5094; Xu Y, 2013, CHEMBIOCHEM, V14, P927, DOI 10.1002/cbic.201300157	40	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115580	10.1371/journal.pone.0115580	http://dx.doi.org/10.1371/journal.pone.0115580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526084	Green Submitted, gold, Green Published			2022-12-27	WOS:000347186200037
J	Zhang, HZ; Wang, XD; Li, YP; Du, RF; Xu, EX; Dong, L; Wang, XD; Yan, ZC; Pang, LJ; Wei, M; She, L				Zhang, Hengzhu; Wang, Xiaodong; Li, Yuping; Du, Renfei; Xu, Enxi; Dong, Lun; Wang, Xingdong; Yan, Zhengcun; Pang, Lujun; Wei, Min; She, Lei			Naloxone for Severe Traumatic Brain Injury: A Meta-Analysis	PLOS ONE			English	Editorial Material							DECOMPRESSIVE CRANIECTOMY	Objective: The efficiency of naloxone for the management of secondary brain injury after severe traumatic brain injury (sTBI) remains undefined. The aim of this study is to evaluate the current evidence regarding the clinical efficiency and safety of naloxone as a treatment for sTBI in mainland China. Methodology/Principal Findings: A systematic search of the China Biology Medicine disc (CBM), China Science and Technology Journal Database (VIP), China National Knowledge Internet (CNKI), and Wan Fang Database was performed to identify randomized controlled trials (RCTs) of naloxone treatment for patients with sTBI in mainland China. The quality of the included trials was assessed, and the RevMan 5.1 software was employed to conduct this meta-analysis. Nineteen RCTs including 2332 patients were included in this study. The odds ratio (OR) showed statistically significant differences between the naloxone group and the control group (placebo) in terms of mortality at 18 months after treatment (OR, 0.51, 95% CI: 0.38-0.67; p<0.00001), prevalence of abnormal heart rates (OR, 0.30, 95% CI: 0.21-0.43; p<0.00001), abnormal breathing rate (OR, 0.25, 95% CI: 0.17-0.36; p, 0.00001) at discharge, the level of intracranial pressure at discharge (OR, 2.00, 95% CI: 1.41-2.83; p=0.0001), verbal or physical dysfunction rate (OR, 0.65, 95% CI: 0.43-0.98; p=0.04), and severe disability rate (OR, 0.47, 95% CI: 0.30-0.73; p=0.0001) at 18 months after the treatment. The mean difference (MD) showed statistically significant differences in awakening time at discharge (MD, 24.81, 95% CI: 25.49 to 24.12; p<0.00001), and GCS at 3 days (MD, 1.00, 95% CI: 0.70-1.30; p, 0.00001) and 10 days (MD, 1.76, 95% CI: 1.55-1.97; p, 0.00001) after treatment comparing naloxone with placebo group. Conclusions/Significance: This study indicated that applying naloxone in the early stage for sTBI patients might effectively reduce mortality, control intracranial pressure (ICP), and significantly improve the prognosis.	[Zhang, Hengzhu; Wang, Xiaodong; Li, Yuping; Dong, Lun; Wang, Xingdong; Yan, Zhengcun; Pang, Lujun; Wei, Min; She, Lei] Yang Zhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China; [Du, Renfei] Chifeng Hosp, Dept Neurosurg, Chifeng, Neimenggu Provi, Peoples R China; [Xu, Enxi] First Peoples Hosp Zhenjiang, Dept Neurosurg, Zhenjiang, Jiangsu, Peoples R China	Yangzhou University	Zhang, HZ (corresponding author), Yang Zhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China.	zhanghengzhu@sina.com	li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022; Li, Yuping/C-4122-2014	Li, Yuping/0000-0002-4527-2582				Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Chen B, 2005, B HUNAN U, V27, P58; Chen DQ, 2006, CHINESE J PRACTICAL, V9, P43; [陈建华 CHEN Jianhua], 2007, [化学工程, Chemical Engineering], V35, P29; Chen YM, 2005, J PRACTICAL NERVOUS, V8, P1; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Gao JG, 2006, NINGXIA MED J, V28, P129; Ge L, 2010, J NANCHANG U, V50, P65; [关国梁 Guang Guoliang], 2003, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V20, P470; Guo JJ, 2011, GUIDE CHINA MED, V9, P197; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; [黄欣 HUANG Xin], 2011, [中华创伤杂志, Chinese Journal of Trauma], V27, P403; Huang YC, 2005, HAINAN MED, V16, P31; Huang ZX, 2001, CHINESE CRITICAL CAR, V14, P695; [江基尧 Jiang Jiyao], 2004, [中华神经外科杂志, Chinese Journal of Neurosurgery], V20, P37; Jiang JY, 1988, NEUROPETIDES, V12, P277; JinErLun Study Group, 2011, CHINESE J NEUROSURGE, V17, P135; JinErLun Study Group, 2001, CHIN J NEUROSURG, V7, P135; Li JQ, 2003, HEBEI MED J, V25, P923; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Ren W, 2008, CHIN J POSTGRAD MED, V31, P63; [施栋良 Shi Dongliang], 2012, [中华神经外科杂志, Chinese Journal of Neurosurgery], V28, P116; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Toussaint CP, 2008, NEUROSURG QUART, V18, P45, DOI 10.1097/WNQ.0b013e3181642924; Wang BM, 2006, CHINA PHARM, V17, P288; Xu YF, 2000, CHINESE J NERVOUS ME, V26, P239; Yuan BQ, 2006, CHINESE J TRAUMA DIS, V14, P14; Zeng XM, 2006, J NAVY MED, V27, P119; 施小燕, 2011, [中华急诊医学杂志, Chinese Journal of Emergency Medicine], V20, P1237; 杨刚, 2001, 中华神经外科杂志, V17, P146; 漆松涛, 2001, 中华神经外科杂志, V17, P149; 富壮, 2008, [中华创伤杂志, Chinese Journal of Trauma], V24, P591	34	8	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e113093	10.1371/journal.pone.0113093	http://dx.doi.org/10.1371/journal.pone.0113093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526618	Green Published, gold			2022-12-27	WOS:000347186200067
J	Rodriguez-Navarro, DN; Rodriguez-Carvajal, MA; Acosta-Jurado, S; Soto, MJ; Margaret, I; Crespo-Rivas, JC; Sanjuan, J; Temprano, F; Gil-Serrano, A; Ruiz-Sainz, JE; Vinardell, JM				Rodriguez-Navarro, Dulce N.; Rodriguez-Carvajal, Miguel A.; Acosta-Jurado, Sebastian; Soto, Maria J.; Margaret, Isabel; Crespo-Rivas, Juan C.; Sanjuan, Juan; Temprano, Francisco; Gil-Serrano, Antonio; Ruiz-Sainz, Jose E.; Vinardell, Jose M.			Structure and Biological Roles of Sinorhizobium fredii HH103 Exopolysaccharide	PLOS ONE			English	Article							FAST-GROWING RHIZOBIA; SP STRAIN NGR234; BRADYRHIZOBIUM-JAPONICUM; SYMBIOTIC PROPERTIES; BIOFILM FORMATION; EXOB MUTANTS; EXTRACELLULAR POLYSACCHARIDES; SURFACE POLYSACCHARIDE; LEUCAENA-LEUCOCEPHALA; ROOT-NODULES	Here we report that the structure of the Sinorhizobium fredii HH103 exopolysaccharide (EPS) is composed of glucose, galactose, glucuronic acid, pyruvic acid, in the ratios 5:2:2:1 and is partially acetylated. A S. fredii HH103 exoA mutant (SVQ530), unable to produce EPS, not only forms nitrogen fixing nodules with soybean but also shows increased competitive capacity for nodule occupancy. Mutant SVQ530 is, however, less competitive to nodulate Vigna unguiculata. Biofilm formation was reduced in mutant SVQ530 but increased in an EPS overproducing mutant. Mutant SVQ530 was impaired in surface motility and showed higher osmosensitivity compared to its wild type strain in media containing 50 mM NaCl or 5% (w/v) sucrose. Neither S. fredii HH103 nor 41 other S. fredii strains were recognized by soybean lectin (SBL). S. fredii HH103 mutants affected in exopolysaccharides (EPS), lipopolysaccharides (LPS), cyclic glucans (CG) or capsular polysaccharides (KPS) were not significantly impaired in their soybean-root attachment capacity, suggesting that these surface polysaccharides might not be relevant in early attachment to soybean roots. These results also indicate that the molecular mechanisms involved in S. fredii attachment to soybean roots might be different to those operating in Bradyrhizobium japonicum.	[Rodriguez-Navarro, Dulce N.; Temprano, Francisco] Ctr Torres Tomejil, IFAPA, Alcala Del Rio, Sevilla, Spain; [Rodriguez-Carvajal, Miguel A.; Gil-Serrano, Antonio] Univ Seville, Fac Quim, Dept Quim Organ, E-41012 Seville, Spain; [Acosta-Jurado, Sebastian; Margaret, Isabel; Crespo-Rivas, Juan C.; Ruiz-Sainz, Jose E.; Vinardell, Jose M.] Univ Seville, Dept Microbiol, Fac Biol, Seville, Spain; [Soto, Maria J.; Sanjuan, Juan] CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain	University of Sevilla; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Vinardell, JM (corresponding author), Univ Seville, Dept Microbiol, Fac Biol, Seville, Spain.	jvinar@us.es	Gil-Serrano, Antonio M/L-2002-2014; Soto, Maria Jose/O-3406-2014; Vinardell, José M/H-5355-2013; Carvajal, Miguel Ángel Rodríguez/F-2577-2012; Jurado, Sebastián Acosta/ABH-3676-2020; Oliver, Isabel Maria Margaret/J-8663-2016	Gil-Serrano, Antonio M/0000-0001-9503-0891; Soto, Maria Jose/0000-0003-2045-7238; Vinardell, José M/0000-0002-7105-5389; Carvajal, Miguel Ángel Rodríguez/0000-0002-2131-6448; Sanjuan, Juan/0000-0002-6404-8754; Margaret Oliver, Isabel Maria/0000-0001-8770-1309; Acosta Jurado, Sebastian/0000-0002-5505-2508	Andalusia Government [P07-CVI-02506]; Spanish Ministry of Science and Innovation [BIO2010-18005, BIO2011-30229-C02-01, AGL2009-13487-C04-02]; European Regional Development Fund (FEDER)	Andalusia Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (FEDER)(European Commission)	This work was supported by grants from the Andalusia Government (P07-CVI-02506) and the Spanish Ministry of Science and Innovation (BIO2010-18005, BIO2011-30229-C02-01, AGL2009-13487-C04-02). The authors also thank the European Regional Development Fund (FEDER) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Grau AM, 2012, APPL ENVIRON MICROB, V78, P1644, DOI 10.1128/AEM.07117-11; Albareda M, 2006, FEMS MICROBIOL LETT, V259, P67, DOI 10.1111/j.1574-6968.2006.00244.x; AN JH, 1995, CARBOHYD RES, V269, P303, DOI 10.1016/0008-6215(94)00361-I; BECKER A, 1998, RHIZOBIACEAE MOL BIO; Becker A, 2005, MOL PLANT MICROBE IN, V18, P899, DOI 10.1094/MPMI-18-0899; Becker BU, 1998, MOL GEN GENET, V259, P161, DOI 10.1007/s004380050801; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bianciotto V, 2001, MOL PLANT MICROBE IN, V14, P255, DOI 10.1094/MPMI.2001.14.2.255; BORTHAKUR D, 1988, MOL GEN GENET, V213, P155, DOI 10.1007/BF00333413; BORTHAKUR D, 1986, MOL GEN GENET, V203, P320, DOI 10.1007/BF00333974; BUENDIACLAVERIA AM, 1994, SYST APPL MICROBIOL, V17, P155, DOI 10.1016/S0723-2020(11)80001-9; CHAPLIN MF, 1982, ANAL BIOCHEM, V123, P336, DOI 10.1016/0003-2697(82)90455-9; Chataigne G, 2008, J CHROMATOGR A, V1185, P241, DOI 10.1016/j.chroma.2008.01.065; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; Crespo-Rivas JC, 2009, MOL PLANT MICROBE IN, V22, P575, DOI 10.1094/MPMI-22-5-0575; D'Haeze W, 2004, MOL MICROBIOL, V52, P485, DOI 10.1111/j.1365-2958.2004.03989.x; de Cordoba FJF, 2008, BIOMACROMOLECULES, V9, P678, DOI 10.1021/bm701011d; Den Herder G, 2009, CURR OPIN PLANT BIOL, V12, P491, DOI 10.1016/j.pbi.2009.05.010; DIEBOLD R, 1989, J BACTERIOL, V171, P4821, DOI 10.1128/jb.171.9.4821-4830.1989; DJORDJEVIC SP, 1986, CARBOHYD RES, V148, P87, DOI 10.1016/0008-6215(86)80039-8; DJORDJEVIC SP, 1987, J BACTERIOL, V169, P53, DOI 10.1128/jb.169.1.53-60.1987; Dominguez-Ferreras A, 2006, J BACTERIOL, V188, P7617, DOI 10.1128/JB.00719-06; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; DYLAN T, 1990, J BACTERIOL, V172, P1409, DOI 10.1128/jb.172.3.1409-1417.1990; Faure R, 2006, J ORG CHEM, V71, P5151, DOI 10.1021/jo0525682; Ferguson GP, 2002, J BACTERIOL, V184, P5625, DOI 10.1128/JB.184.20.5625-5632.2002; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; FRIEDMAN AM, 1982, GENE, V18, P289, DOI 10.1016/0378-1119(82)90167-6; Fujishige NA, 2006, FEMS MICROBIOL ECOL, V56, P195, DOI 10.1111/j.1574-6941.2005.00044.x; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Gao MS, 2010, MOL PLANT MICROBE IN, V23, P355, DOI 10.1094/MPMI-23-4-0355; Gay-Fraret J, 2012, FEMS MICROBIOL LETT, V333, P28, DOI 10.1111/j.1574-6968.2012.02595.x; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; Gil-Serrano AM, 1999, BIOCHEM J, V342, P527, DOI 10.1042/0264-6021:3420527; Goddard TD, 1993, SPARKY 3; Gossmann JA, 2012, NEW PHYTOL, V196, P561, DOI 10.1111/j.1469-8137.2012.04281.x; GRAY JX, 1991, J BACTERIOL, V173, P3066, DOI 10.1128/JB.173.10.3066-3077.1991; Ramirez-Bahena MH, 2009, INT J SYST EVOL MICR, V59, P1929, DOI 10.1099/ijs.0.006320-0; HER GR, 1990, CARBOHYD RES, V198, P305, DOI 10.1016/0008-6215(90)84300-J; Hidalgo A, 2010, MICROBIOL-SGM, V156, P3398, DOI 10.1099/mic.0.042499-0; Hotter GS, 1997, ARCH MICROBIOL, V167, P182, DOI 10.1007/s002030050433; HOTTER GS, 1991, J BACTERIOL, V173, P851, DOI 10.1128/jb.173.2.851-859.1991; HUBER TA, 1984, J BACTERIOL, V158, P1168, DOI 10.1128/JB.158.3.1168-1171.1984; Quelas JI, 2010, MOL PLANT MICROBE IN, V23, P1592, DOI 10.1094/MPMI-05-10-0122; IVASHINA TV, 1994, GENE, V150, P111, DOI 10.1016/0378-1119(94)90868-0; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Janczarek M, 2009, ANTON LEEUW INT J G, V96, P471, DOI 10.1007/s10482-009-9362-3; JANSSON PE, 1993, ACTA CHEM SCAND, V47, P711, DOI 10.3891/acta.chem.scand.47-0711; Jarabo-Lorenzo A, 2003, SYST APPL MICROBIOL, V26, P611, DOI 10.1078/072320203770865927; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Jones KM, 2012, J BACTERIOL, V194, P4322, DOI 10.1128/JB.00751-12; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; KEYSER HH, 1982, SCIENCE, V215, P1631, DOI 10.1126/science.215.4540.1631; Kim JS, 2006, CARBOHYD RES, V341, P1061, DOI 10.1016/j.carres.2006.03.008; Krol Elizaveta, 2009, P189; LAU JM, 1987, CARBOHYD RES, V168, P219, DOI 10.1016/0008-6215(87)80028-9; Laus MC, 2006, MOL MICROBIOL, V59, P1704, DOI 10.1111/j.1365-2958.2006.05057.x; LIANG R, 1987, ANAL BIOCHEM, V164, P488, DOI 10.1016/0003-2697(87)90523-9; Lindberg B., 1975, ADV CARBOHYD CHEM BI, V31, P185, DOI [10.1016/s0065-2318(08)60297-8, DOI 10.1016/S0065-2318(08)60297-8]; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074717; Margaret I, 2012, MOL PLANT MICROBE IN, V25, P825, DOI 10.1094/MPMI-10-11-0262; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; Nogales J, 2012, J BACTERIOL, V194, P2027, DOI 10.1128/JB.06524-11; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parada M, 2006, MOL PLANT MICROBE IN, V19, P43, DOI 10.1094/MPMI-19-0043; Parella T, 2004, PULSE PROGRAM CATALO; PARNISKE M, 1994, MOL PLANT MICROBE IN, V7, P631, DOI 10.1094/MPMI-7-0631; PARNISKE M, 1993, MOL PLANT MICROBE IN, V6, P99, DOI 10.1094/MPMI-6-099; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; PUTNOKY P, 1990, J BACTERIOL, V172, P5450, DOI 10.1128/jb.172.9.5450-5458.1990; REINHOLD BB, 1994, J BACTERIOL, V176, P1997, DOI 10.1128/jb.176.7.1997-2002.1994; REUBER TL, 1993, CELL, V74, P269, DOI 10.1016/0092-8674(93)90418-P; REUHS BL, 1993, J BACTERIOL, V175, P3570, DOI 10.1128/jb.175.11.3570-3580.1993; REUHS BL, 1995, J BACTERIOL, V177, P4289, DOI 10.1128/jb.177.15.4289-4296.1995; RIGAUD J, 1975, J GEN MICROBIOL, V88, P223, DOI 10.1099/00221287-88-2-223; Rinaudi LV, 2010, FEMS MICROBIOL LETT, V304, P1, DOI 10.1111/j.1574-6968.2009.01840.x; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rodriguez-Carvajal MA, 2008, CARBOHYD RES, V343, P3066, DOI 10.1016/j.carres.2008.08.028; Rodriguez-Navarro DN, 2007, FEMS MICROBIOL LETT, V272, P127, DOI 10.1111/j.1574-6968.2007.00761.x; Roslund MU, 2011, CARBOHYD RES, V346, P1311, DOI 10.1016/j.carres.2011.04.033; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassaki GL, 2005, CARBOHYD RES, V340, P731, DOI 10.1016/j.carres.2005.01.020; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Soto MJ, 2006, MICROBIOL-SGM, V152, P3167, DOI 10.1099/mic.0.29112-0; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; Thomas-Oates J, 2003, SYST APPL MICROBIOL, V26, P453, DOI 10.1078/072320203322497491; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; Vanderlinde EM, 2010, FEMS MICROBIOL ECOL, V71, P327, DOI 10.1111/j.1574-6941.2009.00824.x; vanWorkum WAT, 1997, MOL PLANT MICROBE IN, V10, P290, DOI 10.1094/MPMI.1997.10.2.290; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2004, ARCH MICROBIOL, V181, P144, DOI 10.1007/s00203-003-0635-3; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Weidner S, 2012, J BACTERIOL, V194, P1617, DOI 10.1128/JB.06729-11; XU LM, 1995, INT J SYST BACTERIOL, V45, P706, DOI 10.1099/00207713-45-4-706; Yang SS, 2001, J BIOTECHNOL, V91, P243, DOI 10.1016/S0168-1656(01)00340-6	99	30	30	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115391	10.1371/journal.pone.0115391	http://dx.doi.org/10.1371/journal.pone.0115391			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521500	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600041
J	Welak, SR; Rentea, RM; Teng, RJ; Heinzerling, N; Biesterveld, B; Liedel, JL; Pritchard, KA; Fredrich, KM; Gourlay, DM				Welak, Scott R.; Rentea, Rebecca M.; Teng, Ru-Jeng; Heinzerling, Nathan; Biesterveld, Ben; Liedel, Jennifer L.; Pritchard, Kirkwood A., Jr.; Fredrich, Katherine M.; Gourlay, David M.			Intestinal NADPH Oxidase 2 Activity Increases in a Neonatal Rat Model of Necrotizing Enterocolitis	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; NAD(P)H OXIDASE; SUPEROXIDE-PRODUCTION; ALKALINE-PHOSPHATASE; NOX FAMILY; EXPRESSION; SYNTHASE; MECHANISMS; PHYSIOLOGY	Necrotizing enterocolitis (NEC) is a complication of prematurity. The etiology is unknown, but is related to enteral feeding, ischemia, infection, and inflammation. Reactive oxygen species production, most notably superoxide, increases in NEC. NADPH oxidase (NOX) generates superoxide, but its activity in NEC remains unknown. We hypothesize that NOX-derived superoxide production increases in NEC. Newborn Sprague-Dawley rats were divided into control, formula-fed, formula/LPS, formula/hypoxia, and NEC (formula, hypoxia, and LPS). Intestinal homogenates were analyzed for NADPH-dependent superoxide production. Changes in superoxide levels on days 0-4 were measured. Inhibitors for nitric oxide synthase (L-NAME) and NOX2 (GP91-ds-tat) were utilized. RT-PCR for eNOS, NOX1, GP91(phox) expression was performed. Immunofluorescence studies estimated the co-localization of p47(phox) and GP91(phox) in control and NEC animals on D1, D2, and D4. NEC pups generated more superoxide than controls on D4, while all other groups were unchanged. NADPH-dependent superoxide production was greater in NEC on days 0, 3, and 4. GP91-ds-tat decreased superoxide production in both groups, with greater inhibition in NEC. L-NAME did not alter superoxide production. Temporally, superoxide production varied minimally in controls. In NEC, superoxide generation was decreased on day 1, but increased on days 3-4. GP91(phox) expression was higher in NEC on days 2 and 4. NOX1 and eNOS expression were unchanged from controls. GP91(phox) and p47(phox) had minimal co-localization in all control samples and NEC samples on D1 and D2, but had increased co-localization on D4. In conclusion, this study proves that experimentally-induced NEC increases small intestinal NOX activity. All components of NEC model are necessary for increased NOX activity. NOX2 is the major source, especially as the disease progresses.	[Welak, Scott R.; Teng, Ru-Jeng; Liedel, Jennifer L.] Med Coll Wisconsin, Dept Pediat, Div Neonatol, Milwaukee, WI 53226 USA; [Welak, Scott R.; Rentea, Rebecca M.; Teng, Ru-Jeng; Heinzerling, Nathan; Biesterveld, Ben; Liedel, Jennifer L.; Gourlay, David M.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Welak, Scott R.; Teng, Ru-Jeng; Pritchard, Kirkwood A., Jr.; Fredrich, Katherine M.; Gourlay, David M.] Med Coll Wisconsin, Translat Vasc Biol Program, Milwaukee, WI 53226 USA; [Rentea, Rebecca M.; Heinzerling, Nathan; Biesterveld, Ben; Pritchard, Kirkwood A., Jr.; Fredrich, Katherine M.; Gourlay, David M.] Med Coll Wisconsin, Dept Surg, Div Pediat Surg, Milwaukee, WI 53226 USA; [Liedel, Jennifer L.] Med Coll Wisconsin, Dept Pediat, Div Crit Care, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Welak, SR (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Neonatol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	swelak@mcw.edu	Biesterveld, Ben/AAM-1087-2021	Rentea, Rebecca/0000-0002-8689-5989	NHLBI NIH HHS [R01 HL112270] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112270] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abdullah F, 2010, CLIN PEDIATR, V49, P166, DOI 10.1177/0009922809349161; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Aydemir C, 2011, J PEDIATR SURG, V46, P2096, DOI 10.1016/j.jpedsurg.2011.06.032; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Baregamian N, 2006, J SURG RES, V136, P31, DOI 10.1016/j.jss.2006.04.028; Baregamian N, 2009, OXID MED CELL LONGEV, V2, P297, DOI 10.4161/oxim.2.5.9541; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; CLARK DA, 1988, AM J PATHOL, V130, P537; Cui XL, 2006, PLACENTA, V27, P422, DOI 10.1016/j.placenta.2005.04.004; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Heinzerling NP, 2014, J PEDIATR SURG, V49, P954, DOI 10.1016/j.jpedsurg.2014.01.031; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Hilburger EW, 2005, NEUROSCI LETT, V377, P16, DOI 10.1016/j.neulet.2004.11.066; Hink U, 2001, CIRC RES, V88, pE14; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Kelly N, 2004, SURGERY, V136, P557, DOI 10.1016/j.surg.2004.05.034; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee MY, 2009, ARTERIOSCL THROM VAS, V29, P480, DOI 10.1161/ATVBAHA.108.181925; Li JM, 2002, HYPERTENSION, V40, P477, DOI 10.1161/01.HYP.0000032031.30374.32; MUSEMECHE C, 1991, J PEDIATR SURG, V26, P1047, DOI 10.1016/0022-3468(91)90671-F; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P128, DOI 10.3109/14767058.2012.663197; Perrone S, 2010, EARLY HUM DEV, V86, P241, DOI 10.1016/j.earlhumdev.2010.03.008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rentea RM, 2012, J PEDIATR SURG, V47, P1135, DOI 10.1016/j.jpedsurg.2012.03.018; Rentea RM, 2013, EUR J PEDIATR SURG, V23, P39, DOI 10.1055/s-0032-1329704; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Schnabl KL, 2008, WORLD J GASTROENTERO, V14, P2142, DOI 10.3748/wjg.14.2142; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Upperman Jeffrey S, 2005, Semin Pediatr Surg, V14, P159, DOI 10.1053/j.sempedsurg.2005.05.004; Whitehouse JS, 2010, J SURG RES, V161, P1, DOI 10.1016/j.jss.2009.07.028; Xia Y, 1998, J BIOL CHEM, V273, P22635, DOI 10.1074/jbc.273.35.22635; Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954; Yang M, 2006, AM J HYPERTENS, V19, P587, DOI 10.1016/j.amjhyper.2005.11.017; Yasuda M, 2012, AM J PHYSIOL-GASTR L, V302, pG1133, DOI 10.1152/ajpgi.00535.2011	41	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115317	10.1371/journal.pone.0115317	http://dx.doi.org/10.1371/journal.pone.0115317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517730	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600059
J	Yu, CJ; Sun, CJ; Yu, L; Zhu, M; Xu, H; Zhao, JS; Ma, YB; Zhou, GK				Yu, Changjiang; Sun, Changjiang; Yu, Li; Zhu, Ming; Xu, Hua; Zhao, Jinshan; Ma, Yubin; Zhou, Gongke			Comparative Analysis of Duckweed Cultivation with Sewage Water and SH Media for Production of Fuel Ethanol	PLOS ONE			English	Article							SWINE WASTE-WATER; NUTRIENT RECOVERY; BIOETHANOL PRODUCTION; BIOMASS PRODUCTION; GROWING DUCKWEED; FINE-STRUCTURE; LEMNA-MINOR; ANIMAL FEED; CORN FIBER; STARCH	Energy crises and environmental pollution have caused considerable concerns; duckweed is considered to be a promising new energy plant that may relieve such problems. Lemna aequinoctialis strain 6000, which has a fast growth rate and the ability to accumulate high levels of starch was grown in both Schenk & Hildebrandt medium (SH) and in sewage water (SW). The maximum growth rates reached 10.0 g DW m(-2) day(-1) and 4.3 g DW m(-2) day(-1), respectively, for the SH and SW cultures, while the starch content reached 39% (w/w) and 34% (w/w). The nitrogen and phosphorus removal rate reached 80% (SH) and 90% (SW) during cultivation, and heavy metal ions assimilation was observed. About 95% (w/w) of glucose was released from duckweed biomass hydrolysates, and then fermented by Angel yeast with ethanol yield of 0.19 g g(-1) (SH) and 0.17 g g(-1) (SW). The amylose/ amylopectin ratios of the cultures changed as starch content increased, from 0.252 to 0.155 (SH) and from 0.252 to 0.174 (SW). Lemna aequinoctialis strain 6000 could be considered as valuable feedstock for bioethanol production and water resources purification.	[Yu, Changjiang; Yu, Li; Zhu, Ming; Xu, Hua; Ma, Yubin; Zhou, Gongke] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao 266101, Peoples R China; [Sun, Changjiang] Beijing Risun Chem Ind Technol Res Inst Co Ltd, Beijing 100070, Peoples R China; [Zhao, Jinshan] Qingdao Inst Anim Sci, Qingdao 266100, Peoples R China	Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Ma, YB (corresponding author), Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao 266101, Peoples R China.	mayb@qibebt.ac.cn; zhougk@qibebt.ac.cn	SUN, CHANG/GXM-3680-2022; Zhu, Ming/HIR-4229-2022; Ma, Yubin/GZA-7200-2022	Zhu, Ming/0000-0002-4363-0729; Ma, Yubin/0000-0003-1458-5751; Yu, Changjiang/0000-0002-2735-5691	Director Innovation Foundation of the Qingdao Institute of Bioenergy and Bioprocess Technology; National Key Technology Research and Development Program of China [2015BAD15B01]; Shandong Agricultural Significant Application of Technology Innovation Program; China Risun Coal Chemicals Group Limited; Beijing Risun Chemical Industry Technology Research institute Co. Ltd	Director Innovation Foundation of the Qingdao Institute of Bioenergy and Bioprocess Technology; National Key Technology Research and Development Program of China(National Key Technology R&D Program); Shandong Agricultural Significant Application of Technology Innovation Program; China Risun Coal Chemicals Group Limited; Beijing Risun Chemical Industry Technology Research institute Co. Ltd	Support for this study was provided by the Director Innovation Foundation of the Qingdao Institute of Bioenergy and Bioprocess Technology, the National Key Technology Research and Development Program of China (2015BAD15B01), the Shandong Agricultural Significant Application of Technology Innovation Program, and China Risun Coal Chemicals Group Limited. China Risun Coal Chemicals Group Limited and Beijing Risun Chemical Industry Technology Research institute Co. Ltd provided support in the form of salary for author CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai YF, 2011, J AGR FOOD CHEM, V59, P7385, DOI 10.1021/jf2007584; Bergmann BA, 2000, BIORESOURCE TECHNOL, V73, P13, DOI 10.1016/S0960-8524(99)00137-6; Chaiprapat S, 2005, T ASAE, V48, P2247, DOI 10.13031/2013.20088; Chen Y, 2007, APPL BIOCHEM BIOTECH, V142, P276, DOI 10.1007/s12010-007-0026-3; Cheng J, 2002, T ASAE, V45, P1003, DOI 10.13031/2013.9953; Cheng JJ, 2009, CLEAN-SOIL AIR WATER, V37, P17, DOI 10.1002/clen.200800210; Cheng JY, 2002, BIORESOURCE TECHNOL, V81, P81, DOI 10.1016/S0960-8524(01)00098-0; El-Shafai SA, 2007, BIORESOURCE TECHNOL, V98, P798, DOI 10.1016/j.biortech.2006.03.011; Ge XM, 2012, BIORESOURCE TECHNOL, V124, P485, DOI 10.1016/j.biortech.2012.08.050; Ge XM, 2011, BIOTECHNOL J, V6, P66, DOI 10.1002/biot.201000240; Khellaf N, 2010, ECOTOXICOLOGY, V19, P1363, DOI 10.1007/s10646-010-0522-z; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Mohedano RA, 2012, BIORESOURCE TECHNOL, V112, P98, DOI 10.1016/j.biortech.2012.02.083; Murthy GS, 2011, BIOPROC BIOSYST ENG, V34, P879, DOI 10.1007/s00449-011-0539-6; O'Sullivan JE, 2013, TALANTA, V115, P999, DOI 10.1016/j.talanta.2013.06.054; Okuda M, 2005, CEREAL CHEM, V82, P361, DOI 10.1094/CC-82-0361; Qiu HG, 2011, J ENVIRON QUAL, V40, P1058, DOI 10.2134/jeq2011.0012; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Shrestha P, 2010, BIORESOURCE TECHNOL, V101, P8698, DOI 10.1016/j.biortech.2010.06.089; Stomp AM, 2005, BIOTECHNOL ANN REV, V11, P69, DOI 10.1016/S1387-2656(05)11002-3; Suppadit T, 2011, BIORESOURCE TECHNOL, V102, P7388, DOI 10.1016/j.biortech.2011.05.061; Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001; Ucuncu E, 2013, INT J PHYTOREMEDIAT, V15, P376, DOI 10.1080/15226514.2012.702808; Wang K, 2014, J AGR FOOD CHEM, V62, P4443, DOI 10.1021/jf5011676; Wu X, 2006, CEREAL CHEM, V83, P569, DOI 10.1094/CC-83-0569; Wyman CE, 2007, TRENDS BIOTECHNOL, V25, P153, DOI 10.1016/j.tibtech.2007.02.009; Xiao Y, 2013, IND CROP PROD, V48, P183, DOI 10.1016/j.indcrop.2013.04.017; Xie WY, 2013, INT J PHYTOREMEDIAT, V15, P385, DOI 10.1080/15226514.2012.702809; Xu JL, 2012, CLEAN-SOIL AIR WATER, V40, P760, DOI 10.1002/clen.201100108; Xu JL, 2011, WATER ENVIRON RES, V83, P2049, DOI 10.2175/106143011X12989211841377; Xu JL, 2011, BIOSYST ENG, V110, P67, DOI 10.1016/j.biosystemseng.2011.06.007; Xu JL, 2011, BIORESOURCE TECHNOL, V102, P848, DOI 10.1016/j.biortech.2010.09.003; Yangcheng HY, 2013, J AGR FOOD CHEM, V61, P379, DOI 10.1021/jf305100n	35	16	17	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115023	10.1371/journal.pone.0115023	http://dx.doi.org/10.1371/journal.pone.0115023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517893	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600036
J	Albert, JA; Beare, D; Schwarz, AM; Albert, S; Warren, R; Teri, J; Siota, F; Andrew, NL				Albert, Joelle A.; Beare, Doug; Schwarz, Anne-Maree; Albert, Simon; Warren, Regon; Teri, James; Siota, Faye; Andrew, Neil L.			The Contribution of Nearshore Fish Aggregating Devices (FADs) to Food Security and Livelihoods in Solomon Islands	PLOS ONE			English	Article							FISHERIES; FUTURE	Fish aggregating devices, or FADs, are used widely in developing countries to concentrate pelagic fish, making them easier to catch. Nearshore FADs anchored close to the coast allow access for rural communities, but despite their popularity among policy makers, there is a dearth of empirical analysis of their contributions to the supply of fish and to fisheries management. In this paper we demonstrate that nearshore FADs increased the supply of fish to four communities in Solomon Islands. Estimated total annual fish catch ranged from 4300 to 12 000 kg across the study villages, with nearshore FADs contributing up to 45% of the catch. While it is clear that FADs increased the supply of fish, FAD catch rates were not consistently higher than other fishing grounds. Villages with limited access to diverse or productive fishing grounds seemingly utilized FADs to better effect. Villagers believed FADs increased household income and nutrition, as well as providing a source of fish for community events. FADs were also perceived to increase intra-household conflict and reduce fishers' participation in community activities. FADs need to be placed within a broader rural development context and treated as another component in the diversified livelihoods of rural people; as with other livelihood options they bring trade-offs and risks.	[Albert, Joelle A.; Schwarz, Anne-Maree; Warren, Regon; Siota, Faye] WorldFish, Honiara, Solomon Islands; [Beare, Doug; Andrew, Neil L.] WorldFish, George Town, Malaysia; [Albert, Simon] Univ Queensland, Sch Civil Engn, St Lucia, Qld, Australia; [Teri, James] Solomon Isl Minist Fisheries & Marine Resources, Honiara, Solomon Islands; [Andrew, Neil L.] Univ Wollongong, Australian Natl Ctr Ocean Resources & Secur, Wollongong, NSW, Australia	CGIAR; Worldfish; CGIAR; Worldfish; University of Queensland; University of Wollongong	Albert, JA (corresponding author), WorldFish, Honiara, Solomon Islands.	j.albert@cgiar.org	andrew, neil/AAG-6360-2020; Albert, Simon/I-1104-2012	andrew, neil/0000-0002-2337-8722; Albert, Simon/0000-0002-5947-7909	New Zealand Aid Mekem Strong Solomon Island Fisheries (MSSIF) programme; Australian Centre for International Agricultural Research [FIS/2012/074]; Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems; Climate Change, Agriculture and Food Security	New Zealand Aid Mekem Strong Solomon Island Fisheries (MSSIF) programme; Australian Centre for International Agricultural Research; Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems; Climate Change, Agriculture and Food Security	This work was supported by the New Zealand Aid Mekem Strong Solomon Island Fisheries (MSSIF) programme (aid.govt.nz), an Australian Centre for International Agricultural Research (aciar.gov.au) grant (FIS/2012/074), the Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems (aas.cgiar.org) and Climate Change, Agriculture and Food Security (ccafs.cgiar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Anderson J, 1996, PLANNING FAD PROGRAM; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Beverly S, 2012, RAP PUBLICATION, V2012/20; Carney D., 1998, SUSTAINABLE RURAL LI; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Chapman L, 2003, SPC FISHERIES NEWSLE, V106, P43; Chapman L, 2000, P TUN FISH FISH AGGR; Chapman L., 2005, MANUAL FISH AGGREGAT; Chapman L, 2005, SPC FISHERIES NEWSLE, V113, P27; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Desurmont A., 2000, PECHE THONIERE DISPO, V28, P108; Detolle JP, 1998, SPC FISHERIES NEWSLE, V3, P19; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Foale S, 2011, FISH FISH, V12, P357, DOI 10.1111/j.1467-2979.2010.00395.x; Hall SJ, 2013, P NATL ACAD SCI USA, V110, P8393, DOI 10.1073/pnas.1208067110; Hviding E, 1998, OCEAN COAST MANAGE, V40, P253, DOI 10.1016/S0964-5691(98)00042-8; Johannes RE., 1992, MARINE RESOURCE EC, V7, P249, DOI [10.1086/mre.7.4.42629038, DOI 10.1086/MRE.7.4.42629038]; Nash W, 2006, SPC BECHE DE MER INF, V23, P3; Preston G., 1998, VERTICAL LONGLINING; Ramofafia C, 2008, FIS2003051 WORLDFISH; Scoones I., 1998, SUSTAINABLE RURAL LI; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sharp M., 2011, SPC Fisheries Newsletter, P28; Sharp M, 2012, SPC FISHERIES NEWSLE, V136, P46; Sims N., 1988, WORKSH INSH FISH RES; Sokimi W, 2010, SPC FISHERIES NEWSLE, V132; SPC, 2013, STAT REP PAC ISL REE; SPC, 2005, RES MOR COST EFF MOO; Taquet M., 2011, SPC FISH NEWSLETT, V136, P35; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Walton H, 1995, FISHING VESSEL LOGBO; World Bank, 2014, HARDSH VULN PAC ISL	34	43	43	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115386	10.1371/journal.pone.0115386	http://dx.doi.org/10.1371/journal.pone.0115386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25513808	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300055
J	Lin, YR; Chiu, JJ; Tsai, SY				Lin, Yi-Ru; Chiu, Jian-Jia; Tsai, Shang-Yueh			Feasibility and Reproducibility of Echo Planar Spectroscopic Imaging on the Quantification of Hepatic Fat	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; IN-VIVO; NONINVASIVE ASSESSMENT; CHEMICAL-SHIFT; LIVER-DISEASE; HUMAN BRAIN; ARRAY COIL; STEATOSIS; PREVALENCE	Objectives: 1H-MRS is widely regarded as the most accurate noninvasive method to quantify hepatic fat content (HFC). When practical period of breath holding, and acquisition of HFC over multiple liver areas is considered, a fast MR spectroscopic imaging technique is desired. The aim of this study is to examine the feasibility and reproducibility of echo planar spectroscopic imaging (EPSI) on the quantification of HFC in subject with various HFCs. Methods: Twenty two volunteers were examined in a 3T MR system. The acquisition time of proposed EPSI protocol was 18 seconds. The EPSI scans were repeated 8 times for each subject to test reproducibility. The peak of water and individual peaks of fat including methyl, methylene, and allylic peaks at 0.9, 1.3, and 2.0 ppm were fitted. Calculated amount of water and fat content were corrected for T2 relaxation. The total HFC was defined as the combination of individual peaks. Standard deviation (SD), coefficient of variance (COV) and fitting reliability of HFC quantified by LCModel were calculated. Results: Our results show that the SDs of total HFC for all subjects are less than 2.5%. Fitting reliability is mostly under 10% and positively correlates with COV. Subjects separated into three subgroups according to quantified total HFC show that improved fitting reliability and reproducibility can be achieved on subjects with higher total HFC. Conclusions: We have demonstrated feasibility of the proposed EPSI protocols on the quantification of HFC over a whole slice of liver with scan time in a single breath hold.	[Lin, Yi-Ru; Chiu, Jian-Jia] Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan; [Tsai, Shang-Yueh] Natl Chengchi Univ, Grad Inst Appl Phys, Taipei 11623, Taiwan	National Taiwan University of Science & Technology; National Chengchi University	Lin, YR (corresponding author), Natl Taiwan Univ Sci & Technol, Dept Elect & Comp Engn, Taipei, Taiwan.	yrlin@mail.ntust.edu.tw	Tsai, Shang-Yueh/O-2226-2013	Tsai, Shang-Yueh/0000-0002-6310-4750	Ministry of Science and Technology of Taiwan [100-2221-E-011-013-MY3, 01-2320-B-004-001-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan under grant no. 100-2221-E-011-013-MY3 (YRL) and 101-2320-B-004-001-MY2 (SYT) (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Cowin GJ, 2008, J MAGN RESON IMAGING, V28, P937, DOI 10.1002/jmri.21542; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Fishbein MH, 1997, MAGN RESON IMAGING, V15, P287, DOI 10.1016/S0730-725X(96)00224-X; Friedrich-Rust M, 2010, J CLIN GASTROENTEROL, V44, P58, DOI 10.1097/MCG.0b013e3181a84b8d; Gambarota G, 2011, MAGN RESON MATER PHY, V24, P339, DOI 10.1007/s10334-011-0278-3; Guiu B, 2009, RADIOLOGY, V250, P95, DOI 10.1148/radiol.2493080217; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Hamilton G, 2009, J MAGN RESON IMAGING, V30, P145, DOI 10.1002/jmri.21809; Johnson NA, 2008, HEPATOLOGY, V47, P1513, DOI 10.1002/hep.22220; Kang BK, 2012, INVEST RADIOL, V47, P368, DOI 10.1097/RLI.0b013e31824baff3; Katz-Brull R, 2003, MAGNET RESON MED, V50, P461, DOI 10.1002/mrm.10560; Lachin John M, 2004, Clin Trials, V1, P553, DOI 10.1191/1740774504cn057oa; Lin FH, 2007, MAGN RESON MED, V57, P249, DOI 10.1002/mrm.21119; MANSFIELD P, 1984, MAGNET RESON MED, V1, P370, DOI 10.1002/mrm.1910010308; Marsman HA, 2011, J GASTROEN HEPATOL, V26, P356, DOI 10.1111/j.1440-1746.2010.06326.x; Maudsley AA, 2009, MAGN RESON MED, V61, P548, DOI 10.1002/mrm.21875; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Otazo R, 2007, MAGN RESON MED, V58, P1107, DOI 10.1002/mrm.21426; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; POSSE S, 1995, MAGN RESON MED, V33, P34, DOI 10.1002/mrm.1910330106; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Sharma P, 2009, J MAGN RESON IMAGING, V29, P629, DOI 10.1002/jmri.21682; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Tsai SY, 2008, MAGN RESON MED, V59, P989, DOI 10.1002/mrm.21545; Tsai SY, 2012, NEUROIMAGE, V63, P1020, DOI 10.1016/j.neuroimage.2012.07.039; van Werven JR, 2009, J MAGN RESON IMAGING, V30, P444, DOI 10.1002/jmri.21837	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114436	10.1371/journal.pone.0114436	http://dx.doi.org/10.1371/journal.pone.0114436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514348	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300010
J	Andreoni, C; Orsi, G; De Maria, C; Montemurro, F; Vozzi, G				Andreoni, Chiara; Orsi, Gianni; De Maria, Carmelo; Montemurro, Francesca; Vozzi, Giovanni			In Silico Models for Dynamic Connected Cell Cultures Mimicking Hepatocyte-Endothelial Cell-Adipocyte Interaction Circle	PLOS ONE			English	Article							FATTY-ACID UPTAKE; MULTICOMPARTMENTAL BIOREACTOR; LIPID-METABOLISM; MATHEMATICAL-MODEL; MODULAR BIOREACTOR; PATHWAYS; LIVER; SIMULATION; PROGRAM; GLUCOSE	The biochemistry of a system made up of three kinds of cell is virtually impossible to work out without the use of in silico models. Here, we deal with homeostatic balance phenomena from a metabolic point of view and we present a new computational model merging three single-cell models, already available from our research group: the first model reproduced the metabolic behaviour of a hepatocyte, the second one represented an endothelial cell, and the third one described an adipocyte. Multiple interconnections were created among these three models in order to mimic the main physiological interactions that are known for the examined cell phenotypes. The ultimate aim was to recreate the accomplishment of the homeostatic balance as it was observed for an in vitro connected three-culture system concerning glucose and lipid metabolism in the presence of the medium flow. The whole model was based on a modular approach and on a set of nonlinear differential equations implemented in Simulink, applying Michaelis-Menten kinetic laws and some energy balance considerations to the studied metabolic pathways. Our in silico model was then validated against experimental datasets coming from literature about the cited in vitro model. The agreement between simulated and experimental results was good and the behaviour of the connected culture system was reproduced through an adequate parameter evaluation. The developed model may help other researchers to investigate further about integrated metabolism and the regulation mechanisms underlying the physiological homeostasis.	[Andreoni, Chiara; Orsi, Gianni; De Maria, Carmelo; Montemurro, Francesca; Vozzi, Giovanni] Univ Pisa, Res Ctr E Piaggio, Pisa, Italy; [De Maria, Carmelo; Vozzi, Giovanni] Univ Pisa, Dept Informat Engn, Pisa, Italy	University of Pisa; University of Pisa	Andreoni, C (corresponding author), Univ Pisa, Res Ctr E Piaggio, Pisa, Italy.	ing.chiara.andreoni@gmail.com	Vozzi, Giovanni/AAS-5320-2021; Vozzi, Giovanni/F-9787-2014; De Maria, Carmelo/AAC-8978-2021	Vozzi, Giovanni/0000-0002-9414-9994; De Maria, Carmelo/0000-0002-1368-3571				Agre P, 2004, ANGEW CHEM INT EDIT, V43, P4278, DOI 10.1002/anie.200460804; Berk PD, 1999, J BIOL CHEM, V274, P28626, DOI 10.1074/jbc.274.40.28626; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; CORNISHBOWDEN A, 1991, COMPUT APPL BIOSCI, V7, P89; Cutrone A, 2009, COMPUT METH PROG BIO, V94, P181, DOI 10.1016/j.cmpb.2008.12.004; De Maria C, 2008, COMPUT METH PROG BIO, V92, P121, DOI 10.1016/j.cmpb.2008.06.004; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; EHLDE M, 1995, COMPUT APPL BIOSCI, V11, P201; FIGARD PH, 1986, J LIPID RES, V27, P771; Garvey Thomas D., 2003, OMICS A Journal of Integrative Biology, V7, P411, DOI 10.1089/153623103322637715; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; GRUNDY SM, 1990, DM-DIS MON, V36, P641; Guzzardi MA, 2009, TISSUE ENG PT A, V15, P3635, DOI 10.1089/ten.TEA.2008.0695; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P15493, DOI 10.1074/jbc.C500028200; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Iori E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034704; Kettner Carsten, 2007, In Silico Biology, V7, pS57; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kummer Ursula, 2007, In Silico Biology, V7, pS65; MacArthur BD, 2005, NATURE, V433, P19, DOI 10.1038/433019a; Maeda N, 2008, NAT CLIN PRACT ENDOC, V4, P627, DOI 10.1038/ncpendmet0980; Mathews CK, 1998, BIOCHIMICA; Mazzei D, 2008, IEEE T IND ELECTRON, V55, P3273, DOI 10.1109/TIE.2008.928122; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Micheloni A, 2014, COMPUTER METHODS BIO; Monti LD, 2000, METABOLISM, V49, P73, DOI 10.1016/S0026-0495(00)90763-7; Orsi G, 2011, COMPUT METHOD BIOMEC, V14, P837, DOI 10.1080/10255842.2010.497145; Orsi G, 2009, ENMET ENDOTHELIAL CE, P654; Palsson B, 2000, NAT BIOTECHNOL, V18, P1147, DOI 10.1038/81125; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032; Ring A, 2002, J LIPID RES, V43, P2095, DOI 10.1194/jlr.M200285-JLR200; Russell WMS., 1959, MED J AUSTRALIA; SAURO HM, 1993, COMPUT APPL BIOSCI, V9, P441; SAURO HM, 2000, ANIMATING CELLULAR M; Sidoli FR, 2004, CYTOTECHNOLOGY, V44, P27, DOI 10.1023/B:CYTO.0000043397.94527.84; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; SUGIHARA H, 1987, J LIPID RES, V28, P1038; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Valvano G, 2014, IEEE T BIO-MED ENG, V61, P224, DOI 10.1109/TBME.2013.2272942; Verhulst P. F., 1838, CORRES MATH PHYS, V10, P113, DOI DOI 10.1007/BF02309004; Vinci B, 2012, BIOTECHNOL J, V7, P117, DOI 10.1002/biot.201100177; Vinci B, 2010, BIOTECHNOL J, V5, P618, DOI 10.1002/biot.201000009; Vinci B, 2010, BIOTECHNOL J, V5, P232, DOI 10.1002/biot.200900074; Vozzi F, 2009, TISSUE ENG PT A, V15, P1291, DOI 10.1089/ten.tea.2008.0066; Wang G, 2009, ENDOCRINOL METAB, V297, pE271	49	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e111946	10.1371/journal.pone.0111946	http://dx.doi.org/10.1371/journal.pone.0111946			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502576	gold, Green Published			2022-12-27	WOS:000346607100002
J	Berard, V; Fiala, C; Cameron, S; Bombas, T; Parachini, M; Gemzell-Danielsson, K				Berard, Veronique; Fiala, Christian; Cameron, Sharon; Bombas, Teresa; Parachini, Mirella; Gemzell-Danielsson, Kristina			Instability of Misoprostol Tablets Stored Outside the Blister: A Potential Serious Concern for Clinical Outcome in Medical Abortion	PLOS ONE			English	Article							HYDROXYPROPYL METHYLCELLULOSE; MANAGEMENT; RECOMMENDATIONS; MIFEPRISTONE; COMBINATION; KINETICS; HEALTH; TRIAL	Introduction: Misoprostol (Cytotec) is recognised to be effective for many gynaecological indications including termination of pregnancy, management of miscarriage and postpartum haemorrhage. Although not licensed for such indications, it has been used for these purposes by millions of women throughout the world. Misoprostol tablets are most often packaged as multiple tablets within an aluminium strip, each within an individual alveolus. When an alveolus is opened, tablets will be exposed to atmospheric conditions. Objective: To compare the pharmaco technical characteristics (weight, friability), water content, misoprostol content and decomposition product content (type A misoprostol, type B misoprostol and 8-epi misoprostol) of misoprostol tablets Cytotec (Pfizer) exposed to air for periods of 1 hour to 720 hours (30 days), to those of identical non exposed tablets. Methods: Four hundred and twenty (420) tablets of Cytotec (Pfizer) were removed from their alveoli blister and stored at 25 degrees C/60% relative humidity. Water content, and misoprostol degradation products were assayed in tablets exposed from 1 to 720 hours (30 days). Comparison was made with control tablets (N=60) from the same batch stored in non-damaged blisters. Statistical analyses were carried out using Fisher's exact test for small sample sizes. Results: By 48 hours, exposed tablets demonstrated increased weight (+4.5%), friability (+1 300%), and water content (+80%) compared to controls. Exposed tablets also exhibited a decrease in Cytotec active ingredient dosage (-5.1% after 48 hours) and an increase in the inactive degradation products (+25% for type B, +50% for type A and +11% for 8-epi misoprostol after 48 hours) compared to controls. Conclusion: Exposure of Cytotec tablets to 'typical' European levels of air and humidity results in significant time-dependent changes in physical and biological composition that could impact adversely upon clinical efficacy. Health professionals should be made aware of the degradation of misoprostol with inappropriate storage of misoprostol tablets.	[Berard, Veronique] Univ Bourgogne, Dept Neurosci, Div MaNaPI, ICB CNRS, Dijon, France; [Fiala, Christian] Gynmed Clin, Vienna, Austria; [Cameron, Sharon] NHS Lothian, Chalmers Ctr, Edinburgh, Midlothian, Scotland; [Bombas, Teresa] Ctr Hosp Coimbra, Obstetr Serv, Coimbra, Portugal; [Bombas, Teresa] Univ Coimbra, Coimbra, Portugal; [Parachini, Mirella] San Filippo Neri Hosp, Rome, Italy; [Fiala, Christian; Gemzell-Danielsson, Kristina] Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynecol, Stockholm, Sweden; [Fiala, Christian; Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Stockholm, Sweden	Universite de Bourgogne; Universite de Technologie de Belfort-Montbeliard (UTBM); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; San Filippo Neri Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Berard, V (corresponding author), Univ Bourgogne, Dept Neurosci, Div MaNaPI, ICB CNRS, Dijon, France.	vberard@u-bourgogne.fr		Fiala, Christian/0000-0001-6451-7349	Exelgyn	Exelgyn	The authors confirm that Sharon Cameron as well as Kristina Gemzell Danielsson are PLOS ONE Editorial Board members. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria. Veronique Berard received funding from a commercial source "Exelgyn'' but this does not alter Veronique Berard's adherence to PLOS ONE policies on sharing data and materials.	Blanchard K, 2002, OBSTET GYNECOL, V99, P316, DOI 10.1016/S0029-7844(01)01701-X; Carr SA, 2012, APPR HEALTHC TECHN D, P1; Cervagem, 2005, SUMM PROD CHAR; Chung T, 1997, ACTA OBSTET GYN SCAN, V76, P248, DOI 10.1111/j.1600-0412.1997.tb07854.x; COLLINS PW, 1985, DIGEST DIS SCI, V30, pS114, DOI 10.1007/BF01309395; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; Danielsson KG, 1999, OBSTET GYNECOL, V93, P275, DOI 10.1016/S0029-7844(98)00436-0; EDQM, 2013, PHARM EUR 7 6 DIR EV, P5107; EDQM, 2011, PHARM EUR 7 0 DIR EV, P291; Ellertson C, 2001, Curr Womens Health Rep, V1, P184; Exelgyn, 2013, SMPC MIF 200 MG TABL; Faucher P, 2005, Gynecol Obstet Fertil, V33, P220, DOI 10.1016/j.gyobfe.2005.02.021; Hamoda H, 2005, BJOG-INT J OBSTET GY, V112, P1102, DOI 10.1111/j.1471-0528.2005.00638.x; Herabutya Y, 1997, INT J GYNECOL OBSTET, V56, P263, DOI 10.1016/S0020-7292(96)02815-9; KARARLI TT, 1990, PHARMACEUT RES, V7, P1186, DOI 10.1023/A:1015996712794; Kararli TT, 2004, INT J GYNECOL OBSTET, V87, P281; Kulier R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002855.pub4; McCreath Wayne A., 2001, Obstetrics and Gynecology, V97, p67S, DOI 10.1016/S0029-7844(01)01306-0; National Abortion Federation, 2002, EARL MED AB MIF OTH; Newhall Elizabeth Pirruccello, 2000, American Journal of Obstetrics and Gynecology, V183, pS44; Shaw D, 2007, INT J GYNECOL OBSTET, V99, pS155, DOI 10.1016/j.ijgo.2007.09.002; Singh K, 1998, OBSTET GYNECOL, V92, P795, DOI 10.1016/S0029-7844(98)00281-6; Tang J, 2013, INT J GYNECOL OBSTET, V121, P186, DOI 10.1016/j.ijgo.2012.12.009; TOLEDOVELASQUEZ D, 1992, J PHARM SCI, V81, P145, DOI 10.1002/jps.2600810209; Wagaarachchi PT, 2001, HUM REPROD, V16, P1849, DOI 10.1093/humrep/16.9.1849; Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7	26	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e112401	10.1371/journal.pone.0112401	http://dx.doi.org/10.1371/journal.pone.0112401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25502819	Green Published, gold			2022-12-27	WOS:000346607100003
J	De Filette, M; Chabierski, S; Andries, O; Ulbert, S; Sanders, NN				De Filette, Marina; Chabierski, Stefan; Andries, Oliwia; Ulbert, Sebastian; Sanders, Niek N.			T Cell Epitope Mapping of the E-Protein of West Nile Virus in BALB/c Mice	PLOS ONE			English	Article							INFECTION; PREDICTION; IMMUNITY; IMMUNOPATHOLOGY; ENCEPHALITIS; PROTECTION; RESPONSES; ANTIGEN; HUMANS	West Nile virus (WNV) is a zoonotic virus, which is transmitted by mosquitoes. It is the causative agent of the disease syndrome called West Nile fever. In some human cases, a WNV infection can be associated with severe neurological symptoms. The immune response to WNV is multifactorial and includes both humoral and cellular immunity. T-cell epitope mapping of the WNV envelope (E) protein has been performed in C57BL/6 mice, but not in BALB/c mice. Therefore, we performed in BALB/c mice a T-cell epitope mapping using a series of peptides spanning the WNV envelope (E) protein. To this end, the WNV-E specific T cell repertoire was first expanded by vaccinating BALB/c mice with a DNA vaccine that generates subviral particles that resemble West Nile virus. Furthermore, the WNV structural protein was expressed in Escherichia coli as a series of overlapping 20-mer peptides fused to a carrier-protein. Cytokine-based ELISPOT assays using these purified peptides revealed positive WNV-specific T cell responses to peptides within the different domains of the E-protein.	[De Filette, Marina; Andries, Oliwia; Sanders, Niek N.] Univ Ghent, Fac Vet Sci, Lab Gene Therapy, B-9000 Merelbeke, Belgium; [Chabierski, Stefan; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany	Ghent University; Fraunhofer Gesellschaft	Sanders, NN (corresponding author), Univ Ghent, Fac Vet Sci, Lab Gene Therapy, B-9000 Merelbeke, Belgium.	Niek.Sanders@UGent.be		Sanders, Niek/0000-0003-4585-0343; Ulbert, Sebastian/0000-0001-5910-3643	European Union [261426]; Research Foundation Flanders	European Union(European Commission); Research Foundation Flanders(FWO)	This work was supported by the European Union under FP7 (MDF, SC, SU, NNS), Project 261426 (WINGS-West Nile Integrated Shield Project), and by the Research Foundation Flanders (OA, NNS) (http://www.fwo.be/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Brien JD, 2008, J IMMUNOL, V181, P8568, DOI 10.4049/jimmunol.181.12.8568; Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246; Chabierski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066507; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hayes EB, 2005, EMERG INFECT DIS, V11, P1174, DOI 10.3201/eid1108.050289b; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Heinz CM, 2000, 7 INT COMM TAX VIR; Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012; Jung KO, 2012, J VIROL, V86, P7616, DOI 10.1128/JVI.00166-12; Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955; Koo QY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005352; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Morrey JD, 2008, J GEN VIROL, V89, P467, DOI 10.1099/vir.0.83345-0; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Parsons R, 2008, J IMMUNOL, V181, P1563, DOI 10.4049/jimmunol.181.2.1563; Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; SINIGAGLIA F, 1994, CURR OPIN IMMUNOL, V6, P52, DOI 10.1016/0952-7915(94)90033-7; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115343	10.1371/journal.pone.0115343	http://dx.doi.org/10.1371/journal.pone.0115343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506689	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100068
J	Li, Y; Qin, ZP; Guo, HX; Yang, HX; Zhang, GJ; Ji, SL; Zeng, TY				Li, Ye; Qin, Zhenping; Guo, Hongxia; Yang, Hanxiao; Zhang, Guojun; Ji, Shulan; Zeng, Tingying			Low-Temperature Synthesis of Anatase TiO2 Nanoparticles with Tunable Surface Charges for Enhancing Photocatalytic Activity	PLOS ONE			English	Article							TITANIUM-DIOXIDE; HYDROTHERMAL SYNTHESIS; ORGANIC CONTAMINANTS; RUTILE TIO2; DEGRADATION; TRANSFORMATION; NANOCRYSTALS; PARTICLES; NANOTUBES; HYDROGEN	In this work, the positively or negatively charged anatase TiO2 nanoparticles were synthesized via a low temperature precipitation-peptization process (LTPPP) in the presence of poly(ethyleneimine) (PEI) and poly(sodium4-styrenesulfonate) (PSS). X-ray diffraction (XRD) pattern and high-resolution transmission electron microscope (HRTEM) confirmed the anatase crystalline phase. The charges of the prepared TiO2, PEI-TiO2 and PSS-TiO2 nanoparticles were investigated by zeta potentials. The results showed that the zeta potentials of PEI-TiO2 nanoparticles can be tuned from +39.47 mV to +95.46 mV, and that of PSS-TiO2 nanoparticles can be adjusted from -56.63 mV to -119.32 mV. In comparison with TiO2, PSS-TiO2 exhibited dramatic adsorption and degradation of dye molecules, while the PEI modified TiO2 nanoparticles showed lower photocatalytic activity. The photocatalytic performances of these charged nanoparticles were elucidated by the results of UV-vis diffuse reflectance spectra (DRS) and the photoluminescence (PL) spectra, which indicated that the PSS-TiO2 nanoparticles showed a lower recombination rate of electron-hole pairs than TiO2 and PEI-TiO2.	[Li, Ye; Qin, Zhenping; Yang, Hanxiao; Zhang, Guojun; Ji, Shulan] Beijing Univ Technol, Coll Environm & Energy Engn, Beijing, Peoples R China; [Guo, Hongxia] Beijing Univ Technol, Coll Mat Sci & Engn, Beijing, Peoples R China; [Li, Ye; Guo, Hongxia; Ji, Shulan] Beijing Key Lab Green Catalysis & Separat, Beijing, Peoples R China; [Zeng, Tingying] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Beijing University of Technology; Beijing University of Technology; Massachusetts Institute of Technology (MIT)	Guo, HX (corresponding author), Beijing Univ Technol, Coll Mat Sci & Engn, Beijing, Peoples R China.	hxguo@bjut.edu.cn		Guo, Hongxia/0000-0003-0903-8382	National Natural Science Foundation of China [21176005]; National technology support program of China [2011BAE29B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National technology support program of China	This work was financially supported by National Natural Science Foundation of China (21176005), National technology support program of China (Project No., 2011BAE29B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosc F, 2003, CHEM MATER, V15, P2463, DOI 10.1021/cm031025a; Burunkaya E, 2013, APPL SURF SCI, V265, P317, DOI 10.1016/j.apsusc.2012.11.003; Cassaignon S, 2007, J MATER SCI, V42, P6689, DOI 10.1007/s10853-007-1496-y; Chen K, 2012, MAT SCI SEMICON PROC, V15, P20, DOI 10.1016/j.mssp.2011.05.007; Deshpande SB, 2006, MATER CHEM PHYS, V97, P207, DOI 10.1016/j.matchemphys.2005.02.014; Fernandez N. A, 1999, COLLOID SURF A, V148, P231, DOI DOI 10.1016/S0927-7757(98)00763-8; Finnegan MP, 2007, J PHYS CHEM C, V111, P1962, DOI 10.1021/jp063822c; FRANCESCA R, 2013, CATAL TODAY, V209, P28, DOI DOI 10.1016/J.CATT0D.2013.01.008; Gao JC, 2011, INTEGR FERROELECTR, V129, P169, DOI 10.1080/10584587.2011.576944; Gao YN, 2014, APPL SURF SCI, V294, P36, DOI 10.1016/j.apsusc.2013.12.107; Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003; Gnauck M, 2007, LANGMUIR, V23, P377, DOI 10.1021/la0606648; IMAE T, 1991, COLLOID POLYM SCI, V269, P43, DOI 10.1007/BF00654658; Khataee AR, 2010, J MOL CATAL A-CHEM, V328, P8, DOI 10.1016/j.molcata.2010.05.023; Kim J, 2009, ENVIRON SCI TECHNOL, V43, P5488, DOI 10.1021/es900342q; Kumaresan L, 2010, IND ENG CHEM RES, V49, P1480, DOI 10.1021/ie901191z; Li GS, 2005, J AM CHEM SOC, V127, P8659, DOI 10.1021/ja050517g; Li KX, 2013, J HAZARD MATER, V250, P19, DOI 10.1016/j.jhazmat.2013.01.069; Liao DL, 2007, J PHOTOCH PHOTOBIO A, V187, P363, DOI 10.1016/j.jphotochem.2006.11.003; Liao DL, 2009, COLLOID SURFACE A, V348, P270, DOI 10.1016/j.colsurfa.2009.07.036; Libanori R, 2009, J SOL-GEL SCI TECHN, V49, P95, DOI 10.1007/s10971-008-1821-1; Liu N, 2014, CATAL TODAY, V225, P34, DOI 10.1016/j.cattod.2013.10.090; Lu OY, 2008, J MEMBRANE SCI, V310, P76, DOI 10.1016/j.memsci.2007.10.031; Mogilevsky G, 2008, J PHYS CHEM C, V112, P3239, DOI 10.1021/jp076899p; Nguyen TBL, 2011, J MATER SCI, V46, P5615, DOI 10.1007/s10853-011-5511-y; Ni M, 2007, RENEW SUST ENERG REV, V11, P401, DOI 10.1016/j.rser.2005.01.009; Nian JN, 2006, J PHYS CHEM B, V110, P4193, DOI 10.1021/jp0567321; Oliveira EGL, 2011, CHEM ENG J, V172, P96, DOI 10.1016/j.cej.2011.05.069; Park BJ, 2006, J ELECTROCERAM, V17, P1031, DOI 10.1007/s10832-006-9242-4; Pottier A, 2001, J MATER CHEM, V11, P1116, DOI 10.1039/b100435m; Priya DN, 2009, ACS APPL MATER INTER, V1, P2684, DOI 10.1021/am900566n; Qi KH, 2010, ACS APPL MATER INTER, V2, P3479, DOI 10.1021/am1005892; Song HJ, 2006, J PHYS CHEM A, V110, P6178, DOI 10.1021/jp061053r; Song MX, 2008, J RARE EARTH, V26, P693, DOI 10.1016/S1002-0721(08)60165-9; Tayade RJ, 2006, IND ENG CHEM RES, V45, P5231, DOI 10.1021/ie051362o; Thapa R, 2012, J MOL CATAL A-CHEM, V363, P223, DOI 10.1016/j.molcata.2012.06.013; VILLOSLADA IM, 2006, POLYMER, V47, P6496, DOI DOI 10.1016/J.P0LYMER.2006.07.059; Wang H, 2006, LANGMUIR, V22, P1526, DOI 10.1021/la051988j; Wang S, 2012, APPL SURF SCI, V263, P260, DOI 10.1016/j.apsusc.2012.09.040; Weng YX, 2003, J PHYS CHEM B, V107, P4356, DOI 10.1021/jp022534n; Wu XM, 2001, J SOLID STATE CHEM, V156, P220, DOI 10.1006/jssc.2000.8991; Xie MZ, 2010, J HAZARD MATER, V176, P139, DOI 10.1016/j.jhazmat.2009.11.008; Xu SB, 2012, SOL ENERG MAT SOL C, V96, P286, DOI 10.1016/j.solmat.2011.09.022; Yin HB, 2001, J MATER CHEM, V11, P1694, DOI 10.1039/b008974p; Zahng Qing-Hong, 2000, J INORG CHEM, P931; Zhang HZ, 2000, J PHYS CHEM B, V104, P3481, DOI 10.1021/jp000499j; Zhang WF, 2000, APPL PHYS B-LASERS O, V70, P261, DOI 10.1007/s003400050043; Zhang YC, 2013, APPL CATAL B-ENVIRON, V142, P249, DOI 10.1016/j.apcatb.2013.05.023	48	17	17	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114638	10.1371/journal.pone.0114638	http://dx.doi.org/10.1371/journal.pone.0114638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506839	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100016
J	Mancuso, P; Calleri, A; Gregato, G; Labanca, V; Quarna, J; Antoniotti, P; Cuppini, L; Finocchiaro, G; Eoli, M; Rosti, V; Bertolini, F				Mancuso, Patrizia; Calleri, Angelica; Gregato, Giuliana; Labanca, Valentina; Quarna, Jessica; Antoniotti, Pierluigi; Cuppini, Lucia; Finocchiaro, Gaetano; Eoli, Marica; Rosti, Vittorio; Bertolini, Francesco			A Subpopulation of Circulating Endothelial Cells Express CD109 and is Enriched in the Blood of Cancer Patients	PLOS ONE			English	Article							FLOW-CYTOMETRY; METRONOMIC CHEMOTHERAPY; IDENTIFICATION; ANGIOGENESIS; HETEROGENEITY; BEVACIZUMAB; RECEPTOR; GENES; INHIBITOR; VIABILITY	Background: The endothelium is not a homogeneous organ. Endothelial cell heterogeneity has been described at the level of cell morphology, function, gene expression, and antigen composition. As a consequence of the genetic, transcriptome and surrounding environment diversity, endothelial cells from different vascular beds have differentiated functions and phenotype. Detection of circulating endothelial cells (CECs) by flow cytometry is an approach widely used in cancer patients, and their number, viability and kinetic is a promising tool to stratify patient receiving anti-angiogenic treatment. Methodology/Principal Findings: Currently CECs are identified as positive for a nuclear binding antigen (DNA+), negative for the pan leukocyte marker CD45, and positive for CD31 and CD146. Following an approach recently validated in our laboratory, we investigated the expression of CD109 on CECs from the peripheral blood of healthy subject and cancer patients. The endothelial nature of these cells was validated by RT-PCR for the presence of m-RNA level of CDH5 (Ve-Cadherin) and CLDN5 (Claudin5), two endothelial specific transcripts. Before treatment, significantly higher levels of CD109+CECs and viable CD109+CECs were found in breast cancer patients and glioblastoma patients compared to healthy controls, and their number significantly decreased after treatment. Higher levels of endothelial specific transcripts expressed in developing endothelial cells CLEC14a, TMEM204, ARHGEF15, GPR116, were observed in sorted CD109+CECs when compared to sorted CD146+CECs, suggesting that these genes can play an important role not only during embryogenesis but also in adult angiogenesis. Interestingly, mRNA levels of TEM8 (identified as Antrax Toxin Receptor1, Antrax1) were expressed in CD109+CECs+ but not in CD146+CECs. Conclusion: Taken together our results suggest that CD109 represent a rare population of circulating tumor endothelial cells, that play a potentially useful prognostic role in patients with glioblastoma. The role of CD109 expression in cancer vessel-specific endothelial cells deserves to be further investigated by gene expression studies.	[Mancuso, Patrizia; Calleri, Angelica; Gregato, Giuliana; Labanca, Valentina; Quarna, Jessica; Antoniotti, Pierluigi; Bertolini, Francesco] European Inst Oncol, Lab Hematol Oncol, Milan, Italy; [Cuppini, Lucia; Finocchiaro, Gaetano; Eoli, Marica] Fdn IRCCS Ist Neurol C Besta, Dept Neurooncol, Milan, Italy; [Rosti, Vittorio] Fdn IRCCS Policlin San Matteo, Biotechnol Res Labs, Ctr Study & Treatment Myelofibrosis, Pavia, Italy	IRCCS European Institute of Oncology (IEO); IRCCS Istituto Neurologico Besta; IRCCS Fondazione San Matteo	Mancuso, P (corresponding author), European Inst Oncol, Lab Hematol Oncol, Milan, Italy.	patrizia.mancuso@ieo.it	Rosti, Vittorio/K-1743-2018; bertolini, francesco/AAC-9780-2019; Eoli, Marica/K-7748-2016; Gregato, Giuliana/AAO-5668-2020; Finocchiaro, Gaetano/AAG-6791-2020; Calleri, Angelica/AAO-3747-2020	Rosti, Vittorio/0000-0003-4195-2289; bertolini, francesco/0000-0001-5660-3255; Eoli, Marica/0000-0003-4744-9377; Finocchiaro, Gaetano/0000-0003-3583-4040	AIRC (Associazione Italiana per la Ricerca sul Cancro); Fondazione Umberto Veronesi; Ministero della Salute	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Ministero della Salute(Ministry of Health, Italy)	Supported in part by AIRC (Associazione Italiana per la Ricerca sul Cancro), Fondazione Umberto Veronesi, and Ministero della Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bertolini F, 2003, CANCER RES, V63, P4342; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Cuppini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074345; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Fleitas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047365; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Goon PKY, 2006, THROMB HAEMOSTASIS, V96, P45, DOI 10.1160/TH06-04-0185; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kawaishi M, 2009, J THORAC ONCOL, V4, P208, DOI 10.1097/JTO.0b013e318193030d; Keedy VL, 2007, CANCER SCI, V98, P1825, DOI 10.1111/j.1349-7006.2007.00620.x; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kraan J, 2012, J THROMB HAEMOST, V10, P931, DOI 10.1111/j.1538-7836.2012.04681.x; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Mancuso P, 2006, BLOOD, V108, P452, DOI 10.1182/blood-2005-11-4570; Mancuso P, 2009, CLIN CANCER RES, V15, P267, DOI 10.1158/1078-0432.CCR-08-0432; Mehran R, 2014, CANCER RES, V74, P2731, DOI 10.1158/0008-5472.CAN-13-2044; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Murray LJ, 1999, EXP HEMATOL, V27, P1282, DOI 10.1016/S0301-472X(99)00071-5; Mutin M, 1997, TISSUE ANTIGENS, V50, P449, DOI 10.1111/j.1399-0039.1997.tb02899.x; Rajotte D, 1998, J CLIN INVEST, V102, P430, DOI 10.1172/JCI3008; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Shaked Y, 2005, BLOOD, V106, P3058, DOI 10.1182/blood-2005-04-1422; St Croix B, 2000, SCIENCE, V289, P1197; Strijbos MH, 2008, BRIT J CANCER, V98, P1731, DOI 10.1038/sj.bjc.6604383; SUTHERLAND DR, 1991, BLOOD, V77, P84; Takase H, 2012, BLOOD, V120, P914, DOI 10.1182/blood-2011-12-398156; van der Pol MA, 2003, CYTOM PART B-CLIN CY, V55B, P14, DOI 10.1002/cyto.b.10024	44	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114713	10.1371/journal.pone.0114713	http://dx.doi.org/10.1371/journal.pone.0114713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506915	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100022
J	Watanabe, J; Ishibashi, N; Yano, K				Watanabe, Jun-ichiro; Ishibashi, Nozomu; Yano, Kazuo			Exploring Relationship between Face-to-Face Interaction and Team Performance Using Wearable Sensor Badges	PLOS ONE			English	Article							NETWORK	Quantitative analyses of human-generated data collected in various fields have uncovered many patterns of complex human behaviors. However, thus far the quantitative evaluation of the relationship between the physical behaviors of employees and their performance has been inadequate. Here, we present findings demonstrating the significant relationship between the physical behaviors of employees and their performance via experiments we conducted in inbound call centers while the employees wore sensor badges. There were two main findings. First, we found that face-to-face interaction among telecommunicators and the frequency of their bodily movements caused by the face-to-face interaction had a significant correlation with the entire call center performance, which we measured as "Calls per Hour.'' Second, our trial to activate face-to-face interaction on the basis of data collected by the wearable sensor badges the employees wore significantly increased their performance. These results demonstrate quantitatively that human-human interaction in the physical world plays an important role in team performance.	[Watanabe, Jun-ichiro; Yano, Kazuo] Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan; [Ishibashi, Nozomu] Hitachi High Technol Corp, Tokyo 1058717, Japan	Hitachi Limited; Hitachi Limited	Watanabe, J (corresponding author), Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan.	junichiro.watanabe.ws@hitachi.com			Hitachi, Ltd.; Hitachi High-Technologies Corporation	Hitachi, Ltd.; Hitachi High-Technologies Corporation	Financial support for this study was provided by Hitachi, Ltd., and Hitachi High-Technologies Corporation. Jun-ichiro Watanabe and Kazuo Yano are current employees of Hitachi, Ltd. The funders played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript by providing the budget for this study, data collection system (devices and software), and was involved in discussion about this study.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], 1981, GROUP DYNAMICS PSYCH; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guzzo R. A., 1992, HDB IND ORG PSYCHOL, V3, P269; Kientz JA, 2007, IEEE PERVAS COMPUT, V6, P28, DOI 10.1109/MPRV.2007.18; Kirkman BL, 2004, ACAD MANAGE J, V47, P175, DOI 10.2307/20159571; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Olguin DO, 2009, IEEE T SYST MAN CY B, V39, P43, DOI 10.1109/TSMCB.2008.2006638; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Parkka J, 2006, IEEE T INF TECHNOL B, V10, P119, DOI 10.1109/TITB.2005.856863; Pentland A, 2012, HARVARD BUS REV, V90, P61; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Srivastava R. Muntz, 2001, P 7 ANN INT C MOB CO, P132, DOI DOI 10.1145/381677..381690; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stewart GL, 2006, J MANAGE, V32, P29, DOI 10.1177/0149206305277792; Tyler JR, 2005, INFORM SOC, V21, P133, DOI 10.1080/01972240590925348; Watanabe J., 2012, ASE HUMAN JOURNAL, V1, P193; Watanabe J, 2013, 2013 IEEE 10TH INTERNATIONAL CONFERENCE ON AND 10TH INTERNATIONAL CONFERENCE ON AUTONOMIC AND TRUSTED COMPUTING (UIC/ATC) UBIQUITOUS INTELLIGENCE AND COMPUTING, P170, DOI 10.1109/UIC-ATC.2013.86; Wilson HJ, 2013, HARVARD BUS REV, V91, P23; Wu L., 2008, P INT C INF SYST 200	32	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114681	10.1371/journal.pone.0114681	http://dx.doi.org/10.1371/journal.pone.0114681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25501748	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100017
J	Czorlich, P; Burkhardt, T; Knospe, V; Richard, G; Vettorazzi, E; Wagenfeld, L; Westphal, M; Regelsberger, J; Skevas, C				Czorlich, Patrick; Burkhardt, Till; Knospe, Volker; Richard, Gisbert; Vettorazzi, Eik; Wagenfeld, Lars; Westphal, Manfred; Regelsberger, Jan; Skevas, Christos			Ocular Ultrasound as an Easy Applicable Tool for Detection of Terson's Syndrome after Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							ULTRASONOGRAPHY; SAFETY; VITRECTOMY; PREGNANCY; BRAIN	Introduction: Intraocular hemorrhage in patients suffering from aneurysmal subarachnoid hemorrhage is known as Terson's syndrome and is an underestimated but common pathology. We therefore designed a prospective single-blinded study to evaluate the validity of ocular ultrasound compared to the gold standard indirect funduscopy in the diagnosis of Terson's syndrome. Material and Methods: Fifty-two patients (104 eyes in total) suffering from aneurysmal subarachnoid hemorrhage were enrolled in this study. Two investigators independently performed a single-blinded ocular ultrasound using a standard intensive care ultrasound system to detect an intraocular hemorrhage. Indirect funduscopy following iatrogenic mydriasis served as the gold standard for confirmation or exclusion of an intraocular hemorrhage. Statistical analyses were performed to evaluate the sensitivity and specificity, positive and negative predictive values of the method as well as the learning curve of ocular ultrasound. Results: Indirect funduscopy detected Terson's syndrome in 11 of 52 (21.2%) respectively in 21 of 104 (20.2%) eyes in patients suffering from subarachnoid hemorrhage. Sensitivity and specificity increased with the number of ocular ultrasound examinations for both investigators, reaching 81.8% and 100% respectively. Positive and negative predictive values were different for both investigators (63.6% vs. 100% positive and 100% vs. 95.7% negative) but were both correlated to the amount of intraocular hemorrhage. A low Glasgow Coma scale (p=0.015) and high Hunt & Hess grade (p=0.003) was associated with a higher rate of Terson's syndrome. Conclusions: Ocular ultrasound using standard ultrasound equipment has been confirmed as a reliable, easy-to-handle bedside screening tool for detecting Terson's syndrome. Nevertheless funduscopy remains the gold standard to detect Terson's syndrome.	[Czorlich, Patrick; Burkhardt, Till; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Knospe, Volker; Richard, Gisbert; Wagenfeld, Lars; Skevas, Christos] Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Czorlich, P (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	p.czorlich@uke.de	Czorlich, Patrick/H-8934-2019; Vettorazzi, Eik/B-8130-2019	Vettorazzi, Eik/0000-0002-3737-6402				Bello SO, 2012, ANN AFR MED, V11, P1, DOI 10.4103/1596-3519.91006; Berrocal T, 1996, RADIOGRAPHICS, V16, P251, DOI 10.1148/radiographics.16.2.8966285; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1111/j.1553-2712.2003.tb01352.x; Czorlich P, 2015, NEUROSURG REV, V38, P129, DOI 10.1007/s10143-014-0564-4; Ertl M, 2014, ULTRASCHALL MED, V35, P422, DOI 10.1055/s-0034-1366113; FISHER CM, 1967, J NEUROL NEUROSUR PS, V30, P383, DOI 10.1136/jnnp.30.5.383; Fountas KN, 2008, J NEUROSURG, V109, P439, DOI 10.3171/JNS/2008/109/9/0439; Frizzell RT, 1997, NEUROSURGERY, V41, P529, DOI 10.1097/00006123-199709000-00004; GARFINKLE AM, 1992, J NEUROSURG, V76, P766, DOI 10.3171/jns.1992.76.5.0766; Gauntt CD, 2007, J NEURO-OPHTHALMOL, V27, P193, DOI 10.1097/WNO.0b013e31814b22dc; Koskela E, 2014, J NEUROSURG, V120, P1172, DOI 10.3171/2014.2.JNS131248; Kuhn F, 1998, OPHTHALMOLOGY, V105, P472, DOI 10.1016/S0161-6420(98)93030-5; Leo M, 2011, ULTRASOUND CLIN, V6, P227; Litten M, 1881, BERL KLIN WOCHENSCHR, V18, P23; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; Parchand S, 2014, SEMIN OPHTHALMOL, V29, P236, DOI 10.3109/08820538.2013.821506; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Rosa M, 2012, RADIOGRAPHICS, V32, P9; Rubowitz A, 2006, RETINA-J RET VIT DIS, V26, P230; Sharma T, 2002, OPHTHALMIC SURG LAS, V33, P195; Silverman RH, 2001, J ULTRAS MED, V20, P979; Skevas C, 2014, OPHTHALMOLOGY, V121, P1628, DOI 10.1016/j.ophtha.2014.02.015; Terson A, 1900, CLIN OPHTHALMOL, V6, P309; Torloni MR, 2009, ULTRASOUND OBST GYN, V33, P599, DOI 10.1002/uog.6328; WEINGEIST TA, 1986, OPHTHALMOLOGY, V93, P1435; Wietholter S, 1998, ZBL NEUROCHIR, V59, P166; Yoonessi R, 2010, ACAD EMERG MED, V17, P913, DOI 10.1111/j.1553-2712.2010.00809.x	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114907	10.1371/journal.pone.0114907	http://dx.doi.org/10.1371/journal.pone.0114907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502695	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700068
J	Lukovic, JA; Miletic, V; Pekmezovic, T; Trajkovic, G; Ratkovic, N; Aleksic, D; Grgurevic, A				Lukovic, Jasminka Adzic; Miletic, Vladimir; Pekmezovic, Tatjana; Trajkovic, Goran; Ratkovic, Nevena; Aleksic, Danijela; Grgurevic, Anita			Self-Medication Practices and Risk Factors for Self-Medication among Medical Students in Belgrade, Serbia	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; HEALTH-CARE; DRUG-USE; ALCOHOL; SEEKING; ANTIBIOTICS; ADOLESCENTS; ATTITUDES; BEHAVIOR	Introduction: Self-medication among future health care professionals can represent a serious threat to professionalism in medicine and it has potential to put at risk public trust into this profession. The aim of this research was to investigate prevalence and risk factors for self-medication among population of medical students, because it was previously shown that their attitudes towards pharmacotherapy could affect the way they could prescribe medication in the future. Material and Methods: Research was performed as a cross-sectional study and it included 1296 (84.1%) 1st, 3rd and 6th year students of School of Medicine, University of Belgrade. Students filled out a demographic and self-medication questionnaire created for the purpose of this research and the Physical Health Questionnaire - 9 (PHQ-9). Questions about self-medication were related to the period of the previous year. Results: Self-medication was reported by 79.9% students. The most frequently self-prescribed medications were analgesics (55.4%). Independent risk factors for self-medication were possession of home-pharmacies (OR=5.3, CI 95% 3.89-7.23), lower level of father's education (OR=1.6, CI 95% 1.18-2.25), consumption of alcoholic beverages (OR=1.5, CI 95% 1.13-2.08), less than 1 hour spent in physical activity per week (OR=1.4, CI 95% 1.00-2.02), female gender (OR=1.4, CI 95% 1.02-1.89), older age (OR=1.1, CI 95% 1.07-1.21) and higher PHQ-9 score (OR=1.09, CI 95% 1.05-1.12). Conclusions: Self-medication is an important issue among population of medical students. Prevalence of self-medication could be controlled through regulatory authorities and further education.	[Lukovic, Jasminka Adzic; Pekmezovic, Tatjana; Grgurevic, Anita] Univ Belgrade, Sch Med, Inst Epidemiol, Belgrade, Serbia; [Miletic, Vladimir] Assoc Mental Hlth Promot, Belgrade, Serbia; [Trajkovic, Goran] Univ Belgrade, Sch Med, Inst Med Stat & Informat, Belgrade, Serbia; [Ratkovic, Nevena; Aleksic, Danijela] Clin Ctr Serbia, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia	Grgurevic, A (corresponding author), Univ Belgrade, Sch Med, Inst Epidemiol, Belgrade, Serbia.	anita.grgurevic@gmail.com						Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Badiger S, 2012, AUSTRALAS MED J, V5, P217, DOI 10.4066/AMJ.2012.1007; Bertoldi AD, 2010, CAD SAUDE PUBLICA, V26, P1945, DOI 10.1590/S0102-311X2010001000011; Bertoldi AD, 2014, J ADOLESCENT HEALTH, V55, P175, DOI 10.1016/j.jadohealth.2014.02.010; Betancourt J, 2013, P R HEALTH SCI J, V32, P89; Brimstone R, 2007, MED EDUC, V41, P74, DOI 10.1111/j.1365-2929.2006.02649.x; Cheaito L, 2014, INT J PUBLIC HEALTH, V59, P319, DOI 10.1007/s00038-013-0493-y; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; da Silva MGC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-339; Demissie Z, 2014, MATERN CHIL IN PRESS; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; El Ezz N F A, 2011, J Prev Med Hyg, V52, P196; EPSTEIN AM, 1984, AM J MED, V77, P313, DOI 10.1016/0002-9343(84)90709-5; Eticha T, 2014, PLOS ONE, V12; Fayyazi Bordbar MR, 2014, SUBST USE M IN PRESS; Gardiner Paula, 2007, BMC Complement Altern Med, V7, P39, DOI 10.1186/1472-6882-7-39; Gazibara T, 2013, GERIATR NURS, V34, P486, DOI 10.1016/j.gerinurse.2013.08.002; Hofmeister EH, 2010, J VET MED EDUC, V37, P403, DOI 10.3138/jvme.37.4.403; James H, 2006, MED PRIN PRACT, V15, P270, DOI 10.1159/000092989; Kauffman SE, 1997, SOC WORK, V42, P231, DOI 10.1093/sw/42.3.231; Keel PK, 2007, J ABNORM PSYCHOL, V116, P422, DOI 10.1037/0021-843X.116.2.422; Kisic-Tepavcevic D, 2013, AM J DRUG ALCOHOL AB, V39, P130, DOI 10.3109/00952990.2012.746348; Klemenc-Ketis Z, 2010, INT J CLIN PHARM TH, V48, P705; Klemenc-Ketis Z, 2010, MED PRIN PRACT, V19, P395, DOI 10.1159/000316380; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kumar N, 2013, PLOS ONE, V28; Lazareck S, 2012, J CLIN PSYCHIAT, V73, pE588, DOI 10.4088/JCP.11m07345; Montgomery AJ, 2011, OCCUP MED-OXFORD, V61, P490, DOI 10.1093/occmed/kqr098; Pan H, 2012, PLOS ONE, V27; Pekmezovic T, 2011, QUAL LIFE RES, V20, P391, DOI 10.1007/s11136-010-9754-x; Roberts LW, 2000, ACAD MED, V75, P272, DOI 10.1097/00001888-200003000-00019; Roberts LW, 2001, COMPR PSYCHIAT, V42, P1, DOI 10.1053/comp.2001.19747; Sawalha AF, 2008, RES SOC ADMIN PHARM, V4, P164, DOI 10.1016/j.sapharm.2007.04.004; Ullah H, 2013, ACTA POL PHARM, V70, P919; Van der Veer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028038; WHO, 2011, WHO GLOB REP NONC DI WHO GLOB REP NONC DI; World Health Organization, 2000, REG GUID TEL PROD; Zafar Syed Nabeel, 2008, J Pak Med Assoc, V58, P214	38	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114644	10.1371/journal.pone.0114644	http://dx.doi.org/10.1371/journal.pone.0114644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25503967	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700038
J	Thomas, HR; Percival, SM; Yoder, BK; Parant, JM				Thomas, Holly R.; Percival, Stefanie M.; Yoder, Bradley K.; Parant, John M.			High-Throughput Genome Editing and Phenotyping Facilitated by High Resolution Melting Curve Analysis	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; TARGETED GENE DISRUPTION; CAENORHABDITIS-ELEGANS; REVERSE GENETICS; ZEBRAFISH; SYSTEM; CAS9; SPECIFICITY; DROSOPHILA; MUTATION	With the goal to generate and characterize the phenotypes of null alleles in all genes within an organism and the recent advances in custom nucleases, genome editing limitations have moved from mutation generation to mutation detection. We previously demonstrated that High Resolution Melting (HRM) analysis is a rapid and efficient means of genotyping known zebrafish mutants. Here we establish optimized conditions for HRM based detection of novel mutant alleles. Using these conditions, we demonstrate that HRM is highly efficient at mutation detection across multiple genome editing platforms (ZFNs, TALENs, and CRISPRs); we observed nuclease generated HRM positive targeting in 1 of 6 (16%) open pool derived ZFNs, 14 of 23 (60%) TALENs, and 58 of 77 (75%) CRISPR nucleases. Successful targeting, based on HRM of G0 embryos correlates well with successful germline transmission (46 of 47 nucleases); yet, surprisingly mutations in the somatic tail DNA weakly correlate with mutations in the germline F1 progeny DNA. This suggests that analysis of G0 tail DNA is a good indicator of the efficiency of the nuclease, but not necessarily a good indicator of germline alleles that will be present in the F1s. However, we demonstrate that small amplicon HRM curve profiles of F1 progeny DNA can be used to differentiate between specific mutant alleles, facilitating rare allele identification and isolation; and that HRM is a powerful technique for screening possible off-target mutations that may be generated by the nucleases. Our data suggest that micro-homology based alternative NHEJ repair is primarily utilized in the generation of CRISPR mutant alleles and allows us to predict likelihood of generating a null allele. Lastly, we demonstrate that HRM can be used to quickly distinguish genotype-phenotype correlations within F1 embryos derived from G0 intercrosses. Together these data indicate that custom nucleases, in conjunction with the ease and speed of HRM, will facilitate future high-throughput mutation generation and analysis needed to establish mutants in all genes of an organism.	[Thomas, Holly R.; Percival, Stefanie M.; Parant, John M.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA; [Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cellular Dev & Integrated Biol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Parant, JM (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35233 USA.	Jparant@uab.edu			UAB Hepatorenal Fibrocystic Kidney Disease Core Center (UAB HRFDCC) [P30 DK074038]; NIH Neurological disease and stroke [R21 NS092105]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065655, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS092105] Funding Source: NIH RePORTER	UAB Hepatorenal Fibrocystic Kidney Disease Core Center (UAB HRFDCC); NIH Neurological disease and stroke; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	BKY is supported by UAB Hepatorenal Fibrocystic Kidney Disease Core Center (UAB HRFDCC, P30 DK074038). JMP is supported by NIH Neurological disease and stroke (R21 NS092105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper JL, 2008, FLY, V2, P300, DOI 10.4161/fly.7366; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gilchrist EJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-262; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Parant JM, 2009, DEV DYNAM, V238, P3168, DOI 10.1002/dvdy.22143; Paul K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059505; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen B, 2014, NAT METHODS; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Winkler S, 2005, GENOME RES, V15, P718, DOI 10.1101/gr.3721805; Zhou LM, 2013, CLIN CHEM, V59, P1052, DOI 10.1373/clinchem.2013.202689	42	88	98	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114632	10.1371/journal.pone.0114632	http://dx.doi.org/10.1371/journal.pone.0114632			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503746	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700037
J	Brindle, E; Stevens, D; Crudder, C; Levin, CE; Garrett, D; Lyman, C; Boyle, DS				Brindle, Eleanor; Stevens, Daniel; Crudder, Christopher; Levin, Carol E.; Garrett, Dean; Lyman, Chris; Boyle, David S.			A Multiplex Immunoassay Method for Simultaneous Quantification of Iron, Vitamin A and Inflammation Status Markers	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; RETINOL-BINDING-PROTEIN; C-REACTIVE PROTEIN; ENZYME-IMMUNOASSAY; SERUM RETINOL; CHILD UNDERNUTRITION; DEFICIENCY ANEMIA; FERRITIN; NUTRITION; DIAGNOSIS	Deficiencies of vitamin A and iron affect a significant portion of the world's population, and efforts to characterize patterns of these deficiencies are hampered by a lack of measurement tools appropriate for large-scale population-based surveys. Vitamin A and iron are not easily measured directly, so reliable proxy markers for deficiency status have been identified and adopted. Measurement of inflammatory markers is necessary to interpret vitamin A and iron status markers, because circulating levels are altered by inflammation. We developed a multiplex immunoassay method for simultaneous measurement of five markers relevant to assessing inflammation, vitamin A and iron status: alpha-1-acid glycoprotein, C-reactive protein, retinol binding protein 4, ferritin and soluble transferrin receptor. Serum and plasma specimens were used to optimize the assay protocol. To evaluate assay performance, plasma from 72 volunteers was assayed using the multiplex technique and compared to conventional immunoassay methods for each of the five markers. Results of the new and conventional assay methods were highly correlated (Pearson Correlations of 0.606 to 0.991, p<.0001). Inter-assay imprecision for the multiplex panel varied from 1% to 8%, and all samples fell within the limits of quantification for all assays at a single dilution. Absolute values given by the multiplex and conventional assays differed, indicating a need for further work to devise a new standard curve. This multiplexed micronutrient immunoassay technique has excellent potential as a cost effective tool for use in large-scale deficiency assessment efforts.	[Brindle, Eleanor] Univ Washington, Ctr Studies Demog & Ecol, Seattle, WA 98195 USA; [Stevens, Daniel; Crudder, Christopher; Garrett, Dean; Boyle, David S.] PATH, Seattle, WA USA; [Levin, Carol E.] Univ Washington, Dis Control Prior Network, Seattle, WA 98195 USA; [Garrett, Dean] ICF Int, Rockville, MD 20850 USA; [Lyman, Chris] Quansys Biosci, Logan, UT 84321 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brindle, E (corresponding author), Univ Washington, Ctr Studies Demog & Ecol, 218D Raitt Hall,Box 353412, Seattle, WA 98195 USA.	ebrindle@uw.edu	Brindle, Eleanor/AAK-5028-2021	Brindle, Eleanor/0000-0002-4272-0909	Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [R24 HD042828]; Bill and Melinda Gates Foundation; United States Agency for International Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United States Agency for International Development(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Partial support for this research came from a Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant, R24 HD042828, to the Center for Studies in Demography & Ecology at the University of Washington, from the Bill and Melinda Gates Foundation to PATH, and from the United States Agency for International Development to PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Akesson A, 1999, SCAND J CLIN LAB INV, V59, P77, DOI 10.1080/00365519950185788; Baingana RK, 2008, FOOD NUTR BULL, V29, P297, DOI 10.1177/156482650802900406; Baingana RK, 2012, PUBLIC HEALTH NUTR, P1; Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; BENDER DA, 2003, NUTR BIOCH VITAMINS, P30; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brindle E, 2010, J IMMUNOL METHODS, V362, P112, DOI 10.1016/j.jim.2010.09.014; Cascella M, 2013, ARCH BIOCHEM BIOPHYS, V539, P187, DOI 10.1016/j.abb.2013.06.003; Cermak J, 1998, EUR J HAEMATOL, V61, P210; Chaimongkol L, 2011, CLIN BIOCHEM, V44, P1030, DOI 10.1016/j.clinbiochem.2011.05.023; Chang SY, 2013, PEDIATRICS, V131, pE755, DOI 10.1542/peds.2011-3513; Chiba A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3683; Cook JD, 1998, BLOOD, V92, P1807, DOI 10.1182/blood.V92.5.1807.417a03_1807_1813; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Courtright P, 2011, ARCH DIS CHILD, V96, P1129, DOI 10.1136/archdischild-2011-300093; Davies C., 2005, IMMUNOASSAY HDB, P3; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; DERUYTER MGM, 1976, CLIN CHEM, V22, P1593; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Elmadfa I, 2012, INT J VITAM NUTR RES, V82, P342, DOI 10.1024/0300-9831/a000129; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Ervasti M, 2004, CLIN LAB HAEMATOL, V26, P205, DOI 10.1111/j.1365-2257.2004.00600.x; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gamble MV, 2001, AM J CLIN NUTR, V73, P594; Garrett DA, 2011, AM J CLIN NUTR, V94, p685S, DOI 10.3945/ajcn.110.005751; Guagnozzi D, 2006, INFLAMM BOWEL DIS, V12, P150, DOI 10.1097/01.MIB.0000199223.27595.e3; Hikawa A, 1996, CLIN CHIM ACTA, V254, P159, DOI 10.1016/0009-8981(96)06375-9; Hix J, 2004, AM J CLIN NUTR, V79, P93; ISHIKAWA K, 1982, CLIN CHIM ACTA, V123, P73, DOI 10.1016/0009-8981(82)90115-2; Lattie EG, 2012, BRAIN BEHAV IMMUN, V26, P849, DOI 10.1016/j.bbi.2012.02.008; Malope BI, 2001, BRIT J HAEMATOL, V115, P84, DOI 10.1046/j.1365-2141.2001.03063.x; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Miller J., 2013, COLD SPRING HARB PER, V<bold>3</bold>; Mitka M, 2013, JAMA-J AM MED ASSOC, V309, P2428, DOI 10.1001/jama.2013.7239; Muthayya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067860; NG RH, 1983, CLIN CHEM, V29, P1109; Northrop-Clewes CA, 2008, ANN CLIN BIOCHEM, V45, P18, DOI 10.1258/acb.2007.007167; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Thurnham DI, 2014, P NUTR SOC, V73, P1, DOI 10.1017/S0029665113003662; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; WHO, 2009, GLOB PREV VIT A DEF, P55	47	11	11	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115164	10.1371/journal.pone.0115164	http://dx.doi.org/10.1371/journal.pone.0115164			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525806	Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200016
J	Davila, A; Schouten, B; Verfaillie, K				Davila, Alex; Schouten, Ben; Verfaillie, Karl			Perceiving the Direction of Articulatory Motion in Point-Light Actions	PLOS ONE			English	Article							BIOLOGICAL-MOTION; STIMULUS SET; PERCEPTION; ORIENTATION; ATTENTION; FEATURES; OBJECT; DEPTH	Human observers are able to perceive the motion direction of actions (either forward or backward) on the basis of the articulatory, relative motion of the limbs, even when the actions are shown under point-light conditions. However, most studies have focused on the action of walking. The primary purpose of the present study is to further investigate the perception of articulatory motion in different point-light actions (walking, crawling, hand walking, and rowing). On each trial, participants were presented with a forward or backward moving person and they had to decide on the direction of articulatory motion of the person. We analyzed sensitivity (d') as well as response bias (c). In addition to the type of action, the diagnosticity of the available information was manipulated by varying the visibility of the body parts (full body, only upper limbs, or only lower limbs) and the viewpoint from which the action was seen (from frontal view to sagittal view). We observe that, depending on the specific action, perception of direction of motion is driven by different body parts. Implications for the possible existence of a life detector, i.e., an evolutionarily old and innate visual filter that is tuned to quickly and automatically detect the presence of a moving living organism and direct attention to it, are discussed.	[Davila, Alex; Schouten, Ben; Verfaillie, Karl] Univ Leuven, Expt Psychol Lab, Leuven, Belgium	KU Leuven	Verfaillie, K (corresponding author), Univ Leuven, Expt Psychol Lab, Leuven, Belgium.	Karl.Verfaillie@psy.kuleuven.be	Davila, Alex/AAJ-5086-2020		Fund for Scientific Research-Flanders [G.0810.13];  [3H090031]	Fund for Scientific Research-Flanders(FWO); 	The writing of this article was supported by project from the Fund for Scientific Research-Flanders G.0810.13. Alex Davila was supported by Phd Project 3H090031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autodesk Inc, 2011, AUT 3D STUD MAX REL; BARCIKOWSKI RS, 1984, AM STAT, V38, P148, DOI 10.2307/2683254; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Bulthoff I, 1998, NAT NEUROSCI, V1, P254, DOI 10.1038/699; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; Chang DHF, 2008, J VISION, V8, DOI 10.1167/8.5.3; Chang DHF, 2009, J VISION, V9, DOI [10.1167/9.1.19, 10.1167/9.5.8]; Cutting James E, 1981, INTERSENSORY PERCEPT, P249, DOI DOI 10.1007/978-1-4615-9197-9_8; CUTTING JE, 1981, J EXP PSYCHOL HUMAN, V7, P71, DOI 10.1037/0096-1523.7.1.71; Dekeyser M, 2002, BEHAV RES METH INS C, V34, P375, DOI 10.3758/BF03195465; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; HOFFMAN DD, 1982, BIOL CYBERN, V42, P195; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kuhlmann S, 2009, J VISION, V9, DOI 10.1167/9.10.11; Lange Joachim, 2008, Adv Cogn Psychol, V3, P419, DOI 10.2478/v10053-008-0006-3; Lu HJ, 2006, J VISION, V6, P475, DOI 10.1167/6.4.12; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022650; Manera V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014594; Manera V, 2010, BEHAV RES METHODS, V42, P168, DOI 10.3758/BRM.42.1.168; MCBEATH MK, 1992, PSYCHOL SCI, V3, P362, DOI 10.1111/j.1467-9280.1992.tb00048.x; Michotte A, 1954, MICHOTTES EXPT PHENO, P24; Michotte A. E, 1946, PERCEPTION CAUSALITE; Patrick SK, 2009, J NEUROPHYSIOL, V101, P603, DOI 10.1152/jn.91125.2008; Red Eye Studio Inc, 2002, HANDWALK; Saunders DR, 2010, J VISION, V10, DOI 10.1167/10.11.9; Saunders DR, 2009, PERCEPTION, V38, P522, DOI 10.1068/p6140; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schutz-Bosbach S, 2007, TRENDS COGN SCI, V11, P349, DOI 10.1016/j.tics.2007.06.005; Shipley TF, 2003, PSYCHOL SCI, V14, P377, DOI 10.1111/1467-9280.24471; Sterzer P, 2008, CURR BIOL, V18, pR697, DOI 10.1016/j.cub.2008.06.021; Takahashi K, 2011, J VISION, V11, DOI 10.1167/11.14.8; Thompson J, 2012, NEUROIMAGE, V59, P4, DOI 10.1016/j.neuroimage.2011.05.044; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; van Boxtel JJA, 2011, J VISION, V11, DOI 10.1167/11.7.19; Vangeneugden J, 2010, J VISION, V10, DOI 10.1167/10.4.22; Vanrie J, 2004, BEHAV RES METH INS C, V36, P625, DOI 10.3758/BF03206542; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; VERFAILLIE K, 1993, J EXP PSYCHOL HUMAN, V19, P992, DOI 10.1037/0096-1523.19.5.992; Verfaillie K, 2000, BRAIN COGNITION, V44, P192, DOI 10.1006/brcg.2000.1228; WEBB JA, 1982, ARTIF INTELL, V19, P107, DOI 10.1016/0004-3702(82)90023-6; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Withagen R, 2002, ECOL PSYCHOL, V14, P223, DOI 10.1207/S15326969ECO1404_2; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	49	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115117	10.1371/journal.pone.0115117	http://dx.doi.org/10.1371/journal.pone.0115117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526397	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200013
J	Ng, DHJ; Humphries, JD; Byron, A; Millon-Fremillon, A; Humphries, MJ				Ng, Daniel H. J.; Humphries, Jonathan D.; Byron, Adam; Millon-Fremillon, Angelique; Humphries, Martin J.			Microtubule-Dependent Modulation of Adhesion Complex Composition	PLOS ONE			English	Article							CELL-MATRIX ADHESIONS; BINDING PROTEIN RHO; LARGE GENE LISTS; FOCAL ADHESIONS; MYOSIN-II; INTEGRIN ADHESOME; FIBRONECTIN FIBRILLOGENESIS; ACTIN CYTOSKELETON; VINCULIN-BINDING; STRESS FIBERS	The microtubule network regulates the turnover of integrin-containing adhesion complexes to stimulate cell migration. Disruption of the microtubule network results in an enlargement of adhesion complex size due to increased RhoA-stimulated actomyosin contractility, and inhibition of adhesion complex turnover; however, the microtubule-dependent changes in adhesion complex composition have not been studied in a global, unbiased manner. Here we used label-free quantitative mass spectrometry-based proteomics to determine adhesion complex changes that occur upon microtubule disruption with nocodazole. Nocodazole-treated cells displayed an increased abundance of the majority of known adhesion complex components, but no change in the levels of the fibronectin-binding alpha(5)beta(1) integrin. Immunofluorescence analyses confirmed these findings, but revealed a change in localisation of adhesion complex components. Specifically, in untreated cells, alpha(5)-integrin co-localised with vinculin at peripherally located focal adhesions and with tensin at centrally located fibrillar adhesions. In nocodazole-treated cells, however, alpha(5)-integrin was found in both peripherally located and centrally located adhesion complexes that contained both vinculin and tensin, suggesting a switch in the maturation state of adhesion complexes to favour focal adhesions. Moreover, the switch to focal adhesions was confirmed to be force-dependent as inhibition of cell contractility with the Rho-associated protein kinase inhibitor, Y-27632, prevented the nocodazole-induced conversion. These results highlight a complex interplay between the microtubule cytoskeleton, adhesion complex maturation state and intracellular contractile force, and provide a resource for future adhesion signaling studies. The proteomics data have been deposited in the ProteomeXchange with identifier PXD001183.	[Ng, Daniel H. J.; Humphries, Jonathan D.; Byron, Adam; Millon-Fremillon, Angelique; Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Humphries, MJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	martin.humphries@manchester.ac.uk	Ng, Daniel/AAN-2799-2020; Byron, Adam/AID-5111-2022; Byron, Adam/C-4871-2008; Humphries, Jonathan D./AAE-7760-2022	Byron, Adam/0000-0002-5939-9883; Humphries, Jonathan D./0000-0002-8953-7079; Humphries, Martin/0000-0002-4331-6967	Wellcome Trust [092015]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant 092015 to M.J.H.). URL: http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; DANOWSKI BA, 1989, J CELL SCI, V93, P255; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Ghatak S, 2013, BIOCHEM SOC T, V41, P995, DOI 10.1042/BST20130062; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guan JL, 1997, INT J BIOCHEM CELL B, V29, P1085, DOI 10.1016/S1357-2725(97)00051-4; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hemmings L, 1996, J CELL SCI, V109, P2715; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Liu BP, 1998, CELL ADHES COMMUN, V5, P249, DOI 10.3109/15419069809040295; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 1999, J CELL SCI, V112, P1655	55	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115213	10.1371/journal.pone.0115213	http://dx.doi.org/10.1371/journal.pone.0115213			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526367	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200018
J	Naess, S; Lie, BA; Melum, E; Olsson, M; Hov, JR; Croucher, PJP; Hampe, J; Thorsby, E; Bergquist, A; Traherne, JA; Schrumpf, E; Boberg, KM; Schreiber, S; Franke, A; Karlsen, TH				Naess, Sigrid; Lie, Benedicte A.; Melum, Espen; Olsson, Marita; Hov, Johannes R.; Croucher, Peter J. P.; Hampe, Jochen; Thorsby, Erik; Bergquist, Annika; Traherne, James A.; Schrumpf, Erik; Boberg, Kirsten Muri; Schreiber, Stefan; Franke, Andre; Karlsen, Tom H.			Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; MULTIPLE-SCLEROSIS; HLA-B; SUSCEPTIBILITY; HAPLOTYPES; ANTIGEN; LOCI; ALLELES; DISEASE	Background: Genetic variants within the major histocompatibility complex (MHC) represent the strongest genetic susceptibility factors for primary sclerosing cholangitis (PSC). Identifying the causal variants within this genetic complex represents a major challenge due to strong linkage disequilibrium and an overall high physical density of candidate variants. We aimed to refine the MHC association in a geographically restricted PSC patient panel. Methodology/Principal Findings: A total of 365 PSC cases and 368 healthy controls of Scandinavian ancestry were included in the study. We incorporated data from HLA typing (HLA-A, -B, -C, -DRB3, -DRB1, -DQB1) and single nucleotide polymorphisms across the MHC (n = 18,644; genotyped and imputed) alongside previously suggested PSC risk determinants in the MHC, i.e. amino acid variation of DR beta, a MICA microsatellite polymorphism and HLA-C and HLA-B according to their ligand properties for killer immunoglobulin-like receptors. Breakdowns of the association signal by unconditional and conditional logistic regression analyses demarcated multiple PSC associated MHC haplotypes, and for eight of these classical HLA class I and II alleles represented the strongest association. A novel independent risk locus was detected near NOTCH4 in the HLA class III region, tagged by rs116212904 (odds ratio [95% confidence interval] = 2.32 [1.80, 3.00], P=1.35 x 10(-11)). Conclusions/Significance: Our study shows that classical HLA class I and II alleles, predominantly at HLA-B and HLA-DRB1, are the main risk factors for PSC in the MHC. In addition, the present assessments demonstrated for the first time an association near NOTCH4 in the HLA class III region.	[Naess, Sigrid; Melum, Espen; Hov, Johannes R.; Schrumpf, Erik; Boberg, Kirsten Muri; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Dept Transplantat Med,Div C, N-0027 Oslo, Norway; [Naess, Sigrid; Hov, Johannes R.; Thorsby, Erik; Boberg, Kirsten Muri; Karlsen, Tom H.] Univ Oslo, Inst Clin Med, N-0027 Oslo, Norway; [Naess, Sigrid; Melum, Espen; Hov, Johannes R.; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Clin Med, N-0027 Oslo, Norway; [Lie, Benedicte A.; Thorsby, Erik] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway; [Lie, Benedicte A.] Univ Oslo, Dept Med Genet, N-0027 Oslo, Norway; [Lie, Benedicte A.] Oslo Univ Hosp, Oslo, Norway; [Olsson, Marita] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Croucher, Peter J. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Hampe, Jochen] Tech Univ Dresden, Univ Hosp Dresden, Dept Med 1, D-01062 Dresden, Germany; [Bergquist, Annika] Karolinska Univ Hosp, Karolinska Inst, Dept Gastroenterol & Hepatol, Stockholm, Sweden; [Traherne, James A.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England; [Schrumpf, Erik] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 1QP, England; [Boberg, Kirsten Muri; Karlsen, Tom H.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Transplantat Med,Gastroenterol Sect, N-0027 Oslo, Norway; [Schreiber, Stefan; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Kiel, Germany	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Chalmers University of Technology; University of California System; University of California Berkeley; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Cambridge; University of Cambridge; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel	Karlsen, TH (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Norwegian PSC Res Ctr,Dept Transplantat Med,Div C, N-0027 Oslo, Norway.	t.h.karlsen@medisin.uio.no	Franke, Andre/B-2151-2010; Hampe, Jochen/A-2555-2010; Hov, Johannes R/J-1480-2019	Franke, Andre/0000-0003-1530-5811; Hampe, Jochen/0000-0002-2421-6127; Hov, Johannes R/0000-0002-5900-8096; Bergquist, Annika/0000-0002-3858-6241	Norwegian PSC research center; Research Computing Services at the University of Oslo; DFG Excellence Cluster "Inflammation at Interfaces"; EU [262055]	Norwegian PSC research center; Research Computing Services at the University of Oslo; DFG Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)); EU(European Commission)	The study received support from the Norwegian PSC research center, the Research Computing Services at the University of Oslo and the DFG Excellence Cluster "Inflammation at Interfaces". Grant support was also received from the EU Seventh Framework Programme (FP7/2007-2013, grant number 262055, ESGI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowlus CL, 2010, LIVER TRANSPLANT, V16, P1324, DOI 10.1002/lt.22161; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Donaldson PT, 2002, AUTOIMMUNITY, V35, P555, DOI 10.1080/0891693021000054093; DONALDSON PT, 1991, HEPATOLOGY, V13, P129, DOI 10.1016/0270-9139(91)90225-K; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Folseraas T, 2011, BEST PRACT RES CL GA, V25, P713, DOI 10.1016/j.bpg.2011.09.010; Fuchsberger C, 2014, BIOINFORMATICS; Gabriel C, 2014, TISSUE ANTIGENS, V83, P65, DOI 10.1111/tan.12298; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Hov JR, 2011, HEPATOLOGY, V53, P1967, DOI 10.1002/hep.24299; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Karlsen T, 2007, GENES IMMUN, V8, P275, DOI 10.1038/sj.gene.6364377; Karlsen TH, 2007, J HEPATOL, V46, P899, DOI 10.1016/j.jhep.2007.01.032; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Rahman P, 2012, J RHEUMATOL, V39, P1726, DOI 10.3899/jrheum.111242; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Saarinen S, 2000, AM J GASTROENTEROL, V95, P3195; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayer DC, 2004, TISSUE ANTIGENS, V64, P556, DOI 10.1111/j.1399-0039.2004.00283.x; Sayer DC, 2004, TISSUE ANTIGENS, V63, P412, DOI 10.1111/j.0001-2815.2004.00214.x; Shayevitz C, 2012, AM J MED GENET B, V159B, P477, DOI 10.1002/ajmg.b.32050; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Spurkland A, 1999, TISSUE ANTIGENS, V53, P459, DOI 10.1034/j.1399-0039.1999.530502.x; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Trowsdale J., 2013, ANN REV GENOMICS HUM; Valdes AM, 2009, DIABETES OBES METAB, V11, P46, DOI 10.1111/j.1463-1326.2008.01002.x; Wiencke K, 2007, TISSUE ANTIGENS, V69, P161, DOI 10.1111/j.1399-0039.2006.00738.x; Wiencke K, 2001, HEPATOLOGY, V34, P625, DOI 10.1053/jhep.2001.27543; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zachary AA, 2001, HUM IMMUNOL, V62, P1127, DOI 10.1016/S0198-8859(01)00305-6	39	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114486	10.1371/journal.pone.0114486	http://dx.doi.org/10.1371/journal.pone.0114486			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521205	Green Published, gold			2022-12-27	WOS:000348845600002
J	Shan, X; Fu, YS; Aziz, F; Wang, XQ; Yan, Q; Liu, JW				Shan, Xiu; Fu, Yuan-Shan; Aziz, Faisal; Wang, Xiao-Qi; Yan, Qiu; Liu, Ji-Wei			Ginsenoside Rg3 Inhibits Melanoma Cell Proliferation through Down-Regulation of Histone Deacetylase 3 (HDAC3) and Increase of p53 Acetylation	PLOS ONE			English	Article							CANCER-CELLS; BRAF INHIBITORS; EXPRESSION; APOPTOSIS; DIFFERENTIATION; TRICHOSTATIN; COMBINATION; DACARBAZINE; BELINOSTAT; STABILITY	Malignant melanoma is an aggressive and deadly form of skin cancer, and despite recent advances in available therapies, is still lacking in completely effective treatments. Rg3, a monomer extracted from ginseng roots, has been attempted for the treatment of many cancers. It is reported that the expressions of histone deacetylase 3 (HDAC3) and p53 acetylation correlate with tumor cell growth. However, the antitumor effect of Rg3 on melanoma and the mechanism by which it regulates HDAC3 expression and p53 acetylation remain unknown. We found high expression of HDAC3 in human melanoma tissues to be significantly correlated to lymph node metastasis and clinical stage of disease (p<0.05). In melanoma cells, Rg3 inhibited cell proliferation and induced G0/G1 cell cycle arrest. Rg3 also decreased the expression of HDAC3 and increased the acetylation of p53 on lysine (k373/k382). Moreover, suppression of HDAC3 by either siRNA or a potent HDAC3 inhibitor (MS-275) inhibited cell proliferation, increased p53 acetylation and transcription activity. In A375 melanoma xenograft studies, we demonstrated that Rg3 and HDAC3 short hairpin RNA (shHDAC3) inhibited the growth of xenograft tumors with down-regulation of HDAC3 expression and up-regulation of p53 acetylation. In conclusion, Rg3 has antiproliferative activity against melanoma by decreasing HDAC3 and increasing acetylation of p53 both in vitro and in vivo. Thus, Rg3 serves as a potential therapeutic agent for the treatment of melanoma.	[Shan, Xiu; Liu, Ji-Wei] Dalian Med Univ, Dept Oncol, Affiliated Hosp 1, Dalian, Liaoning Provin, Peoples R China; [Fu, Yuan-Shan] Dalian Med Univ, Dept Human Anat, Dalian, Liaoning Provin, Peoples R China; [Aziz, Faisal; Yan, Qiu] Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Liaoning Provin, Peoples R China; [Wang, Xiao-Qi] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA	Dalian Medical University; Dalian Medical University; Dalian Medical University; Northwestern University; Feinberg School of Medicine	Yan, Q (corresponding author), Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Liaoning Provin, Peoples R China.	yanqiu63@126.com; jiweiliudl@126.com	Aziz, Faisal/AAF-4666-2020	Aziz, Faisal/0000-0002-5802-5855	National Natural Science Foundation of China Research Grant [30672753]; Major State basic Research Development Program (973 program) of China [2012CB822103]	National Natural Science Foundation of China Research Grant(National Natural Science Foundation of China (NSFC)); Major State basic Research Development Program (973 program) of China(National Basic Research Program of China)	The project was supported by the National Natural Science Foundation of China Research Grant (No. 30672753) and the Major State basic Research Development Program (973 program) of China (2012CB822103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan LM, 2014, TARGET ONCOL, V9, P63, DOI 10.1007/s11523-013-0276-7; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Bartling B, 2005, LUNG CANCER-J IASLC, V49, P145, DOI 10.1016/j.lungcan.2005.02.006; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Boissinot M, 2012, LEUKEMIA RES, V36, P1304, DOI 10.1016/j.leukres.2012.07.002; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Chen CQ, 2013, MOL CELL BIOCHEM, V383, P137, DOI 10.1007/s11010-013-1762-z; Diyabalanage HVK, 2013, CANCER LETT, V329, P1, DOI 10.1016/j.canlet.2012.09.018; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Feng LF, 2013, J MOL MED, V91, P49, DOI 10.1007/s00109-012-0932-x; Garbe C, 2009, CLIN DERMATOL, V27, P3, DOI 10.1016/j.clindermatol.2008.09.001; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jazirehi AR, 2013, AM J CLIN EXP IMMUNO, V2, P55; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kim SM, 2009, ARCH PHARM RES, V32, P755, DOI 10.1007/s12272-009-1515-4; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lai F, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.192; Lee CK, 2012, FOOD CHEM TOXICOL, V50, P2565, DOI 10.1016/j.fct.2012.01.005; Lee JY, 2013, MOL CANCER THER, V12, P274, DOI 10.1158/1535-7163.MCT-12-0054; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Li DW, 2014, PROTEIN CELL, V5, P214, DOI 10.1007/s13238-013-0010-3; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu JW, 2009, CANCER RES, V69, P8662, DOI 10.1158/0008-5472.CAN-09-1099; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; Ma C, 2014, J DERMATOL TREAT, V25, P401, DOI 10.3109/09546634.2013.813897; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; McDermott J, 2014, DRUG TODAY, V50, P337, DOI 10.1358/dot.2014.50.5.2138703; Menzies AM, 2013, EUR J CANCER, V49, P3229, DOI 10.1016/j.ejca.2013.06.027; Minami J, 2014, LEUKEMIA, V28, P680, DOI 10.1038/leu.2013.231; Minamiya Y, 2010, TUMOR BIOL, V31, P533, DOI 10.1007/s13277-010-0066-0; Molife LR, 2011, EXPERT OPIN INV DRUG, V20, P1723, DOI 10.1517/13543784.2011.629604; Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684; Oie S, 2013, BIOCHEM BIOPH RES CO, V432, P236, DOI 10.1016/j.bbrc.2013.02.007; Pan XY, 2012, EUR J PHARMACOL, V683, P27, DOI 10.1016/j.ejphar.2012.02.040; Park EH, 2014, J GINSENG RES, V38, P22, DOI 10.1016/j.jgr.2013.11.007; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Shen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030815; Sibaud V, 2013, ANN DERMATOL VENER, V140, P510, DOI 10.1016/j.annder.2013.02.031; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; Sun Yan, 2006, Zhongguo Fei Ai Za Zhi, V9, P254, DOI 10.3779/j.issn.1009-3419.2006.03.09; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Yamamoto S, 2003, CANCER GENE THER, V10, P179, DOI 10.1038/sj.cgt.7700551; Yoo JH, 2010, CANCER LETT, V289, P99, DOI 10.1016/j.canlet.2009.08.008; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	49	71	75	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115401	10.1371/journal.pone.0115401	http://dx.doi.org/10.1371/journal.pone.0115401			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521755	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600043
J	Yadav, GP; Shree, S; Maurya, R; Rai, N; Singh, DK; Srivastava, KK; Ramachandran, R				Yadav, Gaya Prasad; Shree, Sonal; Maurya, Ruchi; Rai, Niyati; Singh, Diwakar Kumar; Srivastava, Kishore Kumar; Ramachandran, Ravishankar			Characterization of M. tuberculosis SerB2, an Essential HAD-Family Phosphatase, Reveals Novel Properties	PLOS ONE			English	Article							HUMAN PHOSPHOSERINE PHOSPHATASE; MULTIPLE SEQUENCE ALIGNMENT; PORPHYROMONAS-GINGIVALIS; D-SERINE; DATABASE SEARCH; ACT DOMAIN; BINDING; INTERMEDIATE; INHIBITORS; RESOLUTION	M. tuberculosis harbors an essential phosphoserine phosphatase (MtSerB2, Rv3042c) that contains two small- molecule binding ACT-domains (Pfam 01842) at the N-terminus followed by the phosphoserine phosphatase (PSP) domain. We found that exogenously added MtSerB2 elicits microtubule rearrangements in THP-1 cells. Mutational analysis demonstrates that phosphatase activity is co-related to the elicited rearrangements, while addition of the ACT-domains alone elicits no rearrangements. The enzyme is dimeric, exhibits divalent metal-ion dependency, and is more specific for L-phosphoserine unlike other classical PSPases. Binding of a variety of amino acids to the ACT-domains influences MtSerB2 activity by either acting as activators/inhibitors/have no effects. Additionally, reduced activity of the PSP domain can be enhanced by equimolar addition of the ACT domains. Further, we identified that G18 and G108 of the respective ACT-domains are necessary for ligand-binding and their mutations to G18A and G108A abolish the binding of ligands like L-serine. A specific transition to higher order oligomers is observed upon the addition of L-serine at similar to 0.8 molar ratio as supported by Isothermal calorimetry and Size exclusion chromatography experiments. Mutational analysis shows that the transition is dependent on binding of L-serine to the ACT-domains. Furthermore, the higher-order oligomeric form of MtSerB2 is inactive, suggesting that its formation is a mechanism for feedback control of enzyme activity. Inhibition studies involving over eight inhibitors, MtSerB2, and the PSP domain respectively, suggests that targeting the ACT-domains can be an effective strategy for the development of inhibitors.	[Yadav, Gaya Prasad; Shree, Sonal; Maurya, Ruchi; Rai, Niyati; Ramachandran, Ravishankar] CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226031, Uttar Pradesh, India; [Singh, Diwakar Kumar; Srivastava, Kishore Kumar] CSIR Cent Drug Res Inst, Div Microbiol, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ramachandran, R (corresponding author), CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Shree, Sonal/AAE-9442-2020; yadav, gaya/AAA-3576-2021; Yadav, Gaya P/F-3720-2019	Shree, Sonal/0000-0002-5665-8157; Yadav, Gaya P/0000-0002-4514-4679; Ramachandran, Ravishankar/0000-0002-0723-9861	Council of Scientific and Industrial Research -network grant SPLenDID [BSC0104]; Council of Scientific and Industrial Research -network grant GENESIS [BSC0121]; Department of Biotechnology project [SSP0025]	Council of Scientific and Industrial Research -network grant SPLenDID; Council of Scientific and Industrial Research -network grant GENESIS; Department of Biotechnology project	The work was funded by Council of Scientific and Industrial Research -network grants SPLenDID (BSC0104) and GENESIS (BSC0121) respectively. NR was supported by the Department of Biotechnology project SSP0025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2001, J MOL BIOL, V307, P1271, DOI 10.1006/jmbi.2001.4508; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Collet JF, 1997, FEBS LETT, V408, P281, DOI 10.1016/S0014-5793(97)00438-9; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dunlop DS, 1997, BIOCHEM BIOPH RES CO, V235, P26, DOI 10.1006/bbrc.1997.6724; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Hawkinson JE, 1997, EUR J PHARMACOL, V337, P315, DOI 10.1016/S0014-2999(97)01304-6; Jung SK, 2012, BIOORG MED CHEM LETT, V22, P2084, DOI 10.1016/j.bmcl.2012.01.011; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATSUI T, 1995, J NEUROCHEM, V65, P454; Moffatt CE, 2012, CELL MICROBIOL, V14, P577, DOI 10.1111/j.1462-5822.2011.01743.x; Nakano I, 2007, STEM CELLS, V25, P1975, DOI 10.1634/stemcells.2007-0046; O'Brien R., 2001, PROTEIN LIGAND INTER; Peeraer Y, 2004, EUR J BIOCHEM, V271, P3421, DOI 10.1111/j.0014-2956.2004.04277.x; Peeraer Y, 2003, ACTA CRYSTALLOGR D, V59, P971, DOI 10.1107/S0907444903005407; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SAVOCA R, 1995, J NEUROSCI METH, V61, P159, DOI 10.1016/0165-0270(95)00038-V; Takeuchi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003326; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tribble GD, 2006, P NATL ACAD SCI USA, V103, P11027, DOI 10.1073/pnas.0509813103; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721	34	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115409	10.1371/journal.pone.0115409	http://dx.doi.org/10.1371/journal.pone.0115409			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521849	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600044
J	Labbe, A; Ganopolsky, JG; Martoni, CJ; Prakash, S; Jones, ML				Labbe, Alain; Ganopolsky, Jorge G.; Martoni, Christopher J.; Prakash, Satya; Jones, Mitchell L.			Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN GUT MICROBIOME; ACID RECEPTOR; LIPID-METABOLISM; ASSOCIATION; DIVERSITY; DYSBIOSIS; ARTICLE; GLUCOSE; HEALTH	We performed an analysis to determine the importance of bile acid modification genes in the gut microbiome of inflammatory bowel disease and type 2 diabetic patients. We used publicly available metagenomic datasets from the Human Microbiome Project and the MetaHIT consortium, and determined the abundance of bile salt hydrolase gene (bsh), 7 alpha-dehydroxylase gene (adh) and 7-alpha hydroxysteroid dehydrogenase gene (hsdh) in fecal bacteria in diseased populations of Crohn's disease (CD), Ulcerative Colitis (UC) and Type 2 diabetes mellitus (T2DM). Phylum level abundance analysis showed a significant reduction in Firmicute-derived bsh in UC and T2DM patients but not in CD patients, relative to healthy controls. Reduction of adh and hsdh genes was also seen in UC and T2DM patients, while an increase was observed in the CD population as compared to healthy controls. A further analysis of the bsh genes showed significant differences in the correlations of certain Firmicutes families with disease or healthy populations. From this observation we proceeded to analyse BSH protein sequences and identified BSH proteins clusters representing the most abundant strains in our analysis of Firmicute bsh genes. The abundance of the bsh genes corresponding to one of these protein clusters was significantly reduced in all disease states relative to healthy controls. This cluster includes bsh genes derived from Lachospiraceae, Clostridiaceae, Erysipelotrichaceae and Ruminococcaceae families. This metagenomic analysis provides evidence of the importance of bile acid modifying enzymes in health and disease. It further highlights the importance of identifying gene and protein clusters, as the same gene may be associated with health or disease, depending on the strains expressing the enzyme, and differences in the enzymes themselves.	[Prakash, Satya; Jones, Mitchell L.] Fac Med, Dept Biomed Engn, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada; [Labbe, Alain; Ganopolsky, Jorge G.; Martoni, Christopher J.; Prakash, Satya; Jones, Mitchell L.] Micropharma Ltd, Montreal, PQ, Canada		Jones, ML (corresponding author), Fac Med, Dept Biomed Engn, Biomed Technol & Cell Therapy Res Lab, Montreal, PQ, Canada.	mitchell.jones@mcgill.ca			Micropharma Limited	Micropharma Limited	Micropharma Limited funded this research.	Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Attinkara Ragam, 2012, BMC Res Notes, V5, P461, DOI 10.1186/1756-0500-5-461; Camilleri M, 2011, NEUROGASTROENT MOTIL, V23, P995, DOI 10.1111/j.1365-2982.2011.01772.x; Duboc H, 2012, NEUROGASTROENT MOTIL, V24, P513, DOI 10.1111/j.1365-2982.2012.01893.x; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jess T, 2005, AM J GASTROENTEROL, V100, P2486, DOI 10.1111/j.1572-0241.2005.00224.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Knop FK, 2010, AM J PHYSIOL-ENDOC M, V299, pE10, DOI 10.1152/ajpendo.00137.2010; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Ogilvie LA, 2012, GUT, V61, P1642, DOI 10.1136/gutjnl-2012-302137; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pols TWH, 2011, DIGEST DIS, V29, P37, DOI 10.1159/000324126; Popescu IR, 2010, FEBS LETT, V584, P2845, DOI 10.1016/j.febslet.2010.04.068; Prawitt J, 2011, CURR DIABETES REP, V11, P160, DOI 10.1007/s11892-011-0187-x; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Renga B, 2010, BBA-MOL BASIS DIS, V1802, P363, DOI 10.1016/j.bbadis.2010.01.002; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Strober W, 2013, TRENDS IMMUNOL, V34, P423, DOI 10.1016/j.it.2013.07.001; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Vrieze A, 2013, J HEPATOL; Wewalka M, 2014, J CLIN ENDOCR METAB; Wildenberg ME, 2011, GUT, V60, P432, DOI 10.1136/gut.2010.233304; Zarrinpar A, 2012, ALIMENT PHARM THER, V36, P909, DOI 10.1111/apt.12084	40	81	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115175	10.1371/journal.pone.0115175	http://dx.doi.org/10.1371/journal.pone.0115175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517115	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600048
J	Sandstrom, CAM; Prop, J; van der Jeugd, H; Loonen, MJJE				Sandstrom, Cecilia A. M.; Prop, Jouke; van der Jeugd, Henk; Loonen, Maarten J. J. E.			Baseline Immune Activity Is Associated with Date Rather than with Moult Stage in the Arctic-Breeding Barnacle Goose (Branta leucopsis)	PLOS ONE			English	Article							PARASITE POPULATION INTERACTIONS; ANNUAL-CYCLE; LIFE-HISTORY; TRADE-OFFS; ECOLOGICAL IMMUNOLOGY; LEUKOCYTE PROFILES; PIED FLYCATCHERS; SEASONAL-CHANGES; GLOBAL PATTERNS; WING MOLT	Variation in immune defence in birds is often explained either by external factors such as food availability and disease pressure or by internal factors such as moult and reproductive effort. We explored these factors together in one sampling design by measuring immune activity over the time frame of the moulting period of Arctic-breeding barnacle geese (Branta leucopsis). We assessed baseline innate immunity by measuring levels of complement-mediated lysis and natural antibody-mediated agglutination together with total and differential leukocyte counts. Variation in immune activity during moult was strongly associated with calendar date and to a smaller degree with the growth stage of wing feathers. We suggest that the association with calendar date reflected temporal changes in the external environment. This environmental factor was further explored by comparing the immune activity of geese in the Arctic population with conspecifics in the temperate climate zone at comparable moult stages. In the Arctic environment, which has a lower expected disease load, geese exhibited significantly lower values of complement-mediated lysis, their blood contained fewer leukocytes, and levels of phagocytic cells and reactive leukocytes were relatively low. This suggests that lower baseline immune activity could be associated with lower disease pressure. We conclude that in our study species, external factors such as food availability and disease pressure have a greater effect on temporal variation of baseline immune activity than internal factors such as moult stage.	[Sandstrom, Cecilia A. M.; Prop, Jouke; Loonen, Maarten J. J. E.] Univ Groningen, Arctic Ctr, NL-9700 AS Groningen, Netherlands; [Sandstrom, Cecilia A. M.] Univ Groningen, NL-9747 AG Groningen, Netherlands; [van der Jeugd, Henk] Dutch Ctr Avian Migrat & Demog NIOO KNAW, Vogeltrekstn, NL-6700 AB Wageningen, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Sandstrom, CAM (corresponding author), Univ Groningen, Arctic Ctr, POB 716, NL-9700 AS Groningen, Netherlands.	c.a.m.sandstrom@rug.nl	van der Jeugd, Henk/S-3159-2019; van der Jeugd, Henk P/F-4891-2010; KNAW, NIOO-KNAW/A-4320-2012	van der Jeugd, Henk/0000-0002-5332-9526; van der Jeugd, Henk P/0000-0002-5332-9526; KNAW, NIOO-KNAW/0000-0002-3835-159X; Loonen, Maarten J.J.E./0000-0002-3426-4595	Netherlands Polar Program (HvdJ); Netherlands Organisation for Scientific Research [851.40.071, 851.30.21]; CAMS; Dutch Faunafonds	Netherlands Polar Program (HvdJ); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); CAMS; Dutch Faunafonds	This work was carried out within the frame of the International Polar Year project BIRDHEALTH (MJJEL, JP, HvdJ, CAMS) and by the Netherlands Polar Program (HvdJ), funded by the Netherlands Organisation for Scientific Research (www.nwo.nl; grant 851.40.071 to MJJEL, 851.30.21 to HvdJ). The Faculty of Science, Rijksuniversiteit Groningen, financed CAMS and Dutch Faunafonds supported the field work in the temperate study population. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Ardia DR, 2007, ECOGRAPHY, V30, P23, DOI 10.1111/j.2006.0906-7590.04939.x; Ardia DR, 2008, AVIAN IMMUNOLOGY, P421, DOI 10.1016/B978-012370634-8.50025-1; BAKKER JP, 1993, HYDROBIOLOGIA, V265, P73, DOI 10.1007/BF00007263; BENNETT GF, 1992, CONDOR, V94, P289, DOI 10.2307/1368821; Black J.M., 2014, THE BARNACLE GOOSE; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Buehler DM, 2008, J AVIAN BIOL, V39, P560, DOI 10.1111/j.0908-8857.2008.04408.x; Buehler DM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P673, DOI 10.1086/588591; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Buehler DM, 2010, AUK, V127, P394, DOI 10.1525/auk.2010.09017; Buehler DM, 2009, J COMP PHYSIOL A, V195, P445, DOI 10.1007/s00359-009-0422-y; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Campbell TW, 1995, AVIAN HEMATOLOGY CYT; CECCHINI G, 1992, VET RES COMMUN, V16, P425, DOI 10.1007/BF01839019; Coulson SJ, 2007, ZOOTAXA, P41, DOI 10.11646/zootaxa.1448.1.2; Cramp S, 1977, BIRDS W PALEARCTIC; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Drent RH, 1998, NORSK POLARINST SKRI, P105; Dzubin A. E., 1992, MEASUREMENTS GEESE G; Eichhorn G, 2010, AUK, V127, P162, DOI 10.1525/auk.2009.09057; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; Fox AD, 2005, J AVIAN BIOL, V36, P538, DOI 10.1111/j.0908-8857.2005.03301.x; Gerlach Helga, 1994, P109; Gonzalez-Quevedo C, 2014, J ANIM ECOL, V83, P1091, DOI 10.1111/1365-2656.12214; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hanssen SA, 2005, P ROY SOC B-BIOL SCI, V272, P1039, DOI 10.1098/rspb.2005.3057; Hegemann A, 2012, OECOLOGIA, V170, P605, DOI 10.1007/s00442-012-2339-3; Hegemann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036358; Hohman William L., 1992, P128; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Horrocks NPC, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00287.1; Horrocks NPC, 2012, PHYSIOL BIOCHEM ZOOL, V85, P504, DOI 10.1086/666988; Horrocks NPC, 2011, INTEGR COMP BIOL, V51, P563, DOI 10.1093/icb/icr011; Horrocks NPC, 2012, THESIS RIJKSUNIVERSI, P37; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; Johansen B, 2014, INT J APPL EARTH OBS, V27, P20, DOI 10.1016/j.jag.2013.07.001; Jonker RM, 2013, MOL ECOL, V22, P5835, DOI 10.1111/mec.12548; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Klasing K.C., 2004, ACTA ZOOL SINICA, V50, P961; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loonen MJJE, 1997, ARDEA, V85, P177; Loonen MJJE, 1997, THESIS RIJKSUNIVERSI, P137; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Matson KD, 2005, DEV COMP IMMUNOL, V29, P275, DOI 10.1016/j.dci.2004.07.006; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; Mendes L, 2006, J EXP BIOL, V209, P284, DOI 10.1242/jeb.02015; Moller AP, 2006, OIKOS, V115, P463, DOI 10.1111/j.2006.0030-1299.15312.x; Moreno-Rueda G, 2010, J EVOLUTION BIOL, V23, P2229, DOI 10.1111/j.1420-9101.2010.02090.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Ochsenbein AF, 2000, IMMUNOL TODAY, V21, P624, DOI 10.1016/S0167-5699(00)01754-0; Owen JC, 2011, J FIELD ORNITHOL, V82, P339, DOI 10.1111/j.1557-9263.2011.00338.x; OWEN M, 1979, CONDOR, V81, P42, DOI 10.2307/1367855; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Pinsky NA, 2003, CLIN DIAGN LAB IMMUN, V10, P19, DOI 10.1128/CDLI.10.1.19-21.2003; Pitt T, 2011, ALLERGY ASTHMA CL IM, V7, DOI [10.1186/1710-1492-7-S1-S1, 10.1186/1710-1492-7-S1-S10]; Prop J, 2004, THESIS RIJKSUNIVERSI; R Development Core Team, 2012, R LANG ENV STAT COMP; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Reeson AF, 1998, P ROY SOC B-BIOL SCI, V265, P1787, DOI 10.1098/rspb.1998.0503; Samour Jaime, 2006, P587; Sandstrom CAM, 2013, VET PARASITOL, V194, P9, DOI 10.1016/j.vetpar.2012.12.027; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; SHIELDS WM, 1987, ECOLOGY, V68, P1373, DOI 10.2307/1939221; Silverin B, 1999, J AVIAN BIOL, V30, P255, DOI 10.2307/3677351; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Van der Graaf AJ, 2006, THESIS RIJKSUNIVERSI, P149; van der Graaf SAJ, 2006, ARDEA, V94, P567; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; Zuur Alain F., 2009, P1	85	4	4	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114812	10.1371/journal.pone.0114812	http://dx.doi.org/10.1371/journal.pone.0114812			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517982	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600030
J	Kanchibhotla, C; Mather, KA; Thalamuthu, A; Zhuang, L; Schofield, PR; Kwok, JBJ; Ames, D; Wright, MJ; Trollor, JN; Wen, W; Sachdev, PS				Kanchibhotla, C.; Mather, Karen A.; Thalamuthu, Anbupalam; Zhuang, Lin; Schofield, Peter R.; Kwok, John B. J.; Ames, David; Wright, Margaret J.; Trollor, Julian N.; Wen, Wei; Sachdev, Perminder S.			Genetics of Microstructure of the Corpus Callosum in Older Adults	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; TRAIT LINKAGE ANALYSIS; DIFFUSION TENSOR; INTERHEMISPHERIC-TRANSFER; FIBER COMPOSITION; SEX-DIFFERENCES; BRAIN; INDIVIDUALS; INTEGRITY; AGE	The current study sought to examine the relative influence of genetic and environmental factors on corpus callosum (CC) microstructure in a community sample of older adult twins. Analyses were undertaken in 284 healthy older twins (66% female; 79 MZ and 63 DZ pairs) from the Older Australian Twins Study. The average age of the sample was 69.82 (SD=4.76) years. Brain imaging scans were collected and DTI measures were estimated for the whole CC as well as its five subregions. Parcellation of the CC was performed using Analyze. In addition, white matter lesion (WMLs) burden was estimated. Heritability and genetic correlation analyses were undertaken using the SOLAR software package. Age, sex, scanner, handedness and blood pressure were considered as covariates. Heritability (h(2)) analysis for the DTI metrics of whole CC, indicated significant h(2) for fractional anisotropy (FA) (h(2) = 0.56; p = 2.89 x 10 (10)), mean diffusivity (MD) (h(2) = 0.52; p = 0.30 x 10(-6)), radial diffusivity (RD) (h(2) = 0.49; p = 0.2 x 10(-6)) and axial diffusivity (AD) (h(2) = 0.37; p = 8.15 x 10(-5)). We also performed bivariate genetic correlation analyses between (i) whole CC DTI measures and (ii) whole CC DTI measures with total brain WML burden. Across the DTI measures for the whole CC, MD and RD shared 84% of the common genetic variance, followed by MD- AD (77%), FA - RD (52%), RD - AD (37%) and FA - MD (11%). For total WMLs, significant genetic correlations indicated that there was 19% shared common genetic variance with whole CC MD, followed by CC RD (17%), CC AD (16%) and CC FA (5%). Our findings suggest that the CC microstructure is under moderate genetic control. There was also evidence of shared genetic factors between the CC DTI measures. In contrast, there was less shared genetic variance between WMLs and the CC DTI metrics, suggesting fewer common genetic variants.	[Kanchibhotla, C.; Mather, Karen A.; Thalamuthu, Anbupalam; Zhuang, Lin; Trollor, Julian N.; Wen, Wei; Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia; [Schofield, Peter R.; Kwok, John B. J.] Neurosci Res Australia, Sydney, NSW, Australia; [Schofield, Peter R.; Kwok, John B. J.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Ames, David] Royal Melbourne Hosp, Natl Ageing Res Inst, Melbourne, Vic, Australia; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Wright, Margaret J.] Berghofer Med Res Inst, Queensland Inst Med Res, Brisbane, Qld, Australia; [Trollor, Julian N.] Univ New S Wales, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Wen, Wei; Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; National Ageing Research Institute; Royal Melbourne Hospital; University of Melbourne; QIMR Berghofer Medical Research Institute; University of New South Wales Sydney	Sachdev, PS (corresponding author), Univ New S Wales, Sch Psychiat, Ctr Hlth Brain Ageing, Sydney, NSW, Australia.	p.sachdev@unsw.edu.au	Wright, Margaret Jane/A-4560-2016; Karen, Mather A/O-9795-2016; Sachdev, Perminder/ABC-1137-2020; Thalamuthu, Anbupalam/Z-5545-2019; Schofield, Peter/C-9669-2011	Wright, Margaret Jane/0000-0001-7133-4970; Karen, Mather A/0000-0003-4143-8941; Sachdev, Perminder/0000-0002-9595-3220; Thalamuthu, Anbupalam/0000-0002-7114-1260; Wen, Wei/0000-0003-2753-3870; Trollor, Julian/0000-0002-7685-2977; Schofield, Peter/0000-0003-2967-9662	NHMRC/Australian Research Council [401162]; NHMRC [1045325]; NHMRC Enabling Grant [310667]; Dementia Collaborative Research Centre (DCRC); Alzheimer's Australia Dementia Research Foundation; NHMRC Capacity Building Grant [568940]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020403] Funding Source: NIH RePORTER	NHMRC/Australian Research Council(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Enabling Grant(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centre (DCRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Alzheimer's Australia Dementia Research Foundation; NHMRC Capacity Building Grant(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	OATS is supported by the NHMRC/Australian Research Council Strategic Award 401162 and NHMRC Project Grant 1045325. OATS was facilitated through access to the Australian Twin Registry, a national research resource supported by the NHMRC Enabling Grant 310667, administered by the University of Melbourne. Sri Chandana Kanchibhotla is supported by a scholarship from the Dementia Collaborative Research Centre (DCRC). Karen Mather is supported by an Alzheimer's Australia Dementia Research Foundation Postdoctoral Fellowship and the NHMRC Capacity Building Grant 568940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ABOITIZ F, 1992, BRAIN RES, V598, P154, DOI 10.1016/0006-8993(92)90179-D; Alger JR, 2012, J NEUROSCI, V32, P7418, DOI 10.1523/JNEUROSCI.4687-11.2012; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Alves GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052859; Antenor-Dorsey JAV, 2013, DIABETES, V62, P581, DOI 10.2337/db12-0696; Assareh A, 2011, CNS NEUROSCI THER, V17, P525, DOI 10.1111/j.1755-5949.2010.00181.x; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bastin ME, 2009, NEUROBIOL AGING, V30, P125, DOI 10.1016/j.neurobiolaging.2007.05.013; Batouli SAH, 2012, NEUROIMAGE, V62, P281, DOI 10.1016/j.neuroimage.2012.04.043; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Burgmans S, 2010, NEUROIMAGE, V49, P2083, DOI 10.1016/j.neuroimage.2009.10.035; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; CLARKE JM, 1994, BEHAV BRAIN RES, V64, P185, DOI 10.1016/0166-4328(94)90131-7; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; Di Paola M, 2010, NEUROIMAGE, V49, P141, DOI 10.1016/j.neuroimage.2009.07.050; Duffy SL, 2013, J PSYCHIATR NEUROSCI, V38; FAZEKAS F, 1989, EUR NEUROL, V29, P164, DOI 10.1159/000116401; Fazekas F, 2013, STROKE, V44, P951, DOI 10.1161/STROKEAHA.111.000849; Filippini N, 2010, NEUROLOGY, V75, P1645, DOI 10.1212/WNL.0b013e3181fb84d1; Fling BW, 2011, NEUROPSYCHOLOGIA, V49, P2564, DOI 10.1016/j.neuropsychologia.2011.05.004; Hasan KM, 2008, BRAIN RES, V1227, P52, DOI 10.1016/j.brainres.2008.06.030; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; Hudkins M, 2012, PSYCHOPHARMACOLOGY, V221, P285, DOI 10.1007/s00213-011-2621-9; Iverson GL, 2011, BRAIN INJURY, V25, P1325, DOI 10.3109/02699052.2011.608409; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kanchibhotla C, 2013, AGEING RES REV, V12, P391, DOI 10.1016/j.arr.2012.10.003; Kochunov P, 2010, NEUROIMAGE, V53, P1109, DOI 10.1016/j.neuroimage.2010.01.078; Liu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059440; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Persson J, 2006, CEREB CORTEX, V16, P907, DOI 10.1093/cercor/bhj036; Pfefferbaum A, 2001, NEUROREPORT, V12, P1677, DOI 10.1097/00001756-200106130-00032; Reijmer YD, 2013, DIABETES CARE, V36, P137, DOI 10.2337/dc12-0493; Ryberg C, 2011, J NEUROL SCI, V307, P100, DOI 10.1016/j.jns.2011.05.002; Sachdev PS, 2009, TWIN RES HUM GENET, V12, P573, DOI 10.1375/twin.12.6.573; Salami A, 2012, BBA-MOL BASIS DIS, V1822, P408, DOI 10.1016/j.bbadis.2011.09.001; Salat D, 1997, NEUROBIOL AGING, V18, P191, DOI 10.1016/S0197-4580(97)00014-6; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Seiler S, 2012, J NEUROL SCI, V22, P22; Serbruyns L, 2013, BRAIN STRUCTURE FUNC; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stievenart JL, 1997, BRAIN RES BULL, V44, P117, DOI 10.1016/S0361-9230(97)00113-5; Sullivan EV, 2010, DEV NEUROPSYCHOL, V35, P233, DOI 10.1080/87565641003689556; Takeda S, 2003, NEURORADIOLOGY, V45, P513, DOI 10.1007/s00234-003-1019-8; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Visscher PM, 2008, TWIN RES HUM GENET, V11, P48, DOI 10.1375/twin.11.1.48; Wang JH, 2013, J CLIN NEUROSCI, V20, P1089, DOI 10.1016/j.jocn.2012.09.025; Wang PJ, 2006, NEUROBIOL AGING, V27, P1613, DOI 10.1016/j.neurobiolaging.2005.09.035; WEIS S, 1993, AM J NEURORADIOL, V14, P637; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Williams VJ, 2013, HUM BRAIN MAPP, V34, P1826, DOI 10.1002/hbm.22030; Wiltshire K, 2010, CAN J NEUROL SCI, V37, P595, DOI 10.1017/S0317167100010751; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zahr NM, 2009, NEUROIMAGE, V44, P1050, DOI 10.1016/j.neuroimage.2008.09.046	70	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113181	10.1371/journal.pone.0113181	http://dx.doi.org/10.1371/journal.pone.0113181			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514436	Green Published, gold			2022-12-27	WOS:000349146300003
J	Lamot, L; Borovecki, F; Bukovac, LT; Vidovic, M; Perica, M; Gotovac, K; Harjacek, M				Lamot, Lovro; Borovecki, Fran; Bukovac, Lana Tambic; Vidovic, Mandica; Perica, Marija; Gotovac, Kristina; Harjacek, Miroslav			Aberrant Expression of Shared Master-Key Genes Contributes to the Immunopathogenesis in Patients with Juvenile Spondyloarthritis	PLOS ONE			English	Article							ENTHESITIS-RELATED ARTHRITIS; INFLAMMATORY-BOWEL-DISEASE; ANKYLOSING-SPONDYLITIS; IDIOPATHIC ARTHRITIS; MICROARRAY ANALYSIS; RECEPTOR 4; PROFILES; HLA-B27; CLASSIFICATION; IDENTIFICATION	Association of juvenile spondyloarthritis (jSpA) with the HLA-B27 genotype is well established, but there is little knowledge of other genetic factors with a role in the development of the disease. To date, only a few studies have tried to find those associated genes by obtaining expression profiles, but with inconsistent results due to various patient selection criteria and methodology. The aim of the present study was to identify and confirm gene signatures and novel biomarkers in highly homogeneous cohorts of untreated and treated patients diagnosed with jSpA and other forms of juvenile idiopathic arthritis (JIA) according to ILAR criteria. For the purposes of the research, total RNA was isolated from whole blood of 45 children with jSpA and known HLA genotype, 11 children with oligo-and polyarticular forms of JIA, as well as 12 age and sex matched control participants without diagnosis of inflammatory disease. DNA microarray gene expression was performed in 11 patients with jSpA and in four healthy controls, along with bioinformatical analysis of retrieved data. Carefully selected differentially expressed genes where analyzed by qRT-PCR in all participants of the study. Microarray results and bioinformatical analysis revealed 745 differentially expressed genes involved in various inflammatory processes, while qRT-PCR analysis of selected genes confirmed data universality and specificity of expression profiles in jSpA patients. The present study indicates that jSpA could be a polygenic disease with a possible malfunction in antigen recognition and activation of immunological response, migration of inflammatory cells and regulation of the immune system. Among genes involved in these processes TLR4, NLRP3, CXCR4 and PTPN12 showed almost consistent expression in study patients diagnosed with jSpA. Those genes and their products could therefore potentially be used as novel biomarkers, possibly predictive of disease prognosis and response to therapy, or even as a target for new therapeutic approaches.	[Lamot, Lovro; Harjacek, Miroslav] Univ Zagreb, Sch Med, Dept Pediat, Zagreb 41001, Croatia; [Lamot, Lovro; Bukovac, Lana Tambic; Vidovic, Mandica; Perica, Marija; Harjacek, Miroslav] Childrens Hosp Srebrnjak, Div Pediat & Adolescent Rheumatol, Zagreb, Croatia; [Borovecki, Fran; Gotovac, Kristina] Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Dept Funct Genom, Zagreb 41001, Croatia	University of Zagreb; University of Zagreb	Lamot, L (corresponding author), Univ Zagreb, Sch Med, Dept Pediat, Zagreb 41001, Croatia.	lovro.lamot@gmail.com	Lamot, Lovro/F-1041-2013	Lamot, Lovro/0000-0002-7939-115X; Harjacek, Miroslav/0000-0002-8322-9702	Ministry of Science, Education and Sports of the Republic of Croatia [108-1083107-0351]; Parkinson&quot;s UK [K-1206] Funding Source: researchfish	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was completely funded by the Ministry of Science, Education and Sports of the Republic of Croatia by grant 108-1083107-0351 (www.mzos.hr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2014, J IMMUNOL, V192, P5520, DOI 10.4049/jimmunol.1400343; [Anonymous], 2014, CELL SIGNAL BIOL; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Barnes MG, 2004, RHEUMATOLOGY, V43, P973, DOI 10.1093/rheumatology/keh224; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; CEDOZ JP, 1995, J RHEUMATOL, V22, P1884; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Duan R, 2010, ANN RHEUM DIS, V69, P1724, DOI 10.1136/ard.2009.111690; Fantini MC, 2009, WORLD J GASTROENTERO, V15, P2472, DOI 10.3748/wjg.15.2472; Gu J, 2002, RHEUMATOLOGY, V41, P759, DOI 10.1093/rheumatology/41.7.759; Gu J, 2002, J RHEUMATOL, V29, P2159; Gu JR, 2009, ARTHRITIS RHEUM-US, V60, P3269, DOI 10.1002/art.24968; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; Harjacek M, 2008, CLIN EXP RHEUMATOL, V26, P498; Harjacek M., 2011, CHALLENGES RHEUMATOL; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YT, 2014, ANN APPL STAT, V8, P352, DOI 10.1214/13-AOAS690; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; May E, 2000, GASTROENTEROLOGY, V119, P1745, DOI 10.1053/gast.2000.20173; Myles A, 2012, RHEUMATOLOGY, V51, P1785, DOI 10.1093/rheumatology/kes151; Nurtdinov RN, 2010, NUCLEIC ACIDS RES, V38, pD726, DOI 10.1093/nar/gkp969; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Pimentel-Santos FM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3309; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Reveille John D, 2009, Curr Rheumatol Rep, V11, P340, DOI 10.1007/s11926-009-0049-6; REYNOLDS TL, 1988, J RHEUMATOL, V15, P1454; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Sampaio-Barros PD, 2003, J RHEUMATOL, V30, P2632; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sharma SM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2855; Sheng MHC, 2009, CELL MOL LIFE SCI, V66, P1946, DOI 10.1007/s00018-009-8811-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thomas GP, 2010, DISCOV MED, V10, P263; Thomas T, 2007, CELL CYCLE, V6, P696, DOI 10.4161/cc.6.6.4013; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Wei FY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3930; Werner L, 2013, THERANOSTICS, V3, P40, DOI 10.7150/thno.5135; Yang ZX, 2007, CLIN EXP IMMUNOL, V149, P48, DOI 10.1111/j.1365-2249.2007.03396.x; Yuan XY, 2012, BRAZ J MED BIOL RES, V45, P1334, DOI 10.1590/S0100-879X2012007500163; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002	48	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115416	10.1371/journal.pone.0115416	http://dx.doi.org/10.1371/journal.pone.0115416			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506924	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000346607100074
J	Lefevre, T; Rondet, C; Parizot, I; Chauvin, P				Lefevre, Thomas; Rondet, Claire; Parizot, Isabelle; Chauvin, Pierre			Applying Multivariate Clustering Techniques to Health Data: The 4 Types of Healthcare Utilization in the Paris Metropolitan Area	PLOS ONE			English	Article							GENE-EXPRESSION; INEQUALITIES; SERVICES; PATTERNS; COVERAGE; ACCESS	Background: Cost containment policies and the need to satisfy patients' health needs and care expectations provide major challenges to healthcare systems. Identification of homogeneous groups in terms of healthcare utilisation could lead to a better understanding of how to adjust healthcare provision to society and patient needs. Methods: This study used data from the third wave of the SIRS cohort study, a representative, population-based, socio-epidemiological study set up in 2005 in the Paris metropolitan area, France. The data were analysed using a cross-sectional design. In 2010, 3000 individuals were interviewed in their homes. Non-conventional multivariate clustering techniques were used to determine homogeneous user groups in data. Multinomial models assessed a wide range of potential associations between user characteristics and their pattern of healthcare utilisation. Results: We identified four distinct patterns of healthcare use. Patterns of consumption and the socio-demographic characteristics of users differed qualitatively and quantitatively between these four profiles. Extensive and intensive use by older, wealthier and unhealthier people contrasted with narrow and parsimonious use by younger, socially deprived people and immigrants. Rare, intermittent use by young healthy men contrasted with regular targeted use by healthy and wealthy women. Conclusion: The use of an original technique of massive multivariate analysis allowed us to characterise different types of healthcare users, both in terms of resource utilisation and socio-demographic variables. This method would merit replication in different populations and healthcare systems.	[Lefevre, Thomas; Rondet, Claire; Chauvin, Pierre] INSERM, UMRS 1136, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, Paris, France; [Lefevre, Thomas; Chauvin, Pierre] Sorbonne Univ, Univ Paris 06, UMRS 1136, Paris, France; [Rondet, Claire] Sorbonne Univ, Univ Paris 06, Fac Med Pierre & Marie Curie, Dept Gen Practice, Paris, France; [Parizot, Isabelle] CNRS, UMR 8997, Ctr Maurice Halbwachs, Res Grp Social Inequal, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Lefevre, T (corresponding author), INSERM, UMRS 1136, Pierre Louis Inst Epidemiol & Publ Hlth, Dept Social Epidemiol, Paris, France.	thomas.lefevre@inserm.fr	Chauvin, Pierre/S-2981-2019; Thomas, Lefèvre/AAE-8350-2022	Chauvin, Pierre/0000-0002-9183-6406; Lefevre, Thomas/0000-0003-3038-479X	Institute for Public Health Research (IReSP); Interministerial Committee for Urban Affairs	Institute for Public Health Research (IReSP); Interministerial Committee for Urban Affairs	Funding for this study was provided by the Institute for Public Health Research (IReSP) and the Interministerial Committee for Urban Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov T, 2011, BIOINFORMATICS, V27, pI230, DOI 10.1093/bioinformatics/btr246; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; ARMSTRONG JJ, 2012, ARCH PHYS MED REHABI; Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Balabanova D, 2004, HEALTH SERV RES, V39, P1927, DOI 10.1111/j.1475-6773.2004.00326.x; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Cabieses B, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-68; Carret ML, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-131; Chevreul K., 2010, HLTH SYST TRANSIT, V12, P1, DOI DOI 10.1038/KI.2015.25; Claudot F, 2009, INT J EPIDEMIOL, V38, P1104, DOI 10.1093/ije/dyp164; Conry MC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-692; Cox B, 2009, INT J PUBLIC HEALTH, V54, P55, DOI 10.1007/s00038-009-7104-y; Dalton L, 2009, CURR GENOMICS, V10, P430, DOI 10.2174/138920209789177601; Dias SF, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-207; Droomers M, 2004, EUR J PUBLIC HEALTH, V14, P311, DOI 10.1093/eurpub/14.3.311; *EHEMU EHLEIS TEAM, 2010, EHEMU TECHNICAL REPO; Evans R. G., 1994, WHY ARE SOME PEOPLE; Finlayson TL, 2010, J PUBLIC HEALTH DENT, V70, P292, DOI 10.1111/j.1752-7325.2010.00184.x; Fleury MJ, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-20; Geitona Mary, 2007, Eur J Gen Pract, V13, P144, DOI 10.1080/13814780701541340; Glazier RH, 2009, ANN FAM MED, V7, P396, DOI 10.1370/afm.994; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Gusmano MK, 2014, HEALTH POLICY, V114, P31, DOI 10.1016/j.healthpol.2013.07.011; Habicht J, 2005, SOC SCI MED, V60, P777, DOI 10.1016/j.socscimed.2004.06.026; Harrington DW, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-146; Hwang T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks615; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Kaufman L, 2005, FINDING GROUPS IN DA; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Lochner C, 2005, COMPR PSYCHIAT, V46, P14, DOI 10.1016/j.comppsych.2004.07.020; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Marmot MG., 2006, SOCIAL DETERMINANTS; Martin-Fernandez J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-486; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Newcomer SR, 2011, AM J MANAG CARE, V17, pE324; Parkhurst J, 2008, J HEALTH SERV RES PO, V13, P122, DOI 10.1258/jhsrp.2008.008019; Pearce N, 2003, AM J PUBLIC HEALTH, V93, P122, DOI 10.2105/AJPH.93.1.122; Rondet C, 2013, PREV MED, V57, P386, DOI 10.1016/j.ypmed.2013.06.016; Smith PC, 2013, HEALTH ECON POLICY L, V8, P529, DOI 10.1017/S1744133113000285; Stewart M, 2005, CAN J NURS RES, V37, P104; Strecher VJ, 1997, HDB HLTH BEHAV RES, P71; Sutherland ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036631; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Treanor C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-316; Vallee J, 2010, HEALTH PLACE, V16, P838, DOI 10.1016/j.healthplace.2010.04.009; Wang TF, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-29; Wang Y, 2011, J INT MED RES, V39, P2256, DOI 10.1177/147323001103900622; Watanabe R, 2012, SOC SCI MED, V75, P1372, DOI 10.1016/j.socscimed.2012.06.006; Westert GP, 2001, EUR J PUBLIC HEALTH, V11, P365, DOI 10.1093/eurpub/11.4.365	54	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115064	10.1371/journal.pone.0115064	http://dx.doi.org/10.1371/journal.pone.0115064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506916	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100046
J	Beta, M; Khetan, V; Chatterjee, N; Suganeswari, G; Rishi, P; Biswas, J; Krishnakumar, S				Beta, Madhu; Khetan, Vikas; Chatterjee, Nivedita; Suganeswari, Ganesan; Rishi, Pukhraj; Biswas, Jyotirmay; Krishnakumar, Subramanian			EpCAM Knockdown Alters MicroRNA Expression in Retinoblastoma- Functional Implication of EpCAM Regulated MiRNA in Tumor Progression	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CELL-ADHESION-MOLECULE; EP-CAM; CLUSTER; CANCER; IDENTIFICATION; OVEREXPRESSION; MUTATIONS; PROFILE	The co-ordinated regulation of oncogenes along with miRNAs play crucial role in carcinogenesis. In retinoblastoma (RB), several miRNAs are known to be differentially expressed. Epithelial cell adhesion molecule (EpCAM) gene is involved in many epithelial cancers including, retinoblastoma (RB) tumorigenesis. EpCAM silencing effectively reduces the oncogenic miR-17-92 cluster. In order to investigate whether EpCAM has wider effect as an inducer or silencer of miRNAs, we performed a global microRNA expression profile in EpCAM siRNA knockdown Y79 cells. MicroRNA profiling in EpCAM silenced Y79 cells showed seventy-three significantly up regulated and thirty-six down regulated miRNAs. A subset of these miRNAs was also validated in tumors. Functional studies on Y79 and WERI-Rb-1 cells transfected with antagomirs against two miRNAs of miR-181c and miR-130b showed striking changes in tumor cell properties in RB cells. Treatment with anti-miR-181c and miR-130b showed significant decrease in cell viability and cell invasion. Increase in caspase-3 level was noticed in antagomir transfected cell lines indicating the induction of apoptosis. Possible genes altered by EpCAM influenced microRNAs were predicted by bioinformatic tools. Many of these belong to pathways implicated in cancer. The study shows significant influence of EpCAM on global microRNA expression. EpCAM regulated miR-181c and miR-130b may play significant roles in RB progression. EpCAM based targeted therapies may reduce carcinogenesis through several miRNAs and target genes.	[Beta, Madhu; Chatterjee, Nivedita; Biswas, Jyotirmay; Krishnakumar, Subramanian] Vis Res Fdn, Kamalanayan Bajaj Res Inst, L&T Ocular Pathol Dept, Madras 600006, Tamil Nadu, India; [Khetan, Vikas; Suganeswari, Ganesan; Rishi, Pukhraj] Med Res Fdn, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras 600006, Tamil Nadu, India; [Khetan, Vikas; Suganeswari, Ganesan; Rishi, Pukhraj] Med Res Fdn, Ocular Oncol Serv, Madras 600006, Tamil Nadu, India		Krishnakumar, S (corresponding author), Vis Res Fdn, Kamalanayan Bajaj Res Inst, L&T Ocular Pathol Dept, 18-41 Coll Rd, Madras 600006, Tamil Nadu, India.	drkrishnakumar_2000@yahoo.com	Rishi, Pukhraj/AAZ-5296-2020	Khetan, Vikas/0000-0003-4396-9877	Department of Biotechnology (DBT) [BT/PR12901/AGR/36/636/2009, BT/01/CEIB/11/V/16]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	The authors acknowledge the Department of Biotechnology (DBT) grant numbers BT/PR12901/AGR/36/636/2009 and BT/01/CEIB/11/V/16 for funding this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Bellone S, 2009, INT J GYNECOL CANCER, V19, P860, DOI 10.1111/IGC.0b013e3181a8331f; Beta M, 2013, BIOINFORM BIOL INSIG, V7, P21, DOI 10.4137/BBI.S10501; Brunner A, 2008, ANTICANCER RES, V28, P125; Chevez-Barrios P, 2000, AM J PATHOL, V157, P1405, DOI 10.1016/S0002-9440(10)64653-6; Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Dalgard CL, 2009, INVEST OPHTH VIS SCI, V50, P4542, DOI 10.1167/iovs.09-3520; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Hassan T, 2012, EXPERT REV ANTI-INFE, V10, P359, DOI [10.1586/ERI.11.175, 10.1586/eri.11.175]; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Ji JF, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-4; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kandalam MM, 2012, MOL VIS, V18, P2279; Kim BH, 2013, J SURG ONCOL, V107, P505, DOI 10.1002/jso.23271; Krishnakumar S, 2004, INVEST OPHTH VIS SCI, V45, P4247, DOI 10.1167/iovs.04-0591; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-41; Lai KW, 2010, EUR J CANCER, V46, P1456, DOI 10.1016/j.ejca.2010.01.036; Li C, 2009, BLOOD, V113, P6681, DOI 10.1182/blood-2009-01-202028; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Madhavan J, 2007, INVEST OPHTH VIS SCI, V48, P4901, DOI 10.1167/iovs.07-0063; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Martin A, 2013, BIOCHEM BIOPH RES CO, V440, P599, DOI 10.1016/j.bbrc.2013.09.117; Matsuda T, 2014, ANN SURG ONCOL, V21, P356, DOI 10.1245/s10434-014-3579-8; Mitra M, 2010, MOL VIS, V16, P828; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Mu GY, 2010, HUM PATHOL, V41, P493, DOI 10.1016/j.humpath.2009.08.022; Pinheiro I, 2011, BIOESSAYS, V33, P791, DOI 10.1002/bies.201100047; Rushlow DE, 2013, LANCET ONCOL, V14, P327, DOI 10.1016/S1470-2045(13)70045-7; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; SERENALUNGAROTTI M, 1979, HUM GENET, V52, P269, DOI 10.1007/BF00278676; Singhal R, 2013, AGING-US, V5, P347, DOI 10.18632/aging.100558; Sithambaram D, 2011, HYBRIDOMA, V30, P511, DOI 10.1089/hyb.2011.0069; Sreenivasan S, 2012, CURR EYE RES, V37, P421, DOI 10.3109/02713683.2011.647224; Theriault BL, 2014, CLIN EXP OPHTHALMOL, V42, P33, DOI 10.1111/ceo.12132; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van der Wal JE, 2003, J CLIN PATHOL, V56, P26, DOI 10.1136/jcp.56.1.26; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	43	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114800	10.1371/journal.pone.0114800	http://dx.doi.org/10.1371/journal.pone.0114800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502397	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400054
J	Melotti, P; Mafficini, A; Lebecque, P; Ortombina, M; Leal, T; Pintani, E; Pepermans, X; Sorio, C; Assael, BM				Melotti, Paola; Mafficini, Andrea; Lebecque, Patrick; Ortombina, Myriam; Leal, Teresinha; Pintani, Emily; Pepermans, Xavier; Sorio, Claudio; Assael, Baroukh Maurice			Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; LUNG-FUNCTION DECLINE; DISEASE SEVERITY; MODIFIER GENES; PSEUDOMONAS-AERUGINOSA; FEV1 DECLINE; CLINICAL-USE; CHILDREN; ASSOCIATION; MACROPHAGES	Macrophage migration Inhibitory Factor (MIF) is a pro-inflammatory cytokine sustaining the acute response to gram-negative bacteria and a regulatory role for MIF in Cystic Fibrosis has been suggested by the presence of a functional, polymorphic, four-nucleotide repeat in this gene's promoter at position -794, with the 5-repeat allele displaying lower promoter activity. We aimed at assessing the association of this polymorphism with disease severity in a group of Cystic Fibrosis patients homozygous for F508del CFTR gene mutation. Genotype frequencies were determined in 189 Cystic Fibrosis and 134 control subjects; key clinical features of patients were recorded and compared among homozygous 5-allele patients and the other MIF genotypes. Patients homozygous for the 5-repeat allele of MIF promoter displayed a slower rate of lung function decline ( p=0.027) at multivariate survival analysis. Multiple regression analysis on age-normalized respiratory volume showed no association of the homozygous 5-repeat genotype with lung function under stable conditions and no correlation with P. aeruginosa chronic colonization. Therefore, only the Homozygous 5-repeat genotype at MIF -794 is associated with milder disease in F508del Cystic Fibrosis patients.	[Melotti, Paola; Ortombina, Myriam; Pintani, Emily; Assael, Baroukh Maurice] Univ & Hosp Trust Verona, Cyst Fibrosis Ctr, Verona, Italy; [Mafficini, Andrea; Sorio, Claudio] Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy; [Mafficini, Andrea; Sorio, Claudio] Univ & Hosp Trust Verona, Dept Pathol & Diagnost, Verona, Italy; [Lebecque, Patrick] Catholic Univ Louvain, Pediat Pulmonol & Cyst Fibrosis Unit, B-1200 Brussels, Belgium; [Leal, Teresinha] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, B-1200 Brussels, Belgium; [Pepermans, Xavier] Catholic Univ Louvain, Ctr Human Genet, B-1200 Brussels, Belgium	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Mafficini, A (corresponding author), Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy.	andrea.mafficini@univr.it	Sorio, Claudio/F-2764-2018; Melotti, Paola/J-6205-2018; Mafficini, Andrea/AAK-8158-2020	Sorio, Claudio/0000-0003-2739-4014; Melotti, Paola/0000-0002-5276-1595; Mafficini, Andrea/0000-0002-7471-3121; pepermans, xavier/0000-0001-6497-4443	ABCFoundation; Lega Italiana Fibrosi Cistica - Associazione Veneta Onlus; FFC - Delegazione FFC di V.C.O. Verbania [06/2010]; Associazione Trentina FC Onlus Gruppo di Sostegno FFC in ricordo di Silvia Sommavilla; Consorzio Promotre s.c.r.l., Antonio Guadagnin e Figlio; Alessandra Boccanera; FFC - Donatori SMS Solidale [26/2011]; Delegazione FFC di Varese; Associazione Trentina FC onlus	ABCFoundation; Lega Italiana Fibrosi Cistica - Associazione Veneta Onlus(Italian Cystic Fibrosis Research Foundation); FFC - Delegazione FFC di V.C.O. Verbania; Associazione Trentina FC Onlus Gruppo di Sostegno FFC in ricordo di Silvia Sommavilla; Consorzio Promotre s.c.r.l., Antonio Guadagnin e Figlio; Alessandra Boccanera; FFC - Donatori SMS Solidale; Delegazione FFC di Varese; Associazione Trentina FC onlus(Italian Cystic Fibrosis Research Foundation)	MO was supported by the ABCFoundation while AM by the Lega Italiana Fibrosi Cistica - Associazione Veneta Onlus. The work is also supported by FFC grant# 06/2010, adopted by Delegazione FFC di V.C.O. Verbania, Associazione Trentina FC Onlus Gruppo di Sostegno FFC in ricordo di Silvia Sommavilla, Consorzio Promotre s.c.r.l., Antonio Guadagnin e Figlio, Alessandra Boccanera and FFC # 26/2011, adopted by Donatori SMS Solidale 2011, Delegazione FFC di Varese, Associazione Trentina FC onlus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamali H, 2012, AM J RESP CRIT CARE, V186, P162, DOI 10.1164/rccm.201110-1864OC; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111, DOI 10.1164/ajrccm.152.6.8520783; Boyle Michael P, 2007, Proc Am Thorac Soc, V4, P52, DOI 10.1513/pats.200605-129JG; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Calandra T, 1996, J INFLAMM, V47, P39; Cooke G, 2009, BIOFACTORS, V35, P165, DOI 10.1002/biof.27; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Dahlgren MK, 2012, J MED CHEM, V55, P10148, DOI 10.1021/jm301269s; Davies JC, 2005, PEDIATR PULM, V39, P383, DOI 10.1002/ppul.20198; De Boeck K, 2011, EUR RESPIR J, V37, P1091, DOI 10.1183/09031936.00077210; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; GRASEMANN H, 2006, DIS MODIFIER GENES C, P50; Hansen Christine Ronne, 2005, J Cyst Fibros, V4, P35, DOI 10.1016/j.jcf.2004.09.001; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Konstan MW, 2007, AM J RESP CRIT CARE, V176, P1084, DOI 10.1164/rccm.200702-181OC; Konstan MW, 2011, PEDIATR PULM, V46, P545, DOI 10.1002/ppul.21388; Kulich M, 2005, AM J RESP CRIT CARE, V172, P885, DOI 10.1164/rccm.200410-1335OC; Lai HCJ, 2008, AM J CLIN NUTR, V88, P161, DOI 10.1093/ajcn/88.1.161; Leech M, 1998, ARTHRITIS RHEUM-US, V41, P910, DOI 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E; LESTER LA, 1994, PEDIATRICS, V93, P114; Long AD, 1999, GENOME RES, V9, P720; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Plant BJ, 2005, AM J RESP CRIT CARE, V172, P1412, DOI 10.1164/rccm.200412-1714OC; Ren CL, 2008, J PEDIATR, V153, P746, DOI 10.1016/j.jpeds.2008.07.010; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Sorio C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022212; Sorio C, 2009, J LEUKOCYTE BIOL, V86, P465, DOI 10.1189/jlb.0309120; Stotland PK, 2000, PEDIATR PULM, V30, P413, DOI 10.1002/1099-0496(200011)30:5<413::AID-PPUL8>3.0.CO;2-9; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114274	10.1371/journal.pone.0114274	http://dx.doi.org/10.1371/journal.pone.0114274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503271	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400024
J	Pastor-Clerigues, A; Marti-Bonmati, E; Milara, J; Almudever, P; Cortijo, J				Pastor-Clerigues, Alfonso; Marti-Bonmati, Ezequiel; Milara, Javier; Almudever, Patricia; Cortijo, Julio			Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTESTINAL FAILURE; FATTY-ACIDS; HEPATIC-FIBROSIS; OMEGA-3-FATTY-ACIDS; CHILDREN; HEPATOCYTES; FIBROBLASTS; RECRUITMENT; ADULT	Home parenteral nutrition (PN) is associated with many complications including severe hepatobiliary dysfunction. Commercial omega-6 fatty acid-soybean based-lipid emulsions in PN may mediate long term PN associate liver disease (PNALD) whereas omega-3-fish oil parenteral emulsions have shown to reverse PNALD in children. However, its clinical effectiveness in adults has been scarcely reported. In this work, we study the role of soybean and fish oil lipid commercial emulsions on inflammatory and profibrotic liver markers in adults with long term PNALD and in in vitro cellular models. Inflammatory and profibrotic markers were measured in serum of ten adults with long term PNALD and in culture supernatants of monocytes. Liver epithelial to mesenchymal transition (EMT) was induced by transforming growth factor beta 1 (TGF beta 1) to evaluate in vitro liver fibrosis. Omegaven (R), a 100% fish oil commercial emulsion, was infused during four months in two patients with severe long term PNALD reversing, at the first month, the inflammatory, profibrotic and clinical parameters of PNALD. The effect was maintained during the treatment course but impaired when conventional lipid emulsions were reintroduced. The other patients under chronic soybean oil-based PN showed elevated inflammatory and profibrotic parameters. In vitro human monocytes stimulated with lipopolysaccharide induced a strong inflammatory response that was suppressed by Omegaven (R), but increased by soybean emulsions. In other experiments, TGFb1 induced EMT that was suppressed by Omegaven (R) and enhanced by soybean oil lipid emulsions. Omegaven (R) improves clinical, anti-inflammatory and anti-fibrotic parameters in adults with long-term home PNALD.	[Pastor-Clerigues, Alfonso; Marti-Bonmati, Ezequiel; Milara, Javier] Univ Gen Hosp Consortium, Hosp Pharm, Clin Nutr Unit, Valencia, Spain; [Milara, Javier; Cortijo, Julio] Univ Gen Hosp Consortium, Clin Res Unit UIC, Valencia, Spain; [Milara, Javier; Cortijo, Julio] Gen Hosp Valencia, Res Fdn, Valencia, Spain; [Almudever, Patricia; Cortijo, Julio] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain; [Milara, Javier; Cortijo, Julio] CIBERES, Hlth Inst Carlos III, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Milara, J (corresponding author), Univ Gen Hosp Consortium, Hosp Pharm, Clin Nutr Unit, Valencia, Spain.	xmilara@hotmail.com		MILARA, JAVIER/0000-0001-6033-4211	proyecots de investigacion fundamental no orientada (SAF) [2011-26443]; fondo de investigaciones sanitarias (FIS) [CP11/00293]; centro de investigacion biomedica en red de enfermedades respiratorias (CIBERES) [CB06/06/0027]; Spanish Government [ADE10/00020]; Regional Government Prometeo "Generalitat Valenciana" [II/2013/014]; "centro para el desarrollo tecnologico e industrial (CENIT)'' programme (Spanish Government)	proyecots de investigacion fundamental no orientada (SAF); fondo de investigaciones sanitarias (FIS)(Instituto de Salud Carlos III); centro de investigacion biomedica en red de enfermedades respiratorias (CIBERES); Spanish Government(Spanish GovernmentEuropean Commission); Regional Government Prometeo "Generalitat Valenciana"; "centro para el desarrollo tecnologico e industrial (CENIT)'' programme (Spanish Government)	This work was supported by grants from "proyecots de investigacion fundamental no orientada (SAF) 2011-26443 (JC)'', "fondo de investigaciones sanitarias (FIS) CP11/00293(JM)'', "centro de investigacion biomedica en red de enfermedades respiratorias (CIBERES) CB06/06/0027'', Spanish Government ADE10/00020 (JC), as well as research grants from Regional Government Prometeo II/2013/014 (JC, JM) "Generalitat Valenciana.'' Support from the "centro para el desarrollo tecnologico e industrial (CENIT)'' programme (Spanish Government) was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bianchini F, 2012, BRIT J NUTR, V108, P2129, DOI 10.1017/S0007114512000359; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Burns DL, 2013, JPEN-PARENTER ENTER, V37, P274, DOI 10.1177/0148607112450301; Carter BA, 2007, SEMIN LIVER DIS, V27, P251, DOI 10.1055/s-2007-985070; Cavicchi M, 2000, ANN INTERN MED, V132, P525, DOI 10.7326/0003-4819-132-7-200004040-00003; Chan S, 1999, SURGERY, V126, P28, DOI 10.1067/msy.1999.98925; Chen WJ, 2003, NUTRITION, V19, P275, DOI 10.1016/S0899-9007(02)01009-2; CLAYTON PT, 1993, GASTROENTEROLOGY, V105, P1806, DOI 10.1016/0016-5085(93)91079-W; Dudrick SJ, 2003, JPEN-PARENTER ENTER, V27, P291, DOI 10.1177/0148607103027004291; Fermino ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026004; Galbois A, 2009, HEPATOLOGY, V49, P175, DOI 10.1002/hep.22582; Goulet O, 2009, CURR OPIN ORGAN TRAN, V14, P256, DOI 10.1097/MOT.0b013e32832ac06f; Hasegawa T, 2001, ALIMENT PHARM THERAP, V15, P1667, DOI 10.1046/j.1365-2036.2001.01083.x; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kelly DA, 1998, NUTRITION, V14, P153, DOI 10.1016/S0899-9007(97)00232-3; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le HD, 2010, JPEN-PARENTER ENTER, V34, P477, DOI 10.1177/0148607110371806; Leber B, 2009, WIEN KLIN WOCHENSCHR, V121, P732, DOI 10.1007/s00508-009-1288-2; Lee S, 2007, HEPATOLOGY, V45, P841, DOI 10.1002/hep.21645; Mercer DF, 2013, J PEDIATR GASTR NUTR, V56, P364, DOI 10.1097/MPG.0b013e31827e208c; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Puiggros C, 2009, JPEN-PARENTER ENTER, V33, P501, DOI 10.1177/0148607109333001; Raptis DA, 2014, J HEPATOL, V60, P625, DOI 10.1016/j.jhep.2013.11.006; Sala-Vila A, 2007, CURR OPIN CLIN NUTR, V10, P165, DOI 10.1097/MCO.0b013e32802bf787; Segovia-Silvestre T, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-19; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; Soden JS, 2010, J PEDIATR-US, V156, P327, DOI 10.1016/j.jpeds.2009.08.033; Strandberg K, 2010, PULM PHARMACOL THER, V23, P316, DOI 10.1016/j.pupt.2010.03.004; Suri S, 2008, BIOCHEM PHARMACOL, V76, P645, DOI 10.1016/j.bcp.2008.06.010; Valdes F, 2002, MOL CANCER RES, V1, P68; Vanek VW, 2012, NUTR CLIN PRACT, V27, P150, DOI 10.1177/0884533612439896; Venecourt-Jackson E, 2013, NUTRITION, V29, P356, DOI 10.1016/j.nut.2012.07.009; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Xu ZW, 2012, CLIN NUTR, V31, P217, DOI 10.1016/j.clnu.2011.10.001; Xue ZF, 2013, WORLD J GASTROENTERO, V19, P1380, DOI 10.3748/wjg.v19.i9.1380; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	42	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115404	10.1371/journal.pone.0115404	http://dx.doi.org/10.1371/journal.pone.0115404			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502575	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400093
J	Song, J; Shen, YJ; Zhang, J; Lian, QQ				Song, Jing; Shen, Yenji; Zhang, Jing; Lian, Qingquan			Mini Profile of Potential Anticancer Properties of Propofol	PLOS ONE			English	Article							CARCINOMA-CELLS; CANCER-CELLS; INHIBITS INVASION; RAS MUTATIONS; LUNG-CANCER; APOPTOSIS; PATHWAY; ACTIVATION; EXPRESSION; RAS/RAF/MEK/ERK	Background: Propofol (2, 6-diisopropylphenol) is an intravenous sedative-hypnotic agent administered to induce and maintain anesthesia. It has been recently revealed that propofol has anticancer properties including direct and indirect suppression of the viability and proliferation of cancer cells by promoting apoptosis in some cancer cell lines. Methodology/Principal Findings: This study aimed to establish a profile to quantitatively and functionally evaluate the anticancer properties of propofol in three cancer cell lines: non-small cell lung carcinoma cell line A549, human colon carcinoma cell line LoVo, and human breast cancer cell line SK-BR-3. We demonstrated that the expression level of caspase-3, an apoptosis biomarker, significantly increased in a dose-dependent manner after 24-h stimulation with 100 mu M propofol in A549 cells, and slightly increased in LoVo cells. However, there was no change in caspase-3 expression in SK-BR-3 cells. High caspase-3 expression in A549 cells may be modulated by the ERK1/2 pathway because phosphorylated ERK1/2 dramatically reduced after propofol treatment. BAX, a major protein that promotes apoptosis in the regulation phase, was highly expressed in A549 cells after treatment with 25 mM propofol. Apoptosis induced by propofol may be associated with cancer cells carrying Kras mutations. Conclusions/Significance: Our results suggest that the anti-cancer effects of propofol, which are consistent with those of previous studies, are likely associated with the Kras mutation status. Only Kras mutation in Codon 12 instead of other Kras status has been demonstrated to play an important role in sensitizing the propofol-induced apoptosis in cancer cell lines from our study. These findings may enable us a detailed investigation of propofol/Kras-mediated cancer cell apoptosis in the future.	[Song, Jing] Montefiore Med Ctr, Dept Anesthesiol, New York, NY 10029 USA; [Shen, Yenji; Zhang, Jing; Lian, Qingquan] Wenzhou Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Wenzhou, Zhejiang, Peoples R China; [Shen, Yenji; Zhang, Jing; Lian, Qingquan] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China	Montefiore Medical Center; Wenzhou Medical University; Wenzhou Medical University	Song, J (corresponding author), Montefiore Med Ctr, Dept Anesthesiol, New York, NY 10029 USA.	jsong@montefiore.org			National Nature Science Foundation of China, NSFC [81271469]; National Science Foundation of Zhejiang Province [Z2101211]	National Nature Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); National Science Foundation of Zhejiang Province	Dr. Lian received the following two funds for this study. 1) National Nature Science Foundation of China, NSFC (81271469) and 2) National Science Foundation of Zhejiang Province (Z2101211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetts Paul S, 2010, AANA J, V78, P237; Boch C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002560; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chiu WT, 2009, CHEM-BIOL INTERACT, V181, P430, DOI 10.1016/j.cbi.2009.06.011; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duldulao MP, 2013, ANN SURG ONCOL, V20, P2166, DOI 10.1245/s10434-013-2910-0; Gibson LF, 1999, BREAST CANCER RES TR, V55, P107, DOI 10.1023/A:1006175811676; Gu J, 2013, INT J MED SCI, V10, P599, DOI 10.7150/ijms.5151; Homburger JA, 2006, CURR OPIN ANESTHESIO, V19, P423, DOI 10.1097/01.aco.0000236143.61593.14; Huang H, 2014, BRIT J CANCER, V111, P1338, DOI 10.1038/bjc.2014.426; Kushida A, 2007, IMMUNOPHARM IMMUNOT, V29, P477, DOI 10.1080/08923970701675085; Lalier L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-153; Lee JY, 2010, KOREAN J ANESTHESIOL, V58, P277, DOI 10.4097/kjae.2010.58.3.277; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Mammoto T, 2002, CANCER LETT, V184, P165, DOI 10.1016/S0304-3835(02)00210-0; Melamed R, 2003, ANESTH ANALG, V97, P1331, DOI 10.1213/01.ANE.0000082995.44040.07; Miao YF, 2010, BIOMED PHARMACOTHER, V64, P583, DOI 10.1016/j.biopha.2010.03.006; Ren XF, 2010, ANAESTHESIA, V65, P478, DOI 10.1111/j.1365-2044.2010.06304.x; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schmitz KJ, 2007, VIRCHOWS ARCH, V450, P151, DOI 10.1007/s00428-006-0342-y; Siddiqui RA, 2005, BREAST CANCER RES, V7, pR645, DOI 10.1186/bcr1036; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Takamochi K, 2013, ONCOL LETT, V6, P1207, DOI 10.3892/ol.2013.1551; Tsuchiya M, 2002, ACTA ANAESTH SCAND, V46, P1068, DOI 10.1034/j.1399-6576.2002.460903.x; VACHTENHEIM J, 1995, CLIN CANCER RES, V1, P359; Wada H, 2007, ANESTHESIOLOGY, V106, P499, DOI 10.1097/00000542-200703000-00014; Xu YB, 2013, EUR REV MED PHARMACO, V17, P2486; Zhang J, 2013, CELL BIOL INT, V37, P227, DOI 10.1002/cbin.10034; Zhang LM, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-66	32	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114440	10.1371/journal.pone.0114440	http://dx.doi.org/10.1371/journal.pone.0114440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502773	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700025
J	Tiwari, P; Danish, S; Madabhushi, A				Tiwari, Pallavi; Danish, Shabbar; Madabhushi, Anant			Identifying MRI Markers Associated with Early Response following Laser Ablation for Neurological Disorders: Preliminary Findings	PLOS ONE			English	Article							THERMAL THERAPY LITT; PROSTATE-CANCER; GLIOBLASTOMA-MULTIFORME; INDUCED THERMOTHERAPY; BREAST-CANCER; BRAIN; STANDARDIZATION; BIOMARKERS; CRITERIA; LESIONS	There is a renewed interest in MR-guided laser interstitial thermal therapy (LITT) as a minimally invasive alternative to craniotomy for local treatment of various brain tumors and epilepsy. LITT allows for focused delivery of laser energy monitored in real time by MRI, for precise ablation of the lesion. Although highly promising, the long-term effects of laser ablation as a viable treatment option for neurological disorders have yet to be rigorously studied and quantified. In this work, we present a quantitative framework for monitoring per-voxel thermal-induced changes post-LITT over time on multi parametric MRI. We demonstrate that voxel-by-voxel quantification of MRI markers over time can enable a careful and accurate (a) characterization of early LITT-related changes (if and when they are exaggerated and when they subside), and (b) identification and monitoring of MRI markers that potentially allow for better quantification of response to LITT therapy. The framework was evaluated on two distinct cohorts of patients (GBM, epilepsy), who were monitored post-LITT at regular time-intervals via multi-parametric MRI. On a cohort of six GBM studies we found that (a) it may be important for the initial treatment-related changes to subside to more reliably capture MRI markers relating to tumor recurrence, and (b) T1w MRI and T2-GRE may better differentiate changes that may correspond to tumor recurrence from patients with no recurrence, as compared to T2w-MRI, and FLAIR. Similarly, our preliminary analysis of four epilepsy studies suggests that (a) early LITT changes (attributed to swelling, edema) appear to subside within 4-weeks post-LITT, and (b) ADC may be more reflective of early treatment changes (up to 1 month), while T1w may be more reflective of early delayed treatment changes (1 month, 3 months), while T2-w and T2-FLAIR appeared to be more sensitive to late treatment related changes (6-months post-LITT) compared to the other MRI protocols under evaluation.	[Tiwari, Pallavi; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Danish, Shabbar] Rutgers RWJ Med Sch, Div Neurosurg, New Brunswick, NJ USA	Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Tiwari, P (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	pxt130@case.edu	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399	National Cancer Institute of the Coulter Translational Award [RES508406]; National Institutes of Health [R01CA136535-01, R01CA140772-01, R21CA167811-01, R21CA179327-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE [R01CA140772, R21CA179327, R01CA136535, R21CA167811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the Coulter Translational Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the Coulter Translational Award (RES508406), National Institutes of Health under award numbers R01CA136535-01, R01CA140772-01, R21CA167811-01, R21CA179327-01; the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the Ohio Third Frontier Technology development Grant, the CTSC Coulter Annual Pilot Grant, and the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M, 2006, PATTERN RECOGNITION; Carpentier A, 2002, MED LASER APPL, V17, P147; Carpentier A, 2008, NEUROSURGERY, V63, P21, DOI [10.1227/01.NEU.0000311254.63848.72, 10.1227/01.neu.0000335007.07381.df]; Carpentier A, 2012, LASER SURG MED, V44, P361, DOI 10.1002/lsm.22025; Chan YL, 1999, RADIOLOGY, V213, P800, DOI 10.1148/radiology.213.3.r99dc07800; Curry DJ, 2012, EPILEPSY BEHAV, V24, P408, DOI 10.1016/j.yebeh.2012.04.135; Engel J., 1993, WHO SHOULD BE SURG C; Foltz WD, 2013, J MAGN RESON IMAGING, V37, P909, DOI 10.1002/jmri.23885; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jamin Y, 2013, RADIOLOGY, V266, P130, DOI 10.1148/radiol.12120128; Jethwa PR, 2012, NEUROSURGERY, V71, P133, DOI 10.1227/NEU.0b013e31826101d4; Khayal IS, 2010, NEURO-ONCOLOGY, V12, P908, DOI 10.1093/neuonc/noq049; King AD, 2013, AM J NEURORADIOL, V34, P1237, DOI 10.3174/ajnr.A3378; Li X, 2014, TRANSL ONCOL, V7, P14, DOI 10.1593/tlo.13748; Ma B, 2009, LECT NOTES COMPUT SC, V5636, P276; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Mavroidis P, 2011, MED PHYS, V38, P2382, DOI 10.1118/1.3570613; Morrison PR, 1998, JMRI-J MAGN RESON IM, V8, P57, DOI 10.1002/jmri.1880080114; MullerLisse GU, 1996, RADIOLOGE, V36, P722, DOI 10.1007/s001170050134; Nasseri M, 2014, NEURO-ONCOLOGY, V16, P1146, DOI 10.1093/neuonc/not328; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Patel NV, 2013, LASER SURG MED, V45, P362, DOI 10.1002/lsm.22151; Schulze PC, 2004, ACTA NEUROCHIR, V146, P803, DOI 10.1007/s00701-004-0293-5; Schwabe B, 1997, J COMPUT ASSIST TOMO, V21, P818, DOI 10.1097/00004728-199709000-00031; Schwarzmaier HJ, 2006, EUR J RADIOL, V59, P208, DOI 10.1016/j.ejrad.2006.05.010; Sloan AE, 2013, J NEUROSURG, V118, P1202, DOI 10.3171/2013.1.JNS1291; Spath H., 2004, Mathematical Communications, V9, P27; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Thiesse P, 1997, J CLIN ONCOL, V15, P3507, DOI 10.1200/JCO.1997.15.12.3507; Tiwari P, 2012, NMR BIOMED, V25, P607, DOI 10.1002/nbm.1777; Tiwari P, 2013, MED IMAGE ANAL, V17, P219, DOI 10.1016/j.media.2012.10.004; Tiwari P, 2011, LECT NOTES COMPUT SC, V6963, P80, DOI 10.1007/978-3-642-23944-1_9; Verma R, 2008, ACAD RADIOL, V15, P966, DOI 10.1016/j.acra.2008.01.029; Wolz R, 2012, MED IMAGE ANAL, V16, P819, DOI 10.1016/j.media.2011.12.003	36	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114293	10.1371/journal.pone.0114293	http://dx.doi.org/10.1371/journal.pone.0114293			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503713	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700020
J	Zhang, XB; Jiang, XT; Du, YP; Yuan, YT; Chen, B				Zhang, Xiao-Bin; Jiang, Xing-Tang; Du, Yan-Ping; Yuan, Ya-Ting; Chen, Bo			Efficacy of Continuous Positive Airway Pressure on Testosterone in Men with Obstructive Sleep Apnea: A Meta-Analysis	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; SEXUAL FUNCTION; OBESE MEN; HYPOGONADISM; SECRETION; QUALITY	Objective: To evaluate the efficacy of continuous positive airway pressure (CPAP) on serum testosterone in men with obstructive sleep apnea (OSA). Methods: Two reviewers independently searched PubMed, Cochrane library, Embase and Web of Science before June 2014. Information on characteristics of subjects, study design, pre- and post-CPAP treatment of serum total testosterone, free testosterone and sexual hormone blinding protein (SHBG) was extracted for analysis. Results: A total of 7 studies with 9 cohorts that included 232 men were pooled into meta-analysis. There was no change of total testosterone levels before and after CPAP treatment in OSA men (standardized mean difference (SMD)= -0.14, 95% CI: -0.63 to 0.34, z = 0.59, p = 0.558), even subdivided by CPAP therapeutic duration (>3 months). Meanwhile, no significant differences in free testosterone and SHBG were detected after CPAP treatment (SMD = 0.16, 95% CI: -0.09 to 0.40, z = 1.25, p = 0.211 and SMD = -0.58, 95% CI: -1.30 to 0.14, z = 1.59, p = 0.112, respectively). Conclusion: CPAP has no influence on testosterone levels in men with OSA, further large-scale, well-design interventional investigation is needed.	[Zhang, Xiao-Bin; Jiang, Xing-Tang; Du, Yan-Ping; Yuan, Ya-Ting; Chen, Bo] Xiamen Univ, Zhongshan Hosp, Dept Resp Med, Xiamen, Peoples R China	Xiamen University	Zhang, XB (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Resp Med, Xiamen, Peoples R China.	zhangxiaobincn@126.com			Fujian Provincial Health Bureau [2013-2-88]	Fujian Provincial Health Bureau	This work was supported by grant 2013-2-88 for Youth Research Fund from Fujian Provincial Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahammam SA, 2011, RESP MED, V105, P1755, DOI 10.1016/j.rmed.2011.07.007; Bercea RM, 2015, CLIN RESPIR J, V9, P342, DOI 10.1111/crj.12150; Bratel T, 1999, RESP MED, V93, P1, DOI 10.1016/S0954-6111(99)90068-9; CAMARGO CA, 1983, NEW ENGL J MED, V309, P314; Canguven Onder, 2010, Arch Ital Urol Androl, V82, P143; Celec P, 2014, J ENDOCRINOL INVEST, V37, P9, DOI 10.1007/s40618-013-0003-3; CISTULLI PA, 1994, AM J RESP CRIT CARE, V149, P530, DOI 10.1164/ajrccm.149.2.8306057; Gambineri A, 2003, J ENDOCRINOL INVEST, V26, P493, DOI 10.1007/BF03345209; Giltay EJ, 2010, J SEX MED, V7, P2572, DOI 10.1111/j.1743-6109.2010.01859.x; Goncalves MA, 2005, SLEEP MED, V6, P333, DOI 10.1016/j.sleep.2005.03.001; GRUNSTEIN RR, 1989, J CLIN ENDOCR METAB, V68, P352, DOI 10.1210/jcem-68-2-352; Hoekema A, 2007, J SEX MED, V4, P1153, DOI 10.1111/j.1743-6109.2006.00341.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Karacan I, 1995, J SEX MARITAL THER, V21, P239, DOI 10.1080/00926239508414643; Knapp A, 2014, CLIN ENDOCRINOL, V81, P254, DOI 10.1111/cen.12401; Liao MZ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034085, 10.1371/journal.pone.0039234]; Liu P, 2011, J SLEEP RES, V20, P5; Liu PY, 2003, J CLIN ENDOCR METAB, V88, P3605, DOI 10.1210/jc.2003-030236; Luboshitzky R, 2005, OBES RES, V13, P780, DOI 10.1038/oby.2005.88; Luboshitzky R, 2003, NEUROENDOCRINOL LETT, V24, P463; Luboshitzky R, 2002, J CLIN ENDOCR METAB, V87, P3394, DOI 10.1210/jc.87.7.3394; Macrea MM, 2010, SLEEP BREATH, V14, P253, DOI 10.1007/s11325-010-0373-0; Meston N, 2003, J INTERN MED, V254, P447, DOI 10.1046/j.1365-2796.2003.01212.x; SANDBLOM RE, 1983, NEW ENGL J MED, V308, P508, DOI 10.1056/NEJM198303033080908; Suehiro M, 2014, ENDOCR PRACT, V20, p37A; Takeuchi S, 2015, SLEEP BREATH, V19, P85, DOI 10.1007/s11325-014-0966-0; Vgontzas AN, 2007, J CLIN ENDOCR METAB, V92, P4199, DOI 10.1210/jc.2007-0774; Vlkova B, 2014, ANDROLOGIA, V46, P386, DOI 10.1111/and.12092; White DP, 2005, AM J RESP CRIT CARE, V172, P1363, DOI 10.1164/rccm.200412-1631SO; Wittert G, 2012, ENDOCR REV, P33; Yassin DJ, 2014, J SEX MED, V11, P1567, DOI 10.1111/jsm.12523; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhuravlev VN, 2009, ANDROLOGIA, V41, P193, DOI 10.1111/j.1439-0272.2008.00914.x	33	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115033	10.1371/journal.pone.0115033	http://dx.doi.org/10.1371/journal.pone.0115033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503098	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700086
J	Zhao, YQ; Zhao, M; Li, XM; Ma, XC; Zheng, QH; Chen, XS; Lin, YW; Cai, YF				Zhao, Yuanqi; Zhao, Min; Li, Xiaomin; Ma, Xiancong; Zheng, Qinghao; Chen, Xiaosheng; Lin, Yinwing; Cai, Yefeng			The Predictive Value of the Boston Acute Stroke Imaging Scale (BASIS) in Acute Ischemic Stroke Patients among Chinese Population	PLOS ONE			English	Article							MODIFIED-RANKIN-SCALE; OF-HEALTH STROKE; INTRACRANIAL ATHEROSCLEROSIS; ALBERTA STROKE; GLOBAL BURDEN; SCORE; OUTCOMES; REHABILITATION; PREVALENCE; OCCLUSION	Objective: Evaluate the predictive value of Boston Acute Stroke Imaging Scale (BASIS) in acute ischemic stroke in Chinese population. Methods: This was a retrospective study. 566 patients of acute ischemic stroke were classified as having a major stroke or minor stroke based on BASIS. We compared short-term outcome (death, occurrence of complications, admission to intensive care unit [ICU] or neurological intensive care unit [NICU]), long-term outcome (death, recurrence of stroke, myocardial infarction, modified Rankin scale) and economic index including in-hospital cost and length of hospitalization. Continuous variables were compared by using the Student t test or Kruskal-Wallis test. Categorical variables were tested with the Chisquare test. Cox regression analysis was applied to identify whether BASIS was the independent predictive variable of death. Results: During hospitalization, 9 patients (4.6%) died in major stroke group while no patients died in minor stroke group (p < 0.001), 12 patients in the major stroke group and 5 patients in minor stroke group were admitted to ICU/NICU (p=0.001). There were more complications (cerebral hernia, pneumonia, urinary tract infection) in major stroke group than minor stroke group (p < 0.05). Meanwhile, the average cost of hospitalization in major stroke group was 3,100 US$ and 1,740 US$ in minor stroke group (p < 0.001); the average length of stay in major and minor stroke group was 21.3 days and 17.3 days respectively (p < 0.001). Results of the follow-up showed that 52 patients (26.7%) died in major stroke group while 56 patients (15.1%) died in minor stroke group (P < 0.001). 62.2% of the patients in major stroke group and 80.4% of the patients in minor stroke group were able to live independently (P=0.002). The survival analysis showed that patients with major stroke had 80% higher of risk of death than patients with minor stroke even after adjusting traditional atherosclerotic factors and NIHSS at baseline (HR=1.8, 95% CI: 1.1-3.1). Conclusion: BASIS can predict in-hospital mortality, occurrence of complication, length of stay and hospitalization cost of the acute ischemic stroke patients and can also estimate the long term outcome (death and the dependency). BASIS could and should be used as a dichotomous stroke classification system in the daily practice.	[Zhao, Yuanqi; Cai, Yefeng] Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhao, Min] Southern Med Univ, Natl Clin Res Ctr Kidney Dis, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Li, Xiaomin] JiangmenWuyi Tradit Chinese Med Hosp, Dept Neurol, Jiangmen, Guangdong, Peoples R China; [Ma, Xiancong] Yue Bei Peoples Hosp, Dept Neurol, Shaoguan, Guangdong, Peoples R China; [Zheng, Qinghao] Meizhou Municipal Hosp Tradit Chinese Med, Dept Internal Med, Meizhou, Guangdong, Peoples R China; [Chen, Xiaosheng] Kang Mei Hosp, Dept Neurol, Jieyang, Guangdong, Peoples R China; [Lin, Yinwing] Chinese Univ Hong Kong, Kwong Wah Hosp, Chinese Med Clin Res & Serv Ctr, Dept Chinese Med, Hong Kong, Hong Kong, Peoples R China	Guangzhou University of Chinese Medicine; Southern Medical University - China; Chinese University of Hong Kong; Kwong Wah Hospital	Cai, YF (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	caiyefeng@126.com		zhao, yuanqi/0000-0003-1254-6732	Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China [200707004]; Finance Department of Guangdong Province [[2006] 143]	Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China; Finance Department of Guangdong Province	This work was supported by the Scientific Research Project of Public Welfare Industry, State Administration of Traditional Chinese Medicine of P. R. of China (No. 200707004); and the Finance Department of Guangdong Province (No. [2006] 143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird AE, 2001, LANCET, V357, P2095, DOI 10.1016/S0140-6736(00)05183-7; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Caplan LR, 2004, JAMA-J AM MED ASSOC, V292, P1883, DOI 10.1001/jama.292.15.1883; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Cipriano LE, 2009, AM J NEURORADIOL, V30, P703, DOI 10.3174/ajnr.A1441; Elwood D, 2009, PM&R, V1, P147, DOI 10.1016/j.pmrj.2008.10.010; Ghandehari K, 2013, J RES MED SCI, V18, P906; Gonzalez RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030352; Heldner MR, 2013, STROKE, V44, P1153, DOI 10.1161/STROKEAHA.111.000604; Hill MD, 2014, STROKE, V45, P444, DOI 10.1161/STROKEAHA.113.003580; Huybrechts KF, 2008, CEREBROVASC DIS, V26, P381, DOI 10.1159/000151678; Huybrechts KF, 2007, CURR MED RES OPIN, V23, P1627, DOI 10.1185/030079907X210444; Linfante I, 2001, ARCH NEUROL-CHICAGO, V58, P621, DOI 10.1001/archneur.58.4.621; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Liu XD, 2007, CLIN NEUROL NEUROSUR, V109, P571, DOI 10.1016/j.clineuro.2007.05.008; Maas MB, 2009, STROKE, V40, P2988, DOI 10.1161/STROKEAHA.109.555664; Mahoney FI, 1965, MD STATE MED J; Merino JG, 2008, NAT CLIN PRACT NEURO, V4, P592, DOI 10.1038/ncpneuro0919; Pexman JHW, 2001, AM J NEURORADIOL, V22, P1534; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Quinn TJ, 2009, INT J STROKE, V4, P200, DOI 10.1111/j.1747-4949.2009.00271.x; Rockman CB, 2013, J VASC SURG, V57, P327, DOI 10.1016/j.jvs.2012.08.118; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Sillanpaa N, 2012, NEURORADIOLOGY, V54, P663, DOI 10.1007/s00234-011-0954-z; Torres-Mozqueda F, 2008, AM J NEURORADIOL, V29, P1111, DOI 10.3174/ajnr.A1000; Vora NA, 2011, STROKE, V42, P645, DOI 10.1161/STROKEAHA.110.596312; Wade D T, 1988, Int Disabil Stud, V10, P64; WADE DT, 1992, CURR OPIN NEUROL NEU, V5, P682; Wang YJ, 2014, STROKE, V45, P663, DOI 10.1161/STROKEAHA.113.003508; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Xu GL, 2007, CEREBROVASC DIS, V23, P117, DOI 10.1159/000097047; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1	32	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2014	9	12							e113967	10.1371/journal.pone.0113967	http://dx.doi.org/10.1371/journal.pone.0113967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3ZY	25531102	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845100006
J	Flower, A; Gavin, DG; Heyerdahl, EK; Parsons, RA; Cohn, GM				Flower, Aquila; Gavin, Daniel G.; Heyerdahl, Emily K.; Parsons, Russell A.; Cohn, Gregory M.			Western Spruce Budworm Outbreaks Did Not Increase Fire Risk over the Last Three Centuries: A Dendrochronological Analysis of Inter-Disturbance Synergism	PLOS ONE			English	Article							PINE-BEETLE OUTBREAKS; TREE-RING RECONSTRUCTION; ACTIVE CROWN FIRE; SUB-ALPINE FOREST; MOUNTAIN PINE; STAND DYNAMICS; CLIMATE; WILDFIRE; MORTALITY; HISTORY	Insect outbreaks are often assumed to increase the severity or probability of fire occurrence through increased fuel availability, while fires may in turn alter susceptibility of forests to subsequent insect outbreaks through changes in the spatial distribution of suitable host trees. However, little is actually known about the potential synergisms between these natural disturbances. Assessing inter-disturbance synergism is challenging due to the short length of historical records and the confounding influences of land use and climate changes on natural disturbance dynamics. We used dendrochronological methods to reconstruct defoliator outbreaks and fire occurrence at ten sites along a longitudinal transect running from central Oregon to western Montana. We assessed synergism between disturbance types, analyzed long-term changes in disturbance dynamics, and compared these disturbance histories with dendroclimatological moisture availability records to quantify the influence of moisture availability on disturbances. After approximately 1890, fires were largely absent and defoliator outbreaks became longer-lasting, more frequent, and more synchronous at our sites. Fires were more likely to occur during warm-dry years, while outbreaks were most likely to begin near the end of warm-dry periods. Our results show no discernible impact of defoliation events on subsequent fire risk. Any effect from the addition of fuels during defoliation events appears to be too small to detect given the overriding influence of climatic variability. We therefore propose that if there is any relationship between the two disturbances, it is a subtle synergistic relationship wherein climate determines the probability of occurrence of each disturbance type, and each disturbance type damps the severity, but does not alter the probability of occurrence, of the other disturbance type over long time scales. Although both disturbance types may increase in frequency or extent in response to future warming, our records show no precedent that western spruce budworm outbreaks will increase future fire risk.	[Flower, Aquila; Gavin, Daniel G.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA; [Heyerdahl, Emily K.; Parsons, Russell A.; Cohn, Gregory M.] US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT 59808 USA	University of Oregon; United States Department of Agriculture (USDA); United States Forest Service	Flower, A (corresponding author), Univ Oregon, Dept Geog, 1251 Univ Oregon, Eugene, OR 97403 USA.	Aquila.Flower@wwu.edu	Gavin, Daniel G/C-9214-2009	Gavin, Daniel G/0000-0001-8743-3949	United States Department of Agriculture Joint Fire Science Program [09-1-06-5]; Mazamas Foundation; Doctoral Dissertation Research Improvement grant from the National Science Foundation [1233278]; Rocky Mountain Research Station (Forest Service, U.S. Department of Agriculture) [09-JV-11221637]; University of Oregon	United States Department of Agriculture Joint Fire Science Program; Mazamas Foundation; Doctoral Dissertation Research Improvement grant from the National Science Foundation; Rocky Mountain Research Station (Forest Service, U.S. Department of Agriculture)(United States Department of Agriculture (USDA)United States Forest Service); University of Oregon	This research was supported in part by funds provided by the United States Department of Agriculture Joint Fire Science Program as Project 09-1-06-5 (firescience.gov); funding for AF, DG, EH, RP, and GC. AF was also funded through a Graduate Student Research Grant from the Mazamas Foundation (mazamasfoundation.org) and a Doctoral Dissertation Research Improvement grant (#1233278) from the National Science Foundation (nsf.gov). This research was undertaken with support from the Rocky Mountain Research Station (Forest Service, U.S. Department of Agriculture) under Research Joint Venture Agreement 09-JV-11221637 and the University of Oregon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; ALFARO RI, 1982, CAN J FOREST RES, V12, P780, DOI 10.1139/x82-117; ANDERSON L, 1987, FOREST ECOL MANAG, V22, P251, DOI 10.1016/0378-1127(87)90109-5; Andrews P.L., 2008, BEHAVEPLUS FIRE MODE; [Anonymous], 1968, TREE RING DATING; Arno S.F., 1976, INT187 USDA FOR SERV; Arno SF, 2000, US FOR SERV RMRS-P, P97; Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Belsky AJ, 1997, CONSERV BIOL, V11, P315, DOI 10.1046/j.1523-1739.1997.95405.x; Bigler C, 2007, OIKOS, V116, P1983, DOI 10.1111/j.2007.0030-1299.16034.x; Black SH, 2013, NAT AREA J, V33, P59, DOI 10.3375/043.033.0107; Borman MM, 2005, CONSERV BIOL, V19, P1658, DOI 10.1111/j.1523-1739.2005.00115.x; Bulaon B, 2006, 0607 USDA FOR SERV; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Campbell R, 2006, CAN J FOREST RES, V36, P1758, DOI 10.1139/X06-069; Carolin VM, 1987, FOREST SERVICE TECHN, V1694, P29; Cohn GM, 2014, INT J WILDLAND FIRE, V23, P709, DOI 10.1071/WF13074; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Covington W. W., 1994, Journal of Sustainable Forestry, V2, P13, DOI 10.1300/J091v02n01_02; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Fellin D.G., 1982, W SPRUCE BUDWORM, V53; Ferrell G. T., 1982, PSW164 USDA FOR SERV; Fleming RA, 2002, CLIMATIC CHANGE, V55, P251, DOI 10.1023/A:1020299422491; Flower A, 2014, FOREST ECOL MANAG, V324, P16, DOI 10.1016/j.foreco.2014.03.042; Furyaev V.V., 1983, BARK BEETLES FUELS F, V116; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Grissino-Mayer H.D., 2001, TREE RES, V57, P115; Heppner D., 2006, BC Journal of Ecosystems and Management, V7, P45; Hessburg P. F., 1994, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Hessburg PF, 2007, LANDSCAPE ECOL, V22, P5, DOI 10.1007/s10980-007-9098-2; Heyerdahl E. K., 1997, THESIS U WASHINGTON; Heyerdahl EK, 2001, ECOLOGY, V82, P660, DOI 10.1890/0012-9658(2001)082[0660:SCOHFR]2.0.CO;2; Heyerdahl EK, 2008, ECOLOGY, V89, P705, DOI 10.1890/06-2047.1; Heyerdahl EK, 2008, INT J WILDLAND FIRE, V17, P40, DOI 10.1071/WF07024; Heyerdahl EK, 2006, FOREST ECOL MANAG, V230, P107, DOI 10.1016/j.foreco.2006.04.024; Hicke JA, 2012, FOREST ECOL MANAG, V271, P81, DOI 10.1016/j.foreco.2012.02.005; Hoffman C, 2012, FOREST SCI, V58, P178, DOI 10.5849/forsci.10-137; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hummel S, 2003, NORTHWEST SCI, V77, P159; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Jenkins MJ, 2012, FOREST ECOL MANAG, V275, P23, DOI 10.1016/j.foreco.2012.02.036; Jolly WM, 2012, ECOLOGY, V93, P941; Jolly WM, 2012, FOREST ECOL MANAG, V269, P52, DOI 10.1016/j.foreco.2011.12.022; Keane R., 2002, ROCKY MOUNTAIN RES S, P24; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Kulakowski D, 2003, J BIOGEOGR, V30, P1445, DOI 10.1046/j.1365-2699.2003.00912.x; Kulakowski D, 2011, FOREST ECOL MANAG, V262, P1686, DOI 10.1016/j.foreco.2011.07.016; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Little E.L, 1971, ATLAS US TREES VOLUM, V1, P1146, DOI DOI 10.5962/BHL.TITLE.130546; Lynch HJ, 2008, CAN J FOREST RES, V38, P3112, DOI 10.1139/X08-143; Maclauchlan Lorraine E., 2009, British Columbia Journal of Ecosystems and Management, V10, P37; Marlon JR, 2012, P NATL ACAD SCI USA, V109, pE535, DOI 10.1073/pnas.1112839109; Maruoka KR, 1994, THESIS U WASHINGTON; McCullough DG, 1998, ANNU REV ENTOMOL, V43, P107, DOI 10.1146/annurev.ento.43.1.107; McKenzie D, 2011, ECOL STUD-ANAL SYNTH, V213, P3, DOI 10.1007/978-94-007-0301-8_1; Mote PW, 2010, CLIMATIC CHANGE, V102, P29, DOI 10.1007/s10584-010-9848-z; Mote PW, 2003, TRENDS TEMPERATURE P; Murdock TQ, 2013, ENVIRON SCI POLICY, V26, P75, DOI 10.1016/j.envsci.2012.07.026; Page W, 2007, FOREST SCI, V53, P662; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parker TJ, 2006, AGR FOREST ENTOMOL, V8, P167, DOI 10.1111/j.1461-9563.2006.00305.x; Perry DA, 2011, FOREST ECOL MANAG, V262, P703, DOI 10.1016/j.foreco.2011.05.004; Pickett S.T.A., 1985, SCIENCE, DOI DOI 10.1126/SCIENCE.230.4724.434; Powell D, 1994, EFFECTS 1980S W SPRU; Powell EN, 2012, ECOL MONOGR, V82, P69, DOI 10.1890/11-0607.1; Preisler Haiganoush K., 2010, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P371; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Ryerson DE, 2003, CAN J FOREST RES, V33, P1010, DOI 10.1139/X03-026; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Sokal R.R., 1994, BIOMETRY PRINCIPLES; STOCKS BJ, 1987, FOREST CHRON, V63, P8, DOI 10.5558/tfc63008-1; Sturtevant BR, 2012, ECOL APPL, V22, P1278, DOI 10.1890/11-0590.1; Swetnam T.W., 1995, PNWRP484 USDA FOR SE, DOI DOI 10.2737/PNW-RP-484; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; SWETNAM TW, 1993, ECOL MONOGR, V63, P399, DOI 10.2307/2937153; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; SWETNAM TW, 1989, FOREST SCI, V35, P962; Van Sickle G., 1987, W SPRUCE BUDWORM, P57; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2003, B AM METEOROL SOC, V84, P595, DOI 10.1175/BAMS-84-5-595; Williams CJ, 1971, PSWRP072 USDA FOR SE; ZOBEL DB, 1973, BOT GAZ, V134, P209, DOI 10.1086/336706	86	19	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114282	10.1371/journal.pone.0114282	http://dx.doi.org/10.1371/journal.pone.0114282			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526633	Green Published, gold			2022-12-27	WOS:000347186200004
J	Li, Q; Hua, SR; Wang, C; Cai, SY; Zhang, J				Li, Qiang; Hua, Surong; Wang, Chu; Cai, Siyi; Zhang, Jia			The Value of Routine Biopsy during Percutaneous Kyphoplasty for Vertebral Compression Fractures	PLOS ONE			English	Article							BALLOON KYPHOPLASTY; HISTOLOGICAL-EVALUATION; BONE-BIOPSY; OSTEOPOROSIS; VERTEBROPLASTY; EPIDEMIOLOGY; MYELOMA	Objective: Percutaneous kyphoplasty (PKP) is now widely performed to treat VCF, which is usually caused by osteoporosis. Previous researches have reported unsuspected malignancies found by biopsy. However, the safety and cost-effective profiles of routine biopsy during PKP are unclear. The purpose of this study was to evaluate the feasibility of routine biopsy during PKP in treatment of VCF. Methods: Ninety-three patients (September 2007-November 2010) undergoing PKP without biopsy were reviewed as the control group. One hundred and three consecutive patients (November 2010-September 2013) undergoing PKP with biopsy of every operated vertebral level were prospectively enrolled as the biopsy group. The rate of unsuspected lesions was reported, and the severe adverse events, surgical duration, cement leakage rate and pain control were compared between the two groups. Results: No statistically significant differences were found between the two groups, regarding the severe adverse events, surgical duration, cement leakage rate and pain control. Four unsuspected lesions were found in the biopsy group, three of which were malignancies with a 2.9% (3/103) unsuspected malignancy rate. The economic analysis showed that routine biopsy was cost-effective in finding new malignancies comparing with a routine cancer screening campaign. Conclusions: Routine biopsy during PKP was safe and cost-effective in finding unsuspected malignancies. We advocate routine biopsy in every operated vertebral level during PKP for VCF patients.	[Li, Qiang; Wang, Chu; Cai, Siyi; Zhang, Jia] Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China; [Hua, Surong] Beijing Union Med Coll Hosp, Dept Surg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, J (corresponding author), Beijing Union Med Coll Hosp, Dept Orthoped, Beijing, Peoples R China.	zhangjia3661@163.com	Cai, Siyi/AAL-6676-2020	Hua, Surong/0000-0003-3630-3954				Berenson J, 2011, LANCET ONCOL, V12, P225, DOI 10.1016/S1470-2045(11)70008-0; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Edidin AA, 2012, APPL HEALTH ECON HEA, V10, P273, DOI 10.2165/11633220-000000000-00000; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Ledlie JT, 2003, J NEUROSURG, V98, P36, DOI 10.3171/spi.2003.98.1.0036; Leslie WD, 2014, CURR OPIN RHEUMATOL, V26, P440, DOI 10.1097/BOR.0000000000000064; Li ZF, 2012, ASIAN PAC J CANCER P, V13, P3529, DOI 10.7314/APJCP.2012.13.7.3529; Ma XL, 2012, EUR SPINE J, V21, P1844, DOI 10.1007/s00586-012-2441-6; Muijs SPJ, 2009, SPINE, V34, P2395, DOI 10.1097/BRS.0b013e3181b8707e; Phekoo KJ, 2004, BRIT J HAEMATOL, V127, P299, DOI 10.1111/j.1365-2141.2004.05207.x; Phillips FM, 2003, SPINE, V28, P2260, DOI 10.1097/01.BRS.0000085092.84097.7B; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Schoenfeld AJ, 2008, INJURY, V39, P327, DOI 10.1016/j.injury.2007.06.019; Shindle MK, 2006, J BONE JOINT SURG AM, V88A, P2721, DOI 10.2106/JBJS.F.00100; Svedbom A, 2013, OSTEOPOROSIS INT, V24, P355, DOI 10.1007/s00198-012-2102-y; Togawa D, 2005, SPINE, V30, P781, DOI 10.1097/01.brs.0000157478.03349.57; Wardlaw D, 2009, LANCET, V373, P1016, DOI 10.1016/S0140-6736(09)60010-6; Zhang L, 2013, ONCOL LETT, V5, P135, DOI 10.3892/ol.2012.944	19	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115417	10.1371/journal.pone.0115417	http://dx.doi.org/10.1371/journal.pone.0115417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526360	Green Submitted, gold, Green Published			2022-12-27	WOS:000347186200028
J	Raz, N; Danin-Poleg, Y; Hayman, RB; Bar-On, Y; Linetsky, A; Shmoish, M; Sanjuan, E; Amaro, C; Walt, DR; Kashi, Y				Raz, Nili; Danin-Poleg, Yael; Hayman, Ryan B.; Bar-On, Yudi; Linetsky, Alex; Shmoish, Michael; Sanjuan, Eva; Amaro, Carmen; Walt, David R.; Kashi, Yechezkel			Genome-Wide SNP-Genotyping Array to Study the Evolution of the Human Pathogen Vibrio vulnificus Biotype 3	PLOS ONE			English	Article							IDENTIFICATION; DIVERSITY; PCR; EPIDEMIOLOGY; POLYMORPHISM; INFECTIONS; STRAINS; PLASMID; GENE	Vibrio vulnificus is an aquatic bacterium and an important human pathogen. Strains of V. vulnificus are classified into three different biotypes. The newly emerged biotype 3 has been found to be clonal and restricted to Israel. In the family Vibrionaceae, horizontal gene transfer is the main mechanism responsible for the emergence of new pathogen groups. To better understand the evolution of the bacterium, and in particular to trace the evolution of biotype 3, we performed genome-wide SNP genotyping of 254 clinical and environmental V. vulnificus isolates with worldwide distribution recovered over a 30-year period, representing all phylogeny groups. A custom single-nucleotide polymorphism (SNP) array implemented on the Illumina GoldenGate platform was developed based on 570 SNPs randomly distributed throughout the genome. In general, the genotyping results divided the V. vulnificus species into three main phylogenetic lineages and an additional subgroup, clade B, consisting of environmental and clinical isolates from Israel. Data analysis suggested that 69% of biotype 3 SNPs are similar to SNPs from clade B, indicating that biotype 3 and clade B have a common ancestor. The rest of the biotype 3 SNPs were scattered along the biotype 3 genome, probably representing multiple chromosomal segments that may have been horizontally inserted into the clade B recipient core genome from other phylogroups or bacterial species sharing the same ecological niche. Results emphasize the continuous evolution of V. vulnificus and support the emergence of new pathogenic groups within this species as a recurrent phenomenon. Our findings contribute to a broader understanding of the evolution of this human pathogen.	[Raz, Nili; Danin-Poleg, Yael; Bar-On, Yudi; Linetsky, Alex; Kashi, Yechezkel] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Hayman, Ryan B.; Walt, David R.] Tufts Univ, Dept Chem, Medford, MA USA; [Shmoish, Michael] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, IL-32000 Haifa, Israel; [Sanjuan, Eva; Amaro, Carmen] Univ Valencia, Fac Biol, Dept Microbiol, Valencia, Spain	Technion Israel Institute of Technology; Tufts University; Technion Israel Institute of Technology; University of Valencia	Kashi, Y (corresponding author), Technion Israel Inst Technol, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.	kashi@techunix.technion.ac.il	Amaro, Carmen/K-7873-2014; Kashi, Yechezkel/GWC-2425-2022; sanjuan, Eva/B-1433-2014	Amaro, Carmen/0000-0003-1323-6330; sanjuan, Eva/0000-0001-7671-0779	NATO [CBD.MD.SFP 981456]; Environment and Health Fund's Interdisciplinary Research Fund (Israel) [RGA0804]; FEDER funds; Programa Consolider-Ingenio from MICINN (Spain) [CSD2009-00006];  [AGL2011-29639]	NATO(NATO (North Atlantic Treaty Organisation)); Environment and Health Fund's Interdisciplinary Research Fund (Israel); FEDER funds(European Commission); Programa Consolider-Ingenio from MICINN (Spain); 	This research was supported by NATO, Project CBD.MD.SFP 981456, by the Environment and Health Fund's Interdisciplinary Research Fund RGA0804 (Israel), by grants AGL2011-29639 (co-funded with FEDER funds) and Programa Consolider-Ingenio 2010 CSD2009-00006 from MICINN (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; AKHUNOV E, 2009, THEOR APPL GENET, V119, P507, DOI DOI 10.1007/s00122-009-1059-5; Amaro C, 1996, APPL ENVIRON MICROB, V62, P1454, DOI 10.1128/AEM.62.4.1454-1457.1996; Arias CR, 1998, APPL ENVIRON MICROB, V64, P3403; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Baker-Austin C, 2012, FOOD MICROBIOL, V30, P17, DOI 10.1016/j.fm.2011.09.002; Bier N, 2013, APPL ENVIRON MICROB, V79, P3570, DOI 10.1128/AEM.00477-13; Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Bisharat N, 1999, LANCET, V354, P1421, DOI 10.1016/S0140-6736(99)02471-X; Bisharat N, 2007, INFECT GENET EVOL, V7, P685, DOI 10.1016/j.meegid.2007.07.007; Bisharat N, 2007, MICROBIOL-SGM, V153, P847, DOI 10.1099/mic.0.2006/003723-0; Broza YY, 2007, J CLIN MICROBIOL, V45, P2951, DOI 10.1128/JCM.00236-07; Broza YY, 2012, INT J FOOD MICROBIOL, V153, P436, DOI 10.1016/j.ijfoodmicro.2011.12.011; Broza YY, 2009, EMERG INFECT DIS, V15, P1282, DOI 10.3201/eid1508.080839; Butler H, 2012, METHODS MOL BIOL; Chatzidaki-Livanis M, 2006, APPL ENVIRON MICROB, V72, P6136, DOI 10.1128/AEM.00341-06; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cohen ALV, 2007, APPL ENVIRON MICROB, V73, P5553, DOI 10.1128/AEM.00635-07; Dalsgaard A, 1996, EUR J CLIN MICROBIOL, V15, P227, DOI 10.1007/BF01591359; Danin-Poleg Y, 2013, GENOME ANNOUNC, V1; Davis J.C., 1986, STAT DATA ANAL GEOLO; Efimov V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00393; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fitzgerald JR, 2001, TRENDS MICROBIOL, V9, P547, DOI 10.1016/S0966-842X(01)02228-4; Fouz B, 2010, J FISH DIS, V33, P383, DOI 10.1111/j.1365-2761.2009.01130.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gulig PA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-512; Gutacker M, 2003, APPL ENVIRON MICROB, V69, P3203, DOI 10.1128/AEM.69.6.3203-3212.2003; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harper D.A., 1999, NUMERICAL PALAEOBIOL, DOI [10.5772/intechopen.73573, DOI 10.5772/INTECHOPEN.73573]; Hoi L, 1997, APPL ENVIRON MICROB, V63, P1674; HOLLIS DG, 1976, J CLIN MICROBIOL, V3, P425; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Hyten DL, 2008, THEOR APPL GENET, V116, P945, DOI 10.1007/s00122-008-0726-2; Janda J. M., 2003, MANUAL CLIN MICROBIO, P706; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim IH, 2011, J MICROBIOL BIOTECHN, V21, P1228, DOI 10.4014/jmb.1111.11016; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LUDWIG W, 1992, SYST APPL MICROBIOL, V15, P487, DOI 10.1016/S0723-2020(11)80107-4; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Morrison SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037553; Nilsson WB, 2003, J CLIN MICROBIOL, V41, P442, DOI 10.1128/JCM.41.1.442-446.2003; Oliver JD, 2006, BIOLOGY OF VIBRIOS, P349; Patnala R, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-39; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Quirke AM, 2006, BIOINFORMATICS, V22, P905, DOI 10.1093/bioinformatics/btl015; Roltgen K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000751; Roig FJ, 2009, MICROBIOL-SGM, V155, P489, DOI 10.1099/mic.0.023424-0; Rosche TM, 2005, MICROBIOL IMMUNOL, V49, P381, DOI 10.1111/j.1348-0421.2005.tb03731.x; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Sanjuan E, 2011, APPL ENVIRON MICROB, V77, P688, DOI 10.1128/AEM.01263-10; Sanjuan E, 2009, APPL ENVIRON MICROB, V75, P1604, DOI 10.1128/AEM.01594-08; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Shiu SH, 2008, HEREDITY, V100, P141, DOI 10.1038/sj.hdy.6800916; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Tamura K, 2011, MOLBIOLEVOL; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; TISON DL, 1982, APPL ENVIRON MICROB, V44, P640, DOI 10.1128/AEM.44.3.640-646.1982; Urbanczyk H, 2008, J BACTERIOL, V190, P3494, DOI 10.1128/JB.00101-08; Warner JM, 1999, APPL ENVIRON MICROB, V65, P1141; Zaidenstein R, 2008, EMERG INFECT DIS, V14, P1875, DOI 10.3201/eid1412.080499	70	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114576	10.1371/journal.pone.0114576	http://dx.doi.org/10.1371/journal.pone.0114576			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526263	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200006
J	Vieira, FG; LaDow, E; Moreno, A; Kidd, JD; Levine, B; Thompson, K; Gill, A; Finkbeiner, S; Perrin, S				Vieira, Fernando G.; LaDow, Eva; Moreno, Andy; Kidd, Joshua D.; Levine, Beth; Thompson, Kenneth; Gill, Alan; Finkbeiner, Steven; Perrin, Steven			Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY STANDARDS SUBCOMMITTEE; PRACTICE PARAMETER UPDATE; AMERICAN ACADEMY; MOUSE MODEL; PRAMIPEXOLE; TDP-43; KNS-760704; MANAGEMENT; NEUROLOGY	Treatment options for people living with amyotrophic lateral sclerosis (ALS) are limited and ineffective. Recently, dexpramipexole (RPPX) was advanced into human ALS clinical trials. In the current studies, we investigated RPPX in two parallel screening systems: 1) appropriately powered, sibling-matched, gender-balanced survival efficacy screening in high-copy B6-SJL-SOD1(G93A)/Gur1 mice, and 2) high-content neuronal survival screening in primary rat cortical neurons transfected with wild-type human TDP43 or mutant human TDP43. In both cases, we exposed the test systems to RPPX levels approximating those achieved in human Phase II clinical investigations. In SOD1(G93A) mice, no effect was observed on neuromotor disease progression or survival. In primary cortical neurons transfected with either mutant or wild-type human TDP43, a marginally significant improvement in a single indicator of neuronal survival was observed, and only at the 10 mu M RPPX treatment. These systems reflect both mutant SOD1- and TDP43-mediated forms of neurodegeneration. The systems also reflect both complex non-cell autonomous and neuronal cell autonomous disease mechanisms. The results of these experiments, taken in context with results produced by other molecules tested in both screening systems, do not argue positively for further study of RPPX in ALS.	[Vieira, Fernando G.; Moreno, Andy; Kidd, Joshua D.; Levine, Beth; Thompson, Kenneth; Gill, Alan; Perrin, Steven] ALS Therapy Dev Inst, Cambridge, MA 02139 USA; [LaDow, Eva; Finkbeiner, Steven] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Finkbeiner, Steven] Taube Koret Ctr Neurodegenerat Dis Res, San Francisco, CA USA; [Finkbeiner, Steven] Hellman Family Fdn Alzheimers Dis Res Program, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vieira, FG (corresponding author), ALS Therapy Dev Inst, Cambridge, MA 02139 USA.	fvieira@als.net; sfinkbeiner@gladstone.ucsf.edu	Vieira, Fernando/L-6246-2013; Vieira, Fernando/ABG-9082-2020	Vieira, Fernando/0000-0003-2996-6418; Vieira, Fernando/0000-0003-2996-6418	Taube-Koret Center for Neurodegenerative Disease Research [NS R01 NS083390]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039074, R01NS083390] Funding Source: NIH RePORTER	Taube-Koret Center for Neurodegenerative Disease Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded primarily by way of the grass roots fundraising efforts of people living with ALS and their families and friends. The funds which they raised were donated directly to the ALS Therapy Development Institute, a 501c3 not-for-profit research organization. Additionally, the cell-based research work was funded by the Taube-Koret Center for Neurodegenerative Disease Research (S. F.) and NS R01 NS083390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2012, BRAIN RES, V1446, P1, DOI 10.1016/j.brainres.2012.01.046; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Bozik ME, 2011, J CLIN PHARMACOL, V51, P1177, DOI 10.1177/0091270010379412; Cassarino DS, 1998, J NEUROCHEM, V71, P295; Chang WL, 2012, BRAIN RES, V1437, P69, DOI 10.1016/j.brainres.2011.12.007; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Danzeisen R, 2006, J PHARMACOL EXP THER, V316, P189, DOI 10.1124/jpet.105.092312; Daub A, 2009, CURR OPIN NEUROBIOL, V19, P537, DOI 10.1016/j.conb.2009.10.002; Ferrari-Toninelli Giulia, 2010, BMC Pharmacology, V10, P2, DOI 10.1186/1471-2210-10-2; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; Gordon P, 2012, TCRM, V359, DOI [10.2147/TCRM.S21981, DOI 10.2147/TCRM.S21981]; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Hatzipetros T, 2014, BRAIN RES, V1584, P59, DOI 10.1016/j.brainres.2013.10.013; Lincecum JM, 2010, NAT GENET, V42, P392, DOI 10.1038/ng.557; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Serio A, 2013, P NATL ACAD SCI USA, P1, DOI [10.1073/pnas.1300398110/-/DCSupplemental, DOI 10.1073/PNAS.1300398110/-/DCSUPPLEMENTAL]	28	20	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e91608	10.1371/journal.pone.0091608	http://dx.doi.org/10.1371/journal.pone.0091608			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526593	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200062
J	Miyata, H; Watanabe, S; Minagawa, Y				Miyata, Hiromitsu; Watanabe, Shigeru; Minagawa, Yasuyo			Performance of Young Children on "Traveling Salesperson'' Navigation Tasks Presented on a Touch Screen	PLOS ONE			English	Article							PIGEONS COLUMBA-LIVIA; SALESMAN PROBLEM; ROUTE SELECTION; SPATIAL MEMORY; MAZE PROBLEMS; HEURISTICS; PATHS	Background: The traveling salesperson problem (TSP) refers to a task in which one finds the shortest path when traveling through multiple spatially distributed points. Little is known about the developmental course of the strategies used to solve TSPs. The present study examined young children's performance and route selection strategies in one-way TSPs using a city-block metric. A touch screen-based navigation task was applied. Methodology/Principal Findings: Children (39-70 months) and adults (21-35 years) made serial responses on a touch screen to move a picture of a dog (the target) to two or three identical pictures of a bone (the goals). For all the versions of the tasks, significant improvement in measures of performance was observed from younger to older participants. In TSPs in which a specific route selection strategy such as the nearest-neighbor strategy minimized the total traveling distance, older participants used that strategy more frequently than younger ones. By contrast, in TSPs in which multiple strategies equally led to the minimal traveling distance, children tended to use strategies different from those used by adults, such as traveling straight to the farthest goal first. Conclusions/Significance: The results primarily suggest development of efficient route selection strategies that can optimize total numbers of movements and/or solution time. Unlike adults, children sometimes prioritized other strategies such as traveling straight ahead until being forced to change directions. This may reflect the fact that children were either less attentive to the task or less efficient at perceiving the overall shape of the problem and/or the relative distance from the starting location to each goal.	[Miyata, Hiromitsu] Japan Soc Promot Sci, Tokyo, Japan; [Miyata, Hiromitsu; Minagawa, Yasuyo] Keio Univ, Grad Sch Human Relat, Tokyo, Japan; [Watanabe, Shigeru] Keio Univ, Fac Letters, Tokyo, Japan	Japan Society for the Promotion of Science; Keio University; Keio University	Miyata, H (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	miyata@he.u-tokyo.ac.jp			Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata; Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program [D-09]	Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata; Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the Research Fellowship of the Japan Society for the Promotion of Science (JSPS) for Young Scientists to Hiromitsu Miyata, and by the Japan Ministry of Education, Culture, Sports, Science and Technology Global COE Program, D-09, to Keio University, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applegate DL, 2007, TRAVELING SALESMAN P; Burns NR, 2006, J PROBL SOLVING, V1, P5, DOI 10.7771/1932-6246.1003; Davidse NJ, 2014, COGN NEUROPSYCHOL, V31, P221, DOI 10.1080/02643294.2013.876980; Dry M, 2006, J PROBL SOLVING, V1, P20, DOI 10.7771/1932-6246.1004; Ferguson B, 2014, COGNITION, V131, P139, DOI 10.1016/j.cognition.2013.12.014; Gallistel CR, 1996, J EXP BIOL, V199, P211; GARLING T, 1988, ENVIRON PLANN A, V20, P547, DOI 10.1068/a200547; Gibson B, 2012, ANIM COGN, V15, P379, DOI 10.1007/s10071-011-0463-9; Gibson BM, 2007, J EXP PSYCHOL ANIM B, V33, P244, DOI 10.1037/0097-7403.33.3.244; Graham SM, 2000, MEM COGNITION, V28, P1191, DOI 10.3758/BF03211820; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; HIRTLE SC, 1992, GEOFORUM, V23, P227, DOI 10.1016/0016-7185(92)90019-Z; HUDSON JA, 1995, CHILD DEV, V66, P984, DOI 10.1111/j.1467-8624.1995.tb00917.x; Hui SK, 2009, MARKET SCI, V28, P566, DOI 10.1287/mksc.1080.0402; Janson CH, 1998, ANIM BEHAV, V55, P1229, DOI 10.1006/anbe.1997.0688; Keen R, 2011, ANNU REV PSYCHOL, V62, P1, DOI 10.1146/annurev.psych.031809.130730; MacGregor JN, 2006, J PROBL SOLVING, V1, P33, DOI 10.7771/1932-6246.1005; MacGregor JN, 1996, PERCEPT PSYCHOPHYS, V58, P527, DOI 10.3758/BF03213088; MacGregor JN, 1999, PERCEPTION, V28, P1417, DOI 10.1068/p2863; MENZEL EW, 1973, SCIENCE, V182, P943, DOI 10.1126/science.182.4115.943; Miyata H, 2008, ANIM COGN, V11, P505, DOI 10.1007/s10071-008-0141-8; Miyata H, 2006, J COMP PSYCHOL, V120, P358, DOI 10.1037/0735-7036.120.4.358; Miyata H, 2012, PERCEPT MOTOR SKILL, V115, P27, DOI 10.2466/23.04.22.PMS.115.4.27-42; Miyata H, 2011, J COMP PSYCHOL, V125, P431, DOI 10.1037/a0024240; Miyata H, 2010, J COMP PSYCHOL, V124, P433, DOI 10.1037/a0019931; Miyata H, 2009, J COMP PSYCHOL, V123, P69, DOI 10.1037/a0012890; Miyata H, 2011, BRAIN RES, V1374, P90, DOI 10.1016/j.brainres.2010.12.047; Ormerod TC, 1999, PERCEPT PSYCHOPHYS, V61, P1227, DOI 10.3758/BF03207625; Pellicano E, 2011, P NATL ACAD SCI USA, V108, P421, DOI 10.1073/pnas.1014076108; Polivanova N.I., 1974, VOPROSY PSYCHOL, V4, P41; Rego C, 2011, EUR J OPER RES, V211, P427, DOI 10.1016/j.ejor.2010.09.010; Roderer T, 2014, METACOGN LEARN, V9, P1, DOI 10.1007/s11409-013-9109-4; van Rooij I, 2006, J PROBL SOLVING, V1, P44, DOI 10.7771/1932-6246.1006; Vickers D, 2001, PSYCHOL RES-PSYCH FO, V65, P34, DOI 10.1007/s004260000031; Walwyn AL, 2014, J PROBLEM SOLVING, V3, P93; Wiener JM, 2009, PSYCHOL RES-PSYCH FO, V73, P644, DOI 10.1007/s00426-008-0181-3; YAMAMOTO Y, 1997, JUNKAI SALESMAN MOND	37	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115292	10.1371/journal.pone.0115292	http://dx.doi.org/10.1371/journal.pone.0115292			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25521714	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600031
J	Anderwald, CH; Tura, A; Gessl, A; Smajis, S; Bieglmayer, C; Marculescu, R; Luger, A; Pacini, G; Krebs, M				Anderwald, Christian-Heinz; Tura, Andrea; Gessl, Alois; Smajis, Sabina; Bieglmayer, Christian; Marculescu, Rodrig; Luger, Anton; Pacini, Giovanni; Krebs, Michael			Whole-Body Insulin Sensitivity Rather than Body-Mass-Index Determines Fasting and Post-Glucose-Load Growth Hormone Concentrations	PLOS ONE			English	Article							GH-RELEASING HORMONE; TOLERANCE TEST; RESISTANCE; SECRETION; OBESITY; METABOLISM; INFUSION; IMPACT; ADULTS; CLAMP	Background: Obese, non-acromegalic persons show lower growth hormone (GH) concentrations at fasting and reduced GH nadir during an oral glucose tolerance test (OGTT). However, this finding has never been studied with regard to whole-body insulin-sensitivity as a possible regulator. Methods: In this retrospective analysis, non-acromegalic (NonACRO, n=161) and acromegalic (ACRO, n=35), non-diabetic subjects were subdivided into insulin-sensitive (IS) and -resistant (IR) groups according to the Clamp-like Index (CLIX)-threshold of 5 mg.kg(-1).min(-1) from the OGTT. Results: Non-acromegalic IS (CLIX: 8.8 +/- 0.4 mg.kg(-1).min(-1)) persons with similar age and sex distribution, but lower (p<0.001) body-mass-index (BMI=25 +/- 0 kg/m(2), 84% females, 56 +/- 1 years) had 59% and 70%, respectively, higher (p<0.03) fasting GH and OGTT GH area under the curve concentrations than IR (CLIX: 3.5 +/- 0.1 mg.kg(-1).min(-1), p<0.001) subjects (BMI=29 +/- 1 kg/m(2), 73% females, 58 +/- 1 years). When comparing on average overweight non-acromegalic IS and IR with similar anthropometry (IS: BMI: 27 +/- 0 kg/m(2), 82% females, 58 +/- 2 years; IR: BMI: 27 +/- 0 kg/m(2), 71% females, 60 +/- 1 years), but different CLIX (IS: 8.7 +/- 0.9 vs. IR: 3.8 +/- 0.1 mg.kg(-1).min(-1), p<0.001), the results remained almost the same. In addition, when adjusted for OGTT-mediated glucose rise, GH fall was less pronounced in IR. In contrast, in acromegalic subjects, no difference was found between IS and IR patients with regard to fasting and post-glucose-load GH concentrations. Conclusions: Circulating GH concentrations at fasting and during the OGTT are lower in non-acromegalic insulin-resistant subjects. This study seems the first to demonstrate that insulin sensitivity rather than body-mass modulates fasting and post-glucose-load GH concentrations in non-diabetic non-acromegalic subjects.	[Anderwald, Christian-Heinz; Gessl, Alois; Smajis, Sabina; Luger, Anton; Krebs, Michael] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 2, Vienna, Austria; [Anderwald, Christian-Heinz; Tura, Andrea; Pacini, Giovanni] CNR, Metab Unit, Inst Biomed Engn, ISIB, Padua, Italy; [Anderwald, Christian-Heinz] Mariahilf Community Pharm, Arnoldstein, Austria; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, Micheldorf, Austria; [Bieglmayer, Christian; Marculescu, Rodrig] Med Univ Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria	Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna	Anderwald, CH (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 2, Vienna, Austria.	christian-heinz.anderwald@meduniwien.ac.at	Marculescu, Rodrig/B-6474-2016; Anderwald, Christian Heinz/AAG-2271-2021	Marculescu, Rodrig/0000-0003-1772-6695; Anderwald, Christian Heinz/0000-0001-7485-0815; Krebs, Michael/0000-0002-9265-7274				Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Anderwald C, 2008, EUR J CLIN INVEST, V38, P227, DOI 10.1111/j.1365-2362.2008.01932.x; Anderwald CH, 2010, JOURNAL OF CLINICAL, V1, P61; Anderwald C, 2007, DIABETES CARE, V30, P2374, DOI 10.2337/dc07-0422; Anderwald C, 2011, DIABETES CARE, V34, P1475, DOI 10.2337/dc10-2266; Anderwald C, 2011, J CLIN ENDOCR METAB, V96, P515, DOI 10.1210/jc.2010-1398; Anderwald C, 2010, HEART, V96, P1191, DOI 10.1136/hrt.2009.177436; Anderwald C, 2009, ENDOCRINOLOGIST, V19, P302, DOI 10.1097/TEN.0b013e3181c0479d; Anderwald CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077326; Anderwald CH, 2012, DIABETES CARE, V35, P2580, DOI 10.2337/dc12-0197; Anderwald-Stadler M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1393, DOI 10.1152/ajpendo.00330.2007; Arafat AM, 2010, DIABETOLOGIA, V53, P1304, DOI 10.1007/s00125-010-1738-4; Arafat AM, 2008, J CLIN ENDOCR METAB, V93, P1254, DOI 10.1210/jc.2007-2084; Bredella MA, 2013, J CLIN ENDOCR METAB, V98, P3864, DOI 10.1210/jc.2013-2063; Chanson P, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-17; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cornford AS, 2011, J CLIN ENDOCR METAB, V96, P824, DOI 10.1210/jc.2010-1895; Grottoli S, 1997, J CLIN ENDOCR METAB, V82, P2261, DOI 10.1210/jc.82.7.2261; Iranmanesh A, 2012, J CLIN ENDOCR METAB, V97, P2172, DOI 10.1210/jc.2011-3317; Jessen N, 2005, AM J PHYSIOL-ENDOC M, V288, pE194, DOI 10.1152/ajpendo.00149.2004; Kim SK, 2012, J KOREAN MED SCI, V27, P177, DOI 10.3346/jkms.2012.27.2.177; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Pijl H, 2001, J CLIN ENDOCR METAB, V86, P5509, DOI 10.1210/jc.86.11.5509; Plockinger U, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/268957; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Stadler M, 2009, DIABETOLOGIA, V52, P2435, DOI 10.1007/s00125-009-1520-7; Stadler M, 2010, DIABETES, V59, P215, DOI 10.2337/db09-0354; Tam CS, 2012, DIABETES CARE, V35, P1605, DOI 10.2337/dc11-2339; Tura A, 2011, AM J PHYSIOL-REG I, V300, pR941, DOI 10.1152/ajpregu.00650.2010; Verrua E, 2011, J CLIN ENDOCR METAB, V96, pE83, DOI 10.1210/jc.2010-1115; Vierhapper H, 2003, METABOLISM, V52, P181, DOI 10.1053/meta.2003.50036	34	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115184	10.1371/journal.pone.0115184	http://dx.doi.org/10.1371/journal.pone.0115184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517727	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600051
J	Shimasaki, A; Kondo, K; Saito, T; Esaki, K; Otsuka, Y; Mano, K; Ikeda, M; Iwata, N				Shimasaki, Ayu; Kondo, Kenji; Saito, Takeo; Esaki, Kosei; Otsuka, Yasuyo; Mano, Keiko; Ikeda, Masashi; Iwata, Nakao			A Genetic Variant in 12q13, a Possible Risk Factor for Bipolar Disorder, Is Associated with Depressive State, Accounting for Stressful Life Events	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MAJOR DEPRESSION; METAANALYSIS; 5-HTTLPR; POLYMORPHISMS; EPIDEMIOLOGY; ONSET; LOCI	Genome-wide association studies (GWASs) have identified a number of susceptibility genes for schizophrenia (SCZ) and bipolar disorder (BD). However, the identification of risk genes for major depressive disorder (MDD) has been unsuccessful because the etiology of MDD is more influenced by environmental factors; thus, gene-environment (G x E) interactions are important, such as interplay with stressful life events (SLEs). We assessed the GxE interactions and main effects of genes targeting depressive symptoms. Using a case-control design, 922 hospital staff members were evaluated for depressive symptoms according to Beck Depressive Inventory (BDI; "depression" and "control" groups were classified by scores of 10 in the BDI test), SLEs, and personality. A total of sixty-three genetic variants were selected on the basis of previous GWASs of MDD, SCZ, and BD as well as candidate-gene (SLC6A4, BDNF, DBH, and FKBP5) studies. Logistic regression analysis revealed a marginally significant interaction (genetic variant x SLE) at rs4523957 (P-uncorrected = 0.0034) with depression and a significant association of single nucleotide polymorphism identified from evidence of BD GWAS (rs7296288, downstream of DHH at 12q13.1) with depression as the main effect (P-uncorrected = 9.4x10(-4), P-corrected = 0.0424). We also found that SLEs had a larger impact on depression (odds ratio similar to 3), as reported previously. These results suggest that DHH plays a possible role in depression etiology; however, variants from MDD or SCZ GWAS evidence or candidate genes showed no significant associations or minimal effects of interactions with SLEs on depression.	[Shimasaki, Ayu; Kondo, Kenji; Saito, Takeo; Esaki, Kosei; Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Otsuka, Yasuyo; Mano, Keiko] Fujita Hlth Univ Hosp, Div Nursing, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University	Ikeda, M (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.	ikeda-ma@fujita-hu.ac.jp		IWATA, Nakao/0000-0003-3189-6076	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; "Integrated Research on Neuropsychiatric Disorders'' conducted under the Strategic Research Program for Brain Sciences; SENSHIN Medical Research Foundation, Japan	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Integrated Research on Neuropsychiatric Disorders'' conducted under the Strategic Research Program for Brain Sciences; SENSHIN Medical Research Foundation, Japan	This work is the result of "Integrated Research on Neuropsychiatric Disorders'' conducted under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (Drs. M Ikeda and N Iwata) and the SENSHIN Medical Research Foundation, Japan (Dr. M Ikeda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2012, BMJ OPEN, P2; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Boya FO, 2008, IND HEALTH, V46, P613, DOI 10.2486/indhealth.46.613; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Costa P.T., 1992, PSYCHOL ASSESSMENT R, V396; Farmer A, 2002, BRIT J PSYCHIAT, V181, P118; Fried EI, 2014, PSYCHOL MED, V44, P2067, DOI 10.1017/S0033291713002900; Hosang GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-7; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Peyrot WJ, 2013, J AFFECT DISORDERS, V146, P91, DOI 10.1016/j.jad.2012.08.044; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regier DA, 2013, AM J PSYCHIAT, V170, P59, DOI 10.1176/appi.ajp.2012.12070999; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Tao M, 2011, J AFFECT DISORDERS, V135, P95, DOI 10.1016/j.jad.2011.06.054; Umehara F, 2002, CELL MOL BIOL, V48, P187; Zannas AS, 2014, GENES BRAIN BEHAV, V13, P25, DOI 10.1111/gbb.12104; Zimmermann P, 2011, AM J PSYCHIAT, V168, P1107, DOI 10.1176/appi.ajp.2011.10111577	28	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115135	10.1371/journal.pone.0115135	http://dx.doi.org/10.1371/journal.pone.0115135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517604	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600043
J	Agbor, AA; Bigna, JJR; Billong, SC; Tejiokem, MC; Ekali, GL; Plottel, CS; Noubiap, JJN; Abessolo, H; Toby, R; Koulla-Shiro, S				Agbor, Ako A.; Bigna, Jean Joel R.; Billong, Serges Clotaire; Tejiokem, Mathurin Cyrille; Ekali, Gabriel L.; Plottel, Claudia S.; Noubiap, Jean Jacques N.; Abessolo, Hortence; Toby, Roselyne; Koulla-Shiro, Sinata			Factors Associated with Death during Tuberculosis Treatment of Patients Co-Infected with HIV at the Yaounde Central Hospital, Cameroon: An 8-Year Hospital-Based Retrospective Cohort Study (2006-2013)	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-1 REPLICATION; RURAL SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; MORTALITY; ADULTS; MALAWI; IMPACT; AIDS; COINFECTION; DISTRICT	Background: Contributors to fatal outcomes in TB/HIV co-infected patients actively undergoing TB treatment are poorly characterized. The aim was to assess factors associated with death in TB/HIV co-infected patients during the initial 6 months of TB treatment. Methods: We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at the Yaounde Central Hospital, Cameroon. We reviewed medical records to identify hospitalized co-infected TB/HIV patients aged 15 years and older. Death was defined as any death occurring during TB treatment, as per the World Health Organization's recommendations. We conducted logistic regression analysis to identify factors associated with a fatal outcome. Magnitudes of associations were expressed by adjusted odds ratio (aOR) with 95% confidence interval. Results: The 337 patients enrolled had a mean age of 39.3 (standard deviation 10.3) years and 54.3% were female. TB treatment outcomes were distributed as follows: 205 (60.8%) treatment success, 99 (29.4%) deaths, 18 (5.3%) not evaluated, 14 (4.2%) lost to follow-up, and 1 (0.3%) failed. After exclusion of patients lost to follow-up and not evaluated, death in TB/HIV co-infected patients during TB treatment was associated with a TB diagnosis made before 2010 (aOR=2.50 [1.31-4.78]; p=0.006), the presence of other AIDS-defining diseases (aOR=2.73 [1.27-5.86]; p=0.010), non-AIDS comorbidities (aOR=3.35 [1.37-8.21]; p=0.008), not receiving cotrimoxazole prophylaxis (aOR=3.61 [1.71-7.63]; p=0.001), not receiving antiretroviral therapy (aOR=2.45 [1.18-5.08]; p=0.016), and CD4 cells count <50 cells/mm(3) (aOR=16.43 [1.05-258.04]; p=0.047). Conclusions: The TB treatment success rate among TB/HIV co-infected patients in our setting is low. Mortality was high among TB/HIV co-infected patients during TB treatment and is strongly associated with clinical and biological factors, highlighting the urgent need for specific interventions focused on enhancing patient outcomes.	[Agbor, Ako A.; Billong, Serges Clotaire; Koulla-Shiro, Sinata] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Bigna, Jean Joel R.] Minist Publ Hlth, Goulfey Hlth Dist Unit, Goulfey, Cameroon; [Billong, Serges Clotaire; Ekali, Gabriel L.] Minist Publ Hlth, Natl AIDS Control Comm, Yaounde, Cameroon; [Tejiokem, Mathurin Cyrille] Ctr Pasteur Cameroun, Dept Epidemiol & Publ Hlth, Yaounde, Cameroon; [Plottel, Claudia S.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Plottel, Claudia S.] NYU, Sch Med, Dept Med, New York, NY USA; [Noubiap, Jean Jacques N.] Edea Reg Hosp, Internal Med Unit, Edea, Cameroon; [Abessolo, Hortence; Toby, Roselyne; Koulla-Shiro, Sinata] Yaounde Cent Hosp, Infect Dis Unit, Yaounde, Cameroon	University of Yaounde I; Centre Pasteur du Cameroun; New York University; NYU Langone Medical Center; New York University	Bigna, JJR (corresponding author), Minist Publ Hlth, Goulfey Hlth Dist Unit, POB 62 Kousseri, Goulfey, Cameroon.	bignarimjj@yahoo.fr	Bigna, Jean Joel/A-1781-2015; Loni Ekali, Gabriel/L-1799-2018	Bigna, Jean Joel/0000-0001-8018-6279; Loni Ekali, Gabriel/0000-0003-3693-5097; Noubiap, Jean Jacques/0000-0002-7722-9757; Plottel, Claudia S./0000-0001-6088-6534				Alvarez-Uria G, 2013, BIOIMPACTS, V3, P123, DOI 10.5681/bi.2013.025; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Banerjee A, 1997, T ROY SOC TROP MED H, V91, P707, DOI 10.1016/S0035-9203(97)90533-2; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; Connolly C, 1999, AIDS, V13, P1543, DOI 10.1097/00002030-199908200-00015; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Dou Zhi-hui, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1091; El-Sony AI, 2002, INT J TUBERC LUNG D, V6, P1058; Friedland G, 2007, J INFECT DIS, V196, pS1, DOI 10.1086/518667; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Harries AD, 2000, SCOT MED J, V45, P47, DOI 10.1177/00369330000450S122; Harries AD, 2009, INT J TUBERC LUNG DI, V13; Hoffmann C, 2007, HIV MED, P389; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Kantipong P, 2012, HIV AIDS-RES PALLIAT, V4, P159, DOI 10.2147/HIV.S33535; Kirenga BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090614; Kohli R, 2005, CLIN INFECT DIS, V41, P864, DOI 10.1086/432883; Kuaban C, 1997, E AFR MED J, V74, P474; Kuaban C, 2011, HLTH SCI DIS, V12; Little R. J. A., 1987, STAT ANAL MISSING DA; Marcy O, 2014, CLIN INFECT DIS, V59, P435, DOI 10.1093/cid/ciu283; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Nakata K, 1997, AM J RESP CRIT CARE, V155, P996, DOI 10.1164/ajrccm.155.3.9117038; National AIDS Control Committtee, 2010, NAT GUID MAN HIV INF; Programme National de lutte contre la Tuberculose, 2014, PLAN STRAT LUTT CONT; Programme National de lutte contre la Tuberculose, 2012, GUID PERS SANT; Quinn TC, 2001, B WORLD HEALTH ORGAN, V79, P1159; Rizzardi GP, 1999, INFECT DIS, P1; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Shastri S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-838; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sume G E, 2009, East Afr Med J, V86, P469; Sun Ding-yong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P181; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2011, WHO GLOBAL TUBERCULO; Witor SZ, 1999, LANCET, V353, P1469; Yone EWP, 2012, REV PNEUMOL CLIN, V68, P338, DOI 10.1016/j.pneumo.2012.10.001; Yone EWP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-190; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; ZHANG YH, 1995, J CLIN INVEST, V95, P2324, DOI 10.1172/JCI117924	47	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115211	10.1371/journal.pone.0115211	http://dx.doi.org/10.1371/journal.pone.0115211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506830	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100061
J	Gong, YN; Chen, GW; Chen, CJ; Kuo, RL; Shih, SR				Gong, Yu-Nong; Chen, Guang-Wu; Chen, Chi-Jene; Kuo, Rei-Lin; Shih, Shin-Ru			Computational Analysis and Mapping of Novel Open Reading Frames in Influenza A Viruses	PLOS ONE			English	Article							MESSENGER-RNA; PB1-F2 PROTEIN; SEGMENT 2; TRANSLATION; INITIATION; GENE; AUG; IDENTIFICATION; MECHANISM; TYPE-1	The influenza A virus contains 8 segmented genomic RNAs and was considered to encode 10 viral proteins until investigators identified the 11th viral protein, PB1-F2, which uses an alternative reading frame of the PB1 gene. The recently identified PB1-N40, PA-N155 and PA-N182 influenza A proteins have shown the potential for using a leaking ribosomal scanning mechanism to generate novel open reading frames (ORFs). These novel ORFs provide examples of the manner in which the influenza A virus expands its coding capacity by using overlapping reading frames. In this study, we performed a computational search, based on a ribosome scanning mechanism, on all influenza A coding sequences to identify possible forward-reading ORFs that could be translated into novel viral proteins. We specified that the translated products had a prevalence >= 5% to eliminate sporadic ORFs. A total of 1,982 ORFs were thus identified and presented in terms of their locations, lengths and Kozak sequence strengths. We further provided an abridged list of ORFs by requiring every candidate an upstream start codon ( within the upstream third of the primary transcript), a strong Kozak consensus sequence and high prevalence (>= 95% and >= 50% for in-frame and alternative-frame ORFs, respectively). The PB1-F2, PB1-N40, PA-N155 and PA-N182 proteins all fulfilled our filtering criteria. Subject to these three stringent settings, we additionally named 16 novel ORFs for all influenza A genomes except for HA and NA, for which 43 HA and 11 NA ORFs from their respective subtypes were also recognized.	[Gong, Yu-Nong; Chen, Guang-Wu] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chen, Guang-Wu; Chen, Chi-Jene; Kuo, Rei-Lin; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Chen, Chi-Jene; Kuo, Rei-Lin; Shih, Shin-Ru] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University	Chen, GW (corresponding author), Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.	gwchen@mail.cgu.edu.tw	Shih, Shin-Ru/M-9711-2016; Chen, Guang-Wu/M-6768-2016	Chen, Chi-Jene/0000-0002-2292-7769; Gong, Yu-Nong/0000-0002-6799-1561; Chen, Guang-Wu/0000-0002-5322-4839; Shih, Shin-Ru/0000-0003-4874-401X	Ministry of Science and Technology, Taiwan [100-2221-E-182-056-MY3]; Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD260013]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital)	GWC received two grants from the Ministry of Science and Technology, Taiwan (No. 100-2221-E-182-056-MY3; http://www.most.gov.tw/) and Chang Gung Memorial Hospital, Taoyuan, Taiwan (No. CMRPD260013; http://www.cgmh.org.tw) that partially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Chen GW, 2004, EMERG INFECT DIS, V10, P630, DOI 10.3201/eid1004.030412; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Conenello GM, 2007, CELL HOST MICROBE, V2, P207, DOI 10.1016/j.chom.2007.09.010; DILLON PJ, 1989, J VIROL, V63, P974, DOI 10.1128/JVI.63.2.974-977.1989; Dudek SE, 2011, BIOL CHEM, V392, P1135, DOI [10.1515/BC-2011-174, 10.1515/BC.2011.174]; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Latorre P, 1998, MOL CELL BIOL, V18, P5021, DOI 10.1128/MCB.18.9.5021; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; Tam JS, 2002, VACCINE, V20, pS77, DOI 10.1016/S0264-410X(02)00137-8; Trifonov V., 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1006; Tsai KN, 2011, MICROBES INFECT, V13, P479, DOI 10.1016/j.micinf.2011.01.013; Werten PJL, 1999, MOL BIOL REP, V26, P201, DOI 10.1023/A:1007046926233; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Xu H, 2010, CELL RES, V20, P445, DOI 10.1038/cr.2010.25; Zamarin Dmitriy, 2005, PLoS Pathogens, V1, P40; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0; Zhirnov OP, 2007, DOKL BIOCHEM BIOPHYS, V414, P127, DOI 10.1134/S1607672907030106	34	8	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115016	10.1371/journal.pone.0115016	http://dx.doi.org/10.1371/journal.pone.0115016			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506939	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100043
J	Pasiarski, M; Rolinski, J; Grywalska, E; Stelmach-Goldys, A; Korona-Glowniak, I; Gozdz, S; Hus, I; Malm, A				Pasiarski, Marcin; Rolinski, Jacek; Grywalska, Ewelina; Stelmach-Goldys, Agnieszka; Korona-Glowniak, Izabela; Gozdz, Stanislaw; Hus, Iwona; Malm, Anna			Antibody and Plasmablast Response to 13-Valent Pneumococcal Conjugate Vaccine in Chronic Lymphocytic Leukemia Patients - Preliminary Report	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; SEROLOGIC RESPONSE; PERIPHERAL-BLOOD; DIAGNOSIS; IGG; INFECTIONS; GUIDELINES; CELLS; SERUM	Background: Chronic lymphocytic leukemia (CLL) leads to significant immune system dysfunction. The predominant clinical presentation in 50% of patients involves recurrent, often severe, infections. Infections are also the most common (60-80%) cause of deaths in CLL patients. The scope of infections varies with the clinical stage of the disease. Treatment-naive patients typically present with respiratory tract infections caused by encapsulated bacteria Streptococcus pneumoniae and Haemophilus influenzae. Since 2012, the 13-valent pneumococcal conjugate vaccine (PCV13) has been recommended in the United States and some EU countries for pneumococcal infection prevention in patients with CLL (besides the long-standing standard, 23-valent pneumococcal polysaccharide vaccine, PPV23). The aim of this study was to compare the immune response to PCV13 in 24 previously untreated CLL patients and healthy subjects. Methods: Both groups were evaluated for: the levels of specific pneumococcal antibodies, the levels of IgG and IgG subclasses and selected peripheral blood lymphocyte subpopulations including the frequency of plasmablasts before and after immunization. Results: Adequate response to vaccination, defined as an at least two-fold increase in specific pneumococcal antibody titers versus pre-vaccination baseline titers, was found in 58.3% of CLL patients and 100% of healthy subjects. Both the CLL group and the control group demonstrated a statistically significant increase in the IgG2 subclass levels following vaccination (P=0.0301). After vaccination, the frequency of plasmablasts was significantly lower (P < 0.0001) in CLL patients in comparison to that in controls. Patients who responded to vaccination had lower clinical stage of CLL as well as higher total IgG, and IgG2 subclass levels. No significant vaccine-related side effects were observed. Conclusions: PCV13 vaccination in CLL patients is safe and induces an effective immune response in a considerable proportion of patients. To achieve an optimal vaccination response, the administration of PCV13 is recommended as soon as possible following CLL diagnosis.	[Pasiarski, Marcin; Stelmach-Goldys, Agnieszka] Holycross Canc Ctr, Dept Hematol, Kielce, Poland; [Rolinski, Jacek; Grywalska, Ewelina] Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland; [Rolinski, Jacek; Grywalska, Ewelina] St Johns Canc Ctr, Lublin, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Chemotherapy & Clin Oncol, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland; [Hus, Iwona] Med Univ Lublin, Dept Clin Transplantol, Lublin, Poland; [Korona-Glowniak, Izabela; Malm, Anna] Med Univ Lublin, Dept Pharmaceut Microbiol, Lublin, Poland	Medical University of Lublin; Jan Kochanowski University; Medical University of Lublin; Medical University of Lublin	Rolinski, J (corresponding author), Med Univ Lublin, Dept Clin Immunol & Immunotherapy, Lublin, Poland.	jacek.rolinski@gmail.com	Kielce, SCO/O-6702-2016; Hus, Iwona/AAB-2809-2020; Gozdz, Stanislaw/D-3300-2013	Hus, Iwona/0000-0002-6096-4093; Rolinski, Jacek/0000-0003-4841-6120; Gozdz, Stanislaw/0000-0001-6902-3807; Korona-Glowniak, Izabela/0000-0003-1634-0387; Malm, Anna/0000-0003-1503-7634; Rolinski, Jacek Mariusz/0000-0001-5596-2651; Grywalska, Ewelina/0000-0002-0451-4741; Pasiarski, Marcin/0000-0002-8569-4261	Polish National Science Centre [UMO-2011/01/N/NZ6/01762, UMO-2012/05/B/NZ6/00792]	Polish National Science Centre	The study was subsidized from scientific grants No. UMO-2011/01/N/NZ6/01762 and No. UMO-2012/05/B/NZ6/00792 of the Polish National Science Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BL, 2006, ONCOLOGIST, V11, P21, DOI 10.1634/theoncologist.11-1-21; Bacterial Respiratory Pathogen Reference Laboratory at the University of Alabama at Birmingham (UAB) website, TRAIN MAN ENZ LINK I; Balmer P, 2003, CLIN EXP IMMUNOL, V133, P364, DOI 10.1046/j.1365-2249.2003.02232.x; CHOU MY, 1983, CANCER, V51, P1546, DOI 10.1002/1097-0142(19830415)51:8<1546::AID-CNCR2820510832>3.0.CO;2-A; Chovancova Z, 2011, VACCINE, V29, P4142, DOI 10.1016/j.vaccine.2011.03.087; Corscadden KJ, 2013, VACCINE, V31, P1393, DOI 10.1016/j.vaccine.2012.12.078; DAVEY FR, 1987, AM J CLIN PATHOL, V87, P60, DOI 10.1093/ajcp/87.1.60; Dearden Claire, 2008, Hematology Am Soc Hematol Educ Program, P450, DOI 10.1182/asheducation-2008.1.450; Dighiero G, 1998, NEW ENGL J MED, V338, P1506, DOI 10.1056/NEJM199805213382104; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Freeman JA, 2013, LEUKEMIA LYMPHOMA, V54, P99, DOI 10.3109/10428194.2012.706285; Garcia-Munoz R, 2012, ANN HEMATOL, V91, P981, DOI 10.1007/s00277-012-1460-z; Ghielmini M, 2013, ANN ONCOL, V24, P561, DOI [10.1093/annonc/mds517, 10.1093/annonc/mdr388]; GOLDBLATT D, 1992, J INFECT DIS, V166, P632, DOI 10.1093/infdis/166.3.632; GRIFFITHS H, 1992, CLIN EXP IMMUNOL, V89, P374; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hallek M, 2013, AM J HEMATOL, V88, P803, DOI 10.1002/ajh.23491; Hartkamp A, 2001, VACCINE, V19, P1671, DOI 10.1016/S0264-410X(00)00409-6; He XS, 2011, J IMMUNOL METHODS, V365, P67, DOI 10.1016/j.jim.2010.12.008; Hovenden M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003306; Leggat DJ, 2013, VACCINE, V31, P4632, DOI 10.1016/j.vaccine.2013.07.030; Linet MS, 2007, BRIT J HAEMATOL, V139, P672, DOI 10.1111/j.1365-2141.2007.06847.x; Lobetti-Bodoni C, 2013, EUR J INTERN MED, V24, P401, DOI 10.1016/j.ejim.2013.03.009; Lu CL, 2014, VACCINE, V32, P1031, DOI 10.1016/j.vaccine.2014.01.009; MOLICA S, 1994, LEUKEMIA LYMPHOMA, V13, P203, DOI 10.3109/10428199409056283; Molteni A, 2005, HAEMATOLOGICA, V90, P1145; Morrison VA, 1998, SEMIN ONCOL, V25, P98; Morrison Vicki A, 2007, Hematology Am Soc Hematol Educ Program, P332, DOI 10.1182/asheducation-2007.1.332; Nosari A, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.070; Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521; Obaro SK, 1996, IMMUNOL LETT, V49, P83, DOI 10.1016/0165-2478(95)02487-5; Oscier D, 2004, BRIT J HAEMATOL, V125, P294, DOI 10.1111/j.1365-2141.2004.04898.x; Pollyea DA, 2010, J CLIN ONCOL, V28, P2481, DOI 10.1200/JCO.2009.26.6908; RAI KR, 1975, BLOOD, V46, P219, DOI 10.1182/blood.V46.2.219.219; Ravandi F, 2006, CANCER IMMUNOL IMMUN, V55, P197, DOI 10.1007/s00262-005-0015-8; Safdar A, 2008, CANCER-AM CANCER SOC, V113, P383, DOI 10.1002/cncr.23561; Sigurdardottir ST, 2014, VACCINE, V32, P417, DOI 10.1016/j.vaccine.2013.11.029; Sinisalo M, 2003, LEUKEMIA LYMPHOMA, V44, P649, DOI 10.1080/1042819031000063408; Sinisalo M, 2001, BRIT J HAEMATOL, V114, P107, DOI 10.1046/j.1365-2141.2001.02882.x; Sinisalo M, 2007, VACCINE, V26, P82, DOI 10.1016/j.vaccine.2007.10.053; Uppada SB, 2011, VACCINE, V29, P9352, DOI 10.1016/j.vaccine.2011.09.129; Van der Velden AMT, 2007, EUR J HAEMATOL, V79, P47, DOI 10.1111/j.1600-0609.2007.00862.x; Yri OE, 2011, BLOOD, V118, P6769, DOI 10.1182/blood-2011-08-372649	43	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114966	10.1371/journal.pone.0114966	http://dx.doi.org/10.1371/journal.pone.0114966			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506837	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100037
J	Cheng, LY; Sun, XM; Hu, CM; Jin, R; Sun, BS; Shi, YM; Cui, WG; Zhang, YG				Cheng, Liying; Sun, Xiaoming; Hu, Changmin; Jin, Rong; Sun, Baoshan; Shi, Yaoming; Cui, Wenguo; Zhang, Yuguang			In Vivo Early Intervention and the Therapeutic Effects of 20(S)-Ginsenoside Rg3 on Hypertrophic Scar Formation	PLOS ONE			English	Article							GINSENOSIDE RG3; CANCER CELLS; KELOIDS; EXPRESSION; MANAGEMENT; ACTIVATION; TOXICITY; GROWTH	Background: Intra-lesional injections of corticosteroids, interferon, and chemotherapeutic drugs are currently the most popular treatments of hypertrophic scar formation. However, these drugs can only be used after HS is formed, and not during the inflammatory phase of wound healing, which regulates the HS forming process. Objective: To investigate a new, effective, combining therapeutic and safe drug for early intervention and treatment for hypertrophic scars. Methods: Cell viability assay and flow cytometric analysis were studied in vitro. Animal studies were done to investigate the combining therapeutic effects of 20(S)ginsenoside Rg3 (Rg3) on the inflammatory phase of wound healing and HS formation. Results: In vitro studies showed that Rg3 can inhibit HS fibroblasts proliferation and induce HSF apoptosis in a concentration-dependent manner. In vivo studies demonstrated that Rg3 can limit the exaggerated inflammation, and do not delay the wound healing process, which indicates that Rg3 could be used as an early intervention to reduce HS formation. Topical injection of 4 mg/mL Rg3 can reduce HS formation by 34%. Histological and molecular studies revealed that Rg3 injection inhibits fibroblasts proliferation thus reduced the accumulation of collagen fibers, and down-regulates VEGF expression in the HS tissue. Conclusion: Rg3 can be employed as an early intervention and a combining therapeutic drug to reduce inflammation and HS formation as well.	[Cheng, Liying; Sun, Xiaoming; Jin, Rong; Sun, Baoshan; Shi, Yaoming; Zhang, Yuguang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Plast & Reconstruct Surg, Shanghai 200011, Peoples R China; [Hu, Changmin; Cui, Wenguo] Soochow Univ, Inst Orthoped, Suzhou 215006, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Cui, WG (corresponding author), Soochow Univ, Inst Orthoped, 708 Renmin Rd, Suzhou 215006, Jiangsu, Peoples R China.	wgcui80@hotmail.com; zhangyg18@126.com	Hu, Changmin/N-3508-2017	Hu, Changmin/0000-0002-1472-9981	National Natural Science Foundation of China [81372703, 51373112]; Science and Technology Commission of Shanghai fund grant [11 nm0503400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai fund grant	This work was supported in part by National Natural Science Foundation of China (grant number: 81372703, 51373112) (http://www.nsfc.gov.cn/) and Science and Technology Commission of Shanghai fund grant (grant number: 11 nm0503400) (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir HU, 2014, J THORAC DIS, V6, P66, DOI 10.3978/j.issn.2072-1439.2013.12.54; Alster TS, 2003, AM J CLIN DERMATOL, V4, P235, DOI 10.2165/00128071-200304040-00003; Bae JS, 2012, J NAT MED-TOKYO, V66, P476, DOI 10.1007/s11418-011-0609-8; Berman B, 1998, EUR J DERMATOL, V8, P591; Chen JX, 2008, MELANOMA RES, V18, P322, DOI 10.1097/CMR.0b013e32830b3536; Chen QJ, 2010, CELL PHYSIOL BIOCHEM, V26, P849, DOI 10.1159/000323994; CHEN S E, 1980, European Journal of Drug Metabolism and Pharmacokinetics, V5, P161; Coon JT, 2002, DRUG SAFETY, V25, P323, DOI 10.2165/00002018-200225050-00003; Cui Y, 2010, WORLD J GASTROENTERO, V16, P445, DOI 10.3748/wjg.v16.i4.445; Ghahary A, 2005, J INVEST DERMATOL, V124, P170, DOI 10.1111/j.0022-202X.2004.23521.x; Goppold A, 2011, EUR J DERMATOL, V21, P262, DOI 10.1684/ejd.2010.1230; Haurani MJ, 2009, PLAST RECONSTR SURG, V123, P139, DOI 10.1097/PRS.0b013e3181904d1b; Hayashi T, 2012, DERMATOL SURG, V38, P893, DOI 10.1111/j.1524-4725.2012.02345.x; Jiang JW, 2011, WORLD J GASTROENTERO, V17, P3605, DOI 10.3748/wjg.v17.i31.3605; Joo SS, 2008, BIOL PHARM BULL, V31, P1392, DOI 10.1248/bpb.31.1392; Juckett G, 2009, AM FAM PHYSICIAN, V80, P253; Keum YS, 2003, MUTAT RES-FUND MOL M, V523, P75, DOI 10.1016/S0027-5107(02)00323-8; Kim JW, 2012, PHYTOTHER RES, V26, P1286, DOI 10.1002/ptr.3722; Kim SM, 2010, EUR J PHARMACOL, V631, P1, DOI 10.1016/j.ejphar.2009.12.018; Kwon HY, 2008, ARCH PHARM RES, V31, P171, DOI 10.1007/s12272-001-1137-y; LARRABEE WF, 1990, ARCH OTOLARYNGOL, V116, P1159; Levy LL, 2012, AM J CLIN DERMATOL, V13, P331, DOI 10.2165/11631410-000000000-00000; Liu JP, 2012, FOOD CHEM TOXICOL, V50, P3388, DOI 10.1016/j.fct.2012.07.004; Liu TG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-250; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Sai K, 2006, NEUROTOXICOLOGY, V27, P458, DOI 10.1016/j.neuro.2005.12.008; Saray Y, 2005, INT J DERMATOL, V44, P777, DOI 10.1111/j.1365-4632.2005.02633.x; Seo YJ, 2008, ARCH PHARM RES, V31, P364, DOI [10.1007/s12272-001-1165-x, 10.1007/s00000-001-1165-x]; SHEN R, 2009, ZHONGHUA ZHENG XING, V19, P254; Shockman S, 2010, J DRUGS DERMATOL, V9, P1249; Slemp AE, 2006, CURR OPIN PEDIATR, V18, P396, DOI 10.1097/01.mop.0000236389.41462.ef; Slominski A, 2013, J CLIN ENDOCR METAB, V98, pE298, DOI 10.1210/jc.2012-3074; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; SLOMINSKI AT, 2011, J INVEST DERMATOL; Urioste SS, 1999, SEMIN CUTAN MED SURG, V18, P159, DOI 10.1016/S1085-5629(99)80040-6; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Wang JF, 2007, J INTERF CYTOK RES, V27, P921, DOI 10.1089/jir.2007.0008; Williams CC, 2011, J FAM PRACTICE, V60, P757; Xie HT, 2005, J CHROMATOGR B, V818, P167, DOI 10.1016/j.jchromb.2004.12.028; Yoo HH, 2006, AM J CHINESE MED, V34, P137, DOI 10.1142/S0192415X06003709; Yuan HD, 2010, MOL MED REP, V3, P825, DOI 10.3892/mmr.2010.328; Yue Yi-gang, 2006, Zhonghua Shao Shang Za Zhi, V22, P427; Zhang CL, 2012, MOL MED REP, V5, P1295, DOI 10.3892/mmr.2012.808; Zhang GY, 2011, BRIT J DERMATOL, V164, P729, DOI 10.1111/j.1365-2133.2010.10130.x; Zhang QY, 2008, CANCER BIOTHER RADIO, V23, P647, DOI 10.1089/cbr.2008.0532	47	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113640	10.1371/journal.pone.0113640	http://dx.doi.org/10.1371/journal.pone.0113640			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502572	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400013
J	Poll, G; Li, S; Ohmayer, U; Hierlmeier, T; Milkereit, P; Perez-Fernandez, J				Poell, Gisela; Li, Shuang; Ohmayer, Uli; Hierlmeier, Thomas; Milkereit, Philipp; Perez-Fernandez, Jorge			In Vitro Reconstitution of Yeast tUTP/UTP A and UTP B Subcomplexes Provides New Insights into Their Modular Architecture	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; BIOGENESIS; TRANSCRIPTION; EXPRESSION; PROCESSOME; COMPLEXES; CELLS	Eukaryotic ribosome biogenesis is a multistep process involving more than 150 biogenesis factors, which interact transiently with pre-ribosomal particles to promote their maturation. Some of these auxiliary proteins have been isolated in complexes found separate from the ribosomal environment. Among them, are 3 large UTP subcomplexes containing 6 or 7 protein subunits which are involved in the early steps of ribosome biogenesis. The composition of the UTP subcomplexes and the network of binary interactions between protein subunits have been analyzed previously. To obtain further insights into the structural and biochemical properties of UTP subcomplexes, we established a heterologous expression system to allow reconstitution of the yeast tUTP/UTP A and UTP B subcomplexes from their candidate subunits. The results of a series of reconstitution experiments involving different combinations of protein subunits are in good agreement with most of the previously observed binary interactions. Moreover, in combination with additional biochemical analyses, several stable building blocks of the UTP subcomplexes were identified. Based on these findings, we present a refined model of the tUTP/UTP A and UTP B architecture.	[Poell, Gisela; Li, Shuang; Ohmayer, Uli; Hierlmeier, Thomas; Milkereit, Philipp; Perez-Fernandez, Jorge] Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany	University of Regensburg	Perez-Fernandez, J (corresponding author), Univ Regensburg, Lehrstuhl Biochem 3, D-93053 Regensburg, Germany.	jpfernandez@ur.de	Perez-Fernandez, Jorge/F-6937-2010	Perez-Fernandez, Jorge/0000-0002-0018-5493	Deutsche Forschungsgemeinschaft [SFB 960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant which was given in the collaborative research center SFB 960 from the "Deutsche Forschungsgemeinschaft'' to PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Dosil M, 2004, J BIOL CHEM, V279, P37385, DOI 10.1074/jbc.M404909200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Eswara MBK, 2009, MOL BIOL CELL, V20, P5007, DOI 10.1091/mbc.E09-06-0490; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; Kressler D, 2010, BBA-MOL CELL RES, V1803, P673, DOI 10.1016/j.bbamcr.2009.10.009; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Reiter A, 2011, MOL CELL BIOL, V31, P803, DOI 10.1128/MCB.01227-10; SAMBROOK J, 2000, MOL CLONING LAB MANU; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086540	23	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114898	10.1371/journal.pone.0114898	http://dx.doi.org/10.1371/journal.pone.0114898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501974	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400062
J	Meyers, K; Rodriguez, K; Moeller, RW; Gratch, I; Markowitz, M; Halkitis, PN				Meyers, Kathrine; Rodriguez, Kristina; Moeller, Robert W.; Gratch, Ilana; Markowitz, Martin; Halkitis, Perry N.			High Interest in a Long-Acting Injectable Formulation of Pre-Exposure Prophylaxis for HIV in Young Men Who Have Sex with Men in NYC: A P18 Cohort Substudy	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; BISEXUAL MEN; SERODISCORDANT COUPLES; NEGATIVE GAY; PREVENTION; ACCEPTABILITY; ATTITUDES; BARRIERS; FACILITATORS; WILLINGNESS	Objective: In the context of continued high rates of condomless anal intercourse and HIV-1 infection, young men who have sex with men (YMSM) need additional effective and desirable HIV prevention tools. This study reports on the willingness of a racially-ethnically diverse cohort of YMSM to use a new biomedical prevention approach, a long-acting injectable pre-exposure prophylaxis (LAI-PrEP) agent. Methods: A cross-sectional study conducted between June-August 2013 recruited participants from an ongoing cohort study of YMSM in NYC. Participants included 197 YMSM, of whom 72.6% (n = 143) identified as men of color. Two outcomes were measured through computer-assisted self-interviews: 1) willingness to use long-acting injectable PrEP and 2) preference for route of administration of PrEP. In addition, concerns about perceived impacts of PrEP on health and risk behavior, access to health services, and stigma were investigated. Results: Over 80% (n = 159/197, p < 0.001) of participants stated they would be willing to use LAI-PrEP. With regards to preference for mode of delivery 79.2% (n = 156/197, p < 0.001) stated they would prefer an injection administered every three months over a daily pill or neither one. Conclusions: This study is the first to explore acceptability of LAI-PrEP in the US. A significant majority of participants expressed willingness to use LAI and the majority preferred LAI-PrEP. LAI-PrEP holds great promise in that it could circumvent the adherence challenges associated with daily dosing, especially if nested within appropriate psycho-behavioral support. Medical providers whose patients include YMSM at high risk for HIV infection should note the positive attitudes toward PrEP, and specifically LAI-PrEP.	[Meyers, Kathrine; Rodriguez, Kristina; Markowitz, Martin] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Moeller, Robert W.; Gratch, Ilana] Middlebury Coll, Middlebury, VT 05753 USA; [Halkitis, Perry N.] NYU, Ctr HIV Ident Behav & Prevent Studies, New York, NY 10003 USA; [Halkitis, Perry N.] NYU, Global Inst Publ Hlth, New York, NY USA; [Halkitis, Perry N.] NYU, Dept Populat Hlth, New York, NY USA	New York University; New York University; New York University	Halkitis, PN (corresponding author), NYU, Ctr HIV Ident Behav & Prevent Studies, New York, NY 10003 USA.	pnh1@nyu.edu	Moeller, Robert/AAV-6557-2020	Moeller, Robert/0000-0001-9218-4887	Aaron Diamond AIDS Research Center; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025537] Funding Source: NIH RePORTER	Aaron Diamond AIDS Research Center; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Aaron Diamond AIDS Research Center funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, 2012, RES COMB BIOM BEH AP; Andrews CD, 2014, SCIENCE, V343, P1151, DOI 10.1126/science.1248707; Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; CDC, 2012, HIV SURV REP; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Gilmore HJ, 2013, AIDS PATIENT CARE ST, V27, P560, DOI 10.1089/apc.2013.0116; Goodman E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e31; Grant RM, 2014, LANCET INFECT DIS; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Heffron R, 2012, JAIDS-J ACQ IMM DEF, V61, P116, DOI 10.1097/QAI.0b013e31825da73f; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; Mansergh G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001286; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Mimiaga MJ, 2013, ARCH SEX BEHAV; Nodin N, 2008, AIDS CARE, V20, P106, DOI 10.1080/09540120701449096; NYC DOHMH, 2012, NEW YORK CIT HIV AID; Peinado J, 2013, J INT ASS PHYS AIDS; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Tangmunkongvorakul A, 2013, AIDS CARE, V25, P961, DOI 10.1080/09540121.2012.748871; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Van der Elst EM, 2012, AIDS BEHAV; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329	31	58	58	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114700	10.1371/journal.pone.0114700	http://dx.doi.org/10.1371/journal.pone.0114700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25502768	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700047
J	Puig-Oliveras, A; Ballester, M; Corominas, J; Revilla, M; Estelle, J; Fernandez, AI; Ramayo-Caldas, Y; Folch, JM				Puig-Oliveras, Anna; Ballester, Maria; Corominas, Jordi; Revilla, Manuel; Estelle, Jordi; Fernandez, Ana I.; Ramayo-Caldas, Yuliaxis; Folch, Josep M.			A Co-Association Network Analysis of the Genetic Determination of Pig Conformation, Growth and Fatness	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; TYROSINE KINASES; COMPLEX TRAITS; CELL-ADHESION; MEAT QUALITY; NITRIC-OXIDE; PPAR-GAMMA; METABOLISM; MICE	Background: Several QTLs have been identified for major economically relevant traits in livestock, such as growth and meat quality, revealing the complex genetic architecture of these traits. The use of network approaches considering the interactions of multiple molecules and traits provides useful insights into the molecular underpinnings of complex traits. Here, a network based methodology, named Association Weight Matrix, was applied to study gene interactions and pathways affecting pig conformation, growth and fatness traits. Results: The co-association network analysis underpinned three transcription factors, PPARc, ELF1, and PRDM16 involved in mesoderm tissue differentiation. Fifty-four genes in the network belonged to growth-related ontologies and 46 of them were common with a similar study for growth in cattle supporting our results. The functional analysis uncovered the lipid metabolism and the corticotrophin and gonadotrophin release hormone pathways among the most important pathways influencing these traits. Our results suggest that the genes and pathways here identified are important determining either the total body weight of the animal and the fat content. For instance, a switch in the mesoderm tissue differentiation may determinate the age-related preferred pathways being in the puberty stage those related with the miogenic and osteogenic lineages; on the contrary, in the maturity stage cells may be more prone to the adipocyte fate. Hence, our results demonstrate that an integrative genomic co-association analysis is a powerful approach for identifying new connections and interactions among genes. Conclusions: This work provides insights about pathways and key regulators which may be important determining the animal growth, conformation and body proportions and fatness traits. Molecular information concerning genes and pathways here described may be crucial	[Puig-Oliveras, Anna; Ballester, Maria; Corominas, Jordi; Revilla, Manuel; Ramayo-Caldas, Yuliaxis; Folch, Josep M.] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra 08193, Spain; [Puig-Oliveras, Anna; Ballester, Maria; Corominas, Jordi; Revilla, Manuel; Ramayo-Caldas, Yuliaxis; Folch, Josep M.] Ctr Recerca Agrigen CRAG, Bellaterra 08193, Spain; [Estelle, Jordi; Ramayo-Caldas, Yuliaxis] INRA, GABI, UMR1313, F-78350 Jouy En Josas, France; [Estelle, Jordi; Ramayo-Caldas, Yuliaxis] AgroParisTech, GABI, UMR1313, F-78350 Jouy En Josas, France; [Estelle, Jordi; Ramayo-Caldas, Yuliaxis] CEA, LREG, Commissariat Energie Atom & Energies Alternat, F-78350 Jouy En Josas, France; [Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr Alimentaria INIA, Dept Genet Anim, Madrid 28040, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Puig-Oliveras, A (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Bellaterra 08193, Spain.	anna.puig@cragenomica.es	Ballester, Maria/E-7201-2016; Corominas Galbany, Jordi/B-6356-2018; Folch, Josep M/I-4738-2015; Revilla, Manuel/U-9033-2018; Fernández, Ana Isabel/J-3265-2012; Devis, Maria Ballester/AAV-2467-2020; Estellé, Jordi/A-7976-2008; Caldas, Yuliaxis Ramayo/B-6337-2014; Puig Oliveras, Anna/M-5551-2015	Ballester, Maria/0000-0002-5413-4640; Corominas Galbany, Jordi/0000-0003-1736-1278; Folch, Josep M/0000-0003-3689-1303; Revilla, Manuel/0000-0002-0164-9317; Fernández, Ana Isabel/0000-0002-1509-5191; Devis, Maria Ballester/0000-0002-5413-4640; Estellé, Jordi/0000-0002-6241-1732; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Puig Oliveras, Anna/0000-0003-2551-9012	MICINN project [AGL2011-29821-C02]; Innovation Consolider-Ingenio Program [CSD2007-00036]; Universitat Autonoma de Barcelona [458-01-1/2011]; Spanish Ministerio de Educacion [BES-2009-018223]; Spanish Ministerio [AP2008-01450]; Generalitat de Catalunya [ECO/1639/2013]	MICINN project(Spanish Government); Innovation Consolider-Ingenio Program; Universitat Autonoma de Barcelona; Spanish Ministerio de Educacion(Spanish Government); Spanish Ministerio; Generalitat de Catalunya(Generalitat de Catalunya)	This work has been funded by MICINN project AGL2011-29821-C02 (Ministerio de Economia y Competitividad), and by the Innovation Consolider-Ingenio 2010 Program (CSD2007-00036, Centre de Recerca en Agrigenomica). APO was funded by a Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona (458-01-1/2011). JC was funded by a Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion (BES-2009-018223), YRC by a Formacion del Profesorado Universitario (FPU) PhD grant from the Spanish Ministerio (AP2008-01450), and MR by a Formacio i Contractacio de Personal Investigador Novell (FI-DGR) PhD grant from Generalitat de Catalunya (ECO/1639/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Allen DB, 1996, ENDOCRIN METAB CLIN, V25, P699, DOI 10.1016/S0889-8529(05)70348-0; [Anonymous], 2008, FATS FATT AC HUM NUT; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Baek K, 2013, ADIPOCYTE, V2, P50, DOI 10.4161/adip.22019; Bakthavatsalam D, 2006, TRENDS MICROBIOL, V14, P378, DOI 10.1016/j.tim.2006.07.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Calero-Nieto FJ, 2010, NUCLEIC ACIDS RES, V38, P6363, DOI 10.1093/nar/gkq490; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Chang PY, 2006, MOL CANCER RES, V4, P101, DOI 10.1158/1541-7786.MCR-05-0259; Chen Z, 2011, GENET MOL BIOL, V34, P56, DOI 10.1590/S1415-47572010005000107; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Cordani N, 2014, STEM CELLS, V32, P874, DOI 10.1002/stem.1587; Dai ZL, 2013, BIOFACTORS, V39, P383, DOI 10.1002/biof.1099; Decrock E, 2013, BBA-MOL CELL RES, V1833, P1772, DOI 10.1016/j.bbamcr.2012.12.016; Dodson MV, 2010, INT J BIOL SCI, V6, P691; Dube A, 2001, CIRC RES, V88, P237; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Fernandez A., 2007, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P43; Fernandez AI, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-41; Fortes MRS, 2012, J ANIM SCI, V90, P2894, DOI 10.2527/jas.2011-4601; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gispert M, 2007, MEAT SCI, V77, P397, DOI 10.1016/j.meatsci.2007.04.006; Gjerlaug-Enger E, 2012, ANIMAL, V6, P9, DOI 10.1017/S1751731111001455; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hume JR, 2009, VASC PHARMACOL, V50, P89, DOI 10.1016/j.vph.2008.11.001; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Jung C, 2004, CANCER RES, V64, P9185, DOI 10.1158/0008-5472.CAN-04-1330; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Kantas D, 2014, J ANIM SCI, V92, P2251, DOI 10.2527/jas.2013-6924; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Laumet G, 2010, NEUROSCI LETT, V468, P1, DOI 10.1016/j.neulet.2009.10.040; Lee TK, 2014, PSYCHONEUROENDOCRINO, V47, P166, DOI 10.1016/j.psyneuen.2014.05.015; Leyme A, 2012, MOL BIOL CELL, V23, P3461, DOI 10.1091/mbc.E11-11-0918; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mul D, 2008, EUR J ENDOCRINOL, V159, pS3, DOI 10.1530/EJE-08-0814; Norris JD, 2009, MOL CELL, V36, P405, DOI 10.1016/j.molcel.2009.10.020; O'Gorman CW, 2010, J ANIM PHYSIOL AN N, V94, pE266, DOI 10.1111/j.1439-0396.2009.00968.x; Oettgen P, 1996, MOL CELL BIOL, V16, P5091; OWENS FN, 1993, J ANIM SCI, V71, P3138, DOI 10.2527/1993.71113138x; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2014, J ANIM SCI; Ramayo-Caldas Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-232; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rao DC, 2008, ADV GENET, V60, P3, DOI 10.1016/S0065-2660(07)00401-4; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter Antonio, 2013, Methods Mol Biol, V1019, P437, DOI 10.1007/978-1-62703-447-0_20; Rieusset J, 2004, MOL ENDOCRINOL, V18, P2363, DOI 10.1210/me.2003-0325; Rubinek T, 2005, ENDOCRINE, V28, P209, DOI 10.1385/ENDO:28:2:209; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Serra X, 1998, LIVEST PROD SCI, V56, P215, DOI 10.1016/S0301-6226(98)00151-1; Serrano MP, 2012, SPAN J AGR RES, V11; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Stevens A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-547; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sutton P, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-76; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Widmann P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-798; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xiang P, 2010, EXP HEMATOL, V38, P798, DOI 10.1016/j.exphem.2010.06.006	85	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114862	10.1371/journal.pone.0114862	http://dx.doi.org/10.1371/journal.pone.0114862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503799	Green Published, gold			2022-12-27	WOS:000347146700061
J	Cho, I; Park, H; Choi, YJ; Hwang, MH; Bates, DW				Cho, Insook; Park, Hyeok; Choi, Youn Jeong; Hwang, Mi Heui; Bates, David W.			Understanding the Nature of Medication Errors in an ICU with a Computerized Physician Order Entry System	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; ADVERSE DRUG EVENTS; ADMINISTRATION ERRORS; FACILITIES; SAFETY; IMPACT; RECORD	Objectives: We investigated incidence rates to understand the nature of medication errors potentially introduced by utilizing a computerized physician order entry (CPOE) system in the three clinical phases of the medication process: prescription, administration, and documentation. Methods: Overt observations and chart reviews were employed at two surgical intensive care units of a 950-bed tertiary teaching hospital. Ten categories of high-risk drugs prescribed over a four-month period were noted and reviewed. Error definition and classifications were adapted from previous studies for use in the present research. Incidences of medication errors in the three phases of the medication process were analyzed. In addition, nurses' responses to prescription errors were also assessed. Results: Of the 534 prescriptions issued, 286 (53.6%) included at least one error. The proportion of errors was 19.0% (58) of the 306 drug administrations, of which two-thirds were verbal orders classified as errors due to incorrectly entered prescriptions. Documentation errors occurred in 205 (82.7%) of 248 correctly performed administrations. When tracking incorrectly entered prescriptions, 93% of the errors were intercepted by nurses, but two-thirds of them were recorded as prescribed rather than administered. Conclusion: The number of errors occurring at each phase of the medication process was relatively high, despite long experience with a CPOE system. The main causes of administration errors and documentation errors were prescription errors and verbal order processes. To reduce these errors, hospital-level and unit-level efforts toward a better system are needed.	[Cho, Insook; Choi, Youn Jeong; Hwang, Mi Heui] Inha Univ, Dept Nursing, Inchon, South Korea; [Cho, Insook; Bates, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Cho, Insook; Bates, David W.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Park, Hyeok; Choi, Youn Jeong; Hwang, Mi Heui] Inha Univ Hosp, Dept Nursing, Inchon, South Korea; [Bates, David W.] Partners Healthcare Syst Inc, Wellesley, MA USA	Inha University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Inha University; Inha University Hospital; Partners Healthcare System	Cho, I (corresponding author), Inha Univ, Dept Nursing, Inchon, South Korea.	Insook.cho@inha.ac.kr	Bates, David/AAE-7283-2019	Cho, Insook/0000-0002-5152-9567	Korea Research Foundation Grant - Korean Government (MOEHRD) [331-2007-1-E00273, KRF-2013R1A1A2006387]; Centers for Education and Research on Therapeutics (CERT) [U19HS021094]; Agency for Healthcare Research and Quality, Rockville, MD, USA; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021094] Funding Source: NIH RePORTER	Korea Research Foundation Grant - Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaNational Research Foundation of KoreaKorean Government); Centers for Education and Research on Therapeutics (CERT); Agency for Healthcare Research and Quality, Rockville, MD, USA(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, 331-2007-1-E00273). D.W.B was sponsored by the Centers for Education and Research on Therapeutics (CERT Grant # U19HS021094), Agency for Healthcare Research and Quality, Rockville, MD, USA. I.C. was also supported by a Korea Research Foundation Grant, which was funded by the Korean Government (MOEHRD, No. KRF-2013R1A1A2006387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali J, 2010, ANAESTHESIA, V65, P119, DOI 10.1111/j.1365-2044.2009.06134.x; Aspden P., 2006, I MED, P26; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Bradley Victoria M, 2006, J Healthc Inf Manag, V20, P46; Calabrese AD, 2001, INTENS CARE MED, V27, P1592, DOI 10.1007/s001340101065; Cho I, 2009, STUD HEALTH TECHNOL, V146, P445, DOI 10.3233/978-1-60750-024-7-445; Colpaert K, 2006, CRIT CARE, V10, DOI 10.1186/cc3983; DeYoung JL, 2009, AM J HEALTH-SYST PH, V66, P1110, DOI 10.2146/ajhp080355; Flynn EA, 2002, AM J HEALTH-SYST PH, V59, P436, DOI 10.1093/ajhp/59.5.436; Heo JH, 2013, INT J MED INFORM, V82, P987, DOI 10.1016/j.ijmedinf.2013.07.001; Institute for Safe Medication Practices, 2008, I SAF MED PRACT HIGH; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lee KO, 2000, J KOREAN ACAD NURS, V30, P1243; Magrabi F, 2010, J AM MED INFORM ASSN, V17, P575, DOI 10.1136/jamia.2009.001719; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Middleton B, 2013, J AM MED INFORM ASSN, V20, pE2, DOI 10.1136/amiajnl-2012-001458; Moreland PJ, 2012, CIN-COMPUT INFORM NU, V30, P97, DOI 10.1097/NCN.0b013e318224b54e; Nanji KC, 2011, J AM MED INFORM ASSN, V18, P767, DOI 10.1136/amiajnl-2011-000205; Page A., 2004, KEEPING PATIENTS SAF; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857; van den Bemt PMLA, 2002, CRIT CARE MED, V30, P846, DOI 10.1097/00003246-200204000-00022; Walsh KE, 2006, PEDIATRICS, V118, P1872, DOI 10.1542/peds.2006-0810; Warrick C, 2011, INTENS CARE MED, V37, P691, DOI 10.1007/s00134-010-2126-8; Wilmer A, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030783	25	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114243	10.1371/journal.pone.0114243	http://dx.doi.org/10.1371/journal.pone.0114243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25526059	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200001
J	Du, ZY; Wang, QF				Du, Zhi-Yuan; Wang, Qing-Feng			Correlations of Life Form, Pollination Mode and Sexual System in Aquatic Angiosperms	PLOS ONE			English	Article							EVOLUTION; BIOLOGY; POLLEN; CALLITRICHACEAE; REPRODUCTION; POTAMOGETON; SEAGRASSES; PLANTS	Aquatic plants are phylogenetically well dispersed across the angiosperms. Reproductive and other life-history traits of aquatic angiosperms are closely associated with specific growth forms. Hydrophilous pollination exhibits notable examples of convergent evolution in angiosperm reproductive structures, and hydrophiles exhibit great diversity in sexual system. In this study, we reconstructed ancestral characters of aquatic lineages based on the phylogeny of aquatic angiosperms. Our aim is to find the correlations of life form, pollination mode and sexual system in aquatic angiosperms. Hydrophily is the adaptive evolution of completely submersed angiosperms to aquatic habitats. Hydroautogamy and maleflower-ephydrophily are the transitional stages from anemophily and entomophily to hydrophily. True hydrophily occurs in 18 submersed angiosperm genera, which is associated with an unusually high incidence of unisexual flowers. All marine angiosperms are submersed, hydrophilous species. This study would help us understand the evolution of hydrophilous pollination and its correlations with life form and sexual system.	[Du, Zhi-Yuan; Wang, Qing-Feng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Wang, QF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	qfwang@wbgcas.cn			National Natural Science Foundation of China [31100175]; Chinese Academy of Sciences [XDAO5090305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (Grant No. 31100175) to ZYD and the strategic pilot science and technology projects of the Chinese Academy of Sciences (Grant No. XDAO5090305) to QFW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1995, EVOL ECOL, V9, P139, DOI 10.1007/BF01237753; Ackerman JD, 1998, FUNCT ECOL, V12, P979; Ackerman JD, 2000, PLANT SYST EVOL, V222, P167, DOI 10.1007/BF00984101; Arber A., 1920, WATER PLANTS STUDY A; Barrett Spencer C. H., 1997, P225; Charlesworth D, 2002, HEREDITY, V88, P94, DOI 10.1038/sj.hdy.6800016; Cook C.D.K., 1990, AQUATIC PLANT BOOK; COOK CDK, 1988, ANN MO BOT GARD, V75, P768, DOI 10.2307/2399365; Cook Christopher D.K., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P79, DOI 10.1078/1433-8319-00066; COX PA, 1988, ANNU REV ECOL SYST, V19, P261, DOI 10.1146/annurev.es.19.110188.001401; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; Endress PK, 2004, AUST SYST BOT, V17, P343, DOI 10.1071/SB04004; GRACE JB, 1993, AQUAT BOT, V44, P159, DOI 10.1016/0304-3770(93)90070-D; GUO YH, 1989, AQUAT BOT, V34, P381; GUO YH, 1990, AQUAT BOT, V38, P283, DOI 10.1016/0304-3770(90)90011-9; Iles WJD, 2012, AM J BOT, V99, P663, DOI 10.3732/ajb.1100524; Lansdown R.V., 2012, STATUS DISTRIBUTION, P117; LES DH, 1988, ANN MO BOT GARD, V75, P819, DOI 10.2307/2399370; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Maddison W., 2018, MESQUITE MODULAR SYS; Philbrick CT, 1996, BIOSCIENCE, V46, P813, DOI 10.2307/1312967; PHILBRICK CT, 1992, SYST BOT, V17, P282, DOI 10.2307/2419523; PHILBRICK CT, 1993, AM J BOT, V80, P391, DOI 10.2307/2445385; PHILBRICK CT, 1988, ANN MO BOT GARD, V75, P836, DOI 10.2307/2399371; PHILBRICK CT, 1987, SYST BOT, V12, P98, DOI 10.2307/2419218; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA	27	12	13	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115653	10.1371/journal.pone.0115653	http://dx.doi.org/10.1371/journal.pone.0115653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25525810	gold, Green Submitted, Green Published			2022-12-27	WOS:000347186200041
J	Dziaman, T; Ludwiczak, H; Ciesla, JM; Banaszkiewicz, Z; Winczura, A; Chmielarczyk, M; Wisniewska, E; Marszalek, A; Tudek, B; Olinski, R				Dziaman, Tomasz; Ludwiczak, Hubert; Ciesla, Jaroslaw M.; Banaszkiewicz, Zbigniew; Winczura, Alicja; Chmielarczyk, Mateusz; Wisniewska, Ewa; Marszalek, Andrzej; Tudek, Barbara; Olinski, Ryszard			PARP-1 Expression is Increased in Colon Adenoma and Carcinoma and Correlates with OGG1	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE-1; SER326CYS POLYMORPHISM; REPAIR PATHWAY; LUNG-CANCER; GENE; STRESS; RISK; CARCINOGENESIS; CANCERIZATION	The ethiology of colon cancer is largely dependent on inflammation driven oxidative stress. The analysis of 8-oxodeoxyguanosine (8-oxodGuo) level in leukocyte DNA of healthy controls (138 individuals), patients with benign adenomas (AD, 137 individuals) and with malignant carcinomas (CRC, 169 individuals) revealed a significant increase in the level of 8-oxodGuo in leukocyte DNA of AD and CRC patients in comparison to controls. The counteracting mechanism is base excision repair, in which OGG1 and PARP-1 play a key role. We investigated the level of PARP-1 and OGG1 mRNA and protein in diseased and marginal, normal tissues taken from AD and CRC patients and in leukocytes taken from the patients as well as from healthy subjects. In colon tumors the PARP-1 mRNA level was higher than in unaffected colon tissue and in polyp tissues. A high positive correlation was found between PARP-1 and OGG1 mRNA levels in all investigated tissues. This suggests reciprocal influence of PARP-1 and OGG1 on their expression and stability, and may contribute to progression of colon cancer. PARP-1 and OGG1 proteins level was several fold higher in polyps and CRC in comparison to normal colon tissues. Individuals bearing the Cys326Cys genotype of OGG1 were characterized by higher PARP-1 protein level in diseased tissues than the Ser326Cys and Ser326Ser genotypes. Aforementioned result may suggest that the diseased cells with polymorphic OGG1 recruit more PARP protein, which is necessary to remove 8-oxodGuo. Thus, patients with decreased activity of OGG1/polymorphism of the OGG1 gene and higher 8-oxodGuo level may be more susceptible to treatment with PARP-1 inhibitors.	[Dziaman, Tomasz; Olinski, Ryszard] Nicolaus Copernicus Univ, Dept Clin Biochem, Coll Med, PO-85092 Bydgoszcz, Poland; [Ludwiczak, Hubert; Ciesla, Jaroslaw M.; Winczura, Alicja; Tudek, Barbara] Polish Acad Sci, Inst Biochem & Biophys, PO-02106 Warsaw, Poland; [Banaszkiewicz, Zbigniew] Nicolaus Copernicus Univ, Dept Surg, Coll Med, PO-85092 Bydgoszcz, Poland; [Chmielarczyk, Mateusz; Tudek, Barbara] Univ Warsaw, Inst Genet & Biotechnol, Fac Biol, PO-02106 Warsaw, Poland; [Wisniewska, Ewa; Marszalek, Andrzej] Nicolaus Copernicus Univ, Dept Clin Pathomorphol, Coll Med, PO-85092 Bydgoszcz, Poland; [Marszalek, Andrzej] Univ Med Sci, Dept Oncol Pathol, PO-61868 Poznan, Poland; [Marszalek, Andrzej] Wielkopolskie Oncol Ctr, PO-61868 Poznan, Poland	Nicolaus Copernicus University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Nicolaus Copernicus University; University of Warsaw; Nicolaus Copernicus University; Wielkopolskie Centrum Onkologii	Tudek, B (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Pawinskiego 5a, PO-02106 Warsaw, Poland.	tudek@ibb.waw.pl; ryszardo@cm.umk.pl	Dziaman, Tomasz/E-5240-2014; Dziaman, Tomasz/P-6426-2019; Olinski, Ryszard/E-9607-2014	Dziaman, Tomasz/0000-0001-6802-4832; Ciesla, Jaroslaw/0000-0003-0695-7201; Chmielarczyk, Mateusz/0000-0003-2067-1031; Olinski, Ryszard/0000-0001-9927-8755	Polish Ministry of Science and Higher Education [N N401 280039]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was financed by the Polish Ministry of Science and Higher Education grant N N401 280039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Quesada R, 2007, CURR MED CHEM, V14, P1179, DOI 10.2174/092986707780597998; Amente S, 2010, CELL CYCLE, V9, P3002, DOI 10.4161/cc.9.15.12499; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; Bieche I, 1996, CLIN CANCER RES, V2, P1163; Blake DJ, 2007, TOXICOL SCI, V99, P277, DOI 10.1093/toxsci/kfm166; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Chen L, 2003, J UROLOGY, V170, P2471, DOI 10.1097/01.ju.0000087498.23008.bb; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P1100; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Cooke MS, 2006, CLIN CHIM ACTA, V365, P30, DOI 10.1016/j.cca.2005.09.009; Curtin N, 2014, BIOCHEM SOC T, V42, P82, DOI 10.1042/BST20130187; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Fekete A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042690; Flohr C, 2003, NUCLEIC ACIDS RES, V31, P5332, DOI 10.1093/nar/gkg715; Gackowski D, 2002, INT J CANCER, V101, P395, DOI 10.1002/ijc.10610; Ghabreau L, 2004, INT J CANCER, V109, P317, DOI 10.1002/ijc.11731; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Goodman M, 2008, CANCER CAUSE CONTROL, V19, P1051, DOI 10.1007/s10552-008-9169-y; Hatt L, 2008, MUTAT RES-FUND MOL M, V639, P45, DOI 10.1016/j.mrfmmm.2007.11.002; Hawthorn L, 2014, GENOMICS, V103, P211, DOI 10.1016/j.ygeno.2013.11.003; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; HIRAI K, 1983, CANCER RES, V43, P3441; Idogawa M, 2005, GASTROENTEROLOGY, V128, P1919, DOI 10.1053/j.gastro.2005.03.007; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Janik J, 2011, MUTAT RES-FUND MOL M, V709-10, P21, DOI 10.1016/j.mrfmmm.2011.02.009; JARUGA P, 1994, FEBS LETT, V341, P59, DOI 10.1016/0014-5793(94)80240-8; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Leung EYL, 2008, INT J CANCER, V123, P2460, DOI 10.1002/ijc.23811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Nosho K, 2006, EUR J CANCER, V42, P2374, DOI 10.1016/j.ejca.2006.01.061; Obtulowicz T, 2010, MUTAGENESIS, V25, P463, DOI 10.1093/mutage/geq028; Obtulowicz T, 2010, FREE RADICAL BIO MED, V49, P1064, DOI 10.1016/j.freeradbiomed.2010.06.027; Olinski R, 2003, MUTAT RES-FUND MOL M, V531, P177, DOI 10.1016/j.mrfmmm.2003.07.005; Olinski R, 2002, FREE RADICAL BIO MED, V33, P192, DOI 10.1016/S0891-5849(02)00878-X; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; REMMELE W, 1987, PATHOLOGE, V8, P138; Rodriguez-Hernandez A, 2006, APOPTOSIS, V11, P131, DOI 10.1007/s10495-005-3276-y; Saebo M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-208; Shimizu S, 2004, ONCOL REP, V12, P821; Shinmura K, 2001, ANTIOXID REDOX SIGN, V3, P597, DOI 10.1089/15230860152542952; Storr S J, 2012, Curr Mol Pharmacol, V5, P88; TOMODA T, 1991, AM J HEMATOL, V37, P223, DOI 10.1002/ajh.2830370402; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Xu ZG, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-144	51	40	41	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115558	10.1371/journal.pone.0115558	http://dx.doi.org/10.1371/journal.pone.0115558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526641	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200035
J	Fujimoto, N; Ohnuma, K; Aoe, K; Hosono, O; Yamada, T; Kishimoto, T; Morimoto, C				Fujimoto, Nobukazu; Ohnuma, Kei; Aoe, Keisuke; Hosono, Osamu; Yamada, Taketo; Kishimoto, Takumi; Morimoto, Chikao			Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; ANTI-CD26 MONOCLONAL-ANTIBODY; PROLONGED SURVIVAL; ASBESTOS EXPOSURE; EXPRESSION; OVEREXPRESSION; ASSOCIATION; METASTASIS; DIAGNOSIS; EFFUSION	There is no established single diagnostic marker for malignant pleural mesothelioma (MPM). CD26 is a 110 kDa, multifunctional, membrane-bound glycoprotein that has dipeptidyl peptidase IV (DPPIV) enzyme activity. The aim of this study was to evaluate the clinical significance of soluble CD26 (sCD26) in patients with MPM. The study included 80 MPM patients, 79 subjects with past asbestos exposure (SPE), and 134 patients with other benign pleural diseases (OPD) that were included as a control group. sCD26 levels and DPPIV activity in serum and/or pleural fluid were determined using an ELISA kit. Serum sCD26 levels and DPPIV enzyme activity in patients with MPM were significantly decreased compared with those in the SPE group (P=0.000). The level of serum sCD26 was significantly decreased in patients with advanced stages of MPM compared with those with earlier stages (P=0.047). The median OS of patients with MPM who had higher DPPIV enzyme activity was significantly longer than that of those with lower DPPIV enzyme activity (P=0.032). The sCD26 levels in the pleural fluid of MPM patients with an epithelioid subtype were significantly increased compared with the OPD cohort (P=0.012). Moreover, DPPIV enzyme activity in the pleural fluid of patients with MPM with an epithelioid subtype were significantly increased compared with those in the OPD cohort (P=0.009). Patients with MPM who had lower specific DPPIV activity, determined as DPPIV/sCD26, showed significantly prolonged survival compared with those with higher specific DPPIV activity (P=0.028). Serum sCD26 and DPPIV enzyme activity appear to be useful biomarkers for differentiating patients with MPM from SPE. The sCD26 levels or DPPIV enzyme activity in pleural fluid appear to be biomarkers in patients with an epithelioid subtype of MPM. DPPIV activity in serum or pleural fluid appears to be predictive for the prognosis of patients with MPM.	[Fujimoto, Nobukazu] Okayama Rosai Hosp, Dept Med Oncol, Okayama, Japan; [Ohnuma, Kei; Hosono, Osamu; Morimoto, Chikao] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Bunkyo Ku, Tokyo, Japan; [Aoe, Keisuke] Natl Hosp Org Yamaguchi Ube Med Ctr, Dept Med Oncol & Clin Res, Ube, Yamaguchi, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Kishimoto, Takumi] Okayama Rosai Hosp, Dept Internal Med, Okayama, Japan	Juntendo University; Keio University	Fujimoto, N (corresponding author), Okayama Rosai Hosp, Dept Med Oncol, Okayama, Japan.	nobufujimot@gmail.com	Fujimoto, Nobukazu/U-8488-2019	Fujimoto, Nobukazu/0000-0002-4516-0433	Ministry of Education, Science, Sports and Culture; Ministry of Health, Labor and Welfare, Japan; National Institute of Biomedical Innovation; Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [S1311011]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work was supported by grants-in-aid from the Ministry of Education, Science, Sports and Culture, and Ministry of Health, Labor and Welfare, Japan; by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; and a Grant-in-Aid (S1311011) from the Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.nibio.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, FRONT HORM RES, V36, P182, DOI 10.1159/000115365; AISNER J, 1995, CHEST, V108, P1122; Andrieu T, 2003, J CLIN VIROL, V27, P59, DOI 10.1016/S1386-6532(02)00128-2; Aoe K, 2012, CLIN CANCER RES, V18, P1447, DOI 10.1158/1078-0432.CCR-11-1990; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; CARBONE A, 1995, BLOOD, V86, P4617, DOI 10.1182/blood.V86.12.4617.bloodjournal86124617; Churg A, 2004, TUMOURS PLEURA; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; DROZ D, 1990, AM J PATHOL, V137, P895; Fujimoto N, 2013, RESPIR INVESTIG, V51, P92, DOI 10.1016/j.resinv.2013.02.002; Fujimoto N, 2010, EXP THER MED, V1, P313, DOI 10.3892/etm_00000048; Gemba K, 2013, ACTA ONCOL, V52, P803, DOI 10.3109/0284186X.2012.709948; Gemba K, 2012, CANCER SCI, V103, P483, DOI 10.1111/j.1349-7006.2011.02165.x; Ghani FI, 2011, BIOCHEM BIOPH RES CO, V404, P735, DOI 10.1016/j.bbrc.2010.12.054; Hammar SP, 2011, ASBESTOS INDUCED PLE; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Hirai K, 1999, PATHOL INT, V49, P264, DOI 10.1046/j.1440-1827.1999.00859.x; Ho L, 2001, CLIN CANCER RES, V7, P2031; Inamoto T, 2007, CLIN CANCER RES, V13, P4191, DOI 10.1158/1078-0432.CCR-07-0110; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; Ismail-Khan Roohi, 2006, Cancer Control, V13, P255; Kajiyama H, 2002, CANCER RES, V62, P2753; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Morimoto C, 1998, IMMUNOL REV, V161, P55, DOI 10.1111/j.1600-065X.1998.tb01571.x; Ohnuma K, 2004, P NATL ACAD SCI USA, V101, P14186, DOI 10.1073/pnas.0405266101; Ohnuma K, 2015, J CLIN LAB ANAL, V29, P106, DOI 10.1002/jcla.21736; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Pass HI, 2005, NEW ENGL J MED, V353, P1564, DOI 10.1056/NEJMoa051185; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Scherpereel A, 2006, AM J RESP CRIT CARE, V173, P1155, DOI 10.1164/rccm.200511-1789OC; Shiomi K, 2008, CLIN CANCER RES, V14, P1431, DOI 10.1158/1078-0432.CCR-07-1613; Stange T, 2000, EUR J HISTOCHEM, V44, P157; Sun YX, 2008, CLIN EXP METASTAS, V25, P765, DOI 10.1007/s10585-008-9188-9; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331	38	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115647	10.1371/journal.pone.0115647	http://dx.doi.org/10.1371/journal.pone.0115647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526639	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200040
J	Hirsch, PE; Schillinger, S; Weigt, H; Burkhardt-Holm, P				Hirsch, Philipp Emanuel; Schillinger, Sebastian; Weigt, Hannes; Burkhardt-Holm, Patricia			A Hydro-Economic Model for Water Level Fluctuations: Combining Limnology with Economics for Sustainable Development of Hydropower	PLOS ONE			English	Article							LAKE-LEVEL; RESERVOIR OPERATION; ECOLOGICAL IMPACTS; CLASS STRENGTH; CLIMATE-CHANGE; OPTIMIZATION; COMMUNITIES; INCREASE; RUNOFF; RIVERS	Water level fluctuations in lakes lead to shoreline displacement. The seasonality of flooding or beaching of the littoral area affects nutrient cycling, redox gradients in sediments, and life cycles of aquatic organisms. Despite the ecological importance of water level fluctuations, we still lack a method that assesses water levels in the context of hydropower operations. Water levels in reservoirs are influenced by the operator of a hydropower plant, who discharges water through the turbines or stores water in the reservoir, in a fashion that maximizes profit. This rationale governs the seasonal operation scheme and hence determines the water levels within the boundaries of the reservoir's water balance. For progress towards a sustainable development of hydropower, the benefits of this form of electricity generation have to be weighed against the possible detrimental effects of the anthropogenic water level fluctuations. We developed a hydro-economic model that combines an economic optimization function with hydrological estimators of the water balance of a reservoir. Applying this model allowed us to accurately predict water level fluctuations in a reservoir. The hydro-economic model also allowed for scenario calculation of how water levels change with climate change scenarios and with a change in operating scheme of the reservoir (increase in turbine capacity). Further model development will enable the consideration of a variety of additional parameters, such as water withdrawal for irrigation, drinking water supply, or altered energy policies. This advances our ability to sustainably manage water resources that must meet both economic and environmental demands.	[Hirsch, Philipp Emanuel; Schillinger, Sebastian; Weigt, Hannes] Univ Basel, Res Ctr Sustainable Energy & Water Supply, Basel, Switzerland; [Hirsch, Philipp Emanuel; Schillinger, Sebastian; Burkhardt-Holm, Patricia] Univ Basel, Dept Environm Sci, Program Man Soc Environm, Basel, Switzerland; [Burkhardt-Holm, Patricia] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Basel; University of Basel; University of Alberta	Hirsch, PE (corresponding author), Univ Basel, Res Ctr Sustainable Energy & Water Supply, Basel, Switzerland.	philipp.hirsch@unibas.ch		Weigt, Hannes/0000-0002-2036-9177; Hirsch, Philipp Emanuel/0000-0002-6927-2368	University of Basel; Amt fur Umwelt und Energie AUE, Basel; EBL: Genossenschaft Elektra Baselland; EBM: Genossenschaft Elektra Birseck; IWB: Industrielle Werke Basel	University of Basel; Amt fur Umwelt und Energie AUE, Basel; EBL: Genossenschaft Elektra Baselland; EBM: Genossenschaft Elektra Birseck; IWB: Industrielle Werke Basel	The study was funded by grants from the University of Basel to the Program Man-Society-Environment and conducted within the Research Centre for Sustainable Energy and Water Supply (FoNEW) which is funded by local sponsors (Amt fur Umwelt und Energie AUE, Basel; EBL: Genossenschaft Elektra Baselland; EBM: Genossenschaft Elektra Birseck; IWB: Industrielle Werke Basel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgottspon H, 2012, STOCHASTIC DYNAMIC P, P5; Alfieri L, 2006, WATER RESOUR MANAG, V20, P761, DOI 10.1007/s11269-005-9006-y; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Bednarek AT, 2001, ENVIRON MANAGE, V27, P803, DOI 10.1007/s002670010189; Cott PA, 2008, J AM WATER RESOUR AS, V44, P343, DOI 10.1111/j.1752-1688.2007.00166.x; Dienst M, 2004, LIMNOLOGICA, V34, P29, DOI 10.1016/S0075-9511(04)80019-7; Filippini M, 2001, PERSPEKTIVEN WASSERK; Finger D, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010733; Geraldes Ana Maria, 2005, Lakes & Reservoirs Research and Management, V10, P59, DOI 10.1111/j.1440-1770.2005.00257.x; Grumbine RE, 2013, SCIENCE, V339, P36, DOI 10.1126/science.1227211; Hampton SE, 2011, MAR FRESHWATER RES, V62, P350, DOI 10.1071/MF10229; Helland IP, 2010, STANDARDIZED BROWN T, P23; Hill T., 2006, STAT METHODS APPL; Jager HI, 2008, RIVER RES APPL, V24, P340, DOI 10.1002/rra.1069; Kadioglu M, 1997, ANN GEOPHYS-ATM HYDR, V15, P1489, DOI 10.1007/s00585-997-1489-9; Kahl U, 2008, LIMNOLOGICA, V38, P258, DOI 10.1016/j.limno.2008.06.006; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kimaite FM, 2011, THESIS; Kiviat E, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt008; Kobierska F, 2013, ADV WATER RESOUR, V55, P204, DOI 10.1016/j.advwatres.2012.07.024; Koboltschnig GR, 2008, HYDROL PROCESS, V22, P3950, DOI 10.1002/hyp.7112; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Kuhne A, 1978, GEOGR HELV, V33, P191; Larry W, 2009, WATER RESOURCES ENG; Liebe J, 2005, PHYS CHEM EARTH, V30, P448, DOI 10.1016/j.pce.2005.06.011; Luwesi CN, 2013, J AGR FOOD APPL SCI, V1, P46; Martorella M, 2006, EURASIP J APPL SIG P, DOI 10.1155/ASP/2006/87298; Meyer JL, 1999, J AM WATER RESOUR AS, V35, P1373, DOI 10.1111/j.1752-1688.1999.tb04222.x; Milbrink G, 2011, CAN J FISH AQUAT SCI, V68, P2167, DOI 10.1139/F2011-131; Mortsch LD, 1998, CLIMATIC CHANGE, V40, P391, DOI 10.1023/A:1005445709728; Moss Brian, 2008, Freshwater Reviews, V1, P29, DOI 10.1608/FRJ-1.1.2; Nechwatal J, 2008, HYDROBIOLOGIA, V613, P109, DOI 10.1007/s10750-008-9476-z; Noury M, 2014, WATER RESOUR+, V41, P261, DOI 10.1134/S0097807814030129; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Perez-Diaz JI, 2010, ENERG CONVERS MANAGE, V51, P2955, DOI 10.1016/j.enconman.2010.06.038; Peter A, 2010, HANDB ENVIRON CHEM, V6, P247, DOI 10.1007/978-3-540-88275-6_13; Pfaundler M., 2013, DATENSATZ MQ GWN CH; Poff NL, 2013, CURR OPIN ENV SUST, V5, P667, DOI 10.1016/j.cosust.2013.11.006; Rodrigues LN, 2013, WATER RESOUR IRRIG M, V2, P1; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; Shang SH, 2013, J ARID LAND, V5, P133, DOI 10.1007/s40333-013-0153-3; SOARES S, 1995, IEE P-GENER TRANSM D, V142, P569, DOI 10.1049/ip-gtd:19952156; Sreenivasan KR, 1996, SADHANA-ACAD P ENG S, V21, P503, DOI 10.1007/BF02745572; Stahli M, 2011, KLIMAWANDEL WASSERKR, P18; Stoll S, 2013, J APPL ICHTHYOL, V29, P617, DOI 10.1111/jai.12144; Swiss Federal Office of Energy SFOE, 2014, WAT LEV RES EL STAT; Swiss Federal Office of Energy SFOE, 2013, BEW PUMPSP SCHW RAHM; Swiss Federal Office of Energy SFOE, 2013, EINZ SCHW EZGG CH, P27; Swiss Federal Office of Energy SFOE, 2013, HYDR DAT LAK ZUER SC; Thornton KW., 1990, RESERVOIR LIMNOLOGY; Turner MA, 2005, CAN J FISH AQUAT SCI, V62, P991, DOI 10.1139/F05-003; van der Linden P., 2009, ENSEMBLES CLIMATE CH; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; White MS, 2008, HYDROBIOLOGIA, V613, P21, DOI 10.1007/s10750-008-9469-y; White MS, 2010, LIMNOL OCEANOGR, V55, P2275, DOI 10.4319/lo.2010.55.6.2275; Windels SK, 2013, J WILDLIFE MANAGE, V77, P1626, DOI 10.1002/jwmg.608; Yang L, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017362; Zohary T, 2011, INLAND WATERS, V1, P47, DOI 10.5268/IW-1.1.406	59	19	19	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114889	10.1371/journal.pone.0114889	http://dx.doi.org/10.1371/journal.pone.0114889			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526619	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200008
J	Ye, CL; Yan, WW; Xiang, H; He, HX; Yang, MS; Ijaz, M; Useh, N; Hsieh, CL; McDonough, PL; McDonough, SP; Mohamed, H; Yang, ZB; Chang, YF				Ye, Cuilian; Yan, Weiwei; Xiang, Hua; He, Hongxuan; Yang, Maosheng; Ijaz, Muhammad; Useh, Nicodemus; Hsieh, Ching-Lin; McDonough, Patrick L.; McDonough, Sean P.; Mohamed, Hussni; Yang, Zhibang; Chang, Yung-Fu			Recombinant Antigens rLipL21, rLoa22, rLipL32 and rLigACon4-8 for Serological Diagnosis of Leptospirosis by Enzyme-Linked Immunosorbent Assays in Dogs	PLOS ONE			English	Editorial Material							IMMUNOGLOBULIN-LIKE PROTEIN; CANINE LEPTOSPIROSIS; UNITED-STATES; SEROVARS; SERODIAGNOSIS; INTERROGANS; ANTIBODIES; INFECTION; LIPL32; LIGA	Animal leptospirosis is one of the most common zoonotic diseases in the United States and around the world. In a previous study, we applied four recombinant antigens, rLipL21, rLoa22, rLipL32 and rLigACon4-8 of Leptospira interrogans (L. interrogans) for the serological diagnosis of equine leptospirosis (Ye et al, Serodiagnosis of equine leptospirosis by ELISA using four recombinant protein markers, Clin. Vaccine. Immunol. 21:478-483). In this study, the same four recombinant antigens were evaluated for their potential to diagnose canine leptospirosis by ELISA. A total of 305 canine sera that were Leptospira microscopic agglutination test (MAT)-negative (n=102) and MAT-positive (n=203) to 5 serovars (Pomona, Grippotyphosa, Icterohaemorrhagiae, Canicola and Hardjo) were tested. When individual recombinant antigens were used, the sensitivity and specificity of ELISA were 97.5% and 84.3% for rLigACon4-8; 89.7% and 81.4% for rLoa22; 92.6% and 84.3% for rLipL32 and 99.5% and 84.3% for rLipL21, respectively compared to the MAT. The sensitivity and specificity of ELISA were, 92.6% and 91.2% for rLigACon4-8 and rLipL32, 97.5% and 84.3% for rLigACon4-8 and rLipL21, 89.7% and 87.3% for rLigACon4-8 and rLoa22, 89.7% and 87.3% to rLipL21 and rLoa22, 92.6% and 91.2% for rLipL21 and rLipL32 and 89.2% and 94.1% for rLoa22 and rLipL32 when one of the two antigens was test positive. The use of all four antigens in the ELISA assay was found to be sensitive and specific, easy to perform, and agreed with the results of the standard Leptospira Microscopic Agglutination test (MAT) for the diagnosis of canine leptospirosis.	[Ye, Cuilian; Yan, Weiwei; Xiang, Hua; He, Hongxuan; Yang, Maosheng; Ijaz, Muhammad; Useh, Nicodemus; Hsieh, Ching-Lin; McDonough, Patrick L.; Mohamed, Hussni; Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [McDonough, Sean P.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Ye, Cuilian] Chongqing Univ Technol, Sch Pharm & Bioengn, Chongqing, Peoples R China; [Ye, Cuilian; Yang, Zhibang] Chongqing Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Chongqing, Peoples R China; [Xiang, Hua] Guangdong Acad Agr Sci, Vet Inst, Guangzhou, Guangdong, Peoples R China; [He, Hongxuan] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Yang, Maosheng] Guizhou Acad Agr Sci, Guizhou Inst Anim Husb & Vet Med, Guiyang, Peoples R China	Cornell University; Cornell University; Chongqing University of Technology; Chongqing Medical University; Guangdong Academy of Agricultural Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Guizhou Academy of Agricultural Sciences	Chang, YF (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	yc42@cornell.edu; yc42@cornell.edu	Hsieh, Ching-Lin/ABA-6461-2021; Ijaz, Muhammad/AAX-9864-2020; Hsieh, Ching-Lin/K-4139-2018; HSIEH, CHING-LIN/G-6057-2011	HSIEH, CHING-LIN/0000-0001-9468-9969; Hsieh, Ching-Lin/0000-0002-3665-5717				Andre-Fontaine G, 2013, VET REC, V172, P502, DOI 10.1136/vr.101333; Barmettler R, 2011, JAVMA-J AM VET MED A, V238, P183, DOI 10.2460/javma.238.2.183; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Birnbaum N, 1998, J SMALL ANIM PRACT, V39, P231, DOI 10.1111/j.1748-5827.1998.tb03640.x; Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002; Bourhy P, 2013, J MED MICROBIOL, V62, P822, DOI 10.1099/jmm.0.054304-0; Budihal SV, 2014, J CLIN DIAGN RES, V8, P199, DOI 10.7860/JCDR/2014/6593.3950; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Chalayon P, 2011, T ROY SOC TROP MED H, V105, P289, DOI 10.1016/j.trstmh.2011.01.008; Chen HW, 2013, AM J TROP MED HYG, V89, P1088, DOI 10.4269/ajtmh.13-0041; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; Donskey CJ, 2014, J CLIN MICROBIOL, V52, P315, DOI 10.1128/JCM.01852-13; Ellis WA, 2010, VET REC, V167, P602, DOI 10.1136/vr.c4965; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001; Fraune CK, 2013, JAVMA-J AM VET MED A, V242, P1373, DOI 10.2460/javma.242.10.1373; Gautam R, 2010, JAVMA-J AM VET MED A, V237, P293, DOI 10.2460/javma.237.3.293; Gautam R, 2010, PREV VET MED, V96, P122, DOI 10.1016/j.prevetmed.2010.05.017; Greenlee JJ, 2005, AM J VET RES, V66, P1816, DOI 10.2460/ajvr.2005.66.1816; Greenlee JJ, 2004, AM J VET RES, V65, P1100, DOI 10.2460/ajvr.2004.65.1100; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; Hartleben CP, 2013, CURR MICROBIOL, V66, P106, DOI 10.1007/s00284-012-0237-x; Hennebelle JH, 2013, JAVMA-J AM VET MED A, V242, P941, DOI 10.2460/javma.242.7.941; Joseph S, 2012, J VET SCI, V13, P99, DOI 10.4142/jvs.2012.13.1.99; Klaasen HLBM, 2013, VET REC, V172, P181, DOI 10.1136/vr.101100; Klopfleisch R, 2010, VET MED INT, V2010; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Mayer-Scholl A, 2013, VECTOR-BORNE ZOONOT, V13, P200, DOI 10.1089/vbz.2012.1121; Midence JN, 2012, J VET INTERN MED, V26, P149, DOI 10.1111/j.1939-1676.2011.00852.x; Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878; Oliveira TR, 2008, CLIN VACCINE IMMUNOL, V15, P1715, DOI 10.1128/CVI.00214-08; Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729; Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0; Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002; Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180; Pinne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051025; Public Health Surveillance and Informatics Program Office CfDCaP, 2013, LEPT LEPT INT; Raghavan R, 2011, PREV VET MED, V101, P241, DOI 10.1016/j.prevetmed.2011.05.010; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Sankar S, 2010, RES VET SCI, V88, P375, DOI 10.1016/j.rvsc.2009.11.004; Schreier S, 2013, EXPERT REV CLIN IMMU, V9, P263, DOI [10.1586/eci.12.110, 10.1586/ECI.12.110]; Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012; Stokes JE, 2007, JAVMA-J AM VET MED A, V230, P1657, DOI 10.2460/javma.230.11.1657; Suepaul SM, 2010, EPIDEMIOL INFECT, V138, P1059, DOI 10.1017/S0950268809990902; Sykes JE, 2011, J VET INTERN MED, V25, P1, DOI 10.1111/j.1939-1676.2010.0654.x; Tangeman LE, 2013, JAVMA-J AM VET MED A, V243, P1316, DOI 10.2460/javma.243.9.1316; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Thaipadungpanit J, 2013, AM J TROP MED HYG, V89, P794, DOI 10.4269/ajtmh.13-0124; VANDENBROEK AHM, 1991, J SMALL ANIM PRACT, V32, P118, DOI 10.1111/j.1748-5827.1991.tb00526.x; Yan WW, 2013, CLIN VACCINE IMMUNOL, V20, P1143, DOI 10.1128/CVI.00245-13; Ye CL, 2014, CLIN VACCINE IMMUNOL, V21, P478, DOI 10.1128/CVI.00649-13	54	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e111367	10.1371/journal.pone.0111367	http://dx.doi.org/10.1371/journal.pone.0111367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526513	gold, Green Published, Green Submitted			2022-12-27	WOS:000347186200066
J	Ayton, LN; Blamey, PJ; Guymer, RH; Luu, CD; Nayagam, DAX; Sinclair, NC; Shivdasani, MN; Yeoh, J; McCombe, MF; Briggs, RJ; Opie, NL; Villalobos, J; Dimitrov, PN; Varsamidis, M; Petoe, MA; McCarthy, CD; Walker, JG; Barnes, N; Burkitt, AN; Williams, CE; Shepherd, RK; Allen, PJ				Ayton, Lauren N.; Blamey, Peter J.; Guymer, Robyn H.; Luu, Chi D.; Nayagam, David A. X.; Sinclair, Nicholas C.; Shivdasani, Mohit N.; Yeoh, Jonathan; McCombe, Mark F.; Briggs, Robert J.; Opie, Nicholas L.; Villalobos, Joel; Dimitrov, Peter N.; Varsamidis, Mary; Petoe, Matthew A.; McCarthy, Chris D.; Walker, Janine G.; Barnes, Nick; Burkitt, Anthony N.; Williams, Chris E.; Shepherd, Robert K.; Allen, Penelope J.		Bionic Vision Australia Res	First-in-Human Trial of a Novel Suprachoroidal Retinal Prosthesis	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; ELECTRICAL-STIMULATION; TRANSRETINAL STIMULATION; PERCEPTUAL THRESHOLDS; MORPHOMETRIC-ANALYSIS; GANGLION-CELLS; VISION; ARRAY	Retinal visual prostheses ("bionic eyes") have the potential to restore vision to blind or profoundly vision-impaired patients. The medical bionic technology used to design, manufacture and implant such prostheses is still in its relative infancy, with various technologies and surgical approaches being evaluated. We hypothesised that a suprachoroidal implant location (between the sclera and choroid of the eye) would provide significant surgical and safety benefits for patients, allowing them to maintain preoperative residual vision as well as gaining prosthetic vision input from the device. This report details the first-in-human Phase 1 trial to investigate the use of retinal implants in the suprachoroidal space in three human subjects with endstage retinitis pigmentosa. The success of the suprachoroidal surgical approach and its associated safety benefits, coupled with twelve-month post-operative efficacy data, holds promise for the field of vision restoration.	[Ayton, Lauren N.; Guymer, Robyn H.; Luu, Chi D.; Yeoh, Jonathan; McCombe, Mark F.; Briggs, Robert J.; Opie, Nicholas L.; Dimitrov, Peter N.; Varsamidis, Mary; Allen, Penelope J.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Australia; [Blamey, Peter J.; Nayagam, David A. X.; Sinclair, Nicholas C.; Shivdasani, Mohit N.; Villalobos, Joel; Petoe, Matthew A.; Burkitt, Anthony N.; Williams, Chris E.; Shepherd, Robert K.] Bion Inst, East Melbourne, Australia; [Blamey, Peter J.; Shivdasani, Mohit N.; Shepherd, Robert K.] Univ Melbourne, Dept Med Bion, East Melbourne, Australia; [Nayagam, David A. X.] Univ Melbourne, Dept Pathol, St Vincents Hosp Melbourne, Fitzroy, Vic 3065, Australia; [McCarthy, Chris D.; Walker, Janine G.; Barnes, Nick] NICTA, Comp Vis Res Grp, Canberra, ACT, Australia; [McCarthy, Chris D.; Walker, Janine G.; Barnes, Nick] Australian Natl Univ, Natl Inst Mental Hlth Res, Canberra, ACT, Australia; [Burkitt, Anthony N.] Univ Melbourne, Ctr Neural Engn, Natl Informat & Commun Technol Australia NICTA Lt, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Bionics Institute; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Australian National University; Australian National University; University of Melbourne	Ayton, LN (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, East Melbourne, Australia.	lnayton@unimelb.edu.au	Walker, Janine/S-9985-2019; Ayton, Lauren/AAV-2977-2021; Burkitt, Anthony/N-9077-2013; Petoe, Matthew/ABD-8365-2020; SHIVDASANI, MOHIT/AAN-3438-2020; Barnes, Nick/Y-2744-2018; Opie, Nicholas/M-3831-2017	Ayton, Lauren/0000-0001-9907-084X; Burkitt, Anthony/0000-0001-5672-2772; Petoe, Matthew/0000-0002-1865-3566; SHIVDASANI, MOHIT/0000-0002-0692-4971; Barnes, Nick/0000-0002-9343-9535; Nayagam, David/0000-0002-4380-6640; Shepherd, Robert/0000-0002-4239-3362; McCarthy, Chris/0000-0003-3848-1631; Guymer, Robyn/0000-0002-9441-4356; Blamey, Peter/0000-0002-7579-2255; Luu, Chi/0000-0002-7604-7097; Opie, Nicholas/0000-0002-0342-9457	Australian Research Council; Victorian Government; NH&MRC Centre for Clinical Research Excellence [529923]; NHMRC [529905]; Australian Government through the Department of Communications; Ian Potter Foundation; John T. Reid Charitable Trusts; Retina Australia; Bertalli Family Foundation	Australian Research Council(Australian Research Council); Victorian Government; NH&MRC Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Government through the Department of Communications(Australian Government); Ian Potter Foundation; John T. Reid Charitable Trusts; Retina Australia; Bertalli Family Foundation	This research was supported by the Australian Research Council (http://www.arc.gov.au) through its Special Research Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic Vision Australia (BVA). The Centre for Eye Research Australia (CERA) and the Bionics Institute receive Operational Infrastructure Support from the Victorian Government. CERA is also supported by a NH&MRC Centre for Clinical Research Excellence (#529923) grant - Translational Clinical Research in Major Eye Diseases (https://www.nhmrc.gov.au). RG is supported by an NHMRC practitioner fellowship (#529905). NICTA is funded by the Australian Government through the Department of Communications and the Australian Research Council through the ICT Centre of Excellence Program (http://www.arc.gov.au/ncgp/centres/centres_nicta.htm). Additional support for this project came from the Ian Potter Foundation (http://www.ianpotter.org.au), John T. Reid Charitable Trusts (http://www.johntreidtrusts.com.au), Retina Australia (http://www.retinaaustralia.com.au) and the Bertalli Family Foundation (http://fbe.unimelb.edu.au/scholarships/opportunities/undergraduate/the_bertalli_family_foundation_scholarships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramian M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035004; Allen PJ, 2013, IMPLANTATION SUPRACH; Ayton LN, 2014, INVEST OPHTH VIS SCI, V55, P1332, DOI 10.1167/iovs.13-12657; Ayton LN, 2013, CLIN EXP OPHTHALMOL, V41, P396, DOI 10.1111/j.1442-9071.2012.02867.x; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bach M, 2010, INVEST OPHTH VIS SCI, V51, P1255, DOI 10.1167/iovs.09-3512; Barnes N, 2014, ASS RES VIS OPHTH AN; Bittner AK, 2011, OPTOMETRY VISION SCI, V88, P1496, DOI 10.1097/OPX.0b013e3182348d0b; Bittner AK, 2013, BRIT J OPHTHALMOL, V97, P145, DOI 10.1136/bjophthalmol-2012-302116; Blamey PJ, 2013, PSYCHOPHYSICS SUPRAC; Bron A., 1998, WOLFFS ANATOMY EYE O, V8Ed; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Cicione R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036009; da Cruz L, 2013, BRIT J OPHTHALMOL, V97, P632, DOI 10.1136/bjophthalmol-2012-301525; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Finger RP, 2014, INVEST OPHTH VIS SCI, V55, P6150, DOI 10.1167/iovs.14-14731; Fujikado T, 2007, GRAEF ARCH CLIN EXP, V245, P1411, DOI 10.1007/s00417-007-0563-z; Fujikado T, 2011, INVEST OPHTH VIS SCI, V52, P4726, DOI 10.1167/iovs.10-6836; Hood DC, 2009, INVEST OPHTH VIS SCI, V50, P2328, DOI 10.1167/iovs.08-2936; Huang CQ, 1999, IEEE T BIO-MED ENG, V46, P461, DOI 10.1109/10.752943; Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028; Humayun MS, 2009, IEEE ENG MED BIO, P4566, DOI 10.1109/IEMBS.2009.5332695; Humayun MS, 1999, INVEST OPHTH VIS SCI, V40, P143; John SE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036011; Leung RT, 2014, CLIN EXPT O IN PRESS; Lieby P, 2013, ASS RES VIS OPHTH AR; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Nayagam DAX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097182; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5355, DOI 10.1167/iovs.02-0819; Rizzo JF, 2011, J NEURO-OPHTHALMOL, V31, P160, DOI 10.1097/WNO.0b013e31821eb79e; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; Saunders AL, 2014, CLIN EXP OPHTHALMOL, V42, P665, DOI 10.1111/ceo.12287; Second Sight Medical Products, 2012, SEPT 28 2012 M FDA O; Shepherd RK, 2013, TRENDS BIOTECHNOL, V31, P562, DOI 10.1016/j.tibtech.2013.07.001; Shivdasani MN, 2014, INVEST OPHTH VIS SCI, V55, P6467, DOI 10.1167/iovs.14-14396; Shivdasani MN, 2012, INVEST OPHTH VIS SCI, V53, P6291, DOI 10.1167/iovs.12-9434; Stingl K, 2013, OPHTHALMIC RES, V50, P215, DOI 10.1159/000354424; Stingl K, 2013, INVEST OPHTH VIS SCI, V54, P7658, DOI 10.1167/iovs.13-12835; Stingl K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0077; STONE JL, 1992, ARCH OPHTHALMOL-CHIC, V110, P1634, DOI 10.1001/archopht.1992.01080230134038; van den Honert C, 2007, J ACOUST SOC AM, V121, P3703, DOI 10.1121/1.2722047; Villalobos J, 2013, INVEST OPHTH VIS SCI, V54, P3751, DOI 10.1167/iovs.12-10843; Villalobos J, 2012, GRAEF ARCH CLIN EXP, V250, P399, DOI 10.1007/s00417-011-1794-6; Zrenner E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007399; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	48	205	210	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115239	10.1371/journal.pone.0115239	http://dx.doi.org/10.1371/journal.pone.0115239			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521292	Green Published, Green Submitted, gold			2022-12-27	WOS:000348845600027
J	Cobbin, JCA; Zeng, WG; Jackson, DC; Brown, LE				Cobbin, Joanna C. A.; Zeng, Weiguang; Jackson, David C.; Brown, Lorena E.			Different Arms of the Adaptive Immune System Induced by a Combination Vaccine Work in Concert to Provide Enhanced Clearance of Influenza	PLOS ONE			English	Article							CD8(+) T-CELLS; VIRUS HEMAGGLUTININ; SYNTHETIC PEPTIDE; M2 PROTEIN; ANTIBODY; PROTECTION; RESPONSES; MICE; INDUCTION; NUCLEOPROTEIN	Current split influenza virus vaccines that induce strain-specific neutralising antibodies provide some degree of protection against influenza infection but there is a clear need to improve their effectiveness. The constant antigenic drift of influenza viruses means that vaccines are often not an exact match to the circulating strain and so levels of relevant antibodies may not be sufficiently high to afford protection. In the situation where the emergent influenza virus is completely novel, as is the case with pandemic strains, existing vaccines may provide no benefit. In this study we tested the concept of a combination vaccine consisting of sub-optimal doses of split influenza virus vaccine mixed with a cross-protective T-cell inducing lipopeptide containing the TLR2 ligand Pam2Cys. Mice immunised with combination vaccines showed superior levels of lung viral clearance after challenge compared to either split virus or lipopeptide alone, mediated through activation of enhanced humoral and/or additional cellular responses. The mechanism of action of these vaccines was dependent on the route of administration, with intranasal administration being superior to subcutaneous and intramuscular routes, potentially through the induction of memory CD8(+) T cells in the lungs. This immunisation strategy not only provides a mechanism for minimising the dose of split virus antigen but also, through the induction of cross-protective CD8(+) T cells, proves a breadth of immunity to provide potential benefit upon encounter with serologically diverse influenza isolates.	[Cobbin, Joanna C. A.; Zeng, Weiguang; Jackson, David C.; Brown, Lorena E.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia	University of Melbourne	Brown, LE (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic 3052, Australia.	lorena@unimelb.edu.au		Jackson, David/0000-0001-7255-270X; Brown, Lorena/0000-0001-9342-909X	National Health and Medical Research Council of Australia [567122]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Program Grant 567122 from the National Health and Medical Research Council of Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COMPELLING NEED GAME; Baz M, 2012, CLIN VACCINE IMMUNOL, V19, P209, DOI 10.1128/CVI.05441-11; BODMER HC, 1988, CELL, V52, P253, DOI 10.1016/0092-8674(88)90514-4; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Deliyannis G, 2002, J VIROL, V76, P4212, DOI 10.1128/JVI.76.9.4212-4221.2002; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Harling-McNabb L, 1999, INT IMMUNOL, V11, P1431, DOI 10.1093/intimm/11.9.1431; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; JACKSON DC, 1986, VIROLOGY, V155, P625, DOI 10.1016/0042-6822(86)90222-9; JACKSON DC, 1994, VIROLOGY, V198, P613, DOI 10.1006/viro.1994.1073; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Kendal AP, 1982, CONCEPTS PROCEDURES; Lau YF, 2006, INT IMMUNOL, V18, P1801, DOI 10.1093/intimm/dxl114; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Ng WC, 2009, INFLUENZA OTHER RESP, V3, P177, DOI 10.1111/j.1750-2659.2009.00087.x; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Osterholm MT, 2013, JAMA-J AM MED ASSOC, P1; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; SHERMAN LA, 1992, J EXP MED, V175, P1221, DOI 10.1084/jem.175.5.1221; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tan ACL, 2012, ANTIVIR RES, V94, P168, DOI 10.1016/j.antiviral.2012.03.009; TANNOCK GA, 1984, INFECT IMMUN, V43, P457, DOI 10.1128/IAI.43.2.457-462.1984; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Zeng WG, 2011, MOL IMMUNOL, V48, P490, DOI 10.1016/j.molimm.2010.10.003; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905	38	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115356	10.1371/journal.pone.0115356	http://dx.doi.org/10.1371/journal.pone.0115356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522323	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600036
J	Kalkat, M; Chan, PK; Wasylishen, AR; Srikumar, T; Kim, SS; Ponzielli, R; Bazett-Jones, DP; Raught, B; Penn, LZ				Kalkat, Manpreet; Chan, Pak-Kei; Wasylishen, Amanda R.; Srikumar, Tharan; Kim, Sam S.; Ponzielli, Romina; Bazett-Jones, David P.; Raught, Brian; Penn, Linda Z.			Identification of c-MYC SUMOylation by Mass Spectrometry	PLOS ONE			English	Article							SUMO MODIFICATION; GENE-EXPRESSION; BREAST-CANCER; PROTEIN; PHOSPHORYLATION; UBIQUITIN; SITES; APOPTOSIS; P300; P53	The c-MYC transcription factor is a master regulator of many cellular processes and deregulation of this oncogene has been linked to more than 50% of all cancers. This deregulation can take many forms, including altered post-translational regulation. Here, using immunoprecipitation combined with mass spectrometry, we identified a MYC SUMOylation site (K326). Abrogation of signaling through this residue by substitution with arginine (K326R) has no obvious effects on MYC half-life, intracellular localization, transcriptional targets, nor on the biological effects of MYC overexpression in two different cell systems assessed for soft agar colony formation, proliferation, and apoptosis. While we have definitively demonstrated that MYC SUMOylation can occur on K326, future work will be needed to elucidate the mechanisms and biological significance of MYC regulation by SUMOylation.	[Kalkat, Manpreet; Chan, Pak-Kei; Wasylishen, Amanda R.; Srikumar, Tharan; Kim, Sam S.; Ponzielli, Romina; Raught, Brian; Penn, Linda Z.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kalkat, Manpreet; Wasylishen, Amanda R.; Kim, Sam S.; Raught, Brian; Penn, Linda Z.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bazett-Jones, David P.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Penn, LZ (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	lpenn@uhnresearch.ca	Srikumar, Tharan/Q-5642-2016	Penn, Linda/0000-0001-8133-5459; Wasylishen, Amanda/0000-0002-1940-5169; Kalkat, Manpreet/0000-0002-4843-9755	Canadian Breast Cancer Research Ontario Region Doctoral Fellowship; Canadian Institutes of Health Research [MOP-130340, MOP-27578]	Canadian Breast Cancer Research Ontario Region Doctoral Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	MK is supported by a Canadian Breast Cancer Research Ontario Region Doctoral Fellowship (http://www.cbcf.org/ontario/Pages/default.aspx). Work in the BR lab is funded by a Canadian Institutes of Health Research operating grant MOP-130340 (http://www.cihr-irsc.gc.ca/e/193.html). Work in the LZP and BR lab is funded by a Canadian Institutes of Health Research operating grant MOP-27578 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareeda AT, 2014, BREAST CANCER RES TR, V144, P519, DOI 10.1007/s10549-014-2897-7; Amente S, 2012, AM J CANCER RES, V2, P330; ASKEW DS, 1991, ONCOGENE, V6, P1915; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bertolotto C, 2011, NATURE, V480, P94, DOI 10.1038/nature10539; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Dahle O, 2003, EUR J BIOCHEM, V270, P1338, DOI 10.1046/j.1432-1033.2003.03504.x; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goard CA, 2010, INT J CANCER, V127, P2936, DOI 10.1002/ijc.25295; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hemann MT, 2005, NATURE, V436, P807, DOI 10.1038/nature03845; HENRIKSSON M, 1993, ONCOGENE, V8, P3199; Jeram SM, 2010, PROTEOMICS, V10, P254, DOI 10.1002/pmic.200900648; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Liu HW, 2012, NUCLEIC ACIDS RES, V40, P10172, DOI 10.1093/nar/gks819; Lutz W, 1996, ONCOGENE, V13, P803; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; PULVERER BJ, 1994, ONCOGENE, V9, P59; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sabo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091072; Sahin U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5187; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wasylishen AR, 2014, ONCOGENE, V33, P1066, DOI 10.1038/onc.2013.36; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Wasylishen AR, 2013, CANCER RES, V73, P6504, DOI 10.1158/0008-5472.CAN-12-4063; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Zhang HJ, 2013, CELL BIOCHEM BIOPHYS, V67, P1081, DOI 10.1007/s12013-013-9612-x; Zhang KL, 2005, BIOCHEM BIOPH RES CO, V336, P274, DOI 10.1016/j.bbrc.2005.08.075	44	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115337	10.1371/journal.pone.0115337	http://dx.doi.org/10.1371/journal.pone.0115337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522242	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600035
J	Serrano-Sanchez, JA; Bello-Lujan, LM; Auyanet-Batista, JM; Fernandez-Rodriguez, MJ; Gonzalez-Henriquez, JJ				Serrano-Sanchez, Jose A.; Bello-Lujan, Luis M.; Auyanet-Batista, Juan M.; Fernandez-Rodriguez, Maria J.; Gonzalez-Henriquez, Juan J.			Lack of Exercise of "Moderate to Vigorous" Intensity in People with Low Levels of Physical Activity Is a Major Discriminant for Sociodemographic Factors and Morbidity	PLOS ONE			English	Article							SEDENTARY LIFE-STYLE; LEISURE-TIME; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; PRESCRIBING EXERCISE; JOINT ASSOCIATIONS; SKELETAL-MUSCLE; TRENDS; HEALTH; RISK	Introduction: The aim is to examine the differences between participation at low and zero moderate to vigorous physical activity (MVPA) in relation to their trends and associations with known socio-demographic and health factors. We hypothesised that the number of people at zero MVPA level could be rising despite a parallel increase in the population meeting the recommended MVPA level. We also hypothesised that graded associations of socio-demographic and health factors exist across MVPA levels. Methods: Two independent population-based samples (n=4320 [2004] and n=2176 [1997]), were recruited with a stratified and random sampling procedure and interviewed at home by professional interviewers. The MVPA was assessed by validated questionnaire. The participants were classified into three MVPA levels: zero, low and recommended MVPA. The trend of each MVPA level was analysed with the standardized prevalence ratios. Correlates of low and zero MVPA levels were examined using multinomial logistic regression. Results: The population at zero and recommended MVPA levels rose between 1997-2004 by 12% (95% CI, 5-20%) and 7% (95% CI, 24-19%) respectively, while the population at low MVPA level decreased. At zero MVPA level, associativepatterns were observed with sociodemographic and health factors which were different when compared to the population at low MVPA level. Conclusions: Despite the slight increase of population meeting the recommended MVPA level, a higher trend of increase was observed at zero MVPA level. Both recommended and low MPVA levels increased their participation by absorbing participants from the low MVPA level. The sociodemographic profile of those with low MVPA was more similar to the population at recommended MVPA than at zero MVPA level. Methodological implications about the combination of light and moderate-intensity PA could be derived. The prevention of decline in actual low MVPA could change the trend of increase in the population at zero MVPA level, particularly among young adults.	[Serrano-Sanchez, Jose A.] Univ Las Palmas Gran Canaria, Dept Phys Educ & Sport Sci, Las Palmas Gran Canaria, Spain; [Serrano-Sanchez, Jose A.] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci IUIBS, Las Palmas Gran Canaria, Spain; [Bello-Lujan, Luis M.] Canary Isl Hlth Serv, Directorate Gen Publ Hlth, Las Palmas Gran Canaria, Spain; [Auyanet-Batista, Juan M.] Canary Isl Hlth Serv, Dept Primary Hlth Care, Las Palmas Gran Canaria, Spain; [Fernandez-Rodriguez, Maria J.] Univ Hosp Dr Negrin, Dept Clin Pathobiol, Las Palmas Gran Canaria, Spain; [Gonzalez-Henriquez, Juan J.] Univ Las Palmas Gran Canaria, Dept Matemath, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ & Sport Sci, Las Palmas Gran Canaria, Spain.	jose.serrano@ulpgc.es	Serrano-Sanchez, Jose A/L-3691-2014; Henríquez, Juan José González/AAZ-7810-2020	Serrano-Sanchez, Jose A/0000-0002-4868-8751; Henríquez, Juan José González/0000-0002-0622-5580	Canary Health Services	Canary Health Services	The grants were managed directly by Canary Health Services. Technical work was performed by the authors. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Serrano-Sanchez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038693; Ara I, 2011, INT J OBESITY, V35, P99, DOI 10.1038/ijo.2010.123; Barengo NC, 2002, MED SCI SPORT EXER, V34, P1302, DOI 10.1097/00005768-200208000-00011; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bernstein MS, 1999, AM J PUBLIC HEALTH, V89, P862, DOI 10.2105/AJPH.89.6.862; Boon RM, 2010, BRIT J SPORT MED, V44, P741, DOI 10.1136/bjsm.2008.052167; Brownson RC, 2001, AM J PUBLIC HEALTH, V91, P1995, DOI 10.2105/AJPH.91.12.1995; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cabrera de Leon A, 2008, REV ESP SALUD PUBLIC, V82, P1; de Leon AC, 2007, REV ESP CARDIOL, V60, P244, DOI 10.1157/13100275; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Chan CB, 2009, INT J ENV RES PUB HE, V6, P2639, DOI 10.3390/ijerph6102639; Chau J, 2007, TRENDS POPULATION LE; Chen YJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-427; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Churilla JR, 2012, METAB SYNDR RELAT D, V10, P70, DOI 10.1089/met.2011.0057; Cleland V, 2010, SOC SCI MED, V70, P2011, DOI 10.1016/j.socscimed.2010.02.028; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duncan GE, 2005, ARCH INTERN MED, V165, P2362, DOI 10.1001/archinte.165.20.2362; Duncan GE, 2001, PREV MED, V33, P18, DOI 10.1006/pmed.2001.0847; Elosua R, 2005, J GERONTOL A-BIOL, V60, P760, DOI 10.1093/gerona/60.6.760; Fernandez-Berges D, 2012, REV ESP CARDIOL, V65, P241, DOI [10.1016/j.rec.2011.10.017, 10.1016/j.recesp.2011.10.015]; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; Goldstein H., 1999, MULTILEVEL STAT MODE; Gordon-Larsen P, 2004, AM J PREV MED, V27, P277, DOI 10.1016/j.amepre.2004.07.006; Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E; Hallal Pedro C, 2011, Rev. bras. epidemiol., V14, P53, DOI 10.1590/S1415-790X2011000500006; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hayes DK, 2011, PREV CHRONIC DIS, V8; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Hu G, 2007, AM J HYPERTENS, V20, P1242, DOI 10.1016/j.amjhyper.2007.07.015; IBM Corp, 2010, REL 2010 IBM SPSS ST; Instituto de Evaluacion, 2009, SIST EST IND ED; ISTAC, 2004, HLTH SURV CAN 2004 M; Juneau CE, 2010, PREV MED, V51, P384, DOI 10.1016/j.ypmed.2010.09.002; Katzmarzyk Peter T, 2007, Appl Physiol Nutr Metab, V32 Suppl 2F, pS206, DOI 10.1139/H07-167; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Kruger J., 2005, Morbidity and Mortality Weekly Report, V54, P991; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Li FZ, 2005, J AGING PHYS ACTIV, V13, P87, DOI 10.1123/japa.13.1.87; Liao Y, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-131; Lynch BM, 2011, BREAST CANCER RES TR, V130, P183, DOI 10.1007/s10549-011-1559-2; Lynch BM, 2010, ANN BEHAV MED, V40, P265, DOI 10.1007/s12160-010-9209-1; Marshall SJ, 2011, AM J LIFESTYLE MED, V5, P518, DOI 10.1177/1559827610395487; Meseguer CM, 2011, REV ESP CARDIOL, V64, P21, DOI [10.1016/j.recesp.2010.07.007, 10.1016/j.rec.2010.06.010]; Muthen BO, 1995, SOCIOL METHODOL, V25, P267, DOI 10.2307/271070; Nelson MC, 2005, AM J PREV MED, V28, P259, DOI 10.1016/j.amepre.2004.12.006; NEWMAN S. C., 2001, WILEY S PRO STAT BIO; Ng N, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6347; Nokes N, 2009, J SPORT MED PHYS FIT, V49, P136; Organization WH, 2009, GLOB HLTH RISKS MORT; Pate RR, 2006, CIRCULATION, V114, P1214, DOI 10.1161/CIRCULATIONAHA.106.177052; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Petersen CB, 2010, SCAND J PUBLIC HEALT, V38, P121, DOI 10.1177/1403494809357098; Phillips AC, 2010, BRIT J HEALTH PSYCH, V15, P337, DOI 10.1348/135910709X466180; Pols MA, 1998, EUR J EPIDEMIOL, V14, P63, DOI 10.1023/A:1007427831179; R Core Team, 2012, R LANG ENV STAT COMP; Reddigan JI, 2011, AM J CARDIOL, V108, P1426, DOI 10.1016/j.amjcard.2011.07.005; Redondo A, 2011, REV ESP CARDIOL, V64, P997, DOI [10.1016/j.recesp.2011.06.020, 10.1016/j.rec.2011.06.020]; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rutten A, 2001, J EPIDEMIOL COMMUN H, V55, P139, DOI 10.1136/jech.55.2.139; Schoenborn CA, 2011, AM J PREV MED, V40, P514, DOI 10.1016/j.amepre.2010.12.029; Seefeldt V, 2002, SPORTS MED, V32, P143, DOI 10.2165/00007256-200232030-00001; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Stamatakis E, 2007, PREV MED, V45, P416, DOI 10.1016/j.ypmed.2006.12.014; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; Sugiyama T, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-35; TABATCHNICK BG, 2007, USING MULTIVARIATE S; Tanasescu N, 2002, JAMA-J AM MED ASSOC, V288, P1994, DOI 10.1001/jama.288.16.1994; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tudor-Locke C, 2013, APPL PHYSIOL NUTR ME, V38, P100, DOI 10.1139/apnm-2012-0235; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Vandelanotte C, 2010, AUST NZ J PUBL HEAL, V34, P248, DOI 10.1111/j.1753-6405.2010.00521.x; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; World Health Organization, 1995, PROT GUID COUNTR INT; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502; Zabina E. Y., 1995, EXPERIENCE VALIDATIO	90	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115321	10.1371/journal.pone.0115321	http://dx.doi.org/10.1371/journal.pone.0115321			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25522144	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600034
J	Vulfius, CA; Kasheverov, IE; Starkov, VG; Osipov, AV; Andreeva, TV; Filkin, SY; Gorbacheva, EV; Astashev, ME; Tsetlin, VI; Utkin, YN				Vulfius, Catherine A.; Kasheverov, Igor E.; Starkov, Vladislav G.; Osipov, Alexey V.; Andreeva, Tatyana V.; Filkin, Sergey Yu.; Gorbacheva, Elena V.; Astashev, Maxim E.; Tsetlin, Victor I.; Utkin, Yuri N.			Inhibition of Nicotinic Acetylcholine Receptors, a Novel Facet in the Pleiotropic Activities of Snake Venom Phospholipases A(2)	PLOS ONE			English	Article							LYMNAEA-STAGNALIS NEURONS; NAJA-NAJA-ATRA; ALPHA-BUNGAROTOXIN; PHARMACOLOGICAL-PROPERTIES; ENZYMATIC-ACTIVITY; BINDING-PROTEIN; SKELETAL-MUSCLE; NEUROTOXINS; MECHANISM; AFFINITY	Phospholipases A(2) represent the most abundant family of snake venom proteins. They manifest an array of biological activities, which is constantly expanding. We have recently shown that a protein bitanarin, isolated from the venom of the puff adder Bitis arietans and possessing high phospholipolytic activity, interacts with different types of nicotinic acetylcholine receptors and with the acetylcholine-binding protein. To check if this property is characteristic to all venom phospholipases A(2), we have studied the capability of these enzymes from other snakes to block the responses of Lymnaea stagnalis neurons to acetylcholine or cytisine and to inhibit alpha-bungarotoxin binding to nicotinic acetylcholine receptors and acetylcholine-binding proteins. Here we present the evidence that phospholipases A(2) from venoms of vipers Vipera ursinii and V. nikolskii, cobra Naja kaouthia, and krait Bungarus fasciatus from different snake families suppress the acetylcholine- or cytisine-elicited currents in L. stagnalis neurons and compete with alpha-bungarotoxin for binding to muscle- and neuronal alpha 7-types of nicotinic acetylcholine receptor, as well as to acetylcholine- binding proteins. As the phospholipase A(2) content in venoms is quite high, under some conditions the activity found may contribute to the deleterious venom effects. The results obtained suggest that the ability to interact with nicotinic acetylcholine receptors may be a general property of snake venom phospholipases A(2), which add a new target to the numerous activities of these enzymes.	[Vulfius, Catherine A.; Gorbacheva, Elena V.; Astashev, Maxim E.] Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Moscow Region, Russia; [Kasheverov, Igor E.; Starkov, Vladislav G.; Osipov, Alexey V.; Andreeva, Tatyana V.; Filkin, Sergey Yu.; Tsetlin, Victor I.; Utkin, Yuri N.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Utkin, YN (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Ul Miklukho Maklaya 16-10, Moscow 117997, Russia.	utkin@mx.ibch.ru	Tsetlin, Victor/X-2491-2018; Astashev, Maksim E./A-9122-2015; Utkin, Yuri/L-2952-2019; Alexey, Osipov/AAQ-1422-2021; Utkin, Yuri N./F-1958-2014; Filkin, Sergey/B-9991-2016	Astashev, Maksim E./0000-0002-6591-0748; Utkin, Yuri/0000-0002-4609-970X; Utkin, Yuri N./0000-0002-4609-970X; Filkin, Sergey/0000-0002-4710-6051; Vulfius, Catherine/0000-0002-2904-0976; Osipov, Aleksei/0000-0001-7665-4711	Russian Foundation for Basic Research [12-04-01523, 13-04-01897, 13-04-40377-CoMfi]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The reported study was partially supported by Russian Foundation for Basic Research, research projects Nos. 12-04-01523, 13-04-01897, and 13-04-40377-CoMfi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augert A, 2009, EMBO REP, V10, P271, DOI 10.1038/embor.2008.255; BENJAMIN PR, 1972, Z ZELLFORSCH MIK ANA, V128, P564, DOI 10.1007/BF00306989; Bernard D, 2014, BBA-REV CANCER, V1846, P40, DOI 10.1016/j.bbcan.2014.03.003; BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x; BON C, 1977, EUR J BIOCHEM, V74, P43, DOI 10.1111/j.1432-1033.1977.tb11364.x; Brazil OV, 2000, J NAT TOXINS, V9, P33; Buisson B, 1996, J NEUROSCI, V16, P7880; Burke JE, 2009, CARDIOVASC DRUG THER, V23, P49, DOI 10.1007/s10557-008-6132-9; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; CHEMERIS NK, 1982, J PHYSIOL-LONDON, V323, P1; Coenen MJH, 2013, J AM SOC NEPHROL, V24, P677, DOI 10.1681/ASN.2012070730; CONDREA E, 1981, TOXICON, V19, P705, DOI 10.1016/0041-0101(81)90108-2; Copic A, 1999, J BIOL CHEM, V274, P26315, DOI 10.1074/jbc.274.37.26315; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; DARVENIZA P, 1979, BIOCHEM J, V181, P545, DOI 10.1042/bj1810545; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Heus F, 2013, TOXICON, V61, P112, DOI 10.1016/j.toxicon.2012.11.002; Kang TS, 2011, FEBS J, V278, P4544, DOI 10.1111/j.1742-4658.2011.08115.x; KASTURI S, 1990, IMMUNOLOGY, V70, P175; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; KOSTYUK PG, 1981, J NEUROSCI METH, V4, P201, DOI 10.1016/0165-0270(81)90032-7; KRIZAJ I, 1989, BIOCHIM BIOPHYS ACTA, V999, P198, DOI 10.1016/0167-4838(89)90218-5; Kukhtina VV, 2000, EUR J BIOCHEM, V267, P6784, DOI 10.1046/j.1432-1033.2000.01775.x; LAMBEAU G, 1990, J BIOL CHEM, V265, P9526; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Makarova YaV, 2006, BIOCHEMISTRY-MOSCOW, V71, P838; MEZNA M, 1994, BIOCHEM J, V301, P503, DOI 10.1042/bj3010503; Montecucco C, 2008, CELL MOL LIFE SCI, V65, P2897, DOI 10.1007/s00018-008-8113-3; Mordvintsev DY, 2005, COMPUT BIOL CHEM, V29, P398, DOI 10.1016/j.compbiolchem.2005.08.007; ONO JK, 1981, J NEUROSCI, V1, P259; Osipov AV, 2010, TOXICON, V55, P186, DOI 10.1016/j.toxicon.2009.07.011; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Prijatelj P, 2008, TOXICON, V51, P1520, DOI 10.1016/j.toxicon.2008.03.031; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Purohit P, 2013, J GEN PHYSIOL, V141, P467, DOI 10.1085/jgp.201210946; Quik M, 1996, J NEUROCHEM, V67, P145; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Ramazanova AS, 2008, TOXICON, V51, P524, DOI 10.1016/j.toxicon.2007.11.001; Rossetto O, 2006, J NEUROCHEM, V97, P1534, DOI 10.1111/j.1471-4159.2006.03965.x; Rouault M, 2006, BIOCHEMISTRY-US, V45, P5800, DOI 10.1021/bi060217r; RUFINI S, 1992, BIOCHEMISTRY-US, V31, P12424, DOI 10.1021/bi00164a018; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Sine SM, 2013, BIOCHEM J, V454, P311, DOI 10.1042/BJ20130638; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Tsai IH, 2007, FEBS J, V274, P512, DOI 10.1111/j.1742-4658.2006.05598.x; Tsai IH, 2011, TOXICON, V57, P332, DOI 10.1016/j.toxicon.2010.12.012; Vardjan Nina, 2013, Commun Integr Biol, V6, pe23600, DOI 10.4161/cib.23600; VILLAR MT, 1988, BIOCHIM BIOPHYS ACTA, V938, P35, DOI 10.1016/0005-2736(88)90119-8; Vulfius CA, 2013, BIOCHEM MOSC SUPPL S, V7, P203, DOI 10.1134/S1990747813040077; Vulfius CA, 2005, NEUROSCI LETT, V373, P232, DOI 10.1016/j.neulet.2004.10.010; Vulfius CA, 2001, NEUROSCI LETT, V309, P189, DOI 10.1016/S0304-3940(01)02081-X; Vulfius CA, 2011, TOXICON, V57, P787, DOI 10.1016/j.toxicon.2011.02.013; WARRELL DA, 1989, T ROY SOC TROP MED H, V83, P732, DOI 10.1016/0035-9203(89)90311-8; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645	56	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115428	10.1371/journal.pone.0115428	http://dx.doi.org/10.1371/journal.pone.0115428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522251	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600047
J	Hayashi, Y; Ishii, S; Urakubo, H				Hayashi, Yuichiro; Ishii, Shin; Urakubo, Hidetoshi			A Computational Model of Afterimage Rotation in the Peripheral Drift Illusion Based on Retinal ON/OFF Responses	PLOS ONE			English	Article							MOTION ILLUSION; ILLUSORY MOTION; LIGHT ADAPTATION; VISUAL-SYSTEM; LUMINANCE; TIME; THRESHOLDS; DECREMENTS; INCREMENTS; PERCEPTION	Human observers perceive illusory rotations after the disappearance of circularly repeating patches containing dark-to-light luminance. This afterimage rotation is a very powerful phenomenon, but little is known about the mechanisms underlying it. Here, we use a computational model to show that the afterimage rotation can be explained by a combination of fast light adaptation and the physiological architecture of the early visual system, consisting of ON-and OFF-type visual pathways. In this retinal ON/OFF model, the afterimage rotation appeared as a rotation of focus lines of retinal ON/OFF responses. Focus lines rotated clockwise on a light background, but counterclockwise on a dark background. These findings were consistent with the results of psychophysical experiments, which were also performed by us. Additionally, the velocity of the afterimage rotation was comparable with that observed in our psychophysical experiments. These results suggest that the early visual system (including the retina) is responsible for the generation of the afterimage rotation, and that this illusory rotation may be systematically misinterpreted by our high-level visual system.	[Hayashi, Yuichiro; Ishii, Shin; Urakubo, Hidetoshi] Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishii, S (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Syst Sci, Sakyo Ku, Yoshida Honmachi 36-1, Kyoto 6068501, Japan.	ishii@i.kyoto-u.ac.jp; urakubo-h@sys.i.kyoto-u.ac.jp		Ishii, Shin/0000-0001-9385-8230; Urakubo, Hidetoshi/0000-0002-1816-0040	JSPS KAKENHI [26540154]; Strategic Research Program for Brain Sciences (SRPBS) from the MEXT of Japan; Platform for Dynamic Approaches to Living System from the MEXT of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Program for Brain Sciences (SRPBS) from the MEXT of Japan; Platform for Dynamic Approaches to Living System from the MEXT of Japan	This work was supported by JSPS KAKENHI, No. 26540154; the Strategic Research Program for Brain Sciences (SRPBS) and the Platform for Dynamic Approaches to Living System, both from the MEXT of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2005, J VISION, V5, P1055, DOI 10.1167/5.11.10; Beer AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002741; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BURR DC, 1993, J OPT SOC AM A, V10, P1706, DOI 10.1364/JOSAA.10.001706; Conway BR, 2005, J NEUROSCI, V25, P5651, DOI 10.1523/JNEUROSCI.1084-05.2005; Egashira A, 2012, 2012 THIRD INTERNATIONAL CONFERENCE ON NETWORKING AND COMPUTING (ICNC 2012), P130, DOI 10.1109/ICNC.2012.27; EHRENSTEIN WH, 1983, J OPT SOC AM, V73, P419, DOI 10.1364/JOSA.73.000419; Faubert J, 1999, PERCEPTION, V28, P617, DOI 10.1068/p2825; FRASER A, 1979, NATURE, V281, P565, DOI 10.1038/281565a0; GRAHAM N, 1992, VISION RES, V32, P1373, DOI 10.1016/0042-6989(92)90230-G; HAYHOE MM, 1987, VISION RES, V27, P1981, DOI 10.1016/0042-6989(87)90062-9; Hisakata R, 2008, VISION RES, V48, P1940, DOI 10.1016/j.visres.2008.06.015; Hood DC, 1998, ANNU REV PSYCHOL, V49, P503, DOI 10.1146/annurev.psych.49.1.503; Hsieh P, 2006, VISION RES, V46, P970, DOI 10.1016/j.visres.2005.10.009; Kitaoka A., 2003, VISION, V15, P261, DOI DOI 10.11247/JSSDJ.58; Kitaoka A, 2007, PERCEPTION, V36, P1019, DOI 10.1068/p5362; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Kuriki I, 2008, J VIS, V8, P1; Lu ZL, 1996, VISION RES, V36, P559, DOI 10.1016/0042-6989(95)00139-5; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; MATHER G, 1991, VISION RES, V31, P1013, DOI 10.1016/0042-6989(91)90206-K; Murakami I, 2006, VISION RES, V46, P2421, DOI 10.1016/j.visres.2006.01.030; Naor-Raz G, 2000, PERCEPTION, V29, P325; Otero-Millan J, 2012, J NEUROSCI, V32, P6043, DOI 10.1523/JNEUROSCI.5823-11.2012; Pessoa L, 1998, TRENDS COGN SCI, V2, P422, DOI 10.1016/S1364-6613(98)01237-6; Petrov YA, 2002, J OPT SOC AM A, V19, P1107, DOI 10.1364/JOSAA.19.001107; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Poot L, 1997, J OPT SOC AM A, V14, P2499, DOI 10.1364/JOSAA.14.002499; SCHILLER PH, 1992, TRENDS NEUROSCI, V15, P86, DOI 10.1016/0166-2236(92)90017-3; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Snippe HP, 2000, VISUAL NEUROSCI, V17, P449, DOI 10.1017/S0952523800173110; Tomimatsu E, 2011, ATTEN PERCEPT PSYCHO, V73, P1823, DOI 10.3758/s13414-011-0131-9; Westheimer G, 2007, PROG RETIN EYE RES, V26, P636, DOI 10.1016/j.preteyeres.2007.07.003; Wilson HR, 1997, VISUAL NEUROSCI, V14, P403, DOI 10.1017/S0952523800012098	35	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115464	10.1371/journal.pone.0115464	http://dx.doi.org/10.1371/journal.pone.0115464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517906	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600068
J	Vandercammen, L; Hofmans, J; Theuns, P				Vandercammen, Leen; Hofmans, Joeri; Theuns, Peter			Relating Specific Emotions to Intrinsic Motivation: On the Moderating Role of Positive and Negative Emotion Differentiation	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; NEED SATISFACTION; WORK MOTIVATION; AUTONOMOUS MOTIVATION; EXTRINSIC MOTIVATION; ACADEMIC EMOTIONS; DECISION-MAKING; VALENCE FOCUS; AROUSAL FOCUS; EXPERIENCE	Despite the fact that studies on self-determination theory have traditionally disregarded the explicit role of emotions in the motivation eliciting process, research attention for the affective antecedents of motivation is growing. We add to this emerging research field by testing the moderating role of emotion differentiation -individual differences in the extent to which people can differentiate between specific emotions-on the relationship between twelve specific emotions and intrinsic motivation. To this end, we conducted a daily diary study (N=72) and an experience sampling study (N=34). Results showed that the relationship between enthusiasm, cheerfulness, optimism, contentedness, gloominess, miserableness, uneasiness (in both studies 1 and 2), calmness, relaxation, tenseness, depression, worry (only in Study 1) on one hand and intrinsic motivation on the other hand was moderated by positive emotion differentiation for the positive emotions and by negative emotion differentiation for the negative emotions. Altogether, these findings suggest that for people who are unable to distinguish between different specific positive emotions the relationship between those specific positive emotions and intrinsic motivation is stronger, whereas the relationship between specific negative emotions and intrinsic motivation is weaker for people who are able to distinguish between the different specific negative emotions. Theoretical and practical implications are discussed.	[Vandercammen, Leen; Hofmans, Joeri; Theuns, Peter] Vrije Univ Brussel, Dept Psychol, Elsene, Belgium	Vrije Universiteit Brussel	Hofmans, J (corresponding author), Vrije Univ Brussel, Dept Psychol, Elsene, Belgium.	joeri.hofmans@vub.ac.be	Theuns, Peter/AAD-1336-2019	Hofmans, Joeri/0000-0001-6619-0706; Theuns, Peter/0000-0001-6713-823X				ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; [Anonymous], 1999, J APPL MANAGEMENT ST; Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P266, DOI 10.1037/0022-3514.87.2.266; Barrett LF, 1998, COGNITION EMOTION, V12, P579, DOI 10.1080/026999398379574; Barrett LF, 2001, COGNITION EMOTION, V15, P713, DOI 10.1080/02699930143000239; Basch J., 2000, EMOTIONS WORKPLACE R, P36; Beal DJ, 2011, J ORGAN BEHAV, V32, P526, DOI 10.1002/job.713; Bidee J, 2013, VOLUNTAS, V24, P32, DOI 10.1007/s11266-012-9269-x; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Bono JE, 2007, J APPL PSYCHOL, V92, P1357, DOI 10.1037/0021-9010.92.5.1357; BOS-NEHLES A., 2010, THESIS; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; Britton PC, 2011, COGN BEHAV PRACT, V18, P16, DOI 10.1016/j.cbpra.2009.06.004; Cameron CD, 2013, J EXP SOC PSYCHOL, V49, P719, DOI 10.1016/j.jesp.2013.02.014; Cherniss C., 2000, PROMOTING EMOTIONAL; Custers R, 2005, J PERS SOC PSYCHOL, V89, P129, DOI 10.1037/0022-3514.89.2.129; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Demiralp E, 2012, PSYCHOL SCI, V23, P1410, DOI 10.1177/0956797612444903; Dixon-Gordon KL, 2014, J PSYCHOPATHOL BEHAV, P1; Erez A, 2002, J APPL PSYCHOL, V87, P1055, DOI 10.1037//0021-9010.87.6.1055; FELDMAN LA, 1995, J PERS SOC PSYCHOL, V69, P153, DOI 10.1037/0022-3514.69.1.153; Fisher CD, 2002, MOTIV EMOTION, V26, P3, DOI 10.1023/A:1015190007468; Frijda N. H., 2008, EMOTIES OVERZICHT ON; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Gagne M, 2003, J APPL SPORT PSYCHOL, V15, P372, DOI 10.1080/714044203; Gooty J, 2009, J ORGAN BEHAV, V30, P833, DOI 10.1002/job.619; Grant AM, 2008, J APPL PSYCHOL, V93, P48, DOI 10.1037/0021-9010.93.1.48; Guay F, 2000, MOTIV EMOTION, V24, P175, DOI 10.1023/A:1005614228250; Haivas S, 2013, J APPL SOC PSYCHOL, V43, P1869, DOI 10.1111/jasp.12149; Hill CLM, 2012, EMOTION, V12, P81, DOI 10.1037/a0026355; Humphrey SE, 2007, J APPL PSYCHOL, V92, P1332, DOI 10.1037/0021-9010.92.5.1332; Isen AM, 2005, MOTIV EMOTION, V29, P297, DOI 10.1007/s11031-006-9019-8; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Kashdan TB, 2010, PSYCHOL SCI, V21, P1341, DOI 10.1177/0956797610379863; KATZELL RA, 1990, AM PSYCHOL, V45, P144, DOI 10.1037/0003-066X.45.2.144; Lam CF, 2008, J RES PERS, V42, P1109, DOI 10.1016/j.jrp.2008.02.002; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; LARSON EW, 1985, ACAD MANAGE J, V28, P464, DOI 10.2307/256211; Lin HF, 2007, J INF SCI, V33, P135, DOI 10.1177/0165551506068174; MARTIN LL, 1993, J PERS SOC PSYCHOL, V64, P317, DOI 10.1037/0022-3514.64.3.317; Mathieu JE, 2012, J APPL PSYCHOL, V97, P951, DOI 10.1037/a0028380; MAYER JD, 1993, INTELLIGENCE, V17, P433, DOI 10.1016/0160-2896(93)90010-3; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Meijman T.F., 1994, METEN PSYCHOSOCIALE; Meyer DK, 2006, EDUC PSYCHOL REV, V18, P377, DOI 10.1007/s10648-006-9032-1; Miner AG, 2005, J OCCUP ORGAN PSYCH, V78, P171, DOI 10.1348/096317905X40105; Ouano JA, 2011, ASIA-PAC EDUC RES, V20, P127; Pekrun R, 2002, EDUC PSYCHOL-US, V37, P91, DOI 10.1207/S15326985EP3702_4; Podsakoff PM., 1986, J MANAGE, V12, P69, DOI [DOI 10.1177/014920638601200408, 10.1177/014920638601200408]; Raghunathan R, 1999, ORGAN BEHAV HUM DEC, V79, P56, DOI 10.1006/obhd.1999.2838; Reis HT, 2000, PERS SOC PSYCHOL B, V26, P419, DOI 10.1177/0146167200266002; Russell J., 1989, EMOTION THEORY RES E, V4, P83, DOI 10.1080/02699939208409694; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Ryan R.M., 2009, HDB MOTIVATION SCH, P171; Ryan R. M., 2008, EUROPEAN HLTH PSYCHO, V10, P2, DOI DOI 10.1080/17509840701827437; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryan RM., 2009, HELLENIC J PSYCHOL, V6, P107; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KlausR., 2004, FEELINGS EMOTIONS AM, P136, DOI DOI 10.1017/CBO9780511806582.009; Selby EA, 2014, CLIN PSYCHOL SCI, V2, P514, DOI 10.1177/2167702613512794; Seo MG, 2007, ACAD MANAGE J, V50, P923, DOI 10.2307/20159897; Soriano C, 2013, COMPONENTS EMOTIONAL, DOI [10.1093/acprof:oso/9780199592746.003.0012, DOI 10.1093/ACPROF:OSO/9780199592746.001.0001, 10.1093/acprof:oso/9780199592746.001.0001]; STAW BM, 1993, ADMIN SCI QUART, V38, P304, DOI 10.2307/2393415; TALLIS F, 1994, BEHAV COGN PSYCHOTH, V22, P37, DOI 10.1017/S1352465800011796; Thrash TM, 2010, J PERS SOC PSYCHOL, V98, P488, DOI 10.1037/a0017906; Tugade MM, 2004, INDIVIDUAL DIFFERENC; Uy MA, 2010, ORGAN RES METHODS, V13, P31, DOI 10.1177/1094428109334977; Van den Broeck A, 2008, WORK STRESS, V22, P277, DOI 10.1080/02678370802393672; Van den Broeck A, 2010, J OCCUP ORGAN PSYCH, V83, P981, DOI 10.1348/096317909X481382; Vandercammen L, 2014, EUR J PERSONALITY, V28, P437, DOI 10.1002/per.1968; Vandercammen L, 2014, J OCCUP ORGAN PSYCH, V87, P62, DOI 10.1111/joop.12032; Vansteenkiste M, 2005, BRIT J SOC PSYCHOL, V44, P269, DOI 10.1348/014466604X17641; Vroom V., 1964, WORK MOTIVATION; Walker CO, 2006, LEARN INDIVID DIFFER, V16, P1, DOI 10.1016/j.lindif.2005.06.004; Weiss HM, 1996, RES ORGAN BEHAV, V18, P1	78	21	21	9	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115396	10.1371/journal.pone.0115396	http://dx.doi.org/10.1371/journal.pone.0115396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517984	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600062
J	Abed, RMM; Al-Kharusi, S; Prigent, S; Headley, T				Abed, Raeid M. M.; Al-Kharusi, Samiha; Prigent, Stephane; Headley, Tom			Diversity, Distribution and Hydrocarbon Biodegradation Capabilities of Microbial Communities in Oil-Contaminated Cyanobacterial Mats from a Constructed Wetland	PLOS ONE			English	Article							AEROBIC HETEROTROPHIC BACTERIA; RNA GENE DATABASE; NITROGEN-FIXATION; MARINE SEDIMENT; CRUDE-OIL; WATER; SULFATE; MICROORGANISMS; DEGRADATION; MICROALGAE	Various types of cyanobacterial mats were predominant in a wetland, constructed for the remediation of oil-polluted residual waters from an oil field in the desert of the south-eastern Arabian Peninsula, although such mats were rarely found in other wetland systems. There is scarce information on the bacterial diversity, spatial distribution and oil-biodegradation capabilities of freshwater wetland oil-polluted mats. Microbial community analysis by Automated Ribosomal Spacer Analysis (ARISA) showed that the different mats hosted distinct microbial communities. Average numbers of operational taxonomic units (OTUs(ARISA)) were relatively lower in the mats with higher oil levels and the number of shared OTUs(ARISA) between the mats was,60% in most cases. Multivariate analyses of fingerprinting profiles indicated that the bacterial communities in the wetland mats were influenced by oil and ammonia levels, but to a lesser extent by plant density. In addition to oil and ammonia, redundancy analysis (RDA) showed also a significant contribution of temperature, dissolved oxygen and sulfate concentration to the variations of the mats' microbial communities. Pyrosequencing yielded 282,706 reads with >90% of the sequences affiliated to Proteobacteria (41% of total sequences), Cyanobacteria (31%), Bacteriodetes (11.5%), Planctomycetes (7%) and Chloroflexi (3%). Known autotrophic (e.g. Rivularia) and heterotrophic (e. g. Azospira) nitrogen-fixing bacteria as well as purple sulfur and non-sulfur bacteria were frequently encountered in all mats. On the other hand, sequences of known sulfate-reducing bacteria (SRBs) were rarely found, indicating that SRBs in the wetland mats probably belong to yet-undescribed novel species. The wetland mats were able to degrade 53-100% of C-12-C-30 alkanes after 6 weeks of incubation under aerobic conditions. We conclude that oil and ammonia concentrations are the major key players in determining the spatial distribution of the wetland mats' microbial communities and that these mats contribute directly to the removal of hydrocarbons from oil field wastewaters.	[Abed, Raeid M. M.; Al-Kharusi, Samiha] Sultan Qaboos Univ, Coll Sci, Dept Biol, Al Khoud 123, Oman; [Prigent, Stephane; Headley, Tom] BAUER Resources, Constructed Wetland Competence Ctr, Muscat, Oman	Sultan Qaboos University	Abed, RMM (corresponding author), Sultan Qaboos Univ, Coll Sci, Dept Biol, POB 36, Al Khoud 123, Oman.	rabed@mpi-bremen.de			Research Council (TRC) of Oman [RC/SCI/BIOL/11/01]	Research Council (TRC) of Oman	The Research Council (TRC) of Oman (grant No. RC/SCI/BIOL/11/01) https://home.trc.gov.om/tabid/40/language/en-US/Default.aspx.	Abed RMM, 2010, INT BIODETER BIODEGR, V64, P58, DOI 10.1016/j.ibiod.2009.10.008; Abed Raeid M. M., 2009, Algological Studies, V130, P69, DOI 10.1127/1864-1318/2009/0130-0069; Abed RMM, 2005, INT BIODETER BIODEGR, V55, P29, DOI 10.1016/j.ibiod.2004.07.001; Abed RMM, 2002, APPL ENVIRON MICROB, V68, P1674, DOI 10.1128/AEM.68.4.1674-1683.2002; Acosta-Gonzalez A, 2013, ENVIRON MICROBIOL, V15, P77, DOI 10.1111/j.1462-2920.2012.02782.x; Al-Awadhi H, 2007, APPL MICROBIOL BIOT, V77, P183, DOI 10.1007/s00253-007-1127-1; Alley BL, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1639-5; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Balasooriya WK, 2008, HYDROL EARTH SYST SC, V12, P277, DOI 10.5194/hess-12-277-2008; Bannert A, 2011, APPL ENVIRON MICROB, V77, P6109, DOI 10.1128/AEM.01751-10; BATTERTON JC, 1978, MAR ENVIRON RES, V1, P31, DOI 10.1016/0141-1136(78)90011-9; Baudisova D, 2009, PLANT SOIL ENVIRON, V55, P429, DOI 10.17221/131/2009-PSE; Berrendero E, 2008, INT J SYST EVOL MICR, V58, P447, DOI 10.1099/ijs.0.65273-0; Bottos EM, 2008, ENVIRON MICROBIOL, V10, P950, DOI 10.1111/j.1462-2920.2007.01516.x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cerna B, 2009, HYDROBIOLOGIA, V627, P55, DOI 10.1007/s10750-009-9715-y; Chaillan F, 2006, CHEMOSPHERE, V62, P1574, DOI 10.1016/j.chemosphere.2005.06.050; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Edlund A, 2006, APPL ENVIRON MICROB, V72, P6800, DOI 10.1128/AEM.00971-06; Ferro Dal, 2007, GLOBAL ONSHORE OFFSH; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; HEIJTHUIJSEN JHFG, 1986, FEMS MICROBIOL ECOL, V38, P57, DOI 10.1016/0378-1097(86)90042-X; Hopner T., 1996, MARINE WILDLIFE SANC, P85; Jackson CR, 2009, MICROB ECOL, V57, P402, DOI 10.1007/s00248-008-9409-4; Ji GD, 2002, ECOL ENG, V18, P459, DOI 10.1016/S0925-8574(01)00106-9; Kadlec R.H., 1996, TREATMENT WETLANDS; Kadlec R.H., 2008, TREATMENT WETLANDS, DOI DOI 10.1201/9781420012514; Kleikemper J, 2002, APPL ENVIRON MICROB, V68, P1516, DOI 10.1128/AEM.68.4.1516-1523.2002; Knight R.L., 1992, CONSTRUCTED WETLANDS, P35; Komárek Jiøi, 2007, Hoehnea, V34, P49; Kraigher B, 2006, SOIL BIOL BIOCHEM, V38, P2762, DOI 10.1016/j.soilbio.2006.04.031; Lamers LPM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00156; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loy A, 2010, GEOMICROBIOLOGY: MOLECULAR AND ENVIRONMENTAL PERSPECTIVE, P127, DOI 10.1007/978-90-481-9204-5_6; Megharaj M, 2000, ARCH ENVIRON CON TOX, V38, P439, DOI 10.1007/s002449910058; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Murray-Gulde C, 2003, WATER RES, V37, P705, DOI 10.1016/S0043-1354(02)00353-6; Musat F, 2004, OPHELIA, V58, P217, DOI 10.1080/00785236.2004.10410229; Musat F, 2006, ENVIRON MICROBIOL, V8, P1834, DOI 10.1111/j.1462-2920.2006.01069.x; O'BRIEN P Y, 1976, British Phycological Journal, V11, P115; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Pagano M. C., 2013, British Journal of Environment and Climate Change, V3, P188; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Pester M, 2010, ISME J, V4, P1591, DOI 10.1038/ismej.2010.75; Pruesse E, 2012, BIOINFORMATICS; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radwan SS, 2000, ECOLOGY CYANOBACTERI, P307, DOI DOI 10.1007/0-306-46855-7_11; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Rejmankova E, 2000, HYDROBIOLOGIA, V431, P135, DOI 10.1023/A:1004011318643; Rejmankova E, 2004, BIOGEOCHEMISTRY, V67, P353, DOI 10.1023/B:BIOG.0000015790.28584.ed; Rejmankova E, 2005, AQUAT BOT, V83, P87, DOI 10.1016/j.aquabot.2005.05.011; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Scott JT, 2007, BIOGEOCHEMISTRY, V84, P207, DOI 10.1007/s10533-007-9119-x; Sheppard PJ, 2012, J MICROBIOL BIOTECHN, V22, P1185, DOI 10.4014/jmb.1201.01049; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Shpiner R, 2009, WATER RES, V43, P4258, DOI 10.1016/j.watres.2009.06.004; SORKHOH N, 1992, NATURE, V359, P109, DOI 10.1038/359109a0; Stikker A, 1998, FUTURES, V30, P43, DOI 10.1016/S0016-3287(98)00005-6; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; van de Meene AML, 2007, J BACTERIOL, V189, P4196, DOI 10.1128/JB.01711-06; VANDERMEULEN J H, 1976, P107; Venables WN., 2002, MODERN APPL STAT S 4; Venieraki A, 2011, MICROB ECOL, V61, P277, DOI 10.1007/s00248-010-9747-x; Verhoeven JTA, 1999, ECOL ENG, V12, P5, DOI 10.1016/S0925-8574(98)00050-0; Wang S, 2012, WORLD J MICROB BIOT, V28, P493, DOI 10.1007/s11274-011-0840-1; White JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-152; Whitmire SL, 2005, J ENVIRON QUAL, V34, P2062, DOI 10.2134/jeq2004.0483; Widdel F, 1992, PROKARYOTES, P3353; Wilhelm RC, 2011, CAN J MICROBIOL, V57, P303, DOI [10.1139/w11-004, 10.1139/W11-004]; Winters K, 1977, POLLUTANT EFFECTS MA, P167	76	35	35	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114570	10.1371/journal.pone.0114570	http://dx.doi.org/10.1371/journal.pone.0114570			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514025	Green Published, gold			2022-12-27	WOS:000349146300016
J	Skorheim, S; Razak, K; Bazhenov, M				Skorheim, Steven; Razak, Khaleel; Bazhenov, Maxim			Network Models of Frequency Modulated Sweep Detection	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; MECHANISMS UNDERLYING SELECTIVITY; BAT INFERIOR COLLICULUS; ECHO-LOCATING BATS; PALLID BAT; NEURAL MECHANISMS; SOUND DURATION; DIRECTION SELECTIVITY; COMPUTATIONAL MODELS; RESPONSE PROPERTIES	Frequency modulated (FM) sweeps are common in species-specific vocalizations, including human speech. Auditory neurons selective for the direction and rate of frequency change in FM sweeps are present across species, but the synaptic mechanisms underlying such selectivity are only beginning to be understood. Even less is known about mechanisms of experience-dependent changes in FM sweep selectivity. We present three network models of synaptic mechanisms of FM sweep direction and rate selectivity that explains experimental data: (1) The 'facilitation' model contains frequency selective cells operating as coincidence detectors, summing up multiple excitatory inputs with different time delays. (2) The 'duration tuned' model depends on interactions between delayed excitation and early inhibition. The strength of delayed excitation determines the preferred duration. Inhibitory rebound can reinforce the delayed excitation. (3) The 'inhibitory sideband' model uses frequency selective inputs to a network of excitatory and inhibitory cells. The strength and asymmetry of these connections results in neurons responsive to sweeps in a single direction of sufficient sweep rate. Variations of these properties, can explain the diversity of rate-dependent direction selectivity seen across species. We show that the inhibitory sideband model can be trained using spike timing dependent plasticity (STDP) to develop direction selectivity from a non-selective network. These models provide a means to compare the proposed synaptic and spectrotemporal mechanisms of FM sweep processing and can be utilized to explore cellular mechanisms underlying experience-or training-dependent changes in spectrotemporal processing across animal models. Given the analogy between FM sweeps and visual motion, these models can serve a broader function in studying stimulus movement across sensory epithelia.	[Skorheim, Steven; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Razak, Khaleel] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	maksim.bazhenov@ucr.edu			Direct For Biological Sciences [1252769] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Atencio CA, 2007, J NEUROPHYSIOL, V98, P2182, DOI 10.1152/jn.00394.2007; Aubie B, 2009, J NEUROSCI, V29, P9255, DOI 10.1523/JNEUROSCI.1085-09.2009; Bazhenov M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041903; Bazhenov M, 1998, J NEUROSCI, V18, P6444; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Bazhenov M, 2010, NEURON, V67, P357, DOI 10.1016/j.neuron.2010.07.023; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; Borisyuk A, 2002, J NEUROPHYSIOL, V88, P2134, DOI 10.1152/jn.2002.88.4.2134; Borisyuk A, 2001, NEUROCOMPUTING, V38, P1127, DOI 10.1016/S0925-2312(01)00475-1; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Buss E, 2004, EAR HEARING, V25, P242, DOI 10.1097/01.AUD.0000130796.73809.09; Casseday JH, 2000, J NEUROPHYSIOL, V84, P1475, DOI 10.1152/jn.2000.84.3.1475; Chen JY, 2013, J NEUROSCI, V33, P15915, DOI 10.1523/JNEUROSCI.5088-12.2013; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Ehrlich D, 1997, J NEUROPHYSIOL, V77, P2360, DOI 10.1152/jn.1997.77.5.2360; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fuzessery ZM, 1999, HEARING RES, V137, P137, DOI 10.1016/S0378-5955(99)00133-1; FUZESSERY ZM, 1994, J NEUROPHYSIOL, V72, P1061, DOI 10.1152/jn.1994.72.3.1061; Fuzessery ZM, 2006, J NEUROPHYSIOL, V96, P1320, DOI 10.1152/jn.00021.2006; Fuzessery ZM, 2011, J COMP PHYSIOL A, V197, P615, DOI 10.1007/s00359-010-0554-0; Gittelman JX, 2009, J NEUROSCI, V29, P13030, DOI 10.1523/JNEUROSCI.2477-09.2009; Gordon M, 1998, HEARING RES, V122, P97, DOI 10.1016/S0378-5955(98)00087-2; HEIL P, 1992, HEARING RES, V63, P135, DOI 10.1016/0378-5955(92)90081-W; Hopkins K, 2011, J ACOUST SOC AM, V130, P334, DOI 10.1121/1.3585848; Kossel A, 1990, Neuroreport, V1, P115, DOI 10.1097/00001756-199010000-00008; LANDFIELD PW, 1977, J GERONTOL, V32, P523, DOI 10.1093/geronj/32.5.523; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; LINDBLOM BE, 1967, J ACOUST SOC AM, V42, P830, DOI 10.1121/1.1910655; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; ORBAN GA, 1985, J NEUROPHYSIOL, V54, P1026, DOI 10.1152/jn.1985.54.4.1026; Razak KA, 2005, J NEUROPHYSIOL, V94, P3573, DOI 10.1152/jn.00816.2004; Razak KA, 2008, J NEUROSCI, V28, P9806, DOI 10.1523/JNEUROSCI.1293-08.2008; Razak KA, 2008, P NATL ACAD SCI USA, V105, P4465, DOI 10.1073/pnas.0709504105; Razak KA, 2007, J NEUROSCI, V27, P1769, DOI 10.1523/JNEUROSCI.3851-06.2007; Razak KA, 2006, J NEUROPHYSIOL, V96, P1303, DOI 10.1152/jn.00020.2006; Razak KA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00129; Razak KA, 2009, J NEUROPHYSIOL, V102, P1366, DOI 10.1152/jn.00334.2009; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rulkov NF, 2004, J COMPUT NEUROSCI, V17, P203, DOI 10.1023/B:JCNS.0000037683.55688.7e; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Sadagopan S, 2010, J NEUROSCI, V30, P7314, DOI 10.1523/JNEUROSCI.5072-09.2010; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Sanchez JT, 2008, J NEUROSCI, V28, P80, DOI 10.1523/JNEUROSCI.3572-07.2008; Schauer C, 2000, ACOUSTICS SPEECH SIG, P11865; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Stickney GS, 2005, J ACOUST SOC AM, V118, P2412, DOI 10.1121/1.2031967; SUGA N, 1965, J PHYSIOL-LONDON, V181, P671, DOI 10.1113/jphysiol.1965.sp007791; SUGA N, 1965, J PHYSIOL-LONDON, V179, P26, DOI 10.1113/jphysiol.1965.sp007648; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; Tan AYY, 2009, NEUROSCIENCE, V163, P1302, DOI 10.1016/j.neuroscience.2009.07.032; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; Trujillo M, 2013, HEARING RES, V298, P80, DOI 10.1016/j.heares.2012.12.013; Trujillo M, 2011, J NEUROPHYSIOL, V106, P2825, DOI 10.1152/jn.00480.2011; Van Hooser SD, 2014, J NEUROPHYSIOL, V111, P2355, DOI 10.1152/jn.00891.2013; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; WHITFIEL.IC, 1965, J NEUROPHYSIOL, V28, P655, DOI 10.1152/jn.1965.28.4.655; Williams AJ, 2010, J NEUROPHYSIOL, V104, P1456, DOI 10.1152/jn.00598.2009; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	68	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115196	10.1371/journal.pone.0115196	http://dx.doi.org/10.1371/journal.pone.0115196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514021	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300040
J	von Lindern, E; Mosler, HJ				von Lindern, Eike; Mosler, Hans-Joachim			Insights into Fisheries Management Practices: Using the Theory of Planned Behavior to Explain Fish Stocking among a Sample of Swiss Anglers	PLOS ONE			English	Article							PAST BEHAVIOR; MISSING DATA; ENHANCEMENT; CONSERVATION; SUSTAINABILITY; ORIENTATION; RESOURCES; EMPHASIS; HABITAT; ENGLAND	Using inadequate management tools often threatens the natural environment. This study focuses on the example of Swiss recreational fishermen (hereafter called "anglers") as recreational fisheries management stakeholders. In recreational fisheries, fish stocking conducted by anglers has been identified as one important factor associated with declining fish catches. We therefore aimed to a) gain insights into why anglers want to maintain fish stocking and b) identify entry points for interventions to promote more pro-ecological management practices. Results (N=349) showed that the majority of anglers think very uncritically about stocking and that they frequently engage in it. We conclude that outcome expectancies and beliefs about risks, in combination with a lack of stocking success controls are the main reasons that anglers retain stocking measures. We suggest that providing anglers with direct experience and feedback about stocking success is suitable to change their intentions regarding stocking and their actual stocking behavior, and thus, to promote more pro-ecological management methods. From a more general perspective, the results of this study are likely to help improve pro-ecological ecosystem management in other domains where problems similar to those in recreational fisheries management might exist.	[von Lindern, Eike; Mosler, Hans-Joachim] Eawag, Environm & Hlth Psychol, Dubendorf, Switzerland		von Lindern, E (corresponding author), Uppsala Univ, Inst Housing & Urban Res, Uppsala, Sweden.	eike.von_lindern@ibf.uu.se		von Lindern, Eike/0000-0003-3729-8042	Swiss Federal Office for the Environment (FOEN); EAWAG, the Swiss Federal Institute of Aquatic Science and Technology	Swiss Federal Office for the Environment (FOEN); EAWAG, the Swiss Federal Institute of Aquatic Science and Technology	The project was funded by the Swiss Federal Office for the Environment (FOEN) and EAWAG, the Swiss Federal Institute of Aquatic Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2011, HUM ECOL REV, V18, P30; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Arbuckle JL., 1996, ADV STRUCTURAL EQUAT, P243, DOI DOI 10.4324/9781315827414; Arlinghaus R, 2005, LIMNOLOGICA, V35, P2, DOI 10.1016/j.limno.2004.10.001; Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Arlinghaus R, 2002, FISH FISH, V3, P261, DOI 10.1046/j.1467-2979.2002.00102.x; Asparouhov T, 2010, MULTIPLE IMPUTATION; Baer J., 2007, GUTE FACHLICHE PRAXI; Bamberg S, 2003, BASIC APPL SOC PSYCH, V25, P175, DOI 10.1207/S15324834BASP2503_01; Burkhardt-Holm P, 2005, ENVIRON SCI TECHNOL, V39, p441A, DOI 10.1021/es053375z; Chao YL, 2011, ENVIRON BEHAV, V43, P53, DOI 10.1177/0013916509350849; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Corral-Verdugo V, 2009, J ENVIRON PSYCHOL, V29, P34, DOI 10.1016/j.jenvp.2008.09.001; Cowx IG, 2004, FISHERIES MANAG ECOL, V11, P145, DOI 10.1111/j.1365-2400.2004.00411.x; Cowx IG, 1999, FISHERIES MANAG ECOL, V6, P21, DOI 10.1046/j.1365-2400.1999.00139.x; Daedlow K, 2011, ANGLER ENV SOCIAL EC, P12; Fielding KS, 2008, J ENVIRON PSYCHOL, V28, P318, DOI 10.1016/j.jenvp.2008.03.003; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Geiser C., 2010, DATENANLYSE MPLUS AN; Granek EF, 2008, CONSERV BIOL, V22, P1125, DOI 10.1111/j.1523-1739.2008.00977.x; Hendry K, 2003, FISH RES, V62, P171, DOI 10.1016/S0165-7836(02)00161-3; Hewlett NR, 2009, FISHERIES MANAG ECOL, V16, P248, DOI 10.1111/j.1365-2400.2009.00671.x; Holzer G, 2003, FISCHEREILICHE BEWIR; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson JR, 2004, AM FISH S S, V44, P121; Jager W, 2007, J SOC ISSUES, V63, P97, DOI 10.1111/j.1540-4560.2007.00498.x; Kaiser FG, 2003, J APPL SOC PSYCHOL, V33, P586, DOI 10.1111/j.1559-1816.2003.tb01914.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lorenzen K, 2008, REV FISH SCI, V16, P10, DOI 10.1080/10641260701790291; Ludtke O, 2007, PSYCHOL RUNDSCH, V58, P103, DOI 10.1026/0033-3042.58.2.103; Marie AD, 2010, MOL ECOL, V19, P2025, DOI 10.1111/j.1365-294X.2010.04628.x; Molony BW, 2003, REV FISH BIOL FISHER, V13, P409, DOI 10.1007/s11160-004-1886-z; Muthen L.K., 2010, MPLUS USERS GUIDE; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Pouta E, 2001, SOC NATUR RESOUR, V14, P93, DOI 10.1080/089419201300000517; Rhodes RE, 2005, PREV MED, V40, P547, DOI 10.1016/j.ypmed.2004.07.016; Rogers MW, 2010, ECOL MODEL, V221, P919, DOI 10.1016/j.ecolmodel.2009.12.016; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schwarzel-Klingenstein J, 1999, ANG SCHW; Smith CL, 1997, FISHERIES, V22, P8, DOI 10.1577/1548-8446(1997)022&lt;0008:CVOCRA&gt;2.0.CO;2; Swiss Federal Office for the Environment FOEN, 2006, FISCHB; van Poorten BT, 2011, P NATL ACAD SCI USA, V108, P12554, DOI 10.1073/pnas.1013919108; Verplanken B, 2003, J APPL SOC PSYCHOL, V33, P1313, DOI 10.1111/j.1559-1816.2003.tb01951.x; Wahli T, 2002, J FISH DIS, V25, P491, DOI 10.1046/j.1365-2761.2002.00401.x; Weber ED, 2003, CAN J FISH AQUAT SCI, V60, P1018, DOI 10.1139/F03-087; Welcomme R. L., 1998, Fisheries Management and Ecology, V5, P351, DOI 10.1046/j.1365-2400.1998.550351.x	48	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115360	10.1371/journal.pone.0115360	http://dx.doi.org/10.1371/journal.pone.0115360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514798	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300054
J	Grewal, N; Thornton, GM; Behzad, H; Sharma, A; Lu, A; Zhang, P; Reid, WD; Granville, DJ; Scott, A				Grewal, Navdeep; Thornton, Gail M.; Behzad, Hayedeh; Sharma, Aishwariya; Lu, Alex; Zhang, Peng; Reid, W. Darlene; Granville, David J.; Scott, Alex			Accumulation of Oxidized LDL in the Tendon Tissues of C57BL/6 or Apolipoprotein E Knock-Out Mice That Consume a High Fat Diet: Potential Impact on Tendon Health	PLOS ONE			English	Article							APOE-DEFICIENT MICE; RISK-FACTOR; ATHEROSCLEROSIS; CELLS; SERUM; HYPERCHOLESTEROLEMIA; TENDINOPATHY; LIPOPROTEINS; INFLAMMATION; CHOLESTEROL	Objective: Clinical studies have suggested an association between dyslipidemia and tendon injuries or chronic tendon pain; the mechanisms underlying this association are not yet known. The objectives of this study were (1) to evaluate the impact of a high fat diet on the function of load-bearing tendons and on the distribution in tendons of oxidized low density lipoprotein (oxLDL), and (2) to examine the effect of oxLDL on tendon fibroblast proliferation and gene expression. Methods: Gene expression (Mmp2, Tgfb1, Col1a1, Col3a1), fat content (Oil Red O staining), oxLDL levels (immunohistochemistry) and tendon biomechanical properties were examined in mice (C57BI/6 or ApoE -/-) receiving a standard or a high fat diet. Human tendon fibroblast proliferation and gene expression (COL1A1, COL3A1, MMP2) were examined following oxLDL exposure. Results: In both types of mice (C57BI/6 or ApoE -/-), consumption of a high fat diet led to a marked increase in oxLDL deposition in the load-bearing extracellular matrix of the tendon. The consumption of a high fat diet also reduced the failure stress and load of the patellar tendon in both mouse types, and increased Mmp2 expression. ApoE -/- mice exhibited more pronounced reductions in tendon function than wild-type mice, and decreased expression of Col1a1 compared to wild type mice. Human tendon fibroblasts responded to oxLDL by increasing their proliferation and their mRNA levels of MMP2, while decreasing their mRNA levels for COL1A1 and COL3A1. Conclusion: The consumption of a high fat diet resulted in deleterious changes in tendon function, and these changes may be explained in part by the effects of oxLDL, which induced a proliferative, matrix-degrading phenotype in human tenocytes.	[Grewal, Navdeep; Behzad, Hayedeh; Sharma, Aishwariya] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC V5Z 1M9, Canada; [Grewal, Navdeep; Behzad, Hayedeh; Sharma, Aishwariya; Lu, Alex; Scott, Alex] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Thornton, Gail M.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Thornton, Gail M.] Univ British Columbia, Fac Med, Dept Orthopaed, Vancouver, BC V5Z 1M9, Canada; [Zhang, Peng] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Zhang, Peng] Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Vancouver, BC, Canada; [Reid, W. Darlene] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Granville, David J.] St Pauls Hosp, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of Calgary; University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; University of Toronto; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Scott, A (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	ascott@mail.ubc.ca		Scott, Alex/0000-0003-0366-8404; Reid, W Darlene/0000-0001-9980-8699	Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis Priority Announcement [126604-1]; Michael Smith Clinical Scholar Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Priority Announcement; Michael Smith Clinical Scholar Award	A. Scott received grant funding from the Canadian Institutes of Health Research (www.cihr.ca), Institute of Musculoskeletal Health and Arthritis Priority Announcement (126604-1) and a Michael Smith Clinical Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud JA, 2010, CLIN ORTHOP RELAT R, V468, P1493, DOI 10.1007/s11999-009-1151-9; Alfredson H, 2003, J ORTHOPAED RES, V21, P970, DOI 10.1016/S0736-0266(03)00107-4; Attia M, 2013, AM J SPORT MED, V41, P908, DOI 10.1177/0363546512473817; Bachem MG, 1999, CLIN CHEM LAB MED, V37, P319, DOI 10.1515/CCLM.1999.054; Beason DP, 2013, J SHOULDER ELB SURG, V22, P681, DOI 10.1016/j.jse.2012.07.008; Beason DP, 2011, J ORTHOP RES, V29, P380, DOI 10.1002/jor.21255; Behzad H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4374; Boivin GP, 2013, BONE JOINT RES, V2, P186, DOI 10.1302/2046-3758.29.2000196; Chen KC, 2011, FASEB J, V25, P1718, DOI 10.1096/fj.10-174904; Gaida JE, 2009, ARTHRIT RHEUM-ARTHR, V61, P840, DOI 10.1002/art.24518; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hirata Y, 2002, J DERMATOL SCI, V30, P248, DOI 10.1016/S0923-1811(02)00112-3; Huebbe P, 2010, MOL NUTR FOOD RES, V54, P623, DOI 10.1002/mnfr.200900398; Lusis AJ, 2004, CIRCULATION, V110, P1868, DOI 10.1161/01.CIR.0000143041.58692.CC; Mathiak G, 1999, ARCH ORTHOP TRAUM SU, V119, P280, DOI 10.1007/s004020050410; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozgurtas T, 2003, CLIN CHIM ACTA, V331, P25, DOI 10.1016/S0009-8981(03)00075-5; Pasternak B, 2010, BRIT J SPORT MED, V44, P669, DOI 10.1136/bjsm.2008.049411; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Sereysky JB, 2012, J ORTHOP RES, V30, P965, DOI 10.1002/jor.22012; Sharma A, 2011, J ORTHOP RES, V29, P678, DOI 10.1002/jor.21291; Sommerville LJ, 2012, ATHEROSCLEROSIS, V220, P45, DOI 10.1016/j.atherosclerosis.2011.07.095; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; VANREE JH, 1995, ATHEROSCLEROSIS, V112, P237, DOI 10.1016/0021-9150(94)05419-J; Zhou J, 2001, ARTERIOSCL THROM VAS, V21, P1470, DOI 10.1161/hq0901.096582	26	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114214	10.1371/journal.pone.0114214	http://dx.doi.org/10.1371/journal.pone.0114214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502628	gold, Green Published			2022-12-27	WOS:000346375400023
J	Yeh, JH; Huang, CT; Liu, CH; Ruan, SY; Tsai, YJ; Chien, YC; Yang, CY; Huang, CK; Hsu, CL; Kuo, LC; Lee, PL; Ku, SC; Kuo, PH; Yu, CJ				Yeh, Jiann-Horng; Huang, Chun-Ta; Liu, Chia-Hsiung; Ruan, Sheng-Yuan; Tsai, Yi-Ju; Chien, Ying-Chun; Yang, Ching-Yao; Huang, Chun-Kai; Hsu, Chia-Lin; Kuo, Lu-Cheng; Lee, Pei-Lin; Ku, Shih-Chi; Kuo, Ping-Hung; Yu, Chong-Jen		HINT Study Grp	Cautious Application of Pleural N-Terminal Pro-B-Type Natriuretic Peptide in Diagnosis of Congestive Heart Failure Pleural Effusions among Critically Ill Patients	PLOS ONE			English	Article							LIGHTS CRITERIA; CARDIAC ORIGIN; SEVERE SEPSIS; SEPTIC SHOCK; FLUID; BIAS; IDENTIFICATION; METAANALYSIS; ACCURACY; SPECTRUM	Background and Objective: Several studies on diagnostic accuracy of pleural N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) for effusions from congestive heart failure (CHF) conclude that pleural NT-pro-BNP is a useful biomarker with high diagnostic accuracy for distinguishing CHF effusions. However, its applicability in critical care settings remains uncertain and requires further investigations. Methods: NT-proBNP was measured in pleural fluid samples of a prospective cohort of intensive care unit patients with pleural effusions. Receiver operating characteristic curve analysis was performed to determine diagnostic accuracy of pleural NT-proBNP for prediction of CHF effusions. Results: One hundred forty-seven critically ill patients were evaluated, 38 (26%) with CHF effusions and 109 (74%) with non-CHF effusions of various causes. Pleural NT-proBNP levels were significantly elevated in patients with CHF effusions. Pleural NT-pro-BNP demonstrated the area under the curve of 0.87 for diagnosing effusions due to CHF. With a cutoff of 2200 pg/mL, pleural NT-proBNP displayed high sensitivity (89%) but moderate specificity (73%). Notably, 29 (27%) of 109 patients with non-CHF effusions had pleural NT-proBNP levels >2200 pg/mL and these patients were more likely to experience septic shock (18/29 vs. 10/80, P < 0.001) or acute kidney injury (19/29 vs. 9/80, P<0.001). Conclusions: Among critically ill patients, pleural NT-proBNP measurements remain a useful diagnostic aid in evaluation of pleural effusions. However, patients with non-CHF effusions may exhibit high pleural NT-proBNP concentrations if they suffer from septic shock or acute kidney injury. Accordingly, it is suggested that clinical context should be taken into account when interpreting pleural NT-proBNP values in critical care settings.	[Yeh, Jiann-Horng] Shin Kong Wu Ho Mem Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Chun-Ta; Ruan, Sheng-Yuan; Chien, Ying-Chun; Yang, Ching-Yao; Huang, Chun-Kai; Hsu, Chia-Lin; Kuo, Lu-Cheng; Lee, Pei-Lin; Ku, Shih-Chi; Kuo, Ping-Hung; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei 100, Taiwan; [Huang, Chun-Ta; Liu, Chia-Hsiung] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Liu, Chia-Hsiung] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [HINT Study Grp] Natl Taiwan Univ Hosp, Taipei 100, Taiwan	Shin Kong Wu Ho Su Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital	Huang, CT (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	huangct@ntu.edu.tw	Lee, Pei-Lin/L-5564-2019; Chien, Ying-Chun/M-9595-2016; Ku, Shih-Chi/AAN-5216-2021	Lee, Pei-Lin/0000-0002-6883-9502; Chien, Ying-Chun/0000-0003-0184-323X; HSU, CHIA-LIN/0000-0001-5785-0733; KUO, PING-HUNG/0000-0003-3756-3395; KU, SHIH-CHI/0000-0002-4123-0967; YANG, CHING-YAO/0000-0003-4927-4814; RUAN, SHENG-YUAN/0000-0002-7949-7253; HUANG, CHUN-TA/0000-0002-5234-4986; HUANG, CHUN-KAI/0000-0001-7392-6363; Yu, Chong-Jen/0000-0001-5664-9392	Shin Kong Wu Ho-Su Memorial Hospital [SKH-FJU-9718]; National Taiwan University Hospital [NTUH.102-N2297]	Shin Kong Wu Ho-Su Memorial Hospital; National Taiwan University Hospital(National Taiwan University)	This study was supported by the Shin Kong Wu Ho-Su Memorial Hospital (SKH-FJU-9718) (YJT) and the National Taiwan University Hospital (NTUH.102-N2297) (CTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajwa EK, 2008, CRIT CARE MED, V36, P2322, DOI 10.1097/CCM.0b013e318181040d; Cincin A, 2013, RESP CARE, V58, P313, DOI 10.4187/respcare.01818; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Franz M, 2001, KIDNEY INT, V59, P1928, DOI 10.1046/j.1523-1755.2001.0590051928.x; Han CH, 2008, INTERNAL MED, V47, P1669, DOI 10.2169/internalmedicine.47.1276; Janda S, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-58; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Kelly S, 1997, BRIT J RADIOL, V70, P1028, DOI 10.1259/bjr.70.838.9404207; Kolditz M, 2006, EUR RESPIR J, V28, P144, DOI 10.1183/09031936.06.00113205; Liao H, 2008, RESPIROLOGY, V13, P53, DOI 10.1111/j.1440-1843.2007.01191.x; Light RW, 2002, NEW ENGL J MED, V346, P1971, DOI 10.1056/NEJMcp010731; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Long AC, 2010, CHEST, V137, P1369, DOI 10.1378/chest.09-2193; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Ordonez-Llanos J, 2008, AM J CARDIOL, V101, p9A, DOI 10.1016/j.amjcard.2007.11.013; Porcel JM, 2004, AM J MED, V116, P417, DOI 10.1016/j.amjmed.2003.11.008; Porcel JM, 2007, RESPIROLOGY, V12, P654, DOI 10.1111/j.1440-1843.2007.01109.x; Porcel JM, 2013, RESPIROLOGY, V18, P540, DOI 10.1111/resp.12039; Porcel JM, 2009, CHEST, V136, P671, DOI 10.1378/chest.09-0270; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rehman SU, 2008, CARDIOL REV, V16, P240, DOI 10.1097/CRD.0b013e3181815333; Rudiger A, 2006, CRIT CARE MED, V34, P2140, DOI 10.1097/01.CCM.0000229144.97624.90; Tomcsanyi J, 2004, EUR J HEART FAIL, V6, P753, DOI 10.1016/j.ejheart.2003.11.017; Varpula M, 2007, CRIT CARE MED, V35, P1277, DOI 10.1097/01.CCM.0000261893.72811.0F; Vesely DL, 2003, AM J PHYSIOL-RENAL, V285, pF167, DOI 10.1152/ajprenal.00259.2002; Vives M, 1996, CHEST, V109, P1503, DOI 10.1378/chest.109.6.1503; Zhou Q, 2010, HEART, V96, P1207, DOI 10.1136/hrt.2009.188474	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115301	10.1371/journal.pone.0115301	http://dx.doi.org/10.1371/journal.pone.0115301			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502236	Green Submitted, gold, Green Published			2022-12-27	WOS:000346375400091
J	Jiang, G; Li, RH; Sun, C; Liu, YQ; Zheng, JN				Jiang, Guan; Li, Rong-Hua; Sun, Chao; Liu, Yan-Qun; Zheng, Jun-Nian			Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis	PLOS ONE			English	Article							METASTATIC MELANOMA; DOUBLE-BLIND; PHASE-II; PLUS DACARBAZINE; CANCER STATISTICS; TEMOZOLOMIDE; TRIAL	Background: Malignant melanoma is the most aggressive and deadly form of skin cancer. Dacarbazine (DTIC) has been the approved first-line treatment for metastatic melanoma in routine clinical practice. However, response rates with single-agent DTIC are low. The objective of this study was to compare the efficacy and safety of DTIC with or without placebo and DTIC-based combination therapies in patients with advanced metastatic melanoma. Methods: We searched from electronic databases such as The Cochrane Library, MEDLINE, EBSCO, EMBASE, Ovid, CNKI, and CBMDisc from 2003 to 2013. The primary outcome measures were overall response and 1-year survival, and the secondary outcome measurements were adverse events. Results: Nine randomized controlled trials (RCTs) involving 2,481 patients were included in the meta-analysis. DTIC-based combination therapies was superior to DTIC alone in overall response (combined risk ratio [RR] = 1.60, 95% confidence interval [CI]: 1.27-2.01) and 1-year survival (combined RR=1.26, 95% CI: 1.14-1.39). Patients with DTIC-based combination therapies had higher incidence of adverse events including nausea (combined RR=1.23, 95% CI: 1.10-1.36), vomiting (combined RR=1.73, 95% CI: 1.41-2.12) and neutropenia (combined RR=1.75, 95% CI: 1.42-2.16) compared to the group for DTIC alone. Conclusion: These data suggested that DTIC-based combination therapies could moderately improve the overall response and the 1-year survival but increased the incidence of adverse events. Further large-scale, high-quality, placebo-controlled, double-blind trials are needed to confirm this conclusion.	[Jiang, Guan; Li, Rong-Hua; Sun, Chao; Liu, Yan-Qun] Xuzhou Med Coll, Affiliated Hosp, Dept Dermatol, Xuzhou 221002, Peoples R China; [Jiang, Guan; Zheng, Jun-Nian] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R China; [Jiang, Guan] Ctr Dis Control & Prevent Xuzhou City, Xuzhou 221002, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zheng, JN (corresponding author), Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Peoples R China.	dr.guanjiang@gmail.com	Li, Ronghua/AAP-8236-2021		National Natural Science Foundation of China [81372916]; Xuzhou Medical Young Talents Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xuzhou Medical Young Talents Project	This project is supported by Grants from the National Natural Science Foundation of China (No. 81372916) and Xuzhou Medical Young Talents Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, REV MAN REV MAN COMP; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Crosby T, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001215; Cui CL, 2013, MOL THER, V21, P1456, DOI 10.1038/mt.2013.79; Eggermont AMM, 2004, EUR J CANCER, V40, P1825, DOI 10.1016/j.ejca.2004.04.030; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huncharek M, 2001, MELANOMA RES, V11, P75, DOI 10.1097/00008390-200102000-00009; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang G, 2011, BIOCHEM BIOPH RES CO, V406, P311, DOI 10.1016/j.bbrc.2011.02.042; Kefford RF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-69; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; McDermott DF, 2008, J CLIN ONCOL, V26, P2178, DOI 10.1200/JCO.2007.14.8288; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murrell J, 2013, CANCER TREAT REV, V39, P833, DOI 10.1016/j.ctrv.2013.06.004; O'Day S, 2011, BRIT J CANCER, V105, P346, DOI 10.1038/bjc.2011.183; Plummer ER, 2011, CLIN CANCER RES, V11, P3402; Querfeld C, 2011, CLIN CANCER RES, V17, P5748, DOI 10.1158/1078-0432.CCR-11-0556; Quirin C, 2007, INT J CANCER, V121, P2801, DOI 10.1002/ijc.23052; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rubin Krista M, 2013, Semin Oncol Nurs, V29, P195, DOI 10.1016/j.soncn.2013.06.005; Sasse AD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005413.pub2; Sherrill B, 2013, BRIT J CANCER, V109, P8, DOI 10.1038/bjc.2013.298; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Yin ZQ, 2012, J DERMATOL TREAT, V23, P449, DOI 10.3109/09546634.2011.579082	30	30	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e111920	10.1371/journal.pone.0111920	http://dx.doi.org/10.1371/journal.pone.0111920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502446	Green Published, Green Submitted			2022-12-27	WOS:000347146700003
J	Hou, N; Han, J; Li, J; Liu, YX; Qin, YN; Ni, L; Song, TS; Huang, C				Hou, Ni; Han, Jia; Li, Jie; Liu, Yingxun; Qin, Yannan; Ni, Lei; Song, Tusheng; Huang, Chen			MicroRNA Profiling in Human Colon Cancer Cells during 5-Fluorouracil-Induced Autophagy	PLOS ONE			English	Article							PREDICTION; MECHANISMS; PROTEINS; TARGET	Autophagy modulation is now recognized as a potential therapeutic approach for cancer (including colorectal cancer), yet the molecular mechanisms regulating autophagy in response to cellular stress are still not well understood. MicroRNAs (miRNAs) have been found to play important roles in controlling many cellular functions, including growth, metabolism and stress response. The physiological importance of the miRNA-autophagy interconnection is only beginning to be elucidated. MiRNA microarray technology facilitates analysis of global miRNA expression in certain situations. In this study, we explored the expression profile of miRNAs during the response of human colon cancer cells (HT29s) to 5-FU treatment and nutrient starvation using miRNA microarray analysis. The alteration of miRNA expression showed the same pattern under both conditions was further testified by qRT-PCR in three human colon cancer cell lines. In addition, bioinformatic prediction of target genes, pathway analysis and gene network analysis were performed to better understand the roles of these miRNAs in the regulation of autophagy. We identified and selected four downregulated miRNAs including hsa-miR-302a-3p and 27 upregulated miRNAs under these two conditions as having the potential to target genes involved in the regulation of autophagy in human colon cancer cells. They have the potential to modulate autophagy in 5-FU-based chemotherapy in colorectal cancer.	[Hou, Ni; Han, Jia; Liu, Yingxun; Qin, Yannan; Ni, Lei; Song, Tusheng; Huang, Chen] Xi An Jiao Tong Univ, Dept Genet & Mol Biol, Sch Med, Xian 710049, Peoples R China; [Li, Jie] Xi An Jiao Tong Univ, Affiliated Hosp 2, Sch Med, Dept Gen Surg, Xian 710049, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Key Lab Environm & Genes Related Dis, Sch Med, Xian 710049, Peoples R China; [Huang, Chen] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Sch Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Huang, C (corresponding author), Xi An Jiao Tong Univ, Dept Genet & Mol Biol, Sch Med, Xian 710049, Peoples R China.	hchen@mail.xjtu.edu.cn			National Natural Science Foundation of China [31100969, 81172358]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2013-09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported by grants from the National Natural Science Foundation of China (grant No. 31100969) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2013-09) to Dr. Hou. It was also supported by a grant from the National Natural Science Foundation of China (grant No. 81172358) to Dr. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Chen KL, 2012, CANCER LETT, V317, P89, DOI 10.1016/j.canlet.2011.11.015; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; HE L, 2004, NAT REV GENET, V5, P522; Jegga AG, 2011, AUTOPHAGY, V7, P477, DOI 10.4161/auto.7.5.14811; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kubota C, 2010, J BIOL CHEM, V285, P667, DOI 10.1074/jbc.M109.053058; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Lorin S, 2013, SEMIN CANCER BIOL, V23, P361, DOI 10.1016/j.semcancer.2013.06.007; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Meschini S, 2011, CURR CANCER DRUG TAR, V11, P357, DOI 10.2174/156800911794519707; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; O'Connell MJ, 2009, J CLIN ONCOL, V27, P3082, DOI 10.1200/JCO.2009.22.2919; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perez-Rivas LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091884; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Yin JQ, 2008, TRENDS BIOTECHNOL, V26, P70, DOI 10.1016/j.tibtech.2007.11.007; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zhai HY, 2013, CELL CYCLE, V12, P246, DOI 10.4161/cc.23273; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	30	19	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114779	10.1371/journal.pone.0114779	http://dx.doi.org/10.1371/journal.pone.0114779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526515	Green Submitted, gold, Green Published			2022-12-27	WOS:000347186200007
J	Ibrahim, NI; Khamis, MF; Yunoh, MFM; Abdullah, S; Mohamed, N; Shuid, AN				Ibrahim, Nurul 'Izzah; Khamis, Mohd Fadhli; Yunoh, Mohd Faridz Mod; Abdullah, Shahrum; Mohamed, Norazlina; Shuid, Ahmad Nazrun			Targeted Delivery of Lovastatin and Tocotrienol to Fracture Site Promotes Fracture Healing in Osteoporosis Model: Micro-Computed Tomography and Biomechanical Evaluation	PLOS ONE			English	Article							IN-VITRO; BONE; ESTROGEN; RALOXIFENE; CALCIUM; ALENDRONATE; REPAIR; MICROSTRUCTURE; MICROSPHERES; SUPPRESSION	Osteoporosis is becoming a major health problem that is associated with increased fracture risk. Previous studies have shown that osteoporosis could delay fracture healing. Although there are potential agents available to promote fracture healing of osteoporotic bone such as statins and tocotrienol, studies on direct delivery of these agents to the fracture site are limited. This study was designed to investigate the effects of two potential agents, lovastatin and tocotrienol using targeted drug delivery system on fracture healing of postmenopausal osteoporosis rats. The fracture healing was evaluated using micro CT and biomechanical parameters. Forty-eight Sprague-Dawley female rats were divided into 6 groups. The first group was sham-operated (SO), while the others were ovariectomized (OVx). After two months, the right tibiae of all rats were fractured at metaphysis region using pulsed ultrasound and were fixed with plates and screws. The SO and OVxC groups were given two single injections of lovastatin and tocotrienol carriers. The estrogen group (OVx+EST) was given daily oral gavages of Premarin (64.5 mu g/kg). The Lovastatin treatment group (OVx+Lov) was given a single injection of 750 mu g/kg lovastatin particles. The tocotrienol group (OVx+TT) was given a single injection of 60 mg/kg tocotrienol particles. The combination treatment group (OVx+Lov+TT) was given two single injections of 750 mu g/kg lovastatin particles and 60 mg/kg tocotrienol particles. After 4 weeks of treatment, the fractured tibiae were dissected out for micro-CT and biomechanical assessments. The combined treatment group (OVx+Lov+TT) showed significantly higher callus volume and callus strength than the OVxC group (p<0.05). Both the OVx+Lov and OVx+TT groups showed significantly higher callus strength than the OVxC group (p<0.05), but not for callus volume. In conclusion, combined lovastatin and tocotrienol may promote better fracture healing of osteoporotic bone.	[Ibrahim, Nurul 'Izzah; Mohamed, Norazlina; Shuid, Ahmad Nazrun] Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia; [Khamis, Mohd Fadhli] Univ Sains Malaysia, Sch Dent Sci, Kubang Kerian, Kelantan, Malaysia; [Yunoh, Mohd Faridz Mod; Abdullah, Shahrum] Univ Kebangsaan Malaysia, Fac Engn, Dept Mech & Mat Engn, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Sains Malaysia; Universiti Kebangsaan Malaysia	Shuid, AN (corresponding author), Univ Kebangsaan Malaysia, Med Ctr, Fac Med, Dept Pharmacol, Jalan Yaacob Latif, Kuala Lumpur, Malaysia.	anazrun@yahoo.com	Khamis, Mohd Fadhli/E-6917-2012; Mohamed, Norazlina/M-7306-2017; ABDULLAH, SHAHRUM/AAD-7938-2019; Ibrahim, Nurul 'Izzah/X-7167-2019; SHUID, AHMAD NAZRUN/AAS-7556-2020	Khamis, Mohd Fadhli/0000-0002-2418-7995; Mohamed, Norazlina/0000-0003-2480-0224; ABDULLAH, SHAHRUM/0000-0003-0345-5628; 	Ministry of Higher Education (Malaysia) [/1/2012/SKK03/UKM/02/1]	Ministry of Higher Education (Malaysia)(Ministry of Education, Malaysia)	This work was supported by ERGS (Exploratory Research Grant Scheme),/1/2012/SKK03/UKM/02/1, Ministry of Higher Education (Malaysia), to Ahmad Nazrun Shuid. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Majeed S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/960742; Altundag O, 2004, MED HYPOTHESES, V63, P1010, DOI 10.1016/j.mehy.2004.04.022; Cao YP, 2002, J BONE MINER RES, V17, P2237, DOI 10.1359/jbmr.2002.17.12.2237; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Chiste RC, 2011, FOOD CHEM, V127, P419, DOI 10.1016/j.foodchem.2010.12.139; Cruess RL, 1975, TXB SMALL ANIMAL ORT, P1; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Estai MA, 2011, IRAN J MED SCI, V36, P281; EVANS G, 1994, ENDOCRINOLOGY, V134, P2283, DOI 10.1210/en.134.5.2283; Garrett IR, 2007, J ORTHOP RES, V25, P1351, DOI 10.1002/jor.20391; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gerstenfeld LC, 2009, J BONE MINER RES, V24, P196, DOI 10.1359/JBMR.081113; Giannotti S, 2013, CLIN CASES MINER BON, V10, P116, DOI 10.11138/ccmbm/2013.10.2.116; Giannotti S, 2012, CLIN CASES MINER BON, V9, P56; GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640; Guyton JR, 2006, AM J CARDIOL, V97, p95C, DOI 10.1016/j.amjcard.2005.12.016; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hagihara M, 2011, J BIOL CHEM, V286, P5157, DOI 10.1074/jbc.M110.180919; Hamelin BA, 1998, TRENDS PHARMACOL SCI, V19, P26, DOI 10.1016/S0165-6147(97)01147-4; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu HQ, 2008, BONE, V43, pS54, DOI 10.1016/j.bone.2008.08.048; Maniam S, 2008, BASIC CLIN PHARMACOL, V103, P55, DOI 10.1111/j.1742-7843.2008.00241.x; McAnally JA, 2007, EXP BIOL MED, V232, P523; McCann RM, 2008, J ORTHOP RES, V26, P384, DOI 10.1002/jor.20505; Mehta M, 2013, EUR CELLS MATER, V25, P366, DOI 10.22203/eCM.v025a26; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; Nyman JS, 2009, J BIOMECH, V42, P891, DOI 10.1016/j.jbiomech.2009.01.016; Packer L, 2001, J NUTR, V131, p369S, DOI 10.1093/jn/131.2.369S; PARKER RA, 1993, J BIOL CHEM, V268, P11230; PECK WA, 1993, AM J MED, V94, P646; Rafi Shaik M, 2012, INT J PHARM SCI, V2, P112, DOI DOI 10.1016/j.jconrel.2004.04.023; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Roland S, 2011, J ORTHOPAED RES, V29, P1245; Russell KRM, 2005, PHYTOTHER RES, V19, P433, DOI 10.1002/ptr.1650; SATO M, 1995, J PHARMACOL EXP THER, V272, P1252; Sato M, 1996, J PHARMACOL EXP THER, V279, P298; SERBINOVA E, 1991, FREE RADICAL BIO MED, V10, P263, DOI 10.1016/0891-5849(91)90033-Y; Sharlina M, 2012, EVID-BASED COMPL ALT, V2012; Sheweita SA, 2007, CURR DRUG METAB, V8, P519; Shuid AN, 2010, J ORTHOP RES, V28, P1651, DOI 10.1002/jor.21180; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; TAN B, 2010, TOCOTRIENOLS NEW VIT; Tann B, 2008, TOCOTRIENOLS VITAMIN; Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1; Urata T, 1999, J CONTROL RELEASE, V58, P133, DOI 10.1016/S0168-3659(98)00146-1; WAKIYAMA N, 1981, CHEM PHARM BULL, V29, P3363; Wang WX, 2010, J BONE MINER RES, V25, P1658, DOI 10.1002/jbmr.42; Weis JA, 2010, J BIOMECH, V43, P557, DOI 10.1016/j.jbiomech.2009.09.051; World Health Organization (WHO), 2003, WHO TECHN REP SER, P919	59	34	40	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115595	10.1371/journal.pone.0115595	http://dx.doi.org/10.1371/journal.pone.0115595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526611	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200039
J	Toth, K; Wasserkort, R; Sipos, F; Kalmaar, A; Wichmann, B; Leiszter, K; Valcz, G; Juhasz, M; Miheller, P; Patai, AV; Tulassay, Z; Molnar, B				Toth, Kinga; Wasserkort, Reinhold; Sipos, Ferenc; Kalmar, Alexandra; Wichmann, Barnabas; Leiszter, Katalin; Valcz, Gabor; Juhasz, Mark; Miheller, Pal; Patai, Arpad V.; Tulassay, Zsolt; Molnar, Bela			Detection of Methylated Septin 9 in Tissue and Plasma of Colorectal Patients with Neoplasia and the Relationship to the Amount of Circulating Cell-Free DNA	PLOS ONE			English	Article							AMERICAN-CANCER-SOCIETY; TASK-FORCE; BLOOD-TEST; EXPRESSION; GENE; SERUM; LEUKEMIA; QUANTIFICATION; BIOMARKERS; POLYPS	Background: Determination of methylated Septin 9 (mSEPT9) in plasma has been shown to be a sensitive and specific biomarker for colorectal cancer (CRC). However, the relationship between methylated DNA in plasma and colon tissue of the same subjects has not been reported. Methods: Plasma and matching biopsy samples were collected from 24 patients with no evidence of disease (NED), 26 patients with adenoma and 34 patients with CRC. Following bisulfite conversion of DNA a commercial RT-PCR assay was used to determine the total amount of DNA in each sample and the fraction of mSEPT9 DNA. The Septin-9 protein was assessed using immunohistochemistry. Results: The percent of methylated reference (PMR) values for SEPT9 above a PMR threshold of 1% were detected in 4.2% (1/24) of NED, 100% (26/26) of adenoma and 97.1% (33/34) of CRC tissues. PMR differences between NED vs. adenoma and NED vs. CRC comparisons were significant (p<0.001). In matching plasma samples using a PMR cut-off level of 0.01%, SEPT9 methylation was 8.3% (2/24) of NED, 30.8% (8/26) of adenoma and 88.2% (30/34) of CRC. Significant PMR differences were observed between NED vs. CRC (p<0.01) and adenoma vs. CRC (p<0.01). Significant differences (p<0.01) were found in the amount of cfDNA (circulating cell-free DNA) between NED and CRC, and a modest correlation was observed between mSEPT9 concentration and cfDNA of cancer (R2 50.48). The level of Septin-9 protein in tissues was inversely correlated to mSEPT9 levels with abundant expression in normals, and diminished expression in adenomas and tumors. Conclusions: Methylated SEPT9 was detected in all tissue samples. In plasma samples, elevated mSEPT9 values were detected in CRC, but not in adenomas. Tissue levels of mSEPT9 alone are not sufficient to predict mSEPT9 levels in plasma. Additional parameters including the amount of cfDNA in plasma appear to also play a role.	[Toth, Kinga; Sipos, Ferenc; Kalmar, Alexandra; Leiszter, Katalin; Juhasz, Mark; Miheller, Pal; Patai, Arpad V.; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Wasserkort, Reinhold] Epigenomics AG, Berlin, Germany; [Kalmar, Alexandra; Wichmann, Barnabas; Valcz, Gabor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences	Toth, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	drtothkinga@yahoo.com	Sipos, Ferenc/GYV-6182-2022	Miheller, Pal/0000-0002-7396-3145				Ahlquist DA, 2012, CLIN GASTROENTEROL H, V10, P272, DOI 10.1016/j.cgh.2011.10.008; Ahlquist DA, 2012, GASTROENTEROLOGY, V142, P248, DOI 10.1053/j.gastro.2011.10.031; Amir S, 2010, MOL CANCER RES, V8, P643, DOI 10.1158/1541-7786.MCR-09-0497; Atamaniuk J, 2008, EUR J APPL PHYSIOL, V104, P711, DOI 10.1007/s00421-008-0827-2; Bischoff FZ, 2005, HUM REPROD UPDATE, V11, P59, DOI 10.1093/humupd/dmh053; Boni L, 2007, SURG ONCOL, V16, pS29, DOI 10.1016/j.suronc.2007.10.004; Breitbach S, 2012, SPORTS MED, V42, P565, DOI 10.2165/11631380-000000000-00000; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Church TR, 2014, GUT, V63, P317, DOI 10.1136/gutjnl-2012-304149; Connolly D, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2924; Danese E, 2013, BRIT J CANCER, V109, P807, DOI 10.1038/bjc.2013.351; Danese E, 2010, CLIN CHEM LAB MED, V48, P1665, DOI 10.1515/CCLM.2010.301; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Elshimali YI, 2013, INT J MOL SCI, V14, P18925, DOI 10.3390/ijms140918925; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Federici A, 2005, J MED SCREEN, V12, P83, DOI 10.1258/0969141053908357; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; He QO, 2010, CANCER GENET CYTOGEN, V202, P1, DOI 10.1016/j.cancergencyto.2010.05.018; Jahr S, 2001, CANCER RES, V61, P1659; Johnson DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098238; Kim DS, 2004, NEOPLASIA, V6, P168, DOI 10.1593/neo.03310; Kim HJ, 2003, GENE CHROMOSOME CANC, V38, P8, DOI 10.1002/gcc.10235; Kojima K, 2004, LEUKEMIA, V18, P998, DOI 10.1038/sj.leu.2403334; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Manderson AP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1936; McDade SS, 2007, HUM MOL GENET, V16, P742, DOI 10.1093/hmg/ddm003; Montagna C, 2003, CANCER RES, V63, P2179; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Russell SEH, 2000, CANCER RES, V60, P4729; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Taback B, 2004, ANN NY ACAD SCI, V1022, P17, DOI 10.1196/annals.1318.004; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Tamkovich SN, 2008, B EXP BIOL MED+, V146, P89, DOI 10.1007/s10517-008-0213-4; Tamkovich SN, 2006, ANN NY ACAD SCI, V1075, P191, DOI 10.1196/annals.1368.026; Tanaka Manami, 2003, Med Sci Monit, V9, pMT61; Tatsumi K, 2001, GENE CHROMOSOME CANC, V30, P230, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1084>3.0.CO;2-J; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Toth K, 2011, PATHOL ONCOL RES, V17, P503, DOI 10.1007/s12253-010-9338-7; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang JY, 2004, WORLD J SURG, V28, P721, DOI 10.1007/s00268-004-7366-8; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Wasserkort R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-398	50	73	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115415	10.1371/journal.pone.0115415	http://dx.doi.org/10.1371/journal.pone.0115415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526039	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200027
J	Richter, TA				Richter, Trevor A.			Clinical Research: A Globalized Network	PLOS ONE			English	Article								Clinical research has become increasingly globalized, but the extent of globalization has not been assessed. To describe the globalization of clinical research, we used all (n=13,208) multinational trials registered at ClinicalTrials. gov to analyzed geographic connections among individual countries. Our findings indicate that 95% (n=185) of all countries worldwide have participated in multinational clinical research. Growth in the globalization of clinical research peaked in 2009, suggesting that the global infrastructure that supports clinical research might have reached its maximum capacity. Growth in the globalization of clinical research is attributable to increased involvement of non-traditional markets, particularly in South America and Asia. Nevertheless, Europe is the most highly interconnected geographic region (60.64% of global connections), and collectively, Europe, North America, and Asia comprise more than 85% of all global connections. Therefore, while the expansion of clinical trials into non-traditional markets has increased over the last 20 years and connects countries across the globe, traditional markets still dominate multinational clinical research, which appears to have reached a maximum global capacity.	Canadian Agcy Drugs & Technol Hlth, Ottawa, ON K1S 5S8, Canada		Richter, TA (corresponding author), Canadian Agcy Drugs & Technol Hlth, 600-865 Carling Ave, Ottawa, ON K1S 5S8, Canada.	TrevorR@cadth.ca						Bastian M., 2009, 3 INT AAAI C WEBL SO; European Federation of Pharmaceutical Industries and Associations website, JOINT POS DISCL CLIN; George M, 2013, CURR CLIN PHARMACOL, V8, P115, DOI 10.2174/1574884711308020004; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Hoekman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045984; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Shah S, 2003, INT J HEALTH SERV, V33, P29, DOI 10.2190/5FGJ-03AQ-BKW2-GLAA; Thiers FA, 2008, NAT REV DRUG DISCOV, V7, P13, DOI 10.1038/nrd2441	8	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115063	10.1371/journal.pone.0115063	http://dx.doi.org/10.1371/journal.pone.0115063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517976	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600038
J	Wei, L; Hao, J; Kaffman, A				Wei, Lan; Hao, Jin; Kaffman, Arie			Early Life Stress Inhibits Expression of Ribosomal RNA in the Developing Hippocampus	PLOS ONE			English	Article							EARLY POSTNATAL LIFE; MATERNAL-CARE; CHILDHOOD MALTREATMENT; BRAIN; MICE; SYMPTOMS; RATS; TRANSCRIPTION; DEPRIVATION; METHYLATION	Children that are exposed to abuse or neglect show abnormal hippocampal function. However, the developmental mechanisms by which early life stress (ELS) impairs normal hippocampal development have not been elucidated. Here we propose that exposure to ELS blunts normal hippocampal growth by inhibiting the availability of ribosomal RNA (rRNA). In support of this hypothesis, we show that the normal mouse hippocampus undergoes a growth-spurt during the second week of life, followed by a gradual decrease in DNA and RNA content that persists into adulthood. This developmental pattern is associated with accelerated ribosomal RNA (rRNA) synthesis during the second week of life, followed by a gradual decline in rRNA levels that continue into adulthood. Levels of DNA methylation at the ribosomal DNA (rDNA) promoter are lower during the second week of life compared to earlier development or adulthood. Exposure to brief daily separation (BDS), a mouse model of early life stress, increased DNA methylation at the ribosomal DNA promoter, decreased rRNA levels, and blunted hippocampal growth during the second week of life. Exposure to acute (3 hrs) maternal separation decreased rRNA and increased DNA methylation at the rDNA proximal promoter, suggesting that exposure to stress early in life can rapidly regulate the availability of rRNA levels in the developing hippocampus. Given the critical role that rRNA plays in supporting normal growth and development, these findings suggest a novel molecular mechanism to explain how stress early in life impairs hippocampus development in the mouse.	[Wei, Lan; Hao, Jin; Kaffman, Arie] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University	Kaffman, A (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	arie.kaffman@yale.edu			NIMH [R21MH098181, R01MH100078]; DANA foundation Program in Brain and Immuno-imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100078, R21MH098181] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); DANA foundation Program in Brain and Immuno-imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIMH R21MH098181, NIMH R01MH100078, and DANA foundation Program in Brain and Immuno-imaging 2011 (http://www.dana.org/GrantsLanding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BERREBI AS, 1988, BRAIN RES, V438, P216, DOI 10.1016/0006-8993(88)91340-6; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Carrion VG, 2010, J PEDIATR PSYCHOL, V35, P559, DOI 10.1093/jpepsy/jsp112; CAVANAUGH AH, 1983, J BIOL CHEM, V258, P9768; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Denenberg VH, 1981, BRAIN RES, V254, P417; Garrett AS, 2012, DEPRESS ANXIETY, V29, P449, DOI 10.1002/da.21892; Grummt I, 2010, FEBS J, V277, P4626, DOI 10.1111/j.1742-4658.2010.07892.x; Herringa RJ, 2013, P NATL ACAD SCI USA, V110, P19119, DOI 10.1073/pnas.1310766110; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kaffman A, 2012, METHODS MOL BIOL, V829, P3, DOI 10.1007/978-1-61779-458-2_1; Kikusui T, 2006, BEHAV BRAIN RES, V175, P96, DOI 10.1016/j.bbr.2006.08.007; Li GN, 2005, DEV NEUROSCI-BASEL, V27, P93, DOI 10.1159/000085980; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Parfitt DB, 2004, BRAIN RES, V1016, P111, DOI 10.1016/j.brainres.2004.04.077; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; PAVLIK A, 1980, BRAIN RES, V192, P531, DOI 10.1016/0006-8993(80)90903-8; PAVLIK A, 1979, BRAIN RES, V167, P200, DOI 10.1016/0006-8993(79)90279-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; Ren-Patterson RF, 2006, CELL MOL NEUROBIOL, V26, P755, DOI 10.1007/s10571-006-9048-6; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Santoro R, 2005, CELL MOL LIFE SCI, V62, P2067, DOI 10.1007/s00018-005-5110-7; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Szyf M, 2013, CAN J PSYCHIAT, V58, P697, DOI 10.1177/070674371305801208; Wei L, 2012, NEUROPSYCHOPHARMACOL, V37, P567, DOI 10.1038/npp.2011.239; Wei L, 2010, HORM BEHAV, V57, P396, DOI 10.1016/j.yhbeh.2010.01.007; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437	31	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115283	10.1371/journal.pone.0115283	http://dx.doi.org/10.1371/journal.pone.0115283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517398	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600057
J	Fassotte, B; Fischer, C; Durieux, D; Lognay, G; Haubruge, E; Francis, F; Verheggen, FJ				Fassotte, Berenice; Fischer, Christophe; Durieux, Delphine; Lognay, Georges; Haubruge, Eric; Francis, Frederic; Verheggen, Francois J.			First Evidence of a Volatile Sex Pheromone in Lady Beetles	PLOS ONE			English	Article							HARMONIA-AXYRIDIS PALLAS; FEMALE GERMAN-COCKROACH; CALLING BEHAVIOR; CHEMICAL ECOLOGY; MATING-BEHAVIOR; HOST-PLANT; COLEOPTERA; IDENTIFICATION; SEMIOCHEMICALS; ULTRASTRUCTURE	To date, volatile sex pheromones have not been identified in the Coccinellidae family; yet, various studies have suggested that such semiochemicals exist. Here, we collected volatile chemicals released by virgin females of the multicolored Asian lady beetle, Harmonia axyridis (Pallas), which were either allowed or not allowed to feed on aphids. Virgin females in the presence of aphids, exhibited "calling behavior", which is commonly associated with the emission of a sex pheromone in several Coleoptera species. These calling females were found to release a blend of volatile compounds that is involved in the remote attraction (i.e., from a distance) of males. Gas Chromatography-Mass Spectrometry (GC-MS) analyses revealed that (-)-beta-caryophyllene was the major constituent of the volatile blend (ranging from 80 to 86%), with four other chemical components also being present; beta-elemene, methyl-eugenol, alpha-humulene, and alpha-bulnesene. In a second set of experiments, the emission of the five constituents identified from the blend was quantified daily over a 9-day period after exposure to aphids. We found that the quantity of all five chemicals significantly increased across the experimental period. Finally, we evaluated the activity of a synthetic blend of these chemicals by performing bioassays which demonstrated the same attractive effect in males only. The results confirm that female H. axyridis produce a volatile sex pheromone. These findings have potential in the development of more specific and efficient biological pest-control management methods aimed at manipulating the behavior of this invasive lady beetle.	[Fassotte, Berenice; Durieux, Delphine; Haubruge, Eric; Francis, Frederic; Verheggen, Francois J.] Univ Liege, Gembloux Agrobio Tech, Gembloux, Belgium; [Fischer, Christophe; Lognay, Georges] Univ Liege, Gembloux Agrobio Tech, Analyt Chem Lab, Unit Anal Qual & Risk, Gembloux, Belgium	University of Liege; University of Liege	Fassotte, B (corresponding author), Univ Liege, Gembloux Agrobio Tech, Gembloux, Belgium.	bfassotte@doct.ulg.ac.be		Haubruge, Eric/0000-0002-8138-0476; Verheggen, Francois/0000-0002-5849-1661	"Centre Universitaire de Recherche en Agronomie et ingenierie biologique de Gembloux'' (CURAGx), University of Liege; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA), Belgium	"Centre Universitaire de Recherche en Agronomie et ingenierie biologique de Gembloux'' (CURAGx), University of Liege; "Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA), Belgium(Fonds de la Recherche Scientifique - FNRS)	Berenice Fassotte was financially supported by a PhD grant from the "Centre Universitaire de Recherche en Agronomie et ingenierie biologique de Gembloux'' (CURAGx), University of Liege. Christophe Fischer and Delphine Durieux were financially supported by a PhD grant from the "Fonds pour la formation a la Recherche dans l'Industrie et l'Agriculture'' (FRIA), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, J EXP BIOL, V210, P964, DOI 10.1242/jeb.02726; BARBIER R, 1992, INT J INSECT MORPHOL, V21, P223, DOI 10.1016/0020-7322(92)90018-I; Barbour JD, 2006, J INSECT BEHAV, V19, P623, DOI 10.1007/s10905-006-9050-3; Brown AE, 2006, J CHEM ECOL, V32, P2489, DOI 10.1007/s10886-006-9158-0; Carde R.T., 1984, P355; Durieux D, 2010, BIOTECHNOL AGRON SOC, V14, P351; FINNEGAN DE, 1993, J CHEM ECOL, V19, P971, DOI 10.1007/BF00992532; Fischer CY, 2012, J CHEM EDUC, V89, P1611, DOI 10.1021/ed2007907; FLINT HM, 1979, ENVIRON ENTOMOL, V8, P1123, DOI 10.1093/ee/8.6.1123; Fonseca MG, 2009, J APPL ENTOMOL, V133, P695, DOI 10.1111/j.1439-0418.2009.01424.x; Francis F, 2005, J APPL ENTOMOL, V129, P6, DOI 10.1111/j.1439-0418.2005.00925.x; GUERIN PM, 1983, J CHEM ECOL, V9, P843, DOI 10.1007/BF00987809; HAMMACK L, 1995, ANN ENTOMOL SOC AM, V88, P562, DOI 10.1093/aesa/88.4.562; Hammack L, 2001, J CHEM ECOL, V27, P1373, DOI 10.1023/A:1010365225957; Hemptinne JL, 1996, ECOL ENTOMOL, V21, P165, DOI 10.1111/j.1365-2311.1996.tb01183.x; Heuskin S, 2010, J PHARMACEUT BIOMED, V53, P962, DOI 10.1016/j.jpba.2010.07.014; Heuskin S, 2009, J CHROMATOGR A, V1216, P2768, DOI 10.1016/j.chroma.2008.09.109; JOURDAN H, 1995, INT J INSECT MORPHOL, V24, P307, DOI 10.1016/0020-7322(95)98584-Z; KAMM JA, 1986, ENVIRON ENTOMOL, V15, P388, DOI 10.1093/ee/15.2.388; Landolt Peter J., 1997, American Entomologist, V43, P12; LEAL WS, 1993, J CHEM ECOL, V19, P1381, DOI 10.1007/BF00984883; Leroy PD, 2012, INSECT SCI, V19, P372, DOI 10.1111/j.1744-7917.2011.01449.x; LIANG D, 1993, TISSUE CELL, V25, P763, DOI 10.1016/0040-8166(93)90057-R; LIANG DS, 1993, J INSECT BEHAV, V6, P603, DOI 10.1007/BF01048126; McCornack BP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1001; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; OBATA S, 1991, BEHAVIOUR AND IMPACT OF APHIDOPHAGA, P207; OBATA S, 1987, APPL ENTOMOL ZOOL, V22, P434, DOI 10.1303/aez.22.434; OBATA S, 1987, CAN ENTOMOL, V119, P603, DOI 10.4039/Ent119603-6; OBATA S, 1988, PHYSIOL ENTOMOL, V13, P193, DOI 10.1111/j.1365-3032.1988.tb00923.x; Obata S, 1997, ENTOMOPHAGA, V42, P103, DOI 10.1007/BF02769885; Omkar, 2005, Insect Science, V12, P37, DOI 10.1111/j.1672-9609.2005.00006.x; OSAWA N, 1994, J ETHOL, V12, P63, DOI 10.1007/BF02350081; Paschen MA, 2012, J INSECT BEHAV, V25, P569, DOI 10.1007/s10905-012-9321-0; Pettersson Jan, 2012, P444; QI YT, 1982, J CHEM ECOL, V8, P527, DOI 10.1007/BF00987800; RICHARDS AM, 1980, J AUST ENTOMOL SOC, V19, P26; Rodstein J, 2009, J CHEM ECOL, V35, P590, DOI 10.1007/s10886-009-9623-7; Roy H, 2008, BIOCONTROL, V53, P1, DOI 10.1007/s10526-007-9127-8; Sloggett JJ, 2011, BIOCONTROL, V56, P643, DOI 10.1007/s10526-011-9376-4; Verheggen FJ, 2007, J CHEM ECOL, V33, P2148, DOI 10.1007/s10886-007-9370-6; VET LEM, 1983, PHYSIOL ENTOMOL, V8, P97, DOI 10.1111/j.1365-3032.1983.tb00338.x; Ward A, 2002, J CHEM ECOL, V28, P515, DOI 10.1023/A:1014535910946; Webster B, 2008, J CHEM ECOL, V34, P1153, DOI 10.1007/s10886-008-9510-7; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Zhu JW, 1999, J CHEM ECOL, V25, P1163, DOI 10.1023/A:1020846212465	46	35	36	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115011	10.1371/journal.pone.0115011	http://dx.doi.org/10.1371/journal.pone.0115011			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514321	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300026
J	Gargiulo, P; Banfi, C; Ghilardi, S; Magri, D; Giovannardi, M; Bonomi, A; Salvioni, E; Battaia, E; Filardi, PP; Tremoli, E; Agostoni, P				Gargiulo, Paola; Banfi, Cristina; Ghilardi, Stefania; Magri, Damiano; Giovannardi, Marta; Bonomi, Alice; Salvioni, Elisabetta; Battaia, Elisa; Filardi, Pasquale Perrone; Tremoli, Elena; Agostoni, Piergiuseppe			Surfactant-Derived Proteins as Markers of Alveolar Membrane Damage in Heart Failure	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; LUNG-FUNCTION; PULMONARY SURFACTANT; DIFFUSING-CAPACITY; CAPILLARY BARRIER; PLASMA; RECEPTOR; RAGE; EXERCISE; VENTILATION	Background: In heart failure (HF) alveolar-capillary membrane is abnormal. Surfactant-derived proteins (SPs) and plasma receptor for advanced-glycation-end-products (RAGE) have been proposed as lung damage markers. Methods: Eighty-nine chronic HF and 17 healthy subjects were evaluated by echocardiography, blood parameters, carbon monoxide lung diffusion (DLCO) and cardiopulmonary exercise test. We measured immature SP-B, mature SP-B, SP-A, SP-D and RAGE plasma levels. Results: Immature SP-B (arbitrary units), mature SP-A (ng/ml) and SP-D (ng/ml), but not mature SP-B (ng/ml) and RAGE (pg/ml) levels, were higher in HF than in controls [immature SP-B: 15.6 (13.1, 75th-25th interquartile range) Vs. 11.1 (6.4), p<0.01; SP-A, 29.6 (20.1) Vs. 18.3 (13.5), p=0.01; SP-D: 125 (90) Vs. 78 (58), p<0.01]. Immature SP-B, SP-A, SP-D and RAGE values were related to DLCO, peak oxygen consumption, ventilatory efficiency, and brain natriuretic peptide (BNP), whereas plasma mature SP-B was not. The DLCO Vs. immature SP-B correlation was the strongest one. At multivariate analysis, RAGE was associated to age and creatinine, SP-A to DLCO and BNP, SP-D to BNP, mature SP-B to DLCO and creatinine, and immature SP-B only but strongly to DLCO. Conclusions: Immature SP-B is the most reliable biological marker of alveolar-capillary membrane function in HF.	[Gargiulo, Paola] Inst Diagnost & Nucl Dev, Naples, Italy; [Banfi, Cristina; Ghilardi, Stefania; Giovannardi, Marta; Bonomi, Alice; Salvioni, Elisabetta; Tremoli, Elena; Agostoni, Piergiuseppe] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Milan, Italy; [Magri, Damiano] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy; [Battaia, Elisa] Univ Verona, Dept Med, Cardiol Sect, I-37100 Verona, Italy; [Filardi, Pasquale Perrone] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Tremoli, Elena] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Agostoni, Piergiuseppe] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Centro Cardiologico Monzino; Sapienza University Rome; University of Verona; University of Naples Federico II; University of Milan; University of Milan	Agostoni, P (corresponding author), Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Milan, Italy.	piergiuseppe.agostoni@unimi.it	Agostoni, Piergiuseppe/ABG-9556-2020; Salvioni, Elisabetta/ABD-9775-2020; Perrone Filardi, Pasquale/AAC-7590-2022; Gargiulo, Paola/K-6885-2016; Corrà, Ugo/AAF-8322-2020; Banfi, Cristina/G-6362-2018; Bonomi, Alice/AAB-6147-2020; TREMOLI, ELENA/I-8126-2018	Agostoni, Piergiuseppe/0000-0002-8345-6382; Gargiulo, Paola/0000-0003-4622-1725; Corrà, Ugo/0000-0002-9229-3298; Banfi, Cristina/0000-0003-3346-9879; Bonomi, Alice/0000-0001-5409-0791; Salvioni, Elisabetta/0000-0002-8448-7551; Magri, Damiano/0000-0002-0614-2961; TREMOLI, ELENA/0000-0002-0929-6106; GHILARDI, STEFANIA/0000-0001-9971-7965	Italian Ministry of health, Roma, Italy [2600721]	Italian Ministry of health, Roma, Italy	This study was carried out with the support of a grant from the Italian Ministry of health, Roma, Italy (Current research project 2013, BIO 12, ID 2600721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni P, 2000, J AM COLL CARDIOL, V36, P1600, DOI 10.1016/S0735-1097(00)00929-3; Agostoni P, 2005, EUR J HEART FAIL, V7, P498, DOI 10.1016/j.ejheart.2004.06.007; Agostoni P, 2011, EUR RESPIR J, V37, P841, DOI 10.1183/09031936.00045910; Agostoni P, 2007, EUR J HEART FAIL, V9, P827, DOI 10.1016/j.ejheart.2007.04.006; Agostoni P, 2006, EUR HEART J, V27, P2538, DOI 10.1093/eurheartj/ehl302; Agostoni P, 2013, RESP PHYSIOL NEUROBI, V188, P223, DOI 10.1016/j.resp.2013.04.005; Agostoni P, 2011, RESP PHYSIOL NEUROBI, V178, P256, DOI 10.1016/j.resp.2011.06.019; Agostoni P, 2010, AM HEART J, V159, P1067, DOI 10.1016/j.ahj.2010.03.034; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSIERES LM, 1995, EUR RESPIR J, V8, P959; Calfee CS, 2008, THORAX, V63, P1083, DOI 10.1136/thx.2008.095588; Contini M, 2013, INT J CARDIOL, V168, P2134, DOI 10.1016/j.ijcard.2013.01.277; COTES JE, 1972, CLIN SCI, V42, P325, DOI 10.1042/cs0420325; De Pasquale CG, 2005, CLIN EXP PHARMACOL P, V32, P622, DOI 10.1111/j.0305-1870.2005.04241.x; De Pasquale CG, 2004, CIRCULATION, V110, P1091, DOI 10.1161/01.CIR.0000140260.73611.FA; De Pasquale CG, 2003, CRIT CARE MED, V31, P1060, DOI 10.1097/01.CCM.0000059649.31659.22; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; ELBORN JS, 1990, EUR HEART J, V11, P75, DOI 10.1093/oxfordjournals.eurheartj.a059596; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Hill J, 2011, EUR HEART J, V32, P1918, DOI 10.1093/eurheartj/ehr124; HUANG YCT, 1994, CHEST, V105, P501, DOI 10.1378/chest.105.2.501; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kobayashi H, 2008, BIOMARKERS, V13, P385, DOI [10.1080/13547500801903651, 10.1080/13547500801903651 ]; Magri D, 2013, RESP MED, V107, P1617, DOI 10.1016/j.rmed.2013.07.019; Magri D, 2009, CIRC-HEART FAIL, V2, P175, DOI 10.1161/CIRCHEARTFAILURE.108.819607; Mukherjee TK, 2008, RESP PHYSIOL NEUROBI, V162, P210, DOI 10.1016/j.resp.2008.07.001; Paolillo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061877; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMEKEL B, 1992, THORAX, V47, P603, DOI 10.1136/thx.47.8.603; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Sorensen GL, 2007, IMMUNOBIOLOGY, V212, P381, DOI 10.1016/j.imbio.2007.01.003; Swenson ER, 2002, JAMA-J AM MED ASSOC, V287, P2228, DOI 10.1001/jama.287.17.2228; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Winkler C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-29; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Xie FY, 2013, J CARDIOVASC MED, V14, P461, DOI 10.2459/JCM.0b013e32835dbd24	41	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115030	10.1371/journal.pone.0115030	http://dx.doi.org/10.1371/journal.pone.0115030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514679	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300029
J	Chaves, AJ; Vergara-Alert, J; Busquets, N; Valle, R; Rivas, R; Ramis, A; Darji, A; Majo, N				Chaves, Aida J.; Vergara-Alert, Julia; Busquets, Nuria; Valle, Rosa; Rivas, Raquel; Ramis, Antonio; Darji, Ayub; Majo, Natalia			Neuroinvasion of the Highly Pathogenic Influenza Virus H7N1 Is Caused by Disruption of the Blood Brain Barrier in an Avian Model	PLOS ONE			English	Article							ACUTE NECROTIZING ENCEPHALOPATHY; CENTRAL-NERVOUS-SYSTEM; TIGHT JUNCTION PROTEINS; MICROVASCULAR ENDOTHELIAL-CELLS; A VIRUS; CEREBROSPINAL-FLUID; INFECTED CHICKENS; JAPANESE CHILDREN; CHOROID-PLEXUS; VIRAL ENTRY	Influenza A virus (IAV) causes central nervous system (CNS) lesions in avian and mammalian species, including humans. However, the mechanism used by IAV to invade the brain has not been determined. In the current work, we used chickens infected with a highly pathogenic avian influenza (HPAI) virus as a model to elucidate the mechanism of entry of IAV into the brain. The permeability of the BBB was evaluated in fifteen-day-old H7N1-infected and non-infected chickens using three different methods: (i) detecting Evans blue (EB) extravasation into the brain, (ii) determining the leakage of the serum protein immunoglobulin Y (IgY) into the brain and (iii) assessing the stability of the tight-junction (TJ) proteins zonula occludens-1 and claudin-1 in the chicken brain at 6, 12, 18, 24, 36 and 48 hours post- inoculation (hpi). The onset of the induced viremia was evaluated by quantitative real time RT-PCR (RT-qPCR) at the same time points. Viral RNA was detected from 18 hpi onward in blood samples, whereas IAV antigen was detected at 24 hpi in brain tissue samples. EB and IgY extravasation and loss of integrity of the TJs associated with the presence of viral antigen was first observed at 36 and 48 hpi in the telencephalic pallium and cerebellum. Our data suggest that the mechanism of entry of the H7N1 HPAI into the brain includes infection of the endothelial cells at early stages (24 hpi) with subsequent disruption of the TJs of the BBB and leakage of virus and serum proteins into the adjacent neuroparenchyma.	[Chaves, Aida J.; Vergara-Alert, Julia; Busquets, Nuria; Valle, Rosa; Rivas, Raquel; Ramis, Antonio; Darji, Ayub; Majo, Natalia] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Ramis, Antonio; Majo, Natalia] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; [Darji, Ayub] Inst Recerca & Tecnol Agroalimentaries, Barcelona, Spain	IRTA; Autonomous University of Barcelona; IRTA	Majo, N (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	natalia.majo@cresa.uab.cat	Masferrer, Natàlia Majó/AAV-3696-2021; Vergara-Alert, Júlia/I-5010-2015; Busquets, Núria/T-8431-2017	Vergara-Alert, Júlia/0000-0001-7484-444X; Chaves-Hernandez, Aida Jeannette/0000-0002-2856-7418; Majo, Natalia/0000-0003-0189-9751	European Project Specific Target Research Project, Euroflu; EU [5B-CT2007-044098]; Alban Program; European Union [E07D400404CR]	European Project Specific Target Research Project, Euroflu; EU(European Commission); Alban Program; European Union(European Commission)	This work was partially supported by the European Project Specific Target Research Project, Euroflu, and funded by the sixth Framework Program (FP6) of the EU grant 5B-CT2007-044098. Aida J. Chaves was supported by the Alban Program and the European Union Program of High Level Scholarships for Latin America scholarship E07D400404CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; ANDERSON DK, 1975, AM J PHYSIOL, V228, P415, DOI 10.1152/ajplegacy.1975.228.2.415; ANDERSON JR, 1983, J NEUROL SCI, V60, P181, DOI 10.1016/0022-510X(83)90061-8; Beato MS, 2007, VACCINE, V25, P4064, DOI 10.1016/j.vaccine.2007.02.042; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Chaves AJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-106; Chaves AJ, 2011, AVIAN PATHOL, V40, P163, DOI 10.1080/03079457.2011.551874; Christensen JE, 2006, J IMMUNOL, V176, P4235, DOI 10.4049/jimmunol.176.7.4235; Dallasta LM, 1999, AM J PATHOL, V155, P1915, DOI 10.1016/S0002-9440(10)65511-3; Daly JM, 2011, VET J, V189, P7, DOI 10.1016/j.tvjl.2010.06.026; DAVIDSON F, 2008, AVIAN IMMUNOLOGY; DAVIS LE, 1990, J NEUROL SCI, V97, P221, DOI 10.1016/0022-510X(90)90220-H; Davison F, 2008, AVIAN IMMUNOLOGY, P107, DOI 10.1016/B978-012370634-8.50009-3; del Valle J, 2008, J NEUROSCI METH, V174, P42, DOI 10.1016/j.jneumeth.2008.06.025; DELORME P, 1975, CELL TISSUE RES, V157, P535; FALANGOLA MF, 1995, J NEUROPATH EXP NEUR, V54, P497, DOI 10.1097/00005072-199507000-00003; Fletcher NF, 2011, VET J, V188, P260, DOI 10.1016/j.tvjl.2010.03.022; Fujimoto S, 1998, LANCET, V352, P873, DOI 10.1016/S0140-6736(98)12449-2; Fujimoto Y, 2000, EUR J PEDIATR, V159, P319, DOI 10.1007/s004310051280; Ge SJ, 2005, J NEUROSCI RES, V79, P421, DOI 10.1002/jnr.20313; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; HADGE D, 1980, DEV COMP IMMUNOL, V4, P501, DOI 10.1016/S0145-305X(80)80052-8; Hasebe R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-165; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kansagra SM, 2011, PEDIATR NEUROL, V45, P400, DOI 10.1016/j.pediatrneurol.2011.09.007; Kaptanoglu E, 2004, J CLIN NEUROSCI, V11, P879, DOI 10.1016/j.jocn.2004.04.005; Kim KJ, 2013, ANN REHABIL MED-ARM, V37, P286, DOI 10.5535/arm.2013.37.2.286; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Kobayashi Y, 1996, J COMP PATHOL, V114, P131, DOI 10.1016/S0021-9975(96)80003-X; Kuang F, 2004, INT J NEUROSCI, V114, P575, DOI 10.1080/00207450490422731; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Liebner S, 2000, EUR J CELL BIOL, V79, P707, DOI 10.1078/0171-9335-00101; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lin BW, 2000, BRAIN RES, V865, P237, DOI 10.1016/S0006-8993(00)02228-9; Long SS, 2005, ADV EXP MED BIOL, V568, P1; Maclean AG, 2005, J MED PRIMATOL, V34, P237, DOI 10.1111/j.1600-0684.2005.00121.x; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Martin A, 2010, CLIN INFECT DIS, V50, pE50, DOI 10.1086/651501; Maxie GM, 2007, JUBB KENNEDY PALMERS, P393; Mims CA, 1995, MIMS PATHOGENESIS IN, P9; Mims CA, 1995, MIMS PATHOGENESIS IN, P60; MIZUGUCHI M, 1995, J NEUROL NEUROSUR PS, V58, P555, DOI 10.1136/jnnp.58.5.555; Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630; Nishimura H, 2000, J GEN VIROL, V81, P2503, DOI 10.1099/0022-1317-81-10-2503; Ohtsuki S, 2007, PHARM RES-DORDR, V24, P1745, DOI 10.1007/s11095-007-9374-5; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Pelegri C, 2007, MECH AGEING DEV, V128, P522, DOI 10.1016/j.mad.2007.07.002; Ravenholt R., 1982, LANCET, V320, P860; Redzic Z, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-3; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Romero IA, 2000, J VIROL, V74, P6021, DOI 10.1128/JVI.74.13.6021-6030.2000; Rowe T, 2003, AVIAN DIS, V47, P1122, DOI 10.1637/0005-2086-47.s3.1122; Rudd PA, 2006, J VIROL, V80, P9361, DOI 10.1128/JVI.01034-06; Ruggieri M, 1998, PEDIATRICS, V101, P112, DOI 10.1542/peds.101.1.112; Ryan G, 2005, J NEUROVIROL, V11, P337, DOI 10.1080/13550280500186445; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; Shinya K, 2005, ARCH VIROL, V150, P1653, DOI 10.1007/s00705-005-0539-4; Siso S, 2009, NEUROPATH APPL NEURO, V35, P232, DOI 10.1111/j.1365-2990.2008.00978.x; SOKRAB TEO, 1988, ACTA NEUROPATHOL, V75, P557, DOI 10.1007/BF00686200; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Suja MS, 2009, CLIN NEUROPATHOL, V28, P113; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Swayne DE, 2005, AVIAN DIS, V49, P81, DOI 10.1637/7260-081104R; SWAYNE DE, 1989, AVIAN PATHOL, V18, P385, DOI 10.1080/03079458908418613; Swayne DE., 2008, AVIAN INFLUENZA, V1, P87, DOI 10.1002/9780813818634.ch5; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Togashi T, 2004, VIRUS RES, V103, P75, DOI 10.1016/j.virusres.2004.02.016; Togashi T, 2001, INT CONGR SER, V1219, P609, DOI 10.1016/S0531-5131(01)00406-X; Toovey Stephen, 2008, Travel Med Infect Dis, V6, P114, DOI 10.1016/j.tmaid.2008.03.003; Tsukita S, 1999, CURR OPIN CELL BIOL, V11, P628, DOI 10.1016/S0955-0674(99)00016-2; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Weitkamp JH, 2004, PEDIATR INFECT DIS J, V23, P259, DOI 10.1097/01.inf.0000115631.99896.41; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Yoshikawa H, 2001, J CHILD NEUROL, V16, P885, DOI 10.1177/088307380101601204	80	15	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115138	10.1371/journal.pone.0115138	http://dx.doi.org/10.1371/journal.pone.0115138			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506836	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100053
J	Dieltjens, T; Moonens, I; Van Praet, K; De Buck, E; Vandekerckhove, P				Dieltjens, Tessa; Moonens, Inge; Van Praet, Koen; De Buck, Emmy; Vandekerckhove, Philippe			A Systematic Literature Search on Psychological First Aid: Lack of Evidence to Develop Guidelines	PLOS ONE			English	Article							PSYCHOSOCIAL INTERVENTIONS; MENTAL-HEALTH; SUPPORT	Background: Providing psychological first aid (PFA) is generally considered to be an important element in preliminary care of disaster victims. Using the best available scientific basis for courses and educational materials, the Belgian Red Cross-Flanders wants to ensure that its volunteers are trained in the best way possible. Objective: To identify effective PFA practices, by systematically reviewing the evidence in existing guidelines, systematic reviews and individual studies. Methods: Systematic literature searches in five bibliographic databases (MEDLINE, PsycINFO, The Cochrane Library, PILOTS and G-I-N) were conducted from inception to July 2013. Results: Five practice guidelines were included which were found to vary in the development process (AGREE II score 20-53%) and evidence base used. None of them provides solid evidence concerning the effectiveness of PFA practices. Additionally, two systematic reviews of PFA were found, both noting a lack of studies on PFA. A complementary search for individual studies, using a more sensitive search strategy, identified 11 237 references of which 102 were included for further full-text examination, none of which ultimately provides solid evidence concerning the effectiveness of PFA practices. Conclusion: The scientific literature on psychological first aid available to date, does not provide any evidence about the effectiveness of PFA interventions. Currently it is impossible to make evidence-based guidelines about which practices in psychosocial support are most effective to help disaster and trauma victims.	[Dieltjens, Tessa; De Buck, Emmy; Vandekerckhove, Philippe] Belgian Red Cross Flanders, Ctr Evidence Based Practice, Mechelen, Belgium; [Moonens, Inge; Van Praet, Koen] Belgian Red Cross Flanders, Psychosocial Intervent Serv, Mechelen, Belgium; [Vandekerckhove, Philippe] Cathollic Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Vandekerckhove, Philippe] Univ Ghent, Fac Med, B-9000 Ghent, Belgium	Ghent University	Dieltjens, T (corresponding author), Belgian Red Cross Flanders, Ctr Evidence Based Practice, Mechelen, Belgium.	Tessa.dieltjens@rodekruis.be						American Psychiatric Association, 1980, DIAGN STAT MAN MANT; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; Bisson JI., 2009, SYSTEMATIC REV PSYCH; Bisson JI, 2010, BRIT J PSYCHIAT, V196, P69, DOI 10.1192/bjp.bp.109.066266; Blanchet K., 2013, EVIDENCE REV RES HLT; BRACE S, 2010, J PARAMEDIC PRACTICE, V2, P502; Brake HT, 2009, NURS HEALTH SCI, V11, P336, DOI 10.1111/j.1442-2018.2009.00491.x; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brymer M., 2012, PSYCHOL 1 AID SCH FI; Cassan P, 2011, INT 1 AID RESUSCITAI; Chandra A, 2014, DISASTER MED PUBLIC, V8, P95, DOI 10.1017/dmp.2013.112; De Buck E, 2014, INT J EVID-BASED HEA, V12, P39, DOI 10.1097/01.XEB.0000444637.88465.a3; Declercq F, 2007, J CLIN PSYCHOL, V63, P1239, DOI 10.1002/jclp.20426; Everly George S Jr, 2006, Int J Emerg Ment Health, V8, P93; Evidence Aid Priority Setting Group, 2013, PLOS CURR, V5; Falzon L, 2010, PROF PSYCHOL-RES PR, V41, P550, DOI 10.1037/a0021352; Fox JH, 2012, DISASTER MED PUBLIC, V6, P247, DOI 10.1001/dmp.2012.39; Gerdin M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001632; Gibbons SW, 2013, PSYCHOL SERV; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hollon SD, 2014, ANNU REV CLIN PSYCHO, V10, P213, DOI 10.1146/annurev-clinpsy-050212-185529; Hunt Matthew R, 2012, Am J Disaster Med, V7, P211; Inter-Agency Standing Committee, 2007, IASC GUID MENT HLTH; International Federation Reference Centre for Psychosocial Support, 2009, PSYCH INT HDB; JACOBS GA, 1995, PROF PSYCHOL-RES PR, V26, P543, DOI 10.1037/0735-7028.26.6.543; Jacobs GA, 2007, AM PSYCHOL, V62, P932, DOI 10.1037/0003-066X.62.8.932; Juen B, 2013, ANN ENPS FOR 2013 PS; Kelly CM, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-49; Knudsen L., 1997, PSYCHOL 1 AID HUMAN; Lilienfeld SO, 2013, CLIN PSYCHOL REV, V33, P883, DOI 10.1016/j.cpr.2012.09.008; Moher David, 2009, Open Med, V3, pe123; O'Mathuna Donal P, 2010, J Evid Based Med, V3, P65, DOI 10.1111/j.1756-5391.2010.01076.x; OPSIC: Operationalising psychosocial support in crisis, 2014, EUR UN 7 FRAM PROJ; Pagoto SL, 2007, J CLIN PSYCHOL, V63, P695, DOI 10.1002/jclp.20376; Pekevski Jordan, 2013, J Emerg Manag, V11, P39; Reyes G, 2004, PSYCHOTHERAPY, V41, P399, DOI 10.1037/0033-3204.41.4.399; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Ruzek J.I., 2007, J MENTAL HLTH COUNS, V29, P17, DOI [DOI 10.17744/MEHC.29.1.5RACQXJUEAFABGWP, https://doi.org/10.17744/mehc.29.1.5racqxjueafabgwp]; Salmon TW, 1917, CARE TREATMENT MENT; Shultz James M, 2014, Disaster Health, V2, P3, DOI [10.4161/dish.24414, 10.4161/dish.26006]; SPAITE DW, 1995, ANN EMERG MED, V26, P146, DOI 10.1016/S0196-0644(95)70144-3; Summey JR, 2001, ANN AM PSYCHOTHERAPY, V4, P18; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; Tol WA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001096; van Ommeren M., 2011, PSYCHOL 1 AID GUIDE; Vandekerckhove P, 2013, DISASTER MED PUBLIC, V7, P593, DOI 10.1017/dmp.2013.109; Verschuur M, 2007, SOC SCI MED, V65, P1430, DOI 10.1016/j.socscimed.2007.05.014; Vymetal S, 2011, PREHOSP DISASTER MED, V26, P234, DOI 10.1017/S1049023X11006303; World Health Organization, 2012, WHO HDB GUID DEV	49	75	76	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114714	10.1371/journal.pone.0114714	http://dx.doi.org/10.1371/journal.pone.0114714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25503520	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400047
J	Kwiatkowska, W; Knysz, B; Arczynska, K; Drelichowska, J; Czarnecki, M; Gasiorowski, J; Karczewski, M; Witkiewicz, W				Kwiatkowska, Wieslawa; Knysz, Brygida; Arczynska, Katarzyna; Drelichowska, Justyna; Czarnecki, Marcin; Gasiorowski, Jacek; Karczewski, Maciej; Witkiewicz, Wojciech			Peripheral Arterial Disease and Ankle-Brachial Index Abnormalites in Young and Middle-Aged HIV-Positive Patients in Lower Silesia, Poland	PLOS ONE			English	Article							RISK-FACTORS; INFECTED PATIENTS; PREVALENCE; ATHEROSCLEROSIS; ASSOCIATION; MORTALITY	Background: Peripheral arterial disease (PAD) is a clinical manifestation of atherosclerosis and mainly refers to elderly patients, having a negative impact on their functionality and quality of life. The findings of previous studies in HIV-infected patients have shown that cardiovascular risk is higher and PAD occurs more frequently than in the general population. There are also contradictory observations. Much less is known about the ankle-brachial index (ABI) value in asymptomatic HIV-infected patients. The aim of this study was to evaluate the prevalence of PAD and ankle-brachial index abnormalities as well as to determine risk factors related to the disease in a group of Polish HIV-positive patients. Methods and Findings: One hundred and eleven young to middle aged HIV-positive subjects and 40 noninfected subjects were enrolled into the study. Resting ABI measurements were performed and cardiovascular risk was analysed as well. Subgroups were created according to the ABI values: low (PAD), borderline, normal, high and altered ABI. Symptomatic PAD was observed in 2 HIV-positive patients, asymptomatic PAD was not diagnosed. The ABI value is lower and more varied, in 22.5% of the study group altered ABI values were found. Six subjects demonstrated borderline ABI, and 15 high ABI, including >1.4. In the control group no low or very high values were reported. A relation between low ABI and cardiovascular family history and between altered ABI and high-density-lipoprotein cholesterol (HDL-C) level was demonstrated. Conclusions: In young and middle-aged HIV-positive patients, symptomatic PAD prevalence is comparable to that observed in the overall population. Among asymptomatic patients PAD is not reported. The ABI value in HIV-positive patients is more varied compared to the HIV-negative subjects; the altered ABI shows a strong relation with low HDL-C levels and metabolic syndrome.	[Kwiatkowska, Wieslawa; Knysz, Brygida; Arczynska, Katarzyna; Drelichowska, Justyna; Czarnecki, Marcin; Gasiorowski, Jacek; Karczewski, Maciej; Witkiewicz, Wojciech] Reg Specialist Hosp, Res & Dev Ctr Wroclaw, Wrovasc Integrated Cardiovasc Ctr, Wroclaw, Poland; [Kwiatkowska, Wieslawa; Drelichowska, Justyna; Witkiewicz, Wojciech] Reg Specialist Hosp Wroclaw, Res & Dev Ctr Wroclaw, Dept Angiol, Wroclaw, Poland; [Knysz, Brygida; Czarnecki, Marcin; Gasiorowski, Jacek] Wroclaw Med Univ, Dept Infect Dis, Wroclaw, Poland	Wroclaw Medical University	Knysz, B (corresponding author), Reg Specialist Hosp, Res & Dev Ctr Wroclaw, Wrovasc Integrated Cardiovasc Ctr, Wroclaw, Poland.	brygida.knysz@gmail.com		Karczewski, Maciej/0000-0001-8811-8916; Knysz, Brygida/0000-0003-2605-1079; Czarnecki, Marcin/0000-0003-2108-295X	European Regional Development Fund within Innovative Economy Operational Program; European Funds - for the development of innovative economy	European Regional Development Fund within Innovative Economy Operational Program; European Funds - for the development of innovative economy	This publication is part of Project "Wrovasc - Integrated Cardiovascular Centre,'' co-financed by the European Regional Development Fund within Innovative Economy Operational Program 2007-2013, realized in Regional Specialist Hospital, Research and Development Center in Wroclaw. This work is also supported by "European Funds - for the development of innovative economy.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernal E, 2008, JAIDS-J ACQ IMM DEF, V47, P126, DOI 10.1097/QAI.0b013e318157b0b3; Canalejo E, 2011, ENFERM INFEC MICR CL, V29, P672, DOI 10.1016/j.eimc.2011.07.006; CRIQUI MH, 1985, CIRCULATION, V71, P510, DOI 10.1161/01.CIR.71.3.510; Diez JMB, 2005, REV ESP CARDIOL, V58, P367, DOI 10.1157/13073893; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gutierrez F, 2008, AIDS, V22, P1369, DOI 10.1097/QAD.0b013e3282f7cb88; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; International Diabetes Federation, IDF CONS WORLDW DEF; Jang JJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-12; Johns K, 2010, AIDS RES HUM RETROV, V26, P955, DOI 10.1089/aid.2009.0275; Kwiatkowska W, 2011, POSTEP HIG MED DOSW, V65, P770, DOI 10.5604/17322693.967075; McDermott MM, 2004, JAMA-J AM MED ASSOC, V292, P453, DOI 10.1001/jama.292.4.453; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Olalla J, 2009, HIV MED, V10, P1, DOI 10.1111/j.1468-1293.2008.00638.x; Olin JW, 2010, J AM COLL CARDIOL, V56, P2147, DOI 10.1016/j.jacc.2010.08.606; Palacios R, 2008, AIDS RES HUM RETROV, V24, P1; PELL JP, 1995, EUR J VASC ENDOVASC, V9, P469, DOI 10.1016/S1078-5884(05)80018-8; Periard D, 2008, CLIN INFECT DIS, V46, P761, DOI 10.1086/527564; Qaqa AY, 2011, ANGIOLOGY, V62, P10, DOI 10.1177/0003319710385339; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Sharma A, 2007, HIV MED, V8, P555, DOI 10.1111/j.1468-1293.2007.00509.x; Signorelli SS, 2011, ARCH GERONTOL GERIAT, V53, P55, DOI 10.1016/j.archger.2010.05.020; Third Report of the Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2004, 3 NAT HEART LUND BLO; Tomiyama H, 2005, HYPERTENSION, V45, P997, DOI 10.1161/01.HYP.0000165018.63523.8a; Valentine RJ, 2004, J VASC SURG, V39, P351, DOI 10.1016/j.jvs.2003.07.011; Zdrojewski T., 2004, KARDIOL POL, V61, P1; Zheng ZJ, 2005, AM J PREV MED, V29, P42, DOI 10.1016/j.amepre.2005.07.019	29	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113857	10.1371/journal.pone.0113857	http://dx.doi.org/10.1371/journal.pone.0113857			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503743	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400017
J	Loera, B; Converso, D; Viotti, S				Loera, Barbara; Converso, Daniela; Viotti, Sara			Evaluating the Psychometric Properties of the Maslach Burnout Inventory-Human Services Survey (MBI-HSS) among Italian Nurses: How Many Factors Must a Researcher Consider?	PLOS ONE			English	Article							FIT INDEXES; VALIDITY; CONSISTENCY; METAANALYSIS; COEFFICIENT; VALIDATION; INVARIANCE; SAMPLE	Background: The Maslach Burnout Inventory (MBI) is the mainstream measure for burnout. However, its psychometric properties have been questioned, and alternative measurement models of the inventory have been suggested. Aims: Different models for the number of items and factors of the MBI-HSS, the version of the Inventory for the Human Service sector, were tested in order to identify the most appropriate model for measuring burnout in Italy. Methods: The study dataset consisted of a sample of 925 nurses. Ten alternative models of burnout were compared using confirmatory factor analysis. The psychometric properties of items and reliability of the MBI-HSS subscales were evaluated. Results: Item malfunctioning may confound the MBI-HSS factor structure. The analysis confirmed the factorial structure of the MBI-HSS with a three-dimensional, 20-item assessment. Conclusions: The factorial structure underlying the MBI-HSS follows Maslach's definition when items are reduced from the original 22 to a 20-item set. Alternative models, either with fewer items or with an increased number of latent dimensions in the burnout structure, do not yield better results to justify redefining the item set or theoretically revising the syndrome construct.	[Loera, Barbara; Converso, Daniela; Viotti, Sara] Univ Turin, Dept Psychol, Turin, Italy	University of Turin	Converso, D (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	daniela.converso@unito.it	Loera, Barbara/AAA-5418-2020; viotti, sara/L-2650-2015; Converso, Daniela/K-6369-2017	viotti, sara/0000-0001-9026-9334; Converso, Daniela/0000-0002-6780-4746; loera, barbara/0000-0002-4210-1796	Fondazione CRT [R.O.L 2624/2011]; Department of Psychology, University of Turin	Fondazione CRT(Fondazione CRT); Department of Psychology, University of Turin	The data collection was originally promoted by an initiative of the local government of Piedmont Region, Italy, started with the project "Organizational well-being in the health sector'' (D.G.R 22-7777) according to the objectives of the healthcare local programme 2007-2010. In the further years the research project was developed and continued with the grant (R.O.L 2624/2011), "Contrasting the malaise and promoting well-being among workers in heath care sector'', funded by Fondazione CRT and Department of Psychology, University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Beckstead JW, 2002, INT J NURS STUD, V39, P785, DOI 10.1016/S0020-7489(02)00012-3; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bollen KA, 1989, STRUCTURAL EQUATIONS; BOYLE GJ, 1985, BRIT J CLIN PSYCHOL, V24, P45, DOI 10.1111/j.2044-8260.1985.tb01312.x; BOYLE GJ, 1991, PERS INDIV DIFFER, V12, P291, DOI 10.1016/0191-8869(91)90115-R; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; BROWNE MW, 1989, MULTIVAR BEHAV RES, V24, P445, DOI 10.1207/s15327906mbr2404_4; Bryant FB, 2012, STRUCT EQU MODELING, V19, P372, DOI 10.1080/10705511.2012.687671; Chao SF, 2011, J INTELL DISABIL RES, V55, P529, DOI 10.1111/j.1365-2788.2011.01413.x; CONVERSO D, 2009, RISORSA UOMO, V15, P241; Cordoba L, 2011, COLOMB MEDICA, V42, P286; Densten IL, 2001, J ORGAN BEHAV, V22, P833, DOI 10.1002/job.115; Gil-Monte PR, 2005, REV SAUDE PUBL, V39, P1, DOI 10.1590/S0034-89102005000100001; GREEN DE, 1991, J SOC BEHAV PERS, V6, P453; Hallberg UE, 2004, EUR J PSYCHOL ASSESS, V20, P320, DOI 10.1027/1015-5759.20.4.320; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; J?reskog K.G., 2018, LISREL 10 WINDOWS CO; JORESKOG KG, 1981, LISREL USERS GUIDE; Kalliath TJ, 2000, WORK STRESS, V14, P35, DOI 10.1080/026783700417212; Kanste Outi, 2006, Nurs Health Sci, V8, P201, DOI 10.1111/j.1442-2018.2006.00283.x; Kim H, 2009, RES SOCIAL WORK PRAC, V19, P325, DOI 10.1177/1049731508318550; Lee HF, 2013, J NURS MANAGE, V21, P648, DOI 10.1111/j.1365-2834.2012.01427.x; Loera B, 2013, PSICOLOGIA SALUTE, V1, P27, DOI DOI 10.3280/PDS2013-001002; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C., 1997, EVALUATING STRESS BO, V3rd ed., P191; Maslach C, 1982, BURNOUT COST CARING; Maslach C.J.S., 1997, MASLACH BURNOUT INVE, V3rd; Meszaros V, 2014, STRESS HEALTH, V30, P82, DOI 10.1002/smi.2481; Oh SH, 2009, CHILD YOUTH SERV REV, V31, P206, DOI 10.1016/j.childyouth.2008.07.012; Olivares Faundez V., 2009, CIENCIA TRABAJO, V11, P160; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [DOI 10.1016/B978-0-12-590241-0.50006-X, 10.1016/B978-0-12-590241-0.50006-X]; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Pisanti R, 2013, J ADV NURS, V69, P697, DOI 10.1111/j.1365-2648.2012.06114.x; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Richardsen AM, 2004, J OCCUP ORGAN PSYCH, V77, P377, DOI 10.1348/0963179041752691; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, DOI DOI 10.1037/1072-5245.15.3.235; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; Sirigatti S., 1993, ADAPTATION ADJUSTMEN; Sirigatti S., 1992, B PSICOLOGIA APPL, V1, P3; Sirigatti S, 1991, B PSICOLOGIA APPL, V200, P39; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Stefanile C., 1988, B PSICOLOGIA APPL, V187, P29; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vanheule S, 2007, STRESS HEALTH, V23, P87, DOI 10.1002/smi.1124; Viotti Sara, 2012, G Ital Med Lav Ergon, V34, pB52; Wheeler DL, 2011, EDUC PSYCHOL MEAS, V71, P231, DOI 10.1177/0013164410391579; Worley JA, 2008, EDUC PSYCHOL MEAS, V68, P797, DOI 10.1177/0013164408315268; ZERBE WJ, 1987, ACAD MANAGE REV, V12, P250, DOI 10.2307/258533; Ziegler M, 2013, EUR J PSYCHOL ASSESS, V29, P81, DOI 10.1027/1015-5759/a000167	54	82	86	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114987	10.1371/journal.pone.0114987	http://dx.doi.org/10.1371/journal.pone.0114987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25501716	Green Published, gold			2022-12-27	WOS:000346375400066
J	Xu, L; Wang, DX; Lu, LL; Jin, L; Liu, JW; Song, DY; Guo, ZW; Xiao, M				Xu, Li; Wang, Dongxue; Lu, Lili; Jin, Lan; Liu, Jiawei; Song, Deyong; Guo, Zhongwu; Xiao, Min			Purification, Cloning, Characterization, and N-Glycosylation Analysis of a Novel beta-Fructosidase from Aspergillus oryzae FS4 Synthesizing Levan- and Neolevan-Type Fructooligosaccharides	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; INVERTASE; FRUCTOSYLTRANSFERASE; THERMOSTABILITY; PROTEIN; FRUCTOFURANOSIDASE; 6-KESTOSE; SUCROSE; CHAIN	beta-Fructosidases are a widespread group of enzymes that catalyze the hydrolysis of terminal fructosyl units from various substrates. These enzymes also exhibit transglycosylation activity when they function with high concentrations of sucrose, which is used to synthesize fructooligosaccharides (FOS) in the food industry. A beta-fructosidase (BfrA) with high transglycosylation activity was purified from Aspergillus oryzae FS4 as a monomeric glycoprotein. Compared with the most extensively studied Aspergillus spp. fructosidases that synthesize inulin-type beta-(2-1)-linked FOS, BfrA has unique transfructosylating property of synthesizing levan- and neolevan-type beta-(2-6)-linked FOS. The coding sequence (bfrAFS4, 1.86 kb) of BfrA was amplified and expressed in Escherichia coli and Pichia pastoris. Both native and recombinant proteins showed transfructosylation and hydrolyzation activities with broad substrate specificity. These proteins could hydrolyze the following linkages: Glc alpha-1, 2-beta Fru; Glc alpha-1, 3-alpha Fru; and Glc alpha-1, 5-beta Fru. Compared with the unglycosylated E. coli-expressed BfrA (E. BfrA), the Nglycosylated native (N. BfrA) and the P. pastoris-expressed BfrA (P. BfrA) were highly stable at a wide pH range (pH 4 to 11), and significantly more thermostable at temperatures up to 50 degrees C with a maximum activity at 55 degrees C. Using sucrose as substrate, the Km and k(cat) values for total activity were 37.19 +/- 5.28 mM and 1.0016 +/- 0.039 x 10(4) s(-1) for N. BfrA. Moreover, 10 of 13 putative N-glycosylation sites were glycosylated on N. BfrA, and N-glycosylation was essential for enzyme thermal stability and optima activity. Thus, BfrA has demonstrated as a well-characterized A. oryzae fructosidase with unique transfructosylating capability of synthesizing levan- and neolevan-type FOS.	[Xu, Li; Wang, Dongxue; Lu, Lili; Jin, Lan; Liu, Jiawei; Song, Deyong; Guo, Zhongwu; Xiao, Min] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Xu, Li; Wang, Dongxue; Lu, Lili; Jin, Lan; Liu, Jiawei; Song, Deyong; Guo, Zhongwu; Xiao, Min] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Xiao, M (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	minxiao@sdu.edu.cn			Major State Basic Research Development Program of China (973 Program) [2012CB822102]; National Major Scientific and Technological Special Project for Significant New Drugs Development [2012ZX09502001-005]; National High Technology Research and Development Program of China (863 Program) [2012AA021504]; National Natural Science Foundation of China [31070064, 31301155]; Shandong Provincial Natural Science Foundation, China [ZR2013CQ043]; Independent Innovation Foundation of Shandong University, IIFSDU [2012GN013, 2012TS014]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Major Scientific and Technological Special Project for Significant New Drugs Development; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University, IIFSDU	This work was supported by the Major State Basic Research Development Program of China (973 Program, 2012CB822102) http://www.973.gov.cn/English/Index.aspx, the National Major Scientific and Technological Special Project for Significant New Drugs Development (2012ZX09502001-005), http://www.nmp.gov.cn/, the National High Technology Research and Development Program of China (863 Program, 2012AA021504), http://www.863.gov.cn/, the National Natural Science Foundation of China (31070064, 31301155), http://www.nsfc.gov.cn/publish/portal1/, Shandong Provincial Natural Science Foundation, China (ZR2013CQ043) http://www.sdnsf.gov.cn/portal/, and the Independent Innovation Foundation of Shandong University, IIFSDU (2012GN013, 2012TS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro-Benito M, 2007, J BIOTECHNOL, V132, P75, DOI 10.1016/j.jbiotec.2007.07.939; Aslam A, 2013, PAK J BOT, V45, P285; Bao LG, 2001, ARCH BIOCHEM BIOPHYS, V386, P17, DOI 10.1006/abbi.2000.2187; Boer E, 2004, ANTON LEEUW INT J G, V86, P121, DOI 10.1023/B:ANTO.0000036135.69810.df; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chuankhayan P, 2010, J BIOL CHEM, V285, P23249, DOI 10.1074/jbc.M110.113027; Clark SE, 2004, PROTEIN ENG DES SEL, V17, P245, DOI 10.1093/protein/gzh028; Du LQ, 2010, WORLD J MICROB BIOT, V26, P419, DOI 10.1007/s11274-009-0184-2; Farine S, 2001, APPL MICROBIOL BIOT, V55, P55, DOI 10.1007/s002530000493; Fialho MB, 2013, MYCOSCIENCE, V54, P198, DOI 10.1016/j.myc.2012.09.012; Gallagher JA, 2004, J EXP BOT, V55, P557, DOI 10.1093/jxb/erh056; Ghazi I, 2007, J BIOTECHNOL, V128, P204, DOI 10.1016/j.jbiotec.2006.09.017; HASEGAWA M, 1992, EUR J BIOCHEM, V210, P9, DOI 10.1111/j.1432-1033.1992.tb17384.x; Hsieh CW, 2006, J AGR FOOD CHEM, V54, P3101, DOI 10.1021/jf052711s; Kilian S, 2002, WORLD J MICROB BIOT, V18, P637, DOI 10.1023/A:1016808015630; Kurakake M, 2010, J AGR FOOD CHEM, V58, P488, DOI 10.1021/jf903303w; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Linde D, 2009, APPL ENVIRON MICROB, V75, P1065, DOI 10.1128/AEM.02061-08; Marx SP, 2000, FEMS MICROBIOL LETT, V182, P163, DOI 10.1016/S0378-1097(99)00584-4; Menendez C, 2013, APPL MICROBIOL BIOT, V97, P1201, DOI 10.1007/s00253-012-4270-2; Mona MR., 2009, AUST J BASIC APPL SC, V3, P1910; MORENO S, 1990, BIOCHEM J, V267, P697, DOI 10.1042/bj2670697; MURAMATSU K, 1994, BIOSCI BIOTECH BIOCH, V58, P1642, DOI 10.1271/bbb.58.1642; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; RODRIGUEZ J, 1995, BIOCHEM J, V306, P235, DOI 10.1042/bj3060235; Rubio MC, 2002, PHYTOCHEMISTRY, V61, P605, DOI 10.1016/S0031-9422(02)00336-9; RUBIO MC, 1995, CURR MICROBIOL, V31, P80, DOI 10.1007/BF00294280; Sangeetha PT, 2005, TRENDS FOOD SCI TECH, V16, P442, DOI 10.1016/j.tifs.2005.05.003; Sangeetha PT, 2005, PROCESS BIOCHEM, V40, P1085, DOI 10.1016/j.procbio.2004.03.009; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Tahiri M, 2003, AM J CLIN NUTR, V77, P449, DOI 10.1093/ajcn/77.2.449; TERASHIMA M, 1994, EUR J BIOCHEM, V226, P249, DOI 10.1111/j.1432-1033.1994.tb20048.x; van Hijum SAFT, 2004, MICROBIOL-SGM, V150, P621, DOI 10.1099/mic.0.26671-0; Verhaest M, 2005, PLANT J, V41, P400, DOI 10.1111/j.1365-313X.2004.02304.x	35	9	9	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114793	10.1371/journal.pone.0114793	http://dx.doi.org/10.1371/journal.pone.0114793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25501957	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400052
J	Berg, A; Patel, S; Gonca, M; David, C; Otterdal, K; Ueland, T; Dalen, I; Kvaloy, JT; Mollnes, TE; Aukrust, P; Langeland, N				Berg, Aase; Patel, Sam; Gonca, Miguel; David, Catarina; Otterdal, Kari; Ueland, Thor; Dalen, Ingvild; Kvaloy, Jan T.; Mollnes, Tom E.; Aukrust, Pal; Langeland, Nina			Cytokine Network in Adults with Falciparum Malaria and HIV-1: Increased IL-8 and IP-10 Levels Are Associated with Disease Severity	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CEREBRAL MALARIA; IMMUNE ACTIVATION; INFECTED ADULTS; CHILDREN; CHEMOKINES; PREVALENCE; PATHOGENESIS; INDIVIDUALS; EXHAUSTION	Background: Co-infection with malaria and HIV increases the severity and mortality of both diseases, but the cytokine responses related to this co-infection are only partially characterised. The aim of this study was to explore cytokine responses in relation to severity and mortality in malaria patients with and without HIV co-infection. Methods: This was a prospective cross-sectional study. Clinical data and blood samples were collected from adults in Mozambique. Plasma was analysed for 21 classical pro-and anti-inflammatory cytokines, including interleukins, interferons, and chemokines. Results: We included 212 in-patients with fever and/or suspected malaria and 56 healthy controls. Falciparum malaria was diagnosed in 131 patients, of whom 70 were co-infected with HIV-1. The malaria patients had marked increases in their cytokine responses compared with the healthy controls. Some of these changes, particularly interleukin 8 (IL-8) and interferon-gamma-inducing protein 10 (IP-10) were strongly associated with falciparum malaria and disease severity. Both these chemokines were markedly increased in patients with falciparum malaria as compared with healthy controls, and raised levels of IL-8 and IP-10 were associated with increased disease severity, even after adjusting for relevant confounders. For IL-8, particularly high levels were found in malaria patients that were co-infected with HIV and in those who died during hospitalization. Interpretations: Our findings underscore the complex role of inflammation during infection with P. falciparum, and suggest a potential pathogenic role for IL-8 and IP-10. However, the correlations do not necessarily mean any causal relationship, and further both clinical and mechanistic research is necessary to elucidate the role of cytokines in pathogenesis and protection during falciparum malaria.	[Berg, Aase] Stavanger Univ Hosp, Dept Med, Stavanger, Norway; [Berg, Aase; Patel, Sam; Gonca, Miguel; David, Catarina] Cent Hosp Maputo, Dept Med, Maputo, Mozambique; [Berg, Aase; Langeland, Nina] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Otterdal, Kari; Ueland, Thor; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway; [Dalen, Ingvild; Kvaloy, Jan T.] Stavanger Univ Hosp, Res Dept, Stavanger, Norway; [Kvaloy, Jan T.] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway; [Mollnes, Tom E.; Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Mollnes, Tom E.; Aukrust, Pal] Univ Oslo, Fac Med, Oslo, Norway; [Ueland, Thor; Mollnes, Tom E.; Aukrust, Pal] Univ Oslo, KG Jebsen Inflammatory Res Ctr, Oslo, Norway; [Mollnes, Tom E.] Oslo Univ Hosp, Rikshosp, Inst Immunol, Oslo, Norway; [Mollnes, Tom E.] Res Lab Nordland Hosp, Bodo, Norway; [Mollnes, Tom E.] Univ Tromso, Fac Hlth Sci, Tromso, Norway; [Langeland, Nina] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway	Stavanger University Hospital; University of Bergen; University of Oslo; National Hospital Norway; Stavanger University Hospital; Universitetet i Stavanger; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; University of Bergen; Haukeland University Hospital	Berg, A (corresponding author), Stavanger Univ Hosp, Dept Med, Stavanger, Norway.	beaa@sus.no	Berg, Aase/AAS-7666-2020; Mollnes, Tom/ABI-5183-2020	Berg, Aase/0000-0002-6937-3580; 	Western Norway Regional Health Authority; National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway; Medical Association for Infectious Diseases	Western Norway Regional Health Authority; National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway; Medical Association for Infectious Diseases	Funding was provided by the Western Norway Regional Health Authority to AB. Economic support was also received from the National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway and the Medical Association for Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Gamra Maha M. M., 2001, Journal of the Egyptian Society of Parasitology, V31, P905; [Anonymous], NORMAS TRATAMENTO MA; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Baker VS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-41; Berg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088257; Berg A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-252; Bostrom S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-109; Brentlinger PE, 2007, ARCH INTERN MED, V167, P1827, DOI 10.1001/archinte.167.17.1827; BURGMANN H, 1995, CLIN IMMUNOL IMMUNOP, V76, P32, DOI 10.1006/clin.1995.1084; Chalwe V, 2012, INT J EPIDEMIOL, V41, P890, DOI 10.1093/ije/dys079; Clark IA, 2000, PARASITOL TODAY, V16, P451, DOI 10.1016/S0169-4758(00)01757-9; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Davenport GC, 2012, AM J HEMATOL, V87, P652, DOI 10.1002/ajh.23200; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; de Oliveira AM, 2011, AM J TROP MED HYG, V85, P1002, DOI 10.4269/ajtmh.2011.11-0365; Dettling M, 2004, J MULTIVARIATE ANAL, V90, P106, DOI 10.1016/j.jmva.2004.02.012; Erdman LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017440; Ferrando-Martinez S, 2011, CURR HIV RES, V9, P289, DOI 10.2174/157016211797636008; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Hawkes M, 2013, VIRULENCE, V4, P543, DOI 10.4161/viru.25949; HORUK R, 1994, IMMUNOL TODAY, V15, P169, DOI 10.1016/0167-5699(94)90314-X; Hosmer SW, 2000, APPL LOGISTIC REGRES; Ioannidis LJ, 2014, PARASITOLOGY, V141, P602, DOI 10.1017/S0031182013001984; Iriemenam NC, 2009, AFR HEALTH SCI, V9, P66; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; John CC, 2008, CYTOKINE, V41, P204, DOI 10.1016/j.cyto.2007.12.008; Lourembam SD, 2013, CYTOKINE, V64, P503, DOI 10.1016/j.cyto.2013.08.007; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacDonald SM, 2001, P NATL ACAD SCI USA, V98, P10829, DOI 10.1073/pnas.201191498; Mahanta A, 2014, CYTOKINE, V65, P210, DOI 10.1016/j.cyto.2013.11.001; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; PATNAIK JK, 1994, AM J TROP MED HYG, V51, P642, DOI 10.4269/ajtmh.1994.51.642; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; Ronsholt FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065182; Sinha S, 2010, EUR CYTOKINE NETW, V21, P232, DOI 10.1684/ecn.2010.0208; Sun T, 2012, P NATL ACAD SCI USA, V109, pE2117, DOI 10.1073/pnas.1206573109; WHO, 2007, HIV AIDS PROGR; World Health Organization, 2011, GUID TREATM MAL	45	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114480	10.1371/journal.pone.0114480	http://dx.doi.org/10.1371/journal.pone.0114480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503583	Green Submitted, Green Published, gold			2022-12-27	WOS:000347146700029
J	Hsu, CC; Wu, PS; Chen, TC; Yu, CW; Tsai, WC; Wu, KQ; Wu, WL; Chen, WH; Chen, HH				Hsu, Chia-Chi; Wu, Pei-Shan; Chen, Tien-Chih; Yu, Chun-Wei; Tsai, Wen-Chieh; Wu, Keqiang; Wu, Wen-Luan; Chen, Wen-Huei; Chen, Hong-Hwa			Histone Acetylation Accompanied with Promoter Sequences Displaying Differential Expression Profiles of B-Class MADS-Box Genes for Phalaenopsis Floral Morphogenesis	PLOS ONE			English	Article							TRANSIENT TRANSFORMATION; EPIGENETIC MAINTENANCE; FLOWER DEVELOPMENT; PROTOPLAST SYSTEM; HOMEOTIC GENES; ORGAN IDENTITY; EVOLUTION; ORCHID; TRANSCRIPTION; ELEMENTS	Five B-class MADS-box genes, including four APETALA3 (AP3)-like PeMADS2 similar to 5 and one PISTILLATA (PI)-like PeMADS6, specify the spectacular flower morphology in orchids. The PI-like PeMADS6 ubiquitously expresses in all floral organs. The four AP3-like genes, resulted from two duplication events, express ubiquitously at floral primordia and early floral organ stages, but show distinct expression profiles at late floral organ primordia and floral bud stages. Here, we isolated the upstream sequences of PeMADS2 similar to 6 and studied the regulatory mechanism for their distinct gene expression. Phylogenetic footprinting analysis of the 1.3-kb upstream sequences of AP3-like PeMADS2 similar to 5 showed that their promoter regions have sufficiently diverged and contributed to their subfunctionalization. The amplified promoter sequences of PeMADS2,6 could drive beta-glucuronidase (GUS) gene expression in all floral organs, similar to their expression at the floral primordia stage. The promoter sequence of PeMADS4, exclusively expressed in lip and column, showed a 1.6 similar to 3-fold higher expression in lip/column than in sepal/petal. Furthermore, we noted a 4.9-fold increase in histone acetylation (H3K9K14ac) in the translation start region of PeMADS4 in lip as compared in petal. All these results suggest that the regulation via the upstream sequences and increased H3K9K14ac level may act synergistically to display distinct expression profiles of the AP3-like genes at late floral organ primordia stage for Phalaenopsis floral morphogenesis.	[Hsu, Chia-Chi; Wu, Pei-Shan; Chen, Tien-Chih; Wu, Wen-Luan; Chen, Hong-Hwa] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Yu, Chun-Wei; Wu, Keqiang] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Tsai, Wen-Chieh] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan 70101, Taiwan; [Chen, Wen-Huei; Chen, Hong-Hwa] Natl Cheng Kung Univ, Orchid Res Ctr, Tainan 70101, Taiwan	National Cheng Kung University; National Taiwan University; National Cheng Kung University; National Cheng Kung University	Chen, HH (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan.	hhchen@mail.ncku.edu.tw	Wu, Keqiang/C-9743-2013	Wu, Keqiang/0000-0002-5791-3594	National Science Council, Taiwan [NSC 102-2811-B-006-022]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (Grant no.: NSC 102-2811-B-006-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Aceto S, 2010, J HERED, V101, P124, DOI 10.1093/jhered/esp082; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Baum K, 1997, PLANT J, V12, P463, DOI 10.1046/j.1365-313X.1997.12020463.x; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Blachutzik JO, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-28; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Bulyk ML, 2004, GENOME BIOL, V5; Burgos-Rivera B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051388; CARLSON JE, 1991, THEOR APPL GENET, V83, P194, DOI 10.1007/BF00226251; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Charron JBF, 2009, PLANT CELL, V21, P3732, DOI 10.1105/tpc.109.066845; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Chuzhanova NA, 2000, GENE, V254, P9, DOI 10.1016/S0378-1119(00)00308-5; Cozzolino S, 2005, TRENDS ECOL EVOL, V20, P487, DOI 10.1016/j.tree.2005.06.004; De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016; Denecke J, 2012, PLANT CELL, V24, P1316, DOI 10.1105/tpc.112.096362; Dennis ES, 2007, CURR OPIN PLANT BIOL, V10, P520, DOI 10.1016/j.pbi.2007.06.009; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; DOLAN JW, 1991, BIOCHIM BIOPHYS ACTA, V1088, P155, DOI 10.1016/0167-4781(91)90051-M; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Gramzow L, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-214; HAMILTON DA, 1992, PLANT MOL BIOL, V18, P211, DOI 10.1007/BF00034950; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; Hill TA, 1998, DEVELOPMENT, V125, P1711; Honma T, 2000, DEVELOPMENT, V127, P2021; Hsiao YY, 2013, GENE, V518, P91, DOI 10.1016/j.gene.2012.11.069; Hsu CT, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-60; Hsu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-3; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kellogg EA, 2004, CURR OPIN PLANT BIOL, V7, P92, DOI 10.1016/j.pbi.2003.11.004; Kramer EM, 1998, GENETICS, V149, P765; Kramer EM, 2005, J EXP ZOOL PART B, V304B, P526, DOI 10.1002/jez.b.21046; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; LI YH, 1994, PLANT CELL REP, V13, P661, DOI 10.1007/BF00231619; Luo M, 2012, J EXP BOT, V63, P3297, DOI 10.1093/jxb/ers059; Mondragon-Palomino M, 2008, TRENDS PLANT SCI, V13, P51, DOI 10.1016/j.tplants.2007.11.007; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Mondragon-Palomino M, 2009, ANN BOT-LONDON, V104, P583, DOI 10.1093/aob/mcn258; Mondragon-Palomino M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-81; Moon YH, 2003, PLANT CELL, V15, P681, DOI 10.1105/tpc.007831; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Pan ZJ, 2011, PLANT CELL PHYSIOL, V52, P1515, DOI 10.1093/pcp/pcr092; Roudier F, 2009, TRENDS GENET, V25, P511, DOI 10.1016/j.tig.2009.09.013; Rudall PJ, 2002, BIOL REV, V77, P403, DOI 10.1017/S1464793102005936; Sambrook J., 2001, MOL CLONING LAB MANU; SANFORD JC, 1993, METHOD ENZYMOL, V217, P483; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sidorov VA, 1999, PLANT J, V19, P209, DOI 10.1046/j.1365-313X.1999.00508.x; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Tautz D, 2000, CURR OPIN GENET DEV, V10, P575, DOI 10.1016/S0959-437X(00)00130-1; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Tilly JJ, 1998, DEVELOPMENT, V125, P1647; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; Tsai WC, 2005, PLANT CELL PHYSIOL, V46, P1125, DOI 10.1093/pcp/pci125; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Ueki S, 2009, NAT PROTOC, V4, P71, DOI 10.1038/nprot.2008.217; WANG YC, 1988, PLANT MOL BIOL, V11, P433, DOI 10.1007/BF00039024; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Weitzman Jonathan B, 2003, J Biol, V2, P9, DOI 10.1186/1475-4924-2-9; Whipple CJ, 2004, DEVELOPMENT, V131, P6083, DOI 10.1242/dev.01523; Xu FY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-497; Yamaguchi T, 2006, PLANT CELL, V18, P15, DOI 10.1105/tpc.105.037200; Yang SH, 2002, J EXP BOT, V53, P1899, DOI 10.1093/jxb/erf055; Zhang G, 2003, PLANT CELL REP, V21, P860, DOI 10.1007/s00299-003-0585-x; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	73	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e106033	10.1371/journal.pone.0106033	http://dx.doi.org/10.1371/journal.pone.0106033			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501842	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700002
J	Wang, GW; Lv, C; Shi, ZR; Zeng, RT; Dong, XY; Zhang, WD; Liu, RH; Shan, L; Shen, YH				Wang, Guo-Wei; Lv, Chao; Shi, Zhi-Ran; Zeng, Ren-Tao; Dong, Xue-Yun; Zhang, Wei-Dong; Liu, Run-Hui; Shan, Lei; Shen, Yun-Heng			Abieslactone Induces Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinomas through the Mitochondrial Pathway and the Generation of Reactive Oxygen Species	PLOS ONE			English	Article							OXIDATIVE STRESS; S-PHASE; BAX ACTIVATION; CANCER; DRUG; TRITERPENOIDS; TRANSLOCATION; PROGRESSION; INHIBITION; MECHANISMS	Abieslactone is a triterpenoid lactone isolated from Abies plants. Previous studies have demonstrated that its derivative abiesenonic acid methyl ester possesses anti-tumor-promoting activity in vitro and in vivo. In the present study, cell viability assay demonstrated that abieslactone had selective cytotoxicity against human hepatoma cell lines. Immunostaining experiments revealed that abieslactone induced HepG2 and SMMC7721 cell apoptosis. Flow cytometry and western blot analysis showed that the apoptosis was associated with cell cycle arrest during the G(1) phase, up-regulation of p53 and p21, and down-regulation of CDK2 and cyclin D1. Furthermore, our results revealed that induction of apoptosis through a mitochondrial pathway led to upregulation of Bax, down-regulation of Bcl-2, mitochondrial release of cytochrome c, reduction of mitochondrial membrane potential (MMP), and activation of caspase cascades (Casp-9 and -3). Activation of caspase cascades also resulted in the cleavage of PARP fragment. Involvement of the caspase apoptosis pathway was confirmed using caspase inhibitor Z-VAD-FMK pretreatment. Recent studies have shown that ROS is upstream of Akt signal in mitochondria-mediated hepatoma cell apoptosis. Our results showed that the accumulation of ROS was detected in HepG2 cells when treated with abieslactone, and ROS scavenger partly blocked the effects of abieslactone-induced HepG2 cell death. In addition, inactivation of total and phosphorylated Akt activities was found to be involved in abieslactone-induced HepG2 cell apoptosis. Therefore, our findings suggested that abieslactone induced G(1) cell cycle arrest and caspase-dependent apoptosis via the mitochondrial pathway and the ROS/Akt pathway in HepG2 cells.	[Wang, Guo-Wei; Zhang, Wei-Dong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China; [Lv, Chao; Shi, Zhi-Ran; Zeng, Ren-Tao; Zhang, Wei-Dong; Liu, Run-Hui; Shan, Lei; Shen, Yun-Heng] Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China; [Lv, Chao; Dong, Xue-Yun] Fujian Univ Tradit Chinese Med, Sch Pharm, Fujian 350108, Peoples R China	Shanghai Jiao Tong University; Naval Medical University; Fujian University of Traditional Chinese Medicine	Shan, L (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China.	shanleicn@126.com; shenyunheng@hotmail.com	Zhang, Weidong/E-6563-2016	Zhang, Weidong/0000-0002-2433-6823	NCET Foundation; NSFC [81230090]; Shanghai Leading Academic Discipline Project [B906]; Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products [10DZ2251300]; Scientific Foundation of Shanghai China [12401900801, 13401900101]; National Major Project of China [2011ZX09307-002-03]; National Key Technology R&D Program of China [2012BAI29B06]	NCET Foundation; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products; Scientific Foundation of Shanghai China; National Major Project of China; National Key Technology R&D Program of China(National Key Technology R&D Program)	The work was supported by program NCET Foundation, NSFC (81230090), Shanghai Leading Academic Discipline Project (B906), Key laboratory of drug research for special environments, PLA, Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products (10DZ2251300), the Scientific Foundation of Shanghai China (12401900801, 13401900101), National Major Project of China (2011ZX09307-002-03) and the National Key Technology R&D Program of China (2012BAI29B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Breitenstein S, 2009, WORLD J SURG, V33, P797, DOI 10.1007/s00268-008-9878-0; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chatterjee S, 2008, TOXICOL LETT, V177, P83, DOI 10.1016/j.toxlet.2007.12.010; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Dong Y, 1997, LIFE SCI, V60, pPL135, DOI 10.1016/S0024-3205(96)00695-9; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; HOLMES FA, 1991, J NATL CANCER I, V83, P1797, DOI 10.1093/jnci/83.24.1797-a; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kawamori T, 1999, CANCER RES, V59, P597; Lavoie S, 2012, ORG LETT, V14, P1504, DOI 10.1021/ol300237f; Li XG, 2013, CLIN CANCER RES, V19, P2917, DOI 10.1158/1078-0432.CCR-12-3258; Li YL, 2012, TETRAHEDRON, V68, P7763, DOI 10.1016/j.tet.2012.07.047; Li YL, 2012, PHYTOCHEMISTRY, V81, P159, DOI 10.1016/j.phytochem.2012.05.032; Liu CY, 2011, INT J CANCER, V129, P1519, DOI 10.1002/ijc.25817; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MATSUNAGA S, 1965, CHEM COMMUN, P525, DOI 10.1039/c19650000525; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Oh SH, 2004, BIOCHEM PHARMACOL, V68, P1845, DOI 10.1016/j.bcp.2004.06.021; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; Pathak N, 2007, TOXICOL LETT, V169, P95, DOI 10.1016/j.toxlet.2006.12.009; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sun ZJ, 2010, APOPTOSIS, V15, P850, DOI 10.1007/s10495-010-0497-5; TAKAYASU J, 1990, CANCER LETT, V53, P141, DOI 10.1016/0304-3835(90)90206-D; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Wu MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055005, 10.1371/journal.pone.0055044]; Xia JH, 2012, PHYTOCHEMISTRY, V74, P178, DOI 10.1016/j.phytochem.2011.11.011; Yin XM, 2000, CELL RES, V10, P161, DOI 10.1038/sj.cr.7290045; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang Y, 2013, MOL MED REP, V8, P967, DOI 10.3892/mmr.2013.1640; Zhang Z, 2002, CHEM RES TOXICOL, V15, P950, DOI 10.1021/tx0255018	45	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115151	10.1371/journal.pone.0115151	http://dx.doi.org/10.1371/journal.pone.0115151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502685	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700095
J	Shiraishi, Y; Fujimoto, A; Furuta, M; Tanaka, H; Chiba, K; Boroevich, KA; Abe, T; Kawakami, Y; Ueno, M; Gotoh, K; Ariizumi, S; Shibuya, T; Nakano, K; Sasaki, A; Maejima, K; Kitada, R; Hayami, S; Shigekawa, Y; Marubashi, S; Yamada, T; Kubo, M; Ishikawa, O; Aikata, H; Arihiro, K; Ohdan, H; Yamamoto, M; Yamaue, H; Chayama, K; Tsunoda, T; Miyano, S; Nakagawa, H				Shiraishi, Yuichi; Fujimoto, Akihiro; Furuta, Mayuko; Tanaka, Hiroko; Chiba, Ken-ichi; Boroevich, Keith A.; Abe, Tetsuo; Kawakami, Yoshiiku; Ueno, Masaki; Gotoh, Kunihito; Ariizumi, Shun-ichi; Shibuya, Tetsuo; Nakano, Kaoru; Sasaki, Aya; Maejima, Kazuhiro; Kitada, Rina; Hayami, Shinya; Shigekawa, Yoshinobu; Marubashi, Shigeru; Yamada, Terumasa; Kubo, Michiaki; Ishikawa, Osamu; Aikata, Hiroshi; Arihiro, Koji; Ohdan, Hideki; Yamamoto, Masakazu; Yamaue, Hiroki; Chayama, Kazuaki; Tsunoda, Tatsuhiko; Miyano, Satoru; Nakagawa, Hidewaki			Integrated Analysis of Whole Genome and Transcriptome Sequencing Reveals Diverse Transcriptomic Aberrations Driven by Somatic Genomic Changes in Liver Cancers	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MUTATIONS; SUPPRESSES; ALIGNMENT; TRANSLOCATIONS	Recent studies applying high-throughput sequencing technologies have identified several recurrently mutated genes and pathways in multiple cancer genomes. However, transcriptional consequences from these genomic alterations in cancer genome remain unclear. In this study, we performed integrated and comparative analyses of whole genomes and transcriptomes of 22 hepatitis B virus (HBV)-related hepatocellular carcinomas (HCCs) and their matched controls. Comparison of whole genome sequence (WGS) and RNA-Seq revealed much evidence that various types of genomic mutations triggered diverse transcriptional changes. Not only splice-site mutations, but also silent mutations in coding regions, deep intronic mutations and structural changes caused splicing aberrations. HBV integrations generated diverse patterns of virus-human fusion transcripts depending on affected gene, such as TERT, CDK15, FN1 and MLL4. Structural variations could drive overexpression of genes such as WNT ligands, with/without creating gene fusions. Furthermore, by taking account of genomic mutations causing transcriptional aberrations, we could improve the sensitivity of deleterious mutation detection in known cancer driver genes (TP53, AXIN1, ARID2, RPS6KA3), and identified recurrent disruptions in putative cancer driver genes such as HNF4A, CPS1, TSC1 and THRAP3 in HCCs. These findings indicate genomic alterations in cancer genome have diverse transcriptomic effects, and integrated analysis of WGS and RNA-Seq can facilitate the interpretation of a large number of genomic alterations detected in cancer genome.	[Shiraishi, Yuichi; Chiba, Ken-ichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo 1088639, Japan; [Fujimoto, Akihiro; Furuta, Mayuko; Nakano, Kaoru; Sasaki, Aya; Maejima, Kazuhiro; Kitada, Rina; Nakagawa, Hidewaki] RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Yokohama, Kanagawa 2300045, Japan; [Fujimoto, Akihiro; Boroevich, Keith A.; Abe, Tetsuo; Tsunoda, Tatsuhiko] RIKEN, Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Hiroko; Shibuya, Tetsuo; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo 1088639, Japan; [Kawakami, Yoshiiku; Aikata, Hiroshi; Chayama, Kazuaki] Hiroshima Univ, Sch Med, Dept Med & Mol Sci, Hiroshima 7348551, Japan; [Ueno, Masaki; Hayami, Shinya; Shigekawa, Yoshinobu; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama 6418510, Japan; [Gotoh, Kunihito; Marubashi, Shigeru; Yamada, Terumasa; Ishikawa, Osamu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Tokyo 5378511, Japan; [Ariizumi, Shun-ichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo 1628666, Japan; [Arihiro, Koji] Hiroshima Univ, Dept Anat Pathol, Sch Med, Hiroshima 7348551, Japan; [Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Surg Gastroenterol, Hiroshima 7348551, Japan; [Kubo, Michiaki] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; RIKEN; RIKEN; University of Tokyo; Hiroshima University; Wakayama Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University; Hiroshima University; Hiroshima University; RIKEN	Nakagawa, H (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Yokohama, Kanagawa 2300045, Japan.	hidewaki@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Hayami, Shinya/Y-3354-2019; Tsunoda, Tatsuhiko/K-2061-2014; Chayama, Kazuaki/B-2493-2016; Ohdan, Hideki/G-4719-2019	Hayami, Shinya/0000-0001-8392-2382; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ohdan, Hideki/0000-0002-9066-1288; Chayama, Kazuaki/0000-0002-5530-5341; Miyano, Satoru/0000-0002-1753-6616; Boroevich, Keith/0000-0001-7095-7332	RIKEN President's Fund; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention;  [24700272]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	RIKEN President's Fund; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding for this work came from the RIKEN President's Fund 2011, the Princess Takamatsu Cancer Research Fund, Takeda Science Foundation, Grand-in Aid for Scientific Research on Innovative Areas (Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention), and Grant-in-Aid for Young Scientists (B) 24700272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ding D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003065; Dyomin VG, 1997, P NATL ACAD SCI USA, V94, P5728, DOI 10.1073/pnas.94.11.5728; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Flanagan SE, 2013, AM J HUM GENET, V92, P131, DOI 10.1016/j.ajhg.2012.11.017; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Hatziapostolou M, 2011, CELL, V147, P1233, DOI 10.1016/j.cell.2011.10.043; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Liu JF, 2012, GENOME RES, V22, P2315, DOI 10.1101/gr.140988.112; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Merz C, 2007, RNA, V13, P116, DOI 10.1261/rna.336807; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; ZHUANG Y, 1986, CELL, V46, P827, DOI 10.1016/0092-8674(86)90064-4	36	55	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114263	10.1371/journal.pone.0114263	http://dx.doi.org/10.1371/journal.pone.0114263			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526364	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200002
J	Zabetakis, D; Olson, MA; Anderson, GP; Legler, PM; Goldman, ER				Zabetakis, Dan; Olson, Mark A.; Anderson, George P.; Legler, Patricia M.; Goldman, Ellen R.			Evaluation of Disulfide Bond Position to Enhance the Thermal Stability of a Highly Stable Single Domain Antibody	PLOS ONE			English	Article							HEAVY-CHAIN ANTIBODIES; STABILIZATION; FRAGMENTS; IDENTIFICATION; REPERTOIRE; REGIONS; TOXIN; TOOL; VHH	Single domain antibodies are the small recombinant variable domains derived from camelid heavy-chain-only antibodies. They are renowned for their stability, in large part due to their ability to refold following thermal or chemical denaturation. In addition to refolding after heat denaturation, A3, a high affinity anti-Staphylococcal Enterotoxin B single domain antibody, possesses a melting temperature of similar to 84 degrees C, among the highest reported for a single domain antibody. In this work we utilized the recently described crystal structure of A3 to select locations for the insertion of a second disulfide bond and evaluated the impact that the addition of this second bond had on the melting temperature. Four double-disulfide versions of A3 were constructed and each was found to improve the melting temperature relative to the native structure without reducing affinity. Placement of the disulfide bond at a previously published position between framework regions 2 and 3 yielded the largest improvement (>6 degrees C), suggesting this location is optimal, and seemingly provides a universal route to raise the melting temperature of single domain antibodies. This study further demonstrates that even single domain antibodies with extremely high melting points can be further stabilized by addition of disulfide bonds.	[Zabetakis, Dan; Anderson, George P.; Legler, Patricia M.; Goldman, Ellen R.] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Olson, Mark A.] USAMRIID, Dept Cell Biol & Biochem, Frederick, MD 21702 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Army Medical Research Institute of Infectious Diseases	Goldman, ER (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	ellen.goldman@nrl.navy.mil	Anderson, George P/D-2461-2011	Anderson, George P/0000-0001-7545-9893	Defense Threat Reduction Agency [CBCALL12-LS6-2-0036]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency (CBCALL12-LS6-2-0036). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achour I, 2008, J IMMUNOL, V181, P2001, DOI 10.4049/jimmunol.181.3.2001; Anderson GP, 2012, ANAL CHEM, V84, P5198, DOI 10.1021/ac300864j; Compton JR, 2011, PROTEINS, V79, P1048, DOI 10.1002/prot.22933; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; De Genst E, 2006, DEV COMP IMMUNOL, V30, P187, DOI 10.1016/j.dci.2005.06.010; Dona V, 2010, J AGR FOOD CHEM, V58, P918, DOI 10.1021/jf902973c; Eyer L, 2012, VET MED-CZECH, V57, P439, DOI 10.17221/6336-VETMED; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; George J, 2014, PROTEINS, V82, P3101, DOI 10.1002/prot.24671; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Goldman ER, 2014, PROTEIN EXPRES PURIF, V95, P226, DOI 10.1016/j.pep.2014.01.003; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Graef RR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-86; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hagihara Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2016, DOI 10.1016/j.bbapap.2014.07.005; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hussack G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028218; Kim DY, 2012, PROTEIN ENG DES SEL, V25, P581, DOI 10.1093/protein/gzs055; Kim HJ, 2012, ANAL CHEM, V84, P1165, DOI 10.1021/ac2030255; Lee MS, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603964; Lee MS, 2010, J CHEM THEORY COMPUT, V6, P2477, DOI 10.1021/ct100062b; Liu JL, 2014, MOL IMMUNOL, V59, P194, DOI 10.1016/j.molimm.2014.02.014; Miklos AE, 2012, CHEM BIOL, V19, P449, DOI 10.1016/j.chembiol.2012.01.018; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Perchiacca JM, 2014, PROTEIN ENG DES SEL, V27, P29, DOI 10.1093/protein/gzt058; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Turner KB, 2014, PROTEIN ENG DES SEL, V27, P89, DOI 10.1093/protein/gzu001; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; van der Linden RHJ, 2000, J BIOTECHNOL, V80, P261, DOI 10.1016/S0168-1656(00)00274-1; Walper SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106263; Wang N, 2009, PROTEINS, V76, P99, DOI 10.1002/prot.22319; Wang YR, 2013, ANAL CHEM, V85, P8298, DOI 10.1021/ac4015885; Yeh IC, 2008, J PHYS CHEM B, V112, P15064, DOI 10.1021/jp802469g; Zabetakis D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077678; Zarebski LM, 2005, J MOL BIOL, V349, P814, DOI 10.1016/j.jmb.2005.03.072	39	31	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115405	10.1371/journal.pone.0115405	http://dx.doi.org/10.1371/journal.pone.0115405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526640	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200025
J	Clements, GR; Lynam, AJ; Gaveau, D; Yap, WL; Lhota, S; Goosem, M; Laurance, S; Laurance, WF				Clements, Gopalasamy Reuben; Lynam, Antony J.; Gaveau, David; Yap, Wei Lim; Lhota, Stanislav; Goosem, Miriam; Laurance, Susan; Laurance, William F.			Where and How Are Roads Endangering Mammals in Southeast Asia's Forests?	PLOS ONE			English	Article							NATIONAL-PARK; PROTECTED AREA; CONSERVATION; IMPACTS; BIODIVERSITY; MITIGATION; ELEPHANTS; INDONESIA; SUMATRA; HABITAT	Habitat destruction and overhunting are two major drivers of mammal population declines and extinctions in tropical forests. The construction of roads can be a catalyst for these two threats. In Southeast Asia, the impacts of roads on mammals have not been well-documented at a regional scale. Before evidence-based conservation strategies can be developed to minimize the threat of roads to endangered mammals within this region, we first need to locate where and how roads are contributing to the conversion of their habitats and illegal hunting in each country. We interviewed 36 experts involved in mammal research from seven Southeast Asian countries to identify roads that are contributing the most, in their opinion, to habitat conversion and illegal hunting. Our experts highlighted 16 existing and eight planned roads - these potentially threaten 21% of the 117 endangered terrestrial mammals in those countries. Apart from gathering qualitative evidence from the literature to assess their claims, we demonstrate how species-distribution models, satellite imagery and animal-sign surveys can be used to provide quantitative evidence of roads causing impacts by (1) cutting through habitats where endangered mammals are likely to occur, (2) intensifying forest conversion, and (3) contributing to illegal hunting and wildlife trade. To our knowledge, ours is the first study to identify specific roads threatening endangered mammals in Southeast Asia. Further through highlighting the impacts of roads, we propose 10 measures to limit road impacts in the region.	[Clements, Gopalasamy Reuben; Goosem, Miriam; Laurance, Susan; Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Clements, Gopalasamy Reuben; Goosem, Miriam; Laurance, Susan; Laurance, William F.] James Cook Univ, Coll Marine & Environm Sci, Cairns, Qld, Australia; [Clements, Gopalasamy Reuben] Univ Malaysia Terengganu, Kenyir Res Inst, Kuala Terengganu, Malaysia; [Clements, Gopalasamy Reuben] Panthera, New York, NY USA; [Clements, Gopalasamy Reuben] Rimba, Selangor, Malaysia; [Clements, Gopalasamy Reuben] Univ Nottingham, Sch Geog, Selangor, Malaysia; [Clements, Gopalasamy Reuben] Monash Univ, Sch Sci, Selangor, Malaysia; [Lynam, Antony J.] Wildlife Conservat Soc, Ctr Global Conservat, New York, NY USA; [Gaveau, David] Ctr Int Forestry Res, Bogor, Indonesia; [Yap, Wei Lim] World Wide Fund Nat Malaysia, Petaling Jaya, Selangor, Malaysia; [Lhota, Stanislav] Czech Univ Life Sci, Dept Husb & Ethol, Prague, Czech Republic	James Cook University; James Cook University; Universiti Malaysia Terengganu; University of Nottingham Malaysia; Monash University; Monash University Sunway; Wildlife Conservation Society; CGIAR; Center for International Forestry Research (CIFOR); Czech University of Life Sciences Prague	Clements, GR (corresponding author), James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia.	mailtoreuben@myrimba.org	Laurance, Susan/G-6021-2011; Laurance, William F/B-2709-2012; Lynam, Antony/H-3036-2015; Goosem, Miriam/D-8677-2012	Laurance, Susan/0000-0002-2831-2933; Laurance, William F/0000-0003-4430-9408; Lynam, Antony/0000-0002-8395-7902; Goosem, Miriam/0000-0001-9332-022X; Clements, Gopalasamy Reuben/0000-0002-9715-4385	United States Fish and Wildlife Service Rhino and Tiger Conservation Fund [96200-0-G279]; Rufford Small Grant for Nature Conservation [8320-1]; Universiti Malaya Research Grant [RG359-12HNE]; Cleveland Metroparks Zoo and Cleveland Zoological Society Asian Seed Grant; IDEA WILD; James Cook University Graduate Research Scheme and James Cook University Postgraduate Research Scholarship; Australian Research Council	United States Fish and Wildlife Service Rhino and Tiger Conservation Fund; Rufford Small Grant for Nature Conservation; Universiti Malaya Research Grant; Cleveland Metroparks Zoo and Cleveland Zoological Society Asian Seed Grant; IDEA WILD; James Cook University Graduate Research Scheme and James Cook University Postgraduate Research Scholarship; Australian Research Council(Australian Research Council)	GRC received funding support from the United States Fish and Wildlife Service Rhino and Tiger Conservation Fund (96200-0-G279), Rufford Small Grant for Nature Conservation (8320-1), Universiti Malaya Research Grant (RG359-12HNE), Cleveland Metroparks Zoo and Cleveland Zoological Society Asian Seed Grant, IDEA WILD, James Cook University Graduate Research Scheme and James Cook University Postgraduate Research Scholarship. GRC and WFL also received support from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldwaik SZ, 2012, LANDSCAPE URBAN PLAN, V106, P103, DOI 10.1016/j.landurbplan.2012.02.010; [Anonymous], 2009, NEW STRAITS TIMES; [Anonymous], 2011, NEW STRAITS TIMES; Asian Development Bank, 2005, GREAT MEK SUBR BIOD; Asian Development Bank, 2008, PERF EV REP; Asian Development Bank, 2010, HIV PREV INFR MIT RI; Austin Sean C., 2007, Acta Zoologica Sinica, V53, P373; Aziz SA, 2010, FRONT ECOL ENVIRON, V8, P178, DOI 10.1890/10.WB.014; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett EL, 2008, HUNTING WILDLIFE TRO; Bennett EL, 2011, ORYX, V45, P476, DOI 10.1017/S003060531000178X; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Carlson KM, 2013, NAT CLIM CHANGE, V3, P283, DOI [10.1038/nclimate1702, 10.1038/NCLIMATE1702]; Channa P., 2009, STATUS HABITAT YELLO; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Clements GR, 2012, INTEGR ZOOL, V7, P400, DOI 10.1111/j.1749-4877.2012.00314.x; Clements Gopalasamy Reuben, 2012, Malaysian Naturalist, V65, P56; Clements GR, 2010, CONSERV BIOL, V24, P1437, DOI 10.1111/j.1523-1739.2010.01584.x; Clements GR, 2013, THESIS JAMES COOK U; Colon CP, 2002, J ZOOL, V257, P473, DOI 10.1017/S0952836902001073; *DEP WILDL NAT PAR, 2008, NAT TIG ACT PLAN MAL; Down to Earth, 2002, AC PUSH LEUS ROAD PL; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fahrig L, 2009, ECOL SOC, V14; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Gaveau DLA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034013; Goosem M, 2001, WILDLIFE RES, V28, P351, DOI 10.1071/WR99093; Goosem Miriam, 1997, P241; Goosem Miriam, 2001, Ecological Management & Restoration, V2, P196, DOI 10.1046/j.1442-8903.2001.00084.x; Government of Laos, 2000, OV QUANT PART POV ST; Gray DD, 2006, HO CHI MINH TRAIL VI; Grieser-Johns A., 2005, GOING GOING GONE ILL; Gubbi S, 2012, CURR SCI INDIA, V102, P1047; International Centre for Environmental Management, 2003, LAO PDR NAT REP PROT; Jepson P, 2002, NAT AREA J, V22, P28; Johnson Arlyne, 2006, P232; Jones S, 2006, IDS BULL-I DEV STUD, V37, P28, DOI 10.1111/j.1759-5436.2006.tb00268.x; Karanth KK, 2009, J APPL ECOL, V46, P1189, DOI 10.1111/j.1365-2664.2009.01710.x; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Laurance WF, 2001, CONSERV BIOL, V15, P4, DOI 10.1046/j.1523-1739.2001.00_11-2.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Laurance WF, 2006, CONSERV BIOL, V20, P1251, DOI 10.1111/j.1523-1739.2006.00420.x; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Laurance WF, 2013, NATURE, V495, P308, DOI 10.1038/495308a; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Lesbarreres D, 2012, TRENDS ECOL EVOL, V27, P374, DOI 10.1016/j.tree.2012.01.015; Linkie M, 2003, ORYX, V37, P41, DOI 10.1017/S0030605303000103; Linkie M, 2008, BIOL CONSERV, V141, P2410, DOI 10.1016/j.biocon.2008.07.002; Long B, 2007, SMALL CARNIV CONSERV, V34, P39; Lynam A. J., 2003, NATL TIGER ACTION PL; Lynam AJ, 2006, ENVIRON MANAGE, V37, P30, DOI 10.1007/s00267-004-0273-9; Lynam AJ, 2013, LAW ENFORCEMENT ACTI; Lynam AJ, 1999, WILDLIFE CONSERVATIO, V102, P36; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Marris G, 2002, ENV BASELINE STUDY R; Martin Esmond, 2000, Biologist (London), V47, P27; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard E, 2004, MAKE WILDLIFE CONSER; Ministry of Forestry, 2007, STRAT ACT PLAN SUM T; Nepstad D, 2001, FOREST ECOL MANAG, V154, P395, DOI 10.1016/S0378-1127(01)00511-4; Oswell AH., 2010, BIG CAT TRADE MYANMA; Peh KSH, 2011, BIOSCIENCE, V61, P27, DOI 10.1525/bio.2011.61.1.8; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Quintero JD, 2010, SMART GREEN INFRASTR; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Reid J, 2013, FINANCIAL MECH ENV C; Reuters, 2001, VIETN NEW HIGHW MAY; Robertson Y., 2002, BRIEFING DOCUMENT RO; Robichaud R, 2001, REV NATL PROTECTED A; Roger E, 2011, POPUL ECOL, V53, P215, DOI 10.1007/s10144-010-0209-6; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Shepherd C., 2008, WILD CAT TRADE MYANM; Shepherd CR, 2008, BIODIVERS CONSERV, V17, P35, DOI 10.1007/s10531-007-9228-9; Shepherd CR, 2007, TRANSPORT INFRASTRUC; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singleton I., 2004, ORANGUTAN POPULATION; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Solichin S, 2002, THESIS U FREIBURG; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Sunderlin W. D, 2002, WHICH WAY FORWARD PE, P246; Taylor BD, 2010, WILDLIFE RES, V37, P320, DOI 10.1071/WR09171; TRAFFIC, 2001, NEW DOC SHEDS LIGHT; Travers H, 2011, INVESTIGATION DRIVER; van Beukering PJH, 2003, ECOL ECON, V44, P43, DOI 10.1016/S0921-8009(02)00224-0; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; Vanthomme H, 2013, CONSERV BIOL, V27, P281, DOI 10.1111/cobi.12017; Varma S, 2008, ORYX, V42, P92, DOI 10.1017/S0030605308010090; Vayda Andrew P., 1996, BUGIS SETTLERS E KAL; Vidya TNC, 2010, BIOL CONSERV, V143, P1891, DOI 10.1016/j.biocon.2010.04.043; Weston Nigel, 2011, Australian Mammalogy, V33, P93, DOI 10.1071/AM11003; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; Wijedasa LS, 2012, REMOTE SENS-BASEL, V4, P2595, DOI 10.3390/rs4092595; Wildlife Conservation Society, 1999, SURV ASS CONS SUM TI; Wilkie D, 2000, CONSERV BIOL, V14, P1614, DOI 10.1046/j.1523-1739.2000.99102.x; World Bank, 2013, DAT ROADS PAV TOT RO; Wulder MA, 2011, REMOTE SENS ENVIRON, V115, P747, DOI 10.1016/j.rse.2010.11.002; Zaw M, 2005, OPEN BORDERS DEMAND	105	151	156	4	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115376	10.1371/journal.pone.0115376	http://dx.doi.org/10.1371/journal.pone.0115376			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521297	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000348845600039
J	de Barra, E; Hodgson, SH; Ewer, KJ; Bliss, CM; Hennigan, K; Collins, A; Berrie, E; Lawrie, AM; Gilbert, SC; Nicosia, A; McConkey, SJ; Hill, AVS				de Barra, Eoghan; Hodgson, Susanne H.; Ewer, Katie J.; Bliss, Carly M.; Hennigan, Kerrie; Collins, Ann; Berrie, Eleanor; Lawrie, Alison M.; Gilbert, Sarah C.; Nicosia, Alfredo; McConkey, Samuel J.; Hill, Adrian V. S.			A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; PLASMODIUM CIRCUMSPOROZOITE PROTEIN; FOWLPOX STRAIN FP9; VIRUS ANKARA; PROTECTIVE IMMUNITY; NAIVE ADULTS; LIVER STAGES; PROTRACTED PROTECTION; FALCIPARUM-MALARIA; STERILE PROTECTION	Background: Plasmodium falciparum (P. falciparum) malaria remains a significant cause of mortality and morbidity throughout the world. Development of an effective vaccine would be a key intervention to reduce the considerable social and economic impact of malaria. Methodology: We conducted a Phase Ia, non-randomized, clinical trial in 24 healthy, malaria-naive adults of the chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) replication-deficient viral vectored vaccines encoding the circumsporozoite protein (CS) of P. falciparum. Results: ChAd63-MVA CS administered in a heterologous prime-boost regime was shown to be safe and immunogenic, inducing high-level T cell responses to CS. With a priming ChAd63 CS dose of 5x10(9)vp responses peaked at a mean of 1947 SFC/million PBMC (median 1524) measured by ELIspot 7 days after the MVA boost and showed a mixed CD4+/CD8+ phenotype. With a higher priming dose of ChAd63 CS dose 5x10(10) vp T cell responses did not increase (mean 1659 SFC/million PBMC, median 1049). Serum IgG responses to CS were modest and peaked at day 14 post ChAd63 CS (median antibody concentration for all groups at day 14 of 1.3 mg/ml (range 0-11.9), but persisted throughout late follow-up (day 140 median antibody concentration groups 1B & 2B 0.9 mu g/ml (range 0-4.7). Conclusions: ChAd63-MVA is a safe and highly immunogenic delivery platform for the CS antigen in humans which warrants efficacy testing.	[de Barra, Eoghan; Hennigan, Kerrie; Collins, Ann; McConkey, Samuel J.] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Hodgson, Susanne H.; Lawrie, Alison M.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Churchill Hosp, Oxford, England; [Ewer, Katie J.; Bliss, Carly M.; Gilbert, Sarah C.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Berrie, Eleanor] Univ Oxford, Churchill Hosp, Clin Biomfg Facil, Oxford, England; [Nicosia, Alfredo] Okairos AG, Rome, Italy; [Nicosia, Alfredo] CEINGE, Naples, Italy	Royal College of Surgeons - Ireland; University of Oxford; University of Oxford; Jenner Institute; University of Oxford; CEINGE Biotecnologie Avanzate	de Barra, E (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	edebarra@rcsi.ie	Gilbert, Sarah C./H-2857-2019; Ewer, Katie J/B-4328-2011	Gilbert, Sarah C./0000-0002-6823-9750; Ewer, Katie J/0000-0001-9827-9836; Hodgson, Susanne/0000-0002-0895-3442; de Barra, Eoghan/0000-0001-7679-5565; Bliss, Carly/0000-0002-5117-1016	European Vaccine Initiative (EVI); Malaria Vaccine Initiative; UK National Institute of Health Research through the Oxford Biomedical Research Centre [A91301]; Wellcome Trust [084113/Z/07/Z, 45488/Z/05, 097940/Z/11/Z]	European Vaccine Initiative (EVI); Malaria Vaccine Initiative; UK National Institute of Health Research through the Oxford Biomedical Research Centre; Wellcome Trust(Wellcome Trust)	The study was funded by a grant from the European Vaccine Initiative (EVI), http://www.euvaccine.eu/. Antibody assays were performed at WRAIR and were funded by the Malaria Vaccine Initiative. This work was also supported by the UK National Institute of Health Research through the Oxford Biomedical Research Centre (A91301 Adult Vaccine) and the Wellcome Trust (084113/Z/07/Z). SCG and AVSH are Jenner Investigators; AVSH is supported by a Wellcome Trust Principal Research Fellowship (45488/Z/05); and SHH holds a Wellcome Trust Research Training Fellowship (097940/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejon P, 2006, CLIN INFECT DIS, V42, P1102, DOI 10.1086/501459; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bruna-Romero O, 2004, VACCINE, V22, P3575, DOI 10.1016/j.vaccine.2004.03.050; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; Doolan DL, 1997, IMMUNITY, V7, P97, DOI 10.1016/S1074-7613(00)80513-0; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Dunachie SJ, 2006, VACCINE, V24, P2850, DOI 10.1016/j.vaccine.2005.12.041; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Hill AVS, 2011, PHILOS T R SOC B, V366, P2806, DOI 10.1098/rstb.2011.0091; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Imoukhuede EB, 2006, VACCINE, V24, P6526, DOI 10.1016/j.vaccine.2006.06.022; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Moorthy VS, 2004, PLOS MED, V1, P128, DOI 10.1371/journal.pmed.0010033; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; NUSSENZWEIG RS, 1969, NATURE, V222, P488, DOI 10.1038/222488a0; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; RIECKMANN KH, 1974, T ROY SOC TROP MED H, V68, P258, DOI 10.1016/0035-9203(74)90129-1; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Tarun AS, 2007, J INFECT DIS, V196, P608, DOI 10.1086/519742; Tatsis N, 2007, MOL THER, V15, P608, DOI 10.1038/sj.mt.6300078; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; WHO, 2012, WORLD MALARIA REPORT 2012, P1; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	51	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115161	10.1371/journal.pone.0115161	http://dx.doi.org/10.1371/journal.pone.0115161			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522180	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000348845600022
J	Osman, M; Pagnoux, C; Dryden, DM; Storie, D; Yacyshyn, E				Osman, Mohammed; Pagnoux, Christian; Dryden, Donna M.; Storie, Dale; Yacyshyn, Elaine			The Role of Biological Agents in the Management of Large Vessel Vasculitis (LVV): A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GIANT-CELL ARTERITIS; REFRACTORY TAKAYASU ARTERITIS; NECROSIS FACTOR THERAPY; ANTI-TNF-ALPHA; POLYMYALGIA-RHEUMATICA; INFLIXIMAB; TOCILIZUMAB; RHEUMATOLOGY; EXPERIENCE; REMISSION	Background: Giant cell arteritis (GCA) and Takayasu's arteritis (TAA) are large vessel vasculitides (LVV) for which corticosteroids (CS) are the mainstay for treatment. In patients with LVV unable to tolerate CS, biological agents have been used with variable effectiveness. Objective: To systematically review the effectiveness and safety of biological agents in patients with LVV. Methods: We searched 5 electronic databases (inception to October 2012) and conference abstracts with no language restrictions. Two reviewers independently selected studies, extracted data and assessed methodological quality. Our protocol was registered in PROSPERO. Results: We included 25 studies (3 RCTs and 22 case series with >= 2 cases). 95 GCA and 98 TAA patients received biological agents. The RCTs using anti-TNF agents (infliximab, etanercept and adalimumab) did not suggest a benefit in GCA. GCA patients receiving tocilizumab, in case series, achieved remission (19 patients) and reduction of corticosteroid dose (mean difference, -16.55 mg/day (95% CI: -26.24, -6.86)). In case series, 75 patients with refractory TAA treated with infliximab discontinued CS 32% of the time. Remission was variably defined and the studies were clinically heterogeneous which precluded further analysis. Conclusion: This systematic review demonstrated a weak evidence base on which to assess the effectiveness of biological treatment in LVV. Evidence from RCTs suggests that anti-TNF agents are not effective for remission or reduction of CS use. Tocilizumab and infliximab may be effective in the management of LVV and refractory TAA, respectively, although the evidence comes from case series. Future analytical studies are needed to confirm these findings.	[Osman, Mohammed; Yacyshyn, Elaine] Univ Alberta, Dept Med, Div Rheumatol, Edmonton, AB, Canada; [Pagnoux, Christian] Univ Toronto, Dept Med, Div Rheumatol, Toronto, ON, Canada; [Storie, Dale] Univ Alberta, Hlth Sci Lib, Edmonton, AB, Canada; [Dryden, Donna M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Toronto; University of Alberta; University of Alberta	Yacyshyn, E (corresponding author), Univ Alberta, Dept Med, Div Rheumatol, Edmonton, AB, Canada.	eyacyshyn@ualberta.ca	Pagnoux, Christian/C-4612-2015; Storie, Dale/AAF-3830-2019	Storie, Dale/0000-0001-6704-1585				Andonopoulos AP, 2003, ANN RHEUM DIS, V62, P1116, DOI 10.1136/ard.62.11.1116; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Beyer C, 2011, ANN RHEUM DIS, V70, P1874, DOI 10.1136/ard.2010.149351; Borenstein M, 2009, INTRO META ANAL; Buonuomo PS, 2011, RHEUMATOL INT, V31, P93, DOI 10.1007/s00296-009-1147-5; Canas C, 2012, ANN RHEUM DIS, V71, P681; Cantini F, 2003, ANN RHEUM DIS, V62, P207; Cantini F, 2001, ARTHRITIS RHEUM, V44, P2933, DOI 10.1002/1529-0131(200112)44:12<2933::AID-ART482>3.0.CO;2-Y; Comarmond C, 2012, AUTOIMMUN REV, V11, P678, DOI 10.1016/j.autrev.2011.11.025; Dagna L, 2011, ANN INTERN MED, V155, P425, DOI 10.7326/0003-4819-155-7-201110040-00005; Della Rossa A, 2005, RHEUMATOLOGY, V44, P1074, DOI 10.1093/rheumatology/keh661; Filocamo G, 2008, J PEDIATR-US, V153, P432, DOI 10.1016/j.jpeds.2008.04.049; Galarza C, 2008, CLIN REV ALLERG IMMU, V34, P124, DOI 10.1007/s12016-007-8028-z; Grayson PC, 2012, ANN RHEUM DIS, V71, P1329, DOI 10.1136/annrheumdis-2011-200795; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Hoffman GS, 2004, ARTHRITIS RHEUM, V50, P2296, DOI 10.1002/art.20300; Hoyer BF, 2012, ANN RHEUM DIS, V71, P75, DOI 10.1136/ard.2011.153007; Ishihara T, 2013, CIRC J, V77, P477, DOI 10.1253/circj.CJ-12-0131; Jennette J, 2012, ARTHRITIS RHEUM; Kaneko U, 2010, J CLIN IMMUNOL, V33, P317; Karageorgaki ZT, 2007, CLIN RHEUMATOL, V26, P984, DOI 10.1007/s10067-006-0227-0; Kotter I, 2012, CLIN EXP RHEUMATOL, V30, pS114; Li C, 2000, CLIN EXP RHEUMATOL, V18, pS56; Mahr AD, 2007, ARTHRITIS RHEUM, V56, P2789, DOI 10.1002/art.22754; Martinez-Taboada VM, 2008, ANN RHEUM DIS, V67, P625, DOI 10.1136/ard.2007.082115; Mekinian A, 2012, RHEUMATOLOGY, V51, P882, DOI 10.1093/rheumatology/ker380; Molloy ES, 2008, ANN RHEUM DIS, V67, P1567, DOI 10.1136/ard.2008.093260; Nunes G, 2010, REV BRAS REUMATOL, V50, P295, DOI 10.1590/S0482-50042010000300009; Osman M, 2012, PROSPERO INT PROSPEC; Osman M, 2011, CLIN RHEUMATOL, V30, P703, DOI 10.1007/s10067-010-1658-1; Pipitone N, 2012, CLIN EXP RHEUMATOL, V30, pS139; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Salvarani C, 2012, RHEUMATOLOGY, V51, P151, DOI 10.1093/rheumatology/ker296; Schafer VS, 2012, CURR OPIN RHEUMATOL, V24, P31, DOI 10.1097/BOR.0b013e32834dc392; Schmidt J, 2012, ARTHRIT CARE RES, V64, P1079, DOI 10.1002/acr.21636; Sciascia S, 2011, J RHEUMATOL, V38, P2080, DOI 10.3899/jrheum.110496; Seida JC, 2010, ANN INTERN MED, V153, P246, DOI 10.7326/0003-4819-153-4-201008170-00263; Seitz M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13156; Seror R., 2013, ANN RHEUM DIS; Tezuka D, 2012, JACC-CARDIOVASC IMAG, V5, P422, DOI 10.1016/j.jcmg.2012.01.013; Tombetti E, 2013, J RHEUMATOL, V40, P2047, DOI 10.3899/jrheum.130536; Unizony S, 2012, ARTHRIT CARE RES, V64, P1720, DOI 10.1002/acr.21750; Unizony S, 2013, CURR OPIN RHEUMATOL, V25, P3, DOI 10.1097/BOR.0b013e32835b133a; Unizony SH, 2013, INT J RHEUMATOL, V2013, DOI 10.1155/2013/912562; Weyand CM, 2004, AUTOIMMUN REV, V3, P46, DOI 10.1016/S1568-9972(03)00064-8; Xenitidis T, 2013, RHEUMATOLOGY, V52, P1729, DOI 10.1093/rheumatology/ket107	48	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115026	10.1371/journal.pone.0115026	http://dx.doi.org/10.1371/journal.pone.0115026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517966	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600037
J	Wild, K; Scholz, M; Ropohl, A; Brauer, L; Paulsen, F; Burger, PHM				Wild, Katharina; Scholz, Michael; Ropohl, Axel; Braeuer, Lars; Paulsen, Friedrich; Burger, Pascal H. M.			Strategies against Burnout and Anxiety in Medical Education - Implementation and Evaluation of a New Course on Relaxation Techniques (Relacs) for Medical Students	PLOS ONE			English	Article							HEALTH; DEPRESSION; PREVALENCE	Burnout and stress-related mental disorders (depression, anxiety) occur in medical students and physicians with a significantly higher prevalence than in the general population. At the same time, the learning of coping mechanisms against stress is still not an integral part of medical education. In this pilot study we developed an elective course for learning relaxation techniques and examined the condition of the students before and after the course. 42 students participated in the semester courses in 2012 and 2013 as well as in a survey at the start and end of each course. The students were instructed in autogenic training (AT) and progressive muscle relaxation according to Jacobsen (PMR) with the goal of independent and regular exercising. At the beginning and the end of the semester/course the students were interviewed using standardized, validated questionnaires on burnout (BOSS-II) and anxiety (STAI-G), depression (BDI), quality of life (SF-12) and sense of coherence (SOC-L9). We compared the results of our students participating in Relacs with results from eight semester medical students (n=88), assessed with the same questionnaires at similar points of time within their semester. Participating students showed a significant decline in cognitive and emotional burnout stress and in trait anxiety. Furthermore, they showed a reduction in state anxiety and a conspicuous decrease in mean depression. The sense of coherence increased at the same time. A comparative cohort of medical students of 8th semester students, showed lower values for the specified measurement parameters at the beginning, but showed no progressive changes. Our course introducing AT and PMR led to a significant reduction of burnout and anxiety within the participating group of medical students. Even the course attendance for just one semester resulted in significant improvements in the evaluated parameters in contrast to those students who did not attend the course.	[Wild, Katharina; Scholz, Michael; Braeuer, Lars; Paulsen, Friedrich] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Ropohl, Axel; Burger, Pascal H. M.] Psychiat & Psychotherapeut Specialist Hosp Women, Hosp Meissenberg, Zug, Switzerland	University of Erlangen Nuremberg	Scholz, M (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	michael.scholz@fau.de		Paulsen, Friedrich/0000-0002-0527-0953; Scholz, Michael/0000-0001-8440-6785				Arigoni F, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13070; Arigoni F, 2009, SUPPORT CARE CANCER, V17, P75, DOI 10.1007/s00520-008-0465-6; Bailer J, 2008, PSYCHOTHER PSYCH MED, V58, P423, DOI 10.1055/s-2007-986293; Beck AT, 2009, BDI 2 BECK DEPRESSIO; BLANCHARD EB, 1991, J CONSULT CLIN PSYCH, V59, P467, DOI 10.1037/0022-006X.59.3.467; Buddeberg-Fischer B, 2009, Z PSYCHOSOM MED PSYC, V55, P37, DOI 10.13109/zptm.2009.55.1.37; Burger PHM, 2014, PSYCHOTHER IN PRESS; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P733, DOI 10.1007/s00103-013-1688-3; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; Dehghan-nayeri N, 2011, COMPLEMENT THER MED, V19, P194, DOI 10.1016/j.ctim.2011.06.002; Dyrbye LN, 2009, MED EDUC, V43, P274, DOI 10.1111/j.1365-2923.2008.03282.x; Dyrbye LN, 2005, MAYO CLIN PROC, V80, P1613, DOI 10.4065/80.12.1613; Hagemann W, 2009, BOSS BURNOUT SCREENI; Hyman SA, 2011, ANESTHESIOLOGY, V114, P194, DOI 10.1097/ALN.0b013e318201ce9a; Ishak W, 2013, CLIN TEACH, V10, P242, DOI 10.1111/tct.12014; Ishak Waguih William, 2009, J Grad Med Educ, V1, P236, DOI 10.4300/JGME-D-09-00054.1; Jurkat HB, 2011, NERVENARZT, V82, P646, DOI 10.1007/s00115-010-3039-z; Laux L, 1970, STATE TRAIT ANGST IN; Park CL, 2003, HEALTH PSYCHOL, V22, P627, DOI 10.1037/0278-6133.22.6.627; Prinz P., 2012, GMS Z MED AUSBILD, V29; Raskin, 2007, NERVENARZT S2, V78, P162; Saarschmidt UF, 2008, AVEM ARBEITSBEZOGENE, P31; Scholz M, 2014, PSYCHOTHER PSYCHOSOM; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Singer S., 2007, SENSE COHERENCE SCAL; Song QH, 2013, INT J CLIN EXP MED, V6, P979; Stetter F, 2002, APPL PSYCHOPHYS BIOF, V27, P45, DOI 10.1023/A:1014576505223; Thomas K., 2006, PRAXIS AUTOGENEN TRA; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Voltmer E, 2010, MED TEACH, V32, pE422, DOI 10.3109/0142159X.2010.496008; Warnecke E, 2011, MED EDUC, V45, P381, DOI 10.1111/j.1365-2923.2010.03877.x; Whitehouse WG, 1996, PSYCHOSOM MED, V58, P249, DOI 10.1097/00006842-199605000-00009	32	49	49	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114967	10.1371/journal.pone.0114967	http://dx.doi.org/10.1371/journal.pone.0114967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25517399	Green Submitted, Green Published, gold			2022-12-27	WOS:000347215600033
J	Cousijn, J; Koolschijn, PCMP; Zanolie, K; Kleibeuker, SW; Crone, EA				Cousijn, Janna; Koolschijn, P. Cedric M. P.; Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.			The Relation between Gray Matter Morphology and Divergent Thinking in Adolescents and Young Adults	PLOS ONE			English	Article							CORTICAL DEVELOPMENT; CREATIVE COGNITION; PREFRONTAL CORTEX; BRAIN MATURATION; REGIONAL GRAY; VOLUME; MEMORY; SPECIALIZATION; CONNECTIVITY; TRAJECTORIES	Adolescence and early adulthood are developmental time periods during which creative cognition is highly important for adapting to environmental changes. Divergent thinking, which refers to generating novel and useful solutions to open-ended problems, has often been used as a measure of creative cognition. The first goal of this structural neuroimaging study was to elucidate the relationship between gray matter morphology and performance in the verbal (AUT; alternative uses task) and visuo-spatial (CAT; creative ability test) domain of divergent thinking in adolescents and young adults. The second goal was to test if gray matter morphology is related to brain activity during AUT performance. Neural and behavioral data were combined from a cross-sectional study including 25 adolescents aged 15-17 and 20 young adults aged 25-30. Brain-behavior relationships were assessed without a priori location assumptions and within areas that were activated during an AUT-scanner task. Gray matter volume and cortical thickness were not significantly associated with verbal divergent thinking. However, visuo-spatial divergent thinking (CAT originality and fluency) was positively associated with cortical thickness of the right middle temporal gyrus and left brain areas including the superior frontal gyrus and various occipital, parietal, and temporal areas, independently of age. AUT brain activity was not associated with cortical thickness. The results support an important role of a widespread brain network involved in flexible visuo-spatial divergent thinking, providing evidence for a relation between cortical thickness and visuo-spatial divergent thinking in adolescents and young adults. However, studies including visuo-spatial divergent thinking tasks in the scanner are warranted.	[Cousijn, Janna; Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.] Leiden Univ, Brain & Dev Lab, Dept Psychol, Leiden, Netherlands; [Cousijn, Janna] Univ Utrecht, Dept Dev & Expt Psychol, Utrecht, Netherlands; [Koolschijn, P. Cedric M. P.] Univ Amsterdam, Dept Psychol, Dutch Autism & ADHD Res Ctr, Amsterdam, Netherlands; [Zanolie, Kiki; Kleibeuker, Sietske W.; Crone, Eveline A.] Leiden Inst Brain & Cognit, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University; University of Amsterdam; Leiden University; Leiden University Medical Center (LUMC)	Cousijn, J (corresponding author), Leiden Univ, Brain & Dev Lab, Dept Psychol, Leiden, Netherlands.	j.cousijn@gmail.com		Zanolie, Kiki/0000-0001-6101-1000; Koolschijn, P Cedric/0000-0002-0625-1447; Crone, Eveline/0000-0002-7508-6078; Cousijn, Janna/0000-0002-7699-2582	Netherlands Organisation for Scientific Research (NWO) [400-08-023]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant from The Netherlands Organisation for Scientific Research (NWO; open competition program; grant nr. 400-08-023) awarded to EAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00246; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; Arden R, 2010, BEHAV BRAIN RES, V214, P143, DOI 10.1016/j.bbr.2010.05.015; Aziz-Zadeh L, 2013, SOC COGN AFFECT NEUR, V8, P475, DOI 10.1093/scan/nss021; Baas M, 2014, PERS SOC PSYCHOL B, V40, P1092, DOI 10.1177/0146167214535813; BARRON F, 1981, ANNU REV PSYCHOL, V32, P439, DOI 10.1146/annurev.ps.32.020181.002255; Batey M, 2006, GENET SOC GEN PSYCH, V132, P355, DOI 10.3200/MONO.132.4.355-430; Benedek M, 2013, NEUROIMAGE; Brett M, 2002, NEUROIMAGE; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Cousijn J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105780; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; CSIKSZENTMIHALYI M, 1977, J YOUTH ADOLESCENCE, V6, P281, DOI 10.1007/BF02138940; Csikszentmihalyi M., 2001, BECOMING ADULT TEENA; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; De Dreu CKW, 2008, J PERS SOC PSYCHOL, V95, P648, DOI 10.1037/0022-3514.95.3.648; De Dreu CKW, 2014, SOC COGN AFFECT NEUR, V9, P1159, DOI 10.1093/scan/nst094; Dewhurst SA, 2011, PERS INDIV DIFFER, V51, P73, DOI 10.1016/j.paid.2011.03.018; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fink A, 2013, BRAIN STRUCT FUNCT; Fink A, 2010, NEUROIMAGE, V52, P1687, DOI 10.1016/j.neuroimage.2010.05.072; Fink A, 2009, HUM BRAIN MAPP, V30, P734, DOI 10.1002/hbm.20538; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franconeri SL, 2012, COGNITION, V122, P210, DOI 10.1016/j.cognition.2011.11.002; Gansier DA, 2011, NEUROPSYCHOLOGIA, V49, P2527, DOI 10.1016/j.neuropsychologia.2011.05.001; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; Hartley T, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00338; Herve PY, 2013, TRENDS COGN SCI, V17, P69, DOI 10.1016/j.tics.2012.12.004; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kim KH, 2008, J CREATIVE BEHAV, V42, P106, DOI 10.1002/j.2162-6057.2008.tb01290.x; Kleibeuker SW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00905; Kleibeuker SW, 2013, DEV COGN NEUROS-NETH, V5, P197, DOI 10.1016/j.dcn.2013.03.003; Kleibeuker SW, 2013, DEVELOPMENTAL SCI, V16, P2, DOI 10.1111/j.1467-7687.2012.01176.x; Koolschijn PCMP, 2013, DEV COGN NEUROS-NETH, V5, P106, DOI 10.1016/j.dcn.2013.02.003; Leech R., 2013, BRAIN; Lu LH, 2009, CEREB CORTEX, V19, P2595, DOI 10.1093/cercor/bhp011; Nijstad BA, 2010, EUR REV SOC PSYCHOL, V21, P34, DOI 10.1080/10463281003765323; Palmiero M, 2010, CREATIVITY RES J, V22, P369, DOI 10.1080/10400419.2010.523396; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Rietzschel EF, 2006, J EXP SOC PSYCHOL, V42, P244, DOI 10.1016/j.jesp.2005.04.005; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Sawyer K, 2011, CREATIVITY RES J, V23, P137, DOI 10.1080/10400419.2011.571191; Scharinger M, 2014, NEUROPSYCHOLOGIA, V53, P75, DOI 10.1016/j.neuropsychologia.2013.09.012; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Stevenson CE, 2014, FRONT HUM N IN PRESS; Takeuchi H, 2012, NEUROIMAGE, V59, P2899, DOI 10.1016/j.neuroimage.2011.09.064; Takeuchi H, 2010, NEUROIMAGE, V51, P578, DOI 10.1016/j.neuroimage.2010.02.078; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Tsapkini K, 2011, BRAIN, V134, P3094, DOI 10.1093/brain/awr050; Van Dam A. G., 2006, CAT CREATIEVE AANLEG; Van Wesel F, 2006, CREATIEVE AANLEG TES; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wei DT, 2014, CORTEX, V51, P92, DOI 10.1016/j.cortex.2013.09.004; Witter MP, 2000, HIPPOCAMPUS, V10, P398; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhu FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079272	68	15	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114619	10.1371/journal.pone.0114619	http://dx.doi.org/10.1371/journal.pone.0114619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514366	gold, Green Published			2022-12-27	WOS:000349146300018
J	Hanski, L; Genina, N; Uvell, H; Malinovskaja, K; Gylfe, A; Laaksonen, T; Kolakovic, R; Makila, E; Salonen, J; Hirvonen, J; Elofsson, M; Sandler, N; Vuorela, PM				Hanski, Leena; Genina, Natalja; Uvell, Hanna; Malinovskaja, Kristina; Gylfe, Asa; Laaksonen, Timo; Kolakovic, Ruzica; Makila, Ermei; Salonen, Jarno; Hirvonen, Jouni; Elofsson, Mikael; Sandler, Niklas; Vuorela, Pia M.			Inhibitory Activity of the Isoflavone Biochanin A on Intracellular Bacteria of Genus Chlamydia and Initial Development of a Buccal Formulation	PLOS ONE			English	Article							FAST DISSOLVING FILMS; RED-CLOVER; REPLACEMENT THERAPY; PHENOLIC-COMPOUNDS; CACO-2 CELLS; STRAIN TWAR; IN-VITRO; PNEUMONIAE; TRACHOMATIS; PHARMACOKINETICS	Given the established role of Chlamydia spp. as causative agents of both acute and chronic diseases, search for new antimicrobial agents against these intracellular bacteria is required to promote human health. Isoflavones are naturally occurring phytoestrogens, antioxidants and efflux pump inhibitors, but their therapeutic use is limited by poor water-solubility and intense first-pass metabolism. Here, we report on effects of isoflavones against C. pneumoniae and C. trachomatis and describe buccal permeability and initial formulation development for biochanin A. Biochanin A was the most potent Chlamydia growth inhibitor among the studied isoflavones, ;with an IC50=12 mu M on C. pneumoniae inclusion counts and 6.5 mu M on infectious progeny production, both determined by immunofluorescent staining of infected epithelial cell cultures. Encouraged by the permeation of biochanin A across porcine buccal mucosa without detectable metabolism, oromucosal film formulations were designed and prepared by a solvent casting method. The film formulations showed improved dissolution rate of biochanin A compared to powder or a physical mixture, presumably due to the solubilizing effect of hydrophilic additives and presence of biochanin A in amorphous state. In summary, biochanin A is a potent inhibitor of Chlamydia spp., and the in vitro dissolution results support the use of a buccal formulation to potentially improve its bioavailability in antichlamydial or other pharmaceutical applications.	[Hanski, Leena; Vuorela, Pia M.] Univ Helsinki, Fac Pharm, CDR, Div Pharmaceut Biosci, Helsinki, Finland; [Genina, Natalja; Kolakovic, Ruzica; Sandler, Niklas] Abo Akad Univ, Pharmaceut Sci Lab, Dept Biosci, Turku, Finland; [Uvell, Hanna] Umea Univ, Labs Chem Biol, Umea, Sweden; [Malinovskaja, Kristina; Laaksonen, Timo; Hirvonen, Jouni] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Gylfe, Asa] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Gylfe, Asa; Elofsson, Mikael] Umea Univ, Umea Ctr Microbial Res, Umea, Sweden; [Gylfe, Asa; Elofsson, Mikael] Umea Univ, Lab Mol Infect Med, Umea, Sweden; [Makila, Ermei; Salonen, Jarno] Univ Turku, Dept Phys & Astron, Lab Ind Phys, Turku, Finland; [Elofsson, Mikael] Umea Univ, Dept Chem, Umea, Sweden	University of Helsinki; Abo Akademi University; Umea University; University of Helsinki; Umea University; Umea University; Umea University; University of Turku; Umea University	Vuorela, PM (corresponding author), Univ Helsinki, Fac Pharm, CDR, Div Pharmaceut Biosci, Helsinki, Finland.	pia.vuorela@helsinki.fi	Hanski, Leena/AAD-5096-2019; Laaksonen, Timo J/C-7141-2009	Hanski, Leena/0000-0002-3121-8542; Genina, Natalja/0000-0002-9947-6900; Hirvonen, Jouni Tapio/0000-0002-5029-1657; Laaksonen, Timo/0000-0002-6699-3004; Elofsson, Mikael/0000-0002-3219-4669; Makila, Ermei/0000-0002-8300-6533	Academy of Finland [252216, 258114, 264988]; Tor, Joe och Pentti Borgs minnesfond grants; Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland; Knut & Alice Wallenberg Foundation; Swedish Research Council; Vinnova	Academy of Finland(Academy of Finland); Tor, Joe och Pentti Borgs minnesfond grants; Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland; Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova)	This work has been funded by Academy of Finland grants 252216 (LH), 258114 and 264988 (TL and KM), by Tor, Joe och Pentti Borgs minnesfond grants (LH and PV), as well as by support from the Drug Discovery and Chemical Biology (DDCB) network of Biocenter Finland to PV. ME, HU and AG are grateful for financial support from the Knut & Alice Wallenberg Foundation, the Swedish Research Council and Vinnova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvesalo J, 2006, BIOCHEM PHARMACOL, V71, P735, DOI 10.1016/j.bcp.2005.12.006; Alvesalo JKO, 2006, J MED CHEM, V49, P2353, DOI 10.1021/jm051209w; Alvesalo J, 2008, J INFECT DIS, V197, P156, DOI 10.1086/524142; Arya A., 2010, INT J CHEMTECH RES, V2, P576; Balin BJ, 1998, MED MICROBIOL IMMUN, V187, P23, DOI 10.1007/s004300050071; Beck VB, 2005, J STEROID BIOCHEM, V94, P499, DOI 10.1016/j.jsbmb.2004.12.038; Bhosai SJ, 2012, CURR OPIN OPHTHALMOL, V23, P288, DOI 10.1097/ICU.0b013e32835438fc; Busby MG, 2002, AM J CLIN NUTR, V75, P126, DOI 10.1093/ajcn/75.1.126; CHIRGWIN K, 1989, ANTIMICROB AGENTS CH, V33, P1634, DOI 10.1128/AAC.33.9.1634; Cilurzo F, 2008, EUR J PHARM BIOPHARM, V70, P895, DOI 10.1016/j.ejpb.2008.06.032; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Dean D, 2009, DRUG TODAY, V45, P25; Dinge A, 2008, AAPS PHARMSCITECH, V9, P349, DOI 10.1208/s12249-008-9047-7; Dixit RP, 2009, J CONTROL RELEASE, V139, P94, DOI 10.1016/j.jconrel.2009.06.014; Dornstauder E, 2001, J STEROID BIOCHEM, V78, P67, DOI 10.1016/S0960-0760(01)00075-9; EKMAN MR, 1993, CLIN INFECT DIS, V17, P420, DOI 10.1093/clinids/17.3.420; Gieffers J, 2001, CIRCULATION, V103, P351; Hadfield TL, 1995, MODERN PATHOL, V8, P924; Hahn DL, 2002, FRONT BIOSCI-LANDMRK, V7, pE66, DOI 10.2741/hahn; Hammerschlag Margaret R, 2002, Semin Pediatr Infect Dis, V13, P239, DOI 10.1053/spid.2002.127201; Han HK, 2011, INT J PHARMACEUT, V415, P89, DOI 10.1016/j.ijpharm.2011.05.055; Hoffmann EM, 2011, EXPERT OPIN DRUG DEL, V8, P299, DOI 10.1517/17425247.2011.553217; Hu M, 2003, DRUG METAB DISPOS, V31, P924, DOI 10.1124/dmd.31.7.924; Jia XB, 2004, J PHARMACOL EXP THER, V310, P1103, DOI 10.1124/jpet.104.068403; Kabir M.A., 2009, HDB PHARM EXCIPIENTS, P317; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kibbe AH, 2009, HDB PHARM EXCIPIENTS, P208; Krenn L, 2002, J CHROMATOGR B, V777, P123, DOI 10.1016/S1570-0232(02)00079-X; KUO CC, 1990, J INFECT DIS, V162, P755, DOI 10.1093/infdis/162.3.755; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Leinonen M, 2002, LANCET INFECT DIS, V2, P11, DOI 10.1016/S1473-3099(01)00168-2; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Maass M, 1998, J AM COLL CARDIOL, V31, P827, DOI 10.1016/S0735-1097(98)00016-3; Marwaha S, 2014, ANTIMICROB AGENTS CH, V58, P2968, DOI 10.1128/AAC.02015-13; Morales JO, 2011, EUR J PHARM BIOPHARM, V77, P187, DOI 10.1016/j.ejpb.2010.11.023; Morel C, 2003, J AGR FOOD CHEM, V51, P5677, DOI 10.1021/jf0302714; Nicolazzo Joseph A., 2008, V7, P89; Peng SX, 2006, J PHARM SCI-US, V95, P1984, DOI 10.1002/jps.20664; Preis M, 2013, EXPERT OPIN DRUG DEL, V10, P1303, DOI 10.1517/17425247.2013.804058; Salin O, 2011, J AGR FOOD CHEM, V59, P12836, DOI 10.1021/jf2032473; Setchell KDR, 2001, J NUTR, V131, p1362S, DOI 10.1093/jn/131.4.1362S; Shima K, 2011, ANTIMICROB AGENTS CH, V55, P2319, DOI 10.1128/AAC.01655-10; Shima K, 2010, MED MICROBIOL IMMUN, V199, P283, DOI 10.1007/s00430-010-0162-1; Steiner C, 2008, BRIT J NUTR, V99, pES78, DOI 10.1017/S0007114508965788; Tammela P, 2004, ARCH BIOCHEM BIOPHYS, V425, P193, DOI 10.1016/j.abb.2004.03.023; Ullah MF, 2009, MOL NUTR FOOD RES, V53, P1376, DOI 10.1002/mnfr.200800547; Ur-Rehman T, 2012, J ANTIBIOT, V65, P397, DOI 10.1038/ja.2012.43; Wei P, 2012, ASIAN PAC J TROP MED, V5, P243, DOI 10.1016/S1995-7645(12)60033-9; Young P. M., 2009, HDB PHARM EXCIPIENTS, P663; Zhang SZ, 2003, PHARMACEUT RES, V20, P1184, DOI 10.1023/A:1025044913766	51	29	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115115	10.1371/journal.pone.0115115	http://dx.doi.org/10.1371/journal.pone.0115115			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514140	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300033
J	Harel, L; Gefen, N; Carmi, O; Orbach, P; Einat, P; Abitbol, G				Harel, Liraz; Gefen, Nir; Carmi, Ofira; Orbach, Pini; Einat, Paz; Abitbol, Guy			Novel Expression Vectors Enabling Induction of Gene Expression by Small-Interfering RNAs and MicroRNAs	PLOS ONE			English	Article							LARGE T-ANTIGEN; DIPHTHERIA-TOXIN; TRANSGENE EXPRESSION; EUKARYOTIC RIBOSOMES; THERAPY; CANCER; EFFICIENCY; CARCINOMA; UPSTREAM; GENOMICS	Small-interfering RNAs and microRNAs are small similar to 21-22 nucleotide long RNAs capable of posttranscriptional suppression of gene expression. The synthetic siRNAs are especially designed to target pre-specified genes and are common molecular biology tools. The miRNAs are endogenous regulators of gene expression found in a wide variety of eukaryotes. miRNAs are currently utilized for diagnostics applications. Therapeutically, various miRNA-antagonizing tools are being explored and miRNAs are also utilized for cell-specific inhibition of the expression of gene therapy vectors harboring target sites for specific miRNAs. Here we show, for the first time, that siRNAs and miRNAs can be harnessed to induce gene expression. We designed special expression vectors in which target sites for artificial siRNAs or endogenous miRNAs are located between the transgene and an Upstream Inhibitory Region (UIR). We hypothesized that cleavage of the mRNA by siRNAs or miRNAs will separate the transgene from the UIR and the resulting uncapped mRNA will be capable of being translated. A UIR composed of seven open reading frames was found to be the most efficient inhibitor of the translation of the downstream transgene. We show that under such a configuration both artificial siRNAs and endogenous miRNAs were capable of inducing transgene expression. We show that using the diphtheria toxin A-chain gene, in combination with target sites for highly expressed miRNAs, specific induction of cell-death can be achieved, setting the stage for application to cancer therapy.	[Harel, Liraz; Gefen, Nir; Carmi, Ofira; Orbach, Pini; Abitbol, Guy] Nanodoc Biotechnol, IL-7403630 Ness Ziona, Israel; [Einat, Paz] Dr Paz Einat Biotechnol Projects & Consulting, IL-74207 Ness Ziona, Israel		Einat, P (corresponding author), Nanodoc Biotechnol, 7 Sapir Str, IL-7403630 Ness Ziona, Israel.	paz@pazeinat.com			Nanodoc Biotechnology	Nanodoc Biotechnology	The research was funded by Nanodoc Biotechnology funds through private funding by Mr. Moshe Arkin, holder of the majority of the shares. Nanodoc Biotechnology provided support in the form of salaries for authors GA, PO, OC, NG, and LH. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders had a role in the decision to publish. PE is employed by "Dr. Paz Einat Biotechnology Projects & Consulting" and has been a paid consultant for the company with a role in experimental design, data analysis and writing the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Black JH, 2003, LEUKEMIA, V17, P155, DOI 10.1038/sj.leu.2402744; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; COLLIER RJ, 1971, J BIOL CHEM, V246, P1496; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Eliasz S, 2007, ONCOL REV, V1, P131, DOI 10.1007/s12156-007-0015-3; Ferreira JP, 2013, P NATL ACAD SCI USA, V110, P11284, DOI 10.1073/pnas.1305590110; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; GILL DM, 1971, J BIOL CHEM, V246, P1485; Gofrit ON, 2013, J UROL; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lachmann N, 2012, GENE THER, V19, P915, DOI 10.1038/gt.2011.148; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ohana P, 2002, INT J CANCER, V98, P645, DOI 10.1002/ijc.10243; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Ziegelbauer JM, 2014, CURR OPIN VIROL, V7, P33, DOI 10.1016/j.coviro.2014.03.014	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115327	10.1371/journal.pone.0115327	http://dx.doi.org/10.1371/journal.pone.0115327			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514749	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300053
J	Leon, G; Sanchez-Ruiloba, L; Perez-Rodriguez, A; Gragera, T; Martinez, N; Hernandez, S; Anta, B; Calero, O; Garcia-Dominguez, CA; Dura, LM; Pena-Jimenez, D; Castro, J; Zarich, N; Sanchez-Gomez, P; Calero, M; Iglesias, T; Oliva, JL; Rojas, JM				Leon, Gonzalo; Sanchez-Ruiloba, Lucia; Perez-Rodriguez, Andrea; Gragera, Teresa; Martinez, Natalia; Hernandez, Silvia; Anta, Berta; Calero, Olga; Garcia-Dominguez, Carlota A.; Dura, Lara M.; Pena-Jimenez, Daniel; Castro, Judit; Zarich, Natasha; Sanchez-Gomez, Pilar; Calero, Miguel; Iglesias, Teresa; Oliva, Jose L.; Rojas, Jose M.			Shoc2/Sur8 Protein Regulates Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; KINASE ACTIVATION; SCAFFOLD PROTEINS; RAS; DIFFERENTIATION; PATHWAY; COMPLEX; CELLS; SUR-8; INHIBITION	The Shoc2 protein has been implicated in the positive regulation of the Ras-ERK pathway by increasing the functional binding interaction between Ras and Raf, leading to increased ERK activity. Here we found that Shoc2 overexpression induced sustained ERK phosphorylation, notably in the case of EGF stimulation, and Shoc2 knockdown inhibited ERK activation. We demonstrate that ectopic overexpression of human Shoc2 in PC12 cells significantly promotes neurite extension in the presence of EGF, a stimulus that induces proliferation rather than differentiation in these cells. Finally, Shoc2 depletion reduces both NGF-induced neurite outgrowth and ERK activation in PC12 cells. Our data indicate that Shoc2 is essential to modulate the Ras-ERK signaling outcome in cell differentiation processes involved in neurite outgrowth.	[Leon, Gonzalo; Perez-Rodriguez, Andrea; Gragera, Teresa; Martinez, Natalia; Hernandez, Silvia; Anta, Berta; Garcia-Dominguez, Carlota A.; Dura, Lara M.; Pena-Jimenez, Daniel; Castro, Judit; Zarich, Natasha; Oliva, Jose L.; Rojas, Jose M.] Inst Salud Carlos III, Unidad Biol Celular, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain; [Sanchez-Ruiloba, Lucia; Iglesias, Teresa] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Sanchez-Ruiloba, Lucia; Calero, Olga; Calero, Miguel; Iglesias, Teresa] CIBERNED, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Calero, Olga; Calero, Miguel] Inst Salud Carlos III, Unidad Encefalopatias Espongiformes, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain; [Sanchez-Gomez, Pilar] Inst Salud Carlos III, Unidad Neurooncol, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain	Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED; Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC); Instituto de Salud Carlos III; Unidad Funcional de Investigacion de Enfermedades Cronicas (UFIEC)	Oliva, JL (corresponding author), Inst Salud Carlos III, Unidad Biol Celular, Unidad Func Invest Enfermedades Cron, Madrid 28220, Spain.	jloliva@isciii.es; jmrojas@isciii.es	Vacas, Teresa Iglesias/ABF-8663-2020; Rojas, José M/D-3718-2018; Rojas, José M./AAA-3354-2021; LEON ESPINOSA, GONZALO/I-4135-2015; Calero, Miguel/H-5691-2015; Sánchez-Gómez, Pilar/K-8256-2014	Vacas, Teresa Iglesias/0000-0002-4326-9005; Rojas, José M/0000-0002-5383-3482; Rojas, José M./0000-0002-7547-2825; LEON ESPINOSA, GONZALO/0000-0002-9921-2614; Calero, Miguel/0000-0001-5366-3324; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Pena-Jimenez, Daniel/0000-0002-3192-464X; Zarich, Natasha/0000-0003-1058-6191; Sanchez-Ruiloba, Lucia/0000-0001-5418-2290	Ministerio de Educacion y Ciencia (MEC); Fondo de Investigaciones Sanitarias (FIS); CIBERNED [SAF2008-01951]; FIS [PI10/00815, PI12/00775, PI09/0562, PI13/00703]; Comunidad Autonoma de Madrid (CAM) [S-SAL-0202-2006-01]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer) [RD12/0036/0027]; Instituto de Salud Carlos III; ISCIII-RETIC [RD06/0020/0003, RD12/0036/0021]; Spanish Association Against Cancer (AECC)	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); CIBERNED(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid (CAM)(Comunidad de Madrid); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer)(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII-RETIC(Instituto de Salud Carlos III); Spanish Association Against Cancer (AECC)	GL, TG and LMD were recipients of fellowships from the Ministerio de Educacion y Ciencia (MEC) (to GL, TG), and Fondo de Investigaciones Sanitarias (FIS) (to LMD). LSR held a postdoctoral research contract from CIBERNED. This work was supported by FIS grant (PI10/00815) to JLO; CIBERNED to MC; SAF2008-01951, Comunidad Autonoma de Madrid (CAM) S-SAL-0202-2006-01 and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) to TI; FIS grant PI12/00775 and ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer) RD12/0036/0027 from the Instituto de Salud Carlos III to PSG; and FIS grants (PI09/0562 and PI13/00703), ISCIII-RETIC (RD06/0020/0003 and RD12/0036/0021), and the Spanish Association Against Cancer (AECC) to JMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo AN, 2002, J BIOL CHEM, V277, P5940, DOI 10.1074/jbc.M110498200; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cesarini L, 2009, AM J MED GENET A, V149A, P140, DOI 10.1002/ajmg.a.32488; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Ferron SR, 2010, CELL STEM CELL, V7, P367, DOI 10.1016/j.stem.2010.06.021; Galperin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036469; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Harmon RM, 2013, J CLIN INVEST, V123, P1556, DOI 10.1172/JCI65220; Izawa I, 2008, GENES CELLS, V13, P691, DOI 10.1111/j.1365-2443.2008.01198.x; Jeoung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066067; Jung GA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-66; Kaplan FM, 2012, J BIOL CHEM, V287, P41797, DOI 10.1074/jbc.M112.390906; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li WQ, 2000, GENE DEV, V14, P895; Martinez N, 2007, CELL SIGNAL, V19, P2277, DOI 10.1016/j.cellsig.2007.07.008; Matsunaga-Udagawa R, 2010, J BIOL CHEM, V285, P7818, DOI 10.1074/jbc.M109.053975; Moon BS, 2011, STEM CELLS, V29, P320, DOI 10.1002/stem.586; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rojas Jose M., 2002, Current Genomics, V3, P295, DOI 10.2174/1389202023350381; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yi J, 2010, DEV DYNAM, V239, P2005, DOI 10.1002/dvdy.22343; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Young LC, 2013, MOL CELL, V52, P679, DOI 10.1016/j.molcel.2013.10.004; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104; Zeke A, 2009, TRENDS CELL BIOL, V19, P364, DOI 10.1016/j.tcb.2009.05.007	46	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114837	10.1371/journal.pone.0114837	http://dx.doi.org/10.1371/journal.pone.0114837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514808	Green Published, gold			2022-12-27	WOS:000349146300022
J	Leydon, C; Imaizumi, M; Bartlett, RS; Wang, SF; Thibeault, SL				Leydon, Ciara; Imaizumi, Mitsuyoshi; Bartlett, Rebecca S.; Wang, Sarah F.; Thibeault, Susan L.			Epithelial Cells Are Active Participants in Vocal Fold Wound Healing: An In Vivo Animal Model of Injury	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; EGF-RECEPTOR; SCAR FORMATION; FACTOR-BETA; TGF-ALPHA; VITRO; REGENERATION; ACTIVATION; EXPRESSION; REPAIR	Vocal fold epithelial cells likely play an important, yet currently poorly defined, role in healing following injury, irritation and inflammation. In the present study, we sought to identify a possible role for growth factors, epidermal growth factor (EGF) and transforming growth factor-beta 1 (TGF beta 1), in epithelial regeneration during wound healing as a necessary first step for uncovering potential signaling mechanisms of vocal fold wound repair and remodeling. Using a rat model, we created unilateral vocal fold injuries and examined the timeline for epithelial healing and regeneration during early and late stages of wound healing using immunohistochemistry (IHC). We observed time-dependent secretion of the proliferation marker, ki67, growth factors EGF and TGF beta 1, as well as activation of the EGF receptor (EGFR), in regenerating epithelium during the acute phase of injury. Ki67, growth factor, and EGFR expression peaked at day 3 post-injury. Presence of cytoplasmic and intercellular EGF and TGF beta 1 staining occurred up to 5 days post-injury, consistent with a role for epithelial cells in synthesizing and secreting these growth factors. To confirm that epithelial cells contributed to the cytokine secretion, we examined epithelial cell growth factor secretion in vitro using polymerase chain reaction (PCR). Cultured pig vocal fold epithelial cells expressed both EGF and TGF beta 1. Our in vivo and in vitro findings indicate that epithelial cells are active participants in the wound healing process. The exact mechanisms underlying their roles in autocrine and paracrine signaling guiding wound healing await study in a controlled, in vitro environment.	[Leydon, Ciara; Imaizumi, Mitsuyoshi; Bartlett, Rebecca S.; Wang, Sarah F.; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Leydon, C (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA.	leydonc@sacredheart.edu	Leydon, Ciara/AAW-7151-2021; Imaizumi, Mitsuyosi/Y-6253-2019		National Institutes of Health National Institute of Deafness and Other Communication Disorders DC [R03 DC011355, R01 DC012773]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC011355, R01DC012773] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Deafness and Other Communication Disorders DC; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health National Institute of Deafness and Other Communication Disorders DC R03 DC011355 (CL) and R01 DC012773 (ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19, DOI 10.1177/000348940511400105; Branski RC, 2009, ANN OTO RHINOL LARYN, V118, P218, DOI 10.1177/000348940911800310; Chang Z, 2014, DIS MODEL MECH, V7, P83, DOI 10.1242/dmm.013326; Cohen SM, 2005, ANN OTO RHINOL LARYN, V114, P296, DOI 10.1177/000348940511400408; Dupuit F, 2000, AM J PHYSIOL-LUNG C, V278, pL165, DOI 10.1152/ajplung.2000.278.1.L165; Erickson-DiRenzo E, METHOD PORCINE UNPUB; Hirano S, 2003, ANN OTO RHINOL LARYN, V112, P966; Imaizumi I, 2014, LARYNGOSCOP IN PRESS; Ip WK, 2007, IMMUNOLOGY, V122, P532, DOI 10.1111/j.1365-2567.2007.02668.x; Krecicki T, 1999, ORAL ONCOL, V35, P180, DOI 10.1016/S1368-8375(98)00100-6; Krishna P, 2010, LARYNGOSCOPE, V120, P2247, DOI 10.1002/lary.21087; Kutta H, 2002, ANAT EMBRYOL, V205, P315, DOI 10.1007/s00429-002-0255-8; Lee CS, 1996, AUST NZ J SURG, V66, P464, DOI 10.1111/j.1445-2197.1996.tb00783.x; Leydon C, 2013, TISSUE ENG PT A, V19, P2233, DOI [10.1089/ten.tea.2012.0744, 10.1089/ten.TEA.2012.0744]; Leydon C, 2011, J SPEECH LANG HEAR R, V54, P1060, DOI 10.1044/1092-4388(2010/10-0267); Leydon C, 2009, J VOICE, V23, P658, DOI 10.1016/j.jvoice.2008.03.010; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Ohno S, 2012, LARYNGOSCOPE, V122, P583, DOI 10.1002/lary.22389; Ohno T, 2009, LARYNGOSCOPE, V119, P806, DOI 10.1002/lary.20174; Popovic N, 2009, AM J PHYSIOL-HEART C, V297, pH2044, DOI 10.1152/ajpheart.01015.2008; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x; Rousseau B, 2004, ANN OTO RHINOL LARYN, V113, P767, DOI 10.1177/000348940411301001; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Semlali A, 2010, ALLERGY, V65, P1438, DOI 10.1111/j.1398-9995.2010.02376.x; Suzuki T, 2002, ANN OTO RHINOL LARYN, V111, P684, DOI 10.1177/000348940211100805; Taipale J, 1997, FASEB J, V11, P51, DOI 10.1096/fasebj.11.1.9034166; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; VAUGHAN TJ, 1992, DEVELOPMENT, V116, P663; Wang ZF, 2003, J AM SOC NEPHROL, V14, P3147, DOI 10.1097/01.ASN.0000098681.56240.1A; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145, DOI 10.1177/000348940811700213; Wilson SE, 1999, EXP EYE RES, V68, P377, DOI 10.1006/exer.1998.0603; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1756; Xu YR, 2010, MOL BIOL CELL, V21, P29, DOI 10.1091/mbc.E09-08-0710; Zieske JD, 2000, INVEST OPHTH VIS SCI, V41, P1346; Znalesniak EB, 2010, CELL PHYSIOL BIOCHEM, V25, P533, DOI 10.1159/000303057	41	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115389	10.1371/journal.pone.0115389	http://dx.doi.org/10.1371/journal.pone.0115389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514022	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300056
J	Lai, YQ; Shi, LW; Lin, Q; Fu, LR; Ha, HM				Lai, Youqun; Shi, Liwan; Lin, Qin; Fu, Lirong; Ha, Huiming			Planning Study of Flattening Filter Free Beams for Volumetric Modulated Arc Therapy in Squamous Cell Carcinoma of the Scalp	PLOS ONE			English	Article							RADIATION-THERAPY; PROSTATE-CANCER; STEREOTACTIC RADIOTHERAPY; PHOTON BEAMS; IRRADIATION; TOMOTHERAPY; IMRT	Purpose: Flattening filter free (FFF) beams show the potential for a higher dose rate and lower peripheral dose. We investigated the planning study of FFF beams with their role for volumetric modulated arc therapy (VMAT) in squamous cell carcinoma of the scalp. Methods and Materials: One patient with squamous cell carcinoma which had involvement of entire scalp was subjected to VMAT using TrueBeam linear accelerator. As it was a rare skin malignancy, CT data of 7 patients with brain tumors were also included in this study, and their entire scalps were outlined as target volumes. Three VMAT plans were employed with RapidArc form: two half field full-arcs VMAT using 6 MV standard beams (HFF-VMAT-FF), eight half-field quarter-arcs VMAT using 6 MV standard beams (HFQ-VMAT-FF), and HFQ-VMAT using FFF beams (HFQ-VMAT-FFF). Prescribed dose was 25x2 Gy (50 Gy). Plan quality and efficiency were assessed for all plans. Results: There were no statistically significant differences among the three VMAT plans in target volume coverage, conformity, and homogeneity. For HFQ-VMAT-FF plans, there was a significant decrease by 12.6% in the mean dose to the brain compared with HFF-VMAT-FF. By the use of FFF beams, the mean dose to brain in HFQ-VMAT-FFF plans was further decreased by 7.4% compared with HFQ-VMATFF. Beam delivery times were similar for each technique. Conclusions: The HFQ-VMAT-FF plans showed the superiority in dose distributions compared with HFF-VMAT-FF. HFQ-VMAT-FFF plans might provide further normal tissue sparing, particularly in the brain, showing their potential for radiation therapy in squamous cell carcinoma of the scalp.	[Lai, Youqun; Shi, Liwan; Lin, Qin; Fu, Lirong; Ha, Huiming] Xiamen Univ, Dept Radiat Oncol, Affiliated Hosp 1, Xiamen, Peoples R China	Xiamen University	Lin, Q (corresponding author), Xiamen Univ, Dept Radiat Oncol, Affiliated Hosp 1, Xiamen, Peoples R China.	linqin05@163.com						Alongi F, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-171; Della Biancia C, 2011, INT J RADIAT ONCOL, V81, pS908, DOI 10.1016/j.ijrobp.2011.06.1632; Georg D, 2011, MED PHYS, V38, P1280, DOI 10.1118/1.3554643; Hall WA, 2013, J AM COLL RADIOL, V10, P128, DOI 10.1016/j.jacr.2012.06.014; Hrbacek J, 2011, INT J RADIAT ONCOL, V80, P1228, DOI 10.1016/j.ijrobp.2010.09.050; Kuo YC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-76; Lang S, 2013, RADIOTHER ONCOL, V106, P255, DOI 10.1016/j.radonc.2012.12.012; Lu SH, 2012, RADIOTHER ONCOL, V104, P324, DOI 10.1016/j.radonc.2011.11.017; Murao K, 2011, EUR J DERMATOL, V21, P1005, DOI 10.1684/ejd.2011.1520; Ong CL, 2013, INT J RADIAT ONCOL, V86, P743, DOI 10.1016/j.ijrobp.2013.03.038; Ong CL, 2010, RADIOTHER ONCOL, V97, P437, DOI 10.1016/j.radonc.2010.09.027; Pipitone MA, 2006, DERMATOL SURG, V32, P756, DOI 10.1111/j.1524-4725.2006.32153.x; Reggiori G, 2012, MED PHYS, V39, P1112, DOI 10.1118/1.3679858; Ronel DN, 2004, DERMATOL SURG, V30, P446, DOI 10.1111/j.1524-4725.2004.30123.x; Song J., 2014, J NANOMATER, P1; Spruijt KH, 2013, INT J RADIAT ONCOL, V85, P506, DOI 10.1016/j.ijrobp.2012.03.040; Stieler F, 2013, RADIOTHER ONCOL, V109, P448, DOI 10.1016/j.radonc.2013.10.017; Wojcicka JB, 2009, RADIOTHER ONCOL, V91, P255, DOI 10.1016/j.radonc.2008.09.022; Yang RJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-515; Zwahlen DR, 2012, INT J RADIAT ONCOL, V83, P1655, DOI 10.1016/j.ijrobp.2011.10.019	20	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114953	10.1371/journal.pone.0114953	http://dx.doi.org/10.1371/journal.pone.0114953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506701	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100036
J	Vassar, RL; Barnea-Goraly, N; Rose, J				Vassar, Rachel L.; Barnea-Goraly, Naama; Rose, Jessica			Identification of Neonatal White Matter on DTI: Influence of More Inclusive Thresholds for Atlas Segmentation	PLOS ONE			English	Article							MICROSTRUCTURAL DEVELOPMENT; BRAIN-DEVELOPMENT; HUMAN FETAL; DIFFUSION; MRI; MATURATION; INFANTS; AGE	Purpose: Semi-automated diffusion tensor imaging (DTI) analysis of white matter (WM) microstructure offers a clinically feasible technique to assess neonatal brain development and provide early prognosis, but is limited by variable methods and insufficient evidence regarding optimal parameters. The purpose of this research was to investigate the influence of threshold values on semi-automated, atlas-based brain segmentation in very-low-birth-weight (VLBW) preterm infants at nearterm age. Materials and Methods: DTI scans were analyzed from 45 VLBW preterm neonates at near-term-age with no brain abnormalities evident on MRI. Brain regions were selected with a neonatal brain atlas and threshold values: trace<0.006 mm(2)/s, fractional anisotropy (FA)>0.15, FA>0.20, and FA>0.25. Relative regional volumes, FA, axial diffusivity (AD), and radial diffusivity (RD) were compared for twelve WM regions. Results: Near-term brain regions demonstrated differential effects from segmentation with the three FA thresholds. Regional DTI values and volumes selected in the PLIC, CereP, and RLC varied the least with the application of different FA thresholds. Overall, application of higher FA thresholds significantly reduced brain region volume selected, increased variability, and resulted in higher FA and lower RD values. The lower threshold FA>0.15 selected 78 +/- 21% of original volumes segmented by the atlas, compared to 38 +/- 12% using threshold FA>0.25. Conclusion: Results indicate substantial and differential effects of atlas-based DTI threshold parameters on regional volume and diffusion scalars. A lower, more inclusive FA threshold than typically applied for adults is suggested for consistent analysis of WM regions in neonates.	[Vassar, Rachel L.; Barnea-Goraly, Naama; Rose, Jessica] Stanford Univ, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA; [Vassar, Rachel L.; Barnea-Goraly, Naama; Rose, Jessica] Stanford Univ, Sch Med, Neonatal Neuroimaging Lab, Stanford, CA 94305 USA; [Barnea-Goraly, Naama] Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Vassar, RL (corresponding author), Stanford Univ, Dept Orthopaed Surg, Sch Med, Stanford, CA 94305 USA.	rvassar@stanford.edu			NIH Clinical and Translational Science Award [1UL1 RR025744]; Lucile Packard Foundation for Children's Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	NIH Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is supported in part by the NIH Clinical and Translational Science Award 1UL1 RR025744 for the Stanford Center for Clinical and Translational Education and Research (Spectrum) (http://www.ncats.nih.gov/research/cts/ctsa/ctsa. html) and by the Lucile Packard Foundation for Children's Health (http://lpfch.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J PEDIATR-US, V156, P882, DOI 10.1016/j.jpeds.2009.12.030; Aeby A, 2013, NEUROIMAGE, V78, P145, DOI 10.1016/j.neuroimage.2013.03.076; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Benini R, 2013, J PEDIATR-US, V162, P369, DOI 10.1016/j.jpeds.2012.07.044; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Heemskerk AM, 2013, AM J NEURORADIOL, V34, P1496, DOI 10.3174/ajnr.A3465; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Huang H, 2009, J NEUROSCI, V29, P4263, DOI 10.1523/JNEUROSCI.2769-08.2009; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Lee AY, 2013, PEDIATR RADIOL, V43, P612, DOI 10.1007/s00247-012-2545-5; Loh KB, 2012, EUR RADIOL, V22, P1413, DOI 10.1007/s00330-012-2396-3; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Rose J, 2007, DEV MED CHILD NEUROL, V49, P745, DOI 10.1111/j.1469-8749.2007.00745.x; Rose J, 2014, NEUROIMAGE-CLIN, V5, P169, DOI 10.1016/j.nicl.2014.05.013; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Rose J, 2009, DEV MED CHILD NEUROL, V51, P526, DOI 10.1111/j.1469-8749.2008.03231.x; Spittle AJ, 2011, DEV MED CHILD NEUROL, V53, P1000, DOI 10.1111/j.1469-8749.2011.04095.x; Tang X, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003631; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Zhang YJ, 2014, NEUROIMAGE, V101, P256, DOI 10.1016/j.neuroimage.2014.07.001	26	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115426	10.1371/journal.pone.0115426	http://dx.doi.org/10.1371/journal.pone.0115426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506943	Green Published, gold			2022-12-27	WOS:000346607100075
J	Wee, CD; Havens, MA; Jodelka, FM; Hastings, ML				Wee, Claribel D.; Havens, Mallory A.; Jodelka, Francine M.; Hastings, Michelle L.			Targeting SR Proteins Improves SMN Expression in Spinal Muscular Atrophy Cells	PLOS ONE			English	Article							MOTOR-NEURON SMN; EXONIC SPLICING ENHANCER; RNA RECOGNITION MOTIFS; MESSENGER-RNA; SINGLE NUCLEOTIDE; SITE SELECTION; STEM-CELLS; HNRNP A1; IN-VIVO; SURVIVAL	Spinal muscular atrophy (SMA) is one of the most common inherited causes of pediatric mortality. SMA is caused by deletions or mutations in the survival of motor neuron 1 (SMN1) gene, which results in SMN protein deficiency. Humans have a centromeric copy of the survival of motor neuron gene, SMN2, which is nearly identical to SMN1. However, SMN2 cannot compensate for the loss of SMN1 because SMN2 has a single-nucleotide difference in exon 7, which negatively affects splicing of the exon. As a result, most mRNA produced from SMN2 lacks exon 7. SMN2 mRNA lacking exon 7 encodes a truncated protein with reduced functionality. Improving SMN2 exon 7 inclusion is a goal of many SMA therapeutic strategies. The identification of regulators of exon 7 inclusion may provide additional therapeutic targets or improve the design of existing strategies. Although a number of regulators of exon 7 inclusion have been identified, the function of most splicing proteins in exon 7 inclusion is unknown. Here, we test the role of SR proteins and hnRNP proteins in SMN2 exon 7 inclusion. Knockdown and overexpression studies reveal that SRSF1, SRSF2, SRSF3, SRSF4, SRSF5, SRSF6, SRSF7, SRSF11, hnRNPA1/B1 and hnRNP U can inhibit exon 7 inclusion. Depletion of two of the most potent inhibitors of exon 7 inclusion, SRSF2 or SRSF3, in cell lines derived from SMA patients, increased SMN2 exon 7 inclusion and SMN protein. Our results identify novel regulators of SMN2 exon 7 inclusion, revealing potential targets for SMA therapeutics.	[Wee, Claribel D.; Havens, Mallory A.; Jodelka, Francine M.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA.	michelle.hastings@rosalindfranklin.edu	Hastings, MICHELLE L./AAK-6627-2021	Hastings, Michelle L./0000-0002-4253-9261; Jodelka, Francine/0000-0001-9374-8437	National Institutes of Health [NS069759, 1F31NS076237]; Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; NCRR (Health Resources and Service Administration) [S10 OD01662, C76 HF03610-01-00]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069759, F31NS076237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship; NCRR (Health Resources and Service Administration); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NS069759 to M.L.H, 1F31NS076237 to M.A.H., NCRR S10 OD01662 and C76 HF03610-01-00 (Health Resources and Service Administration) to the Midwest Proteome Center at Rosalind Franklin University]; C.D.W. was supported by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship. No individuals employed or contracted by the funders played any role in: study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Baughan TD, 2009, HUM MOL GENET, V18, P1600, DOI 10.1093/hmg/ddp076; Bebee TW, 2010, FRONT BIOSCI-LANDMRK, V15, P1191, DOI 10.2741/3670; Behzadnia N, 2007, EMBO J, V26, P1737, DOI 10.1038/sj.emboj.7601631; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chandler SD, 1997, P NATL ACAD SCI USA, V94, P3596, DOI 10.1073/pnas.94.8.3596; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Cho S, 2014, BIOCH BIOPHYS ACTA; de Araujo MM, 2009, RNA, V15, P515, DOI 10.1261/rna.1273209; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Doktor TK, 2011, HUM MUTAT, V32, P220, DOI 10.1002/humu.21419; Ebert AD, 2013, STEM CELL RES, V10, P417, DOI 10.1016/j.scr.2013.01.009; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Farooq F, 2009, HUM MOL GENET, V18, P4035, DOI 10.1093/hmg/ddp352; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Grosso AR, 2008, NUCLEIC ACIDS RES, V36, P4823, DOI 10.1093/nar/gkn463; Hanamura A, 1998, RNA, V4, P430; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hastings ML, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000538; Hastings ML, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000208; Hastings ML, 2001, RNA, V7, P471, DOI 10.1017/S1355838201002552; Heinrich B, 2009, J BIOL CHEM, V284, P14303, DOI 10.1074/jbc.M901026200; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Irimura Sanae, 2009, Kobe J Med Sci, V54, pE227; Jodelka FM, 2010, HUM MOL GENET, V19, P4906, DOI 10.1093/hmg/ddq425; Jong YJ, 2000, J NEUROL SCI, V173, P147, DOI 10.1016/S0022-510X(99)00325-1; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; Kashima T, 2007, P NATL ACAD SCI USA, V104, P3426, DOI 10.1073/pnas.0700343104; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Li J, 2008, NEUROCHEM RES, V33, P483, DOI 10.1007/s11064-007-9461-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Mallinjoud P, 2014, GENOME RES, V24, P511, DOI 10.1101/gr.162933.113; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mende Y, 2010, HUM MOL GENET, V19, P2154, DOI 10.1093/hmg/ddq094; Miyajima H, 2002, J BIOL CHEM, V277, P23271, DOI 10.1074/jbc.M200851200; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Moursy A, 2014, NUCL ACIDS RES; Osman EY, 2014, HUM MOL GENET; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Paz I., 2014, NUCL ACIDS RES; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Porensky PN, 2013, HUM GENE THER, V24, P489, DOI 10.1089/hum.2012.225; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Prior TW, 2010, AM J MED GENET A, V152A, P1608, DOI 10.1002/ajmg.a.33474; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Rigo F, 2012, NAT CHEM BIOL, V8, P555, DOI [10.1038/nchembio.939, 10.1038/NCHEMBIO.939]; Rochette CF, 2001, HUM GENET, V108, P255, DOI 10.1007/s004390100473; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; Singh NN, 2013, NUCLEIC ACIDS RES, V41, P8144, DOI 10.1093/nar/gkt609; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2011, MOL CELL BIOL, V31, P935, DOI 10.1128/MCB.00945-10; Sivanesan S, 2013, TRANSL NEUROSCI, V4, P1, DOI 10.2478/s13380-013-0109-2; WANG J, 1995, RNA, V1, P335; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yang XM, 2014, NEUROL SCI, V35, P391, DOI 10.1007/s10072-013-1524-4; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Yuo CY, 2008, ANN NEUROL, V63, P26, DOI 10.1002/ana.21241; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799	88	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115205	10.1371/journal.pone.0115205	http://dx.doi.org/10.1371/journal.pone.0115205			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506695	Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100060
J	Seki, T; Asanuma, K; Asao, R; Nonaka, K; Sasaki, Y; Trejo, JAO; Kurosawa, H; Hirayama, Y; Horikoshi, S; Tomino, Y; Saito, A				Seki, Takuto; Asanuma, Katsuhiko; Asao, Rin; Nonaka, Kanae; Sasaki, Yu; Trejo, Juan Alejandro Oliva; Kurosawa, Hiroyuki; Hirayama, Yoshiaki; Horikoshi, Satoshi; Tomino, Yasuhiko; Saito, Akihiko			Significance of Urinary Full-Length Megalin in Patients with IgA Nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; HEYMANN NEPHRITIS; TNF-ALPHA; IN-VITRO; INJURY; RECEPTOR; PODOCYTES; PROTEIN; GP330; COMMUNICATION	Background and Objectives: Megalin is highly expressed at the apical membranes of proximal tubular epithelial cells. A urinary full-length megalin (C-megalin) assay is linked to the severity of diabetic nephropathy in type 2 diabetes. This study examined the relationship between levels of urinary C-megalin and histological findings in adult patients with IgA nephropathy (IgAN). Design, Setting, Participants, & Measurements: Urine samples voided in the morning on the day of renal biopsy were obtained from 73 patients with IgAN (29 men and 44 women; mean age, 33 years) and 5 patients with membranous nephropathy (MN). Renal pathologic variables were analyzed using the Oxford classification of IgAN, the Shigematsu classification and the Clinical Guidelines of IgAN in Japan. The levels of urinary C-megalin were measured by sandwich ELISA. Results: Histological analysis based on the Oxford classification revealed that the levels of urinary C-megalin were correlated with mesangial hypercellularity in IgAN patients (OR=1.76, 95% CI: 1.04-3.27, P<0.05). There was a significant correlation between the levels of urinary C-megalin and the severity of chronic extracapillary abnormalities according to the Shigematsu classification in IgAN patients (beta=0.33, P=0.008). The levels of urinary C-megalin were significantly higher in all risk levels of IgAN patients requiring dialysis using the Clinical Guidelines of IgAN in Japan than in the control group. The levels of urinary C-megalin were significantly higher in the high risk and very high risk grades than in the low risk grade (P<0.05). The levels of urinary C-megalin were significantly higher in MN patients compared to the control group. Conclusions: The levels of urinary C-megalin are associated with histological abnormalities in adult IgAN patients. There is a possibility that urinary C-megalin is	[Seki, Takuto; Asanuma, Katsuhiko; Asao, Rin; Nonaka, Kanae; Sasaki, Yu; Trejo, Juan Alejandro Oliva; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Div Nephrol, Tokyo, Japan; [Seki, Takuto; Asanuma, Katsuhiko; Nonaka, Kanae] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, TMK Project, Kyoto, Japan; [Kurosawa, Hiroyuki; Hirayama, Yoshiaki] Denka Seiken Co Ltd, Reagents Dev Dept, Niigata, Japan; [Saito, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Appl Mol Med, Niigata, Japan	Juntendo University; Kyoto University; Denka Company Limited; Niigata University	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp		Asao, Rin/0000-0001-6511-4226	Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Kowa Life Science Foundation [21659217, 23591201]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Kowa Life Science Foundation	This work was supported by research grants from the Takeda Science Foundation, the Kanae Foundation for the Promotion of Medical Science, and by a Kowa Life Science Foundation, a Grant for Challenging Exploratory Research (21659217) https://www.jsps.go.jp/english/e-grants/grants01.html and a Grant-in-Aid for Scientific Research (C) (23591201) to KA, https://www.jsps.go.jp/english/e-grants/grants01.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; BACHINSKY DR, 1993, AM J PATHOL, V143, P598; Barrett J, 2011, SEMIN NEPHROL, V31, P349, DOI 10.1016/j.semnephrol.2011.06.006; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; BIRK HW, 1991, KIDNEY INT, V40, P823, DOI 10.1038/ki.1991.282; Boyd JK, 2012, KIDNEY INT, V81, P833, DOI 10.1038/ki.2011.501; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hjalm G, 1996, EUR J BIOCHEM, V239, P132, DOI 10.1111/j.1432-1033.1996.0132u.x; KERJASCHKI D, 1987, AM J PATHOL, V129, P183; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P14176; Lai KN, 2008, AM J PHYSIOL-RENAL, V294, pF945, DOI 10.1152/ajprenal.00423.2007; Lai KN, 2011, ADV OTO-RHINO-LARYNG, V72, P40, DOI 10.1159/000324593; Lai KN, 2009, NEPHROL DIAL TRANSPL, V24, P62, DOI 10.1093/ndt/gfn441; Lai KN, 2005, KIDNEY INT, V67, pS110, DOI 10.1111/j.1523-1755.2005.09426.x; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Moriyama T, 2011, CLIN EXP NEPHROL, V15, P700, DOI 10.1007/s10157-011-0455-8; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; no author, 2011, Nihon Jinzo Gakkai Shi, V53, P123; Ogasawara S, 2012, DIABETES CARE, V35, P1112, DOI 10.2337/dc11-1684; Peters HPE, 2009, NETH J MED, V67, P54; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Saito A, 2005, NEPHROLOGY, V10, pS26, DOI 10.1111/j.1440-1797.2005.00453.x; Saito A, 2003, J AM SOC NEPHROL, V14, P2025, DOI 10.1097/01.ASN.0000078804.98322.4A; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Shigematsu H, 1997, PATHOL INT, V47, P194, DOI 10.1111/j.1440-1827.1997.tb04480.x; Tam KY, 2009, KIDNEY INT, V75, P1330, DOI 10.1038/ki.2009.71; Tanuma A, 2007, NEPHRON PHYSIOL, V107, pP87, DOI 10.1159/000111253; Thrailkill KM, 2009, DIABETES CARE, V32, P1266, DOI 10.2337/dc09-0112; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114400	10.1371/journal.pone.0114400	http://dx.doi.org/10.1371/journal.pone.0114400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502002	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400030
J	Boucquemont, J; Metzger, M; Combe, C; Stengel, B; Leffondre, K				Boucquemont, Julie; Metzger, Marie; Combe, Christian; Stengel, Benedicte; Leffondre, Karen		NephroTest Study Grp	Should We Use Standard Survival Models or the Illness-Death Model for Interval-Censored Data to Investigate Risk Factors of Chronic Kidney Disease Progression?	PLOS ONE			English	Article							STAGE RENAL-DISEASE; COMPETING RISKS; EPIDEMIOLOGY; MORTALITY	Background: In studies investigating risk factors of chronic kidney disease (CKD) progression, one may be interested in estimating factors effects on both a fall of glomerular filtration rate (GFR) below a specific level (i.e., a CKD stage) and death. Such studies have to account for the fact that GFR is measured at intermittent visit only, which implies that progression to the stage of interest is unknown for patients who die before being observed at that stage. Our objective was to compare the results of an illness-death model that handles this uncertainty, with frequently used survival models. Methods: This study included 1,519 patients from the NephroTest cohort with CKD stages 1-4 at baseline (69% males, 59 +/- 15 years, median protein/creatinine ratio [PCR] 27.4 mg/mmol) and subsequent annual measures of GFR (follow-up time 4.3 +/- 2.7 years). Each model was used to estimate the effects of sex, age, PCR, and GFR at baseline on the hazards of progression to CKD stage 5 (GFR < 15 mL/min/1.73 m(2), n = 282 observed) and death (n = 168). Results: For progression to stage 5, there were only minor differences between results from the different models. The differences between results were higher for the hazard of death before or after progression. Our results also suggest that previous findings on the effect of age on end-stage renal disease are more likely due to a strong impact of age on death than to an effect on progression. The probabilities of progression were systematically under-estimated with the survival model as compared with the illness-death model. Conclusions: This study illustrates the advantages of the illness-death model for accurately estimating the effects of risk factors on the hazard of progression and death, and probabilities of progression. It avoids the need to choose arbitrary time-to-event and time-to-censoring, while accounting for both interval censoring and competition by death, using a single analytical model.	[Boucquemont, Julie; Leffondre, Karen] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol & Biostat U897, Bordeaux, France; [Metzger, Marie; Stengel, Benedicte] INSERM, Unit 1018, CESP, Res Ctr Epidemiol & Populat Hlth, Villejuif, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris 11, UMRS 1018, Villejuif, France; [Combe, Christian] Ctr Hosp Univ Bordeaux, Serv Nephrol Transplantat Dialyse, Bordeaux, France; [Combe, Christian] Univ Bordeaux, Unite INSERM 1026, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Leffondre, K (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol & Biostat U897, Bordeaux, France.	karen.leffondre@isped.u-bordeaux2.fr	Karen, Leffondre/AAF-6490-2019; Stengel, Benedicte/G-5730-2015; Combe, Christian/N-3726-2015; Metzger, Marie/K-9772-2018	Karen, Leffondre/0000-0002-1269-8069; Stengel, Benedicte/0000-0001-9469-0804; Combe, Christian/0000-0002-0360-573X; Metzger, Marie/0000-0003-3597-5409	INSERM GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]; European Community's Seventh Framework Program [HEALTH-F2-2009-241544-SysKid]	INSERM GIS-IReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); European Community's Seventh Framework Program(European Commission)	The NephroTest CKD cohort study is supported by the following grants: INSERM GIS-IReSP AO 8113LS TGIR (B. Stengel), French Ministry of Health AOM 09114 (M. Froissart and B. Stengel), INSERM AO 8022LS (B. Stengel), Agence de la Biomedecine R0 8156LL (B. Stengel), AURA (M. Froissart), and Roche 2009-152-447G (M. Froissart). This work was funded by a grant from the European Community's Seventh Framework Program (HEALTH-F2-2009-241544-SysKid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Andersen PK, 2012, STAT MED, V31, P1074, DOI 10.1002/sim.4385; Boucquemont J, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-45; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Hoefield RA, 2010, AM J KIDNEY DIS, V56, P1072, DOI 10.1053/j.ajkd.2010.06.010; Joly P, 2002, BIOSTATISTICS, V3, P433, DOI 10.1093/biostatistics/3.3.433; JUCKETT DA, 1993, MECH AGEING DEV, V69, P1, DOI 10.1016/0047-6374(93)90068-3; Kessler M, 2008, NEPHROL THER, V4, P155, DOI 10.1016/j.nephro.2007.11.008; LaMattina JC, 2011, CLIN J AM SOC NEPHRO, V6, P1851, DOI 10.2215/CJN.00650111; Leffondre K, 2015, NEPHROL DIAL TRANSPL, V30, P1237, DOI 10.1093/ndt/gfu320; Leffondre K, 2014, NEPHROL DIAL TRANSPL, V29, P1806, DOI 10.1093/ndt/gft500; Leffondre K, 2013, INT J EPIDEMIOL, V42, P1177, DOI 10.1093/ije/dyt126; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Touraine C., 2013, 1312 U COP DEP BIOST; Touraine C, 2016, STAT METHODS MED RES, V25, P1452, DOI 10.1177/0962280213489234; Van Pottelbergh G, 2012, NEPHROL DIAL TRANSPL, V27, P2297, DOI 10.1093/ndt/gfr659; Weis L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081835	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114839	10.1371/journal.pone.0114839	http://dx.doi.org/10.1371/journal.pone.0114839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503256	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700058
J	Fenley, AT; Muddana, HS; Gilson, MK				Fenley, Andrew T.; Muddana, Hari S.; Gilson, Michael K.			Calculation and Visualization of Atomistic Mechanical Stresses in Nanomaterials and Biomolecules	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; TENSOR ANALYSIS; MECHANOCHEMISTRY; LEVEL; SYSTEM; FORCE; AMBER; TRANSDUCTION; ALGORITHMS; CHANNEL	Many biomolecules have machine-like functions, and accordingly are discussed in terms of mechanical properties like force and motion. However, the concept of stress, a mechanical property that is of fundamental importance in the study of macroscopic mechanics, is not commonly applied in the biomolecular context. We anticipate that microscopical stress analyses of biomolecules and nanomaterials will provide useful mechanistic insights and help guide molecular design. To enable such applications, we have developed Calculator of Atomistic Mechanical Stress (CAMS), an open-source software package for computing atomic resolution stresses from molecular dynamics (MD) simulations. The software also enables decomposition of stress into contributions from bonded, nonbonded and Generalized Born potential terms. CAMS reads GROMACS topology and trajectory files, which are easily generated from AMBER files as well; and time-varying stresses may be animated and visualized in the VMD viewer. Here, we review relevant theory and present illustrative applications.	[Fenley, Andrew T.; Muddana, Hari S.; Gilson, Michael K.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gilson, MK (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	mgilson@ucsd.edu	Muddana, Hari/F-7796-2010		National Institute of General Medical Sciences (NIGMS) [GM61300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061300] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by grant GM61300 from the National Institute of General Medical Sciences (NIGMS) to MKG (http://www.nigms.nih.gov/Pages/default.aspx). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brantley JN, 2013, POLYM INT, V62, P2, DOI 10.1002/pi.4350; Bratzel G, 2012, BIOPOLYMERS, V97, P408, DOI 10.1002/bip.21729; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bukoreshtliev NV, 2013, CELL TISSUE RES, V352, P77, DOI 10.1007/s00441-012-1531-4; Case DA, 2012, AMBER 12; Chen YP, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166387; CHEUNG KS, 1991, J APPL PHYS, V70, P5688, DOI 10.1063/1.350186; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; Cohen-Tanugi D, 2012, NANO LETT, V12, P3602, DOI 10.1021/nl3012853; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Costescu BI, 2014, PHYS CHEM CHEM PHYS, V16, P12582, DOI 10.1039/c3cp55341h; Costescu BI, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-5; Delph TJ, 2005, MODEL SIMUL MATER SC, V13, P585, DOI 10.1088/0965-0393/13/4/009; DIBROZOLO FR, 1994, NATURE, V369, P37, DOI 10.1038/369037a0; El-Kady MF, 2012, SCIENCE, V335, P1326, DOI 10.1126/science.1216744; Fenley AT, 2012, P NATL ACAD SCI USA, V109, P20006, DOI 10.1073/pnas.1213180109; FENLEY AT, 2014, J PHYS CHEM B; Friscic T, 2012, CHEM SOC REV, V41, P3493, DOI 10.1039/c2cs15332g; Ghosh S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2907977; Gilson MK, 2010, J CHEM THEORY COMPUT, V6, P637, DOI 10.1021/ct900668k; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gusev AA, 1996, PHYS REV B, V54, P1, DOI 10.1103/PhysRevB.54.1; Hao F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3615290; HARDY RJ, 1982, J CHEM PHYS, V76, P622, DOI 10.1063/1.442714; Hatch HW, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734007; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iozzi MF, 2011, J PHYS CHEM A, V115, P2308, DOI 10.1021/jp109428g; Ishikura T, 2012, CHEM PHYS LETT, V539, P144, DOI 10.1016/j.cplett.2012.05.005; Ivanovskii AL, 2012, RUSS CHEM REV+, V81, P571, DOI 10.1070/RC2012v081n07ABEH004302; James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a; Koike K, 2008, PHYS CHEM CHEM PHYS, V10, P1400, DOI 10.1039/b714618c; Lai JY, 2013, PROTEIN SCI, V22, P502, DOI 10.1002/pro.2222; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; Liang J, 2009, ACS NANO, V3, P1628, DOI 10.1021/nn900294n; Liu B, 2009, J COMPUT THEOR NANOS, V6, P1081, DOI 10.1166/jctn.2009.1148; LUTSKO JF, 1988, J APPL PHYS, V64, P1152, DOI 10.1063/1.341877; MACKERELL AD, 2002, CHARMM THE ENERGY FU; Mobley DL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2221683; Nair AK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2720; Noji H, 2011, CHEM SCI, V2, P2086, DOI 10.1039/c1sc00276g; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Orsi M, 2013, FARADAY DISCUSS, V161, P249, DOI 10.1039/c2fd20110k; Palmai Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003444; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rafii-Tabar H, 2004, PHYS REP, V390, P235, DOI 10.1016/j.physrep.2003.10.012; Ribas-Arino J, 2012, CHEM REV, V112, P5412, DOI 10.1021/cr200399q; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sielaff H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0024; Sirk TW, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789961; Sonne J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862624; Sordan R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079663; Stacklies W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-101; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000574; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000306; Stoller MD, 2008, NANO LETT, V8, P3498, DOI 10.1021/nl802558y; THEODOROU DN, 1986, MACROMOLECULES, V19, P379, DOI 10.1021/ma00156a026; TSAI DH, 1979, J CHEM PHYS, V70, P1375, DOI 10.1063/1.437577; Valle F, 2007, PHYS LIFE REV, V4, P157, DOI 10.1016/j.plrev.2007.06.001; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velez-Vega C, 2012, J CHEM THEORY COMPUT, V8, P966, DOI 10.1021/ct2006902; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe R, 2013, FEBS LETT, V587, P1030, DOI 10.1016/j.febslet.2013.01.063; Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o; Xiao SB, 2009, BIOPHYS J, V96, P3997, DOI 10.1016/j.bpj.2009.02.052; Zhou M, 2003, P ROY SOC A-MATH PHY, V459, P2347, DOI 10.1098/rspa.2003.1127; Zimmerman JA, 2004, MODEL SIMUL MATER SC, V12, pS319, DOI 10.1088/0965-0393/12/4/S03	74	8	8	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113119	10.1371/journal.pone.0113119	http://dx.doi.org/10.1371/journal.pone.0113119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503996	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700006
J	Schully, KL; Bell, MG; Ward, JM; Keane-Myers, AM				Schully, Kevin L.; Bell, Matthew G.; Ward, Jerrold M.; Keane-Myers, Andrea M.			Oropharyngeal Aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c Mice	PLOS ONE			English	Article							C-REACTIVE PROTEIN; C57BL/6 MICE; MURINE MODEL; B. THAILANDENSIS; ALLERGIC INFLAMMATION; MOLECULAR-PATTERNS; SEVERE MELIOIDOSIS; GAMMA-INTERFERON; NATURAL-HISTORY; ANIMAL-MODELS	Burkholderia mallei and Burkholderia pseudomallei are potentially lethal pathogens categorized as biothreat agents due, in part, to their ability to be disseminated via aerosol. There are no protective vaccines against these pathogens and treatment options are limited and cumbersome. Since disease severity is greatest when these agents are inhaled, efforts to develop pre- or post- exposure prophylaxis focus largely on inhalation models of infection. Here, we demonstrate a non- invasive and technically simple method for affecting the inhalational challenge of BALB/c mice with B. pseudomallei and B. mallei. In this model, two investigators utilized common laboratory tools such as forceps and a micropipette to conduct and characterize an effective and reproducible inhalational challenge of BALB/c mice with B. mallei and B. pseudomallei. Challenge by oropharyngeal aspiration resulted in acute disease. Additionally, 50% endpoints for B. pseudomallei K96243 and B. mallei ATCC 23344 were nearly identical to published aerosol challenge methods. Furthermore, the pathogens disseminated to all major organs typically targeted by these agents where they proliferated. The pro- inflammatory cytokine production in the proximal and peripheral fluids demonstrated a rapid and robust immune response comparable to previously described murine and human studies. These observations demonstrate that OA is a viable alternative to aerosol exposure.	[Schully, Kevin L.; Bell, Matthew G.; Keane-Myers, Andrea M.] Naval Med Res Ctr Frederick, Frederick, MD 21702 USA; [Ward, Jerrold M.] Global Vet Pathol, Montgomery, MD USA	Naval Medical Research Center (NMRC)	Keane-Myers, AM (corresponding author), Naval Med Res Ctr Frederick, Frederick, MD 21702 USA.	keanemyers@yahoo.com			Defense Advanced Research Projects Agency (DARPA); Defense Threat Reduction Agency (DTRA) [HDTRA1-08-CBDIF-CBT-BAA]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	Funding for this work was provided by The Defense Advanced Research Projects Agency (DARPA). DARPA Order G677/00 and the Defense Threat Reduction Agency (DTRA), HDTRA1-08-CBDIF-CBT-BAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MT, 2012, VACCINE, V30, P4872, DOI 10.1016/j.vaccine.2012.04.078; [Anonymous], 1995, CONTROL COMMUNICABLE; ASHDOWN LR, 1992, AM J TROP MED HYG, V46, P151, DOI 10.4269/ajtmh.1992.46.151; Barnes JL, 2005, EMERG INFECT DIS, V11, P638, DOI 10.3201/eid1104.041051; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; BOONSAWAT W, 1990, Journal of the Medical Association of Thailand, V73, P345; Ceballos-Olvera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002452; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2004, AM J TROP MED HYG, V70, P580, DOI 10.4269/ajtmh.2004.70.580; Cheng AC, 2007, INTENS CARE MED, V33, P562, DOI 10.1007/s00134-006-0527-5; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; Currie Bart J, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS1, DOI 10.1016/S0035-9203(08)70002-6; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; Egger C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063432; Fisher NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-117; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Gan YH, 2002, MOL MICROBIOL, V44, P1185, DOI 10.1046/j.1365-2958.2002.02957.x; Gauthier YP, 2001, FEMS IMMUNOL MED MIC, V30, P53, DOI 10.1016/S0928-8244(00)00234-0; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; HOWE C, 1950, OXFORD MED, P185; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Keane-Myers AM, 1998, J IMMUNOL, V160, P1036; Koo GC, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-19; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Lauw FN, 1999, J INFECT DIS, V180, P1878, DOI 10.1086/315155; Leakey AK, 1998, MICROB PATHOGENESIS, V24, P269, DOI 10.1006/mpat.1997.0179; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Lever MS, 2003, J MED MICROBIOL, V52, P1109, DOI 10.1099/jmm.0.05180-0; Liu BP, 2002, INFECT IMMUN, V70, P504, DOI 10.1128/IAI.70.2.504-511.2002; Mandell GL., 1995, PRINCIPLES PRACTICE, P2003; Massey S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04305; McConchie BW, 2006, INFECT IMMUN, V74, P6632, DOI 10.1128/IAI.00720-06; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Norris HH, 2007, J LEUKOCYTE BIOL, V82, P1531, DOI 10.1189/jlb.1106667; O'Quinn AL, 2001, CELL MICROBIOL, V3, P381, DOI 10.1046/j.1462-5822.2001.00118.x; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Pratt TS, 2007, EXP LUNG RES, V33, P459, DOI 10.1080/01902140701731805; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; Revelli DA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00164; Rowland CA, 2006, INFECT IMMUN, V74, P5333, DOI 10.1128/IAI.02046-05; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Sarkar-Tyson M, 2009, VACCINE, V27, P4447, DOI 10.1016/j.vaccine.2009.05.040; Schell MA, 2008, J BACTERIOL, V190, P2306, DOI 10.1128/JB.01735-07; Schully KL, 2013, RAPID VACCINATION US; Shevchenko MA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-78; Shields AM, 2011, CLIN EXP IMMUNOL, V165, P292, DOI 10.1111/j.1365-2249.2011.04433.x; Shields AM, 2012, RHEUMATOLOGY, V51, P780, DOI 10.1093/rheumatology/ker412; Silva EB, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00010; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Soffler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043207; Spittler A, 2000, CLIN INFECT DIS, V31, P1338, DOI 10.1086/317499; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Stanton AT, 1921, T 4 C FAR E ASS TROP, V2, P196; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Team R. D. C, 2011, R LANG ENV STAT COMP; Titball Richard W, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS111, DOI 10.1016/S0035-9203(08)70026-9; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; Utaisincharoen P, 2001, MICROBIOL IMMUNOL, V45, P307, DOI 10.1111/j.1348-0421.2001.tb02623.x; Voynow JA, 2004, AM J PHYSIOL-LUNG C, V287, pL1293, DOI 10.1152/ajplung.00140.2004; Waag D, 2005, BIOL WEAPONS DEFENSE, P209; Wand ME, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-11; Warawa JM, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00141; West TE, 2012, INT J EXP PATHOL, V93, P421, DOI 10.1111/j.1365-2613.2012.00842.x; West TE, 2010, AM J TROP MED HYG, V83, P1066, DOI 10.4269/ajtmh.2010.10-0306; Whitmore A, 1913, J HYG-CAMBRIDGE, V13, P1, DOI 10.1017/S0022172400005234; Woods DE, 1999, MICROBES INFECT, V1, P157, DOI 10.1016/S1286-4579(99)80007-0; Yeager JJ, 2012, INFECT IMMUN, V80, P3332, DOI 10.1128/IAI.00675-12	76	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115066	10.1371/journal.pone.0115066	http://dx.doi.org/10.1371/journal.pone.0115066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503969	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700090
J	Hu, QY; Fink, E; Grant, CK; Elder, JH				Hu, Qiong-Ying; Fink, Elizabeth; Grant, Chris K.; Elder, John H.			Selective Interaction of Heparin with the Variable Region 3 within Surface Glycoprotein of Laboratory-Adapted Feline Immunodeficiency Virus	PLOS ONE			English	Article							CD4(+) T-CELLS; SULFATE PROTEOGLYCANS; TUMOR-GROWTH; BINDING; INHIBITION; INFECTION; HIV-1; ANGIOGENESIS; METASTASIS; SYNDECANS	Heparan sulfate proteoglycans (HSPG) can act as binding receptors for certain laboratory-adapted (TCA) strains of feline immunodeficiency virus (FIV) and human immunodeficiency virus (HIV). Heparin, a soluble heparin sulfate (HS), can inhibit TCA HIV and FIV entry mediated by HSPG interaction in vitro. In the present study, we further determined the selective interaction of heparin with the V3 loop of TCA of FIV. Our current results indicate that heparin selectively inhibits infection by TCA strains, but not for field isolates (FS). Heparin also specifically interferes with TCA surface glycoprotein (SU) binding to CXCR4, by interactions with HSPG binding sites on the V3 loop of the FIV envelope protein. Peptides representing either the Nor C-terminal side of the V3 loop and containing HSPG binding sites were able to compete away the heparin block of TCA SU binding to CXCR4. Heparin does not interfere with the interaction of SU with anti-V3 antibodies that target the CXCR4 binding region or with the interaction between FS FIV and anti-V3 antibodies since FS SU has no HSPG binding sites within the HSPG binding region. Our data show that heparin blocks TCA FIV infection or entry not only through its competition of HSPG on the cell surface interaction with SU, but also by its interference with CXCR4 binding to SU. These studies aid in the design and development of heparin derivatives or analogues that can inhibit steps in virus infection and are informative regarding the HSPG/SU interaction.	[Hu, Qiong-Ying] Taizhou Univ, Sch Med, Taizhou, Zhejiang, Peoples R China; [Hu, Qiong-Ying; Fink, Elizabeth; Elder, John H.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Grant, Chris K.] Custom Monoclonals Int Inc, W Sacramento, CA USA	Taizhou University; Scripps Research Institute	Elder, JH (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jelder@scripps.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI25825]; Custom Monoclonals International, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025825] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Custom Monoclonals International, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (R01 AI25825). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Chris K. Grant is employed by Custom Monoclonals International, Inc. which provided support in the form of salary for author CKG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Basu A, 2007, J VIROL, V81, P3933, DOI 10.1128/JVI.02622-06; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; BOACKLE RJ, 1983, MOL IMMUNOL, V20, P1157, DOI 10.1016/0161-5890(83)90139-6; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Budge PJ, 2004, J ANTIMICROB CHEMOTH, V54, P299, DOI 10.1093/jac/dkh355; Clayette P, 1996, AIDS RES HUM RETROV, V12, P63, DOI 10.1089/aid.1996.12.63; Couchman JR, 2001, INT REV CYTOL, V207, P113; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; de Parseval A, 2005, NAT STRUCT MOL BIOL, V12, P60, DOI 10.1038/nsmb872; de Parseval A, 2004, J VIROL, V78, P9132, DOI 10.1128/JVI.78.17.9132-9143.2004; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; de Parseval A, 2004, J VIROL, V78, P2597, DOI 10.1128/JVI.78.5.2597-2600.2004; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; De Rozieres S, 2008, J VIROL, V82, P7953, DOI 10.1128/JVI.00337-08; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; deParseval A, 1997, J VIROL, V71, P5742, DOI 10.1128/JVI.71.8.5742-5749.1997; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; Fuster MM, 2010, PROG MOL BIOL TRANSL, V93, P179, DOI 10.1016/S1877-1173(10)93009-3; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Gallay P, 2004, MICROBES INFECT, V6, P617, DOI 10.1016/j.micinf.2004.02.004; Giffin MJ, 2008, J MED CHEM, V51, P6263, DOI 10.1021/jm800149m; Harbrecht U, 2011, HAMOSTASEOLOGIE, V31, P21, DOI 10.5482/ha-1149; Horvath CAJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-11; Hu Qiong-Ying, 2012, Retrovirology (Auckl), V2012, P1; Hu QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010689; Hu QY, 2011, J VIROL; Johnston JC, 1999, J VIROL, V73, P4991, DOI 10.1128/JVI.73.6.4991-5000.1999; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Laubli H, 2009, CANCER INVEST, V27, P474, DOI 10.1080/07357900802647136; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lerner DL, 1998, VET IMMUNOL IMMUNOP, V65, P277, DOI 10.1016/S0165-2427(98)00162-7; Li JP, 2009, THROMB HAEMOSTASIS, V102, P823, DOI 10.1160/TH09-02-0091; Liu DF, 2002, SEMIN THROMB HEMOST, V28, P67, DOI 10.1055/s-2002-20565; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; NORTH TW, 1995, NAT MED, V1, P410, DOI 10.1038/nm0595-410; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Park K, 2008, PHARM RES-DORDR, V25, P2786, DOI 10.1007/s11095-008-9643-y; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PERSSON E, 1990, SCAND J CLIN LAB INV, V50, P43, DOI 10.3109/00365519009091563; PHILLIPS TR, 1990, J VIROL, V64, P4605, DOI 10.1128/JVI.64.10.4605-4613.1990; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Rider CC, 1997, GLYCOCONJUGATE J, V14, P639, DOI 10.1023/A:1018596728605; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Sundstrom M, 2008, J VIROL, V82, P9134, DOI 10.1128/JVI.00394-08; TALBOTT RL, 1989, P NATL ACAD SCI USA, V86, P5743, DOI 10.1073/pnas.86.15.5743; Vaheri A, 2007, APMIS, V115, P565; Van Rompay KKA, 2010, ANTIVIR RES, V85, P159, DOI 10.1016/j.antiviral.2009.07.008; Villanueva R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-218	58	5	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115252	10.1371/journal.pone.0115252	http://dx.doi.org/10.1371/journal.pone.0115252			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521480	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600029
J	Ikeda, T; Hirata, S; Takamatsu, K; Haruta, M; Tsukamoto, H; Ito, T; Uchino, M; Ando, Y; Nagafuchi, S; Nishimura, Y; Senju, S				Ikeda, Tokunori; Hirata, Shinya; Takamatsu, Koutaro; Haruta, Miwa; Tsukamoto, Hirotake; Ito, Takaaki; Uchino, Makoto; Ando, Yukio; Nagafuchi, Seiho; Nishimura, Yasuharu; Senju, Satoru			Suppression of Th1-Mediated Autoimmunity by Embryonic Stem Cell-Derived Dendritic Cells	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; GLUTAMIC-ACID DECARBOXYLASE; REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; NOD MOUSE MODEL; MULTIPLE-SCLEROSIS; IN-VIVO; ADOPTIVE TRANSFER; IMMUNE-RESPONSE; GENE-EXPRESSION	We herein demonstrate the immune-regulatory effect of embryonic stem cell-derived dendritic cells (ES-DCs) using two models of autoimmune disease, namely non-obese diabetic (NOD) mice and experimental autoimmune encephalomyelitis (EAE). Treatment of pre-diabetic NOD mice with ES-DCs exerted almost complete suppression of diabetes development during the observation period for more than 40 weeks. The prevention of diabetes by ES-DCs was accompanied with significant reduction of insulitis and decreased number of Th1 and Th17 cells in the spleen. Development of EAE was also inhibited by the treatment with ES-DCs, and the therapeutic effect was obtained even if ES-DCs were administrated after the onset of clinical symptoms. Treatment of EAE-induced mice with ES-DCs reduced the infiltration of inflammatory cells into the spinal cord and suppressed the T cell response to the myelin antigen. Importantly, the ES-DC treatment did not affect T cell response to an exogenous antigen. As the mechanisms underlying the reduction of the number of infiltrating Th1 cells, we observed the inhibition of differentiation and proliferation of Th1 cells by ES-DCs. Furthermore, the expression of VLA-4 alpha on Th1 cells was significantly inhibited by ES-DCs. Considering the recent advances in human induced pluripotent stem cell-related technologies, these results suggest a clinical application for pluripotent stem cell-derived dendritic cells as a therapy for T cell-mediated autoimmune diseases.	[Ikeda, Tokunori; Takamatsu, Koutaro; Haruta, Miwa; Tsukamoto, Hirotake; Nishimura, Yasuharu; Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan; [Ikeda, Tokunori; Takamatsu, Koutaro; Haruta, Miwa; Senju, Satoru] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Hirata, Shinya] Kumamoto Univ, Grad Sch Med Sci, Dept Hematol, Kumamoto, Japan; [Takamatsu, Koutaro; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan; [Uchino, Makoto] Jonan Hosp, Kumamoto, Japan; [Nagafuchi, Seiho] Kyushu Univ, Dept Med Sci & Technol, Grad Sch Med Sci, Fukuoka 812, Japan	Kumamoto University; Japan Science & Technology Agency (JST); Kumamoto University; Kumamoto University; Kumamoto University; Kyushu University	Ikeda, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan.	ryousei@kumamoto-u.ac.jp	Tsukamoto, Hirotake/S-2448-2019; Tsukamoto, Hirotake/GRJ-7436-2022; Ikeda, Tokunori/S-6043-2019	Tsukamoto, Hirotake/0000-0003-3214-1652; Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25870540, 23659158, 26290057, 23650609, 24300334]; Japan Science and Technology Agency (JST), Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST), Japan(Japan Science & Technology Agency (JST))	This work was supported by Grants Numbers 25870540 (to TI), 23659158 and 26290057 (to SS), and 23650609 and 24300334 (to YN) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI, grants from the Japan Science and Technology Agency (JST), Japan, http://www.jst.go.jp/EN/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ablamunits V, 2012, DIABETES, V61, P145, DOI 10.2337/db11-1033; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Archambault AS, 2006, J NEUROIMMUNOL, V181, P122, DOI 10.1016/j.jneuroim.2006.08.012; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Baeke F, 2012, DIABETOLOGIA, V55, P2723, DOI 10.1007/s00125-012-2630-1; Besin G, 2008, DIABETES, V57, P2107, DOI 10.2337/db08-0171; Birk OS, 1996, P NATL ACAD SCI USA, V93, P1032, DOI 10.1073/pnas.93.3.1032; BURKLY LC, 1994, DIABETES, V43, P529, DOI 10.2337/diabetes.43.4.529; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Cheatem D, 2009, CLIN IMMUNOL, V131, P260, DOI 10.1016/j.clim.2008.12.001; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; CLARESALZLER MJ, 1992, J CLIN INVEST, V90, P741, DOI 10.1172/JCI115946; Comabella M, 2010, NAT REV NEUROL, V6, P499, DOI 10.1038/nrneurol.2010.112; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Feili-Hariri M, 2002, EUR J IMMUNOL, V32, P2021, DOI 10.1002/1521-4141(200207)32:7<2021::AID-IMMU2021>3.0.CO;2-J; Fujii S, 1998, HUM IMMUNOL, V59, P607, DOI 10.1016/S0198-8859(98)00058-5; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Hirata S, 2005, J IMMUNOL, V174, P1888, DOI 10.4049/jimmunol.174.4.1888; Hirata S, 2007, J IMMUNOL, V178, P918, DOI 10.4049/jimmunol.178.2.918; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Ikeda T, 2010, J IMMUNOL, V185, P5259, DOI 10.4049/jimmunol.0902797; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Lionakis MS, 2003, LANCET, V362, P1828, DOI 10.1016/S0140-6736(03)14904-5; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Machen J, 2004, J IMMUNOL, V173, P4331, DOI 10.4049/jimmunol.173.7.4331; Matsuyoshi H, 2004, J IMMUNOL, V172, P776, DOI 10.4049/jimmunol.172.2.776; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nagafuchi S, 1999, FEBS LETT, V455, P101, DOI 10.1016/S0014-5793(99)00801-7; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Quinn A, 2001, J IMMUNOL, V166, P2982, DOI 10.4049/jimmunol.166.5.2982; Quinn A, 1996, J AUTOIMMUN, V9, P365, DOI 10.1006/jaut.1996.0049; RABINOVITCH A, 1995, J IMMUNOL, V154, P4874; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Rissoan MC, 1999, SCIENCE, V283, P1183, DOI 10.1126/science.283.5405.1183; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Senju S, 2003, BLOOD, V101, P3501, DOI 10.1182/blood-2002-07-2254; Senju S, 2007, STEM CELLS, V25, P2720, DOI 10.1634/stemcells.2007-0321; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Solvason N, 2008, J IMMUNOL, V181, P8298, DOI 10.4049/jimmunol.181.12.8298; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman L, 2013, NAT MED, V19, P139, DOI 10.1038/nm.3088; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TREMBLEAU S, 1995, J EXP MED, V181, P817, DOI 10.1084/jem.181.2.817; Verginis P, 2005, J IMMUNOL, V174, P7433, DOI 10.4049/jimmunol.174.11.7433; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	65	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115198	10.1371/journal.pone.0115198	http://dx.doi.org/10.1371/journal.pone.0115198			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25522369	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600025
J	Mjorud, M; Rosvik, J; Rokstad, AMM; Kirkevold, M; Engedal, K				Mjorud, Marit; Rosvik, Janne; Rokstad, Anne Marie Mork; Kirkevold, Marit; Engedal, Knut			Variables Associated with Change in Quality of Life among Persons with Dementia in Nursing Homes: A 10 Months Follow-Up Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; DEPRESSIVE SYMPTOMS; PEOPLE; CARE; PREVALENCE; SCALE; CHALLENGES; RESIDENTS	Aim: To investigate variables associated with change in quality of life (QOL), measured by QUALID scale and three subscales; tension, sadness and wellbeing, among dementia patients in nursing homes. Method: A 10 months follow-up study including 198 (female 156, 79%) nursing home patients, mean age 87 (s.d 7.7) years. Scales applied; quality of life in late stage dementia (QUALID) scale and three subscales (wellbeing, sadness and tension), neuropsychiatric inventory questionnaire 10 items (NPI-10-Q), clinical dementia rating (CDR) scale, physical self-maintenance (PSMS) scale and a scale of general medical health. Use of psychotropic medication, gender and age was collected from the patient's records. Results: Mean baseline QUALID score: 20.6 (s.d. 7.0), follow-up score: 22.9 (s.d. 7.4), mean change 2.8 (s.d. 7.4). QOL improved in 30.8%, were unchanged in 14.7%, deteriorated in 54.6% of patients. A regression analysis revealed that change in QUALID score was significantly associated with: QUALID baseline score (beta -.381, p-value. 000), change in NPI score (beta. 421, p-value. 000), explained variance 38.1%. Change in score on wellbeing subscale associated with: change in PSMS score (beta. 185, p-value. 019), wellbeing baseline score (beta -.370, p-value. 000), change in NPI score (beta. 186, p-value. 017), explained variance 25.3%. Change in score on tension subscale associated with: change in CDR sum-of-boxes (beta. 214, p-value. 003), change in NPI score (beta. 270, p-value. 000), tension baseline score (beta -.423, p-value. 000), explained variance 34.6%. Change in score on sadness subscale associated with: change in NPI score (beta. 404, p-value. 000), sadness baseline score (beta -.438, p-value.000), explained variance 38.8%. Conclusion: The results imply that a lower baseline score (better QOL) results in a larger change in QOL (towards worse QOL). Change in QOL is mostly associated with change in neuropsychiatric symptoms. In almost 50% of patients QOL did not deteriorate.	[Mjorud, Marit; Rosvik, Janne; Engedal, Knut] Vestfold Hosp Trust, Norwegian Ctr Ageing & Hlth, Tonsberg, Norway; [Rokstad, Anne Marie Mork] Vestfold Hosp Trust, Molde Univ Coll, Norwegian Ctr Ageing & Hlth, Tonsberg, Norway; [Kirkevold, Marit] Univ Oslo, Dept Nursing Sci, Inst Hlth & Soc, Oslo, Norway	Molde University College; University of Oslo	Mjorud, M (corresponding author), Vestfold Hosp Trust, Norwegian Ctr Ageing & Hlth, Tonsberg, Norway.	marit.mjorud@aldringoghelse.no		Mjorud, Marit/0000-0002-2604-4074	Norwegian Centre for Aging and Health	Norwegian Centre for Aging and Health	Study funded by the Norwegian Centre for Aging and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson K, 2012, GERONTOLOGIST, V52, P632, DOI 10.1093/geront/gnr137; Banerjee S, 2009, INT J GERIATR PSYCH, V24, P15, DOI 10.1002/gps.2090; Barca ML, 2011, DEMENT GERIATR COGN, V31, P435, DOI 10.1159/000328969; Barca ML, 2008, INT J GERIATR PSYCH, V23, P1058, DOI 10.1002/gps.2033; Barca ML, 2010, J AFFECT DISORDERS, V120, P141, DOI 10.1016/j.jad.2009.04.028; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; Beerens HC, 2014, J AM MED DIR ASSOC, V15, P54, DOI 10.1016/j.jamda.2013.09.010; Beerens HC, 2013, INT J NURS STUD, V50, P1259, DOI 10.1016/j.ijnurstu.2013.02.005; Bjorklof GH, 2013, DEMENT GERIATR COGN, V35, P121, DOI 10.1159/000346633; Castro-Monteiro E, 2014, QUAL LIFE RES; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Garre-Olmo J, 2010, QUAL LIFE RES, V19, P445, DOI 10.1007/s11136-010-9594-8; Gerritsen DL, 2005, AGING MENT HEALTH, V9, P135, DOI 10.1080/13607860412331336797; Gonzalez-Velez AE, 2014, GERIATR GERONTOL INT; Helvik AS, 2010, AGING MENT HEALTH, V14, P861, DOI 10.1080/13607861003801003; Hoe J, 2009, ALZ DIS ASSOC DIS, V23, P285, DOI 10.1097/WAD.0b013e318194fc1e; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/appi.neuropsych.12.2.233; Kirkevold O, 2005, USE RESTRAINTS NORWE; Kok JS, 2013, DEMENT GER COGN D EX, V3, P360, DOI 10.1159/000353441; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Leon-Salas B, 2013, ARCH GERONTOL GERIAT, V57, P257, DOI 10.1016/j.archger.2013.04.013; Lyketsos CG, 2003, INT J GERIATR PSYCH, V18, P275, DOI 10.1002/gps.796; Lyketsos CG, 1997, J NEUROPSYCH CLIN N, V9, P556; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Mjorud M, 2014, AGING MENT HEALTH, P1; Mjorud M, 2014, DEMENT GERIATR COGN, V37, P265, DOI 10.1159/000356497; Moyle W, 2013, EXPERT REV PHARM OUT, V13, P109, DOI [10.1586/ERP.12.84, 10.1586/erp.12.84]; Moyle W, 2012, CURR OPIN PSYCHIATR, V25, P480, DOI 10.1097/YCO.0b013e32835a1ccf; Moyle W, 2011, AGING MENT HEALTH, V15, P970, DOI 10.1080/13607863.2011.583620; Moyle W, 2010, INT J OLDER PEOPLE N, V5, P245, DOI 10.1111/j.1748-3743.2010.00230.x; Nakanishi K, 2011, DEMENT GERIATR COGN, V32, P39, DOI 10.1159/000329443; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Rabins PV, 2007, INT PSYCHOGERIATR, V19, P401, DOI 10.1017/S1041610207004863; Roen I, 2009, RELIABILITY VALIDITY; Rokstad AMM, 2013, DEMENT GERIATR COGN, V36, P340, DOI 10.1159/000354366; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Selbaek G, 2014, INT PSYCHOGERIATR, V26, P81, DOI 10.1017/S1041610213001609; Selwood A, 2005, INT J GERIATR PSYCH, V20, P232, DOI 10.1002/gps.1271; van de Ven-Vakhteeva J, 2013, INT J GERIATR PSYCH, V28, P530, DOI 10.1002/gps.3858; Verkaik R, 2007, INT J GERIATR PSYCH, V22, P1063, DOI 10.1002/gps.1809; Vogel A, 2012, INT PSYCHOGERIATR, V24, P82, DOI 10.1017/S1041610211001128; Weiner M F, 2000, J Am Med Dir Assoc, V1, P114; Wetzels RB, 2010, DEMENT GERIATR COGN, V29, P189, DOI 10.1159/000280437; WHO, 2012, ICD 10 CLASS MENT BE; Yeager CA, 2008, PSYCHOL REP, V102, P718, DOI 10.2466/PR0.102.3.718-722	47	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115248	10.1371/journal.pone.0115248	http://dx.doi.org/10.1371/journal.pone.0115248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA4AC	25521336	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600028
J	Bondar, G; Cadeiras, M; Wisniewski, N; Maque, J; Chittoor, J; Chang, E; Bakir, M; Starling, C; Shahzad, K; Ping, P; Reed, E; Deng, M				Bondar, Galyna; Cadeiras, Martin; Wisniewski, Nicholas; Maque, Jetrina; Chittoor, Jay; Chang, Eleanor; Bakir, Maral; Starling, Charlotte; Shahzad, Khurram; Ping, Peipei; Reed, Elaine; Deng, Mario			Comparison of Whole Blood and Peripheral Blood Mononuclear Cell Gene Expression for Evaluation of the Perioperative Inflammatory Response in Patients with Advanced Heart Failure	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; PROFILES; TRANSPLANTATION; MICROFLUIDICS; DATABASE	Background: Heart failure (HF) prevalence is increasing in the United States. Mechanical Circulatory Support (MCS) therapy is an option for Advanced HF (AdHF) patients. Perioperatively, multiorgan dysfunction (MOD) is linked to the effects of device implantation, augmented by preexisting HF. Early recognition of MOD allows for better diagnosis, treatment, and risk prediction. Gene expression profiling (GEP) was used to evaluate clinical phenotypes of peripheral blood mononuclear cells (PBMC) transcriptomes obtained from patients' blood samples. Whole blood (WB) samples are clinically more feasible, but their performance in comparison to PBMC samples has not been determined. Methods: We collected blood samples from 31 HF patients (57 +/- 15 years old) undergoing cardiothoracic surgery and 7 healthy age-matched controls, between 2010 and 2011, at a single institution. WB and PBMC samples were collected at a single timepoint postoperatively (median day 8 postoperatively) (25-75% IQR 7-14 days) and subjected to Illumina single color Human BeadChip HT12 v4 whole genome expression array analysis. The Sequential Organ Failure Assessment (SOFA) score was used to characterize the severity of MOD into low (<= 4 points), intermediate (5-11), and high (>= 12) risk categories correlating with GEP. Results: Results indicate that the direction of change in GEP of individuals with MOD as compared to controls is similar when determined from PBMC versus WB. The main enriched terms by Gene Ontology (GO) analysis included those involved in the inflammatory response, apoptosis, and other stress response related pathways. The data revealed 35 significant GO categories and 26 pathways overlapping between PBMC and WB. Additionally, class prediction using machine learning tools demonstrated that the subset of significant genes shared by PBMC and WB are sufficient to train as a predictor separating the SOFA groups. Conclusion: GEP analysis of WB has the potential to become a clinical tool for immune-monitoring in patients with MOD.	[Bondar, Galyna; Cadeiras, Martin; Wisniewski, Nicholas; Maque, Jetrina; Chittoor, Jay; Chang, Eleanor; Bakir, Maral; Starling, Charlotte; Ping, Peipei; Reed, Elaine; Deng, Mario] Univ Calif Los Angeles, Los Angeles, CA 90045 USA; [Shahzad, Khurram; Deng, Mario] Columbia Univ, New York, NY USA; [Shahzad, Khurram] E Carolina Univ, Greenville, NC USA	University of California System; University of California Los Angeles; Columbia University; University of North Carolina; East Carolina University	Deng, M (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90045 USA.	mdeng@mednet.ucla.edu	Shahzad, Khurram/GRX-8200-2022	Ping, Peipei/0000-0003-3583-3881	NHLBI [R21 HL 120040-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114437, R21HL120040] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported through R21 HL 120040-01A1 NHLBI, the kind Advanced Heart Failure Research gifts from Philip Geier, John Tocco, Robert Milo, and Juan Mulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG TECHN, GEN MANUAL12 5; Barnes K, 2008, DIMENS CRIT CARE NUR, V27, P233, DOI 10.1097/01.DCC.0000338867.24293.20; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Cabre L, 2005, INTENS CARE MED, V31, P927, DOI 10.1007/s00134-005-2640-2; Cadeiras M, 2011, J HEART LUNG TRANSPL, V30, P733, DOI 10.1016/j.healun.2011.01.723; Cine N, 2013, EXP THER MED, V5, P23, DOI 10.3892/etm.2012.754; Debey S, 2004, PHARMACOGENOMICS J, V4, P193, DOI 10.1038/sj.tpj.6500240; Debey-Pascher S, 2011, J MOL DIAGN, V13, P452, DOI 10.1016/j.jmoldx.2011.03.006; Deng MC, 2014, TRANSPLANTATION, V97, P708, DOI 10.1097/01.TP.0000443897.29951.cf; Deng MC, 2005, J HEART LUNG TRANSPL, V24, P1182, DOI 10.1016/j.healun.2005.07.002; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Erickson LM, 2003, TRANSPLANTATION, V76, P582, DOI 10.1097/01.TP.0000081398.65568.1B; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jison ML, 2004, BLOOD, V104, P270, DOI 10.1182/blood-2003-08-2760; Joehanes R, 2012, PHYSIOL GENOMICS, V44, P59, DOI 10.1152/physiolgenomics.00130.2011; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Kirklin JK, 2012, J THORAC CARDIOV SUR, V144, P584, DOI 10.1016/j.jtcvs.2012.05.044; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Li L, 2008, PHYSIOL GENOMICS, V32, P190, DOI 10.1152/physiolgenomics.00216.2007; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Mehra MR, 2006, CIRCULATION, V114, pI21, DOI 10.1161/CIRCULATIONAHA.105.000513; Min JL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-96; Munch EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050564; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; *QUINT CO, GLOB RNA RED BLOOD S; Raghavachari N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006484; Rainen L, 2002, CLIN CHEM, V48, P1883; Redmond Avril, 2004, Nurs Stand, V18, P46; Rosenbach AE, 2011, CTS-CLIN TRANSL SCI, V4, P63, DOI 10.1111/j.1752-8062.2010.00255.x; SHAHZAD K, 2011, CARDIAC SUPPORT MULT; Shahzad K, 2011, J HEART LUNG TRANSPL, V30, P194, DOI 10.1016/j.healun.2010.08.026; Shahzad K, 2010, J TRANSPLANT, V2010, DOI 10.1155/2010/719696; Sinha A, 2010, HUM IMMUNOL, V71, P164, DOI 10.1016/j.humimm.2009.10.012; Starling, 2007, J HEART LUNG TRANSPL, V26, P204, DOI 10.1016/j.healun.2007.01.016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Xie LL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S4; YENTIS SM, 1995, CLIN EXP IMMUNOL, V100, P330; Yndestad A, 2006, HEART FAIL REV, V11, P83, DOI 10.1007/s10741-006-9196-2; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; 2003, AN BLOOD PROC METH P; 2003, GLOB RED PROT METH P	46	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115097	10.1371/journal.pone.0115097	http://dx.doi.org/10.1371/journal.pone.0115097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517110	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600040
J	Dolcino, M; Lunardi, C; Ottria, A; Tinazzi, E; Patuzzo, G; Puccetti, A				Dolcino, Marzia; Lunardi, Claudio; Ottria, Andrea; Tinazzi, Elisa; Patuzzo, Giuseppe; Puccetti, Antonio			Crossreactive Autoantibodies Directed against Cutaneous and Joint Antigens Are Present in Psoriatic Arthritis	PLOS ONE			English	Article							NEBULIN-RELATED PROTEIN; CLASSIFICATION CRITERIA; N-RAP; PATHOGENESIS; DIAGNOSIS; PROMOTES; GENE	Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease of unknown origin, characterized by erosions and new bone formation. Diagnosis of PsA is mainly clinical and there are no biomarkers available. Moreover in PsA autoantibodies have not been described so far. Indeed an autoimmune origin has been suggested but never proven. Aim of the study was to investigate the possible presence of autoantibodies typically associated with PsA. Methods: We used pooled IgG immunoglobulins derived from 30 patients with PsA to screen a random peptide library in order to identify disease relevant autoantigen peptides. Results: Among the selected peptides, one was recognised by nearly all the patients' sera. The identified peptide (PsA peptide: TNRRGRGSPGAL) shows sequence similarities with skin autoantigens, such as fibrillin 3, a constituent of actin microfibrils, desmocollin 3, a constituent of the desmosomes and keratin 78, a component of epithelial cytoskeleton. Interestingly the PsA peptide shares homology with the nebulin-related anchoring protein (N-RAP), a protein localized in the enthesis (point of insertion of a tendon or ligament to the bone), which represents the first affected site during early PsA. Antibodies affinity purified against the PsA peptide recognize fibrillin, desmocollin, keratin and N-RAP. Moreover antibodies directed against the PsA peptide are detectable in 85% of PsA patients. Such antibodies are not present in healthy donors and are present in 13/100 patients with seroposive rheumatoid arthritis (RA). In seronegative RA these antibodies are detectable only in 3/100 patients. Conclusions: Our results indicate that PsA is characterized by the presence of serum autoantibodies crossreacting with an epitope shared by skin and joint antigens.	[Dolcino, Marzia; Puccetti, Antonio] Inst Giannina Gaslini, Genoa, Italy; [Lunardi, Claudio; Tinazzi, Elisa; Patuzzo, Giuseppe] Univ Verona, Dept Med, I-37100 Verona, Italy; [Ottria, Andrea; Puccetti, Antonio] Univ Genoa, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; University of Genoa	Puccetti, A (corresponding author), Inst Giannina Gaslini, Genoa, Italy.	antonio.puccetti@unige.it	Tinazzi, Elisa/AAB-9450-2020	PATUZZO, Giuseppe/0000-0001-8011-0004; Ottria, Andrea/0000-0001-8722-3968				Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Butt C, 2005, ANN RHEUM DIS, V64, P114; Davis MR, 2014, MOL GENET METAB, V112, P73, DOI 10.1016/j.ymgme.2013.12.006; Duarte GV, 2012, BEST PRACT RES CL RH, V26, P147, DOI 10.1016/j.berh.2012.01.003; Eder L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0316-4; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; He Z, 2012, SCAND J IMMUNOL, V76, P483, DOI 10.1111/j.1365-3083.2012.02759.x; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2009, J INTERN MED, V265, P250, DOI 10.1111/j.1365-2796.2008.02013.x; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Luo G, 1997, CELL MOTIL CYTOSKEL, V38, P75; Luo G, 1999, BIOCHEMISTRY-US, V38, P6135, DOI 10.1021/bi982395t; McGonagle D, 2011, ANN RHEUM DIS, V70, pI71, DOI 10.1136/ard.2010.144097; McGonagle DG, 2012, DERMATOLOGY, V225, P100, DOI 10.1159/000341536; Mease P, 2013, CURR OPIN RHEUMATOL, V25, P287, DOI 10.1097/BOR.0b013e32835fd8d5; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Rahman P, 2005, ANN RHEUM DIS, V64, P1370, DOI 10.1136/ard.2004.031765; Raychaudhuri SK, 2014, AUTOIMMUN REV, V13, P490, DOI 10.1016/j.autrev.2014.01.008; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ritchlin C, 2012, J RHEUMATOL, V39, P57, DOI 10.3899/jrheum.120245; Ritchlin CT, 2005, CURR OPIN RHEUMATOL, V17, P406, DOI 10.1097/01.bor.0000167752.93543.76; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Saruta H, 2013, JAMA DERMATOL, V149, P1209, DOI 10.1001/jamadermatol.2013.5244; Stolwijk C, 2012, RHEUM DIS CLIN N AM, V38, P441, DOI 10.1016/j.rdc.2012.09.003; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Villanova F, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-203037; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358	31	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115424	10.1371/journal.pone.0115424	http://dx.doi.org/10.1371/journal.pone.0115424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514237	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300058
J	Hall, FS; Sora, I; Hen, R; Uhl, GR				Hall, Frank Scott; Sora, Ichiro; Hen, Rene; Uhl, George R.			Serotonin/Dopamine Interactions in a Hyperactive Mouse: Reduced Serotonin Receptor 1B Activity Reverses Effects of Dopamine Transporter Knockout	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PREPULSE INHIBITION DEFICITS; NUCLEUS ACCUMBENS SEPTI; VENTRAL TEGMENTAL AREA; 5-HT1B RECEPTOR; LOCOMOTOR-ACTIVITY; MICE LACKING; IN-VIVO; 5-HYDROXYTRYPTAMINE(1B) RECEPTORS; AGGRESSIVE-BEHAVIOR	Knockout (KO) mice that lack the dopamine transporter (SL6A3; DAT) display increased locomotion that can be attenuated, under some circumstances, by administration of drugs that normally produce psychostimulant-like effects, such as amphetamine and methylphenidate. These results have led to suggestions that DAT KO mice may model features of attention deficit hyperactivity disorder (ADHD) and that these drugs may act upon serotonin (5-HT) systems to produce these unusual locomotor decreasing effects. Evidence from patterns of brain expression and initial pharmacologic studies led us to use genetic and pharmacologic approaches to examine the influence of altered 5-HT1B receptor activity on hyperactivity in DAT KO mice. Heterozygous 5-HT1B KO and pharmacologic 5-HT1B antagonism both attenuated locomotor hyperactivity in DAT KO mice. Furthermore, DAT KO mice with reduced, but not eliminated, 5-HT1B receptor expression regained cocaine-stimulated locomotion, which was absent in DAT KO mice with normal levels of 5-HT1B receptor expression. Further experiments demonstrated that the degree of habituation to the testing apparatus determined whether cocaine had no effect on locomotion in DAT KO or reduced locomotion, helping to resolve differences among prior reports. These findings of complementation of the locomotor effects of DAT KO by reducing 5-HT1B receptor activity underscore roles for interactions between specific 5-HT receptors and dopamine (DA) systems in basal and cocaine-stimulated locomotion and support evaluation of 5-HT1B antagonists as potential, non-stimulant ADHD therapeutics.	[Hall, Frank Scott] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol, Toledo, OH 43606 USA; [Hall, Frank Scott; Uhl, George R.] NIDA, Mol Neurobiol Branch, Intramural Res Program, Baltimore, MD USA; [Sora, Ichiro] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY USA; [Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA	University System of Ohio; University of Toledo; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Kobe University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Hall, FS (corresponding author), Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol, 2801 W Bancroft St, Toledo, OH 43606 USA.	frank.hall@utoledo.edu	Hall, F. Scott/C-3036-2013	Hall, F. Scott/0000-0002-0822-4063	National Institute on Drug Abuse, Intramural Research Program (NIH/DHHS, USA)	National Institute on Drug Abuse, Intramural Research Program (NIH/DHHS, USA)	This research was supported by the National Institute on Drug Abuse, Intramural Research Program (NIH/DHHS, USA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arime Y, 2012, NEUROPSYCHOPHARMACOL, V37, P2522, DOI 10.1038/npp.2012.114; Arime Y, 2011, BIOL PHARM BULL, V34, P1373, DOI 10.1248/bpb.34.1373; Ase AR, 2008, J CHEM NEUROANAT, V35, P356, DOI 10.1016/j.jchemneu.2008.02.007; Ase AR, 2000, J NEUROCHEM, V75, P2415, DOI 10.1046/j.1471-4159.2000.0752415.x; Ase AR, 2001, J NEUROCHEM, V78, P619, DOI 10.1046/j.1471-4159.2001.00437.x; Banerjee E, 2012, PSYCHIAT RES, V200, P1083, DOI 10.1016/j.psychres.2012.04.003; Barr CL, 2001, BIOL PSYCHIAT, V49, P333, DOI 10.1016/S0006-3223(00)01053-2; BONHOMME N, 1995, NEUROPHARMACOLOGY, V34, P269, DOI 10.1016/0028-3908(94)00145-I; Boulenguez P, 1996, NEUROPHARMACOLOGY, V35, P1521, DOI 10.1016/S0028-3908(96)00099-8; Bowers BJ, 2000, J NEUROCHEM, V75, P1625, DOI 10.1046/j.1471-4159.2000.0751625.x; CAMERON DL, 1994, J NEUROSCI, V14, P6763; CARTER CJ, 1979, N-S ARCH PHARMACOL, V308, P51, DOI 10.1007/BF00499718; Chaouloff F, 1999, PSYCHOPHARMACOLOGY, V141, P326, DOI 10.1007/s002130050841; Clifton PG, 2003, EUROPEAN J NEUROSCIE, V17; COOK EH, 1995, AM J HUM GENET, V56, P993; CREESE I, 1974, PSYCHOPHARMACOLOGIA, V39, P345, DOI 10.1007/BF00422974; CREESE I, 1972, NATURE-NEW BIOL, V238, P247, DOI 10.1038/newbio238247a0; CREESE I, 1973, BRAIN RES, V55, P369, DOI 10.1016/0006-8993(73)90302-8; DeDeurwaerdere P, 1997, J NEUROCHEM, V68, P195; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; Faccidomo S, 2012, PSYCHOPHARMACOLOGY, V222, P117, DOI 10.1007/s00213-011-2629-1; Fauchey V, 2000, EUR J NEUROSCI, V12, P3415, DOI 10.1046/j.1460-9568.2000.00220.x; Fauchey V, 2000, EUR J NEUROSCI, V12, P19, DOI 10.1046/j.1460-9568.2000.00876.x; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2001, J AM ACAD CHILD PSY, V40, P380, DOI 10.1097/00004583-200103000-00020; GATELY PF, 1985, PSYCHOPHARMACOLOGY, V87, P400, DOI 10.1007/BF00432502; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GLICK SD, 1973, EUR J PHARMACOL, V24, P266, DOI 10.1016/0014-2999(73)90082-4; Hawi Z, 2002, MOL PSYCHIATR, V7, P718, DOI 10.1038/sj.mp.4001048; Humphries MD, 2010, PROG NEUROBIOL, V90, P385, DOI 10.1016/j.pneurobio.2009.11.003; Igari M, BEHAV PHARM IN PRESS; Iversen S D, 1977, Adv Biochem Psychopharmacol, V16, P209; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; JOYCE EM, 1983, NEUROPHARMACOLOGY, V22, P1141, DOI 10.1016/0028-3908(83)90051-5; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; Kirley A, 2002, NEUROPSYCHOPHARMACOL, V27, P607; KOOB GF, 1978, J COMP PHYSIOL PSYCH, V92, P917, DOI 10.1037/h0077542; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Li BJ, 2010, EUR J PHARMACOL, V628, P104, DOI 10.1016/j.ejphar.2009.11.036; Lucas JJ, 1997, MOL PHARMACOL, V51, P755, DOI 10.1124/mol.51.5.755; Malleret G, 1999, 5 HT1B RECEPTOR KNOC; Matthies S, 2013, J ATTEN DISORD, V17, P176, DOI 10.1177/1087054711428739; MILLER R, 1974, BRAIN RES, V81, P387, DOI 10.1016/0006-8993(74)90957-3; Morikawa H, 2000, MOL PHARMACOL, V58, P1271, DOI 10.1124/mol.58.6.1271; NEILL DB, 1972, PHYSIOL BEHAV, V9, P655, DOI 10.1016/0031-9384(72)90026-1; Neumaier JF, 2002, J NEUROSCI, V22, P10856; O'Dell LE, 2006, J NEUROCHEM, V99, P1363, DOI 10.1111/j.1471-4159.2006.04163.x; O'Dell LE, 2004, J PHARMACOL EXP THER, V311, P711, DOI 10.1124/jpet.104.069278; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Parent M, 2011, J CHEM NEUROANAT, V41, P256, DOI 10.1016/j.jchemneu.2011.04.005; Pentkowski NS, 2012, BIOL PSYCHIAT, V72, P396, DOI 10.1016/j.biopsych.2012.03.024; Pentkowski NS, 2009, ADDICT BIOL, V14, P419, DOI 10.1111/j.1369-1600.2009.00162.x; Pereira DB, 2012, FRONT BIOSCI-LANDMRK, V17, P2740, DOI 10.2741/4083; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ramboz S, 1996, BEHAV BRAIN RES, V73, P305; Ramos-Quiroga JA, 2014, J PSYCHIATR RES, V49, P60, DOI 10.1016/j.jpsychires.2013.10.022; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Rocha BA, 1998, NATURE, V393, P175, DOI 10.1038/30259; Sanchez-Mora C, 2013, EUR NEUROPSYCHOPHARM, V23, P1463, DOI 10.1016/j.euroneuro.2013.07.002; Sari Y, 1997, BRAIN RES, V760, P281, DOI 10.1016/S0006-8993(97)00400-9; Sari Y, 1999, NEUROSCIENCE, V88, P899, DOI 10.1016/S0306-4522(98)00256-5; Sarkis EH, 2000, SCIENCE, V287, P2160; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Smoller JW, 2006, BIOL PSYCHIAT, V59, P460, DOI 10.1016/j.biopsych.2005.07.017; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Sotnikova Tatyana D., 2006, CNS & Neurological Disorders-Drug Targets, V5, P45, DOI 10.2174/187152706784111579; STECK H, 1954, Ann Med Psychol (Paris), V112, P737; Teicher MH, 2003, J CHILD ADOL PSYCHOP, V13, P41, DOI 10.1089/104454603321666180; TRICKLEBANK MD, 1986, NEUROPHARMACOLOGY, V25, P877, DOI 10.1016/0028-3908(86)90014-6; Uchiumi O, 2013, NEUROPHARMACOLOGY, V64, P348, DOI 10.1016/j.neuropharm.2012.07.016; Vandenbergh DJ, 2000, MOL PSYCHIATR, V5, P283, DOI 10.1038/sj.mp.4000701; Volkow N D, 2000, Science, V288, P11; Volkow ND, 2002, EUR NEUROPSYCHOPHARM, V12, P557, DOI 10.1016/S0924-977X(02)00104-9; West AR, 1996, SYNAPSE, V23, P20, DOI 10.1002/(SICI)1098-2396(199605)23:1<20::AID-SYN3>3.0.CO;2-J; YADID G, 1994, J PHARMACOL EXP THER, V270, P1158; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yamashita M, 2013, PSYCHOPHARMACOLOGY, V227, P741, DOI 10.1007/s00213-013-3009-9; Zhang X.W., 2010, PLOS ONE, V5	83	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115009	10.1371/journal.pone.0115009	http://dx.doi.org/10.1371/journal.pone.0115009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514162	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300025
J	Lutkenhoff, ES; Rosenberg, M; Chiang, J; Zhang, KY; Pickard, JD; Owen, AM; Monti, MM				Lutkenhoff, Evan S.; Rosenberg, Matthew; Chiang, Jeffrey; Zhang, Kunyu; Pickard, John D.; Owen, Adrian M.; Monti, Martin M.			Optimized Brain Extraction for Pathological Brains (optiBET)	PLOS ONE			English	Article							MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; IMAGE-ANALYSIS; ROBUST; REGISTRATION; FSL	The study of structural and functional magnetic resonance imaging data has greatly benefitted from the development of sophisticated and efficient algorithms aimed at automating and optimizing the analysis of brain data. We address, in the context of the segmentation of brain from non-brain tissue (i.e., brain extraction, also known as skull-stripping), the tension between the increased theoretical and clinical interest in patient data, and the difficulty of conventional algorithms to function optimally in the presence of gross brain pathology. Indeed, because of the reliance of many algorithms on priors derived from healthy volunteers, images with gross pathology can severely affect their ability to correctly trace the boundaries between brain and non-brain tissue, potentially biasing subsequent analysis. We describe and make available an optimized brain extraction script for the pathological brain (optiBET) robust to the presence of pathology. Rather than attempting to trace the boundary between tissues, optiBET performs brain extraction by (i) calculating an initial approximate brain extraction; (ii) employing linear and non-linear registration to project the approximate extraction into the MNI template space; (iii) back-projecting a standard brain-only mask from template space to the subject's original space; and (iv) employing the back-projected brain-only mask to mask-out non-brain tissue. The script results in up to 94% improvement of the quality of extractions over those obtained with conventional software across a large set of severely pathological brains. Since optiBET makes use of freely available algorithms included in FSL, it should be readily employable by anyone having access to such tools.	[Lutkenhoff, Evan S.; Rosenberg, Matthew; Chiang, Jeffrey; Zhang, Kunyu; Monti, Martin M.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Pickard, John D.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Cambridge CB2 2QQ, England; [Owen, Adrian M.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada; [Monti, Martin M.] Univ Calif Los Angeles, Ronald Reagan Med Ctr, Dept Neurosurg, BIRC, Los Angeles, CA USA	University of California System; University of California Los Angeles; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center	Monti, MM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	monti@psych.ucla.edu	Owen, Adrian M/B-4997-2015; Monti, Martin/G-8352-2011	Monti, Martin/0000-0001-5511-3780; Chiang, Jeffrey/0000-0002-6843-1355	James S. McDonnell Foundation Scholar Award; Medical Research Council [U. 1055.01.002.00007.01, U. 1055.01.002.00001.01]; European Commission ICT Programme [FP7-247919]	James S. McDonnell Foundation Scholar Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission ICT Programme	This work was supported by the James S. McDonnell Foundation Scholar Award, the Medical Research Council (U. 1055.01.002.00007.01 and U. 1055.01.002.00001.01), and the European Commission ICT Programme Project FP7-247919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Friston KJ, 1997, HUMAN BRAIN FUNCTION, P25; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Hendrson A, 2004, PARAVIEW GUIDE PARAL; Iglesias JE, 2011, IEEE T MED IMAGING, V30, P1617, DOI 10.1109/TMI.2011.2138152; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Monti MM, 2013, HUM BRAIN MAPP, V34, P1245, DOI 10.1002/hbm.21507; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Monti MM, 2009, PROG BRAIN RES, V177, P249, DOI 10.1016/S0079-6123(09)17717-8; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Monti MM, NEUROLOGY IN PRESS; Popescu V, 2012, NEUROIMAGE, V61, P1484, DOI 10.1016/j.neuroimage.2012.03.074; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051	19	123	123	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115551	10.1371/journal.pone.0115551	http://dx.doi.org/10.1371/journal.pone.0115551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514672	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300061
J	Michel, A; Downey, P; Nicolas, JM; Scheller, D				Michel, Anne; Downey, Patrick; Nicolas, Jean-Marie; Scheller, Dieter			Unprecedented Therapeutic Potential with a Combination of A(2A)/NR2B Receptor Antagonists as Observed in the 6-OHDA Lesioned Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NR2B-CONTAINING NMDA RECEPTORS; DOPA-INDUCED DYSKINESIA; GLUTAMATE RECEPTORS; ANIMAL-MODELS; ANTIPARKINSONIAN ACTIONS; MOLECULAR-MECHANISMS; MOTOR FLUCTUATIONS; MARMOSET MODEL; RODENT MODELS; DOUBLE-BLIND	In Parkinson's disease, the long-term use of dopamine replacing agents is associated with the development of motor complications; therefore, there is a need for non-dopaminergic drugs. This study evaluated the potential therapeutic impact of six different NR2B and A(2A) receptor antagonists given either alone or in combination in unilateral 6-OHDA-lesioned rats without (monotherapy) or with (add-on therapy) the co-administration of L-Dopa: Sch-58261+ Merck 22; Sch58261+Co-101244; Preladenant + Merck 22; Preladenant + Radiprodil; Tozadenant + Radiprodil; Istradefylline + Co-101244. Animals given monotherapy were assessed on distance traveled and rearing, whereas those given add-on therapy were assessed on contralateral rotations. Three-way mixed ANOVA were conducted to assess the main effect of each drug separately and to determine whether any interaction between two drugs was additive or synergistic. Additional post hoc analyses were conducted to compare the effect of the combination with the effect of the drugs alone. Motor activity improved significantly and was sustained for longer when the drugs were given in combination than when administered separately at the same dose. Similarly, when tested as add-on treatment to L-Dopa, the combinations resulted in higher levels of contralateral rotation in comparison to the single drugs. Of special interest, the activity observed with some combinations could not be described by a simplistic additive effect and involved more subtle synergistic pharmacological interactions. The combined administration of A(2A)/NR2B-receptor antagonists improved motor behaviour in 6-OHDA rats. Given the proven translatability of this model such a combination may be expected to be effective in improving motor symptoms in patients.	[Michel, Anne; Downey, Patrick; Scheller, Dieter] UCB BioPharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium; [Nicolas, Jean-Marie] UCB BioPharma SPRL, Nonclin Dev, Braine Lalleud, Belgium		Michel, A (corresponding author), UCB BioPharma SPRL, Neurosci TA Biol, Braine Lalleud, Belgium.	anne.michel@ucb.com						Acquas E, 1999, BEHAV BRAIN RES, V103, P219, DOI 10.1016/S0166-4328(99)00038-8; Addy C, 2009, J CLIN PHARMACOL, V49, P856, DOI 10.1177/0091270009336735; Aman TK, 2014, J BIOL CHEM; Armentero MT, 2011, PHARMACOL THERAPEUT, V132, P280, DOI 10.1016/j.pharmthera.2011.07.004; Atack JR, 2014, PRECLINICAL MODELS P; Bargiotas P, 2013, NEUROPSYCH DIS TREAT, V9, P1605, DOI 10.2147/NDT.S36693; Barta-Szalai G, 2004, BIOORG MED CHEM LETT, V14, P3953, DOI 10.1016/j.bmcl.2004.05.053; Bibbiani F, 2003, EXP NEUROL, V184, P285, DOI 10.1016/S0014-4886(03)00250-4; Blanchet PJ, 1999, J PHARMACOL EXP THER, V290, P1034; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Haes JU, 2013, CLIN PHARMACOL THER, V93, pS111; Delfino MA, 2004, BEHAV BRAIN RES, V152, P297, DOI 10.1016/j.bbr.2003.10.009; Duty S, 2012, CNS DRUGS, V26, P1017, DOI 10.1007/s40263-012-0016-z; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Fernandez HH, 2010, PARKINSONISM RELAT D, V16, P16, DOI 10.1016/j.parkreldis.2009.06.008; Ferre S, 2001, PARKINSONISM RELAT D, V7, P235, DOI 10.1016/S1353-8020(00)00063-8; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fox SH, 2008, LANCET NEUROL, V7, P927, DOI 10.1016/S1474-4422(08)70214-X; Fuxe K, 2005, J MOL NEUROSCI, V26, P209, DOI 10.1385/JMN:26:2-3:209; Gallagher DA, 2007, MOVEMENT DISORD, V22, P1757, DOI 10.1002/mds.21611; Hallett PJ, 2004, PHARMACOL THERAPEUT, V102, P155, DOI 10.1016/j.pharmthera.2004.04.001; Hauber W, 1996, N-S ARCH PHARMACOL, V354, P179; Hauser RA, 2014, LANCET NEUROL, V13, P767, DOI 10.1016/S1474-4422(14)70148-6; Hodgson RA, 2009, J PHARMACOL EXP THER, V330, P294, DOI 10.1124/jpet.108.149617; Janhunen S, 2005, EUR J PHARMACOL, V511, P143, DOI 10.1016/j.ejphar.2005.02.017; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Johnson KA, 2009, CNS NEUROL DISORD-DR, V8, P475, DOI 10.2174/187152709789824606; Kelsey JE, 2004, PSYCHOPHARMACOLOGY, V175, P179, DOI 10.1007/s00213-004-1799-5; Kelsey JE, 2009, PSYCHOPHARMACOLOGY, V201, P529, DOI 10.1007/s00213-008-1319-0; Kuppenbender KD, 2000, J COMP NEUROL, V419, P407, DOI 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I; Laloux C, 2012, PHARMACOL RES, V65, P514, DOI 10.1016/j.phrs.2012.02.008; Layton ME, 2011, ACS CHEM NEUROSCI, V2, P352, DOI 10.1021/cn200013d; LeWitt PA, 2008, ANN NEUROL, V63, P295, DOI 10.1002/ana.21315; Loftis JM, 2003, PHARMACOL THERAPEUT, V97, P55, DOI 10.1016/S0163-7258(02)00302-9; Loschmann PA, 2004, EXP NEUROL, V187, P86, DOI 10.1016/j.expneurol.2004.01.018; Lundblad M, 2003, J NEUROCHEM, V84, P1398, DOI 10.1046/j.1471-4159.2003.01632.x; Marino MJ, 2002, AMINO ACIDS, V23, P185, DOI 10.1007/s00726-001-0127-1; Marino MJ, 2003, DRUG AGING, V20, P377, DOI 10.2165/00002512-200320050-00006; Michel A., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Mignon L, 2007, PSYCHOPHARMACOLOGY, V192, P49, DOI 10.1007/s00213-006-0680-0; Mihara T, 2007, MODELS PARKINSON S D; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Nadjar A, 2009, PROG NEUROBIOL, V87, P1, DOI 10.1016/j.pneurobio.2008.09.013; Nash JE, 1999, EXP NEUROL, V155, P42, DOI 10.1006/exnr.1998.6963; Nash JE, 2004, EXP NEUROL, V188, P471, DOI 10.1016/j.expneurol.2004.05.004; Nash JE, 2000, EXP NEUROL, V165, P136, DOI 10.1006/exnr.2000.7444; Nash JE, 2000, J NEUROSCI, V20, P7782; Neustadt BR, 2007, BIOORG MED CHEM LETT, V17, P1376, DOI 10.1016/j.bmcl.2006.11.083; Nutt JG, 2008, MOVEMENT DISORD, V23, P1860, DOI 10.1002/mds.22169; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Orru M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016088; Pinna A, 2005, EUR J PHARMACOL, V512, P157, DOI 10.1016/j.ejphar.2005.01.057; Pinna A, 2001, SYNAPSE, V39, P233, DOI 10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K; Pinna A, 1996, EUR J NEUROSCI, V8, P1176, DOI 10.1111/j.1460-9568.1996.tb01285.x; Pinna A, 2014, CNSDRUGS; Quiroz C, 2006, J NEUROSCI, V26, P10808, DOI 10.1523/JNEUROSCI.1661-06.2006; Ramirez-Zamora A, 2014, EXPERT REV NEUROTHER, V14, P93, DOI 10.1586/14737175.2014.868306; Rao N, 2008, J CLIN PHARMACOL, V48, P1092, DOI 10.1177/0091270008320924; Schapira AHV, 2005, J NEUROL NEUROSUR PS, V76, P1472, DOI 10.1136/jnnp.2004.035980; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Shook BC, 2010, J MED CHEM, V53, P8104, DOI 10.1021/jm100971t; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Stacy M, 2008, NEUROLOGY, V70, P2233, DOI 10.1212/01.wnl.0000313834.22171.17; Steece-Collier K, 2000, EXP NEUROL, V163, P239, DOI 10.1006/exnr.2000.7374; Tronci E, 2007, EUR J PHARMACOL, V566, P94, DOI 10.1016/j.ejphar.2007.03.021; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Wessell RH, 2004, NEUROPHARMACOLOGY, V47, P184, DOI 10.1016/j.neuropharm.2004.03.011; Zhou ZL, 1999, J MED CHEM, V42, P2993, DOI 10.1021/jm990246i	74	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e114086	10.1371/journal.pone.0114086	http://dx.doi.org/10.1371/journal.pone.0114086			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25513815	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300007
J	Papazachariou, L; Demosthenous, P; Pieri, M; Papagregoriou, G; Savva, I; Stavrou, C; Zavros, M; Athanasiou, Y; Ioannou, K; Patsias, C; Panagides, A; Potamitis, C; Demetriou, K; Prikis, M; Hadjigavriel, M; Kkolou, M; Loukaidou, P; Pastelli, A; Michael, A; Lazarou, A; Arsali, M; Damianou, L; Goutziamani, I; Soloukides, A; Yioukas, L; Elia, A; Zouvani, I; Polycarpou, P; Pierides, A; Voskarides, K; Deltas, C				Papazachariou, Louiza; Demosthenous, Panayiota; Pieri, Myrtani; Papagregoriou, Gregory; Savva, Isavella; Stavrou, Christoforos; Zavros, Michael; Athanasiou, Yiannis; Ioannou, Kyriakos; Patsias, Charalambos; Panagides, Alexia; Potamitis, Costas; Demetriou, Kyproula; Prikis, Marios; Hadjigavriel, Michael; Kkolou, Maria; Loukaidou, Panayiota; Pastelli, Androulla; Michael, Aristos; Lazarou, Akis; Arsali, Maria; Damianou, Loukas; Goutziamani, Ioanna; Soloukides, Andreas; Yioukas, Lakis; Elia, Avraam; Zouvani, Ioanna; Polycarpou, Polycarpos; Pierides, Alkis; Voskarides, Konstantinos; Deltas, Constantinos			Frequency of COL4A3/COL4A4 Mutations amongst Families Segregating Glomerular Microscopic Hematuria and Evidence for Activation of the Unfolded Protein Response. Focal and Segmental Glomerulosclerosis Is a Frequent Development during Ageing	PLOS ONE			English	Article							IV COLLAGEN ALPHA-3; ALPORT SYNDROME; RENAL-FAILURE; COL4A4 GENE; ER STRESS; BENIGN; IDENTIFICATION; CHILDREN; SURVEYOR; DISEASES	Familial glomerular hematuria(s) comprise a genetically heterogeneous group of conditions which include Alport Syndrome (AS) and thin basement membrane nephropathy (TBMN). Here we investigated 57 Greek-Cypriot families presenting glomerular microscopic hematuria (GMH), with or without proteinuria or chronic kidney function decline, but excluded classical AS. We specifically searched the COL4A3/A4 genes and identified 8 heterozygous mutations in 16 families (28,1%). Eight non-related families featured the founder mutation COL4A3-p.(G1334E). Renal biopsies from 8 patients showed TBMN and focal segmental glomerulosclerosis (FSGS). Ten patients (11.5%) reached end-stage kidney disease (ESKD) at ages ranging from 37-69-yo (mean 50,1-yo). Next generation sequencing of the patients who progressed to ESKD failed to reveal a second mutation in any of the COL4A3/A4/A5 genes, supporting that true heterozygosity for COL4A3/A4 mutations predisposes to CRF/ESKD. Although this could be viewed as a milder and late-onset form of autosomal dominant AS, we had no evidence of ultrastructural features or extrarenal manifestations that would justify this diagnosis. Functional studies in cultured podocytes transfected with wild type or mutant COL4A3 chains showed retention of mutant collagens and differential activation of the unfolded protein response (UPR) cascade. This signifies the potential role of the UPR cascade in modulating the final phenotype in patients with collagen IV nephropathies.	[Papazachariou, Louiza; Demosthenous, Panayiota; Pieri, Myrtani; Papagregoriou, Gregory; Savva, Isavella; Voskarides, Konstantinos; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, CY-1678 Nicosia, Cyprus; [Papazachariou, Louiza; Demosthenous, Panayiota; Pieri, Myrtani; Papagregoriou, Gregory; Savva, Isavella; Voskarides, Konstantinos; Deltas, Constantinos] Univ Cyprus, Lab Mol & Med Genet, CY-1678 Nicosia, Cyprus; [Stavrou, Christoforos] Evangelismos Med Ctr, Dept Nephrol, Pafos, Cyprus; [Zavros, Michael; Athanasiou, Yiannis; Ioannou, Kyriakos; Patsias, Charalambos; Panagides, Alexia; Potamitis, Costas; Demetriou, Kyproula; Prikis, Marios] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Hadjigavriel, Michael; Kkolou, Maria; Loukaidou, Panayiota; Pastelli, Androulla] Larnaca Gen Hosp, Dept Nephrol, Larnax, Cyprus; [Michael, Aristos; Lazarou, Akis; Arsali, Maria; Damianou, Loukas; Goutziamani, Ioanna; Soloukides, Andreas] Limassol Gen Hosp, Dept Nephrol, Limassol, Cyprus; [Yioukas, Lakis] Paphos Gen Hosp, Dept Nephrol, Paphos, Cyprus; [Elia, Avraam] Archbishop Makarios III Hosp, Dept Pediat, Nicosia, Cyprus; [Zouvani, Ioanna] Nicosia Gen Hosp, Dept Histopathol, Nicosia, Cyprus; [Polycarpou, Polycarpos] Apollon Private Hosp, Dept Nephrol, Nicosia, Cyprus; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus	University of Cyprus; University of Cyprus; Hippocrateon Private Hospital	Pierides, A (corresponding author), Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus.	a.pierides@hippocrateon.com; deltas@ucy.ac.cy	Voskarides, Konstantinos/A-4669-2013; Deltas, Constantinos/A-4936-2013	Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Papagregoriou, Gregory/0000-0002-2440-9789; Pieri, Myrtani/0000-0002-8883-4434	European Regional Development Fund; Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project) [NEW INFRASTRUCTURE/STRATEGIC/0308/24]	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project)	This research project was supported by a grant co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Strategic Infrastructure Project NEW INFRASTRUCTURE/STRATEGIC/0308/24) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Boot-Handford RP, 2010, CELL TISSUE RES, V339, P197, DOI 10.1007/s00441-009-0877-8; Boye E, 1998, AM J HUM GENET, V63, P1329, DOI 10.1086/302106; Buzza M, 2001, KIDNEY INT, V59, P1670, DOI 10.1046/j.1523-1755.2001.0590051670.x; Castelletti F, 2008, P NATL ACAD SCI USA, V105, P2538, DOI 10.1073/pnas.0707730105; Deltas C, 2013, NEPHROL DIAL TRANSPL; Deltas C, 2013, NEPHROL DIAL TRANSPL, V28, P2946, DOI 10.1093/ndt/gft253; Demosthenous P, 2012, CLIN GENET, V81, P240, DOI 10.1111/j.1399-0004.2011.01647.x; Erguler K, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-16; Fallerini C, 2013, CLIN GENET; Fukuda K, 1997, BIOCHEM BIOPH RES CO, V231, P178, DOI 10.1006/bbrc.1997.6069; Gale DP, 2013, PEDIATR NEPHROL, V28, P1183, DOI 10.1007/s00467-012-2399-y; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gross O, 2014, NEPHROL DIAL TRANSPL, V29, P124, DOI 10.1093/ndt/gfu028; Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671; Heidet L, 2001, J AM SOC NEPHROL, V12, P97, DOI 10.1681/ASN.V12197; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kashtan CE, 2009, PEDIATR NEPHROL, V24, P1951, DOI 10.1007/s00467-007-0622-z; Kobayashi T, 2003, KIDNEY INT, V64, P1986, DOI 10.1046/j.1523-1755.2003.00323.x; Kobayashi T, 2010, PEDIATR NEPHROL, V25, P1169, DOI 10.1007/s00467-009-1433-1; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Leinonen A, 1999, KIDNEY INT, V55, P926, DOI 10.1046/j.1523-1755.1999.055003926.x; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Marcocci E, 2009, NEPHROL DIAL TRANSPL, V24, P1464, DOI 10.1093/ndt/gfn681; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miner JH, 2014, KIDNEY INT; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pieri M, 2014, J AM SOC NEPHROL, V25, P260, DOI 10.1681/ASN.2012121217; Pierides A, 2013, HIPPOKRATIA, V17, P207; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Rana K, 2005, PEDIATR NEPHROL, V20, P1729, DOI 10.1007/s00467-005-2034-2; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Savige J, 2004, NEPHROLOGY, V9, P52, DOI 10.1111/j.1440-1797.2004.00243.x; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; Taylor J, 2014, ARCH DIS CHILD; Temme J, 2012, KIDNEY INT, V81, P779, DOI 10.1038/ki.2011.452; Tonna S, 2005, SEMIN NEPHROL, V25, P171, DOI 10.1016/j.semnephrol.2005.01.009; Tonna S, 2008, PEDIATR NEPHROL, V23, P2201, DOI 10.1007/s00467-008-0934-7; Tryggvason K, 2006, J AM SOC NEPHROL, V17, P813, DOI 10.1681/ASN.2005070737; Van Agtmael T, 2010, CELL TISSUE RES, V339, P167, DOI 10.1007/s00441-009-0866-y; Voskarides K, 2008, PEDIATR NEPHROL, V23, P1373, DOI 10.1007/s00467-008-0804-3; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Voskarides K, 2012, PEDIATR NEPHROL, V27, P675, DOI 10.1007/s00467-011-2084-6; Voskarides K, 2009, J MOL DIAGN, V11, P311, DOI 10.2353/jmoldx.2009.080144; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; ZHOU J, 1991, GENOMICS, V9, P10, DOI 10.1016/0888-7543(91)90215-Z	56	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115015	10.1371/journal.pone.0115015	http://dx.doi.org/10.1371/journal.pone.0115015			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514610	gold, Green Published			2022-12-27	WOS:000349146300028
J	Brouwer, M; Coelho, E; Mosse, CD; Brondi, L; Winterton, L; van Leth, F				Brouwer, Miranda; Coelho, Eliana; Mosse, Carla das Dores; Brondi, Luciana; Winterton, Laura; van Leth, Frank			Healthcare Workers' Challenges in the Implementation of Tuberculosis Infection Prevention and Control Measures in Mozambique	PLOS ONE			English	Article							CONTROL KNOWLEDGE	Objective: Healthcare Workers (HCWs) have a higher frequency of TB exposure than the general population and have therefore an occupational TB risk that infection prevention and control (IPC) measures aim to reduce. HCWs are crucial in the implementation of these measures. The objective of the study was to investigate Mozambican HCWs' perceptions of their occupational TB risk and the measures they report using to reduce this risk. In addition, we explored the challenges HCWs encounter while using these TBIPC measures. Methods: Focus group discussion. Analysis according content method. Participants: Four categories of HCWs: auxiliary workers, medical (doctors and clinical officers), nurses and TB program staff. Results: HCWs are aware of their occupational TB risk and use various measures to reduce their risk of infection. HCWs find it challenging to employ measures that minimize such risks and a lack of clear guidelines contributes to these challenges. HCWs' and patient behavior further complicate the use of TBIPC measures. Conclusion: HCWs in Mozambique perceive a high occupational risk of TB infection. They report several challenges using measures to reduce this risk such as shortage of material, lack of clear guidelines, insufficient motivation and inadequate training. Robust training with motivational approaches, alongside supervision and support for HCWs could improve implementation of TBIPC measures. Healthcare management should address the areas for improvement that are beyond the individual HCW's control.	[Brouwer, Miranda] Hlth Alliance Int, Tech Assistance Unit, Maputo, Mozambique; [Coelho, Eliana] Minist Hlth, Maputo, Mozambique; [Mosse, Carla das Dores] Minist Hlth, Prov Directorate, Tete, Mozambique; [Winterton, Laura] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [van Leth, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands	University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam	Brouwer, M (corresponding author), Hlth Alliance Int, Tech Assistance Unit, Maputo, Mozambique.	brouwer.miranda@gmail.com		van Leth, Frank/0000-0002-5490-8968	United States Agency for International Development	United States Agency for International Development(United States Agency for International Development (USAID))	This research was part of the activities supported by a grant from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buregyeya E, 2012, J PUBLIC HEALTH-HEID, V20, P599, DOI 10.1007/s10389-012-0503-1; Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; Hobday RA, 2013, J HOSP INFECT, V84, P271, DOI 10.1016/j.jhin.2013.04.011; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kamulegeya A, 2013, J INFECT DEV COUNTR, V7, P726, DOI 10.3855/jidc.2486; Kanjee Z, 2012, J Infect Public Health, V5, P67, DOI 10.1016/j.jiph.2011.10.008; Ministerio da Saude & Instituto Nacional de Saude, 2009, INQ NAC PREV RISC CO; Ministerio de Saude Direccao Nacional de Saude Publica Programa Nacional de Controlo da Tuberculose, 2010, POL PLAN NAC CONTR I; Ministry of Health National Directorate of Human Resources, 2008, NAT PLAN HLTH HUM RE; Ministry of Health of The Republic of Uganda, UG NAT GUID TUB INF; Mulder C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049649; Robert J, 2013, INFECT CONT HOSP EP, V34, P190, DOI 10.1086/669085; Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262; Tenna A, 2013, INFECT CONT HOSP EP, V34, P1289, DOI 10.1086/673979; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woith W, 2012, INT J TUBERC LUNG D, V16, P1092, DOI 10.5588/ijtld.10.0779; World Health Organization, 2009, POL TB INF CONTR HLT	18	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114364	10.1371/journal.pone.0114364	http://dx.doi.org/10.1371/journal.pone.0114364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25501847	Green Submitted, gold, Green Published			2022-12-27	WOS:000346607100013
J	Kawahara, R; Granato, DC; Carnielli, CM; Cervigne, NK; Oliveria, CE; Martinez, CAR; Yokoo, S; Fonseca, FP; Lopes, M; Santos-Silva, AR; Graner, E; Coletta, RD; Leme, AFP				Kawahara, Rebeca; Granato, Daniela C.; Carnielli, Carolina M.; Cervigne, Nilva K.; Oliveria, Carine E.; Martinez, Cesar A. R.; Yokoo, Sami; Fonseca, Felipe P.; Lopes, Marcio; Santos-Silva, Alan R.; Graner, Edgard; Coletta, Ricardo D.; Paes Leme, Adriana Franco			Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; TUMOR-GROWTH; MOLECULAR-MECHANISMS; BASEMENT-MEMBRANES; CANCER; METASTASIS; EXPRESSION; IDENTIFICATION; ANGIOGENESIS; ADHESION	Oral squamous cell carcinoma is the most common type of cancer in the oral cavity, representing more than 90% of all oral cancers. The characterization of altered molecules in oral cancer is essential to understand molecular mechanisms underlying tumor progression as well as to contribute to cancer biomarker and therapeutic target discovery. Proteoglycans are key molecular effectors of cell surface and pericellular microenvironments, performing multiple functions in cancer. Two of the major basement membrane proteoglycans, agrin and perlecan, were investigated in this study regarding their role in oral cancer. Using real time quantitative PCR (qRT-PCR), we showed that agrin and perlecan are highly expressed in oral squamous cell carcinoma. Interestingly, cell lines originated from distinct sites showed different expression of agrin and perlecan. Enzymatically targeting chondroitin sulfate modification by chondroitinase, oral squamous carcinoma cell line had a reduced ability to adhere to extracellular matrix proteins and increased sensibility to cisplatin. Additionally, knockdown of agrin and perlecan promoted a decrease on cell migration and adhesion, and on resistance of cells to cisplatin. Our study showed, for the first time, a negative regulation on oral cancer-associated events by either targeting chondroitin sulfate content or agrin and perlecan levels.	[Kawahara, Rebeca; Granato, Daniela C.; Carnielli, Carolina M.; Martinez, Cesar A. R.; Yokoo, Sami; Paes Leme, Adriana Franco] CNPEM, Lab Nacl Biociencias, Lab Espectrometria Massas, Campinas, SP, Brazil; [Cervigne, Nilva K.; Oliveria, Carine E.; Fonseca, Felipe P.; Lopes, Marcio; Santos-Silva, Alan R.; Graner, Edgard; Coletta, Ricardo D.] Univ Estadual Campinas, UNICAMP, Fac Odontol Piracicaba, Piracicaba, Brazil	Universidade Estadual de Campinas	Leme, AFP (corresponding author), CNPEM, Lab Nacl Biociencias, Lab Espectrometria Massas, Campinas, SP, Brazil.	adriana.paesleme@lnbio.cnpem.org.br	Leme, Adriana F Paes/C-9679-2012; Coletta, Ricardo D./B-4909-2015; Santos-Silva, Alan Roger/B-6121-2008; Cervigne, Nilva K/L-1341-2016; Graner, Edgard/K-4411-2012; Santos-Silva, Alan/C-9947-2016; Rivera, César/AFL-7931-2022; Fonseca, Felipe P/C-4158-2012; de Oliveira, Carine Ervolino/I-3087-2013; Graner, Edgard/P-4651-2019; Lopes, Marcio Ajudarte/AAV-1018-2020; Rivera, César/H-6109-2011; Carnielli, Carolina Moretto/V-2739-2019; Kawahara, Rebeca/B-1532-2015	Leme, Adriana F Paes/0000-0001-7959-147X; Coletta, Ricardo D./0000-0001-5285-3046; Santos-Silva, Alan Roger/0000-0003-2040-6617; Cervigne, Nilva K/0000-0002-6129-9136; Graner, Edgard/0000-0002-4737-7935; Santos-Silva, Alan/0000-0003-2040-6617; Rivera, César/0000-0002-5491-4233; Fonseca, Felipe P/0000-0002-6657-4547; Rivera, César/0000-0002-5491-4233; Carnielli, Carolina Moretto/0000-0001-8336-7390; Kawahara, Rebeca/0000-0002-0292-2637; Yokoo, Sami/0000-0003-4658-9319; Ajudarte Lopes, Marcio/0000-0001-6677-0065	FAPESP [2009/54067-3, 2010/19278-0, 2011/22421-2]; CNPq [470549/2011-4, 301702/2011-0, 470268/2013-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP Grants 2009/54067-3, 2010/19278-0, 2011/22421-2, and CNPq Grants 470549/2011-4, 301702/2011-0 and 470268/2013-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Agostini M, 2014, MOL CANCER THER, V13, P585, DOI 10.1158/1535-7163.MCT-12-1136; Aragao AZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043521; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Batmunkh E, 2007, HUM PATHOL, V38, P1508, DOI 10.1016/j.humpath.2007.02.017; Belcher R, 2014, J SURG ONCOL; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chai YD, 2014, HEAD NECK; Chang KP, 2011, J PROTEOME RES, V10, P4935, DOI 10.1021/pr200311p; da Silva SD, 2011, ORAL ONCOL, V47, P783, DOI 10.1016/j.oraloncology.2011.07.004; Dasari S., 2014, EUR J PHARM; Eberle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021496; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Feller L., 2012, J CANC THER, V3, P263, DOI [10.4236/jct.2012.34037, DOI 10.4236/JCT.2012.34037]; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Goldshmidt O, 2002, P NATL ACAD SCI USA, V99, P10031, DOI 10.1073/pnas.152070599; HAYASHI K, 1992, J CELL BIOL, V119, P945, DOI 10.1083/jcb.119.4.945; Ida-Yonemochi H, 2002, VIRCHOWS ARCH, V441, P165, DOI 10.1007/s00428-001-0556-y; Ikarashi T, 2004, J ORAL PATHOL MED, V33, P87, DOI 10.1111/j.1600-0714.2004.00026.x; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; KLEIN G, 1995, MATRIX BIOL, V14, P457, DOI 10.1016/0945-053X(95)90003-9; Martin PT, 1997, DEVELOPMENT, V124, P3909; Mishra Mithilesh, 2013, J Oral Maxillofac Pathol, V17, P31, DOI 10.4103/0973-029X.110704; Mundhenke C, 2002, AM J PATHOL, V160, P185, DOI 10.1016/S0002-9440(10)64362-3; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; Mydlarz Wojciech K, 2010, Expert Opin Med Diagn, V4, P53; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Pantazaka E, 2014, BBA-GEN SUBJECTS, V1840, P2643, DOI 10.1016/j.bbagen.2014.01.009; Pereira MC, 2007, J CAN DENT ASSOC, V73, P339; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Silva H, 2012, MOL PHARMACEUT, V9, P1795, DOI 10.1021/mp300098t; Somoracz A, 2010, HUM PATHOL, V41, P1310, DOI 10.1016/j.humpath.2009.10.029; Tatrai P, 2006, LAB INVEST, V86, P1149, DOI 10.1038/labinvest.3700475; Teng PN, 2014, BRIT J CANCER, V110, P123, DOI 10.1038/bjc.2013.687; Terp MG, 2012, CANCER GENOM PROTEOM, V9, P265; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; van Kempen LCLT, 2003, EUR J CELL BIOL, V82, P539, DOI 10.1078/0171-9335-00346; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; Yip GW, 2006, MOL CANCER THER, V5, P2139, DOI 10.1158/1535-7163.MCT-06-0082; Zhang JS, 2011, CARBOHYD RES, V346, P631, DOI 10.1016/j.carres.2011.01.007; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	54	32	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115004	10.1371/journal.pone.0115004	http://dx.doi.org/10.1371/journal.pone.0115004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506919	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100042
J	Shrestha, B; Sripadi, P; Reschke, BR; Henderson, HD; Powell, MJ; Moody, SA; Vertes, A				Shrestha, Bindesh; Sripadi, Prabhakar; Reschke, Brent R.; Henderson, Holly D.; Powell, Matthew J.; Moody, Sally A.; Vertes, Akos			Subcellular Metabolite and Lipid Analysis of Xenopus laevis Eggs by LAESI Mass Spectrometry	PLOS ONE			English	Article							ABLATION ELECTROSPRAY-IONIZATION; SPERM CHEMOATTRACTANT; SINGLE CELLS; IN-VIVO; OOCYTE; ALLURIN; TISSUE; KEGG	Xenopus laevis eggs are used as a biological model system for studying fertilization and early embryonic development in vertebrates. Most methods used for their molecular analysis require elaborate sample preparation including separate protocols for the water soluble and lipid components. In this study, laser ablation electrospray ionization (LAESI), an ambient ionization technique, was used for direct mass spectrometric analysis of X. laevis eggs and early stage embryos up to five cleavage cycles. Single unfertilized and fertilized eggs, their animal and vegetal poles, and embryos through the 32-cell stage were analyzed. Fifty two small metabolite ions, including glutathione, GABA and amino acids, as well as numerous lipids including 14 fatty acids, 13 lysophosphatidylcholines, 36 phosphatidylcholines and 29 triacylglycerols were putatively identified. Additionally, some proteins, for example thymosin beta 4 (Xen), were also detected. On the subcellular level, the lipid profiles were found to differ between the animal and vegetal poles of the eggs. Radial profiling revealed profound compositional differences between the jelly coat vitelline/plasma membrane and egg cytoplasm. Changes in the metabolic profile of the egg following fertilization, e.g., the decline of polyamine content with the development of the embryo were observed using LAESI-MS. This approach enables the exploration of metabolic and lipid changes during the early stages of embryogenesis.	[Shrestha, Bindesh; Sripadi, Prabhakar; Vertes, Akos] George Washington Univ, Dept Chem, WM Keck Inst Prote Technol & Applicat, Washington, DC 20052 USA; [Moody, Sally A.] George Washington Univ, Dept Anat & Regenerat Biol, Washington, DC USA; [Reschke, Brent R.; Henderson, Holly D.; Powell, Matthew J.] Protea Biosci, Morgantown, WV USA	George Washington University; George Washington University	Vertes, A (corresponding author), George Washington Univ, Dept Chem, WM Keck Inst Prote Technol & Applicat, Washington, DC 20052 USA.	vertes@gwu.edu	Moody, Sally A./AAI-3660-2020; Vertes, Akos/B-7159-2008; Shrestha, Bindesh/B-8821-2008	Moody, Sally A./0000-0003-4192-1087; Vertes, Akos/0000-0001-5186-5352; Shrestha, Bindesh/0000-0002-7595-3506	U.S. National Science Foundation [CHE-1152302, IOS-0817902, MCB-1121711]; George Washington University; Protea Biosciences	U.S. National Science Foundation(National Science Foundation (NSF)); George Washington University; Protea Biosciences	The authors gratefully acknowledge funding by the U.S. National Science Foundation through Grant No. CHE-1152302 to A.V. for the development of single cell and subcellular analysis methods, and through Grant Nos. IOS-0817902 and MCB-1121711 to S.A.M. for studying molecular changes in embryonic development. The George Washington University Selective Excellence Fund also provided financial contribution to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Protea Biosciences provided support in the form of salaries for authors BRR, HDH and MJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEZ T, 1990, DEVELOPMENT, V110, P955; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Elkan ER, 1938, BMJ-BRIT MED J, V4, P1253, DOI 10.1136/bmj.2.4067.1253; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Ferreira CR, 2012, J MASS SPECTROM, V47, P29, DOI 10.1002/jms.2022; Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u; Gonzalez-Serrano AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074981; Gurdon JB, 2000, INT J DEV BIOL, V44, P43; HANNAPPEL E, 1988, ARCH BIOCHEM BIOPHYS, V260, P546, DOI 10.1016/0003-9861(88)90480-8; Hausen P., 1991, EARLY DEV XENOPUS LA; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khokha MK, 2012, GENESIS, V50, P133, DOI 10.1002/dvg.22015; King ML, 2005, BIOL CELL, V97, P19; Koek MM, 2010, ANAL CHEM, V82, P156, DOI 10.1021/ac9015787; Lee SC, 2006, BIOPHYS J, V90, P1797, DOI 10.1529/biophysj.105.073502; Moody SA, 1999, CELL LINEAGE ANAL XE, P331; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nemes P, 2008, ANAL CHEM, V80, P4575, DOI 10.1021/ac8004082; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; OHLENDORF DH, 1977, J BIOL CHEM, V252, P7992; Olson JH, 2001, P NATL ACAD SCI USA, V98, P11205, DOI 10.1073/pnas.211316798; OSBORNE HB, 1989, BIOCHEM BIOPH RES CO, V158, P520, DOI 10.1016/S0006-291X(89)80080-4; Petcoff DW, 2008, J LIPID RES, V49, P2365, DOI 10.1194/jlr.M800159-JLR200; Sato K-i, 2006, STUDYING FERTILIZATI, P395; Shechter D, 2009, J BIOL CHEM, V284, P1064, DOI 10.1074/jbc.M807273200; Shrestha B, 2014, ANAL CHEM, V86, P4308, DOI 10.1021/ac500007t; Shrestha B, 2010, APPL PHYS A-MATER, V101, P121, DOI 10.1007/s00339-010-5781-2; Shrestha B, 2010, ANALYST, V135, P751, DOI 10.1039/b922854c; Shrestha B, 2009, ANAL CHEM, V81, P8265, DOI 10.1021/ac901525g; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; Stith BJ, 2000, J LIPID RES, V41, P1448; Stolee JA, 2012, ANGEW CHEM INT EDIT, V51, P10386, DOI 10.1002/anie.201205436; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; WASSERMAN WJ, 1976, SCIENCE, V191, P1266, DOI 10.1126/science.1083070; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Xiang XY, 2005, MOL REPROD DEV, V70, P344, DOI 10.1002/mrd.20201; YUREWICZ EC, 1975, BIOCHEMISTRY-US, V14, P3101, DOI 10.1021/bi00685a010; Zhang JH, 2004, ANAL BIOCHEM, V334, P20, DOI 10.1016/j.ab.2004.07.012	43	29	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115173	10.1371/journal.pone.0115173	http://dx.doi.org/10.1371/journal.pone.0115173			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506922	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100054
J	Bressan, MC; Louie, JD; Mikawa, T				Bressan, Michael C.; Louie, Jonathan D.; Mikawa, Takashi			Hemodynamic Forces Regulate Developmental Patterning of Atrial Conduction	PLOS ONE			English	Article							ENDOTHELIN-CONVERTING ENZYME-1; IN-SITU HYBRIDIZATION; MYOSIN HEAVY-CHAIN; CARDIAC CONDUCTION; VENTRICULAR MYOCARDIUM; PURKINJE-FIBERS; ANISOTROPIC CONDUCTION; PROLIFERATIVE STATE; CELL-PROLIFERATION; CHICK-EMBRYO	Anomalous action potential conduction through the atrial chambers of the heart can lead to severe cardiac arrhythmia. To date, however, little is known regarding the mechanisms that pattern proper atrial conduction during development. Here we demonstrate that atrial muscle functionally diversifies into at least two heterogeneous subtypes, thin-walled myocardium and rapidly conducting muscle bundles, during a developmental window just following cardiac looping. During this process, atrial muscle bundles become enriched for the fast conduction markers Cx40 and Nav1.5, similar to the precursors of the fast conduction Purkinje fiber network located within the trabeculae of the ventricles. In contrast to the ventricular trabeculae, however, atrial muscle bundles display an increased proliferation rate when compared to the surrounding myocardium. Interestingly, mechanical loading of the embryonic atrial muscle resulted in an induction of Cx40, Nav1.5 and the cell cycle marker Cyclin D1, while decreasing atrial pressure via in vivo ligation of the vitelline blood vessels results in decreased atrial conduction velocity. Taken together, these data establish a novel model for atrial conduction patterning, whereby hemodynamic stretch coordinately induces proliferation and fast conduction marker expression, which in turn promotes the formation of large diameter muscle bundles to serve as preferential routes of conduction.	[Bressan, Michael C.; Louie, Jonathan D.; Mikawa, Takashi] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mikawa, T (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	Takashi.Mikawa@UCSF.edu			National Institute of Health, Heart, Lung, Blood, Institute [R01 HL093566, R01 HL112268, R01 HL078921, 1K99HL122360]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL078921, R01HL112268, R01HL078921, R01HL122375, K99HL122360, R01HL093566, T32HL007544, R00HL122360] Funding Source: NIH RePORTER	National Institute of Health, Heart, Lung, Blood, Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institute of Health, Heart, Lung, Blood, Institute, http://www.nhlbi.nih.gov (R01 HL093566, R01 HL112268, R01 HL078921 to TM, and 1K99HL122360 to MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RH, 1998, J CARDIOVASC ELECTR, V9, P1233, DOI 10.1111/j.1540-8167.1998.tb00097.x; ANDERSON RH, 1981, ANAT REC, V201, P75, DOI 10.1002/ar.1092010110; Aschoff L., 1910, VERH DEUTSCH PATHOL, V14, P3; Bachmann G, 1916, AM J PHYSIOL, V41, P309, DOI 10.1152/ajplegacy.1916.41.3.309; Benes J, 2014, FEBS LETT, V588, P1465, DOI 10.1016/j.febslet.2014.01.032; Berenfeld O, 2004, ANAT REC PART A, V280A, P1053, DOI 10.1002/ar.a.20106; Betts TR, 2002, J CARDIOVASC ELECTR, V13, P1152, DOI 10.1046/j.1540-8167.2002.01152.x; Bressan M, 2014, DEVELOPMENT, V141, P4149, DOI 10.1242/dev.110007; Bressan M, 2013, SCIENCE, V340, P744, DOI 10.1126/science.1232877; Cheng AW, 2004, DEV BIOL, V272, P203, DOI 10.1016/j.ydbio.2004.04.031; DECARVALHO AP, 1959, AM J PHYSIOL, V196, P483, DOI 10.1152/ajplegacy.1959.196.3.483; DRAPER M. H., 1959, QUART JOUR EXPTL PHYSIOL, V44, P91; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; FUJII S, 1988, J MEMBRANE BIOL, V101, P209, DOI 10.1007/BF01872836; GOURDIE RG, 1995, DEVELOPMENT, V121, P1423; Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145; Hall CE, 2004, DEVELOPMENT, V131, P581, DOI 10.1242/dev.00947; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Ho SY, 2002, CARDIOVASC RES, V54, P325, DOI 10.1016/S0008-6363(02)00226-2; Hocini M, 1998, J AM COLL CARDIOL, V31, P629, DOI 10.1016/S0735-1097(97)00519-6; HOLSINGE.JW, 1968, ANN SURG, V167, P447, DOI 10.1097/00000658-196804000-00001; Hurtado R, 2006, DEV DYNAM, V235, P2811, DOI 10.1002/dvdy.20909; Jalife Jose, 1997, P357; JAMES TN, 1971, AM J CARDIOL, V28, P414, DOI 10.1016/0002-9149(71)90005-1; JETER JR, 1971, J EMBRYOL EXP MORPH, V25, P405; KAMINO K, 1991, PHYSIOL REV, V71, P53, DOI 10.1152/physrev.1991.71.1.53; KLEBER AG, 2011, NORMAL AND ABNORMAL, DOI DOI 10.1002/CPHY.CP020112; Kucera JP, 2002, CIRC RES, V91, P1176, DOI 10.1161/01.RES.0000046237.54156.0A; Lewis T, 1910, HEART-J STUD CIRC, V2, P147; LEWIS T, 1914, SERIES B CONTAINING, V205, P375, DOI DOI 10.2307/92042; Litchenberg WH, 2000, CARDIOVASC RES, V45, P379, DOI 10.1016/S0008-6363(99)00363-6; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Miquerol L, 2004, CARDIOVASC RES, V63, P77, DOI 10.1016/j.cardiores.2004.03.007; Miquerol L, 2013, DEV DYNAM, V242, P665, DOI 10.1002/dvdy.23964; MONCKEBERG JG, 1921, ERGEB ALLG PATH PATH, V19, P328; Nakajima K, 2011, DEVELOPMENT, V138, P1771, DOI 10.1242/dev.059295; Oana S, 1998, BIOL CELL, V90, P605; OOSTHOEK PW, 1993, CIRC RES, V73, P482, DOI 10.1161/01.RES.73.3.482; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Remme CA, 2009, BASIC RES CARDIOL, V104, P511, DOI 10.1007/s00395-009-0012-8; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Rentschler S, 2001, DEVELOPMENT, V128, P1785; SAFFITZ JE, 1994, CIRC RES, V74, P1065, DOI 10.1161/01.RES.74.6.1065; Sankova B, 2010, AM J PHYSIOL-HEART C, V298, pH1571, DOI 10.1152/ajpheart.00721.2009; Sedmera D, 2003, ANAT REC PART A, V274A, P773, DOI 10.1002/ar.a.10085; Sedmera D, 2006, AM J PHYSIOL-HEART C, V291, pH1646, DOI 10.1152/ajpheart.01007.2005; Somi S, 2006, J HISTOCHEM CYTOCHEM, V54, P649, DOI 10.1369/jhc.5A6846.2006; SPACH MS, 1982, CIRC RES, V50, P175, DOI 10.1161/01.RES.50.2.175; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; SPACH MS, 1969, CIRC RES, V24, P857, DOI 10.1161/01.RES.24.6.857; Stekelenburg-de Vos S, 2003, J EXP BIOL, V206, P1051, DOI 10.1242/jeb.00216; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Takebayashi-Suzuki K, 2000, DEVELOPMENT, V127, P3523; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Thorel C, 1910, MUNCHEN MED WCHNSCHR, V57, P183; Todorova MG, 2008, J CELL PHYSIOL, V214, P354, DOI 10.1002/jcp.21203; TRUEX RAYMOND D., 1965, ANN N Y ACAD SCI, V127, P19, DOI 10.1111/j.1749-6632.1965.tb49390.x; VANMIEROP LH, 1967, AM J PHYSIOL, V212, P407, DOI 10.1152/ajplegacy.1967.212.2.407; WAGNER ML, 1966, CIRC RES, V18, P502, DOI 10.1161/01.RES.18.5.502; WENCKEBACH KF, 1907, VIRCHOWS ARCHIV FUR, V1, P1; YAMADA K, 1968, CIRC RES, V22, P707, DOI 10.1161/01.RES.22.6.707; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883	64	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115207	10.1371/journal.pone.0115207	http://dx.doi.org/10.1371/journal.pone.0115207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503944	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400082
J	Cheng, Y; Wang, XY; Hu, H; Killiny, N; Xu, JP				Cheng, Yang; Wang, Xue-Yang; Hu, Hao; Killiny, Nabil; Xu, Jia-Ping			A Hypothetical Model of Crossing Bombyx mori Nucleopolyhedrovirus through Its Host Midgut Physical Barrier	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; PHOSPHOGLYCERATE KINASE; DIGESTIVE JUICE; ARGININE KINASE; PROTEIN; VIRUS; BACULOVIRUS; SILKWORM; EXPRESSION; INFECTION	Bombyx mori nucleopolyhedrovirus (BmNPV) is a primary pathogen of silkworm (B. mori) that causes severe economic losses each year. However, the molecular mechanisms of silkworm-BmNPV interactions, especially the silkworm proteins that can interact with the virus, are still largely unknown. In this study, the total and membrane proteins of silkworm midguts were displayed using one-and two-dimensional electrophoresis. A virus overlay assay was used to detect B. mori proteins that specifically bind to BmNPV particles. Twelve proteins were located and identified using mass spectrometry, and the different expression of the corresponding genes in BmNPV susceptible and resistant silkworm strains also indicated their involvement in BmNPV infection. The 12 proteins are grouped based on their potential roles in viral infection, for example, endocytosis, intracellular transportation, and host responses. Based on these results, we hypothesize the following: I) vacuolar ATP synthase catalytic subunit A and subunit B may be implicated in the process of the membrane fusion of virus and the release of the nucleocapsid into cytoplasm; II) actin, enolase and phosphoglycerate kinase are cytoskeleton associated proteins and may play an important role in BmNPV intracellular transportation; III) mitochondrial prohibitin complex protein 2, ganglioside-induced differentiation-associated protein, calreticulin, regucalcin-like isoform X1 and 60 kDa heat shock protein are involved in cell apoptosis regulation during BmNPV infection in larvae midguts; IV) ribosomal P0 may be associated with BmNPV infection by regulating gene expression of BmNPV; V) arginine kinase has a role in the antiviral activities against BmNPV. Our work should prove informative by providing multiple protein targets and a novel direction to investigate the molecular mechanisms of the interactions between silkworms and BmNPV.	[Cheng, Yang; Wang, Xue-Yang; Xu, Jia-Ping] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China; [Hu, Hao; Killiny, Nabil] Univ Florida, IFAS, Citrus Res & Educ Ctr, Dept Entomol & Nematol, Lake Alfred, FL USA	Anhui Agricultural University; State University System of Florida; University of Florida	Xu, JP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	jiapingxu@163.com	Xu, Jiaping/T-4327-2019; Wang, Xue-yang/ABB-8298-2021	Cheng, Yang/0000-0003-2126-282X; Xu, Jiaping/0000-0001-9020-7248; Killiny, Nabil/0000-0002-3895-6943	Natural Science Foundation of China [31472148]; National 863 plans projects of China [2011AA100306]; International cooperation project of Anhui province [1403062018]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 plans projects of China(National High Technology Research and Development Program of China); International cooperation project of Anhui province	This work was supported by the Natural Science Foundation of China (31472148), the National 863 plans projects of China (2011AA100306) and International cooperation project of Anhui province (1403062018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandla MD, 1998, PHYTOPATHOLOGY, V88, P98, DOI 10.1094/PHYTO.1998.88.2.98; Bao YY, 2010, INSECT MOL BIOL, V19, P347, DOI 10.1111/j.1365-2583.2010.00993.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLANCHAER MC, 1955, AM J PHYSIOL, V181, P602, DOI 10.1152/ajplegacy.1955.181.3.602; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; Boone TJ, 2011, MICROB PATHOGENESIS, V51, P255, DOI 10.1016/j.micpath.2011.06.005; Cheng Y, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.76; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; DICKERSON HW, 1989, J PROTOZOOL, V36, P159, DOI 10.1111/j.1550-7408.1989.tb01065.x; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gao K, 2012, GENE, V497, P208, DOI 10.1016/j.gene.2012.01.037; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Hafren A, 2013, J VIROL, V87, P4302, DOI 10.1128/JVI.03198-12; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Kang LQ, 2011, COMP BIOCHEM PHYS B, V158, P230, DOI 10.1016/j.cbpb.2010.12.001; Kikkert M, 1998, PHYTOPATHOLOGY, V88, P63, DOI 10.1094/PHYTO.1998.88.1.63; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Li S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026585; Liu ZG, 2009, INT ARCH ALLERGY IMM, V150, P8, DOI 10.1159/000210375; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long G, 2006, J VIROL, V80, P8830, DOI 10.1128/JVI.00880-06; Ma FF, 2014, GENE, V539, P99, DOI 10.1016/j.gene.2014.01.047; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; Matthews JD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-121; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Nakagawa T, 2005, J CELL BIOCHEM, V96, P1274, DOI 10.1002/jcb.20617; Nakazawa H, 2004, VIROLOGY, V321, P154, DOI 10.1016/j.virol.2003.12.011; Nanda SK, 2004, ARCH VIROL, V149, P93, DOI 10.1007/s00705-003-0196-4; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ponnuvel KM, 2012, ARCH INSECT BIOCHEM, V81, P90, DOI 10.1002/arch.21046; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Rahman MM, 2004, VIRUS RES, V101, P109, DOI 10.1016/j.virusres.2003.12.027; Rattanarojpong T, 2007, PROTEOMICS, V7, P3809, DOI 10.1002/pmic.200700202; ROHRMANN GF, 1992, J GEN VIROL, V73, P749, DOI 10.1099/0022-1317-73-4-749; Song JJ, 2008, J GEN VIROL, V89, P2331, DOI 10.1099/vir.0.2008/002352-0; STERN H, 1952, J GEN PHYSIOL, V36, P181, DOI 10.1085/jgp.36.2.181; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Wang HC, 2009, GENE, V430, P38, DOI 10.1016/j.gene.2008.10.021; Watthanasurorot A, 2013, J MOL CELL BIOL, V5, P120, DOI 10.1093/jmcb/mjt005; Wesolowska A, 2013, EXP PARASITOL, V134, P33, DOI 10.1016/j.exppara.2013.01.013; WOOL IG, 1991, BIOCHIMIE, V73, P861, DOI 10.1016/0300-9084(91)90127-M; Wu Y, 2013, FEBS LETT, V587, P600, DOI 10.1016/j.febslet.2013.01.072; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xu JP, 2008, AFR J BIOTECHNOL, V7, P3424	54	15	19	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115032	10.1371/journal.pone.0115032	http://dx.doi.org/10.1371/journal.pone.0115032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502928	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400069
J	Sridhara, V; Meyer, AG; Rai, P; Barrick, JE; Ravikumar, P; Segre, D; Wilke, CO				Sridhara, Viswanadham; Meyer, Austin G.; Rai, Piyush; Barrick, Jeffrey E.; Ravikumar, Pradeep; Segre, Daniel; Wilke, Claus O.			Predicting Growth Conditions from Internal Metabolic Fluxes in an In-Silico Model of E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; ASSOCIATION; ADAPTATION; SELECTION; NUTRIENT; MUTANTS; MG1655	A widely studied problem in systems biology is to predict bacterial phenotype from growth conditions, using mechanistic models such as flux balance analysis (FBA). However, the inverse prediction of growth conditions from phenotype is rarely considered. Here we develop a computational framework to carry out this inverse prediction on a computational model of bacterial metabolism. We use FBA to calculate bacterial phenotypes from growth conditions in E. coli, and then we assess how accurately we can predict the original growth conditions from the phenotypes. Prediction is carried out via regularized multinomial regression. Our analysis provides several important physiological and statistical insights. First, we show that by analyzing metabolic end products we can consistently predict growth conditions. Second, prediction is reliable even in the presence of small amounts of impurities. Third, flux through a relatively small number of reactions per growth source (similar to 10) is sufficient for accurate prediction. Fourth, combining the predictions from two separate models, one trained only on carbon sources and one only on nitrogen sources, performs better than models trained to perform joint prediction. Finally, that separate predictions perform better than a more sophisticated joint prediction scheme suggests that carbon and nitrogen utilization pathways, despite jointly affecting cellular growth, may be fairly decoupled in terms of their dependence on specific assortments of molecular precursors.	[Sridhara, Viswanadham; Meyer, Austin G.; Barrick, Jeffrey E.; Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Meyer, Austin G.; Barrick, Jeffrey E.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Rai, Piyush; Ravikumar, Pradeep] Univ Texas Austin, Dept Comp Sci, Austin, TX 78712 USA; [Barrick, Jeffrey E.; Wilke, Claus O.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Barrick, Jeffrey E.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Wilke, Claus O.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Boston University; Boston University; University of Texas System; University of Texas Austin	Wilke, CO (corresponding author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.	wilke@austin.utexas.edu	Segre, Daniel/A-1993-2009	Segre, Daniel/0000-0003-4859-1914; Sridhara, Viswanadham/0000-0003-0688-6140; Meyer, Austin/0000-0002-0581-800X	Army Research Office (ARO) [W911NF-12-1-0390]	Army Research Office (ARO)	This project was funded by Army Research Office (ARO) grant W911NF-12-1-0390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brandes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036947; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1111/j.1574-6968.2001.tb10892.x; Casanova R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044877; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; KUPOR SR, 1972, J BIOL CHEM, V247, P1904; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Menendez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014147; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ravikumar P, 2010, ANN STAT, V38, P1287, DOI 10.1214/09-AOS691; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Snitkin Evan S, 2008, Genome Inform, V20, P123; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Rijsewijk BRBH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.9; Wang H, 2012, BIOINFORMATICS, V28, pI619, DOI 10.1093/bioinformatics/bts411; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041	30	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114608	10.1371/journal.pone.0114608	http://dx.doi.org/10.1371/journal.pone.0114608			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502413	gold, Green Published, Green Submitted			2022-12-27	WOS:000346375400038
J	van Doorn, KJ; Verbrugghe, W; Wouters, K; Jansens, H; Jorens, PG				van Doorn, Karin Janssen; Verbrugghe, Walter; Wouters, Kristien; Jansens, Hilde; Jorens, Philippe G.			The Duration of Hypotension Determines the Evolution of Bacteremia-Induced Acute Kidney Injury in the Intensive Care Unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; TARGET BLOOD-PRESSURE; SEPTIC SHOCK; SEVERE SEPSIS; HEMODYNAMIC VARIABLES; MANAGEMENT; MORTALITY; MULTICENTER; DEFINITION; PREDICTORS	Background: Exploration of the impact of severe hypotension on the evolution of acute kidney injury in septic patients. Methods and Results: We reviewed the hemodynamic parameters of 137 adults with septic shock and proven blood stream infection in the ICU. Severe hypotension was defined as a mean arterial blood pressure (MAP) <= 65 mmHg. The influence of the duration of severe hypotension on the evolution of acute kidney injury was evaluated according to the RIFLE classification, with day 0 defined as the day of a positive blood stream infection. After bloodstream infection, the probability for a patient to be in Failure was significantly higher than before blood stream infection (OR=1.94, p=0.0276). Patients have a significantly higher risk of evolving to Failure if the duration of severe hypotension is longer (OR=1.02 for each 10 minutes increase in duration of a MAP <65 mmHg, p=0.0472). A cut-off of at least 51 minutes of severe hypotension (<65 mmHg) or at least 5.5 periods of severe hypotension within 1 day identified patients with increased risk to evolve to Failure. Conclusions: There is a significant influence of both the duration and the number of periods of severe hypotension on the evolution to Failure. Blood stream infection has a significantly negative effect on the relationship between severe hypotension and Failure.	[van Doorn, Karin Janssen] Univ Antwerp, Univ Antwerp Hosp, Dept Nephrol Hypertens, B-2020 Antwerp, Belgium; [Verbrugghe, Walter; Jorens, Philippe G.] Univ Antwerp, Univ Antwerp Hosp, Dept Crit Care Med, B-2020 Antwerp, Belgium; [Wouters, Kristien] Univ Antwerp, Univ Antwerp Hosp, Dept Biostat, B-2020 Antwerp, Belgium; [Jansens, Hilde] Univ Antwerp, Univ Antwerp Hosp, Dept Microbiol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	van Doorn, KJ (corresponding author), Univ Antwerp, Univ Antwerp Hosp, Dept Nephrol Hypertens, B-2020 Antwerp, Belgium.	k.janssenvandoorn@gmail.com	Wouters, Kristien/ADM-4146-2022					Albanese J, 2004, CHEST, V126, P534, DOI 10.1378/chest.126.2.534; Bagshaw SM, 2007, CLIN J AM SOC NEPHRO, V2, P431, DOI 10.2215/CJN.03681106; Bagshaw SM, 2010, CAN J ANESTH, V57, P999, DOI 10.1007/s12630-010-9376-3; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Barochia AV, 2013, CURR INFECT DIS REP, V15, P385, DOI 10.1007/s11908-013-0351-3; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Beloncle F, 2013, CRIT CARE, V17, DOI 10.1186/cc12543; Boerma EC, 2010, INTENS CARE MED, V36, P2004, DOI 10.1007/s00134-010-1970-x; Correa TD, 2013, CRIT CARE, V17, DOI 10.1186/cc12495; Cruz DN, 2009, CRIT CARE, V13, DOI 10.1186/cc7759; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dunser MW, 2009, CRIT CARE, V13, DOI 10.1186/cc8167; Dunser MW, 2009, INTENS CARE MED, V35, P1225, DOI 10.1007/s00134-009-1427-2; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Honore PM, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-32; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Joannidis M, 2009, INTENS CARE MED, V35, P1692, DOI 10.1007/s00134-009-1530-4; Kim WY, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.04.005; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Langenberg C, 2008, CRIT CARE, V12, DOI [10.1186/cc6823, 10.1186/cc6863]; Ledoux D, 2008, INTENS CARE MED, V34, P1873, DOI 10.1007/s00134-008-1187-4; Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9; Macedo E, 2010, CRIT CARE, V14, DOI 10.1186/cc9004; Nadeau-Fredette AC, 2013, ADV CHRONIC KIDNEY D, V20, P45, DOI 10.1053/j.ackd.2012.09.005; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Poukkanen M, 2013, CRIT CARE, V17, DOI 10.1186/cc13161; Rivers EP, 2012, MINERVA ANESTESIOL, V78, P712; Ronco C, 2013, BLOOD PURIFICAT, V36, P65, DOI 10.1159/000354768; Shih CY, 2006, J THORAC CARDIOV SUR, V131, P632, DOI 10.1016/j.jtcvs.2005.10.052; Simon PM, 2011, SHOCK, V36, P553, DOI 10.1097/SHK.0b013e318235331e; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Srisawat N, 2010, BLOOD PURIFICAT, V29, P300, DOI 10.1159/000280099; Takala J, 2010, CRIT CARE MED, V38, pS613, DOI 10.1097/CCM.0b013e3181f2430c; Teixeira C, 2013, CRIT CARE, V17, DOI 10.1186/cc12484; Varpula M, 2005, INTENS CARE MED, V31, P1066, DOI 10.1007/s00134-005-2688-z; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; WERNOVSKY G, 1995, CIRCULATION, V92, P2226, DOI 10.1161/01.CIR.92.8.2226	38	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114312	10.1371/journal.pone.0114312	http://dx.doi.org/10.1371/journal.pone.0114312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504214	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400026
J	Wei, XH; Shen, HC; Ren, JL; Li, XL; Xu, XD; Yang, RM; Lai, LS; Chen, LA; Hu, JA; Liu, WH; Jiang, XQ				Wei, Xinhua; Shen, Huicong; Ren, Jiliang; Li, Xueli; Xu, Xiangdong; Yang, Ruimeng; Lai, Lisha; Chen, Liang; Hu, Jiani; Liu, Wenhua; Jiang, Xinqing			Altered Resting-State Connectivity in College Students with Nonclinical Depressive Symptoms	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FUNCTIONAL MAGNETIC-RESONANCE; MOOD REGULATING CIRCUIT; DEFAULT-MODE NETWORK; LINE BRAIN ACTIVITY; MAJOR DEPRESSION; BIPOLAR DEPRESSION; EMOTION REGULATION; CINGULATE CORTEX; FMRI	Background: The underlying brain basis of nonclinical depressive symptoms (nCDSs) is largely unknown. Recently, the seed-based functional connectivity (FC) approach for analyzing resting-state fMRI (rs-fMRI) data has been increasingly used to explore the neural basis of depressive disorders. Other than common seed-based FC method using an a priori seed region, we conducted FC analysis based on regions with altered spontaneous activity revealed by the fractional amplitude of low-frequency fluctuations (fALFF) approach. The aim of the present study was to provide novel insight in the underlying mechanism of nCDSs in college students. Methodology/Principal Findings: A total number of 1105 college students were recruited to participant in a survey for assessing depressive symptoms. Subsequently, 17 individuals with nCDSs and 20 healthy controls (HCs) were enrolled to perform MR studies. Alternations of fALFF were identified in the right superior parietal lobule (SPL) and left lingual gyrus, both of which were used as ROIs for further FC analysis. With right SPL, compare with HCs, subjects with nCDSs showed reduced FCs in the bilateral dorsal lateral prefrontal cortex (DLPFC), left inferior frontal gurus (IFG), left premotor cortex (PMC), DMN network [i.e., bilateral precuneus, posterior cingulate cortex (PCC), right supramarginal gyrus (SMG), right parahippocampal gyrus (PHG), bilateral inferior temporal gurus (ITG)] and left cerebellum posterior lobe (CPL). In addition, increased FCs were observed between the left lingual gyrus and right fusiform gyrus as well as in the left precuneus. Conclusion/Significance: Our results indicate the abnormalities of spontaneous activity in the right SPL and left lingual gyrus and their corresponding dysfunction of the brain circuits might be related to the pathophysiology of nCDSs.	[Wei, Xinhua; Ren, Jiliang; Li, Xueli; Xu, Xiangdong; Yang, Ruimeng; Lai, Lisha; Chen, Liang; Jiang, Xinqing] Guangzhou Med Univ, Guangzhou Hosp 1, Dept Radiol, Guangzhou 510180, Guangdong, Peoples R China; [Shen, Huicong] Capital Med Univ, Tiantan Hosp, Dept Radiol, Beijing 100050, Peoples R China; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI 48202 USA; [Liu, Wenhua] Guangzhou Med Univ, Fac Hlth Management, Guangzhou 510180, Guangdong, Peoples R China	Guangzhou Medical University; Capital Medical University; Wayne State University; Guangzhou Medical University	Liu, WH (corresponding author), Guangzhou Med Univ, Fac Hlth Management, Guangzhou 510180, Guangdong, Peoples R China.	2394674931@qq.com; weixinhua.hy@gmail.com	; yang, karen/A-4677-2019	Jiang, Xinqing/0000-0003-0773-523X; yang, karen/0000-0002-6065-6197				Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Al-Busaidi Zakiya, 2011, Oman Med J, V26, P235, DOI 10.5001/omj.2011.58; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Bandelow B, 2008, WORLD J BIOL PSYCHIA, V9, P248, DOI 10.1080/15622970802465807; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cullen KR, 2009, NEUROSCI LETT, V460, P227, DOI 10.1016/j.neulet.2009.05.022; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Georgades K, 2006, J AM ACAD CHILD PSY, V45, P936, DOI 10.1097/01.chi.0000223313.25536.47; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Hoff GEAJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00650; Ignjatovic-Ristic D, 2012, W INDIAN MED J, V61, P489, DOI 10.7727/wimj.2011.215; Jamison DT., 2006, PRIORITIES HLTH; Kerestes R, 2014, NEUROIMAGE-CLIN, V4, P209, DOI 10.1016/j.nicl.2013.11.009; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; Lee M.H., 2012, AJNR AM J NEURORADIO; Liberg B, 2013, J NERV MENT DIS, V201, P885, DOI 10.1097/NMD.0b013e3182a5c2a7; Liu CH, 2012, NEUROSCI LETT, V516, P202, DOI 10.1016/j.neulet.2012.03.083; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Lui S, 2011, AM J PSYCHIAT, V168, P642, DOI 10.1176/appi.ajp.2010.10101419; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Margulies DS, 2010, MAGN RESON MATER PHY, V23, P289, DOI 10.1007/s10334-010-0228-5; Melo-Carrillo A, 2012, J AFFECT DISORDERS, V136, P1098, DOI 10.1016/j.jad.2011.10.040; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; Mikolajczyk RT, 2008, CLIN PRACT EPIDEMIOL, V4, P19, DOI DOI 10.1186/1745-0179-4-19; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Rogers MA, 2002, J CLIN EXP NEUROPSYC, V24, P101, DOI 10.1076/jcen.24.1.101.974; Rosazza C, 2012, AM J NEURORADIOL, V33, P180, DOI 10.3174/ajnr.A2733; Schraa-Tam CKL, 2012, CEREBELLUM, V11, P233, DOI 10.1007/s12311-011-0301-2; Schutter DJLG, 2009, CEREBELLUM, V8, P28, DOI 10.1007/s12311-008-0056-6; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tadayonnejad R, 2014, J GERIATR PSYCH NEUR, V27, P5, DOI 10.1177/0891988713516539; Tahmasian M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00639; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Turner JA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00137; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vargas C, 2013, J AFFECT DISORDERS, V150, P727, DOI 10.1016/j.jad.2013.05.083; Viviani R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00746; Walther S, 2012, J AFFECT DISORDERS, V136, P124, DOI 10.1016/j.jad.2011.08.020; Wang L, 2012, J AFFECT DISORDERS, V142, P6, DOI 10.1016/j.jad.2012.04.013; Wang LH, 2008, PSYCHIAT RES-NEUROIM, V163, P143, DOI 10.1016/j.pscychresns.2007.10.004; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Weng SJ, 2010, BRAIN RES, V1313, P202, DOI 10.1016/j.brainres.2009.11.057; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Ye T, 2012, EUR J RADIOL, V81, P4035, DOI 10.1016/j.ejrad.2011.04.058; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023; Zhang XC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085241, 10.1371/journal.pone.0100240]; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	67	23	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114603	10.1371/journal.pone.0114603	http://dx.doi.org/10.1371/journal.pone.0114603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502215	gold, Green Submitted, Green Published			2022-12-27	WOS:000346375400037
J	Yoon, YJ; Kim, DK; Yoon, CM; Park, J; Kim, YK; Roh, TY; Gho, YS				Yoon, Yae Jin; Kim, Dae-Kyum; Yoon, Chang Min; Park, Jaesung; Kim, Yoon-Keun; Roh, Tae-Young; Gho, Yong Song			Egr-1 Activation by Cancer-Derived Extracellular Vesicles Promotes Endothelial Cell Migration via ERK1/2 and JNK Signaling Pathways	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR-1; MEMBRANE-VESICLES; PROTEOMIC ANALYSIS; ALPHA EXPRESSION; GENE-EXPRESSION; MESSENGER-RNAS; OVARIAN-CANCER; TISSUE FACTOR; UP-REGULATION; TUMOR-GROWTH	Various mammalian cells, including cancer cells, shed extracellular vesicles (EVs), also known as exosomes and microvesicles, into surrounding tissues. These EVs play roles in tumor growth and metastasis by promoting angiogenesis. However, the detailed mechanism of how cancer-derived EVs elicit endothelial cell activation remains unknown. Here, we provide evidence that early growth response-1 (Egr-1) activation in endothelial cells is involved in the angiogenic activity of colorectal cancer cell-derived EVs. Both RNA interference-mediated downregulation of Egr-1 and ERK1/2 or JNK inhibitor significantly blocked EV-mediated Egr-1 activation and endothelial cell migration. Furthermore, lipid raft-mediated endocytosis inhibitor effectively blocked endothelial Egr-1 activation and migration induced by cancer-derived EVs. Our results suggest that Egr-1 activation in endothelial cells may be a key mechanism involved in the angiogenic activity of cancer-derived EVs. These findings will improve our understanding regarding the proangiogenic activities of EVs in diverse pathological conditions including cancer, cardiovascular diseases, and neurodegenerative diseases.	[Yoon, Yae Jin; Roh, Tae-Young] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Kim, Dae-Kyum; Yoon, Chang Min; Roh, Tae-Young; Gho, Yong Song] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Park, Jaesung] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang 790784, South Korea; [Kim, Yoon-Keun] Ewha Womans Univ, Med Ctr, Ewha Inst Convergence Med, Seoul 158710, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Ewha Womans University	Roh, TY (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.	tyroh@postech.edu; ysgho@postech.ac.kr		Kim, Dae-Kyum/0000-0003-4568-8278; Roh, Tae-Young/0000-0001-5833-0844	Mid-career Researcher Program through NRF grant - MEST [2014023004]; BK21 Plus - Ministry of Education, Korea [10Z20130012243]; National Research Foundation of Korea [2011-0030049]	Mid-career Researcher Program through NRF grant - MEST; BK21 Plus - Ministry of Education, Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Mid-career Researcher Program through NRF grant funded by the MEST (No. 2014023004), BK21 Plus (10Z20130012243) funded by the Ministry of Education, Korea, and the National Research Foundation of Korea (2011-0030049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Choi DS, 2007, J PROTEOME RES, V6, P4646, DOI 10.1021/pr070192y; Choi DS, 2012, J PROTEOME RES, V11, P1144, DOI 10.1021/pr200842h; Choi DS, 2011, PROTEOMICS, V11, P2745, DOI 10.1002/pmic.201100022; Choi DS, 2013, PROTEOMICS; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gho YS, 1999, CANCER RES, V59, P5128; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hao F, 2008, J BIOL CHEM, V283, P26928, DOI 10.1074/jbc.M803071200; Harja E, 2004, CIRC RES, V94, P333, DOI 10.1161/01.RES.0000112405.61577.95; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Khachigian LM, 1997, CIRC RES, V81, P457, DOI 10.1161/01.RES.81.4.457; Kim CW, 2002, CANCER RES, V62, P6312; Kim DK, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20384; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Lee HM, 2010, BIOCHEM BIOPH RES CO, V397, P251, DOI 10.1016/j.bbrc.2010.05.094; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Shin SY, 2009, J BIOL CHEM, V284, P30583, DOI 10.1074/jbc.M109.010678; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Yan SF, 2000, NAT MED, V6, P1355, DOI 10.1038/82168; Yao HH, 2011, BLOOD, V117, P2538, DOI 10.1182/blood-2010-10-313593	47	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115170	10.1371/journal.pone.0115170	http://dx.doi.org/10.1371/journal.pone.0115170			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502753	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400077
J	Howland, B; Stojanovic, D; Gordon, IJ; Manning, AD; Fletcher, D; Lindenmayer, DB				Howland, Brett; Stojanovic, Dejan; Gordon, Iain J.; Manning, Adrian D.; Fletcher, Don; Lindenmayer, David B.			Eaten Out of House and Home: Impacts of Grazing on Ground-Dwelling Reptiles in Australian Grasslands and Grassy Woodlands	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; SPECIES RICHNESS; LARGE HERBIVORES; WALLABY CREEK; VEGETATION; ECOSYSTEM; HABITAT; MANAGEMENT; LANDSCAPE; DIVERSITY	Large mammalian grazers can alter the biotic and abiotic features of their environment through their impacts on vegetation. Grazing at moderate intensity has been recommended for biodiversity conservation. Few studies, however, have empirically tested the benefits of moderate grazing intensity in systems dominated by native grazers. Here we investigated the relationship between (1) density of native eastern grey kangaroos, Macropus giganteus, and grass structure, and (2) grass structure and reptiles (i.e. abundance, richness, diversity and occurrence) across 18 grassland and grassy Eucalyptus woodland properties in south-eastern Australia. There was a strong negative relationship between kangaroo density and grass structure after controlling for tree canopy cover. We therefore used grass structure as a surrogate for grazing intensity. Changes in grazing intensity (i.e. grass structure) significantly affected reptile abundance, reptile species richness, reptile species diversity, and the occurrence of several ground-dwelling reptiles. Reptile abundance, species richness and diversity were highest where grazing intensity was low. Importantly, no species of reptile was more likely to occur at high grazing intensities. Legless lizards (Delma impar, D. inornata) were more likely to be detected in areas subject to moderate grazing intensity, whereas one species (Hemiergis talbingoensis) was less likely to be detected in areas subject to intense grazing and three species (Menetia greyii, Morethia boulengeri, and Lampropholis delicata) did not appear to be affected by grazing intensity. Our data indicate that to maximize reptile abundance, species richness, species diversity, and occurrence of several individual species of reptile, managers will need to subject different areas of the landscape to moderate and low grazing intensities and limit the occurrence and extent of high grazing.	[Howland, Brett; Stojanovic, Dejan; Gordon, Iain J.; Manning, Adrian D.; Lindenmayer, David B.] ANU Coll Med Biol & Environm, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Gordon, Iain J.] James Hutton Inst, Dundee DD2 5DA, Scotland; [Fletcher, Don] Environm & Sustainable Dev Directorate, Canberra, ACT 2601, Australia	Australian National University; James Hutton Institute	Howland, B (corresponding author), ANU Coll Med Biol & Environm, Fenner Sch Environm & Soc, Frank Fenner Bldg,141 Australian Natl Univ, Canberra, ACT 0200, Australia.	brett.howland@anu.edu.au	Manning, Adrian/AAX-7288-2021; Gordon, Iain/S-8076-2019; Stojanovic, Dejan/AAB-3113-2019; Manning, Adrian/AAG-2949-2019; Lindenmayer, David B/P-7183-2017; Gordon, Iain J/K-8636-2012	Manning, Adrian/0000-0003-0989-9203; Gordon, Iain/0000-0001-9704-0946; Stojanovic, Dejan/0000-0002-1176-3244; Lindenmayer, David B/0000-0002-4766-4088; Gordon, Iain J/0000-0001-9704-0946	Canberra Birds Conservation Fund; Bush Heritage Andyinc Foundation Environmental Research Postgraduate Scholarship; Australian Government's Department of Industry, Innovation, Science, Research and; Australian Government; ARC Future fellowship [FT 100100358]; Tertiary Education Australian Postgraduate Award	Canberra Birds Conservation Fund; Bush Heritage Andyinc Foundation Environmental Research Postgraduate Scholarship; Australian Government's Department of Industry, Innovation, Science, Research and(Australian Government); Australian Government(Australian GovernmentCGIAR); ARC Future fellowship(Australian Research Council); Tertiary Education Australian Postgraduate Award	Financial support was provided by Canberra Birds Conservation Fund to BH (http://cbcf.canberrabirds.org.au), Bush Heritage Andyinc Foundation Environmental Research Postgraduate Scholarship to BH (http://www.bushheritage.org.au) and the Australian Government's Department of Industry, Innovation, Science, Research and Tertiary Education Australian Postgraduate Award to BH (http://www.innovation.gov.au/research/researchblockgrants/pages/australianpostgraduateawards.aspx). Financial support was provided to BH by the Australian Government for monitoring activities undertaken at a single property used in this research. AM was funded by ARC Future fellowship FT 100100358. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACT Parks Conservation and Lands, 2010, ACT KANG MAN PLAN; Australian Government Bureau of Meteorology, 2014, ANN CLIM SUMM 2009; Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Beever EA, 2004, J ARID ENVIRON, V59, P271, DOI 10.1016/j.jaridenv.2003.12.008; Bennett, 2011, REPTILES FROGS AUSTR; Biehl L, 2002, COMPUT GEOSCI-UK, V28, P1153, DOI 10.1016/S0098-3004(02)00033-X; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Booth DT, 2006, ENVIRON MONIT ASSESS, V123, P97, DOI 10.1007/s10661-005-9164-7; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown GW, 2008, WILDLIFE RES, V35, P8, DOI 10.1071/WR07010; Brown GW, 2011, LANDSCAPE URBAN PLAN, V103, P277, DOI 10.1016/j.landurbplan.2011.08.002; Brown GW, 2001, BIODIVERS CONSERV, V10, P161, DOI 10.1023/A:1008919521638; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burrow AL, 2001, J WILDLIFE MANAGE, V65, P645, DOI 10.2307/3803015; Castellano MJ, 2006, J ARID ENVIRON, V66, P87, DOI 10.1016/j.jaridenv.2005.10.016; Caughley G., 1987, P159; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Cooke BD, 2002, WILDLIFE RES, V29, P689, DOI 10.1071/WR02010; COUGHENOUR MB, 2000, GREATER YELLOWSTONE, P209; Crain CM, 2006, BIOSCIENCE, V56, P211; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; Dorrough J, 2004, ECOGRAPHY, V27, P798, DOI 10.1111/j.0906-7590.2004.04004.x; Dorrough J, 2004, AUST J AGR RES, V55, P279, DOI 10.1071/AR03024; Dorrough J, 1999, AUST J ECOL, V24, P614, DOI 10.1046/j.1442-9993.1999.00995.x; Dorrough J, 2012, AUSTRAL ECOLOGY; ESCAVI (Executive Steering Committee for Australian Vegetation Information), 2003, AUSTR VEG ATTR MAN N; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Fischer J, 2004, J APPL ECOL, V41, P32, DOI 10.1111/j.1365-2664.2004.00869.x; Fletcher D, 2005, POPULATION DYN UNPUB; Foster CN, 2014, J APPL ECOL, V51, P929, DOI 10.1111/1365-2664.12268; Franklin SE, 2002, PROG PHYS GEOG, V26, P173, DOI 10.1191/0309133302pp332ra; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Green DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048410; Grigg GC, 1989, KANGAROOS WALLABIES; Hadden SA, 1996, WILDLIFE RES, V23, P363, DOI 10.1071/WR9960363; Haydock K. P., 1975, AUSTR J EXPT AGR ANI, V15, P66, DOI DOI 10.1071/EA9750663; Hobbs R.J., 2000, TEMPERATE EUCALYPT W; Hobbs RJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P1, DOI 10.1111/j.1466-822X.2004.00130.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; James C, 2003, AUSTRAL ECOL, V28, P137, DOI 10.1046/j.1442-9993.2003.01259.x; JANZEN DH, 1976, AM NAT, V110, P371, DOI 10.1086/283074; JOHNSON CN, 1987, AUST WILDLIFE RES, V14, P133; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Joseph Jr FH, 1984, MULTIVARIATE DATA AN; Knowles RL, 1998, AGROFOREST SYST, V43, P109, DOI 10.1023/A:1026463623463; Kohler AE, 2013, CAN J FISH AQUAT SCI, V70, P502, DOI 10.1139/cjfas-2012-0347; Kutt AS, 2007, J TROP ECOL, V23, P95, DOI 10.1017/S0266467406003579; Lee Y, 1996, J ROY STAT SOC B MET, V58, P619; Manly B.F.J., 1994, MULTIVARIATE STAT ME; Manning AD, 2013, BIOL CONSERV, V157, P204, DOI 10.1016/j.biocon.2012.06.028; Martin TG, 2005, ECOL APPL, V15, P266, DOI 10.1890/03-5400; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McIntyre S, 2003, J APPL ECOL, V40, P445, DOI 10.1046/j.1365-2664.2003.00823.x; McIntyre S., 2010, Cunninghamia, V11, P319; Meers Trevor, 2003, Ecological Management & Restoration, V4, P126, DOI 10.1046/j.1442-8903.2003.00147.x; Michael DR, 2012, WILDLIFE RES, V39, P149, DOI 10.1071/WR11118; Michael DR, 2010, AUSTRAL ECOL, V35, P215, DOI 10.1111/j.1442-9993.2009.02029.x; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Milsom TP, 2000, J APPL ECOL, V37, P706, DOI 10.1046/j.1365-2664.2000.00529.x; Moir ML, 2005, FOREST ECOL MANAG, V217, P294, DOI 10.1016/j.foreco.2005.06.012; Moore RM, 1970, AUSTR GRASSLANDS; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 2006, WILDLIFE BIOL, V12, P129, DOI 10.2981/0909-6396(2006)12[129:TCOOAI]2.0.CO;2; Nasseri NA, 2011, AFR J ECOL, V49, P133, DOI 10.1111/j.1365-2028.2010.01238.x; NEAVE HM, 1989, AUST WILDLIFE RES, V16, P337, DOI 10.1071/WR9890337; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Pitkanen S, 1998, FOREST ECOL MANAG, V112, P121, DOI 10.1016/S0378-1127(98)00319-3; POOLE WE, 1975, AUST J ZOOL, V23, P333, DOI 10.1071/ZO9750333; Poyry J, 2006, OIKOS, V115, P401, DOI 10.1111/j.2006.0030-1299.15126.x; Prober Suzanne M., 2005, Ecological Management & Restoration, V6, P16, DOI 10.1111/j.1442-8903.2005.00215.x; Ripple WJ, 2000, BIOL CONSERV, V95, P361, DOI 10.1016/S0006-3207(00)00014-8; Smith GT, 1996, J APPL ECOL, V33, P1302, DOI 10.2307/2404771; SOUTHWELL C, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P659; SOUTHWELL C, 1987, AUST WILDLIFE RES, V14, P15; Stevens TA, 2010, AUST J ZOOL, V58, P76, DOI 10.1071/ZO09076; TAYLOR RJ, 1983, AUST WILDLIFE RES, V10, P203; TOFT CA, 1985, COPEIA, P1; Tzaros C., 2005, WILDLIFE BOX IRONBAR; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Vandvik V, 2005, J APPL ECOL, V42, P139, DOI 10.1111/j.1365-2664.2005.00982.x; Viggers KL, 2005, J APPL ECOL, V42, P99, DOI 10.1111/j.1365-2664.2005.01001.x; VSN International, 2012, GENSTAT WIND; Wilson S., 2008, COMPLETE GUIDE REPTI; Woinarski JCZ, 2002, AUSTRAL ECOL, V27, P311, DOI 10.1046/j.1442-9993.2002.01182.x; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2; Young KD, 2009, AUSTRAL ECOL, V34, P329, DOI 10.1111/j.1442-9993.2009.01934.x	90	73	75	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e105966	10.1371/journal.pone.0105966	http://dx.doi.org/10.1371/journal.pone.0105966			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25501680	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000347146700001
J	Li, L; Jiao, ZW; Hale, L; Wu, WL; Guo, YB				Li, Lei; Jiao, Ziwei; Hale, Lauren; Wu, Wenliang; Guo, Yanbin			Disruption of Gene pqqA or pqqB Reduces Plant Growth Promotion Activity and Biocontrol of Crown Gall Disease by Rahnella aquatilis HX2	PLOS ONE			English	Article							PHOSPHATE-SOLUBILIZING BACTERIA; PSEUDOMONAS-FLUORESCENS; PYRROLOQUINOLINE QUINONE; BIOLOGICAL-CONTROL; ESCHERICHIA-COLI; GLUCONIC ACID; CLONING; BIOSYNTHESIS; SEQUENCE; EXOPOLYSACCHARIDE	Rahnella aquatilis strain HX2 has the ability to promote maize growth and suppress sunflower crown gall disease caused by Agrobacterium vitis, A. tumefaciens, and A. rhizogenes. Pyrroloquinoline quinone (PQQ), a cofactor of aldose and alcohol dehydrogenases, is required for the synthesis of an antibacterial substance, gluconic acid, by HX2. Mutants of HX2 unable to produce PQQ were obtained by in-frame deletion of either the pqqA or pqqB gene. In this study, we report the independent functions of pqqA and pqqB genes in relation to PQQ synthesis. Interestingly, both the pqqA and pqqB mutants of R. aquatilis eliminated the ability of strain HX2 to produce antibacterial substance, which in turn, reduced the effectiveness of the strain for biological control of sunflower crown gall disease. The mutation also resulted in decreased mineral phosphate solubilization by HX2, which reduced the efficacy of this strain as a biological fertilizer. These functions were restored by complementation with the wild-type pqq gene cluster. Additionally, the phenotypes of HX2 derivatives, including colony morphology, growth dynamic, and pH change of culture medium were impacted to different extents. Our findings suggested that pqqA and pqqB genes individually play important functions in PQQ biosynthesis and are required for antibacterial activity and phosphorous solubilization. These traits are essential for R. aquatilis efficacy as a biological control and plant growth promoting strain. This study enhances our fundamental understanding of the biosynthesis of an environmentally significant cofactor produced by a promising biocontrol and biological fertilizer strain.	[Li, Lei; Wu, Wenliang; Guo, Yanbin] China Agr Univ, Dept Ecol Sci & Engn, Coll Resources & Environm Sci, Beijing 100094, Peoples R China; [Li, Lei; Wu, Wenliang; Guo, Yanbin] China Agr Univ, Beijing Key Lab Biodivers & Organ Farming, Beijing 100094, Peoples R China; [Jiao, Ziwei] Yi Li Normal Univ, Coll Chem & Biol Sci, Yining, Xinjiang, Peoples R China; [Hale, Lauren] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	China Agricultural University; China Agricultural University; University of California System; University of California Riverside	Guo, YB (corresponding author), China Agr Univ, Dept Ecol Sci & Engn, Coll Resources & Environm Sci, Beijing 100094, Peoples R China.	guoyb@cau.edu.cn		Hale, Lauren/0000-0002-2574-2225	National Natural Science Foundation of China [31200386]; Special Fund for Agro-scientific Research in the Public Interest [201303106]; National Key Technology Research and Development Program in Rural Areas [2012BAD15B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology Research and Development Program in Rural Areas	This work was supported by National Natural Science Foundation of China (31200386), Special Fund for Agro-scientific Research in the Public Interest (201303106), and National Key Technology Research and Development Program in Rural Areas (2012BAD15B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; BABUKHAN S, 1995, APPL ENVIRON MICROB, V61, P972, DOI 10.1128/AEM.61.3.972-978.1995; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; BERGE O, 1991, CAN J MICROBIOL, V37, P195, DOI 10.1139/m91-030; Calvo J, 2007, INT J FOOD MICROBIOL, V113, P251, DOI 10.1016/j.ijfoodmicro.2006.07.003; Chen F, 2007, PLANT DIS, V91, P957, DOI 10.1094/PDIS-91-8-0957; Chen F, 2009, EUR J PLANT PATHOL, V124, P427, DOI 10.1007/s10658-009-9429-z; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; de Werra P, 2009, APPL ENVIRON MICROB, V75, P4162, DOI 10.1128/AEM.00295-09; Dey R, 2004, MICROBIOL RES, V159, P371, DOI 10.1016/j.micres.2004.08.004; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; El-Hendawy HH, 2003, FOLIA MICROBIOL, V48, P799, DOI 10.1007/BF02931517; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Ge X, 2013, J BASIC MICROB, V53, P1; GOLDSTEIN AH, 1994, PHOSPHATE IN MICROORGANISMS, P197; GOLDSTEIN AH, 1995, BIOL AGRIC HORTIC, V12, P185, DOI 10.1080/01448765.1995.9754736; GOOSEN N, 1992, J BACTERIOL, V174, P1426, DOI 10.1128/jb.174.4.1426-1427.1992; Guo YB, 2009, APPL ENVIRON MICROB, V75, P6792, DOI 10.1128/AEM.00902-09; Guo YB, 2012, J BACTERIOL, V194, P6646, DOI 10.1128/JB.01769-12; HALDER AK, 1990, J GEN APPL MICROBIOL, V36, P81, DOI 10.2323/jgam.36.81; Hameeda B, 2008, MICROBIOL RES, V163, P234, DOI 10.1016/j.micres.2006.05.009; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JAMES DW, 1986, APPL ENVIRON MICROB, V52, P1183, DOI 10.1128/AEM.52.5.1183-1189.1986; Kaur R, 2006, PHYTOCHEMISTRY, V67, P595, DOI 10.1016/j.phytochem.2005.12.011; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim CH, 2003, CURR MICROBIOL, V47, P457, DOI 10.1007/s00284-003-4068-7; Kim KY, 1998, FEMS MICROBIOL LETT, V159, P121, DOI 10.1111/j.1574-6968.1998.tb12850.x; Kim KY, 1997, FEMS MICROBIOL LETT, V153, P273, DOI 10.1016/S0378-1097(97)00246-2; Kim KY, 1997, BIOL FERT SOILS, V24, P347, DOI 10.1007/s003740050256; KPOMBLEKOUA K, 1994, SOIL SCI, V158, P442, DOI 10.1097/00010694-199415860-00006; Maliha Rashid, 2004, Pakistan Journal of Biological Sciences, V7, P187, DOI 10.3923/pjbs.2004.187.196; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; MEULENBERG JJM, 1992, MOL GEN GENET, V232, P284, DOI 10.1007/BF00280008; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Sahin F, 2004, PLANT SOIL, V265, P123, DOI 10.1007/s11104-005-0334-8; Salomone JY, 1996, MOL PLANT MICROBE IN, V9, P401, DOI 10.1094/MPMI-9-0401; Sambrook J., 2001, MOL CLONING LAB MANU; SCHNIDER U, 1995, APPL ENVIRON MICROB, V61, P3856, DOI 10.1128/AEM.61.11.3856-3864.1995; Toyama H, 1997, MICROBIOL-SGM, V143, P595, DOI 10.1099/00221287-143-2-595; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Vikram A, 2007, WORLD J MICROB BIOT, V23, P1333, DOI 10.1007/s11274-007-9365-z; Yan Q, 2009, MICROBIOL-SGM, V155, P124, DOI 10.1099/mic.0.020750-0; Yi YM, 2008, WORLD J MICROB BIOT, V24, P1059, DOI 10.1007/s11274-007-9575-4; Zhou HY, 2005, CHINESE SCI BULL, V50, P775, DOI 10.1360/982005-84	48	26	29	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115010	10.1371/journal.pone.0115010	http://dx.doi.org/10.1371/journal.pone.0115010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502691	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700083
J	Suomi, F; Menger, KE; Monteuuis, G; Naumann, U; Kursu, VAS; Shvetsova, A; Kastaniotis, AJ				Suomi, Fumi; Menger, Katja E.; Monteuuis, Geoffray; Naumann, Uta; Kursu, V. A. Samuli; Shvetsova, Antonina; Kastaniotis, Alexander J.			Expression and Evolution of the Non-Canonically Translated Yeast Mitochondrial Acetyl-CoA Carboxylase Hfa1p	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; TRANSFER-RNA-SYNTHETASES; SACCHAROMYCES-CEREVISIAE; GENOME DUPLICATION; GENE ENCODES; EFFICIENCY; INITIATION; CODON; TRANSFORMATION; RESPIRATION	The Saccharomyces cerevisiae genome encodes two sequence related acetyl-CoA carboxylases, the cytosolic Acc1p and the mitochondrial Hfa1p, required for respiratory function. Several aspects of expression of the HFA1 gene and its evolutionary origin have remained unclear. Here, we determined the HFA1 transcription initiation sites by 5' RACE analysis. Using a novel "Stop codon scanning" approach, we mapped the location of the HFA1 translation initiation site to an upstream AUU codon at position -372 relative to the annotated start codon. This upstream initiation leads to production of a mitochondrial targeting sequence preceding the ACC domains of the protein. In silico analyses of fungal ACC genes revealed conserved "cryptic" upstream mitochondrial targeting sequences in yeast species that have not undergone a whole genome duplication. Our Delta hfa1 baker's yeast mutant phenotype rescue studies using the protoploid Kluyveromyces lactis ACC confirmed functionality of the cryptic upstream mitochondrial targeting signal. These results lend strong experimental support to the hypothesis that the mitochondrial and cytosolic acetyl-CoA carboxylases in S. cerevisiae have evolved from a single gene encoding both the mitochondrial and cytosolic isoforms. Leaning on a cursory survey of a group of genes of our interest, we propose that cryptic 5' upstream mitochondrial targeting sequences may be more abundant in eukaryotes than anticipated thus far.	[Kastaniotis, Alexander J.] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu	Kastaniotis, AJ (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland.	alexander.kastaniotis@oulu.fi		Kastaniotis, Alexander/0000-0003-3624-9214; Menger, Katja/0000-0002-6972-7326; Monteuuis, Geoffray/0000-0001-7193-7771; Suomi, Fumi/0000-0001-8883-3338	Academy of Finland [263776]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland Decision Number 263776 (AJK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1995, BBA-MOL BASIS DIS, V1272, P168, DOI 10.1016/0925-4439(95)00082-8; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Bailey LM, 2010, ARCH BIOCHEM BIOPHYS, V496, P45, DOI 10.1016/j.abb.2010.01.015; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen SJ, 2008, J BIOL CHEM, V283, P3173, DOI 10.1074/jbc.M706968200; CHEREST H, 1978, MOL GEN GENET, V163, P153, DOI 10.1007/BF00267406; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; HARINGTON A, 1993, MOL MICROBIOL, V9, P545, DOI 10.1111/j.1365-2958.1993.tb01715.x; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kaiser C., 1994, METHODS YEAST GENETI; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kostrub CF, 1998, NUCLEIC ACIDS RES, V26, P4783, DOI 10.1093/nar/26.20.4783; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Kursu VAS, 2013, MOL MICROBIOL, V90, P824, DOI 10.1111/mmi.12402; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Menger K, 2008, STUDY EXPRESSION YEA, V72; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nadeau JH, 1997, GENETICS, V147, P1259; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Ohno S., 1970, EVOLUTION GENE DUPLI; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Schonauer MS, 2008, MOL CELL BIOL, V28, P6646, DOI 10.1128/MCB.01162-08; SCHUGHART K, 1989, P NATL ACAD SCI USA, V86, P7067, DOI 10.1073/pnas.86.18.7067; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Torkko JM, 2001, MOL CELL BIOL, V21, P6243, DOI 10.1128/MCB.21.18.6243-6253.2001; Turunen O, 2009, FEMS YEAST RES, V9, P16, DOI 10.1111/j.1567-1364.2008.00451.x; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	44	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114738	10.1371/journal.pone.0114738	http://dx.doi.org/10.1371/journal.pone.0114738			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503745	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700049
J	Puschel, TA; Espejo, J; Sanzana, MJ; Benitez, HA				Pueschel, Thomas A.; Espejo, Jaime; Sanzana, Maria-Jose; Benitez, Hugo A.			Analysing the Floral Elements of the Lost Tree of Easter Island: A Morphometric Comparison between the Remaining Ex-Situ Lines of the Endemic Extinct Species Sophora toromiro	PLOS ONE			English	Article							COROLLA SHAPE; GEOMETRIC MORPHOMETRICS; PLANT; SELECTION; FABACEAE; LEGUMINOSAE; ONTOGENY; PAPILIONOIDEAE; COLONIZATION; CONSERVATION	Sophora toromiro (Phil) Skottsb. is a species that has been extinct in its natural habitat Easter Island (Rapa Nui) for over 50 years. However, seed collections carried out before its extinction have allowed its persistence ex-situ in different botanical gardens and private collections around the world. The progenies of these diverse collections have been classified in different lines, most of them exhibiting high similarity as corroborated by molecular markers. In spite of this resemblance observed between the different lines, one of them (Titze) has dissimilar floral elements, thus generating doubts regarding its species classification. The floral elements (wing, standard and keel) belonging to three different S. toromiro lines and two related species were analyzed using geometric morphometrics. This method was applied in order to quantify the floral shape variation of the standard, wing, and keel between the different lines and control species. Geometric morphometrics analyses were able to distinguish the floral elements at both intra (lines) and inter-specific levels. The present results are on line with the cumulative evidence that supports the Titze line as not being a proper member of the S. toromiro species, but probably a hybridization product or even another species of the Edwardsia section. The reintroduction programs of S. toromiro should consider this information when assessing the authenticity and origin of the lines that will be used to repopulate the island.	[Pueschel, Thomas A.; Benitez, Hugo A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Benitez, Hugo A.] Univ Tarapaca, Inst Alta Invest, Arica, Chile; [Espejo, Jaime] Univ Concepcion, Programa Postgrad, Fac Cs Forestales, Concepcion, Chile; [Sanzana, Maria-Jose] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Concepcion, Chile	University of Manchester; Universidad de Tarapaca; Universidad de Concepcion; Universidad de Concepcion	Benitez, HA (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	hugo.benitez@postgrad.manchester.ac.uk	Benitez, Hugo/AAI-1928-2019; Püschel, Thomas A/AAS-4535-2020; Benítez, Hugo A/C-5077-2011	Benitez, Hugo/0000-0001-7553-9893; Püschel, Thomas A/0000-0002-2231-2297; Benítez, Hugo A/0000-0001-7553-9893	Forestal Mininco	Forestal Mininco	The authors thank the reviewers for their suggestions that significantly improved this work. JE is grateful for the research support provided by Forestal Mininco as part of his PhD thesis focused on the genetics and conservation of the Sophora toromiro. HAB and TP give great gratitude to Becas Chile Scholarship program, CONICYT.	Adams DC, 1997, SYST BIOL, V46, P180, DOI 10.2307/2413642; [Anonymous], 1893, MEM CULT COL PRES C, P176; Benitez-Vieyra S, 2009, J EVOLUTION BIOL, V22, P2354, DOI 10.1111/j.1420-9101.2009.01840.x; Canellas-Bolta N, 2013, QUATERNARY SCI REV, V72, P36, DOI 10.1016/j.quascirev.2013.04.004; Cauwe N, 2011, ISLA PASCUA GRAN TAB; Chandler GT, 1998, PLANT SYST EVOL, V209, P93, DOI 10.1007/BF00991527; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Cordoba SA, 2011, ANN BOT-LONDON, V108, P919, DOI 10.1093/aob/mcr196; Donoso C, 1971, B TECNICO FACULTAD C, V30, P12; DRANSFIELD J, 1984, NATURE, V312, P750, DOI 10.1038/312750a0; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Espejo J, 2008, ACCIONES CONSERVACIO; Espejo J, 2013, GAYANA BOT, V70, P383, DOI 10.4067/S0717-66432013000200015; FLENLEY JR, 1984, NATURE, V307, P47, DOI 10.1038/307047a0; FLENLEY JR, 1991, J QUATERNARY SCI, V6, P85, DOI 10.1002/jqs.3390060202; Gana I, 1870, MEMORIA MARINA, V1, P90; Gomez JM, 2007, PLANT SYST EVOL, V268, P119, DOI 10.1007/s00606-007-0568-4; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Gomez JM, 2008, P ROY SOC B-BIOL SCI, V275, P2241, DOI 10.1098/rspb.2008.0512; Gomez JM, 2009, ECOL LETT, V12, P672, DOI 10.1111/j.1461-0248.2009.01324.x; Heenan PB, 2004, BOT J LINN SOC, V146, P439, DOI 10.1111/j.1095-8339.2004.00348.x; Heenan PB, 2001, NEW ZEAL J BOT, V39, P17; Henderson A, 2006, BOT J LINN SOC, V151, P103, DOI 10.1111/j.1095-8339.2006.00526.x; Hunt TL, 2006, SCIENCE, V311, P1603, DOI 10.1126/science.1121879; Ibanez P, 2003, ARBOLES RECURSOS NAT, P36; Kaczorowski RL, 2012, FUNCT ECOL, V26, P577, DOI 10.1111/j.1365-2435.2012.01982.x; KIRCH PV, 1994, ANTIQUITY, V68, P310, DOI 10.1017/S0003598X00046615; Klingenberg CP, 2012, J EVOLUTION BIOL, V25, P115, DOI 10.1111/j.1420-9101.2011.02410.x; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lavanchery H, 1935, ILE PAQUES; Lihova J, 2004, SYST BOT, V29, P134, DOI 10.1600/036364404772974059; Mackinder Barbara, 1997, Curtis's Botanical Magazine, V14, P221, DOI 10.1111/1467-8748.00111; Mann D, 2008, QUATERNARY RES, V69, P16, DOI 10.1016/j.yqres.2007.10.009; Maunder M, 1999, MOL ECOL, V8, P725, DOI 10.1046/j.1365-294X.1999.00609.x; Maunder M, 2000, CONSERV BIOL, V14, P1341, DOI 10.1046/j.1523-1739.2000.98520.x; Meng TT, 2009, ANN BOT-LONDON, V104, P1217, DOI 10.1093/aob/mcp230; Moreira-Munoz A, 2011, PLANT VEG, V5, P3, DOI 10.1007/978-90-481-8748-5_1; Moreira-Munoz A, 2011, PLANT VEG, V5, P87, DOI 10.1007/978-90-481-8748-5_3; Mulrooney MA, 2013, J ARCHAEOL SCI, V40, P4377, DOI 10.1016/j.jas.2013.06.020; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NUNN PD, 1990, GEOGR J, V156, P125, DOI 10.2307/635320; Orliac C, 2007, P MIGRATION IDENTITY; Oyarzun A, 1921, REV CHIL HIST NAT, V25, P133; PALMER JL, 1870, J ROYAL GEOGRAPHICAL, V40, P167, DOI DOI 10.2307/1798641; Pena R. C., 2000, Pacific Science, V54, P159; PHILIPPI Rodulfo A, 1873, ANALES U SANTIAGO CH, V43, P365; POLHILL RM, 1981, ADV LEGUME SYSTEMATI, V1, P213; Prebble M, 2008, QUATERNARY SCI REV, V27, P2546, DOI 10.1016/j.quascirev.2008.09.015; Rapaport M, 2006, ISLAND STUDIES J, V1, P109; Reiche K, 1896, SOPHOREAS, V2, P52; Ricci M, 1997, BIODIVERS CONSERV, V6, P1697, DOI 10.1023/A:1018387024505; Richtsmeier JT, 2002, YEARB PHYS ANTHROPOL, V45, P63, DOI 10.1002/ajpa.10174; Rodriguez R, 1983, FLORA ARBOREA CHILE; Rohlf F.J., 2013, TPSDIG V 2 17; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rolett B, 2004, NATURE, V431, P443, DOI 10.1038/nature02801; Savriama Y, 2012, NEW PHYTOL, V196, P945, DOI 10.1111/j.1469-8137.2012.04312.x; Savriama Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-280; Skottsberg C, 1922, NATURAL HIST J FERNA; Stevenson C.M., 2008, PREHISTORIC RAPA NUI; Tucker SC, 2006, AUST SYST BOT, V19, P193, DOI 10.1071/SB05004; Tucker SC, 2002, AM J BOT, V89, P748, DOI 10.3732/ajb.89.5.748; TUCKER SC, 1994, AM J BOT, V81, P368, DOI 10.2307/2445465; van der Niet T, 2010, TRENDS PLANT SCI, V15, P423, DOI 10.1016/j.tplants.2010.05.005; Vargas P, 2006, 1 000 ANOS RAPA NUI; Viscosi V, 2009, PLANT BIOSYST, V143, P575, DOI 10.1080/11263500902775277; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Zizka G., 1991, FLOWERING PLANTS EAS	68	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115548	10.1371/journal.pone.0115548	http://dx.doi.org/10.1371/journal.pone.0115548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526512	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200033
J	Huang, H; Koelle, P; Fendler, M; Schroettle, A; Czihal, M; Hoffmann, U; Kuhlencordt, PJ				Huang, Hua; Koelle, Pirkko; Fendler, Markus; Schroettle, Angelika; Czihal, Michael; Hoffmann, Ulrich; Kuhlencordt, Peter Jan			Niacin Reverses Migratory Macrophage Foam Cell Arrest Mediated by oxLDL In Vitro	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; EXTENDED-RELEASE NIACIN; FOCAL ADHESION; TYROSINE PHOSPHORYLATION; OXIDATIVE STRESS; LIPID PEROXIDES; NICOTINIC-ACID; KNOCKOUT MICE; PLASMA	Introduction: Niacin reduces vascular oxidative stress and down regulates inducible nitric oxide synthase, an enzyme mediating proatherosclerotic effects in part by increasing oxidative stress. Here, we evaluate whether Niacin reverses the redox sensitive migratory arrest of macrophages in response to oxidised(ox) LDL uptake. Material and Methods: Migration of RAW264.7 cells, a murine macrophage cell line and bone marrow derived macrophages from wildtype and iNOS knockout mice was quantified using a modified Boyden chamber. Unstimulated cells or cells preincubated with oxLDL or non-oxidised (n)LDL were treated with Nicotinic acid or Nicotinamide. Nitric oxide, peroxynitrite and ROS production were assessed using electron paramagnetic resonance (ESR). Additionally, flow cytometry analysis of apoptosis, fokal adhesion kinase (FAK), phalloidin, CD36, F4/80 macrophage marker and iNOS gene expression (PCR) were assessed. Results: Migration of Nicotinic acid, Nicotinamide treated cells or unstimulated cells did not differ (P>0.05). oxLDL treatment significantly reduced migration vs. unstimulated cells (p,0.05). In contrast, migratory arrest in response to oxLDL treatment was reversed by co-incubation with Nicotinic acid and Nicotinamide. The oxLDL-induced peroxynitrite formation in RAW264.7 cells was abolished by Niacin and glutathion (GSH) oxidation was significantly reduced. However, nitric oxide (NO)- and reactive oxygen species (ROS) production induced by oxLDL were not affected by Niacin treatment of RAW264.7 cells. In addition, Nicotinic acid and Nicotinamide reduced actin polymerization, a marker for migratory arrest. Discussion: Our data shows that oxLDL induced inhibition of macrophage migration in vitro can be reversed by Niacin. Furthermore, Niacin reduces peroxynitite formation and improves antioxidant GSH.	[Huang, Hua; Koelle, Pirkko; Fendler, Markus; Schroettle, Angelika; Czihal, Michael; Hoffmann, Ulrich; Kuhlencordt, Peter Jan] Univ Hosp Munich, Div Vasc Med, Med Clin & Policlin 4, Munich, Germany	University of Munich	Kuhlencordt, PJ (corresponding author), Univ Hosp Munich, Div Vasc Med, Med Clin & Policlin 4, Munich, Germany.	peter.kuhlencordt@med.uni-muenchen.de	Hoffmann, Ulrich/AAF-9798-2020		Merck, Sharp Dhome; Essex Pharma GmbH	Merck, Sharp Dhome; Essex Pharma GmbH	This work was supported by a grant from Merck, Sharp & Dhome and Essex Pharma GmbH to P.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hijji M, 2013, AM J CARDIOL, V112, P1697, DOI 10.1016/j.amjcard.2013.07.030; Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; Chen JQ, 2003, ARTERIOSCL THROM VAS, V23, P97, DOI 10.1161/01.ATV.0000040223.74255.5A; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Feussner A, 1997, EUR J CLIN CHEM CLIN, V35, P687; Ganji SH, 2009, ATHEROSCLEROSIS, V202, P68, DOI 10.1016/j.atherosclerosis.2008.04.044; Giordano A, 2002, FEBS LETT, V514, P135, DOI 10.1016/S0014-5793(02)02245-7; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Huang H, 2014, ATHEROSCLEROSIS, V235, P213, DOI 10.1016/j.atherosclerosis.2014.04.020; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Kuhnast S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066467; Kuzkaya N, 2005, BIOCHEM PHARMACOL, V70, P343, DOI 10.1016/j.bcp.2005.05.009; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan JM, 1996, BIOCHEM J, V314, P889, DOI 10.1042/bj3140889; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Ponnuswamy P, 2009, AM J PATHOL, V174, P2400, DOI 10.2353/ajpath.2009.080730; Rubbo H, 1996, CHEM RES TOXICOL, V9, P809, DOI 10.1021/tx960037q; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; Sharma M, 2011, CURR OPIN CARDIOL, V26, P420, DOI 10.1097/HCO.0b013e3283499ef1; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Soskic SS, 2011, OPEN CARDIOVASC MED, V5, P153, DOI 10.2174/1874192401105010153; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; STOSSEL TP, 1994, SCI AM, V271, P54, DOI 10.1038/scientificamerican0994-54; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Taylor W R, 1999, Curr Hypertens Rep, V1, P96, DOI 10.1007/s11906-999-0079-5; The AIM-HIGH Investigators, 2013, EUROPEAN HEART J, V34, P1279; Vaca P, 2003, TRANSPL P, V35, P2021, DOI 10.1016/S0041-1345(03)00735-8; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; Yu DH, 1998, J BIOL CHEM, V273, P21125, DOI 10.1074/jbc.273.33.21125	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114643	10.1371/journal.pone.0114643	http://dx.doi.org/10.1371/journal.pone.0114643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521578	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600005
J	Riters, LV; Stevenson, SA; DeVries, MS; Cordes, MA				Riters, Lauren V.; Stevenson, Sharon A.; DeVries, M. Susan; Cordes, Melissa A.			Reward Associated with Singing Behavior Correlates with Opioid-Related Gene Expression in the Medial Preoptic Nucleus in Male European Starlings	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; STURNUS-VULGARIS; SOCIAL-BEHAVIOR; ZEBRA FINCH; DOPAMINERGIC SYSTEM; INCENTIVE SALIENCE; UNDIRECTED SONG; SEXUAL REWARD; BRAIN; AREA	Birdsong consists of species-specific learned vocal sequences that are used primarily to attract mates and to repel competitors during the breeding season. However, many birds continue to sing at times when vocal production has no immediate or obvious impact on conspecific behavior. The mechanisms that ensure that animals produce important behaviors in contexts in which the function of these behaviors is not immediate or obvious are not known. One possibility is that animals engage in such behaviors because they are associated with pleasure. Here we examined the hypothesis that male European starlings sing outside of the breeding season in part because the act of singing in this context is facilitated and/or maintained by opioid-mediated reward. We measured song-associated reward using a conditioned place preference (CPP) test in male starlings producing fall, non-breeding season-typical song. We used quantitative real time PCR to measure expression of the enkephalin opioid precursor preproenkephalin (PENK) and mu opioid receptors (MOR) in the medial preoptic nucleus (POM; a region in which opioids are implicated in both reward and starling fall song) and additionally the song control region HVC as a control. Starlings developed a strong preference for a place that had been paired previously with the act of producing fall-typical song, indicating that fall song production was associated with a positive affective state. Both PENK and MOR mRNA expression in the POM, but not HVC, correlated positively with both individual reward state (as reflected in CPP) and undirected singing behavior. These results suggest that singing induces opioid receptor and enkephalin expression in the POM and consequent reward, and/or that opioid release in the POM induced by individual or environmental factors (e.g., the presence of food, safety of a flock or the absence of predators) induces a positive affective state which then facilitates singing behavior.	[Riters, Lauren V.; Stevenson, Sharon A.; DeVries, M. Susan; Cordes, Melissa A.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Riters, LV (corresponding author), Univ Wisconsin, Dept Zool, 428 Birge Hall, Madison, WI 53706 USA.	LVRiters@wisc.edu			National Institute of Mental Health [R01MH080225]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080225] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health, R01MH080225, to LVR.http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMO A, 1993, BEHAV NEUROSCI, V107, P812, DOI 10.1037/0735-7044.107.5.812; AGMO A, 1991, BRAIN RES, V550, P343, DOI 10.1016/0006-8993(91)91339-3; AGMO A, 1990, BEHAV NEUROSCI, V104, P177, DOI 10.1037/0735-7044.104.1.177; Ahmed M, 2014, J PEDIAT HEMATOL ONC, V36, P152, DOI 10.1097/MPH.0000000000000024; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Barbano MF, 2007, PSYCHOPHARMACOLOGY, V191, P497, DOI 10.1007/s00213-006-0521-1; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bodnar RJ, 2013, PEPTIDES, V50, P55, DOI 10.1016/j.peptides.2013.10.001; CARDEN SE, 1990, BEHAV NEUROSCI, V104, P457, DOI 10.1037/0735-7044.104.3.457; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; CHANG KJ, 1982, NATURE, V296, P446, DOI 10.1038/296446a0; CHENG MF, 1994, J NEUROBIOL, V25, P361, DOI 10.1002/neu.480250403; Clift SM, 2001, J R SOC PROMO HEALTH, V121, P248, DOI 10.1177/146642400112100409; Darwin C, 1882, DESCENT MAN SELECTIO; Dawson A, 1997, J REPROD FERTIL, V111, P1; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dunbar RIM, 2012, P ROY SOC B-BIOL SCI, V279, P1161, DOI 10.1098/rspb.2011.1373; Dunn AM, 1996, ETHOLOGY, V102, P529; EAST M, 1982, ORNIS SCAND, V13, P85, DOI 10.2307/3676194; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Feare C.J., 1984, STARLING; GISPEN WH, 1976, NATURE, V264, P794, DOI 10.1038/264794a0; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Gulledge CC, 1999, J COMP NEUROL, V404, P505; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Harrison LM, 1998, PEPTIDES, V19, P1603, DOI 10.1016/S0196-9781(98)00126-0; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Heimovics SA, 2009, NEUROSCIENCE, V159, P962, DOI 10.1016/j.neuroscience.2009.01.042; Heimovics SA, 2008, PHYSIOL BEHAV, V95, P258, DOI 10.1016/j.physbeh.2008.06.009; Heimovics SA, 2011, HORM BEHAV, V60, P529, DOI 10.1016/j.yhbeh.2011.08.001; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Holveck MJ, 2010, P ROY SOC B-BIOL SCI, V277, P153, DOI 10.1098/rspb.2009.1222; Jesse F, 2012, BEHAV PROCESS, V91, P262, DOI 10.1016/j.beproc.2012.09.006; KATZ RJ, 1979, NEUROSCI LETT, V13, P209, DOI 10.1016/0304-3940(79)90043-0; Kelm-Nelson CA, 2013, BRAIN RES, V1527, P29, DOI 10.1016/j.brainres.2013.06.010; Kelm-Nelson CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046721; Khurshid N, 2010, BEHAV BRAIN RES, V208, P359, DOI 10.1016/j.bbr.2009.12.003; Khurshid N, 2009, J CHEM NEUROANAT, V37, P158, DOI 10.1016/j.jchemneu.2008.12.001; King AP, 2005, ETHOLOGY, V111, P101, DOI 10.1111/j.1439-0310.2004.01039.x; Kleitz-Nelson HK, 2010, BEHAV NEUROSCI, V124, P300, DOI 10.1037/a0018767; Ko HJ, 2011, GERIATR GERONTOL INT, V11, P267, DOI 10.1111/j.1447-0594.2010.00680.x; Kreutz G, 2004, J BEHAV MED, V27, P623, DOI 10.1007/s10865-004-0006-9; Kubikova L, 2010, J CHEM NEUROANAT, V39, P112, DOI 10.1016/j.jchemneu.2009.10.004; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Lehrer P. M., 1994, BEHAV PSYCHOL APPROA, P191; MARLER P, 1990, PHILOS T ROY SOC B, V329, P109, DOI 10.1098/rstb.1990.0155; PANKSEPP J, 1980, NEUROSCI BIOBEHAV R, V4, P473, DOI 10.1016/0149-7634(80)90036-6; PANKSEPP J, 1981, BRAIN RES BULL, V7, P405, DOI 10.1016/0361-9230(81)90038-1; PANKSEPP J, 1980, PHARMACOL BIOCHEM BE, V13, P673, DOI 10.1016/0091-3057(80)90011-8; PANKSEPP J, 1979, PHARMACOL BIOCHEM BE, V11, P131, DOI 10.1016/0091-3057(79)90002-9; Panksepp J, 2007, BEHAV BRAIN RES, V182, P231, DOI 10.1016/j.bbr.2007.02.015; Panksepp J, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P67; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaus JG, 2001, HORM BEHAV, V40, P291, DOI 10.1006/hbeh.2001.1686; Riters LV, 2012, FRONT NEUROENDOCRIN, V33, P194, DOI 10.1016/j.yfrne.2012.04.002; Riters LV, 2012, PHYSIOL BEHAV, V106, P87, DOI 10.1016/j.physbeh.2012.01.010; Riters LV, 2011, NEUROSCI BIOBEHAV R, V35, P1837, DOI 10.1016/j.neubiorev.2010.12.017; Riters LV, 2010, J CHEM NEUROANAT, V39, P141, DOI 10.1016/j.jchemneu.2009.03.008; Riters LV, 2000, HORM BEHAV, V38, P250, DOI 10.1006/hbeh.2000.1623; Riters LV, 2005, BEHAV NEUROSCI, V119, P245, DOI 10.1037/0735-7044.119.1.245; Robertson SA, 2005, J VET PHARMACOL THER, V28, P453, DOI 10.1111/j.1365-2885.2005.00677.x; Sakata JT, 2012, J EXP BIOL, V215, P201, DOI 10.1242/jeb.056911; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Skingley A, 2010, Nurs Stand, V24, P35; Stephens R, 2009, NEUROREPORT, V20, P1056, DOI 10.1097/WNR.0b013e32832e64b1; Stevenson TJ, 2012, J CHEM NEUROANAT, V43, P87, DOI 10.1016/j.jchemneu.2011.12.001; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0	74	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115285	10.1371/journal.pone.0115285	http://dx.doi.org/10.1371/journal.pone.0115285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521590	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600030
J	Basson, A; Swart, R; Jordaan, E; Mazinu, M; Watermeyer, G				Basson, Abigail; Swart, Rina; Jordaan, Esme; Mazinu, Mikateko; Watermeyer, Gillian			The Association between Childhood Environmental Exposures and the Subsequent Development of Crohn's Disease in the Western Cape, South Africa	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HUMAN MICROBIOME; SMOKING; EPIDEMIOLOGY; HYGIENE; RISK; PREVALENCE; PREDICTORS; TOWN	Background: Environmental factors during childhood are thought to play a role in the aetiolgy of Crohn's Disease (CD). However the association between age at time of exposure and the subsequent development of CD in South Africa is unknown. Methods: A case control study of all consecutive CD patients seen at 2 large inflammatory bowel disease (IBD) referral centers in the Western Cape, South Africa between September 2011 and January 2013 was performed. Numerous environmental exposures during 3 age intervals; 0-5, 6-10 and 11-18 years were extracted using an investigator administered questionnaire. An agreement analysis was performed to determine the reliability of questionnaire data for all the relevant variables. Results: This study included 194 CD patients and 213 controls. On multiple logistic regression analysis, a number of childhood environmental exposures during the 3 age interval were significantly associated with the risk of developing CD. During the age interval 6-10 years, never having had consumed unpasteurized milk (OR=5.84; 95% CI, 2.73-13.53) and never having a donkey, horse, sheep or cow on the property (OR=2.48; 95% CI, 1.09-5.98) significantly increased the risk of developing future CD. During the age interval 11-18 years, an independent risk-association was identified for; never having consumed unpasteurized milk (OR=2.60; 95% CI, 1.17-6.10) and second-hand cigarette smoke exposure (OR=1.93; 95% CI, 1.13-3.35). Conclusion: This study demonstrates that both limited microbial exposures and exposure to second-hand cigarette smoke during childhood is associated with future development of CD.	[Basson, Abigail; Swart, Rina] Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa; [Jordaan, Esme; Mazinu, Mikateko] Med Res Council South Africa, Biostat Unit, Parow, Western Cape, South Africa; [Jordaan, Esme] Univ Western Cape, Stat & Populat Studies Dept, ZA-7535 Bellville, Western Cape, South Africa; [Watermeyer, Gillian] Groote Schuur Hosp, Dept Gastroenterol, ZA-7925 Cape Town, Western Cape, South Africa; [Watermeyer, Gillian] Univ Cape Town, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa	University of the Western Cape; University of the Western Cape; University of Cape Town; University of Cape Town	Basson, A (corresponding author), Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa.	abbasson@uwc.ac.za	; Swart, Elizabeth/O-9619-2014	Basson, Abigail/0000-0002-8369-919X; Swart, Elizabeth/0000-0002-7786-3117	AstraZeneca/South African Gastroenterology Society (SAGES)	AstraZeneca/South African Gastroenterology Society (SAGES)	This research was supported by the 2011 Scholarship in Gastroenterology; a grant from the AstraZeneca/South African Gastroenterology Society (SAGES). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. [http://www.sages.co.za/D_AN_ScholTravel.asp]	Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104859; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Bisgaard H, 2014, CLIN EXP ALLERGY, V44, P475, DOI 10.1111/cea.12291; Blanchard JF, 2001, AM J EPIDEMIOL, V154, P328, DOI 10.1093/aje/154.4.328; Chu KM, 2013, INFLAMM BOWEL DIS, V19, P614, DOI 10.1097/MIB.0b013e31827f27f4; Duggan AE, 1998, GUT, V43, P494, DOI 10.1136/gut.43.4.494; EKBOM A, 1991, GASTROENTEROLOGY, V100, P350, DOI 10.1016/0016-5085(91)90202-V; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; Koloski NA, 2008, WORLD J GASTROENTERO, V14, P165, DOI 10.3748/wjg.14.165; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Mahid SS, 2007, DIGEST DIS SCI, V52, P2897, DOI 10.1007/s10620-006-9624-0; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Mahid SS, 2007, INFLAMM BOWEL DIS, V13, P431, DOI 10.1002/ibd.20070; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; PERSSON PG, 1990, GUT, V31, P1377, DOI 10.1136/gut.31.12.1377; Proal AD, 2013, CURR OPIN RHEUMATOL, V25, P234, DOI 10.1097/BOR.0b013e32835cedbf; Small K, 2008, DEMOGRAPHIC SOCIOECO; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wadee S, 2007, RHEUMATOLOGY, V46, P1487, DOI 10.1093/rheumatology/kem180; WRIGHT JP, 1986, S AFR MED J, V70, P10; WRIGHT JP, 1983, S AFR MED J, V63, P226	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115492	10.1371/journal.pone.0115492	http://dx.doi.org/10.1371/journal.pone.0115492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514591	Green Published, Green Submitted, gold			2022-12-27	WOS:000349146300060
J	Fung, TT; Kashambwa, R; Sato, K; Chiuve, SE; Fuchs, CS; Wu, KN; Giovannucci, E; Ogino, S; Hu, FB; Meyerhardt, JA				Fung, Teresa T.; Kashambwa, Rutendo; Sato, Kaori; Chiuve, Stephanie E.; Fuchs, Charles S.; Wu, Kana; Giovannucci, Edward; Ogino, Shuji; Hu, Frank B.; Meyerhardt, Jeffrey A.			Post Diagnosis Diet Quality and Colorectal Cancer Survival in Women	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; MEDITERRANEAN DIET; PROSPECTIVE COHORT; COLON-CANCER; ALL-CAUSE; RISK; MORTALITY; PATTERNS	Background: Dietary factors are known to influence colorectal cancer (CRC) risk, however, their association with CRC survival is unclear. Therefore, we prospectively examined the association between diet quality scores, dietary patterns and colorectal cancer (CRC) survival. Methods: 1201 women diagnosed with stage I-III CRC between 1986 and 2008, were followed through 2010. Diet was assessed via a food frequency questionnaire administered at least 6 months after diagnosis. We computed the Alternate Healthy Eating Index-2010 (AHEI-2010), alternate Mediterranean Diet score (aMED) and Dietary Approaches to Stop Hypertension score (DASH) and derived two dietary patterns, Western (unhealthy) and prudent (healthy), by principal component analysis for each woman. Results: During follow-up, we documented 435 deaths, including 162 from CRC. After adjusting for potential confounders, only a higher AHEI-2010 score was significantly associated with lower overall mortality (HR comparing extreme quintiles=0.71, 95% CI 0.52-0.98, p trend=0.01) as well as borderline significantly with lower risk of CRC mortality by the trend test (HR Q5 vs Q1=0.72, 95% CI=0.43-1.21, p trend=0.07). When AHEI-2010 components were examined separately, inverse associations for overall mortality were primarily accounted for by moderate alcohol intake (HR comparing abstainers vs 5-15 g/d=1.30, 95% CI=1.05-1.61) and lower intake of sugar sweetened beverages and fruit juices combined (HR for each additional serving=1.11, 95% CI=1.01-1.23). No other diet quality score or dietary pattern was associated with overall or CRC-specific mortality. Conclusion: Higher AHEI-2010 score may be associated with lower overall mortality, moderate alcohol consumption and lower consumption of sugar sweetened beverages and juices combined appeared to account for most of the observed associations.	[Fung, Teresa T.] Simmons Coll, Dept Nutr, Boston, MA 02115 USA; [Kashambwa, Rutendo] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Chiuve, Stephanie E.; Wu, Kana; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ogino, Shuji] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med,Dept Surg, Boston, MA 02115 USA; [Fuchs, Charles S.; Hu, Frank B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Fuchs, Charles S.; Ogino, Shuji; Meyerhardt, Jeffrey A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Simmons University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Fung, TT (corresponding author), Simmons Coll, Dept Nutr, Boston, MA 02115 USA.	fung@simmons.edu		Ogino, Shuji/0000-0002-3909-2323; Chiuve, Stephanie/0000-0002-3524-8917	National Institute of Health [CA87969, CA127003, CA149222, CA95589, CA151993, CA169141, CA 118553, UM1CA167552, U54CA155626, UM1 CA167552]; NATIONAL CANCER INSTITUTE [P50CA127003, R01CA149222, R01CA095589, R01CA169141, R01CA118553, P01CA087969, U54CA155626, UM1CA167552, R01CA151993] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is funded by the National Institute of Health research grants CA87969, CA127003, CA149222, CA95589, CA151993, CA169141, CA 118553, UM1CA167552, U54CA155626, UM1 CA167552. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Abhari S, 2013, EUR J EPIDEMIOL, V28, P541, DOI 10.1007/s10654-013-9819-6; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Bystrom P, 2009, UPSALA J MED SCI, V114, P160, DOI 10.1080/03009730903027172; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cooney RV, 2013, CANCER EPIDEM BIOMAR, V22, P1278, DOI 10.1158/1055-9965.EPI-13-0199; Crozier J, 2006, BRIT J CANCER, V94, P1833, DOI 10.1038/sj.bjc.6603185; Dehal AN, 2012, J CLIN ONCOL, V30, P53, DOI 10.1200/JCO.2011.38.0303; Fung Teresa T, 2013, Curr Nutr Rep, V2, P48; Fung TT, 2010, AM J CLIN NUTR, V92, P1429, DOI 10.3945/ajcn.2010.29242; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2005, AM J CLIN NUTR, V82, P163; HENNEKENS CH, 1979, LANCET, V1, P1390; Hoensch H, 2008, WORLD J GASTROENTERO, V14, P2187, DOI 10.3748/wjg.14.2187; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kim EHJ, 2011, NUTR CANCER, V63, P381, DOI 10.1080/01635581.2011.535963; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Leung EYL, 2008, INT J CANCER, V123, P2460, DOI 10.1002/ijc.23811; Lofano Katia, 2013, J Gastrointest Cancer, V44, P1, DOI 10.1007/s12029-012-9425-y; McCullough ML, 2013, J CLIN ONCOL, V31, P2773, DOI 10.1200/JCO.2013.49.1126; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Mitrou PN, 2007, ARCH INTERN MED, V167, P2461, DOI 10.1001/archinte.167.22.2461; Randi G, 2010, NUTR REV, V68, P389, DOI 10.1111/j.1753-4887.2010.00299.x; Reedy J, 2008, AM J EPIDEMIOL, V168, P38, DOI 10.1093/aje/kwn097; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schwingshackl L, 2014, INT J CANCER, V135, P1884, DOI 10.1002/ijc.28824; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Walter V, 2014, ANN ONCOL, V25, P1517, DOI 10.1093/annonc/mdu040; Willett W., 2012, NUTR EPIDEMIOLOGY; Wolpin BM, 2008, J CLIN ONCOL, V26, P3222, DOI 10.1200/JCO.2008.16.1943; Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945; Yang Y, 2013, CANCER-AM CANCER SOC, V119, P1512, DOI 10.1002/cncr.27923; Yoshida M, 2007, J NUTR, V137, P2121, DOI 10.1093/jn/137.9.2121; Zhu Y, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002270	39	67	66	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115377	10.1371/journal.pone.0115377	http://dx.doi.org/10.1371/journal.pone.0115377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506700	Green Published, gold			2022-12-27	WOS:000346607100072
J	Murakami, I; Chaleckis, R; Pluskal, T; Ito, K; Hori, K; Ebe, M; Yanagida, M; Kondoh, H				Murakami, Itsuo; Chaleckis, Romanas; Pluskal, Tomas; Ito, Ken; Hori, Kousuke; Ebe, Masahiro; Yanagida, Mitsuhiro; Kondoh, Hiroshi			Metabolism of Skin-Absorbed Resveratrol into Its Glucuronized Form in Mouse Skin	PLOS ONE			English	Article							CANCER CHEMOPREVENTIVE AGENT; LIFE-SPAN; TRANS-RESVERATROL; UDP-GLUCURONOSYLTRANSFERASE; MITOCHONDRIAL-FUNCTION; CALORIE RESTRICTION; HUMAN LIVER; IN-VIVO; CELLS; YEAST	Resveratrol (RESV) is a plant polyphenol, which is thought to have beneficial metabolic effects in laboratory animals as well as in humans. Following oral administration, RESV is immediately catabolized, resulting in low bioavailability. This study compared RESV metabolites and their tissue distribution after oral uptake and skin absorption. Metabolomic analysis of various mouse tissues revealed that RESV can be absorbed and metabolized through skin. We detected sulfated and glucuronidated RESV metabolites, as well as dihydroresveratrol. These metabolites are thought to have lower pharmacological activity than RESV. Similar quantities of most RESV metabolites were observed 4 h after oral or skin administration, except that glucuronidated RESV metabolites were more abundant in skin after topical RESV application than after oral administration. This result is consistent with our finding of glucuronidated RESV metabolites in cultured skin cells. RESV applied to mouse ears significantly suppressed inflammation in the TPA inflammation model. The skin absorption route could be a complementary, potent way to achieve therapeutic effects with RESV.	[Murakami, Itsuo; Chaleckis, Romanas; Ito, Ken; Hori, Kousuke; Kondoh, Hiroshi] Kyoto Univ Hosp, Geriatr Unit, Sakyo Ku, Kyoto 606, Japan; [Chaleckis, Romanas; Pluskal, Tomas; Ebe, Masahiro; Yanagida, Mitsuhiro] Grad Univ OIST, Cell Unit G0, Okinawa Inst Sci & Technol, Okinawa, Japan	Kyoto University; Okinawa Institute of Science & Technology Graduate University	Kondoh, H (corresponding author), Kyoto Univ Hosp, Geriatr Unit, Sakyo Ku, Kyoto 606, Japan.	myanagid@gmail.com; hkondoh@kuhp.kyoto-u.ac.jp	Chaleckis, Romanas/K-2629-2014; Pluskal, Tomáš/C-6247-2012	Chaleckis, Romanas/0000-0001-8042-1005; Pluskal, Tomáš/0000-0002-6940-3006	Okinawa Intellectual Cluster Program; Japanese government (Monbukagakusho: MEXT) scholarship; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Okinawa Intellectual Cluster Program; Japanese government (Monbukagakusho: MEXT) scholarship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Itsuo Murakami was supported by a postdoctoral fellowship from Okinawa Intellectual Cluster Program. Romanas Chaleckis was supported by Japanese government (Monbukagakusho: MEXT) scholarship. This work was supported in part by grants from the Okinawa Intellectual Cluster Program, from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from Japan Science and Technology Agency (to H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Aziz MH, 2005, PHOTOCHEM PHOTOBIOL, V81, P25, DOI 10.1562/2004-08-13-RA-274.1; Azorin-Ortuno M, 2011, MOL NUTR FOOD RES, V55, P1154, DOI 10.1002/mnfr.201100140; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bralley EE, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-1; Chaleckis R, 2014, MOL BIOSYST, V10, P2538, DOI 10.1039/c4mb00346b; Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589; De Santi C, 2000, XENOBIOTICA, V30, P1047, DOI 10.1080/00498250010002487; Dirks AJ, 2006, MECH AGEING DEV, V127, P1, DOI 10.1016/j.mad.2005.09.001; DURRHEIM H, 1980, J PHARM SCI, V69, P781, DOI 10.1002/jps.2600690709; Juan ME, 2010, J PHARMACEUT BIOMED, V51, P391, DOI 10.1016/j.jpba.2009.03.026; Everitt AV, 2010, CALORIE RESTRICTION, AGING AND LONGEVITY, P1, DOI 10.1007/978-90-481-8556-6; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hung CF, 2008, BIOL PHARM BULL, V31, P955, DOI 10.1248/bpb.31.955; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jung CM, 2009, FEMS MICROBIOL LETT, V297, P266, DOI 10.1111/j.1574-6968.2009.01691.x; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kuehnbaum NL, 2013, CHEM REV, V113, P2437, DOI 10.1021/cr300484s; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lancon A, 2007, DRUG METAB DISPOS, V35, P699, DOI 10.1124/dmd.106.013664; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Maier-Salamon A, 2008, J PHARM SCI-US, V97, P1615, DOI 10.1002/jps.21057; Maier-Salamon A, 2013, ANN NY ACAD SCI, V1290, P98, DOI 10.1111/nyas.12198; Maier-Salamon A, 2011, DRUG METAB PHARMACOK, V26, P364, DOI 10.2133/dmpk.DMPK-11-RG-006; Martin GM, 2011, FASEB J, V25, P3756, DOI 10.1096/fj.11-1102.ufm; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miksits M, 2010, CANCER LETT, V289, P237, DOI 10.1016/j.canlet.2009.08.020; Mizutani K, 2000, J NUTR SCI VITAMINOL, V46, P78, DOI 10.3177/jnsv.46.78; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; Nerurkar Pratibha V, 2008, Cellscience, V4, P82; Pluskal T, 2012, ANAL CHEM, V84, P4396, DOI 10.1021/ac3000418; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Pluskal T, 2010, MOL BIOSYST, V6, P182, DOI 10.1039/b908784b; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reagan-Shaw S, 2004, ONCOGENE, V23, P5151, DOI 10.1038/sj.onc.1207666; Sabolovic N, 2006, BIOPHARM DRUG DISPOS, V27, P181, DOI 10.1002/bdd.498; Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568; Sasaki H, 2008, GERIATR GERONTOL INT, V8, P1, DOI 10.1111/j.1447-0594.2008.00439.x; Scully T, 2012, NATURE, V492, pS2, DOI 10.1038/492S2a; Sumida K, 2013, MOL PHARMACOL, V84, P679, DOI 10.1124/mol.113.088112; Sun Z, 2012, FEBS J, V279, P2381, DOI 10.1111/j.1742-4658.2012.08617.x; Timmers S, 2012, AGING-US, V4, P146, DOI 10.18632/aging.100445; Ung D, 2009, XENOBIOTICA, V39, P72, DOI [10.1080/00498250802604082, 10.1080/00498250802604082 ]; Vang O, 2013, ANN NY ACAD SCI, V1290, P1, DOI 10.1111/nyas.12173; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; Vanltallie TB, 2003, METABOLISM, V52, P22, DOI 10.1053/S0026-0495(03)00297-X; Vitrac X, 2003, LIFE SCI, V72, P2219, DOI 10.1016/S0024-3205(03)00096-1; WAWRZYNIAK CJ, 1989, MOL CELL BIOL, V9, P4074, DOI 10.1128/MCB.9.9.4074; Wenzel E, 2005, MOL NUTR FOOD RES, V49, P482, DOI 10.1002/mnfr.200500003; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Wu Y, 2013, J EUR ACAD DERMATOL, V27, P345, DOI 10.1111/j.1468-3083.2011.04414.x; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zillich OV, 2013, INT J COSMETIC SCI, V35, P491, DOI 10.1111/ics.12072	64	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115359	10.1371/journal.pone.0115359	http://dx.doi.org/10.1371/journal.pone.0115359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506824	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100069
J	Baeumler, PI; Fleckenstein, J; Takayama, S; Simang, M; Seki, T; Irnich, D				Baeumler, Petra I.; Fleckenstein, Johannes; Takayama, Shin; Simang, Michael; Seki, Takashi; Irnich, Dominik			Effects of Acupuncture on Sensory Perception: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COLD-PRESSOR PAIN; ELECTRICAL NERVE-STIMULATION; MYOFASCIAL TRIGGER POINTS; TENSION-TYPE HEADACHE; THERMAL PAIN; CHRONIC NECK; MANUAL ACUPUNCTURE; SHAM ACUPUNCTURE; CONTROLLED-TRIAL; DOUBLE-BLIND	Background: The effect of acupuncture on sensory perception has never been systematically reviewed; although, studies on acupuncture mechanisms are frequently based on the idea that changes in sensory thresholds reflect its effect on the nervous system. Methods: Pubmed, EMBASE and Scopus were screened for studies investigating the effect of acupuncture on thermal or mechanical detection or pain thresholds in humans published in English or German. A meta-analysis of high quality studies was performed. Results: Out of 3007 identified articles 85 were included. Sixty five studies showed that acupuncture affects at least one sensory threshold. Most studies assessed the pressure pain threshold of which 80% reported an increase after acupuncture. Significant short-and long-term effects on the pressure pain threshold in pain patients were revealed by two meta-analyses including four and two high quality studies, respectively. In over 60% of studies, acupuncture reduced sensitivity to noxious thermal stimuli, but measuring methods might influence results. Few but consistent data indicate that acupuncture reduces pin-prick like pain but not mechanical detection. Results on thermal detection are heterogeneous. Sensory threshold changes were equally frequent reported after manual acupuncture as after electroacupuncture. Among 48 sham-controlled studies, 25 showed stronger effects on sensory thresholds through verum than through sham acupuncture, but in 9 studies significant threshold changes were also observed after sham acupuncture. Overall, there is a lack of high quality acupuncture studies applying comprehensive assessments of sensory perception. Conclusions: Our findings indicate that acupuncture affects sensory perception. Results are most compelling for the pressure pain threshold, especially in pain conditions associated with tenderness. Sham acupuncture can also cause such effects. Future studies should incorporate comprehensive, standardized assessments of sensory profiles in order to fully characterize its effect on sensory perception and to explore the predictive value of sensory profiles for the effectiveness of acupuncture.	[Baeumler, Petra I.; Fleckenstein, Johannes; Simang, Michael; Irnich, Dominik] Univ Munich LMU, Dept Anaesthesiol, Ctr Multidisciplinary Pain, Munich, Germany; [Takayama, Shin; Seki, Takashi] Tohoku Univ, Dept Tradit Asian Med, Sendai, Miyagi 980, Japan; [Simang, Michael] Univ Munich LMU, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany	University of Munich; Tohoku University; University of Munich	Baeumler, PI (corresponding author), Univ Munich LMU, Dept Anaesthesiol, Ctr Multidisciplinary Pain, Munich, Germany.	Petra.Baeumler@med.uni-muenchen.de	Fleckenstein, Johannes/AAL-1315-2021; Takayama, Shin/AAP-7007-2021; Takayama, Shin/GSN-7228-2022	Takayama, Shin/0000-0002-6388-4566; Fleckenstein, Johannes/0000-0003-3442-0380	University of Munich & Tohoku University	University of Munich & Tohoku University	University of Munich & Tohoku University provided support in the form of salaries for all authors as depicted in the corresponding affiliations, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abuaisha BB, 1998, DIABETES RES CLIN PR, V39, P115, DOI 10.1016/S0168-8227(97)00123-X; Agostinho CMS, 2009, EUR J PAIN, V13, P779, DOI 10.1016/j.ejpain.2008.10.002; Ahn Andrew C, 2007, Acupunct Med, V25, P11; Amand M, 2011, ACUPUNCT MED, V29, P47, DOI 10.1136/aim.2010.002485; ANDERSON DG, 1974, CAN J PSYCHOL, V28, P239, DOI 10.1037/h0081990; Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; ASHTON H, 1984, J PSYCHOSOM RES, V28, P301, DOI 10.1016/0022-3999(84)90052-7; Barlas P, 2000, CLIN PHYSIOL, V20, P449, DOI 10.1046/j.1365-2281.2000.00280.x; Barlas P, 2006, PAIN, V122, P81, DOI 10.1016/j.pain.2006.01.012; Barnes PM, 2008, NATL HLTH STAT REPOR, V12, P1, DOI DOI 10.1037/E623942009-001; Benoliel R, 2011, J OROFAC PAIN, V25, P32; BERLIN FS, 1975, ANESTHESIOLOGY, V42, P527, DOI 10.1097/00000542-197505000-00002; BROCKHAUS A, 1990, PAIN, V43, P181, DOI 10.1016/0304-3959(90)91071-P; Carlsson Christer, 2002, Acupunct Med, V20, P82; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chae Y, 2006, J PHYSIOL SCI, V56, P425, DOI 10.2170/physiolsci.RP010206; Chou LW, 2011, AM J PHYS MED REHAB, V90, P1036, DOI 10.1097/PHM.0b013e3182328875; CLARK WC, 1974, SCIENCE, V184, P1096, DOI 10.1126/science.184.4141.1096; CROZE S, 1976, BRAIN RES, V104, P335, DOI 10.1016/0006-8993(76)90628-4; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; DAY RL, 1975, ANESTHESIOLOGY, V43, P507, DOI 10.1097/00000542-197511000-00005; DELUZE C, 1992, BRIT MED J, V305, P1249, DOI 10.1136/bmj.305.6864.1249; Downs NM, 2005, ARCH PHYS MED REHAB, V86, P1252, DOI 10.1016/j.apmr.2004.10.037; DYCK PJ, 1993, NEUROLOGY, V43, P1500, DOI 10.1212/WNL.43.8.1500; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; Eardley S, 2012, FORSCH KOMPLEMENTMED, V19, P18, DOI 10.1159/000342708; Edwards Janet, 2003, Acupunct Med, V21, P80; Farber PL, 1997, ACUPUNCTURE ELECTRO, V22, P109, DOI 10.3727/036012997816356725; Fernandez-Carnero J, 2010, J OROFAC PAIN, V24, P106; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3; Fu ZH, 2007, J ALTERN COMPLEM MED, V13, P47, DOI 10.1089/acm.2006.6125; Galloon S, 1977, DTSCH ARZTEBLATT, V74, P879; Garell PC, 1996, J NEUROPHYSIOL, V75, P1177, DOI 10.1152/jn.1996.75.3.1177; GARNSWORTHY RK, 1988, J NEUROPHYSIOL, V59, P1083, DOI 10.1152/jn.1988.59.4.1083; Goddard G, 2002, J OROFAC PAIN, V16, P71; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Harris RE, 2008, ARTHRITIS RHEUM, V58, P903, DOI 10.1002/art.23223; Harris RE, 2006, J PAIN, V7, P521, DOI 10.1016/j.jpain.2006.01.455; He D, 2004, PAIN, V109, P299, DOI 10.1016/j.pain.2004.01.018; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Hubscher M, 2008, J ALTERN COMPLEM MED, V14, P1011, DOI 10.1089/acm.2008.0173; Ilbuldu E, 2004, PHOTOMED LASER SURG, V22, P306; Irnich D, 2003, PHYS MED REHAB KUROR, V13, P215; Irnich D, 2002, SCHMERZ, V16, P93, DOI 10.1007/s004820100094; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Irnich D, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq009; Itoh K, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-24; Jensen TS, 2003, PAIN, V102, P1, DOI 10.1016/S0304-3959(03)00006-X; Jones L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009234.pub2; Karst M, 2000, PAIN, V88, P199, DOI 10.1016/S0304-3959(00)00315-8; KITADE T, 1981, AM J CHINESE MED, V9, P243, DOI 10.1142/S0192415X81000329; KITADE T, 1988, ACUPUNCTURE ELECTRO, V13, P87, DOI 10.3727/036012988816358705; KITADE T, 1979, AM J CHINESE MED, V7, P241, DOI 10.1142/S0192415X79000209; KNOX VJ, 1977, PAIN, V4, P49, DOI 10.1016/0304-3959(77)90086-0; KNOX VJ, 1981, J ABNORM PSYCHOL, V90, P28, DOI 10.1037/0021-843X.90.1.28; KNOX VJ, 1979, PSYCHOSOM MED, V41, P477; KNOX VJ, 1977, J ABNORM PSYCHOL, V86, P639; Kong J, 2005, J PAIN, V6, P55, DOI 10.1016/j.jpain.2004.10.005; Kong J, 2009, NEUROIMAGE, V45, P940, DOI 10.1016/j.neuroimage.2008.12.025; Konopka KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043526; Kotani N, 2001, REGION ANESTH PAIN M, V26, P532, DOI 10.1053/rapm.2001.25897; Kumnerddee Wipoo, 2009, J Med Assoc Thai, V92 Suppl 1, pS117; LAMOTTE RH, 1978, J NEUROPHYSIOL, V41, P509, DOI 10.1152/jn.1978.41.2.509; Lang PM, 2010, ANESTH ANALG, V110, P1448, DOI 10.1213/ANE.0b013e3181d3e7ef; Langhorst J, 2010, RHEUMATOLOGY, V49, P778, DOI 10.1093/rheumatology/kep439; Le Bars D, 2002, BRAIN RES REV, V40, P29, DOI 10.1016/S0165-0173(02)00186-8; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Leung A, 2005, J ALTERN COMPLEM MED, V11, P653, DOI 10.1089/acm.2005.11.653; Leung AY, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-18; LI SC, 1983, ACUPUNCTURE ELECTRO, V8, P105, DOI 10.3727/036012983816714984; Li WH, 2008, COMPLEMENT THER MED, V16, P278, DOI 10.1016/j.ctim.2008.02.011; LIM TW, 1977, MED J AUSTRALIA, V1, P440, DOI 10.5694/j.1326-5377.1977.tb130796.x; Lin JG, 2008, AM J CHINESE MED, V36, P635, DOI 10.1142/S0192415X08006107; LIN MT, 1981, AM J CHINESE MED, V9, P305, DOI 10.1142/S0192415X81000408; Linde K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-75; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007587; List Thomas, 1993, Journal of Orofacial Pain, V7, P275; LLOYD MA, 1976, ANESTHESIOLOGY, V44, P147, DOI 10.1097/00000542-197602000-00011; LUNDEBERG T, 1989, AM J CHINESE MED, V17, P99, DOI 10.1142/S0192415X89000176; Lundeberg T, 1988, EAR NOSE THROAT J, V67; LYNN B, 1977, PAIN, V3, P339, DOI 10.1016/0304-3959(77)90064-1; Ma C, 2010, CLIN J PAIN, V26, P251, DOI 10.1097/AJP.0b013e3181b8cdc8; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; MacPherson H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077438; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Manheimer E, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001977.pub2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MORET V, 1991, PAIN, V45, P135, DOI 10.1016/0304-3959(91)90178-Z; Nabeta T, 2002, COMPLEMENT THER MED, V10, P217, DOI 10.1016/S0965-2299(02)00082-1; OCHOA J, 1983, J PHYSIOL-LONDON, V342, P633, DOI 10.1113/jphysiol.1983.sp014873; PAUSER G, 1975, WIEN KLIN WOCHENSCHR, V87, P25; Perez-Palomares S, 2010, J MUSCULOSKELET PAIN, V18, P23, DOI 10.3109/10582450903496047; Petersen GL, 2012, PAIN, V153, P1292, DOI 10.1016/j.pain.2012.03.011; Pfau DB, 2012, CURR PAIN HEADACHE R, V16, P199, DOI 10.1007/s11916-012-0261-3; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Pittler MH, 2008, CLIN J PAIN, V24, P731, DOI 10.1097/AJP.0b013e3181759231; PRICE DD, 1984, PAIN, V19, P27, DOI 10.1016/0304-3959(84)90062-9; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Sandkuhler J, 1997, J NEUROSCI, V17, P6483; Schliessbach J, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/785613; Schliessbach J, 2011, PAIN MED, V12, P268, DOI 10.1111/j.1526-4637.2010.01051.x; Schmelz M, 2010, NEUROSCI LETT, V470, P158, DOI 10.1016/j.neulet.2009.05.064; SEIDEL U, 2002, DTSCH Z AKUPUNKTUR, V45, P258; Shen Yoshi F, 2007, Pain Pract, V7, P256; Shen YF, 2009, J OROFAC PAIN, V23, P353; Shukla S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-45; Singh BB, 2006, ALTERN THER HEALTH M, V12, P34; Smith CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007854.pub2; Sprenger C, 2011, PAIN, V152, P428, DOI 10.1016/j.pain.2010.11.018; Sprott H, 2000, WIEN KLIN WOCHENSCHR, V112, P580; Srbely JZ, 2010, J REHABIL MED, V42, P463, DOI 10.2340/16501977-0535; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Stern J A, 1977, Ann N Y Acad Sci, V296, P175, DOI 10.1111/j.1749-6632.1977.tb38171.x; STEWART D, 1977, BRIT MED J, V1, P67, DOI 10.1136/bmj.1.6053.67; Takeda W, 1994, Arthritis Care Res, V7, P118, DOI 10.1002/art.1790070304; TALBOT JD, 1987, PAIN, V30, P221, DOI 10.1016/0304-3959(87)91078-5; Tampin B, 2012, PAIN; Targino RA, 2008, J REHABIL MED, V40, P582, DOI 10.2340/16501977-0216; Tobbackx Y, 2013, EUR J PAIN, V17, P279, DOI 10.1002/j.1532-2149.2012.00215.x; Tong YQ, 2010, J ACUPUNCT MERIDIAN, V3, P95, DOI 10.1016/S2005-2901(10)60018-0; Treede RD, 2002, PAIN, V98, P235, DOI 10.1016/S0304-3959(02)00203-8; ULETT GA, 1978, ACUPUNCTURE ELECTRO, V3, P191, DOI 10.3727/036012978817553131; UMINO M, 1984, Bulletin of Tokyo Medical and Dental University, V31, P93; VERDUGO R, 1992, BRAIN, V115, P893, DOI 10.1093/brain/115.3.893; Vicente-Barrero M, 2012, MED ORAL PATOL ORAL; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; WAND-TETLEY J I, 1956, Ann Phys Med, V3, P90; Wang SM, 2009, ANESTH ANALG, V109, P932, DOI 10.1213/ane.0b013e3181ad9292; Westermann A, 2011, CLIN J PAIN, V27, P782, DOI 10.1097/AJP.0b013e31821d8fce; WIESENFELDHALLIN Z, 1984, BRAIN RES, V311, P375, DOI 10.1016/0006-8993(84)90104-5; World Health Organisation, 1993, STAND AC NOM; Wylde V, 2012, RHEUMATOLOGY, V51, P535, DOI 10.1093/rheumatology/ker343; Xue CCL, 2004, HEADACHE, V44, P333, DOI 10.1111/j.1526-4610.2004.04077.x; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819; YOON SH, 1986, AM J CHINESE MED, V14, P179, DOI 10.1142/S0192415X86000296; Zaslawski CJ, 2003, COMPLEMENT THER MED, V11, P11, DOI 10.1016/S0965-2299(02)00116-4; Zhang SP, 2009, EVID BASED COMPLEMEN; Zhang WT, 2003, NEUROREPORT, V14, P1591, DOI 10.1097/00001756-200308260-00010; Zhang Y, 2012, BRIT J ANAESTH, V109, P245, DOI 10.1093/bja/aes136; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zhu XM, 2002, AM J CHINESE MED, V30, P13, DOI 10.1142/S0192415X02000028	146	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e113731	10.1371/journal.pone.0113731	http://dx.doi.org/10.1371/journal.pone.0113731			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502787	gold, Green Published			2022-12-27	WOS:000346375400014
J	Gao, JL; Weaver, SR; Fua, H; Pan, ZG				Gao, Junling; Weaver, Scott R.; Fua, Hua; Pan, Zhigang			Does Workplace Social Capital Associate with Hazardous Drinking Among Chinese Rural-Urban Migrant Workers?	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; FINNISH PUBLIC-SECTOR; ALCOHOL-USE; SELF-CONTROL; MULTILEVEL ANALYSIS; POLITICAL-ECONOMY; HEALTH-STATUS; SMOKING; STRESS; EMPLOYEES	Background: The present study sought to investigate the associations between workplace social capital and hazardous drinking (HD) among Chinese rural-urban migrant workers (RUMW). Methods: A cross sectional study with a multi-stage stratified sampling procedure was conducted in Shanghai during July 2012 to January 2013. In total, 5,318 RUMWs from 77 workplaces were involved. Work-place social capital was assessed using a validated and psychometrically tested eight-item measure. The Chinese version of Alcohol Use Disorders Identification Test (AUDIT) was used to assess hazardous drinking. Control variables included gender, age, marital status, education level, salary, and current smoking. Multilevel logistic regression analysis was conducted to test whether individual-and workplace-level social capital was associated with hazardous drinking. Results: Overall, the prevalence of HD was 10.6%. After controlling for individual-level socio-demographic and lifestyle variables, compared to workers in the highest quartile of individual-level social capital, the odds of HD for workers in the three bottom quartiles were 1.13(95% CI: 1.04-1.23), 1.17(95% CI: 1.05-1.56) and 1.26(95% CI: 1.13-1.72), respectively. However, contrary to hypothesis, there was no relationship between workplace-level social capital and hazardous drinking. Conclusions: Higher individual-level social capital may protect against HD among Chinese RUMWs. Interventions to build individual social capital among RUMWs in China may help reduce HD among this population.	[Gao, Junling; Fua, Hua] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Weaver, Scott R.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Pan, Zhigang] Fudan Univ, Affiliated Zhongshan Hosp, Dept Gen Med, Shanghai 200433, Peoples R China	Fudan University; University System of Georgia; Georgia State University; Fudan University	Pan, ZG (corresponding author), Fudan Univ, Affiliated Zhongshan Hosp, Dept Gen Med, Shanghai 200433, Peoples R China.	zhigang_pan@163.com	gao, junling/L-7465-2019		Humanity and Social Science Youth Foundation of Ministry of Education of China [13YJCZH043]; National Institute of Minority Health and Health Disparities of the National Institutes of Health [1P20MD004806]	Humanity and Social Science Youth Foundation of Ministry of Education of China; National Institute of Minority Health and Health Disparities of the National Institutes of Health	This work was funded by the Humanity and Social Science Youth Foundation of Ministry of Education of China (Grant No: 13YJCZH043), and partially supported by the National Institute of Minority Health and Health Disparities of the National Institutes of Health (Grant No: 1P20MD004806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allik J, 2004, J CROSS CULT PSYCHOL, V35, P29, DOI 10.1177/0022022103260381; Botchkovar EV, 2013, INT J OFFENDER THER, V57, P357, DOI 10.1177/0306624X11435318; Burnhams NH, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-14; Chen WQ, 2008, J OCCUP HEALTH, V50, P262, DOI 10.1539/joh.L7149; Chen XG, 2011, HUM ORGAN, V70, P22, DOI 10.17730/humo.70.1.k76047734m703500; Chen YY, 2013, HEALTH CARE WOMEN IN, V34, P122, DOI 10.1080/07399332.2011.610535; China National Bureau Statistics, 2001, CHAR CHIN RUR MIGR 2; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Coleman J. S., 1998, FDN SOCIAL THEORY; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Cui XB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-979; Dawson DA, 2005, ALCOHOL ALCOHOLISM, V40, P453, DOI 10.1093/alcalc/agh176; Foster DW, 2014, SUBST USE MISUSE, V49, P1340, DOI 10.3109/10826084.2014.901387; Gao J, 2012, CHINESE J HLTH ED, V28, P806, DOI DOI 10.16168/J.CNKI.ISSN.1002; Gao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085005; Gao JL, 2013, PREV MED, V57, P831, DOI 10.1016/j.ypmed.2013.09.009; Helliwell JF, 2004, PHILOS T R SOC B, V359, P1435, DOI 10.1098/rstb.2004.1522; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; John F. Kennedy School of Government Harvard University, BETTER WORK SOCIAL C; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kawachi I, 2013, GLOBAL PERSPECTIVES; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; [李冰 Li Bing], 2003, [中国心理卫生杂志, Chinese Mental Health Journal], V17, P1; Li Q, 2011, ALCOHOL ALCOHOLISM, V46, P416, DOI 10.1093/alcalc/agr012; Li Y, 2010, ELECTRICAL CONDUCTIVE ADHESIVES WITH NANOTECHNOLOGIES, P25, DOI 10.1007/978-0-387-88783-8_2; Lin D, 2006, PSYCHOL DEV ED, V22, P52; Ma GuanSheng, 2005, Acta Nutrimenta Sinica, V27, P362; Marchand A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-333; Meng TG, 2014, HEALTH PLACE, V27, P38, DOI 10.1016/j.healthplace.2014.01.009; Mou J, 2013, BRIT MED BULL, V106, P19, DOI 10.1093/bmb/ldt016; Mowbray O, 2014, AM J DRUG ALCOHOL AB, V40, P181, DOI 10.3109/00952990.2013.860984; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Oksanen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065846; Piquero Alex R, 2002, Crim Behav Ment Health, V12, P135, DOI 10.1002/cbm.492; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Prusak L, 2001, HARVARD BUS REV, V79, P86; Pulkkinen L, 2011, INT J BEHAV DEV, V35, P475, DOI 10.1177/0165025411422993; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Shortt SED, 2004, HEALTH POLICY, V70, P11, DOI 10.1016/j.healthpol.2004.01.007; Suzuki E, 2009, J EPIDEMIOL COMMUN H, V63, P692, DOI 10.1136/jech.2008.082453; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Wang HM, 2009, SOC SCI MED, V68, P133, DOI 10.1016/j.socscimed.2008.09.038; Wang J.C, 2008, MULTILEVEL MODELS ME; Weitzman ER, 2005, J EPIDEMIOL COMMUN H, V59, P303, DOI 10.1136/jech.2004.024711; Weitzman ER, 2000, AM J PUBLIC HEALTH, V90, P1936, DOI 10.2105/AJPH.90.12.1936; World Health Organization, 2011, GLOB STAT REP ALC HL; Yang TZ, 2012, COMMUNITY MENT HLT J, V48, P342, DOI 10.1007/s10597-011-9395-8; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Zaller N, 2014, ALCOHOL ALCOHOLISM, V49, P321, DOI 10.1093/alcalc/agt184	53	11	13	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115286	10.1371/journal.pone.0115286	http://dx.doi.org/10.1371/journal.pone.0115286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25502013	gold, Green Published			2022-12-27	WOS:000346375400090
J	Jiang, YM; Zhang, CF; Chen, K; Chen, Z; Sun, ZG; Zhang, ZQ; Ding, DB; Ren, SY; Zuo, YF				Jiang, Yanmei; Zhang, Changfu; Chen, Kai; Chen, Zhe; Sun, Zhigang; Zhang, Zhuqing; Ding, Dongbing; Ren, Shuangyi; Zuo, Yunfei			The Clinical Significance of DC-SIGN and DC-SIGNR, which Are Novel Markers Expressed in Human Colon Cancer	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; DENDRITIC CELLS; COLORECTAL-CANCER; GRABBING NONINTEGRIN; ENDOTHELIAL-CELLS; TUMOR-MARKERS; LECTIN; ADHESION; PROTEIN; RECOGNIZES	Background: Colon cancer has always been diagnosed at a late stage, which is associated with poor prognosis. The currently used serum tumor markers CEA and CA19-9 display low sensitivity and specificity and may not have diagnostic value in early stage colon cancer. Thus, there is an urgent need to identify novel serum biomarkers for use in the early detection of colon cancer. Methods: In this study, the expression of DC-SIGN and DC-SIGNR in serum was detected by enzyme-linked immunosorbent assay (ELISA). DC-SIGN and DC-SIGNR expression was detected in cancer tissues by immunohistochemistry (IHC). Results: The level of sDC-SIGN was lower in patients than in the healthy controls, while the level of sDC-SIGNR in patients was higher than in the healthy controls. Both sDC-SIGN and sDC-SIGNR had diagnostic significances for cancer patients, and the combined diagnosis of these two markers was higher than both of them alone. Furthermore, there were significant differences between both sDC-SIGN and sDC-SIGNR in stage I/II patients and the healthy controls. Moreover, high sDC-SIGN level was accompanied with the long survival time. Additionally, DC-SIGNR was negative in the cancer foci and matched normal colon tissues but was weakly positive between the cancer foci. DC-SIGN staining was faint in matched normal colon tissues, strong in the tumor stroma and the invasive margin of colon cancer tissues, and negatively correlated with the sDC-SIGN level in serum from the same patient. Interestingly, the percent survival of patients with a DC-SIGN mean density of. 0.001219 (the upper 95% confidence interval of matched normal colon tissues) was higher than for all other patients. Conclusion: DC-SIGN and DC-SIGNR are blood-based molecular markers that can potentially be used for the diagnosis of early stage patients. Moreover, expression of DC-SIGN in serum and cancer tissues may affect the survival time for colon cancer patients.	[Jiang, Yanmei; Zhang, Changfu; Zhang, Zhuqing; Zuo, Yunfei] Dalian Med Univ, Coll Lab Diagnost Med, Dept Clin Biochem, Dalian 116044, Peoples R China; [Chen, Kai; Chen, Zhe; Ding, Dongbing; Ren, Shuangyi] Dalian Med Univ, Affiliated Hosp 2, Dept Surg, Dalian 116023, Peoples R China; [Jiang, Yanmei; Sun, Zhigang] Dalian Med Univ, Affiliated Hosp 1, Dept Clin Lab, Dalian 116011, Peoples R China; [Zhang, Changfu] Dalian Med Univ, Affiliated Hosp 1, Dept Neurosurg, Dalian 116011, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University	Zuo, YF (corresponding author), Dalian Med Univ, Coll Lab Diagnost Med, Dept Clin Biochem, Dalian 116044, Peoples R China.	rsydl@aliyun.com; zyf04112002@dlmedu.edu.cn			Chinese National Science Foundation Projects [81372669, 31270867]; Chinese State Key Program in Basic Research [2012CB822103]; Science and Technology Planning Project of Liao Ning province, China [2012225020]; Project of Chinese Ministry of Health [W2012RQ23]	Chinese National Science Foundation Projects; Chinese State Key Program in Basic Research; Science and Technology Planning Project of Liao Ning province, China; Project of Chinese Ministry of Health	This work was supported by Chinese National Science Foundation Projects (81372669, 31270867), the Chinese State Key Program in Basic Research (2012CB822103), the Science and Technology Planning Project of Liao Ning province, China (2012225020), and the Project of Chinese Ministry of Health (W2012RQ23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaria Bhawna, 2013, Cancer Biology Medicine, V10, P148, DOI 10.7497/j.issn.2095-3941.2013.03.005; Caligaris-Cappio F, 2007, BEST PRACT RES CL HA, V20, P385, DOI 10.1016/j.beha.2007.02.005; Dadabayev AR, 2004, CANCER IMMUNOL IMMUN, V53, P978, DOI 10.1007/s00262-004-0548-2; Duffy MJ, 2007, EUR J INTERN MED, V18, P175, DOI 10.1016/j.ejim.2006.12.001; Duffy MJ, 2001, CLIN CHEM, V47, P624; Edge SB, 2010, AJCC CANC STAGING MA; Engering A, 2002, BLOOD, V100, P1780, DOI 10.1182/blood-2001-12-0179; Fan NJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-54; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferroni P, 2010, CANCER-AM CANCER SOC, V116, P2913, DOI 10.1002/cncr.25094; Flamini E, 2006, CLIN CANCER RES, V12, P6985, DOI 10.1158/1078-0432.CCR-06-1931; Gdowski A, 2014, ADV EXP MED BIOL, V807, P33, DOI 10.1007/978-81-322-1777-0_4; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Ghia P, 2007, CRIT REV ONCOL HEMAT, V64, P234, DOI 10.1016/j.critrevonc.2007.04.008; Gulubova MV, 2012, INT J COLORECTAL DIS, V27, P159, DOI 10.1007/s00384-011-1334-1; Koppel EA, 2005, CELL MICROBIOL, V7, P157, DOI 10.1111/J.1462-5822.2004.00480.x; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Martens JH, 2006, J PATHOL, V208, P574, DOI 10.1002/path.1921; Martinez O, 2005, INT IMMUNOL, V17, P769, DOI 10.1093/intimm/dxh258; Meyer S, 2005, J BIOL CHEM, V280, P37349, DOI 10.1074/jbc.M507100200; Meyer S, 2007, GLYCOBIOLOGY, V17, P1104, DOI 10.1093/glycob/cwm073; Mori T, 2010, CANCER INVEST, V28, P387, DOI 10.3109/07357900903287055; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Nonaka M, 2008, J IMMUNOL, V180, P3347, DOI 10.4049/jimmunol.180.5.3347; Nonaka M, 2014, J IMMUNOL, V192, P1294, DOI 10.4049/jimmunol.1203023; Nonaka M, 2011, J BIOL CHEM, V286, P22403, DOI 10.1074/jbc.M110.215301; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Plazolles N, 2011, J LEUKOCYTE BIOL, V89, P329, DOI 10.1189/jlb.0710386; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Robbins SL, 2005, ROBBINS COTRAN PATHO, P314; ROULSTON JE, 1990, BRIT J SURG, V77, P961, DOI 10.1002/bjs.1800770903; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Tan E, 2009, SURG ONCOL, V18, P15, DOI 10.1016/j.suronc.2008.05.008; Tao HQ, 2011, HUM PATHOL, V42, P1401, DOI 10.1016/j.humpath.2010.08.023; THOMSON DMP, 1969, P NATL ACAD SCI USA, V64, P161, DOI 10.1073/pnas.64.1.161; van Gisbergen KPJM, 2005, CANCER RES, V65, P5935, DOI 10.1158/0008-5472.CAN-04-4140; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Zhang ZQ, 2013, BIOCHEM CELL BIOL, V91, P214, DOI 10.1139/bcb-2012-0110; Zuo YF, 2013, GUT, V62, P1169, DOI 10.1136/gutjnl-2011-300593	44	32	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114748	10.1371/journal.pone.0114748	http://dx.doi.org/10.1371/journal.pone.0114748			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25504222	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400050
J	Kamae, Y; Uryu, O; Miki, T; Tomioka, K				Kamae, Yuichi; Uryu, Outa; Miki, Taiki; Tomioka, Kenji			The Nuclear Receptor Genes HR3 and E75 Are Required for the Circadian Rhythm in a Primitive Insect	PLOS ONE			English	Article							CRICKET GRYLLUS-BIMACULATUS; REV-ERB-ALPHA; HEMATOPHAGOUS INSECT; DROSOPHILA-CLOCK; EXPRESSION; TRANSCRIPTION; COMPONENT; TIMELESS; REVEALS; VRILLE	Insect circadian rhythms are generated by a circadian clock consisting of transcriptional/translational feedback loops, in which CYCLE and CLOCK are the key elements in activating the transcription of various clock genes such as timeless (tim) and period (per). Although the transcriptional regulation of Clock (Clk) has been profoundly studied, little is known about the regulation of cycle (cyc). Here, we identify the orphan nuclear receptor genes HR3 and E75, which are orthologs of mammalian clock genes, Rora and Rev-erba, respectively, as factors involved in the rhythmic expression of the cyc gene in a primitive insect, the firebrat Thermobia domestica. Our results show that HR3 and E75 are rhythmically expressed, and their normal, rhythmic expression is required for the persistence of locomotor rhythms. Their RNAi considerably altered the rhythmic transcription of not only cyc but also tim. Surprisingly, the RNAi of HR3 revealed the rhythmic expression of Clk, suggesting that this ancestral insect species possesses the mechanisms for rhythmic expression of both cyc and Clk genes. When either HR3 or E75 was knocked down, tim, cyc, and Clk or tim and cyc, respectively, oscillated in phase, suggesting that the two genes play an important role in the regulation of the phase relationship among the clock genes. Interestingly, HR3 and E75 were also found to be involved in the regulation of ecdysis, suggesting that they interconnect the circadian clock and developmental processes.	[Kamae, Yuichi; Uryu, Outa; Tomioka, Kenji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Miki, Taiki] Okayama Univ, Fac Sci, Dept Biol, Okayama 7008530, Japan	Okayama University; Okayama University	Tomioka, K (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	tomioka@cc.okayama-u.ac.jp	Tomioka, Kenji/B-2632-2011	Tomioka, Kenji/0000-0001-7951-8950	Grants-in-Aid for Scientific Research [23370033] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bebas P, 2009, FASEB J, V23, P523, DOI 10.1096/fj.08-113191; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hardin PE, 2009, SLEEP BIOL RHYTHMS, V7, P235, DOI 10.1111/j.1479-8425.2009.00412.x; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Kamae Y, 2012, J BIOL RHYTHM, V27, P126, DOI 10.1177/0748730411435997; Kamae Y, 2010, J INSECT PHYSIOL, V56, P1291, DOI 10.1016/j.jinsphys.2010.04.012; Meireles ACA, 2006, FEBS LETT, V580, P2, DOI 10.1016/j.febslet.2005.11.031; Meireles ACA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-38; Moriyama Y, 2012, J BIOL RHYTHM, V27, P467, DOI 10.1177/0748730412462207; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Pittendrigh C.S., 1971, BIOCHRONOMETRY, P212; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schmid B, 2011, J BIOL RHYTHM, V26, P464, DOI 10.1177/0748730411414264; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stanewsky R, 2002, CELL TISSUE RES, V309, P11, DOI 10.1007/s00441-002-0569-0; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tong YH, 2004, J BIOL RHYTHM, V19, P113, DOI 10.1177/0748730403262871; Uryu O, 2013, J INSECT PHYSIOL, V59, P697, DOI 10.1016/j.jinsphys.2013.04.011; Uryu O, 2013, J INSECT PHYSIOL, V59, P494, DOI 10.1016/j.jinsphys.2013.02.009	28	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114899	10.1371/journal.pone.0114899	http://dx.doi.org/10.1371/journal.pone.0114899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502221	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700065
J	Knauff, M; Nejasmic, J				Knauff, Markus; Nejasmic, Jelica			An Efficiency Comparison of Document Preparation Systems Used in Academic Research and Development	PLOS ONE			English	Article								The choice of an efficient document preparation system is an important decision for any academic researcher. To assist the research community, we report a software usability study in which 40 researchers across different disciplines prepared scholarly texts with either Microsoft Word or LaTeX. The probe texts included simple continuous text, text with tables and subheadings, and complex text with several mathematical equations. We show that LaTeX users were slower than Word users, wrote less text in the same amount of time, and produced more typesetting, orthographical, grammatical, and formatting errors. On most measures, expert LaTeX users performed even worse than novice Word users. LaTeX users, however, more often report enjoying using their respective software. We conclude that even experienced LaTeX users may suffer a loss in productivity when LaTeX is used, relative to other document preparation systems. Individuals, institutions, and journals should carefully consider the ramifications of this finding when choosing document preparation strategies, or requiring them of authors.	[Knauff, Markus; Nejasmic, Jelica] Univ Giessen, Dept Psychol Expt Psychol & Cognit Sci, D-35390 Giessen, Germany	Justus Liebig University Giessen	Knauff, M (corresponding author), Univ Giessen, Dept Psychol Expt Psychol & Cognit Sci, D-35390 Giessen, Germany.	markus.knauff@psychol.uni-giessen.de			University of Giessen	University of Giessen	The study was financially supported by the University of Giessen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	15	16	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115069	10.1371/journal.pone.0115069	http://dx.doi.org/10.1371/journal.pone.0115069			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526083	Green Published, gold, Green Submitted			2022-12-27	WOS:000347186200011
J	Malone, SL; Staudhammer, CL; Oberbauer, SF; Olivas, P; Ryan, MG; Schedlbauer, JL; Loescher, HW; Starr, G				Malone, Sparkle L.; Staudhammer, Christina L.; Oberbauer, Steven F.; Olivas, Paulo; Ryan, Michael G.; Schedlbauer, Jessica L.; Loescher, Henry W.; Starr, Gregory			El Nino Southern Oscillation (ENSO) Enhances CO2 Exchange Rates in Freshwater Marsh Ecosystems in the Florida Everglades	PLOS ONE			English	Article							CARBON-DIOXIDE; PRECIPITATION; PATTERNS; TEMPERATURE; VEGETATION; FREQUENCY; PHENOLOGY; DROUGHT; FORESTS; BALANCE	This research examines the relationships between El Nino Southern Oscillation (ENSO), water level, precipitation patterns and carbon dioxide (CO2) exchange rates in the freshwater wetland ecosystems of the Florida Everglades. Data was obtained over a 5-year study period (2009-2013) from two freshwater marsh sites located in Everglades National Park that differ in hydrology. At the short-hydroperiod site (Taylor Slough; TS) and the long-hydroperiod site (Shark River Slough; SRS) fluctuations in precipitation patterns occurred with changes in ENSO phase, suggesting that extreme ENSO phases alter Everglades hydrology which is known to have a substantial influence on ecosystem carbon dynamics. Variations in both ENSO phase and annual net CO2 exchange rates co-occurred with changes in wet and dry season length and intensity. Combined with site-specific seasonality in CO2 exchanges rates, El Nino and La Nina phases magnified season intensity and CO2 exchange rates at both sites. At TS, net CO2 uptake rates were higher in the dry season, whereas SRS had greater rates of carbon sequestration during the wet season. As La Nina phases were concurrent with drought years and extended dry seasons, TS became a greater sink for CO2 on an annual basis (-11 to -110 g CO2 m(-2) yr(-1)) compared to El Nino and neutral years (-5 to -43.5 g CO2 m(-2) yr(-1)). SRS was a small source for CO2 annually (1.81 to 80 g CO2 m(-2) yr(-1)) except in one exceptionally wet year that was associated with an El Nino phase (-16 g CO2 m(-2) yr(-1)). Considering that future climate predictions suggest a higher frequency and intensity in El Nino and La Nina phases, these results indicate that changes in extreme ENSO phases will significantly alter CO2 dynamics in the Florida Everglades.	[Malone, Sparkle L.; Staudhammer, Christina L.; Starr, Gregory] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Malone, Sparkle L.; Ryan, Michael G.] US Forest Serv, Rocky Mt Res Stn, Ft Collins, CO USA; [Olivas, Paulo; Schedlbauer, Jessica L.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Ryan, Michael G.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Schedlbauer, Jessica L.] W Chester Univ, Dept Biol, W Chester, PA 19380 USA; [Loescher, Henry W.] Natl Ecol Observ Network Inc, Boulder, CO 80301 USA; [Loescher, Henry W.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	University of Alabama System; University of Alabama Tuscaloosa; United States Department of Agriculture (USDA); United States Forest Service; State University System of Florida; Florida International University; Colorado State University; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; University of Colorado System; University of Colorado Boulder	Malone, SL (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	sparklelmalone@fs.fed.us	Malone, Sparkle/ABH-8402-2020; Ryan, Michael G/A-9805-2008	Malone, Sparkle/0000-0001-9034-1076; Ryan, Michael G/0000-0002-2500-6738; Staudhammer, Christina/0000-0003-1887-418X; Olivas, Paulo/0000-0002-6308-4470	National Science Foundations (NSF) Division of Atmospheric and Geospace Sciences (AGS) Atmospheric Chemistry program [1233006]; Department of Energy's (DOE) National Institute for Climate Change Research (NICCR) [07-SC-NICCR-1059]; US Department of Education Graduate Assistantships in Areas of National Need (GAANN); National Science Foundation (NSF) through the Florida Coastal Everglades Long Term Ecological Research program under Cooperative Agreements [DBI-0620409, DEB-9910514]; Direct For Biological Sciences [1202716] Funding Source: National Science Foundation; Div Atmospheric & Geospace Sciences [1233006] Funding Source: National Science Foundation; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	National Science Foundations (NSF) Division of Atmospheric and Geospace Sciences (AGS) Atmospheric Chemistry program; Department of Energy's (DOE) National Institute for Climate Change Research (NICCR)(United States Department of Energy (DOE)); US Department of Education Graduate Assistantships in Areas of National Need (GAANN)(US Department of Education); National Science Foundation (NSF) through the Florida Coastal Everglades Long Term Ecological Research program under Cooperative Agreements(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for the research was provided by the National Science Foundations (NSF) Division of Atmospheric and Geospace Sciences (AGS) Atmospheric Chemistry program through grant 1233006 [GS SFO], the Department of Energy's (DOE) National Institute for Climate Change Research (NICCR) through grant 07-SC-NICCR-1059 [GS SFO], and the US Department of Education Graduate Assistantships in Areas of National Need (GAANN) grant [SLM]. This research was also supported by the National Science Foundation (NSF) through the Florida Coastal Everglades Long Term Ecological Research program under Cooperative Agreements DBI-0620409 and DEB-9910514 [GS SFO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; [Anonymous], 1994, EVERGLADES ECOSYSTEM, DOI DOI 10.1201/9781466571754; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Barr J.G., 2010, J GEOPHYS RES-BIOGEO, P115, DOI DOI 10.1002/(ISSN)1525-2027; Beckage B, 2003, ECOLOGY, V84, P3124, DOI 10.1890/02-0183; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Brocklebank JC, 2003, SAS SYSTEM FORECASTI; Chen E, 1992, ECOSYSTEMS FLORIDA; Childers DL, 2006, HYDROBIOLOGIA, V569, P531, DOI 10.1007/s10750-006-0154-8; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark KL, 1999, ECOL APPL, V9, P936, DOI 10.1890/1051-0761(1999)009[0936:ECONEO]2.0.CO;2; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Clement R, 1999, EDIRE; Cubasch U, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P525; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Duever M. J., 1994, EVERGLADES ECOSYSTEM; Duever MJ, 1978, 4 NAT SCI FDN ROCK F, P534; Foken T, 2004, AGR FOREST METEOROL, V127, P223, DOI 10.1016/j.agrformet.2004.07.015; Foken T, 1996, AGR FOREST METEOROL, V78, P83, DOI 10.1016/0168-1923(95)02248-1; Godfrey R.K., 1979, AQUATIC WETLAND PLAN; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; HANSON K, 1991, Florida Scientist, V54, P160; Hashimoto H, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004959; Hintze J, 2004, NUMBER CRUNCHING STA; Jimenez KL, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002117; Kiladis GN, 1989, J CLIMATE, V2, P1069, DOI 10.1175/1520-0442(1989)002<1069:GCAAWE>2.0.CO;2; Kljun N, 2004, BOUND-LAY METEOROL, V112, P503, DOI 10.1023/B:BOUN.0000030653.71031.96; Kljun N, 2002, BOUND-LAY METEOROL, V103, P205, DOI 10.1023/A:1014556300021; Latif M, 2009, P NATL ACAD SCI USA, V106, P20578, DOI 10.1073/pnas.0710860105; Li L., 2011, CLIM DYNAM, V39, P1401, DOI [10.1007/s00382-011-1214-y, DOI 10.1007/S00382-011-1214-Y]; Livezey RE, 1997, J CLIMATE, V10, P1787, DOI 10.1175/1520-0442(1997)010<1787:TROTPN>2.0.CO;2; Loescher H. W, 2006, J GEOPHYS RES ATMOSP, V111; LOVELESS CM, 1959, ECOLOGY, V40, P1, DOI 10.2307/1929916; Malone SL, 2014, J GEOPHYS RES-BIOGEO, V119, P1487, DOI 10.1002/2014JG002700; Malone SL, 2013, GLOBAL CHANGE BIOL, V19, P2511, DOI 10.1111/gcb.12211; Mason SJ, 2001, B AM METEOROL SOC, V82, P619, DOI 10.1175/1520-0477(2001)082<0619:PPAAWE>2.3.CO;2; Massman WJ, 2004, ATMOS ENVIRON, V38, P2323, DOI 10.1016/j.atmosenv.2003.09.079; Meyers S.D., 1995, EOS T AM GEOPHYS UNI, V76, P533, DOI [10.1029/95EO00326, DOI 10.1029/95EO00326]; Moses CS, 2013, J PALEOLIMNOL, V49, P5, DOI 10.1007/s10933-012-9635-0; Nuttle WK, 1997, WETLANDS, V17, P82, DOI 10.1007/BF03160720; Obeysekera J., 1999, URBAN ECOSYST, V3, P223, DOI DOI 10.1023/A:1009552500448; Palmer W.C., 1965, WEATHER BUREAU RES P; Pankratz A., 2009, FORECASTING UNIVARIA; Patricia L, 2003, TASK VEG SC, V39, P75; Piechota TC, 1996, WATER RESOUR RES, V32, P1359, DOI 10.1029/96WR00353; Radford AE, 1968, MANUAL VASCULAR FLOR; Randerson JT, 1999, GEOPHYS RES LETT, V26, P2765, DOI 10.1029/1999GL900500; REICH PB, 1995, CAN J BOT, V73, P164, DOI 10.1139/b95-020; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; ROPELEWSKI CF, 1986, MON WEATHER REV, V114, P2352, DOI 10.1175/1520-0493(1986)114<2352:NAPATP>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Sanchez-Azofeifa A, 2003, TASK VEG SC, V39, P121; Schedlbauer JL, 2012, WETLANDS, V32, P801, DOI 10.1007/s13157-012-0311-y; Schedlbauer JL, 2010, AGR FOREST METEOROL, V150, P994, DOI 10.1016/j.agrformet.2010.03.005; Schmidt N, 2001, J CLIMATE, V14, P615, DOI 10.1175/1520-0442(2001)014<0615:EIOSRA>2.0.CO;2; SCHOTANUS P, 1983, BOUND-LAY METEOROL, V26, P81, DOI 10.1007/BF00164332; Sittel MC, 1994, TECHNICAL REPORT; Stanton EA, 2007, FLORIDA CLIMATE CHAN; Svoboda M, 2000, DROUGHT NETWORK NEWS; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Veldkamp E, 2000, SOIL SCI SOC AM J, V64, P1549, DOI 10.2136/sssaj2000.6451549x; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Whiting GJ, 2001, TELLUS B, V53, P521, DOI 10.1034/j.1600-0889.2001.530501.x	65	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115058	10.1371/journal.pone.0115058	http://dx.doi.org/10.1371/journal.pone.0115058			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521299	Green Submitted, Green Published, gold			2022-12-27	WOS:000348845600015
J	Barra, NG; Palanivel, R; Denou, E; Chew, MV; Gillgrass, A; Walker, TD; Kong, J; Richards, CD; Jordana, M; Collins, SM; Trigatti, BL; Holloway, AC; Raha, S; Steinberg, GR; Ashkar, AA				Barra, Nicole G.; Palanivel, Rengasamy; Denou, Emmanuel; Chew, Marianne V.; Gillgrass, Amy; Walker, Tina D.; Kong, Josh; Richards, Carl D.; Jordana, Manel; Collins, Stephen M.; Trigatti, Bernardo L.; Holloway, Alison C.; Raha, Sandeep; Steinberg, Gregory R.; Ashkar, Ali A.			Interleukin-15 Modulates Adipose Tissue by Altering Mitochondrial Mass and Activity	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRANSGENIC MICE; NATURAL-KILLER; GUT MICROBIOTA; INTESTINAL MICROBIOTA; NUTRIENT ABSORPTION; INSULIN SENSITIVITY; LIPID OXIDATION; T-CELLS; OBESITY	Interleukin-15 (IL-15) is an immunomodulatory cytokine that affects body mass regulation independent of lymphocytes; however, the underlying mechanism(s) involved remains unknown. In an effort to investigate these mechanisms, we performed metabolic cage studies, assessed intestinal bacterial diversity and macronutrient absorption, and examined adipose mitochondrial activity in cultured adipocytes and in lean IL-15 transgenic (IL-15tg), overweight IL-15 deficient (IL-15-/-), and control C57Bl/6 (B6) mice. Here we show that differences in body weight are not the result of differential activity level, food intake, or respiratory exchange ratio. Although intestinal microbiota differences between obese and lean individuals are known to impact macronutrient absorption, differing gut bacteria profiles in these murine strains does not translate to differences in body weight in colonized germ free animals and macronutrient absorption. Due to its contribution to body weight variation, we examined mitochondrial factors and found that IL-15 treatment in cultured adipocytes resulted in increased mitochondrial membrane potential and decreased lipid deposition. Lastly, IL-15tg mice have significantly elevated mitochondrial activity and mass in adipose tissue compared to B6 and IL15-/- mice. Altogether, these results suggest that IL-15 is involved in adipose tissue regulation and linked to altered mitochondrial function.	[Barra, Nicole G.; Chew, Marianne V.; Gillgrass, Amy; Walker, Tina D.; Kong, Josh; Richards, Carl D.; Jordana, Manel; Ashkar, Ali A.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Barra, Nicole G.; Chew, Marianne V.; Gillgrass, Amy; Walker, Tina D.; Kong, Josh; Richards, Carl D.; Jordana, Manel; Ashkar, Ali A.] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Barra, Nicole G.; Chew, Marianne V.; Gillgrass, Amy; Ashkar, Ali A.] McMaster Univ, Inst Infect Dis Res, Hamilton, ON, Canada; [Palanivel, Rengasamy; Denou, Emmanuel; Collins, Stephen M.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Palanivel, Rengasamy; Denou, Emmanuel; Steinberg, Gregory R.] McMaster Univ, Div Endocrinol & Metab, Hamilton, ON, Canada; [Denou, Emmanuel; Collins, Stephen M.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Trigatti, Bernardo L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Trigatti, Bernardo L.] McMaster Univ, Atherothrombosis Res Grp, Hamilton, ON, Canada; [Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Raha, Sandeep] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Ashkar, AA (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	ashkara@mcmaster.ca	RENGASAMY, PALANIVEL/GMW-4099-2022; Raha, Sandeep/AAF-3655-2020; Barra, Nicole/ABG-2670-2021	Raha, Sandeep/0000-0001-7307-3292; Barra, Nicole/0000-0002-2605-0845; Trigatti, Bernardo (Dino) L./0000-0002-4556-119X; Richards, Carl/0000-0002-0081-2231; Steinberg, Gregory/0000-0001-5425-8275; Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Almendro V, 2006, BBA-MOL CELL BIOL L, V1761, P37, DOI 10.1016/j.bbalip.2005.12.006; Almendro V, 2008, OBESITY, V16, P285, DOI 10.1038/oby.2007.47; Almendro V, 2009, INT J MOL MED, V24, P453, DOI 10.3892/ijmm_00000252; Alvarez B, 2002, BBA-GEN SUBJECTS, V1570, P33, DOI 10.1016/S0304-4165(02)00148-4; Amengual-Cladera E, 2012, BR J NUTR, P1; Barra NG, 2012, DIABETES OBES METAB, V14, P190, DOI 10.1111/j.1463-1326.2011.01495.x; Barra NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039553; Barra NG, 2010, OBESITY, V18, P1601, DOI 10.1038/oby.2009.445; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bruin JE, 2010, ENDOCRINE, V37, P303, DOI 10.1007/s12020-009-9294-8; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Camacho A, 2012, EXP NEUROL, V237, P396, DOI 10.1016/j.expneurol.2012.06.031; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Daniels J, 2006, AM J NURS, V106, P40, DOI 10.1097/00000446-200601000-00028; Davies E, 2010, J LEUKOCYTE BIOL, V88, P529, DOI 10.1189/jlb.0909648; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Figueiredo PA, 2008, J GERONTOL A-BIOL, V63, P350, DOI 10.1093/gerona/63.4.350; Fuster G, 2011, LIPIDS, V46, P1033, DOI 10.1007/s11745-011-3594-5; Ji CB, 2011, J BIOENERG BIOMEMBR, V43, P367, DOI 10.1007/s10863-011-9361-8; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kanegane H, 1996, BLOOD, V88, P230; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; Kuo JJ, 2012, INT J MOL MED, V30, P673, DOI 10.3892/ijmm.2012.1049; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Marcovina SM, 2013, TRANSL RES, V161, P73, DOI 10.1016/j.trsl.2012.10.006; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024; Pistilli EE, 2013, CYTOKINE, V61, P41, DOI 10.1016/j.cyto.2012.09.025; Pistilli EE, 2011, J CLIN INVEST, V121, P3120, DOI 10.1172/JCI44945; Quinn LBS, 2005, CELL BIOL INT, V29, P449, DOI 10.1016/j.cellbi.2005.02.005; Quinn LS, 2013, ENDOCRINOLOGY, V154, P232, DOI 10.1210/en.2012-1773; Quinn LS, 2009, AM J PHYSIOL-ENDOC M, V296, pE191, DOI 10.1152/ajpendo.90506.2008; QUINN LS, 1995, ENDOCRINOLOGY, V136, P3669, DOI 10.1210/en.136.8.3669; Rogge MM, 2009, BIOL RES NURS, V10, P356, DOI 10.1177/1099800408329408; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Sharma AM, 2010, OBES REV, V11, P362, DOI 10.1111/j.1467-789X.2009.00689.x; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Yang CJ, 2012, BIOSCIENCE REP, V32, P465, DOI 10.1042/BSR20120034; Yang HT, 2013, ENDOCRINE, V43, P579, DOI 10.1007/s12020-012-9809-6; Yokoyama S, 2011, J CLIN IMMUNOL, V31, P1038, DOI 10.1007/s10875-011-9586-7; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106	64	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114799	10.1371/journal.pone.0114799	http://dx.doi.org/10.1371/journal.pone.0114799			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517731	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600027
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			A Small Short-Necked Hupehsuchian from the Lower Triassic of Hubei Province, China	PLOS ONE			English	Article								Hupehsuchia is a group of enigmatic Triassic marine reptiles that is known exclusively from two counties in Hubei Province, China. One of the common features of the group was a modestly long neck with nine to ten cervical vertebrae. We report a new species of Hupehsuchia, Eohupehsuchus brevicollis gen. et sp. nov., which for the first time shows a short neck in this group, with six cervicals. The configuration of the skull roof in Eohupehsuchus is also unique among Hupehsuchia, with narrow frontals and posteriorly shifted parietals, warranting recognition of a new species. The taxon superficially resembles Nanchangosaurus in retaining hupehsuchian plesiomorphies, such as low neural spines and small body size. However, its limbs are well-developed, unlike in Nanchangosaurus, although the latter genus is marginally larger in body length. Thus, the individual is unlikely to be immature. Also, Eohupehsuchus shares a suite of synapomorphies with Hupehsuchus, including the second and third layers of dermal ossicles above the dorsal neural spines. A phylogenetic analysis suggests that the new species is not the most basal hupehsuchian despite its short neck, and instead forms the sister taxon of Hupehsuchidae. Until recently, Hupehsuchia contained only two monotypic genera. Now there are at least four genera among Hupehsuchia, and the undescribed diversity is even higher. The left forelimb of the only specimen is incomplete, ending with broken phalanges distally. The breakage could only have occurred pre-burial. The individual may have been attacked by a predator and escaped, given that scavenging is unlikely.	[Chen, Xiao-hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan 430023, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Lab Orogen Belt & Crustal Evolut, MOE, Dept Geol, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL 60605 USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	China Geological Survey Project [1212010611603]; China Geological Survey Projects [1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]	China Geological Survey Project(China Geological Survey); China Geological Survey Projects(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Geological Survey Project 1212010611603 to Xiao-hong Chen, the China Geological Survey Projects 1212011120148 to Long Cheng, and the National Natural Science Foundation of China Projects 40920124002 and 41372016 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARROLL RL, 1991, PHILOS T ROY SOC B, V331, P131, DOI 10.1098/rstb.1991.0004; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102361; Chen XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094396; GOLOBOFF P, 2000, TNT TREE ANAL USING; Laurenti J. N, 1768, SPECIMEN MEDICUM EXH; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; MCGOWAN C, 1992, CAN J EARTH SCI, V29, P380, DOI 10.1139/e92-034; Motani R, NATURE IN PRESS; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Rieppel O, 1998, J VERTEBR PALEONTOL, V18, P545, DOI 10.1080/02724634.1998.10011082; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Young C. c., 1965, Vertebrata Palasiatica, V9, P315; Young CC, 1972, AQUATIC REPTILES TRI, P17; Young CC, 1972, AQUATIC REPTILES TRI, P28	17	13	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115244	10.1371/journal.pone.0115244	http://dx.doi.org/10.1371/journal.pone.0115244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517113	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600056
J	Iorns, E; Gunn, W; Erath, J; Rodriguez, A; Zhou, J; Benzinou, M				Iorns, Elizabeth; Gunn, William; Erath, Jessey; Rodriguez, Ana; Zhou, Jian; Benzinou, Michael		Reproducibil Initiat	Replication Attempt: "Effect of BMAP-28 Antimicrobial Peptides on Leishmania Major Promastigote and Amastigote Growth: Role of Leishmanolysin in Parasite Survival''	PLOS ONE			English	Article								This study describes an attempt to replicate experiments from the paper "Effect of BMAP-28 Antimicrobial Peptides on Leishmania major Promastigote and Amastigote Growth: Role of Leishmanolysin in Parasite Survival,'' which was submitted to the Reproducibility Initiative for independent validation. The cathelicidin bovine myeloid antimicrobial peptide 28 (BMAP-28) and its isomers were previously shown to have potent antiparasitic activity against Leishmania major. We tested the effectiveness of L-BMAP-28 and two of its isomers, the D-amino acid form (D-BMAP-28) and the retro-inverso form (RI-BMAP-28), in both unamidated and amidated forms, as anti-leishmanial agents against Leishmania major promastigotes in vitro. We observed that L-BMAP-28, as well as its D and RI isomers, demonstrate anti-leishmanial activity against L. major promastigotes in vitro. The inhibitory effect was lower than what was seen in the original study. At 2 mu M of amidated peptides, the viability was 94%, 36%, and 66% with L-, D-and RIpeptides, versus 57%, 6%, and 18% in the original study.	[Iorns, Elizabeth; Gunn, William; Benzinou, Michael; Reproducibil Initiat] Reproducibil Initiat, Palo Alto, CA 94301 USA; [Erath, Jessey; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Antiinfect Screening Core Facil, New York, NY 10016 USA; [Zhou, Jian] LifeTein LLC, Hillsborough, NJ USA	New York University	Iorns, E (corresponding author), Reproducibil Initiat, Palo Alto, CA 94301 USA.	Elizabeth.iorns@gmail.com	Li, J L/E-6100-2018; Rodríguez, Ana/GQR-0554-2022; Li, Jian-Liang/AAE-9315-2019	Li, J L/0000-0002-6487-081X; Li, Jian-Liang/0000-0002-6487-081X; Nosek, Brian/0000-0001-6797-5476; Robertson, George/0000-0001-8411-7721; Rodriguez, Ana/0000-0002-0060-3405; Erath, Jessey/0000-0001-8802-635X; Bandrowski, Anita/0000-0002-5497-0243				Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Croft SL, 2002, CURR PHARM DESIGN, V8, P319, DOI 10.2174/1381612023396258; Ioannidis JPA, 2012, NAT MED, V18, P1736, DOI 10.1038/nm.3020; Kindrachuk J, 2011, BIOPOLYMERS, V96, P14, DOI 10.1002/bip.21441; Kuckelhaus SAS, 2009, EXP PARASITOL, V123, P11, DOI 10.1016/j.exppara.2009.05.002; Lynn MA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001141; McConville MJ, 2007, INT J PARASITOL, V37, P1047, DOI 10.1016/S0020-7519(07)00216-0; Nguyen LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012684; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1	10	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114614	10.1371/journal.pone.0114614	http://dx.doi.org/10.1371/journal.pone.0114614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517992	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600023
J	Lounes, N; Cherfa, MA; Le Carrou, G; Bouyoucef, A; Jay, M; Garin-Bastuji, B; Mick, V				Lounes, Nedjma; Cherfa, Moulay-Ali; Le Carrou, Gilles; Bouyoucef, Abdellah; Jay, Maryne; Garin-Bastuji, Bruno; Mick, Virginie			Human Brucellosis in Maghreb: Existence of a Lineage Related to Socio-Historical Connections with Europe	PLOS ONE			English	Article							NORTH-AFRICA; MELITENSIS; PREVALENCE; LOCI; EAST; SPP.; PCR	Despite control/eradication programs, brucellosis, major worldwide zoonosis due to the Brucella genus, is endemic in Northern Africa and remains a major public health problem in the Maghreb region (Algeria/Morocco/Tunisia). Brucella melitensis biovar 3 is mostly involved in human infections and infects mainly small ruminants. Human and animal brucellosis occurrence in the Maghreb seems still underestimated and its epidemiological situation remains hazy. This study summarizes official data, regarding Brucella melitensis infections in Algeria, from 1989 to 2012, with the purpose to provide appropriate insights concerning the epidemiological situation of human and small ruminant brucellosis in Maghreb. Algeria and Europe are closely linked for historical and economical reasons. These historical connections raise the question of their possible impact on the genetic variability of Brucella strains circulating in the Maghreb. Other purpose of this study was to assess the genetic diversity among Maghreb B. melitensis biovar 3 strains, and to investigate their possible epidemiological relationship with European strains, especially with French strains. A total of 90 B. melitensis biovar 3 Maghreb strains isolated over a 25 year-period (1989-2014), mainly from humans, were analysed by MLVA-16. The obtained results were compared with genotypes of European B. melitensis biovar 3 strains. Molecular assays showed that Algerian strains were mainly distributed into two distinct clusters, one Algerian cluster related to European sub-cluster. These results led to suggest the existence of a lineage resulting from socio-historical connections between Algeria and Europe that might have evolved distinctly from the Maghreb autochthonous group. This study provides insights regarding the epidemiological situation of human brucellosis in the Maghreb and is the first molecular investigation regarding B. melitensis biovar 3 strains circulating in the Maghreb.	[Cherfa, Moulay-Ali; Le Carrou, Gilles; Jay, Maryne; Garin-Bastuji, Bruno; Mick, Virginie] Paris Est Univ Anses, EU OIE FAO, Maisons Alfort, France; [Cherfa, Moulay-Ali; Le Carrou, Gilles; Jay, Maryne; Garin-Bastuji, Bruno; Mick, Virginie] Paris Est Univ Anses, Natl Reference Lab Brucellosis, Maisons Alfort, France; [Lounes, Nedjma] Higher Natl Vet Sch ENSV, Algiers, Algeria; [Bouyoucef, Abdellah] Saad Dahleb Univ, Inst Vet Sci, Blida, Algeria	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Saad Dahlab de Blida	Mick, V (corresponding author), Paris Est Univ Anses, EU OIE FAO, Maisons Alfort, France.	virginie.mick@anses.fr	Lounes, Nedjma/AAX-2653-2021	Jay, Maryne/0000-0003-0443-5565; Garin-Bastuji, Bruno/0000-0002-4486-1182				Aggad H., 2006, Eastern Mediterranean Health Journal, V12, P119; Akakpo A., 2009, C OIE, P71; Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Al-Anazi K.A., 2013, BACTERIAL MYCOTIC IN; Alvarez J, 2011, RES VET SCI, V90, P208, DOI 10.1016/j.rvsc.2010.05.028; [Anonymous], 2005, JOINT WHO DFID AHP M; BENAISSA R, 1984, DEV BIOL STAND, V56, P727; Benhabyles N, 1992, CIHEAM PUBLICATION, V1; Benkirane A, 2006, SMALL RUMINANT RES, V62, P19, DOI 10.1016/j.smallrumres.2005.07.032; Benkirane A, 2001, REV SCI TECH OIE, V20, P757, DOI 10.20506/rst.20.3.1314; Boudilmi B, 1990, BRUC M GHARD ALG NOV; Bounaadja L, 2009, VET MICROBIOL, V137, P156, DOI 10.1016/j.vetmic.2008.12.023; Bouzouaia N, 1995, Tunis Med, V73, P443; Calvez D, 2001, 10 INT S VET LAB DIA; Cherif A, 1986, Arch Inst Pasteur Alger, V55, P9; El Hicheri K, 1992, CIHEAM PUBLICATION, V1; El Idrissi AH, 1996, BRUCELLOSE PETITS RU; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Garin-Bastuji B, 2014, EMERG INFECT DIS, V20, P1570, DOI 10.3201/eid2009.131517; Garofolo G, 2013, INFECT GENET EVOL, V19, P59, DOI 10.1016/j.meegid.2013.06.021; Garofolo G, 2013, J MICROBIOL METH, V92, P103, DOI 10.1016/j.mimet.2012.11.007; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475; Jiang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076332; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lounes N, 2009, RECUEIL ATELIERS EPI, V1, P5; Marianelli C, 2008, J HOSP INFECT, V68, P274, DOI 10.1016/j.jhin.2008.01.003; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551; Mick E, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087257, 10.1371/journal.pone.0094168]; Nicoletti P, 1982, DIAGNOSTIC VACCINATI, V38; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Refai M, 2002, VET MICROBIOL, V90, P81, DOI 10.1016/S0378-1135(02)00248-1; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Valdezate S, 2010, J CLIN MICROBIOL, V48, P2734, DOI 10.1128/JCM.00533-10; Verger JM, 1988, TECHNIQUES BRUCELLOS; WHO, 2006, CONTR NEGL ZOON DIS; World Organisation for Animal Health, HAND; Zribi M, 2009, PATHOL BIOL, V57, P349, DOI 10.1016/j.patbio.2008.02.003	40	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115319	10.1371/journal.pone.0115319	http://dx.doi.org/10.1371/journal.pone.0115319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517901	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600060
J	Asmyhr, MG; Linke, S; Hose, G; Nipperess, DA				Asmyhr, Maria G.; Linke, Simon; Hose, Grant; Nipperess, David A.			Systematic Conservation Planning for Groundwater Ecosystems Using Phylogenetic Diversity	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; RESERVE SELECTION; WATER; DNA; FAUNA; SCALE; MODEL	Aquifer ecosystems provide a range of important services including clean drinking water. These ecosystems, which are largely inaccessible to humans, comprise a distinct invertebrate fauna (stygofauna), which is characterized by narrow distributions, high levels of endemism and cryptic species. Although being under enormous anthropogenic pressure, aquifers have rarely been included in conservation planning because of the general lack of knowledge of species diversity and distribution. Here we use molecular sequence data and phylogenetic diversity as surrogates for stygofauna diversity in aquifers of New South Wales, Australia. We demonstrate how to incorporate these data as conservation features in the systematic conservation planning software Marxan. We designated each branch of the phylogenetic tree as a conservation feature, with the branch length as a surrogate for the number of distinct characters represented by each branch. Two molecular markers (nuclear 18S ribosomal DNA and mitochondrial cytochrome oxidase subunit I) were used to evaluate how marker variability and the resulting tree topology affected the site-selection process. We found that the sites containing the deepest phylogenetic branches were deemed the most irreplaceable by Marxan. By integrating phylogenetic data, we provide a method for including taxonomically undescribed groundwater fauna in systematic conservation planning.	[Asmyhr, Maria G.; Hose, Grant; Nipperess, David A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Linke, Simon] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia	Macquarie University; Griffith University	Nipperess, DA (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	david.nipperess@mq.edu.au	Nipperess, David/H-2707-2019	Hose, Grant/0000-0003-2106-5543; Linke, Simon/0000-0002-1797-3947	Australian Research Council [DP1095200, DE130100565]; Department of Biological Sciences, Macquarie University; Gosford City Council; Linnean Society of New South Wales	Australian Research Council(Australian Research Council); Department of Biological Sciences, Macquarie University(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gosford City Council; Linnean Society of New South Wales	This work was supported by the Australian Research Council (DP1095200 and DE130100565; http://www.arc.gov.au/); the Department of Biological Sciences, Macquarie University (http://www.bio.mq.edu.au/); Gosford City Council (http://www.gosford.nsw.gov.au/) and the Linnean Society of New South Wales (http://linneansocietynsw.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmyhr MG, 2012, INVERTEBR SYST, V26, P583, DOI 10.1071/IS12032; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Billionnet A, 2013, SYST BIOL, V62, P147, DOI 10.1093/sysbio/sys081; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Boulton AJ, 2009, AQUAT CONSERV, V19, P731, DOI 10.1002/aqc.1073; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Corse E, 2010, MOL ECOL RESOUR, V10, P96, DOI 10.1111/j.1755-0998.2009.02795.x; Culver DC, 2000, CONSERV BIOL, V14, P386, DOI 10.1046/j.1523-1739.2000.99026.x; Davies TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1096, DOI 10.1111/j.1466-8238.2012.00759.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eamus D, 2006, AUST J BOT, V54, P97, DOI 10.1071/BT05031; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Faith Daniel P., 2008, P99; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Diniz JAF, 2012, CONSERV GENET, V13, P1085, DOI 10.1007/s10592-012-0356-8; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Ferreira D, 2007, BIODIVERS CONSERV, V16, P567, DOI 10.1007/s10531-005-0305-7; Game ET, 2008, MARXAN USER MANUAL M; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Guzik MT, 2010, INVERTEBR SYST, V24, P407, DOI 10.1071/IS10038; Hahn HJ, 2006, LIMNOLOGICA, V36, P119, DOI 10.1016/j.limno.2006.02.001; Hancock PJ, 2009, FRESHWATER BIOL, V54, P902, DOI 10.1111/j.1365-2427.2007.01878.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hermoso V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059662; Hermoso V, 2012, DIVERS DISTRIB, V18, P448, DOI 10.1111/j.1472-4642.2011.00879.x; Higgins JV, 2005, CONSERV BIOL, V19, P432, DOI 10.1111/j.1523-1739.2005.00504.x; Humphreys WF, 2006, AUST J BOT, V54, P115, DOI 10.1071/BT04151; Januchowski-Hartley SR, 2011, BIOL CONSERV, V144, P2499, DOI 10.1016/j.biocon.2011.07.004; Karanovic T, 2013, INVERTEBR SYST, V27, P540, DOI 10.1071/IS12084; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDonnell MD, 2002, ENVIRON MODEL ASSESS, V7, P107, DOI 10.1023/A:1015649716111; Michel G, 2009, FRESHWATER BIOL, V54, P861, DOI 10.1111/j.1365-2427.2009.02192.x; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Morris BL, 2003, GROUNDWATER ITS SUSC; Nipperess DA, 2013, METHODS ECOL EVOL, V4, P566, DOI 10.1111/2041-210X.12042; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; REBELO AG, 1992, CONSERV BIOL, V6, P243, DOI 10.1046/j.1523-1739.1992.620243.x; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Segan DB, 2010, BIOL CONSERV, V143, P2, DOI 10.1016/j.biocon.2009.09.014; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Stoch F, 2009, FRESHWATER BIOL, V54, P745, DOI 10.1111/j.1365-2427.2008.02143.x; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Grelle CEV, 2010, NAT CONSERVACAO, V8, P46, DOI 10.4322/natcon.00801007; Walker PA, 1995, BIODIVERSITY LETT, V2, P132	54	29	32	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115132	10.1371/journal.pone.0115132	http://dx.doi.org/10.1371/journal.pone.0115132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514422	gold, Green Submitted, Green Published			2022-12-27	WOS:000349146300035
J	Bardine, N; Lamers, G; Wacker, S; Donow, C; Knoechel, W; Durston, A				Bardine, Nabila; Lamers, Gerda; Wacker, Stephan; Donow, Cornelia; Knoechel, Walter; Durston, Antony			Vertical Signalling Involves Transmission of Hox Information from Gastrula Mesoderm to Neurectoderm	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL INDUCTION; XENOPUS EMBRYOS; ENGRAILED HOMEOPROTEIN; ANTEROPOSTERIOR AXIS; OTX2 HOMEOPROTEIN; SPEMANN ORGANIZER; RETINAL AXONS; PLANAR; EXPRESSION	Development and patterning of neural tissue in the vertebrate embryo involves a set of molecules and processes whose relationships are not fully understood. Classical embryology revealed a remarkable phenomenon known as vertical signalling, a gastrulation stage mechanism that copies anterior-posterior positional information from mesoderm to prospective neural tissue. Vertical signalling mediates unambiguous copying of complex information from one tissue layer to another. In this study, we report an investigation of this process in recombinates of mesoderm and ectoderm from gastrulae of Xenopus laevis. Our results show that copying of positional information involves non cell autonomous autoregulation of particular Hox genes whose expression is copied from mesoderm to neurectoderm in the gastrula. Furthermore, this information sharing mechanism involves unconventional translocation of the homeoproteins themselves. This conserved primitive mechanism has been known for three decades but has only recently been put into any developmental context. It provides a simple, robust way to pattern the neurectoderm using the Hox pattern already present in the mesoderm during gastrulation. We suggest that this mechanism was selected during evolution to enable unambiguous copying of rather complex information from cell to cell and that it is a key part of the original ancestral mechanism mediating axial patterning by the highly conserved Hox genes.	[Bardine, Nabila; Lamers, Gerda; Durston, Antony] Leiden Univ, Inst Biol, Sylvius Lab, Leiden, Netherlands; [Wacker, Stephan; Donow, Cornelia; Knoechel, Walter] Univ Ulm, Inst Biochem, D-89069 Ulm, Germany	Leiden University; Leiden University - Excl LUMC; Ulm University	Bardine, N (corresponding author), Leiden Univ, Inst Biol, Sylvius Lab, Leiden, Netherlands.	bardine.nabila@gmail.com; A.J.Durston@gmail.com		Bardine, Nabila/0000-0002-4365-5336				ALTABA ARI, 1992, DEVELOPMENT, V116, P67; Bardine N, 2009, DEV DYNAM, V238, P755, DOI 10.1002/dvdy.21889; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chatelin J, 1996, MECH DEVELOP, V55, P111; Chen YL, 2000, MECH DEVELOP, V90, P53, DOI 10.1016/S0925-4773(99)00229-4; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Di Lullo E, 2011, DEVELOPMENT, V138, P4991, DOI 10.1242/dev.066282; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; Fujii H, 2002, DEV BIOL, V252, P15, DOI 10.1006/dbio.2002.0843; Gavalas A, 2000, CURR OPIN GENET DEV, V10, P380, DOI 10.1016/S0959-437X(00)00100-3; Godsave SF, 1998, DEV DYNAM, V213, P39, DOI 10.1002/(SICI)1097-0177(199809)213:1<39::AID-AJA4>3.0.CO;2-Z; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GRUNZ H, 1995, INT J DEV BIOL, V39, P539; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Jansen HJ, 2007, MECH DEVELOP, V124, P668, DOI 10.1016/j.mod.2007.07.004; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joliot A, 1998, CURR BIOL, V8, P856, DOI 10.1016/S0960-9822(07)00346-6; Joubin K, 2001, INT J DEV BIOL, V45, P165; KENGAKU M, 1995, DEVELOPMENT, V121, P3121; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kolm PJ, 1997, COLD SPRING HARB SYM, V62, P511; Layalle S, 2011, DEVELOPMENT, V138, P2315, DOI 10.1242/dev.057059; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; McNulty CL, 2005, DEVELOPMENT, V132, P2861, DOI 10.1242/dev.01872; Muhr J, 1997, NEURON, V19, P487, DOI 10.1016/S0896-6273(00)80366-9; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P83, DOI 10.1002/jez.1401200104; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pownall ME, 1996, DEVELOPMENT, V122, P3881; Poznanski A, 1997, DEV BIOL, V184, P351, DOI 10.1006/dbio.1996.8500; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Spatazza J, 2013, CELL REP, V3, P1815, DOI 10.1016/j.celrep.2013.05.014; Spemann H., 1924, FDN EXPT EMBRYOLOGY, P144; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Swindell EC, 1999, DEV BIOL, V216, P282, DOI 10.1006/dbio.1999.9487; VILASPASA FL, 2010, INT J DEV BIOL, V54, P599, DOI DOI 10.1387/IJDB.082705FL; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wizenmann A, 2009, NEURON, V64, P355, DOI 10.1016/j.neuron.2009.09.018; Woo K, 1997, SCIENCE, V277, P254, DOI 10.1126/science.277.5323.254	43	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115208	10.1371/journal.pone.0115208	http://dx.doi.org/10.1371/journal.pone.0115208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514127	gold, Green Published			2022-12-27	WOS:000349146300041
J	Chen, JY; Liu, ZJ; Hong, MM; Zhang, HZ; Chen, C; Xiao, MY; Wang, JX; Yao, F; Ba, MC; Liu, JH; Guo, ZK; Zhong, JX				Chen, Jianying; Liu, Zhenjun; Hong, Mian Ming; Zhang, Hongzhe; Chen, Can; Xiao, Mengyuan; Wang, Junxian; Yao, Feng; Ba, Mingchuan; Liu, Jinghu; Guo, Zi-Kuan; Zhong, Jixin			Proangiogenic Compositions of Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells	PLOS ONE			English	Article							IN-VITRO; MATRIX METALLOPROTEINASES; REPERFUSION INJURY; ANGIOGENESIS; ACTIVATION; MECHANISMS; EXOSOMES; THERAPY; BLOOD; VIVO	Introduction & Objective: Microvesicles (MVs) derived from mesenchymal stem cells (MSCs) have been shown to promote angiogenesis. This study was aimed to shed a light on the mechanisms by analyzing the angiogenesis-promoting compositions of MSC-MVs. Also we try to figure out the impact of hypoxia on angiogenesis. Methods: MVs were isolated from the culture supernatants of MSCs under hypoxia/normoxia and serum-deprivation condition. The morphological features of MVs were revealed by an electron microscope and the origin of the MVs was identified by a bead-bound assay. An antibody array was used to analyze the expression of angiogenic cytokines from MVs and the parent MSCs as well. The major candidate factors were screened and the results were validated by immune blotting. Results: MSC-MVs were around 80 nm in diameter. They expressed CD29, CD44, and CD73, but not CD31 and CD45. Antibody array showed that both MSCs and MVs expressed many angiogenesis-promoting biomolecules, including interleukin-6 (IL-6), basic fibroblast growth factors (bFGF), and recptor of urokinase-type plasminogen activator (UPAR). MSC-MVs contained angiogenin, vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1) and the receptor-2 for vascular endothelial growth factor at higher levels than the parent MSCs. Under hypoxic condition most cytokines were expressed in greater quantity than normoxic in MSCs while in MVs there was no significant difference between hypoxic and normoxic conditions except UPAR, Angiogenin, VEGF, IGF, Tie-2/TEK, and IL-6 which were higher in MVs under hypoxic conditions than those in normoxic condition. Conclusion: Upon serum-deprivation condition, MSCs could secrete MVs that contain a variety of factors contributing to their angiogenesis-promoting function. And among them, Angiogenin, VEGF, MCP-1, VEGF R2 might be of greater importance than the other cytokines. Also UPAR, Angiogenin, VEGF, IGF, Tie-2/TEK, IL-6 might be responsible for hypoxia-augmented proangiogenic effects of MVs.	[Chen, Jianying; Liu, Zhenjun; Hong, Mian Ming; Zhang, Hongzhe; Chen, Can; Xiao, Mengyuan; Wang, Junxian; Yao, Feng; Ba, Mingchuan; Liu, Jinghu; Zhong, Jixin] Affiliated Hosp, Guangdong Med Coll, Dept Internal Med, Div Cardiovasc Dis, Zhanjiang, Guangdong, Peoples R China; [Guo, Zi-Kuan] Beijing Inst Radiat Med, Dept Expt Hematol, Beijing, Peoples R China; [Zhong, Jixin] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA	Guangdong Medical University; Academy of Military Medical Sciences - China; University System of Maryland; University of Maryland Baltimore	Chen, JY (corresponding author), Affiliated Hosp, Guangdong Med Coll, Dept Internal Med, Div Cardiovasc Dis, Zhanjiang, Guangdong, Peoples R China.	jychen271@126.com; guozk@bmi.ac.cn	Zhong, Jixin/ABE-3768-2020	Zhong, Jixin/0000-0002-3534-7480; Liu, Jinghu/0000-0002-9798-1639	National Natural Science Foundation of China [81370242, 81101553]; Guangdong Natural Science Foundation [S2013010015005]; Science and Technology Planning Project of Guangdong [2009B030801378, 2012B031800224]; Science and Technology Innovation Fund of Guangdong Medical College [STIF201128]; Financial Foundation of Zhanjiang [(2011)79, (2010)174]; American Heart Association [13POST17210033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong; Science and Technology Innovation Fund of Guangdong Medical College; Financial Foundation of Zhanjiang; American Heart Association(American Heart Association)	This study was supported by grants from the National Natural Science Foundation of China (81370242 and 81101553), Guangdong Natural Science Foundation (S2013010015005), Science and Technology Planning Project of Guangdong (2009B030801378 and 2012B031800224), Science and Technology Innovation Fund of Guangdong Medical College (STIF201128), Financial Foundation of Zhanjiang [(2011)79 and (2010)174], and American Heart Association (13POST17210033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoulvant D, 2011, J HEART LUNG TRANSPL, V30, P95, DOI 10.1016/j.healun.2010.08.023; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Boomsma RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035685; Bussolino F, 1997, TRENDS BIOCHEM SCI, V22, P251, DOI 10.1016/S0968-0004(97)01074-8; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Hoffman EA, 2009, INVEST OPHTH VIS SCI, V50, P1313, DOI 10.1167/iovs.08-2326; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Kurz H, 2000, J NEURO-ONCOL, V50, P17, DOI 10.1023/A:1006485716743; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lai RC, 2013, REGEN MED, V8, P197, DOI [10.2217/rme.13.4, 10.2217/RME.13.4]; Lau CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033037; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Richardson JD, 2013, STEM CELL REV REP, V9, P281, DOI 10.1007/s12015-012-9366-7; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Wollert KC, 2010, NAT REV CARDIOL, V7, P204, DOI 10.1038/nrcardio.2010.1; Zhang HC, 2012, STEM CELLS DEV, V21, P3289, DOI 10.1089/scd.2012.0095	28	65	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115316	10.1371/journal.pone.0115316	http://dx.doi.org/10.1371/journal.pone.0115316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514634	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300052
J	Ji, R; Meng, LB; Jiang, X; Kumar, CVMN; Ding, JX; Li, QT; Lu, QX				Ji, Rui; Meng, Lingbin; Jiang, Xin; Kumar, Naresh C. V. M.; Ding, Jixiang; Li, Qiutang; Lu, Qingxian			TAM Receptors Support Neural Stem Cell Survival, Proliferation and Neuronal Differentiation	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TYROSINE KINASES; APOPTOTIC CELLS; NERVOUS-SYSTEM; TRK RECEPTORS; TYRO-3 FAMILY; NEUROTROPHINS; AXL; NGF; MER	Tyro3, Axl and Mertk (TAM) receptor tyrosine kinases play multiple functional roles by either providing intrinsic trophic support for cell growth or regulating the expression of target genes that are important in the homeostatic regulation of immune responses. TAM receptors have been shown to regulate adult hippocampal neurogenesis by negatively regulation of glial cell activation in central nervous system (CNS). In the present study, we further demonstrated that all three TAMreceptors were expressed by cultured primary neural stem cells (NSCs) and played a direct growth trophic role in NSCs proliferation, neuronal differentiation and survival. The cultured primary NSCs lacking TAM receptors exhibited slower growth, reduced proliferation and increased apoptosis as shown by decreased BrdU incorporation and increased TUNEL labeling, than those from the WT NSCs. In addition, the neuronal differentiation and maturation of themutant NSCs were impeded, as characterized by less neuronal differentiation (beta-tubulin III+) and neurite outgrowth than their WT counterparts. To elucidate the underlying mechanism that the TAM receptors play on the differentiating NSCs, we examined the expression profile of neurotrophins and their receptors by real-time qPCR on the total RNAs from hippocampus and primary NSCs; and found that the TKO NSC showed a significant reduction in the expression of both nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), but accompanied by compensational increases in the expression of the TrkA, TrkB, TrkC and p75 receptors. These results suggest that TAM receptors support NSCs survival, proliferation and differentiation by regulating expression of neurotrophins, especially the NGF.	[Ji, Rui; Kumar, Naresh C. V. M.; Li, Qiutang; Lu, Qingxian] Univ Louisville, Dept Ophthalmol & Visual Sci, Sch Med, Louisville, KY 40202 USA; [Ji, Rui; Meng, Lingbin; Lu, Qingxian] Univ Louisville, Dept Anat Sci & Neurobiol, Sch Med, Louisville, KY 40202 USA; [Jiang, Xin] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130021, Peoples R China; [Ding, Jixiang] Univ Louisville, Sch Dent, Birth Defects Ctr, Louisville, KY 40202 USA	University of Louisville; University of Louisville; Jilin University; University of Louisville	Lu, QX (corresponding author), Univ Louisville, Dept Ophthalmol & Visual Sci, Sch Med, Louisville, KY 40202 USA.	q.lu@louisville.edu	Jiang, Xin/AHA-9454-2022	Jiang, Xin/0000-0002-4613-7438	National Institutes of Health, National Eye Institute [R01-EY018830]; NIH, National Eye Institute [R01-EY019891]; NATIONAL EYE INSTITUTE [R01EY018830, R01EY019891] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (R01-EY018830), National Eye Institute (http://www.nei.nih.gov/) to Q. Lu, and NIH (R01-EY019891), National Eye Institute (http://www.nei.nih.gov/) to Q. Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; BRADSHAW RA, 1993, TRENDS BIOCHEM SCI, V18, P48, DOI 10.1016/0968-0004(93)90052-O; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gely-Pernot A, 2012, STEM CELLS, V30, P719, DOI 10.1002/stem.1045; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Middleton G, 2001, DEVELOPMENT, V128, P447; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nguyen N, 2009, NEUROCHEM RES, V34, P942, DOI 10.1007/s11064-008-9848-9; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Wang J, 2011, STEM CELLS, V29, P1589, DOI 10.1002/stem.699; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Ye F, 2011, INVEST OPHTH VIS SCI, V52, P4239, DOI 10.1167/iovs.10-6700; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WH, 2002, J NEUROCHEM, V80, P1049, DOI 10.1046/j.0022-3042.2002.00783.x; Zheng Y, 2009, BIOCHEM BIOPH RES CO, V378, P371, DOI 10.1016/j.bbrc.2008.11.049	39	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115140	10.1371/journal.pone.0115140	http://dx.doi.org/10.1371/journal.pone.0115140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514676	gold, Green Published, Green Submitted			2022-12-27	WOS:000349146300037
J	Pope, L; Hanks, AS; Just, DR; Wansink, B				Pope, Lizzy; Hanks, Andrew S.; Just, David R.; Wansink, Brian			New Year's Res-Illusions: Food Shopping in the New Year Competes with Healthy Intentions	PLOS ONE			English	Article							HOUSEHOLD FOOD; WEIGHT; SUPERMARKET; PURCHASES; RECEIPTS; PATTERNS; ADULTS; FAT	Objective: How do the holidays - and the possible New Year's resolutions that follow - influence a household's purchase patterns of healthier foods versus less healthy foods? This has important implications for both holiday food shopping and post-holiday shopping. Methods: 207 households were recruited to participate in a randomized-controlled trial conducted at two regional-grocery chain locations in upstate New York. Item-level transaction records were tracked over a seven-month period (July 2010 to March 2011). The cooperating grocer's proprietary nutrient-rating system was used to designate "healthy,'' and "less healthy'' items. Calorie data were extracted from online nutritional databases. Expenditures and calories purchased for the holiday period (Thanksgiving-New Year's), and the post-holiday period (New Year's-March), were compared to baseline (July-Thanksgiving) amounts. Results: During the holiday season, household food expenditures increased 15% compared to baseline ($ 105.74 to $ 121.83; p<0.001), with 75% of additional expenditures accounted for by less-healthy items. Consistent with what one would expect from New Year's resolutions, sales of healthy foods increased 29.4% ($ 13.24/week) after the holiday season compared to baseline, and 18.9% ($ 9.26/week) compared to the holiday period. Unfortunately, sales of less-healthy foods remained at holiday levels ($ 72.85/week holiday period vs. $ 72.52/week post-holiday). Calories purchased each week increased 9.3% (450 calories per serving/week) after the New Year compared to the holiday period, and increased 20.2% (890 calories per serving/week) compared to baseline. Conclusions: Despite resolutions to eat more healthfully after New Year's, consumers may adjust to a new "status quo'' of increased less-healthy food purchasing during the holidays, and dubiously fulfill their New Year's resolutions by spending more on healthy foods. Encouraging consumers to substitute healthy items for less-healthy items may be one way for practitioners and public health officials to help consumers fulfill New Year's resolutions, and reverse holiday weight gain.	[Pope, Lizzy; Hanks, Andrew S.; Just, David R.; Wansink, Brian] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Food & Brand Lab, Ithaca, NY USA	Cornell University	Pope, L (corresponding author), Univ Vermont, Dept Nutr & Food Sci, Burlington, VT 05405 USA.	efpope@uvm.edu		Hanks, Andrew/0000-0003-0687-4772	National Institutes of Health (NIH) [1RC1HD063370-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC1HD063370] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully acknowledge financial support from the National Institutes of Health (NIH), grant 1RC1HD063370-01. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister R., 2011, WILLPOWER; Cook CM, 2012, AM J CLIN NUTR, V95, P726, DOI 10.3945/ajcn.111.023036; Cullen K, 2007, J AM DIET ASSOC, V107, P1747, DOI 10.1016/j.jada.2007.07.007; Ehrich KR, 2005, J MARKETING RES, V42, P266, DOI 10.1509/jmkr.2005.42.3.266; Fischer LM, 2011, AM J HLTH PROMOT, V26, pe55, DOI DOI 10.4278/AJHP.100709-QUAL-238; Flegal KM, 2000, INT J OBESITY, V24, P807, DOI 10.1038/sj.ijo.0801232; French SA, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-37; French SA, 2008, J AM DIET ASSOC, V108, P2051, DOI 10.1016/j.jada.2008.09.001; Hetherington MM, 2006, PHYSIOL BEHAV, V88, P498, DOI 10.1016/j.physbeh.2006.04.025; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hull HR, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-29; Kassirer JP, 1998, NEW ENGL J MED, V338, P52, DOI 10.1056/NEJM199801013380109; Khare A, 2009, J PUBLIC POLICY MARK, V28, P234, DOI 10.1509/jppm.28.2.234; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Ma Y, 2006, EUR J CLIN NUTR, V60, P519, DOI 10.1038/sj.ejcn.1602346; Ogden CL, 2004, MEAN BODY WEIGHT BOD; Rankin JW, 1998, J NUTR EDUC, V30, P81, DOI 10.1016/S0022-3182(98)70284-5; Ransley JK, 2001, PUBLIC HEALTH NUTR, V4, P1279, DOI 10.1079/PHN2001171; Reid R, 1999, J HUM NUTR DIET, V12, P513, DOI 10.1046/j.1365-277x.1999.00205.x; Rossner SM, 2011, OBESITY FACTS, V4, P3, DOI 10.1159/000324861; Spencer R.J., 2013, PUBLIC HEALTH NUTR, V17, P1; Stevenson J, 2013, EUROPEAN J CLIN NUTR; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; Wansink B, 2014, J MARKETING RES, V36, P380; Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605; Wilcox K, 2009, J CONSUM RES, V36, P380, DOI 10.1086/599219; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Yanovski JA, 2000, NEW ENGL J MED, V342, P861, DOI 10.1056/NEJM200003233421206	29	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e110561	10.1371/journal.pone.0110561	http://dx.doi.org/10.1371/journal.pone.0110561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25514158	Green Published, gold			2022-12-27	WOS:000349146300001
J	Abidin, NZ; Mamat, M; Dangerfield, B; Zulkepli, JH; Baten, MA; Wibowo, A				Abidin, Norhaslinda Zainal; Mamat, Mustafa; Dangerfield, Brian; Zulkepli, Jafri Haji; Baten, Md. Azizul; Wibowo, Antoni			Combating Obesity through Healthy Eating Behavior: A Call for System Dynamics Optimization	PLOS ONE			English	Article							PREVENTION; FOOD; CONSUMPTION; CHILDHOOD; DESIGN; DIET	Poor eating behavior has been identified as one of the core contributory factors of the childhood obesity epidemic. The consequences of obesity on numerous aspects of life are thoroughly explored in the existing literature. For instance, evidence shows that obesity is linked to incidences of diseases such as heart disease, type-2 diabetes, and some cancers, as well as psychosocial problems. To respond to the increasing trends in the UK, in 2008 the government set a target to reverse the prevalence of obesity (POB) back to 2000 levels by 2020. This paper will outline the application of system dynamics (SD) optimization to simulate the effect of changes in the eating behavior of British children (aged 2 to 15 years) on weight and obesity. This study also will identify how long it will take to achieve the government's target. This paper proposed a simulation model called Intervention Childhood Obesity Dynamics (ICOD) by focusing the interrelations between various strands of knowledge in one complex human weight regulation system. The model offers distinct insights into the dynamics by capturing the complex interdependencies from the causal loop and feedback structure, with the intention to better understand how eating behaviors influence children's weight, body mass index (BMI), and POB measurement. This study proposed a set of equations that are revised from the original (baseline) equations. The new functions are constructed using a RAMP function of linear decrement in portion size and number of meal variables from 2013 until 2020 in order to achieve the 2020 desired target. Findings from the optimization analysis revealed that the 2020 target won't be achieved until 2026 at the earliest, six years late. Thus, the model suggested that a longer period may be needed to significantly reduce obesity in this population.	[Abidin, Norhaslinda Zainal; Zulkepli, Jafri Haji; Baten, Md. Azizul; Wibowo, Antoni] Univ Utara Malaysia, Coll Arts & Sci, Sch Quantitat Sci, Sintok, Kedah, Malaysia; [Mamat, Mustafa] Univ Malaysia Terengganu, Fac Sci & Technol, Dept Math, Kuala Terengganu, Terengganu, Malaysia; [Dangerfield, Brian] Univ Bristol, Sch Econ Finance & Management, Dept Management, Bristol, Avon, England	Universiti Utara Malaysia; Universiti Malaysia Terengganu; University of Bristol	Abidin, NZ (corresponding author), Univ Utara Malaysia, Coll Arts & Sci, Sch Quantitat Sci, Sintok, Kedah, Malaysia.	nhaslinda@uum.edu.my	Mamat, Mustafa/AAF-7716-2019; Zulkepli, Jafri/AAY-2849-2020; Abidin, Norhaslinda Zainal/AAY-1335-2021	Baten, Md. Azizul/0000-0001-9786-6369; Dangerfield, Brian/0000-0003-2435-2169	Universiti Malaysia Terengganu (UMT) under the Fundamental Research Grant Scheme (FRGS) [59256]	Universiti Malaysia Terengganu (UMT) under the Fundamental Research Grant Scheme (FRGS)	The authors wish to thank Universiti Malaysia Terengganu (UMT) for the financial support in conducting the research, provided under the Fundamental Research Grant Scheme (FRGS) with grant number: 59256. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid TK, 2003, MED SCI SPORT EXER, V35, P400, DOI 10.1249/01.MSS.0000053659.32126.2D; [Anonymous], 2013, OB OV; Bazin E, 2011, THESIS U SALFORD; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; Campbell K, 2001, Obes Rev, V2, P149, DOI 10.1046/j.1467-789x.2001.00035.x; Coyle RG, 1985, SYST DYNAM REV, V1, P81, DOI 10.1002/sdr.4260010107; Dangerfield B, 1996, J OPER RES SOC, V47, P405, DOI 10.2307/3010583; Dangerfield BC, 2011, ONL P 29 INT SYST DY; Dehghan M, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-24; Department of Health, 2008, HLTH WEIGHT HLTH LIV; Duggan J, 2008, SYST DYNAM REV, V24, P97, DOI 10.1002/sdr.393; Forrester J.W., 1961, IND DYNAMICS; Forrester JW, 2007, SYST DYNAM REV, V23, P345, DOI 10.1002/sdr.382; HOMER J, 2004, DIABETES SYSTEM MODE; Homer J, 2006, ONL P 24 INT SYST DY; INFORMS Computing Society, 2013, NAT MATH PROGR; KELOHARJU R, 1989, J OPER RES SOC, V40, P221, DOI 10.1057/jors.1989.33; Kumanyika S, 2002, INT J OBESITY, V26, P425, DOI 10.1038/sj.ijo.0801938; Lebcir M., 2006, HLTH CARE MANAGEMENT; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Meyers RA, 2009, ENCY COMPLEXITY SYST; Mohapatra PKJ, 1985, SYST DYNAM REV, V1, P63, DOI 10.1002/sdr.4260010106; Neumark-Sztainer D, 2003, PREV MED, V37, P41, DOI 10.1016/S0091-7435(03)00057-4; NHS, 2011, HLTH SURV ENGL 2009; NHS, 2011, STAT OB PHYS ACT DIE; Norhaslinda Zainal Abidin, 2012, THESIS U SALFORD; Northstone K, 2012, J EPIDEMIOL COMMUN H, V66, P624, DOI 10.1136/jech.2010.111955; Rennie KL, 2005, BEST PRACT RES CL EN, V19, P343, DOI 10.1016/j.beem.2005.04.003; Senge P.M., 1980, SYSTEM DYNAMICS TIMS, V14, P209; Stamatakis E, 2010, J EPIDEMIOL COMMUN H, V64, P167, DOI 10.1136/jech.2009.098723; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Theodore RF, 2009, INTELLIGENCE, V37, P506, DOI 10.1016/j.intell.2009.07.001; Townshend JRP, 2000, J OPER RES SOC, V51, P812, DOI 10.2307/253962; VENSIM, 2010, VENT SYST; Wolstenholme EF, 1987, SYST DYNAM REV, V3, P102, DOI 10.1002/sdr.4260030203; Young LR, 2007, J PUBLIC HEALTH POL, V28, P238, DOI 10.1057/palgrave.jphp.3200127	40	22	22	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114135	10.1371/journal.pone.0114135	http://dx.doi.org/10.1371/journal.pone.0114135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25502170	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000346607100008
J	Boesjes, M; Bloks, VW; Hageman, J; Bos, T; van Dijk, TH; Havinga, R; Wolters, H; Jonker, JW; Kuipers, F; Groen, AK				Boesjes, Marije; Bloks, Vincent W.; Hageman, Jurre; Bos, Trijnie; van Dijk, Theo H.; Havinga, Rick; Wolters, Henk; Jonker, Johan W.; Kuipers, Folkert; Groen, Albert K.			Hepatic Farnesoid X-Receptor Isoforms alpha 2 and alpha 4 Differentially Modulate Bile Salt and Lipoprotein Metabolism in Mice	PLOS ONE			English	Article							TRANSINTESTINAL CHOLESTEROL EXCRETION; GREEN FLUORESCENT PROTEIN; NUCLEAR RECEPTOR; ADENOASSOCIATED VIRUS; ACID SYNTHESIS; FEEDBACK-REGULATION; DEFICIENT MICE; FXR; EXPRESSION; LIVER	The nuclear receptor FXR acts as an intracellular bile salt sensor that regulates synthesis and transport of bile salts within their enterohepatic circulation. In addition, FXR is involved in control of a variety of crucial metabolic pathways. Four FXR splice variants are known, i.e. FXR alpha 1-4. Although these isoforms show differences in spatial and temporal expression patterns as well as in transcriptional activity, the physiological relevance hereof has remained elusive. We have evaluated specific roles of hepatic FXR alpha 2 and FXR alpha 4 by stably expressing these isoforms using liver-specific self-complementary adeno-associated viral vectors in total body FXR knock-out mice. The hepatic gene expression profile of the FXR knock-out mice was largely normalized by both isoforms. Yet, differential effects were also apparent; FXR alpha 2 was more effective in reducing elevated HDL levels and transrepressed hepatic expression of Cyp8b1, the regulator of cholate synthesis. The latter coincided with a switch in hydrophobicity of the bile salt pool. Furthermore, FXR alpha 2-transduction caused an increased neutral sterol excretion compared to FXR alpha 4 without affecting intestinal cholesterol absorption. Our data show, for the first time, that hepatic FXR alpha 2 and FXR alpha 4 differentially modulate bile salt and lipoprotein metabolism in mice.	[Boesjes, Marije; Bloks, Vincent W.; Hageman, Jurre; Bos, Trijnie; van Dijk, Theo H.; Havinga, Rick; Wolters, Henk; Jonker, Johan W.; Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Kuipers, Folkert; Groen, Albert K.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen	Boesjes, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.	m.boesjes@umcg.nl	Jonker, Johan W./ABE-6853-2020; Bloks, Vincent Walter/A-7609-2012	Jonker, Johan W./0000-0002-3919-5437; Bloks, Vincent Walter/0000-0001-6493-7482; Kuipers, Folkert/0000-0003-2518-737X	Top Institute Pharma, The Netherlands [T2-110]	Top Institute Pharma, The Netherlands(Netherlands Government)	Supported within the framework of Top Institute Pharma, The Netherlands, project T2-110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; Anakk S, 2010, J CLIN INVEST; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottcher CFJ, 2011, ANAL CHIM ACTA, V1961, P203; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chen WL, 2003, GENE, V313, P71, DOI 10.1016/S0378-1119(03)00631-0; Claudel T, 2002, J CLIN INVEST, V109, P961; Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5; del Castillo-Olivares A, 2001, NUCLEIC ACIDS RES, V29, P4035, DOI 10.1093/nar/29.19.4035; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; GAMBLE W, 1978, J LIPID RES, V19, P1068; Gautier T, 2013, J LIPID RES; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hambruch E, 2012, J PHARMACOL EXP THER, V343, P556, DOI 10.1124/jpet.112.196519; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Hoeke MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088011; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Kemper JK, 2011, BBA-MOL BASIS DIS, V1812, P842, DOI 10.1016/j.bbadis.2010.11.011; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kuipers F, 1996, HEPATOLOGY, V24, P241; Le May C, 2013, ARTERIOSCL THROM VAS, V33, P1484, DOI 10.1161/ATVBAHA.112.300263; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Martinez-Becerra P, 2012, PHARMACOL RES, V66, P419, DOI 10.1016/j.phrs.2012.07.005; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Montenegro-Miranda PS, 2011, HUM GENE THER, V22, P605, DOI 10.1089/hum.2010.222; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Nathwani AC, 2006, BLOOD, V107, P2653, DOI 10.1182/blood-2005-10-4035; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rosenzweig M, 2001, BLOOD, V97, P1951, DOI 10.1182/blood.V97.7.1951; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Seppen J, 2006, MOL THER, V13, P1085, DOI 10.1016/j.ymthe.2006.01.014; Sirvent A, 2004, FEBS LETT, V566, P173, DOI 10.1016/j.febslet.2004.04.026; Stricker D, 2008, COMPUT METH PROG BIO, V92, P135, DOI 10.1016/j.cmpb.2008.06.010; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Stroeve JH, 2010, LAB INVEST; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van der Velde AE, 2008, AM J PHYSIOL-GASTR L, V295, pG203, DOI 10.1152/ajpgi.90231.2008; Van der Velde AE, 2007, GASTROENTEROLOGY, V133, P967, DOI 10.1053/j.gastro.2007.06.019; Vaquero J, 2013, BIOCHEM PHARMACOL, V86, P926, DOI 10.1016/j.bcp.2013.07.022; Vrins CLJ, 2010, WORLD J GASTROENTERO, V16, P5953, DOI 10.3748/wjg.v16.i47.5953; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Woollett LA, 2006, GUT, V55, P197, DOI 10.1136/gut.2005.069906; Zhang M, 2001, J BIOL CHEM, V276, P41690, DOI 10.1074/jbc.M105117200; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006	56	20	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115028	10.1371/journal.pone.0115028	http://dx.doi.org/10.1371/journal.pone.0115028			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506828	gold, Green Published, Green Submitted			2022-12-27	WOS:000346607100045
J	Du, JY; Reznikov, LR; Welsh, MJ				Du, Jianyang; Reznikov, Leah R.; Welsh, Michael J.			Expression and Activity of Acid-Sensing Ion Channels in the Mouse Anterior Pituitary	PLOS ONE			English	Article							RAT HIPPOCAMPAL-NEURONS; SENSORY NEURONS; NA+ CHANNEL; SYNAPTIC PLASTICITY; ACTIVATED CURRENTS; EVOKED CURRENTS; GATED CHANNELS; CELLS; H+; ISCHEMIA	Acid sensing ion channels (ASICs) are proton-gated cation channels that are expressed in the nervous system and play an important role in fear learning and memory. The function of ASICs in the pituitary, an endocrine gland that contributes to emotions, is unknown. We sought to investigate which ASIC subunits were present in the pituitary and found mRNA expression for all ASIC isoforms, including ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3 and ASIC4. We also observed acid-evoked ASIC-like currents in isolated anterior pituitary cells that were absent in mice lacking ASIC1a. The biophysical properties and the responses to PcTx1, amiloride, Ca2+ and Zn2+ suggested that ASIC currents were mediated predominantly by heteromultimeric channels that contained ASIC1a and ASIC2a or ASIC2b. ASIC currents were also sensitive to FMRFamide (Phe-Met-Arg-Phe amide), suggesting that FMRFamide-like compounds might endogenously regulate pituitary ASICs. To determine whether ASICs might regulate pituitary cell function, we applied low pH and found that it increased the intracellular Ca2+ concentration. These data suggest that ASIC channels are present and functionally active in anterior pituitary cells and may therefore influence their function.	[Du, Jianyang; Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Du, Jianyang; Reznikov, Leah R.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa	Du, JY (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	jianyang-du@uiowa.edu	Reznikov, Leah R./J-4314-2019	Reznikov, Leah R./0000-0002-4074-9070; Welsh, Michael/0000-0002-1646-6206	Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL119560] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Howard Hughes Medical Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CH, 2009, J PHYSIOL-LONDON, V587, P1727, DOI 10.1113/jphysiol.2008.166918; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Dhingra A, 2008, J COMP NEUROL, V510, P484, DOI 10.1002/cne.21807; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Du JY, 2014, P NATL ACAD SCI USA, V111, P8961, DOI 10.1073/pnas.1407018111; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Graeff Frederico Guilherme, 2010, Psychol. Neurosci., V3, P3, DOI 10.3922/j.psns.2010.1.002; Grunder S, 2000, NEUROREPORT, V11, P1607; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hattori T, 2009, CIRC RES, V105, P279, DOI 10.1161/CIRCRESAHA.109.202036; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jiang Q, 2010, NEUROSCIENCE, V169, P574, DOI 10.1016/j.neuroscience.2010.05.043; Jiang Q, 2009, NEUROSCIENCE, V162, P55, DOI 10.1016/j.neuroscience.2009.04.029; Li MH, 2014, J GEN PHYSIOL, V143, P719, DOI 10.1085/jgp.201310990; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Stojilkovic SS, 2005, TRENDS ENDOCRIN MET, V16, P81, DOI 10.1016/j.tem.2005.02.002; Stojilkovic SS, 2010, ENDOCR REV, V31, P845, DOI 10.1210/er.2010-0005; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Ukena K, 2001, NEUROSCI LETT, V300, P153, DOI 10.1016/S0304-3940(01)01583-X; Van Goor F, 2001, MOL ENDOCRINOL, V15, P1222, DOI 10.1210/me.15.7.1222; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Weng XC, 2004, NEUROSCI RES, V50, P493, DOI 10.1016/j.neures.2004.09.001; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yamazaki M, 2012, NEUROSCI LETT, V526, P29, DOI 10.1016/j.neulet.2012.07.063; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029; Zorec R, 1996, TRENDS ENDOCRIN MET, V7, P384, DOI 10.1016/S1043-2760(96)00169-5	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115310	10.1371/journal.pone.0115310	http://dx.doi.org/10.1371/journal.pone.0115310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506946	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100067
J	Guo, ZL; Zhang, H; Lin, SJ				Guo, Zhiling; Zhang, Huan; Lin, Senjie			Light-Promoted Rhodopsin Expression and Starvation Survival in the Marine Dinoflagellate Oxyrrhis marina	PLOS ONE			English	Article							PROTON PUMP; MICROBIAL RHODOPSINS; GRAZING RESPONSES; GENE SEQUENCE; IDENTIFICATION; BACTERIAL; PROTEIN; GROWTH; RNA; XANTHORHODOPSIN	The discovery of microbial rhodopsins in marine proteobacteria changed the dogma that photosynthesis is the only pathway to use the solar energy for biological utilization in the marine environment. Although homologs of these rhodopsins have been identified in dinoflagellates, the diversity of the encoding genes and their physiological roles remain unexplored. As an initial step toward addressing the gap, we conducted high-throughput transcriptome sequencing on Oxyrrhis marina to retrieve rhodopsin transcripts, rapid amplification of cDNA ends to isolate full-length cDNAs of dominant representatives, and quantitative reverse-transcription PCR to investigate their expression under varying conditions. Our phylogenetic analyses showed that O. marina contained both the proton-pumping type (PR) and sensory type (SR) rhodopsins, and the transcriptome data showed that the PR type dominated over the SR type. We compared rhodopsin gene expression for cultures kept under light: dark cycle and continuous darkness in a time course of 24 days without feeding. Although both types of rhodopsin were expressed under the two conditions, the expression levels of PR were much higher than SR, consistent with the transcriptomic data. Furthermore, relative to cultures kept in the dark, rhodopsin expression levels and cell survival rate were both higher in cultures grown in the light. This is the first report of light-dependent promotion of starvation survival and concomitant promotion of PR expression in a eukaryote. While direct evidence needs to come from functional test on rhodopsins in vitro or gene knockout/knockdown experiments, our results suggest that the proton-pumping rhodopsin might be responsible for the light-enhanced survival of O. marina, as previously demonstrated in bacteria.	[Guo, Zhiling; Zhang, Huan; Lin, Senjie] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Guo, Zhiling] Chinese Acad Sci, South China Sea Inst Oceanol, Key Lab Trop Marine Bioresources & Ecol, Guangzhou, Guangdong, Peoples R China; [Zhang, Huan] Ocean Univ China, Dept Environm Sci, Qingdao 266100, Shandong, Peoples R China; [Lin, Senjie] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Fujian, Peoples R China	University of Connecticut; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Ocean University of China; Xiamen University	Zhang, H (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	huan.zhang@uconn.edu; senjie.lin@uconn.edu	Lin, Senjie/A-7466-2011; Guo, chentao/G-7320-2016; Guo, Zhiling/AAJ-6843-2020	Guo, Zhiling/0000-0001-9549-2164	National Science Foundation of the US grant [1212392]; National Science Foundation of China [41129001, 41176091, 41330959]; National Science of China overseas collaboration Fund [41129001]; Gordon and Betty Moore Foundation [2637]	National Science Foundation of the US grant; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science of China overseas collaboration Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was supported by the National Science Foundation of the US grant 1212392 and National Science Foundation of China (41129001, 41176091, 41330959) (http://www.nsfc.gov.cn/), and National Science of China overseas collaboration Fund (41129001). Transcriptome sequencing was supported by the Gordon and Betty Moore Foundation through Grant #2637 to the National Center for Genome Resource (NCGR). Samples MMETSP0451 and MMETSP0452 were sequenced at NCGR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Atamna-Ismaeel N, 2012, ENVIRON MICROBIOL, V14, P140, DOI 10.1111/j.1462-2920.2011.02554.x; Balashov SP, 2007, CELL MOL LIFE SCI, V64, P2323, DOI 10.1007/s00018-007-7167-y; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; BARSANTI L, 1993, VISION RES, V33, P2043, DOI 10.1016/0042-6989(93)90002-E; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; CARON DA, 1993, MICROBIAL ECOL, V25, P93, DOI 10.1007/BF00182132; ENGLANDER JJ, 1977, NATURE, V265, P658, DOI 10.1038/265658a0; Feinstein TN, 2002, J PHYCOL, V38, P659, DOI 10.1046/j.1529-8817.2002.01175.x; Feng S, 2013, ISME J, V7, P2206, DOI 10.1038/ismej.2013.97; Finkel OM, 2013, ISME J, V7, P448, DOI 10.1038/ismej.2012.112; Frassanito AM, 2010, CELL MOL LIFE SCI, V67, P965, DOI 10.1007/s00018-009-0225-x; Fuhrman JA, 2008, NAT REV MICROBIOL, V6, P488, DOI 10.1038/nrmicro1893; Gomez-Consarnau L, 2007, NATURE, V445, P210, DOI 10.1038/nature05381; Gomez-Consarnau L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000358; Graul RC, 1997, PHARMACEUT RES, V14, P1533, DOI 10.1023/A:1012166015402; GUALTIERI P, 1992, BIOCHIM BIOPHYS ACTA, V1117, P55, DOI 10.1016/0304-4165(92)90162-N; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Zhiling, 2013, Microorganisms, V1, P33; Hartz AJ, 2011, J EUKARYOT MICROBIOL, V58, P171, DOI 10.1111/j.1550-7408.2011.00529.x; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Idnurm A, 2001, GENOME, V44, P167, DOI 10.1139/gen-44-2-167; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Jeong HJ, 2008, J EUKARYOT MICROBIOL, V55, P271, DOI 10.1111/j.1550-7408.2008.00336.x; Kikukawa T., 2012, MOL PHOTOCHEMISTRY V, P89; Kuo RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060826; Li AS, 2000, J PHYCOL, V36, P33, DOI 10.1046/j.1529-8817.2000.98076.x; Lin S, 2010, P 13 INT C HARMF ALG, P166; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; Lin X, 2011, J PHYCOL, V47, P1110, DOI 10.1111/j.1529-8817.2011.01038.x; Lowe CD, 2011, J PLANKTON RES, V33, P555, DOI 10.1093/plankt/fbq110; Lowe CD, 2010, PROTIST, V161, P212, DOI 10.1016/j.protis.2009.11.003; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Moreno-Paz M, 2006, ENVIRON MICROBIOL, V8, P1064, DOI 10.1111/j.1462-2920.2006.00998.x; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Ruiz-Gonzalez MX, 2004, J MOL EVOL, V58, P348, DOI 10.1007/s00239-003-2557-8; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Sineshchekov OA, 2005, BIOPHYS J, V89, P4310, DOI 10.1529/biophysj.105.070920; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Skovgaard A, 1996, MAR ECOL PROG SER, V143, P247, DOI 10.3354/meps143247; Slamovits CH, 2011, J PLANKTON RES, V33, P591, DOI 10.1093/plankt/fbq153; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMIOKA H, 1986, BIOCHEM BIOPH RES CO, V139, P389, DOI 10.1016/S0006-291X(86)80003-1; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036961; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yutin N, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-34; Zhang H, 2006, J EUKARYOT MICROBIOL, V53, P142, DOI 10.1111/j.1550-7408.2005.00085.x; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2013, J EXP MAR BIOL ECOL, V446, P57, DOI 10.1016/j.jembe.2013.04.021; Zhang H, 2013, PROTIST, V164, P510, DOI 10.1016/j.protis.2013.04.002	65	22	22	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114941	10.1371/journal.pone.0114941	http://dx.doi.org/10.1371/journal.pone.0114941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506945	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100035
J	Chiarella, E; Carra, G; Scicchitano, S; Codispoti, B; Mega, T; Lupia, M; Pelaggi, D; Marafioti, MG; Aloisio, A; Giordano, M; Nappo, G; Spoleti, CB; Grillone, T; Giovannone, ED; Spina, R; Bernaudo, F; Moore, MAS; Bond, HM; Mesuraca, M; Morrone, G				Chiarella, Emanuela; Carra, Giovanna; Scicchitano, Stefania; Codispoti, Bruna; Mega, Tiziana; Lupia, Michela; Pelaggi, Daniela; Marafioti, Maria G.; Aloisio, Annamaria; Giordano, Marco; Nappo, Giovanna; Spoleti, Cristina B.; Grillone, Teresa; Giovannone, Emilia D.; Spina, Raffaella; Bernaudo, Francesca; Moore, Malcolm A. S.; Bond, Heather M.; Mesuraca, Maria; Morrone, Giovanni			UMG Lenti: Novel Lentiviral Vectors for Efficient Transgene- and Reporter Gene Expression in Human Early Hematopoietic Progenitors	PLOS ONE			English	Article							HUMAN CD34(+) CELLS; FINGER PROTEIN 521; SELF-RENEWAL; STEM-CELLS; CONSTITUTIVE ACTIVATION; ENFORCED EXPRESSION; DIFFERENTIATION; PROMOTES; LEUKEMIA; PROLIFERATION	Lentiviral vectors are widely used to investigate the biological properties of regulatory proteins and/or of leukaemia-associated oncogenes by stably enforcing their expression in hematopoietic stem and progenitor cells. In these studies it is critical to be able to monitor and/or sort the infected cells, typically via fluorescent proteins encoded by the modified viral genome. The most popular strategy to ensure co-expression of transgene and reporter gene is to insert between these cDNAs an IRES element, thus generating bi-cistronic mRNAs whose transcription is driven by a single promoter. However, while the product of the gene located upstream of the IRES is generally abundantly expressed, the translation of the downstream cDNA (typically encoding the reporter protein) is often inconsistent, which hinders the detection and the isolation of transduced cells. To overcome these limitations, we developed novel lentiviral dual-promoter vectors (named UMG-LV5 and -LV6) where transgene expression is driven by the potent UBC promoter and that of the reporter protein, EGFP, by the minimal regulatory element of the WASP gene. These vectors, harboring two distinct transgenes, were tested in a variety of human haematopoietic cell lines as well as in primary human CD34(+) cells in comparison with the FUIGW vector that contains the expression cassette UBC-transgene-IRES-EGFP. In these experiments both UMG-LV5 and UMG-LV6 yielded moderately lower transgene expression than FUIGW, but dramatically higher levels of EGFP, thereby allowing the easy distinction between transduced and non-transduced cells. An additional construct was produced, in which the cDNA encoding the reporter protein is upstream, and the transgene downstream of the IRES sequence. This vector, named UMG-LV11, proved able to promote abundant expression of both transgene product and EGFP in all cells tested. The UMG-LVs represent therefore useful vectors for gene transfer-based studies in hematopoietic stem and progenitor cells, as well as in non-hematopoietic cells.	[Chiarella, Emanuela; Carra, Giovanna; Scicchitano, Stefania; Codispoti, Bruna; Mega, Tiziana; Lupia, Michela; Pelaggi, Daniela; Marafioti, Maria G.; Aloisio, Annamaria; Giordano, Marco; Nappo, Giovanna; Spoleti, Cristina B.; Grillone, Teresa; Spina, Raffaella; Bernaudo, Francesca; Bond, Heather M.; Mesuraca, Maria; Morrone, Giovanni] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Lab Mol Haematopoiesis & Stem Cell Biol, I-88100 Catanzaro, Italy; [Giovannone, Emilia D.] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Mol Oncol Lab, I-88100 Catanzaro, Italy; [Moore, Malcolm A. S.] Mem Sloan Kettering Canc Ctr, Dept Cell Biol, New York, NY 10065 USA	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Memorial Sloan Kettering Cancer Center	Mesuraca, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Lab Mol Haematopoiesis & Stem Cell Biol, I-88100 Catanzaro, Italy.	mes@unicz.it; morrone@unicz.it	Carrà, Giovanna/ABF-4205-2020; Chiarella, Emanuela/H-4665-2018; Scicchitano, Stefania/AAG-4643-2021; Giordano, Marco/AAO-6102-2020; Lupia, Michela/AAP-2653-2020; Morrone, Giovanni/A-7202-2008	Carrà, Giovanna/0000-0002-6263-6800; Chiarella, Emanuela/0000-0002-8314-715X; Giordano, Marco/0000-0001-6335-0030; Morrone, Giovanni/0000-0002-1978-340X; GIOVANNONE, EMILIA DORA/0000-0002-3549-1415; Bond, Heather Mandy/0000-0003-4033-2985; Codispoti, Bruna/0000-0001-8802-3546; MESURACA, Maria/0000-0002-5455-168X; Scicchitano, Stefania/0000-0002-3566-7214	Ministero dell'Istruzione, Universita e Ricerca (MIUR) - Progetti di ricerca di interesse nazionale (PRIN); Associazione Italiana per la Ricerca sul Cancro (AIRC); Gar-Reichman Cancer Research Institute Fund; Rudin Foundation; AIRC post-doctoral fellowship; Molecular Oncology Programme; POR Calabria FSE [1007-2013]; Prometeo training fellowship [PON01_2834];  [PON01_2834 Prometeo];  [PON03PE_00009_2 ICaRe]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Ministero dell'Istruzione, Universita e Ricerca (MIUR) - Progetti di ricerca di interesse nazionale (PRIN); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Gar-Reichman Cancer Research Institute Fund; Rudin Foundation; AIRC post-doctoral fellowship(Fondazione AIRC per la ricerca sul cancro); Molecular Oncology Programme; POR Calabria FSE(Regione Calabria); Prometeo training fellowship; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ministero dell'Istruzione, Universita e Ricerca (MIUR) - Progetti di ricerca di interesse nazionale (PRIN) to GM and HMB; Associazione Italiana per la Ricerca sul Cancro (AIRC) to GM; PON01_2834 Prometeo to GM; PON03PE_00009_2 ICaRe to GM; Gar-Reichman Cancer Research Institute Fund and Rudin Foundation to MASM; AIRC post-doctoral fellowship to TM; PhD fellowships from the Molecular Oncology Programme to FB, BC, EC, ML, GN, RS and SS; POR Calabria FSE 1007-2013 "HEMMAS" post-doctoral fellowship to MG; PON01_2834 Prometeo training fellowship to MGM, AA, CBS and TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Bond HM, 2004, BLOOD, V103, P2062, DOI 10.1182/blood-2003-07-2388; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Chung KY, 2005, BLOOD, V105, P77, DOI 10.1182/blood-2003-12-4445; Curtin JA, 2008, GENE THER, V15, P384, DOI 10.1038/sj.gt.3303105; de Andres-Aguayo L, 2011, BLOOD, V118, P554, DOI 10.1182/blood-2010-12-322081; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Giordano V, 1997, J IMMUNOL, V158, P4097; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Horton SJ, 2013, LEUKEMIA, V27, P1116, DOI 10.1038/leu.2012.343; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kiviranta R, 2013, J EXP MED, V210, P969, DOI 10.1084/jem.20121187; La Rocca R, 2009, J IMMUNOL, V182, P4529, DOI 10.4049/jimmunol.0802109; Leuci V, 2009, STEM CELLS, V27, P2815, DOI 10.1002/stem.224; Logan AC, 2002, CURR OPIN BIOTECH, V13, P429, DOI 10.1016/S0958-1669(02)00346-4; Mega T, 2011, CELL CYCLE, V10, P2129, DOI 10.4161/cc.10.13.16045; Mesuraca M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/318793; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; Petrella A, 1998, BLOOD, V91, P4554, DOI 10.1182/blood.V91.12.4554.412k26_4554_4560; Rizo A, 2010, BLOOD, V116, P4621, DOI 10.1182/blood-2010-02-270660; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Scherr Michaela, 2002, Current Gene Therapy, V2, P45, DOI 10.2174/1566523023348237; Schuringa JJ, 2004, J EXP MED, V200, P623, DOI 10.1084/jem.20041024; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Spina R, 2013, ONCOTARGET, V4, P1280, DOI 10.18632/oncotarget.1176; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wunderlich M, 2006, BLOOD, V108, P1690, DOI 10.1182/blood-2005-12-012773; Ye Q, 2004, LEUKEMIA, V18, P777, DOI 10.1038/sj.leu.2403291; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7	37	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114795	10.1371/journal.pone.0114795	http://dx.doi.org/10.1371/journal.pone.0114795			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502183	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400053
J	Swaminathan, B; Goikuria, H; Vega, R; Rodriguez-Antigudad, A; Medina, AL; Freijo, MD; Vandenbroeck, K; Alloza, I				Swaminathan, Bhairavi; Goikuria, Haize; Vega, Reyes; Rodriguez-Antiguedad, Alfredo; Lopez Medina, Antonio; del Mar Freijo, Maria; Vandenbroeck, Koen; Alloza, Iraide			Autophagic Marker MAP1LC3B Expression Levels Are Associated with Carotid Atherosclerosis Symptomatology	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE PROTEIN; PLAQUE; HMGB1; ATHEROGENESIS; INFLAMMATION; DISEASES; AREAS	Objectives: The mechanism by which atheroma plaque becomes unstable is not completely understood to date but analysis of differentially expressed genes in stable versus unstable plaques may provide clues. This will be crucial toward disclosing the mechanistic basis of plaque instability, and may help to identify prognostic biomarkers for ischaemic events. The objective of our study was to identify differences in expression levels of 59 selected genes between symptomatic patients (unstable plaques) and asymptomatic patients (stable plaques). Methods: 80 carotid plaques obtained by carotid endarterectomy and classified as symptomatic (>70% stenosis) or asymptomatic (>80% stenosis) were used in this study. The expression levels of 59 genes were quantified by qPCR on RNA extracted from the carotid plaques obtained by endarterectomy and analyzed by means of various bioinformatic tools. Results: Several genes associated with autophagy pathways displayed differential expression levels between asymptomatic and symptomatic (i.e. MAP1LC3B, RAB24, EVA1A). In particular, mRNA levels of MAP1LC3B, an autophagic marker, showed a 5-fold decrease in symptomatic samples, which was confirmed in protein blots. Immune system-related factors and endoplasmic reticulum-associated markers (i.e. ERP27, ITPR1, ERO1LB, TIMP1, IL12B) emerged as differently expressed genes between asymptomatic and symptomatic patients. Conclusions: Carotid atherosclerotic plaques in which MAP1LC3B is underexpressed would not be able to benefit from MAP1LC3B-associated autophagy. This may lead to accumulation of dead cells at lesion site with subsequent plaque destabilization leading to cerebrovascular events. Identified biomarkers and network interactions may represent novel targets for development of treatments against plaque destabilization and thus for the prevention of cerebrovascular events.	[Swaminathan, Bhairavi; Goikuria, Haize; Vandenbroeck, Koen; Alloza, Iraide] Univ Basque Country, Fac Med & Odontol, Dept Neurosci, Leioa, Spain; [Vandenbroeck, Koen; Alloza, Iraide] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Goikuria, Haize; Vandenbroeck, Koen; Alloza, Iraide] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Vega, Reyes; Rodriguez-Antiguedad, Alfredo; Lopez Medina, Antonio; del Mar Freijo, Maria] Basurto Hosp, Dept Neurol, Bilbao, Spain	University of Basque Country; Basque Foundation for Science; Basurto Hospital	Alloza, I (corresponding author), Univ Basque Country, Fac Med & Odontol, Dept Neurosci, Leioa, Spain.	iraide.alloza@ehu.es	Vandenbroeck, Koen/D-6845-2012; Rodriguez-Antigüedad, Alfredo/AAT-1760-2021	Vandenbroeck, Koen/0000-0002-6967-6485; Alloza, Iraide/0000-0002-8949-7732; Rodriguez-Antiguedad, Alfredo/0000-0001-5975-725X	Basque Government (Proyectos de Investigacion Sanitaria) [2008111024]; Basque Government (Grupos de Investigacion del Sistema Universitario Vasco) [IT512-10]	Basque Government (Proyectos de Investigacion Sanitaria)(Basque Government); Basque Government (Grupos de Investigacion del Sistema Universitario Vasco)(Basque Government)	This work was supported by grants from the Basque Government (Proyectos de Investigacion Sanitaria; ref. 2008111024) (http://www.osasun.ejgv.euskadi.net) and from the Basque Government (Grupos de Investigacion del Sistema Universitario Vasco; ref. IT512-10 (http://www.hezkuntza.ejgv.euskadi.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Bjornheden T, 1999, ARTERIOSCL THROM VAS, V19, P870, DOI 10.1161/01.ATV.19.4.870; Chen SA, 2010, J INNATE IMMUN, V2, P325, DOI 10.1159/000314626; Danzaki K, 2012, ARTERIOSCL THROM VAS, V32, P273, DOI 10.1161/ATVBAHA.111.229997; de Souza AWS, 2012, AUTOIMMUN REV, V11, P909, DOI 10.1016/j.autrev.2012.03.007; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083119; Duan XH, 2009, BIOCHEM BIOPH RES CO, V387, P694, DOI 10.1016/j.bbrc.2009.07.085; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hennerici MG, 2004, CEREBROVASC DIS, V17, P17, DOI 10.1159/000075300; Ijas P, 2007, ARTERIOSCL THROM VAS, V27, P154, DOI 10.1161/01.ATV.0000251991.64617.e7; Kowala M C, 1997, Adv Pharmacol, V37, P299; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Li L, 2012, EXP NEUROL, V234, P181, DOI 10.1016/j.expneurol.2011.12.038; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malaud E, 2014, ATHEROSCLEROSIS, V233, P551, DOI 10.1016/j.atherosclerosis.2013.12.019; Martinet W, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0321-1; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mehta TA, 2005, EUR J VASC ENDOVASC, V29, P395, DOI 10.1016/j.ejvs.2005.01.005; Morgan AR, 2004, STROKE, V35, P1310, DOI 10.1161/01.STR.0000126822.01756.99; Munafo DB, 2002, TRAFFIC, V3, P472, DOI 10.1034/j.1600-0854.2002.30704.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Paschen W, 1996, MED HYPOTHESES, V47, P283, DOI 10.1016/S0306-9877(96)90068-7; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Robert L, 1998, ATHEROSCLEROSIS, V140, P281, DOI 10.1016/S0021-9150(98)00171-3; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Saksi J, 2011, J MOL MED, V89, P1015, DOI 10.1007/s00109-011-0773-z; Schrijvers DM, 2011, ARTERIOSCL THROM VAS, V31, P2787, DOI 10.1161/ATVBAHA.111.224899; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stenina OI, 2008, CIRC RES, V103, P1053, DOI 10.1161/CIRCRESAHA.108.188870; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Tang DL, 2010, J CELL BIOL, V190, P881, DOI 10.1083/jcb.200911078; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang L, 2007, APOPTOSIS, V12, P1489, DOI 10.1007/s10495-007-0073-9; Wei K, 2012, CNS NEUROSCI THER, V18, P879, DOI 10.1111/cns.12005	49	28	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115176	10.1371/journal.pone.0115176	http://dx.doi.org/10.1371/journal.pone.0115176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25503069	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400079
J	Xu, X; Variyam, JN; Zhao, ZX; Chaloupka, FJ				Xu, Xin; Variyam, Jayachandran N.; Zhao, Zhenxiang; Chaloupka, Frank J.			Relative Food Prices and Obesity in US Metropolitan Areas: 1976-2001	PLOS ONE			English	Article							BODY-MASS INDEX; DIETARY ENERGY DENSITY; ADULT OBESITY; TIME-SERIES; PHYSICAL-ACTIVITY; PANEL-DATA; ENVIRONMENT; PREVALENCE; WEIGHT; CONSUMPTION	This study investigates the impact of food price on obesity, by exploring the co-occurrence of obesity growth with relative food price reduction between 1976 and 2001. Analyses control for female labor participation and metropolitan outlet densities that might affect body weight. Both the first-difference and fixed effects approaches provide consistent evidence suggesting that relative food prices have substantial impacts on obesity and such impacts were more pronounced among the low-educated. These findings imply that relative food price reductions during the time period could plausibly explain about 18% of the increase in obesity among the U.S. adults in metropolitan areas.	[Xu, Xin; Zhao, Zhenxiang] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA; [Variyam, Jayachandran N.] USDA, Econ Res Serv, Food Econ Div, Washington, DE USA; [Chaloupka, Frank J.] Univ Illinois, Natl Bur Econ Res, Inst Hlth Res & Policy, Dept Econ, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; United States Department of Agriculture (USDA); National Bureau of Economic Research; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Xu, X (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA.	xxu11@uic.edu		Xu, Xin/0000-0002-5219-499X; Variyam, Jayachandran/0000-0001-5358-2209	United States Department of Agriculture-Economic Research Service Cooperative Agreement [58-4000-9-0047]	United States Department of Agriculture-Economic Research Service Cooperative Agreement	Research for this study was supported by United States Department of Agriculture-Economic Research Service Cooperative Agreement No. 58-4000-9-0047. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Antman F, 2007, ECON DEV CULT CHANGE, V56, P125, DOI 10.1086/520561; Auld MC, 2009, ECONOMICA, V76, P719, DOI 10.1111/j.1468-0335.2008.00709.x; Beydoun MA, 2008, SOC SCI MED, V66, P2218, DOI 10.1016/j.socscimed.2008.01.018; Beydoun MA, 2011, J NUTR, V141, P304, DOI 10.3945/jn.110.132613; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; BLUNDELL R, 1993, J ECONOMETRICS, V59, P137, DOI 10.1016/0304-4076(93)90043-5; Brown M. G., 2008, Journal of Agricultural and Applied Economics, V40, P593; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; Chou SY, 2004, J HEALTH ECON, V23, P565, DOI 10.1016/j.jhealeco.2003.10.003; CORNWELL C, 1994, REV ECON STAT, V76, P360, DOI 10.2307/2109893; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Dalton M, 2013, OBESITY FACTS, V6, P348, DOI 10.1159/000354599; Dargay JM, 1999, J TRANSP ECON POLICY, V33, P287; DEATON A, 1985, J ECONOMETRICS, V30, P109, DOI 10.1016/0304-4076(85)90134-4; Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Duffey KJ, 2010, ARCH INTERN MED, V170, P420, DOI 10.1001/archinternmed.2009.545; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gardes F, 2005, J BUS ECON STAT, V23, P242, DOI 10.1198/073500104000000587; Gelbach J., 2007, 261 COLL LAW; Goldman D., 2011, FOOD PRICES DYNAMICS; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Grossman M, 2014, ECON HUM BIOL, V12, P4, DOI 10.1016/j.ehb.2013.10.003; Gustafson A, 2012, J COMMUN HEALTH, V37, P897, DOI 10.1007/s10900-011-9524-x; Han E, 2011, PUBLIC HEALTH, V125, P129, DOI 10.1016/j.puhe.2010.11.014; Han EN, 2013, CONTEMP ECON POLICY, V31, P528, DOI 10.1111/j.1465-7287.2012.00322.x; Heshmati A, 1997, J AGR ECON, V48, P22, DOI 10.1111/j.1477-9552.1997.tb01128.x; Inagami S, 2006, AM J PREV MED, V31, P10, DOI 10.1016/j.amepre.2006.03.019; Jeffery RW, 2007, DIABETES, V56, P2673, DOI 10.2337/db07-1029; Jetter KM, 2006, AM J PREV MED, V30, P38, DOI 10.1016/j.amepre.2005.08.039; Jue JJS, 2012, PREV MED, V55, P629, DOI 10.1016/j.ypmed.2012.10.009; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Lakdawalla D, 2005, AM ECON REV, V95, P253, DOI 10.1257/000282805774670266; Maddock J, 2004, AM J HEALTH PROMOT, V19, P137, DOI 10.4278/0890-1171-19.2.137; Meng Y, 2014, J HLTH EC; Meyer KA, 2014, JAMA INTERN MED, V174, P434, DOI 10.1001/jamainternmed.2013.13922; Mijkovic D, 2008, AGR ECON-BLACKWELL, V38, P375, DOI 10.1111/j.1574-0862.2008.00307.x; Mobley LR, 2006, AM J PREV MED, V30, P327, DOI 10.1016/j.amepre.2005.12.001; MOFFITT R, 1993, J ECONOMETRICS, V59, P99, DOI 10.1016/0304-4076(93)90041-3; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morrissey TW, 2014, PEDIATRICS, V133, P422, DOI 10.1542/peds.2013-1963; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007; Powell LM, 2011, AM J AGR ECON, V93, P378, DOI 10.1093/ajae/aaq106; Powell LM, 2009, J HEALTH ECON, V28, P963, DOI 10.1016/j.jhealeco.2009.06.009; Powell LM, 2009, ECON HUM BIOL, V7, P64, DOI 10.1016/j.ehb.2009.01.004; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Powell LM, 2006, ADV HEALTH ECON HEAL, V17, P23, DOI 10.1016/S0731-2199(06)17002-8; Richards TJ, 2007, CONTEMP ECON POLICY, V25, P309, DOI 10.1111/j.1465-7287.2007.00047.x; Schroeter C, 2008, J HEALTH ECON, V27, P45, DOI 10.1016/j.jhealeco.2007.04.001; Smith T.A., 2010, TAXING CALORIC SWEET; Stafford M, 2007, SOC SCI MED, V65, P1882, DOI 10.1016/j.socscimed.2007.05.042; Sturm R, 2008, PUBLIC HEALTH, V122, P1140, DOI 10.1016/j.puhe.2008.04.001; Sturm R, 2005, PUBLIC HEALTH, V119, P1059, DOI 10.1016/j.puhe.2005.05.007; Sturm R, 2011, PUBLIC HEALTH, V125, P136, DOI 10.1016/j.puhe.2010.11.016; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; VERBEEK M, 1993, J ECONOMETRICS, V59, P125, DOI 10.1016/0304-4076(93)90042-4; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zheng Y. Q., 2008, Journal of Agricultural and Applied Economics, V40, P837; Zheng YQ, 2010, APPL ECON, V42, P1601, DOI 10.1080/00036840701721570	69	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114707	10.1371/journal.pone.0114707	http://dx.doi.org/10.1371/journal.pone.0114707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW6JI	25502888	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400045
J	Lv, MM; Zhu, XY; Wang, H; Wang, F; Guan, WX				Lv, Mengmeng; Zhu, Xingya; Wang, Hao; Wang, Feng; Guan, Wenxian			Roles of Caloric Restriction, Ketogenic Diet and Intermittent Fasting during Initiation, Progression and Metastasis of Cancer in Animal Models: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR-I; FACTOR-BINDING PROTEIN-3; DISEASE RISK MARKERS; SKIN TUMOR PROMOTION; C-REACTIVE PROTEIN; PROSTATE-CANCER; ENERGY RESTRICTION; WEIGHT-LOSS; MAMMARY CARCINOGENESIS	Background: The role of dietary restriction regimens such as caloric restriction, ketogenic diet and intermittent fasting in development of cancers has been detected via abundant preclinical experiments. However, the conclusions are controversial. We aim to review the relevant animal studies systematically and provide assistance for further clinical studies. Methods: Literatures on associations between dietary restriction and cancer published in PubMed in recent twenty years were comprehensively searched. Animal model, tumor type, feeding regimen, study length, sample size, major outcome, conclusion, quality assessment score and the interferential step of cancer were extracted from each eligible study. We analyzed the tumor incidence rates from 21 studies about caloric restriction. Results: Fifty-nine studies were involved in our system review. The involved studies explored roles of dietary restriction during initiation, progression and metastasis of cancer. About 90.9% of the relevant studies showed that caloric restriction plays an anti-cancer role, with the pooled OR (95% CI) of 0.20 (0.12, 0.34) relative to controls. Ketogenic diet was also positively associated with cancer, which was indicated by eight of the nine studies. However, 37.5% of the related studies obtained a negative conclusion that intermittent fasting was not significantly preventive against cancer. Conclusions: Caloric restriction and ketogenic diet are effective against cancer in animal experiments while the role of intermittent fasting is doubtful and still needs exploration. More clinical experiments are needed and more suitable patterns for humans should be investigated.	[Lv, Mengmeng] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Lv, Mengmeng] Nanjing Med Univ, Clin Sch 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Xingya] Nanjing Med Univ, Gulou Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zhu, Xingya; Wang, Hao; Wang, Feng; Guan, Wenxian] Nanjing Univ, Nanjing Gulou Hosp, Coll Med, Dept Gastrointestinal Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University	Guan, WX (corresponding author), Nanjing Univ, Nanjing Gulou Hosp, Coll Med, Dept Gastrointestinal Surg, Nanjing 210008, Jiangsu, Peoples R China.	guanwx810@126.com						Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Birt DF, 1997, CARCINOGENESIS, V18, P2107, DOI 10.1093/carcin/18.11.2107; Blando J, 2011, CANCER PREV RES, V4, P2002, DOI 10.1158/1940-6207.CAPR-11-0182; Boileau TWM, 2003, JNCI-J NATL CANCER I, V95, P1578, DOI 10.1093/jnci/djg081; Bonorden MJL, 2009, NUTR CANCER, V61, P265, DOI 10.1080/01635580802419798; Buschemeyer WC, 2010, PROSTATE, V70, P1037, DOI 10.1002/pros.21136; Carver DK, 2011, CANCER PREV RES, V4, P562, DOI 10.1158/1940-6207.CAPR-10-0294; Cava E, 2013, AGING-US, V5, P507, DOI 10.18632/aging.100581; Cleary MP, 2007, EXP BIOL MED, V232, P70; Cleary Margot P, 2011, J Carcinog, V10, P21, DOI 10.4103/1477-3163.85181; Coffer PJ, 2009, CELL RES, V19, P797, DOI 10.1038/cr.2009.81; De Lorenzo MS, 2011, CARCINOGENESIS, V32, P1381, DOI 10.1093/carcin/bgr107; Dirx MJM, 2003, INT J CANCER, V106, P766, DOI 10.1002/ijc.11277; Dogan S, 2010, ONCOL LETT, V1, P167, DOI 10.3892/ol_00000031; Dunlap SM, 2012, CANCER PREV RES, V5, P930, DOI 10.1158/1940-6207.CAPR-12-0034; Dunn SE, 1997, CANCER RES, V57, P4667; ENGELMAN RW, 1994, CANCER RES, V54, P5724; Eslami S, 2012, BIOIMPACTS, V2, P213, DOI 10.5681/bi.2012.028; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Freedland SJ, 2008, PROSTATE, V68, P11, DOI 10.1002/pros.20683; Galet C, 2013, INT J MOL SCI, V14, P13782, DOI 10.3390/ijms140713782; Gillette CA, 1997, CARCINOGENESIS, V18, P1183, DOI 10.1093/carcin/18.6.1183; Golan T, 2011, ONCOLOGY-NY, V25, P518; Harvey AE, 2013, MOL CARCINOGEN, V52, P997, DOI 10.1002/mc.21940; Harvie MN, 2011, INT J OBESITY, V35, P714, DOI 10.1038/ijo.2010.171; Harvie M, 2013, BRIT J NUTR, V110, P1534, DOI 10.1017/S0007114513000792; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973; Hursting SD, 1997, CANCER RES, V57, P2843; Hursting SD, 2010, CARCINOGENESIS, V31, P83, DOI 10.1093/carcin/bgp280; Imayama I, 2012, CANCER RES, V72, P2314, DOI 10.1158/0008-5472.CAN-11-3092; JAMES SJ, 1994, CANCER RES, V54, P5508; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Jiang YS, 2013, J NEURO-ONCOL, V114, P25, DOI 10.1007/s11060-013-1154-y; Kandori H, 2005, CANCER SCI, V96, P221, DOI 10.1111/j.1349-7006.2005.00041.x; Lanza-Jacoby S, 2013, EXP BIOL MED, V238, P787, DOI 10.1177/1535370213493727; Lashinger LM, 2011, CANCER PREV RES, V4, P1041, DOI 10.1158/1940-6207.CAPR-11-0023; Lashinger LM, 2011, CANCER PREV RES, V4, P1030, DOI 10.1158/1940-6207.CAPR-11-0027; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Liu B, 2007, ONCOGENE, V26, P1811, DOI 10.1038/sj.onc.1209977; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Mai V, 2003, CANCER RES, V63, P1752; Maroon J, 2013, J CHILD NEUROL, V28, P1002, DOI 10.1177/0883073813488670; Marsh J, 2008, CLIN CANCER RES, V14, P7751, DOI 10.1158/1078-0432.CCR-08-0213; Martin-Montalvo A, 2011, ONCOGENE, V30, P505, DOI 10.1038/onc.2010.492; Mason C, 2013, CANCER EPIDEM BIOMAR, V22, P1457, DOI 10.1158/1055-9965.EPI-13-0337; Mavropoulos JC, 2009, CANCER PREV RES, V2, P557, DOI 10.1158/1940-6207.CAPR-08-0188; McCormick DL, 2007, NUTR CANCER, V57, P194, DOI 10.1080/01635580701277494; Mizuno NK, 2013, CANCER PREV RES, V6, P540, DOI 10.1158/1940-6207.CAPR-13-0033; Moore T, 2012, CANCER PREV RES, V5, P1236, DOI 10.1158/1940-6207.CAPR-12-0234; Mulrooney TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018085; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Nogueira LM, 2012, ENDOCR-RELAT CANCER, V19, P57, DOI 10.1530/ERC-11-0213; Ong KR, 2009, CANCER PREV RES, V2, P720, DOI 10.1158/1940-6207.CAPR-09-0008; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Pape-Ansorge KA, 2002, NUTR CANCER, V44, P161, DOI 10.1207/S15327914NC4402_07; Phoenix KN, 2010, BREAST CANCER RES TR, V123, P333, DOI 10.1007/s10549-009-0647-z; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Rocha NS, 2002, TERATOGEN CARCIN MUT, V22, P129, DOI 10.1002/tcm.10005; Rogozina OP, 2013, BREAST CANCER RES TR, V138, P395, DOI 10.1007/s10549-013-2464-7; Rowlands MA, 2012, CANCER RES, V72, P503, DOI 10.1158/0008-5472.CAN-11-1601; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Saleh AD, 2013, CELL CYCLE, V12, P1955, DOI 10.4161/cc.25016; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Seyfried BTN, 2009, J CANCER RES THER, V5, P7, DOI 10.4103/0973-1482.55134; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shelton LM, 2010, ASN NEURO, V2, DOI 10.1042/AN20100002; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Simone BA, 2013, FUTURE ONCOL, V9, P959, DOI [10.2217/fon.13.31, 10.2217/FON.13.31]; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Stewart JW, 2005, CARCINOGENESIS, V26, P1077, DOI 10.1093/carcin/bgi051; Suttie AW, 2005, TOXICOL PATHOL, V33, P386, DOI 10.1080/01926230590930272; Tagliaferro AR, 1996, J NUTR, V126, P1398, DOI 10.1093/jn/126.5.1398; Thomas JA, 2010, PROSTATE CANCER P D, V13, P350, DOI 10.1038/pcan.2010.24; Thompson HJ, 2004, CANCER RES, V64, P5643, DOI 10.1158/0008-5472.CAN-04-0787; Tomasi C, 1999, CARCINOGENESIS, V20, P1979, DOI 10.1093/carcin/20.10.1979; Tomita Mariko, 2012, J Carcinog, V11, P10, DOI 10.4103/1477-3163.99176; Tsao JL, 2002, CARCINOGENESIS, V23, P1807, DOI 10.1093/carcin/23.11.1807; van Ginhoven TM, 2010, J SURG ONCOL, V102, P348, DOI 10.1002/jso.21649; VonTungeln LS, 1996, CANCER LETT, V104, P133, DOI 10.1016/0304-3835(96)04232-2; Wang T, 2011, CANCER EPIDEM BIOMAR, V20, P971, DOI 10.1158/1055-9965.EPI-10-1222; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Wright JL, 2013, PROSTATE, V73, P1345, DOI 10.1002/pros.22682; Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071	88	122	123	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e115147	10.1371/journal.pone.0115147	http://dx.doi.org/10.1371/journal.pone.0115147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502434	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700093
J	Rihani, A; De Wilde, B; Zeka, F; Laureys, G; Francotte, N; Tonini, GP; Coco, S; Versteeg, R; Noguera, R; Schulte, JH; Eggert, A; Stallings, RL; Speleman, F; Vandesompele, J; Van Maerken, T				Rihani, Ali; De Wilde, Bram; Zeka, Fjoralba; Laureys, Genevieve; Francotte, Nadine; Tonini, Gian Paolo; Coco, Simona; Versteeg, Rogier; Noguera, Rosa; Schulte, Johannes H.; Eggert, Angelika; Stallings, Raymond L.; Speleman, Frank; Vandesompele, Jo; Van Maerken, Tom			CASP8 SNP D302H (rs1045485) Is Associated with Worse Survival in MYCN-Amplified Neuroblastoma Patients	PLOS ONE			English	Article							CANCER; P53; CASPASE-8; SUSCEPTIBILITY; PROGRESSION; GENOTYPE; PATHWAY; GENES	Background: Neuroblastoma is a pediatric cancer that exhibits a wide clinical spectrum ranging from spontaneous regression in low-risk patients to fatal disease in high-risk patients. The identification of single nucleotide polymorphisms (SNPs) may help explain the heterogeneity of neuroblastoma and assist in identifying patients at higher risk for poor survival. SNPs in the TP53 pathway are of special importance, as several studies have reported associations between TP53 pathway SNPs and cancer. Of note, less than 2% of neuroblastoma tumors have a TP53 mutation at diagnosis. Patients and Methods: We selected 21 of the most frequently studied SNPs in the TP53 pathway and evaluated their association with outcome in 500 neuroblastoma patients using TaqMan allelic discrimination assays. Results and Conclusion: We investigated the impact of 21 SNPs on overall survival, event-free survival, age at diagnosis, MYCN status, and stage of the disease in 500 neuroblastoma patients. A missense SNP in exon 10 of the CASP8 gene SNP D302H was associated with worse overall and event-free survival in patients with MYCN-amplified neuroblastoma tumors.	[Rihani, Ali; De Wilde, Bram; Zeka, Fjoralba; Speleman, Frank; Vandesompele, Jo; Van Maerken, Tom] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium; [Francotte, Nadine] CHC, Dept Pediat Hemato Oncol, SUHOPL, Serv Univ Hemato Oncol Pediat, St Nicolas, Belgium; [Tonini, Gian Paolo] Univ Padua, Fdn Citta Speranza, Pediat Res Inst, Dept Womens & Childrens Hlth,Neuroblastoma Lab,On, Padua, Italy; [Coco, Simona] Univ San Martino, Azienda Osped, IRCCS, IST Ist Nazl Ric Cancro,Lung Canc Unit, Genoa, Italy; [Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Noguera, Rosa] Univ Valencia, Sch Med, Dept Pathol, Valencia, Spain; [Schulte, Johannes H.] German Canc Consortium DKTK, Heidelberg, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Essen, Germany; [Schulte, Johannes H.] German Canc Res Ctr, Heidelberg, Germany; [Schulte, Johannes H.; Eggert, Angelika] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany; [Schulte, Johannes H.] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany; [Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Stallings, Raymond L.] Natl childrens Res Ctr, Dublin, Ireland	Ghent University; Ghent University; Ghent University Hospital; Fondazione Citta della Speranza; University of Padua; University of Genoa; IRCCS AOU San Martino IST; University of Amsterdam; Academic Medical Center Amsterdam; University of Valencia; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Duisburg Essen; Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Trinity College Dublin	Van Maerken, T (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.	Tom.VanMaerken@UGent.be	Stallings, Raymond/A-7213-2008; Rihani, Ali/R-6608-2019; Schulte, Johannes H./V-2474-2018; speleman, frank/AAR-5184-2020; Coco, Simona/J-6051-2016; Eggert, Angelika/AAE-6907-2022; Vandesompele, Jo/W-3411-2018; laureys, genevieve/AAG-2390-2021; Versteeg, Rogier/AAQ-1765-2020	Rihani, Ali/0000-0002-6176-0519; speleman, frank/0000-0002-6628-8559; Coco, Simona/0000-0002-5296-4325; Eggert, Angelika/0000-0003-3476-8184; Vandesompele, Jo/0000-0001-6274-0184; De Wilde, Bram/0000-0003-0213-1322; Schulte, Johannes Hubertus/0000-0003-0671-1201; Versteeg, Rogier/0000-0001-7172-0388	Ghent University research fund (BOF) [01D02210]; FWO [12B9912N]; FIS [PI10/15]; RTICC [RD06/0020/0102, RD12/0036/0020]; Instituto Carlos III Madrid ERDF, Spain; BOF; Childhood Cancer Fund; National Cancer Plan of the Belgian State [29]	Ghent University research fund (BOF)(Ghent University); FWO(FWO); FIS(Instituto de Salud Carlos III); RTICC(Instituto de Salud Carlos III); Instituto Carlos III Madrid ERDF, Spain; BOF; Childhood Cancer Fund; National Cancer Plan of the Belgian State	AR is supported by a PhD fellowship from the Ghent University research fund (BOF; 01D02210). TVM is a postdoctoral fellow of the FWO (12B9912N). RN is supported by FIS (contract PI10/15) and RTICC (contracts RD06/0020/0102; RD12/0036/0020), Instituto Carlos III Madrid & ERDF, Spain. Italian Neuroblastoma Foundation supported the Italian samples collection and preparation. This work was supported by the BOF, the FWO, the Childhood Cancer Fund, and the National Cancer Plan of the Belgian State (Action 29). The study sponsors have no role in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.	Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Dai ZY, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-24; Decock A, 2011, EPIGENETICS-US, V6, P962, DOI 10.4161/epi.6.8.16516; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Grochola LF, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001032; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Kamimatsuse A, 2009, PEDIATR BLOOD CANCER, V52, P777, DOI 10.1002/pbc.21977; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Paulin FEM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-281; Perfumo C, 2008, EUR J CANCER, V44, P2634, DOI 10.1016/j.ejca.2008.08.018; Perfumo C, 2009, PEDIATR BLOOD CANCER, V53, P576, DOI 10.1002/pbc.22132; Rihani A, 2014, PEDIATR BLOOD CANCER, V61, P1867, DOI 10.1002/pbc.24927; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Stacey SN, 2011, NAT GENET, V43, P1098, DOI 10.1038/ng.926; Stupack DG, 2013, CANCER LETT, V332, P133, DOI 10.1016/j.canlet.2010.07.022; Takita J, 2001, ONCOGENE, V20, P4424, DOI 10.1038/sj.onc.1204521; Teitz T, 2013, CANCER RES, V73, P4086, DOI 10.1158/0008-5472.CAN-12-2681; Tweddle DA, 2001, CANCER RES, V61, P8; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; van Noesel MM, 2003, CANCER LETT, V197, P165, DOI 10.1016/S0304-3835(03)00101-0; Vazquez A, 2010, CANCER RES, V70, P172, DOI 10.1158/0008-5472.CAN-09-2218; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wynendaele J, 2010, CANCER RES, V70, P9641, DOI 10.1158/0008-5472.CAN-10-0527	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114696	10.1371/journal.pone.0114696	http://dx.doi.org/10.1371/journal.pone.0114696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502557	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700045
J	Gory-Faure, S; Windscheid, V; Brocard, J; Montessuit, S; Tsutsumi, R; Denarier, E; Fukata, Y; Bosc, C; Delaroche, J; Collomb, N; Fukata, M; Martinou, JC; Pernet-Gallay, K; Andrieux, A				Gory-Faure, Sylvie; Windscheid, Vanessa; Brocard, Jacques; Montessuit, Sylvie; Tsutsumi, Ryouhei; Denarier, Eric; Fukata, Yuko; Bosc, Christophe; Delaroche, Julie; Collomb, Nora; Fukata, Masaki; Martinou, Jean-Claude; Pernet-Gallay, Karin; Andrieux, Annie			Non-Microtubular Localizations of Microtubule-Associated Protein 6 (MAP6)	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; ABNORMAL INTERACTION; GOLGI LOCALIZATION; STOP PROTEIN; TAU-PROTEIN; RICH DOMAIN; MOUSE; ACTIN; STABILITY; INTERACTS	MAP6 proteins (MAP6s), which include MAP6-N (also called Stable Tubule Only Polypeptide, or STOP) and MAP6d1 (MAP6 domain-containing protein 1, also called STOP-Like protein 21 kD, or SL21), bind to and stabilize microtubules. MAP6 deletion in mice severely alters integrated brain functions and is associated with synaptic defects, suggesting that MAP6s may also have alternative cellular roles. MAP6s reportedly associate with the Golgi apparatus through palmitoylation of their N-terminal domain, and specific isoforms have been shown to bind actin. Here, we use heterologous systems to investigate several biochemical properties of MAP6 proteins. We demonstrate that the three N-terminal cysteines of MAP6d1 are palmitoylated by a subset of DHHC-type palmitoylating enzymes. Analysis of the subcellular localization of palmitoylated MAP6d1, including electron microscopic analysis, reveals possible localization to the Golgi and the plasma membrane but no association with the endoplasmic reticulum. Moreover, we observed localization of MAP6d1 to mitochondria, which requires the N-terminus of the protein but does not require palmitoylation. We show that endogenous MAP6d1 localized at mitochondria in mature mice neurons as well as at the outer membrane and in the intermembrane space of purified mouse mitochondria. Last, we found that MAP6d1 can multimerize via a microtubule-binding module. Interestingly, most of these properties of MAP6d1 are shared by MAP6-N. Together, these results describe several properties of MAP6 proteins, including their intercellular localization and multimerization activity, which may be relevant to neuronal differentiation and synaptic functions.	[Gory-Faure, Sylvie; Windscheid, Vanessa; Brocard, Jacques; Denarier, Eric; Bosc, Christophe; Delaroche, Julie; Collomb, Nora; Pernet-Gallay, Karin; Andrieux, Annie] INSERM, U836, Grenoble, France; [Gory-Faure, Sylvie; Windscheid, Vanessa; Brocard, Jacques; Denarier, Eric; Bosc, Christophe; Delaroche, Julie; Collomb, Nora; Pernet-Gallay, Karin; Andrieux, Annie] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Montessuit, Sylvie; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, Geneva, Switzerland; [Tsutsumi, Ryouhei; Fukata, Masaki] Natl Inst Physiol Sci, Dept Cell Physiol, Div Membrane Physiol, Okazaki, Aichi, Japan; [Denarier, Eric; Andrieux, Annie] CEA, Inst Rech Technol & Sci Vivant, Grp Physiopathol Cytosquelette, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Geneva; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); CEA	Gory-Faure, S (corresponding author), INSERM, U836, BP170, Grenoble, France.	sylvie.gory-faure@ujf-grenoble.fr; annie.andrieux@ujf-grenoble.fr	Denarier, Eric/H-3555-2017; Bosc, Christophe/P-3401-2017; ANDRIEUX, ANNIE/B-2134-2017; Denarier, Eric/X-6137-2019; Bosc, Christophe/Q-8877-2019; Fukata, Masaki/AAZ-2476-2021; Brocard, Jacques/I-3135-2017	Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; ANDRIEUX, ANNIE/0000-0002-4022-6405; Denarier, Eric/0000-0002-4169-397X; Bosc, Christophe/0000-0002-3195-6692; Fukata, Masaki/0000-0001-5200-9806; Brocard, Jacques/0000-0002-0752-5737; Gory, Sylvie/0000-0001-5743-8079; PERNET GALLAY, Karin/0000-0003-3468-3316; Tsutsumi, Ryouhei/0000-0002-1704-0362; Fukata, Yuko/0000-0001-7724-8643; martinou, Jean-claude/0000-0002-9847-2051; Delaroche, Julie/0000-0003-2529-0270	INSERM; CEA; Grenoble Alpes University; French National Research Agency [2010Blan120201 CBioS]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CEA(French Atomic Energy Commission); Grenoble Alpes University; French National Research Agency(French National Research Agency (ANR))	This work was supported by INSERM, CEA, Grenoble Alpes University, and French National Research Agency Awards 2010Blan120201 CBioS (to AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguezzoul M, 2003, GENOMICS, V81, P623, DOI 10.1016/S0888-7543(03)00053-3; Amadoro G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.001; Arama J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035488; BAAS PW, 1991, J NEUROSCI RES, V30, P134, DOI 10.1002/jnr.490300115; Baratier J, 2006, J BIOL CHEM, V281, P19561, DOI 10.1074/jbc.M509602200; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Barth J, 2011, EXPERT REV PROTEOMIC, V8, P211, DOI [10.1586/EPR.11.7, 10.1586/epr.11.7]; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Boulay AC, 2013, BIOCHIMIE, V95, P799, DOI 10.1016/j.biochi.2012.11.016; Bouquet C, 2007, MOL CELL NEUROSCI, V36, P235, DOI 10.1016/j.mcn.2007.07.002; Brenner E, 2007, J NEUROSCI RES, V85, P3487, DOI 10.1002/jnr.21200; Chauvin S, 2008, BIOL CELL; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Chu CT, 2013, AUTOPHAGY, V10; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Couegnas A, 2007, J NEUROSCI RES, V85, P1515, DOI 10.1002/jnr.21278; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Da Cruz S, 2008, BBA-MOL CELL RES, V1783, P904, DOI 10.1016/j.bbamcr.2008.02.006; Delphin C, 2012, J BIOL CHEM, V287, P35127, DOI 10.1074/jbc.M112.398339; Denarier E, 1998, P NATL ACAD SCI USA, V95, P6055, DOI 10.1073/pnas.95.11.6055; Denarier E, 1998, BIOCHEM BIOPH RES CO, V243, P791, DOI 10.1006/bbrc.1998.8179; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DuBoff B, 2012, NEURON, V75, P618, DOI 10.1016/j.neuron.2012.06.026; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Farias GA, 2002, J CELL BIOCHEM, V85, P315, DOI 10.1002/jcb.10133; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Galiano MR, 2004, J NEUROSCI RES, V78, P329, DOI 10.1002/jnr.20260; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Gory-Faure S, 2006, J BIOL CHEM, V281, P28387, DOI 10.1074/jbc.M603380200; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; He HJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-81; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; JOB D, 1984, BIOCHEMISTRY-US, V23, P3025, DOI 10.1021/bi00308a028; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; PIROLLET F, 1992, BIOCHEMISTRY-US, V31, P8849, DOI 10.1021/bi00152a022; Roger B, 2004, CURR BIOL, V14, P363, DOI 10.1016/j.cub.2004.01.058; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; WEHLAND J, 1983, J CELL BIOL, V97, P1476, DOI 10.1083/jcb.97.5.1476; Yu JZ, 2006, FASEB J, V20, P1452, DOI 10.1096/fj.05-5206com	59	6	6	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e114905	10.1371/journal.pone.0114905	http://dx.doi.org/10.1371/journal.pone.0114905			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526643	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200009
J	Tsuber, V; Kadamov, Y; Tarasenko, L				Tsuber, Viktoriia; Kadamov, Yunus; Tarasenko, Lydia			Activation of Antioxidant Defenses in Whole Saliva by Psychosocial Stress Is More Manifested in Young Women than in Young Men	PLOS ONE			English	Article							SECRETORY IMMUNOGLOBULIN-A; ORAL ACADEMIC EXAMINATION; OXIDATIVE DNA-DAMAGE; SEX-DIFFERENCES; ALPHA-AMYLASE; PSYCHOLOGICAL STRESS; FREE-RADICALS; SIALIC-ACID; FLOW-RATE; SUPEROXIDE-DISMUTASE	Psychosocial stress has been long known to have deleterious effects on health. Nevertheless, an exposure to moderate stressors enhances resilience and promotes health benefits. Male and female organisms differ in many aspects of health and disease. The aim of this study was to investigate antioxidant activity and oxidative damage in saliva in a psychosocial stress paradigm in men and women. Here, we show that an acute stressor of moderate strength augments antioxidant activity and decreases oxidative damage in whole saliva of young people. An examination stress caused a significant increase of catalase activity, accompanied by a decrease of levels of oxidized proteins. Levels of thiobarbituric acid-reacting substances did not increase at stress, indicating that lipid peroxidation was not activated. The stress-induced alterations were more manifested in young women compared to young men. Thus, antioxidant protective mechanisms are more activated by a moderate stressor in young women than in young men.	[Tsuber, Viktoriia; Kadamov, Yunus; Tarasenko, Lydia] Ukrainian Med Stomatol Acad, Dept Med Bioorgan & Biol Chem, Poltava, Ukraine	Poltava State Medical University	Tsuber, V (corresponding author), Ukrainian Med Stomatol Acad, Dept Med Bioorgan & Biol Chem, Poltava, Ukraine.	victoriya.tsuber@gmail.com		Tsuber, Viktoriia/0000-0001-7362-7275				Amirmozafari Nour, 2013, J Oral Biol Craniofac Res, V3, P78, DOI 10.1016/j.jobcr.2013.05.004; Aschbacher K, 2013, PSYCHONEUROENDOCRINO; Azarbayjani MA, 2011, J HUM SPORT EXERC, V6, P385, DOI 10.4100/jhse.2011.62.19; Baggio G, 2013, CLIN CHEM LAB MED, V51, P713, DOI 10.1515/cclm-2012-0849; Bakke M, 2004, GERONTOLOGY, V50, P383, DOI 10.1159/000080176; BENARYEH H, 1986, BIOCHEM MED METAB B, V36, P260, DOI 10.1016/0885-4505(86)90134-9; Benschop RJ, 1996, FASEB J, V10, P517, DOI 10.1096/fasebj.10.4.8647351; Borras C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Bosch JA, 1996, PSYCHOSOM MED, V58, P374, DOI 10.1097/00006842-199607000-00010; Bradley MM, 2001, EMOTION, V1, P300, DOI 10.1037//1528-3542.1.3.300; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Buege J A, 1978, Methods Enzymol, V52, P302; Canli T, 2002, P NATL ACAD SCI USA, V99, P10789, DOI 10.1073/pnas.162356599; CECONI C, 1988, MOL CELL BIOCHEM, V81, P131; Chaplin TM, 2008, ALCOHOL CLIN EXP RES, V32, P1242, DOI 10.1111/j.1530-0277.2008.00679.x; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Forte LFDP, 2010, J ORAL PATHOL MED, V39, P765, DOI 10.1111/j.1600-0714.2010.00933.x; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Dhabhar FS, 2003, ANN NY ACAD SCI, V992, P205, DOI 10.1111/j.1749-6632.2003.tb03151.x; Eggers-Lura H, 1949, ENZYME SPEICHELS ZAH; Eguchi H, 2005, GLYCOBIOLOGY, V15, P1094, DOI 10.1093/glycob/cwj003; Erfani A, 2013, SPORT MED J, V35; Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; GRISHAM MB, 1987, AM J PHYSIOL, V253, pG93, DOI 10.1152/ajpgi.1987.253.1.G93; GUEMOURI L, 1991, CLIN CHEM, V37, P1932; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; HENRY RJ, 1957, ANAL CHEM, V29, P1491, DOI 10.1021/ac60130a028; HESS EL, 1957, J CLIN INVEST, V36, P449, DOI 10.1172/JCI103442; Hucklebridge F, 2000, BIOL PSYCHOL, V53, P25, DOI 10.1016/S0301-0511(00)00040-5; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Irie M, 2003, BIOCHEM BIOPH RES CO, V311, P1014, DOI 10.1016/j.bbrc.2003.10.105; Irie M, 2001, JPN J CANCER RES, V92, P367, DOI 10.1111/j.1349-7006.2001.tb01104.x; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kang DH, 1996, BRAIN BEHAV IMMUN, V10, P164, DOI 10.1006/brbi.1996.0015; KANNEL WB, 1976, ANN INTERN MED, V85, P447, DOI 10.7326/0003-4819-85-4-447; Kardash VV, 2003, CONCEPTUAL METHODOLO; Kardash W, 2000, DIFFERENTIAL DIAGNOS; KAUL N, 1993, J PHARMACOL TOX MET, V30, P55, DOI 10.1016/1056-8719(93)90008-3; KIRSCHBAUM C, 1992, PSYCHOSOM MED, V54, P648, DOI 10.1097/00006842-199211000-00004; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kivlighan KT, 2006, PSYCHONEUROENDOCRINO, V31, P703, DOI 10.1016/j.psyneuen.2006.01.007; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kumsta R, 2007, BIOL PSYCHIAT, V62, P863, DOI 10.1016/j.biopsych.2007.04.013; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lacey K, 2000, PSYCHONEUROENDOCRINO, V25, P339, DOI 10.1016/S0306-4530(99)00059-1; Liu JK, 1997, ANAL BIOCHEM, V245, P161, DOI 10.1006/abio.1996.9990; Lovallo WR, 2006, PHARMACOL BIOCHEM BE, V83, P441, DOI 10.1016/j.pbb.2006.03.005; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; MORSE DR, 1982, J HUM STRESS, V8, P31, DOI 10.1080/0097840X.1982.9936117; Naito Y., 2005, Current Drug Targets - Inflammation and Allergy, V4, P511, DOI 10.2174/1568010054526269; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Naumova EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051323; NICKERSON JF, 1957, P SOC EXP BIOL MED, V95, P405; Ogasawara Y, 2007, FEBS LETT, V581, P2473, DOI 10.1016/j.febslet.2007.04.062; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Poulsen HE, 2012, FREE RADICAL BIO MED, V52, P1353, DOI 10.1016/j.freeradbiomed.2012.01.009; Queiroz CS, 2002, EUR J ORAL SCI, V110, P337, DOI 10.1034/j.1600-0722.2002.21320.x; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Ring C, 2002, BIOL PSYCHOL, V59, P1, DOI 10.1016/S0301-0511(01)00128-4; Rohleder N, 2001, PSYCHOSOM MED, V63, P966, DOI 10.1097/00006842-200111000-00016; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Sapolsky, 1997, Stress, V2, P1; Schoofs D, 2008, STRESS, V11, P52, DOI 10.1080/10253890701453943; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Shear MK, 1989, MEASURING MENTAL ILL, P113; SINGAL PK, 1983, ADV EXP MED BIOL, V161, P391; Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Spielberger CD, 1987, STATE TRAIT INVENTOR; Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341; Takai N, 2004, ARCH ORAL BIOL, V49, P963, DOI 10.1016/j.archoralbio.2004.06.007; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; Vileikyte L, 2007, CLIN DERMATOL, V25, P49, DOI 10.1016/j.clindermatol.2006.09.005; Vina Jose, 2005, Sci Aging Knowledge Environ, V2005, ppe17, DOI 10.1126/sageke.2005.23.pe17; Walter MF, 2004, J AM COLL CARDIOL, V44, P1996, DOI 10.1016/j.jacc.2004.08.029	85	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115048	10.1371/journal.pone.0115048	http://dx.doi.org/10.1371/journal.pone.0115048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8WK	25525800	Green Published, Green Submitted, gold			2022-12-27	WOS:000347186200010
J	Takeda-Kawaguchi, T; Sugiyama, K; Chikusa, S; Iida, K; Aoki, H; Tamaoki, N; Hatakeyama, D; Kunisada, T; Shibata, T; Fusaki, N; Tezuka, K				Takeda-Kawaguchi, Tomoko; Sugiyama, Ken; Chikusa, Shunji; Iida, Kazuki; Aoki, Hitomi; Tamaoki, Naritaka; Hatakeyama, Daijiro; Kunisada, Takahiro; Shibata, Toshiyuki; Fusaki, Noemi; Tezuka, Ken-ichi			Derivation of iPSCs after Culture of Human Dental Pulp Cells under Defined Conditions	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; SENDAI-VIRUS; INDUCTION	Human dental pulp cells (hDPCs) are a promising resource for regenerative medicine and tissue engineering and can be used for derivation of induced pluripotent stem cells (iPSCs). However, current protocols use reagents of animal origin (mainly fetal bovine serum, FBS) that carry the potential risk of infectious diseases and unwanted immunogenicity. Here, we report a chemically defined protocol to isolate and maintain the growth and differentiation potential of hDPCs. hDPCs cultured under these conditions showed significantly less primary colony formation than those with FBS. Cell culture under stringently defined conditions revealed a donor-dependent growth capacity; however, once established, the differentiation capabilities of the hDPCs were comparable to those observed with FBS. DNA array analyses indicated that the culture conditions robustly altered hDPC gene expression patterns but, more importantly, had little effect on neither pluripotent gene expression nor the efficiency of iPSC induction. The chemically defined culture conditions described herein are not perfect serum replacements, but can be used for the safe establishment of iPSCs and will find utility in applications for cell-based regenerative medicine.	[Takeda-Kawaguchi, Tomoko; Sugiyama, Ken; Iida, Kazuki; Tamaoki, Naritaka; Hatakeyama, Daijiro; Shibata, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Oral & Maxillofacial Sci, Gifu, Japan; [Chikusa, Shunji; Aoki, Hitomi; Kunisada, Takahiro; Tezuka, Ken-ichi] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan; [Fusaki, Noemi] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan	Gifu University; Gifu University; Keio University	Tezuka, K (corresponding author), Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan.	tezuka@gifu-u.ac.jp	Fusaki, Noemi/U-1628-2019; Tezuka, Ken-ichi/B-3836-2012	Kunisada, Takahiro/0000-0003-1651-2716	Ministry of Education, Science, and Culture of Japan [22592181]; JST Yamanaka iPS Cell Project	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST Yamanaka iPS Cell Project	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm; grant number: 22592181 TK), and the JST Yamanaka iPS Cell Project (http://www.jst.go.jp; TK, TS, KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Eloit M, 1999, Dev Biol Stand, V99, P9; ERICKSON GA, 1991, DEV BIOLOGICALS, V75, P173; Escobedo-Lucea C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067870; Ferro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041774; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Iida K, 2013, J DENT RES, V92, P905, DOI 10.1177/0022034513502204; Iida K, 2010, ARCH ORAL BIOL, V55, P648, DOI 10.1016/j.archoralbio.2010.06.005; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Lizier NF, 2013, INTECH, P131; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Shah G, 1999, Dev Biol Stand, V99, P17; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeda T, 2008, J DENT RES, V87, P676, DOI 10.1177/154405910808700716; Tamaoki N, 2010, J DENT RES, V89, P773, DOI 10.1177/0022034510366846; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wessman S J, 1999, Dev Biol Stand, V99, P3; Willkommen H, 1999, Dev Biol Stand, V99, P131; Yan X, 2010, STEM CELLS DEV, V19, P469, DOI 10.1089/scd.2009.0314	27	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115392	10.1371/journal.pone.0115392	http://dx.doi.org/10.1371/journal.pone.0115392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521610	gold, Green Published, Green Submitted			2022-12-27	WOS:000348845600042
J	Kang, HB; Ahn, KS; Oh, SR; Kim, JW				Kang, Ho-Bum; Ahn, Kyung-Seop; Oh, Sei-Ryang; Kim, Jae Wha			Genkwadaphnin Induces IFN-gamma via PKD1/NF-kappa B/STAT1 Dependent Pathway in NK-92 Cells	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSES; INTERFERON-GAMMA; NK-CELLS; DAPHNE-GENKWA; ACTIVATING RECEPTORS; DIRECT STIMULATION; VIRUS-INFECTION; IL-18; MACROPHAGES	The flower buds of Daphne genkwa Sieb. et Zucc. have been used as a traditional Chinese medicine although their functional mechanisms have not been discovered yet. We have studied the potential effects of the plant extracts on natural killer (NK) cell activation, and isolated an active fraction. Genkwadaphnin (GD-1) displayed a potent efficacy to induce IFN-gamma transcription in NK cells with concentration-and time-dependent manners. GD-1 treatment triggered the phosphorylation of PKD1, a member of PKC family, MEK and ERK, resulting in IKK activation to induce I kappa B degradation, and the nuclear localization of p65, an NF-kappa B subunit, which regulates IFN-gamma transcription. GD-1 effect on IFN-gamma production was blocked by the addition of Rottlerin, a PKC inhibitor, CID 755673, a PKD inhibitor, or Bay11-7082, an IKK alpha inhibitor. The nuclear localization of p65 was also inhibited by the kinase inhibitors. Secreted IFN-gamma activates STAT1 phosphorylation as autocrine-loops to sustain its secretion. GD-1 induced the phosphorylation of STAT1 probably through the increase of IFN-gamma. STAT1 inhibitor also abrogated the sustained IFN-gamma secretion. These results suggest that GD-1 is involved in the activation of PKD1 and/or ERK pathway, which activate NK-kappa B triggering IFN-gamma production. As positive feedback loops, secreted IFN-gamma activates STAT1 and elongates its production in NK-92 cells.	[Kang, Ho-Bum; Kim, Jae Wha] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Ahn, Kyung-Seop; Oh, Sei-Ryang] Korea Res Inst Biosci & Biotechnol, Immune Modulator Res Ctr, Cheongwon Gun, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea.	wjkim@kribb.re.kr			Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program [KCS3021413]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2102R1A1A2043799]; Small & Medium Business Administration of Korea [SCE0101312]	Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Small & Medium Business Administration of Korea	Funding for this work came from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program (KCS3021413, https://www.kribb.re.kr/eng/, JWK) and grants from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2102R1A1A2043799, http://www.nrf.re.kr/nrf_eng_cms/, JWK) and Small & Medium Business Administration of Korea (SCE0101312, http://www.smba.go.kr/eng/index.do, JWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, CURR OPIN IMMUNOL, V12, P59, DOI 10.1016/S0952-7915(99)00051-5; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Carnaud C, 1999, J IMMUNOL, V163, P4647; Carson WE, 2001, EUR J IMMUNOL, V31, P3016, DOI 10.1002/1521-4141(2001010)31:10<3016::AID-IMMU3016>3.0.CO;2-J; Cederarv M, 2009, IMMUNOBIOLOGY, V214, P331, DOI 10.1016/j.imbio.2008.10.009; Chuang SS, 2001, J IMMUNOL, V167, P6210, DOI 10.4049/jimmunol.167.11.6210; De Pascalis R, 2008, INFECT IMMUN, V76, P4311, DOI 10.1128/IAI.00514-08; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Golab J, 2000, IMMUNOL LETT, V72, P153, DOI 10.1016/S0165-2478(00)00178-4; HALL IH, 1982, J PHARM SCI, V71, P1263, DOI 10.1002/jps.2600711120; Huang Kenneth H, 2006, J Immune Based Ther Vaccines, V4, P7, DOI 10.1186/1476-8518-4-7; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jennings P, 2009, J IMMUNOL, V182, P2879, DOI 10.4049/jimmunol.0803220; Jo SK, 2012, BIOMOL THER, V20, P513, DOI 10.4062/biomolther.2012.20.6.513; Kakugawa S, 2009, J VIROL, V83, P2510, DOI 10.1128/JVI.02416-08; Lee MMK, 2009, J LEUKOCYTE BIOL, V86, P1319, DOI 10.1189/jlb.0209052; Li HS, 2012, RES INTEGR TRADIT CH, V4, P93; Li SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-159; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Montoya CJ, 2006, CLIN IMMUNOL, V120, P138, DOI 10.1016/j.clim.2006.02.008; Munder M, 2001, IMMUNOL LETT, V75, P159, DOI 10.1016/S0165-2478(00)00288-1; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Otani T, 1999, CELL IMMUNOL, V198, P111, DOI 10.1006/cimm.1999.1589; Page KM, 2008, J LEUKOCYTE BIOL, V83, P1267, DOI 10.1189/jlb.1107745; Parihar R, 2002, J CLIN INVEST, V110, P983, DOI 10.1172/JCI200215950; Park BY, 2007, J ETHNOPHARMACOL, V111, P496, DOI 10.1016/j.jep.2006.12.023; PERUSSIA B, 1983, J EXP MED, V158, P2058, DOI 10.1084/jem.158.6.2058; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Pfeffer LM, 1997, SEMIN ONCOL, V24, pS9; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roda JM, 2006, J IMMUNOL, V177, P120, DOI 10.4049/jimmunol.177.1.120; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; STRATOWA C, 1995, IMMUNOBIOLOGY, V193, P293, DOI 10.1016/S0171-2985(11)80558-9; Street SEA, 2001, BLOOD, V97, P192, DOI 10.1182/blood.V97.1.192; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Tassi I, 2008, BLOOD, V112, P4109, DOI 10.1182/blood-2008-02-139527; Tong QY, 2012, J EMERG TRADIT CHIN, V21, P1166; WELSH RM, 1978, J EXP MED, V148, P163, DOI 10.1084/jem.148.1.163; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zeng KW, 2013, TOXICOL APPL PHARM, V273, P159, DOI 10.1016/j.taap.2013.08.028; Zheng WF, 2007, INT IMMUNOPHARMACOL, V7, P128, DOI 10.1016/j.intimp.2006.07.011	52	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115146	10.1371/journal.pone.0115146	http://dx.doi.org/10.1371/journal.pone.0115146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517939	Green Published, gold, Green Submitted			2022-12-27	WOS:000347215600045
J	Lu, XB; Huang, W				Lu, Xibin; Huang, Wei			PiggyBac Mediated Multiplex Gene Transfer in Mouse Embryonic Stem Cell	PLOS ONE			English	Article							FIBROBLAST FEEDER LAYERS; GERM-LINE TRANSMISSION; HOMOLOGOUS RECOMBINATION; PLURIPOTENTIAL CELLS; SLEEPING-BEAUTY; TRANSGENIC MICE; TRANSPOSON; EXPRESSION; DIFFERENTIATION; BACULOVIRUSES	PiggyBac system has been shown to have a high efficiency to mediate gene transfer. However, there are no reports on its efficiency to mediate multiplex transgenes in mouse embryonic stem cells. Here we first established an immortalized feeder cell line by introducing four antibiotic resistance genes simultaneously into the original SNL 76/7 feeder cell line utilizing the PiggyBac system. This is the feeder cell line with the most diverse types of antibiotic resistance genes reported so far, which will enable researchers to perform simultaneous multiplex gene transfer or gene targeting experiments in ES cells. With such feeder cell line, we were able to quantitatively characterize the transposition efficiency of PiggyBac system in mouse ES cells using five transposons carrying different inducible fluorescence proteins and antibiotic resistance genes, and the efficiency ranged from about 2% for one transposon to 0.5% for five transposons. The highly efficient multiplex gene transfer mediated by PiggyBac will no doubt provide researchers with more choices in biomedical research and development.	[Lu, Xibin; Huang, Wei] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Huang, Wei] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen, Peoples R China	University of Hong Kong; Southern University of Science & Technology	Huang, W (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	huang.w@sustc.edu.cn	Huang, Wei/AAW-1423-2021		Research Grants Council of Hong Kong General Research Fund [767711]; National Natural Science Foundation of China Fund [31270887]; Shenzhen Commission of Science and Innovation Fund [ZDSYS20140509142721429]	Research Grants Council of Hong Kong General Research Fund(Hong Kong Research Grants Council); National Natural Science Foundation of China Fund(National Natural Science Foundation of China (NSFC)); Shenzhen Commission of Science and Innovation Fund	This work is supported by a Research Grants Council of Hong Kong General Research Fund (No. 767711), a National Natural Science Foundation of China Fund (No. 31270887) and a Shenzhen Commission of Science and Innovation Fund (ZDSYS20140509142721429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Chen YT, 2010, STEM CELLS DEV, V19, P763, DOI 10.1089/scd.2009.0118; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; Hamlet MRJ, 2006, GENESIS, V44, P438, DOI 10.1002/dvg.20234; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Iuchi S, 2006, DIFFERENTIATION, V74, P160, DOI 10.1111/j.1432-0436.2006.00067.x; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2009, BIOL RES, V6; JOHNSON KA, 1995, NUCLEIC ACIDS RES, V23, P1273, DOI 10.1093/nar/23.7.1273; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kim J, 2008, STEM CELLS, V26, P2516, DOI 10.1634/stemcells.2008-0379; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Linnell ER, 2001, MAMM GENOME, V12, P169, DOI 10.1007/s003350010238; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Mossine VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085494; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan CY, 2010, J GENET GENOMICS, V37, P241, DOI 10.1016/S1673-8527(09)60042-4; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; VandenDriessche T, 2009, BLOOD, V114, P1461, DOI 10.1182/blood-2009-04-210427; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	41	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115072	10.1371/journal.pone.0115072	http://dx.doi.org/10.1371/journal.pone.0115072			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517991	Green Submitted, gold, Green Published			2022-12-27	WOS:000347215600039
J	Yan, LF; Guo, WH; Wu, SM; Liu, JN; Zhang, SH; Shi, LL; Ji, GX; Gu, AH				Yan, Lifeng; Guo, Wenhui; Wu, Shengmin; Liu, Jining; Zhang, Shenghu; Shi, Lili; Ji, Guixiang; Gu, Aihua			Genetic Variants in Nitric Oxide Synthase Genes and the Risk of Male Infertility in a Chinese Population: A Case-Control Study	PLOS ONE			English	Article							SPERM DNA FRAGMENTATION; HUMAN SEMINAL PLASMA; ENOS GENE; HUMAN SPERMATOZOA; OXIDATIVE STRESS; IN-VITRO; POLYMORPHISM; MEN; MORPHOLOGY; PROTEINS	Background: In recent years, oxidative stress has been studied extensively as a main contributing factor to male infertility. Nitric Oxide, a highly reactive free radical gas, is potentially detrimental to sperm function and sperm DNA integrity at high levels. Thus, the aim of this study was to investigate the associations between five polymorphisms in nitric oxide synthase genes (NOSs) and the risk of male infertility and sperm DNA damage as well. Methods: Genotypes were determined by the OpenArray platform. Sperm DNA fragmentation was detected using the Tdt-mediated dUTP nick-end labeling assay, and the level of 8-hydroxydeoxyguanosine (8-OHdG) in sperm DNA was measured using immunofluorescence. The adjusted odds ratio (OR) and 95% confidence interval (CI) were estimated using unconditional logistic regression. Results: Our results revealed a statistically significant difference between the cases and controls in both genotypic distribution (P<0.001) and allelic frequency (P=0.021) only for the NOS3 rs1799983 SNP. Multivariate logistic regression analyses revealed that rs1799983 was associated with a borderline significantly increased risk of male infertility (GT vs. GG: adjusted OR=1.30, 95% CI: 1.00-1.70; GT+TT vs. GG: adjusted OR=1.34, 95% CI: 1.03-1.74; P-trend=0.020). Moreover, NOS3 rs1799983 was positively associated with higher levels of sperm DNA fragmentation (beta=0.223, P=0.044). However, the other 4 polymorphisms (NOS1 rs2682826, NOS1 rs1047735, NOS2 rs2297518, and NOS2 rs10459953) were not found to have any apparent relationships with male infertility risk. Conclusions: Of five NOS gene polymorphisms investigated in the present study, we found NOS3 rs1799983 might cause oxidative sperm DNA damage, thereby contributing to male infertility.	[Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, State Key Lab Reprod Med, Inst Toxicol,Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Guo, Wenhui; Wu, Shengmin; Liu, Jining; Zhang, Shenghu; Shi, Lili; Ji, Guixiang] Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Ji, GX (corresponding author), Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China.	jgx@nies.org; aihuagu@njmu.edu.cn			National Natural Science Foundation of China [81202243, 81172694, 30901210]; Natural Science Foundation of Jiangsu Province [BK2012087]; practice innovation training program projects for the Jiangsu College students [2012JSSPTTP1018]; Jiangsu Province's Qinglan project [JX2161015124]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); practice innovation training program projects for the Jiangsu College students; Jiangsu Province's Qinglan project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (Grant No. 81202243, Grant No. 81172694 and Grant No. 30901210); the Natural Science Foundation of Jiangsu Province (Grant No. BK2012087); the practice innovation training program projects for the Jiangsu College students (2012JSSPTTP1018), the Jiangsu Province's Qinglan project (JX2161015124), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2003, HUM REPROD UPDATE, V9, P331, DOI 10.1093/humupd/dmg027; Agarwal A, 2009, UROLOGY, V73, P461, DOI 10.1016/j.urology.2008.07.053; Aitken RJ, 2010, HUM REPROD, V25, P2415, DOI 10.1093/humrep/deq214; Amiri Iraj, 2007, Iran Biomed J, V11, P259; Balercia G, 2004, J ANDROL, V25, P245; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Bianco B, 2013, GENE, V519, P13, DOI 10.1016/j.gene.2013.02.001; Borini A, 2006, HUM REPROD, V21, P2876, DOI 10.1093/humrep/del251; Brugh VM, 2004, MED CLIN N AM, V88, P367, DOI 10.1016/S0025-7125(03)00150-0; Buldreghini E, 2010, J ANDROL, V31, P482, DOI 10.2164/jandrol.109.008979; Burnett AL, 1996, MOL MED, V2, P288, DOI 10.1007/BF03401627; COOKE JP, 1993, CIRCULATION, V88, P2451, DOI 10.1161/01.CIR.88.5.2451; Davidoff MS, 1997, CELL TISSUE RES, V287, P161; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Herrero MB, 1999, BIOL REPROD, V61, P575, DOI 10.1095/biolreprod61.3.575; Herrero MB, 2001, J ANDROL, V22, P349; Huang I, 2006, MED SCI MONITOR, V12, pCR103; Ji GX, 2013, REPRODUCTION, V145, P463, DOI 10.1530/REP-12-0370; Joshi MS, 2008, ACTA BIOCH BIOPH SIN, V40, P47, DOI 10.1111/j.1745-7270.2008.00369.x; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Koppenol WH, 1996, METHOD ENZYMOL, V268, P3; Lee NPY, 2004, BIOL REPROD, V70, P267, DOI 10.1095/biolreprod.103.021329; Lewis SE, 1996, MOL HUM REPROD, V2, P873, DOI 10.1093/molehr/2.11.873; Lu Jin-Chun, 2010, Zhonghua Nan Ke Xue, V16, P867; Mahfouz R, 2009, FERTIL STERIL, V91, P805, DOI 10.1016/j.fertnstert.2008.01.022; Muratori M, 2008, CYTOM PART A, V73A, P785, DOI 10.1002/cyto.a.20615; Okumura T, 2009, NEUROMOL MED, V11, P123, DOI 10.1007/s12017-009-8068-z; Qidwai T, 2010, SCAND J IMMUNOL, V72, P375, DOI 10.1111/j.1365-3083.2010.02458.x; Revelli A, 1999, J CELL PHYSIOL, V178, P85, DOI 10.1002/(SICI)1097-4652(199901)178:1<85::AID-JCP11>3.0.CO;2-Y; Safarinejad MR, 2010, MOL REPROD DEV, V77, P720, DOI 10.1002/mrd.21210; Srivastava K, 2008, CLIN CHIM ACTA, V387, P80, DOI 10.1016/j.cca.2007.09.007; Sun JG, 1997, BIOL REPROD, V56, P602, DOI 10.1095/biolreprod56.3.602; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Thundathil J, 2003, BIOL REPROD, V68, P1291, DOI 10.1095/biolreprod.102.008276; Wang XL, 2000, FEBS LETT, V471, P45, DOI 10.1016/S0014-5793(00)01356-9; Wu TP, 2004, ARCH ANDROLOGY, V50, P173, DOI 10.1080/01485010490425494; Yoon Y, 2000, CLIN CHEM, V46, P1626; Yun YJ, 2008, FERTIL STERIL, V90, P1126, DOI 10.1016/j.fertnstert.2007.07.1382	40	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115190	10.1371/journal.pone.0115190	http://dx.doi.org/10.1371/journal.pone.0115190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517965	gold, Green Submitted, Green Published			2022-12-27	WOS:000347215600053
J	Niu, XY; Lu, C; Xiao, C; Zhang, ZG; Jiang, M; He, D; Bian, YQ; Zhang, G; Bian, ZX; Lu, AP				Niu, Xuyan; Lu, Cheng; Xiao, Cheng; Zhang, Zhiguo; Jiang, Miao; He, Dan; Bian, Yanqin; Zhang, Ge; Bian, Zhaoxiang; Lu, Aiping			The Shared Crosstalk of Multiple Pathways Involved in the Inflammation between Rheumatoid Arthritis and Coronary Artery Disease Based on a Digital Gene Expression Profile	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR RISK-FACTORS; CELL CO-STIMULATION; PERIPHERAL-BLOOD; HEART-DISEASE; ACCELERATED ATHEROSCLEROSIS; TRANSCRIPTOME ANALYSIS; SYSTEMIC INFLAMMATION; COMMON DISEASES; MICROARRAY	Rheumatoid arthritis (RA) and coronary artery disease (CAD) are both complex inflammatory diseases, and an increased prevalence of CAD and a high rate of mortality have been observed in RA patients. But the molecular mechanism of inflammation that is shared between the two disorders is unclear. High-throughput techniques, such as transcriptome analysis, are becoming important tools for genetic biomarker discovery in highly complex biological samples, which is critical for the diagnosis, prognosis, and treatment of disease. In the present study, we reported one type of transcriptome analysis method: digital gene expression profiling of peripheral blood mononuclear cells of 10 RA patients, 10 CAD patients and 10 healthy people. In all, 213 and 152 differently expressed genes (DEGs) were identified in RA patients compared with normal controls (RA vs. normal) and CAD patients compared with normal controls (CAD vs. normal), respectively, with 73 shared DEGs between them. Using this technique in combination with Ingenuity Pathways Analysis software, the effects on inflammation of four shared canonical pathways, three shared activated predicted upstream regulators and three shared molecular interaction networks were identified and explored. These shared molecular mechanisms may provide the genetic basis and potential targets for optimizing the application of current drugs to more effectively treat these diseases simultaneously and for preventing one when the other is diagnosed.	[Niu, Xuyan; Lu, Cheng; Jiang, Miao; Lu, Aiping] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China; [Xiao, Cheng] China Japan Friendship Hosp, Beijing 100029, Peoples R China; [Zhang, Zhiguo] China Acad Chinese Med Sci, Inst Basic Theory, Beijing 100700, Peoples R China; [He, Dan; Bian, Yanqin; Lu, Aiping] Shanghai Municipal Educ Commiss, E Inst Chinese Tradit Internal Med, Shanghai 201203, Peoples R China; [Zhang, Ge; Bian, Zhaoxiang; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China-Japan Friendship Hospital; China Academy of Chinese Medical Sciences; Institute of Basic Theory for Chinese Medicine, CACMS; Shanghai Municipal Education Commission (SHMEC); Hong Kong Baptist University	Lu, AP (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China.	lap64067611@126.com	Zhang, Ge/K-9118-2019; Xiao, Cheng/AAM-7764-2020	Zhang, Ge/0000-0002-7807-7695; 	International cooperation project of Ministry of science and technology [2014DFA31490]; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University [RC-IRMS/12-13/02]; Research Committee of Hong Kong Baptist University [FRG2/12-13/027]; Science and Technology Projects for supervisors of Beijing outstanding doctorate dissertation [20118450201]	International cooperation project of Ministry of science and technology; Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University; Research Committee of Hong Kong Baptist University; Science and Technology Projects for supervisors of Beijing outstanding doctorate dissertation	This study was supported by (1) International cooperation project of Ministry of science and technology (Project ID: 2014DFA31490) to Cheng Xiao, (2) Interdisciplinary Research Matching Scheme (IRMS) of Hong Kong Baptist University (Project ID: RC-IRMS/12-13/02), Research Committee of Hong Kong Baptist University (Project ID: FRG2/12-13/027) to Ge Zhang, and (3) Science and Technology Projects for supervisors of Beijing outstanding doctorate dissertation (Project ID: 20118450201) to Aiping Lu.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bili A, 2014, ARTHRIT CARE RES, V66, P355, DOI 10.1002/acr.22166; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Crowson CS, 2013, AM HEART J, V166, P622, DOI 10.1016/j.ahj.2013.07.010; Cunha TM, 2008, BRIT J PHARMACOL, V154, P460, DOI 10.1038/bjp.2008.94; Cynthia S, 2013, AM HEART J, V166, p[622, e621]; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; Dessein PH, 2005, J RHEUMATOL, V32, P435; Dessein PH, 2013, MEDIATORS INFLAMM; Ewing MM, 2013, INT J CARDIOL, V168, P1965, DOI 10.1016/j.ijcard.2012.12.085; Farzaneh-Far A, 2005, INT J CLIN PRACT, V59, P823, DOI 10.1111/j.1742-1241.2005.00489.x; Ferrari R, 1999, PHARMACOL RES, V40, P97, DOI 10.1006/phrs.1998.0463; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Javed Q, 2013, HEART LUNG CIRC, V22, P323, DOI 10.1016/j.hlc.2012.12.002; Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169; Kaiser C, 2012, RHEUMATOL INT, V32, P295, DOI 10.1007/s00296-011-2096-3; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Korhonen R, 2009, BASIC CLIN PHARMACOL, V104, P276, DOI 10.1111/j.1742-7843.2009.00375.x; Krintus M, 2014, CRIT REV CLIN LAB SC, V11, P1; Kriszbacher I, 2005, NEW ENGL J MED, V353, P429; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; Leonard DA, 2011, CORONARY ARTERY DIS, V22, P491, DOI 10.1097/MCA.0b013e32834b67e2; Li JY, 2013, CARDIOLOGY, V124, P53, DOI 10.1159/000345772; Liao KP, 2013, RHEUMATOLOGY, V52, P45, DOI 10.1093/rheumatology/kes243; Ljung L, 2012, ARTHRITIS RHEUM-US, V64, P42, DOI 10.1002/art.30654; Llorens F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-326; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mattey DL, 2007, ARTHRITIS RHEUM-US, V56, P1408, DOI 10.1002/art.22527; Min SH, 2010, BIOCHEM BIOPH RES CO, V391, P1080, DOI 10.1016/j.bbrc.2009.12.025; Mira E, 2004, J CELL SCI, V117, P1847, DOI 10.1242/jcs.01035; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nguyen CM, 2012, PHARMACOECONOMICS, V30, P575, DOI 10.2165/11594990-000000000-00000; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Nordang GBN, 2013, RHEUMATOLOGY, V52, P1973, DOI 10.1093/rheumatology/ket252; Nuhrenberg TG, 2013, J CARDIOVASC TRANSL, V6, P81, DOI 10.1007/s12265-012-9420-5; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Qamar A, 2012, CURR OPIN LIPIDOL, V23, P548, DOI 10.1097/MOL.0b013e328359b0a6; Rho YH, 2009, ARTHRIT RHEUM-ARTHR, V61, P1580, DOI 10.1002/art.25009; Rodriguez-Lopez J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1849; Sarzi-Puttini P, 2010, AUTOIMMUN REV, V9, P849, DOI 10.1016/j.autrev.2010.08.002; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Stavropoulos-Kalinoglou A, 2009, ANN RHEUM DIS, V68, P242, DOI 10.1136/ard.2008.095596; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang Weihong, 2007, BMC Cardiovasc Disord, V7, P30, DOI 10.1186/1471-2261-7-30; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; UNEMORI EN, 1993, J BIOL CHEM, V268, P1338; Wang XD, 2013, BONE, V52, P111, DOI 10.1016/j.bone.2012.09.018; Yonezawa K, 2012, KOBE J MED SCI, V58, pE128, DOI DOI 10.24546/81005037	69	11	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113659	10.1371/journal.pone.0113659	http://dx.doi.org/10.1371/journal.pone.0113659			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514790	Green Published, gold			2022-12-27	WOS:000349146300006
J	Pan, YX; Ye, Q; Shao, WX; Shang, SQ; Mao, JH; Zhang, T; Shen, HQ; Zhao, N				Pan, Yan-Xiang; Ye, Qing; Shao, Wen-Xia; Shang, Shi-Qiang; Mao, Jian-Hua; Zhang, Ting; Shen, Hong-Qiang; Zhao, Ning			Relationship between Immune Parameters and Organ Involvement in Children with Henoch-Schonlein Purpura	PLOS ONE			English	Article							CHINESE CHILDREN; IGA NEPHROPATHY; DIFFERENTIATION; GLYCOSYLATION; PATHOGENESIS; PROTEIN	Henoch-Schonlein purpura (HSP) is the most common type of connective tissue diseases which increasingly occurs in children in recent years and its pathogenesis remains unclear. In order to explore the immune parameters and underlying pathogenesis mechanism of children with HSP, the study involved 1232 patients with HSP having different clinical symptoms and their laboratory indicators were evaluated. Th1/Th2 imbalance and overactivity of Th2 cells can cause increase in the synthesis and release of immunoglobulins in children with HSP. The number of red blood cells and white blood cells in urine was directly proportional to the level of IgA and inversely proportional to the level of serum complements (C3 and C4). Activation of these complements caused by immunoglobulin in patients with HSP plays an important role in renal injury. The urinary protein content in children with HSP along with proteinuria was positively correlated with IgE level, and IgE mediated type 1 hypersensitivity can cause increase in capillary permeability and weakened the charge barrier; hence, it could be considered as one of the causes of proteinuria in HSP. Additionally, the NK cells percentage was reduced and impaired immune function of NK cells were related to the immune injury of the digestive tract and kidney.	[Pan, Yan-Xiang; Ye, Qing; Shang, Shi-Qiang; Shen, Hong-Qiang; Zhao, Ning] Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Wen-Xia] Hangzhou First Peoples Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ting] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China; [Ye, Qing] Zhejiang Key Lab Diag & Treatment Neonatal Dis, Hangzhou, Zhejiang, Peoples R China; [Mao, Jian-Hua] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Nephrol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University; Zhejiang University	Ye, Q (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	yeqingkaoyan@163.com	Mao, Jianhua/GOK-2713-2022	Shen, Hongqiang/0000-0001-7188-5289				Besbas N, 1997, SCAND J RHEUMATOL, V26, P456, DOI 10.3109/03009749709065719; Civilibal M, 2012, PEDIATR NEPHROL, V27, P1685; Davin JC, 2001, KIDNEY INT, V59, P823, DOI 10.1046/j.1523-1755.2001.059003823.x; DAVIN JC, 1994, PEDIATR NEPHROL, V8, P169, DOI 10.1007/BF00865470; Devata S, 2011, J GEN INTERN MED, V26, pS366; Dodig S, 2008, BIOCHEM MEDICA, V18, P52; Drake L, 2013, J IMMUNOL, V190; DUNCAN DD, 1994, EUR J IMMUNOL, V24, P2506, DOI 10.1002/eji.1830241037; Guo ZY, 2013, J IMMUNOL, V190, P3153, DOI 10.4049/jimmunol.1200751; Hung SP, 2009, PEDIATR NEONATOL, V50, P162, DOI 10.1016/S1875-9572(09)60056-5; Kannan A, 2012, J IMMUNOL, V188; Kawasaki Y, 2011, CLIN EXP NEPHROL, V15, P648, DOI 10.1007/s10157-011-0478-1; Kiryluk K, 2011, KIDNEY INT, V80, P79, DOI 10.1038/ki.2011.16; Lau KK, 2010, PEDIATR NEPHROL, V25, P19, DOI 10.1007/s00467-009-1230-x; Le Gallou S, 2012, J IMMUNOL, V189, P161, DOI 10.4049/jimmunol.1200301; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Litman GW, 2014, CURR OPIN IMMUNOL, V27, pV, DOI 10.1016/j.coi.2014.02.008; Luca CM, 2014, WORLD J PEDIATR, V10, P90, DOI 10.1007/s12519-014-0462-4; Mao YY, 2014, J INT MED RES, V42, P1043, DOI 10.1177/0300060514530879; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Park SJ, 2013, EXPERT REV CLIN IMMU, V9, P1223, DOI 10.1586/1744666X.2013.850028; Prais D, 2007, JCR-J CLIN RHEUMATOL, V13, P25, DOI 10.1097/01.rhu.0000255692.46165.19; Rigante D, 2013, AUTOIMMUN REV, V12, P1016, DOI 10.1016/j.autrev.2013.04.003; Saulsbury FT, 2010, CURR OPIN RHEUMATOL, V22, P598, DOI 10.1097/BOR.0b013e32833af608; Shi JS, 2013, PEDIATR NEPHROL, V28, P1424; Trnka P, 2013, J PAEDIATR CHILD H, V49, P995, DOI 10.1111/jpc.12403; van den Ham HJ, 2013, PARASITE IMMUNOL, V35, P318, DOI 10.1111/pim.12053; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Xiong LJ, 2012, WORLD J PEDIATR, V8, P301, DOI 10.1007/s12519-012-0373-1; Ye Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098745; Ye Q, 2014, SCI WORLD J, DOI 10.1155/2014/986527; Yu HH, 2012, J FORMOS MED ASSOC, V111, P121, DOI 10.1016/j.jfma.2011.04.002	32	28	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115261	10.1371/journal.pone.0115261	http://dx.doi.org/10.1371/journal.pone.0115261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514176	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300049
J	Soderquist, P; Norrstrom, J; Elmberg, J; Guillemain, M; Gunnarsson, G				Soderquist, Par; Norrstrom, Joanna; Elmberg, Johan; Guillemain, Matthieu; Gunnarsson, Gunnar			Wild Mallards Have More "Goose-Like" Bills Than Their Ancestors: A Case of Anthropogenic Influence?	PLOS ONE			English	Article							GAME-FARM MALLARDS; DABBLING DUCKS; ANAS-PLATYRHYNCHOS; LAMELLAR DENSITY; MATE PREFERENCE; BODY LENGTH; MORPHOLOGY; HYBRIDIZATION; ECOMORPHOLOGY; CONSEQUENCES	Wild populations of the world's most common dabbling duck, the mallard (Anas platyrhynchos), run the risk of genetic introgression by farmed conspecifics released for hunting purposes. We tested whether bill morphology of free-living birds has changed since large-scale releases of farmed mallards started. Three groups of mallards from Sweden, Norway and Finland were compared: historical wild (before large-scale releases started), present-day wild, and present-day farmed. Higher density of bill lamellae was observed in historical wild mallards (only males). Farmed mallards had wider bills than present-day and historical wild ones. Present-day wild and farmed mallards also had higher and shorter bills than historical wild mallards. Present-day mallards thus tend to have more "goose-like" bills (wider, higher, and shorter) than their ancestors. Our study suggests that surviving released mallards affect morphological traits in wild population by introgression. We discuss how such anthropogenic impact may lead to a maladapted and genetically compromised wild mallard population. Our study system has bearing on other taxa where large-scale releases of conspecifics with 'alien genes' may cause a cryptic invasive process that nevertheless has fitness consequences for individual birds.	[Soderquist, Par; Norrstrom, Joanna; Elmberg, Johan; Gunnarsson, Gunnar] Kristianstad Univ, Div Nat Sci, SE-29188 Kristianstad, Sweden; [Soderquist, Par] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, SE-90183 Umea, Sweden; [Guillemain, Matthieu] CNERA Avifaune Migratrice, Off Natl Chasse & Faune Sauvage, F-13200 Arles, France	Kristianstad University; Swedish University of Agricultural Sciences	Soderquist, P (corresponding author), Kristianstad Univ, Div Nat Sci, SE-29188 Kristianstad, Sweden.	par.soderquist@hkr.se			Swedish Environmental Protection Agency [V-205-09]	Swedish Environmental Protection Agency	Funding provided by V-205-09 The Swedish Environmental Protection Agency, http://www.naturvardsverket.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champagnon J., 2011, THESIS U MONTPELLIER; Champagnon J, 2011, EUROPEAN J WILDLIFE, V58, P1; Champagnon J, 2012, J NAT CONSERV, V20, P231, DOI 10.1016/j.jnc.2012.02.002; Champagnon J, 2010, BIRD STUDY, V57, P344, DOI 10.1080/00063657.2010.486028; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CHENG KM, 1979, ANIM BEHAV, V27, P417, DOI 10.1016/0003-3472(79)90177-5; CHENG KM, 1978, ANIM BEHAV, V26, P996, DOI 10.1016/0003-3472(78)90088-X; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Deceuninck B., 2014, SYNTHESE DENOMBREMEN; Delany S, 2006, WATERBIRD POPULATION; DESFORGES MF, 1976, ANIM BEHAV, V24, P391, DOI 10.1016/S0003-3472(76)80049-8; DESFORGES MF, 1975, ANIM BEHAV, V23, P692, DOI 10.1016/0003-3472(75)90145-1; Elmberg Johan, 2009, Wildfowl, P9; Gille U, 1999, CONDOR, V101, P710, DOI 10.2307/1370207; Greenwood RJ., 1975, PRAIRIE NAT, V7, P9; Guay P. -J., 2014, Pacific Conservation Biology, V20, P41; Guay PJ, 2008, CONDOR, V110, P276, DOI 10.1525/cond.2008.8424; Guillemain M, 2002, OIKOS, V98, P547, DOI 10.1034/j.1600-0706.2002.980321.x; Guillemain M., 1999, Wildfowl, V50, P123; Guillemain M, 2010, AMBIO, V39, P170, DOI 10.1007/s13280-010-0020-9; Gunnarsson G, 2011, AMBIO, V40, P338, DOI 10.1007/s13280-010-0117-1; Gurd DB, 2007, AM NAT, V169, P334, DOI 10.1086/510924; Gurd DB, 2005, THESIS SIMON FRASER; KEHOE FP, 1987, CAN J ZOOL, V65, P1818, DOI 10.1139/z87-275; KOOLOOS JGM, 1989, ZOOMORPHOLOGY, V108, P269, DOI 10.1007/BF00312160; Kraus RHS, 2013, MOL ECOL, V22, P41, DOI 10.1111/mec.12098; Laikre L, 2006, AMBIO, V35, P255, DOI 10.1579/05-A-060R.1; Lockwood JL, 2007, INVASION ECOLOGY; Mank JE, 2004, CONSERV GENET, V5, P395, DOI 10.1023/B:COGE.0000031139.55389.b1; Mondain-Monval J-Y, 2000, FAUNE SAUVAGE, V251, P124; Moore SJ, 2006, BIRD CONSERV INT, V16, P253, DOI 10.1017/S0959270906000396; NUDDS TD, 1984, CAN J ZOOL, V62, P2009, DOI 10.1139/z84-294; NUDDS TD, 1994, OIKOS, V69, P295, DOI 10.2307/3546150; NUDDS TD, 1984, CAN J ZOOL, V62, P2002, DOI 10.1139/z84-293; Nudds TD, 2000, OIKOS, V91, P583, DOI 10.1034/j.1600-0706.2000.910321.x; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; Ottosson U., 2012, FAGLARNA I SVERIGE A; Pehrsson O, 1982, VILTNYTT, V16, P23; POYSA H, 1983, ORNIS SCAND, V14, P317, DOI 10.2307/3676325; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Randi E, 2008, MOL ECOL, V17, P285, DOI 10.1111/j.1365-294X.2007.03417.x; Rhymer J.M., 2006, ACTA ZOOLOGICAL SINI, V52, P583, DOI DOI 10.1146/annurev.ecolsys.27.1.83; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Tolkamp CR, 1993, THESIS U GUELPH; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wilson RE, 2008, WILSON J ORNITHOL, V120, P390, DOI 10.1676/07-040.1	46	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115143	10.1371/journal.pone.0115143	http://dx.doi.org/10.1371/journal.pone.0115143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514789	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300038
J	Thibodeau, JF; Holterman, CE; Burger, D; Read, NC; Reudelhuber, TL; Kennedy, CRJ				Thibodeau, Jean-Francois; Holterman, Chet E.; Burger, Dylan; Read, Naomi C.; Reudelhuber, Timothy L.; Kennedy, Christopher R. J.			A Novel Mouse Model of Advanced Diabetic Kidney Disease	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; ANGIOTENSIN-II; RAS BLOCKADE; NEPHROPATHY; HYPERTENSION; RENIN; MICE; INHIBITION; DEFICIENCY; EXPRESSION	Currently available rodent models exhibit characteristics of early diabetic nephropathy (DN) such as hyperfiltration, mesangial expansion, and albuminuria yet features of late DN (hypertension, GFR decline, tubulointerstitial fibrosis) are absent or require a significant time investment for full phenotype development. Accordingly, the aim of the present study was to develop a mouse model of advanced DN with hypertension superimposed (HD mice). Mice transgenic for human renin cDNA under the control of the transthyretin promoter (TTRhRen) were employed as a model of angiotensin-dependent hypertension. Diabetes was induced in TTRhRen mice through low dose streptozotocin (HD-STZ mice) or by intercrossing with OVE26 diabetic mice (HD-OVE mice). Both HD-STZ and HD-OVE mice displayed more pronounced increases in urinary albumin levels as compared with their diabetic littermates. Additionally, HD mice displayed renal hypertrophy, advanced glomerular scarring and evidence of tubulointerstitial fibrosis. Both HD-OVE and HD-STZ mice showed evidence of GFR decline as FITC-inulin clearance was decreased compared to hyperfiltering STZ and OVE mice. Taken together our results suggest that HD mice represent a robust model of type I DN that recapitulates key features of human disease which may be significant in studying the pathogenesis of DN and in the assessment of putative therapeutics.	[Thibodeau, Jean-Francois; Holterman, Chet E.; Burger, Dylan; Read, Naomi C.; Kennedy, Christopher R. J.] Ottawa Hosp, Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada; [Thibodeau, Jean-Francois; Burger, Dylan; Read, Naomi C.; Kennedy, Christopher R. J.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Reudelhuber, Timothy L.] Univ Montreal, Clin Res Inst Montreal, Montreal, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Kennedy, CRJ (corresponding author), Ottawa Hosp, Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada.	ckennedy@uottawa.ca	Burger, Dylan/ABD-2727-2020; Thibodeau, Jean-Francois/AAC-6752-2019	Burger, Dylan/0000-0003-3951-2911; Thibodeau, Jean-Francois/0000-0002-9322-4868; Holterman, Chet/0000-0002-9002-6073	Ontario Graduate Scholarship; Heart & Stroke/Pfizer Canada Fellowship; Canadian Institutes of Health Research	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Heart & Stroke/Pfizer Canada Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	J-F.T. is a recipient of an Ontario Graduate Scholarship. D. B. is a recipient of a Heart & Stroke/Pfizer Canada Fellowship. C.RJ.K. is the guarantor of this study. Funding was also received from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brezniceanu ML, 2007, KIDNEY INT, V71, P912, DOI 10.1038/sj.ki.5002188; Brosius FC, 2013, CURR OPIN NEPHROL HY, V22, P17, DOI 10.1097/MNH.0b013e32835b3766; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Burger D, 2014, CLIN SCI LOND; Caron KMI, 2005, PHYSIOL GENOMICS, V20, P203, DOI 10.1152/physiolgenomics.00221.2004; Caron KMI, 2004, P NATL ACAD SCI USA, V101, P3106, DOI 10.1073/pnas.0307333101; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Cheng HF, 2012, KIDNEY INT, V82, P1176, DOI 10.1038/ki.2012.248; Conway BR, 2011, J AM SOC NEPHROLOGY; Durvasula RV, 2004, KIDNEY INT, V65, P30, DOI 10.1111/j.1523-1755.2004.00362.x; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Fletcher Sarah J, 2012, Front Endocrinol (Lausanne), V3, P166, DOI 10.3389/fendo.2012.00166; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Soler MJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/616313; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Kobori H, 2012, J INVESTIG MED; Lo CS, 2012, AM J PHYSIOL-RENAL, V302, pF840, DOI 10.1152/ajprenal.00340.2011; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Powell DW, 2013, LIFE SCI, V93, P257, DOI 10.1016/j.lfs.2013.06.016; Prescott G, 2000, PHYSIOL GENOMICS, V4, P67, DOI 10.1152/physiolgenomics.2000.4.1.67; Qi ZH, 2004, AM J PHYSIOL-RENAL, V286, pF590, DOI 10.1152/ajprenal.00324.2003; Redon J, 2012, J AM COLL CARDIOL, V59, P74, DOI 10.1016/j.jacc.2011.09.040; Reiser J, 2007, CURR HYPERTENS REP, V9, P403, DOI 10.1007/s11906-007-0074-7; Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060; Remuzzi Giuseppe, 2005, Kidney Int Suppl, pS57; Singh R, 1999, DIABETES, V48, P2066, DOI 10.2337/diabetes.48.10.2066; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Teiken JM, 2008, ANAT REC, V291, P114, DOI 10.1002/ar.20625; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Touyz RM, 2005, HYPERTENSION, V45, P530, DOI 10.1161/01.HYP.0000158845.49943.5e; Zhang MZ, 2011, AM J PHYSL RENAL PHY; Zhao HJ, 2006, J AM SOC NEPHROL, V17, P2664, DOI 10.1681/ASN.2006070798; Zheng SR, 2004, DIABETES, V53, P3248, DOI 10.2337/diabetes.53.12.3248	37	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e113459	10.1371/journal.pone.0113459	http://dx.doi.org/10.1371/journal.pone.0113459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514595	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300004
J	Antoci, A; Russu, P; Ticci, E				Antoci, Angelo; Russu, Paolo; Ticci, Elisa			Rural Poor Economies and Foreign Investors: An Opportunity or a Risk?	PLOS ONE			English	Article							DIRECT-INVESTMENT; DEVELOPING-COUNTRIES; RENEWABLE RESOURCES; SUSTAINABLE GROWTH; DOMESTIC FIRMS; FDI; TECHNOLOGY; SPILLOVERS; TRADE	In the current age of commercial and financial openness, remote and poor local economies are becoming increasingly exposed to inflows of external capital. The new investors - enjoying lower credit constraints than local dwellers - might play a propulsive role in local development. At the same time, inflows of external capital can have negative impacts on local natural resource-dependent activities. We analyze a two-sector model where both sectors damage the environment, but only that of domestic producers relies on natural resources. We assess under which conditions the coexistence of the two sectors is compatible with sustainability, defined as convergence to a stationary state characterized by a positive stock of the natural resource. Moreover, we find that capital inflows can be stimulated by an increase in the pollution intensity of incoming activities, but also in the pollution intensity of the domestic sector; in both cases, capital inflows generate environmental degradation and a decrease in welfare for the local population. Finally, we show that a reduction in the cost of capital for external investors and the consequent capital inflows have the effect to increase wages, local investments and welfare of the local populations only if the environmental impact of the external sector is relatively low with respect to that of local activities. Otherwise, an unexpected scenario characterized by a reduction in domestic capital accumulation and the impoverishment of local agents can occur.	[Antoci, Angelo; Russu, Paolo] Univ Sassari, Dept Econ & Business CRENoS, I-07100 Sassari, Italy; [Ticci, Elisa] Univ Siena, Dept Econ & Stat, I-53100 Siena, Italy	University of Sassari; University of Siena	Russu, P (corresponding author), Univ Sassari, Dept Econ & Business CRENoS, I-07100 Sassari, Italy.	russu@uniss.it	Antoci, Angelo/AAG-2800-2021	Antoci, Angelo/0000-0003-3719-0437; russu, paolo/0000-0002-6999-7617	University of Sassari; Regione Autonoma della Sardegna [L.R. 7/2007]	University of Sassari; Regione Autonoma della Sardegna(Regione Sardegna)	The research of Angelo Antoci and Paolo Russu is financed by the University of Sassari and by Regione Autonoma della Sardegna (L.R. 7/2007), under the project "Capitale sociale e divari economici regionali." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosin MR, 2005, OXF DEV STUD, V33, P149, DOI 10.1080/13600810500137749; Aitken BJ, 1999, AM ECON REV, V89, P605, DOI 10.1257/aer.89.3.605; Alfaro L, 2004, J INT ECON, V64, P89, DOI 10.1016/S0022-1996(03)00081-3; Alguacil M, 2011, J POLICY MODEL, V33, P481, DOI 10.1016/j.jpolmod.2010.12.004; Amiti M, 2003, J INT ECON, V61, P101, DOI 10.1016/S0022-1996(02)00079-X; Aykut D, 2007, INT BUS MANAG-SER, V22, P35; Balasubramanyam VN, 1996, ECON J, V106, P92, DOI 10.2307/2234933; Barbier EB, 2010, ENVIRON DEV ECON, V15, P635, DOI 10.1017/S1355770X1000032X; Barrios S, 2003, OXFORD B ECON STAT, V65, P475, DOI 10.1111/1468-0084.t01-1-00058; Blomstrom RE, 1994, NBER WORKING PAPERS, V4132; Borensztein E, 1998, J INT ECON, V45, P115, DOI 10.1016/S0022-1996(97)00033-0; Chakraborty C, 2008, WORLD DEV, V36, P1192, DOI 10.1016/j.worlddev.2007.06.014; Copeland BR, 2009, AM ECON REV, V99, P725, DOI 10.1257/aer.99.3.725; D'Alessandro S, 2007, ECOL ECON, V62, P473, DOI 10.1016/j.ecolecon.2006.07.008; Damijan J.P., 2003, EC SUS, V27, P189, DOI [DOI 10.1016/S0939-3625(03)00039-6, 10.1016/S0939-3625(03)00039-6]; Damijan JP, 2013, J COMP ECON, V41, P895, DOI 10.1016/j.jce.2012.12.001; Djankov S, 2000, WORLD BANK ECON REV, V14, P49, DOI 10.1093/wber/14.1.49; European Environmental Agency, 2010, EUR ENV STAT OUTL 20; FINDLAY R, 1978, Q J ECON, V92, P1, DOI 10.2307/1885996; Fons-Rosen C., 2013, NBER WORKING PAPERS; Guadalupe M, 2012, AM ECON REV, V102, P3594, DOI 10.1257/aer.102.7.3594; Herzer D, 2008, ECON MODEL, V25, P793, DOI 10.1016/j.econmod.2007.11.005; Janeba E, 2004, J DEV ECON, V74, P367, DOI 10.1016/j.jdeveco.2003.06.004; Kemeny T, 2010, WORLD DEV, V38, P1543, DOI 10.1016/j.worlddev.2010.03.001; Konings J, 2001, ECON TRANSIT, V9, P619, DOI 10.1111/1468-0351.00091; LALL S, 1978, OXFORD ECON PAP, V30, P217, DOI 10.1093/oxfordjournals.oep.a041410; Le Kama ADA, 2001, J ECON DYN CONTROL, V25, P1911, DOI 10.1016/S0165-1889(00)00007-5; Lenzen M, 2013, ECOL ECON, V94, P78, DOI 10.1016/j.ecolecon.2013.06.018; Li X, 2015, WORLD DEV, V33, P393; Lim EG, 2001, IMF WORKING PAPERS; Luiz R, 1997, STUDIES IN EC; Markusen JR, 1999, EUR ECON REV, V43, P335, DOI 10.1016/S0014-2921(98)00048-8; Reiter SL, 2010, WORLD DEV, V38, P1678, DOI 10.1016/j.worlddev.2010.04.005; Saltz I.S., 1992, RIVISTAINTERNAZIONAL, V39, P617; TEEB (The Economics of Ecosystems and Biodiversity), 2010, MAINSTREAMING EC NAT; UNCTAD, 2006, WORLD INV REP 2006 P; UNCTAD, 2001, WORLD INV REP 2001 P; Waldkirch A, 2010, WORLD DEV, V38, P1114, DOI 10.1016/j.worlddev.2009.12.020; WANG JY, 1992, EUR ECON REV, V36, P137, DOI 10.1016/0014-2921(92)90021-N; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110; Wirl F, 2004, J ECON DYN CONTROL, V28, P1149, DOI 10.1016/S0165-1889(03)00077-0; Wooster RB, 2010, REV DEV ECON, V14, P640, DOI 10.1111/j.1467-9361.2010.00579.x; World Bank, 2005, WORLD DEV REP 2005 B	43	1	1	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114703	10.1371/journal.pone.0114703	http://dx.doi.org/10.1371/journal.pone.0114703			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506694	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100020
J	Mohan, H; Ramesh, N; Mortazavi, S; Le, A; Iwakura, H; Unniappan, S				Mohan, Haneesha; Ramesh, Naresh; Mortazavi, Sima; Le, Anthony; Iwakura, Hiroshi; Unniappan, Suraj			Nutrients Differentially Regulate Nucleobindin-2/Nesfatin-1 In Vitro in Cultured Stomach Ghrelinoma (MGN3-1) Cells and In Vivo in Male Mice	PLOS ONE			English	Article							SECRETION; NESFATIN-1; INSULIN; EXPRESSION; GLUCAGON; PROTEIN; CLONING; GPR120; GPR40	Nesfatin-1 is secreted, meal-responsive anorexigenic peptide encoded in the precursor nucleobindin-2 [NUCB2]. Circulating nesfatin-1 increases post- prandially, but the dietary components that modulate NUCB2/nesfatin-1 remain unknown. We hypothesized that carbohydrate, fat and protein differentially regulate tissue specific expression of nesfatin-1. NUCB2, prohormone convertases and nesfatin-1 were detected in mouse stomach ghrelinoma [MGN3-1] cells. NUCB2 mRNA and protein were also detected in mouse liver, and small and large intestines. MGN3-1 cells were treated with glucose, fatty acids or amino acids. Male C57BL/6 mice were chronically fed high fat, high carbohydrate and high protein diets for 17 weeks. Quantitative PCR and nesfatin-1 assays were used to determine nesfatin-1 at mRNA and protein levels. Glucose stimulated NUCB2 mRNA expression in MGN3-1 cells. L-Tryptophan also increased NUCB2 mRNA expression and ghrelin mRNA expression, and nesfatin-1 secretion. Oleic acid inhibited NUCB2 mRNA expression, while ghrelin mRNA expression and secretion was enhanced. NUCB2 mRNA expression was significantly lower in the liver of mice fed a high protein diet compared to mice fed other diets. Chronic intake of high fat diet caused a significant reduction in NUCB2 mRNA in the stomach, while high protein and high fat diet caused similar suppression of NUCB2 mRNA in the large intestine. No differences in serum nesfatin-1 levels were found in mice at 7 a. m, at the commencement of the light phase. High carbohydrate diet fed mice showed significantly elevated nesfatin-1 levels at 1 p.m. Serum nesfatin-1 was significantly lower in mice fed high fat, protein or carbohydrate compared to the controls at 7 p.m, just prior to the dark phase. Mice that received a bolus of high fat had significantly elevated nesfatin-1/ NUCB2 at all time points tested post-gavage, compared to control mice and mice fed other diets. Our results for the first time indicate that nesfatin-1 is modulated by nutrients.	[Mohan, Haneesha; Ramesh, Naresh; Mortazavi, Sima; Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada; [Le, Anthony] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Iwakura, Hiroshi] Kyoto Univ, Med Innovat Ctr, Grad Sch Med, Sakyo Ku, Kyoto, Japan	University of Saskatchewan; York University - Canada; Kyoto University	Unniappan, S (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Lab Integrat Neuroendocrinol, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada.	suraj.unniappan@usask.ca		Iwakura, Hiroshi/0000-0001-8033-0736	Canadian Insitutes of Health Research (CIHR); Saskatchewan Health Research Foundation	Canadian Insitutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Saskatchewan Health Research Foundation	This research is funded by an open operating grant from the Canadian Insitutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html) and an Establishment Grant from the Saskatchewan Health Research Foundation (http:// shrf.ca/). SU is a CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funders have no role in the research or manuscript preparation.	Al Massadi O, 2010, J ENDOCRINOL INVEST, V33, P599, DOI 10.1007/BF03346655; BARNIKOLWATANABE S, 1994, BIOL CHEM H-S, V375, P497, DOI 10.1515/bchm3.1994.375.8.497; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Broglio F, 2004, CLIN ENDOCRINOL, V61, P503, DOI 10.1111/j.1365-2265.2004.02121.x; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; Gonzalez R, 2011, ENDOCRINOLOGY, V152, P3628, DOI 10.1210/en.2010-1471; Gonzalez R, 2011, J ENDOCRINOL, V208, pR9, DOI 10.1530/JOE-10-0492; Gonzalez R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015201; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V381, P643, DOI 10.1016/j.bbrc.2009.02.104; Greenman Y, 2004, CLIN ENDOCRINOL, V60, P382, DOI 10.1111/j.1365-2265.2004.01993.x; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Koliaki Chrysi, 2010, Int J Pept, V2010, DOI 10.1155/2010/710852; Krause W J, 2000, Prog Histochem Cytochem, V35, P259; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Mohan H, 2012, REGUL PEPTIDES, V175, P61, DOI 10.1016/j.regpep.2012.02.006; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Stengel A, 2013, HISTOCHEM CELL BIOL, V139, P909, DOI 10.1007/s00418-013-1087-8; Stengel A, 2012, PEPTIDES, V35, P143, DOI 10.1016/j.peptides.2012.03.015; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P515, DOI 10.1007/s00210-007-0250-y; Varricchio E, 2013, ACTA HISTOCHEM; Walker AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064882; Xia ZF, 2012, AM J PHYSIOL-GASTR L, V303, pG570, DOI 10.1152/ajpgi.00178.2012; Zhang AQ, 2010, WORLD J GASTROENTERO, V16, P1735, DOI 10.3748/wjg.v16.i14.1735; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115102	10.1371/journal.pone.0115102	http://dx.doi.org/10.1371/journal.pone.0115102			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506938	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100051
J	Okazaki, Y; Furuhashi, M; Tanaka, M; Mita, T; Fuseya, T; Ishimura, S; Watanabe, Y; Hoshina, K; Akasaka, H; Ohnishi, H; Yoshida, H; Saitoh, S; Shimamoto, K; Miura, T				Okazaki, Yusuke; Furuhashi, Masato; Tanaka, Marenao; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Watanabe, Yuki; Hoshina, Kyoko; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Shimamoto, Kazuaki; Miura, Tetsuji			Urinary Excretion of Fatty Acid-Binding Protein 4 is Associated with Albuminuria and Renal Dysfunction	PLOS ONE			English	Article							LIVER-TYPE; METABOLIC SYNDROME; APOLIPOPROTEIN-E; BIOMARKER; OBESITY; KIDNEY; HEART; AP2; DETERIORATION; DEFICIENT	Background: Fatty acid-binding protein 4 (FABP4/A-FABP/aP2) is expressed in not only adipocytes and macrophages but also peritubular capillaries in the normal kidney. We recently demonstrated that ectopic expression of FABP4, but not FABP1 known as liver FABP (L-FABP), in the glomerulus is associated with progression of proteinuria and renal dysfunction. However, urinary excretion of FABP4 has not been investigated. Methods: Subjects who participated in the Tanno-Sobetsu Study, a study with a population-based cohort design, in 2011 (n=392, male/female: 166/226) were enrolled. Urinary FABP4 (U-FABP4) and urinary albumin-to-creatinine ratio (UACR) were measured. Change in estimated glomerular filtration rate (eGFR) was followed up one year later. Results: In 93 (23.7%) of the 392 subjects, U-FABP4 level was below the sensitivity of the assay. Subjects with undetectable U-FABP4 were younger and had lower UACR and higher eGFR levels than subjects with measurable U-FABP4. U-FABP4 level was positively correlated with age, systolic blood pressure and levels of serum FABP4 (S-FABP4), triglycerides, hemoglobin A1c (HbA1c), urinary FABP1 (U-FABP1) and UACR (r=0.360, p<0.001). Age, S-FABP4, U-FABP1 and UACR were independent predictors of U-FABP4. On the other hand, systolic blood pressure, HbA1c and U-FABP4 were independently correlated with UACR. Reduction in eGFR after one year was significantly larger in a group with the highest tertile of baseline U-FABP4 than a group with the lowest tertile. Conclusions: Urinary FABP4 level is independently correlated with level of albuminuria and possibly predicts yearly decline of eGFR. U-FABP4 would be a novel biomarker of glomerular damage.	[Okazaki, Yusuke; Furuhashi, Masato; Tanaka, Marenao; Mita, Tomohiro; Fuseya, Takahiro; Ishimura, Shutaro; Watanabe, Yuki; Hoshina, Kyoko; Akasaka, Hiroshi; Ohnishi, Hirofumi; Yoshida, Hideaki; Saitoh, Shigeyuki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Ohnishi, Hirofumi] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Saitoh, Shigeyuki] Sapporo Med Univ, Sch Hlth Sci, Dept Nursing, Div Med & Behav Subjects, Sapporo, Hokkaido, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Furuhashi, M (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	furuhasi@sapmed.ac.jp	Furuhashi, Masato/AAT-5518-2021; Marenao, Tanaka/ABA-4054-2020	Furuhashi, Masato/0000-0002-0145-3541; Tanaka, Marenao/0000-0002-6575-9996; Ohnishi, Hirofumi/0000-0002-5873-6438	JSPS KAKENHI; Takeda Science Foundation; Ono Medical Research Foundation; Akiyama Life Science Foundation; Suhara Memorial Foundation; Takeda Medical Research Foundation; Japan Diabetes Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Akiyama Life Science Foundation; Suhara Memorial Foundation; Takeda Medical Research Foundation; Japan Diabetes Foundation	M.F. has been supported by grants from JSPS KAKENHI, Takeda Science Foundation, Ono Medical Research Foundation, Akiyama Life Science Foundation, Suhara Memorial Foundation, Takeda Medical Research Foundation, and Japan Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones G, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-72; Araki S, 2013, DIABETES CARE, V36, P1248, DOI 10.2337/dc12-1298; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Chow WS, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004176; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Furuhashi M, 2014, HYPERTENS R IN PRESS; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Furuhashi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027356; Fuseya T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0126-7; Gilkeson GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064650; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; Kamijo-Ikemori A, 2006, CLIN CHIM ACTA, V374, P1, DOI 10.1016/j.cca.2006.05.038; Karpisek M, 2007, EUR J CLIN INVEST, V37, P637, DOI 10.1111/j.1365-2362.2007.01835.x; Lee MYK, 2007, ARTERIOSCL THROM VAS, V27, P2443, DOI 10.1161/ATVBAHA.107.141705; Lee MYK, 2011, BRIT J PHARMACOL, V162, P1564, DOI 10.1111/j.1476-5381.2010.01158.x; MAATMAN RGHJ, 1992, BIOCHEM J, V288, P285, DOI 10.1042/bj2880285; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mita T, 2015, OBESITY, V23, P359, DOI 10.1002/oby.20954; Miyoshi T, 2011, HEART VESSELS, V26, P408, DOI 10.1007/s00380-010-0060-x; Mou S, 2012, CLIN CHIM ACTA, V413, P187, DOI 10.1016/j.cca.2011.09.018; Noiri E, 2009, AM J PHYSIOL-RENAL, V296, pF669, DOI 10.1152/ajprenal.90513.2008; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Satchell SC, 2009, AM J PHYSIOL-RENAL, V296, pF947, DOI 10.1152/ajprenal.90601.2008; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055027; Tanaka M, 2014, NEPHRON CLIN PRACT, V128, P345, DOI 10.1159/000368412; Terra XM, 2011, EUR J ENDOCRINOL, V164, P539, DOI 10.1530/EJE-10-1195; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; von Eynatten M, 2012, ARTERIOSCL THROM VAS, V32, P2327, DOI 10.1161/ATVBAHA.112.248609; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274; Yuen DA, 2012, J AM SOC NEPHROL, V23, P1810, DOI 10.1681/ASN.2011121170	42	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115429	10.1371/journal.pone.0115429	http://dx.doi.org/10.1371/journal.pone.0115429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25506691	Green Published, gold, Green Submitted			2022-12-27	WOS:000346607100076
J	Vaarala, O; Vuorela, A; Partinen, M; Baumann, M; Freitag, TL; Meri, S; Saavalainen, P; Jauhiainen, M; Soliymani, R; Kirjavainen, T; Olsen, P; Saarenpaa-Heikkila, O; Rouvinen, J; Roivainen, M; Nohynek, H; Jokinen, J; Julkunen, I; Kilpi, T				Vaarala, Outi; Vuorela, Arja; Partinen, Markku; Baumann, Marc; Freitag, Tobias L.; Meri, Seppo; Saavalainen, Paivi; Jauhiainen, Matti; Soliymani, Rabah; Kirjavainen, Turkka; Olsen, Paivi; Saarenpaa-Heikkila, Outi; Rouvinen, Juha; Roivainen, Merja; Nohynek, Hanna; Jokinen, Jukka; Julkunen, Ilkka; Kilpi, Terhi			Antigenic Differences between AS03 Adjuvanted Influenza A (H1N1) Pandemic Vaccines: Implications for Pandemrix-Associated Narcolepsy Risk	PLOS ONE			English	Article							VACCINATION; ANTIBODIES; CHILDREN; PROTEIN; CELLS	Background: Narcolepsy results from immune-mediated destruction of hypocretin secreting neurons in hypothalamus, however the triggers and disease mechanisms are poorly understood. Vaccine-attributable risk of narcolepsy reported so far with the AS03 adjuvanted H1N1 vaccination Pandemrix has been manifold compared to the AS03 adjuvanted Arepanrix, which contained differently produced H1N1 viral antigen preparation. Hence, antigenic differences and antibody response to these vaccines were investigated. Methods and Findings: Increased circulating IgG-antibody levels to Pandemrix H1N1 antigen were found in 47 children with Pandemrix-associated narcolepsy when compared to 57 healthy children vaccinated with Pandemrix. H1N1 antigen of Arepanrix inhibited poorly these antibodies indicating antigenic difference between Arepanrix and Pandemrix. High-resolution gel electrophoresis quantitation and mass spectrometry identification analyses revealed higher amounts of structurally altered viral nucleoprotein (NP) in Pandemrix. Increased antibody levels to hemagglutinin (HA) and NP, particularly to detergent treated NP, was seen in narcolepsy. Higher levels of antibodies to NP were found in children with DQB1*06:02 risk allele and in DQB1*06:02 transgenic mice immunized with Pandemrix when compared to controls. Conclusions: This work identified 1) higher amounts of structurally altered viral NP in Pandemrix than in Arepanrix, 2) detergent-induced antigenic changes of viral NP, that are recognized by antibodies from children with narcolepsy, and 3) increased antibody response to NP in association of DQB1*06:02 risk allele of narcolepsy. These findings provide a link between Pandemrix and narcolepsy. Although detailed mechanisms of Pandemrix in narcolepsy remain elusive, our results move the focus from adjuvant(s) onto the H1N1 viral proteins.	[Vaarala, Outi; Vuorela, Arja; Nohynek, Hanna; Jokinen, Jukka; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Vitalmed Res Ctr Helsinki, Helsinki Sleep Clin, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Haartman Inst, Helsinki, Finland; [Baumann, Marc; Soliymani, Rabah] Univ Helsinki, Inst Biomed Biochem & Dev Biol, Meilahti Clin Prote Core Facil, Helsinki, Finland; [Baumann, Marc; Soliymani, Rabah] Univ Helsinki, NeuroMed Res Program, Helsinki, Finland; [Freitag, Tobias L.; Meri, Seppo; Saavalainen, Paivi] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland; [Freitag, Tobias L.; Meri, Seppo; Saavalainen, Paivi] Univ Helsinki, Res Program Unit, Helsinki, Finland; [Jauhiainen, Matti] Natl Inst Hlth & Welf, Biomedicum, Publ Hlth Genom Res Unit, Helsinki, Finland; [Kirjavainen, Turkka] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat, Helsinki, Finland; [Olsen, Paivi] Oulu Univ Hosp, Dept Child Neurol, Oulu, Finland; [Saarenpaa-Heikkila, Outi] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Rouvinen, Juha] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Rouvinen, Juha] Univ Eastern Finland, Bioctr Kuopio, Joensuu, Finland; [Roivainen, Merja; Julkunen, Ilkka] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Julkunen, Ilkka] Univ Turku, Dept Virol, Turku, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; Tampere University; Tampere University Hospital; University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Turku	Vaarala, O (corresponding author), Natl Inst Hlth & Welf, Dept Vaccinat & Immune Protect, Helsinki, Finland.	outi.vaarala@helsinki.fi	Saavalainen, Päivi M/E-8621-2011	Rouvinen, Juha/0000-0003-1843-5718; Baumann, Marc/0000-0002-2991-889X; Meri, Seppo/0000-0001-9142-501X; Freitag, Tobias/0000-0001-5971-2991; Soliymani, Rabah/0000-0003-0184-3352; Vuorela, Arja/0000-0001-9987-1903; Kirjavainen, Turkka/0000-0002-0043-5093; Partinen, Markku/0000-0002-8182-9368	National Institute for Health and Welfare (THL), Academy of Finland [260603]; Ministry of Social Affairs and Health, Finland	National Institute for Health and Welfare (THL), Academy of Finland; Ministry of Social Affairs and Health, Finland	The following organizations funded the study: National Institute for Health and Welfare (THL), Academy of Finland (260603) and Ministry of Social Affairs and Health, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Billiard M, 1989, SLEEP RES, V18, P201; Choe YJ, 2012, VACCINE, V30, P7439, DOI 10.1016/j.vaccine.2012.10.030; De la Herran-Arita AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007762; European Medicines Agency, EMA6910372013 CHMP; European Medicines Agency, ASS REP IMM DIFF PAN; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Hayward SL, 2006, J IMMUNOL, V176, P7715, DOI 10.4049/jimmunol.176.12.7715; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Hermeling S, 2003, PHARM RES, V20, P1903, DOI 10.1023/B:PHAM.0000008034.61317.02; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lind A, 2014, J AUTOIMMUN, V50, P99, DOI 10.1016/j.jaut.2014.01.031; Melen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068402; Mikk ML, 2014, HUM IMMUNOL, V75, P65, DOI 10.1016/j.humimm.2013.09.008; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Moris P, 2011, J CLIN IMMUNOL, V31, P443, DOI 10.1007/s10875-010-9490-6; Nohynek H, 2012, PLOS ONE, V7; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Prokudina EN, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-37; Samoilovich E, 2003, J MED VIROL, V71, P274, DOI 10.1002/jmv.10480; Strengell M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025848; Vikstedt R, 2007, BIOCHEMISTRY-US, V46, P11979, DOI 10.1021/bi700833h	30	70	71	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e114361	10.1371/journal.pone.0114361	http://dx.doi.org/10.1371/journal.pone.0114361			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW9WY	25501681	Green Published, gold			2022-12-27	WOS:000346607100012
J	Roy, A; Gong, JC; Thomas, DC; Zhang, JF; Kipen, HM; Rich, DQ; Zhu, T; Huang, W; Hu, M; Wang, GF; Wang, YD; Zhu, P; Lu, SE; Ohman-Strickland, P; Diehl, SR; Eckel, SP				Roy, Ananya; Gong, Jicheng; Thomas, Duncan C.; Zhang, Junfeng; Kipen, Howard M.; Rich, David Q.; Zhu, Tong; Huang, Wei; Hu, Min; Wang, Guangfa; Wang, Yuedan; Zhu, Ping; Lu, Shou-En; Ohman-Strickland, Pamela; Diehl, Scott R.; Eckel, Sandrah P.			The Cardiopulmonary Effects of Ambient Air Pollution and Mechanistic Pathways: A Comparative Hierarchical Pathway Analysis	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; OXIDATIVE STRESS; BEIJING OLYMPICS; TIME-COURSE; EXPOSURE; INFLAMMATION; HEALTHY; PARTICULATE; MARKERS; PANEL	Previous studies have investigated the associations between exposure to ambient air pollution and biomarkers of physiological pathways, yet little has been done on the comparison across biomarkers of different pathways to establish the temporal pattern of biological response. In the current study, we aim to compare the relative temporal patterns in responses of candidate pathways to different pollutants. Four biomarkers of pulmonary inflammation and oxidative stress, five biomarkers of systemic inflammation and oxidative stress, ten parameters of autonomic function, and three biomarkers of hemostasis were repeatedly measured in 125 young adults, along with daily concentrations of ambient CO, PM2.5, NO2, SO2, EC, OC, and sulfate, before, during, and after the Beijing Olympics. We used a two-stage modeling approach, including Stage I models to estimate the association between each biomarker and pollutant over each of 7 lags, and Stage II mixed-effect models to describe temporal patterns in the associations when grouping the biomarkers into the four physiological pathways. Our results show that candidate pathway groupings of biomarkers explained a significant amount of variation in the associations for each pollutant, and the temporal patterns of the biomarker pollutant-lag associations varied across candidate pathways (p<0.0001) and were not linear (from lag 0 to lag 3: p=0.0629, from lag 3 to lag 6: p=0.0005). These findings suggest that, among this healthy young adult population, the pulmonary inflammation and oxidative stress pathway is the first to respond to ambient air pollution exposure (within 24 hours) and the hemostasis pathway responds gradually over a 2-3 day period. The initial pulmonary response may contribute to the more gradual systemic changes that likely ultimately involve the cardiovascular system.	[Roy, Ananya] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Gong, Jicheng; Zhang, Junfeng] Duke Univ, Nicholas Sch Environm, Durham, NC USA; [Gong, Jicheng; Zhang, Junfeng] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Thomas, Duncan C.; Eckel, Sandrah P.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Kipen, Howard M.] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, Environm & Occupat Hlth Sci Inst, Piscataway, NJ USA; [Rich, David Q.] Univ Rochester, Sch Med & Dent, Dept Publ Hlth Sci, Rochester, NY USA; [Zhu, Tong; Hu, Min] Peking Univ, Coll Environm Sci & Engn, State Key Lab Environm Simulat & Pollut Control, Beijing 100871, Peoples R China; [Zhu, Tong; Hu, Min] Peking Univ, Ctr Environm & Hlth, Beijing 100871, Peoples R China; [Huang, Wei] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100871, Peoples R China; [Huang, Wei] Peking Univ, Inst Environm Med, Beijing 100871, Peoples R China; [Wang, Guangfa] Peking Univ, Hosp 1, Dept Pulm Med, Beijing 100871, Peoples R China; [Wang, Yuedan] Peking Univ, Hlth Sci Ctr, Dept Immunol, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Hosp 1, Dept Hematol, Beijing 100871, Peoples R China; [Lu, Shou-En; Ohman-Strickland, Pamela] Rutgers State Univ, Sch Publ Hlth, Dept Biostat, Piscataway, NJ USA; [Diehl, Scott R.] Rutgers State Univ, Sch Dent, Ctr Pharmacogen & Complex Dis, Newark, NJ USA	Yale University; Duke University; Duke University; University of Southern California; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Rochester; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Eckel, SP (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	eckel@usc.edu	Zhang, Junfeng/AAJ-9183-2020; Gong, Jicheng/I-5236-2016; HU, Min/D-1037-2011; ZHU, TONG/H-6501-2011; Gong, Jicheng/AAS-4862-2020	Zhang, Junfeng/0000-0003-3759-6672; Gong, Jicheng/0000-0002-8943-8804; HU, Min/0000-0003-4816-9123; ZHU, TONG/0000-0002-2752-7924; 	National Institute of Environmental Health Sciences [1R01ES015864, P30ES005022, 5P30ES007048]; Health Effects Institute [4760-RPFA05-3]; Beijing Environment Protection Bureau [OITC-G08026056]; Beijing Council of Science and Technology [HB200504-6, HB200504-2]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015864, R01ES019876, P30ES005022, P30ES007048] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Health Effects Institute; Beijing Environment Protection Bureau; Beijing Council of Science and Technology; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was jointly funded by grants 1R01ES015864, P30ES005022, and 5P30ES007048 from the National Institute of Environmental Health Sciences, 4760-RPFA05-3 from the Health Effects Institute, OITC-G08026056 from the Beijing Environment Protection Bureau, and HB200504-6, HB200504-2 from the Beijing Council of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163; Baja ES, 2013, J EXPO SCI ENV EPID, V23, P268, DOI 10.1038/jes.2012.106; Baja ES, 2013, ENV HLTH, V12; Bind MA, 2012, EPIDEMIOLOGY, V23, P332, DOI 10.1097/EDE.0b013e31824523f0; Blomberg A, 2005, J THROMB HAEMOST, V3, P2103, DOI 10.1111/j.1538-7836.2005.01559.x; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Carlsten C, 2007, THROMB RES, V120, P849, DOI 10.1016/j.thromres.2007.01.005; Delfino RJ, 2010, EPIDEMIOLOGY, V21, P892, DOI 10.1097/EDE.0b013e3181f20e6c; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Gong H, 2003, INHAL TOXICOL, V15, P305, DOI 10.1080/08958370390168300; Gong JC, 2013, J EXPO SCI ENV EPID, V23, P322, DOI 10.1038/jes.2012.127; He F, 2011, J EXPO SCI ENV EPID, V21, P65, DOI 10.1038/jes.2010.21; Huang W, 2012, AM J RESP CRIT CARE, V186, P1150, DOI 10.1164/rccm.201205-0850OC; Jia XF, 2012, INT ARCH OCC ENV HEA, V85, P97, DOI 10.1007/s00420-011-0646-3; Kan H, 2011, J THROMB HAEMOST, V9, P672, DOI 10.1111/j.1538-7836.2011.04210.x; Kipen H, 2010, ANN NY ACAD SCI, V1203, P160, DOI 10.1111/j.1749-6632.2010.05638.x; Langrish JP, 2012, J INTERN MED, V272, P224, DOI 10.1111/j.1365-2796.2012.02566.x; Laumbach RJ, 2010, ANN NY ACAD SCI, V1203, P107, DOI 10.1111/j.1749-6632.2010.05604.x; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Martinelli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034831; Mills NL, 2008, ENVIRON HEALTH PERSP, V116, P709, DOI 10.1289/ehp.11016; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Moller P, 2010, ENVIRON HEALTH PERSP, V118, P1126, DOI 10.1289/ehp.0901725; Park SK, 2005, ENVIRON HEALTH PERSP, V113, P304, DOI 10.1289/ehp.7447; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Pieters N, 2012, HEART, V98, P1127, DOI 10.1136/heartjnl-2011-301505; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; Rich DQ, 2012, JAMA-J AM MED ASSOC, V307, P2068, DOI 10.1001/jama.2012.3488; Riediker M, 2004, AM J RESP CRIT CARE, V169, P934, DOI 10.1164/rccm.200310-1463OC; Shih RA, 2011, ENVIRON HEALTH PERSP, V119, P326, DOI 10.1289/ehp.1002256; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Van Hee VC, 2011, EPIDEMIOLOGY, V22, P773, DOI 10.1097/EDE.0b013e31823061a9; Wang M, 2009, ATMOS CHEM PHYS, V9, P8247, DOI 10.5194/acp-9-8247-2009; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zhang J, 2013, CARDIORESPIRATORY BI, P174; Zuurbier M, 2011, ENVIRON HEALTH PERSP, V119, P1384, DOI 10.1289/ehp.1003151	37	21	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114913	10.1371/journal.pone.0114913	http://dx.doi.org/10.1371/journal.pone.0114913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502951	Green Published, gold, Green Submitted			2022-12-27	WOS:000346375400063
J	Jaratlerdsiri, W; Deakin, J; Godinez, MR; Shan, X; Peterson, DG; Marthey, S; Lyons, E; McCarthy, FM; Isberg, SR; Higgins, DP; Chong, AY; St John, J; Glenn, TC; Ray, DA; Gongora, J				Jaratlerdsiri, Weerachai; Deakin, Janine; Godinez, Ricardo M.; Shan, Xueyan; Peterson, Daniel G.; Marthey, Sylvain; Lyons, Eric; McCarthy, Fiona M.; Isberg, Sally R.; Higgins, Damien P.; Chong, Amanda Y.; St John, John; Glenn, Travis C.; Ray, David A.; Gongora, Jaime			Comparative Genome Analyses Reveal Distinct Structure in the Saltwater Crocodile MHC	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I REGION; CLASS-IIB; GENES; EVOLUTION; DUPLICATION; SEQUENCE; CHICKEN; ORGANIZATION; POLYMORPHISM	The major histocompatibility complex (MHC) is a dynamic genome region with an essential role in the adaptive immunity of vertebrates, especially antigen presentation. The MHC is generally divided into subregions (classes I, II and III) containing genes of similar function across species, but with different gene number and organisation. Crocodylia (crocodilians) are widely distributed and represent an evolutionary distinct group among higher vertebrates, but the genomic organisation of MHC within this lineage has been largely unexplored. Here, we studied the MHC region of the saltwater crocodile (Crocodylus porosus) and compared it with that of other taxa. We characterised genomic clusters encompassing MHC class I and class II genes in the saltwater crocodile based on sequencing of bacterial artificial chromosomes. Six gene clusters spanning similar to 452 kb were identified to contain nine MHC class I genes, six MHC class II genes, three TAP genes, and a TRIM gene. These MHC class I and class II genes were in separate scaffold regions and were greater in length (2- 6 times longer) than their counterparts in well- studied fowl B loci, suggesting that the compaction of avian MHC occurred after the crocodilianavian split. Comparative analyses between the saltwater crocodile MHC and that from the alligator and gharial showed large syntenic areas (>80% identity) with similar gene order. Comparisons with other vertebrates showed that the saltwater crocodile had MHC class I genes located along with TAP, consistent with birds studied. Linkage between MHC class I and TRIM39 observed in the saltwater crocodile resembled MHC in eutherians compared, but absent in avian MHC, suggesting that the saltwater crocodile MHC appears to have gene organisation intermediate between these two lineages. These observations suggest that the structure of the saltwater crocodile MHC, and other crocodilians, can help determine the MHC that was present in the ancestors of archosaurs.	[Jaratlerdsiri, Weerachai; Isberg, Sally R.; Higgins, Damien P.; Chong, Amanda Y.; Gongora, Jaime] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Deakin, Janine] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Deakin, Janine] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Godinez, Ricardo M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Shan, Xueyan; Ray, David A.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Peterson, Daniel G.; Ray, David A.] Mississippi State Univ, IGBB, Mississippi State, MS 39762 USA; [Marthey, Sylvain] INRA, UMR 1313, F-78352 Jouy En Josas, France; [Lyons, Eric] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [McCarthy, Fiona M.] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA; [Isberg, Sally R.] Ctr Crocodile Res, Noonamah, NT 0837, Australia; [St John, John] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Godinez, Ricardo M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Sydney; Australian National University; University of Canberra; Harvard University; Mississippi State University; Mississippi State University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Arizona; University of Arizona; University of California System; University of California Santa Cruz; University System of Georgia; University of Georgia; Harvard University; Harvard Medical School	Gongora, J (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	jaime.gongora@sydney.edu.au	Deakin, Janine/A-1941-2008; Glenn, Travis C/A-2390-2008; Higgins, Damien P/A-9601-2011; Jaratlerdsiri, Weerachai/ABE-3372-2021	Deakin, Janine/0000-0002-1259-3531; Glenn, Travis C/0000-0001-7725-3637; Lyons, Eric/0000-0002-3348-8845; Jaratlerdsiri, Weerachai/0000-0001-9100-1807; Peterson, Daniel/0000-0002-0274-5968; Higgins, Damien/0000-0003-1215-6523; Gongora, Jaime/0000-0003-2215-656X; Ray, David/0000-0002-3340-3987; Chong, Amanda/0000-0003-4919-2632; Isberg, Sally/0000-0002-8895-2414	Rural Industries Research and Development Corporation grant [PRJ-002461]; US National Science Foundation [MCB-1052500, MCB-0841821]; Direct For Biological Sciences [0841821] Funding Source: National Science Foundation	Rural Industries Research and Development Corporation grant(Rural Industries R&D Corp); US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was partially supported by a Rural Industries Research and Development Corporation grant (http://www.rirdc.gov.au/; PRJ-002461 to SRI JG). Funding for the C. porosus, A. mississippiensis, and G. gangeticus genome drafts was provided, in part, by the US National Science Foundation (http://www.nsf.gov/; MCB-1052500 and MCB-0841821 to DAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadou C, 2003, HUM MOL GENET, V12, P3025, DOI 10.1093/hmg/ddg317; Amadou C, 1999, IMMUNOGENETICS, V49, P362, DOI 10.1007/s002510050507; Anzai T, 2003, P NATL ACAD SCI USA, V100, P7708, DOI 10.1073/pnas.1230533100; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; BARTL S, 1994, P NATL ACAD SCI USA, V91, P262, DOI 10.1073/pnas.91.1.262; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; Bouvier M, 2003, MOL IMMUNOL, V39, P697, DOI 10.1016/S0161-5890(02)00261-4; Brown TA, 2002, SEQUENCING GENOMES G; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burri R, 2008, MOL BIOL EVOL, V25, P1180, DOI 10.1093/molbev/msn065; Chaves LD, 2009, J IMMUNOL, V183, P6530, DOI 10.4049/jimmunol.0901310; Clark MS, 2001, IMMUNOGENETICS, V52, P174, DOI 10.1007/s002510000285; Deakin JE, 2008, CHROMOSOME RES, V16, P1159, DOI 10.1007/s10577-008-1266-y; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Ferreri GC, 2004, CYTOGENET GENOME RES, V107, P115, DOI 10.1159/000079580; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Fukami-Kobayashi K, 2005, P NATL ACAD SCI USA, V102, P9230, DOI 10.1073/pnas.0500770102; Ganapathy G, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-11; Gao JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-466; Green RE, SCIENCE; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Haase D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0044; Hosomichi K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-322; Hughes AL, 2008, MOL BIOL EVOL, V25, P2681, DOI 10.1093/molbev/msn207; Jaratlerdsiri W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087534; Jaratlerdsiri W, 2014, IMMUNOGENETICS, V66, P53, DOI 10.1007/s00251-013-0746-1; Jaratlerdsiri W, 2012, IMMUNOGENETICS, V64, P825, DOI 10.1007/s00251-012-0637-x; Jerome Mariette, 2011, BMC Res Notes, V4, P149, DOI 10.1186/1756-0500-4-149; KASAHARA M, 1993, EUR J IMMUNOL, V23, P2160, DOI 10.1002/eji.1830230917; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; Kaufman J, 2013, MOL IMMUNOL, V55, P159, DOI 10.1016/j.molimm.2012.10.030; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kitts P, 2002, NCBI HDB; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; Kulski JK, 1999, J MOL EVOL, V49, P84, DOI 10.1007/PL00006537; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Kumanovics A, 2003, ANNU REV IMMUNOL, V21, P629, DOI 10.1146/annurev.immunol.21.090501.080116; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kuroda N, 2002, IMMUNOGENETICS, V54, P418, DOI 10.1007/s00251-002-0473-5; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloyd Mark, 1999, Bulletin of the Association of Reptilian and Amphibian Veterinarians, V9, P12; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Lukacs MF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-251; Lyons E., 2008, Tropical Plant Biology, V1, P181, DOI 10.1007/s12042-008-9017-y; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Organ CL, 2007, NATURE, V446, P180, DOI 10.1038/nature05621; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Promerova M, 2009, IMMUNOGENETICS, V61, P451, DOI 10.1007/s00251-009-0375-x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Renard C, 2006, GENOMICS, V88, P96, DOI 10.1016/j.ygeno.2006.01.004; Sambrook JG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-152; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Sato A, 2011, MOL BIOL EVOL, V28, P1943, DOI 10.1093/molbev/msr015; Schut E, 2011, IMMUNOGENETICS, V63, P531, DOI 10.1007/s00251-011-0532-x; Shan X, 2009, BMC GENOMICS, V10, P59; Shiina T, 1999, P NATL ACAD SCI USA, V96, P13282, DOI 10.1073/pnas.96.23.13282; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; Siddle HV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-421; Siddle HV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-310; SNELL GD, 1992, SCAND J IMMUNOL, V36, P513; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; St John JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-415; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Walker BA, 2005, IMMUNOGENETICS, V57, P232, DOI 10.1007/s00251-005-0786-2; Wan QH, 2013, CELL RES, V23, P1091, DOI 10.1038/cr.2013.104; Wang B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-553; Westerdahl H, 2004, HEREDITY, V92, P534, DOI 10.1038/sj.hdy.6800450; Wilming LG, 2013, SEQUENCING COMP ANAL; Yap MW, 2012, TRIM RBCC PROTEINS; Ye Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032154; Yuhki N, 2007, J HERED, V98, P390, DOI 10.1093/jhered/esm056; Zagalska-Neubauer M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-395; Zhan X, 2014, GIGASCIENCE, DOI [10.5524/101006., DOI 10.5524/101006.]; Zhang G, 2014, GIGASCIENCE, DOI [10.5524/101013, DOI 10.5524/101013.]; Zheng J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	93	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114631	10.1371/journal.pone.0114631	http://dx.doi.org/10.1371/journal.pone.0114631			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503521	Green Published, gold			2022-12-27	WOS:000347146700036
J	Marchio, A; Bertani, S; Rojas, TR; Doimi, F; Terris, B; Deharo, E; Dejean, A; Ruiz, E; Pineau, P				Marchio, Agnes; Bertani, Stephane; Rojas, Teresa Rojas; Doimi, Franco; Terris, Benoit; Deharo, Eric; Dejean, Anne; Ruiz, Eloy; Pineau, Pascal			A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							ALPHA-FETOPROTEIN GENE; FREQUENT SOMATIC MUTATIONS; BETA-CATENIN MUTATIONS; TUMOR-SUPPRESSOR GENE; CANCER STEM-CELLS; LIVER-CANCER; LATIN-AMERICA; EXPRESSION; HEPATITIS; EXPOSURE	Hepatocellular carcinoma usually afflicts individuals in their later years following longstanding liver disease. In Peru, hepatocellular carcinoma exists in a unique clinical presentation, which affects patients around age 25 with a normal, healthy liver. In order to deepen our understanding of the molecular processes ongoing in Peruvian liver tumors, mutation spectrum analysis was carried out on hepatocellular carcinomas from 80 Peruvian patients. Sequencing analysis focused on nine genes typically altered during liver carcinogenesis, i.e. ARID2, AXIN1, BRAF, CTNNB1, NFE2L2, H/K/N-RAS, and TP53. We also assessed the transcription level of factors involved in the control of the alpha-fetoprotein expression and the Hippo signaling pathway that controls contact inhibition in metazoans. The mutation spectrum of Peruvian patients was unique with a major class of alterations represented by Insertions/Deletions. There were no changes at hepatocellular carcinoma-associated mutation hotspots in more than half of the specimens analyzed. Furthermore, our findings support the theory of a consistent collapse in the Hippo axis, as well as an expression of the stemness factor NANOG in high alpha-fetoprotein-expressing hepatocellular carcinomas. These results confirm the specificity of Peruvian hepatocellular carcinoma at the molecular genetic level. The present study emphasizes the necessity to widen cancer research to include historically neglected patients from South America, and more broadly the Global South, where cancer genetics and tumor presentation are divergent from canonical neoplasms.	[Marchio, Agnes; Dejean, Anne; Pineau, Pascal] Inst Pasteur, Unite Org Nucl & Oncogenese, Paris, France; [Bertani, Stephane; Dejean, Anne; Pineau, Pascal] INSERM, U993, Paris, France; [Bertani, Stephane; Deharo, Eric] Univ Toulouse 3, UPS, PHARMADEV UMR152, F-31062 Toulouse, France; [Bertani, Stephane] Inst Rech Dev, PHARMADEV UMR152, Lima, Peru; [Rojas, Teresa Rojas] Aix Marseille Univ, Ctr Epidemiol & St Publ Armees, SESSTIM INSERM IRD AMU UMR192, Marseille, France; [Doimi, Franco] Inst Nacl Enfermedades Neoplasicas, Dept Patol Banco Tejidos Tumor, Lima, Peru; [Terris, Benoit] Hop Cochin, AP HP, Serv Anat & Cytol Pathol, F-75674 Paris, France; [Deharo, Eric] Inst Rech Dev, PHARMADEV UMR152, Viangchan, Laos; [Ruiz, Eloy] Inst Nacl Enfermedades Neoplasicas, Dept Cirugia Abdomen, Lima, Peru	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Instituto Nacional de Enfermedades Neoplasicas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Instituto Nacional de Enfermedades Neoplasicas	Pineau, P (corresponding author), Inst Pasteur, Unite Org Nucl & Oncogenese, Paris, France.	pascal.pineau@pasteur.fr	Pineau, Pascal/AAP-5614-2020; Deharo, Eric/I-6026-2015; Rojas, Teresa/E-3057-2016; Bertani, Stephane/B-1250-2013; Dejean, Anne/L-5145-2018; Terris, Benoit/P-1497-2017	Pineau, Pascal/0000-0002-9407-1592; Deharo, Eric/0000-0002-5664-9517; Bertani, Stephane/0000-0002-0398-9745; Rojas, Teresa/0000-0003-1536-3675	French National League against Cancer; Third Cancer Plan, ITMO Cancer of the French National Alliance for Life Sciences and Health (Aviesan) [ENV201408]; Young Teams Associated to IRD Program (INCAnCER); Peruvian FINCyT Science and Technology Program's Scholarships for Doctoral Studies Abroad [BECA-1-P-155-13]	French National League against Cancer; Third Cancer Plan, ITMO Cancer of the French National Alliance for Life Sciences and Health (Aviesan); Young Teams Associated to IRD Program (INCAnCER); Peruvian FINCyT Science and Technology Program's Scholarships for Doctoral Studies Abroad	This work was funded by the French National League against Cancer (team label LNCC) and Odyssey-RE; SB and ED (PI) were supported by the Third Cancer Plan, ITMO Cancer of the French National Alliance for Life Sciences and Health (Aviesan) (ENV201408); FD (PI) and ER were supported by the Young Teams Associated to IRD Program (INCAnCER); TRR was a recipient of a doctoral fellowship from the Peruvian FINCyT Science and Technology Program's Scholarships for Doctoral Studies Abroad (BECA-1-P-155-13). The funders had no role in study design, data collection and analysis, decision	American Joint Committee on Cancer, 2002, AM JOINT COMM CANC S; BECKER FF, 1975, CANCER RES, V35, P1510; Bei R, 2011, CURR MOL MED, V11, P564, DOI 10.2174/156652411800615162; Bertani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067756; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; BOISJOYEUX B, 1995, J BIOL CHEM, V270, P10204, DOI 10.1074/jbc.270.17.10204; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Bryant-Greenwood PK, 1998, FETAL DIAGN THER, V13, P46, DOI 10.1159/000020801; Cabezas César, 2007, Rev. perú. med. exp. salud publica, V24, P378; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; Di Bisceglie AM, 2004, GASTROENTEROLOGY, V127, pS104, DOI 10.1053/j.gastro.2004.09.022; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fassio E, 2010, ANN HEPATOL, V9, P63, DOI 10.1016/S1665-2681(19)31681-3; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Garcia-Diaz M, 2006, TRENDS BIOCHEM SCI, V31, P206, DOI 10.1016/j.tibs.2006.02.004; Gillespie JR, 2000, BBA-PROTEIN STRUCT M, V1480, P41, DOI 10.1016/S0167-4838(00)00104-7; Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2; Greenblatt MS, 1996, CANCER RES, V56, P2130; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Indacochea Sonia, 1997, Rev Gastroenterol Peru, V17, P56; Kenney J.F., 1962, MATH STAT, V3rd ed., P101; KEW M, 1974, GUT, V15, P814, DOI 10.1136/gut.15.10.814; Kew M C, 1995, Trop Gastroenterol, V16, P11; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; KOROPATNICK J, 1988, J BIOCHEM TOXICOL, V3, P159, DOI 10.1002/jbt.2570030304; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; LOGRIECO A, 1993, MYCOPATHOLOGIA, V122, P185, DOI 10.1007/BF01103480; MACNAB GM, 1976, BRIT J CANCER, V33, P544, DOI 10.1038/bjc.1976.86; Magee TR, 1998, J BIOL CHEM, V273, P30024, DOI 10.1074/jbc.273.45.30024; Marcos LA, 2009, J HELMINTHOL, V83, P23, DOI 10.1017/S0022149X08067205; McGlynn KA, 2005, BEST PRACT RES CL GA, V19, P3, DOI 10.1016/j.bpg.2004.10.004; Nuttall KL, 2000, MED HYPOTHESES, V54, P498, DOI 10.1054/mehy.1999.0884; O'Connor ML, 2014, CANCER LETT, V344, P180, DOI 10.1016/j.canlet.2013.11.012; OBrien JE, 1997, OBSTET GYNECOL, V89, P355, DOI 10.1016/S0029-7844(96)00524-8; Peterson ML, 2011, SEMIN CANCER BIOL, V21, P21, DOI 10.1016/j.semcancer.2011.01.001; Pineau P, 2008, MUTAT RES-GEN TOX EN, V653, P6, DOI 10.1016/j.mrgentox.2008.01.012; Ruiz Eloy, 1998, Rev Gastroenterol Peru, V18, P199; Ruiz Eloy, 2007, Rev. gastroenterol. Perú, V27, P223; Sandoval JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073006; SCOTT RJ, 1989, CANCER RES, V49, P6085; Sell S, 1998, PATHOLOGY, V30, P34, DOI 10.1080/00313029800169645; SHUIN T, 1994, CANCER RES, V54, P2852; SIZARET P, 1975, ANN NY ACAD SCI, V259, P136, DOI 10.1111/j.1749-6632.1975.tb25410.x; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; SMALLEY SR, 1988, CANCER-AM CANCER SOC, V62, P1414, DOI 10.1002/1097-0142(19881001)62:7<1414::AID-CNCR2820620729>3.0.CO;2-7; SOLT DB, 1983, CANCER RES, V43, P188; Spear BT, 1999, SEMIN CANCER BIOL, V9, P109, DOI 10.1006/scbi.1998.0087; Sun C, 2013, INT J BIOCHEM CELL B, V45, P1099, DOI 10.1016/j.biocel.2013.02.017; Szymanska K, 2009, CANCER EPIDEM BIOMAR, V18, P1638, DOI 10.1158/1055-9965.EPI-08-1102; Tanase AM, 2015, J EXPO SCI ENV EPID, V25, P256, DOI 10.1038/jes.2014.16; Teschendorff AE, 2006, BIOINFORMATICS, V22, P2269, DOI 10.1093/bioinformatics/btl174; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trevisani F, 2010, DIGEST LIVER DIS, V42, P341, DOI 10.1016/j.dld.2009.09.002; Tsang YT, 2013, J PATHOL, V231, P449, DOI 10.1002/path.4252; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Tsoulfas G, 2012, ANZ J SURG, V82, P510, DOI 10.1111/j.1445-2197.2012.06079.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; VOGEL CL, 1970, LANCET, V2, P621; Wang J, 2009, CANCER INFORM, V7, P199; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Wilkening S, 2007, CARCINOGENESIS, V28, P2262, DOI 10.1093/carcin/bgm191; Yacoub C, 2012, SCI WORLD J, P1, DOI 10.1100/2012/732519; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100	72	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114912	10.1371/journal.pone.0114912	http://dx.doi.org/10.1371/journal.pone.0114912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502816	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700070
J	Meyers, DJ; Hood, ME; Stopka, TJ				Meyers, David J.; Hood, Maria Elena; Stopka, Thomas J.			HIV and Hepatitis C Mortality in Massachusetts, 2002-2011: Spatial Cluster and Trend Analysis of HIV and HCV Using Multiple Cause of Death	PLOS ONE			English	Article								Background: Infectious diseases, while associated with a much smaller proportion of deaths than they were 50 years ago, still play a significant role in mortality across the state of Massachusetts. Most analysis of infectious disease mortality in the state only take into account the underlying cause of death, rather than contributing causes of death, which may not capture the full extent of mortality trends for infectious diseases such as HIV and the Hepatitis C virus (HCV). Methods: In this study we sought to evaluate current trends in infectious disease mortality across the state using a multiple cause of death methodology. We performed a mortality trend analysis, identified spatial clusters of disease using a 5-step geoprocessing approach and examined spatial-temporal clustering trends in infectious disease mortality in Massachusetts from 2002-2011, with a focus on HIV/AIDS and HCV. Results: Significant clusters of high infectious disease mortality in space and time throughout the state were detected through both spatial and space time cluster analysis. The most significant clusters occurred in Springfield, Worcester, South Boston, the Merrimack Valley, and New Bedford with other smaller clusters detected across the state. Multiple cause of death mortality rates were much higher than underlying cause mortality alone, and significant disparities existed across race and age groups. Conclusions: We found that our multi-method analyses, which focused on contributing causes of death, were more robust than analyses that focused on underlying cause of death alone. Our results may be used to inform public health resource allocation for infectious disease prevention and treatment programs, provide novel insight into the current state of infectious disease mortality throughout the state, and benefited from approaches that may more accurately document mortality trends.	[Meyers, David J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Meyers, David J.; Stopka, Thomas J.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Hood, Maria Elena] Massachusetts Dept Publ Hlth, Off Data Management & Outcomes Assessment, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Department of Public Health; Tufts University; Massachusetts Department of Public Health	Meyers, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	dmeyers@hsph.harvard.edu	Meyers, David J/AFI-1703-2022; Stopka, Thomas/GSN-6831-2022	Meyers, David J/0000-0002-4081-1751; 	Office of Data Management and Outcomes Assessment at the Massachusetts Department of Public Health; Department of Public Health and Community Medicine at the Tufts University School of Medicine	Office of Data Management and Outcomes Assessment at the Massachusetts Department of Public Health; Department of Public Health and Community Medicine at the Tufts University School of Medicine	The authors would like to thank Christine Rioux, Kenneth Chui, and Brandon Olsen for additional guidance on the manuscript. This work was supported in kind by the Office of Data Management and Outcomes Assessment at the Massachusetts Department of Public Health and the Department of Public Health and Community Medicine at the Tufts University School of Medicine.	Burra T, 2002, CAN GEOGR-GEOGR CAN, V46, P160, DOI 10.1111/j.1541-0064.2002.tb00737.x; Ed Hsu Chiehwen, 2004, Int J Health Geogr, V3, P4; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gundogdu IB, 2010, SAFETY SCI, V48, P763, DOI 10.1016/j.ssci.2010.02.016; HOOD M, 2013, MASSACHUSETTS DEATHS; KANJALA C, 2010, GLOB HLTH ACTION, V3; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; MACKENBACH JP, 1995, AM J EPIDEMIOL, V141, P466, DOI 10.1093/oxfordjournals.aje.a117449; Mahajan R, 2014, CLIN INFECT DIS, V58, P1055, DOI 10.1093/cid/ciu077; MANTON KG, 1980, GERONTOLOGIST, V20, P480, DOI 10.1093/geront/20.4.480; *MASSGIS, 2014, ADMINISTRATION AND F; *MDPH, 2011, AM J TRANSPLANT, V11, P1535, DOI DOI 10.1111/J.1600-6143.2011.03659.X; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; MJ A, 1994, GASTROENTEROL CLIN N, V23, P437; Nkhoma Ella T, 2004, Int J Health Geogr, V3, P25, DOI 10.1186/1476-072X-3-25; Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6; Rosenberg PS, 1998, JAMA-J AM MED ASSOC, V279, P1894, DOI 10.1001/jama.279.23.1894; Sabel CE, 2007, SOC SCI MED, V65, P43, DOI 10.1016/j.socscimed.2007.02.040; Stopka TJ, 2014, AM J PUBLIC HEALTH, V104, pS183, DOI 10.2105/AJPH.2013.301769	20	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114822	10.1371/journal.pone.0114822	http://dx.doi.org/10.1371/journal.pone.0114822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25502820	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700056
J	Xu, JF; Yang, GH; Pan, XH; Zhang, SJ; Zhao, C; Qiu, BS; Gu, HF; Hong, JF; Cao, L; Chen, Y; Xia, B; Bi, Q; Wang, YP				Xu, Ji-Feng; Yang, Guang-hai; Pan, Xiao-Hong; Zhang, Shui-Jun; Zhao, Chen; Qiu, Bin-Song; Gu, Hai-Feng; Hong, Jian-Fei; Cao, Li; Chen, Yu; Xia, Bing; Bi, Qin; Wang, Ya-Ping			Altered MicroRNA Expression Profile in Exosomes during Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							HUMAN SALIVA; IN-VITRO; MICROVESICLES; MECHANISM; WNT; MICROPARTICLES; INHIBITION; SECRETION; PROTEINS; TARGETS	The physiological role of microRNAs (miRNAs) in osteoblast differentiation remains elusive. Exosomal miRNAs isolated from human bone marrow-derived mesenchymal stem cells (BMSCs) culture were profiled using miRNA arrays containing probes for 894 human matured miRNAs. Seventy-nine miRNAs (similar to 8.84%) could be detected in exosomes isolated from BMSC culture supernatants when normalized to endogenous control genes RNU44. Among them, nine exosomal miRNAs were up regulated and 4 miRNAs were under regulated significantly (Relative fold >2, p<0.05) when compared with the values at 0 day with maximum changes at 1 to 7 days. Five miRNAs (miR-199b, miR-218, miR-148a, miR-135b, and miR-221) were further validated and differentially expressed in the individual exosomal samples from hBMSCs cultured at different time points. Bioinformatic analysis by DIANA-mirPath demonstrated that RNA degradation, mRNA surveillance pathway, Wnt signaling pathway, RNA transport were the most prominent pathways enriched in quantiles with differential exosomal miRNA patterns related to osteogenic differentiation. These data demonstrated exosomal miRNA is a regulator of osteoblast differentiation.	[Xu, Ji-Feng; Zhang, Shui-Jun; Zhao, Chen; Qiu, Bin-Song; Gu, Hai-Feng; Hong, Jian-Fei; Cao, Li; Chen, Yu; Xia, Bing; Bi, Qin] Zhejiang Prov Peoples Hosp, Dept Orthoped & Joint Surg, Hangzhou 310014, Zhejiang, Peoples R China; [Pan, Xiao-Hong; Wang, Ya-Ping] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310009, Zhejiang, Peoples R China; [Yang, Guang-hai] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Thorac Surg, Wuhan 430022, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang University; Huazhong University of Science & Technology	Xu, JF (corresponding author), Zhejiang Prov Peoples Hosp, Dept Orthoped & Joint Surg, Hangzhou 310014, Zhejiang, Peoples R China.	xu_jifeng@hotmail.com; wangypzju@163.com			Medical Scientific Research Foundation of Zhejiang Province, China [2013KYB031]; National Natural Science Foundation of China [81200113]; Fundamental Research Funds for the Central Universities [2014FZA7014]	Medical Scientific Research Foundation of Zhejiang Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by Medical Scientific Research Foundation of Zhejiang Province, China (Grant No. 2013KYB031), National Natural Science Foundation of China (Grant No. 81200113), the Fundamental Research Funds for the Central Universities (Grant No. 2014FZA7014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatonen M, 2012, SEMIN THROMB HEMOST, V38, P102, DOI 10.1055/s-0031-1300956; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Bakhshandeh B, 2012, BIOTECHNOL LETT, V34, P1579, DOI 10.1007/s10529-012-0934-3; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Chen TS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-47; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; Johansson SM, 2008, IMMUNOLOGY, V123, P491, DOI 10.1111/j.1365-2567.2007.02714.x; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Li XB, 2006, J CELL MOL MED, V10, P364, DOI 10.1111/j.1582-4934.2006.tb00405.x; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Liu ZY, 2006, J BIOL CHEM, V281, P17156, DOI 10.1074/jbc.M513812200; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; Okamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043800; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rosen CJ, 2005, NEW ENGL J MED, V353, P595, DOI 10.1056/NEJMcp043801; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sanchez-Arago M, 2013, EMBO REP, V14, P638, DOI 10.1038/embor.2013.72; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vimalraj S, 2013, CURR ISSUES MOL BIOL, V15, P7; Wei JF, 2014, STEM CELLS DEV, V23, P1452, DOI 10.1089/scd.2013.0600; Xu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079752; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhang WB, 2014, BONE, V58, P59, DOI 10.1016/j.bone.2013.09.015; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	57	152	181	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114627	10.1371/journal.pone.0114627	http://dx.doi.org/10.1371/journal.pone.0114627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503309	Green Published, Green Submitted, gold			2022-12-27	WOS:000347146700035
J	Ellis, LD; Soo, EC; Achenbach, JC; Morash, MG; Soanes, KH				Ellis, Lee D.; Soo, Evelyn C.; Achenbach, John C.; Morash, Michael G.; Soanes, Kelly H.			Use of the Zebrafish Larvae as a Model to Study Cigarette Smoke Condensate Toxicity	PLOS ONE			English	Article							GENE-EXPRESSION CHANGES; EARLY DRUG DISCOVERY; DEVELOPMENTAL NEUROTOXICITY; LOCOMOTOR-ACTIVITY; EMBRYOS; TOXICOLOGY; INDUCTION; VALPROATE; RECEPTOR; AIRWAY	The smoking of tobacco continues to be the leading cause of premature death worldwide and is linked to the development of a number of serious illnesses including heart disease, respiratory diseases, stroke and cancer. Currently, cell line based toxicity assays are typically used to gain information on the general toxicity of cigarettes and other tobacco products. However, they provide little information regarding the complex disease-related changes that have been linked to smoking. The ethical concerns and high cost associated with mammalian studies have limited their widespread use for in vivo toxicological studies of tobacco. The zebrafish has emerged as a low-cost, high-throughput, in vivo model in the study of toxicology. In this study, smoke condensates from 2 reference cigarettes and 6 Canadian brands of cigarettes with different design features were assessed for acute, developmental, cardiac, and behavioural toxicity (neurotoxicity) in zebrafish larvae. By making use of this multifaceted approach we have developed an in vivo model with which to compare the toxicity profiles of smoke condensates from cigarettes with different design features. This model system may provide insights into the development of smoking related disease and could provide a cost-effective, high-throughput platform for the future evaluation of tobacco products.	[Ellis, Lee D.; Achenbach, John C.; Morash, Michael G.; Soanes, Kelly H.] Natl Res Council Canada, Aquat & Crop Resource Dev, Halifax, NS B3H 3Z1, Canada; [Soo, Evelyn C.] Hlth Canada, Div Sci, Off Res & Surveillance, Controlled Subst & Tobacco Directorate, Ottawa, ON K1A 0K9, Canada	International Business Machines (IBM); National Research Council Canada; Health Canada	Soo, EC (corresponding author), Hlth Canada, Div Sci, Off Res & Surveillance, Controlled Subst & Tobacco Directorate, 150 Tunneys Pasture Driveway, Ottawa, ON K1A 0K9, Canada.	evelyn.soo@hc-sc.gc.ca		Morash, Michael/0000-0002-2530-3855; Achenbach, John/0000-0002-0267-8398	Health Canada under the Federal Tobacco Control Strategy; National Research Council Canada	Health Canada under the Federal Tobacco Control Strategy; National Research Council Canada	This work was supported by Health Canada under the Federal Tobacco Control Strategy and the National Research Council Canada. Health Canada contributed to study design, decision to publish and preparation of the manuscript. The National Research Council contributed to study design, data collection and analysis, decision to publish and preparation of the manuscript.	Abbott LC, 2012, CRIT REV TOXICOL, V42, P279, DOI 10.3109/10408444.2012.658506; Alderton W.K., 2013, DRUG DISCOV TODAY, V10, pE43, DOI [10.1016/j.ddmod.2012.02.006, DOI 10.1016/J.DDMOD.2012.02.006]; Antal S, 2009, IN VIVO, V23, P267; Bailey J, 2013, BIRTH DEFECTS RES C, V99, P14, DOI 10.1002/bdrc.21027; Baliunas Dolly, 2007, Chronic Dis Can, V27, P154; Barros TP, 2008, BRIT J PHARMACOL, V154, P1400, DOI 10.1038/bjp.2008.249; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Centers for Disease Control and Prevention, 2011, TOB BRAND PREF; Counts ME, 2005, REGUL TOXICOL PHARM, V41, P185, DOI 10.1016/j.yrtph.2004.12.002; Cowden J, 2012, REPROD TOXICOL, V33, P165, DOI 10.1016/j.reprotox.2011.11.111; Dhillon SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060552; Dukovcic SR, 2010, J APPL TOXICOL, V30, P574, DOI 10.1002/jat.1528; Fan CY, 2010, NEUROTOXICOL TERATOL, V32, P91, DOI 10.1016/j.ntt.2009.04.065; Guo XQ, 2011, MUTAGENESIS, V26, P273, DOI 10.1093/mutage/geq083; HAAG HB, 1959, ARCHIV OTOLARYNGOL, V69, P261; Health Canada, 1991, T115 HLTH CAN; Health Canada, 2011, CAN TOB MON SURV CTU; Incardona JP, 2006, TOXICOL APPL PHARM, V217, P308, DOI 10.1016/j.taap.2006.09.018; International Organization for Standardization, 2004, 101852004 ISO; International Standard Organization, 2012, 33082012 ISO; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; ISO, 1999, ICS, V65, P160; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kuo WH, 2005, CHEM-BIOL INTERACT, V155, P31, DOI 10.1016/j.cbi.2005.04.008; Lesser C., 2003, U.S. Patent, Patent No. [6,530,377 B1, 6530377]; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; McGee SP, 2013, TOXICOL SCI, V133, P144, DOI 10.1093/toxsci/kft020; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Muth-Kohne E, 2012, NEUROTOXICOL TERATOL, V34, P413, DOI 10.1016/j.ntt.2012.04.006; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018; Park MJ, 2013, TOXICOL LETT, V216, P9, DOI 10.1016/j.toxlet.2012.10.018; Perkins AC, 1996, P NATL ACAD SCI USA, V93, P12267, DOI 10.1073/pnas.93.22.12267; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; *PHYS SMOK FREE CA, 1999, ENG CAN CIG; Pruvot B, 2012, REPROD TOXICOL, V34, P568, DOI 10.1016/j.reprotox.2012.07.010; Rehm J., 2006, COSTS SUBSTANCES ABU; Seguin B. P., 2012, SRNTS 18 ANN M 13 16; Sipes NS, 2011, BIRTH DEFECTS RES C, V93, P256, DOI 10.1002/bdrc.20214; Siu M, 2013, TOB CONTROL, V22, DOI 10.1136/tobaccocontrol-2012-050450; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Sridhar S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-259; Staddon JER, 2010, J EXP ANAL BEHAV, V94, P261, DOI 10.1901/jeab.2010.94-261; Svoboda KR, 2002, J NEUROSCI, V22, P10731; U. S. Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2004, HLTH CONS SMOK; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; World Health Organization, 2019, WHO REPORT GLOBAL TO; Zellner D, 2011, NEUROTOXICOL TERATOL, V33, P674, DOI 10.1016/j.ntt.2011.06.007	50	34	34	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2014	9	12							e115305	10.1371/journal.pone.0115305	http://dx.doi.org/10.1371/journal.pone.0115305			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8WK	25526262	Green Submitted, Green Published, gold			2022-12-27	WOS:000347186200022
J	Ye, WJ; Paul, D; Gao, LN; Seckute, J; Sangaiah, R; Jayaraj, K; Zhang, ZF; Kaminski, PA; Ealick, SE; Gold, A; Ball, LM				Ye, Wenjie; Paul, Debamita; Gao, Lina; Seckute, Jolita; Sangaiah, Ramiah; Jayaraj, Karupiah; Zhang, Zhenfa; Kaminski, P. Alexandre; Ealick, Steven E.; Gold, Avram; Ball, Louise M.			Ethenoguanines Undergo Glycosylation by Nucleoside 2 '-Deoxyribosyltransferases at Non-Natural Sites	PLOS ONE			English	Article							TRANS-N-DEOXYRIBOSYLASE; LACTOBACILLUS-HELVETICUS; ENZYMATIC-SYNTHESIS; SOFTWARE; PURINE; ADDUCTS; BASES; N2,3-ETHENOGUANINE; 1,N2-ETHENOGUANINE; PURIFICATION	Deoxyribosyl transferases and functionally related purine nucleoside phosphorylases are used extensively for synthesis of non-natural deoxynucleosides as pharmaceuticals or standards for characterizing and quantitating DNA adducts. Hence exploring the conformational tolerance of the active sites of these enzymes is of considerable practical interest. We have determined the crystal structure at 2.1 A resolution of Lactobacillus helveticus purine deoxyribosyl transferase (PDT) with the tricyclic purine 8,9-dihydro-9-oxoimidazo[2,1-b] purine (N-2,3-ethenoguanine) at the active site. The active site electron density map was compatible with four orientations, two consistent with sites for deoxyribosylation and two appearing to be unproductive. In accord with the crystal structure, Lactobacillus helveticus PDT glycosylates the 8,9-dihydro-9-oxoimidazo[2,1-b] purine at N7 and N1, with a marked preference for N7. The activity of Lactobacillus helveticus PDT was compared with that of the nucleoside 2'-deoxyribosyltransferase enzymes (DRT Type II) from Lactobacillus leichmannii and Lactobacillus fermentum, which were somewhat more effective in the deoxyribosylation than Lactobacillus helveticus PDT, glycosylating the substrate with product profiles dependent on the pH of the incubation. The purine nucleoside phosphorylase of Escherichia coli, also commonly used in ribosylation of non-natural bases, was an order of magnitude less efficient than the transferase enzymes. Modeling based on published active-site structures as templates suggests that in all cases, an active site Phe is critical in orienting the molecular plane of the purine derivative. Adventitious hydrogen bonding with additional active site residues appears to result in presentation of multiple nucleophilic sites on the periphery of the acceptor base for ribosylation to give a distribution of nucleosides. Chemical glycosylation of O-9-benzylated 8,9-dihydro-9-oxoimidazo[2,1-b] purine also resulted in N7 and N1 ribosylation. Absent from the enzymatic and chemical glycosylations is the natural pattern of N3 ribosylation, verified by comparison of spectroscopic and chromatographic properties with an authentic standard synthesized by an unambiguous route.	[Ye, Wenjie; Gao, Lina; Sangaiah, Ramiah; Jayaraj, Karupiah; Zhang, Zhenfa; Gold, Avram; Ball, Louise M.] Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Paul, Debamita; Seckute, Jolita; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Kaminski, P. Alexandre] Inst Pasteur, UMR CNRS, Unite Chim & Biocatalyse, Paris, France	University of North Carolina; University of North Carolina Chapel Hill; Cornell University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gold, A (corresponding author), Univ N Carolina, Dept Environm Sci & Engn, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	golda@email.unc.edu		Kaminski, Pierre Alexandre/0000-0001-9841-6837	National Institutes of Health (NIH) [P42-ES05948, P30ES010126, GM73220]; National Institute of General Medical Sciences at NIH [GM103403]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073220, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences at NIH; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Grants P42-ES05948 and P30ES010126 (LMB) and GM73220 (SEE). The crystal structure is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award GM103403 from the National Institute of General Medical Sciences at NIH. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anand R, 2004, BIOCHEMISTRY-US, V43, P2384, DOI 10.1021/bi035723k; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Barth C, 2004, Z NATURFORSCH B, V59, P802; BECK W, 1963, J BIOL CHEM, V238, P702; Bennett EM, 2003, J BIOL CHEM, V278, P47110, DOI 10.1074/jbc.M304622200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DANZIN C, 1974, EUR J BIOCHEM, V48, P255, DOI 10.1111/j.1432-1033.1974.tb03763.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fresco-Taboada A, 2013, APPL MICROBIOL BIOT, V97, P3773, DOI 10.1007/s00253-013-4816-y; Gros L, 2003, MUTAT RES-FUND MOL M, V531, P219, DOI 10.1016/j.mrfmmm.2003.07.008; GUENGERICH FP, 1993, CHEM RES TOXICOL, V6, P635, DOI 10.1021/tx00035a008; HOFFER M, 1960, CHEM BER-RECL, V93, P2777, DOI 10.1002/cber.19600931204; HOLGUINH.J, 1972, FEBS LETT, V20, P171, DOI 10.1016/0014-5793(72)80785-3; HUANG MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P133, DOI 10.1016/0003-9861(83)90510-6; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; Kaminski PA, 2008, J BIOL CHEM, V283, P20053, DOI 10.1074/jbc.M802706200; KHAZANCHI R, 1993, J ORG CHEM, V58, P2552, DOI 10.1021/jo00061a033; Konstantinova ID, 2013, SYNTHESIS-STUTTGART, V45, P272, DOI 10.1055/s-0032-1317782; KRENITSKY TA, 1986, J MED CHEM, V29, P138, DOI 10.1021/jm00151a022; KUSMIEREK JT, 1989, CHEM RES TOXICOL, V2, P230, DOI 10.1021/tx00010a003; LEE H, 1990, TETRAHEDRON LETT, V31, P6773, DOI 10.1016/S0040-4039(00)97168-5; Liang SH, 2010, J BIOSCI BIOENG, V110, P165, DOI 10.1016/j.jbiosc.2010.01.017; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riegelhaupt PM, 2010, MOL BIOCHEM PARASIT, V169, P40, DOI 10.1016/j.molbiopara.2009.10.001; Roivainen J, 2007, NUCLEOS NUCLEOT NUCL, V26, P905, DOI 10.1080/15257770701506343; SANGAIAH R, 1992, TETRAHEDRON LETT, V33, P5487, DOI 10.1016/S0040-4039(00)61124-3; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; Schrodinger LLC, 2011, MACR VERS 9 9; Serra I, 2013, CHEMPLUSCHEM, V78, P157, DOI 10.1002/cplu.201200278; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047	37	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115082	10.1371/journal.pone.0115082	http://dx.doi.org/10.1371/journal.pone.0115082			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25521390	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600016
J	Chang, HT; Hu, C; Chiu, YL; Peng, NJ; Liu, RS				Chang, Hong-Tai; Hu, Chin; Chiu, Yu-Li; Peng, Nan-Jing; Liu, Ren-Shyan			Role of 2-[F-18] Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography/Computed Tomography in the Post-Therapy Surveillance of Breast Cancer	PLOS ONE			English	Article							TUMOR-MARKERS; FOLLOW-UP; FDG-PET; CLINICAL IMPACT; CA 15-3; RECURRENT; MANAGEMENT; DIAGNOSIS	Purpose: To evaluate the usefulness of 2-[F-18] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography (FDG-PET/CT) in the early detection of breast cancer tumor recurrences and its role in post-therapy surveillance. Methods: FDG-PET/CT was performed on patients with increased serum CA 15-3 levels and/or clinical/radiologic suspicion of recurrence. A group of asymptomatic patients who underwent FDG-PET/CT in the post-therapy surveillance of breast cancer served as the controls. The results were analyzed based on the patients' histological data, other imaging modalities and/or clinical follow-up. Recurrence was defined as evidence of recurrent lesions within 12 months of the FDG-PET/CT scan. Results: Based on elevated serum CA15-3 levels (n=31) and clinical/radiologic suspicion (n=40), 71 scans were performed due to suspected recurrence, whereas 69 scans were performed for asymptomatic follow-up. The sensitivity and specificity of FDG-PET/CT were 87.5% and 87.1% in the patients with suspected recurrence and 77.8% and 91.7% in the asymptomatic patients. The positive predictive value in the patients with suspected recurrence (mainly due to elevated serum CA 15-3 levels) was higher than that in asymptomatic patients (P=0.013). Recurrences were proven in 56.3% (40/71) of the patients with suspected recurrence and in 13% (9/69) of the asymptomatic patients (P < 0.001). FDG-PET/CT resulted in changes in the planned management in 49.3% (35/71) of the patients with suspected recurrence and 10.1% (7/69) of the asymptomatic patients (P < 0.001). After follow-up, 77.5% (55/71) of the patients with suspicious recurrences and 97.1% (67/69) of the asymptomatic patients were surviving at the end of the study (P < 0.001). Conclusions: FDG-PET/CT was able to detect recurrence, and the results altered the intended patient management in the post-therapy surveillance of breast cancer. FDG-PET/CT should be used as a priority in patients with increased serum CA 15-3 levels, or with clinical/radiologic suspicion of recurrence, and might be useful for asymptomatic patients.	[Chang, Hong-Tai] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Hu, Chin; Chiu, Yu-Li; Peng, Nan-Jing] Kaohsiung Vet Gen Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Peng, Nan-Jing; Liu, Ren-Shyan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Peng, NJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Nucl Med, Kaohsiung, Taiwan.	njpeng@vghks.gov.tw						Bensouda Y, 2009, B CANCER, V96, P923, DOI 10.1684/bdc.2009.0919; Chang KJ, 2008, J ONCOLOGY SOC, V24, P85; Constantinidou A, 2011, ANN ONCOL, V22, P307, DOI 10.1093/annonc/mdq343; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Eubank WB, 2004, AM J ROENTGENOL, V183, P479, DOI 10.2214/ajr.183.2.1830479; Evangelista L, 2011, EUR J NUCL MED MOL I, V38, P293, DOI 10.1007/s00259-010-1626-7; Grahek D, 2004, EUR J NUCL MED MOL I, V31, P179, DOI 10.1007/s00259-003-1348-1; Grassetto G, 2011, EUR J RADIOL, V80, P828, DOI 10.1016/j.ejrad.2010.04.029; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Haug AR, 2007, J COMPUT ASSIST TOMO, V31, P629, DOI 10.1097/01.rct.0000284394.83696.42; Hillner BE, 2008, J CLIN ONCOL, V26, P2155, DOI 10.1200/JCO.2007.14.5631; Isasi CR, 2005, BREAST CANCER RES TR, V90, P105, DOI 10.1007/s10549-004-3291-7; Kokko R, 2002, EUR J CANCER, V38, P1189, DOI 10.1016/S0959-8049(01)00429-4; Kostakoglu L, 2003, RADIOGRAPHICS, V23, P315, DOI 10.1148/rg.232025705; Liu CS, 2002, JPN J CLIN ONCOL, V32, P244, DOI 10.1093/jjco/hyf052; Manohar K, 2012, NUCL MED COMMUN, V33, P591, DOI 10.1097/MNM.0b013e3283516716; Mariani L, 2009, BIOMARKERS, V14, P130, DOI 10.1080/13547500902770090; Pennant M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14500; Porika M, 2010, ASIAN PAC J CANCER P, V11, P157; Radan L, 2006, CANCER-AM CANCER SOC, V107, P2545, DOI 10.1002/cncr.22292; Ruibal A, 1986, INT J BIOL MARKER, V3, P159; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Suarez M, 2002, Q J NUCL MED, V46, P113; Tietz N. W., 1999, TIETZ TXB CLIN CHEM; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143	26	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e115127	10.1371/journal.pone.0115127	http://dx.doi.org/10.1371/journal.pone.0115127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517451	Green Published, Green Submitted, gold			2022-12-27	WOS:000347215600042
J	Jerardino, A; Fort, J; Isern, N; Rondelli, B				Jerardino, Antonieta; Fort, Joaquim; Isern, Neus; Rondelli, Bernardo			Cultural Diffusion Was the Main Driving Mechanism of the Neolithic Transition in Southern Africa	PLOS ONE			English	Article							ROCK ART; PASTORALISTS; NAMAQUALAND; EXPANSIONS; CHRONOLOGY; ANCESTRY; SPREAD; EUROPE; DATES; BP	It is well known that the Neolithic transition spread across Europe at a speed of about 1 km/yr. This result has been previously interpreted as a range expansion of the Neolithic driven mainly by demic diffusion (whereas cultural diffusion played a secondary role). However, a long-standing problem is whether this value (1 km/yr) and its interpretation (mainly demic diffusion) are characteristic only of Europe or universal (i.e. intrinsic features of Neolithic transitions all over the world). So far Neolithic spread rates outside Europe have been barely measured, and Neolithic spread rates substantially faster than 1 km/yr have not been previously reported. Here we show that the transition from hunting and gathering into herding in southern Africa spread at a rate of about 2.4 km/yr, i.e. about twice faster than the European Neolithic transition. Thus the value 1 km/yr is not a universal feature of Neolithic transitions in the world. Resorting to a recent demic-cultural wave-of-advance model, we also find that the main mechanism at work in the southern African Neolithic spread was cultural diffusion (whereas demic diffusion played a secondary role). This is in sharp contrast to the European Neolithic. Our results further suggest that Neolithic spread rates could be mainly driven by cultural diffusion in cases where the final state of this transition is herding/pastoralism (such as in southern Africa) rather than farming and stockbreeding (as in Europe).	[Jerardino, Antonieta] Univ Pompeu Fabra, ICREA Dept Expt & Hlth Sci, CaSEs Res Grp, Barcelona 08005, Spain; [Fort, Joaquim] Univ Girona, Dept Phys, Complex Syst Lab, Girona 17071, Catalonia, Spain; [Isern, Neus] Univ Autonoma Barcelona, Dept Prehist, Lab Arqueol Quantitat LAQU, Cerdanyola De Valles 08193, Spain; [Rondelli, Bernardo] Spanish Natl Res Council IMF CSIC, Inst Mila I Fontanals, Dept Archaeol & Anthropol, CaSEs Res Grp, Barcelona 08001, Spain	ICREA; Pompeu Fabra University; Universitat de Girona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF)	Jerardino, A (corresponding author), Univ Pompeu Fabra, ICREA Dept Expt & Hlth Sci, CaSEs Res Grp, Ramon Trias Fargas 25-27, Barcelona 08005, Spain.	antonieta.jerardino@upf.edu	Isern, Neus/G-8530-2015; Jerardino, Antonieta/K-3659-2014	Isern, Neus/0000-0001-8386-5373; Jerardino, Antonieta/0000-0002-0078-7718	MINECO [SimulPast-CSD2010-00034, FIS-2009-13050, FIS-2012-31307]; ICREA Funding Source: Custom	MINECO(Spanish Government); ICREA(ICREA)	This work was partially funded by the MINECO projects (http://www.mineco.gob.es/) SimulPast-CSD2010-00034 (all authors), FIS-2009-13050 (JF and NI) and FIS-2012-31307 (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman A. J., 1973, EXPLANATION CULTURE, P345; AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Avery G, 1974, S AFR ARCHAEOL B, V30, P105; Breton G, 2014, CURR BIOL, V24, P852, DOI 10.1016/j.cub.2014.02.041; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; COOKE CK, 1965, AFRICA, V35, P263, DOI 10.2307/1157174; de Smith M, 2013, GEOSPATIAL ANAL COMP; Deacon H. J., 1978, S AFRICAN ARCHAEOLOG, V33, P39, DOI DOI 10.2307/3888251; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Elphick R., 1977, KRAAL CASTLE KHOIKHO; Fort J, 2004, CAMB ARCHAEOL J, V14, P53, DOI 10.1017/S0959774304000046; Fort J, 2012, P NATL ACAD SCI USA, V109, P18669, DOI 10.1073/pnas.1200662109; Gangal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095714; Haines F, 1938, AM ANTHROPOL, V40, P429, DOI 10.1525/aa.1938.40.3.02a00060; Hamilton MJ, 2007, P NATL ACAD SCI USA, V104, P15625, DOI 10.1073/pnas.0704215104; Henn BM, 2008, P NATL ACAD SCI USA, V105, P10693, DOI 10.1073/pnas.0801184105; Henshilwood C, 1996, ANTIQUITY, V70, P945, DOI 10.1017/S0003598X00084210; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Ikeya K., 1993, AFR STUDY MONOGR, V14, P39; Isern N, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10012; KENT S, 1993, MAN, V28, P479, DOI 10.2307/2804236; Kinahan J., 2001, PASTORAL NOMADS NAMI; Kinahan J., 1996, S AFR ARCHAEOL BULL, V51, P106, DOI [10.2307/3888846, DOI 10.2307/3888846]; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; Mehrai H, 1984, THESIS DURHAM U; Mitchell P, 2008, FARMING, V2; Mitchell P, 2002, ARCHAEOLOGY SO AFRIC, P515; Orton J, 2012, THESIS U OXFORD; Orton J, 2013, ANTIQUITY, V87, P108, DOI 10.1017/S0003598X00048651; Ozainne S, 2014, J ARCHAEOL SCI, V50, P359, DOI 10.1016/j.jas.2014.07.025; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Pleurdeau D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040340; Robbins LH, 2005, CURR ANTHROPOL, V46, P671, DOI 10.1086/432748; Robey T, 1987, BRIT ARCHAEOLOGICAL, V332, P294; Russell T, 2004, BAR INT SERIES, V1294; Russell T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087854; Sadr K, 2003, J AFR HIST, V44, P195, DOI 10.1017/S0021853702008393; Sadr K., 2013, PASTORALISM AFRICA P, P171; Sadr K, 1998, AFR ARCHAEOL REV, V15, P101, DOI [10.1023/A:1022158701778, DOI 10.1023/A:1022158701778]; Sadr K, 2005, J HUM EVOL, V20, P217; Sadr K, 2008, SOUTH AFR HUMANIT, V20, P179; SEALY J, 1994, ANTIQUITY, V68, P58, DOI 10.1017/S0003598X00046196; Smith AB, 2005, AFRICAN HERDERS EMER; Smith AB, 2008, BAR INT SERIES, V1849, P94; Smith BW, 2004, CURR ANTHROPOL, V45, P499, DOI 10.1086/422081; SPIEGEL MR, 1975, PROBABILITY STAT, P4308; Stow George W., 1905, NATIVE RACES S AFRIC; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Webley L, 2007, J ARID ENVIRON, V70, P629, DOI 10.1016/j.jaridenv.2006.03.009; Webley L. E., 1992, THESIS U CAPE TOWN; Yellen John, 1984, BAR INT SERIES, P53; Zvelebil M., 1986, HUNTERS TRANSITION M	56	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113672	10.1371/journal.pone.0113672	http://dx.doi.org/10.1371/journal.pone.0113672			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AX9IA	25517968	gold, Green Published, Green Submitted			2022-12-27	WOS:000347215600006
J	Winter, G; Cordente, AG; Curtin, C				Winter, Gal; Cordente, Antonio G.; Curtin, Chris			Formation of Hydrogen Sulfide from Cysteine in Saccharomyces cerevisiae BY4742: Genome Wide Screen Reveals a Central Role of the Vacuole	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; FUNCTIONAL-CHARACTERIZATION; GAMMA-CYSTATHIONASE; SULFUR-COMPOUNDS; YEAST; H2S; GENE; GLUTATHIONE; BIOGENESIS; METABOLISM	Discoveries on the toxic effects of cysteine accumulation and, particularly, recent findings on the many physiological roles of one of the products of cysteine catabolism, hydrogen sulfide (H2S), are highlighting the importance of this amino acid and sulfur metabolism in a range of cellular activities. It is also highlighting how little we know about this critical part of cellular metabolism. In the work described here, a genome-wide screen using a deletion collection of Saccharomyces cerevisiae revealed a surprising set of genes associated with this process. In addition, the yeast vacuole, not previously associated with cysteine catabolism, emerged as an important compartment for cysteine degradation. Most prominent among the vacuole-related mutants were those involved in vacuole acidification; we identified each of the eight subunits of a vacuole acidification sub-complex (V-1 of the yeast V-ATPase) as essential for cysteine degradation. Other functions identified included translation, RNA processing, folate-derived one-carbon metabolism, and mitochondrial iron-sulfur homeostasis. This work identified for the first time cellular factors affecting the fundamental process of cysteine catabolism. Results obtained significantly contribute to the understanding of this process and may provide insight into the underlying cause of cysteine accumulation and H2S generation in eukaryotes.	[Winter, Gal] Univ Western Sydney, Coll Hlth & Sci, Sch Biomed & Hlth Sci, Parramatta, NSW, Australia; [Winter, Gal; Cordente, Antonio G.; Curtin, Chris] Australian Wine Res Inst, Adelaide, SA, Australia; [Winter, Gal] Univ Queensland, Ctr Microbial Electrosynthesis CEMES, Brisbane, Qld, Australia	Western Sydney University; Australian Wine Research Institute; University of Queensland	Winter, G (corresponding author), Univ Western Sydney, Coll Hlth & Sci, Sch Biomed & Hlth Sci, Parramatta, NSW, Australia.	g.winter@uq.edu.au		Winter, Gal/0000-0003-3789-395X; Cordente, Toni/0000-0001-9166-9073	Laffort Australia; Australia's grape growers and winemakers through Grape and Wine Research and Development Corporation; Australian Government; Australian Wine Research Institute	Laffort Australia; Australia's grape growers and winemakers through Grape and Wine Research and Development Corporation(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR); Australian Wine Research Institute	This study was funded by Laffort Australia. Gal Winter was a PhD student at the University of Western Sydney and The Australian Wine Research Institute. Antonio G. Cordente and Chris Curtin are employed by The Australian Wine Research Institute. The Australian Wine Research Institute is supported by Australia's grape growers and winemakers through their investment agency the Grape and Wine Research and Development Corporation, with matching funds from the Australian Government. The funder had no role articulated in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Australian Wine Research Institute provided support in the form of salaries for authors AGC and CC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are in the "author contributions" section.	ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; Arita A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-524; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Balk J, 2004, CHEMBIOCHEM, V5, P1044, DOI 10.1002/cbic.200400061; BARTON AB, 1993, YEAST, V9, P363, DOI 10.1002/yea.320090406; Beard RS, 2011, AM J PHYSIOL-HEART C, V300, pH13, DOI 10.1152/ajpheart.00598.2010; Bengtsson L, 1999, J GEOPHYS RES-ATMOS, V104, P3865, DOI 10.1029/1998JD200046; Brachmann CB, 1998, YEAST, V14, P115; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cossins EA, 1997, PHYTOCHEMISTRY, V45, P437, DOI 10.1016/S0031-9422(96)00833-3; DERIKX PJL, 1990, APPL ENVIRON MICROB, V56, P176, DOI 10.1128/AEM.56.1.176-180.1990; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hansen J, 2000, MOL GEN GENET, V263, P535, DOI 10.1007/s004380051199; HEAFIELD MT, 1990, NEUROSCI LETT, V110, P216, DOI 10.1016/0304-3940(90)90814-P; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kim HS, 2009, FEMS YEAST RES, V9, P713, DOI 10.1111/j.1567-1364.2009.00516.x; Kimura H, 2002, MOL NEUROBIOL, V26, P13, DOI 10.1385/MN:26:1:013; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KRUGER WD, 1994, P NATL ACAD SCI USA, V91, P6614, DOI 10.1073/pnas.91.14.6614; KRUGER WD, 1995, HUM MOL GENET, V4, P1155, DOI 10.1093/hmg/4.7.1155; Kumar A, 2006, BIOCHEM J, V396, P61, DOI 10.1042/BJ20051411; Lee JI, 2004, J NUTR BIOCHEM, V15, P112, DOI 10.1016/j.jnutbio.2003.10.005; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Linderholm AL, 2008, APPL ENVIRON MICROB, V74, P1418, DOI 10.1128/AEM.01758-07; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; NICKERSON WJ, 1953, J INFECT DIS, V93, P43, DOI 10.1093/infdis/93.1.43; OHSUMI Y, 1981, J BIOL CHEM, V256, P2079; Olson KR, 2011, AM J PHYSIOL-REG I, V301, pR297, DOI 10.1152/ajpregu.00045.2011; Oluwatosin YE, 1997, J BIOL CHEM, V272, P28149, DOI 10.1074/jbc.272.44.28149; Ono B, 1996, YEAST, V12, P1153, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1153::AID-YEA16>3.0.CO;2-2; ONO BI, 1991, YEAST, V7, P843, DOI 10.1002/yea.320070809; Park SK, 2008, J MICROBIOL BIOTECHN, V18, P1550; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; R Core Team, 2018, R LANG ENV STAT COMP; Roberts RL, 2003, P NATL ACAD SCI USA, V100, P6634, DOI 10.1073/pnas.1132022100; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Ruotolo R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r67; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Sherman F, 1986, LAB COURSE MANUAL ME; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Suzuki T, 2011, J BIOSCI BIOENG, V112, P107, DOI 10.1016/j.jbiosc.2011.04.007; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; WALTERS DW, 1986, J BIOL CHEM, V261, P5372; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Winter G, 2011, AUST J GRAPE WINE R, V17, P285, DOI 10.1111/j.1755-0238.2011.00127.x; Winter G, 2012, J MICROBIOL METH, V91, P165, DOI 10.1016/j.mimet.2012.08.003; Winter G, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-36; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	62	14	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e113869	10.1371/journal.pone.0113869	http://dx.doi.org/10.1371/journal.pone.0113869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9IA	25517415	gold, Green Published			2022-12-27	WOS:000347215600009
J	Mack, SG; Cook, DJ; Dhurjati, P; Butchbach, MER				Mack, Sean G.; Cook, Daniel J.; Dhurjati, Prasad; Butchbach, Matthew E. R.			Systems Biology Investigation of cAMP Modulation to Increase SMN Levels for the Treatment of Spinal Muscular Atrophy	PLOS ONE			English	Article							MOTOR-NEURON PROTEIN; COPY NUMBER; MESSENGER-RNA; 2,4-DIAMINOQUINAZOLINE DERIVATIVES; SACCHAROMYCES-CEREVISIAE; SINGLE NUCLEOTIDE; DETERMINING GENE; PATIENT CELLS; MOUSE MODEL; SURVIVAL	Spinal muscular atrophy (SMA), a leading genetic cause of infant death worldwide, is an autosomal recessive disorder caused by the loss of SMN1 (survival motor neuron 1), which encodes the protein SMN. The loss of SMN1 causes a deficiency in SMN protein levels leading to motor neuron cell death in the anterior horn of the spinal cord. SMN2, however, can also produce some functional SMN to partially compensate for loss of SMN1 in SMA suggesting increasing transcription of SMN2 as a potential therapy to treat patients with SMA. A cAMP response element was identified on the SMN2 promoter, implicating cAMP activation as a step in the transcription of SMN2. Therefore, we investigated the effects of modulating the cAMP signaling cascade on SMN production in vitro and in silico. SMA patient fibroblasts were treated with the cAMP signaling modulators rolipram, salbutamol, dbcAMP, epinephrine and forskolin. All of the modulators tested were able to increase gem formation, a marker for SMN protein in the nucleus, in a dose-dependent manner. We then derived two possible mathematical models simulating the regulation of SMN2 expression by cAMP signaling. Both models fit well with our experimental data. In silico treatment of SMA fibroblasts simultaneously with two different cAMP modulators resulted in an additive increase in gem formation. This study shows how a systems biology approach can be used to develop potential therapeutic targets for treating SMA.	[Mack, Sean G.; Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Ctr Appl Clin Gen, Wilmington, DE 19803 USA; [Butchbach, Matthew E. R.] Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Ctr Pediat Res, Wilmington, DE USA; [Mack, Sean G.; Cook, Daniel J.; Dhurjati, Prasad] Univ Delaware, Dept Chem & Biomol Engn, Newark, DE USA; [Butchbach, Matthew E. R.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Butchbach, Matthew E. R.] Thomas Jefferson Univ, Dept Pediat, Philadelphia, PA 19107 USA	Nemours Alfred I. duPont Hospital for Children; Nemours Alfred I. duPont Hospital for Children; University of Delaware; University of Delaware; Jefferson University	Butchbach, MER (corresponding author), Nemours Alfred I duPont Hosp Children, Nemours Biomed Res, Ctr Appl Clin Gen, Wilmington, DE 19803 USA.	butchbach@nemoursresearch.org		Butchbach, Matthew/0000-0003-2912-6400	Nemours Foundation; University of Delaware Undergraduate Research Program; Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE) programs of the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103464]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	Nemours Foundation; University of Delaware Undergraduate Research Program; Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE) programs of the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Nemours Foundation (M.E.R.B.), the University of Delaware Undergraduate Research Program (S.G.M.) and the Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE; grant number P20GM103464 to M.E.R.B.) programs of the National Institute of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andreassi C, 2004, EUR J HUM GENET, V12, P59, DOI 10.1038/sj.ejhg.5201102; Andreassi C, 2001, HUM MOL GENET, V10, P2841, DOI 10.1093/hmg/10.24.2841; Angelozzi C, 2008, J MED GENET, V45, P29, DOI 10.1136/jmg.2007.051177; Biondi O, 2010, J NEUROSCI, V30, P11288, DOI 10.1523/JNEUROSCI.1764-10.2010; Branchu J, 2013, J NEUROSCI, V33, P4280, DOI 10.1523/JNEUROSCI.2728-12.2013; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Butchbach MER, 2010, HUM MOL GENET, V19, P454, DOI 10.1093/hmg/ddp510; CERNY V, 1985, J OPTIMIZ THEORY APP, V45, P41, DOI 10.1007/BF00940812; Chaouiya C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-135; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Cusco I, 2002, BJOG-INT J OBSTET GY, V109, P1244, DOI 10.1016/S1470-0328(02)02983-X; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Dhurjati P, 2008, CAN J CHEM ENG, V86, P127, DOI 10.1002/cjce.20025; Elsheikh B, 2009, MUSCLE NERVE, V40, P652, DOI 10.1002/mus.21350; Funahashi Akira, 2003, Biosilico, V1, P159, DOI 10.1016/S1478-5382(03)02370-9; Grzeschik SM, 2005, ANN NEUROL, V58, P194, DOI 10.1002/ana.20548; Heier CR, 2007, J CHILD NEUROL, V22, P1013, DOI 10.1177/0883073807305669; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Jarecki J, 2005, HUM MOL GENET, V14, P2003, DOI 10.1093/hmg/ddi205; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kleppe R, 2011, CURR TOP MED CHEM, V11, P1393, DOI 10.2174/156802611795589629; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lunn MR, 2004, CHEM BIOL, V11, P1489, DOI 10.1016/j.chembiol.2004.08.024; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; Majumder S, 2004, J BIOL CHEM, V279, P14803, DOI 10.1074/jbc.M308225200; Mattis VB, 2008, J NEUROSCI METH, V175, P36, DOI 10.1016/j.jneumeth.2008.07.024; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; Mattis VB, 2009, HUM MOL GENET, V18, P3906, DOI 10.1093/hmg/ddp333; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Riessland M, 2006, HUM GENET, V120, P101, DOI 10.1007/s00439-006-0186-1; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; SCUDIERO DA, 1986, MUTAT RES, V159, P125, DOI 10.1016/0027-5107(86)90121-1; Sumner CJ, 2003, ANN NEUROL, V54, P647, DOI 10.1002/ana.10743; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Thurmond J, 2008, J MED CHEM, V51, P449, DOI 10.1021/jm061475p; Tiziano FD, 2007, NEUROMUSCULAR DISORD, V17, P400, DOI 10.1016/j.nmd.2007.02.006; Tiziano FD, 2010, J MED GENET, V47, P856, DOI 10.1136/jmg.2010.080366; Williamson T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-70; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Wu CY, 2011, BBA-PROTEINS PROTEOM, V1814, P1134, DOI 10.1016/j.bbapap.2011.04.015; Xiao JB, 2011, J MED CHEM, V54, P6215, DOI 10.1021/jm200497t; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858	56	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115473	10.1371/journal.pone.0115473	http://dx.doi.org/10.1371/journal.pone.0115473			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8DI	25514431	Green Published, gold, Green Submitted			2022-12-27	WOS:000349146300059
J	van Os, J; Delespaul, P; Barge, D; Bakker, RP				van Os, Jim; Delespaul, Philippe; Barge, Daniela; Bakker, Roberto P.			Testing an mHealth Momentary Assessment Routine Outcome Monitoring Application: A Focus on Restoration of Daily Life Positive Mood States	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; GENE-ENVIRONMENT INTERACTIONS; RANDOMIZED CONTROLLED-TRIAL; EXPERIENCE-SAMPLING METHOD; MAJOR DEPRESSIVE DISORDER; EMOTIONAL REACTIVITY; STRESS-SENSITIVITY; REWARD EXPERIENCE; SELF-ESTEEM; ANTIDEPRESSANT TREATMENT	Background: Routine Outcome Monitoring (ROM) is used as a means to enrich the process of treatment with feedback on patient outcomes, facilitating patient involvement and shared decision making. While traditional ROM measures focus on retrospective accounts of symptoms, novel mHealth technology makes it possible to collect real life, in-the-moment ambulatory data that allow for an ecologically valid assessment of personalized and contextualized emotional and behavioural adjustment in the flow daily life (mROM). Method: In a sample of 34 patients with major depressive disorder, treated with antidepressants, the combined effect of treatment and natural course was examined over a period of 18 weeks with Ecological Momentary Assessment (EMA). EMA consisted of repeated, within-subject, mini-measurements of experience (eg positive affect, negative affect, medication side effects) and context (eg stressors, situations, activities) at 10 unselected semi-random moments per day, for a period of six days, repeated three times over the 18-week period (baseline, week 6 and week 18). Results: EMA measures of emotional and behavioural adjustment were sensitive to the effects of treatment and natural course over the 18-week period, particularly EMA measures focussing on positive mood states and the ability to use natural rewards (impact of positive events on positive mood states), with standardized effect sizes of 0.4-0.5. EMA measures of activities, social interaction, stress-sensitivity and negative mood states were also sensitive to change over time. Conclusion: This study supports the use of mROM as a means to involve the patient in the process of needs assessment and treatment. EMA data are meaningful to the patient, as they reflect daily life circumstances. Assessment of treatment response with mROM data allows for an interpretation of the effect of treatment at the level of daily life emotional and social adjustment - as an index of health, obviating the need for an exclusive focus on traditional measures of 'sickness'.	[van Os, Jim; Delespaul, Philippe; Bakker, Roberto P.] Maastricht Univ, Med Ctr, South Limburg Mental Hlth & Teaching Network, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, Kings Coll London, London, England; [Barge, Daniela] Leiden Univ, Med Ctr, Leiden, Netherlands; [Bakker, Roberto P.] Psychiat Ctr GGZ Centraal, Amersfoort, Netherlands	Maastricht University; University of London; King's College London; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Os, J (corresponding author), Maastricht Univ, Med Ctr, South Limburg Mental Hlth & Teaching Network, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands.	j.vanos@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; Delespaul, Philippe/E-8982-2011; Barge, Daniela/AAC-4967-2022; van Os, Jim/C-2113-2014; Delespaul, Philippe/L-1396-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022	van Os, Jim/0000-0002-7245-1586; Delespaul, Philippe/0000-0001-7420-0898; Barge, Daniela/0000-0003-4461-4293; Delespaul, Philippe/0000-0001-7420-0898; Bakker, P. Roberto/0000-0002-9964-9939				Barge-Schaapveld DQ, 2001, IMPACT DEPRESSION AN; Barge-Schaapveld DQCM, 2002, J CLIN PSYCHIAT, V63, P477, DOI 10.4088/JCP.v63n0603; Barge-Schaapveld DQCM, 1999, PSYCHIAT RES, V88, P173, DOI 10.1016/S0165-1781(99)00081-5; BARGESCHAAPVELD DQCM, 1995, J AFFECT DISORDERS, V34, P139, DOI 10.1016/0165-0327(95)00012-C; Bower B, 2010, J SLEEP RES, V19, P323, DOI 10.1111/j.1365-2869.2009.00816.x; Carlier IVE, 2012, J EVAL CLIN PRACT, V18, P104, DOI 10.1111/j.1365-2753.2010.01543.x; Cheetham A, 2010, CLIN PSYCHOL REV, V30, P621, DOI 10.1016/j.cpr.2010.04.005; Collip D, 2014, ACTA PSYCHIAT SCAND, V129, P202, DOI 10.1111/acps.12151; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; De Vries M, 1992, EXPERIENCE PSYCHOPAT; Delespaul P, 2002, SOC PSYCH PSYCH EPID, V37, P97, DOI 10.1007/s001270200000; DELESPAUL PAEG, 1987, J NERV MENT DIS, V175, P537, DOI 10.1097/00005053-198709000-00005; Delespaul PAEG, 1995, THESIS MAASTRICHT U; DEVRIES MW, 1989, SCHIZOPHRENIA BULL, V15, P233, DOI 10.1093/schbul/15.2.233; Dietz LJ, 2008, J AM ACAD CHILD PSY, V47, P574, DOI 10.1097/CHI.0b013e3181676595; Eisner LR, 2009, J ANXIETY DISORD, V23, P645, DOI 10.1016/j.janxdis.2009.02.001; Forbes EE, 2007, BIOL PSYCHIAT, V61, P633, DOI 10.1016/j.biopsych.2006.05.026; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Frissen A, 2014, SOC PSYCH PSYCH EPID, V49, P1579, DOI 10.1007/s00127-014-0859-3; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Geschwind N, 2010, ACTA PSYCHIAT SCAND, V122, P129, DOI 10.1111/j.1600-0447.2009.01525.x; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; Geschwind N, 2011, EUR NEUROPSYCHOPHARM, V21, P241, DOI 10.1016/j.euroneuro.2010.11.004; Glaser JP, 2008, PSYCHOL MED, V38, P1231, DOI 10.1017/S0033291707002322; Glaser JP, 2010, ACTA PSYCHIAT SCAND, V121, P125, DOI 10.1111/j.1600-0447.2009.01427.x; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Guy W, 1976, ECDEU ASSESSMENT MAN, P59; Hafkenscheid A, 2014, MAANBLAD GEESTELIJKE, V69, P24; Henquet C, 2010, BRIT J PSYCHIAT, V196, P447, DOI 10.1192/bjp.bp.109.072249; Jacobs N, 2005, LIFE SCI, V76, P2431, DOI 10.1016/j.lfs.2004.10.045; Jacobs N, 2011, BRIT J CLIN PSYCHOL, V50, P19, DOI 10.1348/014466510X491397; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; Kramer IMA, 2012, PSYCHOL MED, V42, P283, DOI 10.1017/S0033291711001474; Kramer I, 2014, SCHIZOPHRENIA BULL, V40, P278, DOI 10.1093/schbul/sbs194; Kramer I, 2014, WORLD PSYCHIATRY, V13, P68, DOI 10.1002/wps.20090; Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827; Lane RM, 2014, J PSYCHOPHARMACOL, V28, P527, DOI 10.1177/0269881114532857; Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x; Lataster J, 2011, J CLIN PSYCHIAT, V72, P1397, DOI 10.4088/JCP.09m05466yel; Lataster T, 2010, ACTA PSYCHIAT SCAND, V122, P395, DOI 10.1111/j.1600-0447.2010.01566.x; Lataster T, 2012, PSYCHOL MED, P1; McMakin DL, 2012, J AM ACAD CHILD PSY, V51, P404, DOI 10.1016/j.jaac.2012.01.011; Menne-Lothmann C, 2012, BEHAV GENET, V42, P778, DOI 10.1007/s10519-012-9553-y; Myin-Germeys I, 2003, ACTA PSYCHIAT SCAND, V107, P124, DOI 10.1034/j.1600-0447.2003.02025.x; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2005, PSYCHOL MED, V35, P733, DOI 10.1017/S0033291704004179; Myin-Germeys I, 2003, PSYCHOL MED, V33, P327, DOI 10.1017/S0033291702006785; Myin-Germeys I, 2009, PSYCHOL MED, V39, P1533, DOI 10.1017/S0033291708004947; Myin-Germeys I, 2011, SCHIZOPHRENIA BULL, V37, P244, DOI 10.1093/schbul/sbq164; Oorschot M, 2012, BRIT J PSYCHIAT, V201, P215, DOI 10.1192/bjp.bp.111.104414; Oorschot M, 2013, SCHIZOPHRENIA BULL, V39, P217, DOI 10.1093/schbul/sbr137; Palmier-Claus JE, 2013, ARCH SUICIDE RES, V17, P275, DOI 10.1080/13811118.2013.805647; Palmier-Claus JE, 2012, PSYCHOL MED, V42, P1003, DOI 10.1017/S0033291711001929; Palmier-Claus JE, 2011, COGN NEUROPSYCHIATRY, V16, P530, DOI 10.1080/13546805.2011.561583; Palmier-Claus JE, 2012, BRIT J CLIN PSYCHOL, V51, P72, DOI 10.1111/j.2044-8260.2011.02013.x; Palmier-Claus J, 2013, PSYCHIAT RES, V206, P240, DOI 10.1016/j.psychres.2012.11.014; Palmier-Claus J, 2011, EARLY INTERV PSYCHIA, V5, P150, DOI 10.1111/j.1751-7893.2010.00250.x; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Simons C, 2014, EFFECTS SELF M UNPUB; Simons CJP, 2009, GENES BRAIN BEHAV, V8, P5, DOI 10.1111/j.1601-183X.2008.00434.x; Simons CJP, 2014, COST EFFECTIVE UNPUB; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Stone AA, 2002, BMJ-BRIT MED J, V324, P1193, DOI 10.1136/bmj.324.7347.1193; STRAUSS JS, 1994, BRIT J PSYCHIAT, V164, P103, DOI 10.1192/S0007125000292830; Thewissen V, 2011, BRIT J CLIN PSYCHOL, V50, P178, DOI 10.1348/014466510X508677; Uher R, 2012, PSYCHOL MED, V42, P967, DOI 10.1017/S0033291711001905; Van der Poel EGT, 1992, EXPERIENCE PSYCHOPAT, P290; van Meter KM, 1987, B METHODOLOGIE SOCIO, P22; Van Os J, 2013, PLOS ONE IN PRESS; van Os J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086652; van Os J, 2013, WORLD PSYCHIATRY, V12, P113, DOI 10.1002/wps.20046; Verdoux H, 2003, PSYCHOL MED, V33, P23, DOI 10.1017/S0033291702006384; Wichers M, 2014, PSYCHOL MED, V44, P1349, DOI 10.1017/S0033291713001979; Wichers M, 2011, ACTA PSYCHIAT SCAND, V123, P402, DOI 10.1111/j.1600-0447.2011.01684.x; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Wichers M, 2012, BRIT J CLIN PSYCHOL, V51, P206, DOI 10.1111/j.2044-8260.2011.02021.x; Wichers M, 2012, HEALTH PSYCHOL, V31, P135, DOI 10.1037/a0025688; Wichers M, 2009, BRIT J PSYCHIAT, V195, P498, DOI 10.1192/bjp.bp.108.056853; Wichers MC, 2008, PSYCHOSOM MED, V70, P314, DOI 10.1097/PSY.0b013e31816b1eee; Wichers MC, 2007, ACTA PSYCHIAT SCAND, V115, P451, DOI 10.1111/j.1600-0447.2006.00924.x; Wigman JTW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054653	85	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2014	9	12							e115254	10.1371/journal.pone.0115254	http://dx.doi.org/10.1371/journal.pone.0115254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8DI	25513813	Green Submitted, Green Published, gold			2022-12-27	WOS:000349146300047
J	Nath, J; Guy, A; Smith, TB; Cobbold, M; Inston, NG; Hodson, J; Tennant, DA; Ludwig, C; Ready, AR				Nath, Jay; Guy, Alison; Smith, Thomas B.; Cobbold, Mark; Inston, Nicholas G.; Hodson, James; Tennant, Daniel A.; Ludwig, Christian; Ready, Andrew R.			Metabolomic Perfusate Analysis during Kidney Machine Perfusion: The Pig Provides an Appropriate Model for Human Studies	PLOS ONE			English	Article							COLD-STORAGE; PULSATILE PERFUSION; BRAIN-DEATH; PRESERVATION; TRANSPLANTATION; DONOR; MANAGEMENT; LIVER; RISK; PUMP	Introduction: Hypothermic machine perfusion offers great promise in kidney transplantation and experimental studies are needed to establish the optimal conditions for this to occur. Pig kidneys are considered to be a good model for this purpose and share many properties with human organs. However it is not established whether the metabolism of pig kidneys in such hypothermic hypoxic conditions is comparable to human organs. Methods: Standard criteria human (n = 12) and porcine (n = 10) kidneys underwent HMP using the LifePort Kidney Transporter 1.0 (Organ Recovery Systems) using KPS-1 solution. Perfusate was sampled at 45 minutes and 4 hours of perfusion and metabolomic analysis performed using 1-D H-1-NMR spectroscopy. Results: There was no inter-species difference in the number of metabolites identified. Of the 30 metabolites analysed, 16 (53.3%) were present in comparable concentrations in the pig and human kidney perfusates. The rate of change of concentration for 3-Hydroxybutyrate was greater for human kidneys (p<0.001). For the other 29 metabolites (96.7%), there was no difference in the rate of change of concentration between pig and human samples. Conclusions: Whilst there are some differences between pig and human kidneys during HMP they appear to be metabolically similar and the pig seems to be a valid model for human studies.	[Nath, Jay; Guy, Alison; Inston, Nicholas G.; Ready, Andrew R.] Univ Hosp Birmingham, Dept Renal Surg, Birmingham, W Midlands, England; [Nath, Jay; Guy, Alison; Smith, Thomas B.; Cobbold, Mark] Univ Birmingham, Dept Immun & Infect, Birmingham, W Midlands, England; [Hodson, James] Univ Hosp Birmingham, Wolfson Comp Lab, Birmingham, W Midlands, England; [Ludwig, Christian] Univ Birmingham, Henry Wellcome Bldg Biomol NMR Spect, Birmingham, W Midlands, England; [Nath, Jay; Tennant, Daniel A.] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Nath, J (corresponding author), Univ Hosp Birmingham, Dept Renal Surg, Birmingham, W Midlands, England.	J.Nath@bham.ac.uk	Nath, Jay/K-1437-2019; Tennant, Daniel/ABE-8145-2021	Tennant, Daniel/0000-0003-0499-2732; Hodson, James/0000-0003-3487-0090	University Hospital Birmingham Charities [Dkaarcde 17496]	University Hospital Birmingham Charities	University Hospital Birmingham Charities 60,000 pound Grant number Dkaarcde 17496. Organ Recovery Systems, Donation of Lifeport machine (value circa 25,000) pound.	Bagul A, 2008, BRIT J SURG, V95, P111, DOI 10.1002/bjs.5909; Barklin A, 2008, ACTA ANAESTH SCAND, V52, P628, DOI 10.1111/j.1399-6576.2008.01606.x; Bon D, 2014, TRANSPLANTATION; Bugge JF, 2009, ACTA ANAESTH SCAND, V53, P1239, DOI 10.1111/j.1399-6576.2009.02064.x; Cannon RM, 2013, J AM COLL SURGEONS, V216, P625, DOI 10.1016/j.jamcollsurg.2012.12.025; Fuller BJ, 2007, CRYOBIOLOGY, V54, P129, DOI 10.1016/j.cryobiol.2007.01.003; GARBER AJ, 1974, J CLIN INVEST, V54, P981, DOI 10.1172/JCI107839; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; GRAMM HJ, 1992, TRANSPLANTATION, V54, P851, DOI 10.1097/00007890-199211000-00016; Guy AJ, 2014, TRANSPLANTATION; HANNON JP, 1990, LAB ANIM SCI, V40, P293; Henry SD, 2012, AM J TRANSPLANT, V12, P2477, DOI 10.1111/j.1600-6143.2012.04086.x; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KOUNDAKJIAN PP, 1970, BIOCHEM J, V119, P49, DOI 10.1042/bj1190049; Kozaki K, 2000, TRANSPLANT P, V32, P164, DOI 10.1016/S0041-1345(99)00896-9; Kwiatkowski A, 2007, AM J TRANSPLANT, V7, P1942, DOI 10.1111/j.1600-6143.2007.01877.x; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lodhi SA, 2012, AM J TRANSPLANT, V12, P2774, DOI 10.1111/j.1600-6143.2012.04179.x; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; Matsuno N, 2000, TRANSPLANT P, V32, P173, DOI 10.1016/S0041-1345(99)00919-7; Matsuokaa L, 2006, AM J TRANSPLANT, V6, P1473, DOI 10.1111/j.1600-6143.2006.01323.x; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Nielsen KL, 2014, AM J CLIN NUTR, V99, P941, DOI 10.3945/ajcn.113.074724; Polyak MMR, 2000, TRANSPLANTATION, V69, P249, DOI 10.1097/00007890-200001270-00010; POWNER DJ, 1990, CRIT CARE MED, V18, P702; SACHS DH, 1994, VET IMMUNOL IMMUNOP, V43, P185, DOI 10.1016/0165-2427(94)90135-X; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Sellers MT, 2000, CLIN TRANSPLANT, V14, P543, DOI 10.1034/j.1399-0012.2000.140605.x; Shah AP, 2008, TRANSPLANTATION, V86, P1006, DOI 10.1097/TP.0b013e318187b978; Smith M, 2004, J HEART LUNG TRANSPL, V23, pS217, DOI 10.1016/j.healun.2004.06.017; Suarez JF, 1999, TRANSPLANT P, V31, P2292, DOI 10.1016/S0041-1345(99)00345-0; Swindle MM, 2012, FUTURE MED CHEM, V4, P1771, DOI [10.4155/FMC.12.113, 10.4155/fmc.12.113]; Wight JP, 2003, CLIN TRANSPLANT, V17, P293, DOI 10.1034/j.1399-0012.2003.00077.x; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103	35	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e114818	10.1371/journal.pone.0114818	http://dx.doi.org/10.1371/journal.pone.0114818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	25502759	Green Published, Green Submitted, gold			2022-12-27	WOS:000346375400056
J	Tahiri-Alaoui, A; Zhao, YG; Sadigh, Y; Popplestone, J; Kgosana, L; Smith, LP; Nair, V				Tahiri-Alaoui, Abdessamad; Zhao, Yuguang; Sadigh, Yashar; Popplestone, James; Kgosana, Lydia; Smith, Lorraine P.; Nair, Venugopal			Poly(A) Binding Protein 1 Enhances Cap-Independent Translation Initiation of Neurovirulence Factor from Avian Herpesvirus	PLOS ONE			English	Article							MAREKS-DISEASE VIRUS; EUKARYOTIC MESSENGER-RNA; POLY(A)-BINDING PROTEIN; CELL-LINE; C-MYC; IDENTIFICATION; INFECTION; ABUNDANCE; SEQUENCE; PABP	Poly(A) binding protein 1 (PABP1) plays a central role in mRNA translation and stability and is a target by many viruses in diverse manners. We report a novel viral translational control strategy involving the recruitment of PABP1 to the 5' leader internal ribosome entry site (5L IRES) of an immediate-early (IE) bicistronic mRNA that encodes the neurovirulence protein (pp14) from the avian herpesvirus Marek's disease virus serotype 1 (MDV1). We provide evidence for the interaction between an internal poly(A) sequence within the 5L IRES and PABP1 which may occur concomitantly with the recruitment of PABP1 to the poly(A) tail. RNA interference and reverse genetic mutagenesis results show that a subset of virally encoded-microRNAs (miRNAs) targets the inhibitor of PABP1, known as paip2, and therefore plays an indirect role in PABP1 recruitment strategy by increasing the available pool of active PABP1. We propose a model that may offer a mechanistic explanation for the cap-independent enhancement of the activity of the 5L IRES by recruitment of a bona fide initiation protein to the 5' end of the message and that is, from the affinity binding data, still compatible with the formation of 'closed loop' structure of mRNA.	[Tahiri-Alaoui, Abdessamad; Sadigh, Yashar; Popplestone, James; Kgosana, Lydia; Smith, Lorraine P.; Nair, Venugopal] Pirbright Inst, Woking, Surrey, England; [Zhao, Yuguang] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford; Wellcome Centre for Human Genetics	Tahiri-Alaoui, A (corresponding author), Pirbright Inst, Ash Rd, Woking, Surrey, England.	abdou.tahiri-alaoui@pirbright.ac.uk; venugopal.nair@pirbright.ac.uk	Nair, Venugopal/D-4447-2016; Sadigh, Yashar/AAL-2996-2020	Nair, Venugopal/0000-0002-8255-516X; Sadigh, Yashar/0000-0003-1892-1361	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H010696/1]; BBSRC [BBS/E/I/00001651, BB/H010696/1, BBS/E/I/00001704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001704, BB/H010696/1, BBS/E/I/00001651] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (BBSRC, grant number BB/H010696/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina ZA, 2014, NUCLEIC ACIDS RES, V42, P9461, DOI 10.1093/nar/gku599; AKIYAMA Y, 1974, BIKEN J, V17, P105; Arias C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000334; Blakqori G, 2009, J VIROL, V83, P3637, DOI 10.1128/JVI.02201-08; Bradrick SS, 2007, RNA, V13, P1582, DOI 10.1261/rna.556107; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Burgess HM, 2011, J CELL SCI, V124, P3344, DOI 10.1242/jcs.087692; Burgess HM, 2010, BIOCHEM SOC T, V38, P1517, DOI 10.1042/BST0381517; Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dobrikova E, 2010, J VIROL, V84, P270, DOI 10.1128/JVI.01740-09; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; GORLACH M, 1994, EXP CELL RES, V211, P400, DOI 10.1006/excr.1994.1104; Gudkov AT, 2005, BIOTECHNOL BIOENG, V91, P468, DOI 10.1002/bit.20525; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jarosinski K, 2007, P NATL ACAD SCI USA, V104, P20025, DOI 10.1073/pnas.0706295104; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Kerekatte V, 1999, J VIROL, V73, P709, DOI 10.1128/JVI.73.1.709-717.1999; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Kumar GR, 2011, MOL CELL BIOL, V31, P3113, DOI 10.1128/MCB.05402-11; McKinney C, 2012, P NATL ACAD SCI USA, V109, P5627, DOI 10.1073/pnas.1202829109; Melo EO, 2003, J BIOL CHEM, V278, P46357, DOI 10.1074/jbc.M307624200; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morgan R, 2008, J VIROL, V82, P12213, DOI 10.1128/JVI.01722-08; Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382; Perez C, 2011, J VIROL, V85, P156, DOI 10.1128/JVI.01778-10; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0; Salaun C, 2010, J VIROL, V84, P8539, DOI 10.1128/JVI.00668-10; Sayer NM, 2004, J BIOL CHEM, V279, P13102, DOI 10.1074/jbc.M310928200; Shirokikh NE, 2008, P NATL ACAD SCI USA, V105, P10738, DOI 10.1073/pnas.0804940105; Sladic RT, 2004, EUR J BIOCHEM, V271, P450, DOI 10.1046/j.1432-1033.2003.03945.x; Smith RWP, 2010, BIOCHEM J, V426, P1, DOI 10.1042/BJ20091571; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Tahiri-Alaoui A, 2013, AVIAN DIS, V57, P387, DOI 10.1637/10322-080912-Reg.1; Tahiri-Alaoui A, 2009, J VIROL, V83, P12769, DOI 10.1128/JVI.01010-09; Tahiri-Alaoui A, 2009, J VIROL, V83, P5846, DOI 10.1128/JVI.02602-08; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Thoma C, 2008, RNA, V14, P1579, DOI 10.1261/rna.1043908; Walsh D, 2005, J VIROL, V79, P8057, DOI 10.1128/JVI.79.13.8057-8064.2005; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Xu HT, 2008, J VIROL METHODS, V149, P201, DOI 10.1016/j.jviromet.2008.02.005; Yao YX, 2008, J VIROL, V82, P4007, DOI 10.1128/JVI.02659-07; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zhao YG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001305; Zhao YG, 2010, METHODS MOL BIOL, V634, P53, DOI 10.1007/978-1-60761-652-8_4; Zhao YG, 2009, J VIROL, V83, P489, DOI 10.1128/JVI.01166-08	54	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114466	10.1371/journal.pone.0114466	http://dx.doi.org/10.1371/journal.pone.0114466			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25503397	gold, Green Published, Green Submitted			2022-12-27	WOS:000347146700028
J	Zhao, CJ; Liu, XY; Yang, D				Zhao, Chenjing; Liu, Xingyue; Yang, Ding			Wing Base Structural Data Support the Sister Relationship of Megaloptera and Neuroptera (Insecta: Neuropterida)	PLOS ONE			English	Article							PHYLOGENY; HOLOMETABOLA; MORPHOLOGY; SCLERITES; POSITION; HOMOLOGY	The phylogenetic status and the monophyly of the holometabolous insect order Megaloptera has been an often disputed and long unresolved problem. The present study attempts to infer phylogenetic relationships among three orders, Megaloptera, Neuroptera, and Raphidioptera, within the superorder Neuropterida, based on wing base structure. Cladistic analyses were carried out based on morphological data from both the fore- and hindwing base. A sister relationship between Megaloptera and Neuroptera was recovered, and the monophyly of Megaloptera was corroborated. The division of the order Megaloptera, the traditional higher classification, into Corydalidae (Corydalinae + Chauliodinae) and Sialidae, was also supported by our wing base data analyses.	[Zhao, Chenjing; Liu, Xingyue; Yang, Ding] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China	China Agricultural University	Liu, XY (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	xingyue_liu@yahoo.com; dyangcau@126.com	Liu, Xingyue/A-3019-2013	Liu, Xingyue/0000-0002-9168-0659	National Natural Science Foundation of China [31322051, 31320103902]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	The research described is supported by the National Natural Science Foundation of China (31322051, 31320103902) and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPOCK H., 1991, RAPHIDIOPTEREN ERDE; Aspock U, 2001, SYST ENTOMOL, V26, P73, DOI 10.1046/j.1365-3113.2001.00136.x; Aspock U, 2008, SYST ENTOMOL, V33, P97, DOI 10.1111/j.1365-3113.2007.00396.x; Aspock U, 2012, ARTHROPOD SYST PHYLO, V70, P119; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Beutel RG, 2008, EUR J ENTOMOL, V105, P917, DOI 10.14411/eje.2008.119; Brodsky A. K., 1994, EVOLUTION INSECT FLI; Buning J, 2005, DEV GENES EVOL, V215, P597, DOI 10.1007/s00427-005-0017-8; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Cameron SL, 2009, ZOOL SCR, V38, P575, DOI 10.1111/j.1463-6409.2009.00392.x; CONTRERASRAMOS A, 1998, T SAY PUBLICATIONS E; Elliott J.M., 1996, Freshwater Biological Association Scientific Publication, V54, P1; Friedrich F, 2010, CLADISTICS, V26, P579, DOI 10.1111/j.1096-0031.2010.00305.x; Goloboff P. A., 1999, NONA VERSION 2 0 COM; Goloboff P, 2008, CLADISTICS, V24, P91; Grimaldi David, 2005, pi; HAMILTON K G A, 1971, Journal of the Kansas Entomological Society, V44, P421; Haring E, 2004, SYST ENTOMOL, V29, P415, DOI 10.1111/j.0307-6970.2004.00263.x; Hornschemeyer T, 2002, ZOOL SCR, V31, P17, DOI 10.1046/j.0300-3256.2001.00086.x; Hunefeld F, 2012, MITT DEUT GES ALLGEM, V18, P53; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Kukalova-Peck J., 1991, INSECTS AUSTR, VI, P141; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; Liu XY, 2013, SYST ENTOMOL, V38, P543, DOI 10.1111/syen.12009; MARDEN JH, 1995, NATURE, V377, P332, DOI 10.1038/377332a0; MARDEN JH, 1994, SCIENCE, V266, P427, DOI 10.1126/science.266.5184.427; MATSUDA R, 1970, MEM ENTOMOL SOC CAN, P1; Ninomiya T, 2009, SYST ENTOMOL, V34, P334, DOI 10.1111/j.1365-3113.2008.00455.x; Nixon K.C., 2002, WINCLADA VER 1 00 08; PENNY ND, 1993, ENTOMOL NEWS, V104, P17; Peters RS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-52; Rieppel O, 2002, BIOL J LINN SOC, V75, P59, DOI 10.1046/j.1095-8312.2002.00006.x; Snodgrass RE, 1935, PRINCIPLES INSECT MO; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047302; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Winterton SL, 2010, SYST ENTOMOL, V35, P349, DOI 10.1111/j.1365-3113.2010.00521.x; WOOTTON RJ, 1979, SYST ENTOMOL, V4, P81, DOI 10.1111/j.1365-3113.1979.tb00614.x; Yang D, 2010, INSECTA, V51; Yoshizawa K, 2001, SYST ENTOMOL, V26, P1, DOI 10.1046/j.1365-3113.2001.00133.x; Yoshizawa K, 2007, ARTHROPOD STRUCT DEV, V36, P277, DOI 10.1016/j.asd.2007.05.004; Yoshizawa K, 2007, SYST ENTOMOL, V32, P197, DOI 10.1111/j.1365-3113.2007.00379.x; Yoshizawa Kazunori, 2005, Insecta Matsumurana, V62, P1; Yoshizawa K, 2012, ENTOMOL SCI, V15, P408, DOI 10.1111/j.1479-8298.2012.00528.x; Yoshizawa K, 2011, SYST ENTOMOL, V36, P377, DOI 10.1111/j.1365-3113.2011.00572.x; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	47	16	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114695	10.1371/journal.pone.0114695	http://dx.doi.org/10.1371/journal.pone.0114695			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25502404	Green Published, gold, Green Submitted			2022-12-27	WOS:000347146700044
J	Adams, J; Light, R				Adams, Jimi; Light, Ryan			Mapping Interdisciplinary Fields: Efficiencies, Gaps and Redundancies in HIV/AIDS Research	PLOS ONE			English	Article								While interdisciplinarity continues to increase in popularity among funders and other scientific organizations, its potential to promote scientific advances remains under-examined. For HIV/AIDS research, we examine the dynamics of disciplinary integration (or lack thereof) providing insight into a field's knowledge base and those questions that remain unresolved. Drawing on the complete histories of two interdisciplinary journals, we construct bibliographic coupling networks based on overlapping citations to identify segregation into research clusters and estimate topic models of research content. We then compare how readily those bibliographic coupling clusters account for the structuring of topics covered within the field as it evolves over two decades. These comparisons challenge one-dimensional and/or cross-sectional approaches to interdisciplinarity. Some topics are increasingly coordinated across disciplinary boundaries (e. g., vaccine development); others remain relatively segmented into disconnected disciplinary domains for the full period (e. g., drug resistance). This divergence indicates heterogeneity in interdisciplinarity and emphasizes the need for critical approaches to studying the organization of science.	[Adams, Jimi] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [Light, Ryan] Univ Oregon, Dept Sociol, Eugene, OR 97403 USA	University of Colorado System; University of Colorado Denver; University of Oregon	Adams, J (corresponding author), Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA.	jimi.adams@ucdenver.edu	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Robert Wood Johnson Foundation's Health and Society Scholars Program at Columbia University provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; [Anonymous], 1992, ASA P STAT GRAPH SEC; [Anonymous], PREP FUT HIV AIDS AF; [Anonymous], CULTURAL BOUNDARIES; [Anonymous], 2012, AIDS 30 HIST; [Anonymous], SCI SCI SCI2 TOOL; Bettencourt LMA, 2008, SCIENTOMETRICS, V75, P495, DOI 10.1007/s11192-007-1888-4; Bettencourt LMA, 2011, P NATL ACAD SCI USA, V108, P19540, DOI 10.1073/pnas.1102712108; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Crane D., 1972, INVISIBLE COLL DIFFU; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Garfield E, 2001, BIBLIOGRAPHIC COUPLI; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Jacobs J., 2013, DEFENSE DISCIPLINES; Jacobs JA, 2009, ANNU REV SOCIOL, V35, P43, DOI 10.1146/annurev-soc-070308-115954; Klavans R, 2006, J AM SOC INF SCI TEC, V57, P251, DOI 10.1002/asi.20274; Knorr-Cetina K., 1999, EPISTEMIC CULTURES S; Leydesdorff L, 2006, J AM SOC INF SCI TEC, V57, P1616, DOI 10.1002/asi.20335; Manton KG, 2009, P NATL ACAD SCI USA, V106, P10981, DOI 10.1073/pnas.0905104106; Moody James, 2006, AM SOCIOL, V37, P67; National Academy of Sciences, 2005, FAC INT RES; National Institutes of Health, 2007, NIH NEWS; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; Small H, 2010, SCIENTOMETRICS, V83, P835, DOI 10.1007/s11192-009-0121-z; Steyvers M, 2007, HDB LATENT SEMANTIC; Wilbur W John, 2002, Pac Symp Biocomput, P386; Yan EJ, 2012, J AM SOC INF SCI TEC, V63, P1313, DOI 10.1002/asi.22680	38	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2014	9	12							e115092	10.1371/journal.pone.0115092	http://dx.doi.org/10.1371/journal.pone.0115092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AW9WY	25506703	Green Published, Green Submitted, gold			2022-12-27	WOS:000346607100048
J	Fisman, D; Patrozou, E; Carmeli, Y; Perencevich, E; Tuite, AR; Mermel, LA				Fisman, David; Patrozou, Eleni; Carmeli, Yehuda; Perencevich, Eli; Tuite, Ashleigh R.; Mermel, Leonard A.		Geographical Variability Bacteremi	Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure	PLOS ONE			English	Article							SEASONAL-VARIATION; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; EPIDEMIOLOGY; SUMMER	Objective: Infections due to Gram-negative bacteria exhibit seasonal trends, with peak infection rates during warmer months. We hypothesized that the likelihood of a bloodstream infection due to Gram-negative bacteria increases with proximity to the equator. We tested this hypothesis and identified geographical, climatic and social factors associated with this variability. Design: We established a network of 23 international centers in 22 cities. Setting: De-identified results of positive blood cultures from 2007-2011 and data sources for geographic, climatic and socioeconomic factors were assembled for each center. Participants: Patients at the 23 centers with positive blood cultures. Main outcome: Due to variability in the availability of total culture volumes across sites, our primary outcome measure was the fraction of positive blood cultures that yielded Gram-negative bacteria; sources of variability in this outcome measure were explored using meta-regression techniques. Results: The mean fraction of bacteremia associated with Gram-negative bacteria was 48.4% (range 26.4% to 61.8%). Although not all sites displayed significant seasonality, the overall P-value for seasonal oscillation was significant (P<0.001). In univariate meta-regression models, temperature, latitude, latitude squared, longitude, per capita gross domestic product and percent of gross domestic product spent on healthcare were all associated with the fraction of bacteremia due to Gram-negative bacteria. In multivariable models, only percent of gross domestic product spent on healthcare and distance from the equator (ie. latitude squared) were significantly associated with the fraction of bacteremia due to Gram-negative bacteria. Conclusions: The likelihood of bacteremia due to Gram-negative bacteria varies markedly between cities, in a manner that appears to have both geographic (latitude) and socioeconomic (proportion gross domestic product devoted to health spending) determinants. Thus, the optimal approach to initial management of suspected bacteremia may be geographically specific. The rapid emergence of highly antibiotic-resistant Gram-negative pathogens may have geographically specific impacts.	[Fisman, David; Tuite, Ashleigh R.] Univ Toronto, Dalla Lana Fac Publ Hlth, Toronto, ON, Canada; [Patrozou, Eleni] Hygeia Gen Hosp, Athens, Greece; [Carmeli, Yehuda] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Perencevich, Eli] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Perencevich, Eli] Iowa City Vet Hlth Care Syst, Iowa City, IA USA; [Mermel, Leonard A.] Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA; [Mermel, Leonard A.] Rhode Isl Hosp, Div Infect Dis, Providence, RI USA	University of Toronto; Hygeia Hospital; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Mermel, LA (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Med, Providence, RI 02912 USA.	lmermel@lifespan.org	Brites, Carlos/D-1353-2013; Mermel, Leonard/Z-1475-2019; Korman, Tony/I-3099-2013	Brites, Carlos/0000-0002-4673-6991; Edmond, Michael/0000-0002-4144-8974; El Kholy, Amani/0000-0002-0645-7664; Camargo, Luis Fernando Aranha/0000-0002-3888-8661; QUIROS, RODOLFO/0000-0002-5820-380X; Miyakis, Spiros/0000-0003-4268-1599; Perencevich, Eli/0000-0002-3721-3355; Korman, Tony/0000-0002-6155-8353	Astrellas; TheravanceBasilia; Merck, Sharp and Dohme; AstraZeneca	Astrellas; TheravanceBasilia; Merck, Sharp and Dohme(Merck & Company); AstraZeneca(AstraZeneca)	Dr. Mermel has received research funding from Astrellas and Theravance. Dr. Carmelli has served as a consultant for Merck, Sharp and Dohme, Johnson & Johnson, AstraZeneca, Rempex, Durata, Achaogen, and Basilia. His institution has received research funding from Basilia, and he has received payment for lectures from Merck, Sharp and Dohme, and AstraZeneca. Drs. Perencevich, Fisman, Tuite, and Patrozou have no conflicts of interest. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Al-Hasan MN, 2009, CLIN MICROBIOL INFEC, V15, P947, DOI 10.1111/j.1469-0691.2009.02877.x; Alcorn K, 2013, AM J INFECT CONTROL, V41, P1205, DOI 10.1016/j.ajic.2013.05.019; Anderson DJ, 2008, J INFECT DIS, V197, P752, DOI 10.1086/527486; Fortaleza CMCB, 2014, INFECT CONT HOSP EP, V35, P85, DOI 10.1086/674392; de Kraker MEA, 2013, CLIN MICROBIOL INFEC, V19, P860, DOI 10.1111/1469-0691.12028; Deeks J, 1995, SYSTEMATIC REV HLTH, VBMJ Publishing Group, P313; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; Fisman DN, 2002, CLIN INFECT DIS, V35, P1368, DOI 10.1086/344271; Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325; Hanon FX, 2002, SCAND J INFECT DIS, V34, P520, DOI 10.1080/00365540110080827; Jackson AL, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-74; Kang CI, 2004, ANTIMICROB AGENTS CH, V48, P4574, DOI 10.1128/AAC.48.12.4574-4581.2004; Kuster SP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001042; McDonald LC, 1999, CLIN INFECT DIS, V29, P1133, DOI 10.1086/313441; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Richet H, 2012, CLIN MICROBIOL INFEC, V18, P934, DOI 10.1111/j.1469-0691.2012.03954.x; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P51; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Suzuki TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1037; Tuite Ashleigh R, 2013, CMAJ Open, V1, pE43, DOI 10.9778/cmajo.20120002	22	77	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e114548	10.1371/journal.pone.0114548	http://dx.doi.org/10.1371/journal.pone.0114548			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	25642358	Green Published, gold, Green Submitted			2022-12-27	WOS:000348845600003
J	Liu, DG; Wang, LJ; Zhai, H; Song, XJ; He, SZ; Liu, QC				Liu, Degao; Wang, Lianjun; Zhai, Hong; Song, Xuejin; He, Shaozhen; Liu, Qingchang			A Novel alpha/beta-Hydrolase Gene IbMas Enhances Salt Tolerance in Transgenic Sweetpotato	PLOS ONE			English	Article							ABIOTIC STRESS TOLERANCE; PROLINE ACCUMULATION; PLANT-REGENERATION; PHOSPHOLIPASE-D; SOYBEAN PLANTS; DROUGHT; MECHANISMS; CLONING; OVEREXPRESSION; PROTEINS	Salt stress is one of the major environmental stresses in agriculture worldwide and affects crop productivity and quality. The development of crops with elevated levels of salt tolerance is therefore highly desirable. In the present study, a novel maspardin gene, named IbMas, was isolated from salt-tolerant sweetpotato (Ipomoea batatas (L.) Lam.) line ND98. IbMas contains maspardin domain and belongs to alpha/beta-hydrolase superfamily. Expression of IbMas was up-regulated in sweetpotato under salt stress and ABA treatment. The IbMas-overexpressing sweetpotato (cv. Shangshu 19) plants exhibited significantly higher salt tolerance compared with the wild-type. Proline content was significantly increased, whereas malonaldehyde content was significantly decreased in the transgenic plants. The activities of superoxide dismutase (SOD) and photosynthesis were significantly enhanced in the transgenic plants. H2O2 was also found to be significantly less accumulated in the transgenic plants than in the wild-type. Overexpression of IbMas up-regulated the salt stress responsive genes, including pyrroline-5-carboxylate synthase, pyrroline-5-carboxylate reductase, SOD, psbA and phosphoribulokinase genes, under salt stress. These findings suggest that overexpression of IbMas enhances salt tolerance of the transgenic sweetpotato plants by regulating osmotic balance, protecting membrane integrity and photosynthesis and increasing reactive oxygen species scavenging capacity.	[Liu, Degao; Wang, Lianjun; Zhai, Hong; Song, Xuejin; He, Shaozhen; Liu, Qingchang] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100094, Peoples R China	China Agricultural University	Liu, QC (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, Lab Crop Heterosis & Utilizat, Minist Educ, Beijing 100094, Peoples R China.	liuqc@cau.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455; Li, Zhineng/0000-0002-6255-5947	National Natural Science Foundation of China [31371680, 31271777]; China Agriculture Research System [CARS-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (31371680, 31271777) and China Agriculture Research System (CARS-11, Sweetpotato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia, 1997, J PHOTOCH PHOTOBIO B, V38, P253, DOI 10.1016/S1011-1344(96)07470-2; ALIA, 1991, BIOCHEM BIOPH RES CO, V181, P1238, DOI 10.1016/0006-291X(91)92071-Q; Alia, 2001, AMINO ACIDS, V21, P195; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bugg TDH, 2004, BIOORG CHEM, V32, P367, DOI 10.1016/j.bioorg.2004.05.005; Chen HC, 2010, INTEGR SER INFORM SY, V21, P167, DOI 10.1007/978-1-4419-1278-7_12; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; de Ronde JA, 2000, PLANT GROWTH REGUL, V32, P13, DOI 10.1023/A:1006338911617; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deng XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069881; Dhir SK, 1998, PLANT CELL REP, V17, P665, DOI 10.1007/s002990050462; Fernandez-Falcon M, 2006, SCI HORTIC-AMSTERDAM, V107, P373, DOI 10.1016/j.scienta.2005.08.009; Gao S, 2011, PLANT CELL TISS ORG, V107, P205, DOI 10.1007/s11240-011-9971-1; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hanna MC, 2009, NEUROGENETICS, V10, P217, DOI 10.1007/s10048-009-0172-6; Hare PD, 1997, PLANT GROWTH REGUL, V21, P79, DOI 10.1023/A:1005703923347; He SZ, 2009, PLANT CELL TISS ORG, V96, P69, DOI 10.1007/s11240-008-9461-2; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Huang P, 2013, PLANT SCI, V203, P98, DOI 10.1016/j.plantsci.2012.12.019; Jiang T, 2013, SCI HORTIC-AMSTERDAM, V158, P22, DOI 10.1016/j.scienta.2013.04.027; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Koca H, 2006, BIOL PLANTARUM, V50, P745, DOI 10.1007/s10535-006-0121-2; Lenfant N, 2013, CHEM-BIOL INTERACT, V203, P266, DOI 10.1016/j.cbi.2012.09.003; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Liu DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093935; Liu DG, 2014, PLANT CELL TISS ORG, V117, P1, DOI 10.1007/s11240-013-0415-y; Liu QC, 2001, IN VITRO CELL DEV-PL, V37, P564; Liu QC, 2011, PLANT OMICS, V4, P295; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Peng XJ, 2013, PLANT CELL TISS ORG, V113, P245, DOI 10.1007/s11240-012-0264-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; Sun YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059924; Swapna T. S., 2002, Indian Journal of Experimental Biology, V40, P1056; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tan CM, 2013, INT J MOL SCI, V14, P20204, DOI 10.3390/ijms141020204; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wang LJ, 2013, J INTEGR AGR, V12, P27, DOI 10.1016/S2095-3119(13)60202-6; Wang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058952; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069810, 10.1371/journal.pone.0079289]; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang L, 2013, PLANT CELL TISS ORG, V113, P407, DOI 10.1007/s11240-012-0280-0; Zang N, 2009, SCI HORTIC-AMSTERDAM, V122, P649, DOI 10.1016/j.scienta.2009.06.023; Zeitlmann L, 2001, J BIOL CHEM, V276, P9123, DOI 10.1074/jbc.M009270200; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang H, 2012, PLANT CELL TISS ORG, V110, DOI 10.1007/s11240-012-0142-9; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	58	58	68	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2014	9	12							e115128	10.1371/journal.pone.0115128	http://dx.doi.org/10.1371/journal.pone.0115128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6JI	24489818	Green Submitted, Green Published, gold			2022-12-27	WOS:000346375400074
J	Thompson, MB; Tangen, JM				Thompson, Matthew B.; Tangen, Jason M.			The Nature of Expertise in Fingerprint Matching: Experts Can Do a Lot with a Little	PLOS ONE			English	Article							DECISION-MAKING; INFORMATION; IDENTIFICATION; RECOGNITION; ERROR	Expert decision making often seems impressive, even miraculous. People with genuine expertise in a particular domain can perform quickly and accurately, and with little information. In the series of experiments presented here, we manipulate the amount of "information'' available to a group of experts whose job it is to identify the source of crime scene fingerprints. In Experiment 1, we reduced the amount of information available to experts by inverting fingerprint pairs and adding visual noise. There was no evidence for an inversion effect-experts were just as accurate for inverted prints as they were for upright prints-but expert performance with artificially noisy prints was impressive. In Experiment 2, we separated matching and nonmatching print pairs in time. Experts were conservative, but they were still able to discriminate pairs of fingerprints that were separated by five-seconds, even though the task was quite different from their everyday experience. In Experiment 3, we separated the print pairs further in time to test the long-term memory of experts compared to novices. Long-term recognition memory for experts and novices was the same, with both performing around chance. In Experiment 4, we presented pairs of fingerprints quickly to experts and novices in a matching task. Experts were more accurate than novices, particularly for similar nonmatching pairs, and experts were generally more accurate when they had more time. It is clear that experts can match prints accurately when there is reduced visual information, reduced opportunity for direct comparison, and reduced time to engage in deliberate reasoning. These findings suggest that non-analytic processing accounts for a substantial portion of the variance in expert fingerprint matching accuracy. Our conclusion is at odds with general wisdom in fingerprint identification practice and formal training, and at odds with the claims and explanations that are offered in court during expert testimony.	[Thompson, Matthew B.; Tangen, Jason M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Thompson, MB (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	mbthompson@gmail.com; jtangen@psy.uq.edu.au	Thompson, Matthew/J-9922-2012; Tangen, Jason/ABH-8577-2020	Thompson, Matthew/0000-0002-5649-1203; Tangen, Jason/0000-0002-0649-2566; Poulsen, Mette Homann/0000-0003-2162-3007; Tarnow, Lise/0000-0002-8735-966X; Feidenhansl, Robert/0000-0002-7963-3649; Mathiesen, Joachim/0000-0002-5621-5487	Australian Research Council Linkage Grant to Tangen [LP120100063]; Fulbright Scholarship; Villum Fonden [00007172] Funding Source: researchfish	Australian Research Council Linkage Grant to Tangen(Australian Research Council); Fulbright Scholarship; Villum Fonden(Villum Fonden)	This research was supported by an Australian Research Council Linkage Grant to Tangen (LP120100063; www.arc.gov.au; see The Forensic Reasoning Project at ForensicReasoning. com), and a Fulbright Scholarship to Thompson (www.fulbright.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1991, INT J SPORT PSYCHOL, V22, P189; [Anonymous], 2009, STRENGTHENING FORENS; BARROWS HS, 1982, CLIN INVEST MED, V5, P49; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Brooks L, 1987, EMORY S COGNITION 1, P141; Brooks LR, 2005, CAN J EXP PSYCHOL, V59, P62, DOI 10.1037/h0087462; BROOKS LR, 1978, NON ANALYTIC CONCEPT; BUSEY T, 2011, J FORENSIC IDENTIF, V60, P61; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Busey TA, 2010, PSYCHON B REV, V17, P155, DOI 10.3758/PBR.17.2.155; CAMPBELL A, 2011, THE FINGERPRINT INQU, P790; Cole SA, 2009, LP R, V8, P233, DOI DOI 10.1093/LPR/MGP016; Cole SA, 2005, J CRIM LAW CRIM, V95, P985; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DEGROOT AD, 1978, THOUGHT AND CHOICE I; Dodson CS, 1997, MEM COGNITION, V25, P129, DOI 10.3758/BF03201107; Dror I.E., 2006, J FORENSIC IDENTIFIC, V56, P600, DOI DOI 10.1016/S1355-0306(98)72118-5; Dror IE, 2006, FORENSIC SCI INT, V156, P74, DOI 10.1016/j.forsciint.2005.10.017; Dror IE, 2011, FORENSIC SCI INT, V208, P10, DOI 10.1016/j.forsciint.2010.10.013; Edmond G, 2015, LAW PROBAB RISK, V14, P1, DOI [10.1093/lpr/mgu018, 10.1093/lpr/mgt011]; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; ERICSSON KA, 1991, TOWARD A GENERAL THE; Evans KK, 2013, PSYCHON B REV, V20, P1170, DOI 10.3758/s13423-013-0459-3; Evans KK, 2011, PSYCHOL SCI, V22, P739, DOI 10.1177/0956797611407930; Evans KK, 2011, ATTEN PERCEPT PSYCHO, V73, P30, DOI 10.3758/s13414-010-0022-5; *FED BUR INV, 1984, THE SCIENCE OF FINGE; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gobet F, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P523; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; HENRY ER, 1900, CLASSIFICATION AND U; Hughson AL, 2001, AUST J PSYCHOL, V53, P103, DOI 10.1080/00049530108255130; INTRAUB H, 1981, J EXP PSYCHOL HUMAN, V7, P604, DOI 10.1037/0096-1523.7.3.604; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Kahneman D., 2011, THINKING FAST AND SL; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kassin SM, 2013, J APPL RES MEM COGN, V2, P42, DOI 10.1016/j.jarmac.2013.01.001; KLEIN GA, 1998, SOURCES OF POWER; Loftus EF, 2004, SCIENCE, V304, P959; Medin DL., 1989, ADV PSYCHOL HUMAN IN, P189, DOI [10.4324/9781315807768-13, DOI 10.4324/9781315807768-13]; Mnookin JL, 2011, UCLA LAW REV, V58, P725; MYLESWORSLEY M, 1988, J EXP PSYCHOL LEARN, V14, P553, DOI 10.1037/0278-7393.14.3.553; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Norman GR, 2010, MED EDUC, V44, P94, DOI 10.1111/j.1365-2923.2009.03507.x; Norman GR, 1997, ADV HEALTH SCI EDUC, V2, P173, DOI 10.1023/A:1009784330364; NORMAN GR, 1989, ARCH DERMATOL, V125, P1063, DOI 10.1001/archderm.125.8.1063; POTTER MC, 1975, NATURE, V253, P437, DOI 10.1038/253437a0; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Saks MJ, 2005, SCIENCE, V309, P892, DOI 10.1126/science.1111565; SEARSTON RA, PUTTING BIAS INTO CO; Spinney L, 2010, NATURE, V464, P344, DOI 10.1038/464344a; Tangen JM, 2011, PSYCHOL SCI, V22, P995, DOI 10.1177/0956797611414729; Thompson MB, 2014, LAW HUMAN BEHAV, V38, P84, DOI 10.1037/lhb0000051; Thompson MB, 2013, J FORENSIC SCI, V58, P1519, DOI 10.1111/1556-4029.12203; Ulery BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032800; Ulery BT, 2011, P NATL ACAD SCI USA, V108, P7733, DOI 10.1073/pnas.1018707108; Vokey JR, 2009, Q J EXP PSYCHOL, V62, P1023, DOI 10.1080/17470210802372987; Wilson T., 2002, STRANGERS TO OURSELV	58	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114759	10.1371/journal.pone.0114759	http://dx.doi.org/10.1371/journal.pone.0114759			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25122138	gold, Green Submitted, Green Published			2022-12-27	WOS:000347215600026
J	Sun, XJ; Zhang, N; Liu, K; Li, W; Oksanen, T; Shi, LZ				Sun, Xiaojie; Zhang, Nan; Liu, Kun; Li, Wen; Oksanen, Tuula; Shi, Lizheng			Effects of a Randomized Intervention to Improve Workplace Social Capital in Community Health Centers in China	PLOS ONE			English	Article							SELF-RATED HEALTH; MULTILEVEL ANALYSIS; JOB-SATISFACTION; EMPLOYEES; PROFESSION; DEPRESSION; PREDICTOR; HOSPITALS; MORTALITY; SMOKING	Objective: To examine whether workplace social capital improved after implementing a workplace social capital intervention in community health centers in China. Methods: This study was conducted in 20 community health centers of similar size in Jinan of China during 2012-2013. Using the stratified site randomization, 10 centers were randomized into the intervention group; one center was excluded due to leadership change in final analyses. The baseline survey including 447 staff (response rate: 93.1%) was conducted in 2012, and followed by a six-month workplace social capital intervention, including team building courses for directors of community health centers, voluntarily public services, group psychological consultation, and outdoor training. The follow-up survey in July 2013 was responded to by 390 staff members (response rate: 86.9%). Workplace social capital was assessed with the translated and culturally adapted scale, divided into vertical and horizontal dimensions. The facility-level intervention effects were based on all baseline (n=427) and follow-up (n=377) respondents, except for Weibei respondents. We conducted a bivariate Difference-in-Difference analysis to estimate the facility-level intervention effects. Results: No statistically significant intervention effects were observed at the center level; the intervention increased the facility-level workplace social capital, and its horizontal and vertical dimensions by 1.0 (p=0.24), 0.4 (p=0.46) and 0.8 (p=0.16), respectively. Conclusions: The comprehensive intervention seemed to slightly improve workplace social capital in community health centers of urban China at the center level. High attrition rate limits any causal interpretation of the results. Further studies are warranted to test these findings.	[Sun, Xiaojie; Zhang, Nan; Liu, Kun] Shandong Univ, Ctr Hlth Management & Policy, Key Lab Hlth Econ & Policy, Natl Hlth & Planning Commiss, Jinan, Shandong, Peoples R China; [Li, Wen] Hlth Bur Jinan, Jinan, Shandong, Peoples R China; [Oksanen, Tuula] Finnish Inst Occupat Hlth, Helsinki, Finland; [Shi, Lizheng] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA	Shandong University; Finnish Institute of Occupational Health; Tulane University	Shi, LZ (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	lshi1@tulane.edu	Song, Weihong/O-7623-2017; Herculano, Bruno/N-4587-2019; Herculano, Bruno/F-8917-2018; Oksanen, Tuula/AAK-5599-2021	Song, Weihong/0000-0001-9928-889X; Herculano, Bruno/0000-0003-0095-3381; Herculano, Bruno/0000-0003-0095-3381; wu, yili/0000-0002-2369-6974	China Medical Board [CMB09-991]; Independent Innovation Foundation of Shandong University [IFYT1227]	China Medical Board; Independent Innovation Foundation of Shandong University	XS was supported by the China Medical Board (http://www.chinamedicalboard.org/) (projects #CMB09-991) and the Independent Innovation Foundation of Shandong University (http://en.sdu.edu.cn/) (project#IFYT1227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almedom A. M., 2008, SOCIAL CAPITAL HLTH, P191; Amos MA, 2005, J NURSES PROF DEV, V21, P10, DOI 10.1097/00124645-200501000-00003; [Anonymous], 2009, BEIJING YOUTH DAILY; Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; CAUDRON S, 1994, PERS J, V73, P38; Chen L, 2009, CHINESE J SOCIAL MED, V29, P200; Cominetti Laura, 2011, Prof Inferm, V64, P102; DiMeglio K, 2005, J NURS ADMIN, V35, P110; Dumville JC, 2006, BMJ-BRIT MED J, V332, P969, DOI 10.1136/bmj.332.7547.969; Engstrom K, 2008, SOC SCI MED, V66, P2268, DOI 10.1016/j.socscimed.2008.01.019; Ferrie JE, 2007, SCAND J PUBLIC HEALT, V35, P62, DOI 10.1080/14034940600813073; Finney MI, 1997, HRM MAGAZINE, P110; Gao J, 2012, CHINESE J HLTH ED, V28, P806, DOI DOI 10.16168/J.CNKI.ISSN.1002; Gao JL, 2013, PREV MED, V57, P831, DOI 10.1016/j.ypmed.2013.09.009; Hayes LJ, 2006, INT J NURS STUD, V43, P237, DOI 10.1016/j.ijnurstu.2005.02.007; Hess D, 2002, CALIF MANAGE REV, V44, P110, DOI 10.2307/41166125; Homans GC, 1995, HUMAN GROUP; Huang HT, 2012, SOC BEHAV PERSONAL, V40, P1201, DOI 10.2224/sbp.2012.40.7.1201; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kennelly B, 2003, SOC SCI MED, V56, P2367, DOI 10.1016/S0277-9536(02)00241-1; Kim D., 2008, SOCIAL CAPITAL HLTH, P139, DOI DOI 10.1007/978-0-387-71311-3_8; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Lindstrom M, 2008, AM J EPIDEMIOL, V167, P1152, DOI 10.1093/aje/kwn070; Ling W., 2001, CHIN SOC STUD, V2, P90; Ma L, 2007, RELATIONSHIPS ORG SO; Markuns JF, 2010, FAM MED, V42, P403; Murayama H, 2013, GLOBAL PERSPECTIVES, P205; Oksanen T., 2013, GLOBAL PERSPECTIVES, P23; Oksanen T, 2008, SOC SCI MED, V66, P637, DOI 10.1016/j.socscimed.2007.10.013; Oksanen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065846; Oksanen T, 2011, AM J PUBLIC HEALTH, V101, P1742, DOI 10.2105/AJPH.2011.300166; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Olsen O, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-39; Ommen O, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-81; Parry J, 2008, J ADV NURS, V64, P157, DOI 10.1111/j.1365-2648.2008.04771.x; Peterson DK, 2004, PERS REV, V33, P615, DOI 10.1108/00483480410561510; Potts H, 2007, ROLE SOCIAL CAPITAL; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Simon M, 2010, J ADV NURS, V66, P616, DOI 10.1111/j.1365-2648.2009.05204.x; Sundquist K, 2007, HEALTH PLACE, V13, P324, DOI 10.1016/j.healthplace.2006.02.002; Suzuki E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-489; Suzuki E, 2010, SOC SCI MED, V70, P1367, DOI 10.1016/j.socscimed.2010.01.014; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Vaananen A, 2009, OCCUP ENVIRON MED, V66, P432, DOI 10.1136/oem.2008.042044; Williams S. D., 2003, Journal of Management Development, V22, P45, DOI 10.1108/02621710310454851	47	75	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114924	10.1371/journal.pone.0114924	http://dx.doi.org/10.1371/journal.pone.0114924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX8FY	25503627	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700073
J	Liu, DF; Sui, SZ; Ma, J; Li, ZN; Guo, YL; Luo, DP; Yang, JF; Li, MY				Liu, Daofeng; Sui, Shunzhao; Ma, Jing; Li, Zhineng; Guo, Yulong; Luo, Dengpan; Yang, Jianfeng; Li, Mingyang			Transcriptomic Analysis of Flower Development in Wintersweet (Chimonanthus praecox)	PLOS ONE			English	Article							FLORAL SCENT PRODUCTION; LINALOOL SYNTHASE GENE; RNA-SEQ DATA; FUNCTIONAL-CHARACTERIZATION; DIFFERENTIAL EXPRESSION; CLARKIA-BREWERI; SALICYLIC-ACID; SENESCENCE; IDENTIFICATION; HORMONE	Wintersweet (Chimonanthus praecox) is familiar as a garden plant and woody ornamental flower. On account of its unique flowering time and strong fragrance, it has a high ornamental and economic value. Despite a long history of human cultivation, our understanding of wintersweet genetics and molecular biology remains scant, reflecting a lack of basic genomic and transcriptomic data. In this study, we assembled three cDNA libraries, from three successive stages in flower development, designated as the flower bud with displayed petal, open flower and senescing flower stages. Using the Illumina RNA-Seq method, we obtained 21,412,928, 26,950,404, 24,912,954 qualified Illumina reads, respectively, for the three successive stages. The pooled reads from all three libraries were then assembled into 106,995 transcripts, 51,793 of which were annotated in the NCBI non-redundant protein database. Of these annotated sequences, 32,649 and 21,893 transcripts were assigned to gene ontology categories and clusters of orthologous groups, respectively. We could map 15,587 transcripts onto 312 pathways using the Kyoto Encyclopedia of Genes and Genomes pathway database. Based on these transcriptomic data, we obtained a large number of candidate genes that were differentially expressed at the open flower and senescing flower stages. An analysis of differentially expressed genes involved in plant hormone signal transduction pathways indicated that although flower opening and senescence may be independent of the ethylene signaling pathway in wintersweet, salicylic acid may be involved in the regulation of flower senescence. We also succeeded in isolating key genes of floral scent biosynthesis and proposed a biosynthetic pathway for monoterpenes and sesquiterpenes in wintersweet flowers, based on the annotated sequences. This comprehensive transcriptomic analysis presents fundamental information on the genes and pathways which are involved in flower development in wintersweet. And our data provided a useful database for further research of wintersweet and other Calycanthaceae family plants.	[Liu, Daofeng; Sui, Shunzhao; Ma, Jing; Li, Zhineng; Guo, Yulong; Luo, Dengpan; Yang, Jianfeng; Li, Mingyang] Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mt Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China	Southwest University - China	Li, MY (corresponding author), Southwest Univ, Coll Hort & Landscape Architecture, Key Lab Hort Sci Southern Mt Reg, Chongqing Engn Res Ctr Floriculture,Minist Educ, Chongqing, Peoples R China.	limy@swu.edu.cn	Liu, Degao/L-3682-2016	Liu, Degao/0000-0002-0090-9455; Li, Zhineng/0000-0002-6255-5947	National Natural Science Foundation of China [31070622]; Fundamental Research Funds for the Central Universities [XDJK2013A004]; postdoctoral research foundation of Chongqing [Xm201345]; "111" Project [B12006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); postdoctoral research foundation of Chongqing; "111" Project(Ministry of Education, China - 111 Project)	This work was supported by National Natural Science Foundation of China (Grant nos. 31070622), the Fundamental Research Funds for the Central Universities (XDJK2013A004), the postdoctoral research foundation of Chongqing (Xm201345) and the "111" Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Ramirez A, 2009, PLANT PHYSIOL, V150, P1335, DOI 10.1104/pp.109.139352; Arora A, 2004, J PLANT BIOCHEM BIOT, V13, P123, DOI 10.1007/BF03263206; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azuma Hiroshi, 2005, APG Acta Phytotaxonomica et Geobotanica, V56, P197; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Benjamini Y, 2001, ANN STAT, V29, P1165; Boatright J, 2004, PLANT PHYSIOL, V135, P1993, DOI 10.1104/pp.104.045468; Boyle P, 2009, PLANT CELL, V21, P3700, DOI 10.1105/tpc.109.069971; Breeze E, 2004, PLANT BIOTECHNOL J, V2, P155, DOI 10.1111/j.1467-7652.2004.00059.x; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Davies B, 2006, ADV BOT RES, V44, P279, DOI 10.1016/S0065-2296(06)44007-6; Davies P. J., 1987, Plant hormones and their role in plant growth and development., P1; Deng CH, 2004, Z NATURFORSCH C, V59, P636; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; Dudareva N, 2000, PLANT PHYSIOL, V122, P627, DOI 10.1104/pp.122.3.627; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; Dudareva N, 1996, PLANT CELL, V8, P1137, DOI 10.1105/tpc.8.7.1137; Dudareva N, 1996, PLANT PHYSIOL, V111, P815; Eason JR, 2002, FUNCT PLANT BIOL, V29, P1055, DOI 10.1071/PP01174; Fahnrich A, 2011, MOL PLANT, V4, P965, DOI 10.1093/mp/ssr021; Feng JQ, 2007, J BEIJING FORESTR S1, P4; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Harada T, 2010, J EXP BOT, V61, P2345, DOI 10.1093/jxb/erq064; Hunter DA, 2002, PLANT SCI, V163, P13, DOI 10.1016/S0168-9452(02)00068-7; Iordachescu M, 2005, J EXP BOT, V56, P2011, DOI 10.1093/jxb/eri199; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; JONES ML, 1995, PLANT MOL BIOL, V28, P505, DOI 10.1007/BF00020397; Kitajima M, 2006, TETRAHEDRON LETT, V47, P3199, DOI 10.1016/j.tetlet.2006.03.047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, PLANT PHYSIOL, V147, P1017, DOI 10.1104/pp.108.115824; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Y., 2000, GUIHAIA, V20, P295; Lin CF, 2008, PLANT PHYSIOL, V146, P940, DOI 10.1104/pp.107.109553; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2012, HORTSCIENCE, V47, P1472, DOI 10.21273/HORTSCI.47.10.1472; Ma L, 2012, AGR SCI TECHN, V13, P88; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martin DM, 2004, PHYTOCHEMISTRY, V65, P1223, DOI 10.1016/j.phytochem.2004.03.018; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Phillips MA, 2003, ARCH BIOCHEM BIOPHYS, V411, P267, DOI 10.1016/S0003-9861(02)00746-4; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2007, TRENDS BIOTECHNOL, V25, P105, DOI 10.1016/j.tibtech.2007.01.002; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Shahri W, 2011, BOT REV, V77, P152, DOI 10.1007/s12229-011-9063-2; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Sheng AiWu, 1999, Journal of Beijing Forestry University, V21, P48; Spiller M, 2010, THEOR APPL GENET, V120, P1461, DOI 10.1007/s00122-010-1268-y; Sui SZ, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/134596; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; VALPUESTA V, 1995, PLANT MOL BIOL, V28, P575, DOI 10.1007/BF00020403; van Doorn WG, 2003, PLANT MOL BIOL, V53, P845, DOI 10.1023/B:PLAN.0000023670.61059.1d; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wagstaff C, 2002, J EXP BOT, V53, P233, DOI 10.1093/jexbot/53.367.233; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xiang L, 2010, PLANT PHYSIOL BIOCH, V48, P845, DOI 10.1016/j.plaphy.2010.08.015; ZHANG RH, 1998, WAX SHRUBS WORLD CAL; Zhao KG, 2007, HORTSCIENCE, V42, P1144, DOI 10.21273/HORTSCI.42.5.1144; [赵莹 ZHAO Ying], 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P622	69	58	68	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2014	9	1							e86976	10.1371/journal.pone.0086976	http://dx.doi.org/10.1371/journal.pone.0086976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301ZC	24489818	gold, Green Published, Green Submitted			2022-12-27	WOS:000330570000087
J	Clutterbuck, S; Adams, J; Nettle, D				Clutterbuck, Stephanie; Adams, Jean; Nettle, Daniel			Childhood Adversity Accelerates Intended Reproductive Timing in Adolescent Girls without Increasing Interest in Infants	PLOS ONE			English	Article							SEX-DIFFERENCES; FATHER ABSENCE; EVOLUTIONARY-THEORY; LIFE-HISTORY; BABY SCHEMA; AGE; RESPONSIVENESS; YOUNG; MENARCHE; BABIES	Women experiencing greater childhood adversity exhibit faster reproductive trajectories. One possible psychological mechanism underlying this phenomenon is an increased interest in infants. Interest in infants is thought to be an adaptation important for successful rearing as it motivates the acquisition of caretaking skills. We investigated the relationships between childhood adversity, intended reproductive timing and interest in infants in a sample of English adolescent girls. Specifically we sought to investigate the relationship between 1) childhood adversity and intended reproductive timing; 2) childhood adversity and interest in infants; and 3) intended reproductive timing and interest in infants. Additionally we explored different methods of measuring interest in infants using self-reported fondness for babies, a forced choice adult versus infant paper-based preference task and a novel computer based attention task using adult and infant stimuli. In total 357 girls aged nine to 14 years participated in the study, which took place in schools. Participants completed the two interest in infants tasks before moving on to a childhood adversity questionnaire. Girls with more childhood adversity reported earlier ideal ages at parenthood. We found some evidence that, contrary to our predictions, girls with less childhood adversity were more interested in infants. There was no relationship between intended reproductive timing and interest in infants. The different measurements for interest in infants were only weakly related, if at all, highlighting the complexity of measuring this construct. Our findings suggest that rather than interest in infants being a mechanism for the effect of childhood adversity on early reproductive timing it might instead be an indicator of future reproductive strategies.	[Clutterbuck, Stephanie; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Adams, Jean] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Clutterbuck, S (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	p.clutterbuck@ncl.ac.uk	Adams, Jean/G-2402-2010; Light, Ryan/AAA-1684-2019; adams, jimi/H-5997-2016	Adams, Jean/0000-0002-5733-7830; adams, jimi/0000-0001-5043-1149; Nettle, Daniel/0000-0001-9089-2599; Light, Ryan/0000-0002-1508-154X	North Tyneside Council [001]; Birtch Control Trust of the Galton Institute [001]; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	North Tyneside Council; Birtch Control Trust of the Galton Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was partly funded from two sources: 1. The North Tyneside Council. Grant Number: 001 URL: http://www.northtyneside.gov.uk/, and 2. The Birtch Control Trust of the Galton Institute. Grant Number: 001 URL: http://www.galtoninstitute.org.uk/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber N, 2001, CROSS-CULT RES, V35, P263, DOI 10.1177/106939710103500301; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; BERMAN PW, 1975, SEX ROLES, V1, P311; BERMAN PW, 1978, CHILD DEV, V49, P917, DOI 10.2307/1128272; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; BLAKEMORE JEO, 1981, CHILD DEV, V52, P386; BLAKEMORE JEO, 1985, SEX ROLES, V13, P405, DOI 10.1007/BF00287951; Blell M, 2008, J BIOSOC SCI, V40, P563, DOI 10.1017/S0021932007002696; Bottino MN, 2012, J AFFECT DISORDERS, V142, P219, DOI 10.1016/j.jad.2012.04.030; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; Duchowski A, 2007, EYE TRACKING METHODO, V373; Elliott D. S., 1985, EXPLAINING DELINQUEN; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; FAIRBANKS LA, 1990, ANIM BEHAV, V40, P553, DOI 10.1016/S0003-3472(05)80536-6; FELDMAN SS, 1979, CHILD DEV, V50, P942, DOI 10.2307/1129318; FELDMAN SS, 1978, CHILD DEV, V49, P617, DOI 10.1111/j.1467-8624.1978.tb02361.x; FELDMAN SS, 1977, DEV PSYCHOL, V13, P675, DOI 10.1037/0012-1649.13.6.675; FRODI AM, 1984, SEX ROLES, V10, P639; FRODI AM, 1978, CHILD DEV, V49, P1182, DOI 10.2307/1128758; FULLARD W, 1976, CHILD DEV, V47, P1191, DOI 10.2307/1128462; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Harden A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4254; Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006; Kiernan KE, 1997, BRIT J SOCIOL, V48, P406, DOI 10.2307/591138; Kim K, 1998, J ADOLESCENCE, V21, P231, DOI 10.1006/jado.1998.0149; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Maestripieri D, 2004, DEVELOPMENTAL SCI, V7, P560, DOI 10.1111/j.1467-7687.2004.00380.x; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Maestripieri D, 2006, DEV REV, V26, P120, DOI 10.1016/j.dr.2006.02.006; McCulloch A, 2001, J EPIDEMIOL COMMUN H, V55, P16, DOI 10.1136/jech.55.1.16; McLennan D., 2011, ENGLISH INDICES DEPR; Mikach SM, 1999, EVOL HUM BEHAV, V20, P141, DOI 10.1016/S1090-5138(98)00045-2; Nettle D., 2010, P R SOC B, V278, P1721, DOI DOI 10.1098/RSPB.2010.1726.PMID:21068037; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; Nettle D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012690; Nettle D, 2010, AM J HUM BIOL, V22, P172, DOI 10.1002/ajhb.20970; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Romans SE, 2003, PSYCHOL MED, V33, P933, DOI 10.1017/S0033291703007530; Russell ST, 2002, J RES ADOLESCENCE, V12, P305, DOI 10.1111/1532-7795.00035; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Seamark CJ, 1997, BRIT J GEN PRACT, V47, P175; Sprengelmeyer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065844; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Wellings K, 1999, REV REPROD, V4, P184, DOI 10.1530/revreprod/4.3.184; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042	58	22	23	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2014	9	1							e85013	10.1371/journal.pone.0085013	http://dx.doi.org/10.1371/journal.pone.0085013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297DQ	25506703	Green Submitted, Green Published, gold			2022-12-27	WOS:000330236000007
J	Sun, XL; Wu, YL; Herculano, B; Song, WH				Sun, Xiulian; Wu, Yili; Herculano, Bruno; Song, Weihong			RCAN1 Overexpression Exacerbates Calcium Overloading-Induced Neuronal Apoptosis	PLOS ONE			English	Article							CALCINEURIN-INTERACTING PROTEIN-1; DOWN-SYNDROME; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; TRANSCRIPTION FACTORS; INHIBITS CALCINEURIN; CARDIAC-HYPERTROPHY; CELL-DEATH; DSCR1	Down Syndrome (DS) patients develop characteristic Alzheimer's Disease (AD) neuropathology after their middle age. Prominent neuronal loss has been observed in the cortical regions of AD brains. However, the underlying mechanism leading to this neuronal loss in both DS and AD remains to be elucidated. Calcium overloading and oxidative stress have been implicated in AD pathogenesis. Two major isoforms of regulator of calcineurin 1 (RCAN1), RCAN1.1 and RCAN1.4, are detected in human brains. In this report we defined the transcriptional regulation of RCAN1.1 and RCAN1.4 by two alternative promoters. Calcium overloading upregulated RCAN1.4 expression by activating RCAN1.4 promoter through calcineurin-NFAT signaling pathway, thus forming a negative feedback loop in isoform 4 regulation. Furthermore, RCAN1.4 overexpression exacerbated calcium overloading-induced neuronal apoptosis, which was mediated by caspase-3 apoptotic pathway. Our results suggest that downregulating RCAN1.4 expression in neurons could be beneficial to AD patients.	[Sun, Xiulian] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing, Peoples R China; [Wu, Yili; Song, Weihong] Chongqing Med Univ, Childrens Hosp, Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Sun, Xiulian; Wu, Yili; Herculano, Bruno; Song, Weihong] Univ British Columbia, Grad Program Neurosci, Brain Res Ctr, Dept Psychiat,Townsend Family Labs, Vancouver, BC V5Z 1M9, Canada	Shandong University; Chongqing Medical University; Chongqing Medical University; University of British Columbia	Song, WH (corresponding author), Chongqing Med Univ, Childrens Hosp, Chongqing City Key Lab Translat Med Res Cognit De, Chongqing, Peoples R China.	weihong@mail.ubc.ca	Song, Weihong/O-7623-2017; Herculano, Bruno/N-4587-2019; Herculano, Bruno/F-8917-2018; Oksanen, Tuula/AAK-5599-2021	Song, Weihong/0000-0001-9928-889X; Herculano, Bruno/0000-0003-0095-3381; Herculano, Bruno/0000-0003-0095-3381; wu, yili/0000-0002-2369-6974	Canadian Institutes of Health Research (CIHR) [TAD-117948]; National Natural Science Foundation of China (NSFC) Grant [30871387]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC) Grant(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant TAD-117948 (WS), and National Natural Science Foundation of China (NSFC) Grant 30871387 (XS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Arlt S, 2002, CURR OPIN LIPIDOL, V13, P289, DOI 10.1097/00041433-200206000-00009; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Baek KH, 2009, NATURE; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bhoiwala DL, 2013, NEUROL RES, V35, P79, DOI 10.1179/1743132812Y.0000000117; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Chan B, 2005, P NATL ACAD SCI USA, V102, P13075, DOI 10.1073/pnas.0503846102; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; de Haan JB, 2003, J NEURAL TRANSM-SUPP, P67; Down J. T., 1866, LONDON HOSP REPORTS, V3, P259; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2012, J BIOL CHEM, V287, P14088, DOI 10.1074/jbc.M111.305342; Ermak G, 2011, FASEB J, V25, P3306, DOI 10.1096/fj.11-185728; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Iannello RC, 1999, J NEURAL TRANSM-SUPP, P257; JACOBS PA, 1959, LANCET, V1, P710; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jung MS, 2011, J BIOL CHEM, V286, P40401, DOI 10.1074/jbc.M111.253971; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Ma H, 2004, J NEUROCHEM, V88, P1485, DOI 10.1046/j.1471-4159.2003.02294.x; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Peiris H, 2012, ENDOCRINOLOGY, V153, P5212, DOI 10.1210/en.2011-2149; Poppek D, 2006, BIOCHEM J, V400, P511, DOI 10.1042/BJ20060463; Porta S, 2007, HUM MOL GENET; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Sobrado M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-48; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Sun XL, 2011, J BIOL CHEM, V286, P9049, DOI 10.1074/jbc.M110.177519; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang W, 2012, EMBO J, V31, P3655, DOI 10.1038/emboj.2012.190; Wu YL, 2013, FASEB J, V27, P208, DOI 10.1096/fj.12-213124; Xing LZ, 2013, MAMM GENOME, V24, P30, DOI 10.1007/s00335-012-9436-9; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zanin MP, 2013, J NEUROCHEM, V124, P290, DOI 10.1111/jnc.12086	56	75	77	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95471	10.1371/journal.pone.0095471	http://dx.doi.org/10.1371/journal.pone.0095471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	25503627	Green Published, Green Submitted, gold			2022-12-27	WOS:000335227400065
J	Thomsen, M; Hernandez-Garcia, A; Mathiesen, J; Poulsen, M; Sorensen, DN; Tarnow, L; Feidenhansl, R				Thomsen, Maria; Hernandez-Garcia, Anier; Mathiesen, Joachim; Poulsen, Mette; Sorensen, Dan N.; Tarnow, Lise; Feidenhansl, Robert			Model Study of the Pressure Build-Up during Subcutaneous Injection	PLOS ONE			English	Article							INSULIN; INFUSION; TISSUE	In this study we estimate the subcutaneous tissue counter pressure during drug infusion from a series of injections of insulin in type 2 diabetic patients using a non-invasive method. We construct a model for the pressure evolution in subcutaneous tissue based on mass continuity and the flow laws of a porous medium. For equivalent injection forces we measure the change in the infusion rate between injections in air at atmospheric pressure and in tissue. From a best fit with our model, we then determine the flow permeability as well as the bulk modulus of the tissue, estimated to be of the order 10(-11) - 10(-10) m(2) and 10(5) Pa, respectively. The permeability is in good agreement with reported values for adipose porcine tissue. We suggest our model as a general way to estimate the pressure build-up in tissue during subcutaneous injection.	[Thomsen, Maria; Hernandez-Garcia, Anier; Mathiesen, Joachim; Feidenhansl, Robert] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Thomsen, Maria; Poulsen, Mette; Sorensen, Dan N.] Novo Nordisk AS, Hillerod, Denmark; [Tarnow, Lise] Nordsjae llands Hosp, Hillerod, Denmark; [Tarnow, Lise] Aarhus Univ Hosp, Klin Epidemiol Afdeling, DK-8000 Aarhus, Denmark; [Tarnow, Lise] Steno Diabet Ctr AS, Gentofte, Denmark	University of Copenhagen; Niels Bohr Institute; Novo Nordisk; Aarhus University; Steno Diabetes Center	Thomsen, M (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	mariath@fys.ku.dk	Thompson, Matthew/J-9922-2012; Tangen, Jason/ABH-8577-2020	Thompson, Matthew/0000-0002-5649-1203; Tangen, Jason/0000-0002-0649-2566; Poulsen, Mette Homann/0000-0003-2162-3007; Tarnow, Lise/0000-0002-8735-966X; Feidenhansl, Robert/0000-0002-7963-3649; Mathiesen, Joachim/0000-0002-5621-5487	Villum Fonden [00007172] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Agache PG, 2004, MEASURING SKIN; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Comley KSC, 2010, THESIS U CAMBRIDGE E; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; De Coninck C, 2010, J DIABETES, V2, P168, DOI 10.1111/j.1753-0407.2010.00077.x; Gentile S, 2011, ACTA DIABETOL, V48, P121, DOI 10.1007/s00592-009-0172-x; Heinemann L, 2013, DIABETES TECHNOL THE, V15, pS48, DOI 10.1089/dia.2013.1506; Holstein A, 2010, EXPERT OPIN DRUG SAF, V9, P225, DOI 10.1517/14740330903496402; Johansson UB, 2005, DIABETES CARE, V28, P2025, DOI 10.2337/diacare.28.8.2025; Johnsen O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011301; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Milan G, 2010, J CLIN ENDOCR METAB, V95, P3126, DOI 10.1210/jc.2009-2773; Omar Magdy A, 2011, BMC Res Notes, V4, P290, DOI 10.1186/1756-0500-4-290; Patte C, 2013, DIABETES TECHNOL THE, V15, P289, DOI 10.1089/dia.2012.0319; Pearson Teresa L, 2010, J Diabetes Sci Technol, V4, P522; Peteiro-Gonzalez D, 2011, DIABETES RES CLIN PR, V91, pE61, DOI 10.1016/j.diabres.2010.11.026; SPIEGELMAN M, 1993, J FLUID MECH, V247, P17, DOI 10.1017/S0022112093000369; STRANDEN E, 1982, MICROVASC RES, V24, P241, DOI 10.1016/0026-2862(82)90015-2; Strauss K, 2002, PRACT DIAB INT, P71, DOI 10.1002/pdi.314; Thomsen M, 2012, PHYS MED BIOL, V57, P7191, DOI 10.1088/0031-9155/57/21/7191; Vardar B, 2007, DIABETES RES CLIN PR, V77, P231, DOI 10.1016/j.diabres.2006.12.023; Wang H.F., 2000, PRI SER GEO; Wielandt JO, 2011, EXPERT OPIN DRUG DEL, V8, P1271, DOI 10.1517/17425247.2011.615308; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x	24	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104054	10.1371/journal.pone.0104054	http://dx.doi.org/10.1371/journal.pone.0104054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122138	Green Published, gold			2022-12-27	WOS:000341017000026
J	Wang, H; Sun, W; Ma, JQ; Pan, YC; Wang, L; Zhang, WB				Wang, Hua; Sun, Wen; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing			Polycystin-1 Mediates Mechanical Strain-Induced Osteoblastic Mechanoresponses via Potentiation of Intracellular Calcium and Akt/beta-Catenin Pathway	PLOS ONE			English	Article							FOCAL ADHESION KINASE; KIDNEY-DISEASE; PROTEIN-KINASE; OSTEOGENIC DIFFERENTIATION; FLUID-FLOW; BONE-CELLS; PKD1 GENE; SKELETAL; ACTIVATION; MECHANOTRANSDUCTION	Mechanical regulation of bone formation involves a complex biophysical process, yet the underlying mechanisms remain poorly understood. Polycystin-1 (PC1) is postulated to function as a mechanosensory molecule mediating mechanical signal transduction in renal epithelial cells. To investigate the involvement of PC1 in mechanical strain-induced signaling cascades controlling osteogenesis, PKD1 gene was stably silenced in osteoblastic cell line MC3T3-E1 by using lentivirus-mediated shRNA technology. Here, our findings showed that mechanical tensile strain sufficiently enhanced osteogenic gene expressions and osteoblastic proliferation. However, PC1 deficiency resulted in the loss of the ability to sense external mechanical stimuli thereby promoting osteoblastic osteogenesis and proliferation. The signal pathways implicated in this process were intracellular calcium and Akt/beta-catenin pathway. The basal levels of intracellular calcium, phospho-Akt, phospho-GSK-3 beta and nuclear accumulation of active beta-catenin were significantly attenuated in PC1 deficient osteoblasts. In addition, PC1 deficiency impaired mechanical strain-induced potentiation of intracellular calcium, and activation of Akt-dependent and Wnt/beta-catenin pathways, which was able to be partially reversed by calcium ionophore A23187 treatment. Furthermore, applications of LiCl or A23187 in PC1 deficient osteoblasts could promote osteoblastic differentiation and proliferation under mechanical strain conditions. Therefore, our results demonstrated that osteoblasts require mechanosensory molecule PC1 to adapt to external mechanical tensile strain thereby inducing osteoblastic mechanoresponse, partially through the potentiation of intracellular calcium and downstream Akt/b-catenin signaling pathway.	[Wang, Hua; Ma, Junqing; Pan, Yongchu; Wang, Lin; Zhang, Weibing] Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China; [Sun, Wen] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, L (corresponding author), Nanjing Med Univ, Inst Stomatol, Nanjing, Jiangsu, Peoples R China.	nydwlktz@gmail.com; weibingzhang.njmu@gmail.com		wang, wei/0000-0002-0440-0859	National Natural Science Foundation of China [30973361, 81170981]; Natural Science Foundation for Colleges and Universities in JiangSu Province [10kJB320004]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ12_0589]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for Colleges and Universities in JiangSu Province; Jiangsu Province Innovation Project for Graduate Student of China	This study was supported in part by the National Natural Science Foundation of China (30973361, 81170981) and Natural Science Foundation for Colleges and Universities in JiangSu Province (10kJB320004) and by the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ12_0589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalagiorgou G, 2013, CELL MOL LIFE SCI, V70, P167, DOI 10.1007/s00018-012-1164-5; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070; Faibish D, 2006, CLIN ORTHOP RELAT R, P28, DOI 10.1097/01.blo.0000200241.14684.4e; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Gao JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063084; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hou B, 2009, BONE, V44, P1121, DOI 10.1016/j.bone.2009.02.018; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Khan KM, 2009, BRIT J SPORT MED, V43, P247, DOI 10.1136/bjsm.2008.054239; Koike M, 2005, J BONE MINER METAB, V23, P219, DOI 10.1007/s00774-004-0587-y; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Kreja L, 2008, BIOCHEM BIOPH RES CO, V368, P582, DOI 10.1016/j.bbrc.2008.01.106; Lei G, 2011, BIOL CELL, V103, P185, DOI 10.1042/BC20100134; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Qiu N, 2012, J CELL BIOCHEM, V113, P967, DOI 10.1002/jcb.23426; Raisz LG, 1999, CLIN CHEM, V45, P1353; Rangaswami H, 2012, J BIOL CHEM, V287, P21509, DOI 10.1074/jbc.M112.347245; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Walker LM, 2000, J CELL BIOCHEM, V79, P648, DOI 10.1002/1097-4644(20001215)79:4<648::AID-JCB130>3.0.CO;2-Q; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weimbs T, 2006, CELL CYCLE, V5, P2425, DOI 10.4161/cc.5.21.3408; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Yu Y, 2012, HISTOCHEM CELL BIOL, V137, P513, DOI 10.1007/s00418-011-0908-x; Zhang WB, 2009, J CELL BIOCHEM, V108, P600, DOI 10.1002/jcb.22291	58	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2014	9	3							e91730	10.1371/journal.pone.0091730	http://dx.doi.org/10.1371/journal.pone.0091730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9GM	24586557	Green Published, gold, Green Submitted			2022-12-27	WOS:000332842400123
J	Wang, H; Zhou, L; Guo, JM; Sun, L; Long, QL; Ma, Y; Zhang, L; Lin, ZM; Zhu, TY; Wang, GM				Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin			Mini-Flank Supra-12th Rib Incision for Open Partial Nephrectomy Compared with Laparoscopic Partial Nephrectomy and Traditional Open Partial Nephrectomy	PLOS ONE			English	Article							RADICAL NEPHRECTOMY; COMPLICATIONS; OUTCOMES; SURGERY; TUMORS	Purpose: The purpose of this study was to report our approach of partial nephrectomy (PN) using a supra-12th rib mini-flank incision. We compared mini-incision open partial nephrectomy (MI-OPN) with open partial nephrectomy (OPN) and laparoscopic partial nephrectomy (LPN) to verify whether MI-OPN can be an alternative to OPN and LPN. Methods: This was a retrospective single-center study including 194 patients who underwent partial nephrectomy (PN) between February 2005 and December 2010. Demographic, perioperative, and complication data were compared among the MI-OPN group, OPN group and LPN group. Results: No statistical differences were reported in either group for age, sex, BMI, tumour side (right or left kidney), RENAL nephrometry scores, PADUA score and preoperative eGFR. The operative time was longer in LPN group when compared with MI-OPN and OPN group (all P < 0.001). The warm ischemia time of LPN group was longer than MI-OPN group (P = 0.032) and OPN group (P = 0.005). The length of stay of LPN group was shorter than OPN group (P = 0.018), but was similar to MI-OPN group (P = 0.094). The incidence of renal artery clamping was lower in OPN group when compared with MI-OPN and LPN group (all P, 0.001). More estimated blood loss was found in OPN group when compared with MI-OPN group (p = 0.003) and LPN group (P = 0.014). The overall incidence of postoperative complications was similar. Conclusions: The approach of MI-OPN can couple the benefits of both minimally invasive and open partial nephrectomy techniques with less estimated blood loss, shorter operative time, shorter length of stay, less postoperative complications, and a smaller incision. MI-OPN may be an effective alternative to laparoscopic or traditional open approaches, which maybe more suitable for the tumors with high RENAL nephrometry score or PADUA score.	[Wang, Hang; Zhou, Lin; Guo, Jianming; Sun, Li'an; Long, Qilai; Ma, Yong; Zhang, Li; Lin, Zongming; Zhu, Tongyu; Wang, Guomin] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China	Fudan University	Wang, H (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	wang.hang@zs-hospital.sh.cn; guo.jianming@zs-hospital.sh.cn		wang, wei/0000-0002-0440-0859				Breda A, 2007, J UROLOGY, V178, P47, DOI 10.1016/j.juro.2007.03.045; Chatterjee S, 2004, UROL ONCOL-SEMIN ORI, V22, P36, DOI 10.1016/S1078-1439(03)00099-1; DiBlasio CJ, 2006, BJU INT, V97, P149, DOI 10.1111/j.1464-410X.2006.05882.x; Ficarra V, 2009, EUR UROL, V56, P786, DOI 10.1016/j.eururo.2009.07.040; Frank I, 2006, J UROLOGY, V175, P849, DOI 10.1016/S0022-5347(05)00346-0; Gill IS, 2000, J UROLOGY, V163, P1665, DOI 10.1016/S0022-5347(05)67516-7; GILL IS, 1995, J UROLOGY, V154, P479, DOI 10.1016/S0022-5347(01)67078-2; Huang WC, 2007, NAT CLIN PRACT UROL, V4, P444, DOI 10.1038/ncpuro0855; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Kenney Chad Wotkowicz, 2012, CAMPBELL WALSH UROLO, V2, P1567; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Marszalek M, 2009, EUR UROL, V55, P1171, DOI 10.1016/j.eururo.2009.01.042; Mitropoulos D, 2012, EUR UROL, V61, P341, DOI 10.1016/j.eururo.2011.10.033; Nadu A, 2009, J UROLOGY, V181, P42, DOI 10.1016/j.juro.2008.09.014; Permpongkosol S, 2007, J UROLOGY, V177, P580, DOI 10.1016/j.juro.2006.09.031; Peycelon M, 2009, J UROLOGY, V181, P35, DOI 10.1016/j.juro.2008.09.025; Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Russo P, 2010, BJU INT, V105, P1494, DOI 10.1111/j.1464-410X.2010.09388.x; Ward J N, 1974, Urology, V3, P163, DOI 10.1016/S0090-4295(74)80006-3	20	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2014	9	2							e89155	10.1371/journal.pone.0089155	http://dx.doi.org/10.1371/journal.pone.0089155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3VI	24586557	Green Submitted, gold, Green Published			2022-12-27	WOS:000331717900058
J	Wang, HB; Fang, G; Yu, WZ; Du, F; Fan, CX; Liu, QL; Hao, LX; Liu, Y; Zheng, JS; Qin, ZY; Xia, W; Zhang, SY; Yin, ZD; Jing, Q; Zhang, YX; Huang, RN; Yang, RP; Tong, WB; Qi, Q; Guan, XJ; Jing, YL; Ma, QL; Wang, J; Ma, XZ; Chen, N; Zheng, HR; Li, YQ; Ma, C; Su, QR; Reilly, KH; Luo, HM; Wu, XP; Wen, N; Yang, WZ				Wang, Hai-Bo; Fang, Gang; Yu, Wen-Zhou; Du, Fei; Fan, Chun-Xiang; Liu, Qing-Lian; Hao, Li-Xin; Liu, Yu; Zheng, Jing-Shan; Qin, Zhi-Ying; Xia, Wei; Zhang, Shi-Yue; Yin, Zun-Dong; Jing, Qiong; Zhang, Yan-Xia; Huang, Rong-Na; Yang, Ru-Pei; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Ma, Chao; Su, Qi-Ru; Reilly, Kathleen H.; Luo, Hui-Ming; Wu, Xian-Ping; Wen, Ning; Yang, Wei-Zhong			An Outbreak of Type Pi Vaccine- Derived Poliovirus in Sichuan Province, China: Emergence and Circulation in an Under-Immunized Population	PLOS ONE			English	Article							POLIOMYELITIS	Background: During August 2011-February 2012, an outbreak of type P circulating vaccine-derived poliovirus (cVDPVs) occurred in Sichuan Province, China. Methods: A field investigation of the outbreak was conducted to characterize outbreak isolates and to guide emergency response. Sequence analysis of poliovirus capsid protein VP1 was performed to determine the viral propagation, and a coverage survey was carried out for risk assessment. Results: One clinical compatible polio case and three VDPV cases were determined in Ngawa County, Ngawa Tibetan and Qiang Autonomous Prefecture, Sichuan Province. Case patients were unimmunized children, 0.8-1 years old. Genetic sequencing showed that the isolates diverged from the VP1 region of the type P Sabin strain by 5-12 nucleotides (nt) and shared the same 5 nt VP1 substitutions, which indicate single lineage of cVDPVs. Of the 7 acute flaccid paralysis cases (all. 6 months) reported in Ngawa Prefecture in 2011, 4 (57.1%) cases (including 2 polio cases) did not receive oral attenuated poliovirus vaccine. Supplementary immunization activities (SIAs) were conducted in February-May, 2012, and the strain has not been isolated since. Conclusion: High coverage of routine immunization should be maintained among children until WPV transmission is globally eradicated. Risk assessments should be conducted regularly to pinpoint high risk areas or subpopulations, with SIAs developed if necessary.	[Wang, Hai-Bo; Yu, Wen-Zhou; Fan, Chun-Xiang; Hao, Li-Xin; Zheng, Jing-Shan; Xia, Wei; Yin, Zun-Dong; Zhang, Yan-Xia; Ma, Chao; Su, Qi-Ru; Luo, Hui-Ming; Wen, Ning; Yang, Wei-Zhong] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Wang, Hai-Bo] Peking Univ, Clin Res Inst, Beijing 100191, Peoples R China; [Fang, Gang; Du, Fei; Liu, Qing-Lian; Liu, Yu; Qin, Zhi-Ying; Tong, Wen-Bin; Qi, Qi; Guan, Xu-Jing; Jing, Yu-Lin; Ma, Qian-Li; Wang, Jin; Ma, Xiao-Zhen; Chen, Na; Zheng, Hong-Ru; Li, Yin-Qiao; Wu, Xian-Ping] Sichuan Prov Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Zhang, Shi-Yue; Jing, Qiong] Ngawa Tibetan & Qiang Autonomous Prefectural Ctr, Chengdu 624000, Sichuan Provinc, Peoples R China; [Huang, Rong-Na; Yang, Ru-Pei] Chengdu City Ctr Dis Control & Prevent, Chengdu 610041, Sichuan Provinc, Peoples R China; [Reilly, Kathleen H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China	Chinese Center for Disease Control & Prevention; Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Luo, HM (corresponding author), Chinese Ctr Dis Control & Prevent, Nanwei Rd 27, Beijing 100050, Peoples R China.	Hmluo@vip.sina.com; wwwuxp@163.com; ning_wen@163.com; yangwz@chinacdc.cn		wang, wei/0000-0002-0440-0859				Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P545; [Anonymous], 1999, MMWR MORB MORTAL WKL, V48, P747; Bahta L., 2005, Morbidity and Mortality Weekly Report, V54, P1053; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P967; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P113; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P357; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P736; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Liang XF, 2006, J INFECT DIS, V194, P545, DOI 10.1086/506359; Lowther SA, 2013, MMWR-MORBID MORTAL W, V62, P335; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mundel T, 2013, NEW ENGL J MED, V369, P2045, DOI 10.1056/NEJMe1311591; *NAT COMM CERT POL, 2000, DOC CERT POL ER; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Tao WJ, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20343; Wassilak Steve, 2012, Morbidity and Mortality Weekly Report, V61, P353; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Organization Advisory Committee on Poliomyelitis Eradication, 2005, Wkly Epidemiol Rec, V80, P410; Yoshida H, 2002, J GEN VIROL, V83, P1107, DOI 10.1099/0022-1317-83-5-1107	26	93	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e113880	10.1371/journal.pone.0113880	http://dx.doi.org/10.1371/journal.pone.0113880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	24586557	gold, Green Submitted, Green Published			2022-12-27	WOS:000347146700011
J	Chen, XX; Shi, Y; Chai, WM; Feng, HL; Zhuang, JX; Chen, QX				Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Zhuang, Jiang-Xing; Chen, Qing-Xi			Condensed Tannins from Ficus virens as Tyrosinase Inhibitors: Structure, Inhibitory Activity and Molecular Mechanism	PLOS ONE			English	Article							TOF MS ANALYSIS; MUSHROOM TYROSINASE; SKIN; PIGMENTATION; DOPAMINE; KINETICS; LEAVES; IONS; HPLC; NMR	Condensed tannins from Ficus virens leaves, fruit, and stem bark were isolated and their structures characterized by C-13 nuclear magnetic resonance spectrometry, high performance liquid chromatography electrospray ionization mass spectrometry, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The results showed that the leaves, fruit, and stem bark condensed tannins were complex mixtures of homo-and heteropolymers of B-type procyanidins and prodelphinidins with degrees of polymerization up to hexamer, dodecamer, and pentadecamer, respectively. Antityrosinase activities of the condensed tannins were studied. The results indicated that the condensed tannins were potent tyrosinase inhibitors. The concentrations for the leaves, fruit, and stem bark condensed tannins leading to 50% enzyme activity were determined to be 131.67, 99.89, and 106.22 mu g/ml on monophenolase activity, and 128.42, 43.07, and 74.27 mu g/ml on diphenolase activity. The inhibition mechanism, type, and constants of the condensed tannins on the diphenolase activity were further investigated. The results indicated that the condensed tannins were reversible and mixed type inhibitors. Fluorescence quenching, copper interacting, and molecular docking techniques were utilized to unravel the molecular mechanisms of the inhibition. The results showed that the hydroxyl group on the B ring of the condensed tannins could chelate the dicopper irons of the enzyme. Moreover, the condensed tannins could reduce the enzyme product o-quinones into colourless compounds. These results would contribute to the development and design of antityrosinase agents.	[Chen, Xiao-Xin; Shi, Yan; Chai, Wei-Ming; Feng, Hui-Ling; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Zhuang, Jiang-Xing] Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Xiamen University; Xiamen University	Zhuang, JX (corresponding author), Xiamen Univ, Coll Med, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China.	jiangxingzhuang@xmu.edu.cn; chenqx@xmu.edu.cn	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Natural Science Foundation of China [31071611, 31070522]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027/J0106]; Science and Technology Foundation of Fujian Province [2010N5013]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China; Science and Technology Foundation of Fujian Province(Natural Science Foundation of Fujian Province); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The present investigation was supported by the Natural Science Foundation of China (No. 31071611; No. 31070522), the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China (Grant No. J1310027/J0106) and by the Science and Technology Foundation of Fujian Province (No. 2010N5013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hameed ESS, 2009, FOOD CHEM, V114, P1271, DOI 10.1016/j.foodchem.2008.11.005; Anandjiwala S, 2008, INDIAN J PHARM SCI, V70, P31, DOI 10.4103/0250-474X.40328; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; Baby Joseph, 2010, International Journal of Pharma and Bio Sciences, V1, pP; Bawadi HA, 2005, CANCER LETT, V218, P153, DOI 10.1016/j.canlet.2004.06.021; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chauhan S, 2013, J MED PLANTS STUD, V1, P3846; Chen QX, 2005, FOOD CHEM, V91, P269, DOI 10.1016/j.foodchem.2004.01.078; Chen XX, 2014, FOOD CHEM, V155, P1, DOI 10.1016/j.foodchem.2014.01.011; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XX, 2013, J ZHEJIANG UNIV-SC B, V14, P903, DOI 10.1631/jzus.B1200365; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Espin JC, 2001, BBA-PROTEIN STRUCT M, V1544, P289, DOI 10.1016/S0167-4838(00)00230-2; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; Haslam E., 1989, Plant polyphenols: vegetable tannins revisited.; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Khatib S, 2007, J MED CHEM, V50, P2676, DOI 10.1021/jm061361d; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kubo I, 1999, J AGR FOOD CHEM, V47, P4121, DOI 10.1021/jf990201q; Lee N, 2012, ACS CHEM BIOL, V7, P1687, DOI 10.1021/cb300222b; Lim YY, 2007, LWT-FOOD SCI TECHNOL, V40, P1664, DOI 10.1016/j.lwt.2006.12.013; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; McDonald M, 1996, J AGR FOOD CHEM, V44, P599, DOI 10.1021/jf950459q; Niranjan S, 2012, GLOBAL J PHARM RES, V1, P318; Sanjust E, 2003, ARCH BIOCHEM BIOPHYS, V412, P272, DOI 10.1016/S0003-9861(03)00053-5; Santos-Buelga C, 2000, J SCI FOOD AGR, V80, P1094, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1094::AID-JSFA569&gt;3.0.CO;2-1, 10.1002/(SICI)1097-0010(20000515)80:7<1094::AID-JSFA569>3.3.CO;2-T]; Sisti M, 2008, LWT-FOOD SCI TECHNOL, V41, P946, DOI 10.1016/j.lwt.2007.05.012; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Takahashi S, 2010, BIOORGAN MED CHEM, V18, P8112, DOI 10.1016/j.bmc.2010.08.056; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Xiang P, 2006, CHINESE J ANAL CHEM, V34, P1019, DOI 10.1016/S1872-2040(06)60047-9; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Zhang LL, 2008, MOLECULES, V13, P2986, DOI 10.3390/molecules13122986; Zhuang JX, 2010, J AGR FOOD CHEM, V58, P12993, DOI 10.1021/jf103723k	38	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 17	2014	9	3							e91809	10.1371/journal.pone.0091809	http://dx.doi.org/10.1371/journal.pone.0091809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD4XD	24622390	Green Published, gold, Green Submitted			2022-12-27	WOS:000333254100063
J	Chen, XH; Scholl, TO				Chen, Xinhua; Scholl, Theresa O.			Maternal Biomarkers of Endothelial Dysfunction and Preterm Delivery	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ADHESION MOLECULE-1; RETROSPECTIVE COHORT; HEART-DISEASE; UNITED-STATES; SE-SELECTIN; PREECLAMPSIA; RISK; WOMEN; INFLAMMATION	Background: Endothelial dysfunction is key to the development of atherosclerosis. Preterm delivery foreshadows later maternal cardiovascular disease (CVD), but it is not known if endothelial dysfunction also occurs. We prospectively measured circulating biomarkers of endothelial dysfunction in pregnant women with preterm or term delivery. Methods: We conducted a case-control study nested within a large prospective epidemiological study of young, generally healthy pregnant women. Women who delivered preterm (, 37 completed weeks gestation, n = 240) and controls who delivered at term (n = 439) were included. Pregnancies complicated by preeclampsia were analyzed separately. Circulating endothelial dysfunction biomarkers included soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1) and soluble E-selectin (sE-selectin). Results: Elevated levels of sICAM-1 and sVCAM-1 were positively associated with preterm delivery independent of usual risk factors. At entry (similar to 16 wks), the adjusted odds ratio (AOR) was 1.73 (95% confidence interval (CI) 1.09-2.74) for the highest quartile of sICAM-1 versus the lowest quartile and for sVCAM-1 the AOR was 2.17 (95% CI 1.36-3.46). When analysis was limited to cases with a spontaneous preterm delivery, the results were unchanged. Similar results were obtained for the 3rd trimester (similar to 30 wks). Elevated sE-selectin was increased only in preterm delivery complicated by preeclampsia; risk was increased at entry (AOR 2.32, 95% CI 1.22-4.40) and in the 3rd trimester (AOR 3.37, 95% CI 1.78-6.39). Conclusions: Impaired endothelial function as indicated by increased levels of soluble molecules commonly secreted by endothelial cells is a pathogenic precursor to CVD that is also present in women with preterm delivery. Our findings underscore the need for follow-up studies to determine if improving endothelial function prevents later CVD risk in women.	[Chen, Xinhua; Scholl, Theresa O.] Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine	Chen, XH (corresponding author), Rowan Univ, Sch Osteopath Med, Dept Obstet & Gynecol, Stratford, NJ 08084 USA.	chenx1@rowan.edu	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	National Institute of Child Health and Human Development [HD061763, HD18269, HD38329]; National Institute on Minority Health and Health Disparities [1R01MD007828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by research grants from the National Institute of Child Health and Human Development (HD061763 to Chen; HD18269 and HD38329 to Scholl) and the National Institute on Minority Health and Health Disparities (1R01MD007828 to Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatisa PK, 2004, AM J PHYSIOL-HEART C, V286, pH1389, DOI 10.1152/ajpheart.00298.2003; [Anonymous], 2006, INCOME EARNINGS POVE; Bartha JL, 2012, J WOMENS HEALTH, V21, P643, DOI 10.1089/jwh.2011.3013; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bonamy AKE, 2011, CIRCULATION, V124, P2839, DOI 10.1161/CIRCULATIONAHA.111.034884; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2002, J Matern Fetal Neonatal Med, V12, P19; Chambers JC, 2001, JAMA-J AM MED ASSOC, V285, P1607, DOI 10.1001/jama.285.12.1607; Clapp BR, 2004, CARDIOVASC RES, V64, P172, DOI 10.1016/j.cardiores.2004.06.020; Frieden Thomas R, 2011, MMWR Suppl, V60, P1; Glowinska B, 2005, METABOLISM, V54, P1020, DOI 10.1016/j.metabol.2005.03.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gong J, 2012, PAEDIATR PERINAT EP, V26, P45, DOI 10.1111/j.1365-3016.2011.01222.x; Hamilton SJ, 2009, DIABETES CARE, V32, P810, DOI 10.2337/dc08-1736; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Hediger ML, 1997, ANN EPIDEMIOL, V7, P400, DOI 10.1016/S1047-2797(97)00046-X; Jenny NS, 2006, J THROMB HAEMOST, V4, P107, DOI 10.1111/j.1538-7836.2005.01678.x; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SY, 2004, J KOREAN MED SCI, V19, P688, DOI 10.3346/jkms.2004.19.5.688; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin Joyce A., 2011, Morbidity and Mortality Weekly Report, V60, P78; Marvin KW, 2000, AM J REPROD IMMUNOL, V43, P264, DOI 10.1111/j.8755-8920.2000.430504.x; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Pell JP, 2004, AM J EPIDEMIOL, V159, P336, DOI 10.1093/aje/kwh064; Pina IL, 2011, CARDIOL REV, V19, P71, DOI 10.1097/CRD.0b013e318209c233; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Steinborn A, 2000, OBSTET GYNECOL, V95, P671, DOI 10.1016/S0029-7844(99)00604-3; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Velez DR, 2009, AJOG, V200; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	33	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e85716	10.1371/journal.pone.0085716	http://dx.doi.org/10.1371/journal.pone.0085716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24622390	Green Submitted, Green Published, gold			2022-12-27	WOS:000330283100065
J	Chen, XK; May, B; Di, YM; Zhang, AL; Lu, CJ; Xue, CC; Lin, L				Chen, Xiankun; May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Lu, Chuanjian; Xue, Charlie Changli; Lin, Lin			Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test	PLOS ONE			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; CORDYCEPS-SINENSIS; ASTRAGALUS-MEMBRANACEUS; DISTANCE; COMPLEMENTARY; MANAGEMENT; PREDICTOR; CAPACITY; OUTCOMES	This systematic review evaluated the effects of Chinese herbal medicine (CHM) plus routine pharmacotherapy (RP) on the objective outcome measures BODE index, 6-minute walk test (6MWT), and 6-minute walk distance (6MWD) in individuals with stable chronic obstructive pulmonary disease (COPD). Searches were conducted of six English and Chinese databases (PubMed, EMBASE, CENTRAL, CINAHL, CNKI and CQVIP) from their inceptions until 18th November 2013 for randomized controlled trials involving oral administration of CHM plus RP compared to the same RP, with BODE Index and/or 6MWT/D as outcomes. Twenty-five studies were identified. BODE Index was used in nine studies and 6MWT/D was used in 22 studies. Methodological quality was assessed using the Cochrane Risk of Bias tool. Weaknesses were identified in most studies. Six studies were judged as 'low' risk of bias for randomisation sequence generation. Twenty-two studies involving 1,834 participants were included in the meta-analyses. The main meta-analysis results showed relative benefits for BODE Index in nine studies (mean difference [MD] -0.71, 95% confidence interval [CI] -0.94, -0.47) and 6MWT/D in 17 studies (MD 54.61 meters, 95% CI 33.30, 75.92) in favour of the CHM plus RP groups. The principal plants used were Astragalus membranaceus, Panax ginseng and Cordyceps sinensis. A. membranaceus was used in combination with other herbs in 18 formulae in 16 studies. Detailed sub-group and sensitivity analyses were conducted. Clinically meaningful benefits for BODE Index and 6MWT were found in multiple studies. These therapeutic effects were promising but need to be interpreted with caution due to variations in the CHMs and RPs used and methodological weakness in the studies. These issues should be addressed in future trials.	[Chen, Xiankun] Guangdong Prov Acad Chinese Med Sci, Evidence Based Med & Clin Res Serv Grp, Guangzhou, Guangdong, Peoples R China; [Chen, Xiankun; Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Hosp Chinese Med, Guangzhou, Guangdong, Peoples R China; [May, Brian; Di, Yuan Ming; Zhang, Anthony Lin; Xue, Charlie Changli] RMIT Univ, Sch Hlth Sci, Hlth Innovat Res Inst, Tradit & Complementary Med Res Program, Melbourne, Vic, Australia; [Lu, Chuanjian; Xue, Charlie Changli] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Lin, Lin] Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Royal Melbourne Institute of Technology (RMIT); Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lin, L (corresponding author), Guangdong Prov Hosp Chinese Med, Dept Resp Med, Guangzhou, Guangdong, Peoples R China.	drlinlin620@163.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China [2012DFA31760]; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	International Science & Technology Cooperation Project of the Ministry of Science and Technology of China; China-Australia International Research Centre for Chinese Medicine; Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS GPHCM); Guangdong China; RMIT University, Australia; GPHCM; School of Health Sciences, RMIT University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is funded by a project grant from the International Science & Technology Cooperation Project of the Ministry of Science and Technology of China (Project Grant Number: 2012DFA31760, Project Title: Evaluation of Traditional and Scientific Evidence of Chinese Medicine). The project is partially supported by the China-Australia International Research Centre for Chinese Medicine, funded by Guangdong Provincial Academy of Chinese Medical Sciences & Guangdong Provincial Hospital of Chinese Medicine (GPACMS & GPHCM), Guangdong China, and RMIT University, Australia. The authors also acknowledge the support provided by the GPHCM and the School of Health Sciences, RMIT University to the first author (XKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; An XD, 2011, RESP MED, V105, P165, DOI 10.1016/j.rmed.2010.11.007; Brown Cynthia D, 2007, COPD, V4, P217; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chen GC, 2012, SHANGHAI J TRADITION, V46, P42; Chen Ning, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P105, DOI 10.3736/jcim20090202; Chen Q, 2009, J FUJIAN U TRAD CHIN, V19, P12; Cote CG, 2008, EUR RESPIR J, V31, P571, DOI 10.1183/09031936.00104507; Cote CG, 2005, EUR RESPIR J, V26, P630, DOI 10.1183/09031936.05.00045505; CSRD, 2007, CHIN J INRERN MED, V46, P254; Cui Peng, 2012, Zhongguo Zhong Yao Za Zhi, V37, P3451; Cui Zhao-bo, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P885; Denzler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012561; Faganello MM, 2010, AM J MED SCI, V339, P10, DOI 10.1097/MAJ.0b013e3181bb8111; Fan BD, 2012, J SICHUAN TRADITIONA, P83; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Glaab T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-79; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Guo WX, 2008, HEBEI J TRADITIONAL, V30, P121; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028696; Hu QG, 2012, J GUIYANG COLLAGE TR, V34, P135; [黄东晖 Huang Donghui], 2005, [第四军医大学学报, Journal of the Fourth Military Medical University], V26, P1611; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Jian XY, 2012, J BEIJING U TRADITIO, V19, P32; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kim HG, 2006, EUR J PHARMACOL, V545, P192, DOI 10.1016/j.ejphar.2006.06.047; Koh JH, 2002, BIOSCI BIOTECH BIOCH, V66, P407, DOI 10.1271/bbb.66.407; Kumar R, 2011, J ETHNOPHARMACOL, V136, P260, DOI 10.1016/j.jep.2011.04.040; Kuo YH, 2009, J ETHNOPHARMACOL, V122, P28, DOI 10.1016/j.jep.2008.11.025; Kuo YC, 1996, AM J CHINESE MED, V24, P111, DOI 10.1142/S0192415X96000165; Kuo YC, 2001, LIFE SCI, V68, P1067, DOI 10.1016/S0024-3205(00)01011-0; Li CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040824; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Liang AW, 2013, J EMERGENCY TRADITIO, P1125; Liao Y.L., 2011, HERALD MED, V30, P63; Lin YZ, 2013, CHINESE MANIPULATION, P103; Liu CS, 2009, GUIDING J TRADITIONA, V11, P10; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mansori F, 2010, CLIN RESPIR J, V4, P241, DOI 10.1111/j.1752-699X.2010.00185.x; Marin JM, 2011, RESP MED, V105, P916, DOI 10.1016/j.rmed.2011.01.007; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ong KC, 2005, CHEST, V128, P3810, DOI 10.1378/chest.128.6.3810; Peng ZQ, 2013, THESIS FUJIAN U TRAD; Pinto-Plata V, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-71; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI 10.1016/j.jep.2007.07.028; Shahed AR, 2001, TRANSPL P, V33, P2986, DOI 10.1016/S0041-1345(01)02282-5; Shan LN, 2011, J GUANGZHOU U TRADIT, V28, P590; Shang QH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/716459; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Shin IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045734; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; Wise Robert A, 2005, COPD, V2, P125; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705315; Xu JZ, 2012, YUNNAN J TRADITIONAL, V33, P31; Xu TingZhen, 2012, Chinese Archives of Traditional Chinese Medicine, V30, P570; Yang CM, 2013, MODERN J INTEGRATED, P729; Yu JY, 2011, J MED INFORM, P4019; Zeng JQ, 2013, J NEW CHINESE MED, P32; Zhang FY, 2007, SHANXI ZHONGYI J, V28, P1594; Zhang FY, 2007, J EMERGENCY TRADITIO, V19, P198; Zhang R.Z., 2011, CHINA PRACTICAL MED, V6, P118; Zhao YL, 2012, J TRADIT CHIN MED, V32, P203, DOI 10.1016/S0254-6272(13)60012-6; 茅蓉, 2009, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V29, P362	70	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2014	9	3							e91830	10.1371/journal.pone.0091830	http://dx.doi.org/10.1371/journal.pone.0091830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9HN	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000332845300132
J	Chen, XF; Li, LZ; Zhou, T; Li, ZZ				Chen, Xiaofang; Li, Lezhi; Zhou, Tao; Li, Zhanzhan			Prevalence of Hypertension in Rural Areas of China: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; RISK-FACTORS; MEN; AWARENESS; MORTALITY	Background: Hypertension is one of the leading causes of disease burden across the world. In China, the latest nationwide survey of prevalence of hypertension was ten year ago, and data in rural areas is little known. More information about hypertension prevalence could help to improve overall antihypertensive health care. We aimed to estimate the pooled prevalence of hypertension in rural areas of China. Methods: Comprehensive electronic searches of PubMed, Web of Knowledge, Chinese Web of Knowledge, Wangfang, Weipu and SinoMed databases were conducted to identify any study in each database published from January 1, 2004 to December 31, 2013, reporting the prevalence of hypertension in Chinese rural areas. Prevalence estimates were stratified by age, area, sex, publication year, and sample size. All statistical calculations were made using the Stata Version 11.0 (College Station, Texas) and Statsdirect Version 2.7.9. Results: We identified 124 studies with a total population of 3,735,534 in the present meta-analysis. Among people aged 18 years old in Chinese rural areas, the summarized prevalence is 22.81% (19.41%-26.41%). Subgroup analysis shows the following results: for male 24.46% (21.19%-27.89%, for female 22.17% (18.25%-26.35%). For 2004-2006: 18.94% (14.41%-23.94%), for 2007-2009, 21.24% (15.98%-27.01%) for 2010-2013: 26.68%, (20.79%-33.02%). For Northern region 25.76% (22.36%-29.32%), for Southern region 19.30%, (15.48%-24.08%). Conclusions: The last decade witnessed the growth in prevalence of hypertension in rural areas of China compared with the fourth national investigation, which has climbed the same level as the urban area. Guidelines for screening and treatment of hypertension in rural areas need to be given enough attention.	[Chen, Xiaofang] Cent South Univ, Xiangya Nursing Sch, Changsha, Hunan, Peoples R China; [Chen, Xiaofang] Southern Med Univ, Affiliated Hostipal 3, Dept Nursing, Guangzhou, Guangdong, Peoples R China; [Li, Lezhi] Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Zhou, Tao] Southern Med Univ, Dept Cardiol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Li, Zhanzhan] Cent South Univ, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Changsha, Hunan, Peoples R China	Central South University; Southern Medical University - China; Central South University; Southern Medical University - China; Central South University	Li, LZ (corresponding author), Cent South Univ, Dept Nursing, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	lilz1988@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Chen B, 2008, MOEDERN PREV MED, V35, P2823; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz AA, 2014, RURAL REMOTE HEALTH, V14; Dong CX, 2013, J INT MED RES, V41, P1291, DOI 10.1177/0300060513488498; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Gong Jie, 2011, Chinese Preventive Medicine, V12, P227; Han B, 2009, J ZHENGZHOU U MED SC, V44, P337; He F, 2012, CHIN J DIS CONTROL P, V16, P560; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu HH, 2008, PREV TREATMENT CARDI, V8, P195; Hu XJ, 2013, CHIN HLTH SERVICE MA, V5, P391; Hu Y, 2000, Zhonghua Liu Xing Bing Xue Za Zhi, V21, P177; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Kannel WB, 1996, JAMA-J AM MED ASSOC, V276, P1269, DOI 10.1001/jama.276.15.1269; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Kokiwar Prashant R, 2012, J Assoc Physicians India, V60, P26; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li LM, 2008, CHINESE REDIDENTS NU; Li Y, 2011, J SHENYANG MED COLL, V13, P228; Lin Kang, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P114; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ma YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058302; Ministry of Health of the People's Republic of China, 2005, CHIN PREV CONTR HYP; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Ni GH, 2013, FOOD NUTR CHIN, V19, P70; O'Brien E, 2000, BMJ-BRIT MED J, V320, P1128, DOI 10.1136/bmj.320.7242.1128; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; PRC National Blood Pressure Survey Cooperative Group, 1995, CHIN J HYPERTENS, V3, P1; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Rostom A, 2004, Evid Rep Technol Assess (Summ), P1; Stuart A, 1996, KENDALLS ADV THEORY; Tozawa M, 2003, HYPERTENSION, V41, P1341, DOI 10.1161/01.HYP.0000069699.92349.8C; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; [王克伟 Wang Kewei], 2011, [中国公共卫生, China Public Health], V27, P1291; Wang YM., 2013, J BENBU MED COLL, V38, P321; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xia YiYin, 2013, Journal of Tropical Medicine (Guangzhou), V13, P350; Xin RB, 2011, GUANGXI MED, V33, P963; Yang HJ, 2010, CHIN J GEN PRAC, V8, P896; Ye HaoFeng, 2005, China Tropical Medicine, V5, P1114; Ye ZW, 2011, ANHUI J PREV MED, V17, P190; Yin CG, 2009, PREV TREATMENT CARDI, V9, P137; Yu QH, 2011, WORLD HLTH DIG MED P, V8, P13; Yu YX, 2009, MED J CHIN PEOPLE HL, V21, P2364; Zhang AH, 2009, PREV MED TRIB, V15, P720; Zhang G, 2009, GONG GONG WEI SHENG, V20, P24; Zhang LJ, 2010, OCCUP HLTH, V26, P1872; Zhang Y., 2011, NINGXIA MED J, V33, P1222; Zhao JiQing, 2013, Bulletin of Disease Control and Prevention, V28, P27; Zheng YT, 2011, CHIN MED J METALL IN, V28, P573; Zheng ZH, 2010, CHINA CHLIN PRAC MED, V4, P219; Zhong DC, 2009, SICHUAN MED J, V30, P1056; Zhou YX, 2011, PRE MED TRIB, V17, P909	59	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2014	9	12							e115462	10.1371/journal.pone.0115462	http://dx.doi.org/10.1371/journal.pone.0115462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA4AC	24622390	Green Submitted, gold, Green Published			2022-12-27	WOS:000348845600050
J	Chen, XL; Chen, XZ; Lu, ZH; Wang, L; Yang, K; Hu, JK; Zhang, B; Chen, ZX; Chen, JP; Zhou, ZG				Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Wang, Li; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang			Comparison of Ultrasonic Scalpel versus Conventional Techniques in Open Gastrectomy for Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACTIVATED SHEARS; CANCER; LYMPHADENECTOMY	Objectives: To compare surgical efficacy and postoperative recovery of ultrasonic scalpel (USS) with conventional techniques for the resection of gastric carcinoma. Methods: A systematic search of major medical databases (PubMed, Embase, CCRT and CNKI) was conducted. Both randomized and non-randomized controlled trials (RCTs and nRCTs) were considered eligible. Operation time (OT), intraoperative blood loss (BL) and postoperative complications (POC) rates as well as postoperative hospitalization days, number of dissected lymph nodes, abdominal drainage volume and time for recovery of gastrointestinal functions were synthesized and compared. Results: Nineteen studies were included (7 RCTs and 12 nRCTs), in which 1930 patients were enrolled totally (946 in the USS group and 984 in the conventional group). Monopolar electrocautery and ligation were used as the conventional methods. Comparative meta-analysis showed perioperative outcomes were significantly improved using USS compared with conventional surgical instrumentation. OT was reduced from a weighted mean of 185.3 min in the conventional group to 151.0 min in the USS group (MD = -33.30, 95% CI [-41.75, -24.86], p<0.001) and intraoperative BL was decreased from a weighted mean of 217.9 ml in the conventional group to 111.6 ml in the USS group (MD = -113.42, 95% CI [-142.05, -84.79], p<0.001). Results from RCTs subgroup were consistent with those from nRCTs subgroup. The weighted cumulative risk of POC accounted for 8.9% (0%-25%) and 12.9% (5.5%-45%) in the USS and conventional groups, respectively. Pooled estimated results from nRCTs (OR = 0.54, 95% CI [0.27, 1.06], p = 0.07) and RCTs (RR = 0.75, 95% CI [0.44, 1.26], p = 0.27) showed no significant difference between the USS and control groups. Analysis of secondary outcomes showed the improvements of the USS group over control group regarding the number of dissected lymph nodes, postoperative hospitalization days, abdominal drainage volume and time for recovery of gastrointestinal functions. Conclusion: Compared with conventional electrosurgery, the USS is a safe and effective technique with more short-term advantages in open surgery for gastric cancer.	[Chen, Xiao-Long; Chen, Xin-Zu; Lu, Zheng-Hao; Yang, Kun; Hu, Jian-Kun; Zhang, Bo; Chen, Zhi-Xin; Chen, Jia-Ping; Zhou, Zong-Guang] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China; [Wang, Li] Sichuan Univ, West China Hosp, Chinese Cochrane Ctr, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Sichuan University	Hu, JK (corresponding author), Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu 610064, Sichuan Provinc, Peoples R China.	hujkwch@126.com	Xue, Charlie C/F-1244-2014; Chen, Xin-Zu/G-6579-2014; Chen, Xin-Zu/K-2988-2019; Yang, Kun/A-4293-2010; Zhang, Anthony Lin/AAR-6673-2021	Zhang, Anthony Lin/0000-0002-0968-9380; Chen, Xiankun/0000-0002-0353-4185; May, Brian/0000-0002-5864-3020; , Zongguang/0000-0002-7616-1199; Xue, Charlie/0000-0001-6937-9088; Chen, Xin-lin/0000-0002-2650-8051	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China [2011SCU04B19]; Ministry of Education of China [2012SCU-NCET-11-0343]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038329, R01HD018269, R21HD061763] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007828] Funding Source: NIH RePORTER	Outstanding Young Scientific Scholarship Foundation of Sichuan University; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Domestic support from (1) Outstanding Young Scientific Scholarship Foundation of Sichuan University, from the Fundamental Research Funds for the Central Universities of China (No. 2011SCU04B19); and (2) New Century Excellent Talents in University support program, Ministry of Education of China (2012SCU-NCET-11-0343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 1998, ONCOLOGY-NY, V12, P44; Ajani JA, 2010, J NATL COMPR CANC NE, V8, P378, DOI 10.6004/jnccn.2010.0030; Chen CP, 2012, GUID CHIN MED, V10, P345; Chen XZ, 2010, J AM COLL SURGEONS, V210, P100, DOI 10.1016/j.jamcollsurg.2009.09.033; Chen Z, 2009, CHIN J MOD OPER SURG, V13, P257; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fu YM, 2011, CONT MED, V17, P104; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hu JK, 2009, SURG TODAY, V39, P207, DOI 10.1007/s00595-008-3856-x; Hu JK, 2008, CHIN J BASES CLIN GE, V15, P718; Inoue K, 2012, J GASTROINTEST SURG, V16, P1840, DOI 10.1007/s11605-012-1970-y; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Li G, 2010, J MED POSTGRA, V23, P1050; Li P, 2011, CHIN MED HERALD, V8, P177; Li ZR, 2009, CHIN ARCH GEN SURG E, V3, P510; Lin YH, 2011, CHIN J CLIN ELECT ED, V5, P975; [陆维祺 LU Weiqi], 2008, [中国实用外科杂志, Chinese Journal of Practical Surgery], V28, P203; Mahabaleshwar V, 2012, CAN J SURG, V55, P307, DOI 10.1503/cjs.000411; McCarus SD, 1996, J AM ASSOC GYN LAP, V3, P601, DOI 10.1016/S1074-3804(05)80174-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mohri Y, 2007, SURG TODAY, V37, P1060, DOI 10.1007/s00595-007-3551-3; Pons Y, 2009, HEAD NECK ONCOL, V24, P1; Shi YF, 2012, GUID CHIN MED, V10, P154; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Tou S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007886.pub2; Tsimoyiannis EC, 2002, WORLD J SURG, V26, P158; Tu JC, 2010, MED J COMMUN, V24, P60; Tu XH, 2009, CHIN J MOD OPER SURG, V13, P407; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Wei ZM, 2010, J MINI INVA MED, V5, P445; Wells G, 2009, OTTAWA HOSP RES I NE; Xu L, 2010, PEOPLES MIL SURG, V53, P490; Yang K, 2009, WORLD J GASTROENTERO, V15, P5352, DOI 10.3748/wjg.15.5352; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Zhang ZY, 2012, CHIN J MOD DRUG APPL, V6, P3; Zhong L, 2012, ANN ACAD MED SINGAP, V41, P161; 尹蓓, 2011, [江苏医药, Jiangsu Medical Journal], V37, P2877; 宋小平, 2011, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V31, P590; 刘磊, 2010, [中国癌症杂志, China Oncology], V20, P799	41	337	358	34	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2014	9	7							e103330	10.1371/journal.pone.0103330	http://dx.doi.org/10.1371/journal.pone.0103330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6EF	24622390	Green Published, Green Submitted, gold			2022-12-27	WOS:000339954800038
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
